Citrus Sinensis ID: 002376
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 929 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.948 | 0.872 | 0.385 | 1e-166 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.954 | 0.860 | 0.376 | 1e-160 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.951 | 0.862 | 0.379 | 1e-151 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.871 | 0.648 | 0.318 | 1e-104 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.871 | 0.690 | 0.336 | 1e-104 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.867 | 0.643 | 0.316 | 1e-103 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.892 | 0.845 | 0.326 | 1e-103 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.908 | 0.841 | 0.306 | 1e-101 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.898 | 0.864 | 0.315 | 1e-101 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.890 | 0.830 | 0.318 | 1e-100 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 585 bits (1509), Expect = e-166, Method: Compositional matrix adjust.
Identities = 382/991 (38%), Positives = 533/991 (53%), Gaps = 110/991 (11%)
Query: 28 TDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
TD++AL+ FKSQ+S E LS WN S C W GV C RV L L L G I
Sbjct: 24 TDRQALLQFKSQVS-EDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP IGNLSFL S+ L N G +P+E+G L RL L++ N L+G +P+ + + L
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
L L +N++ G V +L +L +L LN N + G +P S+ NL
Sbjct: 143 LRLDSNRLGGSVPS-ELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IPSD+++L + L L N +G P +YN++SL L + N G + D+ LPNL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
L F N FTG IP +L N++ ++ + M N L G++P GN+P L+ + N +
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSL-G 319
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
S L F+TSLTN T L L + N+ G +P SI N S +L L LGG I G IP
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY 379
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431
IG L +L L L N +SG +P +G+L L+ L L N + GGIP + N+ L +D
Sbjct: 380 DIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLD 439
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR----------------PLPE 475
LS N G +P S GN LL + + +N++NG IP I++ LP+
Sbjct: 440 LSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ 499
Query: 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535
+I L+N+ T+ L DN LSG LP +L NC ++E L + N F G IP++ L G++ +D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVD 558
Query: 536 LSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC----- 590
LS+N LSGSIP + L LNL+FNNLEG VP +GIF N + V + GN LC
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618
Query: 591 LQLG---CENP---RSHGSRL--IILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVG--- 639
QL + P + H SRL +++ + V I ++ V I +RKRK +
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678
Query: 640 VSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGS----------------VLHNERT 683
+ +V H KISY +LR AT FS N++GSGSFG+ VL+ +R
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 684 GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK 743
G+ KSF+AECE+L+++RHRNLVKL+T+CSS+D + EF AL+YEF+ NGSL W+H E
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 744 NE-----------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
E +D+ S LDYLH C P+ H DLKP N+LLD+++TA V DF
Sbjct: 799 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858
Query: 787 GLARFLLERVDNQS---SISSTHVFMGSIGYVPPEYGLGERPSTAGDV------------ 831
GLAR LL + D +S +SS V G+IGY PEYG+G +PS GDV
Sbjct: 859 GLARLLL-KFDEESFFNQLSSAGV-RGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFT 916
Query: 832 ---PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSV 888
PT+E F G F + + +S LPE +L ++D + + ++ CL T++ V
Sbjct: 917 GKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE---CL-TMVFEV 972
Query: 889 GLSCTTESPGGRIGIREALRRLKSSQEILLK 919
GL C ESP R+ ++ L S +E K
Sbjct: 973 GLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 380/1010 (37%), Positives = 536/1010 (53%), Gaps = 123/1010 (12%)
Query: 3 FATLAVLLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWP 62
F L +LL V A TD +AL+ FKSQ+S+ + L+ WN SS C W
Sbjct: 9 FNALTLLLQVCIFA----QARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWI 64
Query: 63 GVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLR 122
GV C RVI LNL F L G ISP IGNLSFLR + L +N +P+++G LFRL+
Sbjct: 65 GVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQ 124
Query: 123 VLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWG 182
LN+S+N L+G +P ++S + L +DL +N + G +L +L L +L+ KN L G
Sbjct: 125 YLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHL-GHGVPSELGSLSKLAILDLSKNNLTG 183
Query: 183 SIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSL 226
+ P S+ NL IP +++RL + + +N +G P +YN++SL
Sbjct: 184 NFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSL 243
Query: 227 VHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE 286
L LA N G + D LPNL + N+FTG IP +L N+++++ ++ N L
Sbjct: 244 ESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLS 303
Query: 287 GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE 346
G++P G L L I N + + GL FI ++ N T L YL + N+ G++P
Sbjct: 304 GSIPLSFGKLRNLWWLGIR-NNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPA 362
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406
SI N S L+ L+LG N I G IP IG L SL L L N +SGE+P+ G+L LQV+
Sbjct: 363 SIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVV 422
Query: 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIP 466
L N I G IP+ N+ +L ++ L+ N G IP S G + LL + + NR+NG IP
Sbjct: 423 DLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIP 482
Query: 467 KGILR----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEEL 510
+ IL+ PEE+ +LE +V + S N LSG +P ++ C S+E L
Sbjct: 483 QEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFL 542
Query: 511 LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570
M N F G IP+I + L L+ +D S+N LSG IP L +L +LR+LNL+ N EG VP
Sbjct: 543 FMQGNSFDGAIPDI-SRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVP 601
Query: 571 SEGIFRNMSNVHLKGNPKLC-----LQLG-C---ENPRSHGSRLIILSIIVTIMAVIAGC 621
+ G+FRN + V + GN +C +QL C +PR + ++ I IA
Sbjct: 602 TTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASL 661
Query: 622 FLIV------WPIIVRKRKAKRVG---VSALFKVCHPKISYDELRRATGNFSHENLIGSG 672
LI+ W + +K+ G S + H K+SY+EL AT FS NLIGSG
Sbjct: 662 LLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSG 721
Query: 673 SFGS----------------VLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716
+FG+ VL+ + G+ KSF+AECET + +RHRNLVKLIT CSSLDS
Sbjct: 722 NFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDS 781
Query: 717 KNMEFLALVYEFLSNGSLGDWIH---GERKNE--------------LDITSALDYLHNDC 759
+ +F ALVYEF+ GSL W+ ER N+ +D+ SAL+YLH C
Sbjct: 782 EGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHC 841
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS--STHVFMGSIGYVPP 817
PV H D+KP NILLD+++TA V DFGLA+ LL + D +S ++ S+ G+IGY P
Sbjct: 842 HDPVAHCDIKPSNILLDDDLTAHVSDFGLAQ-LLYKYDRESFLNQFSSAGVRGTIGYAAP 900
Query: 818 EYGLGERPSTAGDV---------------PTSESFAGEFNIVKWVESNLPENVLQVLDPE 862
EYG+G +PS GDV PT ESFAG++N+ + +S
Sbjct: 901 EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKS------------I 948
Query: 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
L +S S I D + ++ VG+ C+ E P R+ EA+R L S
Sbjct: 949 LSGCTSSGGSNAI---DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELIS 995
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1381), Expect = e-151, Method: Compositional matrix adjust.
Identities = 378/995 (37%), Positives = 535/995 (53%), Gaps = 111/995 (11%)
Query: 28 TDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
TDK+AL+ FKSQ+S E+ L WN S C+W GV C RV G++L L G +
Sbjct: 39 TDKQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVV 97
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP +GNLSFLRS+ L +N G +P E+GNLFRL+ LN+S N G +PV +S + L
Sbjct: 98 SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLST 157
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
LDL +N + V + +L L +L+ G+N L G P S+ NL
Sbjct: 158 LDLSSNHLEQGVPL-EFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGE 216
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IP D++RL+ + + +N+ G P IYN++SL+ L + N G + D LPNL
Sbjct: 217 IPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNL 276
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKI-- 309
N FTG IP +L N+++++ + + N L G +P G L L + N +
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI 369
SSGD L F+ +LTN + L YL + N+ G++P I N S +L++L LGGN I G I
Sbjct: 337 YSSGD---LDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSI 393
Query: 370 PASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
P IG L SL LDL N ++G++P +G+L L+ + L N + G IP+SL N+ L
Sbjct: 394 PHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTY 453
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR----------------PL 473
+ L N G IP S G+ LL ++L N++NG+IP ++ PL
Sbjct: 454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPL 513
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
++I +L+ ++ +D+S N LSG +P +L NC SLE LL+ N F GPIP+I L GL
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRF 572
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC--- 590
LDLS N LSG+IP + N L++LNL+ NN +G VP+EG+FRN S + + GN LC
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 591 --LQL---GCENPRSHGSRLIILSIIVTIMAVIAGCFLIV------WPIIVRKRKAKRVG 639
LQL E PR H S I++I V+ + + + + V+ +A
Sbjct: 633 PSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNE 692
Query: 640 VSALF---KVCHPKISYDELRRATGNFSHENLIGSGSFGS----------------VLHN 680
F K + KISYDEL + TG FS NLIGSG+FG+ VL+
Sbjct: 693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752
Query: 681 ERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740
+ G+ KSFIAECE L +RHRNLVKL+T CSS D + +F ALVYEF+ NG+L W+H
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812
Query: 741 ERKNE-----------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783
+ E +D+ SAL YLH C P+ H D+KP NILLD+++TA V
Sbjct: 813 DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872
Query: 784 GDFGLARFLL--ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------- 831
DFGLA+ LL +R SS V G+IGY PEYG+G PS GDV
Sbjct: 873 SDFGLAQLLLKFDRDTFHIQFSSAGV-RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEI 931
Query: 832 -----PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIG 886
PT++ F + + +S L + Q LD ++ +Q + +CL T++
Sbjct: 932 FTGKRPTNKLFVDGLTLHSFTKSALQKR--QALDITDETILRGAYAQHFNMVECL-TLVF 988
Query: 887 SVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921
VG+SC+ ESP RI + EA+ +L S +E + +
Sbjct: 989 RVGVSCSEESPVNRISMAEAISKLVSIRESFFRDE 1023
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (978), Expect = e-104, Method: Compositional matrix adjust.
Identities = 309/969 (31%), Positives = 462/969 (47%), Gaps = 159/969 (16%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
L+LS+ L G I N+S L + L NN LSG+LP+ I N L L +S L GE
Sbjct: 292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL--- 191
+PV +SK LK LDL N + G + + L L L L N L G++ PSI+NL
Sbjct: 352 IPVELSKCQSLKQLDLSNNSLAGSIPE-ALFELVELTDLYLHNNTLEGTLSPSISNLTNL 410
Query: 192 -------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGG 238
+P ++S L L+VL L NR +G +P I N TSL + + N G
Sbjct: 411 QWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEG 470
Query: 239 EIPYDV-RDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297
EIP + R NLL N G +P SL N + I+ + N L G++P G L
Sbjct: 471 EIPPSIGRLKELNLLHLRQ--NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLK 528
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLN------------------YLALD--G 337
L + N + + D + SL N T +N YL+ D
Sbjct: 529 GLEQLMLYNNSLQGNLPDS----LISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN 584
Query: 338 NQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI 397
N FE +IP +GN N L +L LG N + GKIP ++G++R L+LLD+S N+++G IP+++
Sbjct: 585 NGFEDEIPLELGNSQN-LDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQL 643
Query: 398 GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLS 457
+ L + L N + G IP L L +L ++ LS N+ +P N LL + L
Sbjct: 644 VLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLD 703
Query: 458 NNRINGNIPKGILR----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSL 501
N +NG+IP+ I LP+ + +L + + LS NSL+G +P +
Sbjct: 704 GNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEI 763
Query: 502 KNCKSLEELL-MAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNL 560
+ L+ L ++YN F+G IP+ + L LE LDLS N+L+G +P + ++++L LN+
Sbjct: 764 GQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNV 823
Query: 561 TFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQ--LGCENPRSHGSR-------LIILSII 611
+FNNL G + + F GN LC C RS+ + ++I+S I
Sbjct: 824 SFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAI 881
Query: 612 VTIMAVIAGCFLIVWPIIVRKRKA--KRVGVSA----------------LFK--VCHPKI 651
+ A+ G ++V + ++R K+VG + LF+ I
Sbjct: 882 SALTAI--GLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDI 939
Query: 652 SYDELRRATGNFSHENLIGSGSFGSV----LHNERTGS-----W-------KSFIAECET 695
++++ AT N S E +IGSG G V L N T + W KSF E +T
Sbjct: 940 RWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKT 999
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE------RKNELD-- 747
L +RHR+LVKL+ CS SK+ L+YE++ NGS+ DW+H + +K LD
Sbjct: 1000 LGRIRHRHLVKLMGYCS---SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWE 1056
Query: 748 --------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
+ ++YLH+DC P+VH D+K N+LLD M A +GDFGLA+ L E D
Sbjct: 1057 ARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCD-- 1114
Query: 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEFNIV 844
++ S F S GY+ PEY + + DV PT F E ++V
Sbjct: 1115 TNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMV 1174
Query: 845 KWVESNLP---ENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI 901
+WVE++L +++DP+L+ L+ E Q+ + + L CT SP R
Sbjct: 1175 RWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLE--------IALQCTKTSPQERP 1226
Query: 902 GIREALRRL 910
R+A L
Sbjct: 1227 SSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 324/962 (33%), Positives = 464/962 (48%), Gaps = 152/962 (15%)
Query: 63 GVICNNFGN--RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR 120
G I +FGN + L L+ LEG I IGN S L ++L +N+L+G +P E+GNL +
Sbjct: 230 GKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQ 289
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L+ L I N L +P ++ +LT+L L L N + G +++ ++ L SL+VL N
Sbjct: 290 LQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISE-EIGFLESLEVLTLHSNNF 348
Query: 181 WGSIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMT 224
G P SI NL +P+DL L NL+ L N L G +PS+I N T
Sbjct: 349 TGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCT 408
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
L L L+ NQ+ GEIP NL N FTG+IP + N +N++ + + N
Sbjct: 409 GLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNN 466
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344
L GTL P +G L LR + +N + E + N LN L L N F G+I
Sbjct: 467 LTGTLKPLIGKLQKLRILQVSYNSLTGPIPRE-------IGNLKDLNILYLHSNGFTGRI 519
Query: 345 PESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404
P + N + L L + N + G IP + ++ L++LDLS N SG+IP +L+ L
Sbjct: 520 PREMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLT 578
Query: 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIP----ISFGNFQSLLSIDLSNNR 460
L L GN+ G IP SL +L LN D+S N LTG IP S N Q L ++ SNN
Sbjct: 579 YLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ--LYLNFSNNL 636
Query: 461 INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL------------- 507
+ G IPK E+ +LE V IDLS+N SG++P SL+ CK++
Sbjct: 637 LTGTIPK--------ELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGH 688
Query: 508 --EELL----------MAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
+E+ ++ N FSG IP + L LDLSSN L+G IP L NL L
Sbjct: 689 IPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTL 748
Query: 556 RSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQLGCENP---------RSHGSR-- 604
+ L L NNL+G VP G+F+N++ L GN LC G + P SH S+
Sbjct: 749 KHLKLASNNLKGHVPESGVFKNINASDLMGNTDLC---GSKKPLKPCTIKQKSSHFSKRT 805
Query: 605 ---LIIL-----SIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVSALFKVCHPKISYDEL 656
LIIL ++V ++ +I C I ++ + + K+ + EL
Sbjct: 806 RVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL--KRFEPKEL 863
Query: 657 RRATGNFSHENLIGSGSFGSVLHNE-----------------RTGSWKSFIAECETLRNV 699
+AT +F+ N+IGS S +V + S K F E +TL +
Sbjct: 864 EQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923
Query: 700 RHRNLVKLIT-SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK------NELD----I 748
+HRNLVK++ + S +K ALV F+ NG+L D IHG ++D I
Sbjct: 924 KHRNLVKILGFAWESGKTK-----ALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHI 978
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVF 808
S +DYLH+ P+VH DLKP NILLD + A V DFG AR L R D S+ +ST F
Sbjct: 979 ASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDG-STTASTSAF 1037
Query: 809 MGSIGYVPPEYGLGERPSTAGDV---------------PTS--ESFAGEFNIVKWVESNL 851
G+IGY+ PE+ + +T DV PTS + + + + + VE ++
Sbjct: 1038 EGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSI 1097
Query: 852 ---PENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
+ +++VLD EL + S + Q + D L + L CT+ P R + E L
Sbjct: 1098 GNGRKGMVRVLDMELGDSIVSLK-QEEAIEDFL-----KLCLFCTSSRPEDRPDMNEILT 1151
Query: 909 RL 910
L
Sbjct: 1152 HL 1153
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 377 bits (967), Expect = e-103, Method: Compositional matrix adjust.
Identities = 304/961 (31%), Positives = 458/961 (47%), Gaps = 155/961 (16%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
L+LSS L G I ++ L + L N+LSG+LP+ I N L+ L +S L GE
Sbjct: 293 LDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGE 352
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL--- 191
+P IS LK+LDL N +TG++ D L L L L N L G++ SI+NL
Sbjct: 353 IPAEISNCQSLKLLDLSNNTLTGQIPDS-LFQLVELTNLYLNNNSLEGTLSSSISNLTNL 411
Query: 192 -------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGG 238
+P ++ L L+++ L NR +G +P I N T L + N+L G
Sbjct: 412 QEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSG 471
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
EIP + L +L N G IP SL N + +I + N L G++P G L
Sbjct: 472 EIPSSI-GRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTA 530
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLN------------------YLALD--GN 338
L + I N + + D + +L N T +N YL+ D N
Sbjct: 531 LELFMIYNNSLQGNLPDS----LINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTEN 586
Query: 339 QFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIG 398
FEG IP +G +N L +L LG N G+IP + G++ L+LLD+S NS+SG IP+E+G
Sbjct: 587 GFEGDIPLELGKSTN-LDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELG 645
Query: 399 QLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSN 458
+ L + L N + G IP L L L ++ LS N+ G +P + ++L++ L
Sbjct: 646 LCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDG 705
Query: 459 NRINGNIPKGILR----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSLK 502
N +NG+IP+ I PLP I +L + + LS N+L+G +P +
Sbjct: 706 NSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIG 765
Query: 503 NCKSLEELL-MAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561
+ L+ L ++YN F+G IP+ ++ L LE LDLS N+L G +P + ++++L LNL+
Sbjct: 766 QLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLS 825
Query: 562 FNNLEGVVPSEGIFRNMSNVHLKGNPKLCL-------QLGCENPRSHGSRLIILSIIVTI 614
+NNLEG + + F GN LC + G +N RS + +++ ++
Sbjct: 826 YNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISS 883
Query: 615 MAVIAGCFLIVWPIIVRKR-----KAKRVGV-----------SALFKVCHPK--ISYDEL 656
+A IA L++ I+ K+ K R G + LF K I +D++
Sbjct: 884 LAAIALMVLVI--ILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDI 941
Query: 657 RRATGNFSHENLIGSGSFGSVLHNE-RTGS--------W-------KSFIAECETLRNVR 700
AT + E +IGSG G V E + G W KSF E +TL +R
Sbjct: 942 MEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIR 1001
Query: 701 HRNLVKLITSCSS-LDSKNMEFLALVYEFLSNGSLGDWIHGE---RKNE----------- 745
HR+LVKL+ CSS D N+ L+YE+++NGS+ DW+H +K E
Sbjct: 1002 HRHLVKLMGYCSSKADGLNL----LIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIA 1057
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
L + ++YLH DC P+VH D+K N+LLD + A +GDFGLA+ L D ++ S
Sbjct: 1058 LGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYD--TNTESN 1115
Query: 806 HVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEFNIVKWVESN 850
+F GS GY+ PEY + + DV PT F E ++V+WVE+
Sbjct: 1116 TMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETV 1175
Query: 851 L-----PENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIRE 905
L E +++D EL+ L+ E Q+ + + L CT P R R+
Sbjct: 1176 LDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLE--------IALQCTKSYPQERPSSRQ 1227
Query: 906 A 906
A
Sbjct: 1228 A 1228
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 307/939 (32%), Positives = 474/939 (50%), Gaps = 110/939 (11%)
Query: 59 CTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNL 118
C W GV CN +VI L++S L G ISP I NL+ L + L N G +P EIG+L
Sbjct: 54 CNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSL 113
Query: 119 FR-LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRN--LRSLQVLNF 175
L+ L++S N L G +P + L L LDL +N++ G + N SLQ ++
Sbjct: 114 HETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDL 173
Query: 176 GKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235
N L G IP + L+ L+ L L N+L GTVPS++ N T+L + L SN
Sbjct: 174 SNNSLTGEIPLNYH-------CHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNM 226
Query: 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGK--------IPGSLHNLTNIQIIRMTHNLLEG 287
L GE+P V +P L +N F SL N +++Q + + N L G
Sbjct: 227 LSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGG 286
Query: 288 TLPPGLGNLPF-LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE 346
+ + +L L ++ N+I S E ++N +L L L N G IP
Sbjct: 287 EITSSVRHLSVNLVQIHLDQNRIHGSIPPE-------ISNLLNLTLLNLSSNLLSGPIPR 339
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406
+ S +L ++YL NH+ G+IP +G + L LLD+S N++SG IP G L L+ L
Sbjct: 340 ELCKLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRL 398
Query: 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS-FGNFQSL-LSIDLSNNRINGN 464
L GN + G +P SL L +DLS N LTG IP+ N ++L L ++LS+N ++G
Sbjct: 399 LLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSG- 457
Query: 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI 524
P+P E+S+++ V+++DLS N LSG +P L +C +LE L ++ N FS +P+
Sbjct: 458 -------PIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSS 510
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLK 584
+ +L L+ LD+S N+L+G+IP Q L+ LN +FN L G V +G F ++
Sbjct: 511 LGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFL 570
Query: 585 GNPKLCLQL----GCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGV 640
G+ LC + C+ + H ++L ++++++A C + +P++ R R K + V
Sbjct: 571 GDSLLCGSIKGMQACK--KKHKYPSVLLPVLLSLIATPVLC-VFGYPLVQRSRFGKNLTV 627
Query: 641 SALFKV-----------CHPKISYDELRRATGNFSHENLIGSGSFG----SVLHNERTGS 685
A +V +P+ISY +L ATG F+ +LIGSG FG VL N +
Sbjct: 628 YAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVA 687
Query: 686 WK------------SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGS 733
K SF EC+ L+ RHRNL+++IT+CS F ALV + NGS
Sbjct: 688 VKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPG-----FNALVLPLMPNGS 742
Query: 734 LGDWIH-GERKNE-----------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781
L ++ GE ++ D+ + YLH+ V VVH DLKP NILLD+EMTA
Sbjct: 743 LERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTA 802
Query: 782 KVGDFGLARFLL---ERVDNQSSI---SSTHVFMGSIGYVPPEYGLGERPSTAGDV---- 831
V DFG++R + E V S+ S+ + GS+GY+ PEYG+G+R ST GDV
Sbjct: 803 LVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFG 862
Query: 832 -----------PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ-LHD 879
PT ++ ++++S+ P+++ +++ L + + + + L
Sbjct: 863 VLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWR 922
Query: 880 CLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918
+I + +GL CT +P R + + + +E L
Sbjct: 923 EVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLF 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (948), Expect = e-101, Method: Compositional matrix adjust.
Identities = 301/981 (30%), Positives = 457/981 (46%), Gaps = 137/981 (13%)
Query: 28 TDKEALMSFKSQI--SQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEG 85
++ AL+S K+ + + + +SPLS W S+S CTW GV C+ V L+LS L G
Sbjct: 24 SEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSG 83
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISK-LTE 144
T+SP + +L L+++ L N +SG +P EI +L LR LN+S N G P IS L
Sbjct: 84 TLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVN 143
Query: 145 LKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL------------- 191
L++LD+ N +TG + + NL L+ L+ G N G IPPS +
Sbjct: 144 LRVLDVYNNNLTGDLP-VSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNEL 202
Query: 192 ---IPSDLSRLENLKVLDL-TINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRD- 246
IP ++ L L+ L + N +P I N++ LV A+ L GEIP ++
Sbjct: 203 VGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKL 262
Query: 247 ----------------------TLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
TL +L N FTG+IP S L N+ ++ + N
Sbjct: 263 QKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNK 322
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344
L G +P +G+LP L + N S L + LN + L N+ G +
Sbjct: 323 LHGEIPEFIGDLPELEVLQLWENNFTG-------SIPQKLGENGKLNLVDLSSNKLTGTL 375
Query: 345 PESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404
P ++ + N+L L GN ++G IP S+G+ SLT + + N ++G IP + L L
Sbjct: 376 PPNMCS-GNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLT 434
Query: 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN 464
+ L N + G +P + L QI LS N+L+G +P + GNF + + L N+ G
Sbjct: 435 QVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQG- 493
Query: 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI 524
P+P E+ +L+ + ID S N SG + + CK L + ++ N+ SG IPN
Sbjct: 494 -------PIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNE 546
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLK 584
+ +K L L+LS N L GSIP + ++Q+L SL+ ++NNL G+VP G F +
Sbjct: 547 ITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFL 606
Query: 585 GNPKLC-LQLG-CEN------PRSHGSRLIILSIIVTIMAVIAGC---FLIVWPIIVRKR 633
GNP LC LG C++ +SH + S+ + ++ + C F +V I++ R
Sbjct: 607 GNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVV--AIIKAR 664
Query: 634 KAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHN----------ERT 683
K+ S +++ + + +N+IG G G V +R
Sbjct: 665 SLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL 724
Query: 684 GSW-------KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGD 736
+ F AE +TL +RHR++V+L+ CS N E LVYE++ NGSLG+
Sbjct: 725 AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCS-----NHETNLLVYEYMPNGSLGE 779
Query: 737 WIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+HG++ K L+ L YLH+DC +VH D+K NILLD A V DF
Sbjct: 780 VLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADF 839
Query: 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV----------PTSES 836
GLA+FL + + GS GY+ PEY + DV T
Sbjct: 840 GLAKFL----QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRK 895
Query: 837 FAGEF----NIVKWVESNLPEN---VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVG 889
GEF +IV+WV N VL+VLDP L +I +H+ +T + V
Sbjct: 896 PVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL---------SSIPIHE--VTHVFYVA 944
Query: 890 LSCTTESPGGRIGIREALRRL 910
+ C E R +RE ++ L
Sbjct: 945 MLCVEEQAVERPTMREVVQIL 965
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 307/974 (31%), Positives = 479/974 (49%), Gaps = 139/974 (14%)
Query: 9 LLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNP--SSSPCTWPGVIC 66
L V ++ FG SA +N + +ALM+ K S + + L W+ +S C+W GV C
Sbjct: 12 LAMVGFMVFGVASA---MNNEGKALMAIKGSFS--NLVNMLLDWDDVHNSDLCSWRGVFC 66
Query: 67 NNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNI 126
+N V+ LNLSS L G ISP IG+L L+SI LQ NKL+G +P EIGN L L++
Sbjct: 67 DNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDL 126
Query: 127 SFNNLQGELPVNISKLTELKMLDLMANKITGRV--TDDQLRNLRSLQVL------NFGKN 178
S N L G++P +ISKL +L+ L+L N++TG V T Q+ NL+ L + +
Sbjct: 127 SENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRL 186
Query: 179 LLWGSIPPSIA-------NLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRL 231
L W + + + SD+ +L L D+ N L GT+P +I N TS L +
Sbjct: 187 LYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDI 246
Query: 232 ASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPP 291
+ NQ+ GEIPY++ + NR TG+IP + + + ++ ++ N L G +PP
Sbjct: 247 SYNQITGEIPYNI--GFLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPP 304
Query: 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF 351
LGNL F L L GN G IP +GN
Sbjct: 305 ILGNLSF-------------------------------TGKLYLHGNMLTGPIPSELGNM 333
Query: 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411
S LS L L N + G IP +G+L L L+L+ N + G IP I L + GN
Sbjct: 334 S-RLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGN 392
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
+ G IP + NL L ++LS N G+IP+ G+ +L +DLS N +G+IP
Sbjct: 393 LLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPL---- 448
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGL 531
+ LE+++ ++LS N LSG LP N +S++ + +++N SG IP + +L+ L
Sbjct: 449 ----TLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNL 504
Query: 532 EVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC- 590
L L++NKL G IP L N L +LN++FNNL G+VP F + GNP LC
Sbjct: 505 NSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCG 564
Query: 591 ---LQLGCENPRSH-GSRLIILSIIVTIMAVIAGCFLIVWPIIVRKR-----KAKRVGVS 641
+ P+S SR ++ I++ ++ ++ FL V+ + +K+ + G++
Sbjct: 565 NWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLT 624
Query: 642 ALFKVCHPKIS---YDELRRATGNFSHENLIGSGSFGSV---------------LHNERT 683
L + H ++ +D++ R T N + + +IG G+ +V L+N+
Sbjct: 625 KLV-ILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYP 683
Query: 684 GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE-R 742
+ + F E ET+ ++RHRN+V L S + N+ F Y+++ NGSL D +HG +
Sbjct: 684 HNLREFETELETIGSIRHRNIVSLHGYALS-PTGNLLF----YDYMENGSLWDLLHGSLK 738
Query: 743 KNELD----------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
K +LD L YLH+DC ++H D+K NILLDE A + DFG+A+
Sbjct: 739 KVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAK-- 796
Query: 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT-----------SESFAGEF 841
+ + +ST+V +G+IGY+ PEY R + D+ + ++ E
Sbjct: 797 --SIPASKTHASTYV-LGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEA 853
Query: 842 NIVKWVESNLPEN-VLQVLDPELRQ--LMTSNESQTIQLHDCLITIIGSVGLSCTTESPG 898
N+ + + S +N V++ +DPE+ + + +T QL L CT +P
Sbjct: 854 NLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQL-----------ALLCTKRNPL 902
Query: 899 GRIGIREALRRLKS 912
R + E R L S
Sbjct: 903 ERPTMLEVSRVLLS 916
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (937), Expect = e-100, Method: Compositional matrix adjust.
Identities = 312/980 (31%), Positives = 453/980 (46%), Gaps = 153/980 (15%)
Query: 39 QISQESPSSPLSYWNPS-SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFL 97
++S + P S LS WN + +SPC W GV C + V ++LSS L G I LS L
Sbjct: 27 KLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVICRLSNL 86
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITG 157
+ L NN ++ LP I L+ L++S N L GELP ++ + L LDL N +G
Sbjct: 87 AHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSG 146
Query: 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT-V 216
+ +L+VL+ NLL G+IPP + N+ LK+L+L+ N + + +
Sbjct: 147 DIPA-SFGKFENLEVLSLVYNLLDGTIPPFLGNI--------STLKMLNLSYNPFSPSRI 197
Query: 217 PSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQ 276
P N+T+L + L L G+IP D L L+D N G IP SL LTN+
Sbjct: 198 PPEFGNLTNLEVMWLTECHLVGQIP-DSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVV 256
Query: 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336
I + +N L G +PP LGNL LR + N++ DE L L L
Sbjct: 257 QIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDE--------LCRVPLESLNLY 308
Query: 337 GNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIE 396
N EG++P SI S L ++ + GN + G +P +G L LD+S N SG++P +
Sbjct: 309 ENNLEGELPASIA-LSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPAD 367
Query: 397 IGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDL 456
+ L+ L + N G IP SLA+ + L +I L+ N +G +P F + ++L
Sbjct: 368 LCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLEL 427
Query: 457 SNNRINGNIPKGI----------------LRPLPEEISRLENVVTIDLSDNSLSGNLPNS 500
NN +G I K I LPEEI L+N+ + S N SG+LP+S
Sbjct: 428 VNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDS 487
Query: 501 L------------------------KNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDL 536
L K+ K L EL +A N+F+G IP+ + L L LDL
Sbjct: 488 LMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDL 547
Query: 537 SSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL--- 593
S N SG IP LQ+L+ L LNL++N L G +P + ++M GNP LC +
Sbjct: 548 SGNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPS-LAKDMYKNSFIGNPGLCGDIKGL 605
Query: 594 -GCEN-PRSHGSRLIILSIIV-TIMAVIAGCFLIVWPIIVRK--RKAKRVGVSALFKVCH 648
G EN + G ++ SI V M ++AG + W + +KA+ + S +
Sbjct: 606 CGSENEAKKRGYVWLLRSIFVLAAMVLLAG---VAWFYFKYRTFKKARAMERSKWTLMSF 662
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSV------------LHNERTGSWK--------- 687
K+ + E + +N+IG+G+ G V + TGS K
Sbjct: 663 HKLGFSE-HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEK 721
Query: 688 ---------SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI 738
+F AE ETL +RH+N+VKL CS+ D K LVYE++ NGSLGD +
Sbjct: 722 GYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCK-----LLVYEYMPNGSLGDLL 776
Query: 739 HGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
H + K LD L YLH+D P+VH D+K NIL+D + A+V DFG+
Sbjct: 777 HSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGV 836
Query: 789 ARFLLERVD-NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------P 832
A+ VD + S V GS GY+ PEY R + D+ P
Sbjct: 837 AK----AVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRP 892
Query: 833 TSESFAGEFNIVKWVESNLPEN-VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLS 891
GE ++VKWV S L + + V+DP+L I+ I +VGL
Sbjct: 893 VDPEL-GEKDLVKWVCSTLDQKGIEHVIDPKLDSCFKEE-----------ISKILNVGLL 940
Query: 892 CTTESPGGRIGIREALRRLK 911
CT+ P R +R ++ L+
Sbjct: 941 CTSPLPINRPSMRRVVKMLQ 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 929 | ||||||
| 255573062 | 1015 | serine-threonine protein kinase, plant-t | 0.990 | 0.906 | 0.572 | 0.0 | |
| 255573058 | 983 | serine-threonine protein kinase, plant-t | 0.964 | 0.911 | 0.577 | 0.0 | |
| 357519429 | 993 | Receptor protein kinase-like protein [Me | 0.982 | 0.919 | 0.530 | 0.0 | |
| 356528416 | 1006 | PREDICTED: LRR receptor-like serine/thre | 0.965 | 0.891 | 0.538 | 0.0 | |
| 357519427 | 1023 | Kinase-like protein [Medicago truncatula | 0.979 | 0.889 | 0.518 | 0.0 | |
| 224076934 | 1005 | predicted protein [Populus trichocarpa] | 0.963 | 0.890 | 0.526 | 0.0 | |
| 449450538 | 1017 | PREDICTED: probable LRR receptor-like se | 0.988 | 0.902 | 0.513 | 0.0 | |
| 449450542 | 988 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.907 | 0.524 | 0.0 | |
| 356511039 | 1019 | PREDICTED: probable LRR receptor-like se | 0.958 | 0.873 | 0.539 | 0.0 | |
| 147843793 | 947 | hypothetical protein VITISV_043616 [Viti | 0.931 | 0.913 | 0.528 | 0.0 |
| >gi|255573062|ref|XP_002527461.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533196|gb|EEF34953.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 579/1011 (57%), Positives = 713/1011 (70%), Gaps = 91/1011 (9%)
Query: 1 MHFATLAVLLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCT 60
M+ LA+L+ S ++ I TDKEAL+ KS++ S LS WN S+SPC+
Sbjct: 10 MYTLLLAILVSFRCKCPLVKSTALSIETDKEALIEIKSRLEPHS----LSSWNQSASPCS 65
Query: 61 WPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR 120
W GV CN +RV+GLNLSS G+ G+ISP+IGNLSFL+S++LQNN+L+G +P EI NL R
Sbjct: 66 WTGVFCNKLNHRVLGLNLSSLGVSGSISPYIGNLSFLQSLELQNNQLTGIIPDEICNLSR 125
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
LRV+N++ NNL+G + NISKL+EL++LDL N+ITG++TD +L +L LQVLN G+N
Sbjct: 126 LRVMNMNSNNLRGSILPNISKLSELRVLDLSMNRITGKITD-ELSSLTKLQVLNLGRNAF 184
Query: 181 WGSIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMT 224
G+IPPS+ANL IPSDLSRL NLKVLDLTIN L G VPS +YNM+
Sbjct: 185 SGTIPPSLANLSSLEDLILGTNTLSGIIPSDLSRLHNLKVLDLTINNLTGIVPSKVYNMS 244
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
SLV+L LASNQL G++P DV TLPNLLDF CFN+FTG +PGSLHNLTNI IIR+ HNL
Sbjct: 245 SLVNLALASNQLWGKLPSDVGVTLPNLLDFNLCFNKFTGLLPGSLHNLTNIHIIRVAHNL 304
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344
LEG +PPGL NLPFL YNIGFN V GD +GL FITSLTNS+ L +LA DGN +G I
Sbjct: 305 LEGKVPPGLENLPFLEMYNIGFNNFVGYGD-KGLDFITSLTNSSRLKFLAFDGNLLQGVI 363
Query: 345 PESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404
PES+GN S LSKLY+GGN IYG IPASIG L SLTLL+LSYNSI+G IP EIGQL+ LQ
Sbjct: 364 PESVGNLSKNLSKLYMGGNQIYGGIPASIGHLSSLTLLNLSYNSITGSIPREIGQLEHLQ 423
Query: 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN 464
LGLAGN+ G IP+SL NL+KLNQIDLS N L G IP +FGNFQSLL++DLSNN++NG+
Sbjct: 424 FLGLAGNQFSGSIPDSLGNLRKLNQIDLSRNGLVGAIPTTFGNFQSLLAMDLSNNKLNGS 483
Query: 465 IPKGILR-----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
I K IL L E+I LE+VVTIDLS+N LSG++P+ +KNC+SL
Sbjct: 484 IAKEILNLPSLSKILNLSNNFLSGNLSEDIGLLESVVTIDLSNNHLSGDIPSLIKNCESL 543
Query: 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567
EEL M+ N FSGP+P ++ E+KGLE LDLS N LSG IP DLQ L+AL+ LNL FN+LEG
Sbjct: 544 EELYMSRNSFSGPVPAVLGEMKGLETLDLSYNHLSGFIPPDLQKLEALQLLNLAFNDLEG 603
Query: 568 VVPSEGIFRNMSNVHLKGNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWP 627
VP G+F N+S VHL+GN KL L+L C+NPRS + ++ +SI++ + A +A C I +
Sbjct: 604 AVPCGGVFTNISKVHLEGNTKLSLELSCKNPRSRRANVVKISIVIAVTATLAFCLSIGYL 663
Query: 628 IIVRKRKAKRVGVS-ALFKVCHPKISYDELRRATGNFSHENLIGSGSFGS---------- 676
+ +R+ K K S L K H +SY ELR+AT NF+ NLIGSG FGS
Sbjct: 664 LFIRRSKGKIEWASNNLIKEQHQIVSYRELRQATDNFAERNLIGSGGFGSVYKGFLVDGS 723
Query: 677 -----VLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSN 731
VL ++TG WKSF+AECE LRNVRHRNLVKLITSCSS+D KN+EFLALVYEFL N
Sbjct: 724 AVAVKVLDIKQTGCWKSFVAECEALRNVRHRNLVKLITSCSSIDFKNVEFLALVYEFLGN 783
Query: 732 GSLGDWIHGERKNE--------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDE 777
GSL DWI G+RK E +D SA+DYLH DCEVPVVH DLKP N+LL E
Sbjct: 784 GSLDDWIKGKRKKENGDGLNLMERLNVVIDAASAMDYLHYDCEVPVVHCDLKPSNVLLKE 843
Query: 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV------ 831
+MTAKVGDFGLA L+E++ Q+SISSTHV GSIGY+PPEYGLG +PSTAGDV
Sbjct: 844 DMTAKVGDFGLATLLVEKIGVQTSISSTHVLKGSIGYIPPEYGLGVKPSTAGDVYSFGVM 903
Query: 832 ---------PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS--NESQTI---QL 877
PT +SF GE N+V WV+S N+LQVLDP L + + ++ Q+I
Sbjct: 904 LLELFTGKSPTCDSFKGEQNLVGWVQSAFSSNILQVLDPVLLLPVDNWYHDDQSIISEIQ 963
Query: 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQVPNGKTK 928
+DCLIT+ VGLSCT ESP RI +R+AL +LK++++ LL VPN K K
Sbjct: 964 NDCLITVC-EVGLSCTAESPDRRISMRDALLKLKAARDNLL-NYVPNYKVK 1012
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573058|ref|XP_002527459.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533194|gb|EEF34951.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1043 bits (2696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/991 (57%), Positives = 698/991 (70%), Gaps = 95/991 (9%)
Query: 21 SASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSS 80
S ++ I TDKEAL++FKS + E P P WN +SSPC W GV CN F +RVIGLNLSS
Sbjct: 2 SVALSIETDKEALLAFKSNL--EPPGLP--SWNQNSSPCNWTGVSCNRFNHRVIGLNLSS 57
Query: 81 FGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNIS 140
+ G+ISP+IGNLSFLRS+QLQNN L G +P EI NLFRL +N+S N+LQG + N+S
Sbjct: 58 LDISGSISPYIGNLSFLRSLQLQNNHLRGTIPDEICNLFRLTAMNLSSNSLQGSISSNLS 117
Query: 141 KLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL--------- 191
KL++L +LDL NKITG++ + +L +L LQVLN G+N+L G+IPPSIANL
Sbjct: 118 KLSDLTVLDLSMNKITGKIPE-ELTSLTKLQVLNLGRNVLSGAIPPSIANLSSLEDLILG 176
Query: 192 -------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDV 244
IPSDLSRL NLKVLDLTIN L G+VPS IYNM+SLV L LASNQL GE+P DV
Sbjct: 177 TNTLSGIIPSDLSRLHNLKVLDLTINNLTGSVPSNIYNMSSLVTLALASNQLWGELPSDV 236
Query: 245 RDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI 304
TLPNLL F +C N+FTG IPGSLHNLTNI++IRM HNLLEGT+PPGLGNLPFL YNI
Sbjct: 237 GVTLPNLLVFNFCINKFTGTIPGSLHNLTNIKVIRMAHNLLEGTVPPGLGNLPFLEMYNI 296
Query: 305 GFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNH 364
GFN IVSSGD +GL FI SLTNST L +LA DGN+ +G IPESIGN S +L +LY+G N
Sbjct: 297 GFNNIVSSGD-KGLDFIASLTNSTRLKFLAFDGNRLQGVIPESIGNLSKDLLQLYMGENQ 355
Query: 365 IYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANL 424
IYG IPASIG L LTLL+LSYNSI+G IP EIGQL+ LQ LGLAGN+ G IP+SL NL
Sbjct: 356 IYGGIPASIGHLSGLTLLNLSYNSITGSIPREIGQLEHLQFLGLAGNQFSGSIPDSLGNL 415
Query: 425 KKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR------------- 471
+KLNQIDLS N L G IP +FGNFQSLL++DLSNN++NG+I K IL
Sbjct: 416 RKLNQIDLSRNGLVGAIPTTFGNFQSLLAMDLSNNKLNGSIAKEILNLPSLSKILNLSNN 475
Query: 472 ----PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAE 527
L E+I LE+VVTIDLS+N LSG++P+ +KNC+SLEEL M+ N FSGP+P ++ E
Sbjct: 476 FLSGNLSEDIGLLESVVTIDLSNNHLSGDIPSLIKNCESLEELYMSRNSFSGPVPAVLGE 535
Query: 528 LKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
+KGLE LDLS N LSG IP DLQ L+AL+ LNL FN+LEG VP G+F N+S VHL+GN
Sbjct: 536 MKGLETLDLSYNHLSGFIPPDLQKLEALQLLNLAFNDLEGAVPCGGVFTNISKVHLEGNT 595
Query: 588 KLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAK-RVGVSALFKV 646
KL L+L C+NPRS + ++ +SI++ + A +A C I + + +R+ K K + L K
Sbjct: 596 KLSLELSCKNPRSRRTNVVKISIVIAVTATLAFCLSIGYLLFIRRSKGKIECASNNLIKE 655
Query: 647 CHPKISYDELRRATGNFSHENLIGSGSFGS---------------VLHNERTGSWKSFIA 691
+SY ELR+AT NF +NLIGSG FGS VL ++TG WKSF+A
Sbjct: 656 QRQIVSYHELRQATDNFDEQNLIGSGGFGSVYKGFLADGSAVAVKVLDIKQTGCWKSFVA 715
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------ 745
ECE LRNVRHRNLVKLITSCSS+D KN+EFLALVYEFL NGSL DWI G+RK E
Sbjct: 716 ECEALRNVRHRNLVKLITSCSSIDFKNVEFLALVYEFLGNGSLEDWIKGKRKKENGDGLN 775
Query: 746 --------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+D SA+DYLH DCEVPVVH DLKP N+LL E+MTAKVGDFGLA L+E++
Sbjct: 776 LMERLNVVIDAASAMDYLHYDCEVPVVHCDLKPSNVLLKEDMTAKVGDFGLATLLVEKIG 835
Query: 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEFN 842
Q+SISSTHV + EYGLG +PSTAGDV PT +SF GE N
Sbjct: 836 IQTSISSTHVXX----HDDAEYGLGVKPSTAGDVYSFGVMLLELFTGKSPTCDSFKGEQN 891
Query: 843 IVKWVESNLPENVLQVLDPELRQLMTS--NESQTI---QLHDCLITIIGSVGLSCTTESP 897
+V WV+S N+LQVLDP L + + ++ Q+I +DCLIT+ VGLSCT ESP
Sbjct: 892 LVGWVQSAFSSNILQVLDPILLLPVDNWYDDDQSIISEIQNDCLITVC-EVGLSCTAESP 950
Query: 898 GGRIGIREALRRLKSSQEILLKQQVPNGKTK 928
RI +R+AL +LK++++ LL VPN K K
Sbjct: 951 ERRISMRDALLKLKAARDNLL-NYVPNHKVK 980
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519429|ref|XP_003630003.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355524025|gb|AET04479.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2493), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/991 (53%), Positives = 672/991 (67%), Gaps = 78/991 (7%)
Query: 1 MHFATLAVLLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSP-LSYWNPSSSPC 59
+HFA L + +H L G S ++ I TDKEAL+ KSQ+S + S P LS W +SSPC
Sbjct: 9 LHFALLMIFIHFNNLLVGVSSTTLSITTDKEALILLKSQLSNNNTSPPPLSSWIHNSSPC 68
Query: 60 TWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLF 119
W GV+C+ RV L+LS FGL G +SP+IGN+S L+S+QLQ+N+ +G +P +I NL+
Sbjct: 69 NWTGVLCDKHNQRVTSLDLSGFGLSGNLSPYIGNMSSLQSLQLQDNQFTGFIPEQITNLY 128
Query: 120 RLRVLNISFNNLQGEL-PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
LRVLN+S N +G + P N++ L EL++LDL +NKI R+ + + +L+ LQVL GKN
Sbjct: 129 NLRVLNMSSNRFEGIMFPSNLTNLDELQILDLSSNKIVSRIPE-HISSLKMLQVLKLGKN 187
Query: 179 LLWGSIPPSIANLIP-SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237
+G+IP S+ N+ ++SRL NL LDL +N L GTVP IYN++SLV+L LASN
Sbjct: 188 SFYGTIPQSLGNISTLKNISRLHNLIELDLILNNLTGTVPPVIYNLSSLVNLPLASNSFS 247
Query: 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297
GEIPYDV LP LL F +CFN+FTG+IPGSLHNLTNI++IRM N LEGT+PPGLGNLP
Sbjct: 248 GEIPYDVGHKLPKLLVFNFCFNKFTGRIPGSLHNLTNIRVIRMASNHLEGTVPPGLGNLP 307
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSK 357
FL YNIG+N+IV++G + GL FITSLTNSTHLN+LA+DGN EG I E+IGN S ELS
Sbjct: 308 FLHMYNIGYNRIVNAGVN-GLDFITSLTNSTHLNFLAIDGNMVEGVISETIGNLSKELSI 366
Query: 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGI 417
LY+G N G IP SIGRL L LL+L YNS SGEIP E+GQL+ LQ L L GN+I G I
Sbjct: 367 LYMGENRFNGSIPLSIGRLSGLKLLNLQYNSFSGEIPNELGQLEELQELYLDGNKITGAI 426
Query: 418 PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR------ 471
PNSL NL LN+IDLS N L G IPISFGNFQ+LL +DLS+N++NG+IP IL
Sbjct: 427 PNSLGNLINLNKIDLSRNLLVGRIPISFGNFQNLLYMDLSSNKLNGSIPAEILNLPTLSN 486
Query: 472 -----------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
P+P ++ +L + +ID S+N L G++P+S +C SLE+L +A N SG
Sbjct: 487 VLNLSMNLLSGPIP-QVGKLTTIASIDFSNNQLYGSIPSSFSSCLSLEKLFLARNMLSGS 545
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
IP + E++ LE LDLSSN L+G IP +LQ+LQ LR LNL++N+LEG +PS G+F+N+SN
Sbjct: 546 IPKALGEVRALETLDLSSNLLTGPIPIELQSLQVLRLLNLSYNDLEGDIPSGGVFQNLSN 605
Query: 581 VHLKGNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGV 640
VHL+GN KLCLQ C P+ H + L II+ I+ + C I + ++ K K
Sbjct: 606 VHLEGNKKLCLQFSCV-PQVHRRSHVRLYIIIAIVVTLVLCLAIGLLLYMKYSKVKVTAT 664
Query: 641 SALFKVCH--PKISYDELRRATGNFSHENLIGSGSFGS----------------VLHNER 682
SA ++ P +SYDELR AT FS ENLIG GSFGS VL R
Sbjct: 665 SASGQIHRQGPMVSYDELRLATEEFSQENLIGIGSFGSVYKGHLSQGNSTTAVKVLDTLR 724
Query: 683 TGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
TGS KSF AECE ++N RHRNLVKLITSCSS+D +N +FLALVYE+LSNGSL DWI G R
Sbjct: 725 TGSLKSFFAECEAMKNSRHRNLVKLITSCSSVDFRNNDFLALVYEYLSNGSLEDWIKG-R 783
Query: 743 KNE---------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787
KN +D+ ALDYLHND E P+ H DLKP NILLDE+MTAKVGDFG
Sbjct: 784 KNHANGNGLNLMERLNIAIDVALALDYLHNDSETPIAHCDLKPSNILLDEDMTAKVGDFG 843
Query: 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------P 832
LAR L++R NQ SISSTHV GSIGY+PPEYG GE+PS AGDV P
Sbjct: 844 LARLLIQRSTNQVSISSTHVLRGSIGYIPPEYGWGEKPSAAGDVYSFGIVLLELFSGKSP 903
Query: 833 TSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT---IQLHDCLITIIGSVG 889
+ F G I KWV+S +QV+DP+L L++ ++S T +QLH C+ I+G VG
Sbjct: 904 QDDCFTGGLGITKWVQSAFKNKTVQVIDPQLLSLISHDDSATDSNLQLH-CVDAIMG-VG 961
Query: 890 LSCTTESPGGRIGIREALRRLKSSQEILLKQ 920
+SCT ++P RIGIR A+R+LK++++ LLK+
Sbjct: 962 MSCTADNPDERIGIRVAVRQLKAARDSLLKK 992
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528416|ref|XP_003532799.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2471), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/988 (53%), Positives = 676/988 (68%), Gaps = 91/988 (9%)
Query: 15 LPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVI 74
L G SA++ I TD+EAL+SFKSQ+S E+ SPLS WN +SSPC W GV+C+ G RV
Sbjct: 25 LLIGVSSATLSITTDREALISFKSQLSNEN-LSPLSSWNHNSSPCNWTGVLCDRLGQRVT 83
Query: 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134
GL+LS +GL G +SP++GNLS L+S+QLQNN+ G +P +IGNL L+VLN+S+N L+G+
Sbjct: 84 GLDLSGYGLSGHLSPYVGNLSSLQSLQLQNNQFRGVIPDQIGNLLSLKVLNMSYNMLEGK 143
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL--- 191
LP NI+ L EL++LDL +NKI ++ +D + +L+ LQ L G+N L+G+IP S+ N+
Sbjct: 144 LPSNITHLNELQVLDLSSNKIVSKIPED-ISSLQKLQALKLGRNSLFGAIPASLGNISSL 202
Query: 192 -------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGG 238
IPS+L RL +L LDL++N L GTVP IYN++SLV+ LASN G
Sbjct: 203 KNISFGTNFLTGWIPSELGRLHDLIELDLSLNHLNGTVPPAIYNLSSLVNFALASNSFWG 262
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
EIP DV LP L+ F CFN FTG+IPGSLHNLTNIQ+IRM N LEG++PPGLGNLPF
Sbjct: 263 EIPQDVGHKLPKLIVFCICFNYFTGRIPGSLHNLTNIQVIRMASNHLEGSVPPGLGNLPF 322
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358
L TYNI +N IVSSG GL FITSLTNSTHLN+LA+DGN EG IPE+IGN S +LS L
Sbjct: 323 LCTYNIRYNWIVSSGV-RGLDFITSLTNSTHLNFLAIDGNMLEGVIPETIGNLSKDLSTL 381
Query: 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP 418
Y+G N G IP+SIGRL L LL+LSYNSISGEIP E+GQL+ LQ L LAGNEI GGIP
Sbjct: 382 YMGQNRFNGSIPSSIGRLSGLKLLNLSYNSISGEIPQELGQLEELQELSLAGNEISGGIP 441
Query: 419 NSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR------- 471
+ L NL KLN +DLS N+L G IP SFGN Q+LL +DLS+N++NG+IP IL
Sbjct: 442 SILGNLLKLNLVDLSRNKLVGRIPTSFGNLQNLLYMDLSSNQLNGSIPMEILNLPTLSNV 501
Query: 472 ----------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI 521
P+P E+ RL +V +ID S+N L G +P+S NC SLE+L + NQ SGPI
Sbjct: 502 LNLSMNFLSGPIP-EVGRLSSVASIDFSNNQLYGGIPSSFSNCLSLEKLFLPRNQLSGPI 560
Query: 522 PNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNV 581
P + +++GLE LDLSSN+LSG+IP +LQNL L+ LNL++N++EG +P G+F+N+S V
Sbjct: 561 PKALGDVRGLETLDLSSNQLSGTIPIELQNLHGLKLLNLSYNDIEGAIPGAGVFQNLSAV 620
Query: 582 HLKGNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVS 641
HL+GN KLCL C P G + I L I++ I + C I + + +K K V+
Sbjct: 621 HLEGNRKLCLHFSCM-PHGQGRKNIRLYIMIAITVTLILCLTIGLLLYIENKKVKVAPVA 679
Query: 642 AL--FKVCHPKISYDELRRATGNFSHENLIGSGSFGS---------------VLHNERTG 684
K P ISYDEL AT FS ENL+G GSFGS VL RTG
Sbjct: 680 EFEQLKPHAPMISYDELLLATEEFSQENLLGVGSFGSVYKGHLSHGATVAVKVLDTLRTG 739
Query: 685 SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN 744
S KSF AECE ++N RHRNLVKLITSCSS+D KN +FLALVYE+L NGSL DWI G RK+
Sbjct: 740 SLKSFFAECEAMKNSRHRNLVKLITSCSSIDFKNNDFLALVYEYLCNGSLDDWIKGRRKH 799
Query: 745 E--------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
E LD+ ALDYLHND E+PVVH DLKP NILLDE+MTAKVGDFGLAR
Sbjct: 800 EKGNGLNLMERLNIALDVACALDYLHNDSEIPVVHCDLKPSNILLDEDMTAKVGDFGLAR 859
Query: 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSE 835
L++R +Q SISST V GSIGY+PPEYG GE+PS AGDV PT E
Sbjct: 860 LLIQRSTSQVSISSTRVLRGSIGYIPPEYGWGEKPSAAGDVYSFGIVLLEMFSGKSPTDE 919
Query: 836 SFAGEFNIVKWVESNLPENVLQVLDPELRQLM-----TSNESQTIQLHDCLITIIGSVGL 890
F G+ +I +WV+S+ + ++QV+DP+L L+ + E +QL+ C+ +I+G VG+
Sbjct: 920 CFTGDLSIRRWVQSSCKDKIVQVIDPQLLSLIFNDDPSEGEGPILQLY-CVDSIVG-VGI 977
Query: 891 SCTTESPGGRIGIREALRRLKSSQEILL 918
+CTT +P RIGIREA+RRLK++++ LL
Sbjct: 978 ACTTNNPDERIGIREAVRRLKAARDSLL 1005
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519427|ref|XP_003630002.1| Kinase-like protein [Medicago truncatula] gi|355524024|gb|AET04478.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/1001 (51%), Positives = 662/1001 (66%), Gaps = 91/1001 (9%)
Query: 1 MHFATLAVLLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSP-LSYWNPSSSPC 59
+HFA L + +H L G S ++ I TDKEAL+ KSQ+S + S P LS W +SSPC
Sbjct: 19 LHFALLMIFIHFNNLLVGVSSTTLSITTDKEALILLKSQLSNNNTSPPPLSSWIHNSSPC 78
Query: 60 TWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLF 119
W GV+C+ RV L+LS FGL G +SP+IGN+S L+S+QLQ+N+ +G +P +I NL+
Sbjct: 79 NWTGVLCDKHNQRVTSLDLSGFGLSGNLSPYIGNMSSLQSLQLQDNQFTGFIPEQITNLY 138
Query: 120 RLRVLNISFNNLQGEL-PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
LRVLN+S N +G + P N++ L EL++LDL +NKI R+ + + +L+ LQVL GKN
Sbjct: 139 NLRVLNMSSNRFEGIMFPSNLTNLDELQILDLSSNKIVSRIPE-HISSLKMLQVLKLGKN 197
Query: 179 LLWGSIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYN 222
+G+IP S+ N+ IPSDL RL NL LDLT+N L GTVP IYN
Sbjct: 198 SFYGTIPQSLGNISTLKNISFGTNSLSGWIPSDLGRLHNLIELDLTLNNLTGTVPPVIYN 257
Query: 223 MTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTH 282
++SLV+L LA+N GEIPYDV LP LL F +CFN+FTG+IPGSLHNLTNI++IRM
Sbjct: 258 LSSLVNLALAANSFWGEIPYDVGHLLPKLLVFNFCFNKFTGRIPGSLHNLTNIRVIRMAS 317
Query: 283 NLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEG 342
N LEG +PPGLGNLPFL YNIG+N+IV++G + GL FITSLTNSTHLN+LA+DGN +G
Sbjct: 318 NHLEGIVPPGLGNLPFLHMYNIGYNRIVTTGVN-GLDFITSLTNSTHLNFLAIDGNMLKG 376
Query: 343 KIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402
IPE+IGN S ELS LY+G N G IP+SI RL L LL+LSYNSISG+IP E+GQL
Sbjct: 377 VIPETIGNLSKELSILYMGENRFNGSIPSSISRLSGLKLLNLSYNSISGDIPKELGQLDE 436
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
LQ L L GN+I G IPNSL NL KLN+IDLS NEL G IP+SFGNFQ+LL +DLS+N++N
Sbjct: 437 LQGLYLDGNKISGDIPNSLGNLIKLNKIDLSRNELVGRIPVSFGNFQNLLYMDLSSNKLN 496
Query: 463 GNIPKGILR-----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCK 505
G+IP IL P+P E+ +L + TID S+N L GN+P+S NC
Sbjct: 497 GSIPVEILNIPTLSNVLNLSKNLLSGPIP-EVGQLTTISTIDFSNNQLYGNIPSSFSNCL 555
Query: 506 SLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
SLE++ ++ N SG IP + ++KGLE LDLSSN LSG IP +LQNL L+ LN+++N+L
Sbjct: 556 SLEKMFLSQNMLSGYIPKALGDVKGLETLDLSSNLLSGPIPIELQNLHVLQLLNISYNDL 615
Query: 566 EGVVPSEGIFRNMSNVHLKGNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIV 625
EG +PS G+F+N+SNVHL+GN KLCL C P+ H + II+ I+ + C I
Sbjct: 616 EGEIPSGGVFQNVSNVHLEGNKKLCLHFACV-PQVHKRSSVRFYIIIAIVVTLVLCLTIG 674
Query: 626 WPIIVRKRKAKRVGVSAL--FKVCHPKISYDELRRATGNFSHENLIGSGSFG-------- 675
+ ++ K K S K P +SYDELR AT FS ENLIG GSFG
Sbjct: 675 LLLYMKYTKVKVTETSTFGQLKPQAPTVSYDELRLATEEFSQENLIGIGSFGKVYKGHLR 734
Query: 676 --------SVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727
VL RTG KSF AECE ++N RHRNLVKLITSCSS+D +N +FLALVYE
Sbjct: 735 QGNSTVAVKVLDTSRTGFLKSFFAECEAMKNSRHRNLVKLITSCSSVDFRNNDFLALVYE 794
Query: 728 FLSNGSLGDWIHGERKNE--------------LDITSALDYLHNDCEVPVVHSDLKPGNI 773
+LS GSL DWI G R + +D+ ALDYLHND E P+VH DLKP NI
Sbjct: 795 YLSKGSLEDWIKGRRNHANGNGLNLMERLNIVIDVALALDYLHNDSETPIVHCDLKPSNI 854
Query: 774 LLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV-- 831
LLDE+MTAKVGDFGLAR L+++ +Q SISSTHV GSIGY+PPEYG GE+PS AGDV
Sbjct: 855 LLDEDMTAKVGDFGLARLLIQKSTSQVSISSTHVLRGSIGYIPPEYGWGEKPSAAGDVYS 914
Query: 832 -------------PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES---QTI 875
P + F G I KWV+S QV+DP+L L+ ++S +
Sbjct: 915 FGIVLLELFCGKSPQDDCFTGGQGITKWVQSAFKNKTAQVIDPQLLSLIFHDDSARDSDL 974
Query: 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916
QL C+ I+G VGLSCT ++P RIGIR A+R+L ++ ++
Sbjct: 975 QLR-CVDAIMG-VGLSCTADNPDERIGIRVAVRQLIAASQL 1013
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076934|ref|XP_002305057.1| predicted protein [Populus trichocarpa] gi|222848021|gb|EEE85568.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/983 (52%), Positives = 670/983 (68%), Gaps = 88/983 (8%)
Query: 20 DSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLS 79
D+A G+ TDKEAL+SFKSQ+ + PS+ LS WN +SSPC W V C+ RVIGL+LS
Sbjct: 27 DAAVPGLFTDKEALLSFKSQVVVD-PSNTLSSWNDNSSPCNWTRVDCSQVHQRVIGLDLS 85
Query: 80 SFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI 139
L G+ISPHIGNLSFLRS+ LQ N+ +G +P +IG LFRL+VLN+SFN + G +P NI
Sbjct: 86 GLRLTGSISPHIGNLSFLRSLHLQENQFTGVIPDQIGALFRLKVLNMSFNTINGPIPSNI 145
Query: 140 SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIAN--------- 190
+ L++LDLM N+I+G + + +L NL+SL++L G N LWG IPP IAN
Sbjct: 146 TNCLNLQILDLMQNEISGAIPE-ELSNLKSLEILKLGGNELWGMIPPVIANISSLLTLDL 204
Query: 191 -------LIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYD 243
+IP+DL RLENLK LDL+IN L G VP ++YN++SLV L +ASNQL G+IP D
Sbjct: 205 VTNNLGGMIPADLGRLENLKHLDLSINNLTGDVPLSLYNISSLVFLAVASNQLRGQIPID 264
Query: 244 VRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYN 303
V D LPNLL F +C N+F G IP SLHNLTN+Q IRM NL G++PP L NLP L YN
Sbjct: 265 VGDRLPNLLSFNFCINKFNGSIPWSLHNLTNMQSIRMADNLFSGSVPPRLRNLPKLTLYN 324
Query: 304 IGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGN 363
IG N+I SSGD EGL F++S TNS++L +LA+DGN EG IPESIGN S L LYLG N
Sbjct: 325 IGGNQIKSSGD-EGLDFLSSFTNSSYLKFLAIDGNLLEGLIPESIGNLSRSLRNLYLGRN 383
Query: 364 HIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLAN 423
IYG IPASI L SL LL+++YN +SGEIP EIG+L LQ L LA N+I G IP+SL N
Sbjct: 384 QIYGSIPASIRHLSSLALLNINYNHVSGEIPPEIGELTDLQELHLAANKISGRIPDSLGN 443
Query: 424 LKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR------------ 471
L+KL +I+LS NEL G +P +F NFQ L S+DLS+NR NG+IPK +
Sbjct: 444 LQKLIKINLSANELVGRLPTTFVNFQQLQSMDLSSNRFNGSIPKEVFNLSSLSATLNLSS 503
Query: 472 -----PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVA 526
PLP+EI RLENV +D S N LSG++P+++ +CKSLEEL M N FSG IP +
Sbjct: 504 NQLTGPLPQEIRRLENVAAVDFSHNYLSGSIPDTIGSCKSLEELFMGNNMFSGSIPATLG 563
Query: 527 ELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
++KGLE+LDLSSN++SG+IP L+NLQAL LNL+FNNLEG++P EG FRN+S +H++GN
Sbjct: 564 DVKGLEILDLSSNQISGTIPKTLENLQALLLLNLSFNNLEGLLPKEGAFRNLSRIHVEGN 623
Query: 587 PKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVSALFKV 646
KLCL L C N + + I++ +A + C +I + VRKRK + + S K+
Sbjct: 624 SKLCLDLSCWNNQHRQRISTAIYIVIAGIAAVTVCSVIAVFLCVRKRKGEIMPRSDSIKL 683
Query: 647 CHPKISYDELRRATGNFSHENLIGSGSFGS---------------VLHNERTGSWKSFIA 691
HP ISY ELR ATG+F ENLIG GSFGS VL +E+ GSWKSF+A
Sbjct: 684 QHPTISYGELREATGSFDAENLIGKGSFGSVYKGELRDATVVAVKVLDSEKYGSWKSFLA 743
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN------- 744
ECE L+NVRHRNL+KLITSCSS+D++ ++F+ALVYE++ NGSL +WI G R+
Sbjct: 744 ECEALKNVRHRNLIKLITSCSSMDNRGLQFVALVYEYMHNGSLEEWIKGSRRRLDGGLLN 803
Query: 745 -------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+D+ A+DYLH+DCEVPVVH DLKP N+L+D++MTAKVGDFGLA+ L ER
Sbjct: 804 ILERLNVAIDVACAVDYLHHDCEVPVVHCDLKPSNVLVDKDMTAKVGDFGLAKLLAERGA 863
Query: 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEFN 842
++ SIS T GS+GY+PPEYGLG + +T+GDV PT E F+ + +
Sbjct: 864 DKQSISCTGGLRGSVGYIPPEYGLGLKATTSGDVYSYGVVLLELFTGKSPTHEIFSRDLS 923
Query: 843 IVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL------HDCLITIIGSVGLSCTTES 896
++KWV+S P N+ +V+DPEL L + Q H+CLI I+G VGLSCT ES
Sbjct: 924 LIKWVKSAFPANIEEVVDPELL-LSIKDFHHGAQFESPEKQHECLIAILG-VGLSCTVES 981
Query: 897 PGGRIGIREALRRLKSSQEILLK 919
PG RI +R++L +LK +++ LLK
Sbjct: 982 PGQRITMRDSLHKLKKARDTLLK 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450538|ref|XP_004143019.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] gi|449482798|ref|XP_004156407.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/1015 (51%), Positives = 678/1015 (66%), Gaps = 97/1015 (9%)
Query: 2 HFATLAVLLHVTWLPFGA----DSASVGINTDKEALMSFKSQISQESPSSPLSYWNP--S 55
HF A+ + + L F + SA++ ++TDK+AL++ KS P +PLS WN +
Sbjct: 7 HFQ-FAIFITIVILKFSSFPTVVSATLNLDTDKQALLAIKSTFQNIRPPNPLSSWNSDQT 65
Query: 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI 115
SSPC W GV C G RV+GLNL+ F L G+I PH+GNLSFL S+QLQ+N+++G +P +I
Sbjct: 66 SSPCNWVGVTCTGDGKRVVGLNLTGFLLSGSIDPHLGNLSFLNSLQLQSNQITGQIPHQI 125
Query: 116 GNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNF 175
NLFRLRVLN+SFNNLQG+LP NIS + +L++LDL +NKI GR+ D +L L LQVLN
Sbjct: 126 TNLFRLRVLNVSFNNLQGQLPSNISNMVDLEILDLTSNKINGRLPD-ELSRLNKLQVLNL 184
Query: 176 GKNLLWGSIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPST 219
+N L+GSIPPS NL +P+ L+ L NLK L +TIN L+GTVP
Sbjct: 185 AQNQLYGSIPPSFGNLSSIVTINLGTNSINGPLPTQLAALPNLKHLIITINNLSGTVPPP 244
Query: 220 IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIR 279
I+NM+SLV L LASNQL G P D+ + LPNLL F +CFN+FTG IP SLHN+T IQ+IR
Sbjct: 245 IFNMSSLVTLALASNQLWGTFPKDIGEKLPNLLVFNFCFNKFTGTIPESLHNITKIQVIR 304
Query: 280 MTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQ 339
HN LEGT+P GL L L YNIG+NK V S + GL FITSLTNS+ L +LALDGN
Sbjct: 305 FAHNFLEGTVPAGLEKLHNLSMYNIGYNKFVGSDTNGGLDFITSLTNSSRLAFLALDGNN 364
Query: 340 FEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQ 399
FEG IP+SIGN S +LSKLY+G N YG IP++I L+ L+LL+LS NS+SGEIP +IG+
Sbjct: 365 FEGVIPDSIGNLSKDLSKLYMGENRFYGNIPSTISNLQGLSLLNLSDNSLSGEIPSQIGK 424
Query: 400 LQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNN 459
L+ LQ+LGLA N++ G IP SL +L+ LNQIDLSGN+L G IP SFGN+ +LLS+DLS N
Sbjct: 425 LEKLQMLGLARNQLSGRIPTSLGDLRMLNQIDLSGNDLVGNIPTSFGNYMNLLSLDLSKN 484
Query: 460 RINGNIPKGILR-----------------PLPEEISRLENVVTIDLSDNSLSGNLPNSLK 502
++NG+IP+ L PLPEEI LENVVTID+S+N GN+P+S+
Sbjct: 485 KLNGSIPRATLALPGLSKILNLSNNFFSGPLPEEIGSLENVVTIDISNNHFFGNIPSSIS 544
Query: 503 NCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTF 562
CKSLE L+MA N+FSGPIP +L+GL++LDLSSN+LSG IP + Q L+AL++LNL+F
Sbjct: 545 GCKSLEALIMANNEFSGPIPRTFEDLRGLQILDLSSNRLSGPIPREFQQLKALQTLNLSF 604
Query: 563 NNLEGVVPSEGIFRNMSNVHLKGNPKLC--LQLGCENPRS-HGSRLIILSIIVTIMAVIA 619
N+LEG+VP+E N++N++L+GNPKLC L L C ++ I++ +++ + I+
Sbjct: 605 NDLEGIVPTE--LENITNLYLQGNPKLCDELNLSCAVTKTKEKVIKIVVVSVLSAVLAIS 662
Query: 620 GCFLIVWPIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGS--- 676
F V ++ RK K K S L K ISY EL AT NFS ENLIG GSFG+
Sbjct: 663 IIFGTVTYLMRRKSKDKSFQSSELVKGMPEMISYRELCLATQNFSSENLIGKGSFGTVYR 722
Query: 677 ------------VLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724
VL+ ER GS +SF+AECE LRNVRHRNLVKLITSCSS+D K EFLAL
Sbjct: 723 GYLEQGTAIAVKVLNMERAGSVRSFLAECEALRNVRHRNLVKLITSCSSIDFKRKEFLAL 782
Query: 725 VYEFLSNGSLGDWIHG-------------ERKN-ELDITSALDYLHNDCEVPVVHSDLKP 770
VYEFLSNGSL WIH ER N +D+ S LDYLHN +VP+VH DLKP
Sbjct: 783 VYEFLSNGSLDSWIHKHKLHADGSGLNLIERLNIAIDVASVLDYLHNGYDVPIVHCDLKP 842
Query: 771 GNILLDEEMTAKVGDFGLARFLLERVDNQ-SSISSTHVFMGSIGYVPPEYGLGERPSTAG 829
NI+L EEMTAKVGDFGLAR L+E +NQ SSI+S+HV GSIGYVPPEYG+G +P+TAG
Sbjct: 843 SNIILSEEMTAKVGDFGLARLLMEGGNNQSSSITSSHVLKGSIGYVPPEYGVGRKPTTAG 902
Query: 830 DV---------------PTSESFAGEFNIVKWVESNLPENVLQVLDPEL-----RQLMTS 869
DV PT ESF+G+ N++KWV+ P+++ +++D L +
Sbjct: 903 DVYSFGVTLMELFTGKCPTHESFSGDLNLIKWVQLAYPKDMDEIMDTTLLESGSKLYYEE 962
Query: 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQVPN 924
E + + +DC ++ SV L CT +SP R +++ L +L+ + L++ N
Sbjct: 963 QEIDSTKQYDCFTDVM-SVALCCTVDSPEKRSCMKDVLLKLQMIRATLIRSSNAN 1016
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450542|ref|XP_004143021.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] gi|449482805|ref|XP_004156409.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/983 (52%), Positives = 667/983 (67%), Gaps = 86/983 (8%)
Query: 19 ADSASVGINTDKEALMSFKSQISQESPSSPLSYW-NPSSSPCTWPGVICNNFGNRVIGLN 77
+SA + I TDK+AL+S KS + +PS+PLS W NP+SSPC W V CN GNRVIGL+
Sbjct: 2 VESARLSIETDKQALISIKSGFTNLNPSNPLSSWDNPNSSPCNWTRVSCNKKGNRVIGLD 61
Query: 78 LSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPV 137
LSS + G++ PHIGNL+FL S+QLQNN L+G +P +I LFRL +LN+SFN+L+G P
Sbjct: 62 LSSLKISGSLDPHIGNLTFLHSLQLQNNLLTGPIPHQISKLFRLNLLNMSFNSLEGGFPS 121
Query: 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL------ 191
NIS + L++LDL +N IT + + +L L +L+VL +N ++G IPPS NL
Sbjct: 122 NISAMAALEILDLTSNNITSTLPN-ELSLLTNLKVLKLAQNHIFGEIPPSFGNLSSLVTI 180
Query: 192 ----------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
IP++LSRL NLK L +TIN L GTVP IYNM+SLV L LASN+L G P
Sbjct: 181 NFGTNSLTGPIPTELSRLPNLKDLIITINNLTGTVPPAIYNMSSLVTLALASNKLWGTFP 240
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
D+ DTLPNLL F +CFN FTG IP SLHN+TNIQIIR +N LEGT+PPGL NL L
Sbjct: 241 MDIGDTLPNLLVFNFCFNEFTGTIPPSLHNITNIQIIRFAYNFLEGTVPPGLENLHNLIM 300
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
YNIG+NK+ S D +G+SFITSLT S+ L++LA+DGN FEG+IPESIGN S LS L++G
Sbjct: 301 YNIGYNKL--SSDKDGISFITSLTKSSRLSFLAIDGNNFEGQIPESIGNLSKSLSILFMG 358
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
GN + G IP +IG L L LL+LSYNS+SGEIP EIGQL+ LQ L LA N+ G IP++L
Sbjct: 359 GNRLSGNIPHTIGNLNGLALLNLSYNSLSGEIPSEIGQLENLQSLVLAKNQFSGWIPSTL 418
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR---------- 471
NL+KL +DLS NEL G +P SF NFQ LLS+DLSNN++NG+IPK L
Sbjct: 419 GNLQKLTNLDLSRNELIGGVPTSFNNFQKLLSMDLSNNKLNGSIPKEALNLPSSIRLNMS 478
Query: 472 ------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIV 525
PLPEEI L N+ IDLS N +SG +P+S+K KS+E+L MA N+ SG IPN +
Sbjct: 479 NNLLTGPLPEEIGYLANLFQIDLSTNLISGEIPSSIKGWKSIEKLFMARNKLSGHIPNSI 538
Query: 526 AELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKG 585
ELK ++++DLSSN LSG IP +LQ L AL+ LNL+FN+LEG VP GIF + +NV L+G
Sbjct: 539 GELKAIQIIDLSSNLLSGPIPDNLQYLAALQYLNLSFNDLEGEVPKGGIFESRANVSLQG 598
Query: 586 NPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVSALFK 645
N KLC C+ S ++ + + I+ + + +A CF+I I ++K+K V + L
Sbjct: 599 NSKLCWYSSCKKSDSKHNKAVKVIILSAVFSTLALCFIIGTLIHFLRKKSKTVPSTELLN 658
Query: 646 VCHPKISYDELRRATGNFSHENLIGSGSFGS---------------VLHNERTGSWKSFI 690
H +SYDELR AT NFS +NLIG GSFGS VL RTGS +SF
Sbjct: 659 SKHEMVSYDELRLATENFSEKNLIGKGSFGSVYKGMLKEDIPVAIKVLDVNRTGSLRSFK 718
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE----- 745
AECE LRNVRHRNLV+LIT+CSS+D NMEF AL+YE LSNGSL +W+HG+R +E
Sbjct: 719 AECEALRNVRHRNLVRLITTCSSIDFSNMEFRALIYELLSNGSLDEWVHGQRSHEYGIGL 778
Query: 746 ---------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796
+D+ SA++YLH+DCE+P+VH DLKP N+LLDE MTAKVGDFGLAR L+E
Sbjct: 779 NILERVNIAIDVASAINYLHHDCELPIVHCDLKPSNVLLDENMTAKVGDFGLARLLMENK 838
Query: 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEF 841
+ QSSI+STHV GSIGY+PPEYG G +P+TAGDV PT E F GE
Sbjct: 839 NAQSSITSTHVLKGSIGYLPPEYGFGVKPTTAGDVYSFGVTLLELFTGKSPTDECFTGEL 898
Query: 842 NIVKWVESNLPENVLQVLDPELRQLMTS--NESQTI---QLHDCLITIIGSVGLSCTTES 896
N++KWVES+ PE++++V+D +L +L +TI DCL +IG V LSCT +
Sbjct: 899 NLIKWVESSYPEDIMEVIDHKLPELFVDLVYRGRTIGSDMQKDCLTKVIG-VALSCTVNT 957
Query: 897 PGGRIGIREALRRLKSSQEILLK 919
P RI + +A+ +L+S+++ L++
Sbjct: 958 PVNRIDMEDAVSKLRSAKDNLIR 980
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511039|ref|XP_003524239.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 935 bits (2416), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/985 (53%), Positives = 670/985 (68%), Gaps = 95/985 (9%)
Query: 18 GADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLN 77
G SA++ I++D+EAL+SFKS++S ++ +PLS WN +SSPC W GV+C+ G RV GL+
Sbjct: 28 GVSSATLSISSDREALISFKSELSNDT-LNPLSSWNHNSSPCNWTGVLCDKHGQRVTGLD 86
Query: 78 LSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPV 137
LS GL G +SP+IGNLS L+S+QLQNN+L+G +P +IGNLF LR+LN+S N L+G+LP
Sbjct: 87 LSGLGLSGHLSPYIGNLSSLQSLQLQNNQLTGVIPDQIGNLFNLRLLNMSTNMLEGKLPS 146
Query: 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL------ 191
N + L +L++LDL +NKI ++ +D + +L+ LQ L G+N L+G+IP SI N+
Sbjct: 147 NTTHLKQLQILDLSSNKIASKIPED-ISSLQKLQALKLGRNSLYGAIPASIGNISSLKNI 205
Query: 192 ----------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
IPSDL RL NL LDLT+N L GTVP IYN++SLV+L LA+N L GEIP
Sbjct: 206 SFGTNFLTGWIPSDLGRLHNLIELDLTLNNLTGTVPPVIYNLSSLVNLALAANSLWGEIP 265
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
DV LP LL F +CFN+FTG IPGSLHNLTNI++IRM NLLEGT+PPGLGNLPFLR
Sbjct: 266 QDVGQKLPKLLVFNFCFNKFTGGIPGSLHNLTNIRVIRMASNLLEGTVPPGLGNLPFLRM 325
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
YNIG+N+IVSSG GL FITSLTNSTHLN+LA+DGN EG IPESIGN S +L+KLY+G
Sbjct: 326 YNIGYNRIVSSGV-RGLDFITSLTNSTHLNFLAIDGNMLEGVIPESIGNLSKDLTKLYMG 384
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
N G IP+SIGRL L LL+LSYNSI G+IP E+GQL+GLQ L LAGNEI GGIPNSL
Sbjct: 385 QNRFNGSIPSSIGRLSGLKLLNLSYNSIFGDIPNELGQLEGLQELSLAGNEISGGIPNSL 444
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR---------- 471
NL KLNQIDLS N+L G IP SFGN Q+LL +DLS+N+++G+IP IL
Sbjct: 445 GNLLKLNQIDLSKNKLVGRIPTSFGNLQNLLYMDLSSNKLDGSIPMEILNLPTLSNVLNL 504
Query: 472 -------PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI 524
P+P +I RL V +ID S N L G +P+S NC SLE L +A NQ SGPIP
Sbjct: 505 SMNFLSGPIP-QIGRLITVASIDFSSNQLFGGIPSSFSNCLSLENLFLARNQLSGPIPKA 563
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLK 584
+ ++KGLE LDLSSN+L G+IP +LQNL L+ LNL++N+LEGV+PS G+F+N+S +HL+
Sbjct: 564 LGDVKGLETLDLSSNQLFGAIPIELQNLHVLKFLNLSYNDLEGVIPSGGVFQNLSAIHLE 623
Query: 585 GNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVSAL- 643
GN KLCL C P HG R L II+ I+ + C I + ++ ++ K +A
Sbjct: 624 GNRKLCLYFPCM-PHGHG-RNARLYIIIAIVLTLILCLTIGLLLYIKNKRVKVTATAATS 681
Query: 644 --FKVCHPKISYDELRRATGNFSHENLIGSGSFGS---------------VLHNERTGSW 686
K P +SYDELR AT FS ENL+G GSFGS VL RTGS
Sbjct: 682 EQLKPHVPMVSYDELRLATEEFSQENLLGVGSFGSVYKGHLSHGATVAVKVLDTLRTGSL 741
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN-- 744
KSF AECE ++N RHRNLVKLITSCSS+D KN +FLALVYE+L NGSL DWI G R +
Sbjct: 742 KSFFAECEAMKNSRHRNLVKLITSCSSVDFKNNDFLALVYEYLCNGSLEDWIKGRRNHAN 801
Query: 745 ------------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+D+ ALDYLHND E+PVVH DLKP NILLDE+MTAKVGDFGLAR L
Sbjct: 802 GNGLNLMERLNIAIDVACALDYLHNDSEIPVVHCDLKPSNILLDEDMTAKVGDFGLARSL 861
Query: 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESF 837
++ NQ SISSTH S EYG GE+PS AGDV PT E F
Sbjct: 862 IQNSTNQVSISSTHYCYLS----NAEYGWGEKPSAAGDVYSFGIVLLELFSGKSPTDECF 917
Query: 838 AGEFNIVKWVESNLPENVLQVLDPELRQLMTSN---ESQTIQLHDCLITIIGSVGLSCTT 894
G +I +WV+S + +QV+DP+L L + E +QL+ T+ VG+SCT
Sbjct: 918 TGGLSIRRWVQSAMKNKTVQVIDPQLLSLTFHDDPSEGPNLQLNYLDATV--GVGISCTA 975
Query: 895 ESPGGRIGIREALRRLKSSQEILLK 919
++P RIGIR+A+R+LK++++ LLK
Sbjct: 976 DNPDERIGIRDAVRQLKAARDSLLK 1000
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147843793|emb|CAN83727.1| hypothetical protein VITISV_043616 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/977 (52%), Positives = 650/977 (66%), Gaps = 112/977 (11%)
Query: 1 MHFATLAVLLHVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCT 60
+H+A AVLL SAS+ +NTDKEAL+SFK +S ES + S+ +SSPC
Sbjct: 7 LHYAVFAVLLSSLSSFRIVCSASLSLNTDKEALLSFKYHLSSESSETLSSWNVNNSSPCN 66
Query: 61 WPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR 120
W GV+CN +RVIGL+LS FGL GTISPHIGNLSFL S++LQ+N+L+G +P ++G+L R
Sbjct: 67 WTGVLCNESRDRVIGLDLSGFGLTGTISPHIGNLSFLSSLELQDNQLTGTIPDQVGDLSR 126
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L VLN+S N+++G +P+NI+ EL++LDL N+I+G + +L LR+L++L G N L
Sbjct: 127 LSVLNMSSNHIRGAIPLNITMCLELEILDLKENEISGTIPA-ELGRLRNLEILKLGSNQL 185
Query: 181 WGSIPPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMT 224
G IPPSI+NL IP DL RL+NLK LDLTIN+L GTVPS+IYN+T
Sbjct: 186 VGDIPPSISNLSSLDTLSLGTNNLGGRIPDDLGRLQNLKELDLTINQLEGTVPSSIYNIT 245
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
SLV+L +ASN L GEIP DV D LPNLL F +C N+FTG IPGSLHNLTNI +IRM HNL
Sbjct: 246 SLVNLAVASNNLWGEIPSDVGDRLPNLLIFNFCINKFTGGIPGSLHNLTNINVIRMAHNL 305
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344
LEG++P GLGNLP LR YNIG+N+I SSGD +GL FITSLTNSTHLN+LA+DGN EG I
Sbjct: 306 LEGSVPSGLGNLPQLRMYNIGYNRIKSSGD-QGLDFITSLTNSTHLNFLAIDGNFLEGVI 364
Query: 345 PESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404
PESIGN S L+ L++G N IYG IP SI L SL LL+LS+N ISGEIP EIG+L +Q
Sbjct: 365 PESIGNLSTSLASLHMGQNKIYGSIPXSISHLSSLALLNLSHNLISGEIPPEIGELGEMQ 424
Query: 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN 464
L LA N I G IP+SL NL++L+Q+DLS N L G IP +F NFQ LLS+DLSNNR+N +
Sbjct: 425 ELYLASNNISGRIPSSLGNLRQLSQLDLSSNRLVGGIPTNFSNFQRLLSMDLSNNRLNES 484
Query: 465 IPKGIL-----------------RPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
IPK IL PLP+E+ LE+VVTIDLS N LSG++P S+ CKSL
Sbjct: 485 IPKEILGLPGLSTLLNLSKNSLTGPLPQEVEALESVVTIDLSHNHLSGSIPESISKCKSL 544
Query: 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567
EEL MA N FSG IP+ + E++GLE+LDLS+N+L+GSIPS LQ L AL+ LNL+FNNLEG
Sbjct: 545 EELFMANNXFSGSIPDTLGEVRGLEILDLSTNQLTGSIPSSLQELXALQLLNLSFNNLEG 604
Query: 568 VVPSEGIFRNMSNVHLKGNPKLCLQLGCENPRSHGSRLIIL-----SIIVTIMAVIAGCF 622
VVPSEG+F+N+S VH++GN KLCL L C + HG R + + + G F
Sbjct: 605 VVPSEGVFKNLSRVHIEGNSKLCLNLACT--KGHGRRFAVFXIILIIASAIAICLAXGSF 662
Query: 623 LIVWPIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNER 682
V+ + + A + VL +R
Sbjct: 663 GSVYKGYLTEGTAVAI-------------------------------------KVLDIQR 685
Query: 683 TGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
GSWKSF AECE LR VRHRNLVKLITSCSSLD KN+EFLAL+Y+F+ NGSL DWI+G R
Sbjct: 686 NGSWKSFFAECEALRXVRHRNLVKLITSCSSLDFKNVEFLALIYDFMHNGSLEDWINGTR 745
Query: 743 KN--------------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
++ +D+ A+DYLH+D E P+ H DLKP N+LLD++MTAKVGDFGL
Sbjct: 746 RHXSGCALNLVERLKIAIDVACAMDYLHHDSETPIAHCDLKPSNVLLDKDMTAKVGDFGL 805
Query: 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848
AR L++R +Q SI+STH GSIGY+PP G PT ESF G + +WV+
Sbjct: 806 ARLLMDRAADQQSIASTHGLRGSIGYIPP-----------GKSPTHESFLGGLTLAQWVQ 854
Query: 849 SNLPENVLQVLDPEL------RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG 902
S P NV QV+DPEL Q S+ +Q H+CLI +IG V LSCT +S RI
Sbjct: 855 SAFPTNVRQVVDPELLLPTGXLQHEGHPISEEVQ-HECLIAVIG-VALSCTVDSSDRRIS 912
Query: 903 IREALRRLKSSQEILLK 919
R+A +LK++ + LLK
Sbjct: 913 SRDAXSQLKTAXKALLK 929
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 929 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.599 | 0.543 | 0.378 | 4.5e-124 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.600 | 0.552 | 0.373 | 2.4e-123 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.599 | 0.552 | 0.368 | 4.5e-122 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.602 | 0.543 | 0.369 | 8.4e-121 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.611 | 0.561 | 0.363 | 1.4e-120 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.728 | 0.832 | 0.328 | 7.6e-118 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.639 | 0.606 | 0.341 | 5e-108 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.700 | 0.655 | 0.308 | 2.3e-98 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.640 | 0.507 | 0.334 | 4.3e-95 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.586 | 0.494 | 0.328 | 2.6e-94 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 4.5e-124, Sum P(2) = 4.5e-124
Identities = 226/597 (37%), Positives = 323/597 (54%)
Query: 28 TDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
TDK+AL+ FKSQ+S E C+W GV C RV G++L L G +
Sbjct: 39 TDKQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVV 97
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP +GNLSFLRS+ L +N G +P E+GNLFRL+ LN+S N G +PV +S + L
Sbjct: 98 SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLST 157
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
LDL +N + V + +L L +L+ G+N L G P S+ NL
Sbjct: 158 LDLSSNHLEQGVPLE-FGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGE 216
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IP D++RL+ + + +N+ G P IYN++SL+ L + N G + D LPNL
Sbjct: 217 IPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNL 276
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKI-- 309
N FTG IP +L N+++++ + + N L G +P G L L + N +
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI 369
SSGD L F+ +LTN + L YL + N+ G++P I N S +L++L LGGN I G I
Sbjct: 337 YSSGD---LDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSI 393
Query: 370 PASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNSLANLKKLNQ 429
P IG L SL LDL N ++G++P + N + G IP+SL N+ L
Sbjct: 394 PHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTY 453
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR----------------PL 473
+ L N G IP S G+ LL ++L N++NG+IP ++ PL
Sbjct: 454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPL 513
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
++I +L+ ++ +D+S N LSG +P +L NC SLE LL+ N F GPIP+I L GL
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRF 572
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
LDLS N LSG+IP + N L++LNL+ NN +G VP+EG+FRN S + + GN LC
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 919 (328.6 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
Identities = 222/595 (37%), Positives = 312/595 (52%)
Query: 28 TDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
TD++AL+ FKSQ+S++ C W GV C RV L L L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHSFPL-CNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP IGNLSFL S+ L N G +P+E+G L RL L++ N L+G +P+ + + L
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
L L +N++ G V + L +L +L LN N + G +P S+ NL
Sbjct: 143 LRLDSNRLGGSVPSE-LGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IPSD+++L + L L N +G P +YN++SL L + N G + D+ LPNL
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
L F N FTG IP +L N++ ++ + M N L G++P GN+P L+ + N +
Sbjct: 262 LSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSL-G 319
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
S L F+TSLTN T L L + N+ G +P SI N S +L L LGG I G IP
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY 379
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNSLANLKKLNQID 431
IG L +L L L N +SG +P + N + GGIP + N+ L +D
Sbjct: 380 DIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLD 439
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR----------------PLPE 475
LS N G +P S GN LL + + +N++NG IP I++ LP+
Sbjct: 440 LSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ 499
Query: 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535
+I L+N+ T+ L DN LSG LP +L NC ++E L + N F G IP++ L G++ +D
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVD 558
Query: 536 LSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
LS+N LSGSIP + L LNL+FNNLEG VP +GIF N + V + GN LC
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 220/597 (36%), Positives = 317/597 (53%)
Query: 28 TDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
+D++AL+ KSQ+S E C+W V C RV L+L L G I
Sbjct: 24 SDRQALLEIKSQVS-ESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVI 82
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP IGNLSFL + L NN G +P+E+GNLFRL+ L + FN L+GE+P ++S + L
Sbjct: 83 SPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLY 142
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
LDL +N + G +L +LR L L G N L G P I NL
Sbjct: 143 LDLFSNNL-GDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IP D++ L + L LT+N +G P YN++SL +L L N G + D + LPN+
Sbjct: 202 IPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKI-- 309
+ N TG IP +L N++ +++ + N + G++ P G L L + N +
Sbjct: 262 HELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGS 321
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI 369
S GD L+F+ +LTN +HL+ L++ N+ G +P SI N S EL+ L L GN IYG I
Sbjct: 322 YSFGD---LAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSI 378
Query: 370 PASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNSLANLKKLNQ 429
P IG L L L L+ N ++G +P + N G IP+ + NL +L +
Sbjct: 379 PHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVK 438
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR-P---------------L 473
+ LS N G +P S G+ +L + + N++NG IPK I++ P L
Sbjct: 439 LYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSL 498
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
P +I RL+N+V + L +N+LSG+LP +L C S+E + + N F G IP+I L G++
Sbjct: 499 PNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKN 557
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
+DLS+N LSGSI +N L LNL+ NN EG VP+EGIF+N + V + GN LC
Sbjct: 558 VDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLC 614
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
Identities = 220/595 (36%), Positives = 317/595 (53%)
Query: 28 TDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGNRVIGLNLSSFGLEGTI 87
TD +AL+ FKSQ+S+ C W GV C RVI LNL F L G I
Sbjct: 30 TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVI 89
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
SP IGNLSFLR + L +N +P+++G LFRL+ LN+S+N L+G +P ++S + L
Sbjct: 90 SPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLST 149
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL---------------- 191
+DL +N + G +L +L L +L+ KN L G+ P S+ NL
Sbjct: 150 VDLSSNHL-GHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IP +++RL + + +N +G P +YN++SL L LA N G + D LPNL
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
+ N+FTG IP +L N+++++ ++ N L G++P G L L I N +
Sbjct: 269 RRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL-G 327
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ GL FI ++ N T L YL + N+ G++P SI N S L+ L+LG N I G IP
Sbjct: 328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPH 387
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNSLANLKKLNQID 431
IG L SL L L N +SGE+P+ N I G IP+ N+ +L ++
Sbjct: 388 DIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLH 447
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR-P---------------LPE 475
L+ N G IP S G + LL + + NR+NG IP+ IL+ P PE
Sbjct: 448 LNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPE 507
Query: 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535
E+ +LE +V + S N LSG +P ++ C S+E L M N F G IP+I + L L+ +D
Sbjct: 508 EVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDI-SRLVSLKNVD 566
Query: 536 LSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
S+N LSG IP L +L +LR+LNL+ N EG VP+ G+FRN + V + GN +C
Sbjct: 567 FSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 910 (325.4 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 222/610 (36%), Positives = 318/610 (52%)
Query: 15 LPFGADSASVGINTDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGNRVI 74
L GAD + TD++AL+ FKSQ+S E C W V C RV
Sbjct: 13 LLLGADGFTD--ETDRQALLEFKSQVS-EGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVT 69
Query: 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134
LNL L G +SP IGN+SFL S+ L +N G +PRE+GNLFRL L ++FN+L+G
Sbjct: 70 HLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGG 129
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL--- 191
+P +S + L LDL +N + V + L +L L +L+ G+N L G +P S+ NL
Sbjct: 130 IPATLSNCSRLLNLDLYSNPLRQGVPSE-LGSLTKLVILDLGRNNLKGKLPRSLGNLTSL 188
Query: 192 -------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGG 238
+P +L+RL + L L++N+ G P IYN+++L L L + G
Sbjct: 189 KSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSG 248
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
+ D + LPN+ + N G IP +L N++ +Q + N++ G + P G +P
Sbjct: 249 SLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPS 308
Query: 299 LRTYNIGFNKIVSS--GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS 356
L+ ++ N + S GD L FI SLTN THL L++ + G +P SI N S EL
Sbjct: 309 LQYLDLSENPLGSYTFGD---LEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELI 365
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGG 416
L L GNH +G IP IG L L L L N ++G +P + N + G
Sbjct: 366 SLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGE 425
Query: 417 IPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR-P--- 472
IP+ + NL +L + LS N G +P S G +L + + N++NG IPK I++ P
Sbjct: 426 IPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLV 485
Query: 473 ------------LPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
LP +I L+N+V + L +N SG+LP +L NC ++E+L + N F G
Sbjct: 486 NLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGA 545
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
IPNI L G+ +DLS+N LSGSIP N L LNL+ NN G VPS+G F+N +
Sbjct: 546 IPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTI 604
Query: 581 VHLKGNPKLC 590
V + GN LC
Sbjct: 605 VFVFGNKNLC 614
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
Identities = 242/736 (32%), Positives = 383/736 (52%)
Query: 29 DKEALMSFKSQIS-QEXXXXXXXXXXXXXXXCTWPGVICNN-FGNRVIGLNLSSFGLEGT 86
D+ AL+SFKS + Q CTW GV+C +RV+ L L S L G
Sbjct: 34 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRHPHRVVKLRLRSSNLAGI 93
Query: 87 ISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELK 146
ISP +GNLSFLR++QL +N LSG +P+E+ L RL+ L ++FN+L GE+P + LT L
Sbjct: 94 ISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSLS 153
Query: 147 MLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206
+L+L N ++G + L L L L +N L GSIP S +L L L
Sbjct: 154 VLELTNNTLSGAIPSS-LGKLTGLTDLALAENTLSGSIP--------SSFGQLRRLSFLS 204
Query: 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
L N L+G +P I+N++SL + SN+L G +P + LP+L + +N+F G+IP
Sbjct: 205 LAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIP 264
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG--FNKIVSSGDDEGLSFITSL 324
S+ N +NI I + N G +PP +G + L+ + ++ + D + ++ +T+
Sbjct: 265 ASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNC 324
Query: 325 TN----------------------STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGG 362
+N S+ L L++ N+ G +P IGN N L L L
Sbjct: 325 SNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVN-LQYLSLAN 383
Query: 363 NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNSLA 422
N + G +P+S +L++L L + N + G +P+ I N G IP++L
Sbjct: 384 NSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLG 443
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSI-DLSNNRINGNIPKGILRPLPEEISRLE 481
NL KL QI+L N G+IPI + +L I D+S+N + G+IPK EI +L+
Sbjct: 444 NLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPK--------EIGKLK 495
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541
N+V N LSG P+++ C+ L+ L + N +G IP + +LKGL+ LDLS N L
Sbjct: 496 NIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNL 555
Query: 542 SGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC-----LQLG-C 595
SG IP L ++ L SLNL+FN+ G VP+ G+F N S ++++GN +C L L C
Sbjct: 556 SGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTC 615
Query: 596 --ENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVSALFKVCHPKISY 653
++ + ++++L +++ +++ +A L+ + KR+ K V + + HP I+Y
Sbjct: 616 SLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQG-HPMITY 674
Query: 654 DELRRATGNFSHENLIGSGSFGSVLHNE---RTGSWKSFIAECETLRNVRHRNLVKLITS 710
+L +AT FS +L+GSGSFGSV E + G S +A L+ + L
Sbjct: 675 KQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVA-VRVLKLETPKALKSFTAE 733
Query: 711 CSSL-DSKNMEFLALV 725
C +L ++++ + +V
Sbjct: 734 CETLRNTRHRNLVKIV 749
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 5.0e-108, Sum P(2) = 5.0e-108
Identities = 221/647 (34%), Positives = 336/647 (51%)
Query: 59 CTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNL 118
C W GV CN +VI L++S L G ISP I NL+ L + L N G +P EIG+L
Sbjct: 54 CNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSL 113
Query: 119 FR-LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRN--LRSLQVLNF 175
L+ L++S N L G +P + L L LDL +N++ G + N SLQ ++
Sbjct: 114 HETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDL 173
Query: 176 GKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235
N L G IP + L+ L+ L L N+L GTVPS++ N T+L + L SN
Sbjct: 174 SNNSLTGEIPLNYH-------CHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNM 226
Query: 236 LGGEIPYDVRDTLPNLLDFIYC-FNRF------TGKIP--GSLHNLTNIQIIRMTHNLLE 286
L GE+P V +P L F+Y +N F T P SL N +++Q + + N L
Sbjct: 227 LSGELPSQVISKMPQL-QFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLG 285
Query: 287 GTLPPGLGNLPF-LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP 345
G + + +L L ++ N+I S E I++L N T LN L N G IP
Sbjct: 286 GEITSSVRHLSVNLVQIHLDQNRIHGSIPPE----ISNLLNLTLLN---LSSNLLSGPIP 338
Query: 346 ESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXX 405
+ S +L ++YL NH+ G+IP +G + L LLD+S N++SG IP
Sbjct: 339 RELCKLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRR 397
Query: 406 XXXXXNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISF-GNFQSL-LSIDLSNNRING 463
N + G +P SL L +DLS N LTG IP+ N ++L L ++LS+N ++G
Sbjct: 398 LLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSG 457
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPN 523
P+P E+S+++ V+++DLS N LSG +P L +C +LE L ++ N FS +P+
Sbjct: 458 --------PIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPS 509
Query: 524 IVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHL 583
+ +L L+ LD+S N+L+G+IP Q L+ LN +FN L G V +G F ++
Sbjct: 510 SLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESF 569
Query: 584 KGNPKLCLQL-GCEN-PRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVS 641
G+ LC + G + + H ++L ++++++A C + +P++ R R K + V
Sbjct: 570 LGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLC-VFGYPLVQRSRFGKNLTVY 628
Query: 642 ALFKV-----------CHPKISYDELRRATGNFSHENLIGSGSFGSV 677
A +V +P+ISY +L ATG F+ +LIGSG FG V
Sbjct: 629 AKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHV 675
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 2.3e-98, Sum P(3) = 2.3e-98
Identities = 222/720 (30%), Positives = 352/720 (48%)
Query: 73 VIGLNLSSFGLEGTI-SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR-LRVLNISFNN 130
+I + LS L GTI S + S L+++ L N SG LP E FR LRVL + N
Sbjct: 100 LINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLP-EFSPEFRKLRVLELESNL 158
Query: 131 LQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIAN 190
GE+P + +LT L++L+L N ++G + L L L L+ L + S PS
Sbjct: 159 FTGEIPQSYGRLTALQVLNLNGNPLSG-IVPAFLGYLTELTRLD----LAYISFDPSP-- 211
Query: 191 LIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPN 250
IPS L L NL L LT + L G +P +I N+ L +L LA N L GEIP + L +
Sbjct: 212 -IPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESI-GRLES 269
Query: 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI------ 304
+ NR +GK+P S+ NLT ++ ++ N L G LP + L + ++N+
Sbjct: 270 VYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLI-SFNLNDNFFT 328
Query: 305 -GFNKIVSSGDD--EGLSFITSLTNS--------THLNYLALDGNQFEGKIPESIGNFSN 353
G +V+ + E F S T + + ++ + N+F G++P + +
Sbjct: 329 GGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLC-YRR 387
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEI 413
+L K+ N + G+IP S G SL + ++ N +SGE+P N++
Sbjct: 388 KLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQL 447
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL 473
G IP S++ + L+Q+++S N +G IP+ + + L IDLS N G+IP I
Sbjct: 448 QGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCI---- 503
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
++L+N+ +++ +N L G +P+S+ +C L EL ++ N+ G IP + +L L
Sbjct: 504 ----NKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNY 559
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL-Q 592
LDLS+N+L+G IP++L L+ L N++ N L G +PS G +++ GNP LC
Sbjct: 560 LDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPS-GFQQDIFRPSFLGNPNLCAPN 617
Query: 593 LGCENP-RSHGSRLIILSIIVTIMAVIAGCFLIVWPII----VRKRKAKRVGVSALFKVC 647
L P RS IL I + + + G +VW I + KRK KR +F+
Sbjct: 618 LDPIRPCRSKRETRYILPISILCIVALTGA--LVWLFIKTKPLFKRKPKRTNKITIFQ-- 673
Query: 648 HPKISYDELRRATGNFSHENLIGSGSFGSV----LHNERTGSWKSFIAEC--ETLRNVRH 701
++ + E + +N+IGSG G V L + +T + K E +T
Sbjct: 674 --RVGFTE-EDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVF 730
Query: 702 RNLVKLITSCSS-------LDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY 754
R+ V+ + + EF LVYEF+ NGSLGD +H E+++ S LD+
Sbjct: 731 RSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRA--VSPLDW 788
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 4.3e-95, Sum P(2) = 4.3e-95
Identities = 218/651 (33%), Positives = 318/651 (48%)
Query: 63 GVICNNFGN--RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR 120
G I GN ++ L L L G I +GNL L+++++ NKL+ ++P + L +
Sbjct: 254 GDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQ 313
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L L +S N+L G + I L L++L L +N TG + NLR+L VL G N
Sbjct: 314 LTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQS-ITNLRNLTVLTVGFN-- 370
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
+I+ +P+DL L NL+ L N L G +PS+I N T L L L+ NQ+ GEI
Sbjct: 371 ------NISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEI 424
Query: 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLR 300
P NL N FTG+IP + N +N++ + + N L GTL P +G L LR
Sbjct: 425 PRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLR 482
Query: 301 TYNIGFNKIVSS-----GD--DEGLSFITS----------LTNSTHLNYLALDGNQFEGK 343
+ +N + G+ D + ++ S ++N T L L + N EG
Sbjct: 483 ILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGP 542
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXX 403
IPE + + LS L L N G+IPA +L SLT L L N +G IP +
Sbjct: 543 IPEEMFDMKL-LSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLL 601
Query: 404 XXXXXXXNEIPGGIPNSL-ANLKKLN-QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRI 461
N + G IP L A+LK + ++ S N LTG IP G + + IDLSNN
Sbjct: 602 NTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLF 661
Query: 462 NGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSL-KNCKSLEELLMAYNQFSGP 520
+G+IP+ + +NV T+D S N+LSG++P+ + + + L ++ N FSG
Sbjct: 662 SGSIPRSL--------QACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
IP + L LDLSSN L+G IP L NL L+ L L NNL+G VP G+F+N++
Sbjct: 714 IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773
Query: 581 VHLKGNPKLCLQLG----C--ENPRSHGS-RLIILSIIVTIMAVIAGCFLIVWPIIVRKR 633
L GN LC C + SH S R ++ II+ A + L+V + K+
Sbjct: 774 SDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKK 833
Query: 634 KAKRVGVSA------LFKVCHPK-ISYDELRRATGNFSHENLIGSGSFGSV 677
K K++ S+ L K EL +AT +F+ N+IGS S +V
Sbjct: 834 KEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTV 884
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 708 (254.3 bits), Expect = 2.6e-94, Sum P(2) = 2.6e-94
Identities = 193/587 (32%), Positives = 292/587 (49%)
Query: 21 SASVGINTDKEALMSFKSQISQEXXXXXXXXXXXXXXXCTWPGVICNNFGN--RVIGLNL 78
S + G+N + + L+ KS+ + C W GV+C+N+ + V+ LNL
Sbjct: 22 SETTGLNLEGQYLLEIKSKFV-DAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNL 80
Query: 79 SSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVN 138
SS L G +SP IG L L+ + L N LSG +P+EIGN L +L ++ N GE+PV
Sbjct: 81 SSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVE 140
Query: 139 ISKLTELKMLDLMANKITGRVTDDQLRNLRSL-QVLNFGKNLLWGSIPPSIANLIPSDLS 197
I KL L+ L + N+I+G + + + NL SL Q++ + N+ G +P SI NL
Sbjct: 141 IGKLVSLENLIIYNNRISGSLPVE-IGNLLSLSQLVTYSNNIS-GQLPRSIGNL-----K 193
Query: 198 RLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC 257
RL + + N ++G++PS I SLV L LA NQL GE+P ++ L L I
Sbjct: 194 RLTSFRAGQ---NMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEI-GMLKKLSQVILW 249
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP---FLRTYNIGFNKIVSS-- 312
N F+G IP + N T+++ + + N L G +P LG+L FL Y G N +
Sbjct: 250 ENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREI 309
Query: 313 GD-------DEGLSFITS-----LTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360
G+ D + +T L N L L L NQ G IP + N LSKL L
Sbjct: 310 GNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKN-LSKLDL 368
Query: 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIXXXXXXXXXXXXXNEIPGGIPNS 420
N + G IP LR L +L L NS+SG IP ++ N + G IP+
Sbjct: 369 SINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSY 428
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
L + ++L N L+G IP ++L+ + L+ N + G P + + +
Sbjct: 429 LCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQV------- 481
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
NV I+L N G++P + NC +L+ L +A N F+G +P + L L L++SSNK
Sbjct: 482 -NVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNK 540
Query: 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGN 586
L+G +PS++ N + L+ L++ NN G +PSE G + + L N
Sbjct: 541 LTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNN 587
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3854 | 0.9483 | 0.8722 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00014914001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (1026 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 929 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.001 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.003 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.004 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.004 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = 2e-91
Identities = 279/1002 (27%), Positives = 453/1002 (45%), Gaps = 201/1002 (20%)
Query: 31 EALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGL-------------- 76
E L+SFKS I P LS WN S+ C W G+ CNN +RV+ +
Sbjct: 32 ELLLSFKSSI--NDPLKYLSNWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSA 88
Query: 77 ----------NLSSFGLEGTISPHI-----------------------GNLSFLRSIQLQ 103
NLS+ L G I I G++ L ++ L
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLS 148
Query: 104 NNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQ 163
NN LSG +P +IG+ L+VL++ N L G++P +++ LT L+ L L +N++ G++ +
Sbjct: 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR-E 207
Query: 164 LRNLRSLQVLNFGKNLLWGSIPPSIANL----------------IPSDLSRLENLKVLDL 207
L ++SL+ + G N L G IP I L IPS L L+NL+ L L
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267
Query: 208 TINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCF-NRFTGKIP 266
N+L+G +P +I+++ L+ L L+ N L GEIP ++ L NL + ++ F N FTGKIP
Sbjct: 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-ELVIQLQNL-EILHLFSNNFTGKIP 325
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTN 326
+L +L +Q++++ N G +P LG
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGK------------------------------- 354
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
+L L L N G+IPE + + S L KL L N + G+IP S+G RSL + L
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
NS SGE+P E +L + L ++ N + G I + ++ L + L+ N+ G +P SFG
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+ + L ++DLS N+ +G +P+ L L E ++ + LS+N LSG +P+ L +CK
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRK-LGSLSE-------LMQLKLSENKLSGEIPDELSSCKK 524
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
L L +++NQ SG IP +E+ L LDLS N+LSG IP +L N+++L +N++ N+L
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 567 GVVPSEGIFRNMSNVHLKGNPKLCLQLG------CENPRSHGSR-LIILSIIVTIMAVIA 619
G +PS G F ++ + GN LC C+ R S I + + +
Sbjct: 585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLAL 644
Query: 620 GCFLIVWPIIVRKRKAKRVGVSALFKVCHPKISYDEL---RRATGNFSHENLIGSGSFGS 676
F V+ +R R L +V + +++ + + + + +++ S +
Sbjct: 645 VAFGFVF---IRGRN-----NLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEEN 696
Query: 677 VLHNERTG-SWK-----------------------SFIAECETLRNVRHRNLVKLITSCS 712
V+ + G S+K S IA+ + ++H N+VKLI C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCR 753
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCEVPVVHSD 767
S + L++E++ +L + + RK + I AL +LH C VV +
Sbjct: 754 S-----EKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE--------- 818
L P I++D + + L L D + ISS YV PE
Sbjct: 809 LSPEKIIIDGKDEPHL-RLSLPGLLC--TDTKCFISS--------AYVAPETRETKDITE 857
Query: 819 ----YGLG--ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV-LDPELRQLMTSNE 871
YG G G P F +IV+W + L + +DP +R ++ N+
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913
++ ++ + ++ L CT P R + L+ L+S+
Sbjct: 918 NEIVE--------VMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 40/194 (20%)
Query: 663 FSHENLIGSGSFGSVL--HNERTG---------------SWKSFIAECETLRNVRHRNLV 705
+ +G GSFG V +++TG + + E + L+ ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NE-------LDITSALDYLHN 757
+L ++ + L LV E+ G L D + + +E I SAL+YLH+
Sbjct: 61 RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS 115
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+VH DLKP NILLDE+ K+ DFGLAR L F+G+ Y+ P
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQL-------DPGEKLTTFVGTPEYMAP 165
Query: 818 EYGLGERPSTAGDV 831
E LG+ A D+
Sbjct: 166 EVLLGKGYGKAVDI 179
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 53/191 (27%), Positives = 77/191 (40%), Gaps = 42/191 (21%)
Query: 669 IGSGSFGSVL-----------------HNERTGSWKSFIAECETLRNVRHRNLVKLITSC 711
+G G FG+V + + + + E E L+ + H N+VKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHNDCEVP 762
++ L LV E+ GSL D + L I L+YLH
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 763 VVHSDLKPGNILLDE-EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
++H DLKP NILLD K+ DFGL++ L S S +G+ Y+ PE L
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLL------TSDKSLLKTIVGTPAYMAPEVLL 166
Query: 822 GERP-STAGDV 831
G+ S D+
Sbjct: 167 GKGYYSEKSDI 177
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 63/190 (33%), Positives = 85/190 (44%), Gaps = 41/190 (21%)
Query: 669 IGSGSFGSV----------------LHNERTGSWK--SFIAECETLRNVRHRNLVKLITS 710
+GSGSFG+V L S K + E LR + H N+V+LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCEVP 762
+ D + L LV E+ G L D++ D I L+YLH++
Sbjct: 65 DAFEDKDH---LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822
++H DLKP NILLDE K+ DFGLA+ LL+ S SS F+G+ Y+ PE LG
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLK------SSSSLTTFVGTPWYMAPEVLLG 172
Query: 823 ERP-STAGDV 831
DV
Sbjct: 173 GNGYGPKVDV 182
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 36/196 (18%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
++ L+G GSFGSV L + ++ E L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NE-------LDITSALDYL 755
+V+ S + L + E++S GSL + K E I L YL
Sbjct: 61 IVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H++ +VH D+K NIL+D + K+ DFG A+ R+ + + T G+ ++
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEGTGSVRGTPYWM 170
Query: 816 PPEYGLGERPSTAGDV 831
PE GE A D+
Sbjct: 171 APEVIRGEEYGRAADI 186
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 39/157 (24%)
Query: 669 IGSGSFGSV--------------------LHNERTGS-WKSFIAECETLRNVRHRNLVKL 707
+G G+FG V L + + + F+ E +R + H N+VKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
+ C+ E L +V E++ G L D++ R EL I ++YL
Sbjct: 67 LGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+H DL N L+ E + K+ DFGL+R L +
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 9e-20
Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 38/157 (24%)
Query: 669 IGSGSFGSV--------------------LHNERTGS-WKSFIAECETLRNVRHRNLVKL 707
+G G+FG V L + + + F+ E +R + H N+VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSALDYLHND 758
+ C+ E L +V E++ G L ++ R L I ++YL
Sbjct: 67 LGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
+H DL N L+ E + K+ DFGL+R L +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 58/195 (29%), Positives = 80/195 (41%), Gaps = 41/195 (21%)
Query: 669 IGSGSFGSVLHNER--TG---SWKS-------------FIAECETLRNVRHRNLVKLITS 710
IG GSFG+V R G WK ++E LR ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSALDYLHN- 757
+D N + L +V E+ G L I +K + AL HN
Sbjct: 68 --IIDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 758 -DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
D V+H DLKP NI LD K+GDFGLA+ L + SS + T+V G+ Y+
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----GHDSSFAKTYV--GTPYYMS 178
Query: 817 PEYGLGERPSTAGDV 831
PE D+
Sbjct: 179 PEQLNHMSYDEKSDI 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 40/188 (21%)
Query: 669 IGSGSFGSV--LHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCS 712
IG G FG V ++RTG + I E + L+ +H N+VK S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY--GS 65
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELDIT-------SALDYLHNDCEVPV 763
L + L +V EF S GSL D + + E I L+YLH++ +
Sbjct: 66 YLKK---DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GI 119
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE 823
+H D+K NILL + K+ DFGL+ L S + + +G+ ++ PE G+
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQL-------SDTKARNTMVGTPYWMAPEVINGK 172
Query: 824 RPSTAGDV 831
D+
Sbjct: 173 PYDYKADI 180
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 40/157 (25%)
Query: 669 IGSGSFGSVLH-------------------NERTGS--WKSFIAECETLRNVRHRNLVKL 707
+G G+FG V E + F+ E ++ + H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
+ C+ + L +V E++ G L D++ + +L I ++YL
Sbjct: 67 LGVCTQGEP-----LYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
VH DL N L+ E + K+ DFGL+R + E
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE 154
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 35/163 (21%), Positives = 60/163 (36%), Gaps = 45/163 (27%)
Query: 667 NLIGSGSFGSVL--------------------HNERTGSWKSFIAECETLRNVRHRNLVK 706
+G G+FG V + K F+ E ++ + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-----------------LDIT 749
L+ + + LV E++ G L D++ R + I
Sbjct: 61 LL-GVCTEEEPLY----LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
++YL VH DL N L+ E++ K+ DFGL+R +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 58/191 (30%), Positives = 82/191 (42%), Gaps = 45/191 (23%)
Query: 669 IGSGSFGSVL--HNERTGSW-------KSFI----------AECETLRNVRHRNLVKLIT 709
+G GSFG VL + TG K I E L + H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDC 759
+ + E L LV E+ G L + H ++ I AL+YLH+
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAEIVLALEYLHS-- 111
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
+ +++ DLKP NILLD + K+ DFGLA+ + S S T+ F G+ Y+ PE
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAK------ELSSEGSRTNTFCGTPEYLAPEV 164
Query: 820 GLGERPSTAGD 830
LG+ A D
Sbjct: 165 LLGKGYGKAVD 175
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 31/146 (21%)
Query: 668 LIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCSSL 714
IG G FG V+ + G + ++F+AE + +RH NLV+L+ L
Sbjct: 13 TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV--L 70
Query: 715 DSKNMEFLALVYEFLSNGSLGDWI------HGERKNEL----DITSALDYLHNDCEVPVV 764
L +V E+++ GSL D++ +L D+ ++YL E V
Sbjct: 71 QGNP---LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLAR 790
H DL N+L+ E++ AKV DFGLA+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 44/190 (23%)
Query: 669 IGSGSFGSVLHNERTGSWKS------------------FIAECETLRNVRHRNLVKLITS 710
+GSG FG V G W+ FI E + + + H NLV+L
Sbjct: 12 LGSGQFGVV----HLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHNDCEV 761
C+ K + +V E+++NG L +++ + D+ A++YL ++
Sbjct: 68 CT----KQRP-IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
+H DL N L+ E+ KV DFGLAR++L D+Q + S F + + PPE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVL---DDQYTSSQGTKF--PVKWAPPEVFD 174
Query: 822 GERPSTAGDV 831
R S+ DV
Sbjct: 175 YSRFSSKSDV 184
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 40/196 (20%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
N+ +LIG G+FG V L + + KS + E + L+N++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-ERKNEL-------DITSALDYL 755
+VK I S + + L ++ E+ NGSL I E + L YL
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H V+H D+K NIL ++ K+ DFG+A +G+ ++
Sbjct: 116 HEQ---GVIHRDIKAANILTTKDGVVKLADFGVA------TKLNDVSKDDASVVGTPYWM 166
Query: 816 PPEYGLGERPSTAGDV 831
PE STA D+
Sbjct: 167 APEVIEMSGASTASDI 182
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 52/212 (24%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETL-RNVRH 701
+F +IG GSF +V+ + + K + E E L R H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKNELD-------ITSAL 752
++KL + D +N L V E+ NG L +I G +E I AL
Sbjct: 62 PGIIKLY--YTFQDEEN---LYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLAL 115
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV----- 807
+YLH+ ++H DLKP NILLD++M K+ DFG A+ L +S+
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 808 ---------FMGSIGYVPPEYGLGERPSTAGD 830
F+G+ YV PE + + D
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSD 204
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 43/117 (36%), Positives = 64/117 (54%), Gaps = 11/117 (9%)
Query: 52 WNPSSSPCT-----WPGVIC---NNFGNRVI-GLNLSSFGLEGTISPHIGNLSFLRSIQL 102
WN PC W G C + G I GL L + GL G I I L L+SI L
Sbjct: 392 WN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINL 449
Query: 103 QNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRV 159
N + GN+P +G++ L VL++S+N+ G +P ++ +LT L++L+L N ++GRV
Sbjct: 450 SGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 40/89 (44%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE 392
L LD G IP I L + L GN I G IP S+G + SL +LDLSYNS +G
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 393 IPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
IP +GQL L++L L GN + G +P +L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 7e-15
Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 46/183 (25%)
Query: 667 NLIGSGSFGSVLHNERTGSWKSFIA------------------ECETLRNVRHRNLVKLI 708
IG GSFG V R K ++ E + L+ + H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LD----ITSALDYL 755
S + K L +V E+ G L I ++K E LD + AL YL
Sbjct: 66 ---ESFEEKGK--LCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H+ ++H D+KP NI L K+GDFG+++ L S++ +G+ Y+
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL------SSTVDLAKTVVGTPYYL 170
Query: 816 PPE 818
PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 35/80 (43%), Positives = 48/80 (60%)
Query: 367 GKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKK 426
G IP I +LR L ++LS NSI G IP +G + L+VL L+ N G IP SL L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 427 LNQIDLSGNELTGEIPISFG 446
L ++L+GN L+G +P + G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 50/185 (27%), Positives = 75/185 (40%), Gaps = 46/185 (24%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFIA--------------------ECETLRNVRH 701
+F +G+GSFG V R + A E L+++RH
Sbjct: 2 DFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALD 753
LV L S D N L LV E++ G L + + + AL+
Sbjct: 61 PFLVNLYGSFQ--DDSN---LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
YLH+ ++ V+ DLKP N+LLD + K+ DFG A+ + R T+ G+
Sbjct: 116 YLHS-LDI--VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---------TYTLCGTPE 163
Query: 814 YVPPE 818
Y+ PE
Sbjct: 164 YLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 15/110 (13%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN------- 744
E E LR + H N+VK C ++ L L+ E+L +GSL D++ R
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLL 112
Query: 745 --ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
I +DYL + +H DL NIL++ E K+ DFGLA+ L
Sbjct: 113 LFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 30/152 (19%)
Query: 667 NLIGSGSFGSVL--HNERTG----------------SWKSFIAECETLRNVRHRNLVKLI 708
IGSG++G V ++RTG K + E + LR++RH N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
++ + +V E + L I + D I L YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---S 121
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
V+H DLKP NIL++ K+ DFGLAR +
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 39/92 (42%), Positives = 59/92 (64%), Gaps = 1/92 (1%)
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLE 532
+P +IS+L ++ +I+LS NS+ GN+P SL + SLE L ++YN F+G IP + +L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 533 VLDLSSNKLSGSIPSDLQNLQALR-SLNLTFN 563
+L+L+ N LSG +P+ L R S N T N
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.2 bits (178), Expect = 2e-13
Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 37/190 (19%)
Query: 662 NFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRH-RNL 704
++ +G GSFG V + F+ E + L ++ H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH-----------GERKNELDITSALD 753
VKL S L LV E++ GSL D + I SAL+
Sbjct: 61 VKLYDFFQDEGS-----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
YLH ++H D+KP NILLD + K+ DFGLA+ L + S + +G+
Sbjct: 116 YLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 813 GYVPPEYGLG 822
GY+ PE LG
Sbjct: 173 GYMAPEVLLG 182
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 48/193 (24%)
Query: 669 IGSGSFGSV---LH--------------NERTGSWKSFIAECETLRNVRHRNLVKL---- 707
+G GS G V H + K + E +TLR+ +VK
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELD-------ITSALDYLHND 758
+++V E++ GSL D + + E I LDYLH
Sbjct: 69 YKEGE---------ISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ +H D+KP N+L++ + K+ DFG+++ L +D ++ F+G++ Y+ PE
Sbjct: 119 RHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT------FVGTVTYMSPE 170
Query: 819 YGLGERPSTAGDV 831
GE S A D+
Sbjct: 171 RIQGESYSYAADI 183
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 44/185 (23%)
Query: 662 NFSHENLIGSGSFGSVL---HNE----------------RTGSWKSFIAECETLRNVRHR 702
+F +IG G+FG V + GS ++ + E L+ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 703 NLVKLITSCSSL-DSKNMEFLALVYEFLSNGSLGDWI-HGERKNE-------LDITSALD 753
LV L S D +NM LV + L G L + + +E +I AL+
Sbjct: 61 FLVNL---WYSFQDEENM---YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE 114
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
YLH+ ++H D+KP NILLDE+ + DF +A + S+ G+ G
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-------GTPG 164
Query: 814 YVPPE 818
Y+ PE
Sbjct: 165 YMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 32/148 (21%)
Query: 669 IGSGSFGSV---LHN-----------ERTGSWKSFIAECETLRNVRHRNLVKLITSCSSL 714
+G+G FG V N T S ++F+ E + ++ +RH LV+L CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-- 71
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALD----------YLHNDCEVPVV 764
E + +V E++S GSL D++ +L + +D YL +
Sbjct: 72 ---EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFL 792
H DL NIL+ E + K+ DFGLAR +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 66/276 (23%)
Query: 669 IGSGSFGSVLHNERTGSWKS------------------FIAECETLRNVRHRNLVKLITS 710
+GSG FG V G W++ FI E + + + H LV+L
Sbjct: 12 LGSGQFGVV----HLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCE 760
C+ + L +V EF+ NG L +++ +R+ +L D+ ++YL +
Sbjct: 68 CT-----QQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
+H DL N L+ KV DFG+ R++L D++ + SS F + + PPE
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL---DDEYTSSSGAKF--PVKWSPPEVF 173
Query: 821 LGERPSTAGDVPTSESFAGEFNIVKW---VESNLP---ENVLQVLDPELRQLMTSNESQT 874
+ S+ DV + F ++ W E +P ++ +V++ M S +
Sbjct: 174 NFSKYSSKSDVWS-------FGVLMWEVFTEGKMPFEKKSNYEVVE------MISRGFRL 220
Query: 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910
+ +T+ V SC E P GR E LR +
Sbjct: 221 YRPKLASMTVY-EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 51/188 (27%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG G++G V + NE+ G + I E + L+ +RH N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 711 CSSLDSKNMEFLALVYEFLS---NGSLGDWIHGERKNELDIT------------SALDYL 755
+S + + +V+E++ G L E+ T L YL
Sbjct: 67 VTSKGKGS---IYMVFEYMDHDLTGLL-------DSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H++ ++H D+K NIL++ + K+ DFGLAR ++S T+ + ++ Y
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPY----TKRNSADYTNR-VITLWYR 168
Query: 816 PPEYGLGE 823
PPE LG
Sbjct: 169 PPELLLGA 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 44/210 (20%)
Query: 644 FKVCHPKISYDELRRATGNFSHENLIGSGSFGSV------------------LHNERTGS 685
F C Y++L IG G+FG V + NE+ G
Sbjct: 5 FPFCDEVSKYEKL----------AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54
Query: 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA---LVYEF-------LSNGSLG 735
+ + E + L+ ++H N+V LI C + + + LV+EF L +
Sbjct: 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV 114
Query: 736 DWIHGERKNELD-ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+ E K + + + L Y+H + ++H D+K NIL+ ++ K+ DFGLAR
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER 824
+++ + + V ++ Y PPE LGER
Sbjct: 172 SKNSKPNRYTNRVV--TLWYRPPELLLGER 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 33/159 (20%)
Query: 663 FSHENLIGSGSFGSV---------------LHNERTGSWKSFIAECETLRNVRHRNLVKL 707
F+ E +GSG FG V L ++ + F E + L+ +RH++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALD----------YLHN 757
CS + + ++ E + GSL ++ L + S +D YL
Sbjct: 68 FAVCSVGEP-----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796
E +H DL NIL+ E++ KV DFGLAR + E V
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 34/85 (40%), Positives = 49/85 (57%)
Query: 382 LDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEI 441
L L + G IP +I +L+ LQ + L+GN I G IP SL ++ L +DLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 442 PISFGNFQSLLSIDLSNNRINGNIP 466
P S G SL ++L+ N ++G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 34/162 (20%)
Query: 662 NFSHENL---IGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVK 706
N L IG G FG+VL E TG + ++F+ E + + H+NLV+
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----------ELDITSALDYLH 756
L L L +V E +S G+L +++ + LD+ ++YL
Sbjct: 64 L------LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798
+ +VH DL NIL+ E+ AKV DFGLAR VDN
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 38/185 (20%)
Query: 669 IGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716
IG G FG V+ + G + ++F+AE + +RH NLV+L+
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 717 KNMEFLALVYEFLSNGSLGDWIH--------GER--KNELDITSALDYLHNDCEVPVVHS 766
L +V E+++ GSL D++ G+ K LD+ A++YL + VH
Sbjct: 74 G----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 767 DLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPS 826
DL N+L+ E+ AKV DFGL + SS T + + PE ++ S
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKL--PVKWTAPEALREKKFS 177
Query: 827 TAGDV 831
T DV
Sbjct: 178 TKSDV 182
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 73/253 (28%), Positives = 111/253 (43%), Gaps = 40/253 (15%)
Query: 307 NKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIY 366
+ + S I+ L T+L L LD N IP IG + L +L L N I
Sbjct: 95 LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI- 152
Query: 367 GKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKK 426
+P+ + L +L LDLS+N +S ++P + L L L L+GN+I +P + L
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSA 210
Query: 427 LNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486
L ++DLS N + E+ S N ++L ++LSNN++
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE------------------------ 245
Query: 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP 546
+LP S+ N +LE L ++ NQ S + + L L LDLS N LS ++P
Sbjct: 246 ---------DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294
Query: 547 SDLQNLQALRSLN 559
L L L
Sbjct: 295 LIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/186 (29%), Positives = 82/186 (44%), Gaps = 36/186 (19%)
Query: 669 IGSGSFGSV------------LHNERTG--SWKSFIAECETLRNVRHRNLVKLITSCSSL 714
IGSG FG V + R G S + FI E + + + H LV+L C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHNDCEVPVVH 765
+ LV+EF+ +G L D++ +R LD+ + YL + V+H
Sbjct: 72 SP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 766 SDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP 825
DL N L+ E KV DFG+ RF+L D+Q + S+ F + + PE +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVL---DDQYTSSTGTKF--PVKWSSPEVFSFSKY 178
Query: 826 STAGDV 831
S+ DV
Sbjct: 179 SSKSDV 184
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 57/187 (30%), Positives = 83/187 (44%), Gaps = 38/187 (20%)
Query: 669 IGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSL 714
+G G FG V G S ++F+ E + ++ +RH LV+L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCEVPVV 764
E + +V E++S GSL D++ GE L I S + Y+ + V
Sbjct: 73 -----EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER 824
H DL+ NIL+ E + KV DFGLAR L+E DN+ + F I + PE L R
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLAR-LIE--DNEYTARQGAKF--PIKWTAPEAALYGR 179
Query: 825 PSTAGDV 831
+ DV
Sbjct: 180 FTIKSDV 186
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 44/190 (23%)
Query: 669 IGSGSFGSVLHNERTGSWK------------------SFIAECETLRNVRHRNLVKLITS 710
+G+G FG V + G W+ FI E + + + H LV+L
Sbjct: 12 LGTGQFGVV----KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYLHNDCEV 761
C+ + +V E++SNG L +++ K +L D+ + YL +
Sbjct: 68 CTK-----QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--- 119
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
+H DL N L+D++ KV DFGL+R++L D++ + S F + + PPE L
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL---DDEYTSSVGSKF--PVRWSPPEVLL 174
Query: 822 GERPSTAGDV 831
+ S+ DV
Sbjct: 175 YSKFSSKSDV 184
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (164), Expect = 7e-12
Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 42/159 (26%)
Query: 663 FSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNL 704
+ +G G++G V L NE G + + E L+ ++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT------------SAL 752
VKL+ + L LV+E+ L ++ K ++ L
Sbjct: 61 VKLLDVIHTERK-----LYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGL 111
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
Y H+ ++H DLKP NIL++ + K+ DFGLAR
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 21/145 (14%)
Query: 685 SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERK 743
S E + + H N+VK TS D L LV +LS GSL D + +
Sbjct: 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE-----LWLVMPYLSGGSLLDIMKSSYPR 96
Query: 744 NELD----------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793
LD + L+YLH++ ++ H D+K GNILL E+ + K+ DFG++ L
Sbjct: 97 GGLDEAIIATVLKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLA 153
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPE 818
+ D + T F+G+ ++ PE
Sbjct: 154 DGGDRTRKVRKT--FVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 35/163 (21%)
Query: 655 ELRRATGNFSHENLIGSGSFGSVL------HN---------ERTGSWKSFIAECETLRNV 699
E+ R + + ++ +G G +G V ++ E T + F+ E ++ +
Sbjct: 2 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 59
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------IT 749
+H NLV+L+ C+ + F ++ EF++ G+L D++ + E++ I+
Sbjct: 60 KHPNLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
SA++YL +H DL N L+ E KV DFGL+R +
Sbjct: 115 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 154
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 36/152 (23%)
Query: 669 IGSGSFGSV---LHNERT---------GSW--KSFIAECETLRNVRHRNLVKLITSCSSL 714
+G+G FG V L N T G+ K F+AE + ++ +RH L++L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALD----------YL--HNDCEVP 762
+ + +V E + GSL +++ G L + +D YL N
Sbjct: 74 EP-----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----- 123
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+H DL N+L+ E KV DFGLAR + E
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKE 155
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 32/165 (19%)
Query: 669 IGSGSFGSVL--HNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713
IG G+ G V + TG + + I E +++ +H N+V S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDS--- 83
Query: 714 LDSKNMEFLALVYEFLSNGSLGDWI--HGERKNE-------LDITSALDYLHNDCEVPVV 764
+ L +V E++ GSL D I + R NE ++ L+YLH+ V+
Sbjct: 84 --YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVI 138
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM 809
H D+K NILL ++ + K+ DFG A L + ++S+ T +M
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 46/152 (30%), Positives = 66/152 (43%), Gaps = 31/152 (20%)
Query: 668 LIGSGSFGSV--------------------LHNERTGSWKSFIAECETLRNVRHRNLVKL 707
+G G+FGSV L + + F E E L++++H N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDC-------E 760
C S +N+ LV E+L GSL D++ + + LD L Y C
Sbjct: 71 KGVCYSAGRRNLR---LVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
VH DL NIL++ E K+GDFGL + L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 34/151 (22%)
Query: 668 LIGSGSFGSVL--HNERTG---SWKSFIA-------------ECETLRNVRHRNLVKLIT 709
L+G GS+G V+ ++ TG + K F+ E L+ +RH NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEV 761
+ + L LV+EF+ + L D RK I +++ H+
Sbjct: 68 VF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
++H D+KP NIL+ + K+ DFG AR L
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 50/205 (24%)
Query: 639 GVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWKSF--------- 689
SA S EL R N IGSG+ G+V + + +
Sbjct: 59 SSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 690 --------IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSL-GDWIHG 740
E E LR+V H N+VK C + N E + ++ EF+ GSL G I
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGE-IQVLLEFMDGGSLEGTHIAD 166
Query: 741 ERKNEL-----DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
E+ L I S + YLH +VH D+KP N+L++ K+ DFG++R L +
Sbjct: 167 EQ--FLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221
Query: 796 VD--NQSSISSTHVFMGSIGYVPPE 818
+D N S +G+I Y+ PE
Sbjct: 222 MDPCNSS--------VGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 36/155 (23%)
Query: 668 LIGSGSFGSVL--HNERTGSW---KSFIA-------------ECETLRNVRHRNLVKLIT 709
++G G++G VL N+ TG K F E + LR +RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSL--------GDWIHGERKNELDITSALDYLH-NDCE 760
+ L LV+E++ L G R + A+ Y H ++
Sbjct: 68 AFRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI- 121
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
+H D+KP NIL+ E K+ DFG AR L R
Sbjct: 122 ---IHRDIKPENILVSESGVLKLCDFGFARALRAR 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 48/186 (25%)
Query: 662 NFSHENLIGSGSFGSV-LHNERTGSWKSFIA--------------------ECETLRNVR 700
+ +G+G+FG V L +R + + A E L+ V
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRIS--EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NEL------DITSAL 752
H +++L + D + FL ++ E++ G L ++ + N +I AL
Sbjct: 60 HPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
+YLH+ +V+ DLKP NILLD+E K+ DFG A+ L +R T G+
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---------TWTLCGTP 162
Query: 813 GYVPPE 818
Y+ PE
Sbjct: 163 EYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 48/188 (25%), Positives = 75/188 (39%), Gaps = 40/188 (21%)
Query: 667 NLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLI 708
N IG G+FG V + + + K E + L ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLHNDCE 760
++ E + + E+ S G+L + + R + L + L YLH
Sbjct: 64 --YYGVEVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---S 117
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV--FMGSIGYVPPE 818
+VH D+KP NI LD K+GDFG A ++ N ++ V G+ Y+ PE
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAV----KLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 819 YGLGERPS 826
G +
Sbjct: 174 VITGGKGK 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 49/179 (27%), Positives = 67/179 (37%), Gaps = 46/179 (25%)
Query: 669 IGSGSFGSV-----LHNERTGSWKSFI--------------AECETLRNVRHRNLVKLIT 709
+G G FG V RT + K +E E L H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDC 759
+ D K + L E+ G L + + D + A +YLHN
Sbjct: 61 TFK--DKKYIYML---MEYCLGGELWTILR--DRGLFDEYTARFYIACVVLAFEYLHNR- 112
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+++ DLKP N+LLD K+ DFG A+ L S T F G+ YV PE
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-------KSGQKTWTFCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 54/189 (28%)
Query: 667 NLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVR---HRNLV 705
IG G++G+V + G S + E L+ + H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 706 KLITSCSSLDSKNMEFLALVYE--------FLSNGS--------LGDWIHGERKNELDIT 749
+L+ C + L LV+E +LS + D + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-------QLL 117
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM 809
+D+LH+ +VH DLKP NIL+ + K+ DFGLAR + +++S V
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVV-- 168
Query: 810 GSIGYVPPE 818
++ Y PE
Sbjct: 169 -TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 48/152 (31%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--- 747
E + L + +VKL S KN L LV E+L G L + LD
Sbjct: 42 TERDILSQAQSPYVVKLY--YSFQGKKN---LYLVMEYLPGGDLASLLENV--GSLDEDV 94
Query: 748 -------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF-LLERVDNQ 799
I AL+YLH+ ++H DLKP NIL+D K+ DFGL++ L+ R N
Sbjct: 95 ARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151
Query: 800 SSISS-THVFMGSIGYVPPEYGLGERPSTAGD 830
+ +G+ Y+ PE LG+ S D
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVD 183
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 83/333 (24%), Positives = 134/333 (40%), Gaps = 20/333 (6%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV-PSTIYNMTSLVHLRLASNQLGGEIP 241
+ P SI P + L L ++ + PS++ + SL L +
Sbjct: 28 TTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE 87
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
+ LD NR L LTN+ + + +N + P L+
Sbjct: 88 NLLNLLPLPSLDLNL--NRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKE 144
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
++ NKI S + L N +L L L N +P+ + N + L+ L L
Sbjct: 145 LDLSDNKI--------ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLS 194
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
GN I +P I L +L LDLS NSI E+ + L+ L L L+ N++ +P S+
Sbjct: 195 GNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESI 251
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLE 481
NL L +DLS N+++ S G+ +L +DLS N ++ +P L L E L
Sbjct: 252 GNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLE-LLLN 308
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY 514
++T+ + L+ L N+ A
Sbjct: 309 LLLTLKALELKLNSILLNNNILSNGETSSPEAL 341
|
Length = 394 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 663 FSHENLIGSGSFGSV---LHNER-----------TGSWKSFIAECETLRNVRHRNLVKLI 708
F +G GS+GSV +H E + I E L+ +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELDITS-------ALDYLHNDC 759
S L +V E+ GS+ D + K E +I + L+YLH+
Sbjct: 65 ---GSYFKNTD--LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-- 117
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM 809
+H D+K GNILL+EE AK+ DFG++ L + + ++++ T +M
Sbjct: 118 -NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWM 166
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 51/247 (20%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFI------------------AECETLRNVRHRN 703
+ ++G G+FG V R K I EC+ L+ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY-------LH 756
+++ + L+ K L +V E+ G+L ++I + LD + L + LH
Sbjct: 61 IIEYYEN--FLEDKA---LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 757 NDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
+ ++H DLK NILLD+ +M K+GDFG+++ L SS S + +G+ Y+
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVVGTPCYI 168
Query: 816 PPEYGLGERPSTAGDVPTSESFAGEFNIVK--WVESNLPENVLQVL-----------DPE 862
PE G+ + D+ E +K + +NLP VL+++ P+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD 228
Query: 863 LRQLMTS 869
LRQL+ S
Sbjct: 229 LRQLILS 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 56/207 (27%), Positives = 84/207 (40%), Gaps = 57/207 (27%)
Query: 640 VSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLH--NERTGS------------ 685
++ LF P+ + +LR IG GSFG+V + RT
Sbjct: 4 IAELFSKDDPEKLFTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 53
Query: 686 -----WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740
W+ I E L+ +RH N ++ C + LV E+ GS D +
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEY-KGCYLREHTAW----LVMEYCL-GSASDILEV 107
Query: 741 ERK--NELDIT-------SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
+K E++I L YLH+ + H D+K GNILL E T K+ DFG A
Sbjct: 108 HKKPLQEVEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSA-- 162
Query: 792 LLERVDNQSSISSTHVFMGSIGYVPPE 818
S +S + F+G+ ++ PE
Sbjct: 163 --------SLVSPANSFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 27/145 (18%)
Query: 669 IGSGSFGSV---LHN-----------ERTGSWKSFIAECETLRNVRHRNLVKLITSCSSL 714
+G+G FG V +N + + S ++F+AE ++ ++H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCE-------VPVVHSD 767
E + ++ E++ NGSL D++ +L I +D E +H D
Sbjct: 73 -----EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 768 LKPGNILLDEEMTAKVGDFGLARFL 792
L+ NIL+ E + K+ DFGLAR +
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 32/180 (17%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721
+F N IG GSFG V R + + + L + R + I L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 722 -------------LALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHND 758
L +V E+ NG L + +R L I L +LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
++H D+K N+ LD K+GD G+A+ L + ++ ++T V G+ Y+ PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL----SDNTNFANTIV--GTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 42/165 (25%), Positives = 61/165 (36%), Gaps = 47/165 (28%)
Query: 668 LIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRHRN 703
+G GSFG V R G W + F+ E + ++ H N
Sbjct: 2 KLGDGSFGVV----RRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALD 753
L++L L M +V E GSL D + + I + +
Sbjct: 58 LIRLYGVV--LTHPLM----MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798
YL + +H DL NILL + K+GDFGL R L + D+
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 25/110 (22%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IP+D+S+L +L+ ++L+ N + G +P ++ ++TSL L L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS------------------- 474
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
+N F G IP SL LT+++I+ + N L G +P LG R
Sbjct: 475 ------YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA 518
|
Length = 623 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 41/152 (26%), Positives = 58/152 (38%), Gaps = 37/152 (24%)
Query: 669 IGSGSFGSV-------------------LHNERTGSWKS-FIAECETLRNVRHRNLVKLI 708
+G G+FGSV L E + K F+ E + + H +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELDIT-------SALDYLHNDCE 760
C E L LV E G L ++ R+ D+ + YL
Sbjct: 63 GVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---S 113
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
VH DL N+LL AK+ DFG++R L
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 39/175 (22%)
Query: 669 IGSGSFGSV--LHNERTGSWKS--------------FIAECETLRNVRHRNLVKLITSCS 712
+G G+FG V ++ TG + + F+ E + L +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY-EAY 71
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWI----HGERKNEL-----DITSALDYLHNDCEVPV 763
++K L ++ EF G+L + G + ++ + AL++LH+ V
Sbjct: 72 FYENK----LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H DLK GNILL + K+ DFG++ N+S++ F+G+ ++ PE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVS------AKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 42/188 (22%), Positives = 68/188 (36%), Gaps = 41/188 (21%)
Query: 669 IGSGSFGSV----------------LHNERTGSW--KSFIAECETLRNVRHRNLVKLITS 710
IG G+ G V + R + E + L+ +H +VKL+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELDITS-------ALDYLHNDCEV 761
LV E++ L + + E + E + S + Y+H
Sbjct: 68 FPHGSG-----FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---AN 118
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
++H DLKP N+L+ + K+ DFGLAR + +H + + Y PE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLF----SEEEPRLYSHQ-VATRWYRAPELLY 173
Query: 822 GERPSTAG 829
G R G
Sbjct: 174 GARKYDPG 181
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 669 IGSGSFGSVLHNERTGSWK--------------SFIAECETLRNVRHRNLVKLITSCSSL 714
+G G FG V G+ K +F+ E + ++ +RH LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72
Query: 715 DSKNMEFLALVYEFLSNGSL------GDWIHGERKNELDITSAL-DYLHNDCEVPVVHSD 767
E + +V EF+ GSL GD + + +D+ + + D + + +H D
Sbjct: 73 -----EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPST 827
L+ NIL+ + + K+ DFGLAR L+E DN+ + F I + PE L R +
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR-LIE--DNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 828 AGDV 831
DV
Sbjct: 183 KSDV 186
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 1/93 (1%)
Query: 96 FLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155
F+ + L N L G +P +I L L+ +N+S N+++G +P ++ +T L++LDL N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSI 188
G + + L L SL++LN N L G +P ++
Sbjct: 479 NGSIP-ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 35/87 (40%), Positives = 53/87 (60%), Gaps = 3/87 (3%)
Query: 314 DDEGL-SFITS-LTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
D++GL FI + ++ HL + L GN G IP S+G+ ++ L L L N G IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSFNGSIPE 484
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIG 398
S+G+L SL +L+L+ NS+SG +P +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 68/255 (26%)
Query: 668 LIGSGSFGSVL-------------------------HNERTGSW-KSFIAECETLRNVRH 701
LIG G++G V H+ R K+ +E ETL+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT--------SALD 753
N+V+ + ++ + L++ E++ GS+G + + E + L
Sbjct: 68 LNIVQYLGFETTEEY-----LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR------------------FLL-- 793
YLH+ ++H DLK N+L+D + K+ DFG+++ F +
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVES-NLP 852
E + + S S V + S+G V E G RP + E+ A F + + +P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKRSAPPIP 234
Query: 853 ENVLQVLDPELRQLM 867
+V L P +
Sbjct: 235 PDVSMNLSPVALDFL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 34/150 (22%)
Query: 669 IGSGSFGSVL------HNERTGSW---------------KSFIAECETLRNVRHRNLVKL 707
+G G FG V N+ TG + E L+ + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCE------- 760
CS K L L+ E++ GSL D++ K++L++ L + CE
Sbjct: 72 KGCCSEQGGKG---LQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+H DL N+LLD + K+GDFGLA+
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 40/199 (20%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG-------------------SWKSFIAECETLRNVR 700
N+ L+G G+FG V ++ TG + E + L+N++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HG------ERKNELDITSAL 752
H +V+ C D E L++ E++ GS+ D + +G RK I +
Sbjct: 63 HERIVQYY-GCLRDD----ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
+YLH++ +VH D+K NIL D K+GDFG ++ L + + + S G+
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTP 171
Query: 813 GYVPPEYGLGERPSTAGDV 831
++ PE GE DV
Sbjct: 172 YWMSPEVISGEGYGRKADV 190
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 26/138 (18%)
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL---- 746
AE L V+H +V LI + + K L L+ E+LS G L ++H ER+
Sbjct: 49 AERNILEAVKHPFIVDLIYAFQT-GGK----LYLILEYLSGGEL--FMHLEREGIFMEDT 101
Query: 747 ------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800
+I+ AL++LH + +++ DLKP NILLD + K+ DFGL + ++
Sbjct: 102 ACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK------ESIH 152
Query: 801 SISSTHVFMGSIGYVPPE 818
+ TH F G+I Y+ PE
Sbjct: 153 EGTVTHTFCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-09
Identities = 23/43 (53%), Positives = 32/43 (74%), Gaps = 2/43 (4%)
Query: 26 INTDKEALMSFKSQISQESPSSPLSYWNPSSS-PCTWPGVICN 67
+N D++AL++FKS ++ PS LS WNPSSS PC+W GV C+
Sbjct: 1 LNDDRDALLAFKSSLN-GDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 385 SYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS 444
++ +P + +L L +L +G G N L NL L +DL+ N L I
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLL-NLLPLPSLDLNLNRLRSNISEL 112
Query: 445 FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC 504
+L S+DL NN I P ++ L + L DLSDN + +LP+ L+N
Sbjct: 113 L-ELTNLTSLDLDNNNITDIPP--LIGLLKSNLKEL------DLSDNKIE-SLPSPLRNL 162
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564
+L+ L +++N S +P +++ L L LDLS NK+S +P +++ L AL L+L+ N+
Sbjct: 163 PNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220
Query: 565 LEGVVPSEGIFRNMSNVHLKGNPKLCLQLGCENPRS 600
+ ++ S +N+S + L N L N +
Sbjct: 221 IIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 44/180 (24%)
Query: 668 LIGSGSFGSVLH--NERTGSW---------------KSFIAECET----LRNVRHRNLVK 706
L+GSGSFGSV N G + + + + E L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNEL------DITSALDYLHND 758
+ + D+ + FL E + GSL + +G + I L+YLH+
Sbjct: 67 YLGTEREEDNLYI-FL----ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VH D+K NIL+D K+ DFG+A+ ++E S S F GS ++ PE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKS---FKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 40/155 (25%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNL----------VKLITSCS 712
F+ IG GSFG V +K+ + ++ +L + I S
Sbjct: 3 FTLLECIGKGSFGEV--------YKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLS 54
Query: 713 SLDS-----------KNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDY 754
S K + L ++ E+ GS D + + +E ++ L+Y
Sbjct: 55 QCRSPYITKYYGSFLKGSK-LWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEY 113
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
LH + +H D+K NILL EE K+ DFG++
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 49/162 (30%)
Query: 666 ENLIGSGSFGSV----------------LHNERTGS----WKSFIAECETLRNVRHRNLV 705
E +IG G FG V + + GS F+ E + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 706 KL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITS 750
+L +T + M ++ E++ NGSL ++ R+N+ I S
Sbjct: 69 RLEGVVTKSRPV----M----IITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIAS 117
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ YL VH DL NIL++ + KV DFGL+R L
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 38/187 (20%)
Query: 669 IGSGSFGSVLHNERTGSWK--------------SFIAECETLRNVRHRNLVKLITSCSSL 714
+G+G FG V G+ K SF+ E + ++ +RH LV+L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE- 72
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIH-GERKN---------ELDITSALDYLHNDCEVPVV 764
E + +V E++S GSL D++ GE + + + + Y+ + +
Sbjct: 73 -----EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER 824
H DL+ NIL+ + + K+ DFGLAR L+E DN+ + F I + PE L R
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLAR-LIE--DNEYTARQGAKF--PIKWTAPEAALYGR 179
Query: 825 PSTAGDV 831
+ DV
Sbjct: 180 FTIKSDV 186
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 6e-09
Identities = 44/162 (27%), Positives = 64/162 (39%), Gaps = 51/162 (31%)
Query: 669 IGSGSFGSVL--HNERTG-------------SWKSFIAECETLRNVR-------HRNLVK 706
+G G+FGSV N+ TG SW+ EC LR V+ H N+VK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNEHPNIVK 62
Query: 707 L---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALD 753
L ++ L V+E++ G+L + + I L
Sbjct: 63 LKEVF-----RENDE---LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
++H H DLKP N+L+ K+ DFGLAR + R
Sbjct: 114 HIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 52/190 (27%), Positives = 81/190 (42%), Gaps = 46/190 (24%)
Query: 669 IGSGSFGSV-LHNER-TGSW-------KSFIAECETLRNVRHRNLVKLITSCS------- 712
I G+FGSV L +R TG + KS + + NV+ + +I S
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 713 -SLDSKNMEFLALVYEFLSNGSLG-----------DWIHGERKNELDITSALDYLHNDCE 760
S SK ++L LV E+L+ G DW ++ ++ ++ LH
Sbjct: 64 YSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWA---KQYIAEVVLGVEDLHQR-- 116
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
++H D+KP N+L+D+ K+ DFGL+R LE F+G+ Y+ PE
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----------FVGTPDYLAPETI 165
Query: 821 LGERPSTAGD 830
LG D
Sbjct: 166 LGVGDDKMSD 175
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF-------------------IAECETL-RNVRHRNLVKL 707
+IG GSFG VL +R K + +AE L +NV+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
S + + L V +F++ G L + H +R+ +I SAL YLH+
Sbjct: 62 HYSFQTTEK-----LYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ +V+ DLKP NILLD + + DFGL + + + D +T F G+ Y+ P
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD------TTTTFCGTPEYLAP 165
Query: 818 E 818
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 36/175 (20%)
Query: 669 IGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM--------- 719
IG GSFG VL + K + + + + + K I + ++ KN+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 720 ------EFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCEVPV 763
+ L V ++++ G L + H +R+ +I SAL YLH + +
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH---SLNI 117
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
++ DLKP NILLD + + DFGL + +E +T F G+ Y+ PE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK------TTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 8e-09
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 41/178 (23%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRNLVKLI 708
L+G G+FG V+ S K + + E L+N RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
S + D L V E+++ G L + ER D I SALDYLH+
Sbjct: 62 YSFQTKDR-----LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+V+ DLK N++LD++ K+ DFGL + E + + +++ + F G+ Y+ PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKT---FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 9e-09
Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 20/111 (18%)
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITS 750
H N+VKL+ + + ++N + + LV+E++ L I R N L+ +
Sbjct: 66 HPNIVKLL---NVIKAENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMYQLLK 118
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801
AL Y+H+ V+H DLKP NILL+ + K+ DFGLAR L E +N +
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 54/191 (28%)
Query: 668 LIGSGSFGSV-------------------LHN--------ERTGSWKSFIAECETLR-NV 699
+GSG+FG V +HN ER S ++E ++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH-----GERKNE-------LD 747
RH N+V+ + D L +V + + LG+ + +R E +
Sbjct: 67 RHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807
+ AL YLH E +VH DL P NI+L E+ + DFGLA+ + +S ++S
Sbjct: 122 MVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSV-- 173
Query: 808 FMGSIGYVPPE 818
+G+I Y PE
Sbjct: 174 -VGTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSA 751
E E LRN+ H N+VK C+ ++ L+ EFL +GSL +++ KN++++
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYL-PRNKNKINLKQQ 111
Query: 752 LDYLHNDCE-------VPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
L Y C+ VH DL N+L++ E K+GDFGL +
Sbjct: 112 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL 207
L L + G + +D + LR LQ +N N + G+IPPS+ + I S L+VLDL
Sbjct: 423 LGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGS-ITS-------LEVLDL 473
Query: 208 TINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
+ N G++P ++ +TSL L L N L G +P
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 30/114 (26%), Positives = 53/114 (46%), Gaps = 24/114 (21%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT 749
+ E + L+ ++H N++ L+ + LV+EF+ D + + +T
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKS-----NINLVFEFME----TDLEKVIKDKSIVLT 100
Query: 750 SA------------LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
A L+YLH++ ++H DLKP N+L+ + K+ DFGLAR
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 657 RRATGNFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRN 698
+R F IG G++G V L NE+ G + I E + LR
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 699 VRHRNLVKL----ITSCSSLD-SKNMEFLALVYEFLSNGSLG-----------DWIHGER 742
+ HRN+V L +LD K+ LV+E++ + +G D I
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 743 KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
K L+ L+Y H +H D+K NILL+ + K+ DFGLAR +++ S
Sbjct: 123 KQLLE---GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY----NSEESR 172
Query: 803 SSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGE 840
T+ + ++ Y PPE LG ER A DV + GE
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGE 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 39/175 (22%)
Query: 669 IGSGSFGSVL--HNERTGS--------------WKSFIAECETLRNVRHRNLVKLITSCS 712
IGSG++G V + TG ++ E L+ RH N+V S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELDIT-------SALDYLHNDCEVPV 763
D L +V E+ GSL D R +EL I L YLH E
Sbjct: 71 RRDK-----LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGK 122
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H D+K NILL E+ K+ DFG++ L ++I+ F+G+ ++ PE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 36/158 (22%)
Query: 667 NLIGSGSFGSVLH--------NERTGSWKS------------FIAECETLRNVRHRNLVK 706
+IG G FG V H + + KS F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHN 757
L+ C L S+ + L Y + +G L ++I E N L + ++YL +
Sbjct: 61 LLGIC--LPSEGSPLVVLPY--MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
VH DL N +LDE T KV DFGLAR + ++
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 28/72 (38%), Positives = 46/72 (63%), Gaps = 9/72 (12%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
++ ALD+LH+ + +++ DLKP NILLDEE K+ DFGL++ E +D++ +
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHE---KKAY 156
Query: 807 VFMGSIGYVPPE 818
F G++ Y+ PE
Sbjct: 157 SFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 44/184 (23%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFIAEC----ETLR--NVRHRNLVKLITS----- 710
+F +G+GSFG V + G+ + + +C E L+ V+H K I
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 711 ------CSSLDSKNMEFLALVYEFLSNGSLGDWIH----GERKNEL------DITSALDY 754
CS D + FL EF+ G L + H G N++ ++ A +Y
Sbjct: 79 FIVNMMCSFQDENRVYFL---LEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLAFEY 133
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH+ +++ DLKP N+LLD + KV DFG A+ + +R T G+ Y
Sbjct: 134 LHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---------TFTLCGTPEY 181
Query: 815 VPPE 818
+ PE
Sbjct: 182 LAPE 185
|
Length = 329 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 27/148 (18%)
Query: 666 ENLIGSGSFGSV---LHNERTG-----------SWKSFIAECETLRNVRHRNLVKLITSC 711
E +G+G FG V +N+ T S ++F+AE ++ ++H LVKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCE-------VPVV 764
+ E + ++ EF++ GSL D++ + ++ + +D+ E +
Sbjct: 71 TK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFL 792
H DL+ NIL+ + K+ DFGLAR +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI 152
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 40/178 (22%)
Query: 668 LIGSGSFGSVL--HNERTGSWKSF-----------------IAECETLRNVRHRNLVKLI 708
L+G G+FG V+ + TG + + + E L+N RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSL-----GDWIHGERKNEL---DITSALDYLHNDCE 760
S + D L V E+ + G L + + E + +I SALDYLH++
Sbjct: 62 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
V V+ DLK N++LD++ K+ DFGL + E + + +++ + F G+ Y+ PE
Sbjct: 117 V--VYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT---FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 31/171 (18%)
Query: 669 IGSGSFGSV----LHNER----------TGSWKSFIAECETLRNVRHRNLVKLITSCSSL 714
+G+G FG V +N T S ++F+ E ++ ++H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-- 71
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCE-------VPVVHSD 767
E + ++ E+++ GSL D++ + ++ + +D+ E +H D
Sbjct: 72 ---KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
L+ N+L+ E + K+ DFGLAR + DN+ + F I + PE
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKF--PIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 31/154 (20%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
NF IG G++G V L E G + I E L+ + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHN------ 757
+VKL+ + + L LV+EFL + L ++ + + + YL
Sbjct: 61 IVKLLDVIHTENK-----LYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 758 DCEV-PVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
C V+H DLKP N+L++ E K+ DFGLAR
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 27/195 (13%)
Query: 76 LNLSSFGLEGTISPHIG-----NLSFLRSIQLQNNKLSGNLPREIGNLFR----LRVLNI 126
L L++ GL + L + L N+L G + R L+ LN+
Sbjct: 113 LKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNL 172
Query: 127 SFNNLQGE----LPVNISKLTELKMLDLMANKIT---GRVTDDQLRNLRSLQVLNFGKNL 179
+ N + L + L++LDL N +T + L +L+SL+VLN G N
Sbjct: 173 ANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232
Query: 180 L--WGSIPPSIANLIPSDLSRLENLKVLDLTINRL----AGTVPSTIYNMTSLVHLRLAS 233
L G A L + LS +L L L+ N + A + + SL+ L L
Sbjct: 233 LTDAG-----AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRG 287
Query: 234 NQLGGEIPYDVRDTL 248
N+ G E + ++L
Sbjct: 288 NKFGEEGAQLLAESL 302
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 22/61 (36%), Positives = 38/61 (62%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
+NLS + G I P +G+++ L + L N +G++P +G L LR+LN++ N+L G +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 136 P 136
P
Sbjct: 507 P 507
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 54/178 (30%), Positives = 78/178 (43%), Gaps = 41/178 (23%)
Query: 668 LIGSGSFGSVL--HNERTGSW-------KSFI----------AECETLRNVRHRNLVKLI 708
L+G G+FG V+ + TG + K I E L+N RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
S + D L V E+ + G L + ER D I SAL YLH+ C+
Sbjct: 62 YSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CD 115
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
V V+ DLK N++LD++ K+ DFGL + + S ++ F G+ Y+ PE
Sbjct: 116 V--VYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 34/150 (22%)
Query: 669 IGSGSFGSVLH--NERTGS-------WKSFIA---------ECETLRNVRHRNLVKLI-- 708
+GSG++G+V + RTG+ ++ F + E L++++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 709 -TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHNDCE 760
T SLD + +F LV F+ LG + E+ +E + L Y+H
Sbjct: 83 FTPDLSLDRFH-DFY-LVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---A 136
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
++H DLKPGN+ ++E+ K+ DFGLAR
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 45/180 (25%)
Query: 668 LIGSGSFGSVL--HNERTGSWKSF-----------------IAECETLRNVRHRNLVKLI 708
L+G G+FG V+ + TG + + + E L+N RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHND 758
+ + D L V E+ + G L + H R+ +I SAL+YLH+
Sbjct: 62 YAFQTHDR-----LCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 114
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VV+ D+K N++LD++ K+ DFGL + E + + +++ + F G+ Y+ PE
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT---FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 668 LIGSGSFGSVLHNERTGS---------WKSFI-----AECETLRNVRHRNLVK----LIT 709
++G GSFG V+ E G+ K I +C T+ R L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC-TMTEKRILALAAKHPFLTA 60
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLHNDCEV 761
+K+ F V E+++ G L I RK + ++T AL +LH
Sbjct: 61 LHCCFQTKDRLFF--VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH--- 115
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
V++ DLK NILLD E K+ DFG+ + + + +T F G+ Y+ PE
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK------EGILNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 35/158 (22%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD- 747
F+ E +R H ++VKLI + + +V E G L ++ K LD
Sbjct: 54 FLQEAYIMRQFDHPHIVKLIGVITE------NPVWIVMELAPLGELRSYLQ-VNKYSLDL 106
Query: 748 ---------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798
+++AL YL + VH D+ N+L+ K+GDFGL+R+L ++
Sbjct: 107 ASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL----ED 159
Query: 799 QSSISSTHVFMGSIGYVP-----PEYGLGERPSTAGDV 831
+S + S G +P PE R ++A DV
Sbjct: 160 ES------YYKASKGKLPIKWMAPESINFRRFTSASDV 191
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 50/161 (31%), Positives = 71/161 (44%), Gaps = 36/161 (22%)
Query: 658 RATGNFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNV 699
R+ F N IG G++G V + NER G S + E L N+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 700 RHRNLVKL--ITSCSSLDSKNMEFLALVYEFLSN--GSLGD-----WIHGERKN-ELDIT 749
RH N+V+L + LDS + LV E+ SL D + + K L +
Sbjct: 64 RHPNIVELKEVVVGKHLDS-----IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
L YLH + ++H DLK N+LL ++ K+ DFGLAR
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 40/153 (26%)
Query: 669 IGSGSFGSVLHNERTGSWKS-------------------FIAECETLRNVRHRNLVKLIT 709
IG+G FG V+ E + F+ E + R+++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-------------DITSALDYLH 756
C+ + +L LV EF G L ++ RK EL +I L +LH
Sbjct: 63 QCTEV----TPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+ +HSDL N LL ++T K+GD+GL+
Sbjct: 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 36/144 (25%), Positives = 61/144 (42%), Gaps = 26/144 (18%)
Query: 669 IGSGSFGSVL--HNERTG----------SWKSFIAECETLRNVR------HRNLVKL--- 707
IG G++G V ++ TG ++S LR ++ H N++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 708 ITSCSSLDSKNMEFL-ALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPVVHS 766
L EF+ +Y+ + + G + + L + H+ ++H
Sbjct: 67 FRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHR 122
Query: 767 DLKPGNILLDEEMTAKVGDFGLAR 790
DLKP N+L++ E K+ DFGLAR
Sbjct: 123 DLKPENLLINTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-07
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 21/166 (12%)
Query: 678 LHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDW 737
E F E + H N+V L+ S + L V+E++ +L +
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP----GLLFAVFEYVPGRTLREV 69
Query: 738 IHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDF 786
+ + + L + AL HN +VH DLKP NI++ AKV DF
Sbjct: 70 LAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 787 GLARFL--LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGD 830
G+ L + D +++ T +G+ Y PE GE + D
Sbjct: 127 GIGTLLPGVRDADVA-TLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 45/188 (23%)
Query: 662 NFSHENLIGSGSFGSV-----LHNERTGSWKSF--------------IAECETLRNVRHR 702
NF E IG G F V L + + + K + E + L+ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERKNEL-----------DITS 750
N++K + S + N +V E G L I + +++ L + S
Sbjct: 63 NVIKYLDSFIEDNELN-----IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
A++++H+ V+H D+KP N+ + K+GD GL RF S ++ H +G
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLVG 168
Query: 811 SIGYVPPE 818
+ Y+ PE
Sbjct: 169 TPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 15/125 (12%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS- 750
E +R+ +H N+V++ +S D L +V EFL G+L D + R NE I +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNEEQIATV 120
Query: 751 ------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
AL +LH V+H D+K +ILL + K+ DFG + + V + S+
Sbjct: 121 CLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177
Query: 805 THVFM 809
T +M
Sbjct: 178 TPYWM 182
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERT--GSW--------KSFIAECET----------LRNVRHRNLVKL 707
+IG GSFG VL +R GS+ K+ + + E L+N++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
S + E L V ++++ G L + H +R+ ++ SA+ YLH+
Sbjct: 62 HYSFQT-----AEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ +++ DLKP NILLD + + DFGL + +E + +T F G+ Y+ P
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE------TTSTFCGTPEYLAP 165
Query: 818 E 818
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 45/190 (23%)
Query: 660 TGNFSHENLIGSGSFGSV-----LHNERTGSWKSF--------------IAECETLRNVR 700
GNF E IG G F V L + R + K + E + L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDI 748
H N++K + +S N L +V E G L I +K + + +
Sbjct: 61 HPNVIKYL---ASFIENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVF 808
SAL+++H ++H D+KP N+ + K+GD GL RF S ++ H
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSL 166
Query: 809 MGSIGYVPPE 818
+G+ Y+ PE
Sbjct: 167 VGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 43/151 (28%), Positives = 63/151 (41%), Gaps = 39/151 (25%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG G++G V L E G + I E L+ + H N+V+L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 711 CSSLDSKNMEFLALVYEFL-----------SNGSLGDWIHGERKNELDITSALDYLHNDC 759
S ++K L LV+EFL L + + + + Y H+
Sbjct: 67 VHS-ENK----LYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSYLYQLLQGIAYCHSH- 118
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
V+H DLKP N+L+D E K+ DFGLAR
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 41/184 (22%)
Query: 668 LIGSGSFGSVL--HNERTGSW-------------------KSFIA----ECETLRNVRHR 702
LIGSGSFGSV N +G +S + E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNEL------DITSALDY 754
N+V+ + S S + + L + E++ GS+ + +G + L I L+Y
Sbjct: 67 NIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LHN ++H D+K NIL+D + K+ DFG+++ L + + + GS+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 815 VPPE 818
+ PE
Sbjct: 179 MAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 625 VWPIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTG 684
+W + R + VG A VC + LR A S F S++H +RT
Sbjct: 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRT- 63
Query: 685 SWKSFIAECETLRNVRHRNLVKLI---TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE 741
E L++++H N++ L+ T SL+ N +L L L + + +
Sbjct: 64 -----YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV---THLMGADLNNIVKCQ 115
Query: 742 RKNE-------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + I L Y+H+ ++H DLKP N+ ++E+ K+ DFGLAR
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 45/161 (27%)
Query: 669 IGSGSFGSV---------------------LHNERTGSWKSFIAECETLRNVRHRNLVKL 707
IG G++G V + TG +S E LR ++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-------------DITSALDY 754
+ L+ + + L++++ + L I R+ + I + + Y
Sbjct: 68 VEVF--LEHADKS-VYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 755 LHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARF 791
LH++ V+H DLKP NIL+ E K+GD GLAR
Sbjct: 124 LHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 40/126 (31%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------ 745
E +R+ H N+V + S D L +V EFL G+L D + R NE
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNEEQIATV 123
Query: 746 -LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
L + AL YLHN V+H D+K +ILL + K+ DFG + + V + S+
Sbjct: 124 CLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180
Query: 805 THVFMG 810
T +M
Sbjct: 181 TPYWMA 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 32/148 (21%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG G++G V L +E G + I E L+ ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-LDITSALDYLHNDCEV-------P 762
+S+ L L++EFLS L ++ K + +D YL+ +
Sbjct: 68 LMQ-ESR----LYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLAR 790
V+H DLKP N+L+D + K+ DFGLAR
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 52/183 (28%), Positives = 76/183 (41%), Gaps = 45/183 (24%)
Query: 669 IGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRNLVKLIT 709
IG GSFG V+ + + + + +AE L V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS----------ALDYLHNDC 759
S S E L LV F++ G L + H +R+ D++ AL+ LH
Sbjct: 61 SFQS-----PEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTAELLCALENLH--- 110
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
+ V++ DLKP NILLD + + DFGL + N T+ F G+ Y+ PE
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKL------NMKDDDKTNTFCGTPEYLAPEL 164
Query: 820 GLG 822
LG
Sbjct: 165 LLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 27/147 (18%)
Query: 668 LIGSGSFGSVLH--NERTGS----------WKSFI------AECETLRNVRHRNLVKLI- 708
+GSG++GSV ++RTG ++S I E L++++H N++ L+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 709 --TSCSSLDSKNMEFLALVYEFLS-NGSLGDWIHGERKNEL--DITSALDYLHNDCEVPV 763
TS S D +L + Y +G + ++ L + L Y+H +
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGI 138
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLAR 790
+H DLKPGN+ ++E+ K+ DFGLAR
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 44/160 (27%), Positives = 66/160 (41%), Gaps = 54/160 (33%)
Query: 669 IGSGSFGSVL--HNERTG---SWKSFIA-------------ECETLRNVRHRNLVKLITS 710
IG GS+G V N TG + K F+ E L+ ++H NLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-----------------ITSALD 753
+ L LV+E+ + L NEL+ A++
Sbjct: 69 -----FRRKRKLHLVFEYCDHTVL---------NELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 754 YLH-NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ H ++C +H D+KP NIL+ ++ K+ DFG AR L
Sbjct: 115 FCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVL----------HNERTGSWKSFIAECET----------LRNVRHRNLVKL 707
+IG GSFG VL + + K+ + + E L+NV+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----------ELDITSALDYLHN 757
S + D L V ++++ G L + H +R+ +I SAL YLH+
Sbjct: 62 HFSFQTADK-----LYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHS 114
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ +V+ DLKP NILLD + + DFGL + +N +T F G+ Y+ P
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTSTFCGTPEYLAP 165
Query: 818 E 818
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-- 746
F+ E E L+ H N+VKLI C + + +V E + GSL ++ + KN L
Sbjct: 39 FLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVPGGSLLTFLRKK-KNRLTV 92
Query: 747 --------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
D + ++YL + +H DL N L+ E K+ DFG++R
Sbjct: 93 KKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 18/113 (15%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE--------FLSN----GSLGDW 737
+A + L H N+V+L+ C++ + + LV+E +L G +
Sbjct: 50 VALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET 109
Query: 738 IHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
I + L LD+LH +C +VH DLKP NIL+ K+ DFGLAR
Sbjct: 110 IKDLMRQFL---RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 43/171 (25%)
Query: 666 ENLIGSGSFGSVLH--------NERTGSWKS------------FIAECETLRNVRHRNLV 705
E +IG+G FG V E + K+ F++E + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSALD 753
L + +K+ + ++ EF+ NG+L ++ R+N+ I + +
Sbjct: 69 HL----EGVVTKSRPVM-IITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
YL E+ VH DL NIL++ + KV DFGL+RFL + + + SS
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 54/191 (28%), Positives = 83/191 (43%), Gaps = 42/191 (21%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFI--------------AECETL-RNV-----RHRNLVKL 707
++G GSFG V E G+ + F EC + + V H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--------DITSALDYLHNDC 759
C+ +N+ F V E+L+ G L I K +L +I L +LH+
Sbjct: 62 Y--CTFQTKENLFF---VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK- 115
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
+V+ DLK NILLD + K+ DFG+ + +N + T F G+ Y+ PE
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEI 167
Query: 820 GLGERPSTAGD 830
LG++ +T+ D
Sbjct: 168 LLGQKYNTSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 53/151 (35%), Positives = 85/151 (56%), Gaps = 15/151 (9%)
Query: 87 ISPHIGNL-SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
I P IG L S L+ + L +NK+ +LP + NL L+ L++SFN+L +LP +S L+ L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
LDL NKI ++ L +L+ L+ N + + S LS L+NL L
Sbjct: 189 NNLDLSGNKI--SDLPPEIELLSALEELDLSNNSI---------IELLSSLSNLKNLSGL 237
Query: 206 DLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
+L+ N+L +P +I N+++L L L++NQ+
Sbjct: 238 ELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267
|
Length = 394 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFIA---------------EC-ETLRNV-----RHRNLVK 706
++G GSFG VL E G+ A EC T + V +H L +
Sbjct: 2 VLGKGSFGKVLLAELKGT-DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--------DITSALDYLHND 758
L SC + + L V E+++ G L I + + +I L +LH
Sbjct: 61 LH-SCF----QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR-FLLERVDNQSSISSTHVFMGSIGYVPP 817
E +++ DLK N+LLD E K+ DFG+ + +L V +T F G+ Y+ P
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-------TTSTFCGTPDYIAP 165
Query: 818 E 818
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 52/179 (29%), Positives = 73/179 (40%), Gaps = 43/179 (24%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
+G GS+G V L N K+ E + L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----------DITSALDYLHNDC 759
D L +V F G L + E+K +L I AL YLH
Sbjct: 68 WEGEDG----LLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
E ++H DLK N+ L KVGD G+AR L +NQ ++ST +G+ Y+ PE
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL----ENQCDMAST--LIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 32/186 (17%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFIAEC----------ETLRNVRHRNLVKLITSCSSLDS- 716
++G GSFG V+ E G+ + F + + + R ++ L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 717 ----KNMEFLALVYEFLSNGSLGDWIHGERKNEL--------DITSALDYLHNDCEVPVV 764
+ E L V E+L+ G L I + + +I L +LH ++
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GII 118
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER 824
+ DLK N+LLD++ K+ DFG+ + E ++ + S+ F G+ Y+ PE G++
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST---FCGTPDYIAPEILKGQK 172
Query: 825 PSTAGD 830
+ + D
Sbjct: 173 YNESVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 38/192 (19%)
Query: 656 LRRATGNFSHENLIGSGSFGSVLH--NERTGSW-------------KSFIAECETLRNV- 699
L TG F +IG G++G V +++TG + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 700 RHRNLVKLITSCSSLDSKNMEF-LALVYEFLSNGSLGDWIHGER------KNEL------ 746
H N+ + + + L LV E GS+ D + G R K E
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
+ L YLH + V+H D+K NILL + K+ DFG++ L S++ +
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL------DSTLGRRN 171
Query: 807 VFMGSIGYVPPE 818
F+G+ ++ PE
Sbjct: 172 TFIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 26/141 (18%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERKNEL-- 746
I E + L+ + H N++K S + N +V E G L I H +++ L
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 747 ---------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ SAL+++H+ V+H D+KP N+ + K+GD GL RF
Sbjct: 105 EKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----- 156
Query: 798 NQSSISSTHVFMGSIGYVPPE 818
S ++ H +G+ Y+ PE
Sbjct: 157 -SSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 35/167 (20%)
Query: 669 IGSGSFGSVLHNERTGSWK---------SFIA---------ECETLRNVRHRNLVKLITS 710
IGSG++G V T S K +F E + LR+ +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 711 CSSLDSKNMEF--LALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
L +F + +V + L L IH ++ + + L Y+H+
Sbjct: 73 ---LRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN- 127
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807
V+H DLKP N+L++E+ ++GDFG+AR L + +V
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 26/84 (30%), Positives = 37/84 (44%), Gaps = 10/84 (11%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
I L++LH +V+ DLKP N+LLD+ ++ D GLA L
Sbjct: 103 QIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-------KKIK 152
Query: 807 VFMGSIGYVPPEYGLGERPSTAGD 830
G+ GY+ PE GE + D
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVD 176
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 39/162 (24%), Positives = 67/162 (41%), Gaps = 42/162 (25%)
Query: 669 IGSGSFGSVLH-------------------NERTG--SWKSFIAECETLRNVRHRNLVKL 707
+GSG+FG+V E T + K + E + +V H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHN 757
+ C S + L+ + + G L D++ K+ + I + YL
Sbjct: 75 LGICLS------SQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLE- 126
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
E +VH DL N+L+ K+ DFGLA+ LL+ + +
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAK-LLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 19/150 (12%)
Query: 692 ECET--LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG--------E 741
ECE L+N++H +V+ L + + L + E++ GS+ D +
Sbjct: 52 ECEIQLLKNLQHERIVQYY---GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108
Query: 742 RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801
RK I + YLH++ +VH D+K NIL D K+GDFG ++ L + +
Sbjct: 109 RKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
I S G+ ++ PE GE DV
Sbjct: 166 IRSV---TGTPYWMSPEVISGEGYGRKADV 192
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 38/177 (21%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFIAEC-----------ETLRNVRHRNLVKLITS------ 710
+IG G FG V + + K + +C ETL + R ++ L+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 59
Query: 711 -CSSLDSKNMEFLALVYEFLSNGSLGDWI--HG------ERKNELDITSALDYLHNDCEV 761
C + + L + + ++ G L + HG R +I L+++HN
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VV+ DLKP NILLDE ++ D GLA S H +G+ GY+ PE
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 44/157 (28%)
Query: 667 NLIGSGSFGSV------------------------LHNERTGSWKSFIAECETLRNVRHR 702
+ +GSG++G V +H +RT E L+++ H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT------YRELRLLKHMDHE 74
Query: 703 NLVKLITSCSSLDSKNMEF--LALVYEFLSNGSLGDWIHGERKNE-------LDITSALD 753
N++ L+ + S +F + LV + L + + ++ ++ I L
Sbjct: 75 NVIGLL-DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLK 132
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
Y+H+ ++H DLKP NI ++E+ K+ DFGLAR
Sbjct: 133 YIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 45/180 (25%)
Query: 665 HENLIGSGSFGSVLH--NERTGS-----------------WKSFIAECETLRNVRHRNLV 705
HE IG GSFG+V N T W+ I E + L+ ++H N +
Sbjct: 27 HE--IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHND 758
+ C + + +L + Y S L + +H + E++I + L YLH+
Sbjct: 85 EY-KGCYLKE--HTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
++H D+K GNILL E K+ DFG A S S + F+G+ ++ PE
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSA----------SKSSPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 52/176 (29%)
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKN 744
K F E E L N +H N+VK C+ D M V+E++ +G L ++ HG
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIM-----VFEYMEHGDLNKFLRSHGPDAA 107
Query: 745 ELD--------------------ITSALDYL---HNDCEVPVVHSDLKPGNILLDEEMTA 781
L I S + YL H VH DL N L+ ++
Sbjct: 108 FLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVV 161
Query: 782 KVGDFGLARFLLERVDNQSSISSTHVF------MGSIGYVPPEYGLGERPSTAGDV 831
K+GDFG++R + +T + M I ++PPE + + +T DV
Sbjct: 162 KIGDFGMSR----------DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 39/153 (25%), Positives = 61/153 (39%), Gaps = 40/153 (26%)
Query: 669 IGSGSFGSVLHNE-RTGSWKS------------------FIAECETLRNVRHRNLVKLIT 709
IG+G FG VL E G K+ F+ E + R + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------------LDITSALDYLH 756
C LV EF G L +++ R ++ S L +LH
Sbjct: 63 QCIESIP-----YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+ +HSDL N L +++ K+GD+GLA
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 43/176 (24%)
Query: 669 IGSGSFGSVL------HNERTG-------------SWKSFIAECETLRNVRHRNLVKLIT 709
IG GSFG+V ++E W+ I E L+ +RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY-R 81
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDCEVP 762
C ++ +L + Y S L + +H + E++I + L YLH+
Sbjct: 82 GCYL--REHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
++H D+K GNILL E K+GDFG A S ++ + F+G+ ++ PE
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA----------SIMAPANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 54/187 (28%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNEL 746
F E E L ++H+++V+ C+ L +V+E++ +G L ++ HG L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL 108
Query: 747 D---------------------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785
I S + YL + VH DL N L+ + + K+GD
Sbjct: 109 AGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGD 165
Query: 786 FGLARFLLERVDNQSSISSTHVF------MGSIGYVPPEYGLGERPSTAGDVPTSESFAG 839
FG++R I ST + M I ++PPE L + +T D+ +
Sbjct: 166 FGMSR----------DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS------ 209
Query: 840 EFNIVKW 846
F +V W
Sbjct: 210 -FGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 29/89 (32%), Positives = 52/89 (58%), Gaps = 6/89 (6%)
Query: 519 GPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP-SEGIFRN 577
G IPN +++L+ L+ ++LS N + G+IP L ++ +L L+L++N+ G +P S G +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 578 MSNVHLKGNPKLCLQLGCENPRSHGSRLI 606
+ ++L GN L P + G RL+
Sbjct: 492 LRILNLNGN-----SLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 32/112 (28%)
Query: 263 GKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFIT 322
G IP + L ++Q I ++ N + G +PP LG+ IT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-------------------------IT 466
Query: 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374
SL L L N F G IPES+G ++ L L L GN + G++PA++G
Sbjct: 467 SLE------VLDLSYNSFNGSIPESLGQLTS-LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 61/252 (24%), Positives = 100/252 (39%), Gaps = 56/252 (22%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG-----------------SWKSFIAECET--LRNVR 700
N+ L+G G+FG V ++ TG S + ECE L+N+R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG--------ERKNELDITSAL 752
H +V+ + K L++ E++ GS+ D + R+ I +
Sbjct: 63 HDRIVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
YLH++ +VH D+K NIL D K+GDFG ++ + + + I S G+
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV---TGTP 173
Query: 813 GYVPPEYGLGERPSTAGDV---------------PTS--ESFAGEFNI-VKWVESNLPEN 854
++ PE GE DV P + E+ A F I + + LP+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 855 VLQVLDPELRQL 866
V L+Q+
Sbjct: 234 VSDACRDFLKQI 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 35/167 (20%), Positives = 61/167 (36%), Gaps = 48/167 (28%)
Query: 669 IGSGSFGSV----LHNERTGSWKSFIA-----ECETLRNVRH-------------RNLVK 706
+G GSFG V G ++ +A E ++R ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------------LDI 748
L+ S+ + +V E ++ G L ++ R +I
Sbjct: 74 LLGVVST-GQPTL----VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
+ YL VH DL N ++ E++T K+GDFG+ R + E
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 48/175 (27%)
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HG---- 740
K F E E L N++H ++VK C D L +V+E++ +G L ++ HG
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAM 106
Query: 741 --------ERKNEL----------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782
+ K EL I S + YL + VH DL N L+ + K
Sbjct: 107 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163
Query: 783 VGDFGLARFLLERVDNQSSISSTHVF------MGSIGYVPPEYGLGERPSTAGDV 831
+GDFG++R + ST + M I ++PPE + + +T DV
Sbjct: 164 IGDFGMSR----------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 38/177 (21%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFIAEC-----------ETLRNVRHRNLVKLITS------ 710
+IG G FG V + + K + +C ETL + R ++ L+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 59
Query: 711 -CSSLDSKNMEFLALVYEFLSNGSLGDWI--HG------ERKNELDITSALDYLHNDCEV 761
C S + L+ + + ++ G L + HG R +I L+++HN
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF-- 117
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VV+ DLKP NILLDE ++ D GLA S H +G+ GY+ PE
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 20/111 (18%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD- 747
AE + L + +VKL S D E L LV E++ G L + + RK+
Sbjct: 48 VRAERDILADADSPWIVKLY--YSFQDE---EHLYLVMEYMPGGDLMNLL--IRKDVFPE 100
Query: 748 ---------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+ ALD +H + +H D+KP NIL+D + K+ DFGL
Sbjct: 101 ETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 28/158 (17%)
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE----- 741
K + E E ++ + +VK + S + + + E+ GSL D I+ +
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSS---IGIAMEYCEGGSL-DSIYKKVKKRG 99
Query: 742 -RKNEL-------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793
R E + L YLH ++H D+KP NILL + K+ DFG++ L+
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
S++ T F G+ Y+ PE G+ S DV
Sbjct: 157 N------SLAGT--FTGTSFYMAPERIQGKPYSITSDV 186
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 43/182 (23%)
Query: 663 FSHENLIGSGSFGSVL--HNERTGS-----------------WKSFIAECETLRNVRHRN 703
F+ IG GSFG+V + RT W+ I E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLH 756
++ C ++ +L + Y S L + +H + E++I + L YLH
Sbjct: 87 SIEY-KGCYL--REHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ ++H D+K GNILL E K+ DFG A S S + F+G+ ++
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSA----------SIASPANSFVGTPYWMA 189
Query: 817 PE 818
PE
Sbjct: 190 PE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 34/181 (18%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFI--------------AECETLRNVRHRNLVKL 707
+F+ ++G GSFG V+ ER G+ + + EC T+ R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC-TMVEKRVLALPGK 59
Query: 708 ITSCSSLDS--KNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLHN 757
+ L S + M+ L V E+++ G L I K + +I L +LH+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+++ DLK N++LD E K+ DFG+ + +N +T F G+ Y+ P
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTFCGTPDYIAP 170
Query: 818 E 818
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 28/74 (37%), Positives = 37/74 (50%), Gaps = 15/74 (20%)
Query: 748 ITSALDYL---HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
I AL YL H V+H D+KP NILLD K+ DFG++ L VD+++ S
Sbjct: 123 IVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKTRS 174
Query: 805 THVFMGSIGYVPPE 818
G Y+ PE
Sbjct: 175 A----GCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 45/172 (26%)
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-------- 738
K F E E L N++H ++VK C D L +V+E++ +G L ++
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDP-----LIMVFEYMKHGDLNKFLRAHGPDAV 106
Query: 739 ---HGERKNEL----------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785
G R EL I + + YL + VH DL N L+ E + K+GD
Sbjct: 107 LMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163
Query: 786 FGLARFLLERVDNQSSISSTHVF------MGSIGYVPPEYGLGERPSTAGDV 831
FG++R + ST + M I ++PPE + + +T DV
Sbjct: 164 FGMSR----------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 205
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 4/146 (2%)
Query: 443 ISFGNFQSLLSIDLSNNRINGNIPKGILRPL--PEEISRLENVVTIDLSDNSLSGNLPNS 500
N LL LS + + L E + L + ++DL+ N L N+ +
Sbjct: 53 NLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SE 111
Query: 501 LKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNL 560
L +L L + N + P I L+ LDLS NK+ S+PS L+NL L++L+L
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 561 TFNNLEGVVPSEGIFRNMSNVHLKGN 586
+FN+L + N++N+ L GN
Sbjct: 171 SFNDLSDLPKLLSNLSNLNNLDLSGN 196
|
Length = 394 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 39/159 (24%)
Query: 668 LIGSGSFGSV----LHNERTGSWK-----------------SFIAECETLRNVRHRNLVK 706
++G G FGSV L + K F++E +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 707 LITSCSSLDSKNMEFLALV-YEFLSNGSLGDWIHGERKNE--------------LDITSA 751
LI C S +V F+ +G L ++ R +DI
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
++YL N +H DL N +L E+MT V DFGL++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 33/150 (22%)
Query: 669 IGSGSFGSV--LHNERTGSWKSFI--------------AECETLRNVR-HRNLVKLITSC 711
IG G++G V + N++ GS K+ + AE L+ + H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGS-KAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWI-----HGERKNELDIT-------SALDYLHNDC 759
D KN + L LV E + GS+ D + GER E I L +LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+H D+K NILL E K+ DFG++
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 49/237 (20%)
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRS-------LTLLDLSYNSISGEIP---IEIGQLQGL 403
L +L L N G+IP + L L LDLS N++ + + + L
Sbjct: 52 SLKELCLSLNET-GRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 404 QVLGLAGNEI-PGGIPNSLANLK----KLNQIDLSGNELTGE--IPIS--FGNFQSLLSI 454
Q L L N + G+ LK L ++ L N L G ++ + L +
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170
Query: 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY 514
+L+NN I GI R L E + N+ +DL++N L+ + +L E L
Sbjct: 171 NLANNGIGD---AGI-RALAEGLKANCNLEVLDLNNNGLTD------EGASALAETL--- 217
Query: 515 NQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQN-----LQALRSLNLTFNNLE 566
A LK LEVL+L N L+ + + L + +L +L+L+ N++
Sbjct: 218 -----------ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 42/185 (22%)
Query: 669 IGSGSFGSV--LHNERTG--------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK- 717
IG G+FG V + + T S K +A+ E + RN I + LD
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN----ILVRTLLDESP 56
Query: 718 ---NMEF-------LALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDC 759
++F L LV +++S G L + E + D + AL++LH
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH--- 113
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
+ +V+ DLKP NILLD + DFGL++ N + +T+ F G+ Y+ PE
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSK------ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 820 GLGER 824
L E+
Sbjct: 168 LLDEK 172
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 24/113 (21%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL---------SNGSLGD-----W 737
E + LR++ H N++ + + + +VYE + S+ +L D +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 738 IHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
++ + L Y+H+ V+H DLKP N+LL+ K+ DFGLAR
Sbjct: 114 LY-------QLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 46/170 (27%)
Query: 662 NFSHENLIGSGSFGSVLH-------NERTGSWK------------SFIAECETLRNV-RH 701
+ E++IG G+FG V+ + + K F E E L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY------- 754
N++ L+ +C +N +L + E+ G+L D++ R E D A ++
Sbjct: 63 PNIINLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 755 --------------LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ E +H DL N+L+ E + +K+ DFGL+R
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 25/124 (20%)
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDC 759
SC +S+ L V E+++ G L H +R+ +L +I+ AL+YLH
Sbjct: 63 SCFQTESR----LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLH--- 113
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
E +++ DLK N+LLD E K+ D+G+ + L D +T F G+ Y+ PE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD------TTSTFCGTPNYIAPEI 167
Query: 820 GLGE 823
GE
Sbjct: 168 LRGE 171
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------ 745
E +R+ +H N+V++ S D L +V EFL G+L D + R NE
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNEEQIAAV 121
Query: 746 -LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
L + AL LH V+H D+K +ILL + K+ DFG + + V + S+
Sbjct: 122 CLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178
Query: 805 THVFMG 810
T +M
Sbjct: 179 TPYWMA 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 52/169 (30%)
Query: 666 ENLIGSGSFGSVLHN-------------ERTGSWKS------FIAECETL-RNVRHRNLV 705
+++IG G+FG VL +R + S F E E L + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------------------ 747
L+ +C ++ +L L E+ +G+L D++ R E D
Sbjct: 72 NLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 748 ------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +DYL + +H DL NIL+ E AK+ DFGL+R
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 717 KNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLHNDCEVPVVHSDL 768
+ + L V EF++ G L I R+ + +ITSAL +LH + +++ DL
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDL 122
Query: 769 KPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
K N+LLD E K+ DFG+ + E + N + S+ F G+ Y+ PE
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTST---FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 29/176 (16%)
Query: 625 VWPIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTG 684
VW + R + VG A VC +YD R + + L S F S++H RT
Sbjct: 10 VWEVPERYQNLTPVGSGAYGSVCS---AYDTRLRQ--KVAVKKL--SRPFQSLIHARRT- 61
Query: 685 SWKSFIAECETLRNVRHRNLVKLI---TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE 741
E L++++H N++ L+ T +S+++ N +L L L + + +
Sbjct: 62 -----YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN---LMGADLNNIVKCQ 113
Query: 742 RKNE-------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ ++ + L Y+H+ ++H DLKP N+ ++E+ ++ DFGLAR
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 26/73 (35%), Positives = 44/73 (60%), Gaps = 9/73 (12%)
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
+ I AL+YLH+ ++ V+H D+KP N+L++ K+ DFG++ +L VD S++ T
Sbjct: 110 VSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL---VD---SVAKT 161
Query: 806 HVFMGSIGYVPPE 818
+ G Y+ PE
Sbjct: 162 -IDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807
I S L++LH +++ DLKP N+LLD + ++ D GLA +E D Q S T
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQ---SKTKG 156
Query: 808 FMGSIGYVPPEYGLGE 823
+ G+ G++ PE GE
Sbjct: 157 YAGTPGFMAPELLQGE 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 46/191 (24%)
Query: 669 IGSGSFGSVL--HNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCS 712
+G G+FG V N+ TG + ++ E + L + H N+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL----- 67
Query: 713 SLDSKNMEF-LALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCEV 761
LD+ E L ++ EF + G++ D + E + L AL+YLH E
Sbjct: 68 -LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH---EN 122
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
++H DLK GNIL + K+ DFG++ N +I F+G+ ++ PE +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 822 GERPSTAGDVP 832
E T+ D P
Sbjct: 177 CE---TSKDRP 184
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 16/109 (14%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GE------RK 743
E + L++++H N+V+ + +C LD +++ EF+ GS+ ++ G K
Sbjct: 52 EVDLLKSLKHVNIVQYLGTC--LDDNT---ISIFMEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 744 NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
I + YLHN+C VVH D+K N++L K+ DFG AR L
Sbjct: 107 YTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 53/164 (32%)
Query: 666 ENLIGSGSFGSVL----------------------HNERTGSWKSFIAECETLRNVRHRN 703
E +IG+G FG V + E+ + F++E + H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPN 66
Query: 704 LVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT----------- 749
++ L +T + +V E++ NGSL ++ RK++ T
Sbjct: 67 IIHLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGI 115
Query: 750 -SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
S + YL ++ VH DL NIL++ + KV DFGL+R L
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 36/190 (18%)
Query: 656 LRRATGNFSHENLIGSGSFGSVLHNE--RTGSWKSFIA------ECETLRN--------V 699
LR G F L+G+G++G V +TG + E E ++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 700 RHRNLVKLITSCSSLDSKNME-FLALVYEFLSNGSLGDWIHGERKNEL----------DI 748
HRN+ + + M+ L LV EF GS+ D I + N L +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVF 808
L +LH V+H D+K N+LL E K+ DFG++ L ++ + F
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTF 171
Query: 809 MGSIGYVPPE 818
+G+ ++ PE
Sbjct: 172 IGTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 39/155 (25%)
Query: 668 LIGSGSFGSV-------------------LHNERTGSWKS--FIAECETLRNVRHRNLVK 706
++GSG+FG+V + NE TG + F+ E + ++ H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHN 757
L+ C S + LV + + +G L D++H + N + I + YL
Sbjct: 74 LLGVCLS------PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE- 126
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
E +VH DL N+L+ K+ DFGLAR L
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 19/124 (15%)
Query: 685 SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN 744
S K + E + +R + H N+VK+ S E + + E S + +++ + N
Sbjct: 45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLAN 104
Query: 745 ELD---------------ITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGL 788
L+ + L Y+H+ V+H DLKP N+ ++ E++ K+GDFGL
Sbjct: 105 VLEQGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGL 161
Query: 789 ARFL 792
AR +
Sbjct: 162 ARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 15/126 (11%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS- 750
E +R+ +H+N+V++ S E L ++ EFL G+L D + R NE I +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQTRLNEEQIATV 122
Query: 751 ------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
AL YLH+ V+H D+K +ILL + K+ DFG + + V + S+
Sbjct: 123 CESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 805 THVFMG 810
T +M
Sbjct: 180 TPYWMA 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 1e-05
Identities = 59/209 (28%), Positives = 84/209 (40%), Gaps = 61/209 (29%)
Query: 669 IGSGSFGSV--LHNERTGS---WKS-------------FIAECETLRNVRHRNLVKLITS 710
IG+G FG V + ++RT WK+ + E +R ++H+N+V+ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI-- 78
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHG--------ERKNELDITS----ALDYLHND 758
+K + L ++ EF G L I E +DIT AL Y HN
Sbjct: 79 -DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 759 CEVP----VVHSDLKPGNILLDEEM-----------------TAKVGDFGLARFLLERVD 797
+ P V+H DLKP NI L + AK+GDFGL++
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK------- 190
Query: 798 NQSSISSTHVFMGSIGYVPPEYGLGERPS 826
N S H +G+ Y PE L E S
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKS 219
|
Length = 1021 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 27/73 (36%), Positives = 42/73 (57%), Gaps = 10/73 (13%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR-FLLERVDNQSSISST 805
+I ALD+LH ++ +++ D+K NILLD E + DFGL++ FL E +
Sbjct: 113 EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER------A 163
Query: 806 HVFMGSIGYVPPE 818
+ F G+I Y+ PE
Sbjct: 164 YSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
I L Y+H+ VVH DLKP NIL++E K+ DFGLAR
Sbjct: 117 ILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 25/124 (20%)
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDC 759
SC +S+ L V EF+S G L H +R+ +L +I+ AL++LH
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH--- 113
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
E +++ DLK N+LLD E K+ D+G+ + + D +T F G+ Y+ PE
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD------TTSTFCGTPNYIAPEI 167
Query: 820 GLGE 823
GE
Sbjct: 168 LRGE 171
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 696 LRNVRHRNLVKLITSCSSLDS-KNMEFLALVYEFLSNGSLGDWIHGERKNE------LDI 748
L+ V H+N++ L+ + S + + + LV E L + +L IH E +E +
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDHERMSYLLYQM 132
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +LH+ ++H DLKP NI++ + T K+ DFGLAR
Sbjct: 133 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 102/395 (25%), Positives = 161/395 (40%), Gaps = 80/395 (20%)
Query: 93 NLSFLRSIQLQNNKL--SGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
+LS L S+ L + S + + NL L L+++ N + +LT L LDL
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLN-LNRLRSNISELLELTNLTSLDL 123
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
N IT IPP I L NLK LDL+ N
Sbjct: 124 DNNNIT--------------------------DIPPLIGLL-------KSNLKELDLSDN 150
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLH 270
++ ++PS + N+ +L +L L+ N L +P L
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDL--------------------------SDLPKLLS 183
Query: 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
NL+N+ + ++ N + LPP + L L ++ N I + ++SL+N +L
Sbjct: 184 NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI--------IELLSSLSNLKNL 234
Query: 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS 390
+ L L N+ E +PESIGN SN L L L N I +S+G L +L LDLS NS+S
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSN-LETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS 290
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450
+P+ L +L L N + L L ++ N T P + +S
Sbjct: 291 NALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET-SSPEALSILES 346
Query: 451 LLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
L ++ +N ++ + + P I L ++V
Sbjct: 347 LNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVK 381
|
Length = 394 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 669 IGSGSFGSVL--HNERTGSW--------------KSFIAECETLRNVRHRNLVKLITSCS 712
+G G+FG V N+ TG+ + ++ E E L H +VKL+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-F 78
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCEVP 762
D K L ++ EF G++ D I E L + AL YLH+ +
Sbjct: 79 YWDGK----LWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MK 130
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822
++H DLK GN+LL + K+ DFG++ N ++ F+G+ ++ PE +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 823 ERPSTAGDVP 832
E T D P
Sbjct: 185 E---TMKDTP 191
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 29/155 (18%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDW--IHGERKNELD 747
I E ++ ++H N+V+L ++K L LV+E++ L + HG R LD
Sbjct: 46 IREISLMKELKHENIVRL-HDVIHTENK----LMLVFEYMDK-DLKKYMDTHGVRG-ALD 98
Query: 748 ITSA----------LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ + + H E V+H DLKP N+L+++ K+ DFGLAR V+
Sbjct: 99 PNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155
Query: 798 NQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDV 831
S+ T + Y P+ LG R ST+ D+
Sbjct: 156 TFSNEVVT------LWYRAPDVLLGSRTYSTSIDI 184
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 38/175 (21%)
Query: 620 GCFLIVWPIIVRKRKAKRVGVSALFKVCHPKIS----YDELRRATGNFSHENLIGSGSFG 675
G F +VW + R KRV + + V +S + EL+ F H+N++ +
Sbjct: 11 GAFGVVWSV-TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC-FFKHDNVLSALD-- 66
Query: 676 SVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLG 735
+L E + + +L K+I S L S +++ +Y+ L
Sbjct: 67 -ILQPPHI----DPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF--LYQILR----- 114
Query: 736 DWIHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
L YLH+ ++H D+KPGN+L++ K+ DFGLAR
Sbjct: 115 ---------------GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 46/149 (30%), Positives = 61/149 (40%), Gaps = 37/149 (24%)
Query: 669 IGSGSFGSVLHNE--RTGSW-------KSFIAE--------CE-----TLRNVRHRNLVK 706
+G G FG VL E +TG K I CE T + RH LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHNDC 759
L +C + + V E+ + G L IH + +E + L YLH
Sbjct: 67 LF-ACFQTEDH----VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH--- 118
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
E +V+ DLK N+LLD E K+ DFGL
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 20/111 (18%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEF-LALVYEFLSN---------GSLGDWIH 739
I E L+N++H N+V L D + E L LV+E+L + G+L +H
Sbjct: 51 IREVSLLKNLKHANIVTL------HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MH 103
Query: 740 GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + L Y H + ++H DLKP N+L++E+ K+ DFGLAR
Sbjct: 104 NVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 49/216 (22%)
Query: 661 GNFSHENLIGSGSFGSVLH--------NERTGSWKS------------FIAECETLRNVR 700
+ + + +IG+G FG V E + K+ F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITS 750
H N+++L + K ++ E++ NG+L ++ + E I +
Sbjct: 65 HHNIIRLEGVVTKF--KPA---MIITEYMENGALDKYLR-DHDGEFSSYQLVGMLRGIAA 118
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
+ YL + + VH DL NIL++ + KV DFGL+R L + + + S +
Sbjct: 119 GMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--- 172
Query: 811 SIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846
I + PE + ++A DV + F IV W
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWS-------FGIVMW 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 30/176 (17%)
Query: 663 FSHENLIGSGSFGSVLH--NERTGSWKSF-IAECETLRNVRHRNLVKLITSCSSLDSKNM 719
F+ IG GSFG V + RT + I + E + ++ + IT S DS +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYV 64
Query: 720 ----------EFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDCEVP 762
L ++ E+L GS D + +E I + LDYLH++ ++
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI- 123
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
H D+K N+LL E+ K+ DFG+A L D Q + F+G+ ++ PE
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQ---IKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 678 LHNERTGSWKSFIAECETLRNVRHRNLVKL--ITSCSSLDSKNMEFLALVYEF------- 728
+ E+ G + + E L ++H N+V + + + N++ + +V E+
Sbjct: 40 MEKEKEGFPITSLREINILLKLQHPNIVTVKEV-----VVGSNLDKIYMVMEYVEHDLKS 94
Query: 729 -LSNGSLGDWIHGERKNEL-DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+ ++ E K + + S + +LH++ ++H DLK N+LL+ K+ DF
Sbjct: 95 LMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDF 150
Query: 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDV 831
GLAR + + + T Y PE LG + STA D+
Sbjct: 151 GLAREYGSPLKPYTQLVVTL------WYRAPELLLGAKEYSTAIDM 190
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 39/194 (20%)
Query: 657 RRATGNFSHENLIGSGSFGSV-----LHNERTGSWKSFIA-------ECETLRNVRHRNL 704
R ++ N+IG+GSFG V + + K + E ++N+ H N+
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINI 121
Query: 705 VKL----ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-----------LDIT 749
+ L T C + KN+ FL +V EF+ H R N +
Sbjct: 122 IFLKDYYYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQSSISSTHVF 808
AL Y+H+ + H DLKP N+L+D T K+ DFG A+ LL Q S+S +
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA---GQRSVS----Y 230
Query: 809 MGSIGYVPPEYGLG 822
+ S Y PE LG
Sbjct: 231 ICSRFYRAPELMLG 244
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 33/131 (25%), Positives = 60/131 (45%), Gaps = 36/131 (27%)
Query: 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI------- 738
+ F E E + +++H N+V L+ C+ + +++E+L++G L +++
Sbjct: 52 QQEFRQEAELMSDLQHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHS 106
Query: 739 -------HGERKNELD----------ITSALDYL--HNDCEVPVVHSDLKPGNILLDEEM 779
K+ LD I + ++YL H+ VH DL N L+ E +
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGL 161
Query: 780 TAKVGDFGLAR 790
T K+ DFGL+R
Sbjct: 162 TVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 42/154 (27%), Positives = 61/154 (39%), Gaps = 36/154 (23%)
Query: 669 IGSGSFGSV-------------------LHNERTGSWKSFIAECETLRNVR---HRNLVK 706
IG G++G V + G S I E LR++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLH 756
L C+ + L LV+E + L ++ + + LD+LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ VVH DLKP NIL+ K+ DFGLAR
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 41/167 (24%), Positives = 61/167 (36%), Gaps = 51/167 (30%)
Query: 667 NLIGSGSFGSVLHNE-------------------RTGS----WKSFIAECETLRNVRHRN 703
N +GSG+FG V R G+ K F+ E + N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------LDI 748
+VKL+ C + ++ E + G L ++ R LD+
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEE-----MTAKVGDFGLAR 790
YL ++ +H DL N L+ E+ K+GDFGLAR
Sbjct: 116 AKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 46/150 (30%), Positives = 65/150 (43%), Gaps = 36/150 (24%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG G++G V L E G + I E L+ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 711 CSSLDSKNMEFLALVYEFLS------NGSLGDWIHGER--KNEL-DITSALDYLHNDCEV 761
S + + L LV+E+L S D+ R K L I + Y H+
Sbjct: 70 VHS-EKR----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--- 121
Query: 762 PVVHSDLKPGNILLDEEMTA-KVGDFGLAR 790
V+H DLKP N+L+D A K+ DFGLAR
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIH--------GERKNELDITSALDYLHNDCEVPVV 764
SL S N + LV E+L G + +H K ++ ALDYLH ++
Sbjct: 72 SLQSAN--NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GII 126
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
H DLKP N+L+ E K+ DFGL++ L R N I +T
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 18/119 (15%)
Query: 687 KSFIAECETLRNVRHRNLVKLI-TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE 745
+ F+ E ++ H N++KLI S S + ++ F+ +G L ++ R E
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105
Query: 746 --------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+DI S ++YL + +H DL N +L+E MT V DFGL++
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 57/259 (22%), Positives = 93/259 (35%), Gaps = 64/259 (24%)
Query: 680 NERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH 739
N + + ++E L+ V H +++KL +CS L L+ E+ GSL ++
Sbjct: 41 NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLR 95
Query: 740 GERKNE-----LDITSALDYLHNDCEVPV------------------------VHSDLKP 770
RK D YL N E + VH DL
Sbjct: 96 ESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155
Query: 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGD 830
N+L+ E K+ DFGL+R + E S + S G +P ++ E S
Sbjct: 156 RNVLVAEGRKMKISDFGLSRDVYE---EDSYVKR------SKGRIPVKWMAIE--SLFDH 204
Query: 831 VPTSESFAGEFNIVKWVESNL---------PENVLQVLDPELRQLMTSNESQTIQLHDCL 881
+ T++S F ++ W L PE + +L R N S+ +
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMY----- 259
Query: 882 ITIIGSVGLSCTTESPGGR 900
++ L+C + P R
Sbjct: 260 -----NLMLTCWKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 25/124 (20%)
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDC 759
SC S+ L LV E+++ G L H +R+ +L +I AL++LH
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH--- 113
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
E +++ DLK N+LLD + K+ D+G+ + L D +T F G+ Y+ PE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD------TTSTFCGTPNYIAPEI 167
Query: 820 GLGE 823
GE
Sbjct: 168 LRGE 171
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 50/229 (21%), Positives = 75/229 (32%), Gaps = 76/229 (33%)
Query: 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRN 698
N + IG G+FG V G F E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 699 VRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGD--------WIH----------- 739
H N+VKL+ C+ + + L++E+++ G L +
Sbjct: 65 FDHPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 740 -GERKNEL----------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
G L + + + YL E VH DL N L+ E M K+ DFGL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 789 ARFLLERVDNQSSISSTHVFMGS------IGYVPPEYGLGERPSTAGDV 831
+R +I S + S I ++PPE R +T DV
Sbjct: 177 SR----------NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDV 215
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 52/244 (21%), Positives = 95/244 (38%), Gaps = 45/244 (18%)
Query: 669 IGSGSFGS-VLHNERTGS----WKSF-------------IAECETLRNVRHRNLVKLITS 710
+G G+FG L+ WK + E L ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDCE 760
+D L + E+ + G+L D I ++ + I SA+ Y+H +
Sbjct: 68 --FMDDNT---LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
++H D+K NI L + K+GDFG+++ L S S +G+ Y+ PE
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL------GSEYSMAETVVGTPYYMSPELC 173
Query: 821 LGERPSTAGDVPTSESFAGEFNIVKWV--ESNLPENVLQVLDPELRQLMTSNESQTIQL- 877
G + + D+ E +K +N V++++ +++ S+ I L
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 878 HDCL 881
H L
Sbjct: 234 HSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 46/193 (23%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFI--------------AECETLRNVRHRNLVK------L 707
++G GSFG VL E G + F EC V R L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTM---VEKRVLALAWENPFL 58
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--------DITSALDYLHNDC 759
+ +K E L V EFL+ G L I + + +L +I L +LH+
Sbjct: 59 THLYCTFQTK--EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV--DNQSSISSTHVFMGSIGYVPP 817
+++ DLK N++LD + K+ DFG+ + E V DN++S F G+ Y+ P
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAS-----TFCGTPDYIAP 165
Query: 818 EYGLGERPSTAGD 830
E G + + + D
Sbjct: 166 EILQGLKYTFSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 28/111 (25%), Positives = 51/111 (45%), Gaps = 17/111 (15%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE----RKN 744
F+ E L+ H N+V+LI C+ + + +V E + G ++ E +
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELVQGGDFLTFLRTEGPRLKVK 94
Query: 745 EL-----DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
EL + + ++YL + +H DL N L+ E+ K+ DFG++R
Sbjct: 95 ELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 63/174 (36%)
Query: 669 IGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNV-RHRN 703
+G G FG V+ E G K I+E E ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPV 763
++ L+ +C+ D L ++ E+ S G+L +++ R ++Y +N +VP
Sbjct: 86 IINLLGACTQ-DGP----LYVIVEYASKGNLREYLRARRP------PGMEYCYNPTQVPE 134
Query: 764 ---------------------------VHSDLKPGNILLDEEMTAKVGDFGLAR 790
+H DL N+L+ E+ K+ DFGLAR
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 44/177 (24%)
Query: 669 IGSGSFGSV---------------LHNERTGSWKSFIAECETLRNV----RHRNLVKLIT 709
+G G +G V + + + T R++ + LVKL+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 710 SCSSLDSKNMEFLALVY-------EFLSN-GSLGDWIHGERKNELDITSALDYLHNDCEV 761
+ D + + +LA+ Y L+N G L + R ++ A+D LH E+
Sbjct: 69 AFQ--DDEYL-YLAMEYVPGGDFRTLLNNLGVLSE--DHARFYMAEMFEAVDALH---EL 120
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H DLKP N L+D K+ DFGL++ ++ + +GS Y+ PE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA---------NSVVGSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 35/151 (23%)
Query: 669 IGSGSFGSV--------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLI 708
+GSG+FG V NE++ + E E + + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMI 61
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDC-------EV 761
C + E L LV E S G L ++ G +K+E+ +++ ++ +H
Sbjct: 62 GVCEA------EALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
VH DL N+LL + AK+ DFGL++ L
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 34/181 (18%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFI--------------AECETLRNVRHRNLVKL 707
+F+ ++G GSFG V+ ER G+ + + EC T+ R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALSGK 59
Query: 708 ITSCSSLDS--KNMEFLALVYEFLSNGSLGDWIH--GERKN------ELDITSALDYLHN 757
+ L S + M+ L V E+++ G L I G K +I L +LH+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+++ DLK N++LD E K+ DFG+ + +N +T F G+ Y+ P
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENMWDGVTTKTFCGTPDYIAP 170
Query: 818 E 818
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-05
Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
I L Y+H+ V+H DLKP N+LL+ K+ DFGLAR
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 15/116 (12%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL-----VYEFLSNGSLGDWIHGE-- 741
+ E L + H+N++ ++ C + FL LG+ + +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 742 RKNEL-----DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+L I + YLH V+H D+ N ++DEE+ K+ D L+R L
Sbjct: 115 STQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 44/197 (22%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRN 703
F ++G G FG V + + K + + E + L V R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKNE--------LDITSALD 753
+V L + + D+ L LV ++ G L I+ GE E +I L+
Sbjct: 62 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
LH + +V+ DLKP NILLD+ ++ D GLA + E + + G++G
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-------GTVG 166
Query: 814 YVPPEYGLGERPSTAGD 830
Y+ PE ER + + D
Sbjct: 167 YMAPEVVKNERYTFSPD 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 674 FGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLI---TSCSSLDSKNMEF--LALVYEF 728
F +V H +R ++ + ++ V H+N++ L+ T SL+ EF + LV E
Sbjct: 53 FQNVTHAKRA--YRELV----LMKLVNHKNIIGLLNVFTPQKSLE----EFQDVYLVMEL 102
Query: 729 LSNGSLGDWIHGERKNE------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782
+ + +L I + +E + + +LH+ ++H DLKP NI++ + T K
Sbjct: 103 M-DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 158
Query: 783 VGDFGLAR 790
+ DFGLAR
Sbjct: 159 ILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 36/175 (20%)
Query: 669 IGSGSFGSVLHNERTGSWKSFI------------------AECETLRNVRHRNLVKLITS 710
IG GSFG + + K ++ E L N++H N+V+ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDC-------EVPV 763
+ L +V ++ G L I+ +R LD+ C + +
Sbjct: 68 FEENGN-----LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H D+K NI L ++ T K+GDFG+AR L S++ +G+ Y+ PE
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807
+ L YLH ++ +H D+KP NIL++ K+ DFG++ L V+ S++ T
Sbjct: 109 VLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQL---VN---SLAKT-- 158
Query: 808 FMGSIGYVPPEYGLGERPSTAGDV 831
F+G+ Y+ PE G S D+
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDI 182
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 18/110 (16%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSN---------GSLGDWIHG 740
I E L++++H N+V L + S L LV+E+L G++ +H
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDDCGNIMS-MHN 105
Query: 741 ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ I L Y H V+H DLKP N+L++E K+ DFGLAR
Sbjct: 106 VKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 35/149 (23%)
Query: 669 IGSGSFGSVL--HNERTGSW-------KSF--IAECETLRNVR-------HRNLVKLITS 710
IG G+F VL + +TG + K F + + LR ++ H N+++LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELDITS-------ALDYLHNDCEV 761
D K LALV+E L + +L + I G ++ E + S +LD++H +
Sbjct: 67 L--FDRKTGR-LALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN--- 119
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ H D+KP NIL+ ++ K+ DFG R
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 402 GLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRI 461
L+ L L+ N + + L L +DLSGN LT P +F SL S+DLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 22/60 (36%), Positives = 33/60 (55%)
Query: 506 SLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
+L+ L ++ N+ + L L+VLDLS N L+ P L +LRSL+L+ NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT 749
I E +R +H N+V + S D L +V E+L+ GSL D + +E I
Sbjct: 64 INEILVMRENKHPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIA 118
Query: 750 S-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+ AL++LH++ V+H D+K NILL + + K+ DFG + +S++
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 803 SSTHVFM 809
T +M
Sbjct: 176 VGTPYWM 182
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 28/121 (23%), Positives = 53/121 (43%), Gaps = 22/121 (18%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE------- 741
F+ E + + +++ N+++L+ C S D L ++ E++ NG L ++
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFT 118
Query: 742 RKNELDITSALDYLHNDCEVP----------VVHSDLKPGNILLDEEMTAKVGDFGLARF 791
N + S + L+ ++ VH DL N L+ T K+ DFG++R
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 792 L 792
L
Sbjct: 179 L 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 26/167 (15%)
Query: 677 VLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGD 736
+L++ER ++ +E L H +VK D K+ + L L+ E+ S G L
Sbjct: 102 MLNDERQAAYAR--SELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYGSGGDLNK 154
Query: 737 WIHGERKNEL------------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784
I K L I ALD +H+ ++H DLK NI L K+G
Sbjct: 155 QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLG 211
Query: 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
DFG ++ + V S+ F G+ Y+ PE +R S D+
Sbjct: 212 DFGFSKQYSDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADM 254
|
Length = 478 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 37/193 (19%)
Query: 662 NFSHENLIGSGSFGSV-LHNERTGSW-----KSFIAECETLRN--VRH----RNLVKLIT 709
+F+ +G+GSFG V L + + K F + + ++ V H R ++ I
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF-EKSKIIKQKQVDHVFSERKILNYIN 89
Query: 710 S--CSSLDS--KNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
C +L K+ +L LV EF+ G ++ ++ D I +YL +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ +V+ DLKP N+LLD++ K+ DFG A+ + R T+ G+ Y+ P
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---------TYTLCGTPEYIAP 197
Query: 818 EYGLGERPSTAGD 830
E L A D
Sbjct: 198 EILLNVGHGKAAD 210
|
Length = 340 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 46/175 (26%), Positives = 69/175 (39%), Gaps = 35/175 (20%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFI-----------------AECETLRNVRHRNLVKLITS 710
++G GSFG L + S + + E L ++H N+V S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDC-------EVPV 763
+ L +V E+ G L I +R + L + C E V
Sbjct: 67 FEADGH-----LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H D+K NI L + K+GDFG AR L + + + T+V G+ YVPPE
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTYV--GTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR-FLLERVDNQSSISSTH 806
I L Y+H+ V+H DLKPGN+L++ + K+ DFGLAR F +N ++
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-- 168
Query: 807 VFMGSIGYVPPEYGLGERP-STAGDV 831
++ + Y PE L + + A DV
Sbjct: 169 -YVATRWYRAPEIMLSFQSYTKAIDV 193
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 16/111 (14%)
Query: 692 ECET--LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG--------E 741
ECE L+N+ H +V+ L L++ E + GS+ D +
Sbjct: 52 ECEIQLLKNLLHERIVQYY---GCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108
Query: 742 RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
RK I + YLH++ +VH D+K NIL D K+GDFG ++ L
Sbjct: 109 RKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNEL 437
+L LDLS N ++ L L+VL L+GN + P + + L L +DLSGN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 37/150 (24%)
Query: 668 LIGSGSFGSV----LHNERTGSWKS------------FIAECETLRNVRHRNLVKLITSC 711
L+G G+FG V L ++ + K+ F++E L+ H N+VKLI C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN-DCE 760
+ + + +V E + G ++ ++K+EL D + + YL + +C
Sbjct: 62 T-----QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC- 114
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+H DL N L+ E K+ DFG++R
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 16/109 (14%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNG------SLGDWI--HGE 741
I E L++++H N+V L + S L LV+E+L G+ I H
Sbjct: 52 IREVSLLKDLKHANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNSINMHNV 106
Query: 742 RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + L+Y H V+H DLKP N+L++E K+ DFGLAR
Sbjct: 107 KLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 34/148 (22%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG G++G+V L ++ G S + E L+ ++H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 711 CSSLDSKNMEFLALVYEFLSNG--SLGDWIHGE------RKNELDITSALDYLHNDCEVP 762
S D K L LV+E+ D +G+ + + L + H
Sbjct: 68 LHS-DKK----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLAR 790
V+H DLKP N+L+++ K+ DFGLAR
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT 749
I E ++ +++ N+V + S D L +V E+L+ GSL D + +E I
Sbjct: 64 INEILVMKELKNPNIVNFLDSFLVGDE-----LFVVMEYLAGGSLTDVVTETCMDEAQIA 118
Query: 750 S-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+ AL++LH + V+H D+K N+LL + + K+ DFG + +S++
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 803 SSTHVFMG 810
T +M
Sbjct: 176 VGTPYWMA 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 15/105 (14%)
Query: 692 ECETLRNVRHRNLVKLI-------TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN 744
E + L+ + HR ++ LI T C + + V + L I +R+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRR- 193
Query: 745 ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+ AL YLH ++H D+K NI LDE A +GDFG A
Sbjct: 194 ---LLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT 749
I E +R ++ N+V + S D L +V E+L+ GSL D + +E I
Sbjct: 64 INEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIA 118
Query: 750 S-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+ ALD+LH++ V+H D+K NILL + + K+ DFG + +S++
Sbjct: 119 AVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 803 SSTHVFMG 810
T +M
Sbjct: 176 VGTPYWMA 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 22/122 (18%)
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKNELD--------ITSALDYLH 756
++ + +SK L LV ++ G L I+ GER E++ IT + +LH
Sbjct: 55 IVNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ +V+ D+KP N+LLD++ ++ D GLA +E D ++ G+ GY+
Sbjct: 113 ---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRA----GTNGYMA 162
Query: 817 PE 818
PE
Sbjct: 163 PE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 39/191 (20%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLIT- 709
+G G+FG V +HNE+ G + + E + L+ ++H N+V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 710 ----SCSSLDSKNMEFLALVYE------FLSNGSLGDWIHGERKN-ELDITSALDYLHND 758
S + ++ Y L N S+ + K L + ++YLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIKCYMLQLLEGINYLH-- 132
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS--STHVFMGSI---G 813
E ++H D+K NIL+D + K+ DFGLAR N T + +
Sbjct: 133 -ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191
Query: 814 YVPPEYGLGER 824
Y PPE LGER
Sbjct: 192 YRPPELLLGER 202
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 39/186 (20%)
Query: 662 NFSHENLIGSGSFGSV-LHNERTGSWKSFIAECETLR---------NVRH----RNLVKL 707
NF ++G+G++G V L + TG + + L+ V H RN+++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 708 ITSCSSLDSKNMEF-----LALVYEFLSNGSLGDWIHGERKNEL----------DITSAL 752
+ L + + F L L+ +++S G + + H +++ +I AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
++LH ++ +V+ D+K NILLD E + DFGL++ L + T+ F G+I
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-----TYSFCGTI 170
Query: 813 GYVPPE 818
Y+ PE
Sbjct: 171 EYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 49/213 (23%)
Query: 669 IGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLI 708
+G G FGSV+ + + F++E ++ H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 709 TSC-SSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------------KNELDITSALD 753
C +++S+ ++ F+ +G L ++ R K DI S ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
YL + +H DL N +L+E M V DFGL++ + + + G I
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIY---------NGDYYRQGRIA 174
Query: 814 YVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846
+P ++ E S A V T++S F + W
Sbjct: 175 KMPVKWIAIE--SLADRVYTTKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 9/68 (13%)
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
AL+YL E+ ++H D+KP NILLD K+ DFG++ L++ SI+ T G
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRD-AG 169
Query: 811 SIGYVPPE 818
Y+ PE
Sbjct: 170 CRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 27/126 (21%), Positives = 52/126 (41%), Gaps = 27/126 (21%)
Query: 687 KSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE 745
++E E ++ + +H+N++ L+ C+ L +V E+ ++G+L D++ R
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGP-----LYVVVEYAAHGNLRDFLRARRPPG 114
Query: 746 LDITSALDYLHND---------CEVPV------------VHSDLKPGNILLDEEMTAKVG 784
+ + V +H DL N+L+ E+ K+
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIA 174
Query: 785 DFGLAR 790
DFGLAR
Sbjct: 175 DFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
++ + NL L+++ L N LS +LP+ + NL L L++S N + +LP I L+ L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
+ LDL N I L NL++L L N L +P + L NL+ L
Sbjct: 212 EELDLSNNSI--IELLSSLSNLKNLSGLELSNNKL---------EDLPESIGNLSNLETL 260
Query: 206 DLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254
DL+ N++ + S++ ++T+L L L+ N L +P L L
Sbjct: 261 DLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 39/130 (30%)
Query: 689 FIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD 747
++E E ++ + +H+N++ L+ +C+ L ++ E+ S G+L +++ R
Sbjct: 64 LVSEMEMMKMIGKHKNIINLLGACTQDGP-----LYVLVEYASKGNLREYLRARRP---- 114
Query: 748 ITSALDYLHNDCEVP---------------------------VVHSDLKPGNILLDEEMT 780
+DY + C++P +H DL N+L+ E+
Sbjct: 115 --PGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172
Query: 781 AKVGDFGLAR 790
K+ DFGLAR
Sbjct: 173 MKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 39/176 (22%), Positives = 66/176 (37%), Gaps = 41/176 (23%)
Query: 632 KRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWK---- 687
K+KA+ V S + V + GS G V + G
Sbjct: 56 KQKAREVVASLGYTVIKT-------------------LTPGSEGRVFVATKPGQPDPVVL 96
Query: 688 ------SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL------VYEFLSNGSLG 735
+ + E L+NV H +++++ +L S + + L +Y +L+ S
Sbjct: 97 KIGQKGTTLIEAMLLQNVNHPSVIRMK---DTLVSGAITCMVLPHYSSDLYTYLTKRSRP 153
Query: 736 DWIHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
I E I L YLH ++H D+K NI +++ +GD G A+F
Sbjct: 154 LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
|
Length = 357 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 44/197 (22%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRN 703
F H ++G G FG V + + K + + E + L V R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG------ERKNEL----DITSALD 753
+V L + + D+ L LV ++ G L I+ + + + +IT L+
Sbjct: 62 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
LH + +V+ DLKP NILLD+ ++ D GLA + +I +G++G
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGR---VGTVG 166
Query: 814 YVPPEYGLGERPSTAGD 830
Y+ PE ER + + D
Sbjct: 167 YMAPEVVKNERYTFSPD 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 56/179 (31%)
Query: 663 FSHENLI-----GSGSFGSVLHNERTGSWKS------------------------FIAEC 693
F + L+ G G FG V+ E G KS I+E
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 694 ETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSAL 752
E ++ + +H+N++ L+ C+ L ++ E+ + G+L +++ R D T +
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 753 DYLHND---------CEVPV------------VHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + C V +H DL N+L+ E+ K+ DFGLAR
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 38/192 (19%)
Query: 657 RRATGNFSHENLIGSGSFGSVL--HNERTGSWKSFIA--------------ECETLRNVR 700
R +F IGSG++G V N TG + E +++ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELDIT-------SAL 752
H N+V S D L + EF GSL D H +E I L
Sbjct: 65 HSNIVAYFGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
YLH+ ++ H D+K NILL + K+ DFG++ + ++I+ F+G+
Sbjct: 120 YYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQI------TATIAKRKSFIGTP 170
Query: 813 GYVPPEYGLGER 824
++ PE ER
Sbjct: 171 YWMAPEVAAVER 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 30/176 (17%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHR--NLVKLITSCSSLDS---- 716
F+ IG GSFG V + K + L ++ + IT S DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 717 -------KNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDCEVP 762
K+ + L ++ E+L GS D + +E I + LDYLH++ ++
Sbjct: 66 KYYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI- 123
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
H D+K N+LL E K+ DFG+A L D Q + F+G+ ++ PE
Sbjct: 124 --HRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQ---IKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 34/181 (18%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFI--------------AECETL--RNVRHRNLV 705
+F+ ++G GSFG V+ ER G+ + + EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKN------ELDITSALDYLHN 757
+T S + ++ L V E+++ G L I G+ K +I+ L +LH
Sbjct: 61 PFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH- 118
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+++ DLK N++LD E K+ DFG+ + ++ +T F G+ Y+ P
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGTPDYIAP 170
Query: 818 E 818
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 46/165 (27%)
Query: 667 NLIGSGSFGSVLHN--ERTG-----------------SWKSFIAECETLRNV-RHRNLVK 706
++IG G+FG VL ++ G + F E E L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------------------- 747
L+ +C ++ +L L E+ +G+L D++ R E D
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + +H DL NIL+ E AK+ DFGL+R
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 12/98 (12%)
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK---NELDITSALDYLHNDC- 759
+V+L+ + L LV+E+L + L ++ + L + +++
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 760 ------EVPVVHSDLKPGNILLDEE-MTAKVGDFGLAR 790
+ V+H DLKP N+L+D++ K+ D GL R
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 39/151 (25%), Positives = 59/151 (39%), Gaps = 37/151 (24%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRNLVKLI 708
L+G G G V G+ K F + E E L + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHND 758
+S ++ +L LV ++ G L + + L ++ AL+YLH
Sbjct: 68 ---ASFQTE--TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL- 121
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+ +V+ DLKP NILL E + DF L+
Sbjct: 122 --LGIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 27/127 (21%), Positives = 56/127 (44%), Gaps = 33/127 (25%)
Query: 689 FIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD 747
++E E ++ + +H+N++ L+ +C+ L ++ E+ S G+L +++ R ++
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGP-----LYVIVEYASKGNLREYLRARRPPGME 121
Query: 748 ------------------------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783
+ ++YL + +H DL N+L+ E K+
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKI 178
Query: 784 GDFGLAR 790
DFGLAR
Sbjct: 179 ADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 47/182 (25%), Positives = 70/182 (38%), Gaps = 38/182 (20%)
Query: 663 FSHENLIGSGSFGSV----------------LHNERTGSWKS---FIAECETLRNVRHRN 703
F H ++G G FG V L +R K + E L V R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDC---- 759
+V L + + D+ L LV ++ G L I+ D A+ Y C
Sbjct: 62 VVSLAYAYETKDA-----LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 760 ---EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+V+ DLKP NILLD+ ++ D GLA + E + + G++GY+
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-------GTVGYMA 169
Query: 817 PE 818
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 43/187 (22%), Positives = 80/187 (42%), Gaps = 46/187 (24%)
Query: 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-----HG 740
W F E + + H N+V L+ + + + +++E+L+ G L +++ H
Sbjct: 51 WGEFQQEASLMAELHHPNIVCLLGVVT-----QEQPVCMLFEYLNQGDLHEFLIMRSPHS 105
Query: 741 ERKNELD----ITSALD---YLHNDCEVPV----------VHSDLKPGNILLDEEMTAKV 783
+ D + S+LD +LH ++ VH DL NIL+ E++ K+
Sbjct: 106 DVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKI 165
Query: 784 GDFGLARFLLE----RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAG 839
D GL+R + RV +S + I ++PPE + + S+ D+ +
Sbjct: 166 SDLGLSREIYSADYYRVQPKSLL--------PIRWMPPEAIMYGKFSSDSDIWS------ 211
Query: 840 EFNIVKW 846
F +V W
Sbjct: 212 -FGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 44/197 (22%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHRN 703
F ++G G FG V + + K + + E + L V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG------ERKNEL----DITSALD 753
+V L + + D+ L LV ++ G L I+ E + L +I L+
Sbjct: 62 VVNLAYAYETKDA-----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
LH + V+ DLKP NILLD+ ++ D GLA ++ SI +G++G
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGR---VGTVG 166
Query: 814 YVPPEYGLGERPSTAGD 830
Y+ PE +R + + D
Sbjct: 167 YMAPEVLNNQRYTLSPD 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 18/110 (16%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL---------SNGSLGDWIHG 740
I E L++++H N+V L + + L LV+E+L G +H
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKT-----LTLVFEYLDTDLKQYMDDCGGGLS-MHN 104
Query: 741 ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
R + L Y H V+H DLKP N+L+ E K+ DFGLAR
Sbjct: 105 VRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 23/69 (33%), Positives = 39/69 (56%), Gaps = 8/69 (11%)
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822
++H D+KP N+L++ K+ DFG++ L+ +SI+ T+V G+ Y+ PE G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------NSIAKTYV--GTNAYMAPERISG 167
Query: 823 ERPSTAGDV 831
E+ DV
Sbjct: 168 EQYGIHSDV 176
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHR--NLVKLITSCSSLDSKNM- 719
F+ IG GSFG V + + + L ++ + IT S DS +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 720 ---------EFLALVYEFLSNGSLGDWIHGERKNEL-------DITSALDYLHNDCEVPV 763
L ++ E+L GS D + E +I LDYLH++ ++
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI-- 123
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
H D+K N+LL E+ K+ DFG+A L D Q + F+G+ ++ PE
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQ---IKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 18/100 (18%)
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCE 760
H N+V L+ +C+ + ++ E+ G L +++ +R++ L + D L +
Sbjct: 98 HENIVNLLGACTIGGP-----ILVITEYCCYGDLLNFLRRKRESFLTLE---DLLSFSYQ 149
Query: 761 VP----------VVHSDLKPGNILLDEEMTAKVGDFGLAR 790
V +H DL N+LL K+ DFGLAR
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 32/192 (16%)
Query: 642 ALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSV--LHNERTGSW------------- 686
LF + + L T + IG G++G V + N++ GS
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD 62
Query: 687 KSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG----- 740
+ AE L+++ H N+VK D L LV E + GS+ + + G
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 741 ERKNELDITS-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL-ARFL 792
+R +E I+ L +LHN+ ++H D+K NILL E K+ DFG+ A+
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 793 LERVDNQSSISS 804
R+ +S+ +
Sbjct: 180 STRLRRNTSVGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 36/195 (18%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNE--RTGSW-------------KSFIAECET 695
I LR G F ++G+G++G V +TG + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 696 LRNV-RHRNLVKLITS-CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------- 746
L+ HRN+ + + + L LV EF GS+ D + + N L
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 747 ---DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS 803
+I L +LH V+H D+K N+LL E K+ DFG++ L ++
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVG 176
Query: 804 STHVFMGSIGYVPPE 818
+ F+G+ ++ PE
Sbjct: 177 RRNTFIGTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 3/45 (6%)
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
L I + L+ LH +H DL P NI ++ + K+ DFGLAR
Sbjct: 126 LQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 9e-04
Identities = 23/68 (33%), Positives = 29/68 (42%), Gaps = 8/68 (11%)
Query: 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVH 228
+L+ L+ N L IP L NLKVLDL+ N L P + SL
Sbjct: 1 NLKSLDLSNNRLT-VIPDGA-------FKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRS 52
Query: 229 LRLASNQL 236
L L+ N L
Sbjct: 53 LDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-04
Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
++T A++ +H + +H D+KP NIL+D + K+ DFGL
Sbjct: 109 ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 20/40 (50%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
AL Y+H V H DLKP NIL + + K+ DFGLAR
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 15/128 (11%)
Query: 690 IAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDIT 749
I E +R ++ N+V + S D L +V E+L+ GSL D + +E I
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIA 119
Query: 750 S-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+ AL++LH++ V+H D+K NILL + + K+ DFG + +S++
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 803 SSTHVFMG 810
T +M
Sbjct: 177 VGTPYWMA 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 42/185 (22%), Positives = 73/185 (39%), Gaps = 42/185 (22%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHR------NLVKLITSC---- 711
+F +G GS+GSV +R + + + L ++ + N ++++ S
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 712 ------SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSALD 753
+ LD L +V E+ G L I +K + + L
Sbjct: 61 IISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
LH E ++H DLK NILL K+GD G+++ L + + + I + H
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQIGTPH------- 166
Query: 814 YVPPE 818
Y+ PE
Sbjct: 167 YMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 35/154 (22%)
Query: 662 NFSHENLIGSGSFGSV--LHNERTGSW-------KSFIAECETLRNVRHRN--------- 703
+F +IG G+FG V + + TG K+ + E E + ++R
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 704 -LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH-----GERKNELDITS---ALDY 754
+VK+ S D +N L L+ EFL G + + E + I A+D
Sbjct: 62 WVVKMFYSFQ--DKRN---LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
+H ++ +H D+KP N+LLD + K+ DFGL
Sbjct: 117 IH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 26/132 (19%)
Query: 699 VRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE----RKNE-------LD 747
++HRN+V+ + S S F + E + GSL + + + NE
Sbjct: 62 LKHRNIVQYLGSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFLLERVDNQSSISSTH 806
I L YLH + +VH D+K N+L++ K+ DFG ++ L ++ T
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGIN-----PCTE 167
Query: 807 VFMGSIGYVPPE 818
F G++ Y+ PE
Sbjct: 168 TFTGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 9/68 (13%)
Query: 145 LKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKV 204
LK LDL N++T + D + L +L+VL+ N ++ ++ P S L +L+
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGN--------NLTSISPEAFSGLPSLRS 52
Query: 205 LDLTINRL 212
LDL+ N L
Sbjct: 53 LDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 23/68 (33%), Positives = 34/68 (50%), Gaps = 8/68 (11%)
Query: 450 SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509
+L S+DLSNNR+ IP G + L N+ +DLS N+L+ P + SL
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFK-------GLPNLKVLDLSGNNLTSISPEAFSGLPSLRS 52
Query: 510 LLMAYNQF 517
L ++ N
Sbjct: 53 LDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 23/60 (38%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 97 LRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155
L+S+ L NN+L+ +P L L+VL++S NNL P S L L+ LDL N +
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 10/80 (12%)
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L YL+N ++H D+KP NIL++ K+ DFG++ L+ +SI+ T F+G+
Sbjct: 116 LTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI------NSIADT--FVGT 165
Query: 812 IGYVPPEYGLGERPSTAGDV 831
Y+ PE G + + DV
Sbjct: 166 STYMSPERIQGGKYTVKSDV 185
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 40/184 (21%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFI------------------AECETLRNVRHRNLVKLIT 709
++GSG+ G+VL +R + F AE L N ++VK
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 710 SCSSLDSKNME---FLALVYEFLSNGSLGDWIHGERKNE------------LDITSALDY 754
+ D +N E +ALV ++ + G L I K + + A+ +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+H+ ++H D+K NILL K+GDFG ++ V + + T F G+ Y
Sbjct: 159 VHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD--DVGRT--FCGTPYY 211
Query: 815 VPPE 818
V PE
Sbjct: 212 VAPE 215
|
Length = 496 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 24/72 (33%), Positives = 40/72 (55%), Gaps = 8/72 (11%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
++ A+D +H ++ VH D+KP NIL+D ++ DFG L+E QSS++
Sbjct: 110 EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--- 163
Query: 807 VFMGSIGYVPPE 818
+G+ Y+ PE
Sbjct: 164 --VGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 35/131 (26%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI---HGERKNE 745
F+ E + L ++ N+++L+ C D L ++ E++ NG L ++ H + K E
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 746 ------------------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781
L I S + YL + + VH DL N L+ E +T
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTI 177
Query: 782 KVGDFGLARFL 792
K+ DFG++R L
Sbjct: 178 KIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 37/156 (23%)
Query: 662 NFSHENLIGSGSFGSV--LHNERTGS-------WKSFIAECETLRNVR-HRNL------- 704
+F +IG G+FG V + + TG KS + + + L +V+ R++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 705 --VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDW-IHGERKNELDITS--------ALD 753
V L S ++ ++L L+ EFL G L I + +E D+T A++
Sbjct: 62 WVVSLYYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-DVTRFYMAECVLAIE 115
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+H ++ +H D+KP NIL+D K+ DFGL+
Sbjct: 116 AVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 28/130 (21%), Positives = 53/130 (40%), Gaps = 21/130 (16%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS- 750
E + L + H +VK S D+ ++ E+ L + + ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDA-----FCIITEYCEGRDLDCKLEELKHTGKTLSEN 106
Query: 751 -----------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
+ Y+H + ++H DLK NI L + K+GDFG++R L+ D
Sbjct: 107 QVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA 162
Query: 800 SSISSTHVFM 809
++ + T +M
Sbjct: 163 TTFTGTPYYM 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 9/68 (13%)
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
AL Y+H +V V+H D+K NIL+ K+ DFG+A L NQ+S S F+G
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNS-SKRSTFVG 163
Query: 811 SIGYVPPE 818
+ ++ PE
Sbjct: 164 TPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF--LSNGSLGDWIHGERKNE------LD 747
++ V H+N++ L+ + K++E VY L + +L I E +E
Sbjct: 70 MKCVNHKNIISLLNVFTP--QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + +LH+ ++H DLKP NI++ + T K+ DFGLAR
Sbjct: 128 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 696 LRNVRHRNLVKLITSCSSLDS-KNMEFLALVYEFLSNGSLGDWIHGERKNE------LDI 748
++ V H+N++ L+ + S + + + +V E L + +L I E +E +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQMELDHERMSYLLYQM 135
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +LH+ ++H DLKP NI++ + T K+ DFGLAR
Sbjct: 136 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 229 LRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT 288
L L + L G IP D+ L +L N G IP SL ++T+++++ +++N G+
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 289 LPPGLGNLPFLRTYNIGFN 307
+P LG L LR N+ N
Sbjct: 482 IPESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 287 GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEG---- 342
+L GL L+ ++ N + G D G + SL S+ L L L+ N
Sbjct: 71 QSLLQGLTKGCGLQELDLSDN---ALGPD-GCGVLESLLRSSSLQELKLNNNGLGDRGLR 126
Query: 343 KIPESIGNFSNELSKLYLGGNHIYGKIPASIGRL----RSLTLLDLSYNSISGEIPIEIG 398
+ + + + L KL LG N + G ++ + R L L+L+ N I +
Sbjct: 127 LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186
Query: 399 Q----LQGLQVLGLAGNEIP----GGIPNSLANLKKLNQIDLSGNELTGEI-----PISF 445
+ L+VL L N + + +LA+LK L ++L N LT
Sbjct: 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALL 246
Query: 446 GNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
SLL++ LS N I + K + L E+ S LE +DL N
Sbjct: 247 SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE----LDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 19/60 (31%), Positives = 31/60 (51%)
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541
N+ ++DLS+N L+ + K +L+ L ++ N + P + L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 39/150 (26%)
Query: 668 LIGSGSFGSV--LHNERTGSW-------KSFIAECETLRNVR-HRNL---------VKLI 708
+IG G+FG V + + TG KS + E E + +VR R++ VKL
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--DITS--------ALDYLHND 758
S D L L+ E+L G + + +K+ + T A+D +H
Sbjct: 68 --YSFQDENY---LYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIH-- 118
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
++ +H D+KP N+LLD + K+ DFGL
Sbjct: 119 -KLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 20/77 (25%), Positives = 37/77 (48%), Gaps = 3/77 (3%)
Query: 723 ALVYEFLSNGSLGDWIHGERKNELD-ITSALDYLHNDCEVPVV-HSDLKPGNILLDEEMT 780
L+ E++ +L + E+++ + + L LH + V+ H DL PGNIL+D+
Sbjct: 69 YLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGNILVDDGKI 127
Query: 781 AKVGDFGLARFLLERVD 797
+ D+ A + D
Sbjct: 128 LGIIDWEYAGYGPPAFD 144
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 38/180 (21%)
Query: 669 IGSGSFGSVL--HNERTGSWK-------------SFIA-ECETLRNVRHRNLVKLITSCS 712
+GSG++G V N TG S I E ++ +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELDIT-------SALDYLHNDCEVPVV 764
S E L + E+ GSL D H +EL I L YLH+ ++
Sbjct: 77 S-----REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM--- 128
Query: 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER 824
H D+K NILL + K+ DFG+A + ++I+ F+G+ ++ PE E+
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKI------TATIAKRKSFIGTPYWMAPEVAAVEK 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 35/175 (20%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF----IAECETLRNV------RHRNLVKLITS------- 710
+IG G+FG V S K + +++ E ++ R+++ S
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHNDCEVPV 763
C+ D K +L +V E++ G L + + E ++ ALD +H+ + +
Sbjct: 110 CAFQDDK---YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS---MGL 163
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H D+KP N+LLD+ K+ DFG + +++ + +G+ Y+ PE
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKM-----DETGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 39/151 (25%)
Query: 669 IGSGSFGSVLHNE-RTGS------------------WKSFIAECETLRNVRHRNLVKLIT 709
IG+G FG VL +E T + F+ + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLG------DWIHGE------RKNELDITSALDYLHN 757
C + + +L LV+E+ G L W ++ +I + + ++H
Sbjct: 63 QCV----EAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
+ +HSDL N L ++T KVGD+G+
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 27/123 (21%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--- 745
F+ E + + ++ N+++L+ C + D L ++ E++ NG L ++ E
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 746 ----------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
I S + YL + + VH DL N L+ + T K+ DFG++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 790 RFL 792
R L
Sbjct: 178 RNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 43/179 (24%)
Query: 669 IGSGSFGSV-LHNERTGSWKSFIAECE-----------------TLRNVRHRNLVKLITS 710
IG GSFG + L ++ S I E + L ++H N+V T
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV---TF 64
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWI---HGERKNE-------LDITSALDYLHNDCE 760
+S F+ V E+ G L I G +E + I+ L ++H+
Sbjct: 65 FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 761 VPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
++H D+K NI L + M AK+GDFG+AR L ++ ++ T V G+ Y+ PE
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCV--GTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 929 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.78 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.55 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.54 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.5 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.49 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.48 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.47 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.39 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.34 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.31 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.28 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.26 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.96 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.96 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.91 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.64 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.26 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.24 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.07 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.06 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.92 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.88 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-107 Score=1033.92 Aligned_cols=851 Identities=30% Similarity=0.482 Sum_probs=611.2
Q ss_pred ChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecC
Q 002376 26 INTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNN 105 (929)
Q Consensus 26 ~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N 105 (929)
.++|++||++||+++. + |.+.+.+|+.+.+||.|.||+|++. ++|+.|||++++++|.+++.+..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~-~~~~~~~w~~~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-D-PLKYLSNWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-C-CcccCCCCCCCCCCCcCcceecCCC-CcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 5799999999999985 3 6778899998889999999999874 59999999999999999999999999999999999
Q ss_pred CCCCCCCcCCC-CCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCC
Q 002376 106 KLSGNLPREIG-NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSI 184 (929)
Q Consensus 106 ~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~ 184 (929)
+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|.. ++++++|++|+|++|.+.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChH-HhcCCCCCEEECccCcccccC
Confidence 99999998765 899999999999999887775 45778888888888887766665 788888888888888877766
Q ss_pred Ccccccc----------------CCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCC
Q 002376 185 PPSIANL----------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTL 248 (929)
Q Consensus 185 p~~i~~l----------------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l 248 (929)
|.++.++ +|..|+++++|+.|+|++|++++.+|..|.++++|++|+|++|++++.+|..+.. +
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l 259 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN-L 259 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC-C
Confidence 6544321 3445555666666666666666666666666666666666666666555555443 5
Q ss_pred CCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCC
Q 002376 249 PNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNST 328 (929)
Q Consensus 249 ~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~ 328 (929)
++|+.|++++|++++.+|..+.++++|+.|++++|.+.+.+|..+.++++|+.|++++|.+.... +..+..++
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-------~~~~~~l~ 332 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI-------PVALTSLP 332 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC-------ChhHhcCC
Confidence 66666666666666666666666666666666666666666666666666666666666554322 13455666
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
+|+.|+|++|.+++.+|..++.+. +|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++
T Consensus 333 ~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 333 RLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 667777777777666666666655 5667777777666666666666666666666666666666666666666666666
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCc---------------ccCC
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI---------------LRPL 473 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~---------------~~~~ 473 (929)
++|++++.+|..|.++++|+.||+++|++++.+|..+..+++|+.|+|++|++.|.+|... ....
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~ 491 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAV 491 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCcc
Confidence 6666666666666666666666666666666666666666666666666666655554321 1234
Q ss_pred chhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCC
Q 002376 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ 553 (929)
Q Consensus 474 p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (929)
|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..|..+++|+.|||++|+++|.+|..+.+++
T Consensus 492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 571 (968)
T PLN00113 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571 (968)
T ss_pred ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence 77888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCCC------CCCCCCCCCCcceeehhhHHHHHHHHHHHHhhhh
Q 002376 554 ALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL------GCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWP 627 (929)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~------~c~~~~~~~~~~~~i~i~~~~~~~l~~~~~~~~~ 627 (929)
+|+.|++++|+++|.+|..++|.++....+.||+.+|+.+ +|.... +...+..++++++ +++++++++++.+
T Consensus 572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~ 649 (968)
T PLN00113 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-KTPSWWFYITCTL-GAFLVLALVAFGF 649 (968)
T ss_pred ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-ccceeeeehhHHH-HHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999754 454321 1122222222222 2222222222222
Q ss_pred hhhhcccccc-cccc---cccc------ccCCCCChHHHHHhhCCCCCceeecccCceeEEeccccCc------------
Q 002376 628 IIVRKRKAKR-VGVS---ALFK------VCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGS------------ 685 (929)
Q Consensus 628 ~~~rrr~~~~-~~~~---~~~~------~~~~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~------------ 685 (929)
+++++|+..+ ...+ ..+. .....++++++. +.|+..++||+|+||+||+|+....
T Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~ 726 (968)
T PLN00113 650 VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726 (968)
T ss_pred HHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCC
Confidence 2223222111 1100 0010 001123444443 4577888999999999999986411
Q ss_pred HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccc-----cccccccHHHHHHHhhhCCC
Q 002376 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCE 760 (929)
Q Consensus 686 ~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-----~~~~~~~ia~aL~yLH~~~~ 760 (929)
.....+|++.+++++|||||+++|+|.+.+ ..|+|||||++|+|.++++. ...++.|||+||+|||+.+.
T Consensus 727 ~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~ 801 (968)
T PLN00113 727 NSIPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCS 801 (968)
T ss_pred ccccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCC
Confidence 112346799999999999999999996543 37999999999999999863 23457899999999998777
Q ss_pred CCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCC
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGE 840 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~ 840 (929)
++|+|||+||+||++++++.+++. ||.+..... .....||++|||||++.+..++.++||||+|+++||
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~e 870 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIE 870 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-ecccccccc----------CCCccccccccCcccccCCCCCcccchhhHHHHHHH
Confidence 799999999999999999988886 666543211 112368899999999999999999999999999888
Q ss_pred cchhHHhhhcCCc----------------hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHH
Q 002376 841 FNIVKWVESNLPE----------------NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIR 904 (929)
Q Consensus 841 ~~~~~~~~~~~~~----------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 904 (929)
+.....++..... .....+|+.+... .....+.+.++++ ++.+||+.||++||+|+
T Consensus 871 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-l~~~Cl~~~P~~RPt~~ 942 (968)
T PLN00113 871 LLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD-------VSVNQNEIVEVMN-LALHCTATDPTARPCAN 942 (968)
T ss_pred HHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC-------CCccHHHHHHHHH-HHHhhCcCCchhCcCHH
Confidence 7665544321100 0111112211110 0011233445555 99999999999999999
Q ss_pred HHHHHHHhhHHHHhhc
Q 002376 905 EALRRLKSSQEILLKQ 920 (929)
Q Consensus 905 ev~~~L~~~~~~~~~~ 920 (929)
||+++|+++.+.....
T Consensus 943 evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 943 DVLKTLESASRSSSSC 958 (968)
T ss_pred HHHHHHHHhhcccccc
Confidence 9999999987755433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=584.23 Aligned_cols=485 Identities=33% Similarity=0.513 Sum_probs=361.9
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccc-cccccceecccccccCCCCChhhhccCCCCcEE
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNIS-KLTELKMLDLMANKITGRVTDDQLRNLRSLQVL 173 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L 173 (929)
.+++.|||++|+++|.+|..|..+++|++|+|++|++++.+|..+. ++++|++|||++|+++|.+|. +.+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence 3689999999999999999999999999999999999999997765 999999999999999988875 468999999
Q ss_pred EccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcce
Q 002376 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253 (929)
Q Consensus 174 ~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 253 (929)
+|++|.+++.+|..+. .+++|++|+|++|.+.+..|..|.++++|++|+|++|++.+.+|..+.. +++|+.
T Consensus 146 ~Ls~n~~~~~~p~~~~--------~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~ 216 (968)
T PLN00113 146 DLSNNMLSGEIPNDIG--------SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKW 216 (968)
T ss_pred ECcCCcccccCChHHh--------cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcC-cCCccE
Confidence 9999999887775443 4455555555555555555555555555555555555555555544433 455555
Q ss_pred eeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCC-----------------
Q 002376 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDE----------------- 316 (929)
Q Consensus 254 l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~----------------- 316 (929)
|++++|++++.+|..+.++++|+.|++++|.+++.+|..|+++++|++|++++|++.......
T Consensus 217 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 296 (968)
T PLN00113 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296 (968)
T ss_pred EECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCee
Confidence 555555555555555555555555555555555555555555555555555555443211100
Q ss_pred CCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCcc
Q 002376 317 GLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIE 396 (929)
Q Consensus 317 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 396 (929)
.-..+..+.++++|++|++++|.+++.+|..+..++ +|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..
T Consensus 297 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~ 375 (968)
T PLN00113 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375 (968)
T ss_pred ccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChh
Confidence 000123455666777777777777766776666665 5777777777777777777777777777777777777777777
Q ss_pred ccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCc-------
Q 002376 397 IGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI------- 469 (929)
Q Consensus 397 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~------- 469 (929)
+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..|.++++|+.|++++|+++|.+|...
T Consensus 376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 455 (968)
T PLN00113 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455 (968)
T ss_pred HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence 7777777777777777777778888888888888888888888888888888888889999888888765421
Q ss_pred ---------ccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCc
Q 002376 470 ---------LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540 (929)
Q Consensus 470 ---------~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 540 (929)
...+|..+ ..++|+.|||++|++++.+|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|+
T Consensus 456 ~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (968)
T PLN00113 456 MLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534 (968)
T ss_pred EEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence 11233322 34678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCcccccCCCCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCCCcCCC
Q 002376 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 541 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~~c~~~ 593 (929)
++|.+|..+.++++|+.|+|++|+++|.+|.. ..+..++.+++++|+..+..|
T Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999999975 457789999999999877443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=399.42 Aligned_cols=252 Identities=37% Similarity=0.621 Sum_probs=203.7
Q ss_pred cCCCCChHHHHHhhCCCCCceeecccCceeEEecccc--------------Cc-HHHHHHHHHHHHccCCccccceeeec
Q 002376 647 CHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERT--------------GS-WKSFIAECETLRNVRHRNLVKLITSC 711 (929)
Q Consensus 647 ~~~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~-~~~~~~E~~~l~~l~Hpniv~l~~~~ 711 (929)
....|+++|+++||++|+..+.||+|+||.||+|... .. .++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 3456999999999999999999999999999998765 12 56799999999999999999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCce
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 781 (929)
.+.+. ..+||||||++|+|.++++... +++.++|+||+|||..+.++||||||||+|||+|+++++
T Consensus 141 ~e~~~----~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGE----HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCc----eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 76442 4799999999999999998544 568999999999999998999999999999999999999
Q ss_pred EEeccccccccccccCCCCCcccccee-ccccccccccccCCCCCCCCCCCCCCcCCCCCcc----------------hh
Q 002376 782 KVGDFGLARFLLERVDNQSSISSTHVF-MGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFN----------------IV 844 (929)
Q Consensus 782 ki~DfGla~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~----------------~~ 844 (929)
||+|||+|+..+.. ....... .||.+|+|||++..+..+.|+||||||+++.|+. +.
T Consensus 217 KlsDFGLa~~~~~~------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred EccCccCcccCCcc------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 99999999765320 1111112 7999999999999999999999999998765532 44
Q ss_pred HHhhhcCCc-hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 845 KWVESNLPE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 845 ~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.|+.....+ .+.+++|+.+... . ....+++.++++ +|.+|++.+|.+||+|.||+++|+.+...
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~----~---~~~~~~~~~~~~-~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEG----E---YPDEKEVKKLAE-LALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCC----C---CChHHHHHHHHH-HHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 555444444 4666677766520 0 000135666777 99999999999999999999999665443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.95 Aligned_cols=370 Identities=24% Similarity=0.275 Sum_probs=303.3
Q ss_pred ceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCC
Q 002376 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTS 225 (929)
Q Consensus 146 ~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 225 (929)
++||+|+|+++ .+....|.++++|+.+++.+|.++ . +|..-....+|+.|+|.+|.|+.+..+.+..++.
T Consensus 81 ~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~--------IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~a 150 (873)
T KOG4194|consen 81 QTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-R--------IPRFGHESGHLEKLDLRHNLISSVTSEELSALPA 150 (873)
T ss_pred eeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-h--------cccccccccceeEEeeeccccccccHHHHHhHhh
Confidence 45666666665 555555666666666666666652 2 2222233456888888888888888888888888
Q ss_pred CceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccc
Q 002376 226 LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305 (929)
Q Consensus 226 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 305 (929)
|+.||||.|.|+ +||..-+..-.++++|+|++|+++...-+.|.++.+|..|.|++|+++...+..|++|++|+.|+|.
T Consensus 151 lrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLn 229 (873)
T KOG4194|consen 151 LRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLN 229 (873)
T ss_pred hhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcc
Confidence 888888888887 7887777766788888888888888888899999999999999999997777889999999999999
Q ss_pred cccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEee
Q 002376 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLS 385 (929)
Q Consensus 306 ~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 385 (929)
.|+|..... ..|.++++|+.|.|..|.+...-...|..+. ++++|+|+.|+++..-..++.++++|+.||||
T Consensus 230 rN~irive~-------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS 301 (873)
T KOG4194|consen 230 RNRIRIVEG-------LTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLS 301 (873)
T ss_pred ccceeeehh-------hhhcCchhhhhhhhhhcCcccccCcceeeec-ccceeecccchhhhhhcccccccchhhhhccc
Confidence 999875422 3578889999999999999854444555555 79999999999998888999999999999999
Q ss_pred CCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCC
Q 002376 386 YNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNI 465 (929)
Q Consensus 386 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i 465 (929)
+|.|..+.++.+...++|++|+|+.|+|+...+.+|..+..|+.|+|++|+++..-...|..+++|+.|||++|.|++.|
T Consensus 302 ~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~I 381 (873)
T KOG4194|consen 302 YNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCI 381 (873)
T ss_pred hhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence 99999888999999999999999999999999999999999999999999999888888999999999999999999877
Q ss_pred CCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCc
Q 002376 466 PKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540 (929)
Q Consensus 466 ~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 540 (929)
..+ ...|..++.|+.|+|.+|++....-.+|.++..|+.|||.+|.|..+-|++|..+ .|+.|.++.-.
T Consensus 382 EDa-----a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 382 EDA-----AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred ecc-----hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 543 4456778888888888888886555788888888888888888888888888888 88888775543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=377.21 Aligned_cols=473 Identities=30% Similarity=0.436 Sum_probs=280.6
Q ss_pred EEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccc
Q 002376 73 VIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA 152 (929)
Q Consensus 73 v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 152 (929)
...+++++|.++ .+.+.+.+|..|++|++++|+++ ..|++++.+..++.|+.|+|+++ .+|+.++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 456778888887 66778888888888888888887 78888888888888888888888 7888888888888888888
Q ss_pred cccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEee
Q 002376 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLA 232 (929)
Q Consensus 153 N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 232 (929)
|.+. .++++ ++.+-.|+.|+..+|+++. .|+++..+.+|..|++.+|++....|..+. ++.|++||..
T Consensus 124 n~~~-el~~~-i~~~~~l~dl~~~~N~i~s---------lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~ 191 (565)
T KOG0472|consen 124 NELK-ELPDS-IGRLLDLEDLDATNNQISS---------LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCN 191 (565)
T ss_pred ccee-ecCch-HHHHhhhhhhhcccccccc---------CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccc
Confidence 8887 67776 7888888888888887643 456667778888888888888855554444 8888888888
Q ss_pred ecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCC
Q 002376 233 SNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312 (929)
Q Consensus 233 ~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 312 (929)
+|.++ .+|.+++. +.+|..|++..|++.. .| +|.+++.|.+++++.|+|+-...+..++++++.+|||..|++++.
T Consensus 192 ~N~L~-tlP~~lg~-l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~ 267 (565)
T KOG0472|consen 192 SNLLE-TLPPELGG-LESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV 267 (565)
T ss_pred hhhhh-cCChhhcc-hhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC
Confidence 88876 77777766 7777777777777763 44 677777777777777777733333345777777777777777766
Q ss_pred CCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCC-----CCcccE----EE
Q 002376 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR-----LRSLTL----LD 383 (929)
Q Consensus 313 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~----L~ 383 (929)
++ .+.-+.+|++||+|+|.|+ .+|.+++++ .|+.|-+.+|.+...-.+.+.+ ++.|+. =-
T Consensus 268 Pd--------e~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dg 336 (565)
T KOG0472|consen 268 PD--------EICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDG 336 (565)
T ss_pred ch--------HHHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCC
Confidence 54 3455667777777777777 566677766 4777777777664211100000 000000 00
Q ss_pred eeCCCC----CcccC----ccccCCCCCCEEEecCCcCCCCCcccccCCCC---CceecccCcccccccCcccccccccc
Q 002376 384 LSYNSI----SGEIP----IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKK---LNQIDLSGNELTGEIPISFGNFQSLL 452 (929)
Q Consensus 384 Ls~N~l----~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~ 452 (929)
+|.-+= .+..| .....+.+.+.|++++-+++. +|+......+ ....+++.|++. ++|..+..+..+.
T Consensus 337 lS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelv 414 (565)
T KOG0472|consen 337 LSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELV 414 (565)
T ss_pred CCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHH
Confidence 000000 00000 011123334445555555542 2222222111 444455555554 3444444443332
Q ss_pred e-ecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCC
Q 002376 453 S-IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGL 531 (929)
Q Consensus 453 ~-L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (929)
+ +.+++|.++ .+ |..++.+++|+.|+|++|-+. .+|..++.+..|+.||+|+|+|. .+|..+-.+..|
T Consensus 415 T~l~lsnn~is-fv--------~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l 483 (565)
T KOG0472|consen 415 TDLVLSNNKIS-FV--------PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL 483 (565)
T ss_pred HHHHhhcCccc-cc--------hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH
Confidence 2 233333332 22 444444555555555544443 34444555555555555555444 344444444444
Q ss_pred CEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCC
Q 002376 532 EVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPK 588 (929)
Q Consensus 532 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~ 588 (929)
+.+-.++|++....|+.+.+|.+|..|||.+|.+...+|..+.+.++..+.+.|||+
T Consensus 484 Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 484 ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred HHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 444444455543333344455555555555555554444444445555555555543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.01 Aligned_cols=456 Identities=27% Similarity=0.400 Sum_probs=328.3
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEE
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLN 174 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 174 (929)
.-|+.|++++|.+. .+-+.+.+|..|.+|++.+|+++ ..|.+++.+..++.|+.|+|+++ .+|++ ++.+.+|..|+
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~-i~s~~~l~~l~ 120 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQ-IGSLISLVKLD 120 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHH-Hhhhhhhhhhh
Confidence 35788999999998 66667888999999999999999 78888999999999999999998 78877 89999999999
Q ss_pred ccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCccee
Q 002376 175 FGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254 (929)
Q Consensus 175 Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l 254 (929)
.++|.+.. .|++++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++. .+|.+..+ ++.|+.+
T Consensus 121 ~s~n~~~e---------l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~l 188 (565)
T KOG0472|consen 121 CSSNELKE---------LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHL 188 (565)
T ss_pred ccccceee---------cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhc
Confidence 99998732 4556777888999999999998 67788888889999999999887 55555544 6667777
Q ss_pred eccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEE
Q 002376 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLA 334 (929)
Q Consensus 255 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~ 334 (929)
+...|-++ .+|..++.+.+|+.|+|.+|+|. .+| .|..+..|+.|+++.|+|...++ ....+++++.+||
T Consensus 189 d~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpa-------e~~~~L~~l~vLD 258 (565)
T KOG0472|consen 189 DCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPA-------EHLKHLNSLLVLD 258 (565)
T ss_pred ccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHH-------HHhcccccceeee
Confidence 76666654 46666666777777777777766 444 66666666666666666655543 2233566666666
Q ss_pred ccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccC-----CCCCCE----
Q 002376 335 LDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQ-----LQGLQV---- 405 (929)
Q Consensus 335 Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~---- 405 (929)
|.+|+++ ..|+.+..+. +|..||+|+|.|++ .|.+++++ .|+.|-+.+|.+..+-.+.+.. ++.|+.
T Consensus 259 LRdNklk-e~Pde~clLr-sL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~ 334 (565)
T KOG0472|consen 259 LRDNKLK-EVPDEICLLR-SLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD 334 (565)
T ss_pred ccccccc-cCchHHHHhh-hhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence 6666666 5666666554 56666666666663 45556666 6666666666654211110000 001110
Q ss_pred EEecCCc----CCCC-Ccc---cccCCCCCceecccCcccccccCcccccccc---cceecccCCcCCCCCCCCcccCCc
Q 002376 406 LGLAGNE----IPGG-IPN---SLANLKKLNQIDLSGNELTGEIPISFGNFQS---LLSIDLSNNRINGNIPKGILRPLP 474 (929)
Q Consensus 406 L~L~~N~----l~~~-~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~g~i~~~~~~~~p 474 (929)
=.++.-+ =.+. .+. ....+.+.+.|++++-+++ .+|........ .+..+++.|++. .+ |
T Consensus 335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-el--------P 404 (565)
T KOG0472|consen 335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-EL--------P 404 (565)
T ss_pred CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hh--------h
Confidence 0000000 0000 111 1233457889999999998 56655433333 788999999996 34 6
Q ss_pred hhhhcccCccE-EEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCC
Q 002376 475 EEISRLENVVT-IDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ 553 (929)
Q Consensus 475 ~~~~~l~~L~~-LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (929)
..+..++.+++ +++++|.++ .+|..+..+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+.
T Consensus 405 k~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq 481 (565)
T KOG0472|consen 405 KRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQ 481 (565)
T ss_pred hhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHH
Confidence 66666655544 566666665 88999999999999999999987 78999999999999999999998 7899888888
Q ss_pred CCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCCCcCCC
Q 002376 554 ALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~~c~~~ 593 (929)
.|+.+-.++|++..+.|++ ..++++..+++.+|...-.+|
T Consensus 482 ~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp 522 (565)
T KOG0472|consen 482 TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPP 522 (565)
T ss_pred HHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCCh
Confidence 8888888889999888874 568999999999998766555
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.29 Aligned_cols=232 Identities=28% Similarity=0.417 Sum_probs=181.0
Q ss_pred ceeecccCceeEEeccccCc-----------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 666 ENLIGSGSFGSVLHNERTGS-----------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~~-----------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.+.||+|+||+||+|.+.+. .++|.+|+.+|++++|||||+++|+|.+... ..++||||
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~iVtEy 121 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCIVTEY 121 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEEEEEe
Confidence 35599999999999988732 3489999999999999999999999975431 37999999
Q ss_pred cCCCCcccccccc--c--------cccccHHHHHHHhhhCCCCC-EEecCCCCCCeeecCCC-ceEEecccccccccccc
Q 002376 729 LSNGSLGDWIHGE--R--------KNELDITSALDYLHNDCEVP-VVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~~~--~--------~~~~~ia~aL~yLH~~~~~~-iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~ 796 (929)
|++|+|.++++.. + .++.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999762 2 3378999999999998 5 99999999999999998 99999999998753211
Q ss_pred CCCCCccccceeccccccccccccC--CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGL--GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
...+...||+.|||||++. ...|+.|+||||||+++||+.+...++..... .++...-... ..+
T Consensus 199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~------~~R 264 (362)
T KOG0192|consen 199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVG------GLR 264 (362)
T ss_pred ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhc------CCC
Confidence 2233368999999999999 56899999999999888887776666555543 1111111111 111
Q ss_pred hhhhH-HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 875 IQLHD-CLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 875 ~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
+..+. |...+.. ++.+||+.||++||++.|++.+|+.+...+..
T Consensus 265 p~~p~~~~~~l~~-l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSS-LMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHH-HHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 22111 3333444 77799999999999999999999999887664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=357.78 Aligned_cols=366 Identities=25% Similarity=0.307 Sum_probs=288.7
Q ss_pred CCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEcc
Q 002376 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176 (929)
Q Consensus 97 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 176 (929)
-+.|||++|+++..-+..|.++++|+.++|.+|.++ .||.......+|+.|+|.+|.|+ .+..+.+..++.|+.||||
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhh
Confidence 367888888888778888888888888888888888 77876666667888888888887 6777778888888888888
Q ss_pred ccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeec
Q 002376 177 KNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY 256 (929)
Q Consensus 177 ~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l 256 (929)
.|.++. +--..|..-.++++|+|++|+|+....+.|.++.+|.+|.|+.|+|+ .+|...|+.+++|+.|+|
T Consensus 158 rN~is~--------i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdL 228 (873)
T KOG4194|consen 158 RNLISE--------IPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDL 228 (873)
T ss_pred hchhhc--------ccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhc
Confidence 887743 22234555667888888888888888888888888888888888888 788888888888888888
Q ss_pred cCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEcc
Q 002376 257 CFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336 (929)
Q Consensus 257 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls 336 (929)
..|++.-..--.|.+|.+|+.|.|..|.+...-...|..|.++++|+|++|++..+.. ..+.+++.|+.|+||
T Consensus 229 nrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~-------g~lfgLt~L~~L~lS 301 (873)
T KOG4194|consen 229 NRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE-------GWLFGLTSLEQLDLS 301 (873)
T ss_pred cccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc-------ccccccchhhhhccc
Confidence 8888876556678888888888888888887777788888888888888888877654 456778888888888
Q ss_pred CCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCC
Q 002376 337 GNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGG 416 (929)
Q Consensus 337 ~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 416 (929)
+|.|...-+++.. +..+|++|+|++|+|+...+.+|..++.|++|+|++|++...--..|..+.+|+.|||++|.|+..
T Consensus 302 ~NaI~rih~d~Ws-ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 302 YNAIQRIHIDSWS-FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred hhhhheeecchhh-hcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 8888855555544 344788888888888888888888888888888888888877677788888888888888888765
Q ss_pred Ccc---cccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecC
Q 002376 417 IPN---SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490 (929)
Q Consensus 417 ~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~ 490 (929)
+.+ .|.++++|+.|+|.+|+|..+.-.+|.++.+|+.|||.+|.|.. |. |..|..+ .|+.|-++.
T Consensus 381 IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS-Iq-------~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 381 IEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS-IQ-------PNAFEPM-ELKELVMNS 448 (873)
T ss_pred EecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee-ec-------ccccccc-hhhhhhhcc
Confidence 543 57788888888888888887666788888888888888888863 32 4445554 566655543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.45 Aligned_cols=232 Identities=24% Similarity=0.367 Sum_probs=177.5
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecc
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCS 712 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 712 (929)
.++.+|+++ .+.||+|..|+|||++++. ..+++.+|++++++++||+||+++|.|+
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 466677765 4789999999999998872 2578899999999999999999999997
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
.... .++++||||++|||+++++... .++.+|++||.|||+. ..||||||||+|||++..|++|||
T Consensus 148 ~~~~----~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 148 SNGE----EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eCCc----eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 6431 4899999999999999987533 3477899999999973 289999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhccCh
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVLDP 861 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~~~ 861 (929)
|||.++.+.. +....++||..|||||-+.+..|+.++||||+|+.+.|+.+++++.....+ .+.+.++.
T Consensus 222 DFGVS~~lvn--------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 222 DFGVSGILVN--------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA 293 (364)
T ss_pred cccccHHhhh--------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence 9999997632 134567999999999999999999999999999776666666555443211 22222222
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
-.. ++.++.+...+-.++ ++++.+|++.||.+||+++|+++
T Consensus 294 Iv~-----~ppP~lP~~~fS~ef-~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 294 IVD-----EPPPRLPEGEFSPEF-RSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred Hhc-----CCCCCCCcccCCHHH-HHHHHHHhcCCcccCCCHHHHhc
Confidence 222 121111111122222 33677999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=346.00 Aligned_cols=232 Identities=25% Similarity=0.358 Sum_probs=177.3
Q ss_pred CCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 664 SHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
+..+.||+|-||+||.|++.+ ..++|.+|+++|.+++|++||+++|+|...++ +|||||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p-----iyIVtE~m 283 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP-----IYIVTEYM 283 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc-----eEEEEEec
Confidence 345789999999999998873 24689999999999999999999999976443 89999999
Q ss_pred CCCCcccccccc-c---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 730 SNGSLGDWIHGE-R---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 730 ~~gsL~~~l~~~-~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
+.|+|.+||+.. + .++.|||+||+||+++ ++|||||.++||||+++..|||+|||+||....+.-
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-- 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-- 358 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce--
Confidence 999999999852 2 2367999999999998 999999999999999999999999999995432111
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
.......-...|.|||.+..++++.|+||||||++++|+.+. +..|. .+....++...+...... +....
T Consensus 359 ---~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~----G~~py--~~msn~ev~~~le~GyRl-p~P~~ 428 (468)
T KOG0197|consen 359 ---TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTY----GRVPY--PGMSNEEVLELLERGYRL-PRPEG 428 (468)
T ss_pred ---eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhcc----CCCCC--CCCCHHHHHHHHhccCcC-CCCCC
Confidence 111112236689999999999999999999999999996544 33331 111112222222211111 11123
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
|...+.+ ||..||+.+|++|||++.+...++++...
T Consensus 429 CP~~vY~-lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 429 CPDEVYE-LMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCHHHHH-HHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 5556666 99999999999999999999988887654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.88 Aligned_cols=226 Identities=23% Similarity=0.219 Sum_probs=170.9
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
+.|...+.+|+|+||.|-+|..+. ......+|+++|++++|||||++++++...+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-- 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-- 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--
Confidence 467778999999999997765441 1123469999999999999999999996544
Q ss_pred CcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEEecc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKVGDF 786 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~Df 786 (929)
+.|||||||+||+|.+++-.. +.+..|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 ---s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 ---SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ---ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 379999999999999987532 23478999999999998 99999999999999755 78999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC---CCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccCh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER---PSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDP 861 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~ 861 (929)
|+|+... ....+..+|||+.|.|||++.++. +..++|+||+||++|-+..+..++..... ...+.+
T Consensus 324 GlAK~~g-------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI-- 394 (475)
T KOG0615|consen 324 GLAKVSG-------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI-- 394 (475)
T ss_pred chhhccc-------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH--
Confidence 9999763 234456789999999999998775 34578999999998887666555543221 122111
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+.+ ...+..+..+.+-..+++.+++..||++|||++|+++
T Consensus 395 -~~G~y----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 -LKGRY----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -hcCcc----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11111 1222333444444445888999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=355.95 Aligned_cols=237 Identities=24% Similarity=0.392 Sum_probs=182.4
Q ss_pred CCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+....+.||+|+||+||+|+.. +..++|.+|+++++.++|||||+++|+|...++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P--- 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP--- 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence 4455688999999999998765 135789999999999999999999999987665
Q ss_pred ceEEEEEEecCCCCcccccccc----------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE----------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE 777 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~----------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 777 (929)
.+||+|||..|||.+||+.+ ..++.|||.||+||-++ .+|||||.++|+||.+
T Consensus 564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 89999999999999999721 12467999999999998 7999999999999999
Q ss_pred CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 778 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
+..|||+|||++|.+...+- ........-..+|||||.+..++||+++||||+|+++||+..+ +..| ..+
T Consensus 639 ~l~VKIsDfGLsRdiYssDY----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy----G~QP--y~g 708 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDY----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY----GKQP--YYG 708 (774)
T ss_pred ceEEEecccccchhhhhhhh----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc----ccCc--ccc
Confidence 99999999999996532110 0011122346799999999999999999999999999985322 2112 222
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.-+.++.+......- -.....|..++.+ ||..||+.+|++||+++||-.+|+...+..+
T Consensus 709 lSn~EVIe~i~~g~l-L~~Pe~CP~~vY~-LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 709 LSNQEVIECIRAGQL-LSCPENCPTEVYS-LMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred cchHHHHHHHHcCCc-ccCCCCCCHHHHH-HHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 223333332222211 1122256677777 9999999999999999999999999877644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=319.44 Aligned_cols=230 Identities=24% Similarity=0.322 Sum_probs=170.0
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|.+.++||+|.||+|||+.+. +..++...|+.+|++++|||||++++.-.. +..+.++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhhH
Confidence 4666789999999999998765 234567799999999999999999985433 2334589
Q ss_pred EEEEecCCCCcccccccc----c--------cccccHHHHHHHhhhCCCCC--EEecCCCCCCeeecCCCceEEeccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE----R--------KNELDITSALDYLHNDCEVP--VVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~----~--------~~~~~ia~aL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
+|||||+.|+|..+++.. + ++..|+++||.++|... +. |+||||||.||+++.+|.+|++|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999988622 1 23579999999999942 24 999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
|.+.. ........+|||.||+||.+.+.+|+.|+||||+||++|||....-++..- ...+ +...+..
T Consensus 176 r~l~s------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~-----L~~KI~q 242 (375)
T KOG0591|consen 176 RFLSS------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLS-----LCKKIEQ 242 (375)
T ss_pred hHhcc------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHH-----HHHHHHc
Confidence 98742 233456679999999999999999999999999999988875544333211 1111 1111111
Q ss_pred cchhhhhhh-HHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 870 NESQTIQLH-DCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 870 ~~~~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
..- ++.+ +..++-+..|+..|++.||+.||+....++.+
T Consensus 243 gd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 243 GDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 111 0111 23344444577799999999999854444333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=325.68 Aligned_cols=175 Identities=30% Similarity=0.471 Sum_probs=149.2
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|...+.||+|+||+||+|+++. ..+....|+.+|+.++|||||++++++... .+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence 4678888899999999999998872 234567899999999999999999999554 45
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC------CceEEeccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE------MTAKVGDFG 787 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~ki~DfG 787 (929)
+|+|||||.+|||.+|++.++ .+..|+|.||++||++ +||||||||.||||+.. -.+||+|||
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999999998553 4478999999999998 99999999999999764 468999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhh
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVES 849 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~ 849 (929)
+||.+.+. ......+|++.|||||+++...|+.|+|+||.|+++|++..+.-++.
T Consensus 161 fAR~L~~~-------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 161 FARFLQPG-------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhhhCCch-------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99987522 23455799999999999999999999999999988888766555443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.51 Aligned_cols=224 Identities=22% Similarity=0.287 Sum_probs=177.5
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
..|...+.||+|||+.||+++.. +..+...+||++.+.++|||||+++++|.+ ..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-----s~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-----SNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-----CCc
Confidence 57999999999999999998873 345678899999999999999999999944 455
Q ss_pred EEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+|.|+|++|+|..+++.+ |.+..||+.||.|||+. +|||||||-.|+++++++++||+|||+|..+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999999998732 34578999999999998 99999999999999999999999999999874
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......+|||-|+|||++....++..+||||.||++|.+.++.-++..- .+.+.. ..-...
T Consensus 170 ~~------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--~vkety--------~~Ik~~ 233 (592)
T KOG0575|consen 170 YD------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--TVKETY--------NKIKLN 233 (592)
T ss_pred Cc------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--hHHHHH--------HHHHhc
Confidence 32 12345679999999999999999999999999999888765544333221 121111 111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....+..++.-.++|+.+.+++||.+|||+++|+.
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222234444455888999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=330.89 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=187.4
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccCc---------------HHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTGS---------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++++...+.+.....||+|+||+||+|++.++ .+.|++|+.++++-+|.||+-+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--- 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--- 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---
Confidence 45555555666778999999999999999843 578999999999999999999999996433
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
..+|+.+|+|-+|+.++|..+ .++.|||+||.|||.+ +|||||+|+.||++.++++|||+|||++
T Consensus 462 ---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 ---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 499999999999999998433 4588999999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
..-..... ......-.|...|||||+++.. +|++.+|||+||+++||+...+|++. .... .+++=.--++.
T Consensus 536 tvk~~w~g----~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~-dqIifmVGrG~ 609 (678)
T KOG0193|consen 536 TVKTRWSG----EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR-DQIIFMVGRGY 609 (678)
T ss_pred eeeeeecc----ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh-hheEEEecccc
Confidence 75432211 1112233578899999998743 69999999999999999998888877 2211 11110001111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
+..+. ......|..++ ++|+..||..+|++||.+.+++.+|+++....+
T Consensus 610 l~pd~--s~~~s~~pk~m-k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 610 LMPDL--SKIRSNCPKAM-KRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred cCccc--hhhhccCHHHH-HHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 11110 11112233333 337779999999999999999999999888654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=356.84 Aligned_cols=465 Identities=28% Similarity=0.384 Sum_probs=284.7
Q ss_pred EEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccc
Q 002376 73 VIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA 152 (929)
Q Consensus 73 v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 152 (929)
++.|++..|-+-...-+.+..--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.+
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 455555555433111111222233777777777765 66667777777777777777776 5666667777777777777
Q ss_pred cccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEee
Q 002376 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLA 232 (929)
Q Consensus 153 N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 232 (929)
|++. ..|.+ +..+.+|++|++|.|++. . +|.-+..++.+..++.++|......+ .+. ++.++|.
T Consensus 101 n~l~-~lP~~-~~~lknl~~LdlS~N~f~-~--------~Pl~i~~lt~~~~~~~s~N~~~~~lg----~~~-ik~~~l~ 164 (1081)
T KOG0618|consen 101 NRLQ-SLPAS-ISELKNLQYLDLSFNHFG-P--------IPLVIEVLTAEEELAASNNEKIQRLG----QTS-IKKLDLR 164 (1081)
T ss_pred chhh-cCchh-HHhhhcccccccchhccC-C--------CchhHHhhhHHHHHhhhcchhhhhhc----ccc-chhhhhh
Confidence 7765 45554 677777777777777652 2 33344456666666666662211121 111 6667777
Q ss_pred ecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCC
Q 002376 233 SNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312 (929)
Q Consensus 233 ~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 312 (929)
.|.+.+.++.++.. +.+ .++|++|++. -..+.++.+|+.|....|+++... -..++|+.|+.++|.+...
T Consensus 165 ~n~l~~~~~~~i~~-l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~ 234 (1081)
T KOG0618|consen 165 LNVLGGSFLIDIYN-LTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTL 234 (1081)
T ss_pred hhhcccchhcchhh-hhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceee
Confidence 77776666655443 332 4677777665 234556667777777777766332 2345677777777777633
Q ss_pred CCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcc
Q 002376 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE 392 (929)
Q Consensus 313 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 392 (929)
.. -..-.+|+++++++|+++ .+|++++.+. +|+.++..+|+|+ .+|..+....+|+.|+..+|.++ -
T Consensus 235 ~~---------~p~p~nl~~~dis~n~l~-~lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-y 301 (1081)
T KOG0618|consen 235 DV---------HPVPLNLQYLDISHNNLS-NLPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-Y 301 (1081)
T ss_pred cc---------ccccccceeeecchhhhh-cchHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-h
Confidence 21 122357788888888887 5667777777 6888888888884 56777777778888888888887 5
Q ss_pred cCccccCCCCCCEEEecCCcCCCCCcccccCCCC-CceecccCcccccccCcccccccccceecccCCcCCCCCCCCccc
Q 002376 393 IPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKK-LNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471 (929)
Q Consensus 393 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~ 471 (929)
+|....++++|++|+|..|+|...++..|.-+.. |..|+.+.|++.......=..+..|+.|++.+|.++...
T Consensus 302 ip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c------ 375 (1081)
T KOG0618|consen 302 IPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC------ 375 (1081)
T ss_pred CCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc------
Confidence 5666777888888888888887544433333332 555666666665322111123455666666666666432
Q ss_pred CCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCccccc
Q 002376 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQN 551 (929)
Q Consensus 472 ~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 551 (929)
-.-+.+...|+.|+|++|+|.......+.++..|++|+||+|+++ .+|..+..++.|++|..-+|+|. ..| .+..
T Consensus 376 --~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 376 --FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred --hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 123455566777777777766444445666667777777777776 45566666777777777777766 455 5666
Q ss_pred CCCCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCCC
Q 002376 552 LQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPKL 589 (929)
Q Consensus 552 l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~~ 589 (929)
++.|+.+|+|.|+|+-..-.. ...++|+.++++||+++
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 677777777777766443222 22266677777777643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.75 Aligned_cols=236 Identities=22% Similarity=0.311 Sum_probs=181.4
Q ss_pred CCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 663 FSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.+++++||.|.||+||+|+.+ +.+.+|..|+.+|.+++||||++|.|+.....+ +
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P-----v 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP-----V 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce-----e
Confidence 346689999999999999876 346789999999999999999999999865443 8
Q ss_pred EEEEEecCCCCccccccccccc---------cccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGERKN---------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~~~---------~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++|.|||++|+|+.||++.-.. ..+||.||.||-+. ++|||||.++|||++.+..+||+|||++|.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999854321 45799999999987 99999999999999999999999999999875
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
++. .....+..-.-..+|.|||.+..++++.++||||+|+++||+.. ++..|- .++-.+++...+..+- .
T Consensus 783 dd~---~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS----yGERPY--WdmSNQdVIkaIe~gy-R 852 (996)
T KOG0196|consen 783 DDP---EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----YGERPY--WDMSNQDVIKAIEQGY-R 852 (996)
T ss_pred cCC---CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecc----cCCCcc--cccchHHHHHHHHhcc-C
Confidence 331 11122222233578999999999999999999999999888432 222221 1222222222111111 1
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
-++..+|...+.+ ||..||+.|-.+||++.+++..|+++.+.-
T Consensus 853 LPpPmDCP~aL~q-LMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 853 LPPPMDCPAALYQ-LMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCCCCcHHHHH-HHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 1223367677777 999999999999999999999999988763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.78 Aligned_cols=267 Identities=21% Similarity=0.327 Sum_probs=194.8
Q ss_pred HHHHHHHHHHhhhhhhhhccccccccccccccccCCCCChHHHHHhhCCCCCceeecccCceeEEeccccCcH------H
Q 002376 614 IMAVIAGCFLIVWPIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSW------K 687 (929)
Q Consensus 614 ~~~~l~~~~~~~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~------~ 687 (929)
..-.++.|+..+|.++........+... ...=.+.|++|.+ .+.+|+|+.|.||.|+..... +
T Consensus 88 ~~~GLfgC~rPV~~~iGk~~s~e~k~qq----~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~netVAVKKV~ 156 (904)
T KOG4721|consen 88 FLEGLFGCLRPVWTMIGKAYSTEHKQQQ----EELWEIPFEEISE-------LEWLGSGAQGAVFLGRLHNETVAVKKVR 156 (904)
T ss_pred HHHHHHhhhHHHHHHhccceeeehhhhh----hhhccCCHHHhhh-------hhhhccCcccceeeeeccCceehhHHHh
Confidence 3445667777777665432211100000 0111345666543 578999999999999987432 2
Q ss_pred H-HHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccccc--------cccHHHHHHHhhhC
Q 002376 688 S-FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--------ELDITSALDYLHND 758 (929)
Q Consensus 688 ~-~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~--------~~~ia~aL~yLH~~ 758 (929)
+ -..+|+.|++++||||+.+.|+|.. ...+|||||||+.|.|+.+|+..+.+ ..+||.||.|||.+
T Consensus 157 elkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h 231 (904)
T KOG4721|consen 157 ELKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH 231 (904)
T ss_pred hhhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh
Confidence 2 2358889999999999999999954 44689999999999999999977655 46899999999998
Q ss_pred CCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCC
Q 002376 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFA 838 (929)
Q Consensus 759 ~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~ 838 (929)
.|||||||+-||||..+..+||+|||.++.+.+ ....+.++||..|||||+++..++++|+||||||+++
T Consensus 232 ---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVL 301 (904)
T KOG4721|consen 232 ---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD-------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVL 301 (904)
T ss_pred ---hHhhhccCCCceEeeccceEEeccccchHhhhh-------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHH
Confidence 899999999999999999999999999987632 2345678999999999999999999999999999998
Q ss_pred CCcchhHHhhhcCCc-hh-hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 839 GEFNIVKWVESNLPE-NV-LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 839 ~~~~~~~~~~~~~~~-~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
||+.+.+.++..+.. .+ ..+-...+.-.++. ..++.+.- |+.+||+..|..||++++++..|+-..+.
T Consensus 302 WEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPs------tcP~Gfkl----L~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 302 WEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPS------TCPDGFKL----LLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHHhcCCCccccchheeEEeccCCcccccCcc------cCchHHHH----HHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 888877776655543 11 11111112111111 11122222 66699999999999999999888765443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.30 Aligned_cols=370 Identities=26% Similarity=0.452 Sum_probs=236.5
Q ss_pred CCCCCCCEEEeecCCCC-CCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCC
Q 002376 92 GNLSFLRSIQLQNNKLS-GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170 (929)
Q Consensus 92 ~~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 170 (929)
+-|+..+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-.+ +..|+.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGE-Ls~Lp~L 80 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGE-LSDLPRL 80 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhh-hccchhh
Confidence 33555666666666666 345666666666666666666665 56666666666666666666665 23222 4445555
Q ss_pred cEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCC
Q 002376 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPN 250 (929)
Q Consensus 171 ~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~ 250 (929)
+.+++..|++.. +-+|..++.+..|+.||||+|++. +.|.++-. -.+
T Consensus 81 Rsv~~R~N~LKn-------------------------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~-AKn 127 (1255)
T KOG0444|consen 81 RSVIVRDNNLKN-------------------------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY-AKN 127 (1255)
T ss_pred HHHhhhcccccc-------------------------------CCCCchhcccccceeeecchhhhh-hcchhhhh-hcC
Confidence 555555554421 123444555555555555555554 44544433 344
Q ss_pred cceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCC
Q 002376 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330 (929)
Q Consensus 251 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L 330 (929)
+.+|+|++|++..+....|-+++.|-.||||+|++. .+|+....|..|++|.|++|.+.... +..+..+++|
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ-------LrQLPsmtsL 199 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ-------LRQLPSMTSL 199 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH-------HhcCccchhh
Confidence 555555555555433344557777777888888877 66767777777777777777664321 1233344555
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
++|++++.+=+ ...+|.++..+.+|..+|||.|.+. .+|..+..+++|+.|+||+
T Consensus 200 ~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~ 254 (1255)
T KOG0444|consen 200 SVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSG 254 (1255)
T ss_pred hhhhcccccch------------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCc
Confidence 55555554432 1235566666666666666666665 5666666666666666666
Q ss_pred CcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecC
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~ 490 (929)
|+|+ .+........+|+.|+||.|+++ .+|.++..++.|+.|++.+|+++ +..+|+.|+.|.+|+.+..++
T Consensus 255 N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~-------FeGiPSGIGKL~~Levf~aan 325 (1255)
T KOG0444|consen 255 NKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT-------FEGIPSGIGKLIQLEVFHAAN 325 (1255)
T ss_pred Ccee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc-------ccCCccchhhhhhhHHHHhhc
Confidence 6665 33444455567777777777777 57777777777888888777775 345677888888888888888
Q ss_pred CCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcC
Q 002376 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541 (929)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 541 (929)
|.+. ..|+.+..|..|+.|.|++|++- ..|+++--++.|+.|||..|.=
T Consensus 326 N~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 326 NKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred cccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 8876 77888888888888888888886 5788888888888888888843
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.11 Aligned_cols=233 Identities=24% Similarity=0.314 Sum_probs=176.9
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.+.|+..++||.|..+.||+|+.. .+.+...+|+..|+.++||||++++..|..... +
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-----L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-----L 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-----e
Confidence 457899999999999999998875 234678899999999999999999999876443 8
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|+||.||.+|++.+.++..- .+..++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999987322 2356899999999999 9999999999999999999999999988776
Q ss_pred ccccCCCCCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc--
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT-- 868 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 868 (929)
..... +.... ...++||+.|||||+++.. .|+.|+||||||+.+.|+..+..++..+|. .+++-..+....+
T Consensus 177 ~~~G~-R~~~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 177 FDSGD-RQVTR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTLQNDPPTL 252 (516)
T ss_pred cccCc-eeeEe-eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhcCCCCCc
Confidence 54321 11111 1667999999999995443 599999999999999888888888887775 1111111111100
Q ss_pred ----ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 ----SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ----~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+..+... ..+-+++++..|++.||++|||++++++
T Consensus 253 ~t~~~~~d~~k~----~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKK----FSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhh----hcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00111111 1122333666999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.76 Aligned_cols=233 Identities=28% Similarity=0.347 Sum_probs=173.0
Q ss_pred CCCCCceeecccCceeEEeccccC------------c----HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------S----WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------~----~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++...+.||+|+||.||.+.... . .+.+.+|+++|++++|||||+.+|.....+. ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 356677899999999999987752 1 3447899999999999999999998544332 35899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~~~~ 794 (929)
.|||+++|+|.+++.... .+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999987543 3367999999999998 9999999999999999 79999999999987642
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
..........+.||+.|||||++..+. ...++||||+||+..||.+..-+|..+-+. ...+....... .
T Consensus 171 ---~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-----~~~~~~ig~~~--~ 240 (313)
T KOG0198|consen 171 ---KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-----AEALLLIGRED--S 240 (313)
T ss_pred ---ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-----HHHHHHHhccC--C
Confidence 011112234578999999999998643 345999999999999887765454442110 11111111111 1
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.+..++.++...++++.+|+..||++||||+|+++.
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 112233344455567779999999999999999865
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.78 Aligned_cols=330 Identities=27% Similarity=0.464 Sum_probs=258.1
Q ss_pred CCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCccccc
Q 002376 193 PSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNL 272 (929)
Q Consensus 193 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l 272 (929)
|+.++.+.+|++|.+++|++. .+-+.+..++.|+.+++..|++.. .-+|..+..+
T Consensus 48 PeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKn------------------------sGiP~diF~l 102 (1255)
T KOG0444|consen 48 PEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKN------------------------SGIPTDIFRL 102 (1255)
T ss_pred hHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcccccc------------------------CCCCchhccc
Confidence 334445555555555555555 344556677778888888887752 2356666677
Q ss_pred ccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcc
Q 002376 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFS 352 (929)
Q Consensus 273 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 352 (929)
..|++||||+|++. ..|..+...+++-.|+|++|+|.+++. .-|.+++.|-+||||+|++. .+|..+..+.
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn-------~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~ 173 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPN-------SLFINLTDLLFLDLSNNRLE-MLPPQIRRLS 173 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCc-------hHHHhhHhHhhhccccchhh-hcCHHHHHHh
Confidence 78888888888887 677778888888888888888877765 35678888889999999998 7788888887
Q ss_pred ccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCC-cccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceec
Q 002376 353 NELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS-GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431 (929)
Q Consensus 353 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 431 (929)
.|++|+|++|.+...--..+-.+++|++|.+|+.+-+ ..+|.++..+.+|..+|+|.|.++ .+|+.+.++.+|+.|+
T Consensus 174 -~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLN 251 (1255)
T KOG0444|consen 174 -MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLN 251 (1255)
T ss_pred -hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheec
Confidence 7999999999876544445566788888999886643 467888888999999999999987 7888999999999999
Q ss_pred ccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCC-CCCCcchhcCcCccee
Q 002376 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS-GNLPNSLKNCKSLEEL 510 (929)
Q Consensus 432 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~-~~~p~~~~~l~~L~~L 510 (929)
||+|+|+ .+....+.+.+|++|+||.|+++ .+|+.+..|+.|+.|++.+|+++ .-+|+.++.+.+|+.+
T Consensus 252 LS~N~it-eL~~~~~~W~~lEtLNlSrNQLt---------~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 252 LSGNKIT-ELNMTEGEWENLETLNLSRNQLT---------VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred cCcCcee-eeeccHHHHhhhhhhccccchhc---------cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 9999988 56666777888999999999886 34888888889999999888876 2478888888889999
Q ss_pred ecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 511 LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 511 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
..++|.+. ..|..++.+..|+.|.|+.|+|- ++|+.+.-|+.|+.|||..|.=--.+|
T Consensus 322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred Hhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 98888887 78888888888999999999887 688888888888888888886444444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.91 Aligned_cols=219 Identities=30% Similarity=0.345 Sum_probs=166.2
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..++||+|+||+||.++.+ +..+...+|..+|.+++||+||+++..|. +.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-----t~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-----TEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----cCC
Confidence 468899999999999999987765 23456778999999999999999998884 445
Q ss_pred eEEEEEEecCCCCccccccccccc--------cccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGERKN--------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~~~--------~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.+|+|+||+.||.|..+|.+.+.+ +.+|+.||.|||+. +|||||+||+|||+|++|.++++|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 699999999999999999855433 56799999999998 9999999999999999999999999999854
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
-. ....+..++||+.|||||++.+..|+..+|-||+|+++|+|....-++... ...++++..+.+.....
T Consensus 176 ~~------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--~~~~~~~~I~~~k~~~~-- 245 (357)
T KOG0598|consen 176 LK------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--DVKKMYDKILKGKLPLP-- 245 (357)
T ss_pred cc------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--cHHHHHHHHhcCcCCCC--
Confidence 21 122344589999999999999999999999999998877764433222111 12223333222211111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCC
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRI 901 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 901 (929)
+..+..-.++++.+.+..||++|-
T Consensus 246 -----p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 -----PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CccCCHHHHHHHHHHhccCHHHhc
Confidence 111222233466699999999995
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.74 Aligned_cols=239 Identities=21% Similarity=0.296 Sum_probs=179.7
Q ss_pred HHhhCCCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
+-..++....++||+|+||+||+|+.. ...++|++|+++|+.++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 333445556689999999999998764 124579999999999999999999999987
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
..+ +++|||+|+||+|.++|++.. .++.++|+||+|||+. ++|||||.++|+|++.++.+||+
T Consensus 233 ~~P-----l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 233 EEP-----LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCc-----cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 665 899999999999999998654 2367899999999998 99999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPEL 863 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 863 (929)
|||+++.-..... ......-...|+|||.+..+.|+.++||||||+.+||+.... ...++. ...++ ...+
T Consensus 305 DFGLs~~~~~~~~------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g--~~Py~g~~~~~v-~~kI 375 (474)
T KOG0194|consen 305 DFGLSRAGSQYVM------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG--AEPYPGMKNYEV-KAKI 375 (474)
T ss_pred ccccccCCcceee------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccC--CCCCCCCCHHHH-HHHH
Confidence 9999985421110 010113467899999999999999999999999999954311 112322 11111 1111
Q ss_pred -HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 864 -RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 864 -~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
...+ +...+...++.++.++.+||..+|++||+|.++.+.++.+.....
T Consensus 376 ~~~~~------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGY------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCc------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111 111222334444457779999999999999999999999887755
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.49 Aligned_cols=233 Identities=21% Similarity=0.332 Sum_probs=168.4
Q ss_pred CCCCCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+.|+...++|+|+||+|||++.+.+ .+-.++|+++|++++|||+|.++++|. ....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 3567778999999999999988721 234669999999999999999999994 44558
Q ss_pred EEEEEecCCCCcccccc--------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIH--------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~--------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++|+|||+..-|.+.=+ ..+.+..|++.|+.|+|++ ++|||||||+||||+.+|.+|+||||+||.+..
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99999998754444322 1235578999999999998 999999999999999999999999999998752
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hh---hhc---cChHHHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NV---LQV---LDPELRQ 865 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~---~~~---~~~~l~~ 865 (929)
.....+..+.|.+|+|||.+.| ..|+..+|||+.||+..|+..++-.|..-.+ .+ ... +-++...
T Consensus 154 ------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 154 ------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred ------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 1223456688999999999998 5799999999999987776555443332222 10 000 0111111
Q ss_pred hhcc----------cchhhhhhh---HHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 866 LMTS----------NESQTIQLH---DCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 866 ~~~~----------~~~~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
.+.. +.+...... ..+..++-+++..|++.||++|++-+|++
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1111 000000000 12233555588999999999999999886
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=346.00 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=182.9
Q ss_pred CCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
+..+..+.||+|+||.||+|... +...+|.+|..+|++++|||||+++|+|.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 34456789999999999998764 235689999999999999999999999987443
Q ss_pred cceEEEEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
.++++|||++|+|..||++.| .++.|||+|+.||++. .+|||||.++|+|+++...|||
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 699999999999999998663 2367999999999998 8999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChH
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPE 862 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 862 (929)
+|||+||.+....--... ....-...|||||.++.+.+++|+||||||+++||+.. .-...|++ .-.+++..-
T Consensus 844 aDFGlArDiy~~~yyr~~----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifs--lG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKH----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFS--LGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred cccchhHhhhhchheecc----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHh--CCCCCCCCcchHHHHHHH
Confidence 999999955322111111 11123468999999999999999999999998888422 22223333 222222222
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
+.+ . .-.+...|..++++ +|..||+.+|++||++++++++++.+.......
T Consensus 918 ~~g-----g-RL~~P~~CP~~ly~-lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 918 LEG-----G-RLDPPSYCPEKLYQ-LMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HhC-----C-ccCCCCCCChHHHH-HHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 221 1 11122346666775 999999999999999999999999998876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=316.12 Aligned_cols=234 Identities=24% Similarity=0.328 Sum_probs=170.6
Q ss_pred hCCCCCceeecccCceeEEeccccCc---------------HHHH--HHHHHHHHccC-CccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS---------------WKSF--IAECETLRNVR-HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~--~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|...++||.|+||.||+|+.... .++. .||++.|++++ |||||++.+++.+.+. .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~----~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR----I 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----e
Confidence 35778889999999999999987622 1222 37999999998 9999999999976442 5
Q ss_pred EEEEEEecCCCCcccccccccc---------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGERK---------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~~---------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+|+|||||+ .+|++.++++++ +..||++||+|+|.+ |++|||+||+|||+.....+||+|||+||.+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999999996 599999986543 367999999999998 9999999999999998899999999999976
Q ss_pred ccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--h---hhhccCh-----
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--N---VLQVLDP----- 861 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~---~~~~~~~----- 861 (929)
.. ....+..+.|.+|+|||++.. +.|+.+.|||++||+++|+....-.+....+ . +-+++..
T Consensus 161 ~S-------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RS-------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cc-------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 31 233566789999999998764 5689999999999999886544333332222 1 1111110
Q ss_pred -----HHHHhhcccchh------hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 862 -----ELRQLMTSNESQ------TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 862 -----~l~~~~~~~~~~------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.+...+.-...+ ..-.+.+..+.++ ++.+|++|||++||||+|+++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~-li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAAS-LIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHH-HHHHHhcCCCccCccHHHHhcC
Confidence 010000000000 0001123344555 8889999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.42 Aligned_cols=233 Identities=24% Similarity=0.338 Sum_probs=180.4
Q ss_pred HHhhCCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
++...+|.+.+.||+|+|++||+|+.... .+-..+|-.+|.++ .||.||+|+..|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 44567899999999999999999987632 22344788899999 8999999999985443
Q ss_pred CCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
.+|+|+||+++|+|.+++++. |.++.+|..|++|||+. |||||||||+|||+|+||++||+|||.
T Consensus 148 ----sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 148 ----SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred ----ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccc
Confidence 499999999999999999853 45688999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCC-------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhcc
Q 002376 789 ARFLLERVDNQS-------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVL 859 (929)
Q Consensus 789 a~~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~ 859 (929)
|+.+.+...... .......++||..|++||++.....+..+|+|++||++|.|..+.-++....+ .+.+++
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 998865433211 11112568999999999999999999999999999988877665555554444 122222
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
+-.. ++++..++.+++|+.+.+..||.+|+|..+|-+-
T Consensus 301 ~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 ALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred Hhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2111 1111223444557779999999999999887653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.90 Aligned_cols=172 Identities=28% Similarity=0.395 Sum_probs=142.0
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+.|+..++||+|+||.||+|++.. ......+||.+|++++||||+++.+..++. ....+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 356667889999999999998762 234567999999999999999999998764 23459
Q ss_pred EEEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
|||+|||++ ||.-++.. .+.+..|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999986 77776652 234578999999999998 99999999999999999999999999999875
Q ss_pred cccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~ 844 (929)
.... ...+..+-|.+|+|||++.|.. |+.++|+||.||++.|+...
T Consensus 270 ~~~~-----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 270 PSGS-----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred CCCC-----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 3311 1244557799999999999875 99999999999988776443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.06 Aligned_cols=226 Identities=22% Similarity=0.285 Sum_probs=174.4
Q ss_pred CCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.|..-.+||+|+.|.||.++... ..+-..+|+.+|+..+|+|||++++.|...+ .+|+|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEEE
Confidence 45556789999999999887652 2345779999999999999999999886543 48999
Q ss_pred EEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 726 YEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||||++|+|.|.+...+ .++.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..+..
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999999987543 3356788999999998 999999999999999999999999999987754321
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.....+||+.|||||++....|++|+||||+|+.+.||.-++-++-. ...+. ++.- +..........+
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~Plr-----AlyL-Ia~ng~P~lk~~ 492 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLR-----ALYL-IATNGTPKLKNP 492 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CChHH-----HHHH-HhhcCCCCcCCc
Confidence 34456999999999999999999999999999777665333322211 00111 1111 111222333444
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.++..++++..+|++.||++||++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 556677777888999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.21 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=171.8
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..++||+|+||.||+|.+. ...+.+.+|+.+++++ +|||||+++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 467888999999999999998531 1134688999999999 8999999999986432
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------------------------------------------
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------------------------------------------ 742 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------ 742 (929)
...++||||+++|+|.++++..+
T Consensus 85 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 85 ---GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 24799999999999998886321
Q ss_pred ----------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccc
Q 002376 743 ----------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806 (929)
Q Consensus 743 ----------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~ 806 (929)
.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~ 234 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKG 234 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc----hhccc
Confidence 1245899999999998 999999999999999999999999999986532111 11112
Q ss_pred eeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHH
Q 002376 807 VFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITII 885 (929)
Q Consensus 807 ~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 885 (929)
...+++.|||||++.+..++.++||||+|+++|++.. ...++..... +..+........... .+......+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~l 306 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTRMR--APENATPEI 306 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCCCC--CCCCCCHHH
Confidence 2356788999999999999999999999988877542 2222221110 111111111111000 011112223
Q ss_pred HHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 886 GSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 886 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
.+++.+||+.||++||||.|++++|+++.+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 348889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.35 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=185.1
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++++...-+....++||-|.||.||.|.|++ ..++|.+|+.+|+.++|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-- 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-- 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--
Confidence 4444434456677899999999999999873 25789999999999999999999999976544
Q ss_pred cceEEEEEEecCCCCcccccccccc----------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGERK----------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~~----------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
+|||+|||.+|+|.+||++..+ .+.||+.||+||... .+||||+.++|+|+.++..+||+|||+
T Consensus 338 ---FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 ---FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred ---eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 7999999999999999985432 267999999999998 899999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLM 867 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~ 867 (929)
+|++..+.- .......-.+.|.|||.+....++.|+|||+||+++||+.++-+ ..||. ...++.+-- ...+
T Consensus 412 sRlMtgDTY-----TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM--sPYPGidlSqVY~LL-Ekgy 483 (1157)
T KOG4278|consen 412 SRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYGLL-EKGY 483 (1157)
T ss_pred hhhhcCCce-----ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC--CCCCCccHHHHHHHH-hccc
Confidence 999864311 11111122568999999999999999999999988888554332 33443 222322211 1112
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
.++..+ -|..++++ ||++||+|+|.+||+++|+-+.+|.+..
T Consensus 484 RM~~Pe-----GCPpkVYe-LMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 484 RMDGPE-----GCPPKVYE-LMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cccCCC-----CCCHHHHH-HHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 222221 36677777 9999999999999999999999988654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=300.61 Aligned_cols=237 Identities=23% Similarity=0.266 Sum_probs=174.1
Q ss_pred HHhhCCCCCceeecccCceeEEecccc------------------------------CcHHHHHHHHHHHHccCCccccc
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT------------------------------GSWKSFIAECETLRNVRHRNLVK 706 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~------------------------------~~~~~~~~E~~~l~~l~Hpniv~ 706 (929)
.+..++|+..+.||+|.||+|-+|+.. ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999776654 11357889999999999999999
Q ss_pred eeeecccCCCCCcceEEEEEEecCCCCcccccc--------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 707 l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~--------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
++++.-+. ....+|||+|||..|.+...-. .+|++..++..||+|||.+ +||||||||+|+|++++
T Consensus 173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 99997553 3456999999999998765322 3566788999999999999 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCC----CCCCCCCCCCcCCCCCcchhHHhhhcCCch
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER----PSTAGDVPTSESFAGEFNIVKWVESNLPEN 854 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~ 854 (929)
|++||+|||.+.......... ........+|||.|||||...++. .+.+.||||+|+++|.+..+..++..- .
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~-~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--~ 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEG-SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--F 323 (576)
T ss_pred CcEEeeccceeeecccCCccc-cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--h
Confidence 999999999998664331111 112234468999999999988743 478999999998777765444443211 2
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+..+......+..... ..+.+.+++|+.++++.||++|.+..||..
T Consensus 324 ~~~l~~KIvn~pL~fP~~------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN------PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHHHHhcCcccCCCc------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 222233322221111000 123455667888999999999999988753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=340.23 Aligned_cols=462 Identities=26% Similarity=0.340 Sum_probs=379.3
Q ss_pred EEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccccccc
Q 002376 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155 (929)
Q Consensus 76 l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 155 (929)
+|++..+++ .||..+-.-..++.|+++.|-+-...-+...+.-+|+.||||+|++. ..|..+..+..|+.|+++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 456666666 67777766667999999999876332333445556999999999998 8999999999999999999999
Q ss_pred CCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 156 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
. .+|.. ..++.+|++|+|.+|.+ ...|..+..+++|+.||+|+|++. .+|..+..++.++.+..++|.
T Consensus 81 ~-~vp~s-~~~~~~l~~lnL~~n~l---------~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~ 148 (1081)
T KOG0618|consen 81 R-SVPSS-CSNMRNLQYLNLKNNRL---------QSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNE 148 (1081)
T ss_pred h-hCchh-hhhhhcchhheeccchh---------hcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcch
Confidence 8 67755 89999999999999986 346778888999999999999998 789999999999999999993
Q ss_pred CCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCC
Q 002376 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDD 315 (929)
Q Consensus 236 l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~ 315 (929)
....++. ...+.+++..|.+.+.++..+.+++. .|||.+|.+. . -.+.++.+|+.+....|++.....
T Consensus 149 ~~~~lg~------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~~- 216 (1081)
T KOG0618|consen 149 KIQRLGQ------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELEI- 216 (1081)
T ss_pred hhhhhcc------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEEe-
Confidence 2212221 22677888889999999988888887 8999999997 2 346788899999999999876532
Q ss_pred CCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCc
Q 002376 316 EGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPI 395 (929)
Q Consensus 316 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 395 (929)
..++|+.|+.++|.++...+.. .+.+|+++++++|++++ +|++++.+.+|+.++..+|+++ .+|.
T Consensus 217 ----------~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ 281 (1081)
T KOG0618|consen 217 ----------SGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPL 281 (1081)
T ss_pred ----------cCcchheeeeccCcceeecccc---ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHH
Confidence 3478999999999998443322 23479999999999995 5699999999999999999996 7899
Q ss_pred cccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccc-cceecccCCcCCCCCCCCcccCCc
Q 002376 396 EIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS-LLSIDLSNNRINGNIPKGILRPLP 474 (929)
Q Consensus 396 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~g~i~~~~~~~~p 474 (929)
.+..+++|+.|....|.++ .+|.....++.|++|||..|+|....+..|.-+.. |..|+.+.|+++. .|.
T Consensus 282 ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~------- 352 (1081)
T KOG0618|consen 282 RISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST-LPS------- 352 (1081)
T ss_pred HHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc-ccc-------
Confidence 9999999999999999998 57777888999999999999998444433443333 7888888888862 220
Q ss_pred hhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCC
Q 002376 475 EEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQA 554 (929)
Q Consensus 475 ~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 554 (929)
-+=.....|+.|++.+|.|+...-..+.+.+.|+.|+|++|+|...+...+.++..|+.|+||+|+|+ .+|..+.++..
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 01123467899999999999888778999999999999999999777778899999999999999999 78999999999
Q ss_pred CCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCC
Q 002376 555 LRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589 (929)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~ 589 (929)
|++|...+|++...+ +..+.+.++.++++.|...
T Consensus 432 L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 432 LHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred hHHHhhcCCceeech-hhhhcCcceEEecccchhh
Confidence 999999999999764 7778899999999988543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.21 Aligned_cols=224 Identities=24% Similarity=0.305 Sum_probs=172.2
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
..|...+.||+|+||.||||.+.. ..++..+|+.++..++++||.+++|.+..... ++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence 356667899999999999998762 24577889999999999999999999876443 89
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||.+|++.+.++... .+..++..|+.|+|.+ +.+|||||+.|||+..+|.+|++|||++..+...
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999887332 2357899999999998 9999999999999999999999999999877432
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~ 874 (929)
......++||+.|||||++.+..|+.|+||||+|++++|+..++-++..... ++.-.+ ++..++.
T Consensus 165 ------~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------pk~~PP~ 230 (467)
T KOG0201|consen 165 ------VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------PKSAPPR 230 (467)
T ss_pred ------hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--------cCCCCCc
Confidence 2223568999999999999988999999999999888776555544433321 111111 1111111
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+ ....+.+++++..|++.||+.||+|.++++
T Consensus 231 L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LD--GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc--cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11 112333444666999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.00 Aligned_cols=237 Identities=23% Similarity=0.311 Sum_probs=167.9
Q ss_pred CCCCCceeecccCceeEEecccc---------------------------------CcHHHHHHHHHHHHccCCccccce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------------------GSWKSFIAECETLRNVRHRNLVKL 707 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------------------~~~~~~~~E~~~l~~l~Hpniv~l 707 (929)
++|...++||+|+||.||++.+. ...++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46788899999999999987521 113468899999999999999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCccccccccc---------------------------cccccHHHHHHHhhhCCC
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------------------------KNELDITSALDYLHNDCE 760 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------~~~~~ia~aL~yLH~~~~ 760 (929)
++++.+.+ ..++||||+++|+|.+++.... .++.|++.||+|||+.
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99986533 3799999999999998875321 3467899999999998
Q ss_pred CCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCC
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGE 840 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~ 840 (929)
+|+||||||+||++++++.+||+|||+++.+..... ........++..|||||++.++.++.++||||+|+++++
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 899999999999999999999999999986532110 011122346789999999998899999999999988877
Q ss_pred cch--hHHhhhcCCc-hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 841 FNI--VKWVESNLPE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 841 ~~~--~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
+.. ...++..... ...+.+............ ....+.+...+ .+++.+||+.||++||||.||.+.|++
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY--LFRPPPCPQGL-YELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc--ccCCCCCCHHH-HHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 532 1122221111 111111010000000000 00001112223 348889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.97 Aligned_cols=226 Identities=28% Similarity=0.344 Sum_probs=171.9
Q ss_pred HhhCCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccC-CccccceeeecccCC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLD 715 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~ 715 (929)
...+.|...+.||+|+||+|+.|+... ..+...+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999986641 1335558999999999 999999999995533
Q ss_pred CCCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEecc
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDF 786 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~Df 786 (929)
.+|+||||+.+|+|.+++... +.+..|++.|++|+|+. +|+||||||+|||+|.+ +.+||+||
T Consensus 94 -----~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 -----KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -----eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence 389999999999999998752 34578999999999998 99999999999999999 99999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC-C-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-P-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|++.... .........+||+.|+|||++.+.. | +.++||||+|+++|.+..+.+++.... .+.+.
T Consensus 166 G~s~~~~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~ 232 (370)
T KOG0583|consen 166 GLSAISP------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLY 232 (370)
T ss_pred ccccccC------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHH
Confidence 9998762 1123345679999999999999987 7 599999999977666655555544311 11111
Q ss_pred HhhcccchhhhhhhHHH-HHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 865 QLMTSNESQTIQLHDCL-ITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~-~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
..+... ....+..+ ..-+++++.+|+..||.+|+++.|++
T Consensus 233 ~ki~~~---~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RKIRKG---EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHhcC---CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111 11111112 22233477799999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=275.94 Aligned_cols=232 Identities=24% Similarity=0.314 Sum_probs=168.1
Q ss_pred CCCCCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|...+++|+|.||.||+|++..+ .....+|++.|+.++||||+.++++|...+ .+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 4677889999999999999987621 345779999999999999999999996544 38
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.+|+|||+ .+|+..++... .++.++.+|++|+|++ .|+|||+||.|+|++++|.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 99999996 49998887543 3467899999999998 89999999999999999999999999999875
Q ss_pred cccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHH-------------hhhcC----Cchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKW-------------VESNL----PENV 855 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~-------------~~~~~----~~~~ 855 (929)
.... ..+..+-|.+|+|||++.|.+ |+..+||||.||+..|+.+..- .++.+ ++.+
T Consensus 153 ~p~~------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 153 SPNR------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred CCCc------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 3321 122226799999999988765 9999999999998766533221 11111 1111
Q ss_pred hhc---cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 856 LQV---LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 856 ~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.++ -|-.-....+.. ....-++.+...++. ++..++..||.+|+++.|++++
T Consensus 227 P~~~~lpdY~~~~~~P~~-~~~~lf~aas~d~ld-Ll~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKP-PLNNLFPAASSDALD-LLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCC-ccccccccccHHHHH-HHHhhhccCchhcccHHHHhcc
Confidence 111 111111111111 111112233344555 8889999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=294.66 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=179.4
Q ss_pred CCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHHc--cCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRN--VRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.....++||+|+||.||||.... +.+.|.+|-++.+. ++|+||++++++-...... ...++||+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLVt~f 289 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLVTEF 289 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEEeee
Confidence 34456789999999999998873 45678888888776 5899999999986554433 4468999999
Q ss_pred cCCCCcccccccc-------ccccccHHHHHHHhhhCC------CCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 729 LSNGSLGDWIHGE-------RKNELDITSALDYLHNDC------EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 729 ~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
.+.|+|.+||+.. .+++..+++||+|||+.. .|+|+|||||++|||+.+|+++.|+|||+|..+...
T Consensus 290 h~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 290 HPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred ccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 9999999999743 355788999999999753 589999999999999999999999999999988654
Q ss_pred cCCCCCccccceeccccccccccccCCCC-C-----CCCCCCCCCcCCCCCcchhHHhh--hcCCc---hhhhc--cChH
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGER-P-----STAGDVPTSESFAGEFNIVKWVE--SNLPE---NVLQV--LDPE 862 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DV~s~g~~~~~~~~~~~~~--~~~~~---~~~~~--~~~~ 862 (929)
..... ....+||.+|||||++.+.. + -.+.||||.|.++||+...--.. +..|+ .+.+. .+|.
T Consensus 370 ~~~~d----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 370 KPQGD----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred CCCcc----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 33322 23358999999999987653 2 24689999997777653322111 22222 11111 1111
Q ss_pred ---HHHhhcccchhhhhhhH-----HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 863 ---LRQLMTSNESQTIQLHD-----CLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 863 ---l~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
++..... ...++.+++ ...+++++.+..||+.||+.|-|+.=|.+++.++....+
T Consensus 446 ~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111111 111222211 123466668889999999999999999999988876554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=281.55 Aligned_cols=213 Identities=23% Similarity=0.261 Sum_probs=164.7
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||.|+||.|..++.+ ++.+...+|..+|+.+.||+++++++.|.+ ...
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-----~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-----NSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-----CCe
Confidence 46777899999999999887765 223456689999999999999999999844 445
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||||++||.|+.++++.+ .++.+|+.|++|||+. .|++||+||+|||+|.+|.+||+|||+|+.+.
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999999998643 4478999999999998 99999999999999999999999999999763
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. .+...||||.|+|||++..+.|..++|=|++|+..|||..+..++..... .++....+.+
T Consensus 196 ~---------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~-------- 256 (355)
T KOG0616|consen 196 G---------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEG-------- 256 (355)
T ss_pred C---------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhC--------
Confidence 1 24567999999999999999999999999999777776554444332221 2222222221
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCC
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGR 900 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~R 900 (929)
.+..+..+...+++|+...++.|-.+|
T Consensus 257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 112222333444456667788888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-34 Score=303.58 Aligned_cols=223 Identities=25% Similarity=0.347 Sum_probs=172.4
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|...+.||+|+||.||||+++. +.+...+|++++++++|||||.++++|. ...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence 578888999999999999999872 2345889999999999999999999994 44459
Q ss_pred EEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+|.||+.| +|+.++... +.++.++..||.|||+. +|+|||+||.|||++..|.+|+||||+||.+..
T Consensus 77 ~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999999975 999998743 34577889999999998 999999999999999999999999999998743
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.....+.+.|||.|||||++.+.+|+..+|.||+||++||+..+.-++... .+.+.+.....+ ...+.
T Consensus 153 ------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d----~v~~p 220 (808)
T KOG0597|consen 153 ------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKD----PVKPP 220 (808)
T ss_pred ------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcC----CCCCc
Confidence 222345678999999999999999999999999999988865544332211 233322222221 22222
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+... +....+..||.+|.+-.+++.
T Consensus 221 ~~~S~~f~n----fl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVN----FLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHH----HHHHHhhcChhhcccHHHHhc
Confidence 223334444 444889999999999888763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-34 Score=295.18 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=171.0
Q ss_pred CCCCCceeecccCceeEEeccccCcHH------------HHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGSWK------------SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~------------~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
-.|...+++|.|+||.||+|......+ ---+|+++|++++|||||++..+|......+.-+..+||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 356778999999999999998764322 22379999999999999999998887665434567899999
Q ss_pred cCCCCccccccc-----c-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEeccccccccccc
Q 002376 729 LSNGSLGDWIHG-----E-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLER 795 (929)
Q Consensus 729 ~~~gsL~~~l~~-----~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~ 795 (929)
||. +|+++++. . +.+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 985 89888872 1 23367999999999997 99999999999999976 89999999999987543
Q ss_pred cCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC-------hHHHH
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD-------PELRQ 865 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~l~~ 865 (929)
.. .....-|..|+|||.+.|.. |+.+.||||.||++.|+..+.-.+..-.. .+.++++ .++..
T Consensus 180 ep-------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 180 EP-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred CC-------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 22 12345688999999998865 99999999999988887555544332111 1111110 01110
Q ss_pred hhcc-----------cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHhhHH
Q 002376 866 LMTS-----------NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSSQE 915 (929)
Q Consensus 866 ~~~~-----------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 915 (929)
.-+. ..-.+......-++.++ ++.+++..+|.+|.++.|++.. .++++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~d-ll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALD-LLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHH-HHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0000 00000011112234555 8889999999999999998743 444433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=285.27 Aligned_cols=171 Identities=26% Similarity=0.364 Sum_probs=141.9
Q ss_pred hCCCCCceeecccCceeEEeccccCcH------------------HHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGSW------------------KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~------------------~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.+.|+..+.|++|+||.||+|+++.+. -...+||.++.+++|||||.+..+.... ....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence 345677799999999999999988432 1356999999999999999999988653 3455
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+|+|||||+. ||...++..+ ....|+++|++|||.. .|+|||+|++|+|+.+.|.+||+|||+||.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999999976 8888776433 3367999999999998 8999999999999999999999999999987
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~ 843 (929)
... ....+..+-|.+|+|||++.+.+ |+++.|+||.||++.|+..
T Consensus 228 gsp------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~ 273 (419)
T KOG0663|consen 228 GSP------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT 273 (419)
T ss_pred cCC------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence 432 22345567899999999998875 9999999999998776533
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-33 Score=299.96 Aligned_cols=227 Identities=27% Similarity=0.324 Sum_probs=179.3
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|...+.+|+|+||.++..+++. .++...+|+.++++++|||||.+.+.|... ....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----CceE
Confidence 578888999999999998777652 244677999999999999999999998643 2348
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||+||+||++.+.+.+.+ .+..|++.|+.|||+. .|+|||||+.||++..+..+|++|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999999987554 2257899999999987 8999999999999999999999999999988
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.... .....++||+.||.||++.+.+|..|+||||+||.+||+....+++..... ...+.......+...+.
T Consensus 157 ~~~~------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--~~Li~ki~~~~~~Plp~ 228 (426)
T KOG0589|consen 157 NPED------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--SELILKINRGLYSPLPS 228 (426)
T ss_pred CCch------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--HHHHHHHhhccCCCCCc
Confidence 5432 133457899999999999999999999999999999999888888765543 11122222221111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.....+.. ++..|+..+|+.||++.+++.+
T Consensus 229 ---~ys~el~~----lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 ---MYSSELRS----LVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---cccHHHHH----HHHHHhhcCCccCCCHHHHhhC
Confidence 11122333 6669999999999999999987
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=312.70 Aligned_cols=234 Identities=19% Similarity=0.294 Sum_probs=168.3
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||.||+|++. ...+.+.+|+++++.+ +|||||+++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 447888899999999999987531 1234678999999999 8999999999996543
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------------------------------------------
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------------------------------------------ 742 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------ 742 (929)
..++||||+++|+|.++++..+
T Consensus 113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 3799999999999998885321
Q ss_pred -----------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 743 -----------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 743 -----------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1245899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.... ........++..|||||++.+..++.++||||+|++++++.. ...++...+. +............
T Consensus 266 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~------~~~~~~~~~~~~~ 335 (375)
T cd05104 266 NDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV------DSKFYKMIKEGYR 335 (375)
T ss_pred Cccc----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc------hHHHHHHHHhCcc
Confidence 2111 011112345678999999999999999999999988877543 2222222211 0111111111000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
...+.....-+++++.+||+.||++||+|+||+++|++.
T Consensus 336 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 --MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000011112233488899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=299.67 Aligned_cols=237 Identities=24% Similarity=0.335 Sum_probs=177.7
Q ss_pred CCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.....++||+|-||+|..+...+ ..++|.+|+++|.+++|||||+++|+|...++ +++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icmI 613 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCMI 613 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHHH
Confidence 44556899999999998765431 35789999999999999999999999987665 8999
Q ss_pred EEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+|||++|+|.+|+.+.. .++.|||.||+||.+. ++||||+.++|+|+|.++++||+|||++|-+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999986431 3478999999999998 9999999999999999999999999999965322
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchh-
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQ- 873 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~- 873 (929)
.........+-..+|||||.+.-+++++++|||+||+++||+...- -...+.+ .-.++++ ...+.+......
T Consensus 691 ----~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C-~e~Py~~lt~e~vve-n~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 691 ----DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC-REQPYSQLTDEQVVE-NAGEFFRDQGRQV 764 (807)
T ss_pred ----CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH-hhCchhhhhHHHHHH-hhhhhcCCCCcce
Confidence 1111223345678999999999999999999999999888853221 1112222 1112222 112222211111
Q ss_pred -hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 874 -TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 874 -~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.....-|..++++ ++.+||.+|.++||+++++...|++.
T Consensus 765 ~l~~P~~cp~~lye-lml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACPQGLYE-LMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCcHHHHH-HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111235566776 99999999999999999999888764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=296.08 Aligned_cols=241 Identities=18% Similarity=0.160 Sum_probs=176.1
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEeccccC--------------c---HHHHHHHHHHHHccCCccccceeeecc
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERTG--------------S---WKSFIAECETLRNVRHRNLVKLITSCS 712 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~---~~~~~~E~~~l~~l~Hpniv~l~~~~~ 712 (929)
.++.+++.. .....||+|++|.||+|++.+ . .+.|.+|+.++++++|||||+++|++.
T Consensus 14 ~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 14 CIESDDIDK-----YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ecCHHHcCC-----CCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 455666633 223689999999999998752 1 356779999999999999999999986
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
+.. ......++||||+++|+|.++++..+ .++.+++.|++|||+.. +++||||||+||++++++.+||+
T Consensus 89 ~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 89 DIV-DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred ecc-cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence 521 12345799999999999999987543 23578999999999742 68899999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPE 862 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (929)
|||+++.+... .....|+..|+|||++.+ ..++.++||||+|+++|++..+..++..... .++.+..
T Consensus 166 dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i 234 (283)
T PHA02988 166 CHGLEKILSSP---------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLI 234 (283)
T ss_pred ccchHhhhccc---------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence 99999865311 122468899999999976 6799999999999888887665555443321 1111111
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
... ... ...+......+++++.+||+.||++||||+|+++.|++...
T Consensus 235 ~~~----~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 INK----NNS--LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred Hhc----CCC--CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111 000 11110112234448889999999999999999999998754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=303.36 Aligned_cols=224 Identities=23% Similarity=0.296 Sum_probs=175.2
Q ss_pred CCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+-|+.++.||+|+-|.|-.|++..+ ...+.+|+.+|+-+.||||+++++++. +..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCce
Confidence 4577789999999999988876521 345779999999999999999999994 4556
Q ss_pred EEEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+|.||+++|.|++++-. +.++..||..|+.|+|+. +|+|||+||+|+|+|.+..+||+|||+|..-.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999999999853 335578999999999998 89999999999999999999999999997532
Q ss_pred cccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.......-||++.|.|||+++|.+| +.++||||.|+++|.+.++.+++. |..++..+.+-..
T Consensus 164 -------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----------DdNir~LLlKV~~ 226 (786)
T KOG0588|consen 164 -------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----------DDNIRVLLLKVQR 226 (786)
T ss_pred -------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----------CccHHHHHHHHHc
Confidence 2223445699999999999999998 899999999987776655555544 2222222222111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
...+.+..++.-+++|..+++..||++|.|++||.+-
T Consensus 227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122223445556668889999999999999999863
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=299.54 Aligned_cols=221 Identities=22% Similarity=0.318 Sum_probs=174.6
Q ss_pred eeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecC
Q 002376 667 NLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLS 730 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~ 730 (929)
-++|+|.||+||.|++.. ..+-...|+..-++++|.|||+++|.|. ..+++-+.||-+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCC
Confidence 479999999999998762 2234668999999999999999999984 3446889999999
Q ss_pred CCCcccccccc-----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEeccccccccccccCC
Q 002376 731 NGSLGDWIHGE-----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 731 ~gsL~~~l~~~-----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+|.+.++.. ..+..||++||.|||.+ .|||||||-.||||+ -.|.+||+|||.++.+..
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg---- 728 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG---- 728 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc----
Confidence 99999998732 13367999999999998 899999999999996 578999999999987632
Q ss_pred CCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
-...+..+.||..|||||++..++ |+.++|||||||...||.++.-++..+......++.-.+.. ..++
T Consensus 729 --inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-------vHP~ 799 (1226)
T KOG4279|consen 729 --INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-------VHPP 799 (1226)
T ss_pred --CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-------cCCC
Confidence 112345678999999999998775 89999999999999888777766655544322222222222 1233
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.++.+.+-.+.++.+|..+||.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 44556666666888999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=296.90 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=174.6
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.|+..+.||+|+||+||++.... ....+.+|+.++++++||+|+++.+++.+. ...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeE
Confidence 36778999999999999987541 123467899999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 99999999999987764221 2357899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
... .......||..|||||++.+..++.++||||+|++++++..+..++..... ...+.++..+... ..
T Consensus 153 ~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~ 222 (285)
T cd05631 153 PEG-------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---QE 222 (285)
T ss_pred CCC-------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc---cc
Confidence 321 112234789999999999999999999999999888776555444432221 1111111111110 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH--HHHhhHHHHhhcc--CCCCCCC
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR--RLKSSQEILLKQQ--VPNGKTK 928 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~--~L~~~~~~~~~~~--~p~~~~~ 928 (929)
. ....+...+.+++.+||+.||++||+ ++|+++ .++++........ .|+-.|.
T Consensus 223 ~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 223 E----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred c----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 0 11112223334777999999999997 788876 3566544433232 4555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=300.55 Aligned_cols=222 Identities=21% Similarity=0.354 Sum_probs=166.6
Q ss_pred ceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 666 ENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
..+||+|+|-+||||-+. ...++|..|+.+|+.++|||||+++.++.+... ..+.+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFI 121 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeee
Confidence 467999999999999876 124689999999999999999999999987543 557899
Q ss_pred EEecCCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~ 796 (929)
+|.|..|+|..|.++.++ ++.||++||.|||++ .|+|||||||..||+|+. .|.|||+|.|+|..+..
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999999986553 378999999999997 689999999999999974 57999999999997632
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.....++|||.|||||++. ..|.+.+|||||||.+.||.+.++++..=.. ..++...-..+..+.. -..+.
T Consensus 199 ------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-~AQIYKKV~SGiKP~s-l~kV~ 269 (632)
T KOG0584|consen 199 ------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-PAQIYKKVTSGIKPAA-LSKVK 269 (632)
T ss_pred ------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-HHHHHHHHHcCCCHHH-hhccC
Confidence 2234479999999999986 7899999999999777666655554432111 1111111111100000 00000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
-++ +++++.+|+.. .++|||+.|++.
T Consensus 270 ----dPe-vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ----DPE-VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----CHH-HHHHHHHHhcC-chhccCHHHHhh
Confidence 011 22377799999 999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-33 Score=267.72 Aligned_cols=228 Identities=25% Similarity=0.282 Sum_probs=166.4
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++.|+.-+.||+|+|+.||++.... +.++..+|+++.+.++|||||++.+.+. ...+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 4577778899999999999877652 3456778999999999999999999874 3456
Q ss_pred EEEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~ 790 (929)
.|+|+|+|.||+|..-+-. ..+...||+.||.|+|.+ +|||||+||+|+++.. .--+|++|||+|.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 8999999999999654321 123467999999999999 9999999999999953 2368999999999
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.+. .......++|||+|||||+++..+|+..+|||+.|+++|-+..+..++..-. ...+......+.+...
T Consensus 162 ~l~-------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVN-------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIKAGAYDYP 232 (355)
T ss_pred EeC-------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhccccCCC
Confidence 774 2234456799999999999999999999999999976654433332222111 1111111111111111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. +.++-+.+-.++++++|+..||++|.|+.|++.
T Consensus 233 ~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 S----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2 122233344455777999999999999999763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=309.59 Aligned_cols=236 Identities=18% Similarity=0.282 Sum_probs=169.4
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLD 715 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 715 (929)
..++|+..+.||+|+||.||+++.. ...+.+.+|+++++.+ +|||||+++++|....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888999999999999987531 0134578999999999 8999999999986543
Q ss_pred CCCcceEEEEEEecCCCCcccccccc------------------------------------------------------
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGE------------------------------------------------------ 741 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~------------------------------------------------------ 741 (929)
..++||||+++|+|.++++..
T Consensus 116 -----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 116 -----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 489999999999999887531
Q ss_pred ------------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 742 ------------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 742 ------------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 12346899999999998 999999999999999999999999999986532110
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........++..|||||++.+..++.++||||+|++++++.. ...++..... +............ ..
T Consensus 268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~------~~~~~~~~~~~~~--~~ 335 (374)
T cd05106 268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV------NSKFYKMVKRGYQ--MS 335 (374)
T ss_pred ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc------cHHHHHHHHcccC--cc
Confidence 011112235678999999999999999999999988777543 3332221111 1111111111000 00
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.+...+.-+.+++.+||+.||++||++.||+++|+++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00111122334777999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=298.72 Aligned_cols=232 Identities=24% Similarity=0.316 Sum_probs=177.9
Q ss_pred CCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.....++||+|-||.||+|.+. .+.+.|..|..+|+.++|||||+++|+|.+..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P----- 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP----- 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence 3445688999999999998765 23578999999999999999999999996532
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.|+|||.++.|.|..|++..+ .++.||+.||+|||+. .+|||||.++|||+.....+|++|||++|.
T Consensus 465 -~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 -MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred -eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 799999999999999998544 2367999999999998 899999999999999999999999999998
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
+... .....+...-...|||||.+--++++.++|||-||+.+||+.. .+.-|. ..+-...+...+..+
T Consensus 541 ~ed~-----~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~----lGvkPf--qgvkNsDVI~~iEnG- 608 (974)
T KOG4257|consen 541 LEDD-----AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS----LGVKPF--QGVKNSDVIGHIENG- 608 (974)
T ss_pred cccc-----chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHH----hcCCcc--ccccccceEEEecCC-
Confidence 7422 1122223345678999999999999999999999988877421 222222 111111111111111
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
+.-+-.+.|.+.++. ++.+||+.||.+||++.|+...|.++.+
T Consensus 609 eRlP~P~nCPp~LYs-lmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYS-LMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCChHHHH-HHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111222356666665 9999999999999999999999999877
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=281.87 Aligned_cols=222 Identities=23% Similarity=0.289 Sum_probs=168.9
Q ss_pred CCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+|++.+.+|+|.||+|-++... ++...+.+|+++|+.++||||++++.+| ++...+
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdKI 128 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDKI 128 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCceE
Confidence 5777789999999999877653 2234577999999999999999999999 445569
Q ss_pred EEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
.+||||..+|.|+||+.+ .|++..||..|+.|+|.+ +++|||+|.+|||+|.++.+||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999999974 346688999999999998 999999999999999999999999999987642
Q ss_pred ccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. ...+.+||++-|.+||++-|.+| +..+|-||+|+.+|.+..+.+++..... . .+...+......
T Consensus 206 ~-------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k-----~lvrQIs~GaYr 271 (668)
T KOG0611|consen 206 K-------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--K-----RLVRQISRGAYR 271 (668)
T ss_pred c-------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--H-----HHHHHhhccccc
Confidence 2 34567899999999999999988 7899999999665554433333332222 1 111111111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.+..+.... . ++++++..+|++|.|+.+|...
T Consensus 272 EP~~PSdA~---g-LIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EPETPSDAS---G-LIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCCchHH---H-HHHHHHhcCcccchhHHHHhhh
Confidence 111111122 2 6669999999999999998743
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-33 Score=268.53 Aligned_cols=224 Identities=20% Similarity=0.288 Sum_probs=175.1
Q ss_pred hhCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.++|+.++.+|+|-||.||.|+.+ +...++.+|+++-+.++||||++++++|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~---- 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK---- 95 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence 3467889999999999999999876 23567889999999999999999999996543
Q ss_pred ceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.+|+++||.+.|+++..|.+.+ .+..|+|.|+.|+|.. +||||||||+|+|++..+..||+|||-+
T Consensus 96 -riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 96 -RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred -eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCce
Confidence 4899999999999999987332 2357899999999997 8999999999999999999999999987
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
..-+ ....+..+||.-|.|||...+..++.++|+|+.|+..||+.++.-++..-.. +...+.....
T Consensus 172 V~~p--------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------~etYkrI~k~ 237 (281)
T KOG0580|consen 172 VHAP--------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------SETYKRIRKV 237 (281)
T ss_pred eecC--------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh------HHHHHHHHHc
Confidence 5421 2234567999999999999999999999999999888876555444432221 1111111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+...+..+..-+++++.+|+..+|.+|.+..|+++
T Consensus 238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11111234445556888999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=300.59 Aligned_cols=174 Identities=23% Similarity=0.362 Sum_probs=144.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence 3688999999999999999987651 134688999999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||+++|+|.+++.... .++.+++.||+|||+.+ +|+||||||+||++++++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999999986433 33678999999999852 699999999999999999999999999876532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. ......||+.|+|||++.+..++.++||||+|++++++.++..++
T Consensus 157 ~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 202 (331)
T cd06649 157 S--------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202 (331)
T ss_pred c--------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 1 122347899999999999999999999999999888876555443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=295.59 Aligned_cols=218 Identities=25% Similarity=0.295 Sum_probs=161.9
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+.||+|+||.||+++... ....+.+|+.++++++||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 469999999999887541 12356789999999999999999998854 345899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----- 147 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----- 147 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----
Confidence 999999998886432 2357999999999998 999999999999999999999999999875321
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
........+||+.|||||++.+..++.++||||+|++++++.++..++..... .+.... ......... .
T Consensus 148 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~----~~~~~~~~p----~ 216 (323)
T cd05571 148 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFEL----ILMEEIRFP----R 216 (323)
T ss_pred -CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHH----HHcCCCCCC----C
Confidence 11122345799999999999999999999999999999987665544432211 111100 000111111 1
Q ss_pred HHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
.+..-+++++.+|++.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1222233477799999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=279.05 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=176.3
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
....|...+.||+|+||.|+.+..+. ..++-.+|++++++++|+||+.+.+++.......-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34456667899999999999887662 234566899999999999999999998774444556
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.+|+|+|+| ..+|.+.++..+ ....|+++||.|+|+. +|+|||+||+|++++.+...||+|||+||..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 799999999 569999887544 3367999999999998 9999999999999999999999999999987
Q ss_pred ccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcC---------------Cc--h
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNL---------------PE--N 854 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~---------------~~--~ 854 (929)
... ......+..+.|.+|+|||++... .|+.+.||||.||++.|+....-.+..- |+ .
T Consensus 176 ~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 176 DKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred ccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 432 222344667889999999987654 5999999999999887765544332211 11 2
Q ss_pred hhhccChHHHHhhcccchhh-hh----hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 VLQVLDPELRQLMTSNESQT-IQ----LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~-~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...+-....+..+...+... .+ ++..-+.++. +..+++..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~Aid-LlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAID-LLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHH-HHHHHhccCccccCCHHHHhc
Confidence 22222233333222211111 11 1112233454 788999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=293.79 Aligned_cols=231 Identities=19% Similarity=0.229 Sum_probs=167.3
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|++. ...+.|.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----N 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----C
Confidence 46788899999999999998542 1134688999999999999999999998643 3
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++.... .++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 4899999999999999886421 2357899999999998 999999999999999999999999998764
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.... .........++..|+|||++.+..++.++||||+|++++++.. ...++..... ..+.......
T Consensus 157 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~ 224 (266)
T cd05064 157 DKSE-----AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDG 224 (266)
T ss_pred cccc-----chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCC
Confidence 3111 0111112345678999999999999999999999988777422 3222221111 1111111110
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.. ...+...+..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 225 ~~--~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FR--LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 000111222333477899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=265.45 Aligned_cols=244 Identities=19% Similarity=0.188 Sum_probs=178.0
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
..++|.+.+.+|+|||.-||.++.. .+.+..++|++..++++||||+++++++...........
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3468889999999999999987732 346678899999999999999999999987666567789
Q ss_pred EEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
|++++|...|+|.+.+.... .+..+|++||++||+. .+++.||||||.|||+.+.+.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999886322 3367899999999997 4579999999999999999999999999988
Q ss_pred ccccccCCCCCcc---ccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhh-hccC
Q 002376 791 FLLERVDNQSSIS---STHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPE---NVL-QVLD 860 (929)
Q Consensus 791 ~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~-~~~~ 860 (929)
...-......... ......-|..|+|||.+.-+ ..++++||||+||++|++....-++...-+ .+. .+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 6543222211111 11122458899999987543 479999999999887776544444332211 110 0111
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+.+. .+ ..... ++.+.+++..|++.||.+||++.|++..++++
T Consensus 258 ~q~s--~P----~~~~y----se~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 258 AQIS--IP----NSSRY----SEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cccc--cC----CCCCc----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 01 11112 23333366699999999999999999998875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=292.16 Aligned_cols=233 Identities=21% Similarity=0.257 Sum_probs=171.3
Q ss_pred HhhCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
...++|+....||+|+||.||.|+.+ ++.+....|-.+|...++|+||+++..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 35678999999999999999998765 2355677899999999999999999998 44
Q ss_pred cceEEEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
.+++||||||++||++..+|.. .+.++.+.+.|++.+|+. |+|||||||+|+|||..|++|++|||++.
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 5569999999999999988863 334566788899999998 99999999999999999999999999996
Q ss_pred cccccc-------------------CC-CCC---c------------------cccceeccccccccccccCCCCCCCCC
Q 002376 791 FLLERV-------------------DN-QSS---I------------------SSTHVFMGSIGYVPPEYGLGERPSTAG 829 (929)
Q Consensus 791 ~~~~~~-------------------~~-~~~---~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 829 (929)
-+.... .. ... . .....++|||-|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 432100 00 000 0 011245899999999999999999999
Q ss_pred CCCCCcCCCCCcchhHHhhhcC-Cc-hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC---HH
Q 002376 830 DVPTSESFAGEFNIVKWVESNL-PE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG---IR 904 (929)
Q Consensus 830 DV~s~g~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~ 904 (929)
|-||+||++||+.++.-++..- |. ....++..+..-..+.+... ..-..|++.+|+. ||++|-. +.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~--------s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDL--------SDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcc--------cHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 9999999999986655444322 22 23333333222111221111 1222347779888 9999975 45
Q ss_pred HHH
Q 002376 905 EAL 907 (929)
Q Consensus 905 ev~ 907 (929)
||-
T Consensus 441 EIK 443 (550)
T KOG0605|consen 441 EIK 443 (550)
T ss_pred HHh
Confidence 543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=296.77 Aligned_cols=235 Identities=20% Similarity=0.283 Sum_probs=172.4
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+|+..+.||+|+||.||+|.+. ...++|.+|+.+++.++||||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 36888999999999999998642 1135688899999999999999999998642
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..++|+||+++|+|.++++... .++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 2589999999999999887432 2367999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.+..... ........++..|||||++.+..++.++||||+|+++|++.. ...++...+. ..+......
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~ 226 (316)
T cd05108 158 LLGADEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEK 226 (316)
T ss_pred cccCCCc----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhC
Confidence 7642211 011112234678999999999999999999999988777533 2222221111 111111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
.... +....+...+.+ ++.+||+.+|++||++.+++..+.++.+..
T Consensus 227 ~~~~-~~~~~~~~~~~~-li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 GERL-PQPPICTIDVYM-IMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCC-CCCCCCCHHHHH-HHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1000 001112233444 888999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=299.87 Aligned_cols=220 Identities=22% Similarity=0.304 Sum_probs=165.7
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++... ..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----NR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CE
Confidence 578889999999999999987652 124578899999999999999999998543 35
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 899999999999999886433 2356899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .....||+.|||||++.+..++.++||||+|+++|++..+..++..... .+.. ........
T Consensus 170 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~----~~i~~~~~-- 232 (329)
T PTZ00263 170 DR---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIY----EKILAGRL-- 232 (329)
T ss_pred CC---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHH----HHHhcCCc--
Confidence 21 1235799999999999999999999999999888776554444322111 0100 00000000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREAL 907 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~ 907 (929)
..+..+...+++++.+||+.||++||+ ++|++
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 011112223344777999999999997 57766
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=297.08 Aligned_cols=221 Identities=25% Similarity=0.317 Sum_probs=172.7
Q ss_pred hhCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|...++||+|.||+|+.+..+ .+.+..+.|.+++... +||.+++++.+| ++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence 3468889999999999999988765 2356677888888877 599999999998 45
Q ss_pred cceEEEEEEecCCCCccccccc-------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHG-------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~-------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++|+||||+.||++..+.+. .+.++..|+.||+|||++ +||+||||-+|||+|.+|.+||+|||++|.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 5669999999999997776652 345578999999999999 999999999999999999999999999985
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.. .....+..++||+.|||||++.+..|+.++|=|++|+.+|||.+++-++..-. -.+++|..+.+ +.
T Consensus 518 ~m------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Eee~FdsI~~d----~~ 585 (694)
T KOG0694|consen 518 GM------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--EEEVFDSIVND----EV 585 (694)
T ss_pred cC------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcC----CC
Confidence 31 12335667899999999999999999999999999998888877665554332 33444444332 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
..+... -.+.+. |+.+.+..+|++|--+
T Consensus 586 ~yP~~l---s~ea~~-il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFL---SKEAIA-IMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcc---cHHHHH-HHHHHhccCcccccCC
Confidence 111111 223444 7779999999999866
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=298.71 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=170.6
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||.||+|+..+ ..+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 3478889999999999999885320 123567899999999 8999999999886433
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------------------------------------------
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------------------------------------------ 742 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------ 742 (929)
..+++||||+++|+|.+++....
T Consensus 85 ---~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 85 ---GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred ---CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 34799999999999998875311
Q ss_pred ---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccce
Q 002376 743 ---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807 (929)
Q Consensus 743 ---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~ 807 (929)
.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+..... ......
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~ 234 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGD 234 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccC
Confidence 1246899999999998 999999999999999999999999999987632211 011122
Q ss_pred eccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHH
Q 002376 808 FMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIG 886 (929)
Q Consensus 808 ~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 886 (929)
..++..|||||++.+..++.++||||+|++++++.. ...++.... .++.+............ ......++.+
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 307 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------IDEEFCRRLKEGTRMRA-PEYATPEIYS 307 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC------ccHHHHHHHhccCCCCC-CccCCHHHHH
Confidence 356788999999999999999999999988877543 222221111 01111111111000000 0011223344
Q ss_pred HHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 887 SVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 887 ~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
++.+||+.+|++||++.|+++.|+++.+
T Consensus 308 -l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 -IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=270.98 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=177.8
Q ss_pred HHhhCCCCCceeecccCceeEEeccccCc------------------------HHHHHHHHHHHHcc-CCccccceeeec
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTGS------------------------WKSFIAECETLRNV-RHRNLVKLITSC 711 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~------------------------~~~~~~E~~~l~~l-~Hpniv~l~~~~ 711 (929)
+...+.|...+.+|.|..+.|-++..+.+ .++-.+|+.+++++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34455677778899998888866544311 23455799999998 599999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCcccccc--------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIH--------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~--------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
. ...++++|+|.|+.|.|+|++. +.|.+..|+..|++|||.. .|||||+||+|||+|++.++||
T Consensus 93 e-----s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 E-----SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred c-----CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEE
Confidence 4 4456899999999999999996 3567788999999999998 8999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCC------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchh-h
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG------ERPSTAGDVPTSESFAGEFNIVKWVESNLPENV-L 856 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~-~ 856 (929)
+|||+|..+.++ ......+|||+|.|||.+.. ..|+..+|.|+.|+++|.+ ..+.-|.+- .
T Consensus 165 sDFGFa~~l~~G-------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTL-----LaGcpPFwHRk 232 (411)
T KOG0599|consen 165 SDFGFACQLEPG-------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTL-----LAGCPPFWHRK 232 (411)
T ss_pred eccceeeccCCc-------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHH-----HcCCCchhHHH
Confidence 999999987533 33456799999999998763 2489999999999766543 333334311 1
Q ss_pred hccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHHH
Q 002376 857 QVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQEI 916 (929)
Q Consensus 857 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~ 916 (929)
+++ .++-.+....+.+.+.|..++.-+++++.+|++.||.+|.|++|+++ .+..+...
T Consensus 233 Qml--MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 233 QML--MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred HHH--HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 111 12222222333344445556667777899999999999999999985 34444443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=295.84 Aligned_cols=223 Identities=22% Similarity=0.238 Sum_probs=167.4
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|+++++.++|||||++++++.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~----- 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE----- 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence 4578889999999999999986431 124567899999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 45899999999999999986433 3367899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... .....+||+.|||||++.+..++.++||||+|+++|++.++..++...... ... ..+. ....
T Consensus 181 ~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~-~~i~---~~~~ 245 (340)
T PTZ00426 181 VDT---------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIY-QKIL---EGII 245 (340)
T ss_pred cCC---------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHH-HHHh---cCCC
Confidence 521 122457999999999999989999999999999888876655444322110 000 0111 1111
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALRR 909 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~~ 909 (929)
..... +..-+++++.+|++.||++|+ +++|+++.
T Consensus 246 ~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111 122233477799999999995 78887653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.58 Aligned_cols=228 Identities=20% Similarity=0.220 Sum_probs=168.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|++++..++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 468889999999999999987641 13457789999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 899999999999999986432 2357899999999998 99999999999999999999999999998542
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhh--cccc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM--TSNE 871 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~ 871 (929)
. ......||+.|+|||++.+..++.++||||+|+++|++.....++..... .+... .+.... ....
T Consensus 153 ~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~-~i~~~~~~~~~~ 220 (333)
T cd05600 153 T---------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NETWE-NLKYWKETLQRP 220 (333)
T ss_pred c---------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HHHHH-HHHhccccccCC
Confidence 1 12345799999999999999999999999999999987665544432221 11100 011000 0000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
...... ..+...+.+++.+|+..+|++||+++|+++.
T Consensus 221 ~~~~~~-~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPR-FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccc-cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000 0111222337779999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=299.62 Aligned_cols=238 Identities=20% Similarity=0.303 Sum_probs=171.1
Q ss_pred HhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccC-CccccceeeecccC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSL 714 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~ 714 (929)
...++|...++||+|+||.||+|+.. ...+.|.+|+++++++. |||||+++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34568888899999999999987631 11356889999999996 99999999999543
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc----------------------------------------------------
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER---------------------------------------------------- 742 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------- 742 (929)
...|+|||||++|+|.++++..+
T Consensus 114 -----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 114 -----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred -----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 34899999999999998875321
Q ss_pred ----------------------------------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 743 ----------------------------------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 743 ----------------------------------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
.++.|++.|++|||+. +|+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence 1245799999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhc
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESN 850 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~ 850 (929)
+||++++++.+||+|||+++....... ........+++.|||||++.+..++.++||||+|++++++.. .+.
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt----~g~ 337 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS----LGG 337 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH----CCC
Confidence 999999999999999999986532111 111223357789999999999999999999999988777532 122
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.|... ...+............ ..........+.+++.+||+.||++||++.++.++|+++.
T Consensus 338 ~P~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 338 TPYPG-MIVDSTFYNKIKSGYR--MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCcc-cchhHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 22100 0011111111111100 0011112223334888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.53 Aligned_cols=215 Identities=27% Similarity=0.303 Sum_probs=158.0
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||.||+++... ..+.+.+|+.++++++||||+++++++.. ....|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 6999999999987641 12456789999999999999999998854 33589999999
Q ss_pred CCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 730 SNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 730 ~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 146 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------ 146 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC------
Confidence 9999999886432 2356899999999998 9999999999999999999999999999853211
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 881 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++.... ..+.... ...... ..+..+
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~----~~~~~~----~~~~~~ 216 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRK----ILQEPL----RFPDGF 216 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--HHHHHHH----HHcCCC----CCCCcC
Confidence 111234579999999999999999999999999988777655444432211 1111111 111111 111112
Q ss_pred HHHHHHHhccccCCCCCCCCC---HHHHH
Q 002376 882 ITIIGSVGLSCTTESPGGRIG---IREAL 907 (929)
Q Consensus 882 ~~~~~~l~~~Cl~~dP~~RPs---~~ev~ 907 (929)
...+++++.+||+.||++||+ +.|++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 233344777999999999985 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.49 Aligned_cols=222 Identities=23% Similarity=0.283 Sum_probs=166.4
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 468889999999999999987651 12357789999999999999999998754 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+++|+|.++++..+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 899999999999999886433 2367899999999998 99999999999999999999999999998652
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .....||+.|+|||++.+..++.++||||+|+++|++.....++..... .+........ ..
T Consensus 153 ~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~~~----~~-- 215 (291)
T cd05612 153 DR---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKILAG----KL-- 215 (291)
T ss_pred CC---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----Cc--
Confidence 11 1234789999999999999999999999999888876555444322111 1111111110 00
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALRR 909 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~~ 909 (929)
..+......+++++.+|++.||.+||+ ++|+++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111223344777999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.82 Aligned_cols=232 Identities=24% Similarity=0.374 Sum_probs=168.2
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||.||+|.... ..++|.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence 367778999999999999876421 134688999999999999999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCee
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNIL 774 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 774 (929)
...+++|||+++|+|.+++.... .++.|++.||+|||+. +++||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 33799999999999999886321 2467899999999998 9999999999999
Q ss_pred ecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc
Q 002376 775 LDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE 853 (929)
Q Consensus 775 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~ 853 (929)
+++++.+||+|||+++...... .........+++.|||||++.+..++.++||||+|++++++.. ...++.....
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSAD----YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred EcCCCcEEECCCcceeeccccc----cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999998653211 1111223356889999999998999999999999988877543 2212111111
Q ss_pred hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 854 NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 854 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
. ++........... ....+..++ .+++.+||+.||++||+++||+++|+.+
T Consensus 233 --~-----~~~~~i~~~~~~~-~~~~~~~~~-~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 --Q-----EVIEMIRSRQLLP-CPEDCPARV-YALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --H-----HHHHHHHcCCcCC-CcccCCHHH-HHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 1111111111000 001112223 3377799999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.82 Aligned_cols=234 Identities=22% Similarity=0.263 Sum_probs=169.0
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||+||+|.+.. ..+++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 356778899999999999987521 12456678888999999999999998742
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++|+||+++|+|.++++... .++.||+.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 12689999999999999986432 2467999999999998 89999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
....... ........|+..|+|||++.++.++.++||||+|+++|++.. ...++..... .........
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~ 226 (279)
T cd05111 158 LLYPDDK----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------HEVPDLLEK 226 (279)
T ss_pred eccCCCc----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHC
Confidence 6532211 111223457789999999999999999999999988777543 2222211110 011111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..... ....+...+.. ++.+||..||++|||+.|+++.|+.+.+.
T Consensus 227 ~~~~~-~~~~~~~~~~~-li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 GERLA-QPQICTIDVYM-VMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCcCC-CCCCCCHHHHH-HHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11000 00011223333 77899999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=290.05 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=170.0
Q ss_pred CCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 664 SHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+..+.||+|+||+||++... ...+.|.+|++++++++||||+++++++...+ ....
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~ 83 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKGL 83 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---CceE
Confidence 77899999999999764311 12456889999999999999999999886422 2357
Q ss_pred EEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||+++|+|.+++.... .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999886432 3467899999999998 9999999999999999999999999999866422
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh--------HHHHhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP--------ELRQLM 867 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~--------~l~~~~ 867 (929)
... ........++..|+|||++.+..++.++||||+|++++++.+...++...+..+.+..+. .+....
T Consensus 161 ~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 161 HEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred chh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 110 000112245677999999998899999999999988877655443332222111111111 111111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.... ....+...+..+.+++.+||+.+|++|||+++++++|+++.
T Consensus 238 ~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 00001111223334888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.85 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=166.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------------------cHHHHHHHHHHHHccCCccccceee
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------------------SWKSFIAECETLRNVRHRNLVKLIT 709 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------------------~~~~~~~E~~~l~~l~Hpniv~l~~ 709 (929)
++|+..+.||+|+||.||+++..+ ..+.|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999875421 1246889999999999999999999
Q ss_pred ecccCCCCCcceEEEEEEecCCCCccccccccc--------------------cccccHHHHHHHhhhCCCCCEEecCCC
Q 002376 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------------------KNELDITSALDYLHNDCEVPVVHSDLK 769 (929)
Q Consensus 710 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk 769 (929)
++...+ ..++||||+++++|.+++.... .++.+++.|++|||+. +++|||||
T Consensus 85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 986433 4799999999999999875321 1356899999999998 99999999
Q ss_pred CCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch--hHHh
Q 002376 770 PGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI--VKWV 847 (929)
Q Consensus 770 ~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~--~~~~ 847 (929)
|+||++++++.+||+|||+++...... .........++..|+|||++.++.++.++||||+|++++++.. ..++
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGD----YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCc----ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999997653211 0111122345778999999999999999999999988777532 1122
Q ss_pred hhcCCchhhhccChHHHHhhcc-cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 848 ESNLPENVLQVLDPELRQLMTS-NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 848 ~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
+..... .+.+... ...... ............+.-+.+++.+||+.||++||+|++|++.|++
T Consensus 233 ~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 233 YSLLSD--EQVIENT-GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CcccCh--HHHHHHH-HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 211111 1111100 000000 0000000000111223348889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=289.35 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=168.0
Q ss_pred CCCCCceeecccCceeEEecccc---------------------------------CcHHHHHHHHHHHHccCCccccce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------------------GSWKSFIAECETLRNVRHRNLVKL 707 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------------------~~~~~~~~E~~~l~~l~Hpniv~l 707 (929)
++|+..+.||+|+||.||+++.. ...++|.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999987421 113568899999999999999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCcccccccc-------------------ccccccHHHHHHHhhhCCCCCEEecCC
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE-------------------RKNELDITSALDYLHNDCEVPVVHSDL 768 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------------~~~~~~ia~aL~yLH~~~~~~iiHrDl 768 (929)
++++...+ ..++||||+++|+|.+++... ..++.|++.|++|||+. +++||||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 99985533 379999999999999988642 12356899999999998 9999999
Q ss_pred CCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch--hHH
Q 002376 769 KPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI--VKW 846 (929)
Q Consensus 769 k~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~--~~~ 846 (929)
||+||++++++.+|++|||+++.+..... ........+++.|+|||+..++.++.++||||+|+++|++.. ..+
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999986532110 011112244678999999888899999999999998888653 223
Q ss_pred hhhcCCchhhhccChHHHHhhccc-chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 847 VESNLPENVLQVLDPELRQLMTSN-ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 847 ~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
++..... .+.+.. ........ ..............+.+++.+||+.||++||+|.||++.|++
T Consensus 233 p~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 233 PYSQLSD--EQVIEN-TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CccccCh--HHHHHH-HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3322221 111110 00000000 000000001111233348889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=292.17 Aligned_cols=217 Identities=27% Similarity=0.347 Sum_probs=157.3
Q ss_pred CCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 663 FSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
|.-.+.||.|+||.||-+++. ..+.++.+|+..|++++|||+|.+.|+|.... ..|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence 334467999999999988765 23568899999999999999999999986433 279
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||| -|+-.|.+.-.+ .+..+++.||+|||+. +.||||||+.|||+.+.|.||++|||.|..+.
T Consensus 103 LVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 999999 568777775333 2356788999999998 89999999999999999999999999987652
Q ss_pred ccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
....++|||.|||||++. .+.|+-|+||||+|++..|+.-..-+...... + ..+..+...+.
T Consensus 178 ---------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-M-----SALYHIAQNes 242 (948)
T KOG0577|consen 178 ---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-M-----SALYHIAQNES 242 (948)
T ss_pred ---------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-H-----HHHHHHHhcCC
Confidence 235589999999999875 56799999999999877664222111111100 0 01111100000
Q ss_pred --hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 --SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 --~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
-+...+.+.+.. ++..|++.=|.+|||.++++.
T Consensus 243 PtLqs~eWS~~F~~----Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRN----FVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCchhHHHHHH----HHHHHHhhCcccCCcHHHHhh
Confidence 011123344444 555999999999999887653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=295.79 Aligned_cols=179 Identities=25% Similarity=0.339 Sum_probs=142.2
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|+... ...++.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999987541 124578999999999999999999998655433344689
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||++ ++|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68988876332 3467999999999998 9999999999999999999999999999864321
Q ss_pred cCCCCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.. .........||+.|+|||++.+ ..++.++||||+|++++++.++..+
T Consensus 157 ~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~p 207 (338)
T cd07859 157 TP---TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207 (338)
T ss_pred cC---ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCC
Confidence 11 1111234579999999999876 5789999999999988887655433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=294.93 Aligned_cols=173 Identities=23% Similarity=0.366 Sum_probs=143.4
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..++||+|+||.||++.+.. ..+.+.+|++++++++||||++++++|.+. .+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 3688999999999999999987641 124688999999999999999999998653 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||+++|+|.++++... .++.+++.|++|||+.. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999999986432 23568999999999742 699999999999999999999999999976532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
. ......||..|+|||++.+..++.++||||+|++++++.....+
T Consensus 157 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 157 S--------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred h--------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 1 11234689999999999998999999999999888876555443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.26 Aligned_cols=233 Identities=21% Similarity=0.269 Sum_probs=168.4
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
++++|+..+.||+|+||.||+|.+. ....+|.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4568999999999999999986532 0124588999999999999999999998543
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
...++||||+++|+|.++++..+ .++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 82 ---QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred ---CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 34799999999999999886421 1245899999999997 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
+.+|++|||+++....... ........+++.|||||++.+..++.++||||+|++++++.. ...++..... .+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~ 229 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQ 229 (277)
T ss_pred CCEEECCCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 9999999999986532111 001112345788999999999899999999999988877643 2333222211 11
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
..+........ . ........+++++.+|++.+|++||++.|+++.|++
T Consensus 230 ~~~~~~~~~~~---~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 230 VLRFVMEGGLL---D----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHHcCCcC---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11000000000 0 001112223348889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.46 Aligned_cols=237 Identities=27% Similarity=0.359 Sum_probs=165.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc---CCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV---RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||+||+|+... ....+.+|+.+++++ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999986521 123566788877766 6999999999986443333
Q ss_pred cceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
....++||||++ ++|.+++... ..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 6888887532 13467999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccCh-----
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDP----- 861 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~----- 861 (929)
++..... .......||+.|+|||++.+..++.++||||+|++++++....-++....+ ...++++.
T Consensus 157 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC-------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9865321 122345789999999999988999999999999888876544333322211 11111100
Q ss_pred --HHH-------Hhhcccchhhh-hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 --ELR-------QLMTSNESQTI-QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 --~l~-------~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ........... .....+...+++++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000000 000112334455888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.65 Aligned_cols=217 Identities=26% Similarity=0.309 Sum_probs=160.7
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+.||+|+||.||+++... ....+.+|+++++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999886531 12456789999999999999999998854 335899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhh-CCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHN-DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
|+++|+|.+++...+ .++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--- 149 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--- 149 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---
Confidence 999999998876432 236789999999997 5 8999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........||+.|||||++.+..++.++||||+|++++++.++..++..... ...+.+. ..... .
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~~~~----~ 215 (325)
T cd05594 150 ---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEIR----F 215 (325)
T ss_pred ---CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cCCCC----C
Confidence 1112335799999999999999999999999999999998766555432221 1111100 00000 0
Q ss_pred hHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
+.....-+.+++.+|++.||++|+ +++++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 011112233377799999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=290.12 Aligned_cols=219 Identities=26% Similarity=0.323 Sum_probs=160.9
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+.||+|+||.||+++... ..+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 469999999999887541 23467789999999999999999998854 345899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---- 148 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---- 148 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc----
Confidence 999999988875432 3467899999999998 9999999999999999999999999998753211
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++..... .+... ............
T Consensus 149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~----~~~~~~~~~p~~--- 217 (328)
T cd05593 149 --AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFE----LILMEDIKFPRT--- 217 (328)
T ss_pred --ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHH----HhccCCccCCCC---
Confidence 1112345799999999999999999999999999888876655444322111 11110 000011111111
Q ss_pred HHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRI-----GIREALRR 909 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~~ 909 (929)
+..-+.+++.+|++.||++|| ++.|+++.
T Consensus 218 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 -LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 122223377799999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=295.12 Aligned_cols=234 Identities=22% Similarity=0.283 Sum_probs=182.1
Q ss_pred CCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 664 SHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+..++||+|+||.||||.+- +..+++..|+-+|.+++|||+++++|+|.... +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 34579999999999999764 23568999999999999999999999996533 6
Q ss_pred EEEEEecCCCCcccccccccc---------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGERK---------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~~---------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.||++||+.|.|.+|++..|. +..|||+||.|||.+ ++|||||.++|||+..-..+||.|||+|+.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 899999999999999986553 257999999999998 99999999999999999999999999999875
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
..... .......-.+.|||-|.+..++|+.++||||||++.||+.+ ++.-|. ..+-..++.+.+...+ .
T Consensus 850 ~d~~e----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT----FGa~Py--~gi~~~eI~dlle~ge-R 918 (1177)
T KOG1025|consen 850 PDEKE----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT----FGAKPY--DGIPAEEIPDLLEKGE-R 918 (1177)
T ss_pred ccccc----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh----cCCCcc--CCCCHHHhhHHHhccc-c
Confidence 43221 11222344678999999999999999999999998888532 233222 1111222333222222 1
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
-.+.+-|...+.. ++.+||..|++.||+++++...+.++.+..+
T Consensus 919 LsqPpiCtiDVy~-~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 919 LSQPPICTIDVYM-VMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred CCCCCCccHHHHH-HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 2333456677777 9999999999999999999999999877644
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=287.66 Aligned_cols=242 Identities=25% Similarity=0.322 Sum_probs=169.8
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||++... ...+.|.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 46788899999999999997631 12357889999999999999999999876432 23
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 4799999999999999986432 2357899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc---------cChH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV---------LDPE 862 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 862 (929)
+...... ........++..|+|||++.+..++.++||||+|++++++....-.....+....+. ....
T Consensus 158 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEY---YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcc---eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 6422110 000111234556999999998899999999999988877644221111111111111 1111
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+.......... .........+.+++.+||+.+|++||||+|++++|+++
T Consensus 235 ~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111100 00011112233488899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=290.08 Aligned_cols=234 Identities=20% Similarity=0.275 Sum_probs=169.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||+||+|.... ..+.|.+|+++++++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence 478888999999999999986431 124688899999999 799999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 721 FLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
..++||||+++|+|.++++... .++.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 4899999999999999886321 2356899999999997 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~ 855 (929)
+++.+||+|||+++..... ........+..|+|||++.+..++.++||||+|++++++.. ...++.... .
T Consensus 154 ~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~ 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY-------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--C 224 (297)
T ss_pred CCCeEEECCcCCCccccce-------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--H
Confidence 9999999999998643111 00111123567999999998899999999999988877543 222221111 1
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.+.... ..... ....+......+.+++.+||+.+|.+||+++++++.|+++.+...
T Consensus 225 ~~~~~~-----~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 225 AELYEK-----LPQGY--RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHHH-----HhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111 10000 000011112233347889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=292.48 Aligned_cols=227 Identities=23% Similarity=0.247 Sum_probs=164.2
Q ss_pred CCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~ 717 (929)
+|+..+.||+|+||.||+++.. ...+.+.+|+.+++++ +||+|+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4778899999999999986542 0123567899999999 59999999988843
Q ss_pred CcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 335899999999999999886433 2356899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLM 867 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~ 867 (929)
+...... ........||+.|||||++.+.. ++.++||||+|++++++.++..++..... .....+...+.
T Consensus 153 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--- 224 (332)
T cd05614 153 KEFLSEE-----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--- 224 (332)
T ss_pred ccccccC-----CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh---
Confidence 8643211 11123457999999999998754 78999999999999998766655432211 11111111111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
..... .+..+...+++++.+|++.||++|| +++++++
T Consensus 225 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 KCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred cCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 1111223334477799999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.98 Aligned_cols=228 Identities=25% Similarity=0.348 Sum_probs=166.1
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||+++... ..++|.+|++++++++||||+++++++... ...++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEEE
Confidence 357778899999999999886641 245788999999999999999999998543 3489999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.++++... .++.+++.||+|||+. +|+||||||+||++++++.+||+|||.++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999999886422 2356899999999998 999999999999999999999999999886532110
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.......++..|+|||++.+..++.++||||+|++++++.. ...++..... .+.+. .+.. .....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~-~i~~---~~~~~--- 221 (256)
T cd05114 156 -----TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVE-MISR---GFRLY--- 221 (256)
T ss_pred -----eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH-HHHC---CCCCC---
Confidence 11122245678999999998899999999999988777544 2322221111 01100 0110 00000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
.+......+.+++.+||+.+|++||+|+|+++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011112233488899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=297.86 Aligned_cols=227 Identities=23% Similarity=0.306 Sum_probs=161.7
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+|+..+.||+|+||.||++++.. ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 149 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQV 149 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEEE
Confidence 34556889999999999987641 13568899999999999999999999854 334899
Q ss_pred EEEecCCCCccccccc----cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCC
Q 002376 725 VYEFLSNGSLGDWIHG----ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~----~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 800 (929)
||||+++|+|.+.... ...++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 150 v~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 222 (353)
T PLN00034 150 LLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---- 222 (353)
T ss_pred EEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc----
Confidence 9999999999765431 124578999999999998 99999999999999999999999999998653211
Q ss_pred CccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhh
Q 002376 801 SISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~ 874 (929)
......+||..|+|||++.. ...+.++||||+|+++|++.....++..... .+.......... ......
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~ 297 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---QPPEAP 297 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---CCCCCC
Confidence 11223479999999998743 2346789999999888776555444331111 111111000000 000000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.....-+++++.+||+.||++||++.|+++.
T Consensus 298 ----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 ----ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223337779999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=297.93 Aligned_cols=171 Identities=21% Similarity=0.294 Sum_probs=140.9
Q ss_pred CCCCCceeecccCceeEEeccccC----------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLS 730 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~ 730 (929)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++|||||++++++... ...++||||+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEEEEecCC
Confidence 579999999999999999987652 234678999999999999999999998543 34799999995
Q ss_pred CCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCc
Q 002376 731 NGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802 (929)
Q Consensus 731 ~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 802 (929)
++|.+++...+ .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-----~~ 237 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-----NA 237 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc-----cc
Confidence 78888775432 3357899999999998 9999999999999999999999999999753211 11
Q ss_pred cccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhH
Q 002376 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 803 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
......+||+.|+|||++.+..++.++||||+|+++|++.+..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~ 280 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 1223457999999999999999999999999999888865543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=290.78 Aligned_cols=218 Identities=24% Similarity=0.294 Sum_probs=159.1
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+.||+|+||.||+++... ....+.+|++++++++||||+++++++... ...|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 469999999999887541 123566899999999999999999988543 35899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---- 148 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 148 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC----
Confidence 999999988876432 3367899999999998 9999999999999999999999999998753211
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
........||+.|||||++.+..++.++||||+|+++|++.....++..... .+.. .............
T Consensus 149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~----~~~~~~~~~~p~~--- 217 (323)
T cd05595 149 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF----ELILMEEIRFPRT--- 217 (323)
T ss_pred --CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHH----HHHhcCCCCCCCC---
Confidence 1112335799999999999999999999999999888776554443322111 1111 1111111111111
Q ss_pred HHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
+..-+++++.+|++.||++|| ++.++++
T Consensus 218 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 122233467799999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.42 Aligned_cols=235 Identities=24% Similarity=0.314 Sum_probs=166.6
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 468889999999999999987651 13467899999999999999999999854 3458
Q ss_pred EEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||++++.+..+.+.. +.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999999988776554311 23467899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--h---hhhccC---hHHHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--N---VLQVLD---PELRQL 866 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~---~~~~~~---~~l~~~ 866 (929)
.. ........||+.|+|||++.+..++.++||||+|+++|++..+..++..... . ..+... ......
T Consensus 153 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 153 GS-----NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cc-----cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 11 1112235789999999999998999999999999988887655433322111 0 000000 000000
Q ss_pred hcccc--------------hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNE--------------SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~--------------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... .........++..+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000112333455888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.91 Aligned_cols=237 Identities=22% Similarity=0.294 Sum_probs=167.7
Q ss_pred hCCCCCceeecccCceeEEecccc---------------------------------CcHHHHHHHHHHHHccCCccccc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT---------------------------------GSWKSFIAECETLRNVRHRNLVK 706 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~---------------------------------~~~~~~~~E~~~l~~l~Hpniv~ 706 (929)
.++|+..+.||+|+||.||+++.. ...+.|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357888999999999999986532 12356888999999999999999
Q ss_pred eeeecccCCCCCcceEEEEEEecCCCCccccccccc-------------------cccccHHHHHHHhhhCCCCCEEecC
Q 002376 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-------------------KNELDITSALDYLHNDCEVPVVHSD 767 (929)
Q Consensus 707 l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------------~~~~~ia~aL~yLH~~~~~~iiHrD 767 (929)
++++|... ...++||||+++++|.+++.... .++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 99998543 34799999999999999886432 2356899999999998 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh--H
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV--K 845 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~--~ 845 (929)
|||+||++++++.+|++|||+++........ .......+++.|||||++.+..++.++||||+|++++++... .
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999865322110 111233567899999999988999999999999887775431 1
Q ss_pred HhhhcCCchhhhccChHHHHhhcc-cchhhh-hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 846 WVESNLPENVLQVLDPELRQLMTS-NESQTI-QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 846 ~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.++...+. .+.+... ...... ...... ....+..++.+ ++.+|++.||++||||+|+++.|++
T Consensus 232 ~p~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~-li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 232 QPYEHLTD--QQVIENA-GHFFRDDGRQIYLPRPPNCPKDIYE-LMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCcCh--HHHHHHH-HhccccccccccCCCccCCCHHHHH-HHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111 1111110 000000 000000 00011123344 8889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=287.17 Aligned_cols=236 Identities=21% Similarity=0.345 Sum_probs=170.1
Q ss_pred HhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
...++|+..+.||+|+||.||++... ....++.+|+++++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34457888899999999999987642 1123578899999999 899999999998543
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
...++||||+++|+|.++++..+ .++.|++.|++|||+. +|+||||||
T Consensus 89 -----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 89 -----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred -----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 34899999999999999885321 2356899999999987 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+||++++++.+|++|||+++.+...... .......++..|+|||++.+..++.++||||+|++++++.. ...++.
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 9999999999999999999865322110 01112235678999999999999999999999998877532 221111
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
..+ ..+ +........... ....+...+.+ ++.+||+.||++||||.|+++.|+++.
T Consensus 237 ~~~--~~~-----~~~~~~~~~~~~-~~~~~~~~~~~-li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIP--VEE-----LFKLLKEGYRME-KPQNCTQELYH-LMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCC--HHH-----HHHHHHcCCcCC-CCCCCCHHHHH-HHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 111 111111110000 00011223333 888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=287.36 Aligned_cols=236 Identities=24% Similarity=0.325 Sum_probs=171.5
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|...+.||+|+||+||++... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 46778899999999999988631 1134688999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc---------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
...++||||+++|+|.++++... .++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 34799999999999998886321 2356899999999998 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
+.+||+|||+++...... .........++..|+|||++.+..++.++||||+|++++++.+ ...++..... .+
T Consensus 157 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~ 230 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230 (288)
T ss_pred CcEEeccCCccccccCCc----eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 999999999998653211 0111122346788999999998899999999999988777543 2222211111 11
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
............ ........+.+++.+||+.||.+|||+.|+.+.|+++....
T Consensus 231 ~~~~i~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 231 VIECITQGRVLQ-------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHHHcCCcCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 111100000000 00011122334888999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=290.97 Aligned_cols=219 Identities=22% Similarity=0.324 Sum_probs=159.2
Q ss_pred ceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
.-.+|.|+||+||++..+ ...++|.-|+++|+.++||+||++++.|+-.+ .+|+..|||
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwiliEFC 111 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWILIEFC 111 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEEEeec
Confidence 456899999999998876 13467899999999999999999999876533 389999999
Q ss_pred CCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCC
Q 002376 730 SNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 730 ~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 800 (929)
+||-....+-+ .+.++.+++.||.|||++ .|||||+|+.|||++-+|.++++|||++.... .
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------~ 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------S 182 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch------h
Confidence 99988765532 234477899999999998 99999999999999999999999999876432 1
Q ss_pred CccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch---
Q 002376 801 SISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES--- 872 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~--- 872 (929)
.......+.|||+|||||++. ..+|+.++||||+|+.+.+|.-.+-+...+. .+.++- .....+++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRVll----KiaKSePPTLl 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLL----KIAKSEPPTLL 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHHHH----HHhhcCCCccc
Confidence 223345689999999999865 5579999999999977666533322221111 111111 11111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++..+...+.. +..+|+..||..||+++++++
T Consensus 257 qPS~Ws~~F~D----fLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSD----FLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHH----HHHHHHhcCCccCCCHHHHhh
Confidence 11112223343 555999999999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=286.67 Aligned_cols=230 Identities=20% Similarity=0.312 Sum_probs=166.2
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||+||+|+.. ...+.|.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 35777899999999999998631 01246889999999999999999999985433
Q ss_pred ceEEEEEEecCCCCccccccccc-------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCee
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER-------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNIL 774 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~-------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 774 (929)
..|+||||+++|+|.+++.... .++.+++.||+|||+. +|+||||||+||+
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 3799999999999999884211 2356899999999998 8999999999999
Q ss_pred ecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc
Q 002376 775 LDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE 853 (929)
Q Consensus 775 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~ 853 (929)
+++++.+|++|||+++....... ........++..|+|||++.+..++.++||||+|++++++.. ...++.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADY----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred EcCCCcEEeccccccccccCCcc----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999986532111 111122346778999999988899999999999988777543 2222211111
Q ss_pred -hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 854 -NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 854 -~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
...+.++. .... ...+.....+.+++.+||+.||++||++.++.++|+.
T Consensus 233 ~~~~~~~~~--------~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRK--------RQLL--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHc--------CCcC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 0000 0001111223337779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=287.37 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=171.8
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+|...+.||+|+||.||+++.. ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence 35777899999999999988631 1135788999999999999999999998543
Q ss_pred ceEEEEEEecCCCCcccccccc------------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE------------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~------------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 775 (929)
...++||||+++++|.+++... ..++.|++.|++|||+. +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 3479999999999999998532 12356899999999998 99999999999999
Q ss_pred cCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCch
Q 002376 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPEN 854 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~ 854 (929)
++++.+||+|||+++....... ........|+..|+|||++.+..++.++||||+|++++++.+ ...++.....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 231 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN- 231 (291)
T ss_pred ccCCcEEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999976532110 011123456889999999999999999999999988777544 3333222211
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.+.++. ... ..... .....+..+.+++.+||+.+|++||++++|+++|+++...
T Consensus 232 -~~~~~~-~~~---~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 232 -TEVIEC-ITQ---GRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHH-HhC---CCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111110 110 00000 0011122233488899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=287.83 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=168.5
Q ss_pred CCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+|...+.||+|+||.||+|... ...+++.+|+.+++.++||||++++++|...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 3667789999999999998642 01346889999999999999999999985433
Q ss_pred ceEEEEEEecCCCCccccccccc--------------------------------cccccHHHHHHHhhhCCCCCEEecC
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------------------------------KNELDITSALDYLHNDCEVPVVHSD 767 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------~~~~~ia~aL~yLH~~~~~~iiHrD 767 (929)
..++||||+++|+|.+++...+ .++.|++.|++|||+. +|+|||
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 3799999999999999875321 2356899999999998 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHH
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKW 846 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~ 846 (929)
|||+||++++++.+||+|||+++....... ........++..|+|||++.+..++.++||||+|++++++.. ...
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccc----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999986532211 011122346778999999988899999999999988777543 332
Q ss_pred hhhcCCc-hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 847 VESNLPE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 847 ~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
++..... .+.+.+.... ... ... .+..++. +++.+|++.+|++||+++|+++.|+++..
T Consensus 229 p~~~~~~~~~~~~~~~~~----~~~--~~~---~~~~~~~-~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 229 PYPGIAPERLFNLLKTGY----RME--RPE---NCSEEMY-NLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCHHHHHHHHhCCC----CCC--CCC---CCCHHHH-HHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2221111 1111111100 000 000 1112233 37789999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=275.92 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=178.0
Q ss_pred CCCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHHcc--CCccccceeeecccCCCCCcceEEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRNV--RHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.+....+.||+|.||+||+|++++ +.+.+.+|.++.+.+ +|+||..+++.-.... ..--++|||.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvTd 289 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVTD 289 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEeee
Confidence 456677999999999999999984 456788999988874 9999999988755433 23446899999
Q ss_pred ecCCCCccccccccc-------cccccHHHHHHHhhhC-----CCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 728 FLSNGSLGDWIHGER-------KNELDITSALDYLHND-----CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|-+.|||+|||.... +.++.+|.||+|||.. ..|.|.|||||+.|||+..++.+.|+|+|+|-.....
T Consensus 290 YHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999999997432 3467899999999964 4689999999999999999999999999999765433
Q ss_pred cCCCCCccccceeccccccccccccCCCC------CCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhcc--ChHHH
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGER------PSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVL--DPELR 864 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~--~~~l~ 864 (929)
.+ .-.......+||-+|||||++.... --..+||||||.++||+.-.--..+...+ ++.+++ ||...
T Consensus 370 t~--~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 370 TD--TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred CC--cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 21 1112234568999999999986542 24679999999777774322221111111 112221 22211
Q ss_pred Hh--------hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 865 QL--------MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 865 ~~--------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
+. +....+.+....+++..+.+ ++..||..+|+.|-|+--+-+.|.++.+
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~k-lMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAK-LMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHH-HHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 11111111222245665666 9999999999999999888888888765
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-31 Score=298.81 Aligned_cols=238 Identities=19% Similarity=0.267 Sum_probs=170.7
Q ss_pred HHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccC-Cccccceeeeccc
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVR-HRNLVKLITSCSS 713 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~ 713 (929)
....++|...+.||+|+||.||+|++. ...+.+.+|++++.++. |||||+++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344456778899999999999998642 11246889999999997 9999999999965
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc---------------------------------------------------
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER--------------------------------------------------- 742 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 742 (929)
.. ..++||||+++|+|.+++++.+
T Consensus 113 ~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 113 GG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred CC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 33 4799999999999999886321
Q ss_pred -------------------------------------------------------cccccHHHHHHHhhhCCCCCEEecC
Q 002376 743 -------------------------------------------------------KNELDITSALDYLHNDCEVPVVHSD 767 (929)
Q Consensus 743 -------------------------------------------------------~~~~~ia~aL~yLH~~~~~~iiHrD 767 (929)
.++.|++.||+|||+. +|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCccc
Confidence 1235899999999987 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHH
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKW 846 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~ 846 (929)
|||+|||+++++.+|++|||+++....... ........|+..|||||++.+..++.++||||+|++++++.. ...
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~ 340 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceecccccc----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999986532111 011122357889999999998889999999999988777543 222
Q ss_pred hhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 847 VESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 847 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
++...+. .+ .......... +...+......+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 341 P~~~~~~--~~----~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 341 PYPELPM--NE----QFYNAIKRGY--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCc--hH----HHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2221111 11 0111110000 00001111222334777999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-32 Score=273.19 Aligned_cols=225 Identities=24% Similarity=0.296 Sum_probs=167.2
Q ss_pred CCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 663 FSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
|+...++|+|+||.||++.++ .+.++..+|+.+|++++.|+||++||.|+... .+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeehhh
Confidence 455688999999999998776 34678999999999999999999999886433 38999999
Q ss_pred cCCCCccccccccccc---------cccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 729 LSNGSLGDWIHGERKN---------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 729 ~~~gsL~~~l~~~~~~---------~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|..|+..+.++.+++. ..+.++||+|||.. .-||||||+.|||++.+|.+|++|||+|..+....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 9999999999855543 34567899999987 78999999999999999999999999998774321
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
.....+.||+.|||||++..-.|..++||||+|+.+.|+.-+.-++..+. .+..++- ++..+++....++
T Consensus 184 ---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH-PMRAIFM------IPT~PPPTF~KPE 253 (502)
T KOG0574|consen 184 ---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH-PMRAIFM------IPTKPPPTFKKPE 253 (502)
T ss_pred ---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc-ccceeEe------ccCCCCCCCCChH
Confidence 12345689999999999999999999999999988877644333222211 1111110 1111111111111
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.-+.-..++++.|+-..|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 12222223666999999999999988764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=288.13 Aligned_cols=218 Identities=24% Similarity=0.297 Sum_probs=160.3
Q ss_pred eeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 667 NLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+.||+|+||.||+++.. .....+.+|+++++.++||||+++++++... ...|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeEE
Confidence 57999999999987642 0123467899999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999999886433 2356899999999998 9999999999999999999999999998753211
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
........||+.|+|||++.+..++.++||||+|+++|++..+..++..... .+.+ ............
T Consensus 154 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~~~----~~~~~~~~~~~~ 221 (323)
T cd05584 154 ------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKTI----DKILKGKLNLPP 221 (323)
T ss_pred ------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCCCC
Confidence 1112335799999999999998999999999999888887665554432221 1111 111111111111
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
.+...+.+++.+|++.||++|| ++.++++
T Consensus 222 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 ----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1122233477799999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=295.01 Aligned_cols=232 Identities=21% Similarity=0.255 Sum_probs=164.2
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.|+..+.||+|+||+||+|+... ..+.+.+|++++++++|||||++++++.+ ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 57788999999999999987641 12357789999999999999999999854 3358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999999886432 3356899999999998 999999999999999999999999999864321
Q ss_pred ccCCC-----------------------------------------CCccccceeccccccccccccCCCCCCCCCCCCC
Q 002376 795 RVDNQ-----------------------------------------SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT 833 (929)
Q Consensus 795 ~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s 833 (929)
..... .........+||+.|||||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00000 0000112357999999999999989999999999
Q ss_pred CcCCCCCcchhHHhhhcCCch--hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhcc--ccCCCCCCCCCHHHHHHH
Q 002376 834 SESFAGEFNIVKWVESNLPEN--VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLS--CTTESPGGRIGIREALRR 909 (929)
Q Consensus 834 ~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~--Cl~~dP~~RPs~~ev~~~ 909 (929)
+|+++|++.++..++...... ...+...... . .............. ++.+ |+..+|.+||+++|++..
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~--~~~~~~~~s~~~~d----li~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENT--L--HIPPQVKLSPEAVD----LITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc--c--CCCCCCCCCHHHHH----HHHHHccCcccccCCCCHHHHhcC
Confidence 999888876665554332210 1111110000 0 00000111122233 4434 677788889999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=294.59 Aligned_cols=180 Identities=24% Similarity=0.279 Sum_probs=144.4
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++.+ ...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCEE
Confidence 68889999999999999987541 12457789999999999999999999854 3458
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999999986433 2357899999999998 999999999999999999999999999853310
Q ss_pred ccCC-------------------------------------CCCccccceeccccccccccccCCCCCCCCCCCCCCcCC
Q 002376 795 RVDN-------------------------------------QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESF 837 (929)
Q Consensus 795 ~~~~-------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~ 837 (929)
.... ..........+||+.|||||++.+..++.++||||+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0000 000001123579999999999999999999999999999
Q ss_pred CCCcchhHHhhh
Q 002376 838 AGEFNIVKWVES 849 (929)
Q Consensus 838 ~~~~~~~~~~~~ 849 (929)
+|++.++..++.
T Consensus 234 lyell~G~~Pf~ 245 (376)
T cd05598 234 LYEMLVGQPPFL 245 (376)
T ss_pred eeehhhCCCCCC
Confidence 999876665554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-31 Score=282.32 Aligned_cols=235 Identities=22% Similarity=0.340 Sum_probs=168.5
Q ss_pred CCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 663 FSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
|+..+.||+|+||.||+|.... ..+.+.+|++.++.++||||+++++++...+. ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999886421 12468899999999999999999998865443 2233
Q ss_pred eEEEEEEecCCCCccccccccc--------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 4799999999999998874221 2357899999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
|+++.+...... .......++..|+|||++.+..++.++||||+|++++++.. ...++..... . .+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~-----~~~~ 226 (273)
T cd05035 158 GLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--H-----EIYD 226 (273)
T ss_pred cceeeccccccc----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--H-----HHHH
Confidence 999865322110 11112235678999999988899999999999988877544 3222221111 1 1111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
......... ....+..++.+ ++.+||+.||++||++.|+++.|+++
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~-li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNRLK-QPEDCLDELYD-LMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCCCC-CCcCCCHHHHH-HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110000 00112233333 78899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=295.76 Aligned_cols=231 Identities=20% Similarity=0.234 Sum_probs=165.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+++... ..+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 478889999999999999987641 12346789999999999999999999854 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 899999999999999886432 3467899999999998 99999999999999999999999999997653
Q ss_pred cccCCCC--------------------------------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCc
Q 002376 794 ERVDNQS--------------------------------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEF 841 (929)
Q Consensus 794 ~~~~~~~--------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~ 841 (929)
....... ........+||+.|||||++.+..++.++||||+|++++++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 2110000 00001124699999999999999999999999999998887
Q ss_pred chhHHhhhcCCc-h-hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC---HHHHHH
Q 002376 842 NIVKWVESNLPE-N-VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG---IREALR 908 (929)
Q Consensus 842 ~~~~~~~~~~~~-~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~ev~~ 908 (929)
..+..++..... . ...+.... ... .........+ .+++++.+|+. +|.+|++ ++|+++
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~~~~~s~----~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWK--ETL--QFPDEVPLSP----EAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCC--Ccc--CCCCCCCCCH----HHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 665554432221 0 11111000 000 0000001112 22336668886 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=311.81 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=173.3
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..++||+|+||.||+|.... ..++|.+|++++++++||||+++++++.+. ..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 578899999999999999986541 134688999999999999999999998543 34
Q ss_pred EEEEEEecCCCCcccccccc-------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 722 LALVYEFLSNGSLGDWIHGE-------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~-------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
.++||||+++|+|.++++.. ..++.||++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999987521 12356899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCC------------CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhc
Q 002376 783 VGDFGLARFLLERVDNQ------------SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESN 850 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~ 850 (929)
|+|||+++......... .........+||+.|||||++.+..++.++||||+|++++++..+..++..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 99999998762111100 001112235799999999999999999999999999888887665544332
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHhhHHH
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI-GIREALRRLKSSQEI 916 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~ 916 (929)
... .++... ........ ......++..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 234 ~~~--~ki~~~---~~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 234 KKG--RKISYR---DVILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred cch--hhhhhh---hhccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 111111 00000000 000011222333477799999999996 677788888877654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=295.27 Aligned_cols=233 Identities=20% Similarity=0.243 Sum_probs=166.8
Q ss_pred HHHhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
+....++|+..+.||+|+||.||+++... ..+.+.+|+.+++.++||||+++++++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--- 114 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--- 114 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc---
Confidence 33445789999999999999999887641 12347789999999999999999999854
Q ss_pred CCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....|+||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 345899999999999999886432 3467899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCC----CCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER----PSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPEL 863 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 863 (929)
+..... ........+||+.|||||++.+.. ++.++||||+|+++|++.++..++..... ...++.+.
T Consensus 190 ~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~-- 262 (370)
T cd05621 190 MKMDET-----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH-- 262 (370)
T ss_pred eecccC-----CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Confidence 865321 111123457999999999987643 78999999999888876655544432211 11111110
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCC--CCCHHHHHHH
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGG--RIGIREALRR 909 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~~ 909 (929)
......+....+...+++++.+|+..+|.+ ||++.|+++.
T Consensus 263 ------~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 ------KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000000000112233344666888755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=286.48 Aligned_cols=225 Identities=30% Similarity=0.436 Sum_probs=157.4
Q ss_pred CceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 665 HENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 665 ~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
..+.||.|+||.||+|.+.. ..+.|.+|++.+++++||||++++|+|...+. .+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----LF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----EE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----cc
Confidence 35789999999999987660 14689999999999999999999999974332 89
Q ss_pred EEEEecCCCCcccccccc--c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE--R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~--~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++|+|.++++.. . .++.|||+||+|||+. +++||||+++||++++++.+||+|||+++...
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999998764 1 2367999999999998 89999999999999999999999999998652
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. ..........+...|+|||++.+..++.++||||||++++|+.. ...++..... ..+...+.....
T Consensus 155 ~~----~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~~~~~~ 223 (259)
T PF07714_consen 155 EK----SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKLKQGQR 223 (259)
T ss_dssp TS----SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHHHTTEE
T ss_pred cc----ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccc
Confidence 11 11111122356788999999999899999999999987777544 2222222211 111111111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
...+.....-+.+++.+||+.||++||+|+|++++|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111111112223377799999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=310.58 Aligned_cols=233 Identities=24% Similarity=0.315 Sum_probs=179.9
Q ss_pred HhhCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
..+-++....+||.|.||.||-|... +..+...+|+.++..++|||+|+++|+-.+++.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH---
Confidence 34556777889999999999987654 223456789999999999999999999766443
Q ss_pred ceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+|.||||++|+|.+.+... +.+..|++.|++|||+. +||||||||+||+++.+|.+|.+|||.|+.
T Consensus 1309 --v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 --VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred --HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 79999999999999998743 23467999999999998 999999999999999999999999999988
Q ss_pred cccccCCCCCccccceeccccccccccccCCCC---CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGER---PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+...... -.......+||+.|||||++.+.. ...++||||+||+..||.++.-+|..+...+.-+..-...
T Consensus 1384 i~~~~~~--~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g---- 1457 (1509)
T KOG4645|consen 1384 IKNNAQT--MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG---- 1457 (1509)
T ss_pred ecCchhc--CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc----
Confidence 7543211 112335678999999999997654 6788999999999999988888887776633211111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..++.++.++..-++++.+|++.||++|.++.|+++
T Consensus 1458 ----h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 ----HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 122233345555556777999999999988876554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=293.35 Aligned_cols=180 Identities=24% Similarity=0.278 Sum_probs=143.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+++... ..+.+.+|++++++++|||||++++++.+ ..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 478889999999999999886541 12457789999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 899999999999999886432 3467899999999998 99999999999999999999999999996432
Q ss_pred cccCCC----------CC-------------------------------ccccceeccccccccccccCCCCCCCCCCCC
Q 002376 794 ERVDNQ----------SS-------------------------------ISSTHVFMGSIGYVPPEYGLGERPSTAGDVP 832 (929)
Q Consensus 794 ~~~~~~----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~ 832 (929)
...... .. .......+||+.|||||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 110000 00 0000124799999999999999999999999
Q ss_pred CCcCCCCCcchhHHhh
Q 002376 833 TSESFAGEFNIVKWVE 848 (929)
Q Consensus 833 s~g~~~~~~~~~~~~~ 848 (929)
|+|++++++.++..++
T Consensus 233 SlGvil~elltG~~Pf 248 (377)
T cd05629 233 SLGAIMFECLIGWPPF 248 (377)
T ss_pred ecchhhhhhhcCCCCC
Confidence 9999999987665544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=288.57 Aligned_cols=226 Identities=19% Similarity=0.204 Sum_probs=165.7
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+++... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 468889999999999999887541 23457789999999999999999998854 335
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 899999999999999986431 2356899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccC------CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHHH
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL------GERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPELR 864 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 864 (929)
.... ........||+.|+|||++. +..++.++||||+|+++|++.++..++..... ....+....
T Consensus 153 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-- 225 (330)
T cd05601 153 TANK-----MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ-- 225 (330)
T ss_pred CCCC-----ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--
Confidence 3211 11122347899999999987 45688999999999999998766655433221 111111100
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ...........+ .+++.+|++ +|++||++.+++.
T Consensus 226 ~~~--~~~~~~~~~~~~----~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 RFL--KFPEDPKVSSDF----LDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred Ccc--CCCCCCCCCHHH----HHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 000001111222 236669997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=286.34 Aligned_cols=215 Identities=25% Similarity=0.293 Sum_probs=158.7
Q ss_pred eeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 667 NLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
+.||+|+||.||+++.. .....+.+|++++++++||||+++++++.+ ....|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 57999999999976542 112346689999999999999999999854 3358999
Q ss_pred EEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 726 YEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 99999999998886432 3367899999999998 9999999999999999999999999998754211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........||+.|||||++.+..++.++||||+|++++++..+..++..... .+.. ..........
T Consensus 152 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~----~~i~~~~~~~---- 217 (318)
T cd05582 152 ----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETM----TMILKAKLGM---- 217 (318)
T ss_pred ----CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHH----HHHHcCCCCC----
Confidence 1112345799999999999998899999999999999998765544432211 1111 1111111111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIRE 905 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~e 905 (929)
+..+..-+++++.+|++.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112222334777999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=296.40 Aligned_cols=232 Identities=20% Similarity=0.225 Sum_probs=166.5
Q ss_pred HhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
...++|+..+.||+|+||.||+++... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----- 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----- 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 345688999999999999999887641 12346789999999999999999998854
Q ss_pred cceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
....|+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 345899999999999999886432 2357899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCC----CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhh
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGE----RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
..... .......+||+.|||||++.+. .++.++||||+|+++|++..+..++..... ... .....
T Consensus 192 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~----~~~i~ 260 (370)
T cd05596 192 MDANG-----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGT----YSKIM 260 (370)
T ss_pred ccCCC-----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--HHH----HHHHH
Confidence 53211 1112335799999999998654 378999999999888776554444332211 000 01111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCC--CCCHHHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGG--RIGIREALR 908 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~ 908 (929)
........+....++..+++++.+|++.+|++ ||++.|+++
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 261 DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred cCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00000000000011223334777999999988 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=282.85 Aligned_cols=232 Identities=18% Similarity=0.280 Sum_probs=167.2
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..++||+|+||.||+|.... ..++|.+|++++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence 367788999999999999987531 135688999999999999999999998653 3479
Q ss_pred EEEEecCCCCcccccc----ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 724 LVYEFLSNGSLGDWIH----GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~----~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
+||||+++|+|..+.+ ....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 76 ICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred EEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999999999976543 1224578999999999998 9999999999999999999999999999765211
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
......||..|+|||++.+..++.++||||+|++++++..+..++............................. .
T Consensus 149 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 223 (279)
T cd06619 149 ----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV-G 223 (279)
T ss_pred ----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC-C
Confidence 12335789999999999999999999999999888876655554432221100001111111100000000000 0
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111122347779999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=279.22 Aligned_cols=232 Identities=21% Similarity=0.258 Sum_probs=169.0
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||+||+|++. ...++|.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-----R 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----C
Confidence 56888999999999999998652 1234688999999999999999999988543 3
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++.... .++.+++.|++|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 3799999999999999986422 2357899999999997 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
...... ........+++.|+|||.+.+..++.++||||+|++++++.+ ...++.... +..+.......
T Consensus 156 ~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~ 224 (266)
T cd05033 156 LEDSEA----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDG 224 (266)
T ss_pred cccccc----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcC
Confidence 631111 011112245678999999999999999999999988777432 222221111 11111111110
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
... .......+.+.+++.+||+.+|++||+++|+++.|+++
T Consensus 225 ~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00011122333488899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=286.77 Aligned_cols=236 Identities=20% Similarity=0.332 Sum_probs=169.5
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|...+.||+|+||.||+++.. ...+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999987521 1124678899999999 899999999998543
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
...++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||
T Consensus 94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 94 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 34799999999999999986432 1245899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+||++++++.+||+|||+++.+...... .......+++.|+|||++.+..++.++||||+|++++++.. ...++.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ceEEEcCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999865321111 11122346778999999999899999999999987766432 111111
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..+ ..+. ........... ....+...+ .+++.+||+.+|++||+|.|+++.|+++...
T Consensus 242 ~~~--~~~~-----~~~~~~~~~~~-~~~~~~~~~-~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 242 GIP--VEEL-----FKLLKEGHRMD-KPANCTNEL-YMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred cCC--HHHH-----HHHHHcCCcCC-CCCCCCHHH-HHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 1111 11111110000 001112223 3377899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=277.43 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=171.2
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|+... ....|.+|+++++.++||||+++++++.+. ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 578889999999999999987531 124678999999999999999999998643 34
Q ss_pred EEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++||||+++|+|.+++... ..++.+++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 79999999999999877421 12356899999999998 9999999999999999999999999998
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+...... .......|++.|+|||++.+..++.++||||+|++++++.....++........ .+......
T Consensus 154 ~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-----~~~~~~~~ 222 (267)
T cd08228 154 RFFSSKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-----SLCQKIEQ 222 (267)
T ss_pred eeccchh------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-----HHHHHHhc
Confidence 8653211 111234688999999999988899999999999877765443332211110111 11111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
... .....+.....+.+++.+||+.+|++||++.||++.+++++
T Consensus 223 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDY-PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC-CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 00111122233445888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=286.86 Aligned_cols=220 Identities=25% Similarity=0.281 Sum_probs=156.6
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+++... ..+.+.+|+.++.++ +||||+++++++... ...++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 469999999999987541 123466788888776 899999999998543 3589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--- 149 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--- 149 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence 9999999988875432 3467899999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhhccChHHHHhhcccchhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........||+.|+|||++.+..++.++||||+|++++++..+..++..... . ........+........ ..
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---~~ 223 (329)
T cd05618 150 ---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---IR 223 (329)
T ss_pred ---CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---CC
Confidence 1112345799999999999999999999999999888887666555432111 0 00000011111111100 01
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
.+..+...+++++.+|++.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111122223347779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=283.31 Aligned_cols=243 Identities=23% Similarity=0.246 Sum_probs=174.0
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
+.++++.++.++|+..+.||+|+||.||++.... ...++.+|+.+++++ +||||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 5567777889999999999999999999986541 135678899999999 699999999998655
Q ss_pred CCCCcceEEEEEEecCCCCcccccccc----c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGE----R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~----~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
+.......++||||+++|+|.++++.. . ..+.|++.|+.|||+. +|+|||+||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 444455689999999999999876421 1 1356899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
++|||+++.+.... .......|++.|+|||++.. ..++.++||||+|++++++.....++..... ...
T Consensus 165 l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTR------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRA 237 (286)
T ss_pred EccCCceeecccCC------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHH
Confidence 99999998653211 11223468999999998753 4578999999999887776544333222111 011
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... ... ........+....+-+.+++.+||+.||++||++.|+++.
T Consensus 238 ~~~--~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFK--IPR----NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhh--ccc----cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000 0000000000011122337779999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=277.91 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=168.8
Q ss_pred CCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.|+..+.||+|+||.||.+++. ...+.+.+|++++++++|||++++++++...+ ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence 4677889999999999987521 11357889999999999999999999886532 23
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++++|.+++.... .++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 4799999999999999885322 2356899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhcc--------ChH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVL--------DPE 862 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~ 862 (929)
+...... ........|+..|+|||++.+..++.++||||+|++++++.+...+.. .+. ...+.. ...
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 159 IETDKEY---YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES-SPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccCccc---eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc-cccchhhhhcccccccccHHH
Confidence 5322110 011123457778999999998899999999999999988654211100 000 000000 000
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
......... .......+..++. +++.+|++.+|++||++.|+++.++++
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~~-~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGK-RLPRPPNCPEEVY-QLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCc-cCCCCCCCCHHHH-HHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000000 0000011122333 388899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=290.96 Aligned_cols=180 Identities=24% Similarity=0.264 Sum_probs=144.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+++... ..+.+.+|+.++.+++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 478889999999999999987641 12356789999999999999999999854 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 899999999999999886432 3467899999999998 99999999999999999999999999998653
Q ss_pred cccCCC-----------------------------CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh
Q 002376 794 ERVDNQ-----------------------------SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 794 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
...... .........+||+.|||||++.+..++.++||||+|+++|++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211000 000011245799999999999999999999999999888887665
Q ss_pred HHhh
Q 002376 845 KWVE 848 (929)
Q Consensus 845 ~~~~ 848 (929)
..++
T Consensus 233 ~~Pf 236 (363)
T cd05628 233 YPPF 236 (363)
T ss_pred CCCC
Confidence 5544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=279.28 Aligned_cols=231 Identities=24% Similarity=0.340 Sum_probs=168.4
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..+.||+|+||.||+|.... ..++|.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeee
Confidence 4568888999999999999987531 246789999999999999999999988543 347999
Q ss_pred EEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++++|.+++.... .++.+++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999986432 2356899999999998 8999999999999999999999999999876421
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.. .......++..|+|||++.+..++.++||||+|++++++.. ...++..... . .+..........
T Consensus 157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~-----~~~~~~~~~~~~- 223 (261)
T cd05068 157 IY-----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--A-----EVLQQVDQGYRM- 223 (261)
T ss_pred cc-----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--H-----HHHHHHHcCCCC-
Confidence 10 01111233468999999999999999999999987776543 2222211111 1 111111000000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.........+.+++.+|++.+|++||+|.++.+.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0001111223337789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=289.45 Aligned_cols=232 Identities=22% Similarity=0.227 Sum_probs=169.7
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|+++++.++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 468889999999999999987651 23457889999999999999999998854 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 899999999999999886432 2367899999999997 99999999999999999999999999998654
Q ss_pred cccCC-----------------------CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhc
Q 002376 794 ERVDN-----------------------QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESN 850 (929)
Q Consensus 794 ~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~ 850 (929)
..... ...........||+.|+|||++.+..++.++||||+|++++++..+..++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 32100 0000112345799999999999999999999999999999987766555433
Q ss_pred CCc--hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-HHHHHHH
Q 002376 851 LPE--NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-IREALRR 909 (929)
Q Consensus 851 ~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~ev~~~ 909 (929)
... ....+.........+ .... +...+.+++.+|+. ||++||+ ++|+++.
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p----~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQETYNKIINWKESLRFP----PDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHHHHHHHhccCCcccCC----CCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 221 111111100000000 0000 11222336669997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=280.63 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=171.7
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||++.... ..++|.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 467788999999999999987531 124678899999999999999999998643 34
Q ss_pred EEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++||||+++++|.++++.. ..++.+++.|++|||+. +++|+||||+||+++.++.+|++|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 89999999999999887521 12256899999999998 9999999999999999999999999998
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+...... .......|+..|+|||++.+..++.++||||+|++++++.....++........+... .+...
T Consensus 154 ~~~~~~~------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~--- 223 (267)
T cd08229 154 RFFSSKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQC--- 223 (267)
T ss_pred hccccCC------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcC---
Confidence 8653211 1122346899999999999889999999999998877765444333211111111111 11110
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
. ............+++++.+||+.||++||||.+|++.++++.
T Consensus 224 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 D--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 000011122333444777999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=299.82 Aligned_cols=242 Identities=19% Similarity=0.228 Sum_probs=173.6
Q ss_pred CCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccC-Cccccceee-ecccCCCCC-cceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVR-HRNLVKLIT-SCSSLDSKN-MEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~-Hpniv~l~~-~~~~~~~~~-~~~~ 722 (929)
++++.++|.+|||+.||.+...+ ..+...+||++|++++ |||||.+++ ........+ ..++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 44567899999999999987653 2456789999999997 999999999 443333333 4678
Q ss_pred EEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+|.||||++|+|-|++..+ .++..|+|+|+++||.. .++|||||||-+||||+.++..||||||-|.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999998732 24567999999999996 789999999999999999999999999987632
Q ss_pred ccccCCCCCc---cccceecccccccccccc---CCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 793 LERVDNQSSI---SSTHVFMGSIGYVPPEYG---LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 793 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
.......... ...-....|+.|+|||++ .+..+++|+|||++||++|.+..+..++..... ..+++....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIlng~Y~-- 272 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAILNGNYS-- 272 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEEecccc--
Confidence 1111000000 001122469999999975 567799999999999877765544444432211 122222211
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
++. .+. ....+++|+..||++||++||++.+|+..+-++...
T Consensus 273 ~P~----~p~----ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 273 FPP----FPN----YSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred CCC----Ccc----HHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 111 011 223334477799999999999999999998887654
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=278.68 Aligned_cols=229 Identities=24% Similarity=0.340 Sum_probs=166.5
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||+|++.+ ..++|.+|++++++++||||+++++++...+ ..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEEEE
Confidence 356778899999999999886531 2457899999999999999999999985433 379999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.+++.... .++.||+.|++|||+. +++||||||+||++++++.+||+|||.++......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 9999999999886422 2367899999999998 99999999999999999999999999988653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........++..|+|||++.+..++.++||||+|++++++.. ...++..... .+..+. +.... .....
T Consensus 155 ----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~-~~~~~---~~~~~- 223 (256)
T cd05113 155 ----YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEK-VSQGL---RLYRP- 223 (256)
T ss_pred ----eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH-HhcCC---CCCCC-
Confidence 011112245678999999998889999999999988877643 3333322221 111111 11100 00000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011122233777999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-31 Score=271.72 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=168.4
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCcc-ccceeeecccCCC-CCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRN-LVKLITSCSSLDS-KNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~~-~~~~~ 721 (929)
.|...++||+|+||+||+|+... ......+|+.++++++|+| ||++++++.+.+. .....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45556789999999999998761 2234579999999999999 9999999976542 22346
Q ss_pred EEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++|+||++ -+|.+++.... .+..|+++||+|||++ +|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 899999995 58888886433 2367999999999999 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc---------------
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE--------------- 853 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--------------- 853 (929)
+...-. ....+..++|..|+|||++.+. .|++..||||.||+..|+....-.+....+
T Consensus 168 ra~~ip------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 168 RAFSIP------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHhcCC------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 965311 1224456889999999999988 699999999999887665332221111111
Q ss_pred --hhhhccC-hHHHHhhcccchhhhhhhHHH----HHHHHHHhccccCCCCCCCCCHHHHHHH--HHhh
Q 002376 854 --NVLQVLD-PELRQLMTSNESQTIQLHDCL----ITIIGSVGLSCTTESPGGRIGIREALRR--LKSS 913 (929)
Q Consensus 854 --~~~~~~~-~~l~~~~~~~~~~~~~~~~~~----~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~ 913 (929)
.+..+.. ++....++.... .......+ ....+ ++.+|++.+|.+|.|++.++.. +.++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~-~~~l~~~~~~~~~~~~d-ll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPG-PKDLSSILPKLDPDGIE-LLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCC-ccchHHhccccCccHHH-HHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111110 000100000000 00001111 12333 7789999999999999999876 5554
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=298.76 Aligned_cols=171 Identities=21% Similarity=0.290 Sum_probs=140.9
Q ss_pred hCCCCCceeecccCceeEEeccccCc----------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS----------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~----------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
..+|...+.||+|+||.||++.+... ...+.+|++++++++|||||++++++... +..++||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEEcc
Confidence 45799999999999999999987632 23567899999999999999999998543 3479999999
Q ss_pred CCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCC
Q 002376 730 SNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 730 ~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 800 (929)
. |+|.+++... ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--- 315 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--- 315 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc---
Confidence 4 7888887532 23467899999999998 999999999999999999999999999986532111
Q ss_pred CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch
Q 002376 801 SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
........||+.|||||++.+..++.++||||+|+++|++.+
T Consensus 316 -~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~ 357 (461)
T PHA03211 316 -TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV 357 (461)
T ss_pred -cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHH
Confidence 111224579999999999999999999999999999888644
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=279.20 Aligned_cols=228 Identities=24% Similarity=0.290 Sum_probs=156.5
Q ss_pred eeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 667 NLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+.||+|+||.||+|+.. .....|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence 35899999999998532 01246888999999999999999999985433 3799999
Q ss_pred ecCCCCccccccccc-------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 728 FLSNGSLGDWIHGER-------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~-------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+++|+|.++++..+ ..+.|++.|++|||+. +++||||||+||++++++.+|++|||+++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999886321 2356899999999998 999999999999999999999999999875321
Q ss_pred ccCCCCCccccceeccccccccccccCCC-------CCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-------RPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
. ..........|+..|+|||++.+. .++.++||||+|++++++.. ...++..... .+.........
T Consensus 153 ~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~ 226 (269)
T cd05087 153 E----DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQ 226 (269)
T ss_pred c----ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcc
Confidence 1 001112234578899999998642 35889999999988777542 3333322211 01000000000
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
..... .+.......+.+.+++.+|| .+|++|||++||++.|+
T Consensus 227 ~~~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLP--KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCC--CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000 00000011222334777999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=279.66 Aligned_cols=232 Identities=23% Similarity=0.293 Sum_probs=168.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|.+.. ..+.|.+|++++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----C
Confidence 467788999999999999996431 124678899999999 899999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 721 FLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
..|+||||+++|+|.++++..+ .++.|++.|++|||+. +|+||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence 4899999999999999886321 2356899999999998 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~ 855 (929)
+++.+||+|||+++..... .......++..|+|||++.+..++.++||||+|++++++.+ ...++.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 229 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 229 (303)
T ss_pred CCCcEEeCccccCcccchh-------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--
Confidence 9999999999998642111 01111234678999999988889999999999988887653 3322211111
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.+ .......... ...+......+.+++.+||+.+|++||+++++++.++++.+.
T Consensus 230 ~~-----~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 230 AE-----LYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HH-----HHHHHhcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111111000 000001112233478899999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=282.60 Aligned_cols=225 Identities=25% Similarity=0.306 Sum_probs=164.4
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+|+..++||+|+||+||++.... ..+.+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence 47778999999999999987541 113467899999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||||+++|+|.+++.... .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 99999999999998875321 2357899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
... .......|++.|||||++.+..++.++||||+|+++|++..+..++..... ...+.+...+.. ..
T Consensus 153 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~ 221 (285)
T cd05605 153 PEG-------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQ 221 (285)
T ss_pred CCC-------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----cc
Confidence 311 111234789999999999998999999999999887776554443332211 000111111111 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
...+..+...+++++.+||+.||++|| +++++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011112233344477899999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-31 Score=287.38 Aligned_cols=174 Identities=25% Similarity=0.334 Sum_probs=139.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|+... ....+.+|+.+++.++||||+++++++.+. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeE
Confidence 4689999999999999999987641 123577899999999999999999998543 358
Q ss_pred EEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++||||++ ++|.+++... +.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99999995 6787776532 23367899999999998 99999999999999999999999999987542
Q ss_pred cccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.. ........||+.|||||++.+. .++.++||||+|++++++..+..++
T Consensus 155 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 204 (303)
T cd07869 155 VP------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204 (303)
T ss_pred CC------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 11 0112234689999999998764 5789999999998888765554444
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=292.57 Aligned_cols=238 Identities=20% Similarity=0.252 Sum_probs=169.0
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
..++....++|+..+.||+|+||.||+++... ..+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44556667899999999999999999887651 12346789999999999999999999853
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
....++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 -----~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 -----DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 345899999999999999886432 3367899999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC----CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER----PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPE 862 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (929)
|+++.+... ........+||+.|||||++.+.. ++.++||||+|+++|++..+..++..... ....
T Consensus 187 G~a~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~--- 256 (371)
T cd05622 187 GTCMKMNKE-----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTY--- 256 (371)
T ss_pred CceeEcCcC-----CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--HHHH---
Confidence 999865321 111123457999999999987543 78999999999888887655544432221 1111
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCC--CCCHHHHHHH
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGG--RIGIREALRR 909 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~~ 909 (929)
.................+...+++++.+|+..++.+ ||+++|+.+.
T Consensus 257 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 -SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111100000000000112233344777999743433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-31 Score=284.66 Aligned_cols=171 Identities=26% Similarity=0.371 Sum_probs=138.0
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...++||+|+||.||+|+... ....+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEE
Confidence 578889999999999999986541 13467799999999999999999999854 33589
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9999997 58988775322 2357899999999998 999999999999999999999999999975421
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
. ........|++.|+|||++.+ ..++.++||||+|++++++.+...
T Consensus 156 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 156 P------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred C------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 1 111223468999999998876 468999999999988887655543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=284.51 Aligned_cols=234 Identities=19% Similarity=0.255 Sum_probs=169.0
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
..++|+..+.||+|+||.||+|..+ .....+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4568899999999999999987432 01235778999999999999999999985433
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++++
T Consensus 83 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 83 ----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred ----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 3799999999999999986321 2356899999999998 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
+.+|++|||+++....... ........++..|+|||.+.+..++.++||||+|++++++.. ...++.... ..
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--~~- 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--NE- 228 (288)
T ss_pred CcEEECcCCcccccccccc----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--HH-
Confidence 9999999999986532111 011122345778999999999899999999999988877543 222221111 11
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
............ ...+.....+++++.+|++.||++||||.|+++.+++.
T Consensus 229 ----~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 ----QVLKFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111000000 00011122334477899999999999999999888874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-31 Score=281.75 Aligned_cols=233 Identities=24% Similarity=0.331 Sum_probs=171.1
Q ss_pred HhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++.++|+..+.||+|+||.||+|.... ..+++.+|+++++.++||||+++++++...+ ..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----PV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----Ce
Confidence 445678888999999999999987642 2457889999999999999999999985433 47
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||||+++|+|.++++... .++.+++.|++|||+. +|+||||||+||++++++.+||+|||.++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999986422 2356899999999998 8999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... .......++..|+|||++.+..++.++||||+|++++++.. ...++..... .+.++..... . ..
T Consensus 155 ~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~-~--~~ 223 (261)
T cd05148 155 KEDV------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAG-Y--RM 223 (261)
T ss_pred CCcc------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhC-C--cC
Confidence 3211 11112345778999999988899999999999987776533 2222221111 1111111110 0 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.... . ....+.+++.+||+.||++|||++++++.|+.+
T Consensus 224 ~~~~---~-~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPA---K-CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCC---C-CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011 1 112233488899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=299.43 Aligned_cols=226 Identities=21% Similarity=0.219 Sum_probs=166.0
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.|...+.||+|+||.||++.... ....+.+|+.+++.++|||||++++++... ...|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence 48888999999999999876431 123567899999999999999999998543 35899
Q ss_pred EEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
||||+++|+|.++++.. ..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999877531 12356899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.... ........+||++|||||++.+..++.++||||+|++++++.....++.... ..+++......... .
T Consensus 220 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~---~ 290 (478)
T PTZ00267 220 SDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLYGKYD---P 290 (478)
T ss_pred CCcc----ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC---C
Confidence 3211 1112234579999999999999999999999999988777655443332111 11111111111100 0
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... +..-+++++.+||+.||++||++++++.
T Consensus 291 ~~~~----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCP----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCcc----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0011 1122333777999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=281.37 Aligned_cols=231 Identities=25% Similarity=0.352 Sum_probs=167.6
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|...+.||+|+||.||+|.... ..+.|.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence 457778999999999999986420 235788999999999999999999998654
Q ss_pred cceEEEEEEecCCCCccccccccc----------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER----------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
...++||||+++|+|.++++... .+..+++.|++|||+. +++||||||+||+++
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~ 156 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG 156 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence 34899999999999999986321 1256899999999998 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~ 855 (929)
.++.+|++|||+++....... ........+++.|+|||++.+..++.++||||+|++++++.. ...++.... .
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~ 230 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--N 230 (280)
T ss_pred CCCeEEECCcccceecccCcc----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 999999999999975422110 011122346788999999999999999999999988777543 222221111 1
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+.++........ ... ......+.+++.+||+.||++||++.||+++|++
T Consensus 231 ~~~~~~~~~~~~~---~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 EEVIECITQGRLL---QRP----RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHHHcCCcC---CCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111110000000 000 1112223347789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=284.93 Aligned_cols=213 Identities=24% Similarity=0.262 Sum_probs=155.4
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+++... ..+.+..|..++... +||||+++++++.. ....|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 469999999999987641 123466788888876 69999999999854 33589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--- 149 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--- 149 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence 9999999998886433 2367899999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........||+.|||||++.+..++.++||||+|+++|++..+..++..... .++. .............
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~----~~i~~~~~~~~~~-- 218 (320)
T cd05590 150 ---GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLF----EAILNDEVVYPTW-- 218 (320)
T ss_pred ---CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHH----HHHhcCCCCCCCC--
Confidence 1122345799999999999999999999999999888776555444432221 1111 1111111110111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
+..-+.+++.+|++.||++||++
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 --LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCHHHHHHHHHHcccCHHHCCCC
Confidence 12222347779999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=284.32 Aligned_cols=218 Identities=25% Similarity=0.271 Sum_probs=158.5
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||+||+|+... ..+.+..|.+++..+ +||||+++++++... ...|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 369999999999987641 123466788888866 799999999998543 3489999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--- 149 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--- 149 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC---
Confidence 9999999998876433 2367899999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........||+.|||||++.+..++.++||||+|++++++..+..++..... .+.. ...............
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~----~~i~~~~~~~p~~~~ 220 (321)
T cd05591 150 ---GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLF----ESILHDDVLYPVWLS 220 (321)
T ss_pred ---CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCCCCCCC
Confidence 1112345799999999999999999999999999988887665544432221 1111 111111111111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCC-------CHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRI-------GIREALR 908 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RP-------s~~ev~~ 908 (929)
. -+.+++.+|++.||++|| ++.++++
T Consensus 221 ~----~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 K----EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred H----HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 2 222377799999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=284.73 Aligned_cols=224 Identities=25% Similarity=0.284 Sum_probs=159.3
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||+||+++... ..+.+.+|..++.++ +||||+++++++... ...|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 469999999999887641 123467899999888 799999999998543 3589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 148 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---- 148 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc----
Confidence 9999999988875332 3367899999999998 999999999999999999999999999874211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhhccChHHHHhhcccchhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........+||+.|||||++.+..++.++||||+|+++|++..+..++..... . ..+.....+........ ..
T Consensus 149 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 223 (329)
T cd05588 149 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---IR 223 (329)
T ss_pred --CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---CC
Confidence 11122345799999999999999999999999999888887655554432111 0 00000011111111110 01
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCC------HHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIG------IREAL 907 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs------~~ev~ 907 (929)
.+..+..-+.+++.+|++.||++||+ ++|++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11112222334777999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=274.01 Aligned_cols=231 Identities=19% Similarity=0.269 Sum_probs=169.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..++||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEE
Confidence 467888999999999999987531 245788999999999999999999988543 3379999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|+|.++++... .++.+++.|++|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999886321 2356899999999997 99999999999999999999999999998653211
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
........++..|+|||++.+..++.++||||+|++++++.. ...++..... .+ ....+..... .....
T Consensus 158 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~-~~~~~~~~~~--~~~~~ 227 (261)
T cd05072 158 -----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SD-VMSALQRGYR--MPRME 227 (261)
T ss_pred -----eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HH-HHHHHHcCCC--CCCCC
Confidence 011122346778999999998899999999999988777553 3322221111 00 0011111000 00000
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
. .+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 228 ~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 N----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 112233377799999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=283.30 Aligned_cols=215 Identities=23% Similarity=0.319 Sum_probs=154.4
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHc-cCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRN-VRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||+||+|+... ..+.+..|..++.. .+||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 369999999999987642 12234556666665 489999999998853 34589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--- 149 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--- 149 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---
Confidence 9999999998886432 2467899999999998 9999999999999999999999999999754211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++..... .++... +.. .... .+
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~-i~~---~~~~----~~ 216 (316)
T cd05592 150 ---EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDS-ILN---DRPH----FP 216 (316)
T ss_pred ---CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHc---CCCC----CC
Confidence 1122345799999999999999999999999999888776555444332211 111110 110 0000 01
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIRE 905 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~e 905 (929)
..+..-+.+++.+||+.||++||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 111222334777999999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=279.11 Aligned_cols=231 Identities=21% Similarity=0.287 Sum_probs=168.2
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|...+.||+|+||.||+|.... ....|.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---- 81 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC----
Confidence 467888999999999999876431 124678999999999999999999998653
Q ss_pred cceEEEEEEecCCCCccccccccc------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT 780 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 780 (929)
...++||||+++|+|.+++.... .++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence 34799999999999999885321 2356899999999987 9999999999999999999
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhcc
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVL 859 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 859 (929)
+||+|||+++.+..... ........++..|+|||.+.+..++.++||||+|++++++.. ...++..... .+
T Consensus 158 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~-- 229 (277)
T cd05032 158 VKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EE-- 229 (277)
T ss_pred EEECCcccchhhccCcc----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HH--
Confidence 99999999986532211 011122356789999999988889999999999998887653 3322221111 11
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
........... ..+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 230 ---~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 230 ---VLKFVIDGGHL--DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111100000 0001112223348889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=281.62 Aligned_cols=235 Identities=22% Similarity=0.282 Sum_probs=170.2
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..++||+|+||.||+|++. ...+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 46788899999999999998642 1134677899999999999999999998542
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..+++|||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 2589999999999999986432 2367999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.+...... .......+++.|||||...+..++.++||||+|++++++.. ...++...+. ..+......
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~ 226 (279)
T cd05109 158 LLDIDETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEK 226 (279)
T ss_pred ecccccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHC
Confidence 76321110 01112235678999999998899999999999988777533 2222221111 111111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
..... ....+...+. +++.+||+.||++||++.|+++.|+++.+..
T Consensus 227 ~~~~~-~~~~~~~~~~-~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 227 GERLP-QPPICTIDVY-MIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCcCC-CCccCCHHHH-HHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 10000 0011122233 3788999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=285.47 Aligned_cols=225 Identities=25% Similarity=0.294 Sum_probs=172.7
Q ss_pred CCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 664 SHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
...++||+|.||+|++|.|+ ....+|.+|+.+|.+++|||+|++||+..+. -..
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhh
Confidence 34578999999999999887 1356899999999999999999999998652 268
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
||||.++.|+|.+.|++.. .++.|||.||+||.++ +.||||+.++|+|+-..-.+||+|||+.|.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999998632 2367999999999998 89999999999999998999999999999886
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
...+.- .......-.+.|.|||.++.++++.++|||+||+.+|||.. ++.+|...+. .+-+.+|..-+ +
T Consensus 264 ~ned~Y---vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--L---- 334 (1039)
T KOG0199|consen 264 ENEDMY---VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--L---- 334 (1039)
T ss_pred CCCcce---EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--C----
Confidence 542221 11122234678999999999999999999999999988633 2333333322 23333442111 1
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
.....|-..++. ++..||..+|++|||+.++.+.+
T Consensus 335 ---pRPk~csedIY~-imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 ---PRPKYCSEDIYQ-IMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---CCCCCChHHHHH-HHHHhccCCccccccHHHHHHhH
Confidence 111234455555 99999999999999999997543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=285.12 Aligned_cols=222 Identities=25% Similarity=0.284 Sum_probs=158.2
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHH---HccCCccccceeeecccCCCCCcc
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETL---RNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l---~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
|+..+.||+|+||.||++.... ..+.+.+|++++ +.++||||+++++++... .
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence 5667899999999999987541 123455666554 567899999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
..|+||||+++|+|..+++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 5899999999999988876422 3467899999999998 99999999999999999999999999987432
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......+||+.|||||++.+..++.++||||+|+++|++..+..++..... .+..+. +. ......
T Consensus 153 ~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~~~~~-i~---~~~~~~ 220 (324)
T cd05589 153 GF------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVFDS-IV---NDEVRY 220 (324)
T ss_pred CC------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHH-HH---hCCCCC
Confidence 11 1112345799999999999999999999999999888776554444322211 111111 11 111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
... +...+.+++.+|++.||++||+ +.++++
T Consensus 221 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 PRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 1222233777999999999995 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=284.71 Aligned_cols=237 Identities=21% Similarity=0.336 Sum_probs=168.0
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||+||+|.+. ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 357888999999999999998631 0124577899999999 6899999999885432
Q ss_pred CCcceEEEEEEecCCCCccccccccc------------------------------------------------------
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER------------------------------------------------------ 742 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------ 742 (929)
...++||||+++|+|.++++..+
T Consensus 85 ---~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 85 ---GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred ---CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 24799999999999998875321
Q ss_pred ---------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 743 ---------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 743 ---------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc----
Confidence 1245899999999998 999999999999999999999999999986532111
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 881 (929)
........+++.|+|||++.+..++.++||||+|++++++.. .+..|..... .+............. ..+...
T Consensus 235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~----~g~~p~~~~~-~~~~~~~~~~~~~~~--~~~~~~ 307 (343)
T cd05103 235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK-IDEEFCRRLKEGTRM--RAPDYT 307 (343)
T ss_pred hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH----CCCCCCCCcc-ccHHHHHHHhccCCC--CCCCCC
Confidence 011112345678999999999899999999999987776432 1222211000 011111111111000 000111
Q ss_pred -HHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 882 -ITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 882 -~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
.++.+ ++.+||+.||++||++.|+++.|+.+.+
T Consensus 308 ~~~~~~-~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQ-TMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHH-HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23334 8889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=292.68 Aligned_cols=180 Identities=23% Similarity=0.279 Sum_probs=142.9
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.|+..++||+|+||.||+|+... ..+.+.+|+.++++++|||||++++++.+. ...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence 57888999999999999987641 123577899999999999999999998543 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+|||||++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999999886432 2356899999999998 999999999999999999999999999864311
Q ss_pred ccCC-----------------------------------------CCCccccceeccccccccccccCCCCCCCCCCCCC
Q 002376 795 RVDN-----------------------------------------QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT 833 (929)
Q Consensus 795 ~~~~-----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s 833 (929)
.... ..........+||+.|||||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0000 00000112357999999999999999999999999
Q ss_pred CcCCCCCcchhHHhhh
Q 002376 834 SESFAGEFNIVKWVES 849 (929)
Q Consensus 834 ~g~~~~~~~~~~~~~~ 849 (929)
+||++|++.++..++.
T Consensus 234 lGvil~elltG~~Pf~ 249 (382)
T cd05625 234 VGVILYEMLVGQPPFL 249 (382)
T ss_pred chHHHHHHHhCCCCCC
Confidence 9998888766554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=283.16 Aligned_cols=214 Identities=27% Similarity=0.300 Sum_probs=154.7
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHH-HHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECE-TLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+|+... ..+.+.+|.. +++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 469999999999987651 1123444544 4678999999999998854 33589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 9999999998876432 2467999999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........||+.|||||++.+..++.++||||+|++++++.....++.... ..+..+..... .........
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~----~~~~~~~~~ 220 (323)
T cd05575 150 ---SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILNK----PLRLKPNIS 220 (323)
T ss_pred ---CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--HHHHHHHHHcC----CCCCCCCCC
Confidence 112234579999999999999999999999999999888765544432221 11111111111 111111112
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIR 904 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ 904 (929)
. .+.+++.+|++.||++||+++
T Consensus 221 ~----~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 V----SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred H----HHHHHHHHHhhcCHHhCCCCC
Confidence 2 233367799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=285.35 Aligned_cols=238 Identities=20% Similarity=0.314 Sum_probs=171.4
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|...+.||+|+||.||+++.. ...+++.+|+.+++++ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999987531 1123577899999999 799999999998543
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+ ..|+||||+++|+|.+++...+ .++.|++.||+|||+. +++||||||
T Consensus 97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 3 4899999999999999986432 1256899999999987 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+||++++++.+||+|||.++....... ........+++.|||||++.+..++.++||||+|++++++.. ...++.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccch----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999876532110 011112234578999999999899999999999987777543 222221
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
..+ ..+ +........ ....+......+.+++.+||+.+|++||+|.||++.|+++.+...
T Consensus 245 ~~~--~~~-----~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 245 GVP--VEE-----LFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred cCC--HHH-----HHHHHHcCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 111 111 111111111 001111122233348889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=279.78 Aligned_cols=235 Identities=22% Similarity=0.278 Sum_probs=170.6
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCC-c
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKN-M 719 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~-~ 719 (929)
+.+++.|+..+.||+|+||.||+|.... ....+.+|+.+++++ +||||+++++++...+... .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3467788889999999999999987641 245788999999998 7999999999987643322 3
Q ss_pred ceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
...|+||||+++|+|.+++...+ .++.|++.|++|||+. +|+|||+||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999887422 1356899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
+...... .......|++.|+|||++. +..++.++||||+|++++++.....++......... ..
T Consensus 159 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~ 227 (272)
T cd06637 159 AQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FL 227 (272)
T ss_pred eeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HH
Confidence 8653211 1123457899999999986 345889999999998888766555444322210000 00
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............. .+..+.+++.+||+.+|++|||++|+++
T Consensus 228 --~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 --IPRNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --HhcCCCCCCCCCC-cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000000001 1122334778999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=275.68 Aligned_cols=229 Identities=24% Similarity=0.314 Sum_probs=167.4
Q ss_pred CCCCCceeecccCceeEEecccc------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
++|+..+.||+|+||.||++... ...+.|.+|+.++++++|||++++++++...+ ...++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEEEEC
Confidence 36778899999999999988654 23457889999999999999999999875432 347999999
Q ss_pred cCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 729 LSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 729 ~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
+++|+|.++++... .++.+++.||+|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 99999999886432 2356899999999998 9999999999999999999999999998754211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.....++..|+|||++.+..++.++||||+|++++++.. .+..|..... ...+.......... ...
T Consensus 156 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~----~g~~p~~~~~--~~~~~~~~~~~~~~--~~~ 221 (256)
T cd05082 156 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----FGRVPYPRIP--LKDVVPRVEKGYKM--DAP 221 (256)
T ss_pred ------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh----CCCCCCCCCC--HHHHHHHHhcCCCC--CCC
Confidence 112244678999999998899999999999987776532 1222211000 00111111111000 011
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+.....+.+++.+|++.+|++|||+++++++|+++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11222334478899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=283.88 Aligned_cols=219 Identities=26% Similarity=0.306 Sum_probs=156.5
Q ss_pred eeecccCceeEEeccccCc-------------------HHHHHHHHH-HHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTGS-------------------WKSFIAECE-TLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||++++... .+.+.+|.. +++.++||||+++++++... ...|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 3699999999999876511 123334443 46778999999999988543 3489999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--- 149 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--- 149 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence 9999999998886432 2467999999999998 9999999999999999999999999999753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|||||++.+..++.++||||+|++++++.....++..... .+..+..... .........
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~----~~~~~~~~~ 220 (325)
T cd05602 150 ---NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNK----PLQLKPNIT 220 (325)
T ss_pred ---CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHhC----CcCCCCCCC
Confidence 1122345799999999999999999999999999988887655444332211 1111111111 111111122
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.. +++++.+|++.||.+||++.+.+..
T Consensus 221 ~~----~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 221 NS----ARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HH----HHHHHHHHcccCHHHCCCCCCCHHH
Confidence 22 3336669999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=279.34 Aligned_cols=224 Identities=24% Similarity=0.299 Sum_probs=160.8
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+|...+ ..+.+.+|+++++++ +||||+++++++... ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence 368999999999986431 124677899999999 899999999998543 3479999
Q ss_pred EecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 727 EFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
||+++|+|.++++..+ .++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 9999999999886422 2356899999999997 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccCh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDP 861 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~ 861 (929)
++|||+++..... ........+..|+|||++.+..++.++||||+|++++++.. ...++..... .
T Consensus 153 l~dfgl~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~ 218 (270)
T cd05047 153 IADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------A 218 (270)
T ss_pred ECCCCCccccchh-------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------H
Confidence 9999998632110 00111234667999999988899999999999988777542 2222211111 1
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
........... .+........+.+++.+||+.+|.+||++.|++++|+++.
T Consensus 219 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111111000 0000011122334888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.26 Aligned_cols=230 Identities=21% Similarity=0.311 Sum_probs=168.1
Q ss_pred CCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+|+..+.||+|+||.||+|.... ..+++.+|++++++++||||+++++++...+ ..++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 81 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYIIT 81 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEEEE
Confidence 46777899999999999987541 2457889999999999999999999986433 379999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|+|.+++.... .++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999999886322 2357899999999998 99999999999999999999999999998653211
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......++..|+|||++.+..++.++||||+|++++++.. ...++... ...+..+ .+..... .
T Consensus 159 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~~~~~~~-~~~~~~~------~ 224 (263)
T cd05052 159 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYE-LLEKGYR------M 224 (263)
T ss_pred e-----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHH-HHHCCCC------C
Confidence 1 11111234678999999999999999999999988777543 22222111 1111110 1111000 0
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
..++..+..+.+++.+||+.||++||+|.|++++|+++
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111222333477899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=300.29 Aligned_cols=179 Identities=26% Similarity=0.345 Sum_probs=137.8
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCC---CCcceEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS---KNMEFLA 723 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---~~~~~~~ 723 (929)
..++|+..+.||+|+||.||+|.... ......+|+.+++.++|||||++++++..... ....+++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 34679999999999999999987642 12345679999999999999999988754321 1223578
Q ss_pred EEEEecCCCCccccccc------------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecccccc
Q 002376 724 LVYEFLSNGSLGDWIHG------------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLAR 790 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~ 790 (929)
+||||+++ ++.+++.. .+.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999974 67666531 122356999999999998 999999999999999665 79999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.+... .......||+.|||||++.+. .++.++||||+|++++++.++..++
T Consensus 220 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 220 NLLAG-------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred hccCC-------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 65321 112234789999999998764 6899999999999888876554433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=298.16 Aligned_cols=239 Identities=22% Similarity=0.271 Sum_probs=173.4
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
.+.+...++|...+.||+|+||+||+++... ....+.+|+..+..++|+|++++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3445566899999999999999999987531 1346778999999999999999988775433
Q ss_pred CC---CcceEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc
Q 002376 716 SK---NMEFLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT 780 (929)
Q Consensus 716 ~~---~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 780 (929)
.. ....+++||||+++|+|.++++... .++.|++.||+|+|+. +|+||||||+|||+++++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 21 1224689999999999999886321 2357899999999998 9999999999999999999
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccC
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLD 860 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (929)
+||+|||+++.+..... .......+||+.|||||++.+..++.++||||+|+++|++.....++... ...++++
T Consensus 182 vkL~DFGls~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--~~~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVS----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--NMEEVMH 255 (496)
T ss_pred EEEEecccCeecccccc----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--CHHHHHH
Confidence 99999999986532211 11123457999999999999999999999999998877765444333211 1122222
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......... .. .....-+.+++.+||+.||++||++.++++
T Consensus 256 ~~~~~~~~~---~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLAGRYDP---LP----PSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhcCCCCC---CC----CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 211111100 01 111222334777999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=282.65 Aligned_cols=219 Identities=29% Similarity=0.290 Sum_probs=156.6
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHH-HHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECE-TLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+++... ..+.+.+|.. +++.++||||+++++++... ...|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence 469999999999987541 1233445554 46779999999999988543 3589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 149 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--- 149 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence 9999999988876432 3467899999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++.... ..+..+..... .....+...
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~~~~~----~~~~~~~~~ 220 (325)
T cd05604 150 ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--VAEMYDNILHK----PLVLRPGAS 220 (325)
T ss_pred ---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--HHHHHHHHHcC----CccCCCCCC
Confidence 112234579999999999999999999999999999998765544432211 11111111111 111111111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... .+++.+|++.+|++||++++.++.
T Consensus 221 ~~~----~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 221 LTA----WSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHH----HHHHHHHhccCHHhcCCCCCCHHH
Confidence 222 236679999999999988654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=288.62 Aligned_cols=178 Identities=26% Similarity=0.296 Sum_probs=141.7
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4689999999999999999986541 23467789999999999999999999864332 1223
Q ss_pred eEEEEEEecCCCCccccccc------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHG------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
..|+||||+++ ++.+.++. ...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 47999999965 56555432 123467999999999998 999999999999999999999999999975421
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. .......||+.|+|||++.+..++.++||||+|+++|++.....++
T Consensus 176 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 176 N-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred C-------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 1 1123347899999999999999999999999999888876555444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=275.92 Aligned_cols=225 Identities=22% Similarity=0.295 Sum_probs=160.3
Q ss_pred eeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 667 NLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
+.||+|+||.||+|.... ....|.+|++++++++||||++++++|.... ..++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence 368999999999986531 1346889999999999999999999986533 479999999
Q ss_pred CCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCC
Q 002376 730 SNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 730 ~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 800 (929)
++++|.++++... ....|++.||+|||+. +|+||||||+||++++++.+|++|||+++.......
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 149 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--- 149 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc---
Confidence 9999999986322 2356899999999998 899999999999999999999999999875432110
Q ss_pred CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 801 SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
........++..|+|||++.++.++.++||||+|++++++.. ...++..... ............ ...++
T Consensus 150 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~~~--~~~~~ 219 (252)
T cd05084 150 -ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQGVR--LPCPE 219 (252)
T ss_pred -cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcCCC--CCCcc
Confidence 000011123567999999999999999999999988777543 2222211111 011111100000 00111
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
..+..+.+++.+|++.+|++||++.|+.++|++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 112223348889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=274.59 Aligned_cols=234 Identities=20% Similarity=0.277 Sum_probs=166.0
Q ss_pred CCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcceE
Q 002376 664 SHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFL 722 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~ 722 (929)
...+.||+|+||.||+|+... ..+.|.+|+++++.++||||++++++|..... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999986431 13468889999999999999999998865332 122347
Q ss_pred EEEEEecCCCCcccccccc--------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
++||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998876311 12356899999999997 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
++.+..... ........+++.|+|||+..+..++.++||||+|++++++.. ...++.... +..+....
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~ 227 (272)
T cd05075 159 SKKIYNGDY----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-------NSEIYDYL 227 (272)
T ss_pred ccccCcccc----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHH
Confidence 986532111 011122346778999999999999999999999988777543 222221111 11111111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
...... .........+++++.+||+.||++|||+.|+++.|+++
T Consensus 228 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111100 00011122234488899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=280.56 Aligned_cols=233 Identities=21% Similarity=0.267 Sum_probs=166.5
Q ss_pred hhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
++++|+..+.||+|+||.||+|.... ....|.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 34678889999999999999886642 1246889999999999999999999886543
Q ss_pred CCcceEEEEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC--
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-- 779 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-- 779 (929)
..++||||+++|+|.++++..+ .++.||+.|++|||+. +++||||||+||++++++
T Consensus 83 ----~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 83 ----PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred ----CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 3699999999999999886432 2356899999999998 899999999999998755
Q ss_pred -ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 780 -TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 780 -~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
.+|++|||+++.+..... ........++..|||||++.+..++.++||||+|++++++.. ...++.... ..+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~ 229 (277)
T cd05036 156 RVAKIADFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQE 229 (277)
T ss_pred cceEeccCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence 699999999986532110 000111234568999999999999999999999988777542 322222111 111
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
..+. +... ....... .+...+. +++.+|++.+|++||++.||++.|++
T Consensus 230 ~~~~-~~~~--~~~~~~~---~~~~~~~-~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 230 VMEF-VTGG--GRLDPPK---GCPGPVY-RIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHH-HHcC--CcCCCCC---CCCHHHH-HHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111 1000 0000011 1112233 37889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=278.58 Aligned_cols=233 Identities=21% Similarity=0.312 Sum_probs=168.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|++++++++|||++++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK----- 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-----
Confidence 467788999999999999886531 1346889999999999999999999985433
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.++++... .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 4799999999999999886421 2357899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
........ ........+..|+|||++.+..++.++||||+|++++++.+ ...++..... ..........
T Consensus 157 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~ 226 (268)
T cd05063 157 LEDDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDG 226 (268)
T ss_pred cccccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcC
Confidence 53221110 11111233567999999998889999999999988777543 2322211111 1111111100
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
. ..+...++...+. +++.+||+.+|++||+|.+|++.|+++
T Consensus 227 ~-~~~~~~~~~~~~~-~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 F-RLPAPMDCPSAVY-QLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-CCCCCCCCCHHHH-HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0000111222333 488899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=280.48 Aligned_cols=220 Identities=25% Similarity=0.293 Sum_probs=157.2
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||+||++.... ..+.+..|++++++++||||+++.+++... ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence 6999999999886541 123567899999999999999999988543 3489999999
Q ss_pred CCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 730 SNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 730 ~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
++|+|.+++... ..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 151 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ- 151 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-
Confidence 999998776321 12357899999999998 99999999999999999999999999997653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......||+.|+|||++.+..++.++||||+|+++|++.....++....... ............. ...
T Consensus 152 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~---~~~ 220 (280)
T cd05608 152 -----SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILNDS---VTY 220 (280)
T ss_pred -----ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcccC---CCC
Confidence 11233578999999999999999999999999988777655444433221100 0011111110000 001
Q ss_pred hHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
+..++..+++++.+|++.||++|| +++|+++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 111222333477799999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=270.97 Aligned_cols=222 Identities=25% Similarity=0.272 Sum_probs=171.5
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.+.|+..++||+|+||+||.++... ......+|..++.+++.|.||.+...|.+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd----- 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD----- 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence 3467888999999999999776542 2234557999999999999999988885544
Q ss_pred eEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
.+++|+..|.||+|.-+|... +.++.+|+.||++||+. +||.||+||+|||+|++|+++|+|.|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEE
Confidence 499999999999999988733 24578999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh-ccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ-VLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~ 869 (929)
.+.+.. .....+||.||||||++.++.|+...|=|++||.+|+|.-++-++....+.+.. -+|.++...
T Consensus 336 ei~~g~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--- 405 (591)
T KOG0986|consen 336 EIPEGK-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--- 405 (591)
T ss_pred ecCCCC-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc---
Confidence 775431 123348999999999999999999999999999888876666666665553322 344444321
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
. ...++..++-.+++...-++.||++|--.
T Consensus 406 ~----~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 P----EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred h----hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1 11223344445556668999999999643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=282.63 Aligned_cols=172 Identities=25% Similarity=0.342 Sum_probs=133.5
Q ss_pred ceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
.++||+|+||+||+|+... ....+.+|++++++++||||+++++++... .....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 4689999999999987431 134678999999999999999999988643 234589999999
Q ss_pred CCCCcccccccc-----------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee----cCCCceEEecccc
Q 002376 730 SNGSLGDWIHGE-----------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDFGL 788 (929)
Q Consensus 730 ~~gsL~~~l~~~-----------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DfGl 788 (929)
+ ++|.+++... +.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 5777765411 23467999999999998 99999999999999 4667999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
|+....... .........||+.|||||++.+. .++.++||||+|++++++....-+
T Consensus 159 a~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 159 ARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eeccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 986532211 11122345789999999998774 589999999999988876555433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=282.59 Aligned_cols=218 Identities=23% Similarity=0.281 Sum_probs=158.6
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+|+..+.||+|+||+||+|+... ..+.+..|..++..+ +||+|+++++++.+. ..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 47788999999999999987652 123456788888777 589999999988543 35
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 899999999999998875432 3467899999999998 99999999999999999999999999987532
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......+||+.|||||++.+..++.++||||+|++++++.++..++..... .+.... +. ......
T Consensus 153 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~-i~---~~~~~~ 220 (323)
T cd05616 153 WD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS-IM---EHNVAY 220 (323)
T ss_pred CC------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHH-HH---hCCCCC
Confidence 11 1122345799999999999999999999999999888886655444432221 111111 11 111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
... +..-+.+++.+|++.||++|+++
T Consensus 221 p~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 111 11222337779999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=283.05 Aligned_cols=218 Identities=25% Similarity=0.292 Sum_probs=158.7
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCc-cccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHR-NLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hp-niv~l~~~~~~~~~~~~~~ 721 (929)
+|+..+.||+|+||.||+|+... ..+.+..|+++++.++|+ +|+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 47788999999999999987652 134567899999999765 57788888743 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 899999999999998886432 2367899999999998 99999999999999999999999999987431
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. ........+||+.|+|||++.+..++.++||||+|++++++.++..++..... .+. ...........
T Consensus 153 ~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~----~~~i~~~~~~~ 220 (324)
T cd05587 153 F------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DEL----FQSIMEHNVSY 220 (324)
T ss_pred C------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHH----HHHHHcCCCCC
Confidence 1 11122345799999999999999999999999999888887655444432221 010 11111111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
. ..+..-+.+++.+|++.||++||+.
T Consensus 221 ~----~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 P----KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 1112222337779999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=285.59 Aligned_cols=181 Identities=24% Similarity=0.268 Sum_probs=145.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+++... ..+.+.+|+.++..++||+|+++++++.+ ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 468889999999999999987641 12456789999999999999999998854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 899999999999999986433 2367899999999998 99999999999999999999999999987553
Q ss_pred cccCCC-----------------------------CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh
Q 002376 794 ERVDNQ-----------------------------SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 794 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
...... .........+||+.|||||++.+..++.++||||+|+++|++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 211000 000011235799999999999999999999999999999998776
Q ss_pred HHhhh
Q 002376 845 KWVES 849 (929)
Q Consensus 845 ~~~~~ 849 (929)
..++.
T Consensus 233 ~~Pf~ 237 (360)
T cd05627 233 YPPFC 237 (360)
T ss_pred CCCCC
Confidence 65553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=277.09 Aligned_cols=227 Identities=26% Similarity=0.377 Sum_probs=164.7
Q ss_pred CCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
+|+..+.||+|+||.||++++.. ....|.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEEEe
Confidence 46677899999999999886541 235788999999999999999999998543 34799999
Q ss_pred ecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 728 FLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
|+++++|.++++... .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-- 154 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-- 154 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc--
Confidence 999999999886322 2367899999999998 89999999999999999999999999998653210
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........++..|+|||++.+..++.++||||+|++++++.. ...++..... .+.. ..+..... ...
T Consensus 155 ---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~-~~~~~~~~------~~~ 222 (256)
T cd05059 155 ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVV-ESVSAGYR------LYR 222 (256)
T ss_pred ---ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHH-HHHHcCCc------CCC
Confidence 011111234568999999999999999999999988777543 2333322211 1100 11111000 000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
+...+..+.+++.+||+.+|++||||.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011122233488899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=276.51 Aligned_cols=227 Identities=23% Similarity=0.277 Sum_probs=155.2
Q ss_pred eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 668 LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.||+|+||+||+|+.. ...+.|.+|+.+++.++||||++++++|.... ..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEec
Confidence 5899999999987532 12357889999999999999999999986533 37999999
Q ss_pred cCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 729 LSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
+++|+|.+++++.. .++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~- 152 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE- 152 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcc-
Confidence 99999999886421 2356899999999997 8999999999999999999999999998642111
Q ss_pred CCCCCccccceeccccccccccccCC-------CCCCCCCCCCCCcCCCCCcchh-HHhhhcCCchhhhccChHHHHhhc
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLG-------ERPSTAGDVPTSESFAGEFNIV-KWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~s~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
..........|+..|+|||++.. ..++.++||||+|++++++... ..++....+ .+.+...+.+...
T Consensus 153 ---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~~ 227 (268)
T cd05086 153 ---DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQV 227 (268)
T ss_pred ---hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhccc
Confidence 00111123467899999998753 2357899999999887775321 111111111 1111111111000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
. ..++.........+.+++..|| .+|++||+|+||++.|.
T Consensus 228 ~--~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 K--LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred c--cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0 0001111111222333666999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=282.45 Aligned_cols=237 Identities=20% Similarity=0.327 Sum_probs=169.2
Q ss_pred CCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLD 715 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 715 (929)
++|...+.||+|+||.||+++.. .....+.+|+++++++ +||||++++++|...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 46778899999999999987531 1134678899999999 699999999998543
Q ss_pred CCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCC
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPG 771 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~ 771 (929)
...++||||+++|+|.+++...+ .++.|++.||+|||+. +++||||||+
T Consensus 91 ----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 91 ----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 34799999999999999986422 1246899999999998 9999999999
Q ss_pred CeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhc
Q 002376 772 NILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESN 850 (929)
Q Consensus 772 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~ 850 (929)
||++++++.+|++|||+++........ .......++..|||||++.+..++.++||||+|++++++.. ...++..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999865321110 01111234567999999999899999999999988777543 1111111
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.+ ..+ +............ ...+..++. +++.+||+.+|++||++.|+++.|+++.....
T Consensus 240 ~~--~~~-----~~~~~~~~~~~~~-~~~~~~~l~-~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 240 IP--VEE-----LFKLLREGHRMDK-PSNCTHELY-MLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred CC--HHH-----HHHHHHcCCCCCC-CCCCCHHHH-HHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 11 111 1111111100000 011112233 37889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=274.86 Aligned_cols=224 Identities=21% Similarity=0.257 Sum_probs=162.1
Q ss_pred eecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 668 LIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.||+|+||.||+|.+. ...+++.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 5899999999998532 113568899999999999999999998742 23689999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|+++|+|.+++...+ .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~- 151 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY- 151 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe-
Confidence 999999999886432 2367899999999998 9999999999999999999999999999865322110
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........++..|+|||.+....++.++||||+|++++++.. ...++..... . .+......... .+.+
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~-----~~~~~i~~~~~--~~~~ 220 (257)
T cd05116 152 --YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--N-----EVTQMIESGER--MECP 220 (257)
T ss_pred --eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H-----HHHHHHHCCCC--CCCC
Confidence 011122245678999999988889999999999988877653 3333322211 1 11111111110 0111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
...+.-+++++.+||+.||++||++++|+++|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1122233347889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=281.67 Aligned_cols=230 Identities=18% Similarity=0.239 Sum_probs=165.0
Q ss_pred CCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+|+..+.||+|+||+||+|.... ..+.|.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~---- 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ---- 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC----
Confidence 35566889999999999986421 1246888999999999999999999986543
Q ss_pred ceEEEEEEecCCCCcccccccc------------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE------------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~------------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 775 (929)
..++++||+++++|.+++... ..++.|++.||+|+|+. +|+||||||+||++
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 379999999999999887411 12356899999999998 99999999999999
Q ss_pred cCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCch
Q 002376 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPEN 854 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~ 854 (929)
++++.+||+|||+++....... ........+++.|+|||++.++.++.++||||+|++++++.. ...++.....
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 232 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 232 (283)
T ss_pred cCCCceEecccccccccccchh----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 9999999999999886532111 111122346789999999988899999999999988877543 2222211111
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+ +.......... .........+.+++.+||+.+|++||+++||+++|+.
T Consensus 233 -~~-----~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QD-----VIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH-----HHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111110000 0001112223348889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=280.23 Aligned_cols=242 Identities=22% Similarity=0.217 Sum_probs=174.6
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
++++++.+++++|+..+.||+|+||.||++.... ..+.+.+|+.+++++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 5567788889999999999999999999987641 235677899999999 899999999998765
Q ss_pred CCCCcceEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
+.......++||||+++|+|.++++.. ..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 433345689999999999999877521 12357899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCCCC-----CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-----PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
|+|||+++....... ......|+..|+|||++.... ++.++||||+|++++++.....++..... ..
T Consensus 169 l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~- 240 (291)
T cd06639 169 LVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VK- 240 (291)
T ss_pred Eeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HH-
Confidence 999999886532110 112346889999999976543 68999999999887776544433322211 00
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+..... .........+.....+.+++.+||+.+|++||++.|+++
T Consensus 241 ----~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 ----TLFKIPR-NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----HHHHHhc-CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0111000 000000001111223444888999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=273.96 Aligned_cols=224 Identities=21% Similarity=0.305 Sum_probs=159.8
Q ss_pred eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 668 LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.||+|+||.||+|.+. ...+.|.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999987542 113468899999999999999999998732 237999999
Q ss_pred cCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 729 LSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 729 ~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
+++|+|.+++...+ .++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~- 151 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY- 151 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc-
Confidence 99999999886322 3367899999999998 9999999999999999999999999999865322110
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........++..|+|||++.+..++.++||||+|++++++.. ...++.... +..+......... .+.+
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~--~~~~ 220 (257)
T cd05115 152 --YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-------GPEVMSFIEQGKR--LDCP 220 (257)
T ss_pred --eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-------HHHHHHHHHCCCC--CCCC
Confidence 011112234678999999988889999999999987776432 222221111 1111111111110 0000
Q ss_pred -HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 879 -DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 879 -~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.+..++. +++.+||..+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~-~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMY-ALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHH-HHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112233 377799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=277.69 Aligned_cols=227 Identities=23% Similarity=0.273 Sum_probs=155.1
Q ss_pred eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 668 LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.||+|+||+||+|... ...+.|.+|+++++.++||||++++++|.... ..++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEEe
Confidence 5899999999988532 11346789999999999999999999986533 37999999
Q ss_pred cCCCCccccccccc-------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 729 LSNGSLGDWIHGER-------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 729 ~~~gsL~~~l~~~~-------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+++|+|.++++..+ .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccc
Confidence 99999999886422 2356899999999998 9999999999999999999999999998754221
Q ss_pred cCCCCCccccceeccccccccccccCC-------CCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLG-------ERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
.. ........+++.|+|||++.. ..++.++||||+|++++++.. ...++....+ .+..........
T Consensus 154 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~ 227 (269)
T cd05042 154 DY----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVREQD 227 (269)
T ss_pred hh----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhhccC
Confidence 00 011122346778999998743 357889999999988777543 2222211111 111111111000
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
. .. ..+.........+.+++..|| .||++||+++||++.|.
T Consensus 228 ~-~~-~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 I-KL-PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c-cC-CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 00 000011112222333666898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=285.59 Aligned_cols=236 Identities=20% Similarity=0.347 Sum_probs=169.5
Q ss_pred CCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLD 715 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 715 (929)
.+|...+.||+|+||.||++... ...+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 36788899999999999987531 1134688999999999 7999999999986533
Q ss_pred CCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCC
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPG 771 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~ 771 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+
T Consensus 92 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 92 -----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 4799999999999999886421 1356899999999998 9999999999
Q ss_pred CeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhc
Q 002376 772 NILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESN 850 (929)
Q Consensus 772 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~ 850 (929)
||++++++.+||+|||+++....... ........++..|||||++.+..++.++||||+|++++++.. ...++..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999986532110 011122234578999999999999999999999987777532 1111111
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
.+ ..+ ............ ....+..++. +++.+||+.+|++||+|.|+++.|+++....
T Consensus 240 ~~--~~~-----~~~~~~~~~~~~-~~~~~~~~l~-~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 240 IP--VEE-----LFKLLKEGHRMD-KPANCTHELY-MIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CC--HHH-----HHHHHHcCCCCC-CCCCCCHHHH-HHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 111 111110000000 0011122333 3888999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=274.41 Aligned_cols=230 Identities=26% Similarity=0.361 Sum_probs=168.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..++||+|+||.||+|++.. ..+.|.+|++++++++||||+++++++.. ...++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEEE
Confidence 568889999999999999986542 24578999999999999999999998632 2369999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|+|.++++... ..+.+++.||+|+|+. +++||||||+||++++++.+||+|||.++.+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999986421 2356899999999998 99999999999999999999999999998653221
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......++..|+|||+..+..++.++||||+|++++++.+ ...++..... .+..+. ...... ....
T Consensus 157 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~~~~~-~~~~~~--~~~~- 225 (262)
T cd05071 157 Y-----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ-VERGYR--MPCP- 225 (262)
T ss_pred c-----ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HHHHHH-HhcCCC--CCCc-
Confidence 1 11122346778999999988899999999999988777544 2222211111 111111 000000 0000
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.+ ..+.+.+++.+|++.||++||+++++++.|++.
T Consensus 226 --~~-~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 --PE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --cc-cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11 122233488899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=277.20 Aligned_cols=219 Identities=24% Similarity=0.256 Sum_probs=157.8
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||.||+++... ..+.+..|++++++++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 6999999999886541 12245569999999999999999998854 33589999999
Q ss_pred CCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 730 SNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 730 ~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
++|+|.+++.... ..+.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---- 148 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---- 148 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----
Confidence 9999988775321 2356899999999998 9999999999999999999999999998765321
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch--hhhccChHHHHhhcccchhhhhh
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN--VLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|+..|+|||++.+..++.++||||+|+++|++.....++...... ..++....... .... .
T Consensus 149 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~--~- 218 (277)
T cd05607 149 ---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----EVKF--E- 218 (277)
T ss_pred ---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----cccc--c-
Confidence 1112346899999999999999999999999998887765554443322111 01111111100 0000 0
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
...+...+++++.+|++.||++||+++|+++.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 01122223447789999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=280.06 Aligned_cols=214 Identities=28% Similarity=0.298 Sum_probs=153.3
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHH-HHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECE-TLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||.||+|+... ..+.+.+|.. +++.++||||+++++++.+ ....|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999987641 1123445544 5788999999999998854 33589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--- 149 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---
Confidence 9999999988775332 2367999999999998 9999999999999999999999999998753111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........||+.|+|||++.+..++.++||||+|+++|++..+..++.... ..+..+..... .........
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~----~~~~~~~~~ 220 (321)
T cd05603 150 ---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDNILHK----PLQLPGGKT 220 (321)
T ss_pred ---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHHHHHHhcC----CCCCCCCCC
Confidence 111234579999999999999999999999999999888765544432221 11111111110 000011111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIR 904 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ 904 (929)
. .+.+++.+|++.||++||++.
T Consensus 221 ~----~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 V----AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred H----HHHHHHHHHccCCHhhcCCCC
Confidence 1 223377799999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=288.66 Aligned_cols=169 Identities=21% Similarity=0.302 Sum_probs=139.3
Q ss_pred hhCCCCCceeecccCceeEEeccccCc----------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGS----------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~----------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
...+|+..+.||+|+||.||+|+.... ......|+.++++++|||||++++++... ...++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEEc
Confidence 345799999999999999999987632 23456799999999999999999998653 347999999
Q ss_pred cCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 729 LSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 729 ~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
+. |+|.+++... ..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 210 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---- 210 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC----
Confidence 94 6888877532 23467999999999998 9999999999999999999999999999753211
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
.......||+.|+|||++.+..++.++||||+|+++|++..
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 11233579999999999999999999999999998888654
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=273.24 Aligned_cols=216 Identities=22% Similarity=0.310 Sum_probs=155.9
Q ss_pred eeecccCceeEEeccccC-----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 667 NLIGSGSFGSVLHNERTG-----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+.||+|+||.||+|.... ..+.|.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 368999999999986521 1246778999999999999999999986533 379
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc--------eEEecc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT--------AKVGDF 786 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~ki~Df 786 (929)
+||||+++|+|.++++... .++.||+.|++|||+. +|+||||||+||+++.++. +|++||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999986432 2357899999999998 9999999999999987765 699999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChH-HH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPE-LR 864 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~ 864 (929)
|++..... .....+++.|||||++.+. .++.++||||+|++++++.... ..+... .++. ..
T Consensus 153 g~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~----~~~~~~---~~~~~~~ 215 (258)
T cd05078 153 GISITVLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG----DKPLSA---LDSQKKL 215 (258)
T ss_pred ccccccCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCC----CCChhh---ccHHHHH
Confidence 98864321 1234678899999999874 5799999999998777754431 111110 0110 01
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
.............+. ++ .+++.+||+.||++|||++|+++.|+
T Consensus 216 ~~~~~~~~~~~~~~~---~~-~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QFYEDRHQLPAPKWT---EL-ANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHccccCCCCCcH---HH-HHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111111111112 22 33777999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=281.81 Aligned_cols=220 Identities=24% Similarity=0.263 Sum_probs=156.6
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+++... ..+.+.+|+.++.++ +||||+++++++.. ....|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999887541 123467899998888 69999999998854 33589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 149 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--- 149 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence 9999999988775332 3467899999999998 9999999999999999999999999998743111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++.........-....+........ ...+
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~p 223 (327)
T cd05617 150 ---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---IRIP 223 (327)
T ss_pred ---CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---CCCC
Confidence 1112345799999999999999999999999999888887665555432211000000001111110000 0111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
..+..-+.+++.+|++.||++||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122223347779999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=287.81 Aligned_cols=179 Identities=25% Similarity=0.282 Sum_probs=142.0
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~ 719 (929)
..++|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999886541 13467789999999999999999998864332 122
Q ss_pred ceEEEEEEecCCCCccccccc------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHG------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
...|+||||+++ ++.+++.. ...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 66665542 123467999999999998 99999999999999999999999999998542
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.. .......||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 171 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 171 TS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred Cc-------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 11 1123347899999999999999999999999999888765554433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=280.07 Aligned_cols=217 Identities=24% Similarity=0.284 Sum_probs=155.7
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||.||+|+... ..+.+..|..++... +||||+++++++.. ....|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 469999999999987652 123456677777754 89999999999854 34589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--- 149 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC---
Confidence 9999999998876432 2356899999999998 9999999999999999999999999998743111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|+|||++.+..++.++||||+|++++++..+..++..... . .+......... ..+
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~-----~~~~~~~~~~~---~~~ 216 (316)
T cd05620 150 ---DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--D-----ELFESIRVDTP---HYP 216 (316)
T ss_pred ---CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--H-----HHHHHHHhCCC---CCC
Confidence 1122345799999999999999999999999999887776554443322211 1 11111100000 000
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHH-HHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIR-EAL 907 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~ 907 (929)
..+..-+++++.+|++.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11112223377799999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=278.13 Aligned_cols=228 Identities=25% Similarity=0.257 Sum_probs=175.6
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~ 719 (929)
.+.|+..+.||+|.||.||+++.+. +.+.+.+|+++|+++. |||||.++++|.+..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence 4578888999999999999987652 2357889999999998 999999999995543
Q ss_pred ceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC----CceEEecccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE----MTAKVGDFGL 788 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ki~DfGl 788 (929)
.+++|||++.||.|.+.+... .....||+.|++|||+. +|+|||+||+|+|+... +.+|++|||+
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 589999999999999988653 12357899999999997 99999999999999533 5799999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
|+.... .......+||++|+|||++....|+..+||||.|++.|.+ ..+..|..... -.........
T Consensus 186 a~~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL-----L~G~~PF~~~~-~~~~~~~i~~ 252 (382)
T KOG0032|consen 186 AKFIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL-----LSGVPPFWGET-EFEIFLAILR 252 (382)
T ss_pred ceEccC-------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH-----hhCCCCCcCCC-hhHHHHHHHc
Confidence 997642 2345667999999999999999999999999999766654 34444431110 0011112222
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+.....+.++.+.+-+++++.+|+..||.+|+|+.++++
T Consensus 253 ~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 253 GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2223333444556666777888999999999999999998
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=270.33 Aligned_cols=234 Identities=23% Similarity=0.322 Sum_probs=171.8
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|... ...+.+.+|++++++++|+|++++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 57889999999999999998764 1245788999999999999999999998643 34
Q ss_pred EEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++||||+++|+|.+++... ..++.+++.|++|||+. +|+||||||+||++++++.+|++|||++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecccee
Confidence 79999999999999887521 12256899999999998 9999999999999999999999999998
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+...... .......|++.|+|||++.+..++.++||||+|++++++.....++........+..+.........
T Consensus 154 ~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08224 154 RFFSSKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227 (267)
T ss_pred eeccCCC------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC
Confidence 8653211 1122346889999999999889999999999998777754433222111101111111111110000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.. .......+.+++.+||+.+|++||++.+|+++|++++
T Consensus 228 -----~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 -----LP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0112223334777999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=268.86 Aligned_cols=225 Identities=23% Similarity=0.282 Sum_probs=167.3
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+|+..+.||+|+||.||++.... ..+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 46778999999999999886541 23567889999999999999999999854 345899
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||+++|+|.+++...+ .++.+++.||+|||+. +|+|+||||+||++++++.++++|||.++....
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999999998875321 2367899999999998 999999999999999999999999999976532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.. .......|++.|+|||++.+..++.++||||+|++++++.....++..... .... ..+.. ....
T Consensus 153 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~-~~~~~---~~~~-- 218 (255)
T cd08219 153 PG------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLI-LKVCQ---GSYK-- 218 (255)
T ss_pred cc------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHH-HHHhc---CCCC--
Confidence 11 112235689999999999988999999999999999887665544432211 1100 00100 0000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
..+......+.+++.+||+.||++||++.|++.+
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0001122233447789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.93 Aligned_cols=217 Identities=26% Similarity=0.341 Sum_probs=157.0
Q ss_pred eeecccCceeEEeccccCc-------------------HHHHHHHHHHHHc-cCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRN-VRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+|+.... .+.+..|..++.. .+||||+++++++.+. ...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 4699999999999876521 2345667888876 4899999999998543 3589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--- 149 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---
Confidence 9999999999886432 3367899999999998 9999999999999999999999999998743111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........||+.|||||++.+..++.++||||+|+++|++..+..++..... .+... .+.. ......
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~-~i~~---~~~~~~---- 216 (316)
T cd05619 150 ---DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQ-SIRM---DNPCYP---- 216 (316)
T ss_pred ---CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHH-HHHh---CCCCCC----
Confidence 1122345799999999999999999999999999888876554443322111 11111 0110 000000
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHH-HHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIR-EAL 907 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~ 907 (929)
.....-+++++.+|++.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11122233477799999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=280.50 Aligned_cols=233 Identities=18% Similarity=0.295 Sum_probs=168.3
Q ss_pred CCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~ 717 (929)
++|...+.||+|+||.||++... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG-- 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--
Confidence 46888899999999999987531 1124688999999999 7999999999985433
Q ss_pred CcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
..++||||+++|+|.++++... .++.+++.|++|||+. +|+||||||+||++++++.+|++|||
T Consensus 113 ---~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 ---PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 3799999999999999986432 2356899999999998 89999999999999999999999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHh
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
+++....... ........++..|+|||++.+..++.++||||+|++++++.. ...++...+. +......
T Consensus 187 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~ 256 (302)
T cd05055 187 LARDIMNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKL 256 (302)
T ss_pred ccccccCCCc----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHH
Confidence 9986532211 011112346788999999999999999999999988777543 2222221111 1111111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
....... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 257 ~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRM--AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1100000 00001112233477799999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=280.72 Aligned_cols=218 Identities=24% Similarity=0.282 Sum_probs=158.8
Q ss_pred eeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+++... ..+.+.+|.++++.+ +||||+++++++.. ....|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999987642 123466788888887 69999999999854 33589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 149 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--- 149 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence 9999999998876432 2367899999999998 9999999999999999999999999998743111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......+||+.|||||++.+..++.++||||+|++++++..+..++..... .+.. ...........
T Consensus 150 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~----~~i~~~~~~~~---- 216 (318)
T cd05570 150 ---GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELF----QSILEDEVRYP---- 216 (318)
T ss_pred ---CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHH----HHHHcCCCCCC----
Confidence 1112335799999999999999999999999999887776554444322211 1100 00000011000
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCH-----HHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGI-----REALR 908 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~-----~ev~~ 908 (929)
..+...+.+++.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1112223347779999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=279.54 Aligned_cols=172 Identities=23% Similarity=0.348 Sum_probs=142.0
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||++.... ..+++.+|++++++++||||++++++|... .+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence 468889999999999999986541 124578999999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++|+|.++++... .++.|++.||+|||+.+ +++||||||+||++++++.+||+|||+++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999999986432 33678999999999732 8999999999999999999999999998754211
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
......|+..|+|||++.+..++.++||||+|++++++.+...+
T Consensus 154 --------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 197 (308)
T cd06615 154 --------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197 (308)
T ss_pred --------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 12234789999999999888899999999999888876655443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=272.05 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=173.5
Q ss_pred CCCCCceeecccCceeEEecccc-------------------C--cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------G--SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.|+..+.||+|+||.||++++. . ..+.|.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 35667789999999999998742 1 245799999999999999999999988542 23
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.+++.... .++.+++.||+|||+. +++||||||+||+++.++.+|++|||.++
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 45799999999999999986433 2367899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh--------ccChH
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ--------VLDPE 862 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 862 (929)
........ ........++..|+|||++.+..++.++||||+|++++++.+...++...+..... .....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 158 VLPEDKDY---YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccCCcc---eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 76422110 01111124566799999999889999999999999999976655333221111100 00111
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+........... ....+..++.+ ++.+||+.+|++||+|.||+++|+++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~-li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLP-RPPSCPDEVYD-LMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCC-CCccCCHHHHH-HHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111000 00111223334 88899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=278.33 Aligned_cols=236 Identities=23% Similarity=0.299 Sum_probs=163.1
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHcc---CCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNV---RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||+||+|+... ....+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999987652 123466788877765 799999999998764434445
Q ss_pred eEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..++||||++ ++|.+++... +.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999997 5888877532 12367899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC-------h
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD-------P 861 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~-------~ 861 (929)
..... .......||..|+|||++.+..++.++||||+|++++++....-++..... ...++.+ .
T Consensus 157 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQ-------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccCc-------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 65321 112234689999999999999999999999999888776443322211111 0101000 0
Q ss_pred HHHH-------hhccc-chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQ-------LMTSN-ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~-------~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... ..... ..........+.+.+++++.+|++.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000 00000000112233445888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.33 Aligned_cols=233 Identities=21% Similarity=0.299 Sum_probs=167.0
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
|++.+++++.....||+|+||.||+|.... ..+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 77 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN---- 77 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC----
Confidence 345677788888899999999999997541 245788999999999999999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~Df 786 (929)
...++||||+++++|.++++... .++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 78 -GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred -CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence 35899999999999999886421 1246899999999998 9999999999999976 679999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|.+....... .......|+..|+|||++.+.. ++.++||||+|++++++.....++................
T Consensus 154 g~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (268)
T cd06624 154 GTSKRLAGIN------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227 (268)
T ss_pred hhheecccCC------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh
Confidence 9987653211 1112235889999999987654 7899999999988777654433322211110001110000
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ... ..+.....-+.+++.+||+.+|++||||.|+++
T Consensus 228 ~---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 K---IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred c---cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 000 011112222333777999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=272.47 Aligned_cols=227 Identities=25% Similarity=0.297 Sum_probs=163.8
Q ss_pred eeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||.||+|.+. ...+++.+|++++++++|||||++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 46999999999988642 123568899999999999999999998742 2369999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.|++.|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999999986433 3367899999999998 8999999999999999999999999999866422111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........++..|+|||.+.+..++.++||||+|++++++.. ...++..... ..+......... ...
T Consensus 152 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~ 219 (257)
T cd05060 152 ---YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------AEVIAMLESGER--LPR 219 (257)
T ss_pred ---cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCc--CCC
Confidence 111112234578999999999999999999999987766542 2222221111 111111111100 011
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
+......+++++.+||..+|++||++.++++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1112233445888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=281.25 Aligned_cols=234 Identities=22% Similarity=0.287 Sum_probs=169.9
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||.||+|.+. ....++.+|+.++++++||||++++++|...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 46777889999999999998642 0123678999999999999999999998542
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..++|+||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 2579999999999999886432 2357999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
....... ........++..|||||++.+..++.++||||+|++++++.. ...++...+. ...+.+ .
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~--------~ 225 (303)
T cd05110 158 LLEGDEK----EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL--------E 225 (303)
T ss_pred cccCccc----ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------H
Confidence 6532211 011122345778999999999999999999999988777543 2222221111 111111 1
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
..... .....+...+.. ++.+||..+|++||+|+|+++.++++....
T Consensus 226 ~~~~~-~~~~~~~~~~~~-li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 226 KGERL-PQPPICTIDVYM-VMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCC-CCCCCCCHHHHH-HHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 00000 000111223333 788999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=270.92 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=166.2
Q ss_pred CCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+|+..+.||+|+||.||+|... ...++|..|+.++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----RP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----Cc
Confidence 4677899999999999987643 1135788999999999999999999998543 34
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+++|+|.++++... .++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 799999999999999886422 2356899999999998 9999999999999999999999999998865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
........ ........++..|+|||++.+..++.++||||+|++++++.. ...++..... . ..........
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~-----~~~~~i~~~~ 228 (269)
T cd05065 157 EDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--Q-----DVINAIEQDY 228 (269)
T ss_pred ccCccccc-cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--H-----HHHHHHHcCC
Confidence 32211110 001111122457999999999999999999999988777432 2222211111 1 1111111100
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+.......+..+.+++.+||+.+|++||+|++++.+|+++
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000011122233477899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=274.32 Aligned_cols=215 Identities=22% Similarity=0.259 Sum_probs=152.9
Q ss_pred eecccCceeEEecccc----------------------------------------CcHHHHHHHHHHHHccCCccccce
Q 002376 668 LIGSGSFGSVLHNERT----------------------------------------GSWKSFIAECETLRNVRHRNLVKL 707 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~----------------------------------------~~~~~~~~E~~~l~~l~Hpniv~l 707 (929)
.||+|+||.||+|... ...++|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999998742 012467789999999999999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
+++|.+.. ..++||||+++|+|.++++..+ .++.|+++||+|||+. +|+||||||+||++++.
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99996533 4799999999999998886422 2367999999999998 99999999999999764
Q ss_pred C-------ceEEeccccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhc
Q 002376 779 M-------TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESN 850 (929)
Q Consensus 779 ~-------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~ 850 (929)
+ .+|++|||+++.... .....++..|+|||++.+ ..++.++||||+|++++++.+ .+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~----~g~ 219 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF----DGE 219 (274)
T ss_pred CcccCccceeeecCCcccccccc----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh----CCC
Confidence 4 479999998864321 112357888999998876 458999999999987776421 122
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
.|.. ..................... ...+.+ ++.+||+.+|++||+|.++++.|
T Consensus 220 ~p~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~-li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 220 VPLK--ERTPSEKERFYEKKHRLPEPS---CKELAT-LISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCcc--ccChHHHHHHHHhccCCCCCC---ChHHHH-HHHHHcccChhhCcCHHHHHHhh
Confidence 2210 000111111111111000001 122333 78899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=270.55 Aligned_cols=216 Identities=21% Similarity=0.266 Sum_probs=154.4
Q ss_pred eeecccCceeEEecccc----------------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 667 NLIGSGSFGSVLHNERT----------------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~----------------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
+.||+|+||.||+|+.. ...+.|.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 36899999999999732 11236778899999999999999999986433
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc-------eE
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-------AK 782 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~k 782 (929)
..++||||+++|+|..+++... .++.||+.||+|||+. +|+||||||+|||++.++. +|
T Consensus 78 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred --CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 3699999999999988876321 3467999999999998 9999999999999987664 89
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccC-CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
++|||++..... .....|+..|||||++. +..++.++||||+|+++|++.. .+..|..... ..
T Consensus 153 l~d~g~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~----~~~~p~~~~~--~~ 216 (262)
T cd05077 153 LSDPGIPITVLS----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----NGEIPLKDKT--LA 216 (262)
T ss_pred eCCCCCCccccC----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh----CCCCCCCCcc--hh
Confidence 999999875421 12236788999999887 4668999999999988777531 1222221000 00
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
..............+. ...+ ++++.+||+.||++||++.|+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~---~~~~-~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 EKERFYEGQCMLVTPS---CKEL-ADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHhcCccCCCCC---hHHH-HHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111000000000111 1222 3378899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=286.32 Aligned_cols=178 Identities=24% Similarity=0.306 Sum_probs=140.2
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++.... ..+++.+|+++++.++||||+++++++...+.......|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47788999999999999987531 235678999999999999999999998765432233689
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+. ++|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 57877664322 2367899999999998 9999999999999999999999999999864321
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. ........+|+.|+|||++.+. .++.++||||+|++++++..+..++
T Consensus 157 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 157 E-----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred c-----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 1 1112234689999999998875 4799999999998888865554433
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=276.82 Aligned_cols=232 Identities=22% Similarity=0.321 Sum_probs=166.6
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||.||+++..+ ..++|.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 4578889999999999999976421 1356889999999999999999999986533
Q ss_pred CcceEEEEEEecCCCCcccccccc------------------------------ccccccHHHHHHHhhhCCCCCEEecC
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGE------------------------------RKNELDITSALDYLHNDCEVPVVHSD 767 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~------------------------------~~~~~~ia~aL~yLH~~~~~~iiHrD 767 (929)
..++||||+++|+|.++++.. ..++.|++.||+|||+. +++|||
T Consensus 82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 82 ---PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred ---ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 379999999999999998632 12467899999999998 999999
Q ss_pred CCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHH
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKW 846 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~ 846 (929)
|||+||++++++.+||+|||+++.+..... ........++..|+|||++.+..++.++||||+|++++++.. ...
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999876532111 001112234678999999998999999999999988777532 111
Q ss_pred hhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 847 VESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 847 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
++... ...+ ............. ...+..++.+ ++.+|++.+|++|||+.|+++.|++
T Consensus 232 p~~~~--~~~~-----~~~~~~~~~~~~~-~~~~~~~l~~-li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 232 PYYGM--AHEE-----VIYYVRDGNVLSC-PDNCPLELYN-LMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCC--CHHH-----HHHHHhcCCCCCC-CCCCCHHHHH-HHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 1111 1111100000000 0011123333 7889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=273.54 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=167.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|...+.||+|+||.||++.... ..+.|.+|++++++++|||++++++++.. ...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEEEE
Confidence 457788999999999999987541 23578899999999999999999998732 2368999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|+|.++++... .++.+++.||+|||+. +++||||||+||++++++.+||+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999886421 2356899999999998 89999999999999999999999999998653211
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......++..|+|||+..+..++.++||||+|++++++.. ...++.... +............ .
T Consensus 157 ~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~--~ 222 (260)
T cd05069 157 Y-----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NREVLEQVERGYR--M 222 (260)
T ss_pred c-----cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCC--C
Confidence 0 11112346778999999998899999999999987776543 222221111 1111111111100 0
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
..+...+..+++++.+||+.||++||++++|.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111122334457779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=268.61 Aligned_cols=231 Identities=23% Similarity=0.327 Sum_probs=162.8
Q ss_pred eeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+|... ...+.+.+|+.+++.++||||+++++++...+ ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence 46899999999987632 11346788999999999999999999875432 2368999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.++++... ..+.+++.|++|||+. +++||||||+||++++++.+||+|||+++.+.....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999999986322 2246899999999997 999999999999999999999999999986532110
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
. .........++..|+|||++.+..++.++||||+|++++++.... ..+..... ............. ...
T Consensus 154 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~----~~~~~~~~--~~~~~~~~~~~~~--~~~ 223 (262)
T cd05058 154 Y--SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG----APPYPDVD--SFDITVYLLQGRR--LLQ 223 (262)
T ss_pred e--eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC----CCCCCCCC--HHHHHHHHhcCCC--CCC
Confidence 0 011112335677899999998889999999999998777653321 11110000 0011111111000 000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.+..+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111222334888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=285.19 Aligned_cols=179 Identities=24% Similarity=0.280 Sum_probs=142.8
Q ss_pred hhCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCC-CCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~ 719 (929)
..++|+..+.||+|+||.||++... ...+.+.+|+.+++.++||||+++++++...+. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999988653 123467789999999999999999998754332 122
Q ss_pred ceEEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
...|+||||+++ ++.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999964 676665421 23467999999999998 99999999999999999999999999998642
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.. .......||+.|+|||++.+..++.++||||+|+++|++..+..++
T Consensus 178 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 178 TS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred CC-------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 11 1123347899999999999999999999999999888876655444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=270.07 Aligned_cols=233 Identities=21% Similarity=0.271 Sum_probs=167.5
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|+.. ...+.|.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----K 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----C
Confidence 46778899999999999987642 1135788999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++.... .++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 4799999999999999986431 2356899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
+..... .........++..|+|||++.+..++.++||||+|++++++.. ...++..... .+ ........
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~-----~~~~~~~~ 225 (267)
T cd05066 156 LEDDPE---AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QD-----VIKAIEEG 225 (267)
T ss_pred cccccc---eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HH-----HHHHHhCC
Confidence 642211 0111112234568999999998899999999999987776432 2222211111 11 11111100
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.. .+.....+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 226 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YR--LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred Cc--CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 000001112233477899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.07 Aligned_cols=173 Identities=25% Similarity=0.334 Sum_probs=134.1
Q ss_pred ceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
.++||+|+||+||+|+... ....+.+|++++++++||||+++++++... .....++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3689999999999997531 124678999999999999999999988653 234579999999
Q ss_pred CCCCcccccccc-----------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee----cCCCceEEecccc
Q 002376 730 SNGSLGDWIHGE-----------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDFGL 788 (929)
Q Consensus 730 ~~gsL~~~l~~~-----------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DfGl 788 (929)
+ ++|.+++... +.++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 6 4776665311 13356899999999998 99999999999999 5677999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
++....... .........||+.|+|||++.+. .++.++||||+|++++++.+...++
T Consensus 159 a~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 159 ARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred eeccCCCcc---cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 986532211 11122345789999999998764 5899999999999888876655443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.49 Aligned_cols=227 Identities=24% Similarity=0.322 Sum_probs=167.3
Q ss_pred CCCCCceeecccCceeEEeccccC-------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
++|+..+.||+|+||.||+|...+ ..+++.+|+.++++++||||+++++++... ...++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEEEEE
Confidence 467888999999999999887652 245788999999999999999999998653 33799999
Q ss_pred ecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 728 FLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|+++++|.++++... .++.|++.|++|||+. +++||||||+||++++++.+||+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999986432 2357899999999998 99999999999999999999999999998653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
....++..|+|||++.++.++.++||||+|++++++.. ...++...+. .+ +.......... .
T Consensus 157 --------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~-----~~~~~~~~~~~--~ 219 (256)
T cd05039 157 --------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KD-----VVPHVEKGYRM--E 219 (256)
T ss_pred --------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HH-----HHHHHhcCCCC--C
Confidence 11234678999999998899999999999987766532 2222111111 11 11111000000 0
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.+...+..+.+++.+|++.+|++||+++|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0011112233377799999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.28 Aligned_cols=229 Identities=21% Similarity=0.261 Sum_probs=164.6
Q ss_pred hCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 347888999999999999998753 1234577899999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++|+|.++++... .++.|++.|++|||+. +|+|||+||+||++++++.+||+|||+++.+...
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999999886332 2367899999999998 9999999999999999999999999999865321
Q ss_pred cCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHHHHhhccc
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPELRQLMTSN 870 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~ 870 (929)
. .......|++.|+|||++. ...++.++||||+|++++++.....++..... ........... ...
T Consensus 160 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 230 (267)
T cd06646 160 I------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---PPK 230 (267)
T ss_pred c------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC---CCC
Confidence 1 1122346889999999874 34578899999999887776544333221111 00000000000 000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.... ......+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKDK----TKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Cccc----cccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0000 0112233347779999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=273.85 Aligned_cols=241 Identities=21% Similarity=0.275 Sum_probs=174.3
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++.++..+.+.|+..+.||+|+||.||+|.... ...++..|+.+++++ +||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4677777888999999999999999999987641 234678899999998 699999999998653
Q ss_pred CC-CCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 715 DS-KNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 715 ~~-~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
.. ......++||||+++|+|.+++...+ .+..|++.|++|||+. +|+|||+||+||++++++.+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 32 12356899999999999999886422 2246899999999998 9999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV 858 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~ 858 (929)
+|||+++..... ........|++.|+|||++. +..++.++||||+|++++++.....++..... ....
T Consensus 163 ~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-~~~~ 235 (282)
T cd06636 163 VDFGVSAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRAL 235 (282)
T ss_pred eeCcchhhhhcc------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-Hhhh
Confidence 999998755321 11123356899999999876 34688999999999887776555444322211 1111
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. . .... .............+. +++.+||+.||++||++.|+++
T Consensus 236 ~-~-~~~~----~~~~~~~~~~~~~~~-~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 F-L-IPRN----PPPKLKSKKWSKKFI-DFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-h-HhhC----CCCCCcccccCHHHH-HHHHHHhCCChhhCcCHHHHhc
Confidence 0 0 0000 000000001112233 3777999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=277.25 Aligned_cols=227 Identities=23% Similarity=0.254 Sum_probs=167.9
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.+|+..+.||+|+||.||+|... ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEE
Confidence 47888899999999999998643 1245788999999999999999999988542 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++|+|.++++... .++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999999999886432 3356899999999998 99999999999999999999999999988653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|++.|+|||++.+..++.++||||+|++++++..+..++..... .. ........ .......
T Consensus 171 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~-----~~~~~~~~-~~~~~~~ 238 (296)
T cd06654 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LR-----ALYLIATN-GTPELQN 238 (296)
T ss_pred -----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HH-----hHHHHhcC-CCCCCCC
Confidence 111234688999999999988899999999999887776554433321110 00 00000000 0000111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+.+...+.+++.+||..+|++||++.|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1223333445888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.52 Aligned_cols=225 Identities=21% Similarity=0.266 Sum_probs=172.1
Q ss_pred CCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
..|+..+.||+||.++||++... ....-|.+|+..|.+++ |.+||++++|-.. .+++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DGYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----CceE
Confidence 35777889999999999998765 22456889999999995 9999999999753 4579
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
||||||- .-+|.++|++.. .+..|++.|+.++|.+ +|||.||||.|+|+-. |.+||.|||.|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9999986 468999887543 2356899999999998 9999999999999974 689999999999875
Q ss_pred cccCCCCCccccceeccccccccccccCCC-----------CCCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhcc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-----------RPSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVL 859 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~ 859 (929)
.+..+ .....-+||+.||+||.+... +++.++||||+||++|+|....-+++.++. ++..+.
T Consensus 511 ~DTTs----I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 511 PDTTS----IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred ccccc----eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 43222 122345899999999987532 367999999999999988777777777764 344555
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
|+...-.++.-... .+++. +|..|+++||++||+..|+++
T Consensus 587 ~P~~~Iefp~~~~~--------~~li~-~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 587 DPNHEIEFPDIPEN--------DELID-VMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCCccccccCCCCc--------hHHHH-HHHHHHhcCcccCCCcHHHhc
Confidence 55332211111111 11444 777999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=272.38 Aligned_cols=230 Identities=20% Similarity=0.278 Sum_probs=166.8
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||.||+|+... ..+.|.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence 467888999999999999987420 135688999999999999999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc-----------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCce
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER-----------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 781 (929)
...++||||+++|+|.++++..+ .+..|++.||+|||+. +|+||||||+||++++++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 34799999999999999986433 1246899999999998 89999999999999999999
Q ss_pred EEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccC
Q 002376 782 KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLD 860 (929)
Q Consensus 782 ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~ 860 (929)
|++|||+++..... .........++..|+|||.+.+..++.++||||+|++++++.. ...++.... +
T Consensus 157 ~l~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-------~ 224 (275)
T cd05046 157 KVSLLSLSKDVYNS-----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-------D 224 (275)
T ss_pred EEcccccccccCcc-----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-------h
Confidence 99999998754211 1111223356788999999988889999999999987776433 222222111 1
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
............. .......+..+.+++.+||+.+|++||++.|++++|+
T Consensus 225 ~~~~~~~~~~~~~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 225 EEVLNRLQAGKLE-LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHcCCcC-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111000000 0001112233444788999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=273.28 Aligned_cols=234 Identities=21% Similarity=0.302 Sum_probs=169.6
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||.||+|... ...+++.+|+.++++++||||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 46777899999999999998642 113568899999999999999999999864
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.++++... ..+.|++.|++|||+. +++||||||+||++++++.+||+|||.++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 23799999999999999886432 2357899999999997 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
........ .......++..|+|||.+....++.++||||+|++++++.. ...++...+ .. .+......
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~-----~~~~~~~~ 226 (279)
T cd05057 158 LLDVDEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AV-----EIPDLLEK 226 (279)
T ss_pred cccCcccc----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HH-----HHHHHHhC
Confidence 76422110 11111234678999999988899999999999987776543 222221111 11 11111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
...... ...+...+. +++.+||..+|++||++.++++.|+++.+.
T Consensus 227 ~~~~~~-~~~~~~~~~-~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GERLPQ-PPICTIDVY-MVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCC-CCCCCHHHH-HHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 100000 001112233 378899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=274.86 Aligned_cols=242 Identities=17% Similarity=0.252 Sum_probs=161.2
Q ss_pred CCCCCceeecccCceeEEeccccCc---------------HHH---------------HHHHHHHHHccCCccccceeee
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS---------------WKS---------------FIAECETLRNVRHRNLVKLITS 710 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~---------------~~~E~~~l~~l~Hpniv~l~~~ 710 (929)
++|+..++||+|+||+||+|..... .+. ...+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999875422 001 1122334556789999999997
Q ss_pred cccCCCCCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 711 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
+..... ...+.++++|++. .++.+.+... ..++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 92 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRC-RMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecC-CceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 654332 2334578888774 3554444321 13578999999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhcc
Q 002376 783 VGDFGLARFLLERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVL 859 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~ 859 (929)
|+|||+|+.+........ .........||+.|+|||+..+..++.++||||+|++++++.....++..... ......
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999987632211110 11112334799999999999999999999999999877776555555443321 111111
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
.......+.... .....+. +.+.+++..|+..+|++||++.++.+.++
T Consensus 247 ~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHEGK---IKIKNAN-KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhhhh---hccCCCC-HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111111111 1111222 22334777999999999999999998763
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=270.60 Aligned_cols=231 Identities=23% Similarity=0.335 Sum_probs=164.6
Q ss_pred CCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..++||+|+||.||++... ...+.|.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 80 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR----- 80 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-----
Confidence 5667789999999999987521 12357889999999999999999999985433
Q ss_pred eEEEEEEecCCCCccccccccc-----------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC
Q 002376 721 FLALVYEFLSNGSLGDWIHGER-----------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE 777 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 777 (929)
..++||||+++|+|.++++... ..+.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 3799999999999999886321 1246899999999998 9999999999999999
Q ss_pred CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 778 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
++.+||+|||+++....... ........+++.|+|||++.+..++.++||||+|++++++.. .+..|.. +
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~----~g~~p~~--~ 227 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT----YGKQPWY--Q 227 (280)
T ss_pred CCCEEECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc----CCCCCCc--c
Confidence 99999999999975532110 011122345788999999999999999999999987777533 1222210 0
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.-+............. ..+...+.-+++++.+||+.||++||+++||.+.|++
T Consensus 228 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 228 LSNTEAIECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CCHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0001111100000000 0001112223347789999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=269.35 Aligned_cols=237 Identities=18% Similarity=0.243 Sum_probs=172.0
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--- 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG--- 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence 4578888999999999999987542 1345788999999999999999999986532
Q ss_pred cceEEEEEEecCCCCccccccccc----------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER----------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
...++++||+++|+|.+++...+ .++.+++.||+|||+. +++||||||+||++++++.+|
T Consensus 82 -~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 82 -EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred -CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 34799999999999999886421 2356899999999987 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccCh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDP 861 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~ 861 (929)
|+|||+++.+...... .......++..|+|||++.+..++.++||||+|++++++.. ...++..... .
T Consensus 158 l~d~g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~ 226 (280)
T cd05043 158 ITDNALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------F 226 (280)
T ss_pred ECCCCCcccccCCceE----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------H
Confidence 9999999865322110 01122346778999999998899999999999987776543 3222221111 1
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.+............ ...+...+ .+++.+||+.||++|||+.|+++.|+++..+
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~-~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 227 EMAAYLKDGYRLAQ-PINCPDEL-FAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHHHcCCCCCC-CCcCCHHH-HHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111111100000 00111122 3377799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=274.77 Aligned_cols=224 Identities=23% Similarity=0.299 Sum_probs=162.8
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
|+..+.||+|+||.||++.... ..+.+.+|+.++++++|++++++++++.+. ...+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEE
Confidence 6677899999999999876641 123467899999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++|+|.+++.... .++.|++.|++|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999999998875321 2357899999999987 99999999999999999999999999987543
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchh-hhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENV-LQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~ 872 (929)
.. .......||..|||||++.+..++.++||||+|++++++..+..++....... .+........ ....
T Consensus 154 ~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~-- 223 (285)
T cd05630 154 EG-------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEE-- 223 (285)
T ss_pred CC-------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhh--
Confidence 11 11123478999999999999999999999999988777655544443221100 0000000000 0000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.......-+.+++.+||+.||++||| ++|+++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 ----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00011122234777999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=287.38 Aligned_cols=175 Identities=22% Similarity=0.267 Sum_probs=141.3
Q ss_pred CCCCCceeecccCceeEEeccccC-------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.+|...+.||+|+||.||++...+ ..+.+.+|++++++++|||||++++++.. ....++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW-----KSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEee-----CCEEEEEeh
Confidence 478889999999999999875431 12356789999999999999999998853 345899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
|+. ++|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~--- 239 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP--- 239 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc---
Confidence 995 68888875322 3467899999999998 99999999999999999999999999998653221
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.........||+.|+|||++.+..++.++||||+|+++|++.+...++
T Consensus 240 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 240 -DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred -ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 111123457999999999999999999999999999888876554443
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=271.11 Aligned_cols=225 Identities=25% Similarity=0.333 Sum_probs=161.8
Q ss_pred eeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 667 NLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+.||+|+||.||+|+.. .....|.+|+++++.++||||++++++|...+ ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence 36899999999988753 12346788999999999999999999985433 479
Q ss_pred EEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-----ceEE
Q 002376 724 LVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-----TAKV 783 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~ki 783 (929)
+||||+++|+|.++++... .++.+++.|++|||+. +++||||||+||+++.++ .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999986321 1356899999999987 899999999999999877 8999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChH
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPE 862 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 862 (929)
+|||+++......... ......++..|+|||++.++.++.++||||+|++++++.. ...++..... ..
T Consensus 153 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-------~~ 221 (269)
T cd05044 153 GDFGLARDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-------QE 221 (269)
T ss_pred CCcccccccccccccc----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-------HH
Confidence 9999998653211100 1112245788999999999999999999999988777543 2222211111 11
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
......... ........+..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 VLQHVTAGG--RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHhcCC--ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111110000 001111223334458889999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=280.08 Aligned_cols=176 Identities=23% Similarity=0.354 Sum_probs=141.3
Q ss_pred HhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KN 718 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~ 718 (929)
+..++|...+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 456789999999999999999986541 12457789999999999999999998854321 12
Q ss_pred cceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
....|+++|++ +++|.++++.. +.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence 23479999998 78898877532 23467999999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
... .....+||+.|+|||++.+ ..++.++||||+|++++++.....
T Consensus 168 ~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (343)
T cd07878 168 ADD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214 (343)
T ss_pred cCC---------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCC
Confidence 421 1223478999999999877 468999999999988887655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=268.07 Aligned_cols=230 Identities=23% Similarity=0.290 Sum_probs=166.2
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 368888999999999999986531 123577899999999999999999987542 22
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 45799999999999999886432 2467899999999987 899999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
+..... .........|+.+|+|||++.+..++.++||||+|++++++.....++..... .. .+......
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~-----~~~~~~~~-- 224 (266)
T cd06651 156 LQTICM---SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MA-----AIFKIATQ-- 224 (266)
T ss_pred cccccc---cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-HH-----HHHHHhcC--
Confidence 532111 11112234689999999999998899999999999887776554433322211 00 01111000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...+..+..+.+.+++++ +||..+|++||+|+||++
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001111222334445455 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=273.77 Aligned_cols=224 Identities=25% Similarity=0.272 Sum_probs=162.1
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
|+..+.||+|+||+||+++... ..+.+.+|++++++++|+||+++.+++... ...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEE
Confidence 5667899999999999987641 123467899999999999999999888543 3489
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999999988875321 2367899999999998 99999999999999999999999999987542
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch-hhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN-VLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~ 872 (929)
.. .......|+..|+|||++.+..++.++||||+|++++++.....++...... ..+.+....... ...
T Consensus 154 ~~-------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~---~~~ 223 (285)
T cd05632 154 EG-------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET---EEV 223 (285)
T ss_pred CC-------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc---ccc
Confidence 11 1112347899999999999999999999999998877765544433322211 111111111110 001
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.. ......+.+++.+|++.||++||+ ++|++.
T Consensus 224 ~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YS----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cC----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11 111222334777999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=271.89 Aligned_cols=225 Identities=21% Similarity=0.295 Sum_probs=160.3
Q ss_pred CCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
|+..+.||+|+||.||+|.... ..+.+.+|+++++.++||||+++++++... ...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEE
Confidence 4556789999999999987641 235688899999999999999999998543 3489999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-- 156 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 156 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc--
Confidence 9999999988765311 2357899999999998 9999999999999999999999999998754211
Q ss_pred CCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
........|+..|+|||++. +..++.++||||+|++++++.....++..... .+.+...... ......
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~-~~~~~~ 229 (282)
T cd06643 157 ----IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKS-EPPTLA 229 (282)
T ss_pred ----ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHHhhc-CCCCCC
Confidence 11123346899999999974 44578899999999887776544333222111 0000000000 000000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. .....-+.+++.+||+.||++||++.++++
T Consensus 230 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QP----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred Cc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 111222334777999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=265.78 Aligned_cols=229 Identities=22% Similarity=0.308 Sum_probs=166.6
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||++... ...++|.+|+.++++++|||++++++++.. ...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEEEE
Confidence 46778899999999999988654 124678999999999999999999998732 2268999
Q ss_pred EecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++++|.++++.. ..++.+++.|++|||+. +|+||||||+||++++++.+||+|||.++.+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999988642 13356899999999998 89999999999999999999999999998653211
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......++..|+|||++.+..++.++||||+|++++++.. ...++.... ..+ ......... ..
T Consensus 157 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~-----~~~~~~~~~--~~ 222 (260)
T cd05070 157 Y-----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NRE-----VLEQVERGY--RM 222 (260)
T ss_pred c-----ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHH-----HHHHHHcCC--CC
Confidence 0 01112245678999999988899999999999987776543 222221111 111 111110000 00
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
+.+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122233447889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=278.20 Aligned_cols=175 Identities=22% Similarity=0.237 Sum_probs=142.4
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+++... ..+.+.+|+.++..++||+|+++++++.+ ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 478889999999999999987651 12346788999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.|+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 899999999999999986421 2356899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.... ........||++|||||++.+ +.++.++||||+|+++|++..+..++
T Consensus 153 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 208 (331)
T cd05624 153 NQDG-----TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred cCCC-----ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence 3211 111223579999999999876 46889999999999998876655444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=294.16 Aligned_cols=172 Identities=18% Similarity=0.216 Sum_probs=138.5
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------------------------CcHHHHHHHHHHHHccCCccc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------------------------GSWKSFIAECETLRNVRHRNL 704 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------------------~~~~~~~~E~~~l~~l~Hpni 704 (929)
..++|+..+.||+|+||+||++..+ ...+.+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999986431 012357789999999999999
Q ss_pred cceeeecccCCCCCcceEEEEEEecCCCCccccccc-------------cccccccHHHHHHHhhhCCCCCEEecCCCCC
Q 002376 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-------------ERKNELDITSALDYLHNDCEVPVVHSDLKPG 771 (929)
Q Consensus 705 v~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~ 771 (929)
|++++++...+ ..|+|+|++. +++.+++.. .+.++.|++.||+|||+. +||||||||+
T Consensus 226 v~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~ 296 (501)
T PHA03210 226 LKIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296 (501)
T ss_pred CcEeEEEEECC-----eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 99999985433 4799999985 567665532 123567999999999998 9999999999
Q ss_pred CeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh
Q 002376 772 NILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 772 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
|||++.++.+||+|||+++.+.... .......+||..|+|||++.+..++.++||||+|++++++...
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~ 364 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKER-----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccc-----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999999998663211 1112335799999999999999999999999999988886543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=269.59 Aligned_cols=232 Identities=21% Similarity=0.282 Sum_probs=165.9
Q ss_pred CCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||.||+|.... ..+.+.+|++++++++|+||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----N 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----C
Confidence 46778999999999999976530 124578899999999999999999998543 4
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++|+|.+++.... .++.|++.|++|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 5899999999999999986432 2357899999999998 8999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.................|+..|+|||++.+..++.++||||+|++++++.....++..... ..... .... .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~--~~~~---~~-~ 225 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-LAAMF--YIGA---HR-G 225 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-HHHHH--Hhhh---cc-C
Confidence 3211111111122345689999999999998899999999999877776554443322211 10000 0000 00 0
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011112222334777999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=263.34 Aligned_cols=224 Identities=23% Similarity=0.289 Sum_probs=166.3
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++... ...+++.+|++++++++|||++++++++... ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 4677899999999999998654 1245788999999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++++|.++++... .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++.+.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 9999999999999986431 2356899999999997 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ........|++.|+|||+..+..++.++||||+|++++++.....++..... .+...........
T Consensus 153 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~----- 219 (256)
T cd08529 153 DN------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIRGVFP----- 219 (256)
T ss_pred Cc------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCC-----
Confidence 21 1112234688999999999999999999999999877776554433322211 1111111111000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........-+.+++.+||+.+|++||+|.++++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 011111122333777999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=275.76 Aligned_cols=175 Identities=25% Similarity=0.278 Sum_probs=141.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+++... ..+.|.+|+.++..++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 478889999999999999887642 12347789999999999999999999854 345
Q ss_pred EEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.|+||||+++|+|.+++.+. +.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 89999999999999988642 22357899999999998 9999999999999999999999999998765
Q ss_pred ccccCCCCCccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.... .......+||+.|||||++.. ..++.++||||+|++++++..+..++
T Consensus 153 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 208 (331)
T cd05597 153 LADG-----TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred CCCC-----CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence 3211 111223469999999999863 45789999999999888876554443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=268.15 Aligned_cols=230 Identities=22% Similarity=0.299 Sum_probs=167.9
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..++||+|+||.||+|... ...++|.+|+.++++++||||+++++++.. ...++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEEE
Confidence 357888899999999999998764 234678999999999999999999998632 237999
Q ss_pred EEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++|+|.++++... .++.+++.||+|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999875321 2356899999999987 9999999999999999999999999999765321
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.. .......++..|+|||++.+..++.++||||+|++++++.. ...++.... ++.......... .
T Consensus 156 ~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~--~ 221 (260)
T cd05067 156 EY-----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-------NPEVIQNLERGY--R 221 (260)
T ss_pred Cc-----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHcCC--C
Confidence 10 11122346778999999998899999999999987776543 222221111 111111111110 0
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.......+..+.+++.+|++.+|++||+++++...|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00111112223347779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=275.22 Aligned_cols=218 Identities=24% Similarity=0.282 Sum_probs=157.1
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+|+..+.||+|+||.||+++... ..+.+..|..+++.+. |++|+++++++.+. ..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence 36778999999999999987641 1234677888888886 56788888887442 34
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 899999999999998876432 3467899999999998 99999999999999999999999999987532
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ........||+.|||||++.+..++.++||||+|++++++.++..++..... .+.... +. ......
T Consensus 153 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~-i~---~~~~~~ 220 (323)
T cd05615 153 VD------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQS-IM---EHNVSY 220 (323)
T ss_pred CC------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH-HH---hCCCCC
Confidence 11 1112335699999999999999999999999999887776554444322211 111111 11 101000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
. ..+...+.+++.+|++.+|++|++.
T Consensus 221 p----~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 P----KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 1112222337779999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=272.17 Aligned_cols=228 Identities=27% Similarity=0.407 Sum_probs=163.2
Q ss_pred CCCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|+||.||+++.... .....+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 56678999999999999887622 1233459999999999999999999865 344899
Q ss_pred EEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||||+++++|.+++.... .++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+.....
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-- 150 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-- 150 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--
Confidence 999999999999887222 3367899999999998 999999999999999999999999999875411
Q ss_pred CCCCCccccceeccccccccccccC-CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGL-GERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.........++..|+|||++. +..++.++||||+|++++++.....++..... ...+.+...............
T Consensus 151 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 151 ----NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp ----TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 112233457899999999998 78899999999999776665443333322211 111111111111111010000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ...+. +++.+|++.||++||++.++++
T Consensus 227 ~~~---~~~l~-~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REK---SEELR-DLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTS---HHHHH-HHHHHHSSSSGGGSTTHHHHHT
T ss_pred chh---HHHHH-HHHHHHccCChhHCcCHHHHhc
Confidence 000 12233 3777999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=297.58 Aligned_cols=233 Identities=23% Similarity=0.270 Sum_probs=167.1
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
....++|.+.+.||+|+||.||+++... ....|..|+.++++++|||||+++++|... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence 3445689999999999999999987641 235688999999999999999999988653 2
Q ss_pred cceEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCC----CCEEecCCCCCCeeecC-----
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCE----VPVVHSDLKPGNILLDE----- 777 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~----~~iiHrDlk~~NILl~~----- 777 (929)
...+|+||||+++|+|.+++... ..++.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 34589999999999999988632 1336799999999998521 36999999999999964
Q ss_pred ------------CCceEEeccccccccccccCCCCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcch
Q 002376 778 ------------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 778 ------------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~~ 843 (929)
.+.+||+|||+++.+... .......||+.|||||++.+ ..++.++||||+||++|++.+
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccc-------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 335899999999865321 11233579999999999864 458999999999988888765
Q ss_pred hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 844 VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...++..... ..+++ ..+...... .... ...-+.+++.+||+.+|++||++.|++.
T Consensus 239 Gk~PF~~~~~-~~qli-----~~lk~~p~l--pi~~-~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 239 GKTPFHKANN-FSQLI-----SELKRGPDL--PIKG-KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCCcCCc-HHHHH-----HHHhcCCCC--CcCC-CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5544432221 11111 111101100 0000 1112233777999999999999999984
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=278.45 Aligned_cols=173 Identities=26% Similarity=0.339 Sum_probs=138.0
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...+.||+|+||.||+|+... ....+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence 578889999999999999986541 123677899999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++ +|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99999974 8887765322 2356899999999998 999999999999999999999999999975421
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.. .......+|+.|+|||++.+ ..++.++||||+|++++++.++..++
T Consensus 157 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf 205 (309)
T cd07872 157 PT------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205 (309)
T ss_pred Cc------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 11 11123467899999998865 45899999999998888776554433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=266.25 Aligned_cols=226 Identities=25% Similarity=0.313 Sum_probs=163.3
Q ss_pred eeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+|.+.. ..+.|.+|++++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999986531 23468899999999999999999999854 3479999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|+|.+++.... .++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccc
Confidence 9999999999886532 1246899999999998 99999999999999999999999999998764321
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
.. ........++..|+|||++.+..++.++||||+|++++++.. +..++..... .+.... .... .. ..
T Consensus 152 ~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~-~~~~---~~--~~ 220 (257)
T cd05040 152 DH---YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKK-IDKE---GE--RL 220 (257)
T ss_pred cc---eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-HHhc---CC--cC
Confidence 11 111123457889999999998899999999999988777543 2222211111 111000 0000 00 00
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
...+..+.-+.+++.+|++.+|++||+++|+++.|.+
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 0011122233347889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=263.33 Aligned_cols=233 Identities=21% Similarity=0.259 Sum_probs=168.0
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|...+.||+|+||.||+|... ...+.|.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------ 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence 45777899999999999998642 1134688999999999999999999988532
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++.... .++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 2689999999999999986422 2357899999999997 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
...... .......++..|+|||++.+..++.++||||+|++++++.. ...++..... .+ ........
T Consensus 157 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~-----~~~~~~~~ 224 (270)
T cd05056 157 LEDESY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--ND-----VIGRIENG 224 (270)
T ss_pred cccccc-----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HH-----HHHHHHcC
Confidence 532210 11112235678999999988889999999999987776432 2222211111 01 11000000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. +...+...+..+.+++.+|+..+|++|||+.|+++.|+++..+
T Consensus 225 ~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 E--RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0001111122333477799999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=266.17 Aligned_cols=230 Identities=21% Similarity=0.316 Sum_probs=167.5
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..+.||+|+||.||++.... ..+.|.+|++++++++|+||+++++++.. ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence 3578889999999999999886531 23578899999999999999999999854 237999
Q ss_pred EEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++|+|.+++.... .++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999986421 2356899999999987 9999999999999999999999999999765321
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.. .......++..|+|||++.+..++.++||||+|++++++.+ ...++..... ..+.........
T Consensus 156 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~-- 221 (260)
T cd05073 156 EY-----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR-- 221 (260)
T ss_pred Cc-----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCC--
Confidence 10 11112345678999999998889999999999987776543 2222221111 111111110000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+........+.+++.+|++.+|++||++.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00001112223347779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=269.63 Aligned_cols=235 Identities=24% Similarity=0.292 Sum_probs=170.0
Q ss_pred HhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccCCC-CCcc
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++++|+..+.||+|+||.||+|.... ..++|.+|+.+++++ +||||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 467899999999999999999988752 235788999999999 79999999999876443 2345
Q ss_pred eEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..++||||+++++|.++++..+ .++.|++.||+|||+. +++||||+|+||++++++.+|++|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 6899999999999998875322 2356899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHH
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPEL 863 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l 863 (929)
+...... ........|+..|+|||++.. ..++.++||||+|++++++.....++..... . ..+
T Consensus 160 ~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~-----~~~ 227 (275)
T cd06608 160 SAQLDST------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-M-----RAL 227 (275)
T ss_pred ceecccc------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-H-----HHH
Confidence 8764321 111223468999999998754 3478899999999887776554444322111 0 011
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ...............+++++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 FKIPR-NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhhc-cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11100 000001111112223334777999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=272.96 Aligned_cols=231 Identities=21% Similarity=0.292 Sum_probs=167.3
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||+||++.... ..+.+.+|+++++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEE
Confidence 467778899999999999977541 135788999999999999999999998643 4589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++|+|.++++... .++.+++.|+.|||+.+ +++||||||+||++++++.++|+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999998876432 33678999999999742 7999999999999999999999999998754211
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch------hhhccChHHHHhhcc
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN------VLQVLDPELRQLMTS 869 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~~~~~ 869 (929)
......|+..|+|||++.+..++.++||||+|++++++.....++...... ..++.+ .......
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~- 227 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQ- 227 (284)
T ss_pred --------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhh-
Confidence 112347899999999998889999999999998877765444443321110 000000 1111110
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.........+ ....+.+++.+|++.||++||++.|+++.
T Consensus 228 ~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 EPPPRLPSSD-FPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ccCCCCCchh-cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111111111 22223348889999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=252.62 Aligned_cols=171 Identities=29% Similarity=0.387 Sum_probs=137.6
Q ss_pred CCCCCceeecccCceeEEeccccCc----------------------HHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS----------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~----------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
..|+....||+|.||.||+|..+.+ .....+|+..++.++|||||.+..++..-
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 4678889999999999999965411 12456899999999999999999998753
Q ss_pred cceEEEEEEecCCCCccccccccc-------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC----Cce
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER-------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE----MTA 781 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ 781 (929)
...+++++||++. +|.+.++-.+ .+..||+.|+.|||++ -|+|||+||+|||+..+ |.+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 3458999999986 8888876322 2246899999999998 79999999999999877 899
Q ss_pred EEeccccccccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcc
Q 002376 782 KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFN 842 (929)
Q Consensus 782 ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~ 842 (929)
||+|||+||.+..... .......++-|++|+|||++.|.+ |+.+.|||+.||+..|+.
T Consensus 176 KIaDlGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred EeecccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 9999999998753221 122334567899999999999876 899999999998765543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=261.86 Aligned_cols=230 Identities=24% Similarity=0.297 Sum_probs=166.8
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 578889999999999999886431 124678899999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++||||+++++|.+++.... .++.+++.|++|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 35899999999999999886432 3467899999999998 999999999999999999999999999976
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
...... .........|+..|+|||++.+..++.++||||+|++++++.....++..... .... ........
T Consensus 154 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~-----~~~~~~~~ 224 (263)
T cd06625 154 LQTICS---SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-MAAI-----FKIATQPT 224 (263)
T ss_pred cccccc---ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-HHHH-----HHHhccCC
Confidence 532111 01111234678899999999999999999999999887776554333221111 1000 00000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
....++.....+.+++.+||+.+|++|||++|+++.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 --NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111122223347779999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=266.13 Aligned_cols=216 Identities=22% Similarity=0.296 Sum_probs=157.0
Q ss_pred eeecccCceeEEeccccC-------------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 667 NLIGSGSFGSVLHNERTG-------------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~-------------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+.||+|+||.||+|.... ..+.|.+|+.++++++||||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 468999999999877631 13568899999999999999999999865 2 2
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-------ceEEec
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-------TAKVGD 785 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~ki~D 785 (929)
.++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 699999999999999886432 2356999999999997 999999999999999888 799999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHH
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPEL 863 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l 863 (929)
||+++.... .....++..|+|||++.+. .++.++||||+|++++++... +..|..... ....
T Consensus 152 fg~a~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~----~~~p~~~~~--~~~~ 215 (259)
T cd05037 152 PGIPITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN----GEEPLSTLS--SSEK 215 (259)
T ss_pred CCccccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhC----CCCCcccCC--chhH
Confidence 999986521 1223567789999999877 789999999999877764331 222210000 0000
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
.............. ...+. +++.+||+.+|++||++.|+++.|+
T Consensus 216 ~~~~~~~~~~~~~~---~~~~~-~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 ERFYQDQHRLPMPD---CAELA-NLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHhcCCCCCCCC---chHHH-HHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000000000 12233 3778999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=269.06 Aligned_cols=229 Identities=21% Similarity=0.271 Sum_probs=162.5
Q ss_pred CCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
++|+..+.||+|+||.||+|+... ....+.+|+.+++.++||||+++++++... ...++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEE
Confidence 467777899999999999987541 224577899999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||||+++|+|.++++... .++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999999999876332 3367899999999998 9999999999999999999999999998765321
Q ss_pred CCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
........|+..|+|||++. ...++.++||||+|++++++.....++..... ...+...............
T Consensus 160 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 160 -----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-MRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred -----ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-hhhHHhhhccCCCCCcccc
Confidence 11123347899999999874 45689999999999887775443332211111 0000000000000000000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....++ .+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~----~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSN----SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCH----HHHHHHHHHccCCchhCcCHHHHhc
Confidence 001112 2334777999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=274.19 Aligned_cols=227 Identities=22% Similarity=0.239 Sum_probs=168.0
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
++|+..+.||+|+||.||++... ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEE
Confidence 57888999999999999998753 1245678899999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++++|.+++.+.. .++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999999999886422 3356899999999998 99999999999999999999999999987653221
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|++.|+|||.+.+..++.++||||+|++++++.....++..... ....... ... .......
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~-~~~-----~~~~~~~ 237 (297)
T cd06656 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLI-ATN-----GTPELQN 237 (297)
T ss_pred -----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeee-ccC-----CCCCCCC
Confidence 111234688999999999998899999999999887776554433321111 0000000 000 0000011
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..+...+++++.+||+.+|++||+++|+++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223333445778999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=261.07 Aligned_cols=228 Identities=25% Similarity=0.278 Sum_probs=170.8
Q ss_pred CCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+|+..+.||.|.-|+||.++..+. ..+...|.+||+.++||.++.+|+.+. ...+.
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~~ 152 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKYS 152 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----cccee
Confidence 344568899999999999887632 235567999999999999999999984 45568
Q ss_pred EEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|+|||||+||+|....+++ |.++.+|..||+|||-. |||.|||||+||||.++|++.++||-++...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999887643 34467899999999998 9999999999999999999999999988643
Q ss_pred cc-----------------------------c---cCC------------------CCCccccceeccccccccccccCC
Q 002376 793 LE-----------------------------R---VDN------------------QSSISSTHVFMGSIGYVPPEYGLG 822 (929)
Q Consensus 793 ~~-----------------------------~---~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~ 822 (929)
.. . ... .........++||-.|+|||+++|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 000 000122356789999999999999
Q ss_pred CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCC
Q 002376 823 ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGR 900 (929)
Q Consensus 823 ~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 900 (929)
...+.++|=|++|+++||+..+.-++..... .+..++...+.- +... .++..++||+++.+..||.+|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F--p~~~--------~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF--PEEP--------EVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC--CCCC--------cchhHHHHHHHHHhccChhhh
Confidence 9999999999999888887655555443322 334444333221 1111 234455668889999999999
Q ss_pred CC----HHHHH
Q 002376 901 IG----IREAL 907 (929)
Q Consensus 901 Ps----~~ev~ 907 (929)
-- ++||-
T Consensus 380 lg~~rGA~eIK 390 (459)
T KOG0610|consen 380 LGSKRGAAEIK 390 (459)
T ss_pred hccccchHHhh
Confidence 87 66664
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=273.79 Aligned_cols=212 Identities=25% Similarity=0.250 Sum_probs=149.1
Q ss_pred ecccCceeEEeccccCc-------------------HHHHHHHHHHHHcc---CCccccceeeecccCCCCCcceEEEEE
Q 002376 669 IGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNV---RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
||+|+||+||+|+.... ...+..|..++.+. +||||+++++++... ...|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 69999999999876411 12334566666655 699999999988543 3489999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--- 149 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD--- 149 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---
Confidence 9999999998876432 2367899999999998 9999999999999999999999999998753211
Q ss_pred CCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......+||+.|||||++.+.. ++.++||||+|+++|++..+..++.... ..+.. ............
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--~~~~~----~~i~~~~~~~~~-- 218 (330)
T cd05586 150 ---NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMY----RNIAFGKVRFPK-- 218 (330)
T ss_pred ---CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--HHHHH----HHHHcCCCCCCC--
Confidence 11123457999999999987654 8999999999999998766554432211 11111 100000000000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
..+...+++++.+|++.||++||++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 0112222346779999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=268.81 Aligned_cols=227 Identities=20% Similarity=0.274 Sum_probs=161.7
Q ss_pred CCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|+..+.||+|+||.||+|+... ..+.+.+|+++++.++||||+++++++... ...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence 567888999999999999987642 235688899999999999999999988543 35899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||+++++|..++.+. .....|++.|++|||+. +++|||+||+||+++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999998776432 12367899999999998 9999999999999999999999999998753211
Q ss_pred cCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
........|++.|+|||++. ...++.++||||+|+++|++.....++..... .+ .........
T Consensus 164 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~----~~~~~~~~~ 231 (292)
T cd06644 164 ------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MR----VLLKIAKSE 231 (292)
T ss_pred ------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HH----HHHHHhcCC
Confidence 11123346889999999985 34478899999999887775544333221111 00 011111000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............++. +++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~-~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PPTLSQPSKWSMEFR-DFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccCCCCcccCHHHH-HHHHHHhcCCcccCcCHHHHhc
Confidence 000000001111223 3777999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=266.06 Aligned_cols=230 Identities=26% Similarity=0.351 Sum_probs=164.3
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.+|+..+.||+|+||.||++.+. ....+|.+|++++++++|||++++++++... ...++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEEEE
Confidence 35677899999999999998653 1245799999999999999999999998543 3479999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.++++... ..+.+++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 9999999999886322 2356889999999998 89999999999999999999999999987653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........++.+|+|||++.++.++.++||||+|++++++.. .+..|... .....+.......... ..
T Consensus 155 ----~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~----~g~~p~~~--~~~~~~~~~~~~~~~~--~~ 222 (256)
T cd05112 155 ----YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS----EGKTPYEN--RSNSEVVETINAGFRL--YK 222 (256)
T ss_pred ----ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc----CCCCCCCc--CCHHHHHHHHhCCCCC--CC
Confidence 011112245678999999998899999999999987766432 12222100 0000111111100000 00
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
+......+.+++.+||+.+|++||+|.|++++|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0011123334888999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=290.68 Aligned_cols=179 Identities=23% Similarity=0.310 Sum_probs=139.6
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCc------cccceeeecc
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHR------NLVKLITSCS 712 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hp------niv~l~~~~~ 712 (929)
+++...+++|+..++||+|+||+||+|++.. ..+.+..|++++++++|. +++++++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445567899999999999999999987641 123456788888877654 5888888875
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-----
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----- 779 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----- 779 (929)
.. ..+.++|||++ +++|.+++.+.. .++.||+.||+|||+. .+||||||||+|||++.++
T Consensus 202 ~~----~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NE----TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cC----CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 32 34589999998 678888876432 3467999999999973 2899999999999998765
Q ss_pred -----------ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 780 -----------TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 780 -----------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.+||+|||.+.... ......+||+.|||||++.+..++.++||||+||++|++..+..++
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~---------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER---------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc---------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999876321 1123468999999999999999999999999999988876655544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=291.22 Aligned_cols=239 Identities=24% Similarity=0.278 Sum_probs=164.6
Q ss_pred HhhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCC---
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK--- 717 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~--- 717 (929)
+...+|+..++||+||||.|||++.+- ......+|++.+++++|||||+++..+.+...+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 345577778899999999999988761 223567899999999999999988776643110
Q ss_pred --------------------------------------------------------------------------------
Q 002376 718 -------------------------------------------------------------------------------- 717 (929)
Q Consensus 718 -------------------------------------------------------------------------------- 717 (929)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -------------------------------CcceEEEEEEecCCCCcccccccccc---------ccccHHHHHHHhhh
Q 002376 718 -------------------------------NMEFLALVYEFLSNGSLGDWIHGERK---------NELDITSALDYLHN 757 (929)
Q Consensus 718 -------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~ia~aL~yLH~ 757 (929)
....+|+-||||+...++++++.... ...+|+.||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 00236788899988778777764332 25689999999999
Q ss_pred CCCCCEEecCCCCCCeeecCCCceEEecccccccccc---c---------cCCCCCccccceeccccccccccccCCCC-
Q 002376 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE---R---------VDNQSSISSTHVFMGSIGYVPPEYGLGER- 824 (929)
Q Consensus 758 ~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~---~---------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~- 824 (929)
. +||||||||.||++|++..+||+|||+|..... . ..........+..+||.-|+|||++.+..
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 8 899999999999999999999999999987320 0 00011122346679999999999998765
Q ss_pred --CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH-HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCC
Q 002376 825 --PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR-QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI 901 (929)
Q Consensus 825 --~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 901 (929)
|+.|+|+||+|++.+|+... +.... ++.. ++ ..++ ..++....... +.+..-.+ ++.++++.||++||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~yP-F~TsM--ERa~-iL-~~LR~g~iP~~~~f~~---~~~~~e~s-lI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLYP-FGTSM--ERAS-IL-TNLRKGSIPEPADFFD---PEHPEEAS-LIRWLLSHDPSKRP 863 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhcc-CCchH--HHHH-HH-HhcccCCCCCCccccc---ccchHHHH-HHHHHhcCCCccCC
Confidence 99999999999887775322 11111 1110 00 1111 11111100000 11222223 77799999999999
Q ss_pred CHHHHHH
Q 002376 902 GIREALR 908 (929)
Q Consensus 902 s~~ev~~ 908 (929)
||.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999874
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=272.87 Aligned_cols=175 Identities=24% Similarity=0.259 Sum_probs=140.7
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..++||+|+||.||+++... ..+.|.+|+.++..++||+|+++++++.+ ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 478889999999999999987642 12247789999999999999999998854 335
Q ss_pred EEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.|+||||+++|+|.+++++. +.++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 89999999999999998642 12356899999999998 9999999999999999999999999998754
Q ss_pred ccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.... .......+||+.|||||++. ...++.++||||+|++++++..+..++
T Consensus 153 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf 208 (332)
T cd05623 153 MEDG-----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208 (332)
T ss_pred ccCC-----cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence 2211 11122357999999999986 346899999999998887765554443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=264.35 Aligned_cols=224 Identities=24% Similarity=0.364 Sum_probs=164.6
Q ss_pred eeecccCceeEEeccccCc--------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTGS--------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~~--------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+|..... .+.+.+|++.++.++|+|++++++++.. ....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4699999999999876421 4678899999999999999999999865 33489999
Q ss_pred EecCCCCcccccccc---------c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 727 EFLSNGSLGDWIHGE---------R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 727 e~~~~gsL~~~l~~~---------~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
||+++|+|.+++... . .++.+++.|++|||+. +++||||||+||++++++.+|++|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999998754 1 2356899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh-HHhhhcCCchhhhccChHHHHhhc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV-KWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+....... ........+++.|+|||.+.+..++.++||||+|++++++... ..++..... ..+.....
T Consensus 153 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~ 221 (262)
T cd00192 153 RDVYDDDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLR 221 (262)
T ss_pred cccccccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHH
Confidence 87643211 1112334678899999999988999999999999877765331 222221111 11111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
... ....+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 222 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCC--CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 00111111222334777999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=271.85 Aligned_cols=227 Identities=22% Similarity=0.259 Sum_probs=166.2
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.+|+..+.||.|+||.||+|... ...+.+.+|+.+++.++|||++++++++... ...++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEE
Confidence 46888899999999999988643 2345788999999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++|+|.+++.... .+..+++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999999999876432 2356899999999998 999999999999999999999999999886532211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
......|+..|+|||.+.+..++.++||||+|++++++.....++..... ..+ ....... .......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-~~~-----~~~~~~~-~~~~~~~ 237 (296)
T cd06655 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRA-----LYLIATN-GTPELQN 237 (296)
T ss_pred ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH-----HHHHHhc-CCcccCC
Confidence 11234688999999999998899999999999887776544333221111 000 0000000 0000001
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..+...+.+++.+||..||++||++.+++.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1112223344778999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=246.78 Aligned_cols=235 Identities=21% Similarity=0.212 Sum_probs=176.0
Q ss_pred hCCCCCc-eeecccCceeEEeccccCcHHHH-----------HHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHE-NLIGSGSFGSVLHNERTGSWKSF-----------IAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~-~~iG~G~~g~Vy~~~~~~~~~~~-----------~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
|++|+.. ++||-|-.|+|..+..+.+.+.| .+|++.--.. .|||||.++++|...- .+...+.+||
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm 138 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM 138 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence 4556544 58999999999988887655544 4788865555 6999999999985432 4567789999
Q ss_pred EecCCCCcccccccccc----------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEeccccccccc
Q 002376 727 EFLSNGSLGDWIHGERK----------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLL 793 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~~----------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~ 793 (929)
|+|+||.|+..+.+++. +..||+.|++|||+. +|.||||||+|+|... +..+|++|||+|+.-.
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999876553 356899999999998 9999999999999964 4579999999998532
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc-ccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT-SNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~ 872 (929)
. .......+-|+.|.|||++...+|+..+|+||.|+++|-+.-+.-++-. .-...+.+.++..+. ....
T Consensus 216 ~-------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS---~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 216 E-------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred C-------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc---cCCccCChhHHhHhhccCcc
Confidence 1 1223445779999999999999999999999999877654332222211 111233444433221 1223
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...+.|.|+++..+++++..+..+|.+|-|+.|++.
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 344567899999999999999999999999998864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=269.40 Aligned_cols=227 Identities=18% Similarity=0.278 Sum_probs=163.5
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEE
Confidence 357788999999999999987641 134688999999999999999999988543 3589
Q ss_pred EEEEecCCCCcccccccc-----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE-----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~-----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+||||+++++|.++++.. ..++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999887642 123568999999999642 8999999999999999999999999998765
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC------CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER------PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
... ......|++.|+|||++.+.. ++.++||||+|++++++.+...++..... .... ..+...
T Consensus 154 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~-~~~~~~ 222 (286)
T cd06622 154 VAS--------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIF-AQLSAI 222 (286)
T ss_pred cCC--------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHH-HHHHHH
Confidence 211 112236888999999986543 58899999999887776554444322111 1110 111111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ...+......+.+++.+||+.+|++||++++++.
T Consensus 223 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcCC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11110 0111112223334777999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=261.00 Aligned_cols=230 Identities=21% Similarity=0.294 Sum_probs=165.3
Q ss_pred CCCCceeecccCceeEEeccccC-------------------------cHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
+|...+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 35677899999999999986531 014577899999999999999999998543
Q ss_pred CCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
...++||||+++++|.+++.... .++.+++.|++|||+. +++||||||+||++++++.+||+|||.
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCC
Confidence 34799999999999999886432 3467899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
++...................|+..|+|||++.+..++.++||||+|++++++.....++..... ...+. ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~--~~~~~~- 228 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIF--KIGENA- 228 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHH--HHhccC-
Confidence 98764221111111112234688999999999998999999999999877775544333322111 10000 000000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ........+.+++.+||+.||++||++.|+++
T Consensus 229 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 -SPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 11112222334777999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-29 Score=269.04 Aligned_cols=232 Identities=21% Similarity=0.217 Sum_probs=167.8
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||.|++|.||++.... ..+++.+|++++++++||||++++++|...+ ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 467888999999999999988641 2356889999999999999999999986532 33579
Q ss_pred EEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+||||+++++|.+++... ..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999998876421 12467899999999998 999999999999999999999999999875
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc-c
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS-N 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~ 870 (929)
.... ......++..|+|||.+.+..++.++|||++|++++++..+..++...... ............. .
T Consensus 155 ~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 224 (287)
T cd06621 155 LVNS--------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMP 224 (287)
T ss_pred cccc--------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCC
Confidence 4221 112345788999999999999999999999998887766555443322110 0000111111000 0
Q ss_pred -c--hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 -E--SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 -~--~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ...........+.+.+++.+||+.+|++||||.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0000000112233445888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=265.10 Aligned_cols=227 Identities=23% Similarity=0.279 Sum_probs=167.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||+|.... ..+++.+|++++++++||||+++++++... ...|+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEE
Confidence 578888999999999999987652 245789999999999999999999998653 4489999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++++|.+++.... .++.+++.|++|||+. +++|||++|+||++++++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 9999999999886322 3467899999999998 89999999999999999999999999998653221
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|+..|+|||++.+..++.++||||+|++++++.....++..... .... ... ..........
T Consensus 154 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~-----~~~-~~~~~~~~~~ 221 (256)
T cd06612 154 -----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAI-----FMI-PNKPPPTLSD 221 (256)
T ss_pred -----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhh-----hhh-ccCCCCCCCc
Confidence 112234588999999999998999999999999887776544333221111 0000 000 0000000000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1111122233777999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=270.81 Aligned_cols=229 Identities=23% Similarity=0.329 Sum_probs=165.4
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||++.... ..+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEE
Confidence 3568888999999999999987641 235688999999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++|+|.+++.... .++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999999999886422 2467899999999998 999999999999999999999999999875421
Q ss_pred ccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
. ........|++.|+|||++. +..++.++||||+|++++++.....++..... .+. +.....
T Consensus 156 ~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~- 222 (280)
T cd06611 156 T------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRV----LLKILK- 222 (280)
T ss_pred c------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHH----HHHHhc-
Confidence 1 11123456899999999875 34578899999999887776544433322111 000 111000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
........++.....+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000000111112223347779999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=291.12 Aligned_cols=238 Identities=23% Similarity=0.378 Sum_probs=175.6
Q ss_pred HHhhCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeec
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSC 711 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~ 711 (929)
+...++.+..+.+|+|+||.|++|... .+.+.+..|+++|..+ +|||||.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333444555679999999999987633 1356889999999998 599999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecC
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSD 767 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrD 767 (929)
... +..++|+||++.|+|.++++..+ .++.|||.||+||++. ++||||
T Consensus 372 t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD 443 (609)
T KOG0200|consen 372 TQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD 443 (609)
T ss_pred ccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence 763 34899999999999999998766 1257999999999998 899999
Q ss_pred CCCCCeeecCCCceEEeccccccccccccCCCCCccccceecc--ccccccccccCCCCCCCCCCCCCCcCCCCCcchhH
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG--SIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
+.++|||+.++..+||+|||+||..... .........| ...|||||.+....|+.|+||||||+.+||+ ..
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~-----~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei--fs 516 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNK-----DYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEI--FT 516 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCC-----CceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHH--hh
Confidence 9999999999999999999999964321 1111111122 4469999999999999999999999988883 22
Q ss_pred HhhhcCCchhhhcc-ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 846 WVESNLPENVLQVL-DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 846 ~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
+....+|. +. ...+.+.+.... .......|..++.. +|..||+.+|++||++.|+++.++....
T Consensus 517 LG~~PYp~----~~~~~~l~~~l~~G~-r~~~P~~c~~eiY~-iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 517 LGGTPYPG----IPPTEELLEFLKEGN-RMEQPEHCSDEIYD-LMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCC----CCcHHHHHHHHhcCC-CCCCCCCCCHHHHH-HHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22233332 11 122222111111 11112234555665 8999999999999999999999999644
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=270.99 Aligned_cols=237 Identities=20% Similarity=0.232 Sum_probs=166.3
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||++.... ..+.+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence 368888999999999999886541 13457789999999999999999998854 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+++|+|.++++... .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 899999999999999986432 2356899999999998 99999999999999999999999999987421
Q ss_pred cccCC---------CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 794 ERVDN---------QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 794 ~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
..... ...........|+..|+|||++.+..++.++||||+|++++++.++..++... ...++......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~ 230 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVIS 230 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHh
Confidence 00000 00000112346788999999999889999999999998877765544333211 11111111111
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.... ..... ...+..+.+++.+||+.||++||++.++.+.++.
T Consensus 231 ~~~~-~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE-WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC-CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000 00000 0122223347779999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=259.34 Aligned_cols=224 Identities=24% Similarity=0.307 Sum_probs=158.9
Q ss_pred eeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecC
Q 002376 667 NLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLS 730 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~ 730 (929)
++||+|+||.||+|.... ....|.+|++++++++||||+++++++.... ..++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECCC
Confidence 368999999999986431 1236889999999999999999999985433 4799999999
Q ss_pred CCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 731 NGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 731 ~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
+|+|.+++.... .+..+++.|+.|+|+. +++||||||+||++++++.+|++|||+++.......
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 148 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---- 148 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc----
Confidence 999999875321 2356899999999998 999999999999999999999999999875422111
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 881 (929)
.......+++.|+|||++.+..++.++||||+|++++++.. .+..|... .............. +...+...
T Consensus 149 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~----~g~~p~~~--~~~~~~~~~~~~~~--~~~~~~~~ 219 (250)
T cd05085 149 -SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS----LGVCPYPG--MTNQQAREQVEKGY--RMSCPQKC 219 (250)
T ss_pred -ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc----CCCCCCCC--CCHHHHHHHHHcCC--CCCCCCCC
Confidence 01111234678999999998899999999999987766432 12222100 00001111000000 00001112
Q ss_pred HHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 882 ITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 882 ~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
...+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 223334888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=259.54 Aligned_cols=225 Identities=25% Similarity=0.348 Sum_probs=164.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
++|+..+.||+|+||.||++...+ ..+.+.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEEEC
Confidence 357788999999999999987652 245788999999999999999999998532 26999999
Q ss_pred cCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 729 LSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 729 ~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
+++|+|.++++... .++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999886322 2356899999999997 9999999999999999999999999998754211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
......+..|+|||++.+..++.++||||+|++++++.. ...++... ...+. .......... ..
T Consensus 154 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~-----~~~~~~~~~~--~~ 218 (254)
T cd05083 154 ------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--SLKEV-----KECVEKGYRM--EP 218 (254)
T ss_pred ------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--CHHHH-----HHHHhCCCCC--CC
Confidence 111234568999999998899999999999987777532 22211111 11111 1111111000 00
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+..+..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11122223347889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=269.28 Aligned_cols=223 Identities=26% Similarity=0.339 Sum_probs=173.0
Q ss_pred hhCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.+..|.....||+|.|++|..++.. ...+.+.+|+++|..++|||||+++.+.... .
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----A 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----c
Confidence 4568889999999999999988765 1234588999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.+|+||||+.+|.+++|+.. .+.+..|+.+|++|+|++ .|||||||++|||++.++.+||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence 48999999999999999963 234467999999999998 8999999999999999999999999999877
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCch---hhhccChHHHHhhc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPEN---VLQVLDPELRQLMT 868 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~ 868 (929)
.. ......++|++.|.|||++.+..| ++++|+|+.|+++|.+. .+.+|.. +.+.-++-++..+.
T Consensus 206 ~~-------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV-----~GsLPFDG~~lk~Lr~rvl~gk~r 273 (596)
T KOG0586|consen 206 DY-------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV-----EGSLPFDGQNLKELRPRVLRGKYR 273 (596)
T ss_pred cc-------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee-----ecccccCCcccccccchheeeeec
Confidence 42 223455799999999999999886 89999999998877654 4444431 11111222222111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.+..+..-.++++++.+..+|.+|++++++.+.
T Consensus 274 --------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 --------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 112233334457779999999999999998753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=270.79 Aligned_cols=224 Identities=25% Similarity=0.283 Sum_probs=162.8
Q ss_pred CCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 664 SHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.....||+|+||.||++... ...+.+.+|+..++.++||||+++++++... ...++|||
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv~e 99 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVVME 99 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEEEe
Confidence 33467999999999988653 1234688999999999999999999998543 34899999
Q ss_pred ecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCC
Q 002376 728 FLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~ 800 (929)
|+++++|.+++...+ .++.+++.|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---- 172 (292)
T cd06658 100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---- 172 (292)
T ss_pred CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc----
Confidence 999999999875332 3367899999999998 99999999999999999999999999987553211
Q ss_pred CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHH
Q 002376 801 SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDC 880 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 880 (929)
.......|+..|+|||+..+..++.++||||+|++++++.+...++..... .+.+ ..+.......... ...
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~-~~~~~~~~~~~~~----~~~ 243 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAM-RRIRDNLPPRVKD----SHK 243 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH-HHHHhcCCCcccc----ccc
Confidence 112234689999999999888899999999999887776554433321111 0000 0111111110000 011
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 881 LITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 881 ~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....+++++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2223344777999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=272.78 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=168.5
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...+.||+|+||.||+|+... ....+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeEE
Confidence 578889999999999999986641 124577899999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||++ ++|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9999997 68888775422 2357899999999998 999999999999999999999999999975421
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-h---hhcc----ChHHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-V---LQVL----DPELR 864 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~---~~~~----~~~l~ 864 (929)
.. .......+++.|+|||++.+. .++.++||||+|++++++.++..++..... . . ...+ +....
T Consensus 157 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 157 PT------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred CC------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 11 111223578999999988764 478999999999888887665544322111 0 0 0000 00000
Q ss_pred Hhhcccc-------hhh----hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHHHHh
Q 002376 865 QLMTSNE-------SQT----IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQEILL 918 (929)
Q Consensus 865 ~~~~~~~-------~~~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~~ 918 (929)
....... ... ......+...+++++.+|++.||.+|||++|+++ .++...+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~ 297 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence 0000000 000 0000112223445888999999999999999986 4555554444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=259.04 Aligned_cols=230 Identities=22% Similarity=0.291 Sum_probs=167.3
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEE
Confidence 3578889999999999999987541 246788999999999999999999988543 3489
Q ss_pred EEEEecCCCCcccccccc-c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE-R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~-~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++++|.+++... . .+..|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999999988644 1 2367899999999998 999999999999999999999999999876532
Q ss_pred ccCCCCCccccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.. .......|+..|+|||++.+. .++.++||||+|++++++.....++..... ..... ......+.
T Consensus 154 ~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-~~~~~-~~~~~~~~--- 222 (262)
T cd06613 154 TI------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-MRALF-LISKSNFP--- 222 (262)
T ss_pred hh------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHH-HHHhccCC---
Confidence 11 112234688999999999877 789999999999887776554433322211 00000 00000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............-+++++.+||..+|++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000001111222334788999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=261.61 Aligned_cols=225 Identities=24% Similarity=0.317 Sum_probs=161.6
Q ss_pred eeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecC
Q 002376 667 NLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLS 730 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~ 730 (929)
++||+|+||.||++.... ..+.|.+|++++++++||||+++++++.... ..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcCC
Confidence 468999999999886541 2457889999999999999999999985433 4799999999
Q ss_pred CCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 731 NGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 731 ~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
+++|.++++... ..+.+++.|++|||+. +++||||||+||++++++.+||+|||+++...... .
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~----~ 148 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI----Y 148 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCc----c
Confidence 999999885321 2246789999999998 89999999999999999999999999998653111 0
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDC 880 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 880 (929)
........++..|+|||++.+..++.++||||+|++.+++.. ...++..... ........... ....++.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~~~~~--~~~~~~~ 219 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERIESGY--RMPAPQL 219 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHHhcCC--CCCCCcc
Confidence 011111234667999999998899999999999987777543 2222211111 01111111100 0001111
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 881 LITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 881 ~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 22234448889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=266.38 Aligned_cols=226 Identities=24% Similarity=0.289 Sum_probs=167.9
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||.|+||.||+|+... ....+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 367788899999999999987641 234688999999999999999999988543 3589
Q ss_pred EEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
+|+||+++++|.++++..+ ..+.|++.|++|||+. +++||||||+||++++++.++++|||+++.+....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999999999987542 3367899999999998 89999999999999999999999999998764221
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.......|++.|+|||++.+..++.++||||+|++++++..+..++..... .+... .+.. .......
T Consensus 153 ------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~-~~~~----~~~~~~~ 219 (274)
T cd06609 153 ------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLF-LIPK----NNPPSLE 219 (274)
T ss_pred ------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHH-Hhhh----cCCCCCc
Confidence 112334688999999999998999999999999888876555444322211 00000 0000 0000000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ....+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~-~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNK-FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccc-cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 000 1222334777999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=274.59 Aligned_cols=176 Identities=17% Similarity=0.136 Sum_probs=134.3
Q ss_pred ceeeccc--CceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 666 ENLIGSG--SFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 666 ~~~iG~G--~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++||+| +||+||++.... ..+.+.+|+++++.++|||||+++++|... ...++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEEE
Confidence 4689999 688999987651 123566799999999999999999998643 348999
Q ss_pred EEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 9999999999988532 12367899999999998 9999999999999999999999999876543211
Q ss_pred cCC-CCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcchhHHhhh
Q 002376 796 VDN-QSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFNIVKWVES 849 (929)
Q Consensus 796 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~~~~~~~~ 849 (929)
... ...........++..|||||++.+ ..++.++||||+|++++++.....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 100 000011122357788999999876 358999999999998888766555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=263.29 Aligned_cols=229 Identities=22% Similarity=0.305 Sum_probs=162.8
Q ss_pred CCCCceeecccCceeEEeccccC--------------------------cHHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG--------------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~--------------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
+|...+.||+|+||.||+|.... ..+.+.+|+.++++++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 46677899999999999986431 013577899999999999999999998543
Q ss_pred CCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
...++||||+++|+|.++++... .++.+++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence 34899999999999999886432 2357899999999997 99999999999999999999999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHH
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPEL 863 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 863 (929)
+++...... .........|+..|+|||++.... ++.++||||+|++++++.....++..... ...+......
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (272)
T cd06629 154 ISKKSDDIY----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229 (272)
T ss_pred ccccccccc----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc
Confidence 997543211 111123346899999999987655 89999999999877775544433321111 0111000000
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ......+...+++++.+||+.+|++||+++||++
T Consensus 230 ~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIP------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCC------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 0000112233344777999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=264.12 Aligned_cols=229 Identities=22% Similarity=0.315 Sum_probs=163.8
Q ss_pred CCCCceeecccCceeEEeccccC---------------------------cHHHHHHHHHHHHc-cCCccccceeeeccc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------------SWKSFIAECETLRN-VRHRNLVKLITSCSS 713 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------------~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~ 713 (929)
+|+..+.||+|+||.||+|.... ..+++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999887642 12346678888865 799999999999854
Q ss_pred CCCCCcceEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCce
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 781 (929)
. ...++||||+++++|.+++... ..++.|++.|+.|||+. .+++||||||+||++++++.+
T Consensus 81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 N-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred C-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcE
Confidence 3 3589999999999999887421 12356899999999963 179999999999999999999
Q ss_pred EEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 782 KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 782 ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
||+|||.+....... ......|+..|+|||++.+..++.++||||+|++++++.....++.... ..... .
T Consensus 154 ~l~dfg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--~~~~~-~ 223 (269)
T cd08528 154 TITDFGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--MLSLA-T 223 (269)
T ss_pred EEecccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--HHHHH-H
Confidence 999999998653211 1233468999999999999889999999999987777544333221111 10000 0
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.+... ..... ........+.+++.+||+.||++||++.|+..++++
T Consensus 224 ~~~~~----~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 KIVEA----VYEPL-PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhhc----cCCcC-CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11110 00000 000112223347779999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=256.81 Aligned_cols=225 Identities=22% Similarity=0.290 Sum_probs=164.8
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||.++.. ...+++.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 4788899999999988776543 1235688999999999999999999998643 3589
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++|+|.+++.... .++.+++.|++|||+. +++||||||+||++++++.+||+|||.++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999999999986531 2356899999999998 89999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.... ......|++.|+|||++.+..++.++||||+|++++++.....++... ...+.............
T Consensus 153 ~~~~------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~--- 221 (256)
T cd08221 153 SEYS------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--NPLNLVVKIVQGNYTPV--- 221 (256)
T ss_pred cccc------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCC---
Confidence 3211 122346899999999998888999999999998877764433222111 11111111111100000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
. ......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 V----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred c----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 1111222337779999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=258.39 Aligned_cols=231 Identities=24% Similarity=0.342 Sum_probs=167.7
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|...+.||+|+||.||++... ...+++.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----CceEEE
Confidence 457888999999999999987653 1246789999999999999999999998543 347999
Q ss_pred EEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++++|.++++... .++.+++.|++|||+. +++||||||+||++++++.+|++|||.++.+...
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999986432 2356899999999998 8999999999999999999999999999865321
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
. ........++..|+|||.+.+..++.++||||+|++++++.. ...++.... ..+..+. +...... ...
T Consensus 157 ~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~-~~~~~~~--~~~ 226 (261)
T cd05034 157 E-----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQ-VERGYRM--PRP 226 (261)
T ss_pred h-----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH-HHcCCCC--CCC
Confidence 1 011112234678999999998899999999999977766443 222221111 1111111 1110000 000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
...+. .+.+++.+|++.+|++||+++|+.+.|++
T Consensus 227 ~~~~~----~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPE----ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCH----HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11112 23337779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=259.25 Aligned_cols=235 Identities=21% Similarity=0.306 Sum_probs=165.2
Q ss_pred CCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC-cc
Q 002376 663 FSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN-ME 720 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~-~~ 720 (929)
|+..+.||+|+||.||+|.+. ...+++.+|++++++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999998642 11346789999999999999999999886543222 22
Q ss_pred eEEEEEEecCCCCcccccccc--------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE--------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~--------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
..++++||+++|+|.+++... ..++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 358899999999998776421 12357899999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
|.++....... ........+++.|++||.+.+..++.++||||+|++.+++.. ...++..... ..+..
T Consensus 158 g~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~ 226 (273)
T cd05074 158 GLSKKIYSGDY----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYN 226 (273)
T ss_pred cccccccCCcc----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHH
Confidence 99986532110 011122345678999999998889999999999988777533 1111111110 11111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.......... ...+...+. +++.+||+.+|++||++.|+++.|+++
T Consensus 227 ~~~~~~~~~~-~~~~~~~~~-~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNRLKQ-PPDCLEDVY-ELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCcCCC-CCCCCHHHH-HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100000000 001122333 388899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=272.25 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=170.7
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+++|+..+.||+|+||.||+|.... ....+.+|+.++++++||||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999986531 23457789999999999999999998765543344568
Q ss_pred EEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||++ +++.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999996 58877765322 3467899999999998 9999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCC-----------------chhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLP-----------------ENVLQ 857 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~-----------------~~~~~ 857 (929)
.. .........||+.|||||++.+ ..++.++||||+|++++++.++..++.... +....
T Consensus 160 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HD---HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cc---ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 11 1111233578999999998755 468999999999998888765543332111 01111
Q ss_pred ccChHHHHhhcccch-hhhhhh---HHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHhh
Q 002376 858 VLDPELRQLMTSNES-QTIQLH---DCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSS 913 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~-~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~ 913 (929)
+.+............ ...... .....-+.+++.+||+.||++|||+.|+++. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 111111111100000 000000 0011223348889999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=260.12 Aligned_cols=234 Identities=24% Similarity=0.283 Sum_probs=168.7
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||+|.... ..+.+.+|++.++.++||||+++++.+... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence 478889999999999999987531 245788999999999999999999988543 3489
Q ss_pred EEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+||||+++++|.++++... ....|++.|++|||+. +++||||||+||++++++.+|++|||++..+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 9999999999999986421 2356899999999998 9999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
....... ........|+..|+|||++... .++.++||||+|++++++..+..++...+. .+........ .....
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~-~~~~~ 227 (267)
T cd06610 153 ADGGDRT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQN-DPPSL 227 (267)
T ss_pred ccCcccc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHHhcC-CCCCc
Confidence 4321111 0122345789999999998877 789999999999887776555444332221 0101011110 00000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ...+...+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGAD-YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccc-cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 0012223334778999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=255.82 Aligned_cols=225 Identities=22% Similarity=0.314 Sum_probs=164.9
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++|||++++++.+... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 47888999999999999876541 134678899999999999999999876432 23479
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++++|.++++... .++.+++.|++|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 9999999999999886421 3357899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... .......|++.|+|||+..+..++.++||||+|++++++.....++.... ..+...........
T Consensus 154 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~----- 220 (257)
T cd08223 154 NQC------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--MNSLVYRIIEGKLP----- 220 (257)
T ss_pred ccC------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCC-----
Confidence 211 11233468999999999999999999999999988777554333222111 11111111111110
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.........+.+++.+|++.+|++||++.|+++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011112233444788999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=266.75 Aligned_cols=228 Identities=23% Similarity=0.259 Sum_probs=167.7
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
++|+..+.||+|+||.||++... ...+.+.+|+.++++++||||+++++++... ...|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEEE
Confidence 57888899999999999998643 1235678899999999999999999998543 34899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|+||+++|+|.+++.+.. .++.+++.|++|||+. +++|||+||+||+++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 999999999999886432 2356899999999998 99999999999999999999999999987553211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|++.|+|||++.+..++.++||||+|++++++.....++..... ..++. . ... ........
T Consensus 170 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~-~~~~~-~-~~~----~~~~~~~~ 237 (293)
T cd06647 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALY-L-IAT----NGTPELQN 237 (293)
T ss_pred -----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hhhee-e-hhc----CCCCCCCC
Confidence 111234688999999999888899999999999877775544333321111 01100 0 000 00001111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.+.+...+++++.+||+.+|++||++++++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12233344558889999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=262.66 Aligned_cols=229 Identities=25% Similarity=0.317 Sum_probs=165.3
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++++... .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 47778999999999999886531 234678899999999999999999987642 234579
Q ss_pred EEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCC--CCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDC--EVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
+||||+++++|.+++... ..++.+++.|++|||..+ ..+++||||||+||++++++.+|++|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999988532 123578999999999332 238999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+...... .......|++.|+|||++.+..++.++|||++|++++++.....++..... . .+.+....
T Consensus 158 ~~~~~~~------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~-----~~~~~~~~ 224 (265)
T cd08217 158 KILGHDS------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--L-----QLASKIKE 224 (265)
T ss_pred ccccCCc------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--H-----HHHHHHhc
Confidence 8763221 111234689999999999998899999999999877775544333322211 1 11111110
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ...+......+.+++.+|++.+|++||++.+|++
T Consensus 225 ~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 GKF--RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCC--CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0011112222334777999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=257.86 Aligned_cols=231 Identities=20% Similarity=0.317 Sum_probs=167.4
Q ss_pred CCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED----- 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence 47778999999999999876431 135688999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~ 790 (929)
+..++||||+++++|.+++.... .++.|++.||+|||+. +++||||||+||+++.++ .+||+|||.++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 34899999999999999886432 2357899999999998 999999999999998776 69999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~ 869 (929)
.+....... ........|+..|+|||++.+..++.++|||++|++++++.....++..... .... ........
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~ 226 (268)
T cd06630 153 RLAAKGTGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA----LIFKIASA 226 (268)
T ss_pred ccccccccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH----HHHHHhcc
Confidence 764321111 1112234689999999999888899999999999888776655444322111 0000 01110000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .....++....-+.+++.+|++.+|++||++.|++.
T Consensus 227 ~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 T--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 011112223333444788999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=268.78 Aligned_cols=223 Identities=24% Similarity=0.263 Sum_probs=161.6
Q ss_pred ceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
...||+|+||.||++... ...+.+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEEecC
Confidence 457999999999998653 1245688999999999999999999998543 3489999999
Q ss_pred CCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCc
Q 002376 730 SNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802 (929)
Q Consensus 730 ~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 802 (929)
++++|.+++.... .++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------ 171 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------ 171 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc------
Confidence 9999998775422 2367899999999998 99999999999999999999999999987553211
Q ss_pred cccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHH
Q 002376 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLI 882 (929)
Q Consensus 803 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 882 (929)
.......|+..|+|||++.+..++.++||||+|++++++.....++..... . +.+ ..+.. .............
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~-~~~-~~~~~----~~~~~~~~~~~~~ 244 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-V-QAM-KRLRD----SPPPKLKNAHKIS 244 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H-HHH-HHHhc----cCCCCccccCCCC
Confidence 112235789999999999988999999999999887776544333221111 0 000 00110 0000000000111
Q ss_pred HHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 883 TIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 883 ~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
..+.+++.+|++.+|++||+++|+++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 223347779999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=256.64 Aligned_cols=230 Identities=22% Similarity=0.240 Sum_probs=164.7
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 468889999999999999886531 1246778999999999999999999875422 2
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..+++||||+++|+|.+++.... ..+.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 35789999999999999885432 2467899999999998 899999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
...... .........|+..|+|||++.+..++.++||||+|++++++.....++...+. ... ........
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~-----~~~~~~~~- 225 (265)
T cd06652 156 LQTICL---SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-MAA-----IFKIATQP- 225 (265)
T ss_pred cccccc---cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-HHH-----HHHHhcCC-
Confidence 532111 11112334689999999999888899999999999877775544333322211 100 01100000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011112233333346668884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=271.47 Aligned_cols=177 Identities=25% Similarity=0.288 Sum_probs=141.2
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~ 719 (929)
..++|+..+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++..... ...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 34689999999999999999987541 12456789999999999999999998864332 122
Q ss_pred ceEEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
...|+||||++ ++|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999996 5887766422 23467899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHH
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
.. .......|+..|+|||++.+..++.++||||+|++++++..+..
T Consensus 170 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 170 TS-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred CC-------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 21 11223468899999999999999999999999988887655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.94 Aligned_cols=169 Identities=28% Similarity=0.386 Sum_probs=135.3
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence 47778999999999999987541 135678999999999999999999998643 3489
Q ss_pred EEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9999997 68887765321 2367899999999998 9999999999999999999999999999754
Q ss_pred ccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhH
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
... ........+++.|+|||++.+. .++.++||||+|++++++.+..
T Consensus 152 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 199 (285)
T cd07861 152 GIP------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199 (285)
T ss_pred CCC------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence 221 1111223578899999988654 4789999999998887765543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=255.55 Aligned_cols=224 Identities=23% Similarity=0.300 Sum_probs=164.9
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+++... ..+++.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence 47788999999999999876531 23468899999999999999999999854 34589
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++++|.++++... .++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 9999999999998886422 2357899999999998 99999999999999999999999999997653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... .......|++.|+|||+..+..++.++||||+|++++++.....++.. ....+.++....+.... .
T Consensus 153 ~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--~~~~~~~~~~~~~~~~~---~ 221 (256)
T cd08218 153 STV------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLVLKIIRGSYPP---V 221 (256)
T ss_pred cch------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC--CCHHHHHHHHhcCCCCC---C
Confidence 211 111234688999999999998999999999999877765443322211 11111111111111100 0
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......-+.+++.+||+.+|++||+|+||++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111222334777999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=261.10 Aligned_cols=223 Identities=24% Similarity=0.283 Sum_probs=163.6
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEE
Confidence 35556789999999999986531 124688999999999999999999998543 34899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++++|.+++.... ..+.+++.|++|||+. +++|+||||+||++++++.+|++|||+++.+....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 999999999999876432 2367899999999997 99999999999999999999999999998653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.......|+..|+|||++.+..++.++||||+|++++++..+..++..... .... .+.. .. ...
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~----~~--~~~ 220 (277)
T cd06642 156 -----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPK----NS--PPT 220 (277)
T ss_pred -----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhc----CC--CCC
Confidence 112234688999999999998999999999999887776544333221111 1000 0000 00 000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......-+.+++.+||+.+|++||+|.|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00111222334778999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=266.63 Aligned_cols=169 Identities=26% Similarity=0.414 Sum_probs=135.0
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 47778999999999999987641 123577899999999999999999998543 3489
Q ss_pred EEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+|+||++ ++|.+++... ..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 9999997 5787776532 23367899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~ 845 (929)
.. .......+++.|+|||++.+.. ++.++||||+|++++++....
T Consensus 152 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 152 PV------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred CC------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 11 1112236789999999987754 799999999998888765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-28 Score=264.60 Aligned_cols=173 Identities=26% Similarity=0.368 Sum_probs=139.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|++++++++|||++++++++.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 468888999999999999987641 12457899999999999999999999854 3358
Q ss_pred EEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||++++.+..+.+.. ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999999998888776432 23467899999999997 999999999999999999999999999986632
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
... ......++..|+|||++.+ ..++.++||||+|++++++.+...+
T Consensus 153 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p 200 (286)
T cd07847 153 PGD------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200 (286)
T ss_pred Ccc------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 211 1123357889999999876 4579999999999888876655433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-28 Score=242.02 Aligned_cols=217 Identities=26% Similarity=0.283 Sum_probs=164.0
Q ss_pred hCCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
-++|+..+++|+|.||+|..++-+.. ...-..|-++++..+||.+..+...| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 35788899999999999987765521 11233588899999999999988776 3445
Q ss_pred eEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++|+||||+.||.|+-++... |.+..+|..||.|||++ +||.||+|.+|.|+|.+|.+||+|||+++.-
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 699999999999999988743 34467899999999998 9999999999999999999999999999842
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
-........++|||.|.|||++....|+.++|-|..|+++|||.-+.+++..-.. .+.+.+-..-..
T Consensus 319 ------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k------ 386 (516)
T KOG0690|consen 319 ------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK------ 386 (516)
T ss_pred ------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc------
Confidence 1223345678999999999999999999999999999999988776666554433 333332221111
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCC
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRI 901 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 901 (929)
.+-...+.... +....+..||.+|-
T Consensus 387 -FPr~ls~eAkt----LLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 -FPRTLSPEAKT----LLSGLLKKDPKKRL 411 (516)
T ss_pred -CCccCCHHHHH----HHHHHhhcChHhhc
Confidence 11111122233 44477889999995
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=266.97 Aligned_cols=230 Identities=24% Similarity=0.262 Sum_probs=165.5
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||++.... ..+.+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence 368888999999999999987641 23457889999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.++||||+++++|.+++.... .++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 899999999999999886431 1256899999999998 999999999999999999999999999876
Q ss_pred cccccCCCC-----------------------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 792 LLERVDNQS-----------------------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 792 ~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
......... .........||..|+|||++.+..++.++||||+|++++++.....++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 532111000 000112357899999999999999999999999998877765544443
Q ss_pred hcCCc--hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC----HHHHHH
Q 002376 849 SNLPE--NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG----IREALR 908 (929)
Q Consensus 849 ~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~ev~~ 908 (929)
..... ...++.+.. .... ....+...+.+++.+|++.||++||+ ++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 233 KGSNRDETFSNILKKE--------VTFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCchHHHHHHHhcCC--------ccCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 22211 111111110 0000 00002223334777999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-29 Score=242.15 Aligned_cols=174 Identities=25% Similarity=0.435 Sum_probs=138.1
Q ss_pred CCCCceeecccCceeEEeccccCcH------------------HHHHHHHHHHHccCCccccceeeecccCCCC---Ccc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGSW------------------KSFIAECETLRNVRHRNLVKLITSCSSLDSK---NME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~~------------------~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~---~~~ 720 (929)
.|....+||+|.||+||+|+..... ....+|+.++..++|+|++.+++.|.+.+.. ...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999877332 2345899999999999999999999876543 234
Q ss_pred eEEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+|+||++|+. +|.-.+... ++...++..||.|+|+. .|+|||+||+|+||+.+|.+||+|||+||.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 58999999975 777666533 23356789999999998 899999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEF 841 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~ 841 (929)
+........ ...+..+-|.+|++||.+.|.+ |+++.|||..||++.++
T Consensus 174 fs~~~n~~k--prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 174 FSTSKNVVK--PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred eecccccCC--CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHH
Confidence 753322211 2234556799999999998865 89999999999987664
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=262.31 Aligned_cols=229 Identities=19% Similarity=0.285 Sum_probs=165.6
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||++.... ..+++.+|++++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 357778899999999999987651 235688999999999999999999998543 4589
Q ss_pred EEEEecCCCCcccccccc-c--------cccccHHHHHHHhhh-CCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE-R--------KNELDITSALDYLHN-DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~-~--------~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+||+++++|.+++... . .++.+++.|++|||+ . +++||||||+||++++++.+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999999998743 1 235789999999999 6 99999999999999999999999999987653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... .....|+..|+|||++.+..++.++||||+|++++++.....++........... ..+...... ...
T Consensus 153 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~ 222 (265)
T cd06605 153 NSL--------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNE-PPP 222 (265)
T ss_pred HHH--------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH-HHHHHHhcC-CCC
Confidence 211 1115788999999999999999999999999877775544333322210000000 011111110 000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...... ....+.+++.+||..||++|||+.|++.
T Consensus 223 ~~~~~~-~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGK-FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhh-cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000000 2222334777999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-28 Score=266.25 Aligned_cols=170 Identities=28% Similarity=0.430 Sum_probs=137.9
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+|.+.. ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 468888999999999999988641 13467889999999999999999999853 3458
Q ss_pred EEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||++++++.++.... ..++.||+.|++|||+. +++|||+||+||++++++.+||+|||+++.+..
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999999888776432 13367899999999998 999999999999999999999999999886532
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~ 844 (929)
.. .......|+..|+|||++.+. .++.++||||+|++++++.++
T Consensus 153 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g 197 (286)
T cd07846 153 PG------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197 (286)
T ss_pred Cc------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence 21 112234678999999998764 478999999999888776554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=262.09 Aligned_cols=220 Identities=25% Similarity=0.309 Sum_probs=163.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence 468888999999999999887641 234577899999999999999999998543 34
Q ss_pred EEEEEEecCCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+++|+|.++++.... ++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 8999999999999999864332 357899999999997 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .....|++.|+|||.+.+..++.++||||+|++++++.....++..... .+. ..........
T Consensus 153 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~~- 216 (290)
T cd05580 153 GR---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQI----YEKILEGKVR- 216 (290)
T ss_pred CC---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHH----HHHHhcCCcc-
Confidence 21 2234689999999999888899999999999877776554443322111 000 0000000000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREAL 907 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~ 907 (929)
.+.....-+++++.+||+.||++|| +++|++
T Consensus 217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0111122233367799999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-28 Score=262.22 Aligned_cols=173 Identities=27% Similarity=0.373 Sum_probs=140.0
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence 368888999999999999987641 134688999999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||++++.+..+..... .++.+|+.|++|||+. +++|||+||+||++++++.+||+|||+++....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999999877766554221 2367899999999998 999999999999999999999999999987643
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
... .......++..|+|||++.+. .++.++||||+|++++++.....
T Consensus 153 ~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 153 RPA-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred Ccc-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 211 112234688999999999888 78999999999988877655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=264.85 Aligned_cols=174 Identities=25% Similarity=0.328 Sum_probs=137.1
Q ss_pred hhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++++|...+.||+|+||.||+|.... ....+.+|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----Ce
Confidence 46789999999999999999986531 123577899999999999999999998543 34
Q ss_pred EEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||++ +++.+++... +.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 899999995 6776665421 22367899999999998 9999999999999999999999999999754
Q ss_pred ccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.... .......+++.|+|||++.+. .++.++||||+|++++++.....+
T Consensus 154 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 154 SIPS------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred CCCC------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 2211 111223578999999998764 478999999999887776554433
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=257.94 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=165.6
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEE
Confidence 56677889999999999987541 134688899999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++|+|.+++.... ..+.+++.|++|+|+. +++|+||+|+||+++.++.++++|||+++......
T Consensus 80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 999999999999886432 2356899999999998 99999999999999999999999999997653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......++..|+|||++.+..++.++||||+|++++++.....++..... .+ ......... ....
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~-----~~~~~~~~~--~~~~ 221 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--MR-----VLFLIPKNN--PPTL 221 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--Hh-----HhhhhhcCC--CCCC
Confidence 112234688899999999988999999999999887776544333221110 00 000000000 0111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
......-+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122233348889999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=253.20 Aligned_cols=223 Identities=23% Similarity=0.354 Sum_probs=162.3
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 4778899999999999987653 124578899999999999999999998743 33589
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfGla~~~ 792 (929)
+||||+++++|.+++.... .++.+++.|++|||+. +++||||||+||+++++ +.+|++|||+++..
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999999999986432 2246899999999998 99999999999999855 46899999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......|+..|+|||++.+..++.++||||+|++++++.....++.... ........... ...
T Consensus 153 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~----~~~ 219 (256)
T cd08220 153 SSK-------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLKIMSG----TFA 219 (256)
T ss_pred CCC-------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHHHHhc----CCC
Confidence 321 11123468899999999998889999999999987777554433322111 11111010100 000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..+....-+++++.+||+.+|++|||++|+++
T Consensus 220 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 ---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001111222334777999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=263.35 Aligned_cols=221 Identities=27% Similarity=0.338 Sum_probs=158.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+.|+..+.||+|+||.||+|.... ..+++.+|+++++.++||||++++++|...+ .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence 458888999999999999986531 1246889999999999999999999996533 3
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||++ |++.+++.... .++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+++..
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 799999996 57766554211 2357899999999998 9999999999999999999999999998754
Q ss_pred ccccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.. .....|+..|+|||++. .+.++.++||||+|++++++..+..++..... . . ..... ..
T Consensus 166 ~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-~-~----~~~~~-~~ 228 (307)
T cd06607 166 SP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-M-S----ALYHI-AQ 228 (307)
T ss_pred CC----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-H-H----HHHHH-hc
Confidence 21 12346788999999874 45689999999999887775544322211110 0 0 00000 00
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........ ......+.+++.+||+.+|++||+|.+++.
T Consensus 229 ~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 229 NDSPTLSS-NDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCCCCCc-hhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 111222334778999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-28 Score=267.40 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=167.9
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 3688889999999999999886541 2346778999999999999999999876533 23456
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+. |+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 899999995 68988875332 2357899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc----------------h-h
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE----------------N-V 855 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~----------------~-~ 855 (929)
..... .........|+..|+|||++.+ ..++.++||||+|++++++.....++..... . .
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 22111 1111233478999999998765 4589999999999988887655544321110 0 0
Q ss_pred hhccChHHHHhhcccchh-hhh---hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 856 LQVLDPELRQLMTSNESQ-TIQ---LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~-~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....+..+.......... ... .......-+.+++.+|++.+|++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011111111110000000 000 00011223344777999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=257.84 Aligned_cols=223 Identities=26% Similarity=0.273 Sum_probs=164.5
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-----EENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-----CCeE
Confidence 47788999999999999987651 23578899999999999999999998853 3358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||+++++|.+++.... .++.++++||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999999999886441 2367899999999998 899999999999999999999999999876532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc-ccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT-SNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~ 873 (929)
.. ......|+..|+|||++.+..++.++||||+|++++++..+..++........ ..+..... .....
T Consensus 153 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~ 221 (258)
T cd05578 153 DT-------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETADVLY 221 (258)
T ss_pred Cc-------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccccccC
Confidence 11 12234688899999999988899999999999877776554444332221100 11111111 01111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCH--HHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGI--REAL 907 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~--~ev~ 907 (929)
. ...+..+.+++.+||+.||++||++ +|+.
T Consensus 222 ~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 P----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 1122233347779999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=267.15 Aligned_cols=241 Identities=22% Similarity=0.270 Sum_probs=177.6
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
+.++.+...++-|.+.++||+|.+|+||+++.. ...++...|.++++.. +|||++.++|++.-.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345555667788999999999999999998765 2346777888888887 699999999999887
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
+....+.+|+|||||.+||..|+++... .+..++++|+.+||.. .++|||||-.|||++.++.+|+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 7777788999999999999999887432 2356789999999998 89999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCC-----CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-----RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL 859 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~ 859 (929)
|||++..+.. .......++||+.|||||++... .|+.++|+||+|+++.|+.-+.-+....- ++..
T Consensus 166 DFGvSaQlds------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-Pmra-- 236 (953)
T KOG0587|consen 166 DFGVSAQLDS------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRA-- 236 (953)
T ss_pred eeeeeeeeec------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhh--
Confidence 9999987742 22334557899999999998754 38899999999998888643332221110 0000
Q ss_pred ChHHHHhhcccchhhhhhhHH-HHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDC-LITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.. .+..+++....++. ..++.. ++..|+..|-++||++.++++
T Consensus 237 ---LF~-IpRNPPPkLkrp~kWs~~Fnd-FIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ---LFL-IPRNPPPKLKRPKKWSKKFND-FISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---hcc-CCCCCCccccchhhHHHHHHH-HHHHHHhhccccCcchhhhcc
Confidence 000 00011111110111 122333 777999999999999988764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=267.02 Aligned_cols=165 Identities=30% Similarity=0.401 Sum_probs=137.1
Q ss_pred CCCCceeecccCceeEEeccccCc---------------HHHHHHHHHHHHccC-Cc-----cccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGS---------------WKSFIAECETLRNVR-HR-----NLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~~~E~~~l~~l~-Hp-----niv~l~~~~~~~~~~~~~ 720 (929)
+|.+.++||+|+||.|.||++.++ ..+-..|+.+|..++ |. |+|++++||...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~----- 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN----- 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-----
Confidence 788899999999999999988742 234456999999996 43 7999999996544
Q ss_pred eEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC--ceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM--TAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~ki~DfGl 788 (929)
+.|||+|.++ .+|+++++..+ .++.||+.||.+||.. +|||+||||+|||+.+-. .+||+|||.
T Consensus 262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 4899999995 59999998543 4578999999999998 999999999999997544 799999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
|....+. ....+-+..|+|||++.|.+|+.+.||||+||++.|+.++
T Consensus 338 Sc~~~q~---------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG 384 (586)
T KOG0667|consen 338 SCFESQR---------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG 384 (586)
T ss_pred ccccCCc---------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC
Confidence 9865321 1134568899999999999999999999999999887655
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=260.22 Aligned_cols=226 Identities=24% Similarity=0.261 Sum_probs=163.4
Q ss_pred CCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.|...+.||+|++|.||++.... ..+.+.+|+.+++.++||||+++++++... .+.++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence 34456799999999999987541 234678999999999999999999988543 347999
Q ss_pred EEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 726 YEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
+||+++++|.+++...+ .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 99999999999886532 2467899999999998 99999999999999999999999999987553211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.......|++.|+|||+..+..++.++||||+|++++++.....++.... ..+.. ..+... ........
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~-~~~~~~----~~~~~~~~ 238 (285)
T cd06648 170 ----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAM-KRIRDN----LPPKLKNL 238 (285)
T ss_pred ----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHH-HHHHhc----CCCCCccc
Confidence 11123468999999999998889999999999987777554433221111 00000 011110 00000000
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001122334777999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=263.54 Aligned_cols=168 Identities=23% Similarity=0.361 Sum_probs=135.8
Q ss_pred CCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||.||+|.... ....+..|++++++++||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 47778899999999999987541 12346689999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+ +|+|.++++... .++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 589999999 899999986433 2367899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchh
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
..... .......+++.|+|||++.+ ..++.++||||+|++++++...
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g 199 (298)
T cd07841 152 FGSPN------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199 (298)
T ss_pred ccCCC------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC
Confidence 53211 11122356888999998865 4579999999999888776544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=266.20 Aligned_cols=178 Identities=28% Similarity=0.346 Sum_probs=142.9
Q ss_pred CCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcceEEEE
Q 002376 664 SHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFLALV 725 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~~lV 725 (929)
...+.||+||||.||+|+.+. ..+...+|+++|++++|||||+++++=.+... --.....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999999662 23456689999999999999999987533220 003457899
Q ss_pred EEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec--CCC--ceEEecccccc
Q 002376 726 YEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD--EEM--TAKVGDFGLAR 790 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~ki~DfGla~ 790 (929)
||||++|||+..+.+.. ....+++.||.|||++ +|+||||||.||++- ++| ..||+|||.||
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999997422 1245788999999988 999999999999983 334 57999999999
Q ss_pred ccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcC
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNL 851 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~ 851 (929)
.+.+. .....++||..|.+||++.. +.|+..+|-||+|+++|+..++..++...
T Consensus 173 el~d~-------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDN-------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCC-------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 77432 24566899999999999984 88999999999999999988888877544
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=260.67 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=163.2
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++ ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999987641 1246788999999995 699999999987654434445
Q ss_pred EEEEEEecCCCCccccccccc-------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEeccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFG 787 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfG 787 (929)
.|+||||+++ +|.+++.... .++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8888765321 2357899999999998 9999999999999998 8899999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhcc----C
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVL----D 860 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~----~ 860 (929)
+++...... .......+++.|+|||++.+ ..++.++||||+|++++++.....++....+ ...+++ +
T Consensus 157 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPV------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCc------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 988652210 11122357889999998865 4579999999999888876555443322211 000000 0
Q ss_pred hH------H-----HHhhcccchhhh-hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 PE------L-----RQLMTSNESQTI-QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ~~------l-----~~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+. . ............ .....+...+.+++.+|+++||++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 000000000000 000112222334888999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=240.28 Aligned_cols=222 Identities=22% Similarity=0.242 Sum_probs=151.7
Q ss_pred ceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEEE
Q 002376 666 ENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
...||.|+.|.|++++... ..+++.+.+.++.+.+ .|.||+.+|||..... +++.||
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----V~IcMe 171 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----VFICME 171 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----HHHHHH
Confidence 4569999999999987662 2355667777766665 8999999999976433 788899
Q ss_pred ecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 728 FLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 728 ~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
.|. .-+...++.. .+....+..||.||...+ +|||||+||+|||+|+.|.+|+||||.+..+....
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 884 2333443321 123456789999999886 89999999999999999999999999998764221
Q ss_pred CCCccccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
..+..+|-+.|||||-+.-. .|+.++||||+|+.++|+.++..++..-.-. .+++..-+ . ++++..
T Consensus 247 -----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvl----n-~ePP~L 315 (391)
T KOG0983|consen 247 -----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVL----N-EEPPLL 315 (391)
T ss_pred -----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHH----h-cCCCCC
Confidence 12334789999999988643 5999999999998777766555544331111 11111111 1 111111
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.....+...++++..|+..|+.+||...++++
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111112222333666999999999999887654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=260.56 Aligned_cols=226 Identities=19% Similarity=0.275 Sum_probs=157.1
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHH-HHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECET-LRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+++... ...++..|+.. ++..+||||+++++++... ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence 468888999999999999987641 12345566665 5667899999999998643 348
Q ss_pred EEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
|+||||++ |+|.++++.. ..++.|++.|++|||+.+ +++||||||+||++++++.+||+|||+++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999996 6887766421 123678999999999853 79999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCC----CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLG----ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
..... .......|+..|+|||++.+ ..++.++||||+|++++++.....++........ .+...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~ 220 (283)
T cd06617 153 YLVDS-------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QLKQV 220 (283)
T ss_pred ccccc-------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HHHHH
Confidence 65321 11123468899999998865 4468999999999887776554443322211111 11111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... ...... .+..+.-+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~-~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEE-PSPQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred Hhc-CCCCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 000000 0112222333777999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=264.44 Aligned_cols=172 Identities=24% Similarity=0.333 Sum_probs=137.4
Q ss_pred CCCCCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+|....+ ...+.+|+.++++++||||+++++++...+ ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5788889999999999999887521 224678999999999999999999986532 2458
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
|+||||++ ++|.+++.... .++.||+.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99999997 58888775322 3467899999999998 89999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhH
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~ 845 (929)
... .......+++.|+|||++.+.. ++.++||||+|++++++....
T Consensus 158 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 158 SPL------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred CCc------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 211 1112335788999999987654 689999999998877765543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=254.55 Aligned_cols=231 Identities=26% Similarity=0.321 Sum_probs=165.5
Q ss_pred CCCCceeecccCceeEEecccc---------------C---cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT---------------G---SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~---------------~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|... . ..+.+.+|+.++++++|+||+++++++... ...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence 4777899999999999998643 1 346788999999999999999999987543 3489
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+|+||+++++|.++++... .++.+++.|++|||+. +|+||||||+||++++++.+||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999999986432 2357899999999998 8999999999999999999999999998865322
Q ss_pred cCCCCCccccceeccccccccccccCCCC---CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGER---PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .........++..|+|||++.+.. ++.++|||++|++++++.....++......... ..........
T Consensus 153 ~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~ 225 (264)
T cd06626 153 TTT--MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVGAGHKP 225 (264)
T ss_pred CCc--ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHhcCCCC
Confidence 111 001012346889999999998776 899999999998877765544433222111100 0000000000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+.. ......+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 001222233777999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=255.17 Aligned_cols=221 Identities=23% Similarity=0.278 Sum_probs=168.3
Q ss_pred CCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+-|+.++.||+|.|.+|-.+++. .....+.+|++-|+-++|||||++|++.- ....+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence 45777889999999998665543 12345779999999999999999999973 33448
Q ss_pred EEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~ 792 (929)
|+|+|.-.+|+|+||+-++ +++..||..|+.|+|+. .+||||+||+||.+- .-|.+|+.|||++..+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999998632 35578999999999998 799999999999874 5679999999999765
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHHHHhhcc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPELRQLMTS 869 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~ 869 (929)
.++ ......+|+..|-|||++.|..| .+++||||+|+++|-+.-+..++....+ .+..++|...
T Consensus 170 ~PG-------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------ 236 (864)
T KOG4717|consen 170 QPG-------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------ 236 (864)
T ss_pred CCc-------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------
Confidence 332 33456799999999999999988 5788999999766554444444433322 2223333221
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+.-+.+-.++++..|+.+||.+|.+.+||+.
T Consensus 237 ------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 ------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 122334555666888999999999999998864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=266.22 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=169.4
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|...+.||+|+||.||+++... ..+.+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3578889999999999999887531 2345778999999999999999999886544333345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+. ++|.+++.... .++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 68888775432 2367899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCC-----------------chh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLP-----------------ENV 855 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~-----------------~~~ 855 (929)
... .......|+..|+|||++.+ ..++.++||||+|++++++..+..++.... +..
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 160 EKG------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred CCc------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 211 11223467899999998765 468999999999988877655443332110 001
Q ss_pred hhccChHHHHhhcc---cchhh-hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHhhH
Q 002376 856 LQVLDPELRQLMTS---NESQT-IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSSQ 914 (929)
Q Consensus 856 ~~~~~~~l~~~~~~---~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~ 914 (929)
..+.+......... ..... ......+...+.+++.+|++.+|++|||++|+++. ++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 11111111111000 00000 00000112223348889999999999999999865 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=252.21 Aligned_cols=224 Identities=27% Similarity=0.320 Sum_probs=164.1
Q ss_pred CCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||+||+|.... ..+.+.+|++++++++||||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence 36677899999999999987541 235688999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++++|.++++... .++.+++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 4899999999999999886433 2356899999999998 9999999999999999999999999998765
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... ......|+..|+|||.+.... ++.++||||+|++++++.....++..... .... ..... .
T Consensus 153 ~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~-----~~~~~--~ 217 (258)
T cd06632 153 VEFS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAV-----FKIGR--S 217 (258)
T ss_pred cccc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHH-----HHHHh--c
Confidence 3211 122346889999999987776 89999999999877776554433322221 0000 00000 0
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......++.....+++++.+||+.+|++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000111112223334777999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-28 Score=260.59 Aligned_cols=170 Identities=30% Similarity=0.410 Sum_probs=135.6
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence 47788999999999999987541 124688999999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||++ ++|.+++.... .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999995 68888775321 2356899999999998 89999999999999999999999999987653
Q ss_pred cccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHH
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
... .......+++.|+|||++.+.. ++.++||||+|++++++.+...
T Consensus 152 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 152 VPV------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred cCc------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 211 1112235788999999887655 6899999999988887655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=241.33 Aligned_cols=231 Identities=22% Similarity=0.265 Sum_probs=162.2
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHH-ccCCccccceeeec
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLR-NVRHRNLVKLITSC 711 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~-~l~Hpniv~l~~~~ 711 (929)
.|+-++++. ...||.|+||+|+|..++ ++.+++..|.++.. .-+.||||+++|.+
T Consensus 60 ~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 355455544 356999999999987665 34567888887644 45789999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCcccccc---c--c--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIH---G--E--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~---~--~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
+..+ ..|+.||.|. -|+..+.+ . . .++......||.||.... .|||||+||+|||+|..
T Consensus 133 F~EG-----dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 133 FSEG-----DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH 204 (361)
T ss_pred hcCC-----ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC
Confidence 6544 3899999994 46655433 1 1 133455678999999865 89999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPENVL 856 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~ 856 (929)
|.+|+||||.+..+... ...+..+|...|||||-+... .|+.++||||+|++++|+.++.++...+..
T Consensus 205 G~vKLCDFGIcGqLv~S-------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--- 274 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDS-------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--- 274 (361)
T ss_pred CCEeeecccchHhHHHH-------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---
Confidence 99999999999876321 234456889999999988643 489999999999999998776666554443
Q ss_pred hccChHHHHhhcccchhhhhhhH---HHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 857 QVLDPELRQLMTSNESQTIQLHD---CLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 857 ~~~~~~l~~~~~~~~~~~~~~~~---~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++++ +......+++.-....+ .-.++++ .+.-|+-.|-.+||...++.+
T Consensus 275 -vfeq-l~~Vv~gdpp~l~~~~~~~~~s~~~~~-fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 275 -VFEQ-LCQVVIGDPPILLFDKECVHYSFSMVR-FINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -HHHH-HHHHHcCCCCeecCcccccccCHHHHH-HHHHHhhcccccCcchhhhhc
Confidence 2221 11111111111111111 1123444 666999999999999988754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=258.32 Aligned_cols=230 Identities=22% Similarity=0.271 Sum_probs=169.1
Q ss_pred HhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
..++.|+..+.||+|+||.||++.+.. ..+.+.+|++.+++++|||++++++++... ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence 356678888999999999999987751 145788999999999999999999998653 358
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++|+||+++++|.+++.... .++.+++.||+|||+. +++|+|+||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999999987542 2367899999999997 99999999999999999999999999987543
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... .......++..|+|||++.+..++.++||||+|++++++.....++..... . . .......... .
T Consensus 168 ~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~-~----~~~~~~~~~~-~ 234 (286)
T cd06614 168 KEK------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-L-R----ALFLITTKGI-P 234 (286)
T ss_pred cch------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-H-H----HHHHHHhcCC-C
Confidence 211 111233578899999999988899999999999887776544433322211 0 0 0000000000 0
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+.+...+++++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00001112223334777999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=267.15 Aligned_cols=181 Identities=28% Similarity=0.385 Sum_probs=141.2
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~ 719 (929)
..++|+..+.||+|+||.||+|.+.. ..+.+.+|+.+++++ +||||++++++|...+ .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---D 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---C
Confidence 34678888999999999999987541 123467899999999 9999999999985422 2
Q ss_pred ceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
...++||||++ ++|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 35799999997 58988775421 2467899999999997 9999999999999999999999999999866
Q ss_pred ccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
....... .........||..|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 158 SELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred ccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 4321110 1112334578999999998765 4578999999999888876655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=253.92 Aligned_cols=225 Identities=24% Similarity=0.294 Sum_probs=164.3
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
-|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 35677899999999999986531 124688899999999999999999998543 34899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||||+++|+|.+++.... ..+.+++.|++|||+. +++|+||||+||+++.++.++|+|||+++.+....
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 999999999999886422 3367899999999998 99999999999999999999999999987653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......|+..|+|||++.+..++.++||||+|++++++.+...++..... . .......... ....
T Consensus 156 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~-----~~~~~~~~~~--~~~~ 221 (277)
T cd06641 156 -----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--M-----KVLFLIPKNN--PPTL 221 (277)
T ss_pred -----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--H-----HHHHHHhcCC--CCCC
Confidence 111234688999999999888899999999999877776544333322111 0 0000000000 0001
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
......-+.+++.+||+.+|++||+|.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11112223347779999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=261.74 Aligned_cols=179 Identities=26% Similarity=0.386 Sum_probs=138.6
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC---C
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK---N 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~---~ 718 (929)
.++|+..+.||+|+||.||+|.... ....+.+|++++++++||||++++++|...+.. .
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4578999999999999999987641 123456899999999999999999998654321 2
Q ss_pred cceEEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||++ +++.+++... ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 345799999996 5787766532 13367899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~ 844 (929)
+......... ........++..|+|||++.+.. ++.++||||+|++++++...
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~ 220 (310)
T cd07865 167 RAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220 (310)
T ss_pred ccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhC
Confidence 8664321111 11122346788999999887654 78999999999888776443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=279.05 Aligned_cols=177 Identities=21% Similarity=0.219 Sum_probs=122.9
Q ss_pred hhCCCCCceeecccCceeEEeccccCc----H---------HHHHHHHHHHHcc---CCccccceeeecccCC-CCCcce
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGS----W---------KSFIAECETLRNV---RHRNLVKLITSCSSLD-SKNMEF 721 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~----~---------~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~-~~~~~~ 721 (929)
..++|+..+.||+|+||.||+|++... . +.-..|+....++ .+.+++.+...+.... ......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 567899999999999999999987533 0 0111233333333 2333443333222111 123445
Q ss_pred EEEEEEecCCCCccccccccc----------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCe
Q 002376 722 LALVYEFLSNGSLGDWIHGER----------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNI 773 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~----------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 773 (929)
.++||||+++++|.++++... .++.|++.||+|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 899999999999988875321 2456889999999998 999999999999
Q ss_pred eecC-CCceEEeccccccccccccCCCCCccccceeccccccccccccCCC----------------------CCCCCCC
Q 002376 774 LLDE-EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE----------------------RPSTAGD 830 (929)
Q Consensus 774 Ll~~-~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 830 (929)
|+++ ++.+||+|||+|+.+.... ......+.||+.|||||.+... .++.++|
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9985 6799999999998653221 1122446789999999965322 2345679
Q ss_pred CCCCcCCCCCcch
Q 002376 831 VPTSESFAGEFNI 843 (929)
Q Consensus 831 V~s~g~~~~~~~~ 843 (929)
|||+||+++++..
T Consensus 362 VwSlGviL~el~~ 374 (566)
T PLN03225 362 IYSAGLIFLQMAF 374 (566)
T ss_pred cHHHHHHHHHHHh
Confidence 9999998887654
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=255.12 Aligned_cols=172 Identities=26% Similarity=0.353 Sum_probs=136.7
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeEE
Confidence 578889999999999999987641 123567899999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||++ ++|.+++.... ..+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 9999997 58988875322 2256899999999998 999999999999999999999999999875321
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
. ........++..|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 156 ~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 156 P------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred C------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 1 011122356889999999876 4589999999999888876554433
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=249.25 Aligned_cols=225 Identities=24% Similarity=0.358 Sum_probs=162.5
Q ss_pred CCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 664 SHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+..+.||+|+||.||+++... ..+.+.+|++.++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence 456889999999999876642 345788999999999999999999998653 348
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||||+++++|.+++.... .++.|++.|++|||+. +++||||||+||++++++.+|++|||+++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999886432 2356899999999998 9999999999999999999999999999866
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
....... .....+++.|+|||.+.+..++.++|||++|++++++.. ...++.... . ..+........
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~-----~~~~~~~~~~~ 221 (258)
T smart00219 154 YDDDYYK-----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--N-----EEVLEYLKKGY 221 (258)
T ss_pred ccccccc-----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--H-----HHHHHHHhcCC
Confidence 4321111 111236789999999988889999999999987776533 111111111 0 11111000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
.. ........-+.+++.+|+..||++|||+.|+++.|
T Consensus 222 ~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RL--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 00011122233377799999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=250.68 Aligned_cols=224 Identities=23% Similarity=0.284 Sum_probs=163.1
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence 47778999999999999987641 234678999999999999999999988543 3589
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~ 792 (929)
+|+||+++++|.+++.... .++.+++.|++|||+. +++|||+||+||++++++ .+|++|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 9999999999999886422 2356899999999998 899999999999999886 5699999998865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.... .......|++.|+|||+..+..++.++||||+|++++++.....++.... ..+.+......... .
T Consensus 153 ~~~~------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~---~ 221 (257)
T cd08225 153 NDSM------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQGYFA---P 221 (257)
T ss_pred cCCc------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhcccCC---C
Confidence 3211 11122468999999999988889999999999988777654443332111 11111000000000 0
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... ...-+++++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPN----FSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCC----CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011 1122333777999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=257.76 Aligned_cols=225 Identities=22% Similarity=0.316 Sum_probs=161.9
Q ss_pred CCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccC---CccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVR---HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.|+..+.||+|+||.||+|... ...+++.+|++++++++ |||++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 4677789999999999998753 12346888999999997 9999999999854 235
Q ss_pred EEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
.++||||+++++|.++++... .++.+++.|++|||+. +|+||||+|+||++++++.++++|||.+.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 899999999999999886432 2356899999999998 999999999999999999999999999986642
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......|+..|+|||++.++ .++.++||||+|++++++..+..++..... .+... ........
T Consensus 154 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~-----~~~~~~~~ 220 (277)
T cd06917 154 NS------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMM-----LIPKSKPP 220 (277)
T ss_pred Cc------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhh-----ccccCCCC
Confidence 21 112234689999999988754 479999999999877776544433322111 00000 00000000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... +.....+.+++.+||+.||++||++.|++.
T Consensus 221 ~~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLED-NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000 001122334778999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=264.10 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=170.5
Q ss_pred hHHHHHh----hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeee
Q 002376 653 YDELRRA----TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITS 710 (929)
Q Consensus 653 ~~~l~~~----~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~ 710 (929)
.+|+.++ .++|...+.||+|+||.||+|.... ..+.+.+|++++++++||||++++++
T Consensus 3 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 3 REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 3455544 3789999999999999999987531 12357789999999999999999999
Q ss_pred cccCCC-CCcceEEEEEEecCCCCccccccc------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 711 CSSLDS-KNMEFLALVYEFLSNGSLGDWIHG------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 711 ~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
+..... ......++|+||+. +++.++... ...++.|++.||+|||+. +|+||||||+||+++.++.+|+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred ecccccCCCCceEEEEecccc-cCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 865332 12234699999996 467665431 123467899999999998 8999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhcc-
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVL- 859 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~- 859 (929)
+|||+++.... ......|+..|+|||++.+ ..++.++||||+|++++++..+..++..... .+..++
T Consensus 159 ~dfg~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 159 LDFGLARHADA---------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred eeCCCCcCCCC---------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999875421 1123467889999999876 4589999999999988886655544332111 000000
Q ss_pred -----ChHHHH---------hhcccch-hhhhh----hHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHHH
Q 002376 860 -----DPELRQ---------LMTSNES-QTIQL----HDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQEI 916 (929)
Q Consensus 860 -----~~~l~~---------~~~~~~~-~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~ 916 (929)
.+.... ....... ..... +..-..+. +++.+||+.||++||+++|++. .+++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV-DLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHH-HHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000 0000000 00000 00111233 4888999999999999999984 47776553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=260.48 Aligned_cols=228 Identities=20% Similarity=0.221 Sum_probs=155.4
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|...+.||+|+||.||++.... ....+.+|+.++.++. ||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence 34456789999999999877641 2346788999999996 99999999988643 3379
Q ss_pred EEEEecCCCCccccc---cc----------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 724 LVYEFLSNGSLGDWI---HG----------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 724 lV~e~~~~gsL~~~l---~~----------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
+||||++. ++.++. .. ...++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 99999864 544432 11 1234678999999999742 89999999999999999999999999997
Q ss_pred ccccccCCCCCccccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhh
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
..... .......|++.|+|||++.+. .++.++||||+|++++++..+..++..... ..+ .+....
T Consensus 157 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~----~~~~~~ 224 (288)
T cd06616 157 QLVDS-------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFD----QLTQVV 224 (288)
T ss_pred HhccC-------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHH----HHhhhc
Confidence 65321 111233688999999998876 689999999999877775444333322211 000 111110
Q ss_pred cccc-hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 868 TSNE-SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 868 ~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.... .........+...+.+++.+||+.+|++|||++||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000122223337889999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=252.74 Aligned_cols=229 Identities=23% Similarity=0.364 Sum_probs=169.4
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|++|.||++.... ..+.+.+|++.+++++|||++++++++... ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence 367888999999999999987652 246788999999999999999999998643 4589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhh-CCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHN-DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++++|.+++.... .++.|+++|++|||+ . +++||||+|+||+++.++.+|++|||.++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999986422 346789999999999 7 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~ 873 (929)
... ......++..|+|||.+.+..++.++|||++|++++++.+...++..... ...+...... .....
T Consensus 153 ~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~ 221 (264)
T cd06623 153 TLD------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-----DGPPP 221 (264)
T ss_pred CCC------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-----cCCCC
Confidence 211 11234688999999999999999999999999888776655544433321 1111111100 00000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 222 ~~~-~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLP-AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCC-cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 01011223337779999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=257.90 Aligned_cols=232 Identities=23% Similarity=0.248 Sum_probs=165.7
Q ss_pred CCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~ 717 (929)
+|+..+.||+|+||.||+++.. ...+.+.+|++++.++ +||||+++++++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 3677899999999999987532 0124577899999999 59999999988743
Q ss_pred CcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||+++|+|.+++.... .++.|+++||+|||+. +++||||||+||++++++.+|++|||++
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 234799999999999998876432 2356899999999997 9999999999999999999999999998
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQL 866 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~ 866 (929)
+....... .......|+..|+|||.+.+.. .+.++||||+|++++++.....++..... .....+......
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 226 (288)
T cd05583 153 KEFLAEEE-----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK- 226 (288)
T ss_pred cccccccc-----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-
Confidence 86532211 1112346899999999987765 78999999999887776555444321111 000001111111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.... .+..+...+++++.+||+.||++|||+++|.+.|+..
T Consensus 227 --~~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 --SKPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --cCCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111 1111222334477799999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=257.89 Aligned_cols=219 Identities=21% Similarity=0.252 Sum_probs=151.3
Q ss_pred eecccCceeEEeccccC-------------------cHHHHHHHHHHHHc---cCCccccceeeecccCCCCCcceEEEE
Q 002376 668 LIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRN---VRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~---l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.||+|+||.||++.... ..+.+.+|..+++. .+||||+.+++++... +..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 48999999999877541 01234445444433 4799999999988543 348999
Q ss_pred EEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 726 YEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 99999999998876432 3467899999999998 8999999999999999999999999998754211
Q ss_pred CCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
......||..|+|||.+.+ ..++.++||||+|++++++.+...++........+ .+..... .....
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~---~~~~~ 217 (279)
T cd05633 151 ------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL---TVNVE 217 (279)
T ss_pred ------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh---cCCcC
Confidence 1122368999999999864 56899999999998887765544443322111101 1111000 00001
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRI-----GIREALRR 909 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~~ 909 (929)
.++....-+.+++.+|++.||++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111222233367799999999999 59988773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=249.63 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=170.4
Q ss_pred CCCCCceeecccCceeEEecccc--------------C---------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------G---------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~---------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
++|-..+++|+|||++||++-+- + ..+...+|.++-+.++||.||++++|+.-...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd- 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD- 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc-
Confidence 45667789999999999987653 1 12456789999999999999999999965332
Q ss_pred CcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec---CCCceEEecc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDF 786 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~Df 786 (929)
.+|-|+|||+|.+|.-|++.. |.+..||..||.||... .++|||-|+||.|||+. ..|.+||.||
T Consensus 542 ---sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 ---SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ---cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 379999999999999999743 45578999999999987 67999999999999995 4578999999
Q ss_pred ccccccccccCCCC-CccccceeccccccccccccCCC----CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 787 GLARFLLERVDNQS-SISSTHVFMGSIGYVPPEYGLGE----RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 787 Gla~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
|+++.+..+..... ....+...+||.+|++||.+.-+ +++.|+||||.|++.|....+.-+++.-.. ..+++..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdILqe 696 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDILQE 696 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHHHhh
Confidence 99999865433322 22334567899999999977644 479999999999988887666555554322 1111111
Q ss_pred H--HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 862 E--LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 862 ~--l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
. +...-...+ ..+ -+....++++++|++..-++|....++.
T Consensus 697 NTIlkAtEVqFP-~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 NTILKATEVQFP-PKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hchhcceeccCC-CCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111000000 111 1222233477799999999998877664
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=252.17 Aligned_cols=219 Identities=22% Similarity=0.315 Sum_probs=158.5
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||.||+++... ..+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 6999999999987751 134688899999999999999999988543 3479999999
Q ss_pred CCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 730 SNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 730 ~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
++|+|.++++.... .+.+++.||+|+|+. +++|+||||+||+++.++.+|++|||+++......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence 99999999875432 356899999999997 99999999999999999999999999998663221
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 881 (929)
......|+..|+|||++.+..++.++|||++|+++|++.....++....+...+.. ...... ......+...
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~ 219 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY----NDILKG--NGKLEFPNYI 219 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH----HHHhcc--CCCCCCCccc
Confidence 12234688999999999888899999999999887776554444332221011111 111100 0000111111
Q ss_pred HHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 882 ITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 882 ~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
..-+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222334777999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=258.84 Aligned_cols=169 Identities=24% Similarity=0.344 Sum_probs=137.6
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|++.. ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 47788999999999999987541 13578899999999999999999999854 33589
Q ss_pred EEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+ +++|.+++... +.++.||+.||+|||+. +++|+||||+||++++++.+|++|||+++....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999999 99999987532 23367899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~ 844 (929)
... .......|+..|+|||++.+.. ++.++||||+|++++++...
T Consensus 152 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 152 EEP-----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred CCC-----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 211 1122346899999999987654 68999999999888776554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=236.84 Aligned_cols=245 Identities=19% Similarity=0.201 Sum_probs=187.0
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeec
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSC 711 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~ 711 (929)
+|+.....+++...++-+|.||.||+|.+.. +...|..|...+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4555556678888899999999999996541 123466788888888999999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc----------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER----------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 775 (929)
.+.. ...+++|.++.-|+|..++...| ..+.|++.|++|||.+ +|||.||.++|.+|
T Consensus 357 ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 357 IEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred eecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 7633 34789999999999999997322 1256899999999998 99999999999999
Q ss_pred cCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchh
Q 002376 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENV 855 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~ 855 (929)
|+..++|++|=.++|.+.+.+-.-- ....-....||+||.+....|+.++||||||+.+||+.+ -+..|
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcL----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt----lg~~P--- 498 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCL----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT----LGKLP--- 498 (563)
T ss_pred hhheeEEeccchhccccCccccccc----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh----cCCCC---
Confidence 9999999999999998754322110 011123568999999999999999999999988777432 11222
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
..-+||.-...+-+++..-.+...|..++.. ++..||+.+|++||++++++.-|.+...+.
T Consensus 499 yaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~-vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 499 YAEIDPFEMEHYLKDGYRLAQPFNCPDELFT-VMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ccccCHHHHHHHHhccceecCCCCCcHHHHH-HHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 2234554444444444444455577778888 999999999999999999999999877654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=256.14 Aligned_cols=168 Identities=29% Similarity=0.408 Sum_probs=134.6
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|++|.||+|.... ..+.+.+|++++++++|||++++++++.+. ...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 5667899999999999987541 124688999999999999999999998543 45899
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||++ ++|.+++.... .++.|+++||+|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 999995 68998876433 2357899999999997 999999999999999999999999999976532
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
.. .......++..|+|||++.+. .++.++||||+|++++++....
T Consensus 152 ~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 152 PV------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred Cc------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 11 111223568899999988665 4799999999998887765544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=252.50 Aligned_cols=235 Identities=23% Similarity=0.289 Sum_probs=162.1
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHcc---CCccccceeeecccCCCCCcce
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNV---RHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
|+..+.||+|+||.||+|+... ....+.+|+.+++++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999998651 123466788777666 5999999999997655433345
Q ss_pred EEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.++||||++ ++|.+++.... .++.|++.||+|||+. +++|+|+||+||++++++.+||+|||.++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58888775321 2367899999999998 899999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChH----H--
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPE----L-- 863 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~----l-- 863 (929)
.... .......++..|+|||++.+..++.++||||+|++++++.....++..... ....+.+.. .
T Consensus 157 ~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFE-------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ccCC-------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 5321 111223578899999999999999999999999888876544333221111 011111000 0
Q ss_pred --------HHhhcccchhh-hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 864 --------RQLMTSNESQT-IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 864 --------~~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........... ......+...+.+++.+||+.||++||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 0000112233344888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-27 Score=259.48 Aligned_cols=177 Identities=27% Similarity=0.355 Sum_probs=136.8
Q ss_pred CCCCceeecccCceeEEeccccCc--------------------HHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGS--------------------WKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~--------------------~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||.||+++.... .+.+.+|+++++++ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 477789999999999999886522 24577899999999 5999999998764322 2233
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++++||++ ++|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 4789999986 68988875332 3467899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhH
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
...... .........||..|+|||++.+ ..++.++||||+|++++++....
T Consensus 156 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~ 207 (332)
T cd07857 156 SENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207 (332)
T ss_pred cccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 432111 1111234578999999998766 46899999999998877764443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-27 Score=260.37 Aligned_cols=183 Identities=25% Similarity=0.359 Sum_probs=140.5
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC---CC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS---KN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---~~ 718 (929)
.++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++++.+... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5689999999999999999987641 12357789999999999999999998765432 12
Q ss_pred cceEEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||+++ ++...+... ..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 3457999999964 666655422 13467899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCC-----CccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHH
Q 002376 790 RFLLERVDNQS-----SISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 790 ~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
+.......... .........|++.|+|||++.+. .++.++||||+|++++++.++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 86543221111 11112345678999999987654 58999999999998888765543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=256.82 Aligned_cols=221 Identities=23% Similarity=0.259 Sum_probs=159.9
Q ss_pred eeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecC
Q 002376 667 NLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLS 730 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~ 730 (929)
.+||+|+||.||++.... ..+.+.+|+.+++.++|||++++++++... ...++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecCC
Confidence 579999999999886641 234688899999999999999999998543 34899999999
Q ss_pred CCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCcc
Q 002376 731 NGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS 803 (929)
Q Consensus 731 ~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~ 803 (929)
+++|.+++...+ .++.|++.|++|||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~ 171 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------P 171 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc------c
Confidence 999998875322 3467899999999998 99999999999999999999999999987553211 1
Q ss_pred ccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHH
Q 002376 804 STHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLIT 883 (929)
Q Consensus 804 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 883 (929)
......|+++|+|||++.+..++.++||||+|++++++.+...++..... .+.+ ..+....+........ ...
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~-~~~~~~~~~~~~~~~~----~~~ 244 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM-KMIRDNLPPKLKNLHK----VSP 244 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH-HHHHhhCCcccCCccc----CCH
Confidence 12234689999999999888899999999999877775543333221111 0000 0111111110000001 111
Q ss_pred HHHHHhccccCCCCCCCCCHHHHHH
Q 002376 884 IIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 884 ~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+.+++.+||+.+|++||++.|+++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2233777999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-27 Score=258.49 Aligned_cols=220 Identities=25% Similarity=0.333 Sum_probs=157.6
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
|+..+.||+|+||.||+++... ..+.+.+|++++++++|||++++++++.+.. ..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eEE
Confidence 5667889999999999987531 1246888999999999999999999986533 479
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||++ |++.+.+.... .++.+++.|+.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 102 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9999996 57777664211 2357899999999998 999999999999999999999999999875421
Q ss_pred ccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.....|++.|+|||++. .+.++.++||||+|++++++.....++..... .+. .........
T Consensus 178 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~----~~~~~~~~~ 241 (317)
T cd06635 178 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA----LYHIAQNES 241 (317)
T ss_pred ----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHH----HHHHHhccC
Confidence 12346889999999974 45689999999999877765443322211110 000 011000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... ..+.....+++++.+||+.+|++||++.|+++.
T Consensus 242 -~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 242 -PTL-QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred -CCC-CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 000 011122334458889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=247.14 Aligned_cols=230 Identities=22% Similarity=0.263 Sum_probs=166.0
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.+.+ .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 468889999999999999986531 1246788999999999999999999885432 2
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++||||+++++|.+++.... .++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 35789999999999998876322 2357899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
...... .........|+..|+|||++.+..++.++||||+|++++++.....++..... ... +......
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~-----~~~~~~~-- 224 (264)
T cd06653 156 IQTICM---SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-MAA-----IFKIATQ-- 224 (264)
T ss_pred cccccc---cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-HHH-----HHHHHcC--
Confidence 532111 11112335689999999999988899999999999877775544333322111 111 1111100
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......++.+.+.+++++.+|++ +|.+||++.+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111222344445557779999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=248.76 Aligned_cols=230 Identities=26% Similarity=0.327 Sum_probs=168.3
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|++|.||+|.... ..+.+.+|+.++++++||||+++++++.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 46778999999999999987641 1457889999999999999999999986531 24589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++++|.+++.... .++.+++.|++|||+. +++|+|++|+||++++++.+||+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999999886442 2367899999999997 9999999999999999999999999999876432
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
... .......++..|+|||...+..++.++|||++|++++++.....++......... ...... .....
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~--~~~~~ 223 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKIGS--SGEPP 223 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhccc--cCCCc
Confidence 110 0123346889999999999888999999999998776654433333222211000 011000 00001
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..++.....+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122333444777999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=258.45 Aligned_cols=177 Identities=27% Similarity=0.318 Sum_probs=142.1
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
++...+++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 82 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL- 82 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence 345678899999999999999999986441 2356788999999999999999999885422
Q ss_pred CCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
...++||||+ +++|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 83 ---~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 ---EDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred ---CcEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 2479999999 568888775322 2367899999999998 9999999999999999999999999998
Q ss_pred cccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+..... .....++..|+|||++.+ ..++.++||||+|++++++.++..++
T Consensus 156 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 156 RIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred cccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 754211 122367889999998766 56899999999998888876554433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-27 Score=259.29 Aligned_cols=247 Identities=24% Similarity=0.268 Sum_probs=171.6
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+|+... ..+.+.+|+.+++.++||||+++.+++...+.......|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999987541 235788999999999999999999998765432334589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||++ ++|.++++... .++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 58888876432 2467899999999998 9999999999999999999999999999876432
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhh---------------
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQ--------------- 857 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~--------------- 857 (929)
... ........++..|+|||++.+. .++.++||||+|++++++.....++..... . ...
T Consensus 157 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 110 0112334678999999999888 799999999999887776555443322111 0 000
Q ss_pred ccChHHHHhhcccc-hhhhhh---hHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHhhHH
Q 002376 858 VLDPELRQLMTSNE-SQTIQL---HDCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSSQE 915 (929)
Q Consensus 858 ~~~~~l~~~~~~~~-~~~~~~---~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 915 (929)
.............. ...... ...+...+.+++.+||+.+|++||+++++++. ++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000 000000 00112223348889999999999999999863 655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=258.22 Aligned_cols=174 Identities=27% Similarity=0.405 Sum_probs=135.9
Q ss_pred CCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 46778899999999999988642 124567899999999999999999999653 224
Q ss_pred eEEEEEEecCCCCcccccccc-------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC----CCceEE
Q 002376 721 FLALVYEFLSNGSLGDWIHGE-------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE----EMTAKV 783 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~ki 783 (929)
..++||||+++ ++.+++... ..++.|++.|++|||+. +|+||||||+||+++. ++.+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEE
Confidence 58999999974 666655311 12357899999999998 8999999999999999 999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhH
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
+|||+++....... .........+++.|+|||++.+. .++.++||||+|++++++....
T Consensus 154 ~Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 154 GDLGLARLFNAPLK---PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred CCCccccccCCCcc---cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 99999986532211 11122345789999999988764 5899999999998887765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-27 Score=258.32 Aligned_cols=175 Identities=29% Similarity=0.361 Sum_probs=137.8
Q ss_pred hCCCCCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|..... ...+.+|+.++++++||||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 46789999999999999999876410 124668999999999999999999986422 235
Q ss_pred EEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||++ ++|.+++... ..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 799999996 4787776532 23467899999999998 8999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.... .......+++.|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 159 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~ 208 (309)
T cd07845 159 GLPA------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL 208 (309)
T ss_pred CCcc------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence 3211 11122345788999999876 4579999999999888886555433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-27 Score=256.64 Aligned_cols=221 Identities=28% Similarity=0.353 Sum_probs=156.7
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.|+..+.||+|+||.||+|+... ..+++.+|+++++.++|||++++.+++... ...
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence 36667889999999999887531 124677899999999999999999998653 347
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++||||+. |++.+++.... ..+.+++.|++|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99999996 68777664211 2356899999999998 99999999999999999999999999987542
Q ss_pred cccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
. .....|++.|+|||++. ...++.++||||+|++++++.....++..... . ........ .
T Consensus 167 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~----~~~~~~~~-~ 229 (308)
T cd06634 167 P----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--M----SALYHIAQ-N 229 (308)
T ss_pred C----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--H----HHHHHHhh-c
Confidence 1 12346889999999974 35688999999999887765443322211110 0 00010000 0
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
...... .......+.+++.+||+.+|++||++.+++..
T Consensus 230 ~~~~~~-~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 230 ESPALQ-SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCCCcC-cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000000 01122233347779999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=247.14 Aligned_cols=223 Identities=22% Similarity=0.308 Sum_probs=158.9
Q ss_pred CCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
+|...+.||+|+||.||+++... ...++..|+.++++++||||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence 47778999999999999875531 1224667999999999999999999985433
Q ss_pred eEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..++||||+++++|.+++... ..++.|++.|++|||+. +++|+|+||+||++++ +.+|++|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCc
Confidence 379999999999999887531 12356899999999998 9999999999999986 5699999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
++...... .......|++.|+|||...+..++.++||||+|++++++.....++... ...+.. .....
T Consensus 152 ~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--~~~~~~----~~~~~ 219 (260)
T cd08222 152 SRLLMGSC------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NFLSVV----LRIVE 219 (260)
T ss_pred eeecCCCc------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--cHHHHH----HHHHc
Confidence 88653211 1112346789999999998888999999999998776654433322111 111100 01000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. ...........+.+++.+||+.+|++||++.|+++
T Consensus 220 -~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 -GP--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CC--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 00111122223334777999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=252.10 Aligned_cols=218 Identities=24% Similarity=0.254 Sum_probs=154.6
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||+||++.... ..+.+.+|++++++++||||+++++++.. ....|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6999999999886441 12356789999999999999999998854 33589999999
Q ss_pred CCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 730 SNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 730 ~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
++++|.+++.... .++.|++.|+.|||+. +++||||||+||++++++.+|++|||.++.....
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 148 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---- 148 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC----
Confidence 9999998886432 1256899999999998 9999999999999999999999999998765321
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
.......|+..|+|||++.+..++.++||||+|++++++.....++...... .....+........ ...+.
T Consensus 149 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---~~~~~ 219 (277)
T cd05577 149 ---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK---VEKEELKRRTLEMA---VEYPD 219 (277)
T ss_pred ---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc---ccHHHHHhcccccc---ccCCc
Confidence 1112346788999999998888999999999998777765444433222110 00111111000000 00111
Q ss_pred HHHHHHHHHhccccCCCCCCCC-----CHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRI-----GIREAL 907 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~ 907 (929)
....-+.+++.+||+.||++|| ++.+++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 1122233477799999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-27 Score=258.58 Aligned_cols=173 Identities=17% Similarity=0.206 Sum_probs=130.2
Q ss_pred eeeccc--CceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSG--SFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G--~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
..||+| +||+||++++.. ..+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence 356666 999999987641 135678899999999999999999999653 3479999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||+++|++.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 9999999999886421 2367899999999987 99999999999999999999999998654332111
Q ss_pred CCCC-CccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 797 DNQS-SISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 797 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.... .........++..|||||++.+. .++.++||||+|++++++.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p 209 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 1100 00011122456779999998764 478999999999888776544333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=253.56 Aligned_cols=226 Identities=20% Similarity=0.257 Sum_probs=160.5
Q ss_pred CCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~ 717 (929)
+|+..+.||+|+||.||+++.. ...+.+.+|+++++++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 4677899999999999987642 1124577899999999 59999999988743
Q ss_pred CcceEEEEEEecCCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||+++|+|.+++..... ++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 2347999999999999998864322 245899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHHHH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPELRQ 865 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 865 (929)
+...... ........|+..|+|||++.+. .++.++||||+|++++++.....++..... ...++.+. ..
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~- 225 (290)
T cd05613 153 KEFHEDE-----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR-IL- 225 (290)
T ss_pred eeccccc-----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-hh-
Confidence 8653211 1112235689999999998753 468899999999888776655444321111 11111110 00
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
..... .+..+...+.+++.+|++.||++|| ++++++.
T Consensus 226 --~~~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 --KSEPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --ccCCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00111 1111223344477799999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=246.94 Aligned_cols=230 Identities=21% Similarity=0.240 Sum_probs=160.1
Q ss_pred HHHHHhhCCCCCceee--cccCceeEEeccccCc----------HHHH-HHHHHHHHcc-CCccccceeeecccCCCCCc
Q 002376 654 DELRRATGNFSHENLI--GSGSFGSVLHNERTGS----------WKSF-IAECETLRNV-RHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~i--G~G~~g~Vy~~~~~~~----------~~~~-~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~ 719 (929)
.+.....++|+..+.+ |+|+||.||++..... .+.+ ..|+.....+ +||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~---- 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLK---- 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCC----
Confidence 4445555677777766 9999999999876521 1111 1133333323 7999999999986533
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~ 790 (929)
..++||||+++|+|.++++... .++.|+++|++|||+. +++||||||+||+++.++ .++|+|||+++
T Consensus 83 -~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 -GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred -eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 4899999999999999986542 2367899999999998 899999999999999998 99999999987
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChH-HHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPE-LRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~ 869 (929)
.... .....|+..|+|||++.+..++.++||||+|++++++.....++..... +.++.. +......
T Consensus 159 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 225 (267)
T PHA03390 159 IIGT----------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQQK 225 (267)
T ss_pred ecCC----------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhhcc
Confidence 5421 1123688999999999998999999999999887776555444332111 111111 1111111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-HHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-IREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~ev~~ 908 (929)
.....+.....+.+++.+|++.+|++||+ ++|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01111112233344777999999999996 588763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=253.99 Aligned_cols=171 Identities=28% Similarity=0.370 Sum_probs=134.4
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|++|.||+|.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence 578889999999999999987541 124678899999999999999999998543 358
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEeccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARF 791 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~ 791 (929)
++||||++ +++.+++.... ..+.||+.||+|||+. +++||||||+||++++ ++.+||+|||+++.
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 99999996 57877664221 2356899999999998 9999999999999985 55799999999975
Q ss_pred cccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
.... ........|++.|+|||++.+. .++.++||||+|++++++.....
T Consensus 153 ~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 153 FGIP------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred cCCC------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 4221 1111233678999999988764 57999999999988777655433
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-27 Score=256.39 Aligned_cols=178 Identities=29% Similarity=0.411 Sum_probs=138.2
Q ss_pred HhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC---
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS--- 716 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~--- 716 (929)
.+.++|+..+.||+|+||.||+|.... ....+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999988641 12456789999999999999999999865431
Q ss_pred --CCcceEEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEec
Q 002376 717 --KNMEFLALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 717 --~~~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
......++|+||+++ ++.+.+... ..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 112368999999975 666655432 13357899999999998 999999999999999999999999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchh
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~ 844 (929)
||.++....... .......++..|+|||++.+. .++.++||||+|++++++...
T Consensus 160 fg~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 160 FGLARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred ccccccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999986532211 111223567889999988654 578999999999887776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-27 Score=217.21 Aligned_cols=165 Identities=28% Similarity=0.459 Sum_probs=134.6
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.|+..++||+|.||+||+|+.. +......+|+.+++.++|.|||+++++..+ .....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence 4667789999999999999865 223567899999999999999999999854 33489
Q ss_pred EEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+|+|||. .+|..+... .+....|+.+|+.|+|++ .+.|||+||.|.||+.+|+.|++|||+||.+.-
T Consensus 78 lvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9999995 466665542 234578999999999998 899999999999999999999999999997632
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEF 841 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~ 841 (929)
. .......+-|.+|++|.++.|.+ |+++.|+||.||+..|+
T Consensus 154 p------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifael 195 (292)
T KOG0662|consen 154 P------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_pred c------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHH
Confidence 1 22223346799999999998876 89999999999876554
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=249.78 Aligned_cols=231 Identities=23% Similarity=0.294 Sum_probs=156.7
Q ss_pred CCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|+||.||+|.... ......+|+.+++++. |||++++++++.+.. .+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 5667899999999999987541 1123457888999885 999999999986531 235899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||++ |++.+++.... .++.|++.||+|||+. +++||||||+||++++ +.+||+|||+++.+...
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999996 58877775322 2367899999999998 9999999999999999 99999999999865321
Q ss_pred cCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hh---hhcc---ChHHHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NV---LQVL---DPELRQL 866 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~---~~~~---~~~l~~~ 866 (929)
.......++..|+|||++.. ..++.++||||+|++++++.....++..... .+ .+.. .+.+...
T Consensus 153 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 -------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred -------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 11122457899999997654 5578999999999888876554333321110 00 0000 0000000
Q ss_pred hcccchhhh-----------hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNESQTI-----------QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~~~~~-----------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......... ......+..+.+++.+||+.+|++||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 000111233334888999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=260.72 Aligned_cols=181 Identities=24% Similarity=0.337 Sum_probs=138.0
Q ss_pred CCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC------
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN------ 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~------ 718 (929)
.+|...+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578889999999999999987641 2456889999999999999999998876533211
Q ss_pred ---cceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEeccc
Q 002376 719 ---MEFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFG 787 (929)
Q Consensus 719 ---~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfG 787 (929)
....++||||++ ++|.+++... +.++.|++.||+|||+. +|+||||||+||+++ +++.+|++|||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 135799999997 5888776532 23467999999999998 999999999999997 45678999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.++.+...... ........|+..|+|||++.+ ..++.++||||+|++++++.....++
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 161 LARIVDPHYSH---KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred cceecCCcccc---ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 99865321111 111122367889999998654 45889999999998888765544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=252.12 Aligned_cols=169 Identities=24% Similarity=0.402 Sum_probs=135.3
Q ss_pred CCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+|+..+.||+|++|.||+|+... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence 47888999999999999988641 1346778999999999999999999986533 4799
Q ss_pred EEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
||||++ |+|.+++.... .++.|++.||+|||+. +++||||||+||++++++.+|++|||+++...
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 999998 48888765321 2357899999999987 99999999999999999999999999997653
Q ss_pred cccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhH
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
... .......++..|+|||++.+. .++.++|||++|++++++....
T Consensus 152 ~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (284)
T cd07836 152 IPV------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198 (284)
T ss_pred CCc------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 211 111223578899999988664 4789999999998877765443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=255.53 Aligned_cols=235 Identities=17% Similarity=0.186 Sum_probs=158.5
Q ss_pred ceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
.+.+|.|+++.||+++.. ...+.+.+|++++++++||||+++++++... ...+++|||+
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~ 81 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLM 81 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEecc
Confidence 445566677777766553 1235788999999999999999999988543 3489999999
Q ss_pred CCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC
Q 002376 730 SNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799 (929)
Q Consensus 730 ~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 799 (929)
++|+|.++++.. ..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.+..+.......
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999988642 12367899999999998 99999999999999999999999999987653221110
Q ss_pred -CCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCch--hhhc--------cChHHHHh
Q 002376 800 -SSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPEN--VLQV--------LDPELRQL 866 (929)
Q Consensus 800 -~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~~ 866 (929)
..........++..|+|||++.+. .++.++||||+|++++++.....++...+.. ..+. ++......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 011112334678899999998764 5889999999998887765544443322210 0000 00000000
Q ss_pred h----c----------ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 M----T----------SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~----~----------~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. . ............+...+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 0 0000000011112223344888999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=250.67 Aligned_cols=231 Identities=24% Similarity=0.311 Sum_probs=162.1
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|++|.||++.... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 5567899999999999987641 134678899999999999999999998653 34899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||+++ ++.+++... ..++.+++.|++|||+. +|+||||||+||++++++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9999975 888777542 12367899999999998 9999999999999999999999999999866432
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc----cC--hHHHH-
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV----LD--PELRQ- 865 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~----~~--~~l~~- 865 (929)
. .......++..|+|||.+.+. .++.++||||+|++++++.....++..... ....+ .+ +....
T Consensus 152 ~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 152 V------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred c------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 1 111224578899999998877 789999999999888776555433221110 00000 00 00000
Q ss_pred ----------hhcccch-hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 ----------LMTSNES-QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ----------~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....... ........+...+.+++.+||++||.+||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 000011122333445888999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=251.41 Aligned_cols=218 Identities=21% Similarity=0.229 Sum_probs=151.4
Q ss_pred eecccCceeEEeccccCc-------------------HHHHHHHHH---HHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 668 LIGSGSFGSVLHNERTGS-------------------WKSFIAECE---TLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~---~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.||+|+||.||+++.... ...+..|.. .++..+||+|+++.+++.+. ...++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 489999999998765310 112344443 34445799999999988543 358999
Q ss_pred EEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 726 YEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||+++|+|.+++.... .++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 99999999998875332 3467899999999997 8999999999999999999999999998754211
Q ss_pred CCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
......|+..|+|||++.++ .++.++||||+|++++++.....++...........+.... .....
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~---- 217 (278)
T cd05606 151 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMAVE---- 217 (278)
T ss_pred ------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---ccCCC----
Confidence 11234689999999998755 58999999999988877665554443221100010111110 00011
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
.+...+.-+.+++.+|+..+|++|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111122233477799999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=242.39 Aligned_cols=224 Identities=24% Similarity=0.354 Sum_probs=164.3
Q ss_pred CCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||++... ...+.+.+|+++++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 4777899999999999988765 1235688999999999999999999988543 4589
Q ss_pred EEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+|+||+++++|.++++... .++.+++.|++|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999886532 2356899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
..... .......|++.|+|||...+..++.++|||++|++++++.....++... ...++..........
T Consensus 153 ~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--~~~~~~~~~~~~~~~--- 221 (258)
T cd08215 153 LSSTV------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--NLLELALKILKGQYP--- 221 (258)
T ss_pred cccCc------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--cHHHHHHHHhcCCCC---
Confidence 53221 1122346889999999999989999999999997766644333222111 111111111110000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 222 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111222334777999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=251.94 Aligned_cols=173 Identities=26% Similarity=0.393 Sum_probs=136.8
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|+||.||+|.... ..+.+.+|++++++++|||++++++++...+ ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 5667899999999999987642 1346889999999999999999999986531 245899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||++ ++|.+++... ..++.+++.|++|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 999997 4888877543 13367899999999998 8999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.. .......++..|+|||.+.+. .++.++|||++|++++++.....+
T Consensus 154 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 154 NS-----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred Cc-----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence 11 112233568899999987654 579999999999888876554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=246.98 Aligned_cols=221 Identities=24% Similarity=0.267 Sum_probs=154.6
Q ss_pred eeecccCceeEEeccccCc-------------------HHHHHHHHHHH-HccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERTGS-------------------WKSFIAECETL-RNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l-~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||.||+|..... ...+..|..++ ...+|||++++++++... ...|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence 4689999999999876410 11234454443 445899999999998543 3589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
||+++|+|.++++... .++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999999886422 3367899999999998 999999999999999999999999999875421
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
.....|++.|+|||.+.+..++.++||||+|++++++.++..++..... .+.......... .......
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~----~~~~~~~ 217 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILSRRI----NWPEEVK 217 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhccc----CCCCccc
Confidence 1234688999999999888899999999999888776555544322211 111111111000 0000011
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
+.+..-+.+++.+||+.+|++||++.++.+.+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 112222334777999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=269.89 Aligned_cols=183 Identities=26% Similarity=0.314 Sum_probs=149.2
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
..+++...++|.+.++||+|+||.|..++.+. +...|..|-.+|..-+.+.||+++..|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-- 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-- 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--
Confidence 35666677899999999999999998877752 234577899999999999999999888
Q ss_pred CCCCCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEec
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
++..++|+|||||+||+|-..+.+. +.+...|..||.-+|+. |+|||||||.|||+|..|++|++|
T Consensus 145 ---QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 145 ---QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ---cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 4456699999999999998877643 34466788999999997 999999999999999999999999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccC----C-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL----G-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
||.+-.+... ........+|||-|++||++. + +.|+..+|-||+|+++|||..+.-++
T Consensus 219 FGsClkm~~d-----G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 219 FGSCLKMDAD-----GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred chhHHhcCCC-----CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9988766432 112334568999999999875 3 56999999999999888876555443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=259.18 Aligned_cols=177 Identities=24% Similarity=0.346 Sum_probs=139.7
Q ss_pred HHHhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
+....++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 33456789999999999999999986531 124577899999999999999999988653321
Q ss_pred -CcceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 718 -NMEFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 718 -~~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.....++||||+ +++|.+++... +.++.|++.|++|||+. +|+||||||+||++++++.+|++|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 123469999999 67888877532 23467999999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
+..... .....+++.|+|||++.+ ..++.++||||+|++++++....
T Consensus 166 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 166 RQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred cccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 854211 123467899999999876 45899999999998877765443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=248.38 Aligned_cols=167 Identities=26% Similarity=0.395 Sum_probs=133.6
Q ss_pred CCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|+||+||+|.... ......+|+..+++++ |||++++++++... ...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence 5667899999999999998642 1123457999999999 99999999998653 34899
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||+ +|+|.+++.... ..+.|++.||+|||+. +++|+||||+||++++++.+||+|||.++....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 99999 889988876432 2356899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
. .......|+..|+|||++.+ ..++.++||||+|++++++....
T Consensus 152 ~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 152 R-------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred C-------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 1 11123467889999998754 45799999999998887765544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=249.41 Aligned_cols=230 Identities=26% Similarity=0.334 Sum_probs=164.9
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|...+.||+|+||.||++.... ..+.+.+|++++++++ ||||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 468888999999999999987641 1245778999999998 99999999988543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++++|.+++.... .++.|++.||+|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 4899999999999999987542 2367899999999998 9999999999999999999999999999866
Q ss_pred ccccCCCC--------------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc
Q 002376 793 LERVDNQS--------------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV 858 (929)
Q Consensus 793 ~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~ 858 (929)
........ .........|+..|+|||+..+..++.++|||++|++++++.....++..... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YL- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HH-
Confidence 43221100 01122345688999999999888899999999999776665433332222111 00
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCH----HHHHH
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI----REALR 908 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~----~ev~~ 908 (929)
............. ....+.+.+++.+|++.+|++||++ +|+++
T Consensus 230 ---~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---TFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111100011111 1112223337779999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=240.06 Aligned_cols=225 Identities=25% Similarity=0.313 Sum_probs=164.6
Q ss_pred CCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
+|+..+.||+|++|.||++.... ..+.+.+|++.+++++||+++++++++... ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 46778999999999999987641 245788999999999999999999998543 348999
Q ss_pred EEecCCCCcccccccc-c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGE-R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~-~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
+||+++++|.+++... + .++.+++.|++|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999988654 1 2357899999999997 99999999999999999999999999988654221
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
. .....|+..|+|||++.+..++.++|||++|++++++.....++..... .+............ ....
T Consensus 153 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~-~~~~-- 220 (253)
T cd05122 153 A-------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--MKALFKIATNGPPG-LRNP-- 220 (253)
T ss_pred c-------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhcCCCC-cCcc--
Confidence 1 2345688999999999988899999999999877765444333222211 00000000000000 0000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....-+.+++.+||+.||++|||+.|+++
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000122333777999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=245.10 Aligned_cols=218 Identities=23% Similarity=0.275 Sum_probs=157.7
Q ss_pred ceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 666 ENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.+++|+|-||+||-|+++ +...+..+|+++|+.++||.||.+...|.+ .+.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceEEEEeh
Confidence 478999999999988776 234678899999999999999999988854 445999999
Q ss_pred ecCCCCccccc-ccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEEecccccccccc
Q 002376 728 FLSNGSLGDWI-HGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKVGDFGLARFLLE 794 (929)
Q Consensus 728 ~~~~gsL~~~l-~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DfGla~~~~~ 794 (929)
-+ +|+..+++ ... +....||+.||.|||.. +|+|+|+||+|||+.+. -.+|+||||+||.+.+
T Consensus 644 Kl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred hh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 99 45655544 211 12257999999999998 99999999999999643 3799999999998864
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
. .....++||+.|.|||+++.+.|...-|+||.|++.|--. .+.+|....+-+...+.... ....
T Consensus 720 k-------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL-----SGTFPFNEdEdIndQIQNAa---FMyP 784 (888)
T KOG4236|consen 720 K-------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL-----SGTFPFNEDEDINDQIQNAA---FMYP 784 (888)
T ss_pred h-------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe-----cccccCCCccchhHHhhccc---cccC
Confidence 3 2345579999999999999999999999999998776533 34444422222222222111 1111
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
+..|..+....-+++...++..-.+|-+.+..+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 222223332222377788888888888877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=256.19 Aligned_cols=221 Identities=25% Similarity=0.261 Sum_probs=171.4
Q ss_pred hCCCCCceeecccCceeEEeccccCcHH------------HHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGSWK------------SFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~------------~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++.|.....+|.|+|+.|-++....+.+ +-.+|+.++... +||||+++.++|.+ ..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYED-----GKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecC-----Cceeeeee
Confidence 5567777889999999998877663322 233577665555 79999999999943 44589999
Q ss_pred EecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee-cCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL-DEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
|++.+|-+.+.+...+ .++.+++.|+.|||++ +|||||+||+|||+ ++.+.++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 9999998877665322 3567889999999998 99999999999999 58999999999999976432
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
....+-|..|.|||++....|++++|+||+|+++|+|..+.-++...|.. ..+...+. .....
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~-----~~~~s 532 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQ-----MPKFS 532 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhc-----CCccc
Confidence 22335688999999999999999999999999988888777777766653 12222111 11122
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++++...++|+..|++.||.+||+|.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 566677777888999999999999999863
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=242.12 Aligned_cols=222 Identities=22% Similarity=0.273 Sum_probs=163.4
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|+||.||+++... ...++.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 47778999999999999986541 134677899999999999999999998643 4589
Q ss_pred EEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+||||+++++|.+++.... .++.+++.|++|||+. +++||||||+||++++++.+|++|||+++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999886411 2356899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... ......|++.|+|||.+.+..++.++||||+|++++++.....++..... . .+........
T Consensus 153 ~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~-----~~~~~~~~~~ 217 (256)
T cd08530 153 LKKN--------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--Q-----DLRYKVQRGK 217 (256)
T ss_pred hccC--------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H-----HHHHHHhcCC
Confidence 6432 11123578899999999999999999999999877775443333221111 0 1111000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ..........+.+++.+|++.+|++||++.|+++
T Consensus 218 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 Y--PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C--CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0011112223344778999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=257.49 Aligned_cols=181 Identities=23% Similarity=0.350 Sum_probs=143.5
Q ss_pred ChHHHHHhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 652 SYDELRRATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 652 ~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
...++..++++|...+.||+|+||.||++.... ..+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 446677788999999999999999999986431 13457789999999999999999998754
Q ss_pred CCC-CCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEec
Q 002376 714 LDS-KNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 714 ~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
... ......++|+|++ +++|.++++..+ .++.|+++|++|||+. +|+||||||+||++++++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 321 1223468888887 788987765322 3467899999999998 999999999999999999999999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhH
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
||+++.... ......|+..|+|||++.+ ..++.++||||+|++++++..+.
T Consensus 164 fg~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 164 FGLARHTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred ccccccccc---------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 999875421 1123468899999999876 46899999999998887765443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=239.47 Aligned_cols=224 Identities=26% Similarity=0.356 Sum_probs=164.2
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
+|+..+.||+|++|.||++.... ..+.+.+|++++++++|||++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 46778999999999999986531 235688999999999999999999998542 4589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++++|.+++.... .++.+++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999999999886432 2367899999999998 9999999999999999999999999999866432
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
.. ......|+..|+|||+..+..++.++|||++|++++++.....++..... ... ........ ..
T Consensus 153 ~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~-----~~~~~~~~---~~ 217 (254)
T cd06627 153 SK------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAA-----LFRIVQDD---HP 217 (254)
T ss_pred cc------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHH-----HHHHhccC---CC
Confidence 11 12234688999999999888899999999999877765443322221111 000 01100000 00
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+..+...+.+++.+|++.+|++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111112223334777999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-27 Score=244.83 Aligned_cols=433 Identities=23% Similarity=0.237 Sum_probs=241.4
Q ss_pred EcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccc-ccc
Q 002376 77 NLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA-NKI 155 (929)
Q Consensus 77 ~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l 155 (929)
|-++.+|+ .||..+- ..-+.++|..|+|+...|.+|+.+++||.||||+|+|+.+-|..|.++.+|.+|-+-+ |+|
T Consensus 52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 33444455 5555443 3458899999999988888999999999999999999999999999999987766555 999
Q ss_pred CCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 156 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
+ .+|.+.|++|.+|+.|.+.-|++.- +....|..|++|..|.|..|.+..+--.+|..+.+++++.+..|.
T Consensus 129 ~-~l~k~~F~gL~slqrLllNan~i~C--------ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 129 T-DLPKGAFGGLSSLQRLLLNANHINC--------IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred h-hhhhhHhhhHHHHHHHhcChhhhcc--------hhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 8 8999999999999999999888733 344577888999999999999996666699999999999999887
Q ss_pred CCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCC-CccceeccccccccCCCC
Q 002376 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNL-PFLRTYNIGFNKIVSSGD 314 (929)
Q Consensus 236 l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~i~~~~~ 314 (929)
+--. . .++.+.... ...|.+++...-..-..+.++++..+-+..|..- ..+..=..+........
T Consensus 200 ~icd-----C-nL~wla~~~-------a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~c- 265 (498)
T KOG4237|consen 200 FICD-----C-NLPWLADDL-------AMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSIC- 265 (498)
T ss_pred cccc-----c-ccchhhhHH-------hhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcC-
Confidence 4310 0 011111100 0122223333333333333333332222222111 00000000000000000
Q ss_pred CCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccC
Q 002376 315 DEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIP 394 (929)
Q Consensus 315 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 394 (929)
....|..+++|+.|+|++|++++.-+.+|.... .+++|+|..|+|...-...|.++..|+.|+|.+|+|+..-|
T Consensus 266 -----P~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 266 -----PAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred -----hHHHHhhcccceEeccCCCccchhhhhhhcchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 012344455555555555555544444444444 45555555555554444455555555555555555555555
Q ss_pred ccccCCCCCCEEEecCCcCCCCCcccccCCCCCcee--cccCcccccccCcccccccccceecccCCcCCCCCCCCcccC
Q 002376 395 IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQI--DLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472 (929)
Q Consensus 395 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~ 472 (929)
..|..+.+|.+|+|-.|.+-- ++ .|.+| .|..+.-.|..|- +.-..++.++++.+.+...--.
T Consensus 340 ~aF~~~~~l~~l~l~~Np~~C-------nC-~l~wl~~Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~----- 404 (498)
T KOG4237|consen 340 GAFQTLFSLSTLNLLSNPFNC-------NC-RLAWLGEWLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCG----- 404 (498)
T ss_pred ccccccceeeeeehccCcccC-------cc-chHHHHHHHhhCCCCCCCCC--CCCchhccccchhccccccccC-----
Confidence 555555555555555544320 00 00000 0111111111111 1111233444444433211000
Q ss_pred Cchhhh---------cccCcc-EEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCC
Q 002376 473 LPEEIS---------RLENVV-TIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 473 ~p~~~~---------~l~~L~-~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (929)
.|++.+ ..+-+. +..-|++.+. .+|..+- ..-.+|++.+|.++ .+|.. .+.+| .+|+|+|+++
T Consensus 405 ~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~ 477 (498)
T KOG4237|consen 405 GPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRIS 477 (498)
T ss_pred CccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCcee
Confidence 011111 011111 1223333333 4443321 23467888888888 55655 56777 8899999888
Q ss_pred CcCCcccccCCCCCeEeCCCC
Q 002376 543 GSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N 563 (929)
-.--..|.++++|.+|-||+|
T Consensus 478 ~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 478 SLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhhcccccchhhhheeEEecC
Confidence 666678888999999988886
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=248.12 Aligned_cols=228 Identities=22% Similarity=0.254 Sum_probs=157.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|++.. ..+++.+|+.++.+.. ||||++++++|.+. ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----Ce
Confidence 3567888999999999999988751 1234667887777775 99999999998643 34
Q ss_pred EEEEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.|+||||++ +++.++... ...++.+++.|++|||+. .+|+||||||+||++++++.+||+|||+++.+
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 899999985 466555432 123577899999999973 28999999999999999999999999998765
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC----CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER----PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
.... ......|+..|+|||++.+.. ++.++||||+|++++++.....++...... .+. +.....
T Consensus 166 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~----~~~~~~ 233 (296)
T cd06618 166 VDSK-------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEV----LTKILQ 233 (296)
T ss_pred cCCC-------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHH----HHHHhc
Confidence 3211 112235788999999987654 889999999998777765443333211110 000 111111
Q ss_pred ccchhhhhhh-HHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 869 SNESQTIQLH-DCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 869 ~~~~~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... ...... .+..++. +++.+||+.||++||++.++++.
T Consensus 234 ~~~-~~~~~~~~~~~~l~-~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 EEP-PSLPPNEGFSPDFC-SFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC-CCCCCCCCCCHHHH-HHHHHHccCChhhCCCHHHHhcC
Confidence 100 000000 0112233 37779999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=245.36 Aligned_cols=227 Identities=23% Similarity=0.292 Sum_probs=159.4
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||.||+++... ..+.+.+|++++++++||||+++++.+.. ....|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 6899999999988651 13467889999999999999999988743 33589999999
Q ss_pred CCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCC--
Q 002376 730 SNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ-- 799 (929)
Q Consensus 730 ~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~-- 799 (929)
++++|.++++... .++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..........
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999999886432 2367899999999998 99999999999999999999999999987543211100
Q ss_pred CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH
Q 002376 800 SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD 879 (929)
Q Consensus 800 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 879 (929)
..........++..|+|||+..+..++.++||||+|++++++.....++..... .+..+. ... ..... +....
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~-~~~---~~~~~-~~~~~ 225 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQN-ILN---GKIEW-PEDVE 225 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-Hhc---CCcCC-Ccccc
Confidence 001122334688899999999888899999999999887776544333322111 111111 110 00000 00000
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 226 -~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 -VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1222233777999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=256.83 Aligned_cols=176 Identities=24% Similarity=0.355 Sum_probs=140.1
Q ss_pred HhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KN 718 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~ 718 (929)
...++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++|||++++++++...+. ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 346789999999999999999987641 12456689999999999999999998765432 22
Q ss_pred cceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
....++|+||+ +++|.+++...+ .++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 23479999999 679988875422 3467899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
.... .....++..|+|||++.+. .++.++||||+|++++++..+..
T Consensus 168 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 168 TDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred cccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 5211 2234678899999998653 67899999999988887655443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=235.74 Aligned_cols=173 Identities=27% Similarity=0.315 Sum_probs=142.2
Q ss_pred CCCCceeecccCceeEEeccccCcHHHH-------------------HHHHHHHHcc-CCccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNV-RHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~~~~~-------------------~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+|....+||+|+||+|..+..+++.+-+ +.|-++|+-- +-|.+|+++.++. ....
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----TmDR 424 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----TMDR 424 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----hhhh
Confidence 7888999999999999999888654432 2466666665 4678999998884 4555
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+||||+.||+|.-++++.. .++.+||-||-|||++ +||.||+|..|||+|.+|.+||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc-
Confidence 999999999999998887433 3477899999999998 9999999999999999999999999999832
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
......+..++||+-|+|||++...+|+.++|-|++|+.+||+..+.-++
T Consensus 501 -----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 501 -----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred -----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence 22233456789999999999999999999999999998877765544443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=244.22 Aligned_cols=219 Identities=26% Similarity=0.324 Sum_probs=154.6
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
|...+.||+|+||+||+|+... ..+.+.+|+++++.++|||++++++++.+. ...|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence 4556789999999999987531 124678899999999999999999998653 3479
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+. |++.+++.... .++.|++.|++|||+. +++||||||+||++++++.+||+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 9999995 57777664321 2356899999999998 99999999999999999999999999986421
Q ss_pred ccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
......|+..|+|||++. ...++.++||||+|++++++.....++..... ... +........
T Consensus 173 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-~~~-----~~~~~~~~~ 237 (313)
T cd06633 173 ---------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSA-----LYHIAQNDS 237 (313)
T ss_pred ---------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHH-----HHHHHhcCC
Confidence 112346899999999974 45689999999999877765433222111110 000 000000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ... .......+++++.+||+.+|++||++.|++.
T Consensus 238 ~-~~~-~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 P-TLQ-SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred C-CCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 0011122334777999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-26 Score=246.40 Aligned_cols=225 Identities=20% Similarity=0.274 Sum_probs=169.9
Q ss_pred cCCCCChHHHHHhhCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccce
Q 002376 647 CHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKL 707 (929)
Q Consensus 647 ~~~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l 707 (929)
....+.++++++ ...+|-|+||.|-..+.. ++.+....|-.+|...+.|.||++
T Consensus 413 e~a~v~l~dl~~-------iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrL 485 (732)
T KOG0614|consen 413 EFAQVKLSDLKR-------IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRL 485 (732)
T ss_pred hhcccchhhhhh-------hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHH
Confidence 334455555544 467999999999655443 234456689999999999999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM 779 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 779 (929)
|..| ++.+++|+.||-|-||.+...++++. .++..|.+|++|||+. +||.||+||+|.++|.+|
T Consensus 486 YrTf-----rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~G 557 (732)
T KOG0614|consen 486 YRTF-----RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRG 557 (732)
T ss_pred HHHh-----ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCC
Confidence 9998 45567999999999999999998554 3456788999999998 999999999999999999
Q ss_pred ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhc
Q 002376 780 TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQV 858 (929)
Q Consensus 780 ~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~ 858 (929)
.+|+.|||+|+.+.. ...+..++||+.|.|||++..+..+.++|.|++|+++||+.++.-+++.... .....
T Consensus 558 y~KLVDFGFAKki~~-------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGS-------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred ceEEeehhhHHHhcc-------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 999999999998742 2345678999999999999999999999999999888887666655554433 22222
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG 902 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs 902 (929)
+-..+..+ ..+..+.+-..+++.+.+..+|.+|--
T Consensus 631 ILkGid~i---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 631 ILKGIDKI---------EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHhhhhhh---------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 22222111 111122222333777888999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=231.44 Aligned_cols=175 Identities=26% Similarity=0.338 Sum_probs=140.4
Q ss_pred hCCCCCceeecccCceeEEeccccCc---------------HHHHHHHHHHHHccC--Ccc----ccceeeecccCCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS---------------WKSFIAECETLRNVR--HRN----LVKLITSCSSLDSKN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~~~E~~~l~~l~--Hpn----iv~l~~~~~~~~~~~ 718 (929)
+++|.....+|+|+||+|.++++... .++.+-|+++++++. -|+ +|++.+++ .-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 67899999999999999998877632 334556999999993 233 77887777 44
Q ss_pred cceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-----------
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE----------- 777 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----------- 777 (929)
.++.|+|+|.+ |-|++++++.. +.++.|++++++|||+. +++|-|+||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 55689999998 56999999753 34467999999999998 9999999999999832
Q ss_pred ---------CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 778 ---------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 778 ---------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+..+||.|||-|+.-.+. ...++.|..|+|||++.+-.++.++||||+||++.|+.++...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~---------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH---------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC---------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 235899999999864221 24467899999999999999999999999999999987777666
Q ss_pred hcCC
Q 002376 849 SNLP 852 (929)
Q Consensus 849 ~~~~ 852 (929)
...+
T Consensus 310 qtHe 313 (415)
T KOG0671|consen 310 QTHE 313 (415)
T ss_pred ccCC
Confidence 5544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=245.05 Aligned_cols=167 Identities=26% Similarity=0.391 Sum_probs=135.3
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
|+..+.||+|+||.||+|+... ..+.+.+|+.++++++|||++++++++.+. ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 4566789999999999987652 124677899999999999999999998643 34899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||++ ++|.+++... ..++.+++.|++|||+. +|+||||+|+||++++++.+||+|||.++.....
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 999997 5899988654 12367899999999998 9999999999999999999999999999865321
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~ 844 (929)
.. ......++..|+|||++.+. .++.++|||++|++++++...
T Consensus 152 ~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 152 LR------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred cc------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC
Confidence 11 11223567889999998777 789999999999888776544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-26 Score=252.67 Aligned_cols=178 Identities=22% Similarity=0.293 Sum_probs=135.2
Q ss_pred CCCCC-ceeecccCceeEEeccccCc------------------------------HHHHHHHHHHHHccCCccccceee
Q 002376 661 GNFSH-ENLIGSGSFGSVLHNERTGS------------------------------WKSFIAECETLRNVRHRNLVKLIT 709 (929)
Q Consensus 661 ~~~~~-~~~iG~G~~g~Vy~~~~~~~------------------------------~~~~~~E~~~l~~l~Hpniv~l~~ 709 (929)
++|.. .+.||+|+||+||+|..... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 46799999999999975410 014678999999999999999999
Q ss_pred ecccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCce
Q 002376 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781 (929)
Q Consensus 710 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 781 (929)
++... ...++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEG-----DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecC-----CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 98543 35899999996 68988875322 2367899999999997 99999999999999999999
Q ss_pred EEeccccccccccccCCC--------CCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHh
Q 002376 782 KVGDFGLARFLLERVDNQ--------SSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 782 ki~DfGla~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
|++|||+++......... ..........+++.|+|||++.+.. ++.++||||+|++++++.....+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999998653110000 0011112335788999999987654 79999999999888876554433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=271.27 Aligned_cols=122 Identities=32% Similarity=0.465 Sum_probs=105.9
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|...++||+|+||.||+|++.. ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----ANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCE
Confidence 578889999999999999987651 12567889999999999999999988743 345
Q ss_pred EEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
.|+||||+++|+|.++++.. +.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 89999999999999988632 23467899999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-26 Score=226.53 Aligned_cols=244 Identities=21% Similarity=0.207 Sum_probs=168.4
Q ss_pred ChHHHHHhhCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccC-CccccceeeecccC
Q 002376 652 SYDELRRATGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSL 714 (929)
Q Consensus 652 ~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~ 714 (929)
+++|+-+-|+ +.+|+|+|+.|-.+... -.+.+..+|++++.+.+ |+||++++++|.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 4677777663 78999999999654432 13567889999999995 9999999999954
Q ss_pred CCCCcceEEEEEEecCCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC---ceEE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM---TAKV 783 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki 783 (929)
...+|+|||-|.||.|..++++++. +..+||.||.|||.. +|.|||+||+|||..+.. -+||
T Consensus 148 ----d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 ----DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ----cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 3348999999999999999976553 357899999999998 999999999999996543 4799
Q ss_pred eccccccccccccCC-CCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc---h
Q 002376 784 GDFGLARFLLERVDN-QSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPE---N 854 (929)
Q Consensus 784 ~DfGla~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~ 854 (929)
+||-++.-+....+- ..........+|+..|||||+.. ...|+.++|.||+|+++|-|.-+..++...-. .
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999887654322111 11112234568999999999753 23589999999999887765444443322211 1
Q ss_pred hh-----hccChHHHHhhcc-cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 VL-----QVLDPELRQLMTS-NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 ~~-----~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+. .+-...+.+.+.+ ..+.+...|.-++...++++...+..|+.+|-++.+++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 1111112211111 111222233445666666788888899999999988876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=266.63 Aligned_cols=344 Identities=22% Similarity=0.318 Sum_probs=228.1
Q ss_pred CCCCCCCCCCEEEeecCC------CCCCCCcCCCCCC-CCcEEeCCCCCCCCCcccccccccccceecccccccCCCCCh
Q 002376 89 PHIGNLSFLRSIQLQNNK------LSGNLPREIGNLF-RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTD 161 (929)
Q Consensus 89 ~~l~~L~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~ 161 (929)
..|..+++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 458889999999997764 3446788887764 6999999999987 678777 5789999999999997 6766
Q ss_pred hhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCC
Q 002376 162 DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241 (929)
Q Consensus 162 ~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 241 (929)
. +..+++|+.|+|++|...+.+| .++.+++|+.|+|++|..-..+|..+.++++|++|++++|..-+.+|
T Consensus 629 ~-~~~l~~Lk~L~Ls~~~~l~~ip---------~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 629 G-VHSLTGLRNIDLRGSKNLKEIP---------DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP 698 (1153)
T ss_pred c-cccCCCCCEEECCCCCCcCcCC---------ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence 6 7889999999999876544444 35678999999999988777889999999999999999976555788
Q ss_pred cccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccc
Q 002376 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFI 321 (929)
Q Consensus 242 ~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 321 (929)
..+ .+++|+.|++++|...+.+|.. ..+|+.|++++|.++ .+|..+ .+++|+.|++..+.......
T Consensus 699 ~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~------- 764 (1153)
T PLN03210 699 TGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWE------- 764 (1153)
T ss_pred CcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccc-------
Confidence 765 4788888888888766666643 357788888888876 455544 46667777665533211100
Q ss_pred cccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCC
Q 002376 322 TSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQ 401 (929)
Q Consensus 322 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 401 (929)
.+. .++......+.+|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|..+ .++
T Consensus 765 -----------------~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~ 825 (1153)
T PLN03210 765 -----------------RVQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLE 825 (1153)
T ss_pred -----------------ccc-ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccc
Confidence 000 0111111122246666666665555556666666666666666554333455444 456
Q ss_pred CCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccC-CcCCCCCCCCcccCCchhhhcc
Q 002376 402 GLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSN-NRINGNIPKGILRPLPEEISRL 480 (929)
Q Consensus 402 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~i~~~~~~~~p~~~~~l 480 (929)
+|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+ |..+..+
T Consensus 826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l--------~~~~~~L 892 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RV--------SLNISKL 892 (1153)
T ss_pred ccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-cc--------Ccccccc
Confidence 6666666665433333332 245666666666665 4566666666666666665 3333 12 3444556
Q ss_pred cCccEEEecCC
Q 002376 481 ENVVTIDLSDN 491 (929)
Q Consensus 481 ~~L~~LdLs~N 491 (929)
+.|+.++++++
T Consensus 893 ~~L~~L~l~~C 903 (1153)
T PLN03210 893 KHLETVDFSDC 903 (1153)
T ss_pred cCCCeeecCCC
Confidence 66666666665
|
syringae 6; Provisional |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=235.81 Aligned_cols=213 Identities=28% Similarity=0.329 Sum_probs=155.0
Q ss_pred ecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 669 IGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
||+|+||.||++.... ..+.+..|+.++++++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 6999999999887541 23368889999999999999999998843 34589999999
Q ss_pred CCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 730 SNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 730 ~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
++++|.+++.... ....|++.|+.|+|+. +++|+||||+||++++++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----- 147 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----- 147 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-----
Confidence 9999999886432 2256899999999997 99999999999999999999999999988653211
Q ss_pred ccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 881 (929)
.......|+..|+|||...+...+.++|||++|++++++.....++..... .+. .......... .+...
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~----~~~~~~~~~~----~~~~~ 216 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEI----YEKILKDPLR----FPEFL 216 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH----HHHHhcCCCC----CCCCC
Confidence 112334688999999999888899999999999877665443333221111 000 1111111111 11111
Q ss_pred HHHHHHHhccccCCCCCCCCCHHH
Q 002376 882 ITIIGSVGLSCTTESPGGRIGIRE 905 (929)
Q Consensus 882 ~~~~~~l~~~Cl~~dP~~RPs~~e 905 (929)
...+.+++.+||..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 222233777999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=252.95 Aligned_cols=243 Identities=21% Similarity=0.258 Sum_probs=153.4
Q ss_pred HhhCCCCCceeecccCceeEEecccc--------------------------------CcHHHH--------------HH
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT--------------------------------GSWKSF--------------IA 691 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------------------------~~~~~~--------------~~ 691 (929)
...++|+..++||+|+||.||+|... +..++| ..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35779999999999999999998531 011223 34
Q ss_pred HHHHHHccCCccc-----cceeeecccCCC---CCcceEEEEEEecCCCCccccccccc---------------------
Q 002376 692 ECETLRNVRHRNL-----VKLITSCSSLDS---KNMEFLALVYEFLSNGSLGDWIHGER--------------------- 742 (929)
Q Consensus 692 E~~~l~~l~Hpni-----v~l~~~~~~~~~---~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------- 742 (929)
|+.++.+++|.++ ++++++|..... ...+..++||||+++|+|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 678888764321 12345799999999999998886311
Q ss_pred -----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccc
Q 002376 743 -----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811 (929)
Q Consensus 743 -----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt 811 (929)
.++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+.... ........+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-----~~~~~~g~~t 373 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-----NFNPLYGMLD 373 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----ccCccccCCC
Confidence 1245789999999998 89999999999999999999999999997653211 0111123458
Q ss_pred cccccccccCCCCC----------------------CCCCCCCCCcCCCCCcchhHH-hhhcCCc--hhhhccChHHHHh
Q 002376 812 IGYVPPEYGLGERP----------------------STAGDVPTSESFAGEFNIVKW-VESNLPE--NVLQVLDPELRQL 866 (929)
Q Consensus 812 ~~y~aPE~~~~~~~----------------------~~~~DV~s~g~~~~~~~~~~~-~~~~~~~--~~~~~~~~~l~~~ 866 (929)
+.|+|||.+..... ..+.||||+|++++++..... ++..... ...+..+..+..+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 89999998764321 234799999988777654332 1110000 0000011111100
Q ss_pred h-cccchhhhhhhHHHHHHHHHHhccccCCCC---CCCCCHHHHHH
Q 002376 867 M-TSNESQTIQLHDCLITIIGSVGLSCTTESP---GGRIGIREALR 908 (929)
Q Consensus 867 ~-~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPs~~ev~~ 908 (929)
. ...........+.......+++.+++..+| .+|+|++|+++
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 000111111112233344457778888766 68999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-25 Score=246.64 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=162.7
Q ss_pred hhCCCCCceeecccCceeEEeccccCc----------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGS----------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~----------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
..++|....++|+|+||.|||+++... .+-...|+-+++..+|||||.++|.|...+. .
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----l 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----L 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----c
Confidence 346788899999999999999998732 2334579999999999999999999865443 7
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+.||||.+|+|++..+... ....+..+|++|||+. +=+|||||-.|||+.+.|.+|++|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999999877433 2245677899999998 889999999999999999999999999886632
Q ss_pred ccCCCCCccccceecccccccccccc---CCCCCCCCCCCCCCcCCCCCcchhHHh-hhcCCchhhhccChHHHHhhccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYG---LGERPSTAGDVPTSESFAGEFNIVKWV-ESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~s~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.......+.||+.|||||+. +.+.|..++|||+.|+.+.|..-.+-+ +...|......+.. .
T Consensus 165 ------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--------S 230 (829)
T KOG0576|consen 165 ------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--------S 230 (829)
T ss_pred ------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--------c
Confidence 23344568999999999975 345699999999999887763211100 11111111111111 1
Q ss_pred chhhhhhhH--HHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 871 ESQTIQLHD--CLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 871 ~~~~~~~~~--~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
..+.+...+ .-.+...++++.|+..+|++||++.-.+
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111111000 0122333466699999999999987654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-26 Score=215.34 Aligned_cols=175 Identities=22% Similarity=0.309 Sum_probs=133.9
Q ss_pred CCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHc-cCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRN-VRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
......||+|+||.|-+.++. +..++..+|+.+..+ ...|.+|.++|.++... .+++
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-----dvwI 122 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-----DVWI 122 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-----cEEE
Confidence 334577999999998554433 234567788887555 47999999999875433 3899
Q ss_pred EEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.||.|. .||..+.++. .+++..|..||.|||++. .+||||+||+||||+.+|++||||||.+..+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999995 5777665421 244677899999999975 8999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCC----CCCCCCCCCCCcCCCCCcchhHHhhhcCC
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE----RPSTAGDVPTSESFAGEFNIVKWVESNLP 852 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~ 852 (929)
... ...+...|.-.|||||.+..+ .|+.|+||||+|+.+.|+.+..++.....
T Consensus 200 ~dS-------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDS-------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhh-------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 422 122334688899999987643 59999999999999888877766655443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-26 Score=223.54 Aligned_cols=177 Identities=27% Similarity=0.355 Sum_probs=138.6
Q ss_pred CCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.+..+.||-|+||+||...++. ..+.+.+|++++..++|.||+..+++..-.....-+++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3456889999999999776652 2356789999999999999999988875544333456799
Q ss_pred EEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
|+|.|. .+|.+.+-.. +.+..||.+||.|||+. +|.||||||.|.|++.+...||||||+||....+
T Consensus 135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh-
Confidence 999994 5787766422 23467999999999998 9999999999999999999999999999975432
Q ss_pred CCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.....+..+-|..|+|||+++|.+ |+.+.||||.||+..|+.-....+
T Consensus 210 ----~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 210 ----DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred ----hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 112234456789999999999865 899999999998866654444433
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=262.08 Aligned_cols=345 Identities=22% Similarity=0.273 Sum_probs=218.6
Q ss_pred CChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCC-CcccEEEeecccCCCccCCccccCCCCceEEeeecCCC
Q 002376 159 VTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRL-ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237 (929)
Q Consensus 159 i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 237 (929)
+...+|.++++|+.|.+.++..... ..+..-+|..|..+ .+|+.|++.+|.+. .+|..| ...+|++|+|++|++.
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~--~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~ 624 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQK--KEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE 624 (1153)
T ss_pred ecHHHHhcCccccEEEEeccccccc--ccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc
Confidence 4556688888888888876643210 01111244555555 35888888888886 556666 5688889999988887
Q ss_pred CcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecccccc-ccCCCCCC
Q 002376 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNK-IVSSGDDE 316 (929)
Q Consensus 238 ~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~ 316 (929)
.+|..+.. +++|+.++++++...+.+|. +..+++|+.|+|++|..-..+|..++++++|+.|++++|. +..++.
T Consensus 625 -~L~~~~~~-l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-- 699 (1153)
T PLN03210 625 -KLWDGVHS-LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-- 699 (1153)
T ss_pred -cccccccc-CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC--
Confidence 67766644 88888888888766566664 7788888899998877666788888888888888888753 433321
Q ss_pred CCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCC------
Q 002376 317 GLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS------ 390 (929)
Q Consensus 317 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------ 390 (929)
..++++|++|+|++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|+.|++.++...
T Consensus 700 -------~i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~ 766 (1153)
T PLN03210 700 -------GINLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERV 766 (1153)
T ss_pred -------cCCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccc
Confidence 125778888888888665555542 236888888888876 455554 5677777777764321
Q ss_pred -cccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCc
Q 002376 391 -GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI 469 (929)
Q Consensus 391 -~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~ 469 (929)
...+..+...++|+.|+|++|...+.+|..+.++++|+.|+|++|..-+.+|..+ ++++|+.|++++|..-..+
T Consensus 767 ~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~---- 841 (1153)
T PLN03210 767 QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTF---- 841 (1153)
T ss_pred cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccc----
Confidence 1112222234566666666666555666666666666666666654333455544 5666666666665432222
Q ss_pred ccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccc-ccccccCCccccCCCCCCEEECCCC
Q 002376 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY-NQFSGPIPNIVAELKGLEVLDLSSN 539 (929)
Q Consensus 470 ~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (929)
|. ..++|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|+++++
T Consensus 842 ----p~---~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 842 ----PD---ISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ----cc---cccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 21 1235666666666665 4555666666666666665 3344 34445555666666666555
|
syringae 6; Provisional |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=234.27 Aligned_cols=204 Identities=22% Similarity=0.135 Sum_probs=146.9
Q ss_pred cCceeEEeccccCc-----------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccc
Q 002376 672 GSFGSVLHNERTGS-----------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740 (929)
Q Consensus 672 G~~g~Vy~~~~~~~-----------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 740 (929)
|.||+||++++..+ ...+.+|...+....||||+++++++.+. ...++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHH
Confidence 78999998877522 22455676666667899999999998543 358999999999999998754
Q ss_pred cc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceecccc
Q 002376 741 ER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812 (929)
Q Consensus 741 ~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~ 812 (929)
.. .++.|++.||+|+|+. +|+||||||+||+++.++.+|++|||.+...... .....++.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~ 146 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEAVEN 146 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCCcCc
Confidence 32 2357899999999997 9999999999999999999999999988754321 11234577
Q ss_pred ccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccc
Q 002376 813 GYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSC 892 (929)
Q Consensus 813 ~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 892 (929)
.|+|||+..+..++.++||||+|++++++.....+....+.......... .+..+..-+++++.+|
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~ 212 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN--------------IPEWVSEEARSLLQQL 212 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccC--------------CcccCCHHHHHHHHHH
Confidence 89999999888899999999999888876554433322221110000000 0001112223377799
Q ss_pred cCCCCCCCCCHHHH
Q 002376 893 TTESPGGRIGIREA 906 (929)
Q Consensus 893 l~~dP~~RPs~~ev 906 (929)
++.||++||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-25 Score=232.54 Aligned_cols=405 Identities=21% Similarity=0.229 Sum_probs=244.0
Q ss_pred ceeeCCCCC---------cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCC-CCCC
Q 002376 63 GVICNNFGN---------RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISF-NNLQ 132 (929)
Q Consensus 63 gv~c~~~~~---------~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 132 (929)
-|.|+..+- ..++++|..|+++...|.+|..+++|+.||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 367887542 567999999999966566899999999999999999999999999999998886665 9999
Q ss_pred CCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccC
Q 002376 133 GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL 212 (929)
Q Consensus 133 ~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l 212 (929)
...-..|++|..|+.|.+.-|++. -++.++|..|++|..|.+..|.+. .+.-..|..+..++.+.+..|.+
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q--------~i~~~tf~~l~~i~tlhlA~np~ 200 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQ--------SICKGTFQGLAAIKTLHLAQNPF 200 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhh--------hhccccccchhccchHhhhcCcc
Confidence 777789999999999999999998 788899999999999999999862 22334788999999999999983
Q ss_pred C------------CccCCccccCCCCceEEeeecCCCCcCCc-ccccCCCCcceeeccCCcCCCCCC-CcccccccccEE
Q 002376 213 A------------GTVPSTIYNMTSLVHLRLASNQLGGEIPY-DVRDTLPNLLDFIYCFNRFTGKIP-GSLHNLTNIQII 278 (929)
Q Consensus 213 ~------------~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~-~~~~~l~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L 278 (929)
. -..|..++...-..-..|.++++. .++. .+...+..+..-..+.+..-++-| ..|..+++|+.|
T Consensus 201 icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~l 279 (498)
T KOG4237|consen 201 ICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKL 279 (498)
T ss_pred ccccccchhhhHHhhchhhcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEe
Confidence 2 223333444333333334444443 1221 111111111111111222222222 235555566666
Q ss_pred eccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEE
Q 002376 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358 (929)
Q Consensus 279 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L 358 (929)
+|++|+|+++-+.+|..+..++.|.|..|+|..+.. ..|.++. .|+.|
T Consensus 280 nlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~-------~~f~~ls-------------------------~L~tL 327 (498)
T KOG4237|consen 280 NLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSS-------GMFQGLS-------------------------GLKTL 327 (498)
T ss_pred ccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHH-------Hhhhccc-------------------------cceee
Confidence 666666655555555555555555555555443322 2233333 45556
Q ss_pred EecCCccccccCCCCCCCCcccEEEeeCCCCCccc-Ccccc---------------CCCCCCEEEecCCcCCCC---Ccc
Q 002376 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEI-PIEIG---------------QLQGLQVLGLAGNEIPGG---IPN 419 (929)
Q Consensus 359 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~---------------~l~~L~~L~L~~N~l~~~---~p~ 419 (929)
+|.+|+|+..-|.+|..+.+|.+|+|-.|.+.-.- -.|++ .-..++.+.++.+.+... .|+
T Consensus 328 ~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~e 407 (498)
T KOG4237|consen 328 SLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPE 407 (498)
T ss_pred eecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCcc
Confidence 66666665555666666666666666555443110 00111 111233333333332210 111
Q ss_pred cccCCCCCceecccCcccccccCccccccccccee-cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCC
Q 002376 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI-DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP 498 (929)
Q Consensus 420 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p 498 (929)
..+.. -++.-| ..++.+.+. .-|++.+ ..+|+++ |. ..++|++.+|.++ .+|
T Consensus 408 e~~~~------------~s~~cP---~~c~c~~tVvRcSnk~l-k~lp~~i----P~------d~telyl~gn~~~-~vp 460 (498)
T KOG4237|consen 408 ELGCL------------TSSPCP---PPCTCLDTVVRCSNKLL-KLLPRGI----PV------DVTELYLDGNAIT-SVP 460 (498)
T ss_pred ccCCC------------CCCCCC---CCcchhhhhHhhcccch-hhcCCCC----Cc------hhHHHhcccchhc-ccC
Confidence 10000 000011 123334333 3333333 3555443 43 3456778888887 566
Q ss_pred cchhcCcCcceeecccccccccCCccccCCCCCCEEECCCC
Q 002376 499 NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539 (929)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (929)
.. .+++| .+|+++|+++..-...|.+++.|.+|-||+|
T Consensus 461 ~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 461 DE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 65 56677 8888888888777778888888888888876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=242.95 Aligned_cols=224 Identities=26% Similarity=0.293 Sum_probs=157.7
Q ss_pred CCCceeecccCcee-EEeccccCc---HH--------HHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEEEec
Q 002376 663 FSHENLIGSGSFGS-VLHNERTGS---WK--------SFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 663 ~~~~~~iG~G~~g~-Vy~~~~~~~---~~--------~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
|...+++|.|+.|. ||+|.+.+. .+ ...+|+..++.- +|||||++++.- +..++.|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEehHh
Confidence 44557889998875 588887643 12 234799998888 599999988764 4556799999999
Q ss_pred CCCCcccccccc-c-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---C--CceEEecccccccc
Q 002376 730 SNGSLGDWIHGE-R-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---E--MTAKVGDFGLARFL 792 (929)
Q Consensus 730 ~~gsL~~~l~~~-~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~--~~~ki~DfGla~~~ 792 (929)
. .+|.++++.. . ....|++.|+++||+. +|||||+||.||||+. + .+++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 5999998752 1 1245799999999997 9999999999999975 3 47999999999988
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh-HHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV-KWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
..+..+- .......||-||+|||++...+-+.++||+|+||+.|..... .-+++..-++-..++.-. ... ..
T Consensus 662 ~~~~sS~---~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-~~L---~~ 734 (903)
T KOG1027|consen 662 AGGKSSF---SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-YTL---VH 734 (903)
T ss_pred CCCcchh---hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-cce---ee
Confidence 6543322 224556899999999999999999999999999987764332 222221111111111100 000 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
- ....++ ..++|+.++++++|..||++.+|+
T Consensus 735 L--~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 L--EPLPDC---EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e--ccCchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 001112 233488899999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=235.07 Aligned_cols=189 Identities=24% Similarity=0.310 Sum_probs=146.1
Q ss_pred ChHHHHHhh---CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceee
Q 002376 652 SYDELRRAT---GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLIT 709 (929)
Q Consensus 652 ~~~~l~~~~---~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~ 709 (929)
.|-.|++|. .-|...+.||-|+||+|..++... .....++|-.+|+.-+.+.||+|+.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 344555554 347788999999999998765431 2234567999999999999999999
Q ss_pred ecccCCCCCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCce
Q 002376 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781 (929)
Q Consensus 710 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 781 (929)
.|.+.+ .+|+||||++||++..+|-+. |.+..+++.|+++.|.. |+|||||||.|||||.+|.+
T Consensus 697 SFQDkd-----nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 697 SFQDKD-----NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EeccCC-----ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCce
Confidence 885544 499999999999999887532 34456788999999987 99999999999999999999
Q ss_pred EEeccccccccc---------cccCCCC---------------------------CccccceeccccccccccccCCCCC
Q 002376 782 KVGDFGLARFLL---------ERVDNQS---------------------------SISSTHVFMGSIGYVPPEYGLGERP 825 (929)
Q Consensus 782 ki~DfGla~~~~---------~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 825 (929)
|+.|||++.-+. +...... ........+||+.|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999986321 0000000 0001234579999999999999999
Q ss_pred CCCCCCCCCcCCCCCcchhHHhh
Q 002376 826 STAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 826 ~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+..+|-||.|+++|||.++.-++
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf 871 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPF 871 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCc
Confidence 99999999999988876665554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=243.63 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=152.8
Q ss_pred CCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEcc
Q 002376 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176 (929)
Q Consensus 97 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 176 (929)
-..|+|++|.|+ .+|+.+. .+|+.|++++|+|+. +|.. +++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL----PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc----ccccceeecc
Confidence 456666666666 5666554 356666666666663 4432 356666666666666 44431 2456666666
Q ss_pred ccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeec
Q 002376 177 KNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY 256 (929)
Q Consensus 177 ~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l 256 (929)
+|.++. +| . ..++|+.|+|++|+|+. +|.. .++|++|+|++|+|+ .+|.. ..+|..|++
T Consensus 271 ~N~L~~-Lp--------~---lp~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~-~Lp~l----p~~L~~L~L 329 (788)
T PRK15387 271 SNPLTH-LP--------A---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPAL----PSELCKLWA 329 (788)
T ss_pred CCchhh-hh--------h---chhhcCEEECcCCcccc-cccc---ccccceeECCCCccc-cCCCC----ccccccccc
Confidence 665532 11 1 11345566666666653 2321 345666666666665 23321 123444444
Q ss_pred cCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEcc
Q 002376 257 CFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336 (929)
Q Consensus 257 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls 336 (929)
++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|+++
T Consensus 330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l----------------------------------p~~L~~L~Ls 370 (788)
T PRK15387 330 YNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL----------------------------------PSELYKLWAY 370 (788)
T ss_pred ccCcccc-cccc---ccccceEecCCCccCC-CCCC----------------------------------Ccccceehhh
Confidence 4444443 2221 1244555555555542 2211 1345566666
Q ss_pred CCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCC
Q 002376 337 GNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGG 416 (929)
Q Consensus 337 ~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 416 (929)
+|+|+ .+|... .+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .
T Consensus 371 ~N~L~-~LP~l~----~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 371 NNRLT-SLPALP----SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-R 436 (788)
T ss_pred ccccc-cCcccc----cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-c
Confidence 66666 355422 257777777777774 4433 2567788888888874 5543 245777888888887 5
Q ss_pred CcccccCCCCCceecccCcccccccCccccc
Q 002376 417 IPNSLANLKKLNQIDLSGNELTGEIPISFGN 447 (929)
Q Consensus 417 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 447 (929)
+|..+.++++|+.|+|++|+|++..+..+..
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 7888888888888888888888776665533
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=217.02 Aligned_cols=175 Identities=25% Similarity=0.291 Sum_probs=141.8
Q ss_pred hCCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHcc-CCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..++||+|+|.+|..++.+++ ..-...|..+..+. +||.+|.++.+|. ..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----te 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----TE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----cc
Confidence 45788999999999999988776532 12234566566554 7999999998883 44
Q ss_pred ceEEEEEEecCCCCcccccccccc--------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGERK--------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..+++|.||+++|+|.-+++++|+ +..+|+.||.|||++ +||.||+|..|||+|..|.+|+.|+|+++.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 458999999999999988875553 356799999999998 999999999999999999999999999984
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
- -.....+..++|||.|+|||++++..|+.++|-|++|+.++||....-++
T Consensus 401 ~------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 401 G------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred C------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 2 12233456789999999999999999999999999998877765554444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=230.19 Aligned_cols=168 Identities=22% Similarity=0.321 Sum_probs=139.5
Q ss_pred hCCCCCceeecccCceeEEeccccCcH------------------------HHHHHHHHHHHccC---Cccccceeeecc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGSW------------------------KSFIAECETLRNVR---HRNLVKLITSCS 712 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~------------------------~~~~~E~~~l~~l~---Hpniv~l~~~~~ 712 (929)
..+|...+.+|+|+||.|+.|.++... -..-.|+++|+.++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 346888999999999999988876221 12336999999997 99999999999
Q ss_pred cCCCCCcceEEEEEEec-CCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 713 SLDSKNMEFLALVYEFL-SNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~-~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
++.+++|++||-- ++-+|++++.. .+.+..||+.|+++||++ +|||||||-+||.+|.+|-+|+
T Consensus 639 ----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 ----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 4455689999964 55689999863 234568999999999998 9999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcch
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNI 843 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~ 843 (929)
.|||.|.... ......++||.+|.|||++.|.+| +..-|||++|+.+|.+..
T Consensus 712 idfgsaa~~k--------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 712 IDFGSAAYTK--------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred eeccchhhhc--------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 9999987652 123456899999999999999987 888999999998887543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=239.65 Aligned_cols=264 Identities=25% Similarity=0.316 Sum_probs=120.7
Q ss_pred cccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEec
Q 002376 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRM 280 (929)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~L 280 (929)
+-..|+|+.|.|+ .+|..+. ++|+.|++++|+|+ .+|.. .++ |++|+|
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~------------------------Lk~LdL 249 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPE------------------------LRTLEV 249 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCC------------------------CcEEEe
Confidence 4567788888887 4566554 36777888887776 34431 234 444444
Q ss_pred cCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEe
Q 002376 281 THNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360 (929)
Q Consensus 281 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 360 (929)
++|+|+. +|.. .++|+.|++++|.+..++. ..++|+.|+|++|+++ .+|.. +++|+.|+|
T Consensus 250 s~N~Lts-LP~l---p~sL~~L~Ls~N~L~~Lp~-----------lp~~L~~L~Ls~N~Lt-~LP~~----p~~L~~LdL 309 (788)
T PRK15387 250 SGNQLTS-LPVL---PPGLLELSIFSNPLTHLPA-----------LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSV 309 (788)
T ss_pred cCCccCc-ccCc---ccccceeeccCCchhhhhh-----------chhhcCEEECcCCccc-ccccc----ccccceeEC
Confidence 4444442 2321 1233333444443332211 0123444555555554 23321 124555555
Q ss_pred cCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccc
Q 002376 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440 (929)
Q Consensus 361 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 440 (929)
++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|++
T Consensus 310 S~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~- 376 (788)
T PRK15387 310 SDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS- 376 (788)
T ss_pred CCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-
Confidence 5555543 22211 234445555555542 3321 1245555555555543 2221 1234445555555542
Q ss_pred cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccccccc
Q 002376 441 IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520 (929)
Q Consensus 441 ~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (929)
+|.. ..+|+.|++++|+|++ +| .. .++|+.||+++|+|++ +|..+ .+|+.|++++|+|+ .
T Consensus 377 LP~l---~~~L~~LdLs~N~Lt~-LP--------~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 377 LPAL---PSGLKELIVSGNRLTS-LP--------VL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-R 436 (788)
T ss_pred Cccc---ccccceEEecCCcccC-CC--------Cc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-c
Confidence 3322 1345555555555542 21 11 1244555555555542 33322 23444555555554 3
Q ss_pred CCccccCCCCCCEEECCCCcCCCcCCccc
Q 002376 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDL 549 (929)
Q Consensus 521 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 549 (929)
+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 44445555555555555555555444433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=236.41 Aligned_cols=356 Identities=19% Similarity=0.288 Sum_probs=190.3
Q ss_pred CChhhHHHHHHHHhhcCCCCCCCCCCC----CCCCCCCCCCcc----------------eeeCCCCCcEEEEEcCCCCCc
Q 002376 25 GINTDKEALMSFKSQISQESPSSPLSY----WNPSSSPCTWPG----------------VICNNFGNRVIGLNLSSFGLE 84 (929)
Q Consensus 25 ~~~~~~~aLl~~k~~~~~~~~~~~l~~----w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l~ 84 (929)
..++|.+.+++..+.+.. .+.+.+ |+.+.+.|.-.. |.|.. +.|+.+...+....
T Consensus 60 ~~~~~~~~~~~~~~~l~~---p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~~ 134 (754)
T PRK15370 60 ASPEEIKSKFECLRMLAF---PAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQA 134 (754)
T ss_pred CCHHHHHHHHHHHHHhcC---CchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccccccc
Confidence 357899999999999854 345555 998889996554 55653 45666554442211
Q ss_pred cccCC--CC-------------------------------CCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCC
Q 002376 85 GTISP--HI-------------------------------GNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL 131 (929)
Q Consensus 85 g~i~~--~l-------------------------------~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 131 (929)
..... +. +--.+.+.|+|++++++ .+|..+. ++|+.|+|++|+|
T Consensus 135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~L 211 (754)
T PRK15370 135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNEL 211 (754)
T ss_pred ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCC
Confidence 11100 00 00123444555554444 3343332 2444555555554
Q ss_pred CCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeeccc
Q 002376 132 QGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211 (929)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~ 211 (929)
+ .+|..+. ++|++|+|++|+|+ .+|.. +. .+| +.|+|++|+
T Consensus 212 t-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~-l~--~~L--------------------------------~~L~Ls~N~ 252 (754)
T PRK15370 212 K-SLPENLQ--GNIKTLYANSNQLT-SIPAT-LP--DTI--------------------------------QEMELSINR 252 (754)
T ss_pred C-cCChhhc--cCCCEEECCCCccc-cCChh-hh--ccc--------------------------------cEEECcCCc
Confidence 4 2333222 24455555555444 33332 11 234 444555554
Q ss_pred CCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccC
Q 002376 212 LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPP 291 (929)
Q Consensus 212 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 291 (929)
+. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|.++. +|.
T Consensus 253 L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 253 IT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred cC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCc
Confidence 44 2333332 24455555555554 3443332 244555555555543 233222 356666666666663 343
Q ss_pred CCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCC
Q 002376 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371 (929)
Q Consensus 292 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~ 371 (929)
.+. ++|+.|++++|.+..++. .+ .++|+.|+|++|+|+ .+|..+. ..|+.|+|++|+|+. +|.
T Consensus 322 ~l~--~sL~~L~Ls~N~Lt~LP~--------~l--~~sL~~L~Ls~N~L~-~LP~~lp---~~L~~LdLs~N~Lt~-LP~ 384 (754)
T PRK15370 322 TLP--PGLKTLEAGENALTSLPA--------SL--PPELQVLDVSKNQIT-VLPETLP---PTITTLDVSRNALTN-LPE 384 (754)
T ss_pred ccc--ccceeccccCCccccCCh--------hh--cCcccEEECCCCCCC-cCChhhc---CCcCEEECCCCcCCC-CCH
Confidence 322 466666777776655432 11 257888888888887 5676543 368888888888874 454
Q ss_pred CCCCCCcccEEEeeCCCCCcccCccc----cCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCccccc-ccCcccc
Q 002376 372 SIGRLRSLTLLDLSYNSISGEIPIEI----GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG-EIPISFG 446 (929)
Q Consensus 372 ~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~ 446 (929)
.+. .+|+.|++++|+|+ .+|..+ +.++++..|++.+|.++. ..+.+|+.| ++.+.+.| .++...+
T Consensus 385 ~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~ 454 (754)
T PRK15370 385 NLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMG 454 (754)
T ss_pred hHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccc
Confidence 443 36888888888887 445443 445778889999998862 334455555 44455543 3344445
Q ss_pred cccccceecccCCcCCCCC
Q 002376 447 NFQSLLSIDLSNNRINGNI 465 (929)
Q Consensus 447 ~l~~L~~L~Ls~N~l~g~i 465 (929)
.+.+++....-.+.+++.+
T Consensus 455 ~~~~l~~~~~l~~a~~~Wl 473 (754)
T PRK15370 455 DFSIVRVTRPLHQAVQGWL 473 (754)
T ss_pred ccccccccchHHHHHhccC
Confidence 5555555444444444433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=216.44 Aligned_cols=201 Identities=29% Similarity=0.317 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhh
Q 002376 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHN 757 (929)
Q Consensus 686 ~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~ 757 (929)
.+.+.+|++.+++++|+|++++++++... ...++||||+++++|.+++.... ....++++|++|||+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 105 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHS 105 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999999999999998643 34899999999999999886433 235689999999999
Q ss_pred CCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCC
Q 002376 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESF 837 (929)
Q Consensus 758 ~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~ 837 (929)
. +++|+||+|+||++++++.++++|||.+....... ......|+..|+|||...+..++.++|||++|++
T Consensus 106 ~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~ 175 (244)
T smart00220 106 N---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVI 175 (244)
T ss_pred c---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHH
Confidence 8 99999999999999999999999999998764321 1233468889999999988889999999999977
Q ss_pred CCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH-HHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 838 AGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD-CLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++++.....++....+ . ................... ...++.. ++.+|+..+|++||++.++++
T Consensus 176 l~~l~~~~~p~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 176 LYELLTGKPPFPGDDQ-L-----LELFKKIGKPKPPFPPPEWKISPEAKD-LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHhCCCCCCCCCc-H-----HHHHHHHhccCCCCccccccCCHHHHH-HHHHHccCCchhccCHHHHhh
Confidence 6664433222211110 0 0111111111100000000 1122333 777999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-23 Score=210.84 Aligned_cols=213 Identities=22% Similarity=0.300 Sum_probs=150.6
Q ss_pred cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcceEEEEEEecCCCCcccccc------ccccccccHHHHHHHhhh
Q 002376 685 SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFLALVYEFLSNGSLGDWIH------GERKNELDITSALDYLHN 757 (929)
Q Consensus 685 ~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~------~~~~~~~~ia~aL~yLH~ 757 (929)
..++..+|...+..+.|+||++++.++.-... .....+|+|||||. ++|...+. ..+.+..|++.|++|||+
T Consensus 58 ~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs 136 (369)
T KOG0665|consen 58 HAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILMELDHETISYILYQMLCGIKHLHS 136 (369)
T ss_pred cchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHhcchHHHHHHHHHHHHHHHHHHh
Confidence 34566789999999999999999999865332 12345799999994 68877765 123457899999999999
Q ss_pred CCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCC
Q 002376 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESF 837 (929)
Q Consensus 758 ~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~ 837 (929)
. +|+||||||+||++..++.+||.|||+|+.-. .. ...+..+.|..|.|||++.+..+.+.+||||.||+
T Consensus 137 ~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~------~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci 206 (369)
T KOG0665|consen 137 A---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED------TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 206 (369)
T ss_pred c---ceeecccCcccceecchhheeeccchhhcccC------cc-cccCchhheeeccCchheeccCCcccchhhhhhhH
Confidence 8 99999999999999999999999999998431 11 23455678999999999999999999999999998
Q ss_pred CCCcchhHHhhhc---------------CCc-hhhhccChHHHHhhcccch--------------hhh--hhhHHHHHHH
Q 002376 838 AGEFNIVKWVESN---------------LPE-NVLQVLDPELRQLMTSNES--------------QTI--QLHDCLITII 885 (929)
Q Consensus 838 ~~~~~~~~~~~~~---------------~~~-~~~~~~~~~l~~~~~~~~~--------------~~~--~~~~~~~~~~ 885 (929)
..|+......+.. .|+ .+.+.+.+..+-.....+. ... +....-..+.
T Consensus 207 ~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~a 286 (369)
T KOG0665|consen 207 MGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLA 286 (369)
T ss_pred HHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHH
Confidence 8776544332211 011 1211111111111110000 000 0000113466
Q ss_pred HHHhccccCCCCCCCCCHHHHHH
Q 002376 886 GSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 886 ~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++++.+++..||++|.+++++++
T Consensus 287 rdll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 287 RDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhccChhhcccHHHHhc
Confidence 77899999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=202.40 Aligned_cols=170 Identities=23% Similarity=0.345 Sum_probs=137.5
Q ss_pred hhCCCCCceeecccCceeEEecccc-------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT-------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~-------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+++|+|-|++||.|... ...+...+|+.+++.+. ||||++++++..++.++ ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk---tpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK---TPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc---Cchh
Confidence 3568888999999999999998743 23567899999999997 99999999999876553 3689
Q ss_pred EEEecCCCCcccccc-----ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEeccccccccccccCC
Q 002376 725 VYEFLSNGSLGDWIH-----GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 725 V~e~~~~gsL~~~l~-----~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~~~ 798 (929)
|+||+.+.+...... +.+....+++.||.|+|+. ||+|||+||.||+||.. -..++.|+|+|.+..++.
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~-- 187 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-- 187 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc--
Confidence 999999887765543 3455678999999999998 99999999999999965 479999999999875331
Q ss_pred CCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCc
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEF 841 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~ 841 (929)
.....+.+..|--||.+..-+ |+.+-|+||+||.+.++
T Consensus 188 -----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m 226 (338)
T KOG0668|consen 188 -----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 226 (338)
T ss_pred -----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence 123346678889999987654 88999999999765443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-22 Score=197.29 Aligned_cols=229 Identities=20% Similarity=0.210 Sum_probs=158.4
Q ss_pred CCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|.+.+.+|+|.||++..+++++ ..++|.+|...--.+ .|.||+.-+++-++ ..+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEEE
Confidence 467788999999999999888763 357888888765555 58999998887654 4456889
Q ss_pred EEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee-c-CCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL-D-EEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-~-~~~~~ki~DfGla~~~~~~ 795 (929)
++||+|.|+|..-+... ++++.|++.|++|||+. .+||||||.+|||| + +..++|+||||..+....
T Consensus 100 ~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred eeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 99999999999887632 34578999999999998 99999999999999 3 344899999999875421
Q ss_pred cCCCCCccccceeccccccccccccCCC-----CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-----RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.-.....+..|-|||..... ...+..|||.||++.+.+.++..+|.. ..+.|+....+..-.
T Consensus 176 --------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-----a~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 176 --------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-----ASIMDKPYWEWEQWL 242 (378)
T ss_pred --------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-----hhccCchHHHHHHHh
Confidence 11112345679999976432 257889999999888777666555542 223344333322111
Q ss_pred chhhhhhh----HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 871 ESQTIQLH----DCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 871 ~~~~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
.......+ ..-.++++ +..+-+.++|++|-...++.++..
T Consensus 243 ~rk~~~~P~~F~~fs~~a~r-~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 243 KRKNPALPKKFNPFSEKALR-LFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cccCccCchhhcccCHHHHH-HHHHhcCCcccccchhHHHHHHHH
Confidence 11111111 11233444 666889999999966666655543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-22 Score=209.92 Aligned_cols=183 Identities=24% Similarity=0.298 Sum_probs=138.7
Q ss_pred HHHhhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC-CccccceeeecccCCCC
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSK 717 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~ 717 (929)
+....+.|..+++||+|.|++||++.... ......+|++.|..+. +.||+++.+++ +
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 33445678899999999999999987642 3456889999999995 99999999998 4
Q ss_pred CcceEEEEEEecCCCCccccccc-----cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEeccccccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARF 791 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~-----~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~ 791 (929)
......+|+||++.-+..++... .+.+......||+|+|.. |||||||||+|+|.+. .+.-.|.|||+|..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHH
Confidence 45568999999999888777653 345567889999999998 9999999999999975 45789999999983
Q ss_pred ccccc------C------C--------------------------CCCccccceeccccccccccccCCCC-CCCCCCCC
Q 002376 792 LLERV------D------N--------------------------QSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVP 832 (929)
Q Consensus 792 ~~~~~------~------~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~ 832 (929)
...+. . . ..........+||+||+|||++...+ .++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 0 00000112346999999999987654 79999999
Q ss_pred CCcCCCCCcchhHH
Q 002376 833 TSESFAGEFNIVKW 846 (929)
Q Consensus 833 s~g~~~~~~~~~~~ 846 (929)
|.|++...+.....
T Consensus 263 s~GVI~Lslls~~~ 276 (418)
T KOG1167|consen 263 SAGVILLSLLSRRY 276 (418)
T ss_pred eccceeehhhcccc
Confidence 99988665443333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=201.92 Aligned_cols=186 Identities=31% Similarity=0.470 Sum_probs=150.6
Q ss_pred ecccCceeEEeccccC-------------c----HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCC
Q 002376 669 IGSGSFGSVLHNERTG-------------S----WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSN 731 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~-------------~----~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~ 731 (929)
||+|++|.||++.... . .+.+.+|++.++.++|++++++++++... ...++||||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 6899999999987651 1 25789999999999999999999998543 458999999999
Q ss_pred CCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEeccccccccccccCCCCC
Q 002376 732 GSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 732 gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
++|.+++... .....+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999998643 12356899999999998 9999999999999999 89999999999986532210
Q ss_pred ccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHH
Q 002376 802 ISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDC 880 (929)
Q Consensus 802 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 880 (929)
......+...|++||..... .++.+.|+|++|++++++ ..
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~ 189 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PE 189 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HH
Confidence 12234578899999999887 789999999999766553 01
Q ss_pred HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 881 LITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 881 ~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
+.+ ++.+|++.+|++||+++++++.
T Consensus 190 ~~~----~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKD----LIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHH----HHHHHhhCCcccCcCHHHHhhC
Confidence 222 6669999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=224.78 Aligned_cols=118 Identities=25% Similarity=0.478 Sum_probs=56.0
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
+|++|+|++|+|+ .+|..+. .+|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++
T Consensus 284 sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~L 353 (754)
T PRK15370 284 ELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDV 353 (754)
T ss_pred CCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEEC
Confidence 4555555555555 2443322 245555666665553 233221 355555555555553 343332 45555555
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCC
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 462 (929)
++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. .+|+.|++++|+|+
T Consensus 354 s~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 354 SKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred CCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc
Confidence 555554 2333332 345555555555552 333322 23555555555554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-22 Score=246.07 Aligned_cols=196 Identities=16% Similarity=0.150 Sum_probs=125.3
Q ss_pred HccCC-ccccceeeecccCCCC--CcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEE
Q 002376 697 RNVRH-RNLVKLITSCSSLDSK--NMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVV 764 (929)
Q Consensus 697 ~~l~H-pniv~l~~~~~~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~ii 764 (929)
+.++| +||++++++|...... ....++.++||+ +++|.++++... .++.||++||+|||++ +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 45567 6899999987433211 123467889988 569999996422 2367999999999998 999
Q ss_pred ecCCCCCCeeecC-------------------CCceEEeccccccccccccCC----------CCCccccceeccccccc
Q 002376 765 HSDLKPGNILLDE-------------------EMTAKVGDFGLARFLLERVDN----------QSSISSTHVFMGSIGYV 815 (929)
Q Consensus 765 HrDlk~~NILl~~-------------------~~~~ki~DfGla~~~~~~~~~----------~~~~~~~~~~~gt~~y~ 815 (929)
||||||+|||++. ++.+|++|||+++........ ..........+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 445667777776542110000 00000112246899999
Q ss_pred cccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch-hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccC
Q 002376 816 PPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN-VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTT 894 (929)
Q Consensus 816 aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~ 894 (929)
|||++.+..++.++||||+||++||+.... .+.. ....+........+. .......+... ++.+||+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPV-----SSREEKSRTMSSLRHRVLPP------QILLNWPKEAS-FCLWLLH 250 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCC-----CchhhHHHHHHHHHHhhcCh------hhhhcCHHHHH-HHHHhCC
Confidence 999999999999999999999888864321 1211 001111000111100 00011222333 7779999
Q ss_pred CCCCCCCCHHHHHH
Q 002376 895 ESPGGRIGIREALR 908 (929)
Q Consensus 895 ~dP~~RPs~~ev~~ 908 (929)
++|.+||+|+|+++
T Consensus 251 ~~P~~Rps~~eil~ 264 (793)
T PLN00181 251 PEPSCRPSMSELLQ 264 (793)
T ss_pred CChhhCcChHHHhh
Confidence 99999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-21 Score=208.77 Aligned_cols=158 Identities=20% Similarity=0.178 Sum_probs=119.7
Q ss_pred HHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
.....++|...+.||+|+||+||+|.+.. ..+.|.+|++++++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34456789999999999999999986531 023588999999999999998633222
Q ss_pred CCCCCcceEEEEEEecCCCCcccccc-ccccccccHHHHHHHhhhCCCCCEEecCC-CCCCeeecCCCceEEeccccccc
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIH-GERKNELDITSALDYLHNDCEVPVVHSDL-KPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~-~~~~~~~~ia~aL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~ki~DfGla~~ 791 (929)
+..|+||||+++++|..... ....+..++++||+|||+. +|+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ------~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred ------CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 12699999999999974321 1234567899999999998 9999999 99999999999999999999997
Q ss_pred cccccCCCC--CccccceeccccccccccccCCCC
Q 002376 792 LLERVDNQS--SISSTHVFMGSIGYVPPEYGLGER 824 (929)
Q Consensus 792 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~ 824 (929)
+........ .....+...|++.|+|||++.-+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 753321111 011124567899999999987554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-21 Score=203.04 Aligned_cols=113 Identities=28% Similarity=0.468 Sum_probs=93.6
Q ss_pred hCCCCCceeecccCceeEEeccccCc---------------HHHHHHHHHHHHccC-----Cc---cccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS---------------WKSFIAECETLRNVR-----HR---NLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~~~E~~~l~~l~-----Hp---niv~l~~~~~~~~~ 716 (929)
..+|...++||-|.|++||.+++.+. .+....||++|++++ |+ .||+++++|...+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 35888999999999999999988632 345668999999983 43 5999999998766
Q ss_pred CCcceEEEEEEecCCCCccccccc----------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHG----------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~----------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
.+..++|||+|+. |-+|..+|.. .+.++.||+.||.|||+.| +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4667899999999 6688888763 2345789999999999987 999999999999983
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-21 Score=188.85 Aligned_cols=220 Identities=20% Similarity=0.258 Sum_probs=164.9
Q ss_pred ceeecccCceeEEeccccCc----------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEec
Q 002376 666 ENLIGSGSFGSVLHNERTGS----------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~~----------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~ 729 (929)
..+|.+...|+.|+|++++. .++|..|.-.++.+.||||.+++|.|.++ ....++..||
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~m 269 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQYM 269 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeeec
Confidence 34688888999999999842 35788899999999999999999999543 4589999999
Q ss_pred CCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe--ccccccccccccC
Q 002376 730 SNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG--DFGLARFLLERVD 797 (929)
Q Consensus 730 ~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~--DfGla~~~~~~~~ 797 (929)
+.|+|+..+++.. +++++||+|++|||+. ++-|..--+.+..|+||++.+++|+ |--++-.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999999998543 4578999999999997 4344445688999999999998875 2222111
Q ss_pred CCCCccccceeccccccccccccCCCCC---CCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhhccChHHHHhhcccch
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERP---STAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQVLDPELRQLMTSNES 872 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~~~~~~~~ 872 (929)
.......+.||+||.++..+. -.++|+|||.+.++|+.+.+.++..++. + -.++.-..++-.++
T Consensus 343 -------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip---- 411 (448)
T KOG0195|consen 343 -------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP---- 411 (448)
T ss_pred -------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC----
Confidence 112245789999999987763 4679999999999998888888877765 1 22222223332222
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
..+..-+.+++.-|++.||.+||.++.|+-.||++.
T Consensus 412 ------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 ------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 223333344777999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-20 Score=196.55 Aligned_cols=171 Identities=26% Similarity=0.319 Sum_probs=134.2
Q ss_pred hCCCCCceeecccCceeEEeccccCc---------------HHHHHHHHHHHHccC------CccccceeeecccCCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS---------------WKSFIAECETLRNVR------HRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------~~~~~~E~~~l~~l~------Hpniv~l~~~~~~~~~~~ 718 (929)
..+|.+....|+|-|+.|.+|.+... .+.=.+|+++|.++. --++++++..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h----- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH----- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-----
Confidence 35788888899999999999987622 123347999999994 3378999888854
Q ss_pred cceEEEEEEecCCCCcccccccc-----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE-----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~-----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~Df 786 (929)
..++|||+|-.. -+|.+++++. +.++.|+.-||..|... +|+|.||||.|||+.+.- ..|||||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 345999999874 5888887632 34467889999999987 999999999999998765 6899999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
|.|....+. ..+.+.-+..|.|||++.|.+|+...|+||.||.+||+.++...
T Consensus 582 GSA~~~~en--------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 582 GSASFASEN--------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccccc--------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 998765321 11122346679999999999999999999999999998665543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=189.27 Aligned_cols=168 Identities=32% Similarity=0.455 Sum_probs=137.2
Q ss_pred CCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
|+..+.||+|++|.||++.... ..+.+.+|++.+++++|+|++++++++... ...++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 4567899999999999987642 356788999999999999999999998543 347999
Q ss_pred EEecCCCCcccccccccc---------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGERK---------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~~---------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
+||+++++|.+++...+. ...+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999999875432 256789999999998 99999999999999999999999999998764321
Q ss_pred CCCCCccccceecccccccccccc-CCCCCCCCCCCCCCcCCCCCcch
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYG-LGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
........++..|++||.. ....++.++|||++|++++++..
T Consensus 153 -----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~ 195 (225)
T smart00221 153 -----AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW 195 (225)
T ss_pred -----cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH
Confidence 0012335678899999998 66678889999999976666443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-20 Score=204.22 Aligned_cols=160 Identities=24% Similarity=0.352 Sum_probs=72.0
Q ss_pred CCCCEEEecCCcCCCC----CcccccCCCCCceecccCcccccc----cCcccccccccceecccCCcCCCCCCCCcccC
Q 002376 401 QGLQVLGLAGNEIPGG----IPNSLANLKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472 (929)
Q Consensus 401 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~ 472 (929)
++|+.|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++.- ...
T Consensus 137 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~----~~~ 212 (319)
T cd00116 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG----ASA 212 (319)
T ss_pred CCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH----HHH
Confidence 4455555555554421 222344444555555555555421 1222333345555555555554211 011
Q ss_pred CchhhhcccCccEEEecCCCCCCCCCcchhc-----CcCcceeeccccccc----ccCCccccCCCCCCEEECCCCcCCC
Q 002376 473 LPEEISRLENVVTIDLSDNSLSGNLPNSLKN-----CKSLEELLMAYNQFS----GPIPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 473 ~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
++..+..+++|++||+++|.+++.....+.. .+.|+.|++++|.++ ..+...+..+++|+++|+++|.++.
T Consensus 213 l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 213 LAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 1223334455555555555555322222211 245566666666554 1223334444566666666666653
Q ss_pred c----CCcccccC-CCCCeEeCCCCc
Q 002376 544 S----IPSDLQNL-QALRSLNLTFNN 564 (929)
Q Consensus 544 ~----~p~~~~~l-~~L~~L~Ls~N~ 564 (929)
. ....+... +.|+++++.+|.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 293 EGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHHHHHHHHhhcCCchhhcccCCCC
Confidence 3 22222223 455555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-19 Score=180.00 Aligned_cols=161 Identities=18% Similarity=0.106 Sum_probs=108.0
Q ss_pred CCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCc
Q 002376 732 GSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802 (929)
Q Consensus 732 gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~ 802 (929)
|+|.++++.. ..++.||+.||+|||+. + ||+||++++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-------
Confidence 5667766532 23467999999999997 4 999999999999999 9999865321
Q ss_pred cccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHH
Q 002376 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLI 882 (929)
Q Consensus 803 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 882 (929)
...||+.|||||++.+..++.++||||+|+++|++..+..++..... ....+..............+ .......
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 136 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPADDPRDR-SNLESVS 136 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccCCcccc-ccHHHHH
Confidence 12589999999999999999999999999888887655544322111 11111111111111100000 0111122
Q ss_pred H--HHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 883 T--IIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 883 ~--~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. -+++++.+||+.+|++||++.|+++.+..+...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2 234488899999999999999999988776544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-19 Score=199.55 Aligned_cols=209 Identities=23% Similarity=0.304 Sum_probs=121.6
Q ss_pred CCCCCCCEEEccCCccccccCchhhhccc--cccEEEecCCcccc----ccCCCCCCC-CcccEEEeeCCCCCcc----c
Q 002376 325 TNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYG----KIPASIGRL-RSLTLLDLSYNSISGE----I 393 (929)
Q Consensus 325 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~--~L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~ 393 (929)
..+++|+.|++++|.+.+..+..+..+.. +|++|++++|++.+ .+...+..+ ++|+.|+|++|.+++. +
T Consensus 78 ~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~ 157 (319)
T cd00116 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL 157 (319)
T ss_pred HhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence 34455555555555555444444443331 26666666665552 222333444 6667777777766632 2
Q ss_pred CccccCCCCCCEEEecCCcCCCC----CcccccCCCCCceecccCcccccc----cCcccccccccceecccCCcCCCCC
Q 002376 394 PIEIGQLQGLQVLGLAGNEIPGG----IPNSLANLKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNI 465 (929)
Q Consensus 394 p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~i 465 (929)
+..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++..
T Consensus 158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~ 237 (319)
T cd00116 158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237 (319)
T ss_pred HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHH
Confidence 33455556677777777776632 233344556777777777776533 2334556677777777777776421
Q ss_pred CCCcccCCchhhh-----cccCccEEEecCCCCCC----CCCcchhcCcCcceeeccccccccc----CCccccCC-CCC
Q 002376 466 PKGILRPLPEEIS-----RLENVVTIDLSDNSLSG----NLPNSLKNCKSLEELLMAYNQFSGP----IPNIVAEL-KGL 531 (929)
Q Consensus 466 ~~~~~~~~p~~~~-----~l~~L~~LdLs~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L 531 (929)
...+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.++.. ....+... +.|
T Consensus 238 --------~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~ 309 (319)
T cd00116 238 --------AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNEL 309 (319)
T ss_pred --------HHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCch
Confidence 11111 13577888888887762 2334555667888888888888744 34444445 678
Q ss_pred CEEECCCCcC
Q 002376 532 EVLDLSSNKL 541 (929)
Q Consensus 532 ~~L~Ls~N~l 541 (929)
+.||+.+|.+
T Consensus 310 ~~~~~~~~~~ 319 (319)
T cd00116 310 ESLWVKDDSF 319 (319)
T ss_pred hhcccCCCCC
Confidence 8888888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-19 Score=167.05 Aligned_cols=178 Identities=32% Similarity=0.540 Sum_probs=120.8
Q ss_pred CCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccccccee
Q 002376 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI 454 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 454 (929)
++++.+.|.||+|+++ .+|..+..+.+|++|++++|+|. .+|..+..+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4556666777777776 55666777777777777777776 56677777777777777777776 677788888888888
Q ss_pred cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEE
Q 002376 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534 (929)
Q Consensus 455 ~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (929)
||.+|+++.. .+|..|..+..|+.|+|+.|.+. .+|..++.+++|+.|
T Consensus 108 dltynnl~e~-------------------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil 155 (264)
T KOG0617|consen 108 DLTYNNLNEN-------------------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL 155 (264)
T ss_pred hccccccccc-------------------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEE
Confidence 8887776521 34555556666666666666666 556666777777777
Q ss_pred ECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCC---CCCCcccccCCCC
Q 002376 535 DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIF---RNMSNVHLKGNPK 588 (929)
Q Consensus 535 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~l~~l~l~~N~~ 588 (929)
.+..|.+- ..|..++.+++|+.|.+.+|+++-.+|+.+.+ .+-+......|||
T Consensus 156 ~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 156 SLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred eeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCC
Confidence 77777665 46777777777777777777777666654432 2224456677776
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-19 Score=166.10 Aligned_cols=165 Identities=32% Similarity=0.496 Sum_probs=84.9
Q ss_pred CCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCC
Q 002376 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170 (929)
Q Consensus 91 l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 170 (929)
+.++++.+.|-||+|+++ .+|+.+..|.+|+.|++++|+|. ..|.+++.+++|+.|+++-|++. .+|.+ |+.++.|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprg-fgs~p~l 104 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRG-FGSFPAL 104 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccc-cCCCchh
Confidence 344555555566666655 55555555555555555555555 45555555555555555555554 33333 5555555
Q ss_pred cEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCC
Q 002376 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPN 250 (929)
Q Consensus 171 ~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~ 250 (929)
++|||.+|++.. ...|+.|+.|+.|+-|+|++|.+. .+|.++.. +.+
T Consensus 105 evldltynnl~e-------------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~-lt~ 151 (264)
T KOG0617|consen 105 EVLDLTYNNLNE-------------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGK-LTN 151 (264)
T ss_pred hhhhcccccccc-------------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhh-hcc
Confidence 555555444422 234555555555555555555554 34444433 344
Q ss_pred cceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCC
Q 002376 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLG 294 (929)
Q Consensus 251 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 294 (929)
|+.|.+..|.+- .+|..++.++.|+.|.+.+|+++ .+|+.++
T Consensus 152 lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 152 LQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred eeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 444444333332 34555555566666666666665 3443333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-18 Score=199.00 Aligned_cols=232 Identities=20% Similarity=0.197 Sum_probs=155.3
Q ss_pred CceeecccCceeEEeccccCc-----HH-----------------HHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 665 HENLIGSGSFGSVLHNERTGS-----WK-----------------SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 665 ~~~~iG~G~~g~Vy~~~~~~~-----~~-----------------~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
..+++|.|++|.|+....... .+ .+..|..+-..++|||++..+..+.+... .
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----~ 396 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----I 396 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----c
Confidence 457899999996654332211 11 13345555666899999988887765432 3
Q ss_pred EEEEEecCCCCcccccccc-c-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE-R-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~-~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+-+||||++ +|+..+... + ....|+..|++|+|+. +|.|||+|++|++++.+|.+||+|||.+....-
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 344999999 999888653 1 2357899999999998 999999999999999999999999999876532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... ........++|+..|+|||++.+..| ....||||.|++...|.+...+|......-.+..+........ ....
T Consensus 473 ~~e--~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-~~~~ 549 (601)
T KOG0590|consen 473 PWE--KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-IFEG 549 (601)
T ss_pred Ccc--hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc-cccC
Confidence 211 11233456789999999999999888 4668999999887776666555543322100000000000000 0111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......++.-.+.++.+++++||.+|.||++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11122334444455777999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-18 Score=171.23 Aligned_cols=157 Identities=13% Similarity=0.124 Sum_probs=119.8
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------cHH---------HHHHHHHHHHccCCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------SWK---------SFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~---------~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+++|+|+||.||...... ..+ .|.+|++.+.+++||+|..+..++...+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 5789999999999999999865421 111 26799999999999999999888654321
Q ss_pred C---CcceEEEEEEecCCCCccccccccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 717 K---NMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 717 ~---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
. .....++||||++|.+|.++.........+++.+++.+|+. +++|||+||+||++++++ ++++|||..+...
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 1 12347999999999999887543333456899999999998 999999999999999998 9999999887542
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCC
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFA 838 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~ 838 (929)
+. ... ..+.....|..++|+|++|++.
T Consensus 186 e~-----~a~-------------d~~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 186 QR-----KAK-------------DRIDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred ch-----hhH-------------HHHHHHhHhcccccccceeEee
Confidence 11 000 1144455677899999999754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=190.01 Aligned_cols=151 Identities=34% Similarity=0.606 Sum_probs=126.4
Q ss_pred CcCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCC-----CCcceeeCC--CC--CcEEEEEcCCCCCccccCCCCCC
Q 002376 23 SVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPC-----TWPGVICNN--FG--NRVIGLNLSSFGLEGTISPHIGN 93 (929)
Q Consensus 23 ~~~~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~~c-----~w~gv~c~~--~~--~~v~~l~l~~~~l~g~i~~~l~~ 93 (929)
..+.++|.+||++||+++.. +.. .+|+. ++| .|.||.|+. .. .+|+.|+|+++++.|.+|+.++.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~--~~~--~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGL--PLR--FGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred cccCchHHHHHHHHHHhcCC--ccc--CCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 34567899999999999853 222 48973 344 799999953 22 25899999999999999999999
Q ss_pred CCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhcc-CCCCcE
Q 002376 94 LSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRN-LRSLQV 172 (929)
Q Consensus 94 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~-l~~L~~ 172 (929)
|++|+.|+|++|++.|.+|..++.+++|+.|||++|+++|.+|..++++++|++|+|++|+++|.+|.. ++. +.++..
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~-l~~~~~~~~~ 519 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA-LGGRLLHRAS 519 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH-HhhccccCce
Confidence 999999999999999999999999999999999999999999999999999999999999999988877 554 356677
Q ss_pred EEcccccc
Q 002376 173 LNFGKNLL 180 (929)
Q Consensus 173 L~Ls~N~l 180 (929)
+++++|..
T Consensus 520 l~~~~N~~ 527 (623)
T PLN03150 520 FNFTDNAG 527 (623)
T ss_pred EEecCCcc
Confidence 77777754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=174.57 Aligned_cols=241 Identities=18% Similarity=0.252 Sum_probs=160.3
Q ss_pred CCCCceeecccCceeEEeccccCc-----------------HHHHHHHHHHHHccCC----ccccceeeecccCCCCCcc
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGS-----------------WKSFIAECETLRNVRH----RNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~-----------------~~~~~~E~~~l~~l~H----pniv~l~~~~~~~~~~~~~ 720 (929)
+|...+.||+|+||.||++..... ...+..|+.++..+.. +++.++++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 799999999999999999875421 1157789999999873 57777777763 1234
Q ss_pred eEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-----CceEEec
Q 002376 721 FLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-----MTAKVGD 785 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~ki~D 785 (929)
+.|+||+.+ |.+|.++.+... .++.|+..||+++|+. +++||||||.|+++... ..+.+.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 579999988 779988764221 2367899999999998 99999999999999754 4689999
Q ss_pred cccccccc--cccCC--CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc--
Q 002376 786 FGLARFLL--ERVDN--QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL-- 859 (929)
Q Consensus 786 fGla~~~~--~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~-- 859 (929)
||+|+... ..... .........+.||..|+++..-.+...+.+.|+||+. ..+.++..+.+|....+..
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~-----Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLF-----YMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHH-----HHHHHHhcCCCCCccccccch
Confidence 99998332 11111 1111112346799999999999999999999999966 3344555454554111111
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
...+........... ...+.+....++...+-..+..++|....+...+++.....
T Consensus 246 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111100000000 00111112222445666689999999999999988876654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=157.73 Aligned_cols=117 Identities=23% Similarity=0.208 Sum_probs=95.1
Q ss_pred CCceeecccCceeEEeccccCc------------------HHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEE
Q 002376 664 SHENLIGSGSFGSVLHNERTGS------------------WKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~~------------------~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.....|++|+||+||.+...+. ...|.+|+++|++++ |+++.+++++. . .++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----RHL 75 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----EEE
Confidence 3457899999999997655411 125789999999995 58899998863 1 599
Q ss_pred EEEecCCCCccccccc-cccccccHHHHHHHhhhCCCCCEEecCC-CCCCeeecCCCceEEecccccccc
Q 002376 725 VYEFLSNGSLGDWIHG-ERKNELDITSALDYLHNDCEVPVVHSDL-KPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~-~~~~~~~ia~aL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~ki~DfGla~~~ 792 (929)
||||++|.+|.+.+.. ......+++.+++|+|+. +|+|||| ||+|||++.++.++|+|||+|...
T Consensus 76 vmeyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 76 DRSYLAGAAMYQRPPRGDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred EEeeecCccHHhhhhhhhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 9999999999766532 223467889999999998 9999999 799999999999999999999854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-17 Score=169.83 Aligned_cols=198 Identities=22% Similarity=0.165 Sum_probs=125.8
Q ss_pred CCccccceeeecccCCC----------------------CCcceEEEEEEecCCCCcccccccc-------ccccccHHH
Q 002376 700 RHRNLVKLITSCSSLDS----------------------KNMEFLALVYEFLSNGSLGDWIHGE-------RKNELDITS 750 (929)
Q Consensus 700 ~Hpniv~l~~~~~~~~~----------------------~~~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~ 750 (929)
+|||||++.++|.+.-. ......|+||.-.+ -+|.+++..+ +.+..|+.+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 69999999998876421 11234788888775 4788877532 233678999
Q ss_pred HHHHhhhCCCCCEEecCCCCCCeee--cCCC--ceEEeccccccccccccCCCCCccccceeccccccccccccCCCC--
Q 002376 751 ALDYLHNDCEVPVVHSDLKPGNILL--DEEM--TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-- 824 (929)
Q Consensus 751 aL~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 824 (929)
|+.|||.+ +|.|||+|+.|||+ |+|+ ...|+|||++-.-....-.-...+..-..-|...-||||+....+
T Consensus 353 av~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 353 AVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999998 99999999999999 4555 578999998753211000001111111224677899999876432
Q ss_pred ----CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCC
Q 002376 825 ----PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGR 900 (929)
Q Consensus 825 ----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 900 (929)
-..|+|.|+.|.++||+....-++..-. ....+.+-.+ +.+-+..++....++++++...+++||++|
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~~r~Yq-----e~qLPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLDTRTYQ-----ESQLPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc---hheechhhhh-----hhhCCCCcccCChHHHHHHHHHhcCCcccc
Confidence 3578999999998888533222222111 1112222111 122223344455667778889999999999
Q ss_pred CCHHHHHHH
Q 002376 901 IGIREALRR 909 (929)
Q Consensus 901 Ps~~ev~~~ 909 (929)
|+..-+...
T Consensus 502 vsp~iAANv 510 (598)
T KOG4158|consen 502 VSPNIAANV 510 (598)
T ss_pred CCccHHHhH
Confidence 986654443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-16 Score=173.66 Aligned_cols=234 Identities=26% Similarity=0.346 Sum_probs=159.3
Q ss_pred CCCceeecccCceeEEecccc--------------C--cHHHHHHHHHHHHccCCc-cccceeeecccCCCCCcceEEEE
Q 002376 663 FSHENLIGSGSFGSVLHNERT--------------G--SWKSFIAECETLRNVRHR-NLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~--------------~--~~~~~~~E~~~l~~l~Hp-niv~l~~~~~~~~~~~~~~~~lV 725 (929)
|...+.||.|+||.||++... . ..+.|.+|+.+++.+.|+ +++++.+++.... ..+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EEEEE
Confidence 566788999999999998765 1 256789999999999988 7999999984322 27999
Q ss_pred EEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEeccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLL 793 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~ 793 (929)
+||+.++++.+++.... .+..+++.+++|+|+. +++|||+||+||+++..+ .+|++|||.++...
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999997765432 2256889999999998 899999999999999988 79999999998553
Q ss_pred cccCCCCCccccceeccccccccccccCC---CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc--cChHHHHhhc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG---ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV--LDPELRQLMT 868 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~ 868 (929)
................||..|+|||.+.+ ..++...|+|++|+..++ ...+..|...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~-----~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE-----LLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH-----HHhCCCCCCCCCccccHHHHHHHHH
Confidence 32111100012345689999999999988 578999999999854444 2333322110000 0011111111
Q ss_pred ccchh--hhhhhHH----HHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 869 SNESQ--TIQLHDC----LITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 869 ~~~~~--~~~~~~~----~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
..... ....... ....+.++..+|+..+|..|.++.+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100 0000000 01233347779999999999998887664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-16 Score=178.18 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=142.5
Q ss_pred HHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCE-Ee
Q 002376 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPV-VH 765 (929)
Q Consensus 696 l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~i-iH 765 (929)
|+.+.|.|+.+++|.+... ...+.|.+||+.|+|.|.+.... ....+|+.||+|+|+- +| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 4578999999999999765 34899999999999999987422 1256899999999986 44 99
Q ss_pred cCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCC-------CCCCCCCCCCcCCC
Q 002376 766 SDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-------PSTAGDVPTSESFA 838 (929)
Q Consensus 766 rDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DV~s~g~~~ 838 (929)
+.++++|.++|..+.+|++|||+......... ........-..-|.|||.+++.. .+.++||||+|+++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred eeeccccceeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 99999999999999999999999887642100 01111122355699999988742 47789999999988
Q ss_pred CCcchhHHhhhcCCc--hhhhccChHHHHhhcccchhhhhhh---HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 839 GEFNIVKWVESNLPE--NVLQVLDPELRQLMTSNESQTIQLH---DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 839 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
+|+....-++..... ...+++.. +.. ......++... +....++. ++.+||..+|++||+++.|-..++.+
T Consensus 149 ~ei~~r~~~~~~~~~~~~~~eii~~-~~~--~~~~~~rP~i~~~~e~~~~l~~-l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 149 YEILFRSGPFDLRNLVEDPDEIILR-VKK--GGSNPFRPSIELLNELPPELLL-LVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HHHHhccCccccccccCChHHHHHH-HHh--cCCCCcCcchhhhhhcchHHHH-HHHHhcccChhhCccHHHHHhhhhhh
Confidence 887666655544332 11222222 111 01111122111 12223455 78899999999999999998888776
Q ss_pred HH
Q 002376 914 QE 915 (929)
Q Consensus 914 ~~ 915 (929)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 54
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-16 Score=183.19 Aligned_cols=132 Identities=20% Similarity=0.293 Sum_probs=107.3
Q ss_pred ChHHHHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceee
Q 002376 652 SYDELRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLIT 709 (929)
Q Consensus 652 ~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~ 709 (929)
++.........|...+.||+|+||.||+|.+.+ ..+++.+|++++++++|++++....
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333334445556778999999999999965431 0235788999999999999988777
Q ss_pred ecccCCCCCcceEEEEEEecCCCCccccccccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 710 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
++...+ ..++||||+++++|.+++.....++.+++++++|||+. +++|||+||+|||+ +++.++|+|||++
T Consensus 404 ~~~~~~-----~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 404 YDVDPE-----EKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEeCC-----CCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 665432 25899999999999999876667788999999999998 99999999999999 5779999999999
Q ss_pred ccc
Q 002376 790 RFL 792 (929)
Q Consensus 790 ~~~ 792 (929)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=153.46 Aligned_cols=122 Identities=18% Similarity=0.249 Sum_probs=92.7
Q ss_pred CCCceeecccCceeEEecccc-------------CcHHHHHHHHHHHHcc-----CCccccceeeecccCCCCCcce-EE
Q 002376 663 FSHENLIGSGSFGSVLHNERT-------------GSWKSFIAECETLRNV-----RHRNLVKLITSCSSLDSKNMEF-LA 723 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~-------------~~~~~~~~E~~~l~~l-----~Hpniv~l~~~~~~~~~~~~~~-~~ 723 (929)
++..+.||+|+||.||.-... ...+.+.+|+.+++.+ .||||++++|++.+.. +.+. +.
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence 345678999999999962211 1356789999999999 5799999999986543 2234 34
Q ss_pred EEEEe--cCCCCcccccccccc-----ccccHHHHH-HHhhhCCCCCEEecCCCCCCeeecC----CCceEEeccccc
Q 002376 724 LVYEF--LSNGSLGDWIHGERK-----NELDITSAL-DYLHNDCEVPVVHSDLKPGNILLDE----EMTAKVGDFGLA 789 (929)
Q Consensus 724 lV~e~--~~~gsL~~~l~~~~~-----~~~~ia~aL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~ki~DfGla 789 (929)
+|+|| +++|+|.+++.+.+. ...+++.++ +|||+. +|+||||||+|||++. ++.++|+||+-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 89999 558999999964321 235667677 999998 9999999999999974 348999995444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-14 Score=173.38 Aligned_cols=115 Identities=33% Similarity=0.533 Sum_probs=100.9
Q ss_pred CccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCC
Q 002376 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561 (929)
Q Consensus 482 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (929)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCCC--CCCCCCcccccCCCCCcCCC---CCC
Q 002376 562 FNNLEGVVPSEG--IFRNMSNVHLKGNPKLCLQL---GCE 596 (929)
Q Consensus 562 ~N~l~~~~p~~~--~~~~l~~l~l~~N~~~c~~~---~c~ 596 (929)
+|+++|.+|..- .+.++..+++.+|+.+|+.+ .|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999998752 23455678899999999875 575
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-15 Score=149.82 Aligned_cols=116 Identities=19% Similarity=0.188 Sum_probs=84.4
Q ss_pred ceeecccCceeEEeccccC-----------c-------------HHHH-----------------HHHHHHHHccCCccc
Q 002376 666 ENLIGSGSFGSVLHNERTG-----------S-------------WKSF-----------------IAECETLRNVRHRNL 704 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~-----------~-------------~~~~-----------------~~E~~~l~~l~Hpni 704 (929)
...||+|+||.||+|.... . ...| .+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999997641 0 0122 239999999988876
Q ss_pred cceeeecccCCCCCcceEEEEEEecCCCCcccc-ccc-------cccccccHHHHHHHh-hhCCCCCEEecCCCCCCeee
Q 002376 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDW-IHG-------ERKNELDITSALDYL-HNDCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 705 v~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~-------~~~~~~~ia~aL~yL-H~~~~~~iiHrDlk~~NILl 775 (929)
.....+.. . ..++||||++++++... +.. ...++.|++.||+|+ |+. +|+||||||+||++
T Consensus 82 ~~p~~~~~--~-----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--K-----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--c-----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 43332211 1 13899999998877544 222 123367899999999 576 89999999999999
Q ss_pred cCCCceEEecccccccc
Q 002376 776 DEEMTAKVGDFGLARFL 792 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~ 792 (929)
+ ++.++++|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.8e-16 Score=171.73 Aligned_cols=161 Identities=27% Similarity=0.240 Sum_probs=126.5
Q ss_pred ecccCceeEEecccc---------------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEE
Q 002376 669 IGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+|+|+||+|+.++.. +.......|..++..++ ||.+|++...+.. ....++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHhh
Confidence 688999998654321 11224556888899997 9999999887744 33489999
Q ss_pred EecCCCCccccccccccc--------cccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGERKN--------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~~~--------~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
+|..+|++...+...... ...++-|++++|.. +|+|||+|++||+++.+|.+|+.|||+++..-+.
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--- 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--- 150 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh---
Confidence 999999999888755433 34678899999998 9999999999999999999999999999865321
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVES 849 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~ 849 (929)
...+||..|||||++. .....+|-||+|+.++++.+...++.
T Consensus 151 -------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 151 -------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred -------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 1128999999999987 57788999999988887665544443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=147.57 Aligned_cols=116 Identities=20% Similarity=0.172 Sum_probs=87.8
Q ss_pred ceeecccCceeEEecccc-C----------c------------------------------HHHHHHHHHHHHccCCccc
Q 002376 666 ENLIGSGSFGSVLHNERT-G----------S------------------------------WKSFIAECETLRNVRHRNL 704 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~-~----------~------------------------------~~~~~~E~~~l~~l~Hpni 704 (929)
...||+|+||.||+|... + . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 367999999999998764 0 0 0113578899999999987
Q ss_pred cceeeecccCCCCCcceEEEEEEecCCCCcccc-ccc-------cccccccHHHHHHHhhh-CCCCCEEecCCCCCCeee
Q 002376 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDW-IHG-------ERKNELDITSALDYLHN-DCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 705 v~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~-------~~~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl 775 (929)
.....+... ..++||||++++++... +.. ...++.+++.|+.|+|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544443321 13899999998755332 322 12346789999999999 7 99999999999999
Q ss_pred cCCCceEEecccccccc
Q 002376 776 DEEMTAKVGDFGLARFL 792 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~ 792 (929)
+ ++.++|+|||+|+.+
T Consensus 152 ~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 152 H-DGKPYIIDVSQAVEL 167 (190)
T ss_pred E-CCCEEEEEcccceec
Confidence 9 789999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-15 Score=177.55 Aligned_cols=211 Identities=22% Similarity=0.300 Sum_probs=141.2
Q ss_pred CCCCCceeecccCceeEEeccccCcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 740 (929)
.+|..++.|-.|+||.||..+++...+.|...+.. +.+--+||..+.+. .+.| |+-...++.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~lilRnilt~a~n-----------pfvv------gDc~tllk~ 144 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNLILRNILTFAGN-----------PFVV------GDCATLLKN 144 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cchhhhccccccCC-----------ccee------chhhhhccc
Confidence 47888999999999999999999888888752210 11112233333222 2334 555555655
Q ss_pred cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc---------cCCCCCccccceeccc
Q 002376 741 ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER---------VDNQSSISSTHVFMGS 811 (929)
Q Consensus 741 ~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---------~~~~~~~~~~~~~~gt 811 (929)
....-.+.+.|++|+|+. +|+|||+||+|.+|+.-|.+|+.|||+++..-.. ............++||
T Consensus 145 ~g~lPvdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgT 221 (1205)
T KOG0606|consen 145 IGPLPVDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGT 221 (1205)
T ss_pred CCCCcchhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCC
Confidence 555556668999999998 9999999999999999999999999999864211 1111111233567999
Q ss_pred cccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh-hcCCchh-hhccChHHHHhhcccchhhhhhhHHHHHHHHHHh
Q 002376 812 IGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE-SNLPENV-LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVG 889 (929)
Q Consensus 812 ~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~-~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 889 (929)
+.|+|||++....|+..+|=|++|++.|++.+...++ +..|+.+ .+++... ..+..+++. ...-+++++
T Consensus 222 PeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-i~wpE~dea--------~p~Ea~dli 292 (1205)
T KOG0606|consen 222 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPEEDEA--------LPPEAQDLI 292 (1205)
T ss_pred ccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-ccccccCcC--------CCHHHHHHH
Confidence 9999999999999999999999999999876665543 3334432 2222221 122211111 112223366
Q ss_pred ccccCCCCCCCC
Q 002376 890 LSCTTESPGGRI 901 (929)
Q Consensus 890 ~~Cl~~dP~~RP 901 (929)
.+.++.+|..|-
T Consensus 293 ~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 293 EQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHhChHhhc
Confidence 688889999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-14 Score=138.63 Aligned_cols=189 Identities=23% Similarity=0.289 Sum_probs=135.6
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccCc--------------HHHHHHHHHHHHccCCc-cccceeeecccCCCC
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTGS--------------WKSFIAECETLRNVRHR-NLVKLITSCSSLDSK 717 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--------------~~~~~~E~~~l~~l~Hp-niv~l~~~~~~~~~~ 717 (929)
.+++.+ .+.|...++||+|+||.+|.|..-.. .-+...|.++.+.++|- .|..+..|..+
T Consensus 8 ~~~~iv-~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e---- 82 (341)
T KOG1163|consen 8 LEELIV-GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE---- 82 (341)
T ss_pred hhhhee-ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc----
Confidence 344444 35899999999999999999876522 22466799999999874 44444444432
Q ss_pred CcceEEEEEEecCCCCccccccc--cc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEEec
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHG--ER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKVGD 785 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~--~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~D 785 (929)
..+-.+|||.. |.+|.+...- ++ ..+-|+..-++|+|.+ ++|||||||+|.|..-+ ..+.+.|
T Consensus 83 -~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 83 -KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred -cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 33458999998 7899887652 11 2256888899999998 89999999999998633 3688999
Q ss_pred cccccccccccC-CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcC
Q 002376 786 FGLARFLLERVD-NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNL 851 (929)
Q Consensus 786 fGla~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~ 851 (929)
||+|+.+..-.. .+..........||.+|.+--...+...+.+.|+-|.|-++..+.-..++|..+
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 999997643211 122223345678999999987777777889999999997766665555565544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.5e-14 Score=145.32 Aligned_cols=115 Identities=23% Similarity=0.313 Sum_probs=93.0
Q ss_pred eecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 668 LIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 668 ~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.||+|+||.||+|.+.+ ..+++.+|+++++.++|+++.....++...+ ..++|
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCEEE
Confidence 48999999999998441 0145668999999999887554444443222 25899
Q ss_pred EEecCCCCccccccccc-cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 726 YEFLSNGSLGDWIHGER-KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~-~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
|||+++++|.+++.... ..+.+++.+++++|+. +++|||+||.||+++ ++.+++.|||+++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999876544 5688999999999998 999999999999999 78999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-15 Score=164.65 Aligned_cols=116 Identities=26% Similarity=0.428 Sum_probs=94.3
Q ss_pred ceEEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
.+.|+.|++|...+|.+|+...+ .+..|++.|++| + +.+|||+||.||....+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 35899999999999999996433 225678889999 4 899999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEF 841 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~ 841 (929)
.................+..+||..||+||.+.+..|+.|+|||++|.+++|+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL 455 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAEL 455 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHH
Confidence 87664332111222234556899999999999999999999999999887774
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.8e-14 Score=145.74 Aligned_cols=116 Identities=22% Similarity=0.322 Sum_probs=95.1
Q ss_pred eeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 667 NLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.||+|++|.||+|...+ ....+.+|++++..++|+++.....++...+ ..++
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NFII 76 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CCEE
Confidence 579999999999985431 0135778999999999999877766654322 2689
Q ss_pred EEEecCCCCccccccccc----cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
||||+++++|.+++.... .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 77 v~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999886432 4567899999999998 999999999999999 78999999999874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.6e-15 Score=161.18 Aligned_cols=196 Identities=30% Similarity=0.503 Sum_probs=161.8
Q ss_pred CCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCE
Q 002376 326 NSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405 (929)
Q Consensus 326 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 405 (929)
.++.-...||+.|++. .+|..+..+. .|+.+.|..|.|. .+|..+.++..|++|||+.|+++ .+|..++.|+ |++
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 3455567899999998 8999988887 7999999999998 78999999999999999999998 7888888886 999
Q ss_pred EEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccE
Q 002376 406 LGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485 (929)
Q Consensus 406 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~ 485 (929)
|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|+++..| .|..
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~---------~lp~El~~L-pLi~ 215 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE---------DLPEELCSL-PLIR 215 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh---------hCCHHHhCC-ceee
Confidence 999999997 67888888899999999999998 67888899999999999999986 236666654 4888
Q ss_pred EEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCC---CCCCEEECCCCc
Q 002376 486 IDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAEL---KGLEVLDLSSNK 540 (929)
Q Consensus 486 LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~ 540 (929)
||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ .+|..+... .-.++|+..-++
T Consensus 216 lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 216 LDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 999999998 78888999999999999999888 455554332 224556655553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.8e-14 Score=142.07 Aligned_cols=127 Identities=19% Similarity=0.104 Sum_probs=97.0
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccCc-------------------------------------HHHHHHHHHHH
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTGS-------------------------------------WKSFIAECETL 696 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------------------------~~~~~~E~~~l 696 (929)
+++.+....|...+.||+|+||.||++..... ...+..|...+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444444477789999999999999876310 01256788889
Q ss_pred HccCCcc--ccceeeecccCCCCCcceEEEEEEecCCCCcccccc--ccccccccHHHHHHHhhhCCCCCEEecCCCCCC
Q 002376 697 RNVRHRN--LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKNELDITSALDYLHNDCEVPVVHSDLKPGN 772 (929)
Q Consensus 697 ~~l~Hpn--iv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~N 772 (929)
.++.|++ +.+.++.+ ..++||||+++++|.+... .....+.+++.++.++|+. +|+||||||+|
T Consensus 88 ~~l~~~~i~v~~~~~~~---------~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 88 KALYEEGFPVPKPIDWN---------RHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HHHHHcCCCCCceeecC---------CceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 9888874 44444321 2489999999999987653 1223467899999999997 99999999999
Q ss_pred eeecCCCceEEecccccccc
Q 002376 773 ILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 773 ILl~~~~~~ki~DfGla~~~ 792 (929)
|++++++.++|+|||++...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=140.70 Aligned_cols=180 Identities=18% Similarity=0.254 Sum_probs=131.5
Q ss_pred CCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+|++.++||+|+||+++.|+.- ...-+..-|.+..+.+. .+.|..++.|- +...+-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 7888999999999999998753 22345677888888875 57777766553 2233458999
Q ss_pred EecCCCCccccccc--c-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-----ceEEecccccccc
Q 002376 727 EFLSNGSLGDWIHG--E-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-----TAKVGDFGLARFL 792 (929)
Q Consensus 727 e~~~~gsL~~~l~~--~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~ki~DfGla~~~ 792 (929)
|.. |.||.|...- + ..++.|+..-++|+|++ ..|.|||||+|.||..-+ .+.|.|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 7788877652 1 23467888899999998 899999999999997543 5899999999987
Q ss_pred ccccCC-CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhc
Q 002376 793 LERVDN-QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESN 850 (929)
Q Consensus 793 ~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~ 850 (929)
...... +..........||.+||+----.|+.-+.+-|.-++|-+.+.+.-+.++|..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 543222 2222334556899999999888899999999999988543333334444433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.1e-15 Score=159.29 Aligned_cols=169 Identities=30% Similarity=0.463 Sum_probs=82.6
Q ss_pred EEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcc
Q 002376 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436 (929)
Q Consensus 357 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 436 (929)
..||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|.+|||+.|+++ ..|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 4455555554 44444455555555555555554 44555555555555555555554 3444444443 4555555555
Q ss_pred cccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccc
Q 002376 437 LTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQ 516 (929)
Q Consensus 437 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (929)
++ .+|..++.+..|..||.+.|.+. .+|..++.+..|+.|.+..|++. .+|..+..| .|..||+|.|+
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~---------slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQ---------SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhh---------hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCc
Confidence 54 34444444445555555555442 22444555555555555555554 333344422 34455555555
Q ss_pred ccccCCccccCCCCCCEEECCCCcCC
Q 002376 517 FSGPIPNIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 517 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (929)
++ .+|-.|.+|+.|++|-|.+|.|.
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCC
Confidence 54 44445555555555555555554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.1e-13 Score=162.34 Aligned_cols=235 Identities=15% Similarity=0.116 Sum_probs=151.7
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccCcHH------------HHHHHHHHHHccC---CccccceeeecccCCCCCc
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTGSWK------------SFIAECETLRNVR---HRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~------------~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~~ 719 (929)
+.+...+.|.+.+.||+|+||+||+|....... +|--=.+++.+++ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--- 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA--- 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc---
Confidence 444556678888999999999999998763110 1111223444444 1234444433322222
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-------CCCceEEe
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-------EEMTAKVG 784 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-------~~~~~ki~ 784 (929)
-++|+||.+.|+|.+++...+ .+..++++-+++||.. +|||+||||.|.||. +...++|+
T Consensus 769 --S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 --SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred --ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 489999999999999987433 2357899999999998 999999999999994 23468999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|||.+..+.- .........+++|-++-.+|+..|++++..+|-|.+..+++-|..+..+. .... ....++..+.
T Consensus 844 DfG~siDm~l----fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g-~~~~~~~~~~ 917 (974)
T KOG1166|consen 844 DFGRSIDMKL----FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNG-SSWMVKTNFP 917 (974)
T ss_pred ecccceeeeE----cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCC-cceeccccch
Confidence 9999976532 12223445678999999999999999999999987765544444444443 1111 1111222222
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
... -..+..++....+++|-..=|...++...++++...
T Consensus 918 Ry~-------------~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 918 RYW-------------KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hhh-------------hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 211 011222355567775555567777777777776554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.5e-13 Score=139.19 Aligned_cols=118 Identities=23% Similarity=0.143 Sum_probs=89.3
Q ss_pred CCCCceeecccCceeEEecc-cc-------------Cc---------------------------HHHHHHHHHHHHccC
Q 002376 662 NFSHENLIGSGSFGSVLHNE-RT-------------GS---------------------------WKSFIAECETLRNVR 700 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~-~~-------------~~---------------------------~~~~~~E~~~l~~l~ 700 (929)
.|+..+.||+|+||.||+|. .. .. ...+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999997 21 00 012457999999997
Q ss_pred Ccc--ccceeeecccCCCCCcceEEEEEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCC-EEecCCC
Q 002376 701 HRN--LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVP-VVHSDLK 769 (929)
Q Consensus 701 Hpn--iv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~-iiHrDlk 769 (929)
+.. +.+.+++. ..++||||++++++..+... ...++.+++.|++|||+. + |+|||+|
T Consensus 109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEec---------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 632 33333321 14899999999888765421 124567899999999998 8 9999999
Q ss_pred CCCeeecCCCceEEecccccccc
Q 002376 770 PGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 770 ~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|+||+++ ++.++++|||.|...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-13 Score=140.15 Aligned_cols=197 Identities=23% Similarity=0.288 Sum_probs=135.3
Q ss_pred HHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCC
Q 002376 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVP 762 (929)
Q Consensus 695 ~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~ 762 (929)
-+-++.|-|+|+++.|+.+....+..+..++.|||+.|++.++|++.+ ++..||..||.|||+. .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 345567999999999998876656677899999999999999998543 3467899999999994 789
Q ss_pred EEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcc
Q 002376 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFN 842 (929)
Q Consensus 763 iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~ 842 (929)
|+|+++..+-|.+..+|-+||.--.-..... . ...........-.|-++|-|||+-.....+..+|||+||+.+.++.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~-s-~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-S-VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccch-h-hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999985322111000 0 0000011122345788999999988888899999999998777766
Q ss_pred hhHHhhhcCCc--hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 843 IVKWVESNLPE--NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 843 ~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.+.-...... ...+-+...+.. .....+ ++.+..|++.+|..||+|++.+.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~--len~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIG--LENGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhheee--ccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 55544322221 111111111111 011111 12667999999999999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.2e-14 Score=164.31 Aligned_cols=225 Identities=19% Similarity=0.182 Sum_probs=143.2
Q ss_pred CCCCceeecccCceeEEeccccC---------------cHHHHHHHHHH--HHccCCccccceeeecccCCCCCcceEEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECET--LRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~--l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+|...+.+|++.|=+|.+|++.. ..+.|.++++- ....+|||++++..+-.. ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-----~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-----DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-----hHHHHH
Confidence 45667889999998888887662 23455554443 445689999998776432 233688
Q ss_pred EEEecCCCCccccccc--------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHG--------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~--------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
|=+|..+ +|+|.+.. .+.++.|+..|+.-+|.. +|+|+|||.+||||+.--.+.++||.--|...-..
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 8888854 89888763 345688999999999998 99999999999999999999999998766432111
Q ss_pred CCCCC-ccccceeccccccccccccCCC----------C-CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHH-
Q 002376 797 DNQSS-ISSTHVFMGSIGYVPPEYGLGE----------R-PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPEL- 863 (929)
Q Consensus 797 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l- 863 (929)
++... ......-.--..|+|||-+... . .+++-||+|.||+..|+.+ .+.-+....+.+.-+-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~----Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL----EGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh----cCCCcccHHHHHhHhcc
Confidence 11110 0000001112369999965431 1 5678899999987655322 2222222222111100
Q ss_pred -----HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 864 -----RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 864 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
...+.+-+.. -++.++..|++.||++|-++++.++.
T Consensus 251 ~~~~~e~~Le~Ied~----------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV----------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCc----------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001111110 12336669999999999999999987
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-12 Score=148.46 Aligned_cols=180 Identities=41% Similarity=0.628 Sum_probs=99.4
Q ss_pred CcccEEEeeCCCCCcccCccccCCC-CCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceec
Q 002376 377 RSLTLLDLSYNSISGEIPIEIGQLQ-GLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID 455 (929)
Q Consensus 377 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 455 (929)
+.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+..+.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44555555555554 3333444442 5555555555554 33344555555666666666655 3343333555566666
Q ss_pred ccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEE
Q 002376 456 LSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535 (929)
Q Consensus 456 Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (929)
+++|+++ .+ |..+.....|++|++++|++. .++..+.++..+..|.+++|++.. ++..++.+++|++|+
T Consensus 193 ls~N~i~-~l--------~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~ 261 (394)
T COG4886 193 LSGNKIS-DL--------PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLD 261 (394)
T ss_pred ccCCccc-cC--------chhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceec
Confidence 6666654 22 443344445666666666433 344556666666666666666652 355566666677777
Q ss_pred CCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC
Q 002376 536 LSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE 572 (929)
Q Consensus 536 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (929)
+++|.++. ++. +..+.+|+.|++++|.++..+|..
T Consensus 262 ~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 262 LSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 77776663 333 666666777777777666655543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.1e-12 Score=132.91 Aligned_cols=101 Identities=20% Similarity=0.188 Sum_probs=79.3
Q ss_pred HHHHHHHHHHHccCCccc--cceeeecccCCCCCcceEEEEEEecCC-CCccccccccc---cccccHHHHHHHhhhCCC
Q 002376 687 KSFIAECETLRNVRHRNL--VKLITSCSSLDSKNMEFLALVYEFLSN-GSLGDWIHGER---KNELDITSALDYLHNDCE 760 (929)
Q Consensus 687 ~~~~~E~~~l~~l~Hpni--v~l~~~~~~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~---~~~~~ia~aL~yLH~~~~ 760 (929)
..+.+|++++.+++|+++ ++.+++..... ......++||||+++ .+|.+++.... ....+++.++.+||+.
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~-~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~-- 161 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRH-GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA-- 161 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeec-CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC--
Confidence 356789999999998875 66676644322 112224699999997 68888875432 2256799999999998
Q ss_pred CCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+|+|||+||.|||++.++.++|+|||.++.
T Consensus 162 -GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 162 -GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred -CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999989999999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-12 Score=123.58 Aligned_cols=122 Identities=20% Similarity=0.221 Sum_probs=97.1
Q ss_pred ceeecccCceeEEeccccC----------c--HHHHHHHHHHHHccCC--ccccceeeecccCCCCCcceEEEEEEecCC
Q 002376 666 ENLIGSGSFGSVLHNERTG----------S--WKSFIAECETLRNVRH--RNLVKLITSCSSLDSKNMEFLALVYEFLSN 731 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~----------~--~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~~~~~~lV~e~~~~ 731 (929)
.+.||+|.++.||++...+ . ...+.+|+..++.++| +.+.++++++... ...+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEEecCC
Confidence 4679999999999887631 1 2478999999999987 4888888877432 347999999998
Q ss_pred CCccccc-cccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 732 GSLGDWI-HGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 732 gsL~~~l-~~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+.+..+- ........+++++++++|.....+++|||+||+||++++.+.+++.|||.++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8887541 112234678999999999865557999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.8e-12 Score=144.15 Aligned_cols=201 Identities=37% Similarity=0.545 Sum_probs=157.2
Q ss_pred EEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC-cccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR-SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 332 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
.++++.|.+...+ ..+.... .++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~-~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELT-NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCc-hhhhccc-ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5777777774332 2333333 6888889988888 5666667774 8999999999998 5667788899999999999
Q ss_pred CcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecC
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~ 490 (929)
|+++ .+|.....++.|+.|++++|+++ .+|........|++|++++|++. ..+..+..+.++..+.+++
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~---------~~~~~~~~~~~l~~l~l~~ 241 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII---------ELLSSLSNLKNLSGLELSN 241 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce---------ecchhhhhcccccccccCC
Confidence 9998 45655557889999999999998 56666556667999999999532 1266778888999999999
Q ss_pred CCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccc
Q 002376 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQ 550 (929)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (929)
|++. .++..++++.++++|++++|+++...+ ++.+.+|+.||+++|.++...|....
T Consensus 242 n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 242 NKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 9887 347788999999999999999985444 88999999999999999977665543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.8e-13 Score=138.07 Aligned_cols=209 Identities=18% Similarity=0.135 Sum_probs=117.7
Q ss_pred CCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCC-----------ccccceeeecc
Q 002376 663 FSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRH-----------RNLVKLITSCS 712 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~H-----------pniv~l~~~~~ 712 (929)
+...+.||.|+++.||.+++.. ..+++.+|.-....+.+ ..++++--.-.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456889999999999988762 35667777655544322 22222211111
Q ss_pred cCCC------CCcc-----eEEEEEEecCCCCccccccc-----cc----------cccccHHHHHHHhhhCCCCCEEec
Q 002376 713 SLDS------KNME-----FLALVYEFLSNGSLGDWIHG-----ER----------KNELDITSALDYLHNDCEVPVVHS 766 (929)
Q Consensus 713 ~~~~------~~~~-----~~~lV~e~~~~gsL~~~l~~-----~~----------~~~~~ia~aL~yLH~~~~~~iiHr 766 (929)
.... .+.. ..+++|+-+ .+||.+++.. .. ....|+.+.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1000 0001 236778877 5688877641 00 1136788999999998 99999
Q ss_pred CCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCC--------CCCCCCCCCCCcCCC
Q 002376 767 DLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE--------RPSTAGDVPTSESFA 838 (929)
Q Consensus 767 Dlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DV~s~g~~~ 838 (929)
||||+|++++.+|.++++||+........ ......+..|.+||..... .++.+.|.|++|+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 99999999999999999999977643211 0102345789999976432 478899999999544
Q ss_pred CCcchhHHhhhcCCch--hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCC
Q 002376 839 GEFNIVKWVESNLPEN--VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGR 900 (929)
Q Consensus 839 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R 900 (929)
+.+....+|.. ..+..+....... . .+++.++.|+...++++|++|
T Consensus 241 -----y~lWC~~lPf~~~~~~~~~~~~f~~C----------~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 -----YSLWCGRLPFGLSSPEADPEWDFSRC----------R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----HHHHHSS-STCCCGGGSTSGGGGTTS----------S----HHHHHHHHHHT-SSGGGS
T ss_pred -----HHHHHccCCCCCCCccccccccchhc----------C-CcCHHHHHHHHHHccCCcccC
Confidence 44444555542 1111111111111 1 244555567779999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.5e-13 Score=155.12 Aligned_cols=231 Identities=25% Similarity=0.264 Sum_probs=155.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~ 720 (929)
..|...+.||+|+|+.|-...... ..+....|..+-..+. |+|++.+++..... .
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----R 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----c
Confidence 356667789999999985544321 1222334666666666 99999999987544 3
Q ss_pred eEEEEEEecCCCCccccc-ccc---------ccccccHHHHHHHhh-hCCCCCEEecCCCCCCeeecCCC-ceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWI-HGE---------RKNELDITSALDYLH-NDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l-~~~---------~~~~~~ia~aL~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGl 788 (929)
..+++.||..+|++.+.+ +.. ..+..|+..|+.|+| .. ++.|||+||+|.+++..+ ..|++|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 479999999999999988 422 233568889999999 65 899999999999999999 999999999
Q ss_pred ccccccccCCCCCccccceecc-ccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 789 ARFLLERVDNQSSISSTHVFMG-SIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
|..+... ..........+| ++.|+|||...+. ......|+||.|+.+..+...+.++..... .+.....+
T Consensus 172 At~~~~~---~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~-----~~~~~~~~ 243 (601)
T KOG0590|consen 172 ATAYRNK---NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR-----KDGRYSSW 243 (601)
T ss_pred hcccccc---CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc-----ccccceee
Confidence 9876431 111222344578 9999999998885 458889999999887776665555433322 11111111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
...........+..+..-..++..+++..+|+.|.+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11110001111112222222266688889999999987764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-11 Score=124.05 Aligned_cols=67 Identities=27% Similarity=0.233 Sum_probs=54.8
Q ss_pred EEEEEEecCCCC-----cccccc--ccccccccHHHHHHHhhh-CCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGS-----LGDWIH--GERKNELDITSALDYLHN-DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gs-----L~~~l~--~~~~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||++++. +.+... ..+..+.+++.++.++|. . +|+|||+||+||+++ ++.++++|||.++..
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 589999999853 433322 234457789999999998 6 999999999999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-11 Score=122.93 Aligned_cols=137 Identities=31% Similarity=0.351 Sum_probs=84.0
Q ss_pred ccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCC
Q 002376 419 NSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP 498 (929)
Q Consensus 419 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p 498 (929)
..+..+..|+.+|||+|.|+ .+..+..-.+.++.|++|+|.|.. + ..+..+.+|+.||||+|.++ .+.
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v---------~nLa~L~~L~~LDLS~N~Ls-~~~ 345 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V---------QNLAELPQLQLLDLSGNLLA-ECV 345 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e---------hhhhhcccceEeecccchhH-hhh
Confidence 33444456667777777776 455555556667777777776652 1 23555666777777777666 344
Q ss_pred cchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcC-CcccccCCCCCeEeCCCCcCcccC
Q 002376 499 NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSI-PSDLQNLQALRSLNLTFNNLEGVV 569 (929)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 569 (929)
.+-..+-+.+.|.|+.|.|... +.++.+-+|..||+++|++.... -..+++++-|+.+.|.+|.+++.+
T Consensus 346 Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 346 GWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 4445566667777777776532 34556667777777777765322 235666777777777777776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.9e-12 Score=132.23 Aligned_cols=212 Identities=21% Similarity=0.205 Sum_probs=104.3
Q ss_pred CCCCCCCEEEeecCCCCCCCC--cCCCCCCCCcEEeCCCCCCCCCcc--cccccccccceecccccccCCCCChhhhccC
Q 002376 92 GNLSFLRSIQLQNNKLSGNLP--REIGNLFRLRVLNISFNNLQGELP--VNISKLTELKMLDLMANKITGRVTDDQLRNL 167 (929)
Q Consensus 92 ~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l 167 (929)
.++.+|+...|.+.... ..+ .....|++++.||||+|-|....| .....|++|+.|+||.|++.-.+....-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34556666666665554 222 234456666666666666553322 2334556666666666666432222222344
Q ss_pred CCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccC
Q 002376 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDT 247 (929)
Q Consensus 168 ~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~ 247 (929)
++|+.|.|+.+.|+..- +. .....+++|+.|+|..|....+.......+..|++|||++|++-. .+.
T Consensus 197 ~~lK~L~l~~CGls~k~---V~----~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~----- 263 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKD---VQ----WILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQ----- 263 (505)
T ss_pred hhhheEEeccCCCCHHH---HH----HHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-ccc-----
Confidence 55555666555543210 00 112234555566666554333333344445555556665555531 110
Q ss_pred CCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCC-ccCC-----CCCCCccceeccccccccCCCCCCCCccc
Q 002376 248 LPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT-LPPG-----LGNLPFLRTYNIGFNKIVSSGDDEGLSFI 321 (929)
Q Consensus 248 l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~i~~~~~~~~~~~~ 321 (929)
-...+.++.|+.|+++.+.++.. .|+. ....++|++|++..|+|.... ..
T Consensus 264 ------------------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~------sl 319 (505)
T KOG3207|consen 264 ------------------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWR------SL 319 (505)
T ss_pred ------------------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccccc------cc
Confidence 12234455555555555555432 1222 345566666666666664332 22
Q ss_pred cccCCCCCCCEEEccCCccc
Q 002376 322 TSLTNSTHLNYLALDGNQFE 341 (929)
Q Consensus 322 ~~~~~l~~L~~L~Ls~N~l~ 341 (929)
..+..+.+|+.|....|.++
T Consensus 320 ~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 320 NHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred chhhccchhhhhhccccccc
Confidence 34444556666666666665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-11 Score=123.36 Aligned_cols=132 Identities=33% Similarity=0.352 Sum_probs=69.9
Q ss_pred CCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccccccee
Q 002376 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI 454 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 454 (929)
.+..|+.+|||+|.|+ .+..+..-++.++.|++|+|.|... +.+..+++|+.||||+|.++ .+-.+-..+-++++|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3445555666666555 3444444555555555555555421 22555556666666666655 223333334455555
Q ss_pred cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccC-CccccCCCCCCE
Q 002376 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI-PNIVAELKGLEV 533 (929)
Q Consensus 455 ~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~ 533 (929)
.|+.|.|.. -+ .++.+-+|..||+++|+|...- -..+++++-|+.
T Consensus 358 ~La~N~iE~----------LS------------------------GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~ 403 (490)
T KOG1259|consen 358 KLAQNKIET----------LS------------------------GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLET 403 (490)
T ss_pred ehhhhhHhh----------hh------------------------hhHhhhhheeccccccchhhHHHhcccccccHHHH
Confidence 555555431 11 2334445555555555554221 235677777788
Q ss_pred EECCCCcCCCc
Q 002376 534 LDLSSNKLSGS 544 (929)
Q Consensus 534 L~Ls~N~l~~~ 544 (929)
|.|.+|.+.+.
T Consensus 404 l~L~~NPl~~~ 414 (490)
T KOG1259|consen 404 LRLTGNPLAGS 414 (490)
T ss_pred HhhcCCCcccc
Confidence 88888877753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.8e-11 Score=116.60 Aligned_cols=130 Identities=32% Similarity=0.434 Sum_probs=45.7
Q ss_pred CCCCCCCCCEEEeecCCCCCCCCcCCC-CCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCC
Q 002376 90 HIGNLSFLRSIQLQNNKLSGNLPREIG-NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLR 168 (929)
Q Consensus 90 ~l~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~ 168 (929)
.+.+...+++|+|++|.|+. + +.++ .+.+|+.||||+|.|+.. + .+..+++|++|+|++|+|+ .+.+.....++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred cccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 34556678999999999873 3 3455 578899999999999843 3 4778899999999999998 56654234688
Q ss_pred CCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccC---CccccCCCCceEEe
Q 002376 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP---STIYNMTSLVHLRL 231 (929)
Q Consensus 169 ~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L 231 (929)
+|+.|+|++|++.. +..+ ..++.+++|++|+|.+|.++...- ..+..+++|+.||-
T Consensus 89 ~L~~L~L~~N~I~~-----l~~l--~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISD-----LNEL--EPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---S-----CCCC--GGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCC-----hHHh--HHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 99999999998743 2221 234567777777777777763211 13445666666553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-11 Score=138.46 Aligned_cols=213 Identities=32% Similarity=0.363 Sum_probs=136.4
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
+|..|++.+|+|... ...+..+++|++|+|++|+|+... .+..++.|+.|++++|.|+.. ..+..++.|+.++++
T Consensus 96 ~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~ 170 (414)
T KOG0531|consen 96 SLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLS 170 (414)
T ss_pred ceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCC
Confidence 455555555555432 222556677777777777776443 244556677777777777632 344557778888888
Q ss_pred CcccccccC-cccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCc--Cccee
Q 002376 434 GNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCK--SLEEL 510 (929)
Q Consensus 434 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~--~L~~L 510 (929)
+|++....+ . ...+.+++.+++.+|.+.- ...+..+..+..+++..|.++-.-+ +..+. .|+.+
T Consensus 171 ~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~----------i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l 237 (414)
T KOG0531|consen 171 YNRIVDIENDE-LSELISLEELDLGGNSIRE----------IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLREL 237 (414)
T ss_pred cchhhhhhhhh-hhhccchHHHhccCCchhc----------ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHH
Confidence 888875444 2 4667788888888888752 2334445556666888888763322 11222 38899
Q ss_pred ecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccC---CC--CCCCCCCCcccccC
Q 002376 511 LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVV---PS--EGIFRNMSNVHLKG 585 (929)
Q Consensus 511 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---p~--~~~~~~l~~l~l~~ 585 (929)
++++|.+. .++..+..+..+..||+++|++... ..+.....+..+.+..|.+...- .. .....++..+.+.+
T Consensus 238 ~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (414)
T KOG0531|consen 238 YLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLEL 314 (414)
T ss_pred hcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccccccc
Confidence 99999987 3435677788899999999998754 23555667777888888876321 11 23345666677777
Q ss_pred CC
Q 002376 586 NP 587 (929)
Q Consensus 586 N~ 587 (929)
||
T Consensus 315 ~~ 316 (414)
T KOG0531|consen 315 NP 316 (414)
T ss_pred Cc
Confidence 76
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-11 Score=138.70 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=142.3
Q ss_pred CCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCc
Q 002376 92 GNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQ 171 (929)
Q Consensus 92 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~ 171 (929)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|||++|+|+ .+.. +..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~-~i~~--l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKIT-KLEG--LSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccc-cccc--hhhccchh
Confidence 35566777777777776 344456777788888888888874 3333667788888888888887 3322 56666678
Q ss_pred EEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccC-CccccCCCCceEEeeecCCCCcCCcccccCCCC
Q 002376 172 VLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP-STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPN 250 (929)
Q Consensus 172 ~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~ 250 (929)
.|++++|.++.. ..+..+.+|+.+++++|++..+.+ . ...+.+++.+++++|.+.. +
T Consensus 144 ~L~l~~N~i~~~----------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~-i---------- 201 (414)
T KOG0531|consen 144 ELNLSGNLISDI----------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE-I---------- 201 (414)
T ss_pred hheeccCcchhc----------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc-c----------
Confidence 888888876421 234457777777888887775554 2 4566777777777777651 1
Q ss_pred cceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCC--ccceeccccccccCCCCCCCCccccccCCCC
Q 002376 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP--FLRTYNIGFNKIVSSGDDEGLSFITSLTNST 328 (929)
Q Consensus 251 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~ 328 (929)
..+..+..+..+++..|.++..-+ +..+. +|+.+++++|.+.... ..+..+.
T Consensus 202 ----------------~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~--------~~~~~~~ 255 (414)
T KOG0531|consen 202 ----------------EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP--------EGLENLK 255 (414)
T ss_pred ----------------cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc--------ccccccc
Confidence 112222233333444444442211 11111 2555555555554431 1234455
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccc---cCCC-CCCCCcccEEEeeCCCCCcccCc
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK---IPAS-IGRLRSLTLLDLSYNSISGEIPI 395 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p~ 395 (929)
.+..|++.+|++...-. +.... .+..+.+..|.+... .... ....+.++...+..|.+....+.
T Consensus 256 ~l~~l~~~~n~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 256 NLPVLDLSSNRISNLEG--LERLP-KLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred cccccchhhcccccccc--ccccc-hHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 66666666666653211 11122 455556666655421 1111 45567788888888877755443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.5e-10 Score=111.59 Aligned_cols=79 Identities=30% Similarity=0.442 Sum_probs=25.3
Q ss_pred cccCccEEEecCCCCCCCCCcch-hcCcCcceeecccccccccCC-ccccCCCCCCEEECCCCcCCCcCCc----ccccC
Q 002376 479 RLENVVTIDLSDNSLSGNLPNSL-KNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLSGSIPS----DLQNL 552 (929)
Q Consensus 479 ~l~~L~~LdLs~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 552 (929)
.++.|++|++++|+++. ++..+ ..+++|++|+|++|+|...-. ..++.+++|++|+|.+|.++.. +. .+..+
T Consensus 62 ~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~l 139 (175)
T PF14580_consen 62 GLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKL 139 (175)
T ss_dssp --TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-
T ss_pred ChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHc
Confidence 34445555555555542 22222 235555555555555543211 2344556666666666665532 21 23445
Q ss_pred CCCCeEe
Q 002376 553 QALRSLN 559 (929)
Q Consensus 553 ~~L~~L~ 559 (929)
|+|+.||
T Consensus 140 P~Lk~LD 146 (175)
T PF14580_consen 140 PSLKVLD 146 (175)
T ss_dssp TT-SEET
T ss_pred ChhheeC
Confidence 6666655
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.1e-11 Score=125.49 Aligned_cols=167 Identities=23% Similarity=0.218 Sum_probs=96.5
Q ss_pred ccccccceecccccccCCCCCh-hhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCC
Q 002376 140 SKLTELKMLDLMANKITGRVTD-DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPS 218 (929)
Q Consensus 140 ~~l~~L~~L~Ls~N~l~~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 218 (929)
+++.+|++..|.+.... ..+. .....|++++.||||+|-|+..-| +..-...|++|+.|+|+.|++.....+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~------v~~i~eqLp~Le~LNls~Nrl~~~~~s 190 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFP------VLKIAEQLPSLENLNLSSNRLSNFISS 190 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHH------HHHHHHhcccchhcccccccccCCccc
Confidence 34556666666666554 2221 345566666666666665543211 111234566666666666666533222
Q ss_pred cc-ccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCc-cCCCCCC
Q 002376 219 TI-YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTL-PPGLGNL 296 (929)
Q Consensus 219 ~~-~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l 296 (929)
.. ..++.|+.|.|++|.|+..--..+....|+|+.|+|..|...+....+...+..|+.|||++|++-... -...+.+
T Consensus 191 ~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l 270 (505)
T KOG3207|consen 191 NTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTL 270 (505)
T ss_pred cchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccc
Confidence 11 145667777777777763211223334677777777777544444455566778888888888876322 1456777
Q ss_pred CccceeccccccccCCC
Q 002376 297 PFLRTYNIGFNKIVSSG 313 (929)
Q Consensus 297 ~~L~~L~L~~N~i~~~~ 313 (929)
+.|+.|+++.+.|.++.
T Consensus 271 ~~L~~Lnls~tgi~si~ 287 (505)
T KOG3207|consen 271 PGLNQLNLSSTGIASIA 287 (505)
T ss_pred cchhhhhccccCcchhc
Confidence 78888888777776653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-12 Score=129.31 Aligned_cols=265 Identities=25% Similarity=0.324 Sum_probs=122.0
Q ss_pred CCCCCCCCcEEeCCCCCCCCC----cccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCcccc
Q 002376 114 EIGNLFRLRVLNISFNNLQGE----LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIA 189 (929)
Q Consensus 114 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~ 189 (929)
.+..+..++.|+||+|.|... +-..+.+.++|+..++|+ -++|..-. .+|..+.
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~---------------------Ei~e~L~ 82 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKD---------------------EIPEALK 82 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHH---------------------HHHHHHH
Confidence 344556677777777766533 223344555666666553 23333221 1222221
Q ss_pred ccCCCccCCCCcccEEEeecccCCCccCCc----cccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCC
Q 002376 190 NLIPSDLSRLENLKVLDLTINRLAGTVPST----IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKI 265 (929)
Q Consensus 190 ~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~ 265 (929)
. +...+.+.++|++||||.|-+.-..+.. +..++.|++|+|.+|.+.-.--..+...+. .+. .|+.
T Consensus 83 ~-l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~---~l~--~~kk---- 152 (382)
T KOG1909|consen 83 M-LSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALF---ELA--VNKK---- 152 (382)
T ss_pred H-HHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHH---HHH--HHhc----
Confidence 1 2223444556777777777665443333 345778888888888775111111111111 111 1111
Q ss_pred CCcccccccccEEeccCccCcCC----ccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccc
Q 002376 266 PGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFE 341 (929)
Q Consensus 266 p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 341 (929)
...-..|+++...+|++... +...|...+.|+.+.+..|.|..-+.. .....+..+++|+.|||.+|-|+
T Consensus 153 ---~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~---al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 153 ---AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVT---ALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred ---cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhH---HHHHHHHhCCcceeeecccchhh
Confidence 12234566666666666532 112334444455555555544322210 01123344444444444444443
Q ss_pred cccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccc-----cCCCCCCEEEecCCcCCCC
Q 002376 342 GKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-----GQLQGLQVLGLAGNEIPGG 416 (929)
Q Consensus 342 ~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~ 416 (929)
..-.. .+...+..+++|+.|+++++.++..-...| ...++|++|.|.+|.|+..
T Consensus 227 ~egs~---------------------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~d 285 (382)
T KOG1909|consen 227 LEGSV---------------------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRD 285 (382)
T ss_pred hHHHH---------------------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHH
Confidence 21111 122344555667777777776654332222 1245556666666655421
Q ss_pred ----CcccccCCCCCceecccCccc
Q 002376 417 ----IPNSLANLKKLNQIDLSGNEL 437 (929)
Q Consensus 417 ----~p~~~~~l~~L~~L~Ls~N~l 437 (929)
+.......+.|..|+|++|++
T Consensus 286 a~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 286 AALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHHHHhcchhhHHhcCCcccc
Confidence 122233344555555555555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.5e-10 Score=126.09 Aligned_cols=98 Identities=19% Similarity=0.207 Sum_probs=66.6
Q ss_pred HHHHHHHHHccC----CccccceeeecccCCCCCcceEEEEEEecCCCCcccccccc------ccccccHHH-HHHHhhh
Q 002376 689 FIAECETLRNVR----HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE------RKNELDITS-ALDYLHN 757 (929)
Q Consensus 689 ~~~E~~~l~~l~----Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~-aL~yLH~ 757 (929)
|.+|++.+.+++ |.+-|.+-.+|.+.. ...++||||++|+++.++.... ...+..++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHh
Confidence 445666555552 333333333332211 1258999999999999876421 122333444 4667787
Q ss_pred CCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 758 ~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
. +++|+|+||.||++++++.+++.|||+++.+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-09 Score=108.94 Aligned_cols=118 Identities=21% Similarity=0.178 Sum_probs=85.6
Q ss_pred ceeecccCceeEEeccccC-------------cHHHHHHHHHHHHccCCccccc-eeeecccCCCCCcceEEEEEEecCC
Q 002376 666 ENLIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVRHRNLVK-LITSCSSLDSKNMEFLALVYEFLSN 731 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~-------------~~~~~~~E~~~l~~l~Hpniv~-l~~~~~~~~~~~~~~~~lV~e~~~~ 731 (929)
.+.++.|.++.||+++..+ ....+.+|+++++.+.+.++++ ++.+.. + ..++||||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-----~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--E-----TGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--C-----CCeEEEEecCC
Confidence 3567888888888765431 1234678999999987666554 444321 1 13799999999
Q ss_pred CCccccccccccccccHHHHHHHhhhCC--CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 732 GSLGDWIHGERKNELDITSALDYLHNDC--EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 732 gsL~~~l~~~~~~~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.++.+.-...+....+++++++.||+.. ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 76 ~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887642223344678999999999873 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-09 Score=80.38 Aligned_cols=40 Identities=53% Similarity=1.184 Sum_probs=31.3
Q ss_pred hhhHHHHHHHHhhcCCCCCCCCCCCCCCC--CCCCCCcceeeC
Q 002376 27 NTDKEALMSFKSQISQESPSSPLSYWNPS--SSPCTWPGVICN 67 (929)
Q Consensus 27 ~~~~~aLl~~k~~~~~~~~~~~l~~w~~~--~~~c~w~gv~c~ 67 (929)
++|++||++||+++..+ |.+.+++|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~-~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNND-PSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-S-C-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccc-cCcccccCCCcCCCCCeeeccEEeC
Confidence 68999999999999865 67999999987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.7e-11 Score=121.72 Aligned_cols=231 Identities=21% Similarity=0.313 Sum_probs=130.1
Q ss_pred cCCCCCCCCCCCEEEeecCCCCC----CCCcCCCCCCCCcEEeCCCC---CCCCCccccc-------ccccccceecccc
Q 002376 87 ISPHIGNLSFLRSIQLQNNKLSG----NLPREIGNLFRLRVLNISFN---NLQGELPVNI-------SKLTELKMLDLMA 152 (929)
Q Consensus 87 i~~~l~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~ 152 (929)
+-+.+..+..++.|+||+|.+.. .+-..+.+.++|+.-++|+- ++...+|+.+ -..++|++||||+
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 33556678899999999999963 35566788889999999864 3334556543 3456788888888
Q ss_pred cccCCCCCh---hhhccCCCCcEEEccccccCCCCCccccc----c-CCCccCCCCcccEEEeecccCCCcc----CCcc
Q 002376 153 NKITGRVTD---DQLRNLRSLQVLNFGKNLLWGSIPPSIAN----L-IPSDLSRLENLKVLDLTINRLAGTV----PSTI 220 (929)
Q Consensus 153 N~l~~~i~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~----l-~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~ 220 (929)
|.|.-.-+. +.+.++.+|+.|.|.+|-+.-.--..++. + ...-...-++|+++...+|++.... ...|
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~ 181 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAF 181 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHH
Confidence 887522221 23456777888888877552100001100 0 1111223345666666666654321 2234
Q ss_pred ccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCC----ccCCCCCC
Q 002376 221 YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNL 296 (929)
Q Consensus 221 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l 296 (929)
...+.|+.+.++.|.|. |..+ ..+-..|..+++|++|||.+|-|+.. +...+..+
T Consensus 182 ~~~~~leevr~~qN~I~---~eG~------------------~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~ 240 (382)
T KOG1909|consen 182 QSHPTLEEVRLSQNGIR---PEGV------------------TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSW 240 (382)
T ss_pred HhccccceEEEeccccc---Cchh------------------HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhccc
Confidence 44455555555555543 1111 01223466777888888888877632 33456666
Q ss_pred CccceeccccccccCCCCCCCCccccccC-CCCCCCEEEccCCccc
Q 002376 297 PFLRTYNIGFNKIVSSGDDEGLSFITSLT-NSTHLNYLALDGNQFE 341 (929)
Q Consensus 297 ~~L~~L~L~~N~i~~~~~~~~~~~~~~~~-~l~~L~~L~Ls~N~l~ 341 (929)
++|+.++++++.+..-+... +...+. ..+.|++|.|.+|.++
T Consensus 241 ~~L~El~l~dcll~~~Ga~a---~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 241 PHLRELNLGDCLLENEGAIA---FVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred chheeecccccccccccHHH---HHHHHhccCCCCceeccCcchhH
Confidence 67777777777765544321 111121 1345555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-08 Score=124.54 Aligned_cols=148 Identities=30% Similarity=0.341 Sum_probs=105.8
Q ss_pred EEEEEcCCCCCccccCCCCCCCCCCCEEEeecCC--CCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 73 VIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNK--LSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 73 v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
|....+.++.+. .++.+.. .+.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|.++++|-+|++|+|
T Consensus 525 ~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L 602 (889)
T KOG4658|consen 525 VRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDL 602 (889)
T ss_pred eeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccc
Confidence 444444455443 2332222 2379999999996 55344455788999999999998777799999999999999999
Q ss_pred cccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccC--CCccCCccccCCCCce
Q 002376 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL--AGTVPSTIYNMTSLVH 228 (929)
Q Consensus 151 s~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~ 228 (929)
++..++ .+|.. +++|+.|.+||+..+.--.. +|.....+++|++|.|-.... ....-..+.++..|+.
T Consensus 603 ~~t~I~-~LP~~-l~~Lk~L~~Lnl~~~~~l~~--------~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ 672 (889)
T KOG4658|consen 603 SDTGIS-HLPSG-LGNLKKLIYLNLEVTGRLES--------IPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLEN 672 (889)
T ss_pred cCCCcc-ccchH-HHHHHhhheecccccccccc--------ccchhhhcccccEEEeeccccccchhhHHhhhcccchhh
Confidence 999998 78888 99999999999998853222 245566799999999876652 2233334455555555
Q ss_pred EEee
Q 002376 229 LRLA 232 (929)
Q Consensus 229 L~Ls 232 (929)
+...
T Consensus 673 ls~~ 676 (889)
T KOG4658|consen 673 LSIT 676 (889)
T ss_pred heee
Confidence 5553
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.5e-09 Score=84.45 Aligned_cols=59 Identities=36% Similarity=0.527 Sum_probs=31.7
Q ss_pred CccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCc
Q 002376 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540 (929)
Q Consensus 482 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 540 (929)
+|++|++++|+++...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34555555555554444455555555555555555555555555555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-08 Score=81.17 Aligned_cols=60 Identities=32% Similarity=0.434 Sum_probs=37.9
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcC
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 413 (929)
+|++|++++|+|+...+.+|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666655556666666666666666666655555666666666666666653
|
... |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-08 Score=116.00 Aligned_cols=73 Identities=18% Similarity=0.221 Sum_probs=49.6
Q ss_pred EEEEEEecCCCCccccc--cccccccccHHH--HHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWI--HGERKNELDITS--ALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l--~~~~~~~~~ia~--aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DfGla~~~~ 793 (929)
.++||||++|+.+.++- .........+++ +-.|+++....+++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999998742 222111111221 11222222223999999999999999888 99999999998764
Q ss_pred c
Q 002376 794 E 794 (929)
Q Consensus 794 ~ 794 (929)
+
T Consensus 316 ~ 316 (537)
T PRK04750 316 K 316 (537)
T ss_pred H
Confidence 3
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.8e-10 Score=123.49 Aligned_cols=110 Identities=25% Similarity=0.376 Sum_probs=47.3
Q ss_pred hhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCC
Q 002376 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555 (929)
Q Consensus 476 ~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 555 (929)
.+.-++.++.||||+|+++... .+..|..|+.|||++|.+...+--....+. |+.|.|++|.++.. ..+.+|.+|
T Consensus 182 SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL 256 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSL 256 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhhh
Confidence 3333444444455555444321 344445555555555555422222222222 55555555554421 234445555
Q ss_pred CeEeCCCCcCcccCCCC--CCCCCCCcccccCCCCCc
Q 002376 556 RSLNLTFNNLEGVVPSE--GIFRNMSNVHLKGNPKLC 590 (929)
Q Consensus 556 ~~L~Ls~N~l~~~~p~~--~~~~~l~~l~l~~N~~~c 590 (929)
+.|||++|-|++.-.-. ..+..+..+++.|||.-|
T Consensus 257 ~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 257 YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 55555555554432111 123334445555555433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-08 Score=114.63 Aligned_cols=167 Identities=26% Similarity=0.274 Sum_probs=117.9
Q ss_pred CCCceeecc--cCceeEEeccc--cCc------------------HHHHHHHHHHHHccC-CccccceeeecccCCCCCc
Q 002376 663 FSHENLIGS--GSFGSVLHNER--TGS------------------WKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 663 ~~~~~~iG~--G~~g~Vy~~~~--~~~------------------~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~ 719 (929)
|.....+|. |.+|.||++.. ..+ ...=.+|...-.+++ |+|.|+.+..+.+ .
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-----~ 190 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-----S 190 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-----C
Confidence 344567899 99999999887 311 112235666566664 9999997776643 3
Q ss_pred ceEEEEEEecCCCCcccccccccc---------ccccHHH----HHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEec
Q 002376 720 EFLALVYEFLSNGSLGDWIHGERK---------NELDITS----ALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGD 785 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~ia~----aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~D 785 (929)
+..++-+|++. .++.++.+..-. ...+..+ |+.++|+. +++|-|+||.||....+ ..++..|
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 44788889884 688777653221 1334455 99999998 89999999999999988 8999999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCC
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGE 840 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~ 840 (929)
||+...+........... .....|...|++||... +.++.++|++++|.+..+
T Consensus 267 f~~v~~i~~~~~~~~~~~-~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKV-SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILE 319 (524)
T ss_pred cceeEEccCCccccceee-eecCCCCceEeChhhhc-cccchHhhhcchhhhhHh
Confidence 999987754322211111 12225777899999874 578999999999966544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.9e-08 Score=92.00 Aligned_cols=96 Identities=25% Similarity=0.296 Sum_probs=70.7
Q ss_pred HHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc-cccccHHHHHHHhhhCCCCCEEe
Q 002376 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-KNELDITSALDYLHNDCEVPVVH 765 (929)
Q Consensus 687 ~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~ia~aL~yLH~~~~~~iiH 765 (929)
++-.+|++++++++--.|..-.=+..+.+ ...+||||++|..|.+.+...+ .....|-.-+.-||.. +|+|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~~I~me~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~---givH 115 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPD-----NGLIVMEYIEGELLKDALEEARPDLLREVGRLVGKLHKA---GIVH 115 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCEEEEEEeCChhHHHHHHhcchHHHHHHHHHHHHHHhc---Ceec
Confidence 45668999999886443322222222222 1479999999988988887552 3355666778889998 9999
Q ss_pred cCCCCCCeeecCCCceEEeccccccc
Q 002376 766 SDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 766 rDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+|+.++||.+..+. +.+.|||++..
T Consensus 116 GDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 116 GDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998764 99999999874
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.4e-10 Score=123.26 Aligned_cols=127 Identities=29% Similarity=0.303 Sum_probs=95.9
Q ss_pred cccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccc
Q 002376 274 NIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN 353 (929)
Q Consensus 274 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 353 (929)
.|...+.++|.+. .+..++.-++.|+.|||++|+++.. ..+..+++|++|||++|.+. .+|..-....
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v---------~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc- 232 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV---------DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC- 232 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh---------HHHHhcccccccccccchhc-cccccchhhh-
Confidence 5777888888887 6677788888889999999988765 35677889999999999988 5665332223
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccC-ccccCCCCCCEEEecCCcCC
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIP-IEIGQLQGLQVLGLAGNEIP 414 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 414 (929)
.|..|.+++|.++.. ..+.++++|+.|||++|-|++.-- ..++.|..|+.|+|.+|.+-
T Consensus 233 ~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 233 KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 588999999988744 356788999999999998875321 22456677888888888774
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.9e-08 Score=117.20 Aligned_cols=128 Identities=24% Similarity=0.276 Sum_probs=82.0
Q ss_pred CcccEEEeecccCCCccCCccccCCCCceEEeeecC--CCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccE
Q 002376 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ--LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQI 277 (929)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~ 277 (929)
...+...+-+|.+.. ++.... .++|++|-+..|. +. .++..++..+|.|.+|+|++|.--+.+|..++++-+|++
T Consensus 523 ~~~rr~s~~~~~~~~-~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH-IAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchhh-ccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 456666677776652 233222 2367777777775 33 566676777777777777777766777777777777777
Q ss_pred EeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCC
Q 002376 278 IRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGN 338 (929)
Q Consensus 278 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N 338 (929)
|+|++..++ .+|..+++|..|.+||+.++.-.... +.....+++|++|.+..-
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-------~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-------PGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccc-------cchhhhcccccEEEeecc
Confidence 777777777 67777777777777777665532221 122333566666655443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.7e-08 Score=109.64 Aligned_cols=226 Identities=19% Similarity=0.090 Sum_probs=139.4
Q ss_pred HHhhCCCCCceeecccCceeEEecccc-------------C------cHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT-------------G------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-------------~------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
...+.+|.....||.|.|+.|++.... . +...-..|+.+...+ .|.++++....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344568888999999999999874422 0 011122455555555 48888887776654332
Q ss_pred CCcceEEEEEEecCCCCcccccc------c--cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEeccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIH------G--ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFG 787 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~------~--~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfG 787 (929)
.|+--|||++++...... . ......+++.|+.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 341 -----~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 -----GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred -----ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 578899999998765442 1 123356888999999976 89999999999999886 789999999
Q ss_pred cccccccccCCCCCccccceeccccccc--cccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYV--PPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
++..+.-. .....++-+|+ +|+......+..++|++++|....+..+.......... +.. +......
T Consensus 413 ~~t~~~~~---------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-~~~-i~~~~~p 481 (524)
T KOG0601|consen 413 CWTRLAFS---------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-SLT-IRSGDTP 481 (524)
T ss_pred ccccccee---------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-cee-eeccccc
Confidence 98643211 11122334455 56666667789999999999665553332221111110 000 0000000
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.. . +.....+.+......+++..||.+.+.....+-
T Consensus 482 ~~---~--------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 NL---P--------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CC---C--------chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00 0 000112225567888999999998877655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.1e-07 Score=87.73 Aligned_cols=118 Identities=24% Similarity=0.296 Sum_probs=83.3
Q ss_pred CceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 665 HENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 665 ~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
....|-+|+=+.|+++.+.+ ..++..+|++.+.+++--.|.--.=++.+... -
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-----~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-----G 85 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-----C
Confidence 35678889988888877652 13467789999998864333222222322222 3
Q ss_pred EEEEEecCC-CCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC---ceEEecccc
Q 002376 723 ALVYEFLSN-GSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM---TAKVGDFGL 788 (929)
Q Consensus 723 ~lV~e~~~~-gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki~DfGl 788 (929)
.++|||+++ .++.+++.... ..+..|-+.+.-||.. .|||+|+.++||++..++ .+.+.|||+
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence 799999976 36777765221 2245677889999998 899999999999997665 458999999
Q ss_pred cc
Q 002376 789 AR 790 (929)
Q Consensus 789 a~ 790 (929)
+.
T Consensus 163 s~ 164 (229)
T KOG3087|consen 163 SS 164 (229)
T ss_pred hh
Confidence 85
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.1e-08 Score=114.06 Aligned_cols=231 Identities=23% Similarity=0.198 Sum_probs=141.1
Q ss_pred hhCCCCCceeecccCceeEEeccccCcH-------------------HHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGSW-------------------KSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-------------------~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
..+++...+-+-+|+++.++-++-.+.. +...++-.+.-..+||.+++...-+....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs---- 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS---- 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC----
Confidence 4456666777888999998866544221 11112222222234566665544422222
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
-.++|++|..+|+|...++... .....+..+.+|||.. .++|||+||.|.++..++..+++|||....
T Consensus 878 -P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 -PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred -CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 2699999999999999887433 2345677899999997 699999999999999999999999984432
Q ss_pred ccc---ccCC----------------------CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHH
Q 002376 792 LLE---RVDN----------------------QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 792 ~~~---~~~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
..- .... ...........||+.|.|||...+......+|.|+.|+.+++..+..-
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 0000 000112345679999999999999999999999999988877554433
Q ss_pred hhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHH
Q 002376 847 VESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIR 904 (929)
Q Consensus 847 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ 904 (929)
.+... ...++++..+... ...+.....+..-+++++.+-+..+|.+|-.|.
T Consensus 1034 p~na~--tpq~~f~ni~~~~-----~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAE--TPQQIFENILNRD-----IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCc--chhhhhhccccCC-----CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 22211 1122222111111 111111112222333455577778888887655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.3e-06 Score=97.14 Aligned_cols=115 Identities=23% Similarity=0.326 Sum_probs=89.1
Q ss_pred ecccCceeEEeccccCc--HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEecCCCCcccccccccc---
Q 002376 669 IGSGSFGSVLHNERTGS--WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--- 743 (929)
Q Consensus 669 iG~G~~g~Vy~~~~~~~--~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--- 743 (929)
-..|++-.||..+.... .....+.++.++.++||||++++..+.. .+..|+|+|-+. -|..++++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk~l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLKELGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHHHhHHHHH
Confidence 34466667766555544 4556788889999999999999998744 335899999874 45555543322
Q ss_pred --ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 744 --NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 744 --~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
...||+.||.|||+.+ +++|++|.-..|.+++.|.-||++|-.+...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 2578999999999875 8999999999999999999999999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.9e-06 Score=89.49 Aligned_cols=123 Identities=21% Similarity=0.252 Sum_probs=86.0
Q ss_pred eeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCc--cccceeeecccCCCCCcceEEEEEEe
Q 002376 667 NLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHR--NLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hp--niv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
+.||.|..+.||+++... ...++.+|+++++.+++. .+.+++.+..... ..+..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 567888888888754321 235688999999999763 4566777764322 11235899999
Q ss_pred cCCCCcccccc-------ccccccccHHHHHHHhhhC-------------------------------------------
Q 002376 729 LSNGSLGDWIH-------GERKNELDITSALDYLHND------------------------------------------- 758 (929)
Q Consensus 729 ~~~gsL~~~l~-------~~~~~~~~ia~aL~yLH~~------------------------------------------- 758 (929)
++++++.+.+. ....++.++++++.+||+.
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99998877652 1112345666667666642
Q ss_pred ----------CCCCEEecCCCCCCeeecC--CCceEEeccccccc
Q 002376 759 ----------CEVPVVHSDLKPGNILLDE--EMTAKVGDFGLARF 791 (929)
Q Consensus 759 ----------~~~~iiHrDlk~~NILl~~--~~~~ki~DfGla~~ 791 (929)
....++|+|++|.||++++ ++.+.|.||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-06 Score=87.22 Aligned_cols=90 Identities=17% Similarity=0.178 Sum_probs=64.4
Q ss_pred HHHHHHHHccCC--ccccceeeecccCCCCCcceEEEEEEecCCCCccc-cccc-------cccccccHHHHHHHh-hhC
Q 002376 690 IAECETLRNVRH--RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGD-WIHG-------ERKNELDITSALDYL-HND 758 (929)
Q Consensus 690 ~~E~~~l~~l~H--pniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~-------~~~~~~~ia~aL~yL-H~~ 758 (929)
.+|.+.|+++.. -++.+.+++. + -++||||+.++.+.. .+++ ......+++.+|.++ |..
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 389999999853 3555666542 1 489999997643321 1211 112346788999988 666
Q ss_pred CCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 759 ~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++||+|+++.||++++ +.+.++|||.|-..
T Consensus 145 ---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 145 ---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred ---CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999999999974 68999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1e-07 Score=96.72 Aligned_cols=45 Identities=27% Similarity=0.328 Sum_probs=24.9
Q ss_pred CCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCcccc
Q 002376 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEG 342 (929)
Q Consensus 292 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 342 (929)
.+..++++..|+|+.|+|.+. ..+.++..+++|..|.+++|.+..
T Consensus 219 ~se~~p~~~~LnL~~~~idsw------asvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 219 GSEPFPSLSCLNLGANNIDSW------ASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cCCCCCcchhhhhcccccccH------HHHHHHcCCchhheeeccCCcccc
Confidence 344455555666666665432 223455566666666666666653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.4e-07 Score=82.73 Aligned_cols=104 Identities=27% Similarity=0.338 Sum_probs=47.2
Q ss_pred cccEEEecCCccccccCCC---CCCCCcccEEEeeCCCCCcccCccccC-CCCCCEEEecCCcCCCCCcccccCCCCCce
Q 002376 354 ELSKLYLGGNHIYGKIPAS---IGRLRSLTLLDLSYNSISGEIPIEIGQ-LQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 429 (929)
.+..++|++++|. -+++. +.....|+..+|++|.+. .+|..|.. .+.+++|+|++|+|+ .+|..++.++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3555666666553 12222 223334444555555555 23333322 234455555555554 23444555555555
Q ss_pred ecccCcccccccCcccccccccceecccCCcC
Q 002376 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRI 461 (929)
Q Consensus 430 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 461 (929)
|+++.|.+. ..|..+..+.+|-.|+..+|.+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 555555554 2333333344444444444443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.2e-06 Score=81.78 Aligned_cols=93 Identities=22% Similarity=0.231 Sum_probs=60.0
Q ss_pred HHHHHHHHHHHHccCCc--cccceeeecccCCCCCcceEEEEEEecC--CCCcccccccc------ccccccHHHHHHHh
Q 002376 686 WKSFIAECETLRNVRHR--NLVKLITSCSSLDSKNMEFLALVYEFLS--NGSLGDWIHGE------RKNELDITSALDYL 755 (929)
Q Consensus 686 ~~~~~~E~~~l~~l~Hp--niv~l~~~~~~~~~~~~~~~~lV~e~~~--~gsL~~~l~~~------~~~~~~ia~aL~yL 755 (929)
.....+|.+.|.++..- ++.+.+++. + -++||||++ +..+..+.... .....++...+..+
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-----~----~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN-----R----NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE-----T----TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe-----C----CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHH
Confidence 35677899999999765 455666553 1 389999998 44443332211 12244566655554
Q ss_pred -hhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 756 -HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 756 -H~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
|.. +|+|+|+.+.||+++++ .+.|.|||.|..
T Consensus 123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HHhc---CceecCCChhhEEeecc-eEEEEecCccee
Confidence 565 99999999999999988 999999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.5e-06 Score=88.43 Aligned_cols=101 Identities=15% Similarity=0.113 Sum_probs=72.3
Q ss_pred HHHHHHHHHHccCCcc--ccceeeecccCCCCCcceEEEEEEecCCC-Cccccccc----------cccccccHHHHHHH
Q 002376 688 SFIAECETLRNVRHRN--LVKLITSCSSLDSKNMEFLALVYEFLSNG-SLGDWIHG----------ERKNELDITSALDY 754 (929)
Q Consensus 688 ~~~~E~~~l~~l~Hpn--iv~l~~~~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~----------~~~~~~~ia~aL~y 754 (929)
.+.+|...+.++..-. +.+.+++...........-++|||++++. +|.+++.. .+.+..+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4778999888885333 33444454322111123468999999876 78887642 11234578999999
Q ss_pred hhhCCCCCEEecCCCCCCeeecC-------CCceEEeccccccc
Q 002376 755 LHNDCEVPVVHSDLKPGNILLDE-------EMTAKVGDFGLARF 791 (929)
Q Consensus 755 LH~~~~~~iiHrDlk~~NILl~~-------~~~~ki~DfGla~~ 791 (929)
||.. +|+|+|++++|||++. ++.+.++||+.++.
T Consensus 154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9998 9999999999999975 46899999998863
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.06 E-value=9.7e-07 Score=89.85 Aligned_cols=119 Identities=29% Similarity=0.353 Sum_probs=67.8
Q ss_pred CCCCcCCCCCCCCcEEeCCCCCCCCCcc-ccc-ccccccceecccccccCCCCCh--hhhccCCCCcEEEccccccCCCC
Q 002376 109 GNLPREIGNLFRLRVLNISFNNLQGELP-VNI-SKLTELKMLDLMANKITGRVTD--DQLRNLRSLQVLNFGKNLLWGSI 184 (929)
Q Consensus 109 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~-~~l~~L~~L~Ls~N~l~~~i~~--~~~~~l~~L~~L~Ls~N~l~~~~ 184 (929)
|..+-.+..+.-++.|-+.+..|..+-- ..| ...+.+++|||.+|+|+ ...+ ..+.+|+.|++|+|+.|.+...|
T Consensus 35 g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iS-dWseI~~ile~lP~l~~LNls~N~L~s~I 113 (418)
T KOG2982|consen 35 GLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLIS-DWSEIGAILEQLPALTTLNLSCNSLSSDI 113 (418)
T ss_pred ccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhc-cHHHHHHHHhcCccceEeeccCCcCCCcc
Confidence 3333344444455566666666653211 123 34577888888888887 2211 12467788888888888775443
Q ss_pred CccccccCCCccCCCCcccEEEeecccCCCc-cCCccccCCCCceEEeeecCC
Q 002376 185 PPSIANLIPSDLSRLENLKVLDLTINRLAGT-VPSTIYNMTSLVHLRLASNQL 236 (929)
Q Consensus 185 p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l 236 (929)
- .+ | ..+.+|++|-|.+..+.-. ....+..++.+++|.+|.|.+
T Consensus 114 ~----~l-p---~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 114 K----SL-P---LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred c----cC-c---ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 2 11 1 2356777777777666533 223445566666666666643
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.3e-07 Score=82.76 Aligned_cols=87 Identities=24% Similarity=0.365 Sum_probs=42.4
Q ss_pred CccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCC
Q 002376 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561 (929)
Q Consensus 482 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (929)
.++.|+|++|.++ .+|..+..++.|+.|+++.|.|. ..|..+..|.+|-.||.-+|.+. .+|..+-.-+.....++.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lg 154 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLG 154 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhc
Confidence 4444555555554 34555555555555555555555 34444444555555555555554 333332222222333445
Q ss_pred CCcCcccCCC
Q 002376 562 FNNLEGVVPS 571 (929)
Q Consensus 562 ~N~l~~~~p~ 571 (929)
++.+.+.-+.
T Consensus 155 nepl~~~~~~ 164 (177)
T KOG4579|consen 155 NEPLGDETKK 164 (177)
T ss_pred CCcccccCcc
Confidence 5555554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.4e-06 Score=97.86 Aligned_cols=160 Identities=20% Similarity=0.130 Sum_probs=113.1
Q ss_pred HHhhCCCCCceeecccCceeEEeccccCc----------HHHHHHHHHHHHccCCcc-ccceeeecccCCCCCcceEEEE
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTGS----------WKSFIAECETLRNVRHRN-LVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~----------~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~~~~~~~~~lV 725 (929)
+..+.-+..-+-.++|+++++||.+.... .....-++++|.+++||| .|+.++-+ ..+.+.+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccC-----Ccccccchh
Confidence 33444444456678999999999887622 234456889999999999 55444443 345568999
Q ss_pred EEecCCC-Ccccccc---------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNG-SLGDWIH---------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~g-sL~~~l~---------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++|+..| +-..-.. +.......-+++++|+|+. .=+||| ||+..+ +..|..||+....+.+.
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999887 2222111 0111123346789999986 458999 777665 68899999998877533
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcC
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSES 836 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~ 836 (929)
. ......+|+.|+|||+.....+..+.|+|+.+.
T Consensus 385 ~-------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 385 M-------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV 418 (829)
T ss_pred c-------ccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence 2 234467999999999999999999999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.2e-06 Score=95.40 Aligned_cols=149 Identities=16% Similarity=0.180 Sum_probs=93.7
Q ss_pred ccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC---CCCccccceeccccccccccccCC
Q 002376 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN---QSSISSTHVFMGSIGYVPPEYGLG 822 (929)
Q Consensus 746 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~ 822 (929)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+....+...- ........-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4566899999986 48999999999999999999999999987654321110 000001111123457999999999
Q ss_pred CCCCCCCCCCCCcCCCCCcc-hhHHhhhcCCc----hhhhc-cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCC
Q 002376 823 ERPSTAGDVPTSESFAGEFN-IVKWVESNLPE----NVLQV-LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTES 896 (929)
Q Consensus 823 ~~~~~~~DV~s~g~~~~~~~-~~~~~~~~~~~----~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~d 896 (929)
...+.++|++|+|+..|-+. -+.|....... ..... .+..... +. . ..++.+.+-++ +.+..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~-~s--~----~~p~el~~~l~----k~l~~~ 252 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFG-YS--N----NLPSELRESLK----KLLNGD 252 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccc-cc--c----cCcHHHHHHHH----HHhcCC
Confidence 88999999999998766543 44554443322 11111 1111111 11 1 11122333333 777899
Q ss_pred CCCCCCHHHHH
Q 002376 897 PGGRIGIREAL 907 (929)
Q Consensus 897 P~~RPs~~ev~ 907 (929)
+..||++.++.
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999877754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.7e-05 Score=81.33 Aligned_cols=101 Identities=22% Similarity=0.258 Sum_probs=75.6
Q ss_pred HHHHHHHHHHHccCCc--cccceeeecccCCCCCcceEEEEEEecCCC-Cccccccc--------cccccccHHHHHHHh
Q 002376 687 KSFIAECETLRNVRHR--NLVKLITSCSSLDSKNMEFLALVYEFLSNG-SLGDWIHG--------ERKNELDITSALDYL 755 (929)
Q Consensus 687 ~~~~~E~~~l~~l~Hp--niv~l~~~~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~--------~~~~~~~ia~aL~yL 755 (929)
..+.+|...+.++... .+.+.+++........ ...++|+|++++. +|.+++.. .+....+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4577888887777533 3445555554433222 4468999999874 78888764 123456789999999
Q ss_pred hhCCCCCEEecCCCCCCeeecCCC---ceEEeccccccc
Q 002376 756 HNDCEVPVVHSDLKPGNILLDEEM---TAKVGDFGLARF 791 (929)
Q Consensus 756 H~~~~~~iiHrDlk~~NILl~~~~---~~ki~DfGla~~ 791 (929)
|.. +|+|+|+++.|||++.+. .+.+.||+-++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 998 999999999999999886 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.88 E-value=7e-06 Score=60.42 Aligned_cols=36 Identities=36% Similarity=0.595 Sum_probs=14.9
Q ss_pred CCcEEeCCCCCCCCCcccccccccccceecccccccC
Q 002376 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKIT 156 (929)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 156 (929)
+|++|+|++|+|+ .+|..|++|++|++|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3444444444444 23333444444444444444443
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 929 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-51 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-51 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 5e-05 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-05 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 7e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 4e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 929 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-135 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-129 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-83 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-90 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-80 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-88 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-81 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-42 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-87 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-60 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-83 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-73 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-65 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-40 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-78 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-09 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-73 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-68 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-32 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-32 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-12 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-40 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-52 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-50 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-48 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-44 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-49 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-29 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-39 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-36 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-34 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-42 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-39 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-39 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-39 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-35 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-25 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-07 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-38 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-33 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-33 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-24 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-17 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 7e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-08 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-32 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-24 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-19 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-11 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-28 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-28 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-27 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-27 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-27 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-14 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-06 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-10 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-23 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-23 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-21 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-20 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-20 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-20 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-20 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-20 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-08 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-09 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-19 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-11 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-19 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-19 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-19 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-05 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-18 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-13 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-08 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-18 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-18 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-18 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-18 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-18 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-18 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-18 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-09 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-17 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-17 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-17 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-17 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-17 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-17 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-17 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-17 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-17 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-17 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-17 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-17 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-17 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-17 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-17 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-16 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-16 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-07 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-16 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-16 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-16 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-16 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-16 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-16 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-16 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-15 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-15 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-15 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-15 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-15 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-15 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-15 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-15 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-15 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-15 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-15 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-15 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-15 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-15 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-15 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-15 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-15 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-14 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-14 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-14 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-14 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-14 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-14 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-14 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-14 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-14 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-14 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-05 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-14 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-14 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-14 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-11 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-14 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-14 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-14 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-14 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-14 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-14 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-13 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-13 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-13 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-13 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-13 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-13 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-13 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-13 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-13 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-12 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-12 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-06 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-12 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 9e-12 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-12 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-12 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-12 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-11 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-11 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-11 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-11 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-11 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-11 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-11 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-11 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 9e-11 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-07 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-10 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-10 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-10 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-10 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-10 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-10 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 6e-10 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-05 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 8e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-10 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 9e-10 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-09 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-05 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-09 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-09 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-09 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 8e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-04 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-06 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 1e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 7e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-05 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 5e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 422 bits (1086), Expect = e-135
Identities = 158/576 (27%), Positives = 261/576 (45%), Gaps = 66/576 (11%)
Query: 21 SASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSS 80
S S + + L+SFK + + L W+ + +PCT+ GV C + ++V ++LSS
Sbjct: 5 SPSQSLYREIHQLISFKDVLP---DKNLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSS 59
Query: 81 FGLE---GTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELP- 136
L +S + +L+ L S+ L N+ ++G++ L L++S N+L G +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT 118
Query: 137 -VNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
++ + LK L++ +N + L SL+VL+ N + G+
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS---- 174
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255
LK L ++ N+++G V + +L L ++SN IP+ L
Sbjct: 175 -DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD--CSALQHLD 229
Query: 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDD 315
N+ +G ++ T ++++ ++ N G +PP
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP------------------------ 265
Query: 316 EGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR 375
L YL+L N+F G+IP+ + + L+ L L GNH YG +P G
Sbjct: 266 ---------LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 376 LRSLTLLDLSYNSISGEIPIE-IGQLQGLQVLGLAGNEIPGGIPNSLANLK-KLNQIDLS 433
L L LS N+ SGE+P++ + +++GL+VL L+ NE G +P SL NL L +DLS
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 434 GNELTGEIPISFGNFQ--SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491
N +G I + +L + L NN G I P +S +V++ LS N
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI--------PPTLSNCSELVSLHLSFN 428
Query: 492 SLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQN 551
LSG +P+SL + L +L + N G IP + +K LE L L N L+G IPS L N
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 552 LQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGN 586
L ++L+ N L G +P G N++ + L N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-129
Identities = 157/520 (30%), Positives = 246/520 (47%), Gaps = 35/520 (6%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
LN+SS G I P L L+ + L NK +G +P + G L L++S N+ G
Sbjct: 252 LNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPS 194
+P + L+ L L +N +G + D L +R L+VL+ N G +P S+ NL
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL--- 366
Query: 195 DLSRLENLKVLDLTINRLAGTVPSTIYN--MTSLVHLRLASNQLGGEIPYDVRDTLPNLL 252
+L LDL+ N +G + + +L L L +N G+IP + + L+
Sbjct: 367 ----SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN-CSELV 421
Query: 253 DFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312
FN +G IP SL +L+ ++ +++ N+LEG +P L + L T + FN + +
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL--T 479
Query: 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPAS 372
G + L+N T+LN+++L N+ G+IP+ IG N L+ L L N G IPA
Sbjct: 480 G-----EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN-LAILKLSNNSFSGNIPAE 533
Query: 373 IGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDL 432
+G RSL LDL+ N +G IP + + G +A N I G + N +
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHG 589
Query: 433 SGN--ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490
+GN E G + ++++ G+ +++ +D+S
Sbjct: 590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS--------PTFDNNGSMMFLDMSY 641
Query: 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQ 550
N LSG +P + + L L + +N SG IP+ V +L+GL +LDLSSNKL G IP +
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 551 NLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
L L ++L+ NNL G +P G F NP LC
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 7e-83
Identities = 113/407 (27%), Positives = 172/407 (42%), Gaps = 68/407 (16%)
Query: 62 PGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL 121
+C N N + L L + G G I P + N S L S+ L N LSG +P +G+L +L
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181
R L + N L+GE+P + + L+ L L N +TG + L N +L ++ N L
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG-LSNCTNLNWISLSNNRLT 503
Query: 182 GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
G IP I LENL +L L+ N +G +P+ + + SL+ L L +
Sbjct: 504 GEIPKWIGR--------LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT-------- 547
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
N F G IP ++ + + N + G + N +
Sbjct: 548 -----------------NLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKE 586
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
+ N +F+G E + S + +
Sbjct: 587 CHGAGNL-----------------------------LEFQGIRSEQLNRLST-RNPCNIT 616
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
G + S+ LD+SYN +SG IP EIG + L +L L N+I G IP+ +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKG 468
+L+ LN +DLS N+L G IP + L IDLSNN ++G IP+
Sbjct: 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 8e-90
Identities = 102/600 (17%), Positives = 186/600 (31%), Gaps = 105/600 (17%)
Query: 46 SSPLSYWNPSSSPCTW---PGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLS------- 95
+ P + WN + W PGV N+ G RV GL+L FG G + IG L+
Sbjct: 54 TQPGANWNFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 96 ---------------------FLRSIQLQNNKLSGNLPREIG--NLFRLRVLNISFNNLQ 132
Q + L I+ + Q
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 133 GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL- 191
+ + + + ++N IT + L L+ G +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITF--VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230
Query: 192 ----------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
L++L +++ +P+ + + + + +A N+
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN-LLEGTLPPGLGNLPFLR 300
+ + IQII + +N L + L + L
Sbjct: 291 -----------------LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360
+N++ + + + L L L NQ IP + F+ ++ L
Sbjct: 334 MLECLYNQLEG--------KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSF 384
Query: 361 GGNHIYGKIPA--SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP 418
N + IP + ++ +D SYN I +
Sbjct: 385 AHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD-----------------PLD 426
Query: 419 NSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEIS 478
+ ++ I+LS N+++ F L SI+L N + IPK L+ E
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFK 485
Query: 479 RLENVVTIDLSDNSLSGNLPN-SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL--- 534
+ +IDL N L+ + L + ++YN FS P L+
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 535 ---DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL 591
D N+ P + +L L + N++ V +E I N+S + +K NP + +
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV--NEKITPNISVLDIKDNPNISI 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-80
Identities = 90/544 (16%), Positives = 179/544 (32%), Gaps = 69/544 (12%)
Query: 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134
LN ++ +G + N +F + + + + + + R+ L++ G
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGV----SLNSNGRVTGLSLEGFGASGR 96
Query: 135 LPVNISKLTELKMLDLMANKITGRVTD---DQLRNLRSLQVLNFGKNLLWGSIPPSIANL 191
+P I +LTEL++L L ++ + S + + +
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 192 ------------------IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLAS 233
I + N + V + +T L + +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGN 215
Query: 234 NQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL 293
+ E + Y + NL ++ + + + LP L
Sbjct: 216 SPFVAENI----CEAWENENSEY--AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 294 GNLPFLRTYNIGFNKIVSSGD-DEGLSFITSLTNSTHLNYLALDGNQF-EGKIPESIGNF 351
LP ++ N+ N+ +S + + + + + N + S+
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411
L L N + GK+P + G L L+L+YN I+ G + ++ L A N
Sbjct: 330 KK-LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 412 EIPGGIPNSLA--NLKKLNQIDLSGNELTG-------EIPISFGNFQSLLSIDLSNNRIN 462
++ IPN ++ ++ ID S NE+ + + ++ SI+LSNN+I+
Sbjct: 388 KL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-------NLPNSLKNCKSLEELLMAYN 515
E S + +I+L N L+ + + KN L + + +N
Sbjct: 447 KFP--------KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 516 QFSGPIPNI-VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSL------NLTFNNLEGV 568
+ + + L L +DLS N S P+ N L+ + N
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 569 VPSE 572
P
Sbjct: 558 WPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-66
Identities = 74/527 (14%), Positives = 150/527 (28%), Gaps = 126/527 (23%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSG-------------------NLPREIG 116
+ S + +S + L+ LR + N+ +
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD 246
Query: 117 NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176
NL L + + +LP + L E++++++ N+
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI-------------------- 286
Query: 177 KNLLWGSIPPSIANL-IPSDLSRLENLKVLDLTINRLA-GTVPSTIYNMTSLVHLRLASN 234
S + +D E ++++ + N L V +++ M L L N
Sbjct: 287 ------SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340
Query: 235 QLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL- 293
QL G++P + + + + + +N + +P
Sbjct: 341 QLEGKLP--------------------------AFGSEIKLASLNLAYNQITE-IPANFC 373
Query: 294 GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN 353
G + + NK+ + + I + + ++ + N+ ++
Sbjct: 374 GFTEQVENLSFAHNKL------KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP--- 424
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN-- 411
+ + + +++ ++LS N IS L + L GN
Sbjct: 425 ---------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 412 -----EIPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNI 465
+ N L IDL N+LT L+ IDLS N +
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-- 527
Query: 466 PKGILRPLPEEISRLENVVTI------DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSG 519
P + + D N P + C SL +L + N
Sbjct: 528 -------FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
Query: 520 PIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
I + VLD+ N S + L ++ +
Sbjct: 581 VNEKI---TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 6e-88
Identities = 102/552 (18%), Positives = 186/552 (33%), Gaps = 27/552 (4%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLF--RLRVLNISFNNLQG 133
L+LS GL T L L+ + L NNK+ E+ L+ L +S N ++
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 134 ELPVNISKLTELKMLDLMANKITGRVTDD--QLRNLRSLQVLNFGKNLLWGSIPPSIANL 191
P + L L L ++ +T+ S++ L+ + L + + L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVR------ 245
+ NL +LDL+ N L + + L + L N + + +
Sbjct: 246 ------KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 246 --DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYN 303
+ + S L ++ + M N + G L L+ +
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 304 IGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGN 363
+ + S +F SL +S L+ L L N+ ++ + L L LG N
Sbjct: 360 LSNSFT-SLRTLTNETF-VSLAHSP-LHILNLTKNKISKIESDAFSWLGH-LEVLDLGLN 415
Query: 364 HIYGKIPAS-IGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI--PGGIPNS 420
I ++ L ++ + LSYN + LQ L L + P+
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
L+ L +DLS N + + L +DL +N + + L
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
++ ++L N K+ L+ + + N + ++ L+ L+L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 541 LSGSIPSDLQ-NLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQLGCENPR 599
++ + L L++ FN + S F N N P+L C P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 600 S-HGSRLIILSI 610
HG + +
Sbjct: 656 HYHGFPVRLFDT 667
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 4e-81
Identities = 93/500 (18%), Positives = 175/500 (35%), Gaps = 55/500 (11%)
Query: 94 LSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMAN 153
+ + + L +N+L +L L++ FN + P KL LK+L+L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 154 KITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213
+++ ++D +L L+ N + +NL LDL+ N L+
Sbjct: 84 ELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK--------QKNLITLDLSHNGLS 134
Query: 214 GTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY-CFNRFTGKIPGSLHNL 272
T T + +L L L++N++ ++ + L + N+ PG H +
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
+ + + + L +L L +T +
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLC----------------------------LELANTSIRN 226
Query: 333 LALDGNQFEGKIPESIGNFSN-ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISG 391
L+L +Q + L+ L L N++ S L L L YN+I
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 392 EIPIEIGQLQGLQVLGLAGN---------EIPGGIPNSLANLKKLNQIDLSGNELTGEIP 442
+ L ++ L L + +P S LK L +++ N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 443 ISFGNFQSLLSIDLSNNRIN-GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSL 501
F +L + LSN+ + + L S L ++L+ N +S ++
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH--SPLH---ILNLTKNKISKIESDAF 401
Query: 502 KNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNL 560
LE L + N+ + L+ + + LS NK + + +L+ L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 561 TFNNLEGVVPSEGIFRNMSN 580
L+ V S F+ + N
Sbjct: 462 RRVALKNVDSSPSPFQPLRN 481
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-69
Identities = 89/471 (18%), Positives = 159/471 (33%), Gaps = 54/471 (11%)
Query: 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
V + S L ++P ++ T + +L+L N++ + L L+ G N
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGE 239
+ P L LKVL+L N L+ T T+L L L SN +
Sbjct: 61 ISKLEPELCQK--------LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI--- 109
Query: 240 IPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFL 299
N+ + ++HN L T L L
Sbjct: 110 ----------------------QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 300 RTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLY 359
+ + NKI + +E + ++ L L L NQ + P L L+
Sbjct: 148 QELLLSNNKIQALKSEE-----LDIFANSSLKKLELSSNQIKEFSPGCFHAIGR-LFGLF 201
Query: 360 LGGNHIYGKIPASIG---RLRSLTLLDLSYNSISGEIPIEIGQLQG--LQVLGLAGNEIP 414
L + + + S+ L LS + +S L+ L +L L+ N +
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 415 GGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL- 473
+S A L +L L N + S ++ ++L + +I L +
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVA----ELK 529
L+ + +++ DN + G N +L+ L ++ + S
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
Query: 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L +L+L+ NK+S L L L+L N + + +R + N
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG-QEWRGLEN 431
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-56
Identities = 84/462 (18%), Positives = 143/462 (30%), Gaps = 61/462 (13%)
Query: 62 PGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL 121
+ L+LS L + L L L+ N + + LF +
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 122 RVLN---------ISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQV 172
R LN IS +L + L L+ L++ N I G + + L +L+
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKY 357
Query: 173 LNFGKNLLWGSIPPSIANLIPSDLSRLEN--LKVLDLTINRLAGTVPSTIYNMTSLVHLR 230
L+ + S+ L L + L +L+LT N+++ + L L
Sbjct: 358 LSLSNSFT------SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 231 LASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLP 290
L N++G E+ L NI I +++N
Sbjct: 412 LGLNEIGQELT------------------------GQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 291 PGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGN 350
+P L+ + + D S L N L L L N + +
Sbjct: 448 NSFALVPSLQRLMLRRVAL--KNVDSSPSPFQPLRN---LTILDLSNNNIANINDDMLEG 502
Query: 351 FSNELSKLYLGGNHI--------YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402
L L L N++ G + L L +L+L N L
Sbjct: 503 LEK-LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG-NFQSLLSIDLSNNRI 461
L+++ L N + + N L ++L N +T FG F++L +D+ N
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
Query: 462 NGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503
+ + I+ E I + N P
Sbjct: 622 DCTCES--IAWFVNWIN--ETHTNIPELSSHYLCNTPPHYHG 659
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-42
Identities = 58/263 (22%), Positives = 109/263 (41%), Gaps = 19/263 (7%)
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
+ + ++P+ + +N ++ L L N + A+ R LT LD+ +
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTN-ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
N+IS P +L L+VL L NE+ + A L ++ L N + F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCK- 505
++L+++DLS+N ++ +LEN+ + LS+N + L
Sbjct: 119 KQKNLITLDLSHNGLSSTK--------LGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 506 -SLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQ---NLQALRSLNLT 561
SL++L ++ NQ P + L L L++ +L S+ L ++R+L+L+
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 562 FNNLEGVVPSEGIFRNMSNVHLK 584
+ L S F + +L
Sbjct: 231 NSQLSTT--SNTTFLGLKWTNLT 251
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 5e-87
Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 15/272 (5%)
Query: 323 SLTNSTHLNYLALDGNQFEG--KIPESIGNFSNELSKLYLGG-NHIYGKIPASIGRLRSL 379
+ T + +N L L G IP S+ N L+ LY+GG N++ G IP +I +L L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 380 TLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG 439
L +++ ++SG IP + Q++ L L + N + G +P S+++L L I GN ++G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 440 EIPISFGNFQSLL-SIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP 498
IP S+G+F L S+ +S NR+ G I P + L N+ +DLS N L G+
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKI--------PPTFANL-NLAFVDLSRNMLEGDAS 214
Query: 499 NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSL 558
+ K+ +++ +A N + + + K L LDL +N++ G++P L L+ L SL
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 559 NLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
N++FNNL G +P G + N LC
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-60
Identities = 86/314 (27%), Positives = 129/314 (41%), Gaps = 48/314 (15%)
Query: 27 NTDKEALMSFKSQISQESPSSPLSYWNPSSSPC--TWPGVICNNFGN--RVIGLNLSSFG 82
DK+AL+ K + +P++ LS W P++ C TW GV+C+ RV L+LS
Sbjct: 5 PQDKQALLQIKKDLG--NPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 83 LEGT---------------------------ISPHIGNLSFLRSIQLQNNKLSGNLPREI 115
L I P I L+ L + + + +SG +P +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 116 GNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL-QVLN 174
+ L L+ S+N L G LP +IS L L + N+I+G + D + L +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP-DSYGSFSKLFTSMT 180
Query: 175 FGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASN 234
+N L G IPP+ ANL NL +DL+ N L G + + + LA N
Sbjct: 181 ISRNRLTGKIPPTFANL---------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 235 QLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLG 294
L ++ V NL NR G +P L L + + ++ N L G +P G G
Sbjct: 232 SLAFDLG-KVGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G 288
Query: 295 NLPFLRTYNIGFNK 308
NL NK
Sbjct: 289 NLQRFDVSAYANNK 302
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 8e-83
Identities = 107/530 (20%), Positives = 176/530 (33%), Gaps = 37/530 (6%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+LS ++ +LS L ++ L N + L L+ L NL
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
I L LK L++ N I + NL +L+ L+ N + + L
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL---- 251
L L LDL++N + P + L L L +N + L L
Sbjct: 177 LLNLS----LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 252 --LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE---GTLPPGLGNLPFLRTYNIGF 306
L +L L N+ I L+ + L + ++++
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 307 NKIVSSGDDEGLS----------FITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS 356
I D + L +G S + + L
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS-LE 350
Query: 357 KLYLGGNHIY--GKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIP 414
L L N + G S SL LDLS+N + + L+ L+ L + +
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 415 GGIPNS-LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL 473
S +L+ L +D+S F SL + ++ N N
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL------- 462
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
P+ + L N+ +DLS L P + + SL+ L M++N F L L+V
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522
Query: 534 LDLSSNKLSGSIPSDLQNL-QALRSLNLTFNNLEGVVPSEGIFRNMSNVH 582
LD S N + S +LQ+ +L LNLT N+ + + + +
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-73
Identities = 102/513 (19%), Positives = 181/513 (35%), Gaps = 52/513 (10%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKIT 156
+++ L N L + L+VL++S +Q L+ L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 157 GRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT- 215
+ L SLQ L + L I + L+ LK L++ N +
Sbjct: 90 S-LALGAFSGLSSLQKLVAVETNLASLENFPIGH--------LKTLKELNVAHNLIQSFK 140
Query: 216 VPSTIYNMTSLVHLRLASNQLGGEIPYDVRDT--LPNLLDFIYC-FNRFTGKIPGSLHNL 272
+P N+T+L HL L+SN++ D+R +P L + N PG+ +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 273 TNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSF--ITSLTNSTH 329
+ + + +N + + L L + + + + G+ E + L N T
Sbjct: 201 -RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 330 LNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSI 389
+ + + I + +N +S L I + L+L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKF 316
Query: 390 S-------------------GEIPIEIGQLQGLQVLGLAGNEI--PGGIPNSLANLKKLN 428
G L L+ L L+ N + G S L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488
+DLS N + + +F + L +D ++ + + L N++ +D+
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-------NLIYLDI 428
Query: 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI-PNIVAELKGLEVLDLSSNKLSGSIPS 547
S SLE L MA N F P+I EL+ L LDLS +L P+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 548 DLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
+L +L+ LN++ NN + ++ +++
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTF--PYKCLNS 519
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-65
Identities = 101/522 (19%), Positives = 176/522 (33%), Gaps = 62/522 (11%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKL-SGNLPREIGNLFRLRVLNISFNNLQG- 133
L L + IG+L L+ + + +N + S LP NL L L++S N +Q
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 134 --------------------------ELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167
+ K L L L N + V ++ L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL---AGTVPSTIYNMT 224
L+V ++ S L L NL + + + L + +T
Sbjct: 225 AGLEVHRLVLGEFRNE--GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
++ L S + + +F L +L + T
Sbjct: 283 NVSSFSLVSVTIERVKDFSY---NFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTS 334
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344
+G +LP L ++ N + G S +T L YL L N +
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKG-----CCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 345 PESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
+ L L +++ S+ LR+L LD+S+ L L
Sbjct: 389 SSNFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 404 QVLGLAGNEIPGGI-PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+VL +AGN P+ L+ L +DLS +L P +F + SL +++S+N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC-KSLEELLMAYNQFSGPI 521
L ++ +D S N + + L++ SL L + N F+
Sbjct: 508 SLDT--------FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 559
Query: 522 PNI--VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561
+ + +K L + ++ + PSD Q + + SLN+T
Sbjct: 560 EHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-40
Identities = 53/271 (19%), Positives = 90/271 (33%), Gaps = 17/271 (6%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409
N L L N + S L +LDLS I L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI 469
GN I + + L L ++ L G+ ++L +++++N I
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF----- 139
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE----ELLMAYNQFSGPIPNIV 525
LPE S L N+ +DLS N + L+ + L ++ N + P
Sbjct: 140 --KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 526 AELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEG----VVPSEGIFRNMSN 580
E++ L L L +N S ++ +Q L L L + + N
Sbjct: 198 KEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 581 VHLKGNPKLCLQLGCENPRSHGSRLIILSII 611
+ ++ L ++ + L +S
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-78
Identities = 112/650 (17%), Positives = 212/650 (32%), Gaps = 111/650 (17%)
Query: 19 ADSASVGINTDKEALMSFKSQISQES---------PSSPLSYWNPSSSPCTWPGVICNNF 69
+ D +AL + + ++ + WN + W +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319
Query: 70 GN--RVIGLNLSSFGLEGTISPHIGNLSFLRSIQL------------------------Q 103
N RV GL+L+ FG +G + IG L+ L+ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 104 NNKLSGNLPRE-IGNLFRLRVLNISFNNLQGELPV-NISKLTELKMLDLMANKITGRVT- 160
+++ + + + RL + ++ + + + I K + + + D +T R+T
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439
Query: 161 -DDQLRNLRSLQVLNFGKNLLWGSIPP-----------SIANLIPSDLSRLENLKVLDLT 208
++ L LQ++ F + S L++L ++L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 209 INRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGS 268
+P +Y++ L L +A N+ T ++
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT----------------RLADD 543
Query: 269 LHNLTNIQIIRMTHNLLEGTLPP--GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTN 326
IQI M +N LE P L + L + NK + + +
Sbjct: 544 EDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNK---------VRHLEAFGT 593
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP--ASIGRLRSLTLLDL 384
+ L L LD NQ E IPE F++++ L N + IP + + + +D
Sbjct: 594 NVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDF 651
Query: 385 SYNSISGEIP-----IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT- 438
SYN I E ++ + + L+ NEI A ++ I LS N +T
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
Query: 439 ------GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
++ N L +IDL N++ + + L + +D+S N
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDF------RATTLPYLSNMDVSYNC 764
Query: 493 LSGNLPNSLKNCKSLEEL------LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP 546
S P N L+ N+ P + L L + SN + +
Sbjct: 765 FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD 822
Query: 547 SDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQLGCE 596
L L L++ N + + + +++ K GC+
Sbjct: 823 EKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 21/201 (10%), Positives = 55/201 (27%), Gaps = 11/201 (5%)
Query: 392 EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSL 451
+ +L + + E I + A +D + + +
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW 302
Query: 452 LSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELL 511
+ + + ++ V + L+ G +P+++ L+ L
Sbjct: 303 -NFNKELDMWGDQPG--------VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS 353
Query: 512 MAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVP 570
+ + E ++ + +++ L Q L +L + + P
Sbjct: 354 FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NP 412
Query: 571 SEGIFRNMSNVHLKGNPKLCL 591
+ S + LK L
Sbjct: 413 EMKPIKKDSRISLKDTQIGNL 433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 1e-73
Identities = 99/518 (19%), Positives = 174/518 (33%), Gaps = 37/518 (7%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L S L + L L + L ++ + RL L ++ N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
+S LK L + I+ + L N ++L+ L G N + P
Sbjct: 98 ETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFP----- 151
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSL--VHLRLASNQLGGEIPYDVRDTLPNLLD 253
E LKVLD N + + ++ + L L N + G P + L+
Sbjct: 152 ---TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208
Query: 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF--LRTYNIGFNKIVS 311
F N + ++ + E P L + + N+ + +
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ + + L L L ++P + S L KL L N
Sbjct: 269 ISSN-------TFHCFSGLQELDLTATHLS-ELPSGLVGLST-LKKLVLSANKFENLCQI 319
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIE-IGQLQGLQVLGLAGNEI--PGGIPNSLANLKKLN 428
S SLT L + N+ E+ + L+ L+ L L+ ++I L NL L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488
++LS NE +F L +DL+ R+ + + L + ++L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH-------LLKVLNL 432
Query: 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI---PNIVAELKGLEVLDLSSNKLSGSI 545
S + L + +L+ L + N F N + L LE+L LS LS
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 546 PSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHL 583
+L+ + ++L+ N L ++ ++L
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIE--ALSHLKGIYL 528
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-68
Identities = 93/516 (18%), Positives = 168/516 (32%), Gaps = 42/516 (8%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
N + GL I + + ++ N L L L L+++ +
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
L L L AN + + + L ++L+ L F + I+++
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQT--------GISSIDFIP 124
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL--LD 253
L + L+ L L N ++ + L L +N + D+ L L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQATNLS 183
Query: 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF--LRTYNIGFNKIVS 311
N G I + Q + + GL N L
Sbjct: 184 LNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ + + L + F + FS L +L L H+ ++P+
Sbjct: 243 ISPA-----VFEGLCEMSVESINLQKHYFFNISSNTFHCFSG-LQELDLTATHL-SELPS 295
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGI-PNSLANLKKLNQI 430
+ L +L L LS N I L L + GN + L NL+ L ++
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 431 DLSGNELT--GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488
DLS +++ + N L S++LS N ++ + P + +DL
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECP-------QLELLDL 407
Query: 489 SDNSLSGNLPNS-LKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSI-- 545
+ L S +N L+ L ++++ + L L+ L+L N
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
Query: 546 -PSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
+ LQ L L L L+F +L + + F ++
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSI--DQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-64
Identities = 94/509 (18%), Positives = 165/509 (32%), Gaps = 72/509 (14%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITG 157
++ +N L+ +P + N L SFN L S+L L LDL +I
Sbjct: 15 KTYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP 217
+ +D ++ L L N + + + LS + LK L ++
Sbjct: 72 -IHEDTFQSQHRLDTLVLTAN--------PLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 218 STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQI 277
++N +L L L SN + + +++
Sbjct: 123 IPLHNQKTLESLYLGSNHI-------------------------SSIKLPKGFPTEKLKV 157
Query: 278 IRMTHNLLEGTLPPGLGNLPFLRTY--NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLAL 335
+ +N + + +L N+ N I +S L
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG--------IEPGAFDSAVFQSLNF 209
Query: 336 DGNQFEGKIPESIGNFS-NELSKLYLGGNHIYGKIPASIGRLRSLTL--LDLSYNSISGE 392
G Q I + + N + L PA L +++ ++L +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 393 IPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLL 452
GLQ L L + +P+ L L L ++ LS N+ IS NF SL
Sbjct: 270 SSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328
Query: 453 SIDLSNNRINGNIPKGILRPLP-------------------EEISRLENVVTIDLSDNSL 493
+ + N + G L L ++ L ++ +++LS N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 494 SGNLPNSLKNCKSLEELLMAYNQFSG-PIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL 552
+ K C LE L +A+ + + L L+VL+LS + L S L
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 553 QALRSLNLTFNNLEGVVPSE-GIFRNMSN 580
AL+ LNL N+ + + +
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-41
Identities = 69/403 (17%), Positives = 126/403 (31%), Gaps = 85/403 (21%)
Query: 62 PGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL 121
P V V +NL S S L+ + L LS LP + L L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303
Query: 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181
+ L +S N + ++ S L L + N + L NL +L+ L+ + +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 182 GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
S ++ L L +L+ L+L+ N L L LA +L +
Sbjct: 364 TSDCCNLQ------LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
NL ++++ ++H+LL+ L
Sbjct: 418 ------------------------QSPFQNLHLLKVLNLSHSLLDI-SSEQL-------- 444
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
L +L L GN F + +
Sbjct: 445 ----------------------FDGLPALQHLNLQGNHFPKGNIQKTNSLQT-------- 474
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL 421
L L +L LS+ +S L+ + + L+ N + +L
Sbjct: 475 --------------LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN 464
++LK + ++L+ N ++ +P +I+L N ++
Sbjct: 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 42/240 (17%), Positives = 82/240 (34%), Gaps = 15/240 (6%)
Query: 349 GNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408
G N L N + + RL +LT LDL+ I L L L
Sbjct: 29 GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88
Query: 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKG 468
N + +L+ K L + ++ I N ++L S+ L +N I+
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK--- 145
Query: 469 ILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE--ELLMAYNQFSGPIPNIVA 526
+ E + +D +N++ + + + L + N +G I
Sbjct: 146 -----LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAF 199
Query: 527 ELKGLEVLDLSSNKLSGSIPSDLQN--LQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLK 584
+ + L+ + I L+N +Q+L + E + S +F + + ++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI--SPAVFEGLCEMSVE 257
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 8e-69
Identities = 101/525 (19%), Positives = 175/525 (33%), Gaps = 42/525 (8%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+LS +E L L ++ L N + P L L L L
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
I +L LK L++ N I NL +L ++ N + + L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR--- 177
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL---- 251
+ LD+++N + + + L L L N I L L
Sbjct: 178 -ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 252 --LDFIYCFNRFTGKIPGSLHNLTNIQI--IRMTHNLLEGTLPPGLGNLPFLRTYNIGFN 307
L P + L ++ I R+T+ L + ++
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 308 KIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYG 367
I ++ + L++ Q + + L L L N
Sbjct: 296 SI---------KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKG-- 340
Query: 368 KIPASIGRLRSLTLLDLSYNSIS--GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK 425
I L SL+ LDLS N++S G L+ L L+ N + + L+
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLE 399
Query: 426 KLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484
+L +D + L S F + + LL +D+S GI L ++
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK-IDFDGIFLGLT-------SLN 451
Query: 485 TIDLSDNSLSGNLP-NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG 543
T+ ++ NS N N N +L L ++ Q + L L++L++S N L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 544 SIPSDLQNLQALRSLNLTFNNLEGVVP-SEGIFRNMSNVHLKGNP 587
S L +L +L+ +FN +E + ++++ +L N
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 8e-62
Identities = 99/516 (19%), Positives = 168/516 (32%), Gaps = 55/516 (10%)
Query: 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154
S ++I L N L N L+ L++S ++ L L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 155 ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214
I + L SL+ L + L I L LK L++ N +
Sbjct: 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQ--------LITLKKLNVAHNFIHS 142
Query: 215 -TVPSTIYNMTSLVHLRLASNQLGGEIPYD---VRDTLPNLLDFIYCFNRFTGKIPGSLH 270
+P+ N+T+LVH+ L+ N + D +R+ L N +
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 271 NLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGL--SFITSLTNS 327
+ + + + N + L NL L + + + + E S + L +
Sbjct: 203 GI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD- 260
Query: 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR------------ 375
++ L +N +S + L G I +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLAN-VSAMSLAGVSI-KYLEDVPKHFKWQSLSIIRCQ 318
Query: 376 --------LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK-- 425
L L L L+ N S I + L L L L+ N + S ++L
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
L +DLS N + +F + L +D ++ + L ++
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE-------KLLY 428
Query: 486 IDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLSGS 544
+D+S + + SL L MA N F N+ A L LDLS +L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 545 IPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L L+ LN++ NNL + + + +
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFL--DSSHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-55
Identities = 91/527 (17%), Positives = 167/527 (31%), Gaps = 84/527 (15%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSG-NLPREIGNLFRLRVLNISFNNLQG- 133
L L S IG L L+ + + +N + LP NL L +++S+N +Q
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 134 --------------------------ELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167
+ + +L L L N + + L+NL
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKV--LDLTINRLAGTVPSTIYNMTS 225
L V ++ PS + L ++ + LT + + +
Sbjct: 229 AGLHVHRLILGEFKDE--RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 226 LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLL 285
+ + LA + K + Q + + L
Sbjct: 287 VSAMSLAGVSI---------------------------KYLEDVPKHFKWQSLSIIRCQL 319
Query: 286 EGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP 345
+ P +LPFL++ + NK S L+YL L N
Sbjct: 320 K-QFPTL--DLPFLKSLTLTMNKG---------SISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 346 ESIGNFSN-ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIE-IGQLQGL 403
S + L L L N + A+ L L LD ++++ L+ L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRIN 462
L ++ L LN + ++GN + F N +L +DLS ++
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
I G+ L + +++S N+L + SL L ++N+
Sbjct: 487 Q-ISWGVFDTLH-------RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
Query: 523 NIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVV 569
+ K L +L++N ++ I + LQ ++ N+E +
Sbjct: 539 ILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMT 584
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 55/244 (22%), Positives = 82/244 (33%), Gaps = 17/244 (6%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409
+ + + L N + S L LDLS I L L L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI 469
GN I P S + L L + +L G +L +++++N I+
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC----- 143
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN----CKSLEELLMAYNQFSGPIPNIV 525
LP S L N+V +DLS N + N L+ + L M+ N
Sbjct: 144 --KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201
Query: 526 AELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGV----VPSEGIFRNMSN 580
+K L L L N S +I LQNL L L + + I + +
Sbjct: 202 QGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 581 VHLK 584
V +
Sbjct: 261 VTID 264
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-55
Identities = 110/524 (20%), Positives = 192/524 (36%), Gaps = 57/524 (10%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKIT 156
+++ L N L + L+VL++S +Q L+ L L L N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 157 GRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA-GT 215
+ L SLQ L + ++A+L + L+ LK L++ N +
Sbjct: 90 -SLALGAFSGLSSLQKLVAVET--------NLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 216 VPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY----CFNRFTGKIPGSLHN 271
+P N+T+L HL L+SN++ I L + N PG+
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 272 LTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
+ + + + +N + + L L + + + + G+ E ++L +L
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK-SALEGLCNL 257
Query: 331 NYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASI--------------- 373
+ + + I F+ +S L I S
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 374 ----GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI--PGGIPNSLANLKKL 427
+L+SL L + N E+ L L+ L L+ N + G S L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487
+DLS N + + +F + L +D ++ + + L N++ +D
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-------NLIYLD 427
Query: 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI-PNIVAELKGLEVLDLSSNKLSGSIP 546
+S SLE L MA N F P+I EL+ L LDLS +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 547 SDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNP 587
+ +L +L+ LN+ N L+ V +GIF +++ + L NP
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSV--PDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-55
Identities = 99/507 (19%), Positives = 181/507 (35%), Gaps = 50/507 (9%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+LS ++ +LS L ++ L N + L L+ L NL
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
I L LK L++ N I + NL +L+ L+ N I ++ +D
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--------KIQSIYCTD 168
Query: 196 LSRLENLKV----LDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
L L + + LDL++N + + + L L L +N + L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 252 ------LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG---TLPPGLGNLPFLRTY 302
L +L L N+ I L+ + L + ++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 303 NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGG 362
++ I + + + +L L +F + + L +L
Sbjct: 288 SLVSVTI---------ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS----LKRLTFTS 334
Query: 363 NHIYGKIPASIGRLRSLTLLDLSYNSIS--GEIPIEIGQLQGLQVLGLAGNEIPGGIPNS 420
N G + + L SL LDLS N +S G L+ L L+ N + + ++
Sbjct: 335 NKG-GNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSN 391
Query: 421 LANLKKLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR 479
L++L +D + L S F + ++L+ +D+S+ GI +
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF-------NG 443
Query: 480 LENVVTIDLSDNSLSGNL-PNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSS 538
L ++ + ++ NS N P+ ++L L ++ Q P L L+VL+++S
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 539 NKLSGSIPSDLQNLQALRSLNLTFNNL 565
N+L L +L+ + L N
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 84/445 (18%), Positives = 148/445 (33%), Gaps = 68/445 (15%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKL-SGNLPREIGNLFRLRVLNISFNNLQG- 133
L L + IG+L L+ + + +N + S LP NL L L++S N +Q
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 134 --------------------------ELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167
+ K L L L N + V ++ L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG------TVPSTIY 221
L+V L + NL D S LE L L + RLA +
Sbjct: 225 AGLEVHR-----LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 222 NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC-FNRFTGKIPGSLH---------- 270
+T++ L S + + + L+ + C F +F SL
Sbjct: 280 CLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 271 ------NLTNIQIIRMTHNLLE--GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFIT 322
+L +++ + ++ N L G L+ ++ FN +++ +
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-----FL 393
Query: 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLL 382
L HL+ + + S+ L L + H L SL +L
Sbjct: 394 GLEQLEHLD---FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 383 DLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEI 441
++ NS +I +L+ L L L+ ++ P + +L L ++++ N+L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 442 PISFGNFQSLLSIDLSNNRINGNIP 466
F SL I L N + + P
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 59/324 (18%), Positives = 118/324 (36%), Gaps = 19/324 (5%)
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
+ + + ++ N L + P L+ ++ +I + D + + +HL+
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-------AYQSLSHLST 80
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSI-SG 391
L L GN + + S+ L KL ++ IG L++L L++++N I S
Sbjct: 81 LILTGNPIQSLALGAFSGLSS-LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 392 EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKL----NQIDLSGNELTGEIPISFGN 447
++P L L+ L L+ N+I L L ++ +DLS N + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 448 FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
L + L NN + N+ K ++ L + V+ ++ +L ++L+ +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAG-LEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 508 EEL---LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP-SDLQNLQALRSLNLTFN 563
L + + I ++ L + L S + S Q L +N F
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 564 NLEGVVPSEGIFRNMSNVHLKGNP 587
+ ++
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAF 341
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 51/252 (20%), Positives = 87/252 (34%), Gaps = 20/252 (7%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
IP+++ L L N + S L +LDLS I L L
Sbjct: 22 IPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
L L GN I + + L L ++ L G+ ++L +++++N I
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE----ELLMAYNQFSG 519
LPE S L N+ +DLS N + L+ + L ++ N +
Sbjct: 139 F-------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 520 PIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEG----VVPSEGI 574
P E++ L L L +N S ++ +Q L L L +
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 575 FRNMSNVHLKGN 586
+ N+ ++
Sbjct: 251 LEGLCNLTIEEF 262
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 10/130 (7%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
+L L + + + L L VL ++ N+ Q +I ++L L LDL
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211
++ +++ +L SLQVLN N L S+P I RL +L+ + L N
Sbjct: 479 QCQLE-QLSPTAFNSLSSLQVLNMASNQL-KSVPDGI-------FDRLTSLQKIWLHTNP 529
Query: 212 LAGTVPSTIY 221
+ P Y
Sbjct: 530 WDCSCPRIDY 539
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-53
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 75/312 (24%)
Query: 652 SYDELRRATGNFSHENLIGSGSFGSV----------------LHNERTGSWKSFIAECET 695
S EL+ A+ NFS++N++G G FG V G F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------- 745
+ HRNL++L C + ++ + LVY +++NGS+ + +++
Sbjct: 81 ISMAVHRNLLRLRGFCMT-PTERL----LVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 746 --LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS 803
L L YLH+ C+ ++H D+K NILLDEE A VGDFGLA+ + +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------- 188
Query: 804 STHV---FMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGE---FN 842
THV G+IG++ PEY + S DV +
Sbjct: 189 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 843 IVKWVESNLPE-NVLQVLDPELRQLMTSNE-SQTIQLHDCLITIIGSVGLSCTTESPGGR 900
++ WV+ L E + ++D +L+ E Q IQ V L CT SP R
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ-----------VALLCTQSSPMER 296
Query: 901 IGIREALRRLKS 912
+ E +R L+
Sbjct: 297 PKMSEVVRMLEG 308
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-53
Identities = 100/478 (20%), Positives = 182/478 (38%), Gaps = 61/478 (12%)
Query: 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
L+ L ++ + +L ++ L ++ + L L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
N++T L+NL L + N + P L+ L NL L L N
Sbjct: 76 SNNQLTD---ITPLKNLTKLVDILMNNNQIADITP----------LANLTNLTGLTLFNN 122
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLH 270
++ T + N+T+L L L+SN + L +L + N+ T P L
Sbjct: 123 QI--TDIDPLKNLTNLNRLELSSNTISDISALS---GLTSL-QQLSFGNQVTDLKP--LA 174
Query: 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
NLT ++ + ++ N + L L L + N+I IT L T+L
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD---------ITPLGILTNL 223
Query: 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS 390
+ L+L+GNQ + ++ + +N L+ L L N I P + L LT L L N IS
Sbjct: 224 DELSLNGNQLKD--IGTLASLTN-LTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450
P+ L L L L N++ + ++NLK L + L N ++ P+S +
Sbjct: 279 NISPL--AGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTK 332
Query: 451 LLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEEL 510
L + NN+++ ++ L N+ + N +S P L N + +L
Sbjct: 333 LQRLFFYNNKVSD----------VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 511 LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568
+ ++ N A + + + L P+ + + + ++T+N
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-48
Identities = 102/467 (21%), Positives = 178/467 (38%), Gaps = 62/467 (13%)
Query: 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
L I+ + ++ + L E L +T V+ L + +LQ G
Sbjct: 2 PLGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLG--- 57
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGE 239
I ++ + L NL ++ + N+L T + + N+T LV + + +NQ+
Sbjct: 58 --------IKSI--DGVEYLNNLTQINFSNNQL--TDITPLKNLTKLVDILMNNNQIADI 105
Query: 240 IPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFL 299
P L NL N+ T P L NLTN+ + ++ N + L L L
Sbjct: 106 TPLA---NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSL 158
Query: 300 RTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLY 359
+ + G ++ + L N T L L + N+ + +N L L
Sbjct: 159 QQLSFGNQ----------VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTN-LESLI 205
Query: 360 LGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPN 419
N I P +G L +L L L+ N + + L L L LA N+I +
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI-SNLAP 260
Query: 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR 479
L+ L KL ++ L N+++ P++ +L +++L+ N++ IS
Sbjct: 261 -LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLED----------ISPISN 307
Query: 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
L+N+ + L N++S P + + L+ L N+ S +A L + L N
Sbjct: 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHN 363
Query: 540 KLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
++S P L NL + L L N+S + N
Sbjct: 364 QISDLTP--LANLTRITQLGLNDQAWTN--APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 96/427 (22%), Positives = 161/427 (37%), Gaps = 58/427 (13%)
Query: 89 PHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKML 148
+ NL+ L I + NN+++ + NL L L + N + + LT L L
Sbjct: 84 TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRL 139
Query: 149 DLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLT 208
+L +N I+ L L SLQ L+FG + L+ L L+ LD++
Sbjct: 140 ELSSNTISD---ISALSGLTSLQQLSFGNQVT-----------DLKPLANLTTLERLDIS 185
Query: 209 INRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGS 268
N++ + S + +T+L L +NQ+ P L NL + N+ G+
Sbjct: 186 SNKV--SDISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKD--IGT 238
Query: 269 LHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGL---------- 318
L +LTN+ + + +N + L L L +G N+I + GL
Sbjct: 239 LASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 296
Query: 319 ---SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR 375
I+ ++N +L YL L N P + + + L +L+ N + +S+
Sbjct: 297 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK-LQRLFFYNNKV--SDVSSLAN 351
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
L ++ L +N IS P+ L + LGL N AN+ N +
Sbjct: 352 LTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
L P + + S D++ N + E VTI + SG
Sbjct: 410 ALI--APATISDGGSYTEPDITWNLPSY---------TNEVSYTFSQPVTIGKGTTTFSG 458
Query: 496 NLPNSLK 502
+ LK
Sbjct: 459 TVTQPLK 465
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-52
Identities = 106/530 (20%), Positives = 192/530 (36%), Gaps = 52/530 (9%)
Query: 90 HIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLD 149
G ++F R L+ +P+ L L +SFN ++ + L +L++L+
Sbjct: 4 FDGRIAFYR-----FCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 150 LMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTI 209
L + + + RNL +L++L+ G + I L P L +L L L
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSS--------KIYFLHPDAFQGLFHLFELRLYF 106
Query: 210 NRLAGTV--PSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPG 267
L+ V N+ +L L L+ NQ+ + L +L + N+
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166
Query: 268 SLHNLT--NIQIIRMTHNLLEGTLPPGLGNLP------FLRTYNIGFNKIVSSGDDEGLS 319
L L + + N L + G L ++ N +
Sbjct: 167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
Query: 320 FIT-----SLTNSTHLNYLALDGNQFEGKIPESIGNFSNE-LSKLYLGGNHIYGKIPASI 373
I+ SL + H+ + + + + + L L ++
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 374 GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433
L+ L +L+L+YN I+ L LQVL L+ N + ++ L K+ IDL
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346
Query: 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT-------I 486
N + +F + L ++DL +N + + + ++L + I
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI 406
Query: 487 DLSDNSLSGNLPNS-LKNCKSLEELLMAYNQFSG-PIPNIVAELKGLEVLDLSSNKLSGS 544
LS+N L L L+ L++ N+FS +E LE L L N L +
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 545 IPSDL-----QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNV---HLKGN 586
++L + L L+ L L N L + G+F +++ + L N
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSL--PPGVFSHLTALRGLSLNSN 514
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-42
Identities = 74/412 (17%), Positives = 141/412 (34%), Gaps = 44/412 (10%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P L+ + L L+ N + S+ + L L L S I + LPNL
Sbjct: 19 VPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG--LGNLPFLRTYNIGFNKI 309
++ P + L ++ +R+ L + NL L ++ N+I
Sbjct: 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN-ELSKLYLGGNHIYGK 368
S L S L + NQ + LS L N +Y +
Sbjct: 136 RS------LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR 189
Query: 369 IPASIG------RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLA 422
+ G R L +LD+S N + +I G N I SL
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT------------GNFSNAISKSQAFSLI 237
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQ--SLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
+ + + +F S+ +DLS+ + ++ + L
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLK------ 290
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
++ ++L+ N ++ + +L+ L ++YN + L + +DL N
Sbjct: 291 -DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQ 592
++ + L+ L++L+L N L + ++ ++ L GN + L
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLP 397
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-38
Identities = 89/536 (16%), Positives = 174/536 (32%), Gaps = 83/536 (15%)
Query: 87 ISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLF--RLRVLNISFNNLQGELPVNISKLTE 144
+ P G L+ L+SI +N++ E+ L L +++ N+L + V+ K
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 145 ------LKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSR 198
L++LD+ N T +T + + Q + L
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS---------------------LIL 238
Query: 199 LENLKVLDLTINRLAGTVPSTIYNM--TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY 256
++ + + +T + +S+ HL L+ + +L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV---------FSLN------- 282
Query: 257 CFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDE 316
L +++++ + +N + L L+ N+ +N +
Sbjct: 283 ---------SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS- 332
Query: 317 GLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRL 376
+ + Y+ L N ++ L L L N + +I +
Sbjct: 333 ------NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK-LQTLDLRDNAL-----TTIHFI 380
Query: 377 RSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436
S+ + LS N + +P + + + I L + L + L+ N
Sbjct: 381 PSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLD--ILYFLLRVPHLQILILNQNR 437
Query: 437 LTG-EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
+ + SL + L N + + + E +S L+ + L+ N L+
Sbjct: 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ---VLYLNHNYLNS 494
Query: 496 NLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
P + +L L + N+ + N + LE+LD+S N+L P +L
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS-- 550
Query: 556 RSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQLGCENPRS-HGSRLIILSI 610
L++T N F N N + C P S G L LS
Sbjct: 551 -VLDITHNKFICECELST-FINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLST 604
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-52
Identities = 92/515 (17%), Positives = 186/515 (36%), Gaps = 47/515 (9%)
Query: 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
+ + L+ + L++++++ +L L L++S N+L L+ LK L+L
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
M N NL +LQ L G + I D + L +L L++
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR-------RIDFAGLTSLNELEIKAL 158
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL--LDFIYC------FNRFT 262
L ++ ++ + HL L ++ + D L ++ L+ F+
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217
Query: 263 GKIPGSLHNLTNIQIIRMTHNLLEG--TLPPGLGNLPFLRTYNIGFNKI--VSSGDDEGL 318
S + +T L + L + + N + + + + +
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277
Query: 319 SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR-LR 377
S + + + + L + + + ++ + + ++ +P S + L+
Sbjct: 278 SELGKV-ETVTIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVF-LVPCSFSQHLK 334
Query: 378 SLTLLDLSYNSISGEI---PIEIGQLQGLQVLGLAGNEIP--GGIPNSLANLKKLNQIDL 432
SL LDLS N + E G LQ L L+ N + L LK L +D+
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 433 SGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
S N +P S + + ++LS+ I + I + + +D+S+N+
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ----------TLEVLDVSNNN 442
Query: 493 LSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL 552
L + L L+EL ++ N+ +P+ L V+ +S N+L L
Sbjct: 443 LD-SFSLFLPR---LQELYISRNKLKT-LPDASL-FPVLLVMKISRNQLKSVPDGIFDRL 496
Query: 553 QALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
+L+ + L N + P N + +
Sbjct: 497 TSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQ 531
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-50
Identities = 87/517 (16%), Positives = 182/517 (35%), Gaps = 52/517 (10%)
Query: 92 GNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
G + ++S+ L NK++ ++ L+VL + + + + + L L+ LDL
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDL 81
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLT-I 209
N ++ ++ L SL+ LN N ++ S L NL+ L + +
Sbjct: 82 SDNHLS-SLSSSWFGPLSSLKYLNLMGNPY-QTLGV------TSLFPNLTNLQTLRIGNV 133
Query: 210 NRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSL 269
+ +TSL L + + L ++ ++ + +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSL-RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 270 HNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTH 329
L++++ + + L L + D+ + L
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 330 LNYLALDGNQFEGKI---PESIGNFSN-------ELSKLYLGGNHIYGKIPASIGRLRSL 379
L+ + D G P S + +L++ +++ + L +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 380 TLLDLSYNSISGEIPIEIGQ-LQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGN 435
+ + + + +P Q L+ L+ L L+ N E L + LS N
Sbjct: 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 436 ELT--GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493
L + ++L S+D+S N P+P+ E + ++LS +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTF---------HPMPDSCQWPEKMRFLNLSSTGI 422
Query: 494 SGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ 553
+ + ++LE L ++ N + L L+ L +S NKL ++P
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD----SFSLFLPRLQELYISRNKLK-TLPDAS-LFP 473
Query: 554 ALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNP 587
L + ++ N L+ V +GIF +++ + L NP
Sbjct: 474 VLLVMKISRNQLKSV--PDGIFDRLTSLQKIWLHTNP 508
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-48
Identities = 93/499 (18%), Positives = 196/499 (39%), Gaps = 41/499 (8%)
Query: 102 LQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTD 161
++ + ++P + ++ L++SFN + ++ L++L L +++I +
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67
Query: 162 DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG-TVPSTI 220
D +L SL+ L+ N +++L S L +LK L+L N V S
Sbjct: 68 DAFYSLGSLEHLDLSDN--------HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 221 YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRM 280
N+T+L LR+ + + EI L +L + SL ++ +I + +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 281 THNLLEGTLPPGLGNLPFLRTYNIGFNKI----VSSGDDEGLSFITSLTNSTHLNYLALD 336
+ L L +R + + S + +S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 337 GNQFEGKIPESIGNFSNELSKLYLGG----NHIYGKIPASIGRLRSLTL--LDLSYNSIS 390
N+ + + E L G N + + +G++ ++T+ L + +
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEI---PISFGN 447
++ L+ ++ + + +++ + +LK L +DLS N + E G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 448 FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
+ SL ++ LS N + ++ E + L+N+ ++D+S N+ +P+S + + +
Sbjct: 360 WPSLQTLVLSQNHLR------SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567
L ++ I + LEVLD+S+N L S L LQ L ++ N L+
Sbjct: 413 RFLNLSSTGIRVVKTCI---PQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK- 464
Query: 568 VVPSEGIFRNMSNVHLKGN 586
+P +F + + + N
Sbjct: 465 TLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-16
Identities = 48/242 (19%), Positives = 97/242 (40%), Gaps = 27/242 (11%)
Query: 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIG-NLFRLRVLNISFNNLQG 133
L++ F L +S L ++ I ++N+K+ +P +L L L++S N +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 134 ELPVN---ISKLTELKMLDLMANKITG-RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIA 189
E N L+ L L N + + T + L L++L L+ +N
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF--------- 399
Query: 190 NLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249
+ +P E ++ L+L+ + V + I +L L +++N L LP
Sbjct: 400 HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSLF----LP 451
Query: 250 NLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNK 308
L + N+ +P + + +++++ N L+ ++P G L L+ + N
Sbjct: 452 RLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNP 508
Query: 309 IV 310
Sbjct: 509 WD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 32/131 (24%), Positives = 57/131 (43%), Gaps = 12/131 (9%)
Query: 450 SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509
+ D + +IP G+ + ++DLS N ++ L+ C +L+
Sbjct: 6 ASGVCDGRSRSFT-SIPSGLTA----------AMKSLDLSFNKITYIGHGDLRACANLQV 54
Query: 510 LLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVV 569
L++ ++ + + L LE LDLS N LS S L +L+ LNL N + +
Sbjct: 55 LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TL 113
Query: 570 PSEGIFRNMSN 580
+F N++N
Sbjct: 114 GVTSLFPNLTN 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-49
Identities = 81/384 (21%), Positives = 141/384 (36%), Gaps = 44/384 (11%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
++P I + P + L L + T T + S+ L +A ++
Sbjct: 7 TLPAPINQIFP--DADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVASIQGI 62
Query: 243 DVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTY 302
+ L NL N+ T P L NL + + + N + T L NL LR
Sbjct: 63 E---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 303 NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGG 362
+ + I +S + +LT + L L N + N + L+ L +
Sbjct: 116 YLNEDNI------SDISPLANLTK---MYSLNLGANHNL-SDLSPLSNMTG-LNYLTVTE 164
Query: 363 NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLA 422
+ + P I L L L L+YN I P+ L L N+I P +A
Sbjct: 165 SKVKDVTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VA 218
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482
N+ +LN + + N++T P N L +++ N+I+ + L
Sbjct: 219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD----------INAVKDLTK 266
Query: 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542
+ +++ N +S + L N L L + NQ ++ L L L LS N ++
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 543 GSIPSDLQNLQALRSLNLTFNNLE 566
P L +L + S + ++
Sbjct: 325 DIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 83/422 (19%), Positives = 160/422 (37%), Gaps = 77/422 (18%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L + P + L E L +T VT L S+ L +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKV 56
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
SI + L NL+ L+L N++ T S + N+ L +L + +N++
Sbjct: 57 -ASIQG---------IEYLTNLEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKI---- 100
Query: 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLR 300
+L NLTN++ + + + + L NL +
Sbjct: 101 -----------------------TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMY 135
Query: 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360
+ N+G N +S ++ L+N T LNYL + ++ + P I N ++ L L L
Sbjct: 136 SLNLGANHNLSD--------LSPLSNMTGLNYLTVTESKVKDVTP--IANLTD-LYSLSL 184
Query: 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNS 420
N I P + L SL N I+ P+ + L L + N+I +
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITD--LSP 238
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
LANL +L +++ N+++ + + L +++ +N+I+ ++ L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD----------ISVLNNL 286
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
+ ++ L++N L + +L L ++ N + P +A L ++ D ++
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
Query: 541 LS 542
+
Sbjct: 345 IK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 82/371 (22%), Positives = 144/371 (38%), Gaps = 43/371 (11%)
Query: 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
+L+ LQ ++ + L + L ++ + + I LT L+ L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
N+IT L NL L L G N + + ++ NL NL+ L L +
Sbjct: 74 NGNQITDI---SPLSNLVKLTNLYIGTNKI--TDISALQNL--------TNLRELYLNED 120
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLH 270
+ + S + N+T + L L +N ++ + L ++ P +
Sbjct: 121 NI--SDISPLANLTKMYSLNLGANHNLSDLS--PLSNMTGLNYLTVTESKVKDVTP--IA 174
Query: 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
NLT++ + + +N +E L +L L + N+I IT + N T L
Sbjct: 175 NLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD---------ITPVANMTRL 223
Query: 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS 390
N L + N+ + N S L+ L +G N I ++ L L +L++ N IS
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQ-LTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS 278
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450
+ L L L L N++ + L L + LS N +T P++ +
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSK 334
Query: 451 LLSIDLSNNRI 461
+ S D +N I
Sbjct: 335 MDSADFANQVI 345
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-49
Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 66/311 (21%)
Query: 650 KISYDELRRATGNFSHENLIGSGSFGSV---------------LHNERTGSWKSFIAECE 694
++ +L AT NF H+ LIG G FG V E + + F E E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
TL RH +LV LI C + M L+Y+++ NG+L ++G
Sbjct: 88 TLSFCRHPHLVSLIGFCD--ERNEM---ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 746 ---LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+ L YLH ++H D+K NILLDE K+ DFG+++ E +Q+ +
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE--LDQTHL 197
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESF-AGEFNIVKW 846
ST V G++GY+ PEY + R + DV +S N+ +W
Sbjct: 198 -STVV-KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 847 VESNLPE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIRE 905
+ + Q++DP L + + G + C S R + +
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRK----------FGDTAVKCLALSSEDRPSMGD 305
Query: 906 ALRRLKSSQEI 916
L +L+ + +
Sbjct: 306 VLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 66/313 (21%), Positives = 112/313 (35%), Gaps = 77/313 (24%)
Query: 652 SYDELRRATGNFSHE------NLIGSGSFGSV----------------LHNERTGS--WK 687
S+ EL+ T NF N +G G FG V + T +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 75
Query: 688 SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-- 745
F E + + +H NLV+L+ S D + LVY ++ NGSL D +
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGD----DLC-LVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 746 ---------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796
+ +++LH + +H D+K NILLDE TAK+ DFGLAR +
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK-- 185
Query: 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEF 841
++ ++ + +G+ Y+ PE G + D+ E
Sbjct: 186 -FAQTVMTSRI-VGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH-REPQ 241
Query: 842 NIVKWVESNLPE--NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGG 899
++ E E + +D ++ +++ V C E
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS-----------VASQCLHEKKNK 290
Query: 900 RIGIREALRRLKS 912
R I++ + L+
Sbjct: 291 RPDIKKVQQLLQE 303
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-45
Identities = 97/501 (19%), Positives = 183/501 (36%), Gaps = 96/501 (19%)
Query: 87 ISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELK 146
I+P + +FL+ ++ L+ +P E N+ +++ + P + E+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 147 MLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206
+ L R L L S+P +L+ L
Sbjct: 62 VSRLRDCL------------DRQAHELELNNLGL-SSLPELPP-----------HLESLV 97
Query: 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
+ N L +P ++ SL+ L LP LL+++ N K+P
Sbjct: 98 ASCNSLT-ELPELPQSLKSLLVDNNNLKAL---------SDLPPLLEYLGVSNNQLEKLP 147
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTN 326
L N + ++II + +N L+ LP +L F+ G N+ L + L N
Sbjct: 148 -ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQ---------LEELPELQN 193
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
L + D N + K+P+ + L + G N + + + L LT +
Sbjct: 194 LPFLTAIYADNNSLK-KLPDLPLS----LESIVAGNNIL--EELPELQNLPFLTTIYADN 246
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
N + +P L+ L V + +P +L L+ + + L+ P
Sbjct: 247 NLLK-TLPDLPPSLEALNVRDNYLTD----LPELPQSLTFLDVSENIFSGLSELPP---- 297
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+L ++ S+N I L + LE +++S+N L LP
Sbjct: 298 ---NLYYLNASSNEIRS---------LCDLPPSLE---ELNVSNNKLI-ELPALPPR--- 338
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
LE L+ ++N + +P + L+ L + N L P ++++ +L N+
Sbjct: 339 LERLIASFNHLAE-VP---ELPQNLKQLHVEYNPLR-EFPDIPESVE-----DLRMNSHL 388
Query: 567 GVVPSEGIFRNMSNVHLKGNP 587
VP +N+ +H++ NP
Sbjct: 389 AEVPEL--PQNLKQLHVETNP 407
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-44
Identities = 90/493 (18%), Positives = 171/493 (34%), Gaps = 99/493 (20%)
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNL-------------FRLRVLNISFNNLQ 132
+ N+ ++ N P G + L ++ L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 133 GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLI 192
LP L L N +T + ++L+SL V N L P
Sbjct: 85 -SLPELPPHLES---LVASCNSLT--ELPELPQSLKSLLVDNNNLKALSDLPP------- 131
Query: 193 PSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLL 252
L+ L ++ N+L +P + N + L + + +N L ++P D P+L
Sbjct: 132 --------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL-KKLP----DLPPSLE 176
Query: 253 DFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312
N+ ++P L NL + I +N L+ LP +L + G N
Sbjct: 177 FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNI---- 226
Query: 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPAS 372
L + L N L + D N + +P+ + L L + N++ +P
Sbjct: 227 -----LEELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYL-TDLPEL 275
Query: 373 IGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDL 432
L L + + ++ +S P L L + NEI + + +L++LN +
Sbjct: 276 PQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEELN---V 324
Query: 433 SGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
S N+L E+P + L S N + +PE L+ + + N
Sbjct: 325 SNNKLI-ELPALPPRLERL---IASFNHLAE---------VPELPQNLK---QLHVEYNP 368
Query: 493 LSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL 552
L P+ ++ + L + + + + + L+ L + +N L P +++
Sbjct: 369 LR-EFPDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESV 418
Query: 553 QALRSLNLTFNNL 565
+ LR + +
Sbjct: 419 EDLRMNSERVVDP 431
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 72/419 (17%), Positives = 133/419 (31%), Gaps = 93/419 (22%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPR---------------EIGNLFR 120
L S L + +L L LS P E+ N
Sbjct: 96 LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L+++++ N+L+ +LP L + N++ +L+NL L + N L
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE---ELPELQNLPFLTAIYADNNSL 207
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
+P +L + + N L + N+ L + +N L +
Sbjct: 208 -KKLPDLPLSL-----------ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TL 252
Query: 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLR 300
P D P+L N T +P +LT + + + L LPP L L
Sbjct: 253 P----DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYL---- 302
Query: 301 TYNIGFNKIVSSGDDEGLSFITSLTNS-THLNYLALDGNQFEGKIPESIGNFSNELSKLY 359
N N+I SL + L L + N+ ++P L +L
Sbjct: 303 --NASSNEI------------RSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLI 343
Query: 360 LGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQ----------------GL 403
NH+ ++P L+ L + YN + E P ++ L
Sbjct: 344 ASFNHL-AEVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNL 398
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+ L + N + P+ +++ L ++ + + L ++ +
Sbjct: 399 KQLHVETNPLRE-FPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 56/323 (17%), Positives = 108/323 (33%), Gaps = 37/323 (11%)
Query: 268 SLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS 327
H+ + + + + L + NS
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-----------NRWHSAWRQANS 55
Query: 328 THLNYLALDGNQFEGKIPESIGNFSNE-LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
+ G + + + + + L L + + P RL L + +
Sbjct: 56 NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDA 113
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
+ E+P + Q GL+ L LA N + +P S+A+L +L ++ + E+P
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 447 NF---------QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNL 497
+ +L S+ L +R LP I+ L+N+ ++ + ++ LS L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTG---------IRSLPASIANLQNLKSLKIRNSPLSA-L 221
Query: 498 PNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRS 557
++ + LEEL + P I L+ L L ++P D+ L L
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 558 LNLTFNNLEGVVPSEGIFRNMSN 580
L+L +PS +
Sbjct: 282 LDLRGCVNLSRLPSL--IAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 57/373 (15%), Positives = 108/373 (28%), Gaps = 52/373 (13%)
Query: 109 GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLR 168
G+ + L + +S+ D R N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR-----QANSN 56
Query: 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVH 228
+ Q+ L + + + L+L L P + ++ L H
Sbjct: 57 NPQIETRTGRAL-KATADLLEDA------TQPGRVALELRSVPLP-QFPDQAFRLSHLQH 108
Query: 229 LRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT 288
+ + + L ++P ++ ++ + + N L
Sbjct: 109 MTIDAAGL--------------------------MELPDTMQQFAGLETLTLARNPLR-A 141
Query: 289 LPPGLGNLPFLRTYNI-GFNKIV----SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGK 343
LP + +L LR +I ++ + L N L L L+
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN---LQSLRLEWTGIR-S 197
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
+P SI N N L L + + + + +I L L LDL + P G L
Sbjct: 198 LPASIANLQN-LKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
+ L L +P + L +L ++DL G +P + I + +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA- 314
Query: 464 NIPKGILRPLPEE 476
+ + P E
Sbjct: 315 QLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-38
Identities = 61/347 (17%), Positives = 113/347 (32%), Gaps = 38/347 (10%)
Query: 220 IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIR 279
++ + +L + + Y +R N N QI
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQ-----WQRHYNADRNRWHSAWRQANSNNPQIET 62
Query: 280 MTHNLLEGTLPPGLGNL--PFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDG 337
T L+ L + P + + F +HL ++ +D
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLPQ--------FPDQAFRLSHLQHMTIDA 113
Query: 338 NQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI 397
++P+++ F+ L L L N + +PASI L L L + E+P +
Sbjct: 114 AGLM-ELPDTMQQFAG-LETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 398 GQ---------LQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNF 448
L LQ L L I +P S+ANL+ L + + + L+ + + +
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 449 QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE 508
L +DL LR P + + L D S LP + LE
Sbjct: 229 PKLEELDLRGCTA--------LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 509 ELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
+L + +P+++A+L ++ + + + A
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 53/359 (14%), Positives = 101/359 (28%), Gaps = 59/359 (16%)
Query: 89 PHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKML 148
H + S ++ Q + + R + + + ++
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIE 61
Query: 149 DLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLT 208
+ + L L P L +L+ + +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRL--------SHLQHMTID 112
Query: 209 INRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGS 268
L +P T+ L L LA N L +P S
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR--------------------------ALPAS 145
Query: 269 LHNLTNIQIIRMTHNLLEGTLPPGLGNLPF---------LRTYNIGFNKIVSSGDDEGLS 319
+ +L ++ + + LP L + L++ + + I S
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-------- 197
Query: 320 FITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSL 379
S+ N +L L + + + +I + L +L L G P G L
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK-LEELDLRGCTALRNYPPIFGGRAPL 255
Query: 380 TLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438
L L S +P++I +L L+ L L G +P+ +A L I + +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 52/316 (16%), Positives = 102/316 (32%), Gaps = 88/316 (27%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L L S L LS L+ + + L LP + L L ++ N L+ L
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-AL 142
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL-IPS 194
P +I+ L L+ L + A L +P +A+
Sbjct: 143 PASIASLNRLRELSIRAC------------------------PEL-TELPEPLASTDASG 177
Query: 195 DLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254
+ L NL+ L L + ++P++I N+ +L L++ ++ L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL------------------ 218
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
+ ++H+L ++ + + PP G L+ +
Sbjct: 219 --------SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK--------- 261
Query: 315 DEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374
D + +P I + L KL L G ++P+ I
Sbjct: 262 ---------------------DCSNLL-TLPLDIHRLTQ-LEKLDLRGCVNLSRLPSLIA 298
Query: 375 RLRSLTLLDLSYNSIS 390
+L + ++ + + +
Sbjct: 299 QLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 12/118 (10%), Positives = 23/118 (19%), Gaps = 22/118 (18%)
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI----- 524
+ + ++ + L + + N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 525 ----------------VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
A G L+L S L P L L+ + + L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-42
Identities = 60/457 (13%), Positives = 131/457 (28%), Gaps = 39/457 (8%)
Query: 111 LPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170
+ N R ++ ++ ++L+ L +K LDL N ++ +++ L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLR 230
++LN N+L+ DL L L+ LDL N + + S+ L
Sbjct: 61 ELLNLSSNVLYE----------TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 231 LASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLP 290
A+N + + + N+ T + +Q + + N ++
Sbjct: 106 AANNNI-SRVS---CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 291 PGL-GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIG 349
L + L N+ +N I + L L L N+ +
Sbjct: 162 AELAASSDTLEHLNLQYNFIYD---------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409
+ + ++ + L N + I ++ ++L DL N + + +V +A
Sbjct: 212 SAAG-VTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVA 268
Query: 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI 469
+ + + L+++ + + +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRKEHALL-SGQGSE 324
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELK 529
L E ID + ++ L + N
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
L+ + + + L+ L E
Sbjct: 385 ELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-39
Identities = 65/480 (13%), Positives = 151/480 (31%), Gaps = 50/480 (10%)
Query: 70 GNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFN 129
GNR ++ L+ ++ + ++ + L N LS ++ +L +LN+S N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 130 NLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIA 189
L E ++ L+ L+ LDL N + +L S++ L+ N + + S
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNI-SRVSCSR- 118
Query: 190 NLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249
+ K + L N++ + + +L L N++ ++ +
Sbjct: 119 ---------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 250 NLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKI 309
L +N + G + ++ + ++ N L + P + + ++ NK+
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI 369
V +L S +L + L GN F FS + +
Sbjct: 227 V--------LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLT 276
Query: 370 PASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI-------PGGIPNSLA 422
+ TL + L L + + +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482
N + +ID + I Q+ ++++ ++ + + L+
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-----EQVSNGRRAHAELDG 388
Query: 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542
+ + L + L ++ Y + + + + D+ +K +
Sbjct: 389 TLQQAVGQIELQHATEE-QSPLQLLRAIVKRYEEMY--VEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-36
Identities = 66/424 (15%), Positives = 129/424 (30%), Gaps = 71/424 (16%)
Query: 162 DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY 221
+ +N ++ + S+ + S N+K LDL+ N L+ + +
Sbjct: 4 EIKQNGNRYKIEKVTDS--------SLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55
Query: 222 NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMT 281
T L L L+SN L L +L+ ++ + +
Sbjct: 56 PFTKLELLNLSSNVLYE---------------------------TLDLESLSTLRTLDLN 88
Query: 282 HNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFE 341
+N ++ L P + T + N I S + + L N+
Sbjct: 89 NNYVQE-----LLVGPSIETLHAANNNISR----------VSCSRGQGKKNIYLANNKIT 133
Query: 342 GKIPESIGNFSNELSKLYLGGNHIYG-KIPASIGRLRSLTLLDLSYNSISGEIPIEIGQL 400
G S + L L N I +L L+L YN I ++ ++
Sbjct: 134 MLRDLDEGCRSR-VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 401 QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNR 460
L+ L L+ N++ + + + I L N+L I + Q+L DL N
Sbjct: 191 AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 461 INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
+ L + S+ + V T+ ++ + + C
Sbjct: 249 FHCG-------TLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 521 IPNIVAELKGLEVLDLSSNKLSGS----IPSDLQNLQALRSLNLTFNNLEGVVPSEGIFR 576
L L+ + + GS + + +N R ++ V + +
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV--IDQVTL 357
Query: 577 NMSN 580
Sbjct: 358 RKQA 361
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 57/269 (21%), Positives = 104/269 (38%), Gaps = 23/269 (8%)
Query: 326 NSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLS 385
N + + + + + N + +L L GN + A + L LL+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 386 YNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISF 445
N + +++ L L+ L L N + L + + + N ++ +S
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSC 116
Query: 446 GNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-NLPNSLKNC 504
Q +I L+NN+I + + V +DL N + N +
Sbjct: 117 SRGQGKKNIYLANNKIT-MLR-------DLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564
+LE L + YN + V L+ LDLSSNKL+ + + Q+ + ++L N
Sbjct: 169 DTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 565 LEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593
L + + +N+ + L+GN C L
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTL 254
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 49/293 (16%), Positives = 100/293 (34%), Gaps = 29/293 (9%)
Query: 294 GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN 353
N + + + + + ++ ++ L L GN + F+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALAS-------LRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413
L L L N +Y + L +L LDL+ N + E+ ++ L A N I
Sbjct: 60 -LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL 473
+ K + L+ N++T + G + +DL N I+
Sbjct: 112 SRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV-------NF 161
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
E + + + ++L N + ++ + L+ L ++ N+ + + G+
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW 218
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
+ L +NKL I L+ Q L +L N + +N +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 27/131 (20%), Positives = 53/131 (40%), Gaps = 19/131 (14%)
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLE 532
+ E ++D+SL L + ++ +++EL ++ N S +A LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 533 VLDLSSNKLSGSIP-----------------SDLQNLQALRSLNLTFNNLEGVVPSEGIF 575
+L+LSSN L ++ +L ++ +L+ NN+ V S
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV--SCSRG 119
Query: 576 RNMSNVHLKGN 586
+ N++L N
Sbjct: 120 QGKKNIYLANN 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-42
Identities = 63/398 (15%), Positives = 135/398 (33%), Gaps = 62/398 (15%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
I S+L + + + + + + ++ + LP
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM---------RKLP-- 61
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIV 310
L + ++++ + +E + ++ +GFN I
Sbjct: 62 --------------AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP 370
N L L L+ N +P I + + +L+ L + N++ +I
Sbjct: 107 YLPPH-------VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIE 157
Query: 371 ASIGR-LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ SL L LS N ++ +++ + L ++ N + ++LA + +
Sbjct: 158 DDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEE 209
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+D S N + + L + L +N + + + +V +DLS
Sbjct: 210 LDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA---------WLLNYPGLVEVDLS 256
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL 549
N L + + + LE L ++ N+ + + L+VLDLS N L + +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
Query: 550 QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
L +L L N++ + + N+ L N
Sbjct: 315 PQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 73/436 (16%), Positives = 152/436 (34%), Gaps = 77/436 (17%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
+++ + L+ + + +N+ + LP + + ++ +LN++ ++ E
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 135 LPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIP 193
+ + ++ L + N I + +N+ L VL +N L S+P I
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRGI----- 136
Query: 194 SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253
L L ++ N L T TSL +L+L+SN+L + +P+L
Sbjct: 137 --FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD---LSLIPSLFH 190
Query: 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSG 313
+N + +L ++ + +HN + + + L + N +
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD-- 240
Query: 314 DDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI 373
L N L + L N+ E KI F
Sbjct: 241 -------TAWLLNYPGLVEVDLSYNELE-KIMYHP--FVK-------------------- 270
Query: 374 GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433
++ L L +S N + + + + L+VL L+ N + + + +L + L
Sbjct: 271 --MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLD 326
Query: 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493
N + + +L ++ LS+N + N + + R NV + D
Sbjct: 327 HNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFR----------NVARPAVDDADQ 373
Query: 494 SGNLPNSLKN---CKS 506
+ L++ CK
Sbjct: 374 HCKIDYQLEHGLCCKE 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 86/498 (17%), Positives = 179/498 (35%), Gaps = 48/498 (9%)
Query: 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQG 133
+++ + L+ + + +N+ + LP + + ++ +LN++ ++
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88
Query: 134 ELPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLI 192
E+ + ++ L + N I + +N+ L VL +N L S+P I
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRGI---- 142
Query: 193 PSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLL 252
L L ++ N L T TSL +L+L+SN+L + +P+L
Sbjct: 143 ---FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD---LSLIPSLF 195
Query: 253 DFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312
+N + +L ++ + +HN + + + L + N +
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD- 246
Query: 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPAS 372
L N L + L N+ E KI L +LY+ N + +
Sbjct: 247 --------TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLY 296
Query: 373 IGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDL 432
+ +L +LDLS+N + + Q L+ L L N I ++ LK L L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TL 352
Query: 433 SGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL--PEEISRLENVVTIDLSD 490
S N+ + F+++ + + + I + L E + + ++
Sbjct: 353 SHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIAL 410
Query: 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS--- 547
S+ + + C + + + + L+G E L+ N+L +
Sbjct: 411 TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTN 470
Query: 548 -DLQNLQALRSLNLTFNN 564
+Q Q L+ L+ +
Sbjct: 471 EQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-39
Identities = 65/404 (16%), Positives = 137/404 (33%), Gaps = 62/404 (15%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
I S+L + + + + + + ++ + LP
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM---------RKLP-- 67
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIV 310
L + ++++ + +E + ++ +GFN I
Sbjct: 68 --------------AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP 370
N L L L+ N +P I + + +L+ L + N++ +I
Sbjct: 113 YLPPH-------VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIE 163
Query: 371 ASIGR-LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ SL L LS N ++ +++ + L ++ N + ++LA + +
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEE 215
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+D S N + + L + L +N + + + +V +DLS
Sbjct: 216 LDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA---------WLLNYPGLVEVDLS 262
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL 549
N L + + + LE L ++ N+ + + L+VLDLS N L + +
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320
Query: 550 QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593
L +L L N++ + + N+ L N C L
Sbjct: 321 PQFDRLENLYLDHNSIVTL--KLSTHHTLKNLTLSHNDWDCNSL 362
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 4e-11
Identities = 24/159 (15%), Positives = 50/159 (31%), Gaps = 10/159 (6%)
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491
N + + + I+ + + + L N + ++
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHID-MQTQDVYFGFED--ITLNNQKIVTFKNS 61
Query: 492 SLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQ 550
++ L + + +E L + Q A ++ L + N + +P Q
Sbjct: 62 TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
Query: 551 NLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGN 586
N+ L L L N+L + GIF N + + N
Sbjct: 121 NVPLLTVLVLERNDLSSL--PRGIFHNTPKLTTLSMSNN 157
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-39
Identities = 101/485 (20%), Positives = 186/485 (38%), Gaps = 46/485 (9%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
+LNIS N + +I L++L++L + N+I + + + L+ L+ N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG-TVPSTIYNMTSLVHLRLASNQLGGE 239
I NLK LDL+ N + NM+ L L L++ L +
Sbjct: 82 VK---------ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL-EK 129
Query: 240 IPYDVRDTLPNLLDFIYCFNRFTGKI-PGSLHNL--TNIQIIRMTHNLLEGTLPPGLGNL 296
L + + K P L + ++ I+ T+ L + +
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 297 PFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF----- 351
L NI + LS + L + L+ L L+ + I
Sbjct: 190 ANLELSNIKCVLEDNKCSYF-LSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 352 --SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409
+S + L G + S L++L++ + + + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 410 GNE---IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIP 466
+ + P+ ++ L D S N LT + + G+ L ++ L N++
Sbjct: 309 VSGTRMVHMLCPSKISPFLHL---DFSNNLLTDTVFENCGHLTELETLILQMNQLK---- 361
Query: 467 KGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC-KSLEELLMAYNQFSGPIPNIV 525
L + E ++++++ +D+S NS+S + + KSL L M+ N + I
Sbjct: 362 --ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-- 417
Query: 526 AELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VH 582
++VLDL SNK+ SIP + L+AL+ LN+ N L+ V +GIF +++ +
Sbjct: 418 CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSV--PDGIFDRLTSLQKIW 474
Query: 583 LKGNP 587
L NP
Sbjct: 475 LHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-35
Identities = 92/482 (19%), Positives = 193/482 (40%), Gaps = 37/482 (7%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
+ + N +S +I +L +LR+L IS N +Q L +++ EL+ LDL NK+
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215
++ NL + L+ N ++P + + LK L L+ L +
Sbjct: 82 VK-ISCHPTVNL---KHLDLSFNAF-DALPI------CKEFGNMSQLKFLGLSTTHLEKS 130
Query: 216 VPSTIYNMTSL-VHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPG-SLHNLT 273
I ++ V L L E P ++D L ++ N+ I S+ +
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190
Query: 274 NIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD--DEGLSFITSLTNSTHLN 331
N+++ + L + L L L+T N +++ + I L T +
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250
Query: 332 YLALDGNQFEGKIPESIGNFSN----ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYN 387
Y ++ + +G++ ++S LS + + ++ + + + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 388 SISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGN 447
+ ++ L + N + + + +L +L + L N+L E+
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEM 369
Query: 448 FQ---SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC 504
SL +D+S N ++ + KG S ++++++++S N L+ + L
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDC-------SWTKSLLSLNMSSNILTDTIFRCLP-- 420
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFN 563
++ L + N+ IP V +L+ L+ L+++SN+L S+P L +L+ + L N
Sbjct: 421 PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
Query: 564 NL 565
Sbjct: 479 PW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 76/432 (17%), Positives = 151/432 (34%), Gaps = 34/432 (7%)
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV 227
+ +LN +N I+ L SD+ L L++L ++ NR+ S L
Sbjct: 21 QKTTILNISQN--------YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTG-KIPGSLHNLTNIQIIRMTHNLLE 286
+L L+ N+L +I NL FN F I N++ ++ + ++ LE
Sbjct: 73 YLDLSHNKL-VKISC---HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 287 GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE 346
+ + +L + + D EGL + + + +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 347 SIGNFSNELSK-LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG--- 402
+ + L + I A + L+ L L+ + I I QL
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 403 -----LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLS 457
+ + L G S +LK L+ + + + F ++ + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 458 NNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQF 517
+ + S++ + +D S+N L+ + + + LE L++ NQ
Sbjct: 309 VSG-TRMVHMLC-------PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 518 S--GPIPNIVAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGI 574
I + ++K L+ LD+S N +S ++L SLN++ N L + +
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF-RCL 419
Query: 575 FRNMSNVHLKGN 586
+ + L N
Sbjct: 420 PPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 65/379 (17%), Positives = 141/379 (37%), Gaps = 23/379 (6%)
Query: 92 GNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL-QGELPVNISKLTELKM-LD 149
GN+S L+ + L L + I +L +VL + + E P + + +
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171
Query: 150 LMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD--LSRLENLKVLDL 207
NK + D ++ + +L++ N K +L + +++ +L NL + ++
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNI-KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 208 TINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC----FNRFTG 263
+ + T++ + +++ +L G++ + D L + + F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 264 KIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITS 323
+N+ I T + + + N + + +
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-------TVFEN 343
Query: 324 LTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHI-YGKIPASIGRLRSLT 380
+ T L L L NQ + ++ + + L +L + N + Y + +SL
Sbjct: 344 CGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440
L++S N ++ I + ++VL L N+I IP + L+ L +++++ N+L
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSV 459
Query: 441 IPISFGNFQSLLSIDLSNN 459
F SL I L N
Sbjct: 460 PDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 57/400 (14%), Positives = 130/400 (32%), Gaps = 50/400 (12%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P DLS+ +L+++ N ++ S I +++ L L ++ N++ L
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI---------QYLD-- 61
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
++ + ++HN L NL L ++ FN +
Sbjct: 62 --------------ISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFDA 104
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ ++ L +L L E I + + L LG + + P
Sbjct: 105 LPICKEFGNMSQLK------FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE 158
Query: 372 SIGRLR--SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ SL ++ + + + + + L++ + L+ L KL
Sbjct: 159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQT 218
Query: 430 ------IDLSGNELTGEIPISFGNFQSLLSI---DLSNNRINGNIPKGILRPLPEEISRL 480
+ L+ E T I ++ +SN ++ G R + L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ---LDFRDFDYSGTSL 275
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
+ + + + + ++ + +++ LD S+N
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L+ ++ + +L L +L L N L+ + + M +
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 48/283 (16%), Positives = 108/283 (38%), Gaps = 21/283 (7%)
Query: 33 LMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIG 92
+S +++ S L+ N ++ ++ ++ + V ++S+ L+G +
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 93 NLSF-----LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
+ S L Q+ ++ + + N + + + + SK++
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 148 LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL 207
LD N +T + +L L+ L N L + I +++++L+ LD+
Sbjct: 329 LDFSNNLLT-DTVFENCGHLTELETLILQMNQL-KELSK-----IAEMTTQMKSLQQLDI 381
Query: 208 TINRLAGTVPSTI-YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY-CFNRFTGKI 265
+ N ++ SL+ L ++SN L + LP + + N+ I
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNIL----TDTIFRCLPPRIKVLDLHSNKIK-SI 436
Query: 266 PGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFN 307
P + L +Q + + N L+ ++P G L L+ + N
Sbjct: 437 PKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 15/163 (9%)
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+D S N L +P Q +++S N I+ + +I L + + +S
Sbjct: 5 VDRSKNGLI-HVPK--DLSQKTTILNISQNYIS-ELW-------TSDILSLSKLRILIIS 53
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL-SGSIPSD 548
N + + K + LE L +++N+ + L+ LDLS N + I +
Sbjct: 54 HNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDLSFNAFDALPICKE 110
Query: 549 LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL 591
N+ L+ L L+ +LE N+S V L
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 34/197 (17%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETL 696
+ + L + + G FG V + SW+ E +L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 697 RNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDIT 749
++H N+++ I + S +++ L+ F GSL D++ + +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSDFLKANVVSWNELCHIAETMA 131
Query: 750 SALDYLHND-------CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
L YLH D + + H D+K N+LL +TA + DFGLA + S
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF----EAGKSA 187
Query: 803 SSTHVFMGSIGYVPPEY 819
TH +G+ Y+ PE
Sbjct: 188 GDTHGQVGTRRYMAPEV 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 46/224 (20%), Positives = 80/224 (35%), Gaps = 28/224 (12%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSV----LHNE-------RTGSWKSFIAECE--TLR 697
+ E N LIG G +G+V L + ++FI E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITS 750
+ H N+ + I + + LV E+ NGSL ++ + +T
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 751 ALDYLHND------CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL--ERVDNQSSI 802
L YLH + + + H DL N+L+ + T + DFGL+ L V
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846
++ +G+I Y+ PE G + + ++ W
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 23/269 (8%)
Query: 326 NSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLS 385
N + + + + + N + +L L GN + A + L LL+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 386 YNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISF 445
N + E ++ L L+ L L N + L + + + N ++ +S
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSC 116
Query: 446 GNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-NLPNSLKNC 504
Q +I L+NN+I + + V +DL N + N +
Sbjct: 117 SRGQGKKNIYLANNKIT-MLR-------DLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564
+LE L + YN + V L+ LDLSSNKL+ + + Q+ + ++L N
Sbjct: 169 DTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 565 LEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593
L + + +N+ + L+GN C L
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTL 254
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 49/292 (16%), Positives = 100/292 (34%), Gaps = 29/292 (9%)
Query: 295 NLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNE 354
N + + + + + ++ ++ L L GN + F+
Sbjct: 8 NGNRYKIEKVTDSSLKQALAS-------LRQSAWNVKELDLSGNPLSQISAADLAPFTK- 59
Query: 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIP 414
L L L N +Y + L +L LDL+ N + E+ ++ L A N I
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 415 GGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLP 474
+ K + L+ N++T + G + +DL N I+
Sbjct: 113 RVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV-------NFA 162
Query: 475 EEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534
E + + + ++L N + ++ + L+ L ++ N+ + + G+ +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219
Query: 535 DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
L +NKL I L+ Q L +L N + +N +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 51/338 (15%), Positives = 110/338 (32%), Gaps = 37/338 (10%)
Query: 111 LPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170
+ N R ++ ++ ++L+ L +K LDL N ++ +++ L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLR 230
++LN N+L L L L+ LDL N + + S+ L
Sbjct: 61 ELLNLSSNVL-YETLD---------LESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 231 LASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLP 290
A+N + + + N+ T + +Q + + N ++ T+
Sbjct: 106 AANNNI-SRVS---CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN 160
Query: 291 PG--LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESI 348
+ L N+ +N I + L L L N+ +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYD---------VKGQVVFAKLKTLDLSSNKLA-FMGPEF 210
Query: 349 GNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408
+ + ++ + L N + I ++ ++L DL N + + +V +
Sbjct: 211 QSAAG-VTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTV 267
Query: 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
A + + + + G ++P F
Sbjct: 268 AKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 61/382 (15%), Positives = 114/382 (29%), Gaps = 70/382 (18%)
Query: 162 DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY 221
+ +N ++ + S+ + S N+K LDL+ N L+ + +
Sbjct: 4 EIKQNGNRYKIEKVTDS--------SLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55
Query: 222 NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMT 281
T L L L+SN L E L +L+ ++ + +
Sbjct: 56 PFTKLELLNLSSNVLY-ETL--------------------------DLESLSTLRTLDLN 88
Query: 282 HNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFE 341
+N ++ L P + T + N I S + + L N+
Sbjct: 89 NNYVQE-----LLVGPSIETLHAANNNISRV----------SCSRGQGKKNIYLANNKIT 133
Query: 342 GKIPESIGNFSNELSKLYLGGNHIYG-KIPASIGRLRSLTLLDLSYNSISGEIPIEIGQL 400
G S + L L N I +L L+L YN I ++ ++
Sbjct: 134 MLRDLDEGCRSR-VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 401 QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNR 460
L+ L L+ N++ + + + I L N+L I + Q+L DL N
Sbjct: 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 461 INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
+ L + S+ + V T+ + C
Sbjct: 249 FHCG-------TLRDFFSKNQRVQTVAKQTVKKLTGQNE--EECTVPTLGHYGAYCCEDL 299
Query: 521 IPNIVAELKGLEVLDLSSNKLS 542
++ L +
Sbjct: 300 -----PAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 40/230 (17%), Positives = 84/230 (36%), Gaps = 19/230 (8%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
I + ++ +S+ + ++ L L+GN + LA KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI-----------LRPLPEEI 477
++LS N L E + +L ++DL+NN + + G + +
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSR 118
Query: 478 SRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSG-PIPNIVAELKGLEVLDL 536
+ I L++N ++ ++ L + N+ + A LE L+L
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 537 SSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
N + + + L++L+L+ N L + P ++ + L+ N
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 40/252 (15%), Positives = 81/252 (32%), Gaps = 25/252 (9%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+LS L + + + L + L +N L ++ +L LR L+++ N +Q
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ--- 93
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
+ ++ L N I + + + + N I L D
Sbjct: 94 --ELLVGPSIETLHAANNNI----SRVSCSRGQGKKNIYLANN--------KITMLRDLD 139
Query: 196 LSRLENLKVLDLTINRLAG-TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254
++ LDL +N + + +L HL L N + ++ V L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV--VFAKLKTL 196
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
N+ + + + I + +N L + L L +++ N
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 315 DEGLSFITSLTN 326
+ S +
Sbjct: 255 RDFFSKNQRVQT 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 52/277 (18%), Positives = 98/277 (35%), Gaps = 34/277 (12%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
LNLSS L + + +LS LR++ L NN + E+ + L+ + NN+ +
Sbjct: 63 LNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
+ K + L NKIT + D +Q L+ N + ++
Sbjct: 115 SCSR--GQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEI-DTVNF------AEL 164
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255
+ + L+ L+L N + V + L L L+SN+L + + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQS-AAGVTWIS 220
Query: 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE-GTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
N+ I +L N++ + N GTL ++T K ++ +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 315 DEGLSF----------ITSLTNSTHLNYLALDGNQFE 341
+E + L +AL +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-35
Identities = 64/342 (18%), Positives = 133/342 (38%), Gaps = 29/342 (8%)
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
+ C + +P + T +++ + N ++ + P L + N + +
Sbjct: 16 VLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73
Query: 315 DEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI- 373
+ N +L L L N+ + IP + + L+KL + N I + +
Sbjct: 74 G-------AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI-VILLDYMF 124
Query: 374 GRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDL 432
L +L L++ N + I L L+ L L + +L++L L + L
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183
Query: 433 SGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
+ SF L +++S+ + L L N+ ++ ++ +
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL--------NLTSLSITHCN 235
Query: 493 LSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQN 551
L+ ++++ L L ++YN S +++ EL L+ + L +L+ + +
Sbjct: 236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRG 294
Query: 552 LQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNPKLC 590
L LR LN++ N L + E +F ++ N + L NP C
Sbjct: 295 LNYLRVLNVSGNQLTTL--EESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 72/399 (18%), Positives = 139/399 (34%), Gaps = 81/399 (20%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITG 157
R++ + +P I R+L++ N ++ + L+ L+L N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP 217
V NL +L+ L N L IP + + L NL LD++ N++ +
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRL-KLIPLGV-------FTGLSNLTKLDISENKIVILLD 121
Query: 218 STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQI 277
++ +L L + N L I + L +++
Sbjct: 122 YMFQDLYNLKSLEVGDNDL-VYIS------------------------HRAFSGLNSLEQ 156
Query: 278 IRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336
+ + L ++P L +L L + I + D S L L +
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDY-------SFKRLYRLKVLEIS 208
Query: 337 GNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA-SIGRLRSLTLLDLSYNSISGEIPI 395
+ + + N L+ L + ++ +P ++ L L L+LSYN IS I
Sbjct: 209 HWPYLDTMTPNCLYGLN-LTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-TIE- 264
Query: 396 EIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID 455
+ L L +L +I L G +L P +F L ++
Sbjct: 265 ----------------------GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302
Query: 456 LSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
+S N++ + + + + N+ T+ L N L+
Sbjct: 303 VSGNQLT-TLEESVFHSVG-------NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 28/303 (9%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
+ L ++L N +S P NLF LR L + N L+ +P+ + + L+ L LD+
Sbjct: 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS 112
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211
NKI + D ++L +L+ L G N + + S L +L+ L L
Sbjct: 113 ENKIV-ILLDYMFQDLYNLKSLEVGDN--------DLVYISHRAFSGLNSLEQLTLEKCN 163
Query: 212 LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHN 271
L + ++ L+ LRL + I L L + + +
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 272 LTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
N+ + +TH L +P + +L +LR N+ +N I + L L
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGS-------MLHELLRL 274
Query: 331 NYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYN 387
+ L G Q + F L L + GN + + S+ + +L L L N
Sbjct: 275 QEIQLVGGQLA-VVEP--YAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSN 330
Query: 388 SIS 390
++
Sbjct: 331 PLA 333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 76/411 (18%), Positives = 144/411 (35%), Gaps = 53/411 (12%)
Query: 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR 260
++ +DL++N +A ++ + L L++ G I + L +L+ +N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 261 FTGKIPGSLHNLTNIQIIRMTHNLL-EGTLPPGL-GNLPFLRTYNIGFNKIVSSGDDEGL 318
F G+ + L N++++ +T L L L L + N I +
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK------I 144
Query: 319 SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRS 378
+ N + L L N+ + I E L RL S
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLL--------------RLSS 189
Query: 379 LTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQI-------- 430
+TL D++ + E + + L L+GN + + +I
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 431 -----DLSGNELTGEIPISFGNFQ--SLLSIDLSNNRINGNIPKGILRPLPEEISRLENV 483
+F + + + DLS ++I + K + ++
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFT-------DL 301
Query: 484 VTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG 543
+ L+ N ++ N+ L +L ++ N + L LEVLDLS N +
Sbjct: 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR- 360
Query: 544 SIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNPKLC 590
++ L L+ L L N L+ V +GIF +++ + L NP C
Sbjct: 361 ALGDQSFLGLPNLKELALDTNQLKSV--PDGIFDRLTSLQKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 89/504 (17%), Positives = 159/504 (31%), Gaps = 108/504 (21%)
Query: 66 CNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLN 125
C+ G + GL P + + + + L N ++ L L+ L
Sbjct: 8 CSVIGYNA---ICINRGL--HQVPEL--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLK 60
Query: 126 ISFNNLQGELPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSI 184
+ + N L+ L +L L N+ ++ L +L+VL + L G++
Sbjct: 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 185 PPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTI-YNMTSLVHLRLASNQLGGEIPYD 243
L +L++L L N + P++ NM L L N++
Sbjct: 120 LSGNF------FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV------- 166
Query: 244 VRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYN 303
++ F GK L L++I + M L + T +
Sbjct: 167 --KSICEED-----LLNFQGKHFTLLR-LSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 304 IGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGN 363
+ N S T + L L + G N
Sbjct: 219 LSGNGFKESMAKR----FFDAIAGTKIQSLILSNSYNMGS-----SFGHTNFKDPD---N 266
Query: 364 HIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLAN 423
+ + AS + DLS + I + + + +
Sbjct: 267 FTFKGLEAS-----GVKTCDLSKSKIF---------------------ALLKSVFSHFTD 300
Query: 424 LKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482
L++L L+ NE+ +I +F LL ++LS N + G+I + L+
Sbjct: 301 LEQL---TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFE-------NLDK 348
Query: 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542
+ +DLS N + L + F G L L+ L L +N+L
Sbjct: 349 LEVLDLSYNHIR-ALGDQS---------------FLG--------LPNLKELALDTNQLK 384
Query: 543 GSIPSD-LQNLQALRSLNLTFNNL 565
S+P L +L+ + L N
Sbjct: 385 -SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 74/347 (21%), Positives = 130/347 (37%), Gaps = 62/347 (17%)
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIV 310
L + C + K+P L + ++ + +N + + G NL L T + NKI
Sbjct: 33 LRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP 370
+ L L L NQ + ++PE + L +L + N I K+
Sbjct: 90 KISPG-------AFAPLVKLERLYLSKNQLK-ELPEKM--PKT-LQELRVHENEIT-KVR 137
Query: 371 ASI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
S+ L + +++L N + IE + +KKL+
Sbjct: 138 KSVFNGLNQMIVVELGTNPLK-SSGIE---------------------NGAFQGMKKLSY 175
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
I ++ +T I G SL + L N+I + L+ L N+ + LS
Sbjct: 176 IRIADTNITT---IPQGLPPSLTELHLDGNKIT-KVDAASLKGLN-------NLAKLGLS 224
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD- 548
NS+S SL N L EL + N+ +P +A+ K ++V+ L +N +S +I S+
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSND 282
Query: 549 ------LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGN 586
+ ++L N ++ FR + V L
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 73/354 (20%), Positives = 128/354 (36%), Gaps = 70/354 (19%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
LRV+ S L+ ++P ++ + +LDL NKIT + D +NL++L L N
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINN-- 86
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
I+ + P + L L+ L L+ N+L +P + +L LR+ N++ ++
Sbjct: 87 ------KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KV 136
Query: 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLL-EGTLPPG-LGNLPF 298
+ L + ++ + N L + G +
Sbjct: 137 R------------------------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNS--THLNYLALDGNQFEGKIPESIGNFSN--E 354
L I I T++ L L LDGN+ K+ +
Sbjct: 173 LSYIRIADTNI------------TTIPQGLPPSLTELHLDGNKIT-KVDA--ASLKGLNN 217
Query: 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIP 414
L+KL L N I S+ L L L+ N + ++P + + +QV+ L N I
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
Query: 415 G------GIPNSLANLKKLNQIDLSGNELT-GEI-PISFGNFQSLLSIDLSNNR 460
P + + L N + EI P +F ++ L N +
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 68/353 (19%), Positives = 123/353 (34%), Gaps = 72/353 (20%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P DL + +LDL N++ N+ +L L L +N++ +I
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS---------- 92
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
PG+ L ++ + ++ N L+ LP + L+ + N+I
Sbjct: 93 --------------PGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK 135
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQF-EGKIPESIGNFSN--ELSKLYLGGNHIYGK 368
+ + L N I G F +LS + + +I
Sbjct: 136 VRKS-------VFNGLNQMIVVELGTNPLKSSGIEN--GAFQGMKKLSYIRIADTNI-TT 185
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKL 427
IP + SLT L L N I+ ++ L L LGL+ N I SLAN L
Sbjct: 186 IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 242
Query: 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487
++ L+ N+L ++P + + + + L NN I+ I P P ++ + +
Sbjct: 243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCP-PGYNTKKASYSGVS 299
Query: 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
L N + ++ P+ + + L + K
Sbjct: 300 LFSNPVQ---------YWEIQ-------------PSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 69/333 (20%), Positives = 117/333 (35%), Gaps = 64/333 (19%)
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV 227
+L+ N I + D L+NL L L N+++ P + L
Sbjct: 52 PDTALLDLQNN--------KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG 287
L L+ NQL LP + +Q +R+ N +
Sbjct: 104 RLYLSKNQL---------KELPEKM-------------------PKTLQELRVHENEIT- 134
Query: 288 TLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE 346
+ L + +G N + SSG + G + L+Y+ + IP+
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENG-----AFQGMKKLSYIRIADTNIT-TIPQ 188
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPA-SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405
G + L++L+L GN I K+ A S+ L +L L LS+NSIS + L+
Sbjct: 189 --GLPPS-LTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244
Query: 406 LGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG------EIPISFGNFQSLLSIDLSNN 459
L L N++ +P LA+ K + + L N ++ P S + L +N
Sbjct: 245 LHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 460 RIN-GNIPKGILRPLPEEISRLENVVTIDLSDN 491
+ I R + + L +
Sbjct: 304 PVQYWEIQPSTFRCVY-------VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/264 (23%), Positives = 103/264 (39%), Gaps = 26/264 (9%)
Query: 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388
HL + E K+P+ + + + L L N I L++L L L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 389 ISGEIPIEIGQ-LQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS 444
IS +I L L+ L L+ N E+P +P +L L + NE+T
Sbjct: 88 IS-KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL------RVHENEITKVRKSV 140
Query: 445 FGNFQSLLSIDLSNNRI-NGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503
F ++ ++L N + + I G + + + I ++D +++ +P L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMK-------KLSYIRIADTNIT-TIPQGL-- 190
Query: 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563
SL EL + N+ + + L L L LS N +S L N LR L+L N
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 564 NLEGVVPSEGIFRNMSNVHLKGNP 587
L V + + V+L N
Sbjct: 251 KLVKVPGGLADHKYIQVVYLHNNN 274
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 71/355 (20%), Positives = 128/355 (36%), Gaps = 54/355 (15%)
Query: 48 PLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKL 107
+ P C P C V S GLE + + + LQNNK+
Sbjct: 14 EVPEIEPMGPVC--PFR-CQCHLRVV---QCSDLGLE-KVPKDLP--PDTALLDLQNNKI 64
Query: 108 SGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKITGRVTDDQLRN 166
+ + NL L L + N + ++ + L +L+ L L N++ + + +
Sbjct: 65 TEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT 122
Query: 167 LRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV--PSTIYNMT 224
L+ L +N + + S+ + L + V++L N L + M
Sbjct: 123 LQE---LRVHENEI-TKVRKSV-------FNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNL--LDFIYCFNRFTGKIP-GSLHNLTNIQIIRMT 281
L ++R+A + IP + P+L L N+ T K+ SL L N+ + ++
Sbjct: 172 KLSYIRIADTNI-TTIP---QGLPPSLTELHLDG--NKIT-KVDAASLKGLNNLAKLGLS 224
Query: 282 HNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQF 340
N + + G L N P LR ++ NK+V L + ++ + L N
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV--------KVPGGLADHKYIQVVYLHNNNI 275
Query: 341 EGKIPES----IGNFSN--ELSKLYLGGNHI-YGKIPASI-GRLRSLTLLDLSYN 387
I + G + S + L N + Y +I S + + L
Sbjct: 276 S-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 79/476 (16%), Positives = 172/476 (36%), Gaps = 29/476 (6%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
+++ L N +S +I L LRVL +S N ++ L ++ +L+ LD+ N++
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215
++ + SL+ L+ N + +P + L L L L+ +
Sbjct: 113 QN-ISCC---PMASLRHLDLSFN-DFDVLPVC------KEFGNLTKLTFLGLSAAKFRQL 161
Query: 216 VPSTIYN-MTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR-FTGKIPGSLHNLT 273
+ + S + L L S + G ++ +L ++ N F+ ++ S++ L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 274 NIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYL 333
++Q+ + N + + + + + YL
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 334 ALDGNQFEGKIPESIGNFSN----ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSI 389
+ +I +S L ++ A + + LS +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 390 SGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQ 449
+ L N + + LK+L + L N L +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 450 SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509
++ S++ + +N ++ + E+++ ++LS N L+G++ L ++
Sbjct: 401 NMSSLETLDVSLN-SLNSHAYDRT---CAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454
Query: 510 LLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNN 564
L + N+ IP V L+ L+ L+++SN+L S+P L +L+ + L N
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 97/493 (19%), Positives = 192/493 (38%), Gaps = 58/493 (11%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
+ L++S N++ +IS L+EL++L L N+I + + L+ L+ N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY--NMTSLVHLRLASNQLGG 238
+I + +L+ LDL+ N +P N+T L L L++ +
Sbjct: 113 Q-NISC----------CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF-R 159
Query: 239 EIPYDVRDTLPNLLDFIYCF-NRFTGKIPGSLH--NLTNIQIIRMTHNLLEGTLPPGLGN 295
++ L + G SL N T + ++ ++L + +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 296 LPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF--SN 353
L L+ NI N ++F++ LT L + L + K + F
Sbjct: 220 LGHLQLSNIKLNDE---NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 354 ELSKLYLGGNHIYGKIPASIGR-----LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408
+ L + I +I L+SL + + + + L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 409 AGNE---IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNI 465
+ ++ I P S ++ L + + N T + + L ++ L N
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQRNG----- 388
Query: 466 PKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC-----KSLEELLMAYNQFSGP 520
L+ + +N+ +++ D SL+ +L + + +S+ L ++ N +G
Sbjct: 389 ----LKNFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
+ + ++VLDL +N++ SIP D+ +LQAL+ LN+ N L+ V +G+F +++
Sbjct: 444 VFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV--PDGVFDRLTS 498
Query: 581 ---VHLKGNPKLC 590
+ L NP C
Sbjct: 499 LQYIWLHDNPWDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 64/408 (15%), Positives = 128/408 (31%), Gaps = 51/408 (12%)
Query: 92 GNLSFLRSIQLQNNKL-SGNLPREIGNLFRLRVLNISFNNLQGELPVNISKL-TELKMLD 149
GNL+ L + L K +L +L++ +++G ++ T + L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 150 LMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTI 209
N + + + L LQ+ N N + + + + L N+ + +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSEL-TRGPTLLNVTLQHIET 261
Query: 210 NRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY----CFNRFTGKI 265
+ + +L + + + I + L + F
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 266 PGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLT 325
+ I ++ + + N N D ++L
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT----DSVFQGCSTLK 377
Query: 326 NSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLS 385
L L L N + + N + SL LD+S
Sbjct: 378 R---LQTLILQRNGLK-NFFKVALMTKN----------------------MSSLETLDVS 411
Query: 386 YNSI-SGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSL-ANLKKLNQIDLSGNELTGEIPI 443
NS+ S + + VL L+ N + G + L +K L DL N + IP
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIM-SIPK 467
Query: 444 SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491
+ Q+L +++++N++ ++P G+ L ++ I L DN
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFDRLT-------SLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 63/414 (15%), Positives = 133/414 (32%), Gaps = 52/414 (12%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P DL K L L+ N ++ I ++ L LRL+ N++ +L
Sbjct: 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI---------RSLD-- 92
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIV 310
+++ + ++HN L+ + + +L L ++ FN
Sbjct: 93 --------------FHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHL---DLSFNDFD 134
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP 370
+ +T LT +L L +F + + L L HI G
Sbjct: 135 VLPVCKEFGNLTKLT------FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 371 ASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK----- 425
S+ + T+L L ++ S + L L L+ ++ L
Sbjct: 189 ESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 426 --KLNQIDLSGNELTGEIPISFGNFQ---SLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
L + L E T + + F + +++ N I I + + L
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR---EEFTYSETAL 304
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
++++ + + + + +++ + L+ + N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQLG 594
+ S+ L+ L++L L N L+ + +NMS++ L
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 52/293 (17%), Positives = 98/293 (33%), Gaps = 24/293 (8%)
Query: 26 INTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVIC---NNFGNRVIGLNLSSFG 82
I + E + +S+ + L TW + + V LN+ +
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 83 LEGTISPHIGN-----LSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPV 137
+ I L L ++N + + + +S ++ V
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLS 197
+ L+ N T L+ LQ L +N L + +
Sbjct: 348 CPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGL-KNFFK-----VALMTK 400
Query: 198 RLENLKVLDLTINRL-AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY 256
+ +L+ LD+++N L + T S++ L L+SN L V LP + +
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML----TGSVFRCLPPKVKVLD 456
Query: 257 -CFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFN 307
NR IP + +L +Q + + N L+ ++P G L L+ + N
Sbjct: 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 49/248 (19%), Positives = 98/248 (39%), Gaps = 17/248 (6%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG---LQVL 406
+ ++L L N + +L LT L LS N +S G L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYL 83
Query: 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNI 465
L+ N + + ++ L++L +D + L S F + ++L+ +D+S+
Sbjct: 84 DLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VA 141
Query: 466 PKGILRPLPEEISRLENVVTIDLSDNSLSGNL-PNSLKNCKSLEELLMAYNQFSGPIPNI 524
GI L ++ + ++ NS N P+ ++L L ++ Q P
Sbjct: 142 FNGIFNGLS-------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPS--EGIFRNMSNVH 582
L L+VL++S N + L +L+ L+ + N++ + +++ ++
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254
Query: 583 LKGNPKLC 590
L N C
Sbjct: 255 LTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/306 (18%), Positives = 99/306 (32%), Gaps = 69/306 (22%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P+ + + L+L N+L +T L L L+SN L
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL--------------- 64
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
F G S T+++ + ++ N + T+ L L + + +
Sbjct: 65 --------SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 115
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKI 369
+S + + +L YL + I F+ L L + GN
Sbjct: 116 ------MSEFSVFLSLRNLIYLDISHTHTR-VAFNGI--FNGLSSLEVLKMAGNSFQENF 166
Query: 370 PASI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
I LR+LT LDLS + ++ P + +L L
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLE-QLS-----------------------PTAFNSLSSLQ 202
Query: 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488
+++S N + SL +D S N I K L+ P ++ L +L
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFL------NL 255
Query: 489 SDNSLS 494
+ N +
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 58/292 (19%), Positives = 98/292 (33%), Gaps = 49/292 (16%)
Query: 124 LNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGS 183
+ + L +P I + L+L +NK+ + L L L+ N L
Sbjct: 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGL--- 64
Query: 184 IPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYD 243
S +LK LDL+ N + T+ S + L HL + L +
Sbjct: 65 ---SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120
Query: 244 VRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYN 303
V +L NL+ G + L+++++++M N + P +
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI---------- 170
Query: 304 IGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGN 363
T +L +L L Q E ++ + N + L L + N
Sbjct: 171 --------------------FTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 364 HIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG----LQVLGLAGN 411
+ + L SL +LD S N I + +LQ L L L N
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHIMT---SKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 19/247 (7%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL--QGELPVNISKLTELKMLDLMANK 154
++L++NKL L +L L++S N L +G + T LK LDL N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 155 ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214
+ ++ + L L+ L+F + L + S L NL LD++
Sbjct: 90 VI-TMSSN-FLGLEQLEHLDFQHSNL-KQMSE------FSVFLSLRNLIYLDISHTHTRV 140
Query: 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274
++SL L++A N D+ L NL + P + ++L++
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 275 IQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYL 333
+Q++ M+HN +L L L+ + N I++S E F +SL +L
Sbjct: 201 LQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA------FL 253
Query: 334 ALDGNQF 340
L N F
Sbjct: 254 NLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 39/193 (20%), Positives = 71/193 (36%), Gaps = 12/193 (6%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
+ L+ + L N + + L +L L+ +NL+ ++ L L LD+
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211
+ L SL+VL N + P I + L NL LDL+ +
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-------FTELRNLTFLDLSQCQ 186
Query: 212 LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHN 271
L P+ +++SL L ++ N + L +L Y N L +
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245
Query: 272 L-TNIQIIRMTHN 283
+++ + +T N
Sbjct: 246 FPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 33/172 (19%), Positives = 61/172 (35%), Gaps = 19/172 (11%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN-GNIPKGIL 470
+P GIP+S L +L N+L F L + LS+N ++
Sbjct: 21 SVPTGIPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD 74
Query: 471 RPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSG-PIPNIVAELK 529
++ +DLS N + + ++ + LE L ++ ++ L+
Sbjct: 75 FGTT-------SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 530 GLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L LD+S + L +L L + N+ + IF + N
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRN 176
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 39/183 (21%), Positives = 72/183 (39%), Gaps = 13/183 (7%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
L+LS G+ T+S + L L + Q++ L + +L L L+IS + +
Sbjct: 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-V 140
Query: 135 LPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIP 193
I + L+ L++L + N D LR+L L+ + L + P+
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA----- 194
Query: 194 SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253
+ L +L+VL+++ N + SL L + N + P+ L
Sbjct: 195 --FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLA 251
Query: 254 FIY 256
F+
Sbjct: 252 FLN 254
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/266 (24%), Positives = 94/266 (35%), Gaps = 78/266 (29%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWKS----------------FIAECE 694
I Y E+ E ++G G+FG V W++ FI E
Sbjct: 5 IDYKEI-------EVEEVVGRGAFGVVCK----AKWRAKDVAIKQIESESERKAFIVELR 53
Query: 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
L V H N+VKL +C + + LV E+ GSL + +HG
Sbjct: 54 QLSRVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 746 --LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-AKVGDFGLARFLLERVDNQSSI 802
L + + YLH+ ++H DLKP N+LL T K+ DFG A +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMT 161
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDV---------------PTSESFAGEFNIVKWV 847
++ GS ++ PE G S DV P E F I+ V
Sbjct: 162 NNK----GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
Query: 848 ESNL----PENVLQVLDPELRQLMTS 869
+ +N+ + LMT
Sbjct: 218 HNGTRPPLIKNL----PKPIESLMTR 239
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 68/375 (18%), Positives = 123/375 (32%), Gaps = 85/375 (22%)
Query: 198 RLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC 257
VL++ + L T+P + + L + N L +LP
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL---------TSLPA------- 78
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEG 317
++ + ++ N L +LP L L ++ + +
Sbjct: 79 -------------LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL----- 119
Query: 318 LSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377
+ L L + GNQ +P L +L + N + +PA L
Sbjct: 120 ---PSGLCK------LWIFGNQLT-SLPVLPPG----LQELSVSDNQL-ASLPALPSELC 164
Query: 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNEL 437
L N ++ +P+ LQ L ++ N++ +P + L KL N L
Sbjct: 165 KL---WAYNNQLT-SLPMLPSGLQ---ELSVSDNQL-ASLPTLPSELYKL---WAYNNRL 213
Query: 438 TGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNL 497
T +P + L +S NR+ LP S L+ + +S N L+ +L
Sbjct: 214 T-SLPALPSGLKEL---IVSGNRLTS---------LPVLPSELKE---LMVSGNRLT-SL 256
Query: 498 PNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRS 557
P L L + NQ + +P + L ++L N LS L+ + +
Sbjct: 257 PMLPSG---LLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPG 312
Query: 558 LNLTFNNLEGVVPSE 572
+ + S
Sbjct: 313 YSGPIIRFDMAGASA 327
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 73/429 (17%), Positives = 136/429 (31%), Gaps = 77/429 (17%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFR--LRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155
R+ + ++ + +++ VLN+ + L LP + + L + N +
Sbjct: 17 RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNL 73
Query: 156 TGRVTDDQL-RNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214
T L L+ L N L +P L L + + L
Sbjct: 74 T------SLPALPPELRTLEVSGNQL---------TSLPVLPPGLLELSIFSNPLTHL-- 116
Query: 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274
P+ + L L + NQL +P P L + N+ +P L
Sbjct: 117 --PALP---SGLCKLWIFGNQLT-SLP----VLPPGLQELSVSDNQLA-SLPALPSELCK 165
Query: 275 IQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS-THLNYL 333
+ +N L +LP L L ++ N++ SL + L L
Sbjct: 166 L---WAYNNQLT-SLPMLPSGLQEL---SVSDNQL------------ASLPTLPSELYKL 206
Query: 334 ALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEI 393
N+ +P L +L + GN + +P L+ L +S N ++ +
Sbjct: 207 WAYNNRLT-SLPALPSG----LKELIVSGNRL-TSLPVLPSELKEL---MVSGNRLT-SL 256
Query: 394 PIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLS 453
P+ L L + N++ +P SL +L ++L GN L+ + + + S
Sbjct: 257 PMLPSGLL---SLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS---ERTLQALREITS 309
Query: 454 IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP----NSLKNCKSLEE 509
+ I P E L L P + + +
Sbjct: 310 APGYSGPI--IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADA 367
Query: 510 LLMAYNQFS 518
+ ++ S
Sbjct: 368 FSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 51/281 (18%)
Query: 321 ITSLTNS--THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRS 378
+T+L + H+ L + N +P L L + GN + +P L
Sbjct: 52 LTTLPDCLPAHITTLVIPDNNLT-SLPALPPE----LRTLEVSGNQLT-SLPVLPPGLLE 105
Query: 379 LTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438
L++ + GL L + GN++ +P L++L +S N+L
Sbjct: 106 LSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSLPVLPPGLQEL---SVSDNQLA 154
Query: 439 GEIPISFGNFQSLLSIDLSNNRINGNIPKGI------------LRPLPEEISRLENVVTI 486
+P L NN++ ++P L LP S L +
Sbjct: 155 -SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQELSVSDNQLASLPTLPSELYK---L 206
Query: 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP 546
+N L+ +LP L+EL+++ N+ + +P L+ L +S N+L+ S+P
Sbjct: 207 WAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257
Query: 547 SDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
L SL++ N L + S + + V+L+GNP
Sbjct: 258 MLPSGLL---SLSVYRNQLTRLPESLIHLSSETTVNLEGNP 295
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 70/414 (16%), Positives = 127/414 (30%), Gaps = 112/414 (27%)
Query: 67 NNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNI 126
+ + L + L ++ L R++++ N+L+ +LP L L + +
Sbjct: 57 DCLPAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSN 111
Query: 127 SFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPP 186
+L + L L + N++T S+P
Sbjct: 112 PLTHLPAL-------PSGLCKLWIFGNQLT--------------------------SLPV 138
Query: 187 SIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRD 246
L+ L ++ N+LA ++P+ + L L +NQL
Sbjct: 139 LP-----------PGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQL---------T 174
Query: 247 TLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGF 306
+LP L L L+ ++ N L +LP L L YN
Sbjct: 175 SLPMLP--------------SGLQELS------VSDNQLA-SLPTLPSELYKLWAYN--- 210
Query: 307 NKIVSSGDDEGLSFITSLTNS-THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHI 365
N+ +TSL + L L + GN+ +P L +L + GN +
Sbjct: 211 NR------------LTSLPALPSGLKELIVSGNRLTS-LPVLPSE----LKELMVSGNRL 253
Query: 366 YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN---EIPGGIPNSLA 422
+P L S L + N ++ +P + L + L GN E +
Sbjct: 254 -TSLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEE 476
+ + + + P + L R P +E
Sbjct: 309 SAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 17/96 (17%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535
+++ ++ L+ LP+ L + L++ N + ++ A L L+
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNN----LTSLPALPPELRTLE 87
Query: 536 LSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPS 571
+S N+L+ S+P L L + +L +
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 54/199 (27%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWK--------------------SFI 690
I + +L + + IG+GSFG+V W F+
Sbjct: 34 IPWCDL-------NIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDFHAERVNEFL 82
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE----- 745
E ++ +RH N+V + + + + L++V E+LS GSL +H E
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 746 ------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
D+ ++YLHN P+VH +LK N+L+D++ T KV DFGL+R
Sbjct: 138 RRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK------A 190
Query: 800 SSISSTHVFMGSIGYVPPE 818
S+ S+ G+ ++ PE
Sbjct: 191 STFLSSKSAAGTPEWMAPE 209
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 53/214 (24%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLH------------------NERTGSWKSFIAE 692
I + EL E +IG G FG V + + + ++ E
Sbjct: 4 IDFAELTL-------EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 693 CETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------- 745
+ ++H N++ L C L LV EF G L + G+R
Sbjct: 57 AKLFAMLKHPNIIALRGVCL-----KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA 111
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM--------TAKVGDFGLARFLLERVD 797
+ I ++YLH++ VP++H DLK NIL+ +++ K+ DFGLAR
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----- 166
Query: 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
+ + G+ ++ PE S DV
Sbjct: 167 -HRTTKMSAA--GAYAWMAPEVIRASMFSKGSDV 197
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 63/347 (18%), Positives = 123/347 (35%), Gaps = 63/347 (18%)
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIV 310
L + C + +P + + ++ + +N + L L L + NKI
Sbjct: 35 LRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS 91
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP 370
+ + + L L + N +IP ++ S+ L +L + N I K+P
Sbjct: 92 KIHEK-------AFSPLRKLQKLYISKNHLV-EIPPNL--PSS-LVELRIHDNRIR-KVP 139
Query: 371 ASI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ LR++ +++ N + E G GL KLN
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGL----------------------KLNY 176
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+ +S +LTG I ++L + L +N+I I L + + L
Sbjct: 177 LRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYS-------KLYRLGLG 225
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD- 548
N + SL +L EL + N+ S +P + +LK L+V+ L +N ++ + +
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVND 283
Query: 549 ------LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGN 586
++L N + FR +++ +
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 34/274 (12%)
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASIGRLRSLTLLDL 384
S L L N ++ + +F L L L N I + LR L L +
Sbjct: 53 SPDTTLLDLQNNDIS-ELRK--DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 385 SYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS 444
S N + I L L + N I + L+ +N I++ GN L
Sbjct: 110 SKNHLVE---IPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-NSGFE 165
Query: 445 FGNFQ--SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLK 502
G F L + +S ++ IPK + L E + L N + L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDLPETLNE----------LHLDHNKIQAIELEDLL 214
Query: 503 NCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTF 562
L L + +NQ ++ L L L L +NKLS +P+ L +L+ L+ + L
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 563 NNLEGVVPSEGIFRNM---------SNVHLKGNP 587
NN+ V F + + + L NP
Sbjct: 274 NNITKV--GVNDFCPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 64/351 (18%), Positives = 116/351 (33%), Gaps = 69/351 (19%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P ++S + +LDL N ++ + L L L +N++ +I
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIH---------- 94
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
+ L +Q + ++ N L +PP L L I N+I
Sbjct: 95 --------------EKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK 137
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN-ELSKLYLGGNHIYGKIP 370
+ ++N + + GN E G F +L+ L + + IP
Sbjct: 138 VPKG-------VFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLRISEAKL-TGIP 188
Query: 371 ASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ +L L L +N I I +E + L LGL N+I SL+ L L +
Sbjct: 189 KDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+ L N+L+ +P + + L + L N I + P+ + R +
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRA------YYN 297
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
SL N + + F + + + K
Sbjct: 298 GISLFNN---------PVPYWEVQPATFRC--------VTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 22/274 (8%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA 152
L L ++ L NNK+S + L +L+ L IS N+L E+P N+ + L L +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL 212
N+I +V LR++ + G N L S L L ++ +L
Sbjct: 133 NRIR-KVPKGVFSGLRNMNCIEMGGNPLENSG-------FEPGAFDGLKLNYLRISEAKL 184
Query: 213 AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNL 272
+P + +L L L N++ I + L N+ GSL L
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
++ + + +N L +P GL +L L+ + N I + + + N
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNG 298
Query: 333 LALDGNQFE-GKIPESIGNFSN--ELSKLYLGGN 363
++L N ++ F + + G
Sbjct: 299 ISLFNNPVPYWEVQP--ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 79/355 (22%), Positives = 118/355 (33%), Gaps = 73/355 (20%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
LRV+ S L+ +P IS + +LDL N I+
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS------------------------ 67
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
+ D L++L L L N+++ + L L ++ N L EI
Sbjct: 68 --ELRKD-------DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VEI 117
Query: 241 PYDVRDTLPNL--LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLL-EGTLPPGLGNLP 297
P + +L L NR G L N+ I M N L PG +
Sbjct: 118 P---PNLPSSLVELRIHD--NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNS--THLNYLALDGNQFEGKIPESIGNFSN-- 353
L I K +T + LN L LD N+ + I +
Sbjct: 173 KLNYLRISEAK------------LTGIPKDLPETLNELHLDHNKIQ-AIEL--EDLLRYS 217
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN-- 411
+L +L LG N I S+ L +L L L N +S +P + L+ LQV+ L N
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
Query: 412 -EIPGGI---PNSLANLKKLNQIDLSGNELTGEI--PISFGNFQSLLSIDLSNNR 460
++ N I L N + P +F L+I N +
Sbjct: 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 60/265 (22%), Positives = 100/265 (37%), Gaps = 29/265 (10%)
Query: 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388
HL + + +P+ I S + + L L N I L+ L L L N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 389 ISGEIPIEI-GQLQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS 444
IS +I + L+ LQ L ++ N EIP +P+SL L + N +
Sbjct: 90 IS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVEL------RIHDNRIRKVPKGV 142
Query: 445 FGNFQSLLSIDLSNNRI-NGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503
F +++ I++ N + N G L + + +S+ L+G + +
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL--------KLNYLRISEAKLTGIPKDLPET 194
Query: 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTF 562
L EL + +N+ + L L L N++ I + L L LR L+L
Sbjct: 195 ---LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDN 250
Query: 563 NNLEGVVPSEGIFRNMSNVHLKGNP 587
N L V + + V+L N
Sbjct: 251 NKLSRVPAGLPDLKLLQVVYLHTNN 275
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 35/198 (17%), Positives = 68/198 (34%), Gaps = 56/198 (28%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWK--------------------SFI 690
I + +L + + G + G W+ F
Sbjct: 7 IDFKQL-------NFLTKLNENHSGELWK----GRWQGNDIVVKVLKVRDWSTRKSRDFN 55
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL---- 746
EC LR H N++ ++ +C S + + L+ ++ GSL + +H +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPH---PTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112
Query: 747 ------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800
D+ + +LH E + L ++++DE+MTA++ +
Sbjct: 113 AVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF---------- 161
Query: 801 SISSTHVFMGSIGYVPPE 818
S S M + +V PE
Sbjct: 162 SFQSPGR-MYAPAWVAPE 178
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 78/480 (16%), Positives = 145/480 (30%), Gaps = 74/480 (15%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKIT 156
S ++ L L L+ +++ ++ I KLT L L +N I
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI- 76
Query: 157 GRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV 216
T L +L L N + NL D++ L L L+ N+L
Sbjct: 77 ---TTLDLSQNTNLTYLACDSN--------KLTNL---DVTPLTKLTYLNCDTNKLTKLD 122
Query: 217 PSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQ 276
S L +L A N L EI L + N+ K+ + T +
Sbjct: 123 VS---QNPLLTYLNCARNTL-TEIDV---SHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336
+ + N + L + L N N I L + L +L
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK----------LDLNQNIQLTFLDCS 220
Query: 337 GNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIE 396
N+ +I + + L+ N + ++ S L LT L + I+
Sbjct: 221 SNKLT-EID--VTPLTQ-LTYFDCSVNPL-TELDVST--LSKLTTLHCIQTDLLE---ID 270
Query: 397 IGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDL 456
+ L G + + +L +D +T + L+ + L
Sbjct: 271 LTHNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYL 325
Query: 457 SNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQ 516
+N + + +S + ++ + + + S+ +L A Q
Sbjct: 326 NNTELT-ELD----------VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQ 372
Query: 517 FSGPIPNIVAELK-----GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPS 571
+ ++LD N ++ P D + +T+ NL P+
Sbjct: 373 TITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQA-TNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 80/447 (17%), Positives = 162/447 (36%), Gaps = 62/447 (13%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
++F ++ T + L+ L S+ N+ ++ ++ I L L L + NN+
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT-- 78
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIA------ 189
+++S+ T L L +NK+T + + L L LN N L + S
Sbjct: 79 -LDLSQNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYL 132
Query: 190 ----NLIPS-DLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDV 244
N + D+S L LD +N+ + T L L + N++ DV
Sbjct: 133 NCARNTLTEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKI---TELDV 187
Query: 245 RDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI 304
L N T K+ L+ + + + N L + + L L ++
Sbjct: 188 SQ-NKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240
Query: 305 GFNKIVSSGDDEGLSFITSL------------TNSTHLNYLALDGNQFEGKIPESIGNFS 352
N + + D LS +T+L T++T L Y +G + ++ + + +
Sbjct: 241 SVNPL-TELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELD--VTHNT 297
Query: 353 NELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNE 412
L L I ++ + + L L L+ ++ +++ L+ L
Sbjct: 298 Q-LYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAH 350
Query: 413 IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472
I S+ + LN + + + N + L+I +S + ++ G
Sbjct: 351 IQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTN--NSLTIAVSPDLLDQF---GNPMN 403
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLPN 499
+ + + T ++ +LS + P
Sbjct: 404 IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 65/389 (16%), Positives = 115/389 (29%), Gaps = 79/389 (20%)
Query: 178 NLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237
N L S + P D N + T + + +L L ++ +
Sbjct: 1 NTLKAGQTQSFNDWFPDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI- 54
Query: 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297
+ + LT + + T N + TL L
Sbjct: 55 --------TDMTGI------------------EKLTGLTKLICTSNNIT-TLD--LSQNT 85
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSK 357
L NK+ + +T T L YL D N+ K+ S + L+
Sbjct: 86 NLTYLACDSNKLTN----------LDVTPLTKLTYLNCDTNKLT-KLDVSQ---NPLLTY 131
Query: 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGI 417
L N + +I + LT LD N +++ L L + N+I
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI---T 183
Query: 418 PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEI 477
++ K LN+++ N +T + L +D S+N++ I +
Sbjct: 184 ELDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID----------V 229
Query: 478 SRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLS 537
+ L + D S N L+ L S L L I + L
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAE 283
Query: 538 SNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
+ + D+ + L L+ +
Sbjct: 284 GCRKIKEL--DVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 49/295 (16%), Positives = 102/295 (34%), Gaps = 37/295 (12%)
Query: 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHI 365
F V++ + + S L L + + I + L+KL N+I
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTG-LTKLICTSNNI 76
Query: 366 YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK 425
+ + + +LT L N ++ +++ L L L N++ ++
Sbjct: 77 -TTLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNP 127
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPE---------- 475
L ++ + N LT I + L +D N+ + L
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE 184
Query: 476 -EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534
++S+ + + ++ N+++ L L L L + N+ + I V L L
Sbjct: 185 LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF 238
Query: 535 DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589
D S N L+ + + L L +L+ +L + + + +G K+
Sbjct: 239 DCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTH--NTQLIYFQAEGCRKI 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 36/182 (19%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK---------------SFIAECE--TLRNVRHRNLVKLI 708
+G G +G V GSW+ S+ E E +RH N++ I
Sbjct: 13 LECVGKGRYGEVWR----GSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHND--- 758
S + + + L L+ + GSL D++ + L I S L +LH +
Sbjct: 69 ASDMTSRHSSTQ-LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 759 --CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ + H DLK NIL+ + + D GLA + + NQ + + +G+ Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPR-VGTKRYMA 185
Query: 817 PE 818
PE
Sbjct: 186 PE 187
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 25/254 (9%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQG 402
+P+ I + L L N+I + L L +L L NSI +I + L
Sbjct: 69 VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSN-NR 460
L L L N + + L KL ++ L N + IP +F SL+ +DL +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 461 INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
+ I +G L N+ ++L ++ ++P +L LEEL M+ N F
Sbjct: 184 LE-YISEGAFEGLF-------NLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEI 233
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMS 579
P L L+ L + ++++S I + L +L LNL NNL + +F +
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSL--PHDLFTPLR 290
Query: 580 N---VHLKGNPKLC 590
+HL NP C
Sbjct: 291 YLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 54/296 (18%)
Query: 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
+ + + L E+P I + + L+LM N I + D R+L L+VL G+N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGE 239
I + + L +L L+L N L ++ L L L +N +
Sbjct: 111 --------IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ES 161
Query: 240 IPYDVRDTLPNLLD-FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
IP + +P+L+ + + G+ L N++ + +
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN-------------- 207
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELS 356
+ + +LT L L + GN F +I G+F L
Sbjct: 208 -------------------IKDMPNLTPLVGLEELEMSGNHFP-EIRP--GSFHGLSSLK 245
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGN 411
KL++ + + + L SL L+L++N++S +P ++ L+ L L L N
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 52/247 (21%), Positives = 93/247 (37%), Gaps = 24/247 (9%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
R + L N + +L L VL + N+++ ++ V + L L L+L N +
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLT-INRLAG 214
T + L L+ L N + SIP +R+ +L LDL + +L
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYA-------FNRVPSLMRLDLGELKKLEY 186
Query: 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274
+ +L +L L + ++P L L + N F PGS H L++
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNI-KDMPNLTP--LVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 275 IQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYL 333
++ + + ++ + + L L N+ N + S D T +L L
Sbjct: 244 LKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHD-------LFTPLRYLVEL 295
Query: 334 ALDGNQF 340
L N +
Sbjct: 296 HLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 43/217 (19%), Positives = 77/217 (35%), Gaps = 15/217 (6%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
+L L +QL N + L L L + N L +P L++L+ L L
Sbjct: 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLR 155
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211
N I + + SL L+ G+ + + L NLK L+L +
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGEL-------KKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 212 LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHN 271
+ + + L L ++ N EI L +L ++ + +
Sbjct: 208 I--KDMPNLTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264
Query: 272 LTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFN 307
L ++ + + HN L +LP L +L ++ N
Sbjct: 265 LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 13/153 (8%)
Query: 86 TISPHI-GNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNISKLT 143
+I + + L + L K + LF L+ LN+ N++ ++P N++ L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLV 218
Query: 144 ELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLK 203
L+ L++ N + L SL+ L + ++ + + L +L
Sbjct: 219 GLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNS--------QVSLIERNAFDGLASLV 269
Query: 204 VLDLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
L+L N L+ + LV L L N
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 69/254 (27%), Positives = 105/254 (41%), Gaps = 25/254 (9%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQG 402
+P+ I S L L N I S LR L +L LS N I I I L
Sbjct: 58 VPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLS-NNR 460
L L L N + + L KL ++ L N + IP +F SL +DL R
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 461 INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
++ I +G L N+ ++L+ +L +P +L L+EL ++ N S
Sbjct: 173 LS-YISEGAFEGLS-------NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMS 579
P L L+ L + +++ I + NLQ+L +NL NNL + +F +
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLL--PHDLFTPLH 279
Query: 580 N---VHLKGNPKLC 590
+ +HL NP C
Sbjct: 280 HLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 54/296 (18%)
Query: 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
+ + NL+ E+P IS T ++L+L N+I + + ++LR L++L +N
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGE 239
I + + L NL L+L NRL ++ L L L +N +
Sbjct: 100 --------IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ES 150
Query: 240 IPYDVRDTLPNLLD-FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
IP + +P+L + R + G+ L+N++ + +
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN-------------- 196
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELS 356
L I +LT L+ L L GN I G+F L
Sbjct: 197 -------------------LREIPNLTPLIKLDELDLSGNHLS-AIRP--GSFQGLMHLQ 234
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGN 411
KL++ + I + L+SL ++L++N+++ +P ++ L L+ + L N
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 24/245 (9%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
R + L N++ +L L +L +S N+++ + + + L L L+L N++
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLT-INRLAG 214
T + + L L+ L N + SIP +R+ +L+ LDL + RL+
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYA-------FNRIPSLRRLDLGELKRLSY 175
Query: 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274
+++L +L LA L EIP L L + N + PGS L +
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNL-REIPNLTP--LIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 275 IQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYL 333
+Q + M + ++ + NL L N+ N + D T HL +
Sbjct: 233 LQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHD-------LFTPLHHLERI 284
Query: 334 ALDGN 338
L N
Sbjct: 285 HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 30/146 (20%), Positives = 52/146 (35%), Gaps = 18/146 (12%)
Query: 448 FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
+ + +P GI L +L +N + NS K+ + L
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI----STNTRLL------NLHENQIQIIKVNSFKHLRHL 90
Query: 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLE 566
E L ++ N L L L+L N+L+ +IP+ L L+ L L N +E
Sbjct: 91 EILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE 149
Query: 567 GVVPSEGIFRNMSNV---HLKGNPKL 589
+ F + ++ L +L
Sbjct: 150 SI--PSYAFNRIPSLRRLDLGELKRL 173
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 44/182 (24%), Positives = 70/182 (38%), Gaps = 36/182 (19%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK---------------SFIAECE--TLRNVRHRNLVKLI 708
IG G +G V G W+ S+ E E +RH N++ I
Sbjct: 42 VKQIGKGRYGEVWM----GKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHND--- 758
+ + L L+ ++ NGSL D++ + S L +LH +
Sbjct: 98 AADIKGTGSWTQ-LYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 759 --CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ + H DLK NIL+ + T + D GLA + + +T V G+ Y+P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV--GTKRYMP 214
Query: 817 PE 818
PE
Sbjct: 215 PE 216
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 49/196 (25%), Positives = 72/196 (36%), Gaps = 52/196 (26%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSW-------------------KSFIA 691
I ++ IGSGSFG+V G W ++F
Sbjct: 21 IPDGQITV-------GQRIGSGSFGTVYK----GKWHGDVAVKMLNVTAPTPQQLQAFKN 69
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN------- 744
E LR RH N++ + ++ LA+V ++ SL +H
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 745 --ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+DYLH ++H DLK NI L E+ T K+GDFGLA +
Sbjct: 124 DIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 803 SSTHVFMGSIGYVPPE 818
+ GSI ++ PE
Sbjct: 181 QLS----GSILWMAPE 192
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 36/182 (19%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK---------------SFIAECE--TLRNVRHRNLVKLI 708
+ IG G FG V G W+ S+ E E +RH N++ I
Sbjct: 47 QESIGKGRFGEVWR----GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHND--- 758
+ + + + L LV ++ +GSL D+++ L S L +LH +
Sbjct: 103 AADNKDNGTWTQ-LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 759 --CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ + H DLK NIL+ + T + D GLA + + I+ H +G+ Y+
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDIAPNHR-VGTKRYMA 219
Query: 817 PE 818
PE
Sbjct: 220 PE 221
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/278 (20%), Positives = 91/278 (32%), Gaps = 87/278 (31%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLH-----------------------NERTGSWK 687
++ +E+ +E IG G FG V E ++
Sbjct: 16 LADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 688 SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--- 744
F E + N+ H N+VKL +V EF+ G L + +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 745 ------ELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-----EMTAKVGDFGLARFLL 793
LDI ++Y+ N P+VH DL+ NI L + AKV DFGL++
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-- 178
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPE-YGLGERPST----------------AGDVPTSES 836
S G+ ++ PE G E T G+ P E
Sbjct: 179 ---SVHSVSGLL----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 837 FAGEFNIVKWVESN-----LPENVLQVLDPELRQLMTS 869
G+ + + +PE+ P LR ++
Sbjct: 232 SYGKIKFINMIREEGLRPTIPEDC----PPRLRNVIEL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 46/230 (20%), Positives = 74/230 (32%), Gaps = 59/230 (25%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSW-------------------KSFIA 691
I +++L LIG G FG V H G W K+F
Sbjct: 30 IPFEQLEI-------GELIGKGRFGQVYH----GRWHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN------- 744
E R RH N+V + +C + LA++ +L + +
Sbjct: 79 EVMAYRQTRHENVVLFMGACM-----SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 745 --ELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
+I + YLH ++H DLK N+ D + DFGL +
Sbjct: 134 QIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDV-PTSE-----SFAGEFNIVKW 846
+ G + ++ PE P T D P S+ + + +
Sbjct: 190 KLR-IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG----TIWY 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 48/227 (21%), Positives = 85/227 (37%), Gaps = 18/227 (7%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
+P I + + L N IS + L +L L N + + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 429 QIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487
Q+DLS N + + F L ++ L + + G+ R L L+ +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA----ALQ---YLY 135
Query: 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547
L DN+L ++ ++ +L L + N+ S L L+ L L N+++ +
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHP 194
Query: 548 D-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNPKLC 590
++L L +L L NNL + + + L NP +C
Sbjct: 195 HAFRDLGRLMTLYLFANNLSAL--PTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 41/192 (21%), Positives = 64/192 (33%), Gaps = 11/192 (5%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
L + L +N L+ L L L++S N + L L L L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211
+ + R L +LQ L N L ++P L NL L L NR
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDT-------FRDLGNLTHLFLHGNR 164
Query: 212 LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHN 271
++ + SL L L N++ + L L+ N + +L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 272 LTNIQIIRMTHN 283
L +Q +R+ N
Sbjct: 224 LRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 61/282 (21%), Positives = 94/282 (33%), Gaps = 75/282 (26%)
Query: 134 ELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIP 193
+PV I + + L N+I+ V R R+L +L N +A +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSN--------VLARIDA 73
Query: 194 SDLSRLENLKVLDLTINRLAGTVPS-TIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLL 252
+ + L L+ LDL+ N +V T + + L L L L E+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELG----------- 121
Query: 253 DFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312
PG L +Q + + N L+ LP
Sbjct: 122 -------------PGLFRGLAALQYLYLQDNALQ-ALPDDT------------------- 148
Query: 313 GDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIP 370
+ +L +L L GN+ +PE F L +L L N + P
Sbjct: 149 -----------FRDLGNLTHLFLHGNRIS-SVPE--RAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 371 ASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGN 411
+ L L L L N++S +P E L+ LQ L L N
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 22/180 (12%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
+P GIP + + L GN ++ SF ++L + L +N + I
Sbjct: 25 AVPVGIPAASQRI------FLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFT 77
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLP-NSLKNCKSLEELLMAYNQFSGPIPNIVAELKG 530
L + +DLSDN+ ++ + L L + P + L
Sbjct: 78 GLA-------LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 531 LEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGN 586
L+ L L N L ++P D ++L L L L N + V E FR + + + L N
Sbjct: 131 LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV--PERAFRGLHSLDRLLLHQN 187
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/213 (22%), Positives = 75/213 (35%), Gaps = 13/213 (6%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
+ I L N++S L +L + N L + + L L+ LDL N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215
V L L L+ + L + P + L L+ L L N L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGL-QELGPGL-------FRGLAALQYLYLQDNALQAL 144
Query: 216 VPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNI 275
T ++ +L HL L N++ +P L +L + NR P + +L +
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 276 QIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFN 307
+ + N L LP L L L+ + N
Sbjct: 204 MTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 16/165 (9%)
Query: 76 LNLSSFGLEGTISPHI-GNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQG 133
L+LS ++ P L L ++ L L L + L L+ L + N LQ
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ- 142
Query: 134 ELPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLI 192
LP + L L L L N+I+ V + R L SL L +N + + P
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV-AHVHPHA---- 196
Query: 193 PSDLSRLENLKVLDLTINRLAGTVPSTIY-NMTSLVHLRLASNQL 236
L L L L N L+ +P+ + +L +LRL N
Sbjct: 197 ---FRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 44/214 (20%), Positives = 75/214 (35%), Gaps = 48/214 (22%)
Query: 651 ISYDELRRATGNFSHENLIGSGSFGSV----------------LHNERTGSWKSFIAECE 694
+L H ++G G FG L + ++F+ E +
Sbjct: 7 FRPSDLI-------HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
+R + H N++K I + L + E++ G+L I
Sbjct: 60 VMRCLEHPNVLKFIGVLY-----KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS-- 803
DI S + YLH + ++H DL N L+ E V DFGLAR +++ +
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 804 ------STHVFMGSIGYVPPEYGLGERPSTAGDV 831
+ +G+ ++ PE G DV
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV 205
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 79/469 (16%), Positives = 133/469 (28%), Gaps = 97/469 (20%)
Query: 111 LPREIGNLFRLRVLNISFNNLQG---ELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167
+ I N F L N +N + G + K + + N+ + + +
Sbjct: 3 IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV 227
L + L S+P ++ + VL++T N L ++P SL
Sbjct: 62 ---SELQLNRLNL-SSLPDNLPP----------QITVLEITQNAL-ISLPELP---ASLE 103
Query: 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG 287
+L N+L TLP L SL +L + +N L
Sbjct: 104 YLDACDNRL---------STLPELP--------------ASLKHL------DVDNNQLT- 133
Query: 288 TLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS-THLNYLALDGNQFEGKIPE 346
LP L ++ N N+ +T L T L L++ NQ +PE
Sbjct: 134 MLPELPALLEYI---NADNNQ------------LTMLPELPTSLEVLSVRNNQLT-FLPE 177
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT----LLDLSYNSISGEIPIEIGQLQG 402
+ L L + N + +PA R N I+ IP I L
Sbjct: 178 LPES----LEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDP 231
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+ L N + I SL+ Q D G + + N D
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQ--TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
Query: 463 GNIPKGI------LRPLPEEISRLENVVTIDLSDN-----SLSGNLPNSLKNCKSLEELL 511
N + + + + + + + L+ + EL
Sbjct: 290 ENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELR 349
Query: 512 MAYNQFSGPIP-----NIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
+ + L L G +D L +L
Sbjct: 350 QQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 37/269 (13%), Positives = 80/269 (29%), Gaps = 30/269 (11%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
+N + L + +L L ++NN+L+ LP +L L++S N L+ L
Sbjct: 145 INADNNQLT-MLPELPTSLEVLS---VRNNQLTF-LPELPESL---EALDVSTNLLE-SL 195
Query: 136 PVNISKLTELK----MLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL 191
P + + N+IT + + +L + N L S
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT--HIPENILSLDPTCTIILEDNPL-----SSRIRE 248
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP-YDVRDTLPN 250
S + + + + G + + V N+ + + +
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEH 308
Query: 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIV 310
F +R + + + Q+ L LR +
Sbjct: 309 ANTFSAFLDRLSDTVSARNTSGFREQVAAW---------LEKLSASAELRQQSFAVAADA 359
Query: 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQ 339
+ ++ ++ + T L + A +G
Sbjct: 360 TESCEDRVALTWNNLRKTLLVHQASEGLF 388
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 48/202 (23%), Positives = 76/202 (37%), Gaps = 45/202 (22%)
Query: 658 RATGNFSHENLIGSGSFGSVLH--NERTG-------------SWKSFIAECETLRNVRHR 702
R +F ++G G+FG V+ N + ++E L ++ H+
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 703 NLVKLITS--------CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------- 747
+V+ + K L + E+ NG+L D IH
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRL 121
Query: 748 ---ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
I AL Y+H+ ++H DLKP NI +DE K+GDFGLA+ + +D S
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 805 T--------HVFMGSIGYVPPE 818
+G+ YV E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE 200
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/327 (17%), Positives = 109/327 (33%), Gaps = 68/327 (20%)
Query: 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVH 228
+++ L+ N I + SDL R NL+ L LT N + + ++ SL H
Sbjct: 53 AVKSLDLSNN--------RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104
Query: 229 LRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT 288
L L+ N L L L+++ + + N + T
Sbjct: 105 LDLSYNYLS---------NLS----------------SSWFKPLSSLTFLNLLGNPYK-T 138
Query: 289 LPPG--LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE 346
L +L L+ +G + + + +T L L +D + + P+
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE------ELEIDASDLQSYEPK 192
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406
S+ + N +S L L + + S+ L+L +
Sbjct: 193 SLKSIQN-VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD---------------- 235
Query: 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIP 466
+E+ G NSL + ++ L ++ LL ++ S N++ ++P
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVP 293
Query: 467 KGILRPLPEEISRLENVVTIDLSDNSL 493
GI L ++ I L N
Sbjct: 294 DGIFDRLT-------SLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 53/275 (19%), Positives = 92/275 (33%), Gaps = 48/275 (17%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLG 407
+ + L L N I I S R +L L L+ N I+ I + L L+ L
Sbjct: 49 GLTEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106
Query: 408 LAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIP 466
L+ N + + L L ++L GN S F + L + + N I
Sbjct: 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 467 KGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVA 526
+ L + +++ + L P SLK+ +++ L++ Q + V
Sbjct: 167 RKDFAGLT-------FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 527 ELKGLEVLDLSSNKLSG-------------------------------SIPSDLQNLQAL 555
+E L+L L + L + L
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL 279
Query: 556 RSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNP 587
L + N L+ V +GIF +++ + L NP
Sbjct: 280 LELEFSRNQLKSV--PDGIFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 61/376 (16%), Positives = 120/376 (31%), Gaps = 110/376 (29%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IPS L+ E +K LDL+ NR+ S + +L L L SN + +T+
Sbjct: 46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI---------NTIE-- 92
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
S +L +++ + +++N L L
Sbjct: 93 --------------EDSFSSLGSLEHLDLSYNYLS-NLSSSW------------------ 119
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ L +L L GN ++ S+ + +L L +G + KI
Sbjct: 120 ------------FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 372 SI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQI 430
L L L++ + + P SL +++ ++ +
Sbjct: 168 KDFAGLTFLEELEIDASDLQ---------------------SYE---PKSLKSIQNVSHL 203
Query: 431 DLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490
L + + I S+ ++L + ++
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF------------------------HF 239
Query: 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-L 549
+ LS NSL + + + + ++ ++ GL L+ S N+L S+P
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIF 297
Query: 550 QNLQALRSLNLTFNNL 565
L +L+ + L N
Sbjct: 298 DRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 48/274 (17%), Positives = 94/274 (34%), Gaps = 39/274 (14%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
L+++ L +N ++ + + +L L L++S+N L L + L+ L L+L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
+ N +L LQ+L G + I D + L L+ L++ +
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ-------RKDFAGLTFLEELEIDAS 184
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLH 270
L P ++ ++ ++ HL L Q + D ++
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECL---------------- 227
Query: 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
L + + + L L R I + + L + L
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL--------FQVMKLLNQISGL 279
Query: 331 NYLALDGNQFEGKIPESI-GNFSNELSKLYLGGN 363
L NQ + +P+ I ++ L K++L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTS-LQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 50/273 (18%), Positives = 99/273 (36%), Gaps = 21/273 (7%)
Query: 121 LRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
++ L++S N + + + + L+ L L +N I + +D +L SL+ L+ N
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY-NMTSLVHLRLASNQLGG 238
L ++ S L +L L+L N ++++ ++T L LR+ +
Sbjct: 112 L-SNLSSSW-------FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL-GNLP 297
+I L L + + P SL ++ N+ + + L
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFIT--SLTNSTHLNYLALDGNQFEGKIPESIGNFSNEL 355
+ + + + E LS SL + + ++ + + S L
Sbjct: 223 SVECLELRDTDLDTFHFSE-LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG-L 279
Query: 356 SKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYN 387
+L N + +P I RL SL + L N
Sbjct: 280 LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 23/167 (13%), Positives = 57/167 (34%), Gaps = 17/167 (10%)
Query: 76 LNLSSFGLEGTISPHI-GNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134
L + + I L+FL +++ + L P+ + ++ + L +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 135 LPVNISKLTELKMLDLMANKITG-------RVTDDQLRNLRSLQVLNFGKNLLWGSIPPS 187
L + + + ++ L+L + + L + + + L
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL------- 266
Query: 188 IANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASN 234
+ L+++ L L+ + N+L +TSL + L +N
Sbjct: 267 --FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 49/195 (25%), Positives = 75/195 (38%), Gaps = 43/195 (22%)
Query: 657 RRATGNFSHENLIGSGSFGSVLHNERTGSWKSFIA------------ECETLRNVRHRNL 704
+R +F LIGSG FG V + K+++ E + L + H N+
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNI 66
Query: 705 VKLITS-----------CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------ 747
V + + L + EF G+L WI R +LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 748 ----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS 803
IT +DY+H+ +++ DLKP NI L + K+GDFGL L +
Sbjct: 127 LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL-------KNDG 176
Query: 804 STHVFMGSIGYVPPE 818
G++ Y+ PE
Sbjct: 177 KRTRSKGTLRYMSPE 191
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 38/188 (20%), Positives = 59/188 (31%), Gaps = 35/188 (18%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF----------------IAECETLRNVRHRNLV 705
++ +G G F V E + E + R H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSALD 753
+L+ C E L+ F G+L + I + L I L+
Sbjct: 90 RLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM---G 810
+H H DLKP NILL +E + D G V+ + +
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 811 SIGYVPPE 818
+I Y PE
Sbjct: 206 TISYRAPE 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 50/183 (27%), Positives = 74/183 (40%), Gaps = 41/183 (22%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF------------------IAECETLRNVRHRNLVKLIT 709
IG+GS+G R K ++E LR ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY- 71
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSALDYLH- 756
+ + L +V E+ G L I K +T AL H
Sbjct: 72 --DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 757 -NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
+D V+H DLKP N+ LD + K+GDFGLAR L ++ +S + T V G+ Y+
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKTFV--GTPYYM 183
Query: 816 PPE 818
PE
Sbjct: 184 SPE 186
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 54/263 (20%), Positives = 86/263 (32%), Gaps = 23/263 (8%)
Query: 318 LSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASIGR 375
L T + S L L + + +I L +L L + G P +
Sbjct: 58 LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
Query: 376 LRSLTLLDLSYNSIS-GEIPIEIGQLQ-----GLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
L L+ ++S + +LQ GL+VL +A + L+
Sbjct: 118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 430 IDLSGNELTGEIPIS----FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
+DLS N GE + F +L + L N + + +
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET-----PSGVCSALAAARVQLQG 232
Query: 486 IDLSDNSLSGNLPNSL-KNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGS 544
+DLS NSL L L +++ + L VLDLS N+L
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL---PAKLSVLDLSYNRLD-R 288
Query: 545 IPSDLQNLQALRSLNLTFNNLEG 567
PS L + +L+L N
Sbjct: 289 NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 55/313 (17%), Positives = 87/313 (27%), Gaps = 56/313 (17%)
Query: 245 RDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI 304
D P+ C ++ G +L + T L + L +
Sbjct: 18 SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLG----QFTDIIKSLSLKRL 73
Query: 305 GFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNE---------- 354
L + + L L L+ + G P + +
Sbjct: 74 TVRAARIP--SRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 355 -------------------LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPI 395
L L + H + +L+ LDLS N GE +
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 396 EI----GQLQGLQVLGLAGNE---IPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGN 447
+ LQVL L G A +L +DLS N L S
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 448 FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507
L S++LS + +PKG+ + +DLS N L P+ + +
Sbjct: 252 PSQLNSLNLSFTGLKQ-VPKGLPA----------KLSVLDLSYNRLDR-NPSPDE-LPQV 298
Query: 508 EELLMAYNQFSGP 520
L + N F
Sbjct: 299 GNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 53/222 (23%), Positives = 75/222 (33%), Gaps = 16/222 (7%)
Query: 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANL--KKLNQIDL 432
L+ LT+ S + + + GLQ L L E+ G P L LN ++L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 433 SGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
Q L L I L T+DLSDN
Sbjct: 129 RNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS---TLDLSDNP 184
Query: 493 LSGNLPNSLKNC----KSLEELLMAYNQF---SGPIPNIVAELKGLEVLDLSSNKLSGSI 545
G C +L+ L + SG + A L+ LDLS N L +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 546 PSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGN 586
+ L SLNL+F L+ V +G+ +S + L N
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLKQV--PKGLPAKLSVLDLSYN 284
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 39/226 (17%), Positives = 78/226 (34%), Gaps = 13/226 (5%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNIS------KLTELK 146
+S L+ + L+N +++G P + + ++ N+ LK
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 147 MLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206
+L + + +Q+R +L L+ N G A L P L+ L + +
Sbjct: 153 VLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISA-LCPLKFPTLQVLALRN 210
Query: 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
+ +G + L L L+ N L D L F ++P
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSS 312
L + ++ +++N L+ P LP + ++ N + S
Sbjct: 270 KGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 51/304 (16%), Positives = 81/304 (26%), Gaps = 40/304 (13%)
Query: 164 LRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNM 223
RSL+ L + + L+ L V I + +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDI----IKSLSLKRLTVRAARIPSRILFGALRVLGI 94
Query: 224 TSLVHLRLASNQLGGEIPYD-VRDTLPNLLDFIYCFNRFTG--KIPGSLHNL--TNIQII 278
+ L L L + ++ G P + T P+L + L ++++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGN 338
+ + P L T ++ N + + GL L LAL
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG---ERGLISALCPLKFPTLQVLALRNA 211
Query: 339 QFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIG 398
G A L LDLS+NS+
Sbjct: 212 GM----------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 399 Q-LQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLS 457
L L L+ + A L L DLS N L P S + ++ L
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLD-RNP-SPDELPQVGNLSLK 304
Query: 458 NNRI 461
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 33/203 (16%), Positives = 58/203 (28%), Gaps = 22/203 (10%)
Query: 392 EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIP---ISFGNF 448
++ + G +L E G + L ++ + + I +
Sbjct: 35 DVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGI 94
Query: 449 QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG--NLPNSLKNC-- 504
L + L N + G P +L + ++ ++L + S + L+
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLE------ATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSI-------PSDLQNLQALRS 557
L+ L +A V L LDLS N G P LQ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 558 LNLTFNNLEGVVPSEGIFRNMSN 580
N GV + +
Sbjct: 209 RNAGMETPSGVCSA--LAAARVQ 229
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 34/191 (17%), Positives = 57/191 (29%), Gaps = 20/191 (10%)
Query: 53 NPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNL- 111
++ W + + L+++ + L ++ L +N G
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 112 ------PREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLR 165
P + L L + N G + +L+ LDL N +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTS 225
L LN L +P + L VLDL+ NRL PS +
Sbjct: 251 WPSQLNSLNLSFTGL-KQVPKGL----------PAKLSVLDLSYNRLD-RNPSPD-ELPQ 297
Query: 226 LVHLRLASNQL 236
+ +L L N
Sbjct: 298 VGNLSLKGNPF 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 42/202 (20%), Positives = 71/202 (35%), Gaps = 44/202 (21%)
Query: 658 RATGNFSHENLIGSGSFGSVLHNERTGSWKSFIA-----------------ECETLRNVR 700
R +F +G G FG V + ++ E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 701 HRNLVKLITS-------CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------ 747
H +V+ + S +L + + +L DW++G E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 748 -----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL---LERVDNQ 799
I A+++LH+ ++H DLKP NI + KVGDFGL + E
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 800 SSISSTHVFMGSIG---YVPPE 818
+ + + G +G Y+ PE
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE 200
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 29/275 (10%)
Query: 321 ITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT 380
I L + ++ + ++ + I + I L ++T
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTD--AVTQNELNS-IDQIIANNSDI-KSVQG-IQYLPNVT 68
Query: 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440
L L+ N ++ P+ L+ L L L N+I + + L +LKKL + L N ++ +
Sbjct: 69 KLFLNGNKLTDIKPLT--NLKNLGWLFLDENKI-KDLSS-LKDLKKLKSLSLEHNGIS-D 123
Query: 441 IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNS 500
I + L S+ L NN+I +SRL + T+ L DN +S ++
Sbjct: 124 IN-GLVHLPQLESLYLGNNKITD----------ITVLSRLTKLDTLSLEDNQIS-DIVP- 170
Query: 501 LKNCKSLEELLMAYNQFSGPIPNI--VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSL 558
L L+ L ++ N I ++ +A LK L+VL+L S + + NL ++
Sbjct: 171 LAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 559 NLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593
T +L P+ ++
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 6e-21
Identities = 54/269 (20%), Positives = 89/269 (33%), Gaps = 49/269 (18%)
Query: 194 SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253
+L + T T + S+ + ++ +
Sbjct: 15 FPDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK---------------- 56
Query: 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSG 313
+ G + L N+ + + N L L NL L + NKI
Sbjct: 57 ----------SVQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIKD-- 101
Query: 314 DDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI 373
++SL + L L+L+ N I + + L LYLG N I +
Sbjct: 102 -------LSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQ-LESLYLGNNKI--TDITVL 149
Query: 374 GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433
RL L L L N IS +P+ L LQ L L+ N I +LA LK L+ ++L
Sbjct: 150 SRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELF 205
Query: 434 GNELTGEIPISFGNFQSLLSIDLSNNRIN 462
E + N ++ ++ +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 49/304 (16%), Positives = 97/304 (31%), Gaps = 61/304 (20%)
Query: 87 ISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELK 146
I P + L+ ++ + L + + + ++++ + I L +
Sbjct: 14 IFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVT 68
Query: 147 MLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206
L L NK+T L NL++L L +N I +L S L L+ LK L
Sbjct: 69 KLFLNGNKLT---DIKPLTNLKNLGWLFLDEN--------KIKDL--SSLKDLKKLKSLS 115
Query: 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
L N + + + + ++ L L L +N++
Sbjct: 116 LEHNGI--SDINGLVHLPQLESLYLGNNKI---------------------------TDI 146
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTN 326
L LT + + + N + + P L L L+ + N I + +L
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD---------LRALAG 195
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
+L+ L L + K N + + + P I ++ +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVV-PNTVKNTDGSLV--TPEIISDDGDYEKPNVKW 252
Query: 387 NSIS 390
+
Sbjct: 253 HLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 18/166 (10%)
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
+S + +L L+S+ L++N +S ++ + +L +L L + N + +S+LT+L
Sbjct: 101 DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKL 155
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
L L N+I+ L L LQ L KN I++L L+ L+NL VL
Sbjct: 156 DTLSLEDNQIS---DIVPLAGLTKLQNLYLSKN--------HISDL--RALAGLKNLDVL 202
Query: 206 DLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+L + N+ ++ L
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 73/464 (15%), Positives = 142/464 (30%), Gaps = 95/464 (20%)
Query: 143 TELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL 202
+++ LD+ +++ + L L+ QV+ + + I S L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC----GLTEARCKDISSALRVNPAL 58
Query: 203 KVLDLTINRLAGTVPSTIYNM-----TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC 257
L+L N L + + L L + L G
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---GCGV----------- 104
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHN---------LLEGTLPPGLGNLPFLRTYNIGFNK 308
+ +L L +Q + ++ N L EG L P L + +
Sbjct: 105 -------LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ----CRLEKLQLEYCS 153
Query: 309 IVSSGDDEGLSFITS-LTNSTHLNYLALDGNQFEGK----IPESIGNFSNELSKLYLGGN 363
+ + S L L + N + + + + +L L L
Sbjct: 154 L----SAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209
Query: 364 HI----YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPN 419
+ + + SL L L N + G+ L
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDV---------GMAELCPGL--------- 251
Query: 420 SLANLKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPE 475
L +L + + +T + + +SL + L+ N + + + L E
Sbjct: 252 -LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 310
Query: 476 EISRLENVVTIDLSDNSLSG----NLPNSLKNCKSLEELLMAYNQFSGP-IPNIVAELK- 529
+LE ++ + S + + + L + L EL ++ N+ + + L
Sbjct: 311 PGCQLE---SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 367
Query: 530 ---GLEVLDLSSNKLS----GSIPSDLQNLQALRSLNLTFNNLE 566
L VL L+ +S S+ + L +LR L+L+ N L
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 84/507 (16%), Positives = 165/507 (32%), Gaps = 94/507 (18%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFR-LRVLNISFNNLQGE----LPVNISKLTELKMLDLM 151
++S+ +Q +LS E+ L + +V+ + L + + L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 152 ANKITGRVTD---DQLRNL-RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL 207
+N++ L+ +Q L+ + + ++ S L L L+ L L
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC----CLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 208 TINRLAGTVPSTIYNM-----TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFT 262
+ N L + L L+L L
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS---------------------C 159
Query: 263 GKIPGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPF-LRTYNIGFNKIVSSGDDEG 317
+ L + + + +++N + L GL + P L + + D
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV---TSDNC 216
Query: 318 LSFITSLTNSTHLNYLALDGNQFEGK----IPESIGNFSNELSKLYLGGNHI----YGKI 369
+ + L LAL N+ + + + S+ L L++ I G +
Sbjct: 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276
Query: 370 PASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429
+ SL L L+ N + E G ++L + L+ L
Sbjct: 277 CRVLRAKESLKELSLAGNELGDE---------GARLLCET-------LLEPGCQLESL-- 318
Query: 430 IDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
+ T + LL + +SNNR+ + + + L + S L
Sbjct: 319 -WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR---V 374
Query: 486 IDLSDNSLS----GNLPNSLKNCKSLEELLMAYNQFSGP-IPNIVAELK----GLEVLDL 536
+ L+D +S +L +L SL EL ++ N I +V ++ LE L L
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 434
Query: 537 SSNKLS----GSIPSDLQNLQALRSLN 559
S + + ++ +LR ++
Sbjct: 435 YDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-10
Identities = 64/370 (17%), Positives = 116/370 (31%), Gaps = 87/370 (23%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFR----LRVLNISFNNLQGE--------LPVNIS 140
L +QL+ LS + ++ R + L +S N++ L +
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199
Query: 141 KLTELKMLDLMANKITGRVTDD---QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLS 197
+L L L + +T D + + SL+ L G N L +A L P L
Sbjct: 200 QLEA---LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV---GMAELCPGLLH 253
Query: 198 RLENLKVLDLTINRL----AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253
L+ L + + G + + SL L LA N+LG E L +
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE-------GARLLCE 306
Query: 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSG 313
+ L ++ + + +
Sbjct: 307 TL-------------LEPGCQLESLWVKSC-------------------SFT-------- 326
Query: 314 DDEGLSFITS-LTNSTHLNYLALDGNQFEGK----IPESIGNFSNELSKLYLGGNHI--- 365
S +S L + L L + N+ E + + +G + L L+L +
Sbjct: 327 -AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
Query: 366 -YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQL-----QGLQVLGLAGNEIPGGIPN 419
+ A++ SL LDLS N + +++ + L+ L L + +
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 445
Query: 420 SLANLKKLNQ 429
L L+K
Sbjct: 446 RLQALEKDKP 455
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 52/274 (18%), Positives = 101/274 (36%), Gaps = 34/274 (12%)
Query: 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF 351
L G + + + + + L+ G I E +
Sbjct: 14 PDPALANAIKIAAGKSNVTD---------TVTQADLDGITTLSAFGTGVT-TI-EGVQYL 62
Query: 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411
+N L L L N I A + L +T L+LS N + + I LQ ++ L L
Sbjct: 63 NN-LIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTST 117
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
+I + LA L L + L N++T P++ +L + + N +++ ++
Sbjct: 118 QI-TDVTP-LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DL------ 166
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGL 531
++ L + T+ DN +S ++ L + +L E+ + NQ S P +A L
Sbjct: 167 ---TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 532 EVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
++ L++ ++ NL +
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413
K+ G +++ + L +T L ++ I + L L L L N+I
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL 473
+ L NL K+ +++LSGN L + + QS+ ++DL++ +I P
Sbjct: 76 -TDLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP------- 124
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
++ L N+ + L N ++ N+ L +L+ L + Q S + + A L L
Sbjct: 125 ---LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPL-ANLSKLTT 177
Query: 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
L NK+S I S L +L L ++L N + V P N+ V L
Sbjct: 178 LKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSPLAN-TSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 59/282 (20%), Positives = 98/282 (34%), Gaps = 31/282 (10%)
Query: 182 GSIPPS--IANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGE 239
GSI I + P L N + + + T T ++ + L +
Sbjct: 1 GSITQPTAINVIFP--DPALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTTI 56
Query: 240 IPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFL 299
L NL+ N+ T + L NLT I + ++ N L + L +
Sbjct: 57 EGVQ---YLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSI 109
Query: 300 RTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLY 359
+T ++ +I + +T L ++L L LD NQ I + +N L L
Sbjct: 110 KTLDLTSTQI---------TDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTN-LQYLS 157
Query: 360 LGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPN 419
+G + + + L LT L N IS P+ L L + L N+I P
Sbjct: 158 IGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP- 212
Query: 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRI 461
LAN L + L+ +T + N + +
Sbjct: 213 -LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 61/329 (18%), Positives = 122/329 (37%), Gaps = 41/329 (12%)
Query: 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLS 197
L + + +T VT +L + L+ + +I +
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGV-TTIEG---------VQ 60
Query: 198 RLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC 257
L NL L+L N++ T + + N+T + L L+ N L L ++
Sbjct: 61 YLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAI---AGLQSIKTLDLT 115
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEG 317
+ T P L L+N+Q++ + N + L L L+ +IG ++
Sbjct: 116 STQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD------ 165
Query: 318 LSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377
+T L N + L L D N+ I + + N L +++L N I P +
Sbjct: 166 ---LTPLANLSKLTTLKADDNKIS-DIS-PLASLPN-LIEVHLKNNQISDVSP--LANTS 217
Query: 378 SLTLLDLSYNSISGEIPIEIGQLQGLQ-VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436
+L ++ L+ +I+ + L V G +G I P ++++ +L+ N
Sbjct: 218 NLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNL 274
Query: 437 LTGEIPISFGNFQSLLSIDLSNNRINGNI 465
+ +S+ F ++ + +G +
Sbjct: 275 TSFINNVSY-TFNQSVTFKNTTVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 46/212 (21%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
L + + ++++ + L G+ L G + I + L L ++L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDN 73
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
++T P+ N + ++LS N + N+ I+ L+++ T+DL+ ++
Sbjct: 74 QITDLAPLK--NLTKITELELSGNPLK-NV---------SAIAGLQSIKTLDLTSTQITD 121
Query: 496 NLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
L +L+ L + NQ + I + A L L+ L + + ++S + + L NL L
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQITN-ISPL-AGLTNLQYLSIGNAQVS-DL-TPLANLSKL 175
Query: 556 RSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
+L N + + P N+ VHLK N
Sbjct: 176 TTLKADDNKISDISPLAS-LPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 56/298 (18%), Positives = 111/298 (37%), Gaps = 38/298 (12%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA 152
L+ I + ++ + +L + L+ + + + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL 212
N+IT L+NL + L N L ++ ++ L+++K LDLT ++
Sbjct: 73 NQIT---DLAPLKNLTKITELELSGNPLK-NVSA---------IAGLQSIKTLDLTSTQI 119
Query: 213 AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNL 272
T + + +++L L L NQ+ P L NL + + + L NL
Sbjct: 120 --TDVTPLAGLSNLQVLYLDLNQITNISPL---AGLTNLQYLSIGNAQVS-DLTP-LANL 172
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
+ + ++ N + + L +LP L ++ N+I ++ L N+++L
Sbjct: 173 SKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISD---------VSPLANTSNLFI 221
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS 390
+ L + N G I PA+I + +L++N S
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI---APATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+ G+ TI + L+ L ++L++N+++ +L + NL ++ L +S N L+ +
Sbjct: 46 LSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NV 100
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
I+ L +K LDL + +IT L L +LQVL N I N+ S
Sbjct: 101 S-AIAGLQSIKTLDLTSTQIT---DVTPLAGLSNLQVLYLDLN--------QITNI--SP 146
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255
L+ L NL+ L + ++ + + + N++ L L+ N++ P +LPNL++
Sbjct: 147 LAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKISDISPL---ASLPNLIEVH 201
Query: 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
N+ + P L N +N+ I+ +T+ + NL ++
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 35/184 (19%), Positives = 76/184 (41%), Gaps = 22/184 (11%)
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
+I+ P L + + + + A+L + + G +T +
Sbjct: 7 TAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQ-- 60
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+L+ ++L +N+I ++ + L + ++LS N L N+ + +S
Sbjct: 61 YLNNLIGLELKDNQIT-DL---------APLKNLTKITELELSGNPLK-NVSA-IAGLQS 108
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
++ L + Q + P +A L L+VL L N+++ +I S L L L+ L++ +
Sbjct: 109 IKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS 164
Query: 567 GVVP 570
+ P
Sbjct: 165 DLTP 168
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 42/179 (23%)
Query: 668 LIGSGSFGSVLHNERTGSWKSF------------------IAECETLRNVRHRNLVKLIT 709
IG GSFG + + T + + E L N++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDC 759
S + L +V ++ G L I+ ++ I AL ++H
Sbjct: 91 SF-----EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--- 142
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ ++H D+K NI L ++ T ++GDFG+AR L S++ +G+ Y+ PE
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL------NSTVELARACIGTPYYLSPE 195
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 41/184 (22%), Positives = 72/184 (39%), Gaps = 47/184 (25%)
Query: 668 LIGSGSFGSVLH--NERTG---------------SWKSFIAECETLRNVRHRNLVKLITS 710
++G G+ +V +++TG + E E L+ + H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------------DITSALDYLHND 758
+ + L+ EF GSL + E N D+ +++L +
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+VH ++KPGNI+ D + K+ DFG AR L + G+ Y
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-----EDDEQFVS--LYGTEEY 181
Query: 815 VPPE 818
+ P+
Sbjct: 182 LHPD 185
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 41/191 (21%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKSF----------------IAECETLRNVR-HRNLVKLI 708
++ G F V + GS + + I E ++ + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 709 TSCSS----LDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----------DITSALD 753
++ S D+ EFL L L G L +++ A+
Sbjct: 93 SAASIGKEESDTGQAEFLLL--TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV------ 807
++H + P++H DLK N+LL + T K+ DFG A + D S +
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 808 FMGSIGYVPPE 818
+ Y PE
Sbjct: 210 RNTTPMYRTPE 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 42/193 (21%), Positives = 70/193 (36%), Gaps = 44/193 (22%)
Query: 655 ELRRATGNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECET 695
+ +F NL+G GSF V + TG K + E +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------- 747
++H ++++L + N +L L E NG + ++ R
Sbjct: 65 HCQLKHPSILELYNY---FEDSNYVYLVL--EMCHNGEMNRYLK-NRVKPFSENEARHFM 118
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
I + + YLH+ ++H DL N+LL M K+ DFGLA +
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA------TQLKMPHEKH 169
Query: 806 HVFMGSIGYVPPE 818
+ G+ Y+ PE
Sbjct: 170 YTLCGTPNYISPE 182
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 47/199 (23%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSV--LHNERTGSW-------KSFIA-------- 691
P++ D R+ + +G G F + + T KS +
Sbjct: 5 PEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM 62
Query: 692 --ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-- 747
E R++ H+++V + + F+ L E SL + +R+ L
Sbjct: 63 SMEISIHRSLAHQHVVGFHGF---FEDNDFVFVVL--ELCRRRSLLELH--KRRKALTEP 115
Query: 748 --------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
I YLH + V+H DLK GN+ L+E++ K+GDFGLA +V+
Sbjct: 116 EARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYD 168
Query: 800 SSISSTHVFMGSIGYVPPE 818
G+ Y+ PE
Sbjct: 169 GERKKV--LCGTPNYIAPE 185
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 48/203 (23%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSW-----------KSFIA----ECETLRNV-RHRNLV 705
+F ++++G G+ G+++ G + + E + LR H N++
Sbjct: 25 SFCPKDVLGHGAEGTIV---YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDYLH 756
+ C+ D +F + E L +L +++ L+ TS L +LH
Sbjct: 82 RYF--CTEKDR---QFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 757 NDCEVPVVHSDLKPGNILLDE-----EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
+ +VH DLKP NIL+ ++ A + DFGL + L + S S G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL---AVGRHSFSRRSGVPGT 189
Query: 812 IGYVPPEY---GLGERPSTAGDV 831
G++ PE E P+ D+
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDI 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 8e-20
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 47/184 (25%)
Query: 668 LIGSGSFGSVLH--NERTG---------------SWKSFIAECETLRNVRHRNLVKLITS 710
++G G+ +V +++TG + E E L+ + H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------------DITSALDYLHND 758
+ + L+ EF GSL + E N D+ +++L +
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+VH ++KPGNI+ D + K+ DFG AR L ++ S G+ Y
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVS---LYGTEEY 181
Query: 815 VPPE 818
+ P+
Sbjct: 182 LHPD 185
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 24/190 (12%), Positives = 66/190 (34%), Gaps = 18/190 (9%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
++ L +S + I Q+ L + LA + + + + + ++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNI 76
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
T PIS +L + + + + +S L ++ +D+S ++
Sbjct: 77 HATNYNPIS--GLSNLERLRIMGKDVTSDKI--------PNLSGLTSLTLLDISHSAHDD 126
Query: 496 NLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQAL 555
++ + + + ++YN I + L L+ L++ + + +++ L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVHDY--RGIEDFPKL 183
Query: 556 RSLNLTFNNL 565
L +
Sbjct: 184 NQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 35/190 (18%), Positives = 74/190 (38%), Gaps = 18/190 (9%)
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413
LG + + ++ SLT + L+ +++ IE ++ L +
Sbjct: 24 AYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA 78
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPL 473
N ++ L L ++ + G ++T + + SL +D+S++ + +I
Sbjct: 79 TN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL------- 129
Query: 474 PEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
+I+ L V +IDLS N ++ LK L+ L + ++ + + L
Sbjct: 130 -TKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 534 LDLSSNKLSG 543
L S + G
Sbjct: 186 LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 32/168 (19%), Positives = 64/168 (38%), Gaps = 14/168 (8%)
Query: 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR 479
+ A + L I L+ +T I ++ + ++N N IS
Sbjct: 39 TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHAT-NY---------NPISG 86
Query: 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
L N+ + + ++ + +L SL L ++++ I + L + +DLS N
Sbjct: 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
Query: 540 KLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
I L+ L L+SLN+ F+ + E F ++ ++
Sbjct: 147 GAITDI-MPLKTLPELKSLNIQFDGVHDYRGIED-FPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 31/181 (17%), Positives = 62/181 (34%), Gaps = 18/181 (9%)
Query: 317 GLSFITSLTNS--THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374
G S ++T + L Y+ L + I N + L + H I
Sbjct: 31 GQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHN-IKDLTINNIHA--TNYNPIS 85
Query: 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434
L +L L + ++ + + L L +L ++ + I + L K+N IDLS
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
N +I L S+++ + ++ + I + + ++
Sbjct: 146 NGAITDIM-PLKTLPELKSLNIQFDGVH-DY---------RGIEDFPKLNQLYAFSQTIG 194
Query: 495 G 495
G
Sbjct: 195 G 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 25/144 (17%), Positives = 54/144 (37%), Gaps = 15/144 (10%)
Query: 422 ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLE 481
+ K L + I+ SL I L+N + ++ I
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL---------TGIEYAH 66
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541
N+ + +++ + N + +LE L + + ++ L L +LD+S +
Sbjct: 67 NIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 542 SGSIPSDLQNLQALRSLNLTFNNL 565
SI + + L + S++L++N
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 28/170 (16%), Positives = 61/170 (35%), Gaps = 15/170 (8%)
Query: 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330
+ ++ I + + + G+ ++ I + I+ L+N L
Sbjct: 42 QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA------TNYNPISGLSN---L 90
Query: 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS 390
L + G ++ ++ L+ L + + I I L + +DLSYN
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440
+I + L L+ L + + + + + KLNQ+ + G+
Sbjct: 150 TDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 29/211 (13%), Positives = 66/211 (31%), Gaps = 43/211 (20%)
Query: 101 QLQNNKLSGNLPREI--GNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGR 158
N L + I + L + ++ N+ +L I +K L + T
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-- 79
Query: 159 VTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPS 218
+ + L +L+ L + + +LS L +L +LD++ + ++ +
Sbjct: 80 -NYNPISGLSNLERLRIMGK--------DVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 219 TIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQII 278
I + + + L+ N +I L L ++ +
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM--------------------------PLKTLPELKSL 164
Query: 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKI 309
+ + + G+ + P L I
Sbjct: 165 NIQFDGV--HDYRGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 31/200 (15%), Positives = 72/200 (36%), Gaps = 27/200 (13%)
Query: 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTS 225
++ G++ S AN+ + ++ L + + ++ + L G I +
Sbjct: 21 TFKAYLNGLLGQS--------STANITEAQMNSLTYITLANINVTDLTG-----IEYAHN 67
Query: 226 LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLL 285
+ L + + P L NL T +L LT++ ++ ++H+
Sbjct: 68 IKDLTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 286 EGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP 345
+ ++ + LP + + ++ +N ++ I L L L + +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITD--------IMPLKTLPELKSLNIQFDGVHD--Y 174
Query: 346 ESIGNFSNELSKLYLGGNHI 365
I +F L++LY I
Sbjct: 175 RGIEDFPK-LNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 25/129 (19%), Positives = 49/129 (37%), Gaps = 15/129 (11%)
Query: 87 ISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELK 146
+P I LS L +++ ++ + + L L +L+IS + + I+ L ++
Sbjct: 81 YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 147 MLDLMANKITGRVTD-DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
+DL N +TD L+ L L+ LN + + + + L L
Sbjct: 140 SIDLSYNG---AITDIMPLKTLPELKSLNIQFD--------GVHDY--RGIEDFPKLNQL 186
Query: 206 DLTINRLAG 214
+ G
Sbjct: 187 YAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 15/103 (14%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L + + P++ L+ L + + ++ ++ +I L ++ +++S+N ++
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
+ L ELK L++ + + + + L L
Sbjct: 153 M-PLKTLPELKSLNIQFDGVH---DYRGIEDFPKLNQLYAFSQ 191
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 52/198 (26%)
Query: 658 RATGNFSHENLIGSGSFGSVLH--NERTG------------------SWKSFIAECETLR 697
+ G + + +G+G FG VL ++ TG W E + ++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMK 67
Query: 698 NVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-ERKNEL------- 746
+ H N+V L ++ LA+ E+ G L +++ E L
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAM--EYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 747 ---DITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLARFLLERVDNQS 800
DI+SAL YLH E ++H DLKP NI+L + + K+ D G A+ L +Q
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-----DQG 177
Query: 801 SISSTHVFMGSIGYVPPE 818
+ + F+G++ Y+ PE
Sbjct: 178 ELCTE--FVGTLQYLAPE 193
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNEL 437
S ++ +++ +P ++ + +L L+ N + +L +L Q++L EL
Sbjct: 11 SHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 438 TGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNL 497
T ++ + G L ++DLS+N+ L+ LP L + +D+S N L+
Sbjct: 68 T-KLQV-DGTLPVLGTLDLSHNQ---------LQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 498 PNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL-QNLQALR 556
+L+ L+EL + N+ P ++ LE L L++N L+ +P+ L L+ L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 557 SLNLTFNNLEGVVPSEGIFRNMS--NVHLKGNPKLC 590
+L L N+L + +G F + L GNP LC
Sbjct: 176 TLLLQENSLYTI--PKGFFGSHLLPFAFLHGNPWLC 209
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 49/160 (30%), Positives = 68/160 (42%), Gaps = 15/160 (9%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
LNL L T G L L ++ L +N+L +LP L L VL++SFN L L
Sbjct: 60 LNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 136 PVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPS 194
P+ L EL+ L L N++ + L L+ L+ N L +P +
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL------ 167
Query: 195 DLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASN 234
L+ LENL L L N L T+P + L L N
Sbjct: 168 -LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 26/217 (11%)
Query: 93 NLSFLRSIQLQNNKLS---GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLD 149
++ + L+ +LP++ +L++S N L + T L L+
Sbjct: 8 KVASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 150 LMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTI 209
L ++T D L L + L+ N L S+P L L VLD++
Sbjct: 62 LDRAELTKLQVDGTLPVLGT---LDLSHNQL-QSLPLLGQT--------LPALTVLDVSF 109
Query: 210 NRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSL 269
NRL + + L L L N+L +P + P L N T G L
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168
Query: 270 HNLTNIQIIRMTHNLLEGTLPPG---LGNLPFLRTYN 303
+ L N+ + + N L T+P G LPF +
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 48/193 (24%), Positives = 67/193 (34%), Gaps = 24/193 (12%)
Query: 273 TNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLN 331
+ I+ ++ NLL T L L N+ ++ D L L
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQVDGTL---------PVLG 80
Query: 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSIS 390
L L NQ + +P L+ L + N + +P L L L L N +
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK 137
Query: 391 GEIPIEI-GQLQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
+P + L+ L LA N E+P G+ N L NL L L N L IP F
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL---LLQENSLYT-IPKGFF 192
Query: 447 NFQSLLSIDLSNN 459
L L N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 19/146 (13%)
Query: 444 SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503
S L ++ + +P + P++ + L LS+N L +L
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDL----PKDTTIL------HLSENLLYTFSLATLMP 53
Query: 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563
L +L + + + + + L L LDLS N+L S+P Q L AL L+++FN
Sbjct: 54 YTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110
Query: 564 NLEGVVPSEGIFRNMSNV---HLKGN 586
L + G R + + +LKGN
Sbjct: 111 RLTSL--PLGALRGLGELQELYLKGN 134
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 31/169 (18%)
Query: 668 LIGSGSFGSVLH--NERTGS---WK-------------SFIAECETLRNVRHRNLVKLIT 709
IG GSF +V + T W F E E L+ ++H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNEL------DITSALDYLHNDCEV 761
S S + + LV E +++G+L ++ K ++ I L +LH
Sbjct: 93 SWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 762 PVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQSSISSTHVFM 809
P++H DLK NI + + K+GD GLA R ++ T FM
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFM 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 47/199 (23%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSV--LHNERTGSW-------KSFIA-------- 691
P++ D R + +G G F + + T KS +
Sbjct: 31 PEVLVDPRSR--RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM 88
Query: 692 --ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-- 747
E R++ H+++V + + F+ L E SL + +R+ L
Sbjct: 89 SMEISIHRSLAHQHVVGFHGF---FEDNDFVFVVL--ELCRRRSLLELH--KRRKALTEP 141
Query: 748 --------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQ 799
I YLH + V+H DLK GN+ L+E++ K+GDFGLA +V+
Sbjct: 142 EARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYD 194
Query: 800 SSISSTHVFMGSIGYVPPE 818
G+ Y+ PE
Sbjct: 195 GERKKV--LCGTPNYIAPE 211
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 41/248 (16%), Positives = 85/248 (34%), Gaps = 21/248 (8%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGL 408
+ +L + + L +++S N + I ++ L L + +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 409 AGN----EIPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRING 463
I P + NL L + +S + +P + + + +D+ +N
Sbjct: 87 EKANNLLYIN---PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH 142
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPN 523
I + L V + L+ N + ++ + E L N +
Sbjct: 143 TIERNSFVGLSF------ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 524 IVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVH 582
+ G +LD+S ++ S+PS L+NL+ LR+ + NL+ + E +
Sbjct: 197 VFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLEK-LVALMEAS 252
Query: 583 LKGNPKLC 590
L C
Sbjct: 253 LTYPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 55/274 (20%), Positives = 85/274 (31%), Gaps = 45/274 (16%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IPSDL R N L + +L L + ++ N + I
Sbjct: 24 IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE---------- 71
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTH-NLLEGTLPPG-LGNLPFLRTYNIGFNKI 309
NL + IR+ N L + P NLP L+ I I
Sbjct: 72 --------------ADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI 116
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPE-SIGNFSNELSKLYLGGNHIYGK 368
D +S L + N I S S E L+L N I +
Sbjct: 117 KHLPDV-------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 168
Query: 369 IPASI-GRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKK 426
I S + L N++ E+P ++ G +L ++ I L NLKK
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227
Query: 427 LNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNR 460
L + ++P + +L+ L+
Sbjct: 228 LRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 45/296 (15%), Positives = 88/296 (29%), Gaps = 55/296 (18%)
Query: 98 RSIQLQNNKLS---GNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMAN 153
R Q +K++ +LPR L L+ + S +L+ +++ N
Sbjct: 12 RVFLCQESKVTEIPSDLPRN------AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQN 64
Query: 154 KITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213
+ + D NL L + K ++ + P L NL+ L ++ +
Sbjct: 65 DVLEVIEADVFSNLPKLHEIRIEKA-------NNLLYINPEAFQNLPNLQYLLISNTGIK 117
Query: 214 GTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIY-CFNRFTGKIPGSLHNL 272
+ V L + N I + L ++ N + +
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGT 177
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
++ +N LE LP ++
Sbjct: 178 QLDELNLSDNNNLE-ELPND------------------------------VFHGASGPVI 206
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388
L + + +P N L KL + K+P ++ +L +L L+Y S
Sbjct: 207 LDISRTRIH-SLPS--YGLEN-LKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 37/212 (17%), Positives = 73/212 (34%), Gaps = 18/212 (8%)
Query: 76 LNLSSFGLEGTISPHI-GNLSFLRSIQLQN-NKLSGNLPREI-GNLFRLRVLNISFNNLQ 132
+ +S + I + NL L I+++ N L + E NL L+ L IS ++
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
Query: 133 GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRS-LQVLNFGKNLLWGSIPPSIANL 191
V+ + +LD+ N + + L +L KN + I S N
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG 176
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+ ++ N L + + V L ++ ++ +P + L L
Sbjct: 177 -------TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKL 228
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
+ + K +L L + +T+
Sbjct: 229 ----RARSTYNLKKLPTLEKLVALMEASLTYP 256
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 39/187 (20%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA-----------ECETLRNVR 700
G + +L+G GS+G V + T K + E + LR +R
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGS--LGDWIHGERKNELD-------ITSA 751
H+N+++L+ + + K ++ V E+ G + D + +R +
Sbjct: 65 HKNVIQLVDVLYN-EEKQKMYM--VMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L+YLH+ +VH D+KPGN+LL T K+ G+A L + + GS
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD----DTCRTSQGS 174
Query: 812 IGYVPPE 818
+ PPE
Sbjct: 175 PAFQPPE 181
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 41/153 (26%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS----------------FIAECETLRNVRHRNLVKLIT 709
IG G FG V+ G ++ F+AE + +RH NLV+L+
Sbjct: 26 LQTIGKGEFGDVML----GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYL--HN 757
+ L +V E+++ GSL D++ ++ L D+ A++YL +N
Sbjct: 82 VIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
VH DL N+L+ E+ AKV DFGL +
Sbjct: 138 -----FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 53/210 (25%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK-------------------SFIAECETLRNVRHRNLVK 706
++ +G G +G V G WK F+ E ++ ++H NLV+
Sbjct: 225 KHKLGGGQYGEVYE----GVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLH 756
L+ C+ ++ EF++ G+L D++ + E+ I+SA++YL
Sbjct: 281 LLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ +H +L N L+ E KV DFGL+R + + + + F I +
Sbjct: 336 ---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFP--IKWTA 387
Query: 817 PEYGLGERPSTAGDVPTSESFAGEFNIVKW 846
PE + S DV F ++ W
Sbjct: 388 PESLAYNKFSIKSDVWA-------FGVLLW 410
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 37/151 (24%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK----------------SFIAECETLRNVRHRNLVKLIT 709
IG G FG V+ G ++ +F+AE + +RH NLV+L+
Sbjct: 198 LQTIGKGEFGDVML----GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDC 759
+ L +V E+++ GSL D++ ++ L D+ A++YL
Sbjct: 254 VIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
VH DL N+L+ E+ AKV DFGL +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 31/232 (13%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEIG---Q 399
IP+++ L L N + + + L +LDLS I IE G
Sbjct: 22 IPDNL---PFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQT---IEDGAYQS 74
Query: 400 LQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDL 456
L L L L GN + G + L++L+KL L G+ ++L +++
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKL---VAVETNLASLENFPIGHLKTLKELNV 131
Query: 457 SNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE----ELLM 512
++N I + LPE S L N+ +DLS N + L+ + L +
Sbjct: 132 AHNLIQ-SFK------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 513 AYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFN 563
+ N + P E++ L+ L L +N+L S+P L +L+ + L N
Sbjct: 185 SLNPMNFIQPGAFKEIR-LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/197 (20%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
+ L+ + L ++ + +L L L ++ N +Q L + S L+ L+ L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
+ + + + + +L++L+ LN NL+ S +P S L NL+ LDL+ N
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFK------LPEYFSNLTNLEHLDLSSN 159
Query: 211 RLAGTVPSTIYNMTSL----VHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
++ + + + + + L L+ N + I + L + N+
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEI-RLKELALDTNQLKSVPD 217
Query: 267 GSLHNLTNIQIIRMTHN 283
G LT++Q I + N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 42/172 (24%), Positives = 68/172 (39%), Gaps = 21/172 (12%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
+IP +P S NL DLS N L SF +F L +DLS I I G
Sbjct: 21 KIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAY- 72
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAE-LKG 530
L ++ T+ L+ N + + SL++L+ + + N LK
Sbjct: 73 ------QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKT 125
Query: 531 LEVLDLSSNKLSGSIPSD--LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L+ L+++ N + S NL L L+L+ N ++ + R +
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSI--YCTDLRVLHQ 174
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 17/187 (9%)
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+ L L+ N + S + +L +DLS E+ ++ + L ++ L+ N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQF-SGPI 521
++ G S L ++ + + +L+ + + K+L+EL +A+N S +
Sbjct: 90 -SLALGAF-------SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 522 PNIVAELKGLEVLDLSSNKLSGSIPSD----LQNLQALR-SLNLTFNNLEGVVPSEGIFR 576
P + L LE LDLSSNK+ SI L + L SL+L+ N + + G F+
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI--QPGAFK 198
Query: 577 NMSNVHL 583
+ L
Sbjct: 199 EIRLKEL 205
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 56/258 (21%), Positives = 87/258 (33%), Gaps = 52/258 (20%)
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
P N+ K LDL N + + + LQVL+ + + +I
Sbjct: 23 PDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGA------- 71
Query: 196 LSRLENLKVLDLTINRLAGTVPSTI-YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254
L +L L LT N + ++ ++SL L L +L
Sbjct: 72 YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL---------ASLE----- 116
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL-GNLPFLRTYNIGFNKI--VS 311
+ +L ++ + + HNL++ P NL L ++ NKI +
Sbjct: 117 -----------NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN-ELSKLYLGGNHIYGKIP 370
D L + L S L L N I G F L +L L N + +P
Sbjct: 166 CTDLRVLHQMPLLNLS-----LDLSLNPMN-FIQP--GAFKEIRLKELALDTNQL-KSVP 216
Query: 371 ASI-GRLRSLTLLDLSYN 387
I RL SL + L N
Sbjct: 217 DGIFDRLTSLQKIWLHTN 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 38/225 (16%), Positives = 88/225 (39%), Gaps = 24/225 (10%)
Query: 347 SIGNFSNELSKLYLGGNHIYGKIPA-SIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQ 404
I + L L H+ IP+ + L +++ + +S + ++ L +
Sbjct: 25 RIPSLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83
Query: 405 VLGLAGN----EIPGGIPNSLANLKKLNQIDLSGNELTGEIP--ISFGNFQSLLSIDLSN 458
+ + I P++L L L + + L P + +++++
Sbjct: 84 HIEIRNTRNLTYID---PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 459 NRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFS 518
N +IP + L E +T+ L +N + ++ N L+ + + N++
Sbjct: 140 NPYMTSIPVNAFQGLCNE------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192
Query: 519 GPIP-NIVAELK-GLEVLDLSSNKLSGSIPSD-LQNLQALRSLNL 560
I + + G +LD+S ++ ++PS L++L+ L + N
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 38/208 (18%), Positives = 73/208 (35%), Gaps = 19/208 (9%)
Query: 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNEL 437
++ I IP Q L L + ++ +NL +++I +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 438 TGEIPI-SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN 496
++ SF N + I++ N R I L+ LP + + + + L
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP-------LLKFLGIFNTGLK-M 119
Query: 497 LPN--SLKNCKSLEELLMAYNQFSGPIP-NIVAEL-KGLEVLDLSSNKLSGSIPSDLQNL 552
P+ + + L + N + IP N L L L +N + S+ N
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178
Query: 553 QALRSLNLTFNNLEGVVPSEGIFRNMSN 580
L ++ L N V+ + F + +
Sbjct: 179 TKLDAVYLNKNKYLTVID-KDAFGGVYS 205
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 36/235 (15%), Positives = 69/235 (29%), Gaps = 38/235 (16%)
Query: 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR 260
+ + L L L N+ ++ + ++ + L +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSID---------------VTLQQLE---- 72
Query: 261 FTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSGDDEGLS 319
S +NL+ + I + + + P L LP L+ I +
Sbjct: 73 -----SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM------FP 121
Query: 320 FITSLTNSTHLNYLALDGNQFEGKIPE-SIGNFSNELSKLYLGGNHIYGKIPASIGRLRS 378
+T + ++ L + N + IP + NE L L N +
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTK 180
Query: 379 LTLLDLSYNSISGEIPIEI--GQLQGLQVLGLAGN---EIPGGIPNSLANLKKLN 428
L + L+ N I + G G +L ++ +P L L N
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 30/213 (14%), Positives = 75/213 (35%), Gaps = 16/213 (7%)
Query: 97 LRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
++++L L NL + + +S + +L + L+++ +++ +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215
+ D L+ L L+ L L P + + +L++T N +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTK------VYSTDIFFILEITDNPYMTS 145
Query: 216 VPS-TIYNMTS-LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP-GSLHNL 272
+P + + + L+L +N + + L N++ I + +
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFN-GTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 273 -TNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYN 303
+ ++ ++ + LP L +L L N
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 15/113 (13%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNK 540
+ T+ L + L ++ N ++ + ++ + + + L + +++ + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 541 LSGSIPSD-LQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNPKL 589
I D L+ L L+ L + L+ + P + + + NP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 45/160 (28%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS-------------------FIAECETLRNVRHRNLVK 706
++ +G G +G V G WK F+ E ++ ++H NLV+
Sbjct: 18 KHKLGGGQYGEVYE----GVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYL- 755
L+ C+ ++ EF++ G+L D++ + E+ I+SA++YL
Sbjct: 74 LLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 756 -HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
N +H DL N L+ E KV DFGL+R +
Sbjct: 129 KKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 45/189 (23%)
Query: 661 GNFSHENLIGSGSFGSVL--HNERTGS---WK--------------SFIAECETLRNVRH 701
NF E IG G F V G K I E + L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD----------IT 749
N++K S L +V E G L I ++K + +
Sbjct: 92 PNVIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM 809
SAL+++H+ V+H D+KP N+ + K+GD GL RF ++++ + + V
Sbjct: 147 SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLV-- 197
Query: 810 GSIGYVPPE 818
G+ Y+ PE
Sbjct: 198 GTPYYMSPE 206
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 29/247 (11%)
Query: 321 ITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT 380
I S L + ++ + ++ + I + I L ++T
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTD--AVTQNELNS-IDQIIANNSDI-KSVQG-IQYLPNVT 71
Query: 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440
L L+ N ++ P+ L+ L L L N++ +SL +LKKL + L N ++ +
Sbjct: 72 KLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-D 126
Query: 441 IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNS 500
I + L S+ L NN+I +I +SRL + T+ L DN +S ++
Sbjct: 127 IN-GLVHLPQLESLYLGNNKIT-DI---------TVLSRLTKLDTLSLEDNQIS-DIVP- 173
Query: 501 LKNCKSLEELLMAYNQFSGPIPNI--VAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSL 558
L L+ L ++ N I ++ +A LK L+VL+L S + + NL ++
Sbjct: 174 LAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 559 NLTFNNL 565
T +L
Sbjct: 230 KNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 38/276 (13%)
Query: 269 LHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNST 328
+ + + L + + I S + +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---------VQGIQYLP 68
Query: 329 HLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
++ L L+GN+ I +N L L+L N + + S+ L+ L L L +
Sbjct: 69 NVTKLFLNGNKLT-----DIKPLANLKNLGWLFLDENKV-KDLS-SLKDLKKLKSLSLEH 121
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
N IS + L L+ L L N+I L+ L KL+ + L N+++ +P++
Sbjct: 122 NGISDINGLV--HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVPLA-- 175
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
L ++ LS N I+ ++ ++ L+N+ ++L N N
Sbjct: 176 GLTKLQNLYLSKNHIS-DL---------RALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542
+ P I+++ E ++ +
Sbjct: 226 PNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/285 (19%), Positives = 95/285 (33%), Gaps = 31/285 (10%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
++P I + +L + T T + S+ + ++ +
Sbjct: 9 TVPTPIKQIFS--DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK----- 59
Query: 243 DVR--DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLR 300
V+ LPN+ N+ T I L NL N+ + + N ++ L +L L+
Sbjct: 60 SVQGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLK 115
Query: 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360
+ ++ N I I L + L L L N+ + + L L L
Sbjct: 116 SLSLEHNGISD---------INGLVHLPQLESLYLGNNKI--TDITVLSRLTK-LDTLSL 163
Query: 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNS 420
N I I + L L L LS N IS ++ + L+ L VL L E N
Sbjct: 164 EDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINH 219
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNI 465
+NL N + + L IS ++ +
Sbjct: 220 QSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 43/261 (16%), Positives = 85/261 (32%), Gaps = 57/261 (21%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMA 152
+ L+ ++ + L + + + ++++ + I L + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77
Query: 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL 212
NK+T L NL++L L +N + +L S L L+ LK L L N +
Sbjct: 78 NKLT---DIKPLANLKNLGWLFLDEN--------KVKDL--SSLKDLKKLKSLSLEHNGI 124
Query: 213 AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNL 272
+ + + ++ L L L +N++ L L
Sbjct: 125 --SDINGLVHLPQLESLYLGNNKI---------------------------TDITVLSRL 155
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
T + + + N + + L L L+ + N I + +L +L+
Sbjct: 156 TKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISD---------LRALAGLKNLDV 204
Query: 333 LALDGNQFEGKIPESIGNFSN 353
L L + K N
Sbjct: 205 LELFSQECLNKPINHQSNLVV 225
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 17/146 (11%)
Query: 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
+ +L L+S+ L++N +S ++ + +L +L L + N + +S+LT+L L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSL 163
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
N+I+ L L LQ L KN I++L L+ L+NL VL+L
Sbjct: 164 EDNQIS---DIVPLAGLTKLQNLYLSKN--------HISDL--RALAGLKNLDVLELFSQ 210
Query: 211 RLAGTVPSTIYNMTSLVHLRLASNQL 236
+ N+ ++ L
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 53/209 (25%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK------------------SFIAECETLRNVRHRNLVKL 707
E +G G FG V G+W +F+ E + ++ +RH LV+L
Sbjct: 189 EVKLGQGCFGEVWM----GTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
S E + +V E++S GSL D++ GE L I S + Y+
Sbjct: 245 YAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ VH DL+ NIL+ E + KV DFGLAR + DN+ + F I + P
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFP--IKWTAP 350
Query: 818 EYGLGERPSTAGDVPTSESFAGEFNIVKW 846
E L R + DV + F I+
Sbjct: 351 EAALYGRFTIKSDVWS-------FGILLT 372
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 41/157 (26%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK------------------SFIAECETLRNVRHRNLVKL 707
E +G+G FG V ++ +F+AE ++ ++H LVKL
Sbjct: 193 EKKLGAGQFGEVWM----ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
+ E + ++ EF++ GSL D++ + ++ I + ++
Sbjct: 249 HAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+ +H DL+ NIL+ + K+ DFGLAR + +
Sbjct: 302 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 40/149 (26%), Positives = 62/149 (41%), Gaps = 21/149 (14%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--- 745
+AE + L V H ++V++ D +V E++ SL +
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185
Query: 746 ---LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSI 802
L+I AL YLH + +V++DLKP NI+L EE K+ D G I
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS----------RI 231
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
+S G+ G+ PE P+ A D+
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDI 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 33/153 (21%)
Query: 666 ENLIGSGSFGSVLH--------------NERTGSWKSFIAECETLRNVRHRNLVKLITSC 711
+G+G FG V + + S +F+AE ++ ++H+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDCEV 761
+ E + ++ E++ NGSL D++ +L I + ++ E
Sbjct: 78 TQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+H DL+ NIL+ + ++ K+ DFGLAR + +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 35/158 (22%)
Query: 666 ENLIGSGSFGSV--------------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
+G G+FGSV L + + F E E L++++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYLH 756
K C S +N+ L+ E+L GSL D++ ++ +L I ++YL
Sbjct: 75 KYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+H DL NIL++ E K+GDFGL + L +
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 43/185 (23%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECETLRNVRH 701
+F +G G FG+V ++ KS + E E ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALD 753
N++++ + +L L EF G L + + +E + AL
Sbjct: 74 PNILRMYNY---FHDRKRIYLML--EFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
Y H V+H D+KP N+L+ + K+ DFG + + G++
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWS--------VHAPSLRRRTMCGTLD 177
Query: 814 YVPPE 818
Y+PPE
Sbjct: 178 YLPPE 182
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 45/185 (24%), Positives = 65/185 (35%), Gaps = 44/185 (23%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSW----------------KSFIAECETLRNV-RHR 702
+F + +G GS+G V ++ G +AE + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNE-------LDITSALD 753
V+L + + L L E SL G E D AL
Sbjct: 118 CCVRLEQA-----WEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
+LH+ +VH D+KP NI L K+GDFGL L + + V G
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-------GTAGAGEVQEGDPR 221
Query: 814 YVPPE 818
Y+ PE
Sbjct: 222 YMAPE 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 30/205 (14%), Positives = 68/205 (33%), Gaps = 62/205 (30%)
Query: 661 GNFSHENLIGSGSFGSVLHNERTGSW-------KSFIA---------------------- 691
++ + G F ++ E+ + KS +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 692 --ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--- 746
E + + ++++ + + + + ++YE++ N S+ + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIIT--NYDE---VYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 747 -------------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793
+ ++ Y+HN E + H D+KP NIL+D+ K+ DFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES---- 199
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPE 818
G+ ++PPE
Sbjct: 200 ----EYMVDKKIKGSRGTYEFMPPE 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 45/206 (21%), Positives = 72/206 (34%), Gaps = 26/206 (12%)
Query: 632 KRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWKSFIA 691
+ K R V AL K+ HP I A E + S
Sbjct: 48 REKVMR-EVKALAKLEHPGIV--RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
Query: 692 ECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--- 747
+R T S +L + + +L DW++ R + D
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREH 163
Query: 748 ---------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798
I A+++LH+ ++H DLKP NI + KVGDFGL + + +
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 799 QSSISSTHVFM---GSIG---YVPPE 818
Q+ ++ + G +G Y+ PE
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 41/179 (22%)
Query: 667 NLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL--VKL 707
IGSG V L + S+ E L ++ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHNDC 759
+++ +V E N L W+ ++ + + + A+ +H
Sbjct: 94 YDYE-----ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+VHSDLKP N L+ + M K+ DFG+A + + S +G++ Y+PPE
Sbjct: 148 ---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS----QVGTVNYMPPE 198
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 38/184 (20%), Positives = 64/184 (34%), Gaps = 46/184 (25%)
Query: 643 LFKVCHPKISYD--ELRRATGNFSHENLIGSGSFGSVLHNERTGSWKS------------ 688
V H + D L + IG G+FG V G ++
Sbjct: 96 SGVVLHRAVPKDKWVLNHE--DLVLGEQIGRGNFGEVFS----GRLRADNTLVAVKSCRE 149
Query: 689 ---------FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH 739
F+ E L+ H N+V+LI C+ + + +V E + G ++
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELVQGGDFLTFLR 204
Query: 740 GERKNE---------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
E D + ++YL +H DL N L+ E+ K+ DFG++R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 791 FLLE 794
+
Sbjct: 262 EEAD 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 40/161 (24%), Positives = 62/161 (38%), Gaps = 35/161 (21%)
Query: 666 ENLIGSGSFGSV--------------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
+ +G G+FGSV L + + F E + L+ + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYLH 756
K +++ LV E+L +G L D++ R L I ++YL
Sbjct: 88 KYRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
VH DL NIL++ E K+ DFGLA+ L D
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 53/209 (25%)
Query: 666 ENLIGSGSFGSVLHNERTGSWK------------------SFIAECETLRNVRHRNLVKL 707
E +G G FG V G+W +F+ E + ++ +RH LV+L
Sbjct: 272 EVKLGQGCFGEVWM----GTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
S E + +V E++S GSL D++ GE L I S + Y+
Sbjct: 328 YAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ VH DL+ NIL+ E + KV DFGLAR + DN+ + F I + P
Sbjct: 381 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFP--IKWTAP 433
Query: 818 EYGLGERPSTAGDVPTSESFAGEFNIVKW 846
E L R + DV + F I+
Sbjct: 434 EAALYGRFTIKSDVWS-------FGILLT 455
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 35/161 (21%)
Query: 666 ENLIGSGSFGSV--------------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
+G G+FGSV L + + F E E L++++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYLH 756
K C S +N+ L+ E+L GSL D++ ++ +L I ++YL
Sbjct: 106 KYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+H DL NIL++ E K+GDFGL + L + +
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 40/160 (25%)
Query: 669 IGSGSFGSV------LHNERTG---------------SWKSFIAECETLRNVRHRNLVKL 707
+G G FG V N+ TG + E + LR + H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHN 757
C + ++ LV E++ GSL D++ ++ + I + YLH
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+H DL N+LLD + K+GDFGLA+ + E +
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 39/184 (21%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSW-------KSFI----------AECETLRNVRHR 702
+F ++G GSF +V+ T K I E + + + H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDY 754
VKL + ++ E L + NG L +I + I SAL+Y
Sbjct: 91 FFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH ++H DLKP NILL+E+M ++ DFG A+ + +S + + F+G+ Y
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK----VLSPESKQARANSFVGTAQY 198
Query: 815 VPPE 818
V PE
Sbjct: 199 VSPE 202
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 42/158 (26%), Positives = 65/158 (41%), Gaps = 43/158 (27%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------FIAECETLRNVRHRNLVKL 707
+GSG FG V G WK F E +T+ + H LVK
Sbjct: 13 LKELGSGQFGVVKL----GKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYL--H 756
CS + +V E++SNG L +++ K +L D+ + +L H
Sbjct: 69 YGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+H DL N L+D ++ KV DFG+ R++L+
Sbjct: 124 Q-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 29/190 (15%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIP--ISFGNFQSLLSIDLSNNRINGNIPKGI 469
+P +P+ A L DLS N L+ + + +L S+ LS+N +N I
Sbjct: 32 NVPQSLPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEA 83
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELK 529
P+P N+ +DLS N L + ++LE LL+ N N ++
Sbjct: 84 FVPVP-------NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA 136
Query: 530 GLEVLDLSSNKLSGSIP----SDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN----- 580
L+ L LS N++S P D L L L+L+ N L+ + + +
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL--PLTDLQKLPAWVKNG 193
Query: 581 VHLKGNPKLC 590
++L NP C
Sbjct: 194 LYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
L+ L S+ L +N L+ + E + LR L++S N+L L + S L L++L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
N I V + ++ LQ L +N + P + D ++L L +LDL+ N
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELI----KDGNKLPKLMLLDLSSN 173
Query: 211 RLAGTVPSTIYNMTSLVH--LRLASNQL 236
+L + + + + V L L +N L
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 34/198 (17%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEI--GQLQGLQVLGLAGNEIPGGIPNSLANLKK 426
+P S+ LLDLS+N++S + E +L L L L+ N + + +
Sbjct: 33 VPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 427 LNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486
L +DLS N L F + Q+L + L NN I + + + + +
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA-------QLQKL 141
Query: 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP 546
LS N +S P L +L L +LDLSSNKL
Sbjct: 142 YLSQNQIS-RFPVEL---------------IKD-----GNKLPKLMLLDLSSNKLKKLPL 180
Query: 547 SDLQNLQALRSLNLTFNN 564
+DLQ L A L +N
Sbjct: 181 TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 24/181 (13%)
Query: 110 NLPREIGNLFRLRVLNISFNNLQGELPVNI--SKLTELKMLDLMANKITGRVTDDQLRNL 167
+LP +L++S NNL L ++LT L L L N + ++ + +
Sbjct: 36 SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV 227
+L+ L+ N L ++ + S L+ L+VL L N + + +M L
Sbjct: 88 PNLRYLDLSSNHL-HTLDEFL-------FSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139
Query: 228 HLRLASNQLGGEIPYDV---RDTLPNLLDFIYCFNRFTGKIPGSLHNLTNI--QIIRMTH 282
L L+ NQ+ P ++ + LP L+ N+ L L + + +
Sbjct: 140 KLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 283 N 283
N
Sbjct: 199 N 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 37/198 (18%), Positives = 63/198 (31%), Gaps = 39/198 (19%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTI-YNMTSLVHLRLASNQLGGEIPYDVRDTLPN 250
+P L +LDL+ N L+ +T+L L L+ N L I
Sbjct: 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FIS--------- 80
Query: 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKI 309
+ + N++ + ++ N L TL +L L + N I
Sbjct: 81 ---------------SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI 124
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYG 367
V + + + L L L NQ E I + + +L L L N +
Sbjct: 125 VVVDRN-------AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 368 KIPASIGRLRSLTLLDLS 385
+ +L + L
Sbjct: 178 LPLTDLQKLPAWVKNGLY 195
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 36/157 (22%)
Query: 666 ENLIGSGSFGSV------LHNERTG---------------SWKSFIAECETLRNVRHRNL 704
+G G FG V + TG E E LRN+ H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDYL 755
VK C+ + L+ EFL +GSL +++ + + I +DYL
Sbjct: 86 VKYKGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
VH DL N+L++ E K+GDFGL + +
Sbjct: 143 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 45/200 (22%), Positives = 72/200 (36%), Gaps = 35/200 (17%)
Query: 655 ELRRATGNFSHENLIGSGSFGSVLH--NERTGSWKSFIA------------ECETLRNVR 700
E R +H+ +G GSFG V +++TG A E +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF---QCAVKKVRLEVFRVEELVACAGLS 108
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERKNE-------LDITSAL 752
+V L + + + E L GSLG I E L
Sbjct: 109 SPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
+YLH ++H D+K N+LL + A + DFG A L+ S+ + G+
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIPGT 219
Query: 812 IGYVPPEYGLGERPSTAGDV 831
++ PE +G+ D+
Sbjct: 220 ETHMAPEVVMGKPCDAKVDI 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 43/159 (27%), Positives = 61/159 (38%), Gaps = 45/159 (28%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------FIAECETLRNVRHRNLVKL 707
IGSG FG V G W + FI E E + + H LV+L
Sbjct: 13 VQEIGSGQFGLVHL----GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYL-- 755
C + LV EF+ +G L D++ ++ D+ + YL
Sbjct: 69 YGVCL-----EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
V+H DL N L+ E KV DFG+ RF+L+
Sbjct: 123 AC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 43/185 (23%), Positives = 74/185 (40%), Gaps = 43/185 (23%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECETLRNVRH 701
+F +G G FG+V +++ K+ + E E ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALD 753
N+++L +L L E+ G++ + K +E + +AL
Sbjct: 69 PNILRLYGY---FHDATRVYLIL--EYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
Y H+ V+H D+KP N+LL K+ DFG + V SS + G++
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTD--LCGTLD 172
Query: 814 YVPPE 818
Y+PPE
Sbjct: 173 YLPPE 177
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 41/179 (22%)
Query: 667 NLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL--VKL 707
IGSG V L + S+ E L ++ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHNDC 759
+++ +V E N L W+ ++ + + + A+ +H
Sbjct: 122 YDYE-----ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+VHSDLKP N L+ + K+ DFG+A + + D S + + +G++ Y+PPE
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDS--QVGAVNYMPPE 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 41/179 (22%)
Query: 667 NLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL--VKL 707
IGSG V L + S+ E L ++ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHNDC 759
+++ +V E N L W+ ++ + + + A+ +H
Sbjct: 75 YDY-----EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+VHSDLKP N L+ + M K+ DFG+A + + +S+ +G++ Y+PPE
Sbjct: 129 ---IVHSDLKPANFLIVDGM-LKLIDFGIANQM---QPDTTSVVKDS-QVGTVNYMPPE 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 44/186 (23%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECETLRNVRH 701
G++ + +G G+FG V ++ TG + I E + L+ RH
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSAL 752
+++KL + + F+ V E++S G L D+I HG R E++ I SA+
Sbjct: 71 PHIIKLYQV---ISTPTDFFM--VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
DY H VVH DLKP N+LLD M AK+ DFGL+ + GS
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEF-----LRTSCGSP 174
Query: 813 GYVPPE 818
Y PE
Sbjct: 175 NYAAPE 180
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 45/184 (24%), Positives = 68/184 (36%), Gaps = 39/184 (21%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA--------ECETLRNVRHRN 703
++ +G G++G V N T E + + H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDY 754
+VK N+++L L E+ S G L D I E D + + + Y
Sbjct: 67 VVKFYGH---RREGNIQYLFL--EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH + H D+KP N+LLDE K+ DFGLA + + G++ Y
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTLPY 173
Query: 815 VPPE 818
V PE
Sbjct: 174 VAPE 177
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 40/160 (25%)
Query: 666 ENLIGSGSFGSVLH------------------NERTG--SWKSFIAECETLRNVRHRNLV 705
+ +IG G FG V H + T ++F+ E +R + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSALDYL- 755
LI + ++ ++ +G L +I ++N L + ++YL
Sbjct: 86 ALIGIMLPPEGLPH----VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 756 -HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
VH DL N +LDE T KV DFGLAR +L+
Sbjct: 142 EQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILD 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 45/167 (26%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 650 KISYDELRRATGNFSHENLIGSGSFGSVL--HNERTGS-------------WKSFIAECE 694
+I LR G F L+G+G++G V + +TG + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 695 TLRNV-RHRNLVKLITSCSSLDSKNMEF-LALVYEFLSNGSLGDWIHGERKNELD----- 747
L+ HRN+ + + M+ L LV EF GS+ D I + N L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 748 -----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
I L +LH V+H D+K N+LL E K+ DFG++
Sbjct: 133 YICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 52/193 (26%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGS-------WKSFIA---------------ECETL 696
+S + +GSG+FG V ++ K + E L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 697 RNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGS-LGDWIHGERKNELD-------- 747
V H N++K++ +++ LV E +G L +I +R LD
Sbjct: 84 SRVEHANIIKVLD---IFENQGFFQ--LVMEKHGSGLDLFAFI--DRHPRLDEPLASYIF 136
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
+ SA+ YL ++H D+K NI++ E+ T K+ DFG A +L
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-------KLF 186
Query: 806 HVFMGSIGYVPPE 818
+ F G+I Y PE
Sbjct: 187 YTFCGTIEYCAPE 199
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 35/174 (20%), Positives = 65/174 (37%), Gaps = 47/174 (27%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGS---------------------WKSFIAECETL 696
L +G G FGSV+ + F++E +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 697 RNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE----------- 745
++ H N+++L+ C + S+ + ++ F+ G L ++ R
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 746 ---LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+DI ++YL N +H DL N +L ++MT V DFGL++ +
Sbjct: 151 KFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 43/185 (23%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA---------ECETLRNVRHR 702
GN+ IG G+F V + TG K+ + E ++ + H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALD 753
N+VKL ++++ +L + E+ S G + D++ HG R E + I SA+
Sbjct: 75 NIVKLFEV---IETEKTLYL--IMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQ 128
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
Y H +VH DLK N+LLD +M K+ DFG + F G+
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----TVGGKLDA--FCGAPP 178
Query: 814 YVPPE 818
Y PE
Sbjct: 179 YAAPE 183
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 47/175 (26%)
Query: 651 ISYD--ELRRATGNFSHENLIGSGSFGSVLHNERTGSWKS------------------FI 690
+ Y E+ + + +G+G FG V + G W+ FI
Sbjct: 14 LGYGSWEIDPK--DLTFLKELGTGQFGVVKY----GKWRGQYDVAIKMIKEGSMSEDEFI 67
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL 746
E + + N+ H LV+L C+ + ++ E+++NG L +++ R +L
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL 122
Query: 747 -----DITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
D+ A++YL +H DL N L++++ KV DFGL+R++L+
Sbjct: 123 LEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 44/162 (27%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
+IG G FG V H G+ F+ E +++ H
Sbjct: 30 NEVIGRGHFGCVYH----GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSAL 752
N++ L+ C + + +V ++ +G L ++I E N L + +
Sbjct: 86 PNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
YL VH DL N +LDE+ T KV DFGLAR + +
Sbjct: 142 KYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 19/134 (14%)
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----- 746
E L+ + H N+VKL+ LD N + L +V+E ++ G + + + +E
Sbjct: 86 EIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 747 --DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
D+ ++YLH ++H D+KP N+L+ E+ K+ DFG++ + S +
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF------KGSDAL 193
Query: 805 THVFMGSIGYVPPE 818
+G+ ++ PE
Sbjct: 194 LSNTVGTPAFMAPE 207
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 35/179 (19%), Positives = 66/179 (36%), Gaps = 54/179 (30%)
Query: 648 HPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTGSWKS------------------- 688
+ E ++ ++GSG+FG+V G W
Sbjct: 9 LRILKETEFKK-------IKVLGSGAFGTV----YKGLWIPEGEKVKIPVAIKELREATS 57
Query: 689 ------FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
+ E + +V + ++ +L+ C + + L+ + + G L D++ +
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHK 111
Query: 743 KN----EL-----DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
N L I ++YL + +VH DL N+L+ K+ DFGLA+ L
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 55/184 (29%)
Query: 651 ISYDELRRATGNFSHENL------IGSGSFGSVLHNERTGSWKS---------------- 688
++ +E+R + L +GSG+FG+V + G ++
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEA 56
Query: 689 --------FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740
+AE ++ + + +V++I C + E LV E G L ++
Sbjct: 57 NDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQ 110
Query: 741 ERK---NEL-----DITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
R + ++ + YL N VH DL N+LL + AK+ DFGL++
Sbjct: 111 NRHVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSK 165
Query: 791 FLLE 794
L
Sbjct: 166 ALRA 169
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 41/169 (24%), Positives = 60/169 (35%), Gaps = 52/169 (30%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS--------------------------FIAECETLRNV 699
+G GSFG V R G W + FI E + ++
Sbjct: 23 LEKLGDGSFGVV----RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITS 750
HRNL++L + + +V E GSL D + + + L +
Sbjct: 79 DHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 751 ALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ YL +H DL N+LL K+GDFGL R L + D
Sbjct: 133 GMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 49/163 (30%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS-----------------------FIAECETLRNVRHR 702
+ +G G+FGSV R G ++ + E + + + +
Sbjct: 15 DIELGCGNFGSV----RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALD 753
+V+LI C + E L LV E G L ++ G+R+ + ++ +
Sbjct: 71 YIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 754 YL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
YL N VH DL N+LL AK+ DFGL++ L
Sbjct: 125 YLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 55/170 (32%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
E +IGSG G V + G + F++E + H
Sbjct: 54 EKIIGSGDSGEVCY----GRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDIT 749
N+++L + +V E++ NGSL ++ R ++ +
Sbjct: 110 PNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVG 161
Query: 750 SALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ + YL VH DL N+L+D + KV DFGL+R L + D
Sbjct: 162 AGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 45/184 (24%), Positives = 68/184 (36%), Gaps = 39/184 (21%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA--------ECETLRNVRHRN 703
++ +G G++G V N T E + + H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDY 754
+VK N+++L L E+ S G L D I E D + + + Y
Sbjct: 67 VVKFYGH---RREGNIQYLFL--EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH + H D+KP N+LLDE K+ DFGLA + + G++ Y
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTLPY 173
Query: 815 VPPE 818
V PE
Sbjct: 174 VAPE 177
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 44/162 (27%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
+IG G FG V H G+ F+ E +++ H
Sbjct: 94 NEVIGRGHFGCVYH----GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSAL 752
N++ L+ C + + +V ++ +G L ++I E N L + +
Sbjct: 150 PNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+L VH DL N +LDE+ T KV DFGLAR + +
Sbjct: 206 KFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 42/214 (19%), Positives = 74/214 (34%), Gaps = 52/214 (24%)
Query: 663 FSHENLIGSGSFGSV-LHNERTGSW---KSFIAECETL---------RNVRHRNLVKLIT 709
E ++G GS G+V G K + + + + H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------LDITSALDY 754
S ++ FL + E L N +L D + + ++ I S + +
Sbjct: 77 SETT-----DRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 755 LHNDCEVPVVHSDLKPGNILLD-------------EEMTAKVGDFGLARFLLERVDNQSS 801
LH+ ++H DLKP NIL+ E + + DFGL + L S
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS--GQSSF 185
Query: 802 ISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSE 835
++ + G+ G+ PE T
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 37/220 (16%), Positives = 76/220 (34%), Gaps = 24/220 (10%)
Query: 346 ESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405
+N K LG + S L + + ++I ++ L+
Sbjct: 13 FPDPGLAN-AVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 406 LGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNI 465
L L+ N+I + L +L KL ++ ++ N L ++ L + L NN +
Sbjct: 68 LHLSHNQI-SDLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD-- 120
Query: 466 PKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIV 525
+ + L+N+ + + +N L ++ L LE L + N+ + +
Sbjct: 121 --------TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--L 168
Query: 526 AELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
LK + +DL+ K L ++
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 43/230 (18%), Positives = 75/230 (32%), Gaps = 31/230 (13%)
Query: 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF 351
L N+G + + S + + D + + + + F
Sbjct: 14 PDPGLANAVKQNLGKQSVTD---------LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFF 62
Query: 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411
+N L +L+L N I + + L L L ++ N + + L L L N
Sbjct: 63 TN-LKELHLSHNQI-SDLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNN 116
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
E+ +SL +LK L + + N+L I G L +DL N I N
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NT------ 165
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI 521
++RL+ V IDL+ + ++ P
Sbjct: 166 ---GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 20/167 (11%)
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
L + +L +T + + + + N+ I ++ +
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL---------AGMQFF 62
Query: 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
N+ + LS N +S +L LK+ LEEL + N+ + I L L L +N+
Sbjct: 63 TNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-LNGI--PSACLSRLFLDNNE 117
Query: 541 LSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587
L L +L+ L L++ N L+ +V + + L GN
Sbjct: 118 LRD--TDSLIHLKNLEILSIRNNKLKSIVMLGF-LSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 38/201 (18%), Positives = 71/201 (35%), Gaps = 24/201 (11%)
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
I+ P L L + S L + + + + +
Sbjct: 7 TPINQVFPDP--GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQ-- 60
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
F +L + LS+N+I+ ++ + L + + ++ N L NL + +
Sbjct: 61 FFTNLKELHLSHNQIS-DL---------SPLKDLTKLEELSVNRNRLK-NLNG-IPSAC- 107
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
L L + N+ + LK LE+L + +NKL SI L L L L+L N +
Sbjct: 108 LSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT 163
Query: 567 GVVPSEGIFRNMSNVHLKGNP 587
+ ++ + L G
Sbjct: 164 NTGGLTR-LKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 32/202 (15%)
Query: 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLS 197
L +L +T V+ + L +Q N + I +L + +
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSN--------IQSL--AGMQ 60
Query: 198 RLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC 257
NLK L L+ N++ + S + ++T L L + N+L + L
Sbjct: 61 FFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRL-KNLNG---IPSACLSRLFLD 114
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEG 317
N L +L N++I+ + +N L+ LG L L ++ N+I +
Sbjct: 115 NNELR-DTDS-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN------ 164
Query: 318 LSFITSLTNSTHLNYLALDGNQ 339
LT +N++ L G +
Sbjct: 165 ---TGGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 35/156 (22%), Positives = 60/156 (38%), Gaps = 22/156 (14%)
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
+SP + +L+ L + + N+L NL L L + N L+ ++ L L
Sbjct: 77 DLSP-LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--TDSLIHLKNL 130
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
++L + NK+ + L L L+VL+ N I N L+RL+ + +
Sbjct: 131 EILSIRNNKLK---SIVMLGFLSKLEVLDLHGN--------EITNT--GGLTRLKKVNWI 177
Query: 206 DLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241
DLT + V + L + G I
Sbjct: 178 DLTGQKC---VNEPVKYQPELYITNTVKDPDGRWIS 210
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 37/161 (22%), Positives = 57/161 (35%), Gaps = 47/161 (29%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS-------------------------FIAECETLRNVR 700
++GSG FG+V G W + ++
Sbjct: 18 LKVLGSGVFGTVHK----GVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSA 751
H ++V+L+ C L LV ++L GSL D + R + I
Sbjct: 74 HAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ YL E +VH +L N+LL +V DFG+A L
Sbjct: 128 MYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 42/184 (22%)
Query: 662 NFSHENLIGSGSFGSVLH--NERTGSW--------------KSFIAECETLRNVRHRNLV 705
S ++G G FG V TG + E + + H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDYLH 756
+L + +SKN + LV E++ G L D I ELD I + ++H
Sbjct: 150 QLY---DAFESKN--DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 757 NDCEVPVVHSDLKPGNILL--DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
++ ++H DLKP NIL + K+ DFGLAR R V G+ +
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-------EKLKVNFGTPEF 254
Query: 815 VPPE 818
+ PE
Sbjct: 255 LAPE 258
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-16
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 55/187 (29%)
Query: 648 HPKISYDELRRATGNFSHENL------IGSGSFGSVLHNERTGSWKS------------- 688
P +EL+ +NL +G G+FGSV R G ++
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSV----RQGVYRMRKKQIDVAIKVLK 372
Query: 689 ----------FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI 738
+ E + + + + +V+LI C + E L LV E G L ++
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFL 426
Query: 739 HGERKN----EL-----DITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787
G+R+ + ++ + YL N VH +L N+LL AK+ DFG
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFG 481
Query: 788 LARFLLE 794
L++ L
Sbjct: 482 LSKALGA 488
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 41/176 (23%)
Query: 669 IGSGSFGSVLHNERTGSWKSFIA---------------ECETLRNVRHRNLVKLITSCSS 713
+G G FG V T S K+++A E L RHRN++ L S S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 714 LDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDYLHNDCEVPVV 764
ME L +++EF+S + + I NE + + AL +LH +
Sbjct: 73 -----MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 765 HSDLKPGNILL--DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
H D++P NI+ T K+ +FG AR L + + + Y PE
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-------DNFRLLFTAPEYYAPE 173
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 42/177 (23%)
Query: 669 IGSGSFGSVLHNERTGSWKSFIA----------------ECETLRNVRHRNLVKLITSCS 712
+G+G+FG V + +F A E +T+ +RH LV L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELD-------ITSALDYLHNDCEVPV 763
+ ++YEF+S G L + + E +E + + L ++H E
Sbjct: 225 D-----DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNY 276
Query: 764 VHSDLKPGNILL--DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VH DLKP NI+ K+ DFGL L + S V G+ + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------QSVKVTTGTAEFAAPE 326
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 37/169 (21%), Positives = 63/169 (37%), Gaps = 44/169 (26%)
Query: 663 FSHENL-----IGSGSFGSVLH---NERTGSW------------------KSFIAECETL 696
+ +G G FGSV + GS+ + F+ E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 697 RNVRHRNLVKLITSCSSLDSKNMEFLAL-VYEFLSNGSLGDWIHGERKNE---------- 745
+ H ++ KL+ +K + + + F+ +G L ++ R E
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 746 ----LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+DI ++YL +H DL N +L E+MT V DFGL+R
Sbjct: 140 VRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 48/196 (24%)
Query: 660 TGNFSH-----ENLIGSGSFGSVLH--NERTG--------------SWKSFIAECETLRN 698
+G F E+++G G+ V N T E E L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 699 VR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELD-------I 748
+ HRN+++LI + + LV+E + GS+ IH +R+ NEL+ +
Sbjct: 67 CQGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDV 120
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISST 805
SALD+LHN + H DLKP NIL ++ K+ DF L + +++ S ST
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI--KLNGDCSPIST 175
Query: 806 HVFM---GSIGYVPPE 818
+ GS Y+ PE
Sbjct: 176 PELLTPCGSAEYMAPE 191
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 54/191 (28%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECETLRNVRH 701
G++ + +G G+FG V +E TG + I E + L+ RH
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSAL 752
+++KL + + + F+ V E++S G L D+I +G R +E + I S +
Sbjct: 76 PHIIKLYQV---ISTPSDIFM--VMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF-----LLERVDNQSSISSTHV 807
DY H VVH DLKP N+LLD M AK+ DFGL+ L
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL------------RT 174
Query: 808 FMGSIGYVPPE 818
GS Y PE
Sbjct: 175 SCGSPNYAAPE 185
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 38/164 (23%), Positives = 63/164 (38%), Gaps = 50/164 (30%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
++G G FG V G + + F++E ++N+ H
Sbjct: 17 NRILGEGFFGEVYE----GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSAL 752
++VKLI E ++ E G LG ++ + + L I A+
Sbjct: 73 PHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 753 DYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
YL N VH D+ NIL+ K+GDFGL+R++ +
Sbjct: 127 AYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 45/223 (20%), Positives = 75/223 (33%), Gaps = 46/223 (20%)
Query: 627 PIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSH----ENLIGSGSFGSVLHNER 682
+ + K ++ K + G+ +GSG+FG V
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 683 TGSWKSFIA----------------ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726
+ + F+A E + + H L+ L + + L+
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVLIL 127
Query: 727 EFLSNGSLGDWI--HGERKNELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL-- 775
EFLS G L D I + +E + L ++H E +VH D+KP NI+
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCET 184
Query: 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ + K+ DFGLA L V + + PE
Sbjct: 185 KKASSVKIIDFGLATKLNPD-------EIVKVTTATAEFAAPE 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 23/85 (27%), Positives = 36/85 (42%), Gaps = 8/85 (9%)
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
I SALD H H D+KP NIL+ + A + DFG+A ++
Sbjct: 142 QIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT-----TDEKLTQLG 193
Query: 807 VFMGSIGYVPPEYGLGERPSTAGDV 831
+G++ Y+ PE + D+
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADI 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 43/184 (23%), Positives = 66/184 (35%), Gaps = 49/184 (26%)
Query: 669 IGSGSFGSV----------------------LHNERTGSWKSFIAECETLRNVRHRNLVK 706
+GSG F V + R S + E LR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHND 758
L + + L+ E +S G L D++ + +E + I ++YLH
Sbjct: 80 LHDVYEN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ H DLKP NI+L K+ DFGLA + + G+ +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-------VEFKNIFGTPEF 184
Query: 815 VPPE 818
V PE
Sbjct: 185 VAPE 188
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 42/184 (22%), Positives = 65/184 (35%), Gaps = 49/184 (26%)
Query: 669 IGSGSFGSV----------------------LHNERTGSWKSFIAECETLRNVRHRNLVK 706
+GSG F V + R + E LR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHND 758
L + + L+ E +S G L D++ + +E + I ++YLH
Sbjct: 80 LHDVYEN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ H DLKP NI+L K+ DFGLA + + G+ +
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-------VEFKNIFGTPEF 184
Query: 815 VPPE 818
V PE
Sbjct: 185 VAPE 188
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 16/116 (13%)
Query: 724 LVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCEVPVVHSDLKPGNILL 775
LV E++ +L ++I +D I + + H ++ +VH D+KP NIL+
Sbjct: 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILI 144
Query: 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
D T K+ DFG+A+ L +++S++ T+ +G++ Y PE GE D+
Sbjct: 145 DSNKTLKIFDFGIAKAL-----SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 19/227 (8%)
Query: 363 NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLA 422
L +LS + + E+ + LQ L P L
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQEL------EPENKWCLLT 387
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482
+ + +D E F +L ++D ++ L +
Sbjct: 388 IILLMRALDPLLYEKET-----LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442
Query: 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542
V + L+ L+ L + L+ + L +++N+ +P +A L+ LEVL S N L
Sbjct: 443 VRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
Query: 543 GSIPSDLQNLQALRSLNLTFNNLEGV--VPSEGIFRNMSNVHLKGNP 587
++ + NL L+ L L N L+ + + ++L+GN
Sbjct: 500 -NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 12/181 (6%)
Query: 26 INTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEG 85
+ +KE L F + + + + S + RV L+L+ L
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDL-- 453
Query: 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
T+ H+ L + + L +N+L LP + L L VL S N L+ + ++ L L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 510
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
+ L L N++ L + L +LN N L + L ++ +
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-----CQEEGIQERLAEMLPSVSSI 565
Query: 206 D 206
Sbjct: 566 L 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 6e-13
Identities = 40/244 (16%), Positives = 81/244 (33%), Gaps = 25/244 (10%)
Query: 319 SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRS 378
+ L L + + + + EL +L I I +R+
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESC-KELQELEPENKWCLLTI---ILLMRA 394
Query: 379 LTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438
L L ++ ++ L ++ + + L+ +LT
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 439 GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP 498
+ + +DLS+NR+ R LP ++ L + + SDN+L N+
Sbjct: 455 -VLC-HLEQLLLVTHLDLSHNRL---------RALPPALAALRCLEVLQASDNALE-NVD 502
Query: 499 NSLKNCKSLEELLMAYNQFSG-PIPNIVAELKGLEVLDLSSNKLS------GSIPSDLQN 551
+ N L+ELL+ N+ + L +L+L N L + L +
Sbjct: 503 G-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561
Query: 552 LQAL 555
+ ++
Sbjct: 562 VSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 35/219 (15%), Positives = 68/219 (31%), Gaps = 24/219 (10%)
Query: 288 TLPPGLGNLPFLRTYNIGFNKIVSS-GDDEGLSFITSLTNSTHLNYLALDGN----QFEG 342
L + K + E + L L +
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 343 KIPESIGNFSN-------ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPI 395
E++ FS + L + + + +L L++ ++ +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC- 457
Query: 396 EIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID 455
+ QL + L L+ N + +P +LA L+ L + S N L + N L +
Sbjct: 458 HLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 456 LSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
L NNR+ + + + +V ++L NSL
Sbjct: 515 LCNNRLQQS-------AAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 50/326 (15%), Positives = 99/326 (30%), Gaps = 54/326 (16%)
Query: 49 LSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLS 108
L + + W N + V +L + L + H + + S + L
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334
Query: 109 ----GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL------------MA 152
R+ +L +S L + EL+ L+ M
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 153 NKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL 212
+ L+ +L+ ++ + + +++VL L L
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 213 AGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNL 272
TV + + + HL L+ N+L +P +L L
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLR--------------------------ALPPALAAL 485
Query: 273 TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNY 332
+++++ + N LE + G+ NLP L+ + N++ S + L L
Sbjct: 486 RCLEVLQASDNALE-NV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL------ 537
Query: 333 LALDGNQFEGKIPESIGNFSNELSKL 358
L L GN + + L +
Sbjct: 538 LNLQGNSLC-QEEGIQERLAEMLPSV 562
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 33/212 (15%), Positives = 67/212 (31%), Gaps = 28/212 (13%)
Query: 78 LSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNI--------SFN 129
L S + P + ++ + L+ ++ +
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 130 NLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIA 189
E V + ++++L L +T L L + L+ N L
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT---VLCHLEQLLLVTHLDLSHNRL--------- 475
Query: 190 NLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249
+P L+ L L+VL + N L + N+ L L L +N+L + P
Sbjct: 476 RALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 250 NL--LDF----IYCFNRFTGKIPGSLHNLTNI 275
L L+ + ++ L ++++I
Sbjct: 534 RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 46/162 (28%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
IG G FG V G + S F+ E T+R H
Sbjct: 20 GRCIGEGQFGDV----HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSAL 752
++VKLI + + ++ E + G L ++ + + L +++AL
Sbjct: 76 PHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
YL VH D+ N+L+ K+GDFGL+R++ +
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 23/143 (16%), Positives = 50/143 (34%), Gaps = 26/143 (18%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNEL 746
FI + +++ + + ++++ + + F + + G+ + H L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 747 D----------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796
+ L LH+ +VH+ L+P +I+LD+ + F
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------ 254
Query: 797 DNQSSISSTHVFMGSIGYVPPEY 819
+ V S G+ PPE
Sbjct: 255 ----RDGARVVSSVSRGFEPPEL 273
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 39/179 (21%), Positives = 75/179 (41%), Gaps = 42/179 (23%)
Query: 668 LIGSGSFGSVLH--NERTGSW--------------KSFIAECETLRNVRHRNLVKLITSC 711
++G G++G V + + E ++++H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGE----RKNE-------LDITSALDYLHNDCE 760
S + F+ E + GSL + + + NE I L YLH++
Sbjct: 89 SENGFIKI-FM----EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 142
Query: 761 VPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+VH D+K N+L++ K+ DFG ++ R+ + + T F G++ Y+ PE
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSK----RLAGINPCTET--FTGTLQYMAPE 193
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 47/158 (29%)
Query: 669 IGSGSFGSVLHNERTGSWKS-------------------------FIAECETLRNVRHRN 703
+GSG+FG+V G W + E + +V + +
Sbjct: 23 LGSGAFGTVYK----GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN----EL-----DITSALDY 754
+ +L+ C + + L+ + + G L D++ + N L I ++Y
Sbjct: 79 VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
L + +VH DL N+L+ K+ DFGLA+ L
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 45/190 (23%)
Query: 657 RRATGNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA----------ECETLR 697
+R G + +G GSFG V + +T + + E L+
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------I 748
+RH +++KL + + + + Y + G L D+I R E + I
Sbjct: 65 LLRHPHIIKLYDV---ITTPTDIVMVIEY---AGGELFDYIVEKK-RMTEDEGRRFFQQI 117
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVF 808
A++Y H +VH DLKP N+LLD+ + K+ DFGL+ + N
Sbjct: 118 ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNF-----LKTS 167
Query: 809 MGSIGYVPPE 818
GS Y PE
Sbjct: 168 CGSPNYAAPE 177
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 45/171 (26%), Positives = 67/171 (39%), Gaps = 37/171 (21%)
Query: 648 HPKISYDELRRA------TGNFSHENLIGSGSFGSVL--HNERTGS------------WK 687
P+ +L F +G GS+GSV ++ TG +
Sbjct: 10 PPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ 69
Query: 688 SFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NE 745
I E ++ ++VK S L +V E+ GS+ D I K E
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 746 LDITS-------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+I + L+YLH +H D+K GNILL+ E AK+ DFG+A
Sbjct: 125 DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 42/177 (23%)
Query: 668 LIGSGSFGSVLHNERTGSWKSFIA--------------ECETLRNVRHRNLVKLITSCSS 713
+G G+ V ++ G+ K + E L + H N++KL +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 714 LDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELD-------ITSALDYLHNDCEVPVV 764
++LV E ++ G L D I E+ +E D I A+ YLH E +V
Sbjct: 120 -----PTEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLH---ENGIV 170
Query: 765 HSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
H DLKP N+L + K+ DFGL++ V++Q + + G+ GY PE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI----VEHQVLMKT---VCGTPGYCAPE 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 724 LVYEFLSNGSLGDWIHGER----KNELDIT----SALDYLHNDCEVPVVHSDLKPGNILL 775
+V E++ +L D +H E K +++ AL++ H + ++H D+KP NI++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMI 149
Query: 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
KV DFG+AR + D+ +S++ T +G+ Y+ PE G+ DV
Sbjct: 150 SATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 19/173 (10%), Positives = 51/173 (29%), Gaps = 21/173 (12%)
Query: 674 FGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGS 733
+ + ++ FI + +++ + + ++++ + + F + +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQSNLQT 193
Query: 734 LGDWIHGERKNE------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA 781
G+ + L + L LH+ +VH+ L+P +I+LD+
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGV 250
Query: 782 KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTS 834
+ F D S++S +
Sbjct: 251 FLTGFEHL-----VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 53/186 (28%)
Query: 669 IGSGSFGSV------------------------LHNERTGSWKSFIAECETLRNVRHRNL 704
+GSG+ G V + E E L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDYL 755
+K+ + D+++ +V E + G L D + + R E + A+ YL
Sbjct: 78 IKIK---NFFDAED---YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL 130
Query: 756 HNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
H + ++H DLKP N+LL +E+ K+ DFG ++ L E +S+ T G+
Sbjct: 131 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-----TSLMRTLC--GTP 180
Query: 813 GYVPPE 818
Y+ PE
Sbjct: 181 TYLAPE 186
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 47/220 (21%), Positives = 81/220 (36%), Gaps = 55/220 (25%)
Query: 638 VGVSALFKVCHPKISYDELRRATGNFSHE----NLIGSGSFGSVL--HNERTGSW----- 686
+ +S ++ D+ E +GSG+ G V +T
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 687 -----------------KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFL 729
+ E E L+ + H ++K+ D+++ +V E +
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAED---YYIVLELM 221
Query: 730 SNGSLGDWIHGERK-NELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL---DEE 778
G L D + G ++ E + A+ YLH E ++H DLKP N+LL +E+
Sbjct: 222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEED 278
Query: 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
K+ DFG ++ L E S G+ Y+ PE
Sbjct: 279 CLIKITDFGHSKILGET-------SLMRTLCGTPTYLAPE 311
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 43/184 (23%), Positives = 67/184 (36%), Gaps = 49/184 (26%)
Query: 669 IGSGSFGSV----------------------LHNERTGSWKSFIAECETLRNVRHRNLVK 706
+GSG F V + R S + E LR +RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHND 758
L ++K + L+ E +S G L D++ + E + I + YLH
Sbjct: 73 LHDIF---ENKT--DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH-- 125
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ H DLKP NI+L K+ DFG+A + + G+ +
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-------NEFKNIFGTPEF 177
Query: 815 VPPE 818
V PE
Sbjct: 178 VAPE 181
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 44/200 (22%), Positives = 73/200 (36%), Gaps = 55/200 (27%)
Query: 658 RATGNFSHE----NLIGSGSFGSV-------------------------LHNERTGSWKS 688
+T F ++G G V E ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 689 FIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--E 745
+ E + LR V H N+++L + + F LV++ + G L D++ E+ E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLT-EKVTLSE 123
Query: 746 LD-------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798
+ + + LH +VH DLKP NILLD++M K+ DFG + L +
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL-----D 175
Query: 799 QSSISSTHVFMGSIGYVPPE 818
G+ Y+ PE
Sbjct: 176 PGEKLREVC--GTPSYLAPE 193
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 52/169 (30%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS-------------------------FIAECETLRNVR 700
+ +IG+G FG V G K+ F+ E +
Sbjct: 49 QKVIGAGEFGEV----YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDI 748
H N+++L S + + ++ E++ NG+L ++ R+ + I
Sbjct: 105 HHNIIRLEGVISK-----YKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGI 156
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ + YL + VH DL NIL++ + KV DFGL+R L + +
Sbjct: 157 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 44/179 (24%)
Query: 669 IGSGSFGSVLH--NERTG----------------SWKSFIAECETLRNVRHRNLVKLITS 710
+G GSFG VL + T + + E E L+ + H N++KL
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD-------ITSALDYLHNDCEVP 762
DS + +V E + G L D I ++ +E D + S + Y+H
Sbjct: 90 LE--DSSS---FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 763 VVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+VH DLKP NILL +++ K+ DFGL+ + + +G+ Y+ PE
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC----FQQNTKMKD---RIGTAYYIAPE 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 46/196 (23%), Positives = 75/196 (38%), Gaps = 54/196 (27%)
Query: 658 RATGNFSH----ENLIGSGSFGSVLH--NERTGSW--------------KSFIAECETLR 697
G+ + EN IG GS+G V + T F E E ++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD-------I 748
++ H N+++L + D+ + + LV E + G L + + ++ E D +
Sbjct: 62 SLDHPNIIRLYETFE--DNTD---IYLVMELCTGGELFERVV-HKRVFRESDAARIMKDV 115
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISST 805
SA+ Y H ++ V H DLKP N L + K+ DFGLA
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR----------FKPG 162
Query: 806 HVFM---GSIGYVPPE 818
+ G+ YV P+
Sbjct: 163 KMMRTKVGTPYYVSPQ 178
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 39/151 (25%), Positives = 56/151 (37%), Gaps = 32/151 (21%)
Query: 663 FSHENLIGSGSFGSVL--HNERTGS---------------WKSFIAECETLRNVRHRNLV 705
F+ IG GSFG V + RT + E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHND 758
K S L ++ E+L GS D + +E I + LDYLH++
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
+H D+K N+LL E K+ DFG+A
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 49/167 (29%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
+ ++G+G FG V +G K F+ E + H
Sbjct: 50 DKVVGAGEFGEV----CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK----NEL-----DITSAL 752
N+++L + + + +V E++ NGSL ++ +L I S +
Sbjct: 106 PNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 753 DYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
YL VH DL NIL++ + KV DFGL R L + +
Sbjct: 161 KYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 49/184 (26%)
Query: 669 IGSGSFGSV---------------------LHNERTGSWKSFIA-ECETLRNVRHRNLVK 706
+GSG F V + R G + I E L+ ++H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERKNELD-------ITSALDYLHND 758
L + ++ L+ E ++ G L D++ E E + I + + YLH
Sbjct: 79 LHEVYE--NKTDV---ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 759 CEVPVVHSDLKPGNILL----DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ + H DLKP NI+L + K+ DFGLA + + G+ +
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-------NEFKNIFGTPEF 183
Query: 815 VPPE 818
V PE
Sbjct: 184 VAPE 187
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 42/184 (22%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIA------ECETLRNVRHRNLV 705
+ IGSG+FG ++ T + E R++RH N+V
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD-------ITSALDYLH 756
+ + + LA++ E+ S G L + I G R +E + + S + Y H
Sbjct: 80 RFKEV---ILTPTH--LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH 133
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTA--KVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ + H DLK N LLD K+ DFG ++ + +Q +G+ Y
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQ-----PKSTVGTPAY 183
Query: 815 VPPE 818
+ PE
Sbjct: 184 IAPE 187
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 52/212 (24%)
Query: 636 KRVGVSALFKVCHPKISYDELRRATGNFSHE----NLIGSGSFGSVLH--NERTG----- 684
+ VGV ++ + H + F+ IG GS+ ++ T
Sbjct: 2 QTVGVHSIVQQLHRN---------SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAV 52
Query: 685 -----SWKSFIAECETL-RNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI 738
S + E E L R +H N++ L + +++ +V E + G L D I
Sbjct: 53 KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD-----DGKYVYVVTELMKGGELLDKI 107
Query: 739 HGERK-NELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDF 786
++ +E + IT ++YLH VVH DLKP NIL + ++ DF
Sbjct: 108 LRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
G A+ L ++ + T + +V PE
Sbjct: 165 GFAKQL----RAENGLLMTPC--YTANFVAPE 190
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 48/196 (24%)
Query: 656 LRRATGNFSH----ENLIGSGSFGSVLH--NERTGSW----------------KSFIAEC 693
+ G+ S +GSG++G VL ++ T + E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 694 ETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD----- 747
L+ + H N++KL D +N LV E G L D I K NE+D
Sbjct: 88 AVLKLLDHPNIMKLYDFFE--DKRN---YYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSI 802
+ S + YLH +VH DLKP N+LL +++ K+ DFGL+ +NQ +
Sbjct: 143 KQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV----FENQKKM 195
Query: 803 SSTHVFMGSIGYVPPE 818
+G+ Y+ PE
Sbjct: 196 KE---RLGTAYYIAPE 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 50/193 (25%)
Query: 660 TGNFSHE----NLIGSGSFGSVLH--NERTG----------------SWKSFIAECETLR 697
+ FS +G G+F V ++ TG ++ E R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD-------I 748
++H N+V+L S F LV++ ++ G L + I R+ E D I
Sbjct: 61 KLQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQI 114
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISST 805
++ Y H++ +VH +LKP N+LL + K+ DFGLA V++ +
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE----VNDSEAWHG- 166
Query: 806 HVFMGSIGYVPPE 818
F G+ GY+ PE
Sbjct: 167 --FAGTPGYLSPE 177
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 50/186 (26%)
Query: 669 IGSGSFGSV---------------------LHNERTGSWKSFIAECETLRNVRHRNLVKL 707
IG G F V + S + E ++H ++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-----HGERKNELD-------ITSALDYL 755
+ + SS L +V+EF+ L I G +E I AL Y
Sbjct: 92 LETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 756 HNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
H + ++H D+KP +LL + K+G FG+A L E ++ V G+
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRV--GTP 197
Query: 813 GYVPPE 818
++ PE
Sbjct: 198 HFMAPE 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 30/174 (17%)
Query: 657 RRATGNFSHENLIGSGSFGSVL--HNERTGSW----KSFIAECETLR------NVRHRNL 704
R +++ +IG+GSFG V +G K + R + H N+
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNI 109
Query: 705 VKLITS-CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS------------A 751
V+L SS + K+ +L LV +++ ++ + + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTA-KVGDFGLARFLLERVDNQSSISS 804
L Y+H+ + H D+KP N+LLD + K+ DFG A+ L+ N S I S
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 51/210 (24%), Positives = 72/210 (34%), Gaps = 57/210 (27%)
Query: 648 HPKISYDELRRATGNFSH----ENLIGSGSFGSVL--HNERTGSW--------------- 686
H S E G + +GSG+FG V +G
Sbjct: 5 HHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM 64
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--- 743
+ AE E L+++ H N++K+ D N + +V E G L + I +
Sbjct: 65 EQIEAEIEVLKSLDHPNIIKIFEVFE--DYHN---MYIVMETCEGGELLERIVSAQARGK 119
Query: 744 --NELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARF 791
+E + +AL Y H VVH DLKP NIL K+ DFGLA
Sbjct: 120 ALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 792 LLERVDNQSSISSTHVFM---GSIGYVPPE 818
S G+ Y+ PE
Sbjct: 177 ----------FKSDEHSTNAAGTALYMAPE 196
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 49/197 (24%)
Query: 656 LRRATGNFSH----ENLIGSGSFGSVLH--NERTG-----------------SWKSFIAE 692
++ +T FS + ++G GSFG V+ ++ TG +S + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 693 CETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-NELD---- 747
+ L+ + H N++KL D LV E + G L D I ++ +E+D
Sbjct: 77 VQLLKQLDHPNIMKLYEFFE--DKGY---FYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 748 ---ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSS 801
+ S + Y+H + +VH DLKP N+LL ++ ++ DFGL+ +
Sbjct: 132 IRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-------EA 181
Query: 802 ISSTHVFMGSIGYVPPE 818
+G+ Y+ PE
Sbjct: 182 SKKMKDKIGTAYYIAPE 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 31/150 (20%)
Query: 663 FSHENLIGSGSFGSVL--HNERTG--------------SWKSFIAECETLRNVRHRNLVK 706
++ IG G+ G+V + TG + I E +R ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDC 759
+ S D L +V E+L+ GSL D + +E I + AL++LH++
Sbjct: 82 YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
V+H D+K NILL + + K+ DFG
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 55/193 (28%), Positives = 75/193 (38%), Gaps = 49/193 (25%)
Query: 658 RATGNFSH----ENLIGSGSFGSV----------------LHNERTGSWKSFIAECETLR 697
T N ++GSG+F V + S E L+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD-------I 748
++H N+V L S LV + +S G L D I ER E D +
Sbjct: 62 KIKHENIVTLEDIYES-----TTHYYLVMQLVSGGELFDRIL-ERGVYTEKDASLVIQQV 115
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISST 805
SA+ YLH E +VH DLKP N+L +E + DFGL++ Q+ I ST
Sbjct: 116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME------QNGIMST 166
Query: 806 HVFMGSIGYVPPE 818
G+ GYV PE
Sbjct: 167 AC--GTPGYVAPE 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 50/199 (25%)
Query: 654 DELRRATGNFSHE----NLIGSGSFGSVLH--NERTG----------------SWKSFIA 691
+ + A+ FS +G G+F V ++ TG ++
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD-- 747
E R ++H N+V+L S F LV++ ++ G L + I R+ E D
Sbjct: 78 EARICRKLQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDIV-AREFYSEADAS 131
Query: 748 -----ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQ 799
I ++ Y H +VH +LKP N+LL + K+ DFGLA V++
Sbjct: 132 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE----VNDS 184
Query: 800 SSISSTHVFMGSIGYVPPE 818
+ F G+ GY+ PE
Sbjct: 185 EAWHG---FAGTPGYLSPE 200
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 33/152 (21%)
Query: 663 FSHENLIGSGSFGSVL--HNERTGS--------------WKSFIAECETLRNVRHRNLVK 706
+ +G G+FG V N+ TG+ + +I E E L H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELDITS-------ALDYLHN 757
L+ + L ++ EF G++ + + E I AL++LH+
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
++H DLK GN+L+ E ++ DFG++
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 61/367 (16%), Positives = 112/367 (30%), Gaps = 82/367 (22%)
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
S+ L + + E D + + L +++ I ++ N
Sbjct: 5 SIEGKSLKLDAITTE---DEKS------------------VFAVLLEDDSVKEIVLSGNT 43
Query: 285 L--EGT--LPPGLGNLPFLRTYNIGFNKIVSSGDD--EGLSFI-TSLTNSTHLNYLALDG 337
+ E L + + L D+ E L + +L L+ + L
Sbjct: 44 IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103
Query: 338 NQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI 397
N F E + +F + + L L L N + +
Sbjct: 104 NAFGPTAQEPLIDF---------------------LSKHTPLEHLYLHNNGLGPQ----- 137
Query: 398 GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE----IPISFGNFQSLLS 453
+ A E+ + N L I N L +F + + L +
Sbjct: 138 ----AGAKIARALQELA--VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191
Query: 454 IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN----LPNSLKNCKSLEE 509
+ + N I P+GI L E ++ + + +DL DN+ + L +LK+ +L E
Sbjct: 192 VKMVQNGIR---PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248
Query: 510 LLMAYNQFSGP-IPNIVAELKG-----LEVLDLSSNKLSGSIPSDL-----QNLQALRSL 558
L + S +V L+ L L N++ L + + L L
Sbjct: 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308
Query: 559 NLTFNNL 565
L N
Sbjct: 309 ELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 38/240 (15%), Positives = 73/240 (30%), Gaps = 52/240 (21%)
Query: 377 RSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436
S+ L ++I+ E + + L + +I LSGN
Sbjct: 4 FSIEGKSLKLDAITTE---------DEKSVFAV-----------LLEDDSVKEIVLSGNT 43
Query: 437 LTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGI--LRPLPEEISRLENVVTIDLSD 490
+ E + + + + L + S+ + LR L + + + + T+ LSD
Sbjct: 44 IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103
Query: 491 NSLSGN----LPNSLKNCKSLEELLMAYNQFS-------------GPIPNIVAELKGLEV 533
N+ L + L LE L + N + L
Sbjct: 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163
Query: 534 LDLSSNKLSG----SIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589
+ N+L Q+ + L ++ + N + EGI + L +L
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR----PEGIEHLLLEG-LAYCQEL 218
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 58/362 (16%), Positives = 107/362 (29%), Gaps = 84/362 (23%)
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL----AGTVPSTIYNM 223
S++ + + +I + + L +++K + L+ N + A + I +
Sbjct: 4 FSIEGKSLKLD----AITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 224 TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
L + G R +IP +L L
Sbjct: 60 KDLEIAEFSDIFTG----------------------RVKDEIPEALRLLLQ--------- 88
Query: 284 LLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQF--- 340
L P L T + N G I L+ T L +L L N
Sbjct: 89 --------ALLKCPKLHTVRLSDNAF---GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137
Query: 341 ---------EGKIPESIGNFSNELSKLYLGGNHIYGK----IPASIGRLRSLTLLDLSYN 387
+ + L + G N + + R L + + N
Sbjct: 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 197
Query: 388 SISGE-IPIEIGQL----QGLQVLGLAGNEI-PGG---IPNSLANLKKLNQIDLSGNELT 438
I E I + + Q L+VL L N G + +L + L ++ L+ L+
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 439 GE------IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492
S L ++ L N I + + + + E++ L ++L+ N
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL---FLELNGNR 314
Query: 493 LS 494
S
Sbjct: 315 FS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 48/322 (14%), Positives = 94/322 (29%), Gaps = 76/322 (23%)
Query: 73 VIGLNLS--SFGLEGT--ISPHIGNLSFLRSIQLQNNKLS----------GNLPREIGNL 118
V + LS + G E +S +I + L + + L + +
Sbjct: 34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93
Query: 119 FRLRVLNISFNNLQGELPVNISKL----TELKMLDLMANKIT------------GRVTDD 162
+L + +S N + T L+ L L N + +
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 163 QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL-----AGTVP 217
+ +N L+ + G+N + L + + N + +
Sbjct: 154 KAKNAPPLRSIICGRN----RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 218 STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTG--KIPGSLHNLTNI 275
+ L L L N G + +L + N+
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHL-----------------------GSSALAIALKSWPNL 246
Query: 276 QIIRMTHNLL--EG--TLPPGLGNLPF--LRTYNIGFNKIVSSGDDEGLSFITSL-TNST 328
+ + + LL G + L L+T + +N+I D + T +
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI---ELDAVRTLKTVIDEKMP 303
Query: 329 HLNYLALDGNQF--EGKIPESI 348
L +L L+GN+F E + + I
Sbjct: 304 DLLFLELNGNRFSEEDDVVDEI 325
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 38/179 (21%), Positives = 69/179 (38%), Gaps = 39/179 (21%)
Query: 666 ENLIGSGSFGSVLH--NERTGSW---------KSFIAECETL-RNVRHRNLVKLITSCSS 713
+ ++G G G VL + RTG E + + ++V ++ +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 714 LDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----------DITSALDYLHNDCEVP 762
+ L ++ E + G L I ER ++ DI +A+ +LH+
Sbjct: 94 MHHGKRCLL-IIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLHSHN--- 148
Query: 763 VVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ H D+KP N+L +++ K+ DFG A+ + T + YV PE
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNA--LQTPC--YTPYYVAPE 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 44/186 (23%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHR 702
F ++G G FG V + + K + + E + L V R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSAL 752
+V L + + D+ L LV ++ G L I+ + I L
Sbjct: 245 FVVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
+ LH + +V+ DLKP NILLD+ ++ D GLA + Q + +G++
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQ----TIKGRVGTV 349
Query: 813 GYVPPE 818
GY+ PE
Sbjct: 350 GYMAPE 355
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 32/140 (22%)
Query: 692 ECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD- 747
E LR V H +++ LI S S F+ LV++ + G L D++ E+ E +
Sbjct: 149 ETHILRQVAGHPHIITLIDSYES-----SSFMFLVFDLMRKGELFDYLT-EKVALSEKET 202
Query: 748 ------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801
+ A+ +LH + +VH DLKP NILLD+ M ++ DFG +
Sbjct: 203 RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH---------- 249
Query: 802 ISSTHVFM---GSIGYVPPE 818
+ G+ GY+ PE
Sbjct: 250 LEPGEKLRELCGTPGYLAPE 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 43/179 (24%), Positives = 69/179 (38%), Gaps = 47/179 (26%)
Query: 669 IGSGSFGSVLH--NERTGSW-------KSFIA----ECETLRNVR-HRNLVKLITSCSSL 714
+G GSF ++++ K A E L+ H N+VKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF--- 75
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKN--ELD-------ITSALDYLHNDCEVPVVH 765
+ LV E L+ G L + I ++K+ E + + SA+ ++H+ VVH
Sbjct: 76 --HDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVG---VVH 129
Query: 766 SDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM---GSIGYVPPE 818
DLKP N+L ++ + K+ DFG AR ++ Y PE
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPP---------DNQPLKTPCFTLHYAAPE 179
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 18/243 (7%), Positives = 40/243 (16%), Gaps = 68/243 (27%)
Query: 631 RKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVL--HNERTG---- 684
+ ++ L + + G V +
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 685 -------------SWKSFIAECETLRNVRHRNLVKLITSC-------------------- 711
+ + + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 712 -SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD---------------ITSALDYL 755
D + L+ S L + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
+ +VH P N+ + + +GD + R + Y
Sbjct: 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYA 258
Query: 816 PPE 818
P E
Sbjct: 259 PRE 261
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 62 PGV-ICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFR 120
GV CNN N V + SS L I +I + + + LQ+NKLS + L +
Sbjct: 9 GGVCSCNNNKNSV---DCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTK 62
Query: 121 LRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNL 179
LR+L ++ N LQ LP I +L L+ L + NK+ + L +L L +N
Sbjct: 63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ 120
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY-NMTSLVHLRLASNQLGG 238
L S+PP + L L L L N L ++P ++ +TSL LRL +NQL
Sbjct: 121 L-KSLPPRV-------FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-K 170
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
+P D L L N+ G+ +L ++++++ N
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 28/204 (13%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI---PGGIPNSLANLK 425
IP++I LDL N +S +L L++L L N++ P GI L NL+
Sbjct: 31 IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 426 KLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484
L ++ N+L +PI F +L + L N++ ++P + L +
Sbjct: 89 TL---WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF-------DSLTKLT 136
Query: 485 TIDLSDNSLSGNLP----NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNK 540
+ L N L +LP + L + L+EL + NQ +L L+ L L +N+
Sbjct: 137 YLSLGYNELQ-SLPKGVFDKLTS---LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 541 LSGSIPSDL-QNLQALRSLNLTFN 563
L +P +L+ L+ L L N
Sbjct: 193 LK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 36/203 (17%)
Query: 259 NRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGL 318
N+ + + H LT ++++ + N L+ TLP G+ F +
Sbjct: 47 NKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI------------FKE---------- 83
Query: 319 SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLR 377
L N L L + N+ + +P + + L++L L N + +P + L
Sbjct: 84 -----LKN---LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLT 133
Query: 378 SLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436
LT L L YN + +P + +L L+ L L N++ + L +L + L N+
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 437 LTGEIPISFGNFQSLLSIDLSNN 459
L +F + + L + L N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 62/257 (24%), Positives = 96/257 (37%), Gaps = 75/257 (29%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
+IP +I P+D K LDL N+L+ + +T L L L N+L
Sbjct: 30 AIPSNI----PADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL------ 73
Query: 243 DVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTY 302
TLP G L N++ + +T N L+ LP G+
Sbjct: 74 ---QTLP----------------AGIFKELKNLETLWVTDNKLQ-ALPIGV--------- 104
Query: 303 NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYL 360
L N L L LD NQ + +P + F + +L+ L L
Sbjct: 105 ------------------FDQLVN---LAELRLDRNQLK-SLPPRV--FDSLTKLTYLSL 140
Query: 361 GGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIP 418
G N + +P + +L SL L L N + +P +L L+ L L N++
Sbjct: 141 GYNEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 419 NSLANLKKLNQIDLSGN 435
+ +L+KL + L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 40/150 (26%), Positives = 60/150 (40%), Gaps = 31/150 (20%)
Query: 663 FSHENLIGSGSFGSVL--HNERTGS--------------WKSFIAECETLRNVRHRNLVK 706
IG GS G V + +G + E +R+ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDC 759
+ S + L ++ EFL G+L D + R NE I + AL YLH
Sbjct: 107 MYKSYLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ- 160
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789
V+H D+K +ILL + K+ DFG
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 45/180 (25%)
Query: 669 IGSGSFGSVL------------------HNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
+G G+F V + E R ++H N+V+L S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK--NELD-------ITSALDYLHNDCEV 761
S L+++ ++ G L + I R+ +E D I A+ + H ++
Sbjct: 79 ISE-----EGHHYLIFDLVTGGELFEDIV-AREYYSEADASHCIQQILEAVLHCH---QM 129
Query: 762 PVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VVH +LKP N+LL + K+ DFGLA V+ + G+ GY+ PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE----VEGEQQAWFGFA--GTPGYLSPE 183
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 48/204 (23%)
Query: 648 HPKISYDELRRATGNFSH----ENLIGSGSFGSVLH--NERTG----------------S 685
H S E G F+ ++G GSFG VL + T
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 686 WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK-N 744
+ + E E L+ + H N++KL DS + +V E + G L D I ++ +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILE--DSSS---FYIVGELYTGGELFDEIIKRKRFS 119
Query: 745 ELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLE 794
E D + S + Y+H +VH DLKP NILL +++ K+ DFGL+
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--- 173
Query: 795 RVDNQSSISSTHVFMGSIGYVPPE 818
+ + +G+ Y+ PE
Sbjct: 174 -FQQNTKMKD---RIGTAYYIAPE 193
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 39/207 (18%), Positives = 66/207 (31%), Gaps = 68/207 (32%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNV-RHR 702
F IGSG FGSV + ++ + E + +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITS 750
++V+ ++ + + + E+ + GSL D I + L +
Sbjct: 72 HVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEE-------------------MTAKVGDFGLARF 791
L Y+H+ +VH D+KP NI + + K+GD G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 792 LLERVDNQSSISSTHVFMGSIGYVPPE 818
ISS V G ++ E
Sbjct: 183 ---------RISSPQVEEGDSRFLANE 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 49/207 (23%), Positives = 74/207 (35%), Gaps = 59/207 (28%)
Query: 656 LRRATGNFSH----ENLIGSGSFGSV-----------------------------LHNER 682
+R+ G +GSG++G V +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 683 TGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
+ E L+++ H N++KL D K LV EF G L + I
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFE--DKKY---FYLVTEFYEGGELFEQIINRH 141
Query: 743 K-NELD-------ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARF 791
K +E D I S + YLH +VH D+KP NILL + + K+ DFGL+ F
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 792 LLERVDNQSSISSTHVFMGSIGYVPPE 818
+ +G+ Y+ PE
Sbjct: 199 ----FSKDYKLRD---RLGTAYYIAPE 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 48/163 (29%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS------------------------FIAECETLRNVRH 701
IG G FG V G + S F+ E T+R H
Sbjct: 395 GRCIGEGQFGDVHQ----GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSA 751
++VKLI + + ++ E + G L ++ RK L +++A
Sbjct: 451 PHIVKLIGVITE------NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTA 503
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
L YL VH D+ N+L+ K+GDFGL+R++ +
Sbjct: 504 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 52/197 (26%), Positives = 76/197 (38%), Gaps = 47/197 (23%)
Query: 627 PIIVRKRKAKRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVL--HNERTG 684
P R K V+ LF P+ + +LR IG GSFG+V + R
Sbjct: 30 PAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRNS 79
Query: 685 S-----------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727
W+ I E L+ +RH N ++ + LV E
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVME 134
Query: 728 FLSNGSLGDWIHGERK--NELDITS-------ALDYLHNDCEVPVVHSDLKPGNILLDEE 778
+ GS D + +K E++I + L YLH+ ++H D+K GNILL E
Sbjct: 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 190
Query: 779 MTAKVGDFGLARFLLER 795
K+GDFG A +
Sbjct: 191 GLVKLGDFGSASIMAPA 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 35/193 (18%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKL--- 707
IG G+FG V + NE+ G + + E + L+ ++H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 708 ITSCSSLDSKNMEFLALVYEFLS-------NGSLGDWIHGERKNELD-ITSALDYLHNDC 759
+ +S ++ + LV++F + L + E K + + + L Y+H +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 144
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
++H D+K N+L+ + K+ DFGLAR ++Q + + V ++ Y PPE
Sbjct: 145 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--TLWYRPPEL 199
Query: 820 GLGERP-STAGDV 831
LGER D+
Sbjct: 200 LLGERDYGPPIDL 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 41/173 (23%)
Query: 663 FSHENLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
+++ +IG+GSFG V E + +R V+H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVV 95
Query: 706 KLITS-CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS------------AL 752
L S+ D K+ FL LV E++ ++ K + + +L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTA-KVGDFGLARFLLERVDNQSSISS 804
Y+H+ + + H D+KP N+LLD K+ DFG A+ L+ N S I S
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 42/200 (21%), Positives = 65/200 (32%), Gaps = 54/200 (27%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTG--------------SWKSFIA------ECETLRN 698
+ L+GSG FGSV W E L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 699 VRHR--NLVKLITSCSSLDSKNMEFLALVYEFLSN-GSLGDWIHGERKNELD-------- 747
V +++L+ + + L + E L D+I + L
Sbjct: 103 VSSGFSGVIRLLDW---FERPDSFVL--ILERPEPVQDLFDFI--TERGALQEELARSFF 155
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISS 804
+ A+ + HN V+H D+K NIL+D K+ DFG L + +
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TV 204
Query: 805 THVFMGSIGYVPPEYGLGER 824
F G+ Y PPE+ R
Sbjct: 205 YTDFDGTRVYSPPEWIRYHR 224
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 43/206 (20%)
Query: 658 RATGNFSHENLIGSGSFGSV-------------------LHNERTGSWKSFIAECETLRN 698
RA + IG G++G V + G S I E LR+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 699 VR---HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------- 747
+ H N+V+L C+ + L LV+E + L ++ + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
+ LD+LH+ VVH DLKP NIL+ K+ DFGLAR ++ T
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQMALT 177
Query: 806 HVFMGSIGYVPPEYGLGERPSTAGDV 831
V + ++ Y PE L +T D+
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDL 202
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 41/188 (21%), Positives = 75/188 (39%), Gaps = 45/188 (23%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHR 702
F ++G G FG V + + K + + E + L V R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------------DITS 750
+V L + + L LV ++ G + I+ ++ I S
Sbjct: 246 FIVSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
L++LH +++ DLKP N+LLD++ ++ D GLA V+ ++ + T + G
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA------VELKAGQTKTKGYAG 351
Query: 811 SIGYVPPE 818
+ G++ PE
Sbjct: 352 TPGFMAPE 359
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 54/184 (29%), Positives = 79/184 (42%), Gaps = 40/184 (21%)
Query: 662 NFSHENLIGSGSFGSVLHNER--TGSW-------KSFI----------AECETLRNVRHR 702
F + L+G G+FG V+ + TG + K I E L+N RH
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDY 754
L L S + + L V E+ + G L + ER D I SALDY
Sbjct: 209 FLTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH+ E VV+ DLK N++LD++ K+ DFGL + + ++ F G+ Y
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEY 315
Query: 815 VPPE 818
+ PE
Sbjct: 316 LAPE 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 40/202 (19%), Positives = 67/202 (33%), Gaps = 56/202 (27%)
Query: 661 GNFSHENLIGSGSFGSVLH--NERTGSW-------KSFIAECETLRNV------------ 699
+ L+G G FG+V ++ + L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 700 -----RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGS-LGDWIHGERKNELD------ 747
H +++L+ +++ L V E L D+I K L
Sbjct: 91 VGAGGGHPGVIRLLDW---FETQEGFML--VLERPLPAQDLFDYI--TEKGPLGEGPSRC 143
Query: 748 ----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQSSI 802
+ +A+ + H+ VVH D+K NIL+D AK+ DFG L +
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-------- 192
Query: 803 SSTHVFMGSIGYVPPEYGLGER 824
F G+ Y PPE+ +
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQ 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 45/208 (21%)
Query: 658 RATGNFSHENLIGSGSFGSV------------------LHNERTGSWK---SFIAECETL 696
AT + IG G++G+V + N G S + E L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 697 RNVR---HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------ 747
R + H N+V+L+ C++ + + LV+E + L ++ L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 748 ----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSIS 803
LD+LH +C +VH DLKP NIL+ T K+ DFGLAR ++
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY------SYQMA 175
Query: 804 STHVFMGSIGYVPPEYGLGERPSTAGDV 831
T V + ++ Y PE L +T D+
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDM 202
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 42/183 (22%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 666 ENLIGSGSFGSVLH--NERTGSW---KSFIAECETLRN--------VRHRNLVKLITSCS 712
++G G G VL N+RT K + +C R + ++V+++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----------DITSALDYLHNDCEV 761
+L + L +V E L G L I +R ++ I A+ YLH +
Sbjct: 126 NLYAGRKCLL-IVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH---SI 180
Query: 762 PVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM---GSIGYV 815
+ H D+KP N+L K+ DFG A+ +S + + YV
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------TTSHNSLTTPCYTPYYV 230
Query: 816 PPE 818
PE
Sbjct: 231 APE 233
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 4e-13
Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 37/157 (23%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
NF IG G++G V L E G + I E L+ + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALD 753
+VKL+ + + L LV+EFL L ++ + + L
Sbjct: 64 IVKLLDVIHTENK-----LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ H+ V+H DLKP N+L++ E K+ DFGLAR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 28/179 (15%), Positives = 53/179 (29%), Gaps = 38/179 (21%)
Query: 660 TGNFSHENLIGSG--SFGSV------------------LHNERTGSWKSFIAECETLRNV 699
G + +IG G +V L E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DIT 749
H N+V + + + L +V F++ GS D I + + +
Sbjct: 84 NHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVF 808
ALDY+H+ VH +K +IL+ + + ++ Q + +
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 54/182 (29%)
Query: 655 ELRRATGNFSHENLIGSGSFGSV-----------------------LHNERTGSWKSFIA 691
++R + +G G+F + L +SF
Sbjct: 4 KIRNE--DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK----NEL- 746
+ + H++LV C E + LV EF+ GSL ++ +
Sbjct: 62 AASMMSKLSHKHLVLNYGVCV----CGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 747 ----DITSALDYL--HNDCEVPVVHSDLKPGNILLD--------EEMTAKVGDFGLARFL 792
+ +A+ +L + ++H ++ NILL K+ D G++ +
Sbjct: 117 EVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 793 LE 794
L
Sbjct: 172 LP 173
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 48/186 (25%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHR 702
F +G+GSFG V+ + S + + E L+ V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSAL 752
LVKL S K+ L +V E+++ G + + H R I
Sbjct: 102 FLVKLEFSF-----KDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
+YLH + +++ DLKP N+L+D++ +V DFG A+ + R T G+
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---------TWTLCGTP 202
Query: 813 GYVPPE 818
+ PE
Sbjct: 203 EALAPE 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 33/141 (23%), Positives = 53/141 (37%), Gaps = 29/141 (20%)
Query: 692 ECETLRNVRHR-NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI---HGERKNELD 747
E L + ++ L ++ + L+ E+ + G + E +E D
Sbjct: 78 EIAVLELAKSCPRVINLHEVYE--NTSEI---ILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 748 -------ITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLLERVD 797
I + YLH + +VH DLKP NILL K+ DFG++R +
Sbjct: 133 VIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-- 187
Query: 798 NQSSISSTHVFMGSIGYVPPE 818
MG+ Y+ PE
Sbjct: 188 -----CELREIMGTPEYLAPE 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 39/169 (23%), Positives = 64/169 (37%), Gaps = 41/169 (24%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG---------------SWKSFIAECETLRNVRHRNL 704
++ + +IGSG+ V + S + E + + H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------------DI 748
V S + L LV + LS GS+ D I ++
Sbjct: 76 VSYY--TSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
L+YLH + +H D+K GNILL E+ + ++ DFG++ FL D
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 52/328 (15%), Positives = 109/328 (33%), Gaps = 52/328 (15%)
Query: 280 MTHNLLEGT----LPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITS--LTNSTHLNYL 333
M + L + + + ++ N + + + L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNL----YSISTVELIQAFANTPASVTSL 56
Query: 334 ALDGNQFEGK----IPESIGNFSNELSKLYLGGNHIYGKIPASIGRL-----RSLTLLDL 384
L GN K + + + ++ L L GN + K + + ++T+LDL
Sbjct: 57 NLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL 116
Query: 385 SYNSISGEIPIEIGQL-----QGLQVLGLAGNEIPGGIPNSLAN-LKKLNQ----IDLSG 434
+N S + E Q + L L GN++ + L L + ++L G
Sbjct: 117 GWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG 176
Query: 435 NELTGEIPISFGNF-----QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
N L + F S+ S+DLS N + + + + +++L
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV---SLNLC 233
Query: 490 DNSLSG----NLPNSLKNCKSLEELLMAYNQFSGP-------IPNIVAELKGLEVLDLSS 538
N L G NL + K L+ + + Y+ + ++ + ++D +
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293
Query: 539 NKLSGSIPSDLQNL-QALRSLNLTFNNL 565
++ PS + +R L+ +
Sbjct: 294 KEIH---PSHSIPISNLIRELSGKADVP 318
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 49/311 (15%), Positives = 106/311 (34%), Gaps = 51/311 (16%)
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSL--TNSTHLNYLALDGNQFEGK----IPESIGNFS 352
+ + N+ N + + + + ++ L L GN K + +++
Sbjct: 53 VTSLNLSGNSL----GFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 353 NELSKLYLGGNHIYGKIPASIGRL-----RSLTLLDLSYNSISGEIPIEIGQL-----QG 402
++ L LG N K + + S+T L+L N + + E+ Q+
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 403 LQVLGLAGNEIP----GGIPNSLANL-KKLNQIDLSGNELT--GEIPISFG---NFQSLL 452
+ L L GN + + LA++ + +DLS N L +++ ++
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 453 SIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-------NLPNSLKNCK 505
S++L N ++G + + L+++ T+ L + + L + N +
Sbjct: 229 SLNLCLNCLHGPSLENLK----LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 506 SLEELLMAYNQFSGPIPNIVAEL-----KGLEVLDLSSNKLS-----GSIPSDLQNLQAL 555
+ + + ++ L +V L + L + DL L
Sbjct: 285 KIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344
Query: 556 RSLNLTFNNLE 566
R T L
Sbjct: 345 RESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 63/370 (17%), Positives = 118/370 (31%), Gaps = 69/370 (18%)
Query: 189 ANLIPSDLSRLENLKVLDLTINRLAGTVPSTI-----YNMTSLVHLRLASNQLGGEIPYD 243
+N + S + LDL++N L + S+ L L+ N LG + +
Sbjct: 11 SNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE 70
Query: 244 VRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPF- 298
+ L N+ + ++ N L L L +PF
Sbjct: 71 LVQILA--------------------AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITS--LTNSTHLNYLALDGNQFEGK----IPESIGNFS 352
+ ++G+N + S + L L GN K + + +
Sbjct: 111 ITVLDLGWNDF----SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 353 NELSKLYLGGNHIYGKIPASIGRL-----RSLTLLDLSYNSISGEIPIEIGQL-----QG 402
++ L L GN++ K A + + S+T LDLS N + + E+ +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226
Query: 403 LQVLGLAGNEIPG----GIPNSLANLKKLNQIDLSGNELTGEIPI-------SFGNFQSL 451
+ L L N + G + +LK L + L + + +F N Q +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 452 LSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS-----GNLPNSLKNCKS 506
+ +D + I+ + I + E + + L + L L
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKAD---VPSLLNQCLIFAQKHQTNIEDLNIPDE 343
Query: 507 LEELLMAYNQ 516
L E +
Sbjct: 344 LRESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 55/361 (15%), Positives = 107/361 (29%), Gaps = 74/361 (20%)
Query: 121 LRVLNISFNNLQGE--------LPVNISKLTELKMLDLMANKIT---GRVTDDQLR-NLR 168
+ L++S NNL + +T L +L N + L
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSL---NLSGNSLGFKNSDELVQILAAIPA 80
Query: 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNM----- 223
++ LN N L + + + + VLDL N + S
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTI---TVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 224 TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
S+ L L N LG + + L+ + N+ + + N
Sbjct: 138 ASITSLNLRGNDLGIK-------SSDELIQILAAIP-------------ANVNSLNLRGN 177
Query: 284 LL--EGT--LPPGLGNLPF-LRTYNIGFNKIVSSGDDEGLSFITSL--TNSTHLNYLALD 336
L + L L ++P + + ++ N + + + + + + H+ L L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLL----GLKSYAELAYIFSSIPNHVVSLNLC 233
Query: 337 GNQFEGKIPESIGNF---SNELSKLYLGGNHIYGK-------IPASIGRLRSLTLLDLSY 386
N G E++ L +YL + + + A+ ++ + L+D +
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293
Query: 387 NSISGEIPIEIGQL-----QGLQVLGLAGNEI-----PGGIPNSLANLKKLNQIDLSGNE 436
I I I L V L + L +L + +
Sbjct: 294 KEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
Query: 437 L 437
L
Sbjct: 354 L 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/333 (14%), Positives = 103/333 (30%), Gaps = 63/333 (18%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFR-----LRVLNISFNNLQGELPVNISKL----- 142
+ + S+ L N L E+ + + LN+S N L + + K
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 143 TELKMLDLMANKITGRVTDDQLRNLR----SLQVLNFGKNLLWGSIPPSIANLIPSDLSR 198
+ +LDL N + + + + + S+ LN N + ++ + L+
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN----DLGIKSSDELIQILAA 164
Query: 199 L-ENLKVLDLTINR--------LAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249
+ N+ L+L N LA + S S+ L L++N LG + +
Sbjct: 165 IPANVNSLNLRGNNLASKNCAELAKFLAS---IPASVTSLDLSANLLGLK-------SYA 214
Query: 250 NLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPFLRTYNIG 305
L ++ + + N L G L +L L+T +
Sbjct: 215 ELAYIF-------------SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQF--EG--KIPESIGNFSNELSKLYLG 361
++ + + ++ + + N + + +G + I I S + L
Sbjct: 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLL 321
Query: 362 GNHIY-----GKIPASIGRLRSLTLLDLSYNSI 389
+ + L + +
Sbjct: 322 NQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 40/206 (19%)
Query: 657 RRATGNFSHENLIGSGSFGSVL--HNERTGSW---------KSF----IAECETLRNVRH 701
R+ F E + G G+FG+V + TG F + + L + H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 702 RNLVKL--ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS--------- 750
N+V+L + +L +V E++ + +L + ++
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 751 ---ALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQSSISSTH 806
++ LH V V H D+KP N+L++E T K+ DFG A+ L N + I S +
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 807 VFMGSIGYVPPEYGLG-ERPSTAGDV 831
Y PE G + +TA D+
Sbjct: 197 -------YRAPELIFGNQHYTTAVDI 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 40/238 (16%), Positives = 70/238 (29%), Gaps = 85/238 (35%)
Query: 656 LRRATGNFSHE----NLIGSGSFGSV---------------------LHNERTGSWKSFI 690
+ + IG GS+G V + +
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 691 AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL---- 746
E ++ + H N+ +L + + ++ LV E G L D ++ +
Sbjct: 77 TEVRLMKKLHHPNIARLY---EVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 747 --------------------------------------------DITSALDYLHNDCEVP 762
I SAL YLHN
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G 188
Query: 763 VVHSDLKPGNILL--DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ H D+KP N L ++ K+ DFGL++ + + + +T G+ +V PE
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPE 244
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 42/197 (21%), Positives = 79/197 (40%), Gaps = 51/197 (25%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSVL--HNERTGSW-------KSFI--------- 690
PK S +F +G+GSFG V + G + K +
Sbjct: 1 PKYSLQ-------DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT 53
Query: 691 -AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-- 747
E L V H ++++ + ++ + + ++ +++ G L + ++
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA 108
Query: 748 ------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801
+ AL+YLH +++ DLKP NILLD+ K+ DFG A+++ +
Sbjct: 109 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------ 159
Query: 802 ISSTHVFMGSIGYVPPE 818
T+ G+ Y+ PE
Sbjct: 160 ---TYTLCGTPDYIAPE 173
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 12/148 (8%)
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
P N+ + + L N I + + L+ ++ N + + P
Sbjct: 27 PTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDA------- 75
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255
L +L L L N++ S + SL L L +N++ + D L NL
Sbjct: 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLS 134
Query: 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
N+ G+ L IQ + + N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 45/183 (24%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471
EIP +P ++ + L N + P +F ++ L IDLSNN+I+ +
Sbjct: 25 EIPTNLPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF- 76
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGL 531
L ++ ++ L N ++ LP SL F G L L
Sbjct: 77 ------QGLRSLNSLVLYGNKIT-ELPKSL---------------FEG--------LFSL 106
Query: 532 EVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNP 587
++L L++NK++ + D Q+L L L+L N L+ + ++G F + +HL NP
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTI--AKGTFSPLRAIQTMHLAQNP 163
Query: 588 KLC 590
+C
Sbjct: 164 FIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 9/131 (6%)
Query: 333 LALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSI 389
+ L+ N + IP G FS +L ++ L N I ++ LRSL L L N I
Sbjct: 37 IRLEQNTIK-VIPP--GAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI 92
Query: 390 SGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNF 448
+ E+P + L LQ+L L N+I ++ +L LN + L N+L +F
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 449 QSLLSIDLSNN 459
+++ ++ L+ N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 34/144 (23%), Positives = 50/144 (34%), Gaps = 37/144 (25%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
LR I L NN++S L + L L L + N + ELP ++ L L++L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210
ANKI + L NL +L L N
Sbjct: 112 NANKIN--------------------------CLRVDA-------FQDLHNLNLLSLYDN 138
Query: 211 RLAGTVPSTIYNMTSLVHLRLASN 234
+L T + ++ + LA N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 31/137 (22%), Positives = 64/137 (46%), Gaps = 10/137 (7%)
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSNNRIN 462
+ L N I P + + KKL +IDLS N+++ E+ +F +SL S+ L N+I
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
+PK + L ++ + L+ N ++ ++ ++ +L L + N+
Sbjct: 94 -ELPKSLFE-------GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145
Query: 523 NIVAELKGLEVLDLSSN 539
+ L+ ++ + L+ N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 24/138 (17%)
Query: 258 FNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG----LGNLPFLRTYNIGFNKIVS-- 311
N PG+ ++ I +++N + L P L +L L Y NKI
Sbjct: 41 QNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG---NKITELP 96
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKI 369
EGL L L L+ N+ + F + L+ L L N +
Sbjct: 97 KSLFEGL---------FSLQLLLLNANKIN-CLRV--DAFQDLHNLNLLSLYDNKLQTIA 144
Query: 370 PASIGRLRSLTLLDLSYN 387
+ LR++ + L+ N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 34/173 (19%), Positives = 58/173 (33%), Gaps = 53/173 (30%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
+ E + +G GSFG V G K F+ E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------- 745
++ ++V+L+ S ++ E ++ G L ++ R
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 746 --------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+I + YL+ VH DL N ++ E+ T K+GDFG+ R
Sbjct: 137 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 39/182 (21%)
Query: 663 FSHENLIGSGSFGSVL-----HNERTGSWKS--------------FIAECETLRNVRHRN 703
+ +IG G+FG V + + K F E + +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------ITSALDYLH 756
+V+L + ++ +L +V E++ G L + + E + ALD +H
Sbjct: 131 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ +H D+KP N+LLD+ K+ DFG + N+ + +G+ Y+
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-----NKEGMVRCDTAVGTPDYIS 237
Query: 817 PE 818
PE
Sbjct: 238 PE 239
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 31/148 (20%), Positives = 51/148 (34%), Gaps = 11/148 (7%)
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
P +I L L N+ T + L L+ +NF N + I
Sbjct: 27 PEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGA------- 76
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255
+ + LT NRL + SL L L SN++ + D L ++
Sbjct: 77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLS 135
Query: 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHN 283
N+ T PG+ L ++ + + N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 28/141 (19%), Positives = 55/141 (39%), Gaps = 12/141 (8%)
Query: 98 RSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKI 155
++L NN+ + I L +LR +N S N + ++ + + + L +N++
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215
V + L SL+ L N + + L ++++L L N++
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS-------FIGLSSVRLLSLYDNQITTV 144
Query: 216 VPSTIYNMTSLVHLRLASNQL 236
P + SL L L +N
Sbjct: 145 APGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 46/181 (25%), Positives = 72/181 (39%), Gaps = 46/181 (25%)
Query: 412 EIPGGIPNSLANLKKLNQIDLSGNELTG-EIPISFGNFQSLLSIDLSNNRINGNIPKGIL 470
+IP IP A L L+ NE T E F L I+ SNN+I +I +G
Sbjct: 25 KIPEHIPQYTAEL------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAF 77
Query: 471 RPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKG 530
V I L+ N L N+ + + F G L+
Sbjct: 78 -------EGASGVNEILLTSNRLE-NVQHKM---------------FKG--------LES 106
Query: 531 LEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGN 586
L+ L L SN+++ + +D L ++R L+L N + V + G F + + ++L N
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTV--APGAFDTLHSLSTLNLLAN 163
Query: 587 P 587
P
Sbjct: 164 P 164
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 29/132 (21%), Positives = 52/132 (39%), Gaps = 10/132 (7%)
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISG 391
L L+ N+F I +L K+ N I I + + L+ N +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE- 94
Query: 392 EIPIEI-GQLQGLQVLGLAGNEI---PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGN 447
+ ++ L+ L+ L L N I L++++ L L N++T P +F
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL---SLYDNQITTVAPGAFDT 151
Query: 448 FQSLLSIDLSNN 459
SL +++L N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 15/134 (11%)
Query: 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGN 363
N+ L L + N+ I E G F ++++ L N
Sbjct: 41 NNEFTV------LEATGIFKKLPQLRKINFSNNKIT-DIEE--GAFEGASGVNEILLTSN 91
Query: 364 HIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSL 421
+ + + L SL L L N I+ + + L +++L L N+I P +
Sbjct: 92 RL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149
Query: 422 ANLKKLNQIDLSGN 435
L L+ ++L N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/162 (20%), Positives = 63/162 (38%), Gaps = 35/162 (21%)
Query: 404 QVLGLAGNEIPGGIPNSL-ANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
L L NE + L +L +I+ S N++T +F + I L++NR+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
N+ + + LE++ T+ L N ++ + N F G
Sbjct: 95 -NVQHKMFK-------GLESLKTLMLRSNRIT-CVGNDS---------------FIG--- 127
Query: 523 NIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFN 563
L + +L L N+++ ++ L +L +LNL N
Sbjct: 128 -----LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/176 (18%), Positives = 58/176 (32%), Gaps = 42/176 (23%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIY-NMTSLVHLRLASNQLGGEIPYDVRDTLPN 250
IP + + L L N + I+ + L + ++N++ +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI---------TDIE- 73
Query: 251 LLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL-GNLPFLRTYNIGFNKI 309
G+ + + I +T N LE + + L L+T + N+I
Sbjct: 74 ---------------EGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI 117
Query: 310 VSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGN 363
G+D S + + L+L NQ + G F LS L L N
Sbjct: 118 TCVGND-------SFIGLSSVRLLSLYDNQIT-TVAP--GAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 33/151 (21%), Positives = 56/151 (37%), Gaps = 17/151 (11%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPNSLANLKKL 427
IP L L+ N + I +L L+ + + N+I + +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 428 NQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486
N+I L+ N L + F +SL ++ L +NRI + L +V +
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLS-------SVRLL 134
Query: 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQF 517
L DN ++ P + SL L + N F
Sbjct: 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 43/195 (22%), Positives = 75/195 (38%), Gaps = 44/195 (22%)
Query: 650 KISYDELRRATGNFSHENLIGSGSFGSVL--HNERTGSW---------------KSFIAE 692
+I Y+ F ++L+G G++G V ++ TG + E
Sbjct: 4 RIVYNISSD----FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 693 CETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----- 747
+ L++ +H N++ + +N + ++ E + L I L
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI---STQMLSDDHIQ 115
Query: 748 -----ITSALDYLH--NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQS 800
A+ LH N V+H DLKP N+L++ KV DFGLAR + E + S
Sbjct: 116 YFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 801 SISSTHVFMGSIGYV 815
+ M + +V
Sbjct: 171 EPTGQQSGM--VEFV 183
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 6e-12
Identities = 43/187 (22%), Positives = 67/187 (35%), Gaps = 46/187 (24%)
Query: 662 NFSHENLIGSGSFGSVLHNER--TGSW-------KSFI-----AEC--------ETLRNV 699
+FS +IG G FG V + TG K I +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSA 751
+V + + + D L+ + + ++ G L + I
Sbjct: 250 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L+++HN VV+ DLKP NILLDE ++ D GLA + H +G+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK--------KKPHASVGT 353
Query: 812 IGYVPPE 818
GY+ PE
Sbjct: 354 HGYMAPE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 36/157 (22%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
+ IG G++G+V L ++ G S + E L+ ++H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELDITS-------ALDY 754
+V+L S L LV+EF L + + + S L +
Sbjct: 63 IVRLHDVLHSDKK-----LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
H+ V+H DLKP N+L++ K+ +FGLAR
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 38/180 (21%), Positives = 66/180 (36%), Gaps = 59/180 (32%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F + L +G G+FG V+ + G K+ ++E +
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 696 LRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
L ++ H N+V L+ +C+ M ++ EF G+L ++ +R
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 746 ---------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +++L +H DL NILL E+ K+ DFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 33/209 (15%), Positives = 67/209 (32%), Gaps = 57/209 (27%)
Query: 655 ELRRATGNFSHENLIGSGSFGSV-------LHNERTGS------------WKSFI--AEC 693
E + + +L+G G+F V L++ + W+ +I
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 694 ETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------- 745
E L+ +K S+ +N LV E S G+L + I+ +
Sbjct: 119 ERLKPSMQHMFMKF---YSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 746 -----LDITSALDYLHNDCEVPVVHSDLKPGNILL-----------DEEMTAKVGDFGLA 789
+ + ++ +H + ++H D+KP N +L D + D G +
Sbjct: 174 VISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 790 RFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ + + G+ E
Sbjct: 231 IDMKLFPKGTIFTA----KCETSGFQCVE 255
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 47/200 (23%), Positives = 75/200 (37%), Gaps = 57/200 (28%)
Query: 667 NLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLI 708
L+G GS+G V ++ K + E + L+ +RH NLV L+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHND 758
C LV+EF+ + ++ D + N LD I + + + H+
Sbjct: 91 EVCKKKKR-----WYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV--- 815
++H D+KP NIL+ + K+ DFG AR L + V
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-----VYDD-------EVATR 188
Query: 816 ---PPEYGLGERP-STAGDV 831
PE +G+ A DV
Sbjct: 189 WYRAPELLVGDVKYGKAVDV 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 40/157 (25%), Positives = 61/157 (38%), Gaps = 37/157 (23%)
Query: 662 NFSHENLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL 704
+ +G G++G V L E G + I E L+ + H N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDY 754
V LI S L LV+EF+ L + E K L + + +
Sbjct: 82 VSLIDVIHSERC-----LTLVFEFMEK-DLKKVLD-ENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
H ++H DLKP N+L++ + K+ DFGLAR
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA 168
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 41/156 (26%), Positives = 63/156 (40%), Gaps = 37/156 (23%)
Query: 662 NFSHENLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL 704
+ IG G++G V L E G + I E L+ ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDY 754
VKL + L LV+E L L + + L+ + + + Y
Sbjct: 63 VKLYDVIHTKKR-----LVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAY 115
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
H+ V+H DLKP N+L++ E K+ DFGLAR
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 50/212 (23%)
Query: 636 KRVGVSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVL-----HNERTGSW---- 686
K + ++ K H K F ++G GSFG V
Sbjct: 6 KEIAITHHVKEGHEKADPS-------QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK 58
Query: 687 ---KSFI-----AECETLRNV----RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSL 734
K+ + + R++ H +VKL + + L L+ +FL G L
Sbjct: 59 VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDL 113
Query: 735 GDWIHGERKNELD--------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+ E + + ALD+LH + +++ DLKP NILLDEE K+ DF
Sbjct: 114 FTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDF 170
Query: 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
GL++ E +D++ + F G++ Y+ PE
Sbjct: 171 GLSK---ESIDHE---KKAYSFCGTVEYMAPE 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 36/151 (23%), Positives = 59/151 (39%), Gaps = 36/151 (23%)
Query: 669 IGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
IG GS+G V + K + E L+ ++H NLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELDITS-------ALDYLHNDCEV 761
L LV+E+ + ++ + + E + S A+++ H
Sbjct: 71 FRRKRR-----LHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+H D+KP NIL+ + K+ DFG AR L
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 34/194 (17%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSW----KSFIA------------ECETLRNVRHRN 703
+ +LIG+GS+G V +++ K E L + H +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFL---------SNGSLGDWIHGERKNEL-DITSALD 753
+VK++ D + + L +V E + L + +H K L ++ +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE-LH--IKTLLYNLLVGVK 170
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
Y+H ++H DLKP N L++++ + KV DFGLAR + + S + +
Sbjct: 171 YVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 814 YVPPEYGLGERPST 827
P +R T
Sbjct: 228 VTFPHTKNLKRQLT 241
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 41/178 (23%)
Query: 668 LIGSGSFGSVLHNER--TGSW-------KSFI----------AECETLRNVRHRNLVKLI 708
L+G G+FG V+ TG + K I E L+N RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
+ + + L V E+ + G L + ER + I SAL+YLH
Sbjct: 72 YA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---S 123
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VV+ D+K N++LD++ K+ DFGL + + S ++ F G+ Y+ PE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPE 175
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 44/186 (23%), Positives = 69/186 (37%), Gaps = 46/186 (24%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKSF-------------------IAECETLRNVRHR 702
+F IG GSFG V ++ + K + E + ++ + H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSAL 752
LV L S ++ E + +V + L G L H ++ + AL
Sbjct: 76 FLVNLWYS-----FQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVMAL 128
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
DYL ++H D+KP NILLDE + DF +A L + G+
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-------TQITTMAGTK 178
Query: 813 GYVPPE 818
Y+ PE
Sbjct: 179 PYMAPE 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 36/179 (20%), Positives = 63/179 (35%), Gaps = 56/179 (31%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F L +G+G+FG V+ G KS ++E +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 696 LRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY 754
L + H N+V L+ +C+ ++ E+ G L +++ +R + + ++
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 755 LHNDCEVP-----------------------VVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +D +H DL NILL K+ DFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 34/151 (22%)
Query: 696 LRNVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------L 746
++ V H+N++ L T SL+ + + +V E + +L I E +E
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLE--EFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY 134
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
+ + +LH+ ++H DLKP NI++ + T K+ DFGLAR + T
Sbjct: 135 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTS 180
Query: 807 VFMGSIGYV------PPEYGLGERPSTAGDV 831
M YV PE LG D+
Sbjct: 181 FMMT--PYVVTRYYRAPEVILGMGYKENVDI 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 47/192 (24%), Positives = 70/192 (36%), Gaps = 41/192 (21%)
Query: 655 ELRRATGNFSHENLIGSGSFGSVLHNERTGSWK-------------------SFIAECET 695
E+R +F +IG G+F V + + + F E +
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELD------ 747
L N R + +L + D L LV E+ G L + GER
Sbjct: 115 LVNGDRRWITQL--HFAFQDENY---LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 748 -ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
I A+D +H + VH D+KP NILLD ++ DFG L +
Sbjct: 170 EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-----RADGTVRSL 221
Query: 807 VFMGSIGYVPPE 818
V +G+ Y+ PE
Sbjct: 222 VAVGTPDYLSPE 233
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 42/175 (24%), Positives = 64/175 (36%), Gaps = 64/175 (36%)
Query: 666 ENLIGSGSFGSVLHNERTGSWKS-----------------------FIAECETLRNV-RH 701
+++IG G+FG VL K F E E L + H
Sbjct: 30 QDVIGEGNFGQVLK----ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------- 745
N++ L+ +C + +L L E+ +G+L D++ R E
Sbjct: 86 PNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 746 --------LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
D+ +DYL +H DL NIL+ E AK+ DFGL+R
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 6e-11
Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 46/187 (24%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSW---------KSFIAE--------CETLRNV----- 699
+F+ ++G GSFG V+ +ER G+ K + + E + V
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRVLALPG 399
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSA 751
+ L +L + + M+ L V E+++ G L I + + I
Sbjct: 400 KPPFLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L +L +++ DLK N++LD E K+ DFG+ + +N +T F G+
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTTKTFCGT 505
Query: 812 IGYVPPE 818
Y+ PE
Sbjct: 506 PDYIAPE 512
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 44/163 (26%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSWKSFIA------------------ECETLRNVRH 701
F +G+G++ +V N+ TG ++A E ++ ++H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGV---YVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSN---GSLGDWIHGERKNELD----------I 748
N+V+L + + L LV+EF+ N + G L+ +
Sbjct: 63 ENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 749 TSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
L + H + ++H DLKP N+L+++ K+GDFGLAR
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 34/151 (22%)
Query: 696 LRNVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------L 746
++ V H+N++ L T +L+ + + LV E + + +L I E +E
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLE--EFQDVYLVMELM-DANLCQVIQMELDHERMSYLLY 171
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
+ + +LH+ ++H DLKP NI++ + T K+ DFGLAR + T
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTS 217
Query: 807 VFMGSIGYV------PPEYGLGERPSTAGDV 831
M YV PE LG D+
Sbjct: 218 FMM--TPYVVTRYYRAPEVILGMGYKENVDI 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 33/154 (21%)
Query: 669 IGSGSFGSVLH--NERTGSW---KSFIAECETLRN--------VRHRNLVKLITSCSSLD 715
+G G G VL N+RT K + +C R + ++V+++ +L
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARREVELHWRASQCPHIVRIVDVYENLY 84
Query: 716 SKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----------DITSALDYLHNDCEVPVV 764
+ L +V E L G L I +R ++ I A+ YLH + +
Sbjct: 85 AGRKCLL-IVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 139
Query: 765 HSDLKPGNILL---DEEMTAKVGDFGLARFLLER 795
H D+KP N+L K+ DFG A+
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 44/160 (27%)
Query: 669 IGSGSFGSVL----------------HNERTGSWKSFIAECETLRNVRHRNLVKLITSCS 712
+G G++G V E TG S E LR ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-----------------ITSALDYL 755
S + L++++ + L I R ++ + I + YL
Sbjct: 89 S---HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTA----KVGDFGLARF 791
H + V+H DLKP NIL+ E K+ D G AR
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 36/180 (20%), Positives = 66/180 (36%), Gaps = 62/180 (34%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F NL +G+G+FG V+ G K ++E +
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 696 LRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
+ ++ +H N+V L+ +C+ L ++ E+ G L +++ + +
Sbjct: 103 MSHLGQHENIVNLLGACT----HGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 746 -------------LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ + +L N +H D+ N+LL AK+GDFGLAR
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 61/184 (33%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F ENL +GSG+FG V++ G K+ ++E +
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 696 LRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY 754
+ + H N+V L+ +C+ + L++E+ G L +++ +R+ + +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 755 LHNDCEVP----------------------------VVHSDLKPGNILLDEEMTAKVGDF 786
E VH DL N+L+ K+ DF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 787 GLAR 790
GLAR
Sbjct: 217 GLAR 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 38/184 (20%), Positives = 61/184 (33%), Gaps = 61/184 (33%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F +NL +G G FG V+ ++E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYL 755
L+ V H +++KL +CS ++ L L+ E+ GSL ++ RK +
Sbjct: 80 LKQVNHPHVIKLYGACS----QDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 756 HNDCEVP-----------------------------VVHSDLKPGNILLDEEMTAKVGDF 786
++ +VH DL NIL+ E K+ DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 787 GLAR 790
GL+R
Sbjct: 195 GLSR 198
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 1e-10
Identities = 99/726 (13%), Positives = 219/726 (30%), Gaps = 221/726 (30%)
Query: 238 GEIPYDVRDTLPNLLD-FIYCFNRFTGKIPGSLHN-LTNIQIIRMTHNLLEGTLPPGLGN 295
GE Y +D L D F+ F+ + + L+ +I H ++
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFD--CKDVQDMPKSILSKEEI---DHIIMSKD------- 59
Query: 296 LPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLAL-DGNQFEGKIPESI-GNFSN 353
T + F ++S ++ F+ + NY L + E + P + +
Sbjct: 60 -AVSGTLRL-FWTLLSKQEEMVQKFVEEVLRI---NYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413
+ +LY N ++ ++ RL+ +L+
Sbjct: 115 QRDRLY-NDNQVF--AKYNVSRLQPYL------------------KLR------------ 141
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID-LSNNRINGNIPKGI--L 470
+L L+ + + G + G G ++ +++D + ++ + I L
Sbjct: 142 -----QALLELRPAKNVLIDG--VLG-----SG--KTWVALDVCLSYKVQCKMDFKIFWL 187
Query: 471 RPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI-PNIVAELK 529
+LKNC S E +L + I PN +
Sbjct: 188 -----------------------------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNV-HLKGNPK 588
+ L + SI ++L+ L + N L + N+ N
Sbjct: 219 HSSNIKLRIH----SIQAELRRLLKSKPYE---NCLL-------VLLNVQNAKAWNA--- 261
Query: 589 LCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKA--KRVGVSALFKV 646
L C ++++ + + ++ + S L K
Sbjct: 262 --FNLSC--------KILLTTRFKQVTDFLSAATTTH-ISLDHHSMTLTPDEVKSLLLKY 310
Query: 647 CHPKISYDELRR--ATGNFSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNL 704
+L R T N ++I + + +W ++ ++V L
Sbjct: 311 LD--CRPQDLPREVLTTNPRRLSII-----AESIRDGLA-TWDNW-------KHVNCDKL 355
Query: 705 VKLITSC-SSLDSKNME--FLAL------------VYEFLSNGSLGDWIHGERKNELDIT 749
+I S + L+ F L + + W + + + +
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI-------WFDVIKSDVMVV- 407
Query: 750 SALDYLHNDCEVPVVHSDLKPG-----NILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
++ LH +V K +I L+ ++ + ++ L R +++ + + S
Sbjct: 408 --VNKLHKYS---LVEKQPKESTISIPSIYLELKVKLE-NEYALHRSIVDHYNIPKTFDS 461
Query: 805 THV--------FMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV----KWVE---- 848
+ F IG+ ER + F +V +++E
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHPERMT-------------LFRMVFLDFRFLEQKIR 508
Query: 849 -SNLPENVLQVLDPELRQL------MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI 901
+ N + L+QL + N+ + +L + ++ + + + S +
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL-ICSKYTDL 567
Query: 902 GIREAL 907
+R AL
Sbjct: 568 -LRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 8e-09
Identities = 71/522 (13%), Positives = 147/522 (28%), Gaps = 163/522 (31%)
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP--------LPEEI 477
+ + ++ + + F + + ++PK IL + +
Sbjct: 10 ETGEHQYQYKDI---LSVFEDAFVD----NFDCKDVQ-DMPKSILSKEEIDHIIMSKDAV 61
Query: 478 SRLENVVTIDLS----------DNSLSGN---LPNSLKN-CKSLEELLMAYNQFSGPIPN 523
S + LS + L N L + +K + + Y + + N
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 524 IVAELKGLEVLDLSSNKLSGSIPSDLQNLQ-ALRSLNLTFNNLEGVVPSEGIFRNMSNVH 582
V S L+ AL L P++ + +
Sbjct: 122 DNQVFAKYNV----------SRLQPYLKLRQALLELR----------PAKNVL-----ID 156
Query: 583 -LKGNPKLCLQLGCENPRSHGSRLIILSIIVTIMAVIAGCFLIVWPIIVRKRKAKRVGVS 641
+ G+ K + L + S+ + M F I W + ++ + +
Sbjct: 157 GVLGSGKTWVAL--DVCLSYK--------VQCKMD-----FKIFW-LNLKNCNSPETVLE 200
Query: 642 ALFKVCH---------PKISY----------DELRRATGNFSHEN-LIGSGSFGSVLHN- 680
L K+ + S ELRR + +EN L+ VL N
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-------VLLNV 253
Query: 681 ERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740
+ +W +F C+ L L T + +FL+ ++ SL
Sbjct: 254 QNAKAWNAFNLSCKIL----------LTTR----FKQVTDFLSAATT--THISLDHHSMT 297
Query: 741 ERKNE-LDITSALDYLHNDCEVPVVHSDLKP----GNILLDEEMTAKVGDFGLARFLLER 795
+E + YL + DL N + + D LA + +
Sbjct: 298 LTPDEVKSLLL--KYLDCRPQ------DLPREVLTTNPRRLSIIAESIRDG-LATW--DN 346
Query: 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENV 855
+ + T + S+ + P + F ++ +++P +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAE-------------YRKMFD-RLSVFP-PSAHIPTIL 391
Query: 856 LQVL-------DPE--LRQLMTS------NESQTIQLHDCLI 882
L ++ D + +L + TI + +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-07
Identities = 87/488 (17%), Positives = 141/488 (28%), Gaps = 136/488 (27%)
Query: 11 HVTWLPFGADSASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFG 70
+ WL ++ T E L QI S N ++
Sbjct: 183 KIFWLNLKNCNSP---ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR--------IHSIQ 231
Query: 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL--RVL---- 124
L P+ L L ++Q N + N F L ++L
Sbjct: 232 AE-----LRRLLKS---KPYENCLLVLLNVQ---NA-------KAWNAFNLSCKILLTTR 273
Query: 125 NIS-FNNLQGELPVNIS------KLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGK 177
+ L +IS LT ++ L+ + R D L +VL
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD-----LPR-EVL--TT 325
Query: 178 NLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237
N SI IA I L+ +N K + ++L + S++ N L
Sbjct: 326 NPRRLSI---IAESIRDGLATWDNWK--HVNCDKLTTIIESSL-------------NVLE 367
Query: 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSL-----HNLTNIQIIRMTHNLLEGTLPPG 292
P + R L + F IP L ++ ++ + + L + +L
Sbjct: 368 ---PAEYRKMFDRL--SV--FPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--- 416
Query: 293 LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLN------YLALDGNQFEGKIPE 346
+ P T +I L L N L+ Y + IP
Sbjct: 417 VEKQPKESTISI---------PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
Query: 347 SIGN--FSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404
+ +S ++ G+H+ L + LD + +E Q ++
Sbjct: 468 YLDQYFYS------HI-GHHLKNIEHPERMTLFRMVFLDFRF--------LE----QKIR 508
Query: 405 VLGLAGNEIPGGIPNSLANLKK-LNQI---DLSGNELTGEIPISF----------GNFQS 450
A N G I N+L LK I D L I + F +
Sbjct: 509 HDSTAWNA-SGSILNTLQQLKFYKPYICDNDPKYERLVNAI-LDFLPKIEENLICSKYTD 566
Query: 451 LLSIDLSN 458
LL I L
Sbjct: 567 LLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 8e-07
Identities = 98/536 (18%), Positives = 182/536 (33%), Gaps = 133/536 (24%)
Query: 83 LEGTISPHIGNLSFLRS-IQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNIS- 140
+E + N FL S I+ + + S I RL +N+ Q N+S
Sbjct: 83 VEEVLRI---NYKFLMSPIKTEQRQPSMMTRMYIEQRDRL------YNDNQVFAKYNVSR 133
Query: 141 --KLTELK--MLDLMANKI--------TGR--VTDDQLRNLRSLQVLNFGKNLLWGSIPP 186
+L+ +L+L K +G+ V D + + ++F + W +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK--IFW--L-- 187
Query: 187 SIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVH-LRLASNQLGGEIPY--- 242
++ N S + LE L+ L I+ + N+ +H ++ +L PY
Sbjct: 188 NLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 243 -----DVRDTLPNLLD-F-IYCFNRFTGKIPGSLHNLT--NIQII------RMTHNLLEG 287
+V++ + F + C KI L LT Q+ TH L+
Sbjct: 247 LLVLLNVQN--AKAWNAFNLSC------KI---L--LTTRFKQVTDFLSAATTTHISLDH 293
Query: 288 TLPPGLG-----NLPFLRTYNIGFNKI---VSSGDDEGLSFI-TSLTNSTHL--NYLALD 336
L +L L+ + + V + + LS I S+ + N+ ++
Sbjct: 294 -HSMTLTPDEVKSL-LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 337 GNQFEGKIPESIGNFS-NELSKLY--LGGNHIY---GKIPASIGRLRSLTLLDLSYNSIS 390
++ I S+ E K++ L ++ IP + L+L+ + +
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLS---VFPPSAHIPTIL-----LSLI---WFDVI 400
Query: 391 GEIPIEIGQLQGLQVLGLA---GNEIPGGIPN-------SLANLKKLNQ--ID------- 431
+ + + L L E IP+ L N L++ +D
Sbjct: 401 KSDVMVV--VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491
++L P F S + L N + + R + + LE + D +
Sbjct: 459 FDSDDLI--PPYLDQYFYSHIGHHLKNIEHPERMT--LFRMVFLDFRFLEQKIRHDSTAW 514
Query: 492 SLSGNLPNSL-----------KNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDL 536
+ SG++ N+L N E L+ A F +P I L + DL
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF---LPKIEENLICSKYTDL 567
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 47/188 (25%)
Query: 662 NFSHENLIGSGSFGSVL-----HNERTGSWKS--------------FIAECETLRNVRHR 702
+F +IG G+FG V + ++ + K F E + L N +
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------------DITS 750
+ L + D N L LV ++ G L + K E ++
Sbjct: 135 WITTLH--YAFQDDNN---LYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVI 186
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
A+D +H + VH D+KP NIL+D ++ DFG L+E Q + V +G
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-----SSVAVG 238
Query: 811 SIGYVPPE 818
+ Y+ PE
Sbjct: 239 TPDYISPE 246
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 41/199 (20%), Positives = 74/199 (37%), Gaps = 50/199 (25%)
Query: 663 FSHENLIGSGSFGSV---LHNERTGSW---------------KSFIAECETLRNVRHRNL 704
F + +G+G+ G V H +G I E + L +
Sbjct: 35 FEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 705 VK----LITSCSSLDSKNMEFLALVYEFLSNGSLGDWI-HGERKNE-------LDITSAL 752
V + +++ E + GSL + R E + + L
Sbjct: 94 VGFYGAFYSDGE---------ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
YL ++ +H D+KP NIL++ K+ DFG++ L++ S++++ V G+
Sbjct: 145 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFV--GTR 194
Query: 813 GYVPPEYGLGERPSTAGDV 831
Y+ PE G S D+
Sbjct: 195 SYMSPERLQGTHYSVQSDI 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 35/182 (19%), Positives = 64/182 (35%), Gaps = 62/182 (34%)
Query: 663 FSHENL-----IGSGSFGSV----LHNERTGSWKS--------------------FIAEC 693
F + L +G G+FG V K ++E
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 694 ETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------- 745
E ++ + +H+N++ L+ +C+ L ++ E+ S G+L +++ R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 746 -----------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788
+ ++YL +H DL N+L+ E K+ DFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 789 AR 790
AR
Sbjct: 204 AR 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 32/175 (18%), Positives = 60/175 (34%), Gaps = 58/175 (33%)
Query: 666 ENLIGSGSFGSV----LHNERTGS------------------WKSFIAECETLRNVRHRN 703
+G FG V L G + F E ++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------------ 745
+V L+ + L++++ + S+G L +++ +
Sbjct: 74 VVCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 746 ------LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
I + ++YL H+ VVH DL N+L+ +++ K+ D GL R +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 27/155 (17%), Positives = 60/155 (38%), Gaps = 20/155 (12%)
Query: 663 FSHENLIGSGSFGSVLHNERTGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722
H N+I + K + + N V ++ ++L
Sbjct: 57 LDHVNII---KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 723 ALVYEFLSNGSLGDWIHGERKNELDITS------------ALDYLHNDCEVPVVHSDLKP 770
++ E++ + +L + ++ I A+ ++H+ + + H D+KP
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 771 GNILLDEEM-TAKVGDFGLARFLLERVDNQSSISS 804
N+L++ + T K+ DFG A+ L+ + + I S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICS 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 45/182 (24%)
Query: 668 LIGSGSFGSVL-----HNERTGSW-------KSFI-----------AECETLRNVRHRNL 704
++G G +G V TG K+ I AE L V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLH 756
V LI K L L+ E+LS G L + E D I+ AL +LH
Sbjct: 84 VDLI-YAFQTGGK----LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ +++ DLKP NI+L+ + K+ DFGL + E + + + TH F G+I Y+
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDG---TVTHTFCGTIEYMA 189
Query: 817 PE 818
PE
Sbjct: 190 PE 191
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 35/156 (22%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSW---------------KSFIAECETLRNVRHRNL 704
+ + +G G++ +V ++ T + + I E L++++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELDITS-------ALDYL 755
V L + S L LV+E+L L ++ G N ++ L Y
Sbjct: 63 VTLHDIIHTEKS-----LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
H V+H DLKP N+L++E K+ DFGLAR
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSW---------KSFIAE--------CETLRNV-----RHRNLV 705
++G GSFG V+ +ER G+ K + + E + V + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRVLALPGKPPFLT 84
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
+L SC + L V E+++ G L I + + I L +L
Sbjct: 85 QLH-SCFQTMDR----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ- 138
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+++ DLK N++LD E K+ DFG+ + E + + +T F G+ Y+ P
Sbjct: 139 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG---VTTKTFCGTPDYIAP 190
Query: 818 E 818
E
Sbjct: 191 E 191
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 35/184 (19%), Positives = 68/184 (36%), Gaps = 66/184 (35%)
Query: 663 FSHENL-----IGSGSFGSV-------LHNERTGSW-----------------KSFIAEC 693
+ L +G G+FG V L ++ I+E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 694 ETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL------ 746
E ++ + +H+N++ L+ +C+ ++ ++ E+ S G+L +++ R L
Sbjct: 126 EMMKMIGKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 747 ------------------DITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+ ++YL +H DL N+L+ E+ K+ DF
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADF 235
Query: 787 GLAR 790
GLAR
Sbjct: 236 GLAR 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 57/173 (32%)
Query: 669 IGSGSFGSV----LHNERTGSWKS-----------------FIAECETLRNVRHRNLVKL 707
+G G+FG V +N K F E E L N++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------------- 745
C D L +V+E++ +G L ++ +
Sbjct: 83 YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 746 --LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
I S + YL + VH DL N L+ + K+GDFG++R +
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 36/167 (21%), Positives = 69/167 (41%), Gaps = 44/167 (26%)
Query: 658 RATGNFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNV 699
+ + +G G++G V L +E G + I E L+ +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------IT 749
+HRN+++L + L L++E+ N L ++ ++ ++ +
Sbjct: 91 QHRNIIELKSVIHHNHR-----LHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLI 142
Query: 750 SALDYLHNDCEVPVVHSDLKPGNILLDEEMTA-----KVGDFGLARF 791
+ +++ H+ +H DLKP N+LL + K+GDFGLAR
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 5/115 (4%)
Query: 326 NSTHLNYLALDGNQF-EGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDL 384
+ + L LD ++ EGK+ F L L + I A++ +L L L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEE-LEFLSTINVGL-TSI-ANLPKLNKLKKLEL 71
Query: 385 SYNSISGEIPIEIGQLQGLQVLGLAGNEIPG-GIPNSLANLKKLNQIDLSGNELT 438
S N +SG + + + L L L+GN+I L L+ L +DL E+T
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+ + L N+R N L E + + + L+ ++ N L
Sbjct: 15 TPSDVKELVLDNSRSN-------EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNK 65
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG-SIPSDLQNLQALRSLNLTFN 563
L++L ++ N+ SG + + + L L+LS NK+ S L+ L+ L+SL+L
Sbjct: 66 LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
++ L L + N ++ + + L+ L + I N L L KL +++LS N
Sbjct: 19 VKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSDN 74
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
++G + + +L ++LS N+I + PL +LEN+ ++DL + ++
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKD---LSTIEPL----KKLENLKSLDLFNCEVT- 126
Query: 496 NLPN----SLKNCKSLEEL 510
NL + K L L
Sbjct: 127 NLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 24/112 (21%), Positives = 46/112 (41%), Gaps = 5/112 (4%)
Query: 479 RLENVVTIDLSDNSLS-GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLS 537
+V + L ++ + G L + LE L + I N+ +L L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANL-PKLNKLKKLELS 72
Query: 538 SNKLSGSIPSDLQNLQALRSLNLTFNNLE--GVVPSEGIFRNMSNVHLKGNP 587
N++SG + + L LNL+ N ++ + N+ ++ L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 91 IGNLSFLRSIQLQNNKLS--GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKML 148
L + N L+ NLP L +L+ L +S N + G L V K L L
Sbjct: 38 TDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 149 DLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
+L NKI T + L+ L +L+ L+
Sbjct: 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/143 (18%), Positives = 56/143 (39%), Gaps = 17/143 (11%)
Query: 117 NLFRLRVLNISFN-NLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNF 175
++ L + + + +G+L + EL+ L + +T + L L L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT---SIANLPKLNKLKKLEL 71
Query: 176 GKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG-TVPSTIYNMTSLVHLRLASN 234
N ++ + + NL L+L+ N++ + + + +L L L +
Sbjct: 72 SDNR--------VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 235 QLGGEIPY--DVRDTLPNL--LD 253
++ Y +V LP L LD
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYLD 146
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 46/193 (23%)
Query: 668 LIGSGSFGSVLHNER--TGSW-------KSFIAE--------CETLRNV-----RHRNLV 705
++G GSFG V E T + K + E + V H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--KRVLSLAWEHPFLT 81
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
+ + + E L V E+L+ G L I K +L I L +LH
Sbjct: 82 HMFCT-----FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH- 135
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+V+ DLK NILLD++ K+ DFG+ + +N + T+ F G+ Y+ P
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGTPDYIAP 187
Query: 818 EYGLGERPSTAGD 830
E LG++ + + D
Sbjct: 188 EILLGQKYNHSVD 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSW---------KSFIAE--------CETLRNV-----RHRNLV 705
++G GSFG V+ + K I + E + + H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLARNHPFLT 87
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
+L + + L V EF++ G L I R+ + I SAL +LH
Sbjct: 88 QLFCCF-----QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH- 141
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ +++ DLK N+LLD E K+ DFG+ + E + N +T F G+ Y+ P
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNG---VTTATFCGTPDYIAP 193
Query: 818 E 818
E
Sbjct: 194 E 194
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 54/179 (30%), Positives = 75/179 (41%), Gaps = 42/179 (23%)
Query: 668 LIGSGSFGSVLHNERTGSW---------KSFIAE--------CET---LRNVRHRNLVKL 707
+IG GSFG VL K I + E L+NV+H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDC 759
S + + L V ++++ G L + ER I SAL YLH
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH--- 156
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+ +V+ DLKP NILLD + + DFGL + +N S+T F G+ Y+ PE
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTTSTFCGTPEYLAPE 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 36/151 (23%)
Query: 669 IGSGSFGSVL--HNERTGSW----KSFIA------------ECETLRNVRHRNLVKLITS 710
IG GS+G V +++ T K E L ++ +++L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 711 CSSLDSKNMEFLALVYEFL---------SNGSLGDWIHGERKNEL--DITSALDYLHNDC 759
D + L +V E + L + E + ++ +++H
Sbjct: 94 IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE----EHIKTILYNLLLGENFIH--- 146
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
E ++H DLKP N LL+++ + KV DFGLAR
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 33/167 (19%), Positives = 52/167 (31%), Gaps = 50/167 (29%)
Query: 669 IGSGSFGSV----LHNERTGS------------------WKSFIAECETLRNVRHRNLVK 706
+G G+FG V + F+ E + H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------LDITSA 751
I ++ E ++ G L ++ R DI
Sbjct: 98 CIGVSLQSLP-----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 752 LDYL-HNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLARFLLE 794
YL N +H D+ N LL AK+GDFG+AR +
Sbjct: 153 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 17/105 (16%)
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------- 747
L RH N++ + + + M+ + +V + + L + + L
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFL 134
Query: 748 --ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
I L Y+H+ V+H DLKP N+LL+ K+ DFGLAR
Sbjct: 135 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-10
Identities = 32/147 (21%), Positives = 55/147 (37%), Gaps = 18/147 (12%)
Query: 88 SPHIGNLSFLRSIQLQNNKLS--GNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTEL 145
+ N R + L+ K+ NL L + ++ S N ++ +L L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLGA---TLDQFDAIDFSDNEIR-KLD-GFPLLRRL 66
Query: 146 KMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
K L + N+I R+ + + L L L N L + +L P L+ L++L L
Sbjct: 67 KTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSL-----VELGDLDP--LASLKSLTYL 118
Query: 206 DLTIN---RLAGTVPSTIYNMTSLVHL 229
+ N IY + + L
Sbjct: 119 CILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 30/120 (25%), Positives = 47/120 (39%), Gaps = 7/120 (5%)
Query: 321 ITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT 380
TN+ L L G + I E++G ++ + N I K+ LR L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VI-ENLGATLDQFDAIDFSDNEI-RKL-DGFPLLRRLK 67
Query: 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI--PGGIPNSLANLKKLNQIDLSGNELT 438
L ++ N I L L L L N + G + + LA+LK L + + N +T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 12/121 (9%)
Query: 444 SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503
+ N +DL +I ++ L + + + ID SDN + L
Sbjct: 14 QYTNAVRDRELDLRGYKIP------VIENLGATLDQFD---AIDFSDNEIR-KLDG-FPL 62
Query: 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG-SIPSDLQNLQALRSLNLTF 562
+ L+ LL+ N+ + L L L L++N L L +L++L L +
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 122
Query: 563 N 563
N
Sbjct: 123 N 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 19/115 (16%), Positives = 44/115 (38%), Gaps = 5/115 (4%)
Query: 475 EEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534
+ + +DL + + N + + + N+ + L+ L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF-PLLRRLKTL 69
Query: 535 DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE--GVVPSEGIFRNMSNVHLKGNP 587
+++N++ Q L L L LT N+L G + ++++ + + NP
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 7/105 (6%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLS--GNLPREIGNLFRLRVLNISFNNLQG 133
L+L + + I L +I +N++ P L RL+ L ++ N +
Sbjct: 24 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICR 78
Query: 134 ELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
L +L L L N + D L +L+SL L +N
Sbjct: 79 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 27/164 (16%), Positives = 50/164 (30%), Gaps = 39/164 (23%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
LDL I I L + + NEI + L++L + ++ N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LDG-FPLLRRLKTLLVNNN 74
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
+ L + L+NN + E+ L+
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSL-------------VELGDLDP------------- 108
Query: 496 NLPNSLKNCKSLEELLMAYNQFSGPIPN----IVAELKGLEVLD 535
L + KSL L + N + + ++ ++ + VLD
Sbjct: 109 -----LASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 20/114 (17%), Positives = 38/114 (33%), Gaps = 14/114 (12%)
Query: 123 VLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWG 182
++ ++ ++ + + LDL KI V ++ L ++F N +
Sbjct: 1 MVKLTAELIEQAA--QYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEI-- 54
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
+ L LK L + NR+ + L L L +N L
Sbjct: 55 ---RKLDGF-----PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 36/158 (22%), Positives = 59/158 (37%), Gaps = 22/158 (13%)
Query: 106 KLSGNLPREI---GNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDD 162
KL+ L + N R R L++ + + + L + +D N+I D
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLD 58
Query: 163 QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA--GTVPSTI 220
LR L+ L N I + L +L L LT N L G + +
Sbjct: 59 GFPLLRRLKTLLVNNN--------RICRIGEGLDQALPDLTELILTNNSLVELGDL-DPL 109
Query: 221 YNMTSLVHLRLASNQLGGEIPY--DVRDTLPNL--LDF 254
++ SL +L + N + + Y V +P + LDF
Sbjct: 110 ASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 147
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSW---------KSFIAE--------CETLRNV-----RHRNLV 705
+IG GS+ VL + K + + E ++V H LV
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHVFEQASNHPFLV 116
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
L SC +S+ L V E+++ G L + +RK + I+ AL+YLH
Sbjct: 117 GLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH- 170
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
E +++ DLK N+LLD E K+ D+G+ + E + +T F G+ Y+ P
Sbjct: 171 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG---DTTSTFCGTPNYIAP 222
Query: 818 E 818
E
Sbjct: 223 E 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 35/184 (19%), Positives = 63/184 (34%), Gaps = 66/184 (35%)
Query: 663 FSHENL-----IGSGSFGSV----LHNERTGSWKS--------------------FIAEC 693
F + L +G G FG V K ++E
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 694 ETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------- 745
E ++ + +H+N++ L+ +C+ L ++ E+ S G+L +++ R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 746 -----------------LDITSALDYL--HNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+ ++YL +H DL N+L+ E K+ DF
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADF 247
Query: 787 GLAR 790
GLAR
Sbjct: 248 GLAR 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 41/183 (22%), Positives = 77/183 (42%), Gaps = 45/183 (24%)
Query: 668 LIGSGSFGSVL-----HNERTGSW-------KSFI-----------AECETLRNVRHRN- 703
++G+G++G V TG K+ I E + L ++R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYL 755
LV L + + L L+ ++++ G L + + I AL++L
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H ++ +++ D+K NILLD + DFGL++ E V +++ + F G+I Y+
Sbjct: 176 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYD--FCGTIEYM 227
Query: 816 PPE 818
P+
Sbjct: 228 APD 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 40/158 (25%), Positives = 54/158 (34%), Gaps = 41/158 (25%)
Query: 669 IGSGSFGSV---------------LHNERTGSWKSFIAECET-----------LRNVRHR 702
I SGS+G+V + N + I L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSAL 752
N++ L + M L LV E + L IH ++ + I L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVISPQHIQYFMYHILLGL 147
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
LH VVH DL PGNILL + + DF LAR
Sbjct: 148 HVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR 182
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 46/181 (25%)
Query: 668 LIGSGSFGSVLHNERTGSW---------KSFIAE--------CETLRNV-----RHRNLV 705
+IG GS+ VL + K + + E ++V H LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHVFEQASNHPFLV 73
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHN 757
L SC +S+ L V E+++ G L + +RK + I+ AL+YLH
Sbjct: 74 GLH-SCFQTESR----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH- 127
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
E +++ DLK N+LLD E K+ D+G+ + E + +T F G+ Y+ P
Sbjct: 128 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG---DTTSTFCGTPNYIAP 179
Query: 818 E 818
E
Sbjct: 180 E 180
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 32/170 (18%), Positives = 60/170 (35%), Gaps = 52/170 (30%)
Query: 669 IGSGSFGSVLHNERTGSWKS---------------------FIAECETLRNVRHRNLVKL 707
+G G+FG V E F E E L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------------- 745
C+ L +V+E++ +G L ++ +
Sbjct: 109 FGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 746 -LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794
+ + + YL + VH DL N L+ + + K+GDFG++R +
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 15/104 (14%)
Query: 696 LRNVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------L 746
L++++H N++ L T SSL N LV F+ L + + E
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLR--NFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVY 133
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ L Y+H+ VVH DLKPGN+ ++E+ K+ DFGLAR
Sbjct: 134 QMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 22/108 (20%)
Query: 696 LRNVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----- 747
L++++H N++ L T SL+ + LV + L + + + +L
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLE--EFNDVYLVTHLM-GADLNNIV---KCQKLTDDHVQ 135
Query: 748 -----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
I L Y+H+ ++H DLKP N+ ++E+ K+ DFGLAR
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 33/167 (19%), Positives = 55/167 (32%), Gaps = 50/167 (29%)
Query: 669 IGSGSFGSV----LHNERTGS------------------WKSFIAECETLRNVRHRNLVK 706
+G G+FG V + F+ E + H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------------LDITSA 751
I +++ ++ E ++ G L ++ R DI
Sbjct: 139 CIGVS----LQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 752 LDYL-HNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLARFLLE 794
YL N +H D+ N LL AK+GDFG+AR +
Sbjct: 194 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 19/165 (11%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGE 134
L+L S GL L+ L + L N+L L + +L L L ++ N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 135 LPVNI-SKLTELKMLDLMANKITG---RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIAN 190
LP+ + LT+L L L N++ V D L L+ L N L SIP
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD----RLTKLKELRLNTNQL-QSIPAGA-- 150
Query: 191 LIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235
+L NL+ L L+ N+L + L + L NQ
Sbjct: 151 -----FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 22/168 (13%)
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEI-- 413
KL L + A+ L LT L+L YN + + + L L LGLA N++
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS 97
Query: 414 -PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI---DLSNNRINGNIPKGI 469
P G+ + L L KL L GN+L + G F L + L+ N++ +IP G
Sbjct: 98 LPLGVFDHLTQLDKL---YLGGNQLKS---LPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQF 517
+L N+ T+ LS N L + L+ + + NQF
Sbjct: 151 FD-------KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 39/178 (21%), Positives = 65/178 (36%), Gaps = 24/178 (13%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI---PGGIPNSLANLK 425
+P+ I LDL ++ L L L L N++ G+ + L L
Sbjct: 29 VPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
L L+ N+L F + L + L N++ +P G+ RL +
Sbjct: 87 TLG---LANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFD-------RLTKLKE 135
Query: 486 IDLSDNSLSGNLPN----SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
+ L+ N L ++P L N L+ L ++ NQ L L+ + L N
Sbjct: 136 LRLNTNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 49/206 (23%), Positives = 73/206 (35%), Gaps = 45/206 (21%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
S+P I P+D +L DL LA +T +T L L L NQL +
Sbjct: 28 SVPSGI----PADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA 76
Query: 243 DVRDTLPNLLDFIYCF-NRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRT 301
V D L L + N+ G +LT + + + N L+ +LP G+
Sbjct: 77 GVFDDLTE-LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV-------- 126
Query: 302 YNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361
F+++ T L L L+ NQ + IP + L L L
Sbjct: 127 ----FDRL------------------TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163
Query: 362 GNHIYGKIPASIGRLRSLTLLDLSYN 387
N + + RL L + L N
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 41/191 (21%), Positives = 71/191 (37%), Gaps = 45/191 (23%)
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
+ L L + + L KL ++L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ------------------------- 72
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDN---SLSGNLPNSLKNCKSLEELLMAYNQFSGP 520
+ G+ L + T+ L++N SL + + L L++L + NQ
Sbjct: 73 TLSAGVF-------DDLTELGTLGLANNQLASLPLGVFDHLTQ---LDKLYLGGNQLKSL 122
Query: 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMS 579
+ L L+ L L++N+L SIP+ L L++L+L+ N L+ V G F +
Sbjct: 123 PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSV--PHGAFDRLG 179
Query: 580 N---VHLKGNP 587
+ L GN
Sbjct: 180 KLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 31/126 (24%), Positives = 53/126 (42%), Gaps = 17/126 (13%)
Query: 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI 524
+P GI P + +L DL L+ + + L L + YNQ +
Sbjct: 29 VPSGI----PADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNV-- 581
+L L L L++N+L+ S+P + +L L L L N L+ + G+F ++ +
Sbjct: 79 FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSL--PSGVFDRLTKLKE 135
Query: 582 -HLKGN 586
L N
Sbjct: 136 LRLNTN 141
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 39/167 (23%)
Query: 655 ELRRATGNFSHENLIGSGSFGSV------------------LHNE---RTGSWKSFIAEC 693
+++ + + +G G F +V L + + G ++ + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 694 ETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWI--HGERKNELDITS- 750
+ L+ + H N++ L+ + + ++LV++F+ L I + I +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSN-----ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY 117
Query: 751 ------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791
L+YLH ++H DLKP N+LLDE K+ DFGLA+
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 22/108 (20%)
Query: 696 LRNVRHRNLVKL---ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----- 747
L+++RH N++ L T +LD + LV F+ LG + + +L
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLD--DFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQ 131
Query: 748 -----ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ L Y+H ++H DLKPGN+ ++E+ K+ DFGLAR
Sbjct: 132 FLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 5/115 (4%)
Query: 326 NSTHLNYLALDGNQF-EGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDL 384
+ L LD + +GKI F N L L L + + +++ +L L L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVN-LEFLSLINVGL-ISV-SNLPKLPKLKKLEL 78
Query: 385 SYNSISGEIPIEIGQLQGLQVLGLAGNEIPG-GIPNSLANLKKLNQIDLSGNELT 438
S N I G + + +L L L L+GN++ L L+ L +DL E+T
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
+R L L D ++ G+I + L+ L L + + N L L KL +++LS N
Sbjct: 26 VRELVL-DNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSEN 81
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495
+ G + + +L ++LS N++ L PL +LE + ++DL + ++
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKD---ISTLEPL----KKLECLKSLDLFNCEVT- 133
Query: 496 NLPN----SLKNCKSLEEL 510
NL + K L L
Sbjct: 134 NLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 7/106 (6%)
Query: 76 LNLSSFGL-EGTISPHIGNLSFLRSIQLQNNKLS--GNLPREIGNLFRLRVLNISFNNLQ 132
L L + +G I L + L N L NLP L +L+ L +S N +
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIF 84
Query: 133 GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN 178
G L + KL L L+L NK+ T + L+ L L+ L+
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 21/119 (17%), Positives = 47/119 (39%), Gaps = 12/119 (10%)
Query: 423 NLKKLNQIDLSGNELT-GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLE 481
+ ++ L + G+I F +L + L N + + + +L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISV-----SNLPKLP 71
Query: 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP-IPNIVAELKGLEVLDLSSN 539
+ ++LS+N + G L + +L L ++ N+ + +L+ L+ LDL +
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 23/112 (20%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 479 RLENVVTIDLSDNSLS-GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLS 537
V + L + + G + +LE L + + N+ +L L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNL-PKLPKLKKLELS 79
Query: 538 SNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGI--FRNMSNVHLKGNP 587
N++ G + + L L LNL+ N L+ + E + + ++ L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 30/145 (20%), Positives = 53/145 (36%), Gaps = 19/145 (13%)
Query: 117 NLFRLRVLNISFNNLQ-GELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNF 175
+R L + G++ ++ L+ L L+ + + L L L+ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI---SVSNLPKLPKLKKLEL 78
Query: 176 GKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA--GTVPSTIYNMTSLVHLRLAS 233
+N I + +L NL L+L+ N+L T+ + + L L L +
Sbjct: 79 SEN--------RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFN 129
Query: 234 NQLGGEIPY--DVRDTLPNL--LDF 254
++ Y V LP L LD
Sbjct: 130 CEVTNLNDYRESVFKLLPQLTYLDG 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR 479
+K+ ++ + ++ + ++ + LS N I I +S
Sbjct: 21 VATEAEKV-ELHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKI---------SSLSG 68
Query: 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
+EN+ + L N + + N +LEEL ++YNQ + + I +L L VL +S+N
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI-EKLVNLRVLYMSNN 125
Query: 540 KLS--GSIPSDLQNLQALRSLNLTFN 563
K++ G I L L L L L N
Sbjct: 126 KITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 36/168 (21%), Positives = 73/168 (43%), Gaps = 25/168 (14%)
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIE-IGQLQGLQVLGLAGNE 412
E +L+ I K+ A++ L++ L LS N+I I + ++ L++L L N
Sbjct: 26 EKVELHGMIPPI-EKMDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNL 81
Query: 413 IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472
I I N A L ++ +S N++ + +L + +SNN+I I
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITN--WGEI--- 133
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLPNS----------LKNCKSLEEL 510
++++ L+ + + L+ N L + + +K +L++L
Sbjct: 134 --DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 35/167 (20%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+S+++ + ++G IP + + +S L+ + LS N++ + + L ++
Sbjct: 16 ERKSVVATEAEKVELHGMIPP--IEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMEN 71
Query: 507 LEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
L L + N I N+ A LE L +S N+++ S+ S ++ L LR L ++ N +
Sbjct: 72 LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
Query: 567 GVVPSEGI--FRNMSNVHLKGNPKLCLQLGCENPRSHGSRLIILSII 611
+ + + ++ L GNP EN + R+ ++ +
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGNP--LYNDYKENNATSEYRIEVVKRL 173
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 40/158 (25%), Positives = 60/158 (37%), Gaps = 26/158 (16%)
Query: 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNK-----------------LSGNLPRE 114
+ L+ +E + + L + + L N L NL ++
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKK 84
Query: 115 IGNLF----RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170
I NL L L IS+N + L I KL L++L + NKIT D+L L L
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 171 QVLNFGKNLLWGSIPP--SIANLIPSDLSRLENLKVLD 206
+ L N L+ + + + RL NLK LD
Sbjct: 143 EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 29/173 (16%)
Query: 99 SIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQG-ELPVNISKLTELKMLDLMANKITG 157
+ + + + L + L +S NN++ ++S + L++L L N I
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKIS---SLSGMENLRILSLGRNLIK- 83
Query: 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP 217
++ +L+ L N IA+L S + +L NL+VL ++ N++
Sbjct: 84 -KIENLDAVADTLEELWISYNQ--------IASL--SGIEKLVNLRVLYMSNNKITNWGE 132
Query: 218 -STIYNMTSLVHLRLASNQLGGEIPYD---------VRDTLPNL--LDFIYCF 258
+ + L L LA N L + + V LPNL LD +
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPVD 185
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/159 (19%), Positives = 53/159 (33%), Gaps = 42/159 (26%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLR---LASNQLGGEIPYDVRDTL 248
+ + LS L+ K L L+ N + I +++ + +LR L N +
Sbjct: 40 MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK----------- 83
Query: 249 PNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNK 308
KI ++ + +++N + +L G+ L LR + NK
Sbjct: 84 ---------------KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNK 126
Query: 309 IVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPES 347
I I L L L L GN E+
Sbjct: 127 I------TNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 35/184 (19%), Positives = 57/184 (30%), Gaps = 61/184 (33%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
+ N+ IG G+FG V G F E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 696 LRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYL 755
+ + N+VKL+ C+ + L++E+++ G L +++ + + S D
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 756 HNDCEVPV-----------------------------VHSDLKPGNILLDEEMTAKVGDF 786
VH DL N L+ E M K+ DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 787 GLAR 790
GL+R
Sbjct: 219 GLSR 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 36/145 (24%), Positives = 58/145 (40%), Gaps = 30/145 (20%)
Query: 669 IGSGSFGSV--LHNERTG-----------SWKSFIAECETLRNVR-HRNLVKLITSCSSL 714
+G G + V N K E + L N+R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103
Query: 715 DSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS-------ALDYLHNDCEVPVVHSD 767
S+ ALV+E ++N + + DI ALDY H + ++H D
Sbjct: 104 VSRT---PALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCH---SMGIMHRD 155
Query: 768 LKPGNILLD-EEMTAKVGDFGLARF 791
+KP N+++D E ++ D+GLA F
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEF 180
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 39/186 (20%), Positives = 69/186 (37%), Gaps = 57/186 (30%)
Query: 669 IGSGSFGSV---LHNERTGSWKSFIA----ECETLRNVRHRNLVKLITSCSSLDSKN--- 718
+G G++G V H +G +A + R L+ L S ++D
Sbjct: 15 LGRGAYGVVEKMRHV-PSGQ---IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 719 --------------MEFLALVYEFLSNGSLGD-----WIHGERKNE-------LDITSAL 752
ME + + SL G+ E + I AL
Sbjct: 71 FYGALFREGDVWICMELM--------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
++LH+ ++ V+H D+KP N+L++ K+ DFG++ +L ++ G
Sbjct: 123 EHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDI-DAGCK 173
Query: 813 GYVPPE 818
Y+ PE
Sbjct: 174 PYMAPE 179
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 39/172 (22%), Positives = 61/172 (35%), Gaps = 32/172 (18%)
Query: 669 IGSGSFGSV---LHNERTGSWKSF-IAECETLRNVRHRNLVKLITSCSSLDSKNM-EF-- 721
+GSG+ G V +TG + + R L+ L S D + +
Sbjct: 33 MGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 722 -------LALVYEFLSNGSLGDWIH-GERKNE-------LDITSALDYLHNDCEVPVVHS 766
+ + E + + E + I AL YL + V+H
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHR 149
Query: 767 DLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
D+KP NILLDE K+ DFG++ L+ + G Y+ PE
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV------DDKAKDR-SAGCAAYMAPE 194
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 21/103 (20%), Positives = 35/103 (33%), Gaps = 9/103 (8%)
Query: 134 ELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIP 193
+ ++ L L + + + LR L L+ L K+ L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA----- 75
Query: 194 SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
L L+L+ N L ++ SL L L+ N L
Sbjct: 76 --FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 19/97 (19%), Positives = 34/97 (35%), Gaps = 2/97 (2%)
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPN-SLKNCKSLEELLMAYNQFSGPIPNIVAEL 528
+ EN+ + + + +L L+ L L + + P+
Sbjct: 20 ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79
Query: 529 KGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
L L+LS N L S+ +L+ L L+ N L
Sbjct: 80 PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 17/95 (17%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIE-IGQLQGLQVLGLAGNEIPGGIPNSLANLKKL 427
+ +LT L + + + + L L+ L + + + P++ +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
++++LS N L + SL + LS N ++
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 18/102 (17%), Positives = 36/102 (35%), Gaps = 8/102 (7%)
Query: 440 EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPN 499
+ ++L + + N + ++ LR L + + + + L P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG-------ELRNLTIVKSGLRFVAPD 74
Query: 500 SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541
+ L L +++N V L L+ L LS N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 17/88 (19%), Positives = 27/88 (30%), Gaps = 8/88 (9%)
Query: 162 DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY 221
L +L L + +L DL L L+ L + + L P +
Sbjct: 25 HHLPGAENLTELYIENQ-------QHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH 77
Query: 222 NMTSLVHLRLASNQLGGEIPYDVRDTLP 249
L L L+ N L + + L
Sbjct: 78 FTPRLSRLNLSFNAL-ESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 21/112 (18%), Positives = 36/112 (32%), Gaps = 10/112 (8%)
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG-LGNLPFLRTYNIGFNKIVSSG 313
+ C L N+ + + + L L L LR I + +
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 314 DDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHI 365
D + + L+ L L N E +++ S L +L L GN +
Sbjct: 73 PD-------AFHFTPRLSRLNLSFNALESLSWKTVQGLS--LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 12/85 (14%), Positives = 25/85 (29%), Gaps = 1/85 (1%)
Query: 209 INRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGS 268
A + +L L + + Q + L L + + P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 269 LHNLTNIQIIRMTHNLLEGTLPPGL 293
H + + ++ N LE +L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKT 99
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 33/174 (18%), Positives = 63/174 (36%), Gaps = 43/174 (24%)
Query: 663 FSHENLIGSGSFGSVL--HNERTGS---------WKSFIA-----ECETLRNVRHRNLVK 706
+ +G G G V + E + +R + H N+VK
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 707 LI---------TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD---------- 747
+ + + + +V E++ L + + + L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQ 128
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERVDNQS 800
+ L Y+H+ V+H DLKP N+ ++ E++ K+GDFGLAR + ++
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 15/110 (13%)
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIG---QLQGLQVLGLAGNE- 412
+LYL GN +P + + LTL+DLS N IS + + L L L+ N
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS---TLSNQSFSNMTQLLTLILSYNRL 90
Query: 413 --IPGGIPNSLANLKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSNN 459
IP + L +L+ L L GN+++ +P +F + +L + + N
Sbjct: 91 RCIPPRTFDGLKSLRLL---SLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 18/127 (14%)
Query: 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNI 524
+PKGI P +++ L L N + +P L N K L + ++ N+ S
Sbjct: 25 LPKGI----PRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS 73
Query: 525 VAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN--- 580
+ + L L LS N+L IP L++LR L+L N++ VVP EG F ++S
Sbjct: 74 FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP-EGAFNDLSALSH 130
Query: 581 VHLKGNP 587
+ + NP
Sbjct: 131 LAIGANP 137
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 29/116 (25%), Positives = 53/116 (45%), Gaps = 12/116 (10%)
Query: 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181
L + N +P +S L ++DL N+I+ +++ N+ L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL- 90
Query: 182 GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY-NMTSLVHLRLASNQL 236
IPP L++L++L L N ++ VP + ++++L HL + +N L
Sbjct: 91 RCIPPRT-------FDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 42/187 (22%), Positives = 66/187 (35%), Gaps = 58/187 (31%)
Query: 669 IGSGSFGSV---LHNERTGSWKSFIA----ECETLRNVRHRNLVKLITSCSSLDSKN--- 718
IG G++GSV +H +G +A + + L+ L S D
Sbjct: 30 IGRGAYGSVNKMVHK-PSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 719 --------------MEFLALVYEFLSNGSLGD------WIHGERKNE-------LDITSA 751
ME ++ S + + E L A
Sbjct: 86 FYGALFREGDCWICMELMS--------TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L++L + ++ +H D+KP NILLD K+ DFG++ L SI+ T G
Sbjct: 138 LNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTR-DAGC 188
Query: 812 IGYVPPE 818
Y+ PE
Sbjct: 189 RPYMAPE 195
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 20/143 (13%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKIT 156
+ + L +N+++ P +L L+ L + N L LPV + LT+L +LDL N++T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 157 G---RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213
V D L L+ L N L +P I RL +L L L N+L
Sbjct: 102 VLPSAVFD----RLVHLKELFMCCNKL-TELPRGI--------ERLTHLTHLALDQNQLK 148
Query: 214 GTVPSTIY-NMTSLVHLRLASNQ 235
++P + ++SL H L N
Sbjct: 149 -SIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 29/133 (21%), Positives = 47/133 (35%), Gaps = 28/133 (21%)
Query: 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSY 386
+L L L NQ +P + + +L+ L LG N + +P+++ RL L L +
Sbjct: 64 INLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCC 121
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
N +L +P + L L + L N+L +F
Sbjct: 122 N-----------KLTE--------------LPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 447 NFQSLLSIDLSNN 459
SL L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 17/145 (11%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI---PGGIPNSLANLK 425
+PA I + +L L N I+ P L L+ L L N++ P G+ +SL L
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
L+ L N+LT F L + + N+ L LP I RL ++
Sbjct: 92 VLD---LGTNQLTVLPSAVFDRLVHLKELFMCCNK---------LTELPRGIERLTHLTH 139
Query: 486 IDLSDNSLSGNLPNSLKNCKSLEEL 510
+ L N L + SL
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 42/178 (23%), Positives = 67/178 (37%), Gaps = 44/178 (24%)
Query: 413 IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472
+P GIP + L L N++T P F + +L + L +N+ L
Sbjct: 34 VPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQ---------LGA 78
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLE 532
LP + +SL L L + NQ + + L L+
Sbjct: 79 LPVGV--------------------FDSLTQ---LTVLDLGTNQLTVLPSAVFDRLVHLK 115
Query: 533 VLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSN---VHLKGNP 587
L + NKL+ +P ++ L L L L N L+ + G F +S+ +L GNP
Sbjct: 116 ELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI--PHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 12/129 (9%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
S+P I P++ ++L L N++ P ++ +L L L SNQL G +P
Sbjct: 33 SVPAGI----PTNA------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPV 81
Query: 243 DVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTY 302
V D+L L N+ T L +++ + M N L LP G+ L L
Sbjct: 82 GVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140
Query: 303 NIGFNKIVS 311
+ N++ S
Sbjct: 141 ALDQNQLKS 149
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 43/153 (28%)
Query: 669 IGSGSFGSVL--HNERTGS-------WKSFIAECETLRNVR----------HRNLVKLIT 709
+G G++G V + RTG + +F + R R H N+V L+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL- 75
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLH--N 757
+ L + N + LV++++ L I N L+ + + YLH
Sbjct: 76 --NVLRADNDRDVYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
++H D+KP NILL+ E KV DFGL+R
Sbjct: 130 -----LLHRDMKPSNILLNAECHVKVADFGLSR 157
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 41/211 (19%), Positives = 72/211 (34%), Gaps = 65/211 (30%)
Query: 668 LIGSGSFGSVL--HNERTGSW-------------KSFIAECETLRNVR-----------H 701
+G G F +V + + ++ E + L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 702 RNLVKLITSCSSLDS-----KNMEFLALVYEFLSNGSLGDWIHGERKNELDIT------- 749
+++KL LD N + +V+E L +L I + +
Sbjct: 86 NHILKL------LDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISK 138
Query: 750 ---SALDYLHNDCEVPVVHSDLKPGNILLDEE------MTAKVGDFGLARFLLERVDNQS 800
LDY+H C + +H+D+KP N+L++ + K+ D G A + E +
Sbjct: 139 QLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TN 194
Query: 801 SISSTHVFMGSIGYVPPEYGLGERPSTAGDV 831
SI + Y PE LG D+
Sbjct: 195 SIQTRE-------YRSPEVLLGAPWGCGADI 218
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 41/143 (28%), Positives = 60/143 (41%), Gaps = 19/143 (13%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLMANKIT 156
+ L+ N L L L L + N LQ LP + +KLT L L+L N++
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 157 G---RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213
V D L L+ L N L S+P + +L LK L L N+L
Sbjct: 90 SLPNGVFD----KLTQLKELALNTNQL-QSLPDGV-------FDKLTQLKDLRLYQNQLK 137
Query: 214 GTVPSTIY-NMTSLVHLRLASNQ 235
+VP ++ +TSL ++ L N
Sbjct: 138 -SVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 18/140 (12%)
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEI-- 413
L L N + L SLT L L N + +P + +L L L L+ N++
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 414 -PGGIPNSLANLKKLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSNNRINGNIPKGILR 471
P G+ + L LK+L L+ N+L +P F L + L N++ ++P G+
Sbjct: 91 LPNGVFDKLTQLKEL---ALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF- 144
Query: 472 PLPEEISRLENVVTIDLSDN 491
RL ++ I L DN
Sbjct: 145 ------DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 41/139 (29%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181
L++ N+L+ +LT L L L NK+ + + L SL LN N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL- 88
Query: 182 GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYN-MTSLVHLRLASNQLGGEI 240
S+P + +L LK L L N+L ++P +++ +T L LRL NQL +
Sbjct: 89 QSLPNGV-------FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-V 139
Query: 241 PYDVRDTLPNLLDFIYCFN 259
P V D L +L I+ +
Sbjct: 140 PDGVFDRLTSLQY-IWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 41/181 (22%), Positives = 65/181 (35%), Gaps = 43/181 (23%)
Query: 183 SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242
S+P I P+ LDL N L +TSL L L N+L +P
Sbjct: 21 SVPTGI----PAQT------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPN 69
Query: 243 DVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTY 302
V + L +L N+ G LT ++ + + N L+ +LP G+
Sbjct: 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGV--------- 119
Query: 303 NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGG 362
F+K+ T L L L NQ + +P+ + + L ++L
Sbjct: 120 ---FDKL------------------TQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHD 157
Query: 363 N 363
N
Sbjct: 158 N 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 16/128 (12%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI---PGGIPNSLANLK 425
+P I T LDL NS+ +L L L L GN++ P G+ N L +L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
LN LS N+L F L + L+ N++ ++P G+ +L +
Sbjct: 80 YLN---LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVF-------DKLTQLKD 128
Query: 486 IDLSDNSL 493
+ L N L
Sbjct: 129 LRLYQNQL 136
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 31/186 (16%)
Query: 317 GLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN--ELSKLYLGGNHIYGKIPASIG 374
++ + ++ + + + + S+ + L LGGN + I
Sbjct: 30 SVTDAVTQNELNSIDQIIANNSDIK-----SVQGIQYLPNVRYLALGGNKL-----HDIS 79
Query: 375 ---RLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEI---PGGIPNSLANLKKL 427
L +LT L L+ N + +P + +L L+ L L N++ P G+ + L NL L
Sbjct: 80 ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487
+L+ N+L F +L +DLS N++ ++P+G+ +L + +
Sbjct: 139 ---NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF-------DKLTQLKDLR 187
Query: 488 LSDNSL 493
L N L
Sbjct: 188 LYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 56/269 (20%), Positives = 98/269 (36%), Gaps = 78/269 (28%)
Query: 98 RSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITG 157
L+ ++ + + L + + + ++++ + I L ++ L L NK+
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH- 76
Query: 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP 217
+ L L NL L LT N+L ++P
Sbjct: 77 -----------DISALK-----------------------ELTNLTYLILTGNQLQ-SLP 101
Query: 218 STIYN-MTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQ 276
+ +++ +T+L L L NQL +P V D L NL N+ G LTN+
Sbjct: 102 NGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160
Query: 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALD 336
+ +++N L+ +LP G+ F+K LT L L L
Sbjct: 161 ELDLSYNQLQ-SLPEGV------------FDK---------------LTQ---LKDLRLY 189
Query: 337 GNQFEGKIPESIGNFSN--ELSKLYLGGN 363
NQ + +P+ G F L ++L N
Sbjct: 190 QNQLKS-VPD--GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 21/149 (14%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREI-GNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDL 150
L+ L + L N+L +LP + L L+ L + N LQ LP + KLT L L+L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 151 MANKITG---RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL 207
N++ V D L +L L+ N L S+P + + +L LK L L
Sbjct: 141 AHNQLQSLPKGVFD----KLTNLTELDLSYNQL-QSLPEGVFD-------KLTQLKDLRL 188
Query: 208 TINRLAGTVPSTIY-NMTSLVHLRLASNQ 235
N+L +VP ++ +TSL ++ L N
Sbjct: 189 YQNQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 28/166 (16%)
Query: 413 IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472
P +L +T + + S+ I +N+ ++
Sbjct: 13 FPDDAFAETIKA------NLKKKSVT-DAV-TQNELNSIDQIIANNSD---------IKS 55
Query: 473 LPEEISRLENVVTIDLSDNSLSGNLP--NSLKNCKSLEELLMAYNQFSGPIPNIVAELKG 530
+ I L NV + L N L ++ L N L L++ NQ + +L
Sbjct: 56 VQG-IQYLPNVRYLALGGNKLH-DISALKELTN---LTYLILTGNQLQSLPNGVFDKLTN 110
Query: 531 LEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIF 575
L+ L L N+L S+P + L L LNL N L+ + G+F
Sbjct: 111 LKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPK--GVF 153
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/311 (12%), Positives = 92/311 (29%), Gaps = 69/311 (22%)
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGK----IPESIGNFSNE 354
L N+ ++ + + + L L N + + + + + +
Sbjct: 103 LDEVNLASCQL---DPAGLRTLLPVFLRARKLG---LQLNSLGPEACKDLRDLLLHDQCQ 156
Query: 355 LSKLYLGGNHIYGK----IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410
++ L L N + + + S+T L L + + E GL++L
Sbjct: 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE---------GLELLAAQ- 206
Query: 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNF----QSLLSIDLSNNRINGNIP 466
L ++L +++++ N ++ SL + L N ++
Sbjct: 207 ----------LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS---S 253
Query: 467 KGILRPLPEEISRLENVVTIDLSDNSLSGN-------LPNSLKNCKSLEELLMAYNQFSG 519
+G + L + E + +S + L +N S + + +
Sbjct: 254 EGR-QVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH---- 308
Query: 520 PIPNIVAELKGLEVLDLSSNKLS----GSIPSDLQNLQALRSLNLTFNNL---EGVVPSE 572
L + DL ++ + L+ +R+L + G
Sbjct: 309 ---------LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWSHP 359
Query: 573 GIFRNMSNVHL 583
+ + H
Sbjct: 360 QFEKGAGHHHH 370
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 41/216 (18%), Positives = 75/216 (34%), Gaps = 30/216 (13%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQL-----QGLQVLGLAGNEI-PGGIPNSLANLKKLNQ 429
L SL L+L+ ++ + + L + LA ++ P G+ L + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 430 IDLSGNELTGE--IPISFG---NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484
+ L N L E + + + ++ LSNN + G+ L E ++ +V
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT---AAGV-AVLMEGLAGNTSVT 186
Query: 485 TIDLSDNSLSGN----LPNSLKNCKSLEELLMAYNQFSGPIPNIVAEL----KGLEVLDL 536
+ L L L L + L+EL +AYN +A LE+L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246
Query: 537 SSNKLS-------GSIPSDLQNLQALRSLNLTFNNL 565
N+LS + + + +
Sbjct: 247 YFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV 282
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 18/229 (7%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQ-LQGLQVLGL 408
+F++ G ++Y I A L + L ++ + I + + +VL L
Sbjct: 78 HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137
Query: 409 AGNEI--PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNF----QSLLSIDLSNNRIN 462
+ E G+ A + L ++DL +++ +F SL+S+++S +
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LA 195
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY------NQ 516
+ L L ++R N+ ++ L+ L L+ LEEL
Sbjct: 196 SEVSFSALERL---VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPD 252
Query: 517 FSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565
+ ++ K L L + + +P+ L +LNL++ +
Sbjct: 253 VYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 37/247 (14%), Positives = 84/247 (34%), Gaps = 13/247 (5%)
Query: 325 TNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGR-LRSLTLLD 383
+ N + + E++ + L ++ L + I + ++ +L
Sbjct: 77 PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV 136
Query: 384 LSY-NSISGEIPIEIGQ-LQGLQVLGLAGNEIPGGIPNSLA----NLKKLNQIDLSG--N 435
LS S + I + L+ L L +++ + L+ L +++S +
Sbjct: 137 LSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLAS 196
Query: 436 ELTGEIPISFG-NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
E++ +L S+ L+ + +L+ P+ + L +
Sbjct: 197 EVSFSALERLVTRCPNLKSLKLNRAVPLEKL-ATLLQRAPQ-LEELGTGGYTAEVRPDVY 254
Query: 495 GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG-SIPSDLQNLQ 553
L +L CK L L ++ +P + + L L+LS + + L
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP 314
Query: 554 ALRSLNL 560
L+ L +
Sbjct: 315 KLQRLWV 321
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 81/527 (15%), Positives = 168/527 (31%), Gaps = 78/527 (14%)
Query: 76 LNLSSFGLEGTISPHIGNLS----FLRSIQLQNNKLSGNLPREIGNLF-RLRVLNISFNN 130
NL G G + P I +S +L I+L+ ++ + I F +VL +S
Sbjct: 82 FNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141
Query: 131 LQGELPVN--ISKLTELKMLDLMANKITGRVTDDQL----RNLRSLQVLNFG-------- 176
+ + LK LDL + + V+ L SL LN
Sbjct: 142 GFSTDGLAAIAATCRNLKELDLRESDVD-DVSGHWLSHFPDTYTSLVSLNISCLASEVSF 200
Query: 177 ----------KNL----LWGSIPPSIANLIPSDLSRLENLKV---LDLTINRLAGTVPST 219
NL L ++P + +LE L + +
Sbjct: 201 SALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260
Query: 220 IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL--LDFIYCFNRFTGKIPGSLHNLTNIQI 277
+ L L + + +P V L L+ Y + + + L +Q
Sbjct: 261 LSGCKELRCLSGFWDAVPAYLPA-VYSVCSRLTTLNLSYATVQ-SYDLVKLLCQCPKLQR 318
Query: 278 IRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD-----DEGLSFITSLTNSTHLNY 332
+ + + + L LR + ++ ++GL + L
Sbjct: 319 LWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV--SMGCPKLES 376
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK-----------IPASIGRLRSLTL 381
+ Q +I +++ L A + + L
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRR 436
Query: 382 LDLSYNSISGEIPIEIGQ-LQGLQVLGLAGNEIPG-GIPNSLANLKKLNQIDLSGNELTG 439
L LS ++ ++ IG + +++L +A G+ + L+ L ++++
Sbjct: 437 LSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495
Query: 440 E-IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP 498
+ + + +++ S+ +S+ ++ K + + +P +L NV ID P
Sbjct: 496 KALLANASKLETMRSLWMSSCSVSFGACKLLGQKMP----KL-NVEVIDERG------AP 544
Query: 499 NSLKNCKSLEELLMAYNQFSGP---IPNIVAELKGLEVLDLSSNKLS 542
+S +E + Y +GP +P V + + S ++
Sbjct: 545 DSRPESCPVERVF-IYRTVAGPRFDMPGFVWNMDQDSTMRFSRQIIT 590
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 36/295 (12%), Positives = 86/295 (29%), Gaps = 38/295 (12%)
Query: 295 NLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNE 354
L+ ++ + + F + T+ LN ++ ++ E +
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN-ISCLASEVSFSALERLVTRCPN 212
Query: 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE------IPIEIGQLQGLQVLGL 408
L L L K+ + R L L + + + + + L+ L
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272
Query: 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISF-GNFQSLLSIDLSNNRINGNIPK 467
+ +P +P + +L ++LS + + L + + + +
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED----- 327
Query: 468 GILRPLPEEISRLENVVTIDLSDNSLSGNLPNS----------LKNCKSLEELLMAYNQF 517
L S +++ + + + PN C LE +L Q
Sbjct: 328 ---AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM 384
Query: 518 SGP-IPNIVAELKGLEVLDLSSNKLSG-----------SIPSDLQNLQALRSLNL 560
+ + I + L + + +++ + LR L+L
Sbjct: 385 TNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL 439
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.3 bits (124), Expect = 4e-07
Identities = 31/212 (14%), Positives = 68/212 (32%), Gaps = 22/212 (10%)
Query: 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREI 115
+ + +G+ S+ + +SP + + L +++++ NL
Sbjct: 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGK 189
Query: 116 GNLFRLRVLNISFNNLQGELPVNI--SKLTELKMLDL--MANKITGRVTDDQL------R 165
L+ L I L + +I S L L+ L L +
Sbjct: 190 KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD 249
Query: 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL----AGTVPSTIY 221
+L+ L + L L+ +D++ L A + +
Sbjct: 250 RFPNLKWLGIVDAEEQNVVVEMFLES-----DILPQLETMDISAGVLTDEGARLLLDHVD 304
Query: 222 NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253
+ L + + N L E+ +++ +LP +D
Sbjct: 305 KIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 8e-07
Identities = 29/203 (14%), Positives = 68/203 (33%), Gaps = 22/203 (10%)
Query: 375 RLRSLTLLDLSYN------SISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
L D+ + ++ + + L L + G NLK L
Sbjct: 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL- 198
Query: 429 QIDLSGNELTGEIP--ISFGNFQSL--LSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484
++ L + I + +L L + + + + RPL + R N+
Sbjct: 199 --EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK-DRFPNLK 255
Query: 485 TIDLSDNSLSGNLPNSL---KNCKSLEELLMAYNQFSG----PIPNIVAELKGLEVLDLS 537
+ + D + LE + ++ + + + V ++K L+ +++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 538 SNKLSGSIPSDL-QNLQALRSLN 559
N LS + +L ++L ++
Sbjct: 316 YNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 25/149 (16%), Positives = 51/149 (34%), Gaps = 18/149 (12%)
Query: 352 SNELSKLYLGGNHIYGKIPASIG--RLRSLTLLDLSYNS--ISGEIPIEI-------GQL 400
L L + + + I L +L L L + + + +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 401 QGLQVLGLAGNEIPGGIPNSLAN---LKKLNQIDLSGNELTGE----IPISFGNFQSLLS 453
L+ LG+ E + L +L +D+S LT E + + L
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 454 IDLSNNRINGNIPKGILRPLPEEISRLEN 482
I++ N ++ + K + + LP +I ++
Sbjct: 312 INMKYNYLSDEMKKELQKSLPMKIDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 32/236 (13%), Positives = 69/236 (29%), Gaps = 25/236 (10%)
Query: 165 RNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMT 224
+ L SL+ + G G IA+ I + + + + L S I +
Sbjct: 104 KKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVD 163
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL 284
L +P L + NL +++II
Sbjct: 164 LSPVLD----------------AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEII-SGGLP 206
Query: 285 LEGTLPPGLGNLPFLRTYNIGFNKIVSSGDD--EGLSFITSLTNSTHLNYLALDGNQFEG 342
+LP L + D + S +L +L + + +
Sbjct: 207 DSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266
Query: 343 KIPESIGNFS--NELSKLYLGGNHIYGK----IPASIGRLRSLTLLDLSYNSISGE 392
+ E +L + + + + + + +++ L +++ YN +S E
Sbjct: 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 15/116 (12%), Positives = 33/116 (28%), Gaps = 16/116 (13%)
Query: 689 FIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA-LVYEFLSNGSLGDWIHG----ERK 743
++ L + + ++ LD + +V E++ GSL +
Sbjct: 78 TLSRTLRLSRIDKPGVARV------LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA 131
Query: 744 NEL--DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797
+ +A D H V S P + + + + + D
Sbjct: 132 IRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDD 184
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 45/194 (23%)
Query: 668 LIGSGSFGSVL--HNERTGSW---------KSF----IAECETLRNVRHR------NLVK 706
+IG GSFG V+ ++ + K F E L ++R + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 707 LITSCSSLDSKN-----MEFLAL-VYEFL-SNGSLGDWIHGERKNELDITSALDYLHNDC 759
++ + +N E L++ +YE + N G + RK I LD LH
Sbjct: 164 ML---ENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 760 EVPVVHSDLKPGNILLDEEMTA--KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+ ++H DLKP NILL ++ + KV DFG + + +RV + I S Y P
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRF-------YRAP 268
Query: 818 EYGLGERPSTAGDV 831
E LG R D+
Sbjct: 269 EVILGARYGMPIDM 282
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 78/516 (15%), Positives = 161/516 (31%), Gaps = 63/516 (12%)
Query: 77 NLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL--QGE 134
NL S L+G P + + ++ + NL +L+ ++ +
Sbjct: 74 NLRSLKLKG--KPRAAMFNLIPENWGGY--VTPWVTEISNNLRQLKSVHFRRMIVSDLDL 129
Query: 135 LPVNISKLTELKMLDLMANKITGRVTDDQL----RNLRSLQVLNFGKNLLWGSIPPSIAN 190
+ ++ +L+ L L T D L + R ++ L ++ +
Sbjct: 130 DRLAKARADDLETLKLDKCS---GFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHE 186
Query: 191 LIPSDLSRLENLKVLDLTINRLAG----TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRD 246
L +L+VL+ + A + + N SLV +++ ++ +
Sbjct: 187 L----AQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV--GFFK 240
Query: 247 TLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMT--HNLLEGTLPPGLGNLPFLRTYNI 304
NL +F +P NL + + + +P +R ++
Sbjct: 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDL 300
Query: 305 GFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNH 364
+ + ++ + I N L L N + E + + +L +L +
Sbjct: 301 LYALLE---TEDHCTLIQKCPN---LEVLET-RNVIGDRGLEVLAQYCKQLKRLRIERGA 353
Query: 365 IYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI----PGGIPNS 420
+ G + L+ L+ Q L+ + + ++I I
Sbjct: 354 DEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITNESLESIGTY 401
Query: 421 LANLKKLNQIDLSGNELTGEIPISFG------NFQSLLSIDLSNNRINGNIPKGILRPLP 474
L NL + L E ++P+ G + L G + L +
Sbjct: 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--QGGLTDLGLSYIG 459
Query: 475 EEISRLENVVTIDLSDNSLSGN-LPNSLKNCKSLEELLMAYNQFSGP-IPNIVAELKGLE 532
+ + + L S L + C +L++L M FS I V +L L
Sbjct: 460 QYSPNVR---WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516
Query: 533 VLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568
L + + S + +Q A N+ V
Sbjct: 517 YLWVQGYRASMTGQDLMQ--MARPYWNIELIPSRRV 550
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 26/129 (20%)
Query: 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSIS 390
L L+ N+ + + L KL L N + I + + L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGEN--- 88
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450
+++ EI + L LK L +L N+++ +P SF + S
Sbjct: 89 --------KIK----------EISNKMFLGLHQLKTL---NLYDNQISCVMPGSFEHLNS 127
Query: 451 LLSIDLSNN 459
L S++L++N
Sbjct: 128 LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 34/128 (26%), Positives = 55/128 (42%), Gaps = 18/128 (14%)
Query: 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSL-KNCKSLEELLMAYNQFSGPIPN 523
IP+ I P + L L+DN L + L L +L + NQ +G PN
Sbjct: 23 IPRDI----PLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 524 IVAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN-- 580
++ L L NK+ I + + L L++LNL N + V G F ++++
Sbjct: 73 AFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCV--MPGSFEHLNSLT 129
Query: 581 -VHLKGNP 587
++L NP
Sbjct: 130 SLNLASNP 137
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 13/117 (11%)
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSD 195
P +I T L L N++ +D L L L +N L I P+
Sbjct: 24 PRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNA------- 73
Query: 196 LSRLENLKVLDLTINRLAGTVPSTIYN-MTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+++ L L N++ + + ++ + L L L NQ+ + + L +L
Sbjct: 74 FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 93 NLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151
L L ++L+ N+L+G P ++ L + N ++ E+ + L +LK L+L
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110
Query: 152 ANKITGRVTDDQLRNLRSLQVLNFGKN 178
N+I+ V +L SL LN N
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 51/195 (26%), Positives = 77/195 (39%), Gaps = 43/195 (22%)
Query: 667 NLIGSGSFGSVL--HNERTGSW---------KSF----IAECETLRNVRHR------NLV 705
+LIG GSFG V+ ++ W K+F E L + +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 706 KLITSCSSLDSKN-----MEFLAL-VYEFL-SNGSLGDWIHGERKNELDITSALDYLHND 758
L +N E L+ +Y+ L + G ++ RK + +AL +L
Sbjct: 120 HLK---RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 759 CEVPVVHSDLKPGNILLDEEMTA--KVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
E+ ++H DLKP NILL + K+ DFG + L +R+ I S Y
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRF-------YRS 226
Query: 817 PEYGLGERPSTAGDV 831
PE LG A D+
Sbjct: 227 PEVLLGMPYDLAIDM 241
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 36/215 (16%), Positives = 79/215 (36%), Gaps = 16/215 (7%)
Query: 356 SKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI-P 414
L L G +++ + + + + + + + + +Q + L+ + I
Sbjct: 50 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 107
Query: 415 GGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLP 474
+ L+ KL + L G L+ I + +L+ ++LS + L+ L
Sbjct: 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---GFSEFALQTLL 164
Query: 475 EEISRLENVV---TIDLSDNSLSGNLPNSLKNCKSLEEL-LMAYNQF--SGPIPNIVAEL 528
SRL+ + D ++ + + +++ +L L Y + + +V
Sbjct: 165 SSCSRLDELNLSWCFDFTEKHVQVAVA---HVSETITQLNLSGYRKNLQKSDLSTLVRRC 221
Query: 529 KGLEVLDLSS-NKLSGSIPSDLQNLQALRSLNLTF 562
L LDLS L + L L+ L+L+
Sbjct: 222 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 3/45 (6%)
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790
+ +++L +H DL NILL E+ K+ DFGLAR
Sbjct: 200 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 29/159 (18%), Positives = 57/159 (35%), Gaps = 33/159 (20%)
Query: 663 FSHENL-----IGSGSFGSVLHNERTGSWKS----------------------FIAECET 695
F + L +G G+FG V+ + G K+ ++E +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 696 LRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-ITSALD 753
L ++ H N+V L+ +C+ M ++ EF G+L ++ +R + T
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ V + DLK + ++ F + L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 34/129 (26%), Positives = 52/129 (40%), Gaps = 27/129 (20%)
Query: 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSIS 390
L L+ N+ + +P + + +L+KL L N I +P + +L LT+L L N
Sbjct: 32 RLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHEN--- 86
Query: 391 GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450
+LQ +P G+ + L LK+L L N+L F S
Sbjct: 87 --------KLQ----------SLPNGVFDKLTQLKEL---ALDTNQLKSVPDGIFDRLTS 125
Query: 451 LLSIDLSNN 459
L I L N
Sbjct: 126 LQKIWLHTN 134
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 32/151 (21%), Positives = 50/151 (33%), Gaps = 21/151 (13%)
Query: 724 LVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDCEVPVVHSDLKPGNI 773
+V+E L + L WI L + LDYLH C + +H+D+KP NI
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI--IHTDIKPENI 178
Query: 774 LLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT 833
LL V + + R E + Q S + P +
Sbjct: 179 LL------SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232
Query: 834 SESFAGEFNIVKWVESNLPENV--LQVLDPE 862
+ + WV + E++ Q E
Sbjct: 233 LKVKIADLGNACWVHKHFTEDIQTRQYRSLE 263
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 929 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.98 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.98 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.98 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.31 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.28 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.47 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.72 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.68 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.58 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.38 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.79 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 93.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.49 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.6 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 80.71 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-80 Score=759.83 Aligned_cols=563 Identities=33% Similarity=0.517 Sum_probs=430.9
Q ss_pred CCCcCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCcceeeCCCCCcEEEEEcCCCCCccc---cC---------
Q 002376 21 SASVGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGT---IS--------- 88 (929)
Q Consensus 21 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---i~--------- 88 (929)
+++++.++||+|||+||+++. | |. .+++|+.+.+||+|.||+|+ ++||+.|||+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~-~-~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLP-D-KN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCS-C-TT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred ccccCCHHHHHHHHHHHhhCC-C-cc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 345557899999999999997 3 56 89999988899999999999 57999999999999987 44
Q ss_pred --------------CCCCCCCCCCEEEeecCCCCCCCCc--CCCCCCCCcEEeCCCCCCCCCccccc-ccccccceeccc
Q 002376 89 --------------PHIGNLSFLRSIQLQNNKLSGNLPR--EIGNLFRLRVLNISFNNLQGELPVNI-SKLTELKMLDLM 151 (929)
Q Consensus 89 --------------~~l~~L~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls 151 (929)
+.|+.+++|++|||++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|||+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 5777888889999999888888877 77777777777777777766665543 333333333333
Q ss_pred ccccC-------------------------------------------------CCCChhhhccCCCCcEEEccccccCC
Q 002376 152 ANKIT-------------------------------------------------GRVTDDQLRNLRSLQVLNFGKNLLWG 182 (929)
Q Consensus 152 ~N~l~-------------------------------------------------~~i~~~~~~~l~~L~~L~Ls~N~l~~ 182 (929)
+|+++ +.+|. ++++++|++|+|++|++++
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~ 237 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSG 237 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCS
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCC
Confidence 33333 22221 3334444444444444433
Q ss_pred CCCccccc--------------------------------------cCCCccCCC-CcccEEEeecccCCCccCCccccC
Q 002376 183 SIPPSIAN--------------------------------------LIPSDLSRL-ENLKVLDLTINRLAGTVPSTIYNM 223 (929)
Q Consensus 183 ~~p~~i~~--------------------------------------l~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l 223 (929)
.+|..+.. .+|..+..+ ++|++|+|++|++++..|..|.++
T Consensus 238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l 317 (768)
T 3rgz_A 238 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317 (768)
T ss_dssp CHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred cccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence 33322211 122333222 444444444444444444445555
Q ss_pred CCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccc-cccEEeccCccCcCCccCCCCC--CCccc
Q 002376 224 TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLT-NIQIIRMTHNLLEGTLPPGLGN--LPFLR 300 (929)
Q Consensus 224 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~ 300 (929)
++|++|+|++|+++|.+|...+..+++|++|++++|++++.+|..+.++. +|+.|++++|.+++.+|..+.. +++|+
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 55555555555554445544333355555555555555555555555554 5555555555555555555444 55555
Q ss_pred eeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCccc
Q 002376 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT 380 (929)
Q Consensus 301 ~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 380 (929)
+|++++|++... .+..+.++++|++|+|++|++++.+|..++.++ +|+.|+|++|++++.+|..++.+++|+
T Consensus 398 ~L~L~~n~l~~~-------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~ 469 (768)
T 3rgz_A 398 ELYLQNNGFTGK-------IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLE 469 (768)
T ss_dssp EEECCSSEEEEE-------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred EEECCCCccccc-------cCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCce
Confidence 555555555432 235688899999999999999999999999987 799999999999999999999999999
Q ss_pred EEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCc
Q 002376 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNR 460 (929)
Q Consensus 381 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 460 (929)
+|+|++|++++.+|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..+.++++|+.|++++|+
T Consensus 470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 549 (768)
T 3rgz_A 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSE
T ss_pred EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccc--------------------------------------------------------------CCchhhh
Q 002376 461 INGNIPKGILR--------------------------------------------------------------PLPEEIS 478 (929)
Q Consensus 461 l~g~i~~~~~~--------------------------------------------------------------~~p~~~~ 478 (929)
++|.+|..++. ..|..+.
T Consensus 550 l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~ 629 (768)
T 3rgz_A 550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629 (768)
T ss_dssp EESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCS
T ss_pred cCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhh
Confidence 99999875432 1234556
Q ss_pred cccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeE
Q 002376 479 RLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSL 558 (929)
Q Consensus 479 ~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 558 (929)
.+++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+.+++|++||||+|+++|.+|..+.++++|++|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eCCCCcCcccCCCCCCCCCCCcccccCCCCCcCCC--CCCCC
Q 002376 559 NLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL--GCENP 598 (929)
Q Consensus 559 ~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~--~c~~~ 598 (929)
||++|+++|.+|..++|.++....+.|||++||.| .|...
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 99999999999999999999999999999999987 78643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=585.32 Aligned_cols=473 Identities=30% Similarity=0.493 Sum_probs=380.0
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|++++|.++|.+|. ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++.+|..|.++++|++|+|+
T Consensus 179 ~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 255 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255 (768)
T ss_dssp TCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred CCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence 566666666666655443 5666666666666666666655 6666666666666666666666666666666666666
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccc-----------------cCCCccCCCCcccEEEeecccCCC
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIAN-----------------LIPSDLSRLENLKVLDLTINRLAG 214 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~-----------------l~p~~~~~l~~L~~L~Ls~N~l~~ 214 (929)
+|++++.+|.. .+++|++|+|++|+++|.+|..+.. ..|..|+.+++|++|+|++|++++
T Consensus 256 ~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 332 (768)
T 3rgz_A 256 SNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332 (768)
T ss_dssp SSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC
Confidence 66666544432 5566666666666666555544322 256677888999999999999988
Q ss_pred ccCCc-cccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccc--cccccEEeccCccCcCCccC
Q 002376 215 TVPST-IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHN--LTNIQIIRMTHNLLEGTLPP 291 (929)
Q Consensus 215 ~~p~~-~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~ 291 (929)
.+|.. |.++++|++|+|++|+++|.+|..+....++|+.|++++|++++.+|..+.. +++|+.|++++|.+++.+|.
T Consensus 333 ~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~ 412 (768)
T 3rgz_A 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412 (768)
T ss_dssp ECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG
T ss_pred cCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH
Confidence 77765 8889999999999999988888888773348899999999988888888877 78889999999998888888
Q ss_pred CCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCC
Q 002376 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371 (929)
Q Consensus 292 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~ 371 (929)
.|.++++|++|++++|++..... ..+.++++|++|+|++|++++.+|..+..+. +|++|+|++|++++.+|.
T Consensus 413 ~l~~l~~L~~L~Ls~N~l~~~~p-------~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~ 484 (768)
T 3rgz_A 413 TLSNCSELVSLHLSFNYLSGTIP-------SSLGSLSKLRDLKLWLNMLEGEIPQELMYVK-TLETLILDFNDLTGEIPS 484 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESCCC-------GGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEEECCSSCCCSCCCG
T ss_pred HHhcCCCCCEEECcCCcccCccc-------HHHhcCCCCCEEECCCCcccCcCCHHHcCCC-CceEEEecCCcccCcCCH
Confidence 88888999999999888875432 4677888888888888888888888888876 788888888888888888
Q ss_pred CCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcc-------
Q 002376 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS------- 444 (929)
Q Consensus 372 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------- 444 (929)
.++++++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..+.++++|++|||++|+++|.+|..
T Consensus 485 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~ 564 (768)
T 3rgz_A 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK 564 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTC
T ss_pred HHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccch
Confidence 8888888888888888888888888888888888888888888888888888888888888888888776654
Q ss_pred ---------------------------------------------------------------cccccccceecccCCcC
Q 002376 445 ---------------------------------------------------------------FGNFQSLLSIDLSNNRI 461 (929)
Q Consensus 445 ---------------------------------------------------------------~~~l~~L~~L~Ls~N~l 461 (929)
|.++++|+.|||++|++
T Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l 644 (768)
T 3rgz_A 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644 (768)
T ss_dssp BCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCC
T ss_pred hhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcc
Confidence 34467899999999999
Q ss_pred CCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcC
Q 002376 462 NGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKL 541 (929)
Q Consensus 462 ~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 541 (929)
+|.+ |.+++.+++|+.|||++|+++|.+|..|+++++|+.|||++|+++|.+|..++.+++|++||||+|++
T Consensus 645 ~g~i--------p~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 645 SGYI--------PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp BSCC--------CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred cccC--------CHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 9887 78899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCcccccCCCCCeEeCCCCc-Ccc
Q 002376 542 SGSIPSDLQNLQALRSLNLTFNN-LEG 567 (929)
Q Consensus 542 ~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 567 (929)
+|.+|.. ..+..+....+.+|. +.|
T Consensus 717 ~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 717 SGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp EEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred cccCCCc-hhhccCCHHHhcCCchhcC
Confidence 9999974 344555666677775 554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=569.46 Aligned_cols=499 Identities=23% Similarity=0.310 Sum_probs=295.8
Q ss_pred CCcCChhhHHHHHHHHhhcCCCC------CCCCCCCCCCCCCCCCC---cceeeCCCCCcEEEEEcCCCCCccccCCCCC
Q 002376 22 ASVGINTDKEALMSFKSQISQES------PSSPLSYWNPSSSPCTW---PGVICNNFGNRVIGLNLSSFGLEGTISPHIG 92 (929)
Q Consensus 22 ~~~~~~~~~~aLl~~k~~~~~~~------~~~~l~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~ 92 (929)
+++...+|++||.+||.++..+. +....++|+.+.+||.| .||+|+.. +||+.|+|++++++|.+|++|+
T Consensus 24 ~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGG
T ss_pred hhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHh
Confidence 33444689999999999986541 22345689999999999 99999876 6999999999999999999999
Q ss_pred CCCCCCEEEeecCCC------CC------CCCcCCCCCCCCcEEeCCCCCCCCCcccccccc-cccceecccccccCCCC
Q 002376 93 NLSFLRSIQLQNNKL------SG------NLPREIGNLFRLRVLNISFNNLQGELPVNISKL-TELKMLDLMANKITGRV 159 (929)
Q Consensus 93 ~L~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~i 159 (929)
+|++|++|+|++|.+ .| .+|... +.+|+ +++++|.+.+.+|..+..+ ..+..+++....+..
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~-- 177 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK-- 177 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC--
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc--
Confidence 999999999999976 33 445444 56777 8888888888888777633 344445544332220
Q ss_pred ChhhhccCCCCcEEEcc--ccccCCCCCccccccCCCccCCCCcccEEEeecccCCCc-----------------cCCcc
Q 002376 160 TDDQLRNLRSLQVLNFG--KNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT-----------------VPSTI 220 (929)
Q Consensus 160 ~~~~~~~l~~L~~L~Ls--~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~ 220 (929)
.....++.+.+. .|+++| +| ..|+++++|++|+|++|++++. +|..+
T Consensus 178 -----~~~~~l~~l~l~~~~n~l~~-ip--------~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l 243 (636)
T 4eco_A 178 -----SSRITLKDTQIGQLSNNITF-VS--------KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243 (636)
T ss_dssp -----CCCCCCCTTTTTCCSCEEEE-EC--------GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred -----ccccchhhhhhccccCCCcc-CC--------HHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence 011111111111 233332 22 2233444455555555554443 44444
Q ss_pred c--cCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCc-CCC-CCCCccccc------ccccEEeccCccCcCCcc
Q 002376 221 Y--NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR-FTG-KIPGSLHNL------TNIQIIRMTHNLLEGTLP 290 (929)
Q Consensus 221 ~--~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p 290 (929)
. ++++|++|+|++|++.|.+|..+.. +++|++|++++|+ ++| .+|..++++ ++|+.|++++|+++ .+|
T Consensus 244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip 321 (636)
T 4eco_A 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP 321 (636)
T ss_dssp CGGGCTTCCEEEEECCTTCSSCCTTTTT-CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCC
T ss_pred hhcccCCCCEEEecCCcCCccChHHHhc-CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccC
Confidence 4 5555555555555554444443333 4444444444444 444 445444443 56666666666666 555
Q ss_pred C--CCCCCCccceecccccccc-CCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCcccc
Q 002376 291 P--GLGNLPFLRTYNIGFNKIV-SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYG 367 (929)
Q Consensus 291 ~--~~~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~ 367 (929)
. .|+++++|++|++++|++. .++ .+.++++|++|+|++|+++ .+|..+..+..+|++|++++|+++
T Consensus 322 ~~~~l~~l~~L~~L~L~~N~l~g~ip---------~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~- 390 (636)
T 4eco_A 322 VETSLQKMKKLGMLECLYNQLEGKLP---------AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK- 390 (636)
T ss_dssp CHHHHTTCTTCCEEECCSCCCEEECC---------CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-
T ss_pred chhhhccCCCCCEEeCcCCcCccchh---------hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-
Confidence 4 4544444444444444443 211 2344556666666777666 666666666522677777777666
Q ss_pred ccCCCCCCCC--cccEEEeeCCCCCcccCcccc-------CCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc
Q 002376 368 KIPASIGRLR--SLTLLDLSYNSISGEIPIEIG-------QLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438 (929)
Q Consensus 368 ~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 438 (929)
.+|..+..++ +|++|+|++|++++.+|..+. .+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 391 ~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 5566665544 666777777776666666666 5566666666666666444444555666666666666666
Q ss_pred cccCc-ccccc-------cccceecccCCcCCCCCCCCcccCCchhhh--cccCccEEEecCCCCCCCCCcchhcCcCcc
Q 002376 439 GEIPI-SFGNF-------QSLLSIDLSNNRINGNIPKGILRPLPEEIS--RLENVVTIDLSDNSLSGNLPNSLKNCKSLE 508 (929)
Q Consensus 439 ~~~p~-~~~~l-------~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~--~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~ 508 (929)
.+|. .+... ++|+.|+|++|+|+ .+ |..+. .+++|+.|||++|++++ +|..+.++++|+
T Consensus 471 -~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l--------p~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~ 539 (636)
T 4eco_A 471 -EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KL--------SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539 (636)
T ss_dssp -BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BC--------CGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCC
T ss_pred -CcCHHHhccccccccccCCccEEECcCCcCC-cc--------ChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCC
Confidence 3333 22222 26666666666665 23 44444 55666666666666665 566666666666
Q ss_pred eeec------ccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 509 ELLM------AYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 509 ~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
.|+| ++|++.+.+|..++.+++|++|||++|++ +.+|..+. ++|+.|||++|++..
T Consensus 540 ~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp EEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred EEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 6666 33455555555555555555555555555 34555443 455555555555544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=550.44 Aligned_cols=502 Identities=22% Similarity=0.252 Sum_probs=439.1
Q ss_pred CcceeeCCCC---------CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCC
Q 002376 61 WPGVICNNFG---------NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL 131 (929)
Q Consensus 61 w~gv~c~~~~---------~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 131 (929)
+.-+.|...+ ..++.|||++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 4456786532 3688999999999988889999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeeccc
Q 002376 132 QGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINR 211 (929)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~ 211 (929)
++..|..|+++++|++|+|++|+++ .+++..|.++++|++|+|++|++.+.. ...+..+++|++|+|++|+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~--------~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIK--------LPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCC--------CCTTCCCTTCCEEECCSSC
T ss_pred cccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCcccccC--------cccccCCcccCEEEcccCc
Confidence 9999999999999999999999998 465556999999999999999986522 1233448999999999999
Q ss_pred CCCccCCccccCCCCc--eEEeeecCCCCcCCcccccCCCCcceeeccCCcC--------------------------CC
Q 002376 212 LAGTVPSTIYNMTSLV--HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRF--------------------------TG 263 (929)
Q Consensus 212 l~~~~p~~~~~l~~L~--~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l--------------------------~~ 263 (929)
+++..|..|..+++|+ +|++++|++++..|. .+. ..+|+.++++.|.. ..
T Consensus 165 l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~-~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~ 242 (606)
T 3t6q_A 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG-AFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242 (606)
T ss_dssp CCEECHHHHHTTTTCCSEEEECTTCCCCEECTT-TTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCC
T ss_pred ccccChhhhhhhcccceeEEecCCCccCccChh-Hhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccc
Confidence 9999899999999999 899999999965444 444 46788888877641 01
Q ss_pred CCCCcccccc--cccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccc
Q 002376 264 KIPGSLHNLT--NIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFE 341 (929)
Q Consensus 264 ~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 341 (929)
..+..+..+. +|+.|++++|.+++..+..|+.+++|++|++++|++..++ ..+.++++|++|++++|+++
T Consensus 243 i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp--------~~l~~l~~L~~L~l~~n~l~ 314 (606)
T 3t6q_A 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP--------SGLVGLSTLKKLVLSANKFE 314 (606)
T ss_dssp CCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC--------SSCCSCTTCCEEECTTCCCS
T ss_pred cChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC--------hhhcccccCCEEECccCCcC
Confidence 1122333333 7999999999999988889999999999999999998654 45788999999999999999
Q ss_pred cccCchhhhccccccEEEecCCccccccCC-CCCCCCcccEEEeeCCCCCccc--CccccCCCCCCEEEecCCcCCCCCc
Q 002376 342 GKIPESIGNFSNELSKLYLGGNHIYGKIPA-SIGRLRSLTLLDLSYNSISGEI--PIEIGQLQGLQVLGLAGNEIPGGIP 418 (929)
Q Consensus 342 ~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p 418 (929)
+..|..+..++ +|++|++++|.+.+.+|. .+..+++|++|++++|.+++.. |..+..+++|++|++++|++.+..|
T Consensus 315 ~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 393 (606)
T 3t6q_A 315 NLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393 (606)
T ss_dssp BGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECT
T ss_pred cCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCH
Confidence 88888888887 899999999999977765 4999999999999999999776 7889999999999999999999999
Q ss_pred ccccCCCCCceecccCcccccccCcc-cccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCC--
Q 002376 419 NSLANLKKLNQIDLSGNELTGEIPIS-FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-- 495 (929)
Q Consensus 419 ~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~-- 495 (929)
..|..+++|++|++++|++++..|.. |.++++|+.|++++|.+++.. |..+..+++|++|+|++|++++
T Consensus 394 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~~~~l~~L~~L~L~~n~l~~~~ 465 (606)
T 3t6q_A 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS--------EQLFDGLPALQHLNLQGNHFPKGN 465 (606)
T ss_dssp TTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTC--------TTTTTTCTTCCEEECTTCBCGGGE
T ss_pred HHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcC--------HHHHhCCCCCCEEECCCCCCCccc
Confidence 99999999999999999999876654 899999999999999998654 6677889999999999999987
Q ss_pred -CCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC-C
Q 002376 496 -NLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-G 573 (929)
Q Consensus 496 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~ 573 (929)
..+..+..+++|++|+|++|++++.+|..|+.+++|+.|||++|++++..|..+.+++.| +|++++|++++.+|.. .
T Consensus 466 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~ 544 (606)
T 3t6q_A 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLP 544 (606)
T ss_dssp ECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHH
T ss_pred cccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcc
Confidence 334679999999999999999999999999999999999999999999999999999999 9999999999887764 4
Q ss_pred CCCCCCcccccCCCCCcC
Q 002376 574 IFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 574 ~~~~l~~l~l~~N~~~c~ 591 (929)
.+++++.+++++||+.|.
T Consensus 545 ~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 545 ILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp HHHTSSEEECTTCCEECS
T ss_pred cCCCCCEEeCCCCCcccc
Confidence 578899999999999983
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=551.42 Aligned_cols=504 Identities=25% Similarity=0.274 Sum_probs=380.1
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
.+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47899999999999877778999999999999999999999999999999999999999999766678999999999999
Q ss_pred cccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccc--cCCCCce
Q 002376 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY--NMTSLVH 228 (929)
Q Consensus 151 s~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~ 228 (929)
++|+++ .+++..|+++++|++|+|++|.+++..| ..|.++++|++|+|++|++++..+..+. .+++|++
T Consensus 105 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 175 (680)
T 1ziw_A 105 MSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKL--------GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175 (680)
T ss_dssp CSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCC--------CSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred CCCccC-ccChhHccccCCCCEEECCCCcccccCc--------hhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence 999998 5676669999999999999998866544 4456677788888888877776666543 4577777
Q ss_pred EEeeecCCCCcCCccccc--------------------------CCCCcceeeccCCcCCCCCCCccccccc--ccEEec
Q 002376 229 LRLASNQLGGEIPYDVRD--------------------------TLPNLLDFIYCFNRFTGKIPGSLHNLTN--IQIIRM 280 (929)
Q Consensus 229 L~Ls~N~l~~~ip~~~~~--------------------------~l~~L~~l~l~~N~l~~~~p~~~~~l~~--L~~L~L 280 (929)
|+|++|++++..|..+.. ..++|+.|++++|++++..|..|.+++. |+.|++
T Consensus 176 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L 255 (680)
T 1ziw_A 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255 (680)
T ss_dssp EECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEEC
T ss_pred EECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEEC
Confidence 777777777554433221 0144556666666666666666666544 666666
Q ss_pred cCccCcCCccCCCCCCCccceeccccccccCCCCCC--C---C-----------------ccc----cccCCCCCCCEEE
Q 002376 281 THNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDE--G---L-----------------SFI----TSLTNSTHLNYLA 334 (929)
Q Consensus 281 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~--~---~-----------------~~~----~~~~~l~~L~~L~ 334 (929)
++|.+++..|..|+.+++|++|++++|++....... + + ..+ ..+..+++|++|+
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~ 335 (680)
T 1ziw_A 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEE
T ss_pred CCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEE
Confidence 666666666666666666666666666654432210 0 0 000 1456677888888
Q ss_pred ccCCccccccCchhhhcc---------------------------ccccEEEecCCccccccCCCCCCCCcccEEEeeCC
Q 002376 335 LDGNQFEGKIPESIGNFS---------------------------NELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYN 387 (929)
Q Consensus 335 Ls~N~l~~~~p~~~~~~~---------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 387 (929)
+++|++++..|..+..+. .+|+.|++++|++++..|..|..+++|++|+|++|
T Consensus 336 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 415 (680)
T 1ziw_A 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415 (680)
T ss_dssp CCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence 888888776666555443 13445555556666666777777777888888888
Q ss_pred CCCcccC-ccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc--cccCcccccccccceecccCCcCCCC
Q 002376 388 SISGEIP-IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT--GEIPISFGNFQSLLSIDLSNNRINGN 464 (929)
Q Consensus 388 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~ 464 (929)
.+++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..|.++++|+.|+|++|+|++.
T Consensus 416 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i 495 (680)
T 1ziw_A 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495 (680)
T ss_dssp CCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred cCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence 7776555 56777777888888888777777777777788888888888776 46777888888888888888888743
Q ss_pred CCCCcccCCchhhhcccCccEEEecCCCCCCCC--------CcchhcCcCcceeecccccccccCCccccCCCCCCEEEC
Q 002376 465 IPKGILRPLPEEISRLENVVTIDLSDNSLSGNL--------PNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDL 536 (929)
Q Consensus 465 i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~--------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 536 (929)
. |..+..+++|++|||++|++++.. +..|.++++|++|+|++|+|+...+..|..+++|+.|||
T Consensus 496 ~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 567 (680)
T 1ziw_A 496 N--------DDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567 (680)
T ss_dssp C--------TTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred C--------hhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeEC
Confidence 2 455777888999999999887542 234788899999999999999666677999999999999
Q ss_pred CCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC-C-CCCCCCcccccCCCCCcC
Q 002376 537 SSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-G-IFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 537 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~-~~~~l~~l~l~~N~~~c~ 591 (929)
++|++++..+..|.++++|+.|+|++|++++.+|.. . .+++++.+++.+||+.|.
T Consensus 568 s~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 999999877777889999999999999999877653 2 478899999999999994
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=555.18 Aligned_cols=494 Identities=21% Similarity=0.229 Sum_probs=414.7
Q ss_pred CCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCC-CcCCCCCCCCcEEeCCCCCCCCCccc
Q 002376 59 CTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNL-PREIGNLFRLRVLNISFNNLQGELPV 137 (929)
Q Consensus 59 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 137 (929)
|.|..|-+ ...+++.|||++|.+++..|.+|.++++|++|||++|.+.+.+ |.+|+++++|++|+|++|.|++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56888776 3458999999999999999999999999999999999777666 78899999999999999999999999
Q ss_pred ccccccccceecccccccCCCCCh-hhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCcc
Q 002376 138 NISKLTELKMLDLMANKITGRVTD-DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV 216 (929)
Q Consensus 138 ~~~~l~~L~~L~Ls~N~l~~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~ 216 (929)
.|.++++|++|+|++|++++.++. ..|+++++|++|+|++|.+++..| +..|+++++|++|+|++|++++..
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~-------~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL-------HPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC-------CGGGGTCSSCCEEEEESSCCCCCC
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc-------chhHhhCCCCCEEECCCCcCCeeC
Confidence 999999999999999999975554 458999999999999999865432 245788999999999999999999
Q ss_pred CCccccC--CCCceEEeeecCCCCcCCcccccCCC------CcceeeccCCcCCCCCCCccccc----------------
Q 002376 217 PSTIYNM--TSLVHLRLASNQLGGEIPYDVRDTLP------NLLDFIYCFNRFTGKIPGSLHNL---------------- 272 (929)
Q Consensus 217 p~~~~~l--~~L~~L~Ls~N~l~~~ip~~~~~~l~------~L~~l~l~~N~l~~~~p~~~~~l---------------- 272 (929)
+..|..+ ++|+.|+|++|.+.+.+|..+.. ++ .|+.|++++|++++.++..+...
T Consensus 165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGK-CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCS-SSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred HHHcccccCCccceEECCCCccccccccchhh-cCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 9999988 89999999999999888876544 33 38999999999888777655432
Q ss_pred ----------------------ccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCC
Q 002376 273 ----------------------TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330 (929)
Q Consensus 273 ----------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L 330 (929)
++|+.|++++|.+.+..|..|..+++|+.|++++|+|..... ..|.++++|
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-------~~~~~l~~L 316 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD-------EAFYGLDNL 316 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT-------TTTTTCSSC
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh-------HHhcCCCCC
Confidence 578888888888888888888888888888888888876543 356778888
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
++|+|++|++++..|..+..++ +|+.|+|++|++.+..+..|..+++|++|+|++|.+++. ..+++|+.|++++
T Consensus 317 ~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~ 390 (844)
T 3j0a_A 317 QVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSG 390 (844)
T ss_dssp CEEEEESCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEES
T ss_pred CEEECCCCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCC
Confidence 8888888888877777777776 688888888888877777888888888888888888742 2377888888888
Q ss_pred CcCCCCCcccccCCCCCceecccCcccccccC-cccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEec
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs 489 (929)
|+++ .+|.. ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+. ..+..+++|+.|+|+
T Consensus 391 N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~~~~~L~~L~Ls 459 (844)
T 3j0a_A 391 NKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD-------QTPSENPSLEQLFLG 459 (844)
T ss_dssp CCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSS-------SSSCSCTTCCBCEEE
T ss_pred CCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccc-------cccccCCccccccCC
Confidence 8887 34443 4578889999999886422 2356889999999999999864322 123446789999999
Q ss_pred CCCCC-----CCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCc
Q 002376 490 DNSLS-----GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 490 ~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (929)
+|.++ +..|..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+
T Consensus 460 ~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~ 537 (844)
T 3j0a_A 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQ 537 (844)
T ss_dssp SCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEEC
T ss_pred CCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCc
Confidence 99997 55567899999999999999999999999999999999999999999987777776 899999999999
Q ss_pred CcccCCCCCCCCCCCcccccCCCCCc
Q 002376 565 LEGVVPSEGIFRNMSNVHLKGNPKLC 590 (929)
Q Consensus 565 l~~~~p~~~~~~~l~~l~l~~N~~~c 590 (929)
+++.+|.. |.+++.+++.+||+.|
T Consensus 538 l~~~~~~~--~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 538 LLAPNPDV--FVSLSVLDITHNKFIC 561 (844)
T ss_dssp CCCCCSCC--CSSCCEEEEEEECCCC
T ss_pred CCCCChhH--hCCcCEEEecCCCccc
Confidence 99998864 7789999999999999
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=552.10 Aligned_cols=510 Identities=23% Similarity=0.308 Sum_probs=311.0
Q ss_pred CCCcCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCC-----CC--CCC------------cceeeCCCCCcEEEEEcCCC
Q 002376 21 SASVGINTDKEALMSFKSQISQESPSSPLSYWNPSS-----SP--CTW------------PGVICNNFGNRVIGLNLSSF 81 (929)
Q Consensus 21 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~ 81 (929)
+++++..+|++||++||+++.+ | +|+.+. +| |.| .||+|+. .+||+.|+|+++
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~~--~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~ 333 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALDG--K-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGF 333 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTG--G-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTT
T ss_pred cccccchHHHHHHHHHHHHcCC--C-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccC
Confidence 3445567899999999999853 3 897654 56 999 9999997 579999999999
Q ss_pred CCccccCCCCCCCCCCCEEEe-ecCCCCCCCCcCCCCC----CC-----CcE------Ee-CCCCCCCC-----------
Q 002376 82 GLEGTISPHIGNLSFLRSIQL-QNNKLSGNLPREIGNL----FR-----LRV------LN-ISFNNLQG----------- 133 (929)
Q Consensus 82 ~l~g~i~~~l~~L~~L~~L~L-s~N~l~~~~p~~~~~l----~~-----L~~------L~-Ls~N~l~~----------- 133 (929)
++.|.+|++|++|++|++||| ++|.++|..|..-... .. ++. ++ .....+.+
T Consensus 334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~ 413 (876)
T 4ecn_A 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413 (876)
T ss_dssp CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence 999999999999999999999 9999988855432211 00 000 00 00011111
Q ss_pred Ccccccccccccceecccc--cccCCCCChhhhccCCCCcEEEccccccCC-CCCccccc--------cCCCccC--CCC
Q 002376 134 ELPVNISKLTELKMLDLMA--NKITGRVTDDQLRNLRSLQVLNFGKNLLWG-SIPPSIAN--------LIPSDLS--RLE 200 (929)
Q Consensus 134 ~~p~~~~~l~~L~~L~Ls~--N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~i~~--------l~p~~~~--~l~ 200 (929)
..+........++.+.+.. |+++| ||.. |+++++|++|+|++|+++| .+|..+.. .+|..++ +++
T Consensus 414 ~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~ 491 (876)
T 4ecn_A 414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK 491 (876)
T ss_dssp SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred ccccccccccchhhceeccccCcccc-hhHH-HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCC
Confidence 1111122334455555554 88886 7776 8888888888888888877 23322211 1455555 788
Q ss_pred cccEEEeecccCCCccCCccccCCCCceEEeeecC-CCC-cCCccccc------CCCCcceeeccCCcCCCCCCC--ccc
Q 002376 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ-LGG-EIPYDVRD------TLPNLLDFIYCFNRFTGKIPG--SLH 270 (929)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~ip~~~~~------~l~~L~~l~l~~N~l~~~~p~--~~~ 270 (929)
+|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..+.. .+++|+.|++++|+++ .+|. .+.
T Consensus 492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~ 570 (876)
T 4ecn_A 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ 570 (876)
T ss_dssp TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT
T ss_pred CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh
Confidence 88888888888888888888888888888888887 776 67765443 2335666666666665 5555 566
Q ss_pred ccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhh
Q 002376 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGN 350 (929)
Q Consensus 271 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 350 (929)
++++|+.|+|++|.++ .+| .|+.+++|+.|++++|+ ++ .+|..++.
T Consensus 571 ~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~-------------------------------l~-~lp~~l~~ 616 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ-------------------------------IE-EIPEDFCA 616 (876)
T ss_dssp TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSC-------------------------------CS-CCCTTSCE
T ss_pred cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCc-------------------------------cc-cchHHHhh
Confidence 6666666666666665 444 55555555555555554 44 44444444
Q ss_pred ccccccEEEecCCccccccCCCCCCCCc--ccEEEeeCCCCCcccCccc---c--CCCCCCEEEecCCcCCCCCcccccC
Q 002376 351 FSNELSKLYLGGNHIYGKIPASIGRLRS--LTLLDLSYNSISGEIPIEI---G--QLQGLQVLGLAGNEIPGGIPNSLAN 423 (929)
Q Consensus 351 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~ 423 (929)
+..+|+.|+|++|+|+ .+|..+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|+++...+..+..
T Consensus 617 l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~ 695 (876)
T 4ecn_A 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695 (876)
T ss_dssp ECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHT
T ss_pred ccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHcc
Confidence 4411555555555554 44444444432 5555555555554433211 1 2235555555555555332233335
Q ss_pred CCCCceecccCcccccccCcccc--------cccccceecccCCcCCCCCCCCcccCCchhhh--cccCccEEEecCCCC
Q 002376 424 LKKLNQIDLSGNELTGEIPISFG--------NFQSLLSIDLSNNRINGNIPKGILRPLPEEIS--RLENVVTIDLSDNSL 493 (929)
Q Consensus 424 l~~L~~L~Ls~N~l~~~~p~~~~--------~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~--~l~~L~~LdLs~N~l 493 (929)
+++|+.|+|++|+++ .+|..+. ++++|+.|+|++|+|+ .+ |..+. .+++|+.|+|++|++
T Consensus 696 l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~l--------p~~l~~~~l~~L~~L~Ls~N~L 765 (876)
T 4ecn_A 696 GSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SL--------SDDFRATTLPYLSNMDVSYNCF 765 (876)
T ss_dssp TCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CC--------CGGGSTTTCTTCCEEECCSSCC
T ss_pred CCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cc--------hHHhhhccCCCcCEEEeCCCCC
Confidence 555555555555555 3333221 1225666666666655 23 44443 555666666666666
Q ss_pred CCCCCcchhcCcCcceeeccc------ccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 494 SGNLPNSLKNCKSLEELLMAY------NQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
++ +|..+.++++|+.|+|++ |++.+.+|..|..+++|+.|+|++|++ +.+|..+. ++|+.|||++|++..
T Consensus 766 ~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 766 SS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS 841 (876)
T ss_dssp SS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred Cc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence 65 555666666666666654 677777777777777777777777777 56776655 577778888777766
Q ss_pred cCCCCC-CCCCCCcccccCCCCCc
Q 002376 568 VVPSEG-IFRNMSNVHLKGNPKLC 590 (929)
Q Consensus 568 ~~p~~~-~~~~l~~l~l~~N~~~c 590 (929)
..+..- .........+.+|+..+
T Consensus 842 i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 842 IDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp EECGGGHHHHHTTCCEEECCTTSE
T ss_pred cChHHccccccchheeecCCCccc
Confidence 544321 11123344555665443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=541.53 Aligned_cols=485 Identities=21% Similarity=0.215 Sum_probs=430.5
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 47899999999999888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCChhhhccCCCCcEEEccccccCC-CCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCc--
Q 002376 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWG-SIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV-- 227 (929)
Q Consensus 151 s~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-- 227 (929)
++|+++ .+++..|+++++|++|+|++|++.+ .+ |..|+++++|++|+|++|++++..|..|..+++|+
T Consensus 112 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~l--------p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~ 182 (606)
T 3vq2_A 112 VETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKL--------PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182 (606)
T ss_dssp TTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCC--------CGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTC
T ss_pred cCCccc-cccccccCCCCCCCEEeCCCCcccceec--------hHhHhhcCCCCEEEccCCcceecChhhhhhhhccccc
Confidence 999998 4665569999999999999999864 33 45677899999999999999999999998888776
Q ss_pred --eEEeeecCCCCcCCcccccCCCCcceeeccCCcCC-CCCCCcccccccccEEec------------------------
Q 002376 228 --HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFT-GKIPGSLHNLTNIQIIRM------------------------ 280 (929)
Q Consensus 228 --~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~-~~~p~~~~~l~~L~~L~L------------------------ 280 (929)
+|++++|+++ .+|...+... +|+.|++++|.++ +.+|..+.++++|+.+++
T Consensus 183 l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~ 260 (606)
T 3vq2_A 183 NLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260 (606)
T ss_dssp CCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGG
T ss_pred cceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhh
Confidence 8999999998 6777776644 8999999999987 455666777777666665
Q ss_pred ---------cCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhc
Q 002376 281 ---------THNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF 351 (929)
Q Consensus 281 ---------s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 351 (929)
..|.+++.+|. +..+++|+.|++++|.+...+ .+..+++|++|++++|++ +.+|. + .+
T Consensus 261 l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~---------~l~~~~~L~~L~l~~n~l-~~lp~-~-~l 327 (606)
T 3vq2_A 261 VTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE---------DVPKHFKWQSLSIIRCQL-KQFPT-L-DL 327 (606)
T ss_dssp SEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC---------CCCTTCCCSEEEEESCCC-SSCCC-C-CC
T ss_pred ccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh---------hccccccCCEEEcccccC-ccccc-C-CC
Confidence 67788888887 999999999999999987653 567789999999999999 68884 4 66
Q ss_pred cccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcc--cCccccCCCCCCEEEecCCcCCCCCcccccCCCCCce
Q 002376 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE--IPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429 (929)
Q Consensus 352 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 429 (929)
+ +|++|++++|+..+.+ .+..+++|++|++++|++++. .|..+..+++|++|++++|.+++ +|..+..+++|++
T Consensus 328 ~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~ 403 (606)
T 3vq2_A 328 P-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403 (606)
T ss_dssp S-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCE
T ss_pred C-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCe
Confidence 5 8999999999766544 678999999999999999876 48889999999999999999985 6688999999999
Q ss_pred ecccCcccccccC-cccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCC-CCCcchhcCcCc
Q 002376 430 IDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG-NLPNSLKNCKSL 507 (929)
Q Consensus 430 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~-~~p~~~~~l~~L 507 (929)
|++++|++++..| ..|.++++|+.|++++|++++.+ |..+..+++|++|++++|++++ .+|..|+.+++|
T Consensus 404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 475 (606)
T 3vq2_A 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF--------DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475 (606)
T ss_dssp EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECC--------TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred eECCCCccCCccChhhhhccccCCEEECcCCCCCccc--------hhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence 9999999998887 68999999999999999998655 6678889999999999999998 479999999999
Q ss_pred ceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCC-CCCcccccCC
Q 002376 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFR-NMSNVHLKGN 586 (929)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~l~~l~l~~N 586 (929)
++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+.++++|++|++++|+++..++....++ +++.+++++|
T Consensus 476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N 555 (606)
T 3vq2_A 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSC
T ss_pred CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCC
Confidence 999999999999999999999999999999999999999999999999999999999996554434454 6999999999
Q ss_pred CCCcC
Q 002376 587 PKLCL 591 (929)
Q Consensus 587 ~~~c~ 591 (929)
|+.|.
T Consensus 556 ~~~c~ 560 (606)
T 3vq2_A 556 SVACI 560 (606)
T ss_dssp CCCCS
T ss_pred CcccC
Confidence 99994
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=520.91 Aligned_cols=494 Identities=22% Similarity=0.283 Sum_probs=366.9
Q ss_pred EEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccccccc
Q 002376 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155 (929)
Q Consensus 76 l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 155 (929)
+|+++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus 9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 85 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85 (680)
T ss_dssp EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence 556666676 6887775 7999999999999988888999999999999999999999999999999999999999999
Q ss_pred CCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 156 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
+ .+|+..|.++++|++|+|++|++++ +.|..|+++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 86 ~-~l~~~~~~~l~~L~~L~L~~n~l~~--------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 156 (680)
T 1ziw_A 86 S-QLSDKTFAFCTNLTELHLMSNSIQK--------IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156 (680)
T ss_dssp C-CCCTTTTTTCTTCSEEECCSSCCCC--------CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSC
T ss_pred C-ccChhhhccCCCCCEEECCCCccCc--------cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCc
Confidence 8 6888779999999999999998854 344567889999999999999999999999999999999999999
Q ss_pred CCCcCCcccc-cCCCCcceeeccCCcCCCCCCCccccc---------------------------ccccEEeccCccCcC
Q 002376 236 LGGEIPYDVR-DTLPNLLDFIYCFNRFTGKIPGSLHNL---------------------------TNIQIIRMTHNLLEG 287 (929)
Q Consensus 236 l~~~ip~~~~-~~l~~L~~l~l~~N~l~~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~ 287 (929)
+++..+..+. ..+++|+.|++++|++++..|..+..+ ++|+.|++++|.+++
T Consensus 157 l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~ 236 (680)
T 1ziw_A 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236 (680)
T ss_dssp CCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCE
T ss_pred ccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccc
Confidence 9865554432 236899999999999999998877655 457888889999999
Q ss_pred CccCCCCCCCc--cceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcc-------------
Q 002376 288 TLPPGLGNLPF--LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFS------------- 352 (929)
Q Consensus 288 ~~p~~~~~l~~--L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~------------- 352 (929)
..|..|.+++. |+.|++++|++..... ..+..+++|++|+|++|++++..|..+..+.
T Consensus 237 ~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~-------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~ 309 (680)
T 1ziw_A 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGN-------DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309 (680)
T ss_dssp ECTTTTGGGGGSCCCEEECTTSCCCEECT-------TTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCC
T ss_pred cChhHhhccCcCCCCEEECCCCCcCccCc-------ccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhh
Confidence 99999999876 9999999999987653 4577888999999999988877776655543
Q ss_pred -------------------ccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcc--cCccccCC--CCCCEEEec
Q 002376 353 -------------------NELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE--IPIEIGQL--QGLQVLGLA 409 (929)
Q Consensus 353 -------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l--~~L~~L~L~ 409 (929)
.+|++|++++|++++..+..|.++++|++|+|++|.++.. .+..|..+ ++|++|+++
T Consensus 310 ~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~ 389 (680)
T 1ziw_A 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389 (680)
T ss_dssp C------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECT
T ss_pred cccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECC
Confidence 1344555555555555555555555555555444432211 01111111 234444445
Q ss_pred CCcCCCCCcccccCCCCCceecccCcccccccC-cccccccccceecccCCcCCCCCCCCc------------------c
Q 002376 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGI------------------L 470 (929)
Q Consensus 410 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~------------------~ 470 (929)
+|++++..|..|..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..+ .
T Consensus 390 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 469 (680)
T 1ziw_A 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469 (680)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT
T ss_pred CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc
Confidence 555555566667777777777777777766554 566677777777777777654322111 1
Q ss_pred cCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCC--------ccccCCCCCCEEECCCCcCC
Q 002376 471 RPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP--------NIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 471 ~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~ 542 (929)
...|..+..+++|+.|||++|++++..|..|.++++|++|+|++|++++..+ ..|+.+++|++|+|++|+++
T Consensus 470 ~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 549 (680)
T 1ziw_A 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549 (680)
T ss_dssp TCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC
T ss_pred ccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC
Confidence 2346667777778888888888777777777777788888888887775422 23677777888888888877
Q ss_pred CcCCcccccCCCCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCC
Q 002376 543 GSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPK 588 (929)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~ 588 (929)
...+..|.++++|+.|+|++|++++.++.. ..+++++.+++++|..
T Consensus 550 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l 596 (680)
T 1ziw_A 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596 (680)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcC
Confidence 544456777788888888888887655543 3456777777777753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=516.11 Aligned_cols=487 Identities=21% Similarity=0.222 Sum_probs=426.9
Q ss_pred CCCcceeeCCCC--CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcc
Q 002376 59 CTWPGVICNNFG--NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELP 136 (929)
Q Consensus 59 c~w~gv~c~~~~--~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 136 (929)
+.-.++...... .+++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|
T Consensus 43 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~ 122 (606)
T 3t6q_A 43 NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122 (606)
T ss_dssp CCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGG
T ss_pred CccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCc
Confidence 344455332222 378899999999999889999999999999999999999999999999999999999999998888
Q ss_pred cccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCccc--EEEeecccCCC
Q 002376 137 VNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLK--VLDLTINRLAG 214 (929)
Q Consensus 137 ~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~--~L~Ls~N~l~~ 214 (929)
..|+++++|++|+|++|++++ ++...+..+++|++|+|++|.+++ +.|..|+.+++|+ .|++++|++++
T Consensus 123 ~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~--------~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 123 IPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHY--------LSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp SCCTTCTTCCEEECCSSCCCC-CCCCTTCCCTTCCEEECCSSCCCE--------ECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred chhccCCcccEEECCCCcccc-cCcccccCCcccCEEEcccCcccc--------cChhhhhhhcccceeEEecCCCccCc
Confidence 999999999999999999985 432335669999999999998754 3445677888998 89999999998
Q ss_pred ccCCccccCCCCceEEeeecCCC-------------------------CcCCcccccCCC--CcceeeccCCcCCCCCCC
Q 002376 215 TVPSTIYNMTSLVHLRLASNQLG-------------------------GEIPYDVRDTLP--NLLDFIYCFNRFTGKIPG 267 (929)
Q Consensus 215 ~~p~~~~~l~~L~~L~Ls~N~l~-------------------------~~ip~~~~~~l~--~L~~l~l~~N~l~~~~p~ 267 (929)
..|..|.. .+|++|++++|... ..++...+..+. +|+.+++++|++++..+.
T Consensus 194 ~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 194 IEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp ECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred cChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 88877655 68999999887510 122333333333 789999999999999999
Q ss_pred cccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCch
Q 002376 268 SLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPES 347 (929)
Q Consensus 268 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 347 (929)
.|.++++|+.|++++|.++ .+|..+.++++|++|++++|++..... ..+.++++|++|++++|.+.+.+|..
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~-------~~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ-------ISASNFPSLTHLSIKGNTKRLELGTG 344 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG-------GCGGGCTTCSEEECCSCSSCCBCCSS
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCch-------hhhhccCcCCEEECCCCCcccccchh
Confidence 9999999999999999999 788899999999999999999976532 46788999999999999999888765
Q ss_pred -hhhccccccEEEecCCcccccc--CCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcc-cccC
Q 002376 348 -IGNFSNELSKLYLGGNHIYGKI--PASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPN-SLAN 423 (929)
Q Consensus 348 -~~~~~~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~ 423 (929)
+..+. +|++|++++|.+++.. +..++.+++|++|++++|++++..|..|..+++|++|++++|++++..|. .+.+
T Consensus 345 ~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 423 (606)
T 3t6q_A 345 CLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423 (606)
T ss_dssp TTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTT
T ss_pred hhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhC
Confidence 66666 8999999999999877 88999999999999999999999999999999999999999999987665 4899
Q ss_pred CCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhc
Q 002376 424 LKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503 (929)
Q Consensus 424 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~ 503 (929)
+++|++|++++|.+++..|..|.++++|++|++++|++++... ..+..+..+++|++|+|++|++++..|..|++
T Consensus 424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 498 (606)
T 3t6q_A 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI-----QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498 (606)
T ss_dssp CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE-----CSSCGGGGCTTCCEEECTTSCCCEECTTTTTT
T ss_pred cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc-----ccchhhccCCCccEEECCCCccCccChhhhcc
Confidence 9999999999999999999999999999999999999976321 11467889999999999999999999999999
Q ss_pred CcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
+++|++|+|++|++++.+|..+..++.| .|||++|++++.+|..+..+++|+.|++++|++++..+
T Consensus 499 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9999999999999999999999999999 99999999999999999999999999999999998655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=506.81 Aligned_cols=465 Identities=22% Similarity=0.187 Sum_probs=407.1
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|+|++|.+++..|..|.++++|++|+|++|.+++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 57 ~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 136 (606)
T 3vq2_A 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136 (606)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECC
T ss_pred cCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCC
Confidence 78999999999998888899999999999999999999999999999999999999999998888999999999999999
Q ss_pred ccccCC-CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCccc----EEEeecccCCCccCCccccCCCC
Q 002376 152 ANKITG-RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLK----VLDLTINRLAGTVPSTIYNMTSL 226 (929)
Q Consensus 152 ~N~l~~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L 226 (929)
+|++++ .+|.. |+++++|++|+|++|++++..| ..|+.+++|+ .|++++|+++++.+..+... +|
T Consensus 137 ~n~l~~~~lp~~-~~~l~~L~~L~Ls~n~l~~~~~--------~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L 206 (606)
T 3vq2_A 137 HNFIHSCKLPAY-FSNLTNLVHVDLSYNYIQTITV--------NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KL 206 (606)
T ss_dssp SSCCCCCCCCGG-GGTCTTCCEEECCSSCCCEECT--------TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EE
T ss_pred CCcccceechHh-HhhcCCCCEEEccCCcceecCh--------hhhhhhhccccccceeeccCCCcceeCcccccCc-ee
Confidence 999985 45655 9999999999999999866444 3445555554 89999999997777666655 89
Q ss_pred ceEEeeecCCCCcCCcccccCCCCcceeec---------------------------------cCCcCCCCCCCcccccc
Q 002376 227 VHLRLASNQLGGEIPYDVRDTLPNLLDFIY---------------------------------CFNRFTGKIPGSLHNLT 273 (929)
Q Consensus 227 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l---------------------------------~~N~l~~~~p~~~~~l~ 273 (929)
++|+|++|.+++.........++.++.+.+ ..|.+++.+|. +..++
T Consensus 207 ~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~ 285 (606)
T 3vq2_A 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLA 285 (606)
T ss_dssp EEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGT
T ss_pred eeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCC
Confidence 999999998874333333334555554444 67788888887 99999
Q ss_pred cccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccc
Q 002376 274 NIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN 353 (929)
Q Consensus 274 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 353 (929)
+|+.|++++|.+.. +| .+..+++|+.|++++|.+..++ .+ .+++|++|++++|+..+.+ .++.++
T Consensus 286 ~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~~lp---------~~-~l~~L~~L~l~~n~~~~~~--~~~~l~- 350 (606)
T 3vq2_A 286 NVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLKQFP---------TL-DLPFLKSLTLTMNKGSISF--KKVALP- 350 (606)
T ss_dssp TCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCSSCC---------CC-CCSSCCEEEEESCSSCEEC--CCCCCT-
T ss_pred CCCEEEecCccchh-hh-hccccccCCEEEcccccCcccc---------cC-CCCccceeeccCCcCccch--hhccCC-
Confidence 99999999999974 56 8999999999999999996543 34 7899999999999766555 455666
Q ss_pred cccEEEecCCccccc--cCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCc-ccccCCCCCcee
Q 002376 354 ELSKLYLGGNHIYGK--IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP-NSLANLKKLNQI 430 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 430 (929)
+|++|++++|++++. .|..+..+++|++|+|++|.+++ +|..+..+++|++|++++|++.+..| ..+.++++|++|
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 899999999999977 48889999999999999999985 67899999999999999999998888 789999999999
Q ss_pred cccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCccee
Q 002376 431 DLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEEL 510 (929)
Q Consensus 431 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L 510 (929)
++++|++++..|..|.++++|++|++++|++++.+ +|..+..+++|++|||++|++++..|..|.++++|++|
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT-------LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE-------ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcc-------hHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 99999999999999999999999999999998742 16677889999999999999999999999999999999
Q ss_pred ecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCC-CCCeEeCCCCcCcccCCC
Q 002376 511 LMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ-ALRSLNLTFNNLEGVVPS 571 (929)
Q Consensus 511 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~ 571 (929)
+|++|++++.+|..|..+++|++|||++|+++ .+|..+..++ +|++|++++|++.+..+.
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999999999999999999999 5777799997 599999999999987664
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=510.49 Aligned_cols=497 Identities=20% Similarity=0.181 Sum_probs=375.0
Q ss_pred EEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCc-ccccccccccceeccccc
Q 002376 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL-PVNISKLTELKMLDLMAN 153 (929)
Q Consensus 75 ~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N 153 (929)
..|.++++++ .+|. -.++|++|||++|.+++..|..|.++++|++|||++|.+.+.+ |..|.++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4566778887 5666 4589999999999999999999999999999999999777666 789999999999999999
Q ss_pred ccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccC-CccccCCCCceEEee
Q 002376 154 KITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP-STIYNMTSLVHLRLA 232 (929)
Q Consensus 154 ~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls 232 (929)
+|++ ++++.|.++++|++|+|++|.+++.+|.. ..|+.+++|++|+|++|++++..+ ..|.++++|++|+|+
T Consensus 84 ~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~------~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls 156 (844)
T 3j0a_A 84 KIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKD------GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156 (844)
T ss_dssp CCCE-ECTTSSCSCSSCCCEECTTCCCSSCCSTT------CCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEE
T ss_pred cCcc-cCHhHccCCcccCEeeCcCCCCCcccccC------ccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECC
Confidence 9985 55556999999999999999997765532 247889999999999999998766 579999999999999
Q ss_pred ecCCCCcCCcccccCC--CCcceeeccCCcCCCCCCCccccccc------ccEEeccCccCcCCccCCCCCC---Cccce
Q 002376 233 SNQLGGEIPYDVRDTL--PNLLDFIYCFNRFTGKIPGSLHNLTN------IQIIRMTHNLLEGTLPPGLGNL---PFLRT 301 (929)
Q Consensus 233 ~N~l~~~ip~~~~~~l--~~L~~l~l~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~ 301 (929)
+|++++..|..+.. + ++|+.|+++.|.+++..|..+..+.+ |+.|++++|.+++..+..+... +.++.
T Consensus 157 ~N~i~~~~~~~l~~-l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~ 235 (844)
T 3j0a_A 157 SNQIFLVCEHELEP-LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235 (844)
T ss_dssp SSCCCCCCSGGGHH-HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSE
T ss_pred CCcCCeeCHHHccc-ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccc
Confidence 99999877776654 5 89999999999999999988877766 9999999999998877766543 44555
Q ss_pred eccccccccCCCCCCCC--ccccccCCC--CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC
Q 002376 302 YNIGFNKIVSSGDDEGL--SFITSLTNS--THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377 (929)
Q Consensus 302 L~L~~N~i~~~~~~~~~--~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 377 (929)
+.++.+.+........+ .....|.++ ++|+.|+|++|.+.+..|..+..+. +|+.|+|++|++++..|..|.+++
T Consensus 236 L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~ 314 (844)
T 3j0a_A 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLD 314 (844)
T ss_dssp EECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCS
T ss_pred eecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCC
Confidence 55553322111000000 000122222 5666667766666666566665555 566677777766666666666666
Q ss_pred cccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceeccc
Q 002376 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLS 457 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 457 (929)
+|++|+|++|++++..|..|..+++|++|++++|++++..+..|.++++|++|+|++|.+++. + .+++|+.|+++
T Consensus 315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~ 389 (844)
T 3j0a_A 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLS 389 (844)
T ss_dssp SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEE
T ss_pred CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccC
Confidence 677777777666666666666666677777776666666666666666666666666666532 1 14455555555
Q ss_pred CCcCCCCCCCCc------------cc--CCchhhhcccCccEEEecCCCCCCCCCc-chhcCcCcceeeccccccc----
Q 002376 458 NNRINGNIPKGI------------LR--PLPEEISRLENVVTIDLSDNSLSGNLPN-SLKNCKSLEELLMAYNQFS---- 518 (929)
Q Consensus 458 ~N~l~g~i~~~~------------~~--~~p~~~~~l~~L~~LdLs~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~---- 518 (929)
+|+++ .+|... +. ..+..+..+++|+.|||++|++++..+. .+..+++|+.|+|++|.++
T Consensus 390 ~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~ 468 (844)
T 3j0a_A 390 GNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468 (844)
T ss_dssp SCCCC-CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCC
T ss_pred CCCcc-cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccc
Confidence 55554 222211 00 1134466889999999999999976554 4567899999999999997
Q ss_pred -ccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcC
Q 002376 519 -GPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 519 -~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~ 591 (929)
+..|..|..+++|++|||++|+|++.+|..|.++++|+.|+|++|+|++.+|.... ++++.+++++|.....
T Consensus 469 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~ 541 (844)
T 3j0a_A 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAP 541 (844)
T ss_dssp SCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCC
T ss_pred cccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCC
Confidence 45567799999999999999999999999999999999999999999987765533 7899999999986653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=495.18 Aligned_cols=483 Identities=19% Similarity=0.213 Sum_probs=300.2
Q ss_pred CCCCcceeeCCCC-----------CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeC
Q 002376 58 PCTWPGVICNNFG-----------NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNI 126 (929)
Q Consensus 58 ~c~w~gv~c~~~~-----------~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 126 (929)
.|.|.|+ |+..+ .+++.|+|++|.+++..|..|.++++|++|+|++|++++..|.+|+++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 86432 25667777777777666667777777777777777777666677777777777777
Q ss_pred CCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEE
Q 002376 127 SFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206 (929)
Q Consensus 127 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~ 206 (929)
++|++++..|..|+++++|++|+|++|++++.-.+..++++++|++|++++|.+.+.+ .+..|.++++|++|+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~-------~~~~~~~l~~L~~L~ 154 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI-------RRIDFAGLTSLNELE 154 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEE-------CTTTTTTCCEEEEEE
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcccccc-------CHhhhhcccccCeee
Confidence 7777776666667777777777777777764211223667777777777777643322 234566677777777
Q ss_pred eecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCC--C-CcccccccccEEeccCc
Q 002376 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKI--P-GSLHNLTNIQIIRMTHN 283 (929)
Q Consensus 207 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~--p-~~~~~l~~L~~L~Ls~N 283 (929)
|++|++++..|..|.++++|++|+++.|.+. .+|..+...+++|++|++++|++++.. | .....+++|+.|++++|
T Consensus 155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n 233 (549)
T 2z81_A 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233 (549)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESC
T ss_pred ccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceecccc
Confidence 7777777777777777777777777777665 455555555677777777777776642 1 12234566777777777
Q ss_pred cCcCCcc----CCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccc-----cCchhhhcccc
Q 002376 284 LLEGTLP----PGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGK-----IPESIGNFSNE 354 (929)
Q Consensus 284 ~l~~~~p----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~~~~~ 354 (929)
.+++..+ ..+..++.|+.+++++|.+......... ....+..+.+|+.|+++++.+... ++.. .....+
T Consensus 234 ~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~-~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~-~~~~~~ 311 (549)
T 2z81_A 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS-ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV-YSLLEK 311 (549)
T ss_dssp EEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCC-TTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHH-HHHSTT
T ss_pred ccchhHHHHHHHHhhhhcccccccccccccccccccccc-chhhhhhhcccccccccccccchhhhcccchhh-hhhccc
Confidence 6665332 3345566677777777766554322111 112344556667777766655421 1111 122235
Q ss_pred ccEEEecCCccccccCCCC-CCCCcccEEEeeCCCCCcccC---ccccCCCCCCEEEecCCcCCCCCc--ccccCCCCCc
Q 002376 355 LSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIP---IEIGQLQGLQVLGLAGNEIPGGIP--NSLANLKKLN 428 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~ 428 (929)
|+.|++++|++. .+|..+ ..+++|++|+|++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|+
T Consensus 312 L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~ 390 (549)
T 2z81_A 312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390 (549)
T ss_dssp CCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCC
T ss_pred ceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCC
Confidence 777777777765 344443 456777777777777766553 235666777777777777765432 4466667777
Q ss_pred eecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcc
Q 002376 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLE 508 (929)
Q Consensus 429 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~ 508 (929)
+||+++|+++ .+|..+..+++|++|++++|++++ +|. .+ .++|++|||++|++++.+ .++++|+
T Consensus 391 ~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~--------~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~ 454 (549)
T 2z81_A 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--------CI--PQTLEVLDVSNNNLDSFS----LFLPRLQ 454 (549)
T ss_dssp EEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCT--------TS--CTTCSEEECCSSCCSCCC----CCCTTCC
T ss_pred EEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccc--------hh--cCCceEEECCCCChhhhc----ccCChhc
Confidence 7777777776 456666666777777777777652 221 11 135667777777766542 3566677
Q ss_pred eeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 509 ELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 509 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
+|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+++|+.|++++|++++..|
T Consensus 455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 7777777776 4444 3456667777777777776666666666777777777766665544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=488.08 Aligned_cols=487 Identities=21% Similarity=0.232 Sum_probs=312.3
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|||++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 56777777777776666677777777777777777777667777777777777777777776666777777777777777
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCC----c
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSL----V 227 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L----~ 227 (929)
+|+++ .++...|+++++|++|+|++|.+.+. -+|..|+++++|++|++++|++++..|..|..+++| +
T Consensus 109 ~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~-------~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~ 180 (570)
T 2z63_A 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSF-------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180 (570)
T ss_dssp TSCCC-CSTTCSCTTCTTCCEEECCSSCCCCC-------CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCC
T ss_pred ccccc-cCCCccccccccccEEecCCCcccee-------cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhh
Confidence 77776 45554477777777777777776431 023445667777777777777777777777777777 6
Q ss_pred eEEeeecCCCCcCCcccccCCCCcceeeccCCcCCC-CCCCcccccccccEEeccCccCc------CCccCCCCCCCc--
Q 002376 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTG-KIPGSLHNLTNIQIIRMTHNLLE------GTLPPGLGNLPF-- 298 (929)
Q Consensus 228 ~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~------~~~p~~~~~l~~-- 298 (929)
+|++++|.+++. +...+... +|+.+++++|.... .++..+.++++++.+++..+.+. ......|..+++
T Consensus 181 ~L~l~~n~l~~~-~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~ 258 (570)
T 2z63_A 181 SLDLSLNPMNFI-QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258 (570)
T ss_dssp EEECTTCCCCEE-CTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSE
T ss_pred hcccCCCCceec-CHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccc
Confidence 777777777743 33333323 67777777664321 23333444444444433322111 111122333322
Q ss_pred cceeccccc-cccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC
Q 002376 299 LRTYNIGFN-KIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377 (929)
Q Consensus 299 L~~L~L~~N-~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 377 (929)
++.++++.| .+.... +..+..+++|++|++++|.++ .+|..+... +|++|++++|.+. .+|. ..++
T Consensus 259 l~~l~l~~~~~~~~~~-------~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~ 325 (570)
T 2z63_A 259 IEEFRLAYLDYYLDDI-------IDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLK 325 (570)
T ss_dssp EEEEEEEETTEEESCS-------TTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCS
T ss_pred hhhhhhhcchhhhhhc-------hhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--cccc
Confidence 233334333 222211 134555667777777777776 466666555 5777777777766 3343 3566
Q ss_pred cccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCC--cccccCCCCCceecccCcccccccCcccccccccceec
Q 002376 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGI--PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID 455 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 455 (929)
+|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|.+++..+. |..+++|+.|+
T Consensus 326 ~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~ 402 (570)
T 2z63_A 326 SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLD 402 (570)
T ss_dssp SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEE
T ss_pred ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEE
Confidence 777777777776655544 56677777777777776543 56666777777777777777654443 66777777777
Q ss_pred ccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccccc-ccCCccccCCCCCCEE
Q 002376 456 LSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFS-GPIPNIVAELKGLEVL 534 (929)
Q Consensus 456 Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 534 (929)
+++|++++..+ +..+..+++|++|++++|.+++..|..|.++++|++|++++|+++ +.+|..+..+++|++|
T Consensus 403 l~~n~l~~~~~-------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 403 FQHSNLKQMSE-------FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp CTTSEEESCTT-------SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccCCccccccc-------hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 77777665432 134556667777777777777777777777777777777777776 4667777777777777
Q ss_pred ECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCCCcC
Q 002376 535 DLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 535 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~~c~ 591 (929)
+|++|++++..|..+.++++|++|++++|++++.+|.. ..+++++.+++++|++.|.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 77777777666777777777777777777777765543 3456667777777777663
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=480.08 Aligned_cols=467 Identities=21% Similarity=0.216 Sum_probs=399.2
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|+|++|.+++..+..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus 53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 132 (570)
T 2z63_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (570)
T ss_dssp SCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC
T ss_pred CceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC
Confidence 68899999999998778889999999999999999998888999999999999999999998777789999999999999
Q ss_pred ccccCC-CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcc----cEEEeecccCCCccCCccccCCCC
Q 002376 152 ANKITG-RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL----KVLDLTINRLAGTVPSTIYNMTSL 226 (929)
Q Consensus 152 ~N~l~~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L 226 (929)
+|.+++ .+|.. |+++++|++|++++|++++. .|..|+.+++| +.|++++|++++..|..|..+ +|
T Consensus 133 ~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~--------~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L 202 (570)
T 2z63_A 133 HNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSI--------YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RL 202 (570)
T ss_dssp SSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEE--------CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EE
T ss_pred CCccceecChhh-hcccCCCCEEeCcCCcccee--------cHHHccchhccchhhhhcccCCCCceecCHHHhccC-cc
Confidence 999985 35655 99999999999999988543 34556667777 899999999999999888776 89
Q ss_pred ceEEeeecCCCCcCCcccccCCCCcceeeccCCcC------CCCCCCcccccc--cccEEeccCc-cCcCCccCCCCCCC
Q 002376 227 VHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRF------TGKIPGSLHNLT--NIQIIRMTHN-LLEGTLPPGLGNLP 297 (929)
Q Consensus 227 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l------~~~~p~~~~~l~--~L~~L~Ls~N-~l~~~~p~~~~~l~ 297 (929)
++|+|++|......-......+++++...+..+.+ .......+..+. .++.+++++| .+.+..|..|..++
T Consensus 203 ~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~ 282 (570)
T 2z63_A 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282 (570)
T ss_dssp EEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT
T ss_pred eeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC
Confidence 99999999655322223333466666555543322 222223344443 3677888888 88888999999999
Q ss_pred ccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC
Q 002376 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377 (929)
Q Consensus 298 ~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 377 (929)
+|+.|++++|.+..++ ..+..+ +|++|++++|.+. .+|. ..++ +|+.|++++|.+.+..+. ..++
T Consensus 283 ~L~~L~l~~~~l~~l~--------~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~-~L~~L~l~~n~~~~~~~~--~~~~ 347 (570)
T 2z63_A 283 NVSSFSLVSVTIERVK--------DFSYNF-GWQHLELVNCKFG-QFPT--LKLK-SLKRLTFTSNKGGNAFSE--VDLP 347 (570)
T ss_dssp TCSEEEEESCEECSCC--------BCCSCC-CCSEEEEESCBCS-SCCB--CBCS-SCCEEEEESCBSCCBCCC--CBCT
T ss_pred cccEEEecCccchhhh--------hhhccC-CccEEeeccCccc-ccCc--cccc-ccCEEeCcCCcccccccc--ccCC
Confidence 9999999999998654 345667 9999999999998 6776 3444 799999999999877665 7899
Q ss_pred cccEEEeeCCCCCccc--CccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccC-ccccccccccee
Q 002376 378 SLTLLDLSYNSISGEI--PIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIP-ISFGNFQSLLSI 454 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 454 (929)
+|++|++++|++++.. |..+..+++|++|++++|.+++..+. +..+++|++|++++|++++..| ..|.++++|++|
T Consensus 348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 9999999999998664 77889999999999999999875554 9999999999999999998766 578999999999
Q ss_pred cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCC-CCCCcchhcCcCcceeecccccccccCCccccCCCCCCE
Q 002376 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS-GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533 (929)
Q Consensus 455 ~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 533 (929)
++++|++++.+ |..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|++++.+|..|..+++|++
T Consensus 427 ~l~~n~l~~~~--------~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 427 DISHTHTRVAF--------NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp ECTTSCCEECC--------TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred eCcCCcccccc--------hhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 99999998654 667888999999999999998 678999999999999999999999999999999999999
Q ss_pred EECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC
Q 002376 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE 572 (929)
Q Consensus 534 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (929)
|+|++|++++..|..+.++++|+.|++++|+++|.+|..
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999988889999999999999999999988864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=474.59 Aligned_cols=488 Identities=17% Similarity=0.205 Sum_probs=401.4
Q ss_pred eeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccc
Q 002376 65 ICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTE 144 (929)
Q Consensus 65 ~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 144 (929)
.|.+.+ | .|+++++++ .+|+.+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++
T Consensus 3 ~C~~~~--~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDASG--V--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTTS--E--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCc--e--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 577643 3 799999998 7888775 89999999999999999999999999999999999999988899999999
Q ss_pred cceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCcc-CCccccC
Q 002376 145 LKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV-PSTIYNM 223 (929)
Q Consensus 145 L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l 223 (929)
|++|||++|+++ .+++..|+++++|++|+|++|++++. -.|..|+++++|++|+|++|++.+.+ +..|.++
T Consensus 76 L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~-------~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 76 LEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTL-------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp CCEEECTTSCCC-SCCHHHHTTCTTCCEEECTTCCCSSS-------CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred CCEEECCCCccC-ccCHHHhccCCCCcEEECCCCccccc-------chhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 999999999998 56777799999999999999998642 12456788999999999999954444 4789999
Q ss_pred CCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCc--c-CCCCCCCccc
Q 002376 224 TSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTL--P-PGLGNLPFLR 300 (929)
Q Consensus 224 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~ 300 (929)
++|++|+|++|++++.+|..+.. +++|+.|+++.|.+....+..+..+++|+.|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKS-IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTT-CSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhc-cccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999888877765 899999999999986543334467899999999999999752 2 3345688999
Q ss_pred eeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccC------chhhhccccccEEEecCCcccccc-----
Q 002376 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP------ESIGNFSNELSKLYLGGNHIYGKI----- 369 (929)
Q Consensus 301 ~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p------~~~~~~~~~L~~L~Ls~N~l~~~~----- 369 (929)
.|++++|.+...... .....+..+++|+.|++++|.+.+... ..+..+. +|+.|+++++.+....
T Consensus 227 ~L~l~~n~l~~~~~~---~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~i~~~~~~~~l 302 (549)
T 2z81_A 227 KLAFRGSVLTDESFN---ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG-KVETVTIRRLHIPQFYLFYDL 302 (549)
T ss_dssp EEEEESCEEEHHHHH---HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT-TCCEEEEESCBCSCGGGSCCC
T ss_pred ceeccccccchhHHH---HHHHHhhhhccccccccccccccccccccccchhhhhhhc-ccccccccccccchhhhcccc
Confidence 999999988642110 112345677899999999999876321 1223344 7999999999876421
Q ss_pred CCCCCCCCcccEEEeeCCCCCcccCccc-cCCCCCCEEEecCCcCCCCCcc---cccCCCCCceecccCcccccccC--c
Q 002376 370 PASIGRLRSLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEIPGGIPN---SLANLKKLNQIDLSGNELTGEIP--I 443 (929)
Q Consensus 370 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p--~ 443 (929)
+..+....+|+.|++++|+++ .+|..+ ..+++|++|++++|++++.+|. .+..+++|++|+|++|++++..+ .
T Consensus 303 ~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 381 (549)
T 2z81_A 303 STVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381 (549)
T ss_dssp CHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHH
T ss_pred hhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchh
Confidence 111233568999999999998 677766 5799999999999999987653 47889999999999999986543 5
Q ss_pred ccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCc
Q 002376 444 SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPN 523 (929)
Q Consensus 444 ~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 523 (929)
.+..+++|++|++++|+++ .+ |..+..+++|++|+|++|++++ +|..+ .++|++|+|++|+|++.+
T Consensus 382 ~~~~l~~L~~L~Ls~N~l~-~l--------p~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~-- 447 (549)
T 2z81_A 382 ILLTLKNLTSLDISRNTFH-PM--------PDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS-- 447 (549)
T ss_dssp HGGGCTTCCEEECTTCCCC-CC--------CSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC--
T ss_pred hhhcCCCCCEEECCCCCCc-cC--------ChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc--
Confidence 6889999999999999997 34 6667788999999999999984 44433 268999999999999754
Q ss_pred cccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC-CCCCCCCcccccCCCCCcC
Q 002376 524 IVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 524 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~l~~N~~~c~ 591 (929)
..+++|++|||++|+|+ .+|. ...+++|++|+|++|++++.+|.. ..+++++.+++++||+.|.
T Consensus 448 --~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 448 --LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp --CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred --ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 57899999999999999 6776 567999999999999999988864 5688999999999999883
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=469.16 Aligned_cols=454 Identities=21% Similarity=0.259 Sum_probs=340.5
Q ss_pred EEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccc
Q 002376 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154 (929)
Q Consensus 75 ~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 154 (929)
.+|+++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 4677777777 5776665 777777777777776666777777777777777777777777777777777777777777
Q ss_pred cCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCC--ceEEee
Q 002376 155 ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSL--VHLRLA 232 (929)
Q Consensus 155 l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls 232 (929)
|+ .+|.. .+++|++|+|++|++++. -.|..|+++++|++|+|++|++++ ..|..+++| ++|+|+
T Consensus 81 l~-~lp~~---~l~~L~~L~L~~N~l~~~-------~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~ 146 (520)
T 2z7x_B 81 LV-KISCH---PTVNLKHLDLSFNAFDAL-------PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLV 146 (520)
T ss_dssp CC-EEECC---CCCCCSEEECCSSCCSSC-------CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEE
T ss_pred ee-ecCcc---ccCCccEEeccCCccccc-------cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEee
Confidence 76 45554 677777777777776541 023445566777777777777765 345556666 777777
Q ss_pred ecCC--CCcCCcccccCCCCcceeeccCCcCCCCCCCcccccc-cccEEeccCccCcCCccC-CCCCCCccceecccccc
Q 002376 233 SNQL--GGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLT-NIQIIRMTHNLLEGTLPP-GLGNLPFLRTYNIGFNK 308 (929)
Q Consensus 233 ~N~l--~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~ 308 (929)
+|++ .+.+| ..+..+. +...+++++|.+.+.++. .+.++++|+.+++++|.
T Consensus 147 ~n~l~~~~~~~-------------------------~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 201 (520)
T 2z7x_B 147 LGETYGEKEDP-------------------------EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201 (520)
T ss_dssp ECTTTTSSCCT-------------------------TTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECC
T ss_pred ccccccccccc-------------------------ccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccc
Confidence 7766 44444 3333332 233445566665554443 45666666666666664
Q ss_pred -------ccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhc--cccccEEEecCCccccccCCCC-----C
Q 002376 309 -------IVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF--SNELSKLYLGGNHIYGKIPASI-----G 374 (929)
Q Consensus 309 -------i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~~~L~~L~Ls~N~l~~~~p~~~-----~ 374 (929)
+.. .+..+..+++|+.|++++|.+++..+..+... ..+|++|++++|+++|.+|..+ +
T Consensus 202 ~~~~~~~~~~--------~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~ 273 (520)
T 2z7x_B 202 EDNKCSYFLS--------ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273 (520)
T ss_dssp STTTTHHHHH--------HHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSC
T ss_pred cccccceeec--------chhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccc
Confidence 211 11356677888888888888876544333221 1279999999999999999988 9
Q ss_pred CCCcccEEEeeCCCCCcccC-ccccCC---CCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccc
Q 002376 375 RLRSLTLLDLSYNSISGEIP-IEIGQL---QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQS 450 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 450 (929)
++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..|.++++
T Consensus 274 ~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 349 (520)
T 2z7x_B 274 SLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349 (520)
T ss_dssp CCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSS
T ss_pred cCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCC
Confidence 999999999999999 455 555555 67999999999987532 1368899999999999999989999999999
Q ss_pred cceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCc-chhcCcCcceeecccccccccCCccccCCC
Q 002376 451 LLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPN-SLKNCKSLEELLMAYNQFSGPIPNIVAELK 529 (929)
Q Consensus 451 L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (929)
|+.|+|++|++++. ..+|..+..+++|++|||++|++++.+|. .+..+++|++|++++|++++.+|..+. +
T Consensus 350 L~~L~L~~N~l~~l------~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 350 LETLILQMNQLKEL------SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCEEECCSSCCCBH------HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred CCEEEccCCccCcc------ccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 99999999999851 12367789999999999999999986665 488899999999999999988887765 7
Q ss_pred CCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCC-CCCCCCCCcccccCCCCCcC
Q 002376 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPS-EGIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~l~~l~l~~N~~~c~ 591 (929)
+|++|||++|+++ .+|..+..+++|++|++++|++++..+. ...+++++.+++++||+.|.
T Consensus 422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 9999999999999 7888888999999999999999965444 34578899999999999883
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=461.23 Aligned_cols=486 Identities=19% Similarity=0.197 Sum_probs=345.6
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
.++.|||++|.+++..+.+|.+|++|++|||++|+|++..|.+|.+|++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 46677777777775555567777777777777777776666667777777777777777776666667777777777777
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCc----
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV---- 227 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---- 227 (929)
+|+|+ .+++..|+++++|++|+|++|++++.. .|..++.+++|++|+|++|+|++..+..|..+.+++
T Consensus 133 ~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~-------~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~ 204 (635)
T 4g8a_A 133 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK-------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 204 (635)
T ss_dssp TSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCC-------CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCC
T ss_pred CCcCC-CCChhhhhcCcccCeeccccCccccCC-------CchhhccchhhhhhcccCccccccccccccchhhhhhhhh
Confidence 77776 455555777777777777777664311 233455667777777777777766666666554433
Q ss_pred eEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCC-CCCcccccccccEEec--------------------------
Q 002376 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGK-IPGSLHNLTNIQIIRM-------------------------- 280 (929)
Q Consensus 228 ~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~-~p~~~~~l~~L~~L~L-------------------------- 280 (929)
.++++.|.++ .++...+. ...+..+++..|..... .+..+..+..++...+
T Consensus 205 ~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~ 282 (635)
T 4g8a_A 205 SLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 282 (635)
T ss_dssp EEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSE
T ss_pred hhhcccCccc-ccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchh
Confidence 4666666665 34433333 22344455554433321 1122233333333333
Q ss_pred ----cCccCcC---CccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccc
Q 002376 281 ----THNLLEG---TLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSN 353 (929)
Q Consensus 281 ----s~N~l~~---~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 353 (929)
..+.... ..+..+..+.+++.+++..|.+... ..+.....|+.|++++|.+.+..+.. +.
T Consensus 283 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~---------~~~~~~~~L~~L~l~~~~~~~~~~~~---l~- 349 (635)
T 4g8a_A 283 IEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV---------KDFSYNFGWQHLELVNCKFGQFPTLK---LK- 349 (635)
T ss_dssp EEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC---------GGGGSCCCCSEEEEESCEESSCCCCB---CT-
T ss_pred hhhhhhhhhcccccchhhhhhhhcccccccccccccccc---------cccccchhhhhhhcccccccCcCccc---ch-
Confidence 2222111 1122334444555555555555432 23455677888888888887544432 22
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCc--ccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceec
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISG--EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 431 (929)
.|+.++++.|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|++++++.|.+.. .+..+..+++|+.++
T Consensus 350 ~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~ 426 (635)
T 4g8a_A 350 SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 426 (635)
T ss_dssp TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEE
T ss_pred hhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchh
Confidence 688888888887643 345678999999999999863 456667788999999999998874 556788899999999
Q ss_pred ccCcccccccC-cccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCC-CCCCCcchhcCcCcce
Q 002376 432 LSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL-SGNLPNSLKNCKSLEE 509 (929)
Q Consensus 432 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l-~~~~p~~~~~l~~L~~ 509 (929)
++.|+.....+ ..|.++.+++.++++.|.+++.. |..+..++.++.|+|++|++ .+.+|..|..+++|++
T Consensus 427 l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~--------~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~ 498 (635)
T 4g8a_A 427 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF--------NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 498 (635)
T ss_dssp CTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECC--------TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred hhhcccccccccccccccccccccccccccccccc--------ccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence 99988876554 46888999999999999998654 56677888999999999985 4567889999999999
Q ss_pred eecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCC-CC-CCCCcccccCCC
Q 002376 510 LLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEG-IF-RNMSNVHLKGNP 587 (929)
Q Consensus 510 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~-~~l~~l~l~~N~ 587 (929)
|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|++.+|..- .+ .+++.+++++||
T Consensus 499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np 578 (635)
T 4g8a_A 499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 578 (635)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence 9999999999999999999999999999999999999999999999999999999999988752 23 689999999999
Q ss_pred CCcC
Q 002376 588 KLCL 591 (929)
Q Consensus 588 ~~c~ 591 (929)
+.|.
T Consensus 579 ~~C~ 582 (635)
T 4g8a_A 579 FACT 582 (635)
T ss_dssp BCCS
T ss_pred Cccc
Confidence 9993
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=472.39 Aligned_cols=462 Identities=20% Similarity=0.278 Sum_probs=325.8
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeC-CCCCCCCCcccccccc----ccc--ceeccc----------ccccCC
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNI-SFNNLQGELPVNISKL----TEL--KMLDLM----------ANKITG 157 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l----~~L--~~L~Ls----------~N~l~~ 157 (929)
.+++.|+|++|.+.|.+|++|++|++|++||| ++|.++|..|-.-... ..+ +.+... ...+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46789999999999999999999999999999 8998887754321111 000 000000 000000
Q ss_pred CCChh----------hhccCCCCcEEEccc--cccCCCCCccccccCCCccCCCCcccEEEeecccCCCc-cCCccccCC
Q 002376 158 RVTDD----------QLRNLRSLQVLNFGK--NLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT-VPSTIYNMT 224 (929)
Q Consensus 158 ~i~~~----------~~~~l~~L~~L~Ls~--N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~ 224 (929)
.++.. .......++.+.++. |+++| + |..|+++++|++|+|++|+|++. +|..+..
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-I--------P~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~-- 471 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-I--------SKAIQRLTKLQIIYFANSPFTYDNIAVDWED-- 471 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-E--------CGGGGGCTTCCEEEEESCCCCGGGBSSSCSC--
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-h--------hHHHhcCCCCCEEECcCCcCCCCcccccccc--
Confidence 00000 001111222222222 33332 2 22334455555555555555541 0000000
Q ss_pred CCceEEeeecCCCCcCCcccc-cCCCCcceeeccCCcCCCCCCCcccccccccEEeccCcc-CcC-CccCCCCCC-----
Q 002376 225 SLVHLRLASNQLGGEIPYDVR-DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL-LEG-TLPPGLGNL----- 296 (929)
Q Consensus 225 ~L~~L~Ls~N~l~~~ip~~~~-~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l----- 296 (929)
++.|.++|.+|..+. ..+++|+.|++++|++.+.+|..|.++++|+.|+|++|+ ++| .+|..++++
T Consensus 472 ------~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~ 545 (876)
T 4ecn_A 472 ------ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545 (876)
T ss_dssp ------TTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTT
T ss_pred ------cccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhccc
Confidence 000111112555542 235556666666666666666666666666666666665 665 555443333
Q ss_pred --CccceeccccccccCCCCCCCCcccc--ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCC
Q 002376 297 --PFLRTYNIGFNKIVSSGDDEGLSFIT--SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPAS 372 (929)
Q Consensus 297 --~~L~~L~L~~N~i~~~~~~~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 372 (929)
++|+.|++++|++..++ . .+.++++|++|+|++|+++ .+| .++.+. +|+.|+|++|+++ .+|..
T Consensus 546 ~l~~L~~L~Ls~N~L~~ip--------~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~ 613 (876)
T 4ecn_A 546 TGPKIQIFYMGYNNLEEFP--------ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPED 613 (876)
T ss_dssp TTTTCCEEECCSSCCCBCC--------CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTT
T ss_pred ccCCccEEEeeCCcCCccC--------ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHH
Confidence 37777777777765432 3 5778889999999999998 888 777776 7999999999999 88999
Q ss_pred CCCCCc-ccEEEeeCCCCCcccCccccCCCC--CCEEEecCCcCCCCCcccc---c--CCCCCceecccCcccccccCcc
Q 002376 373 IGRLRS-LTLLDLSYNSISGEIPIEIGQLQG--LQVLGLAGNEIPGGIPNSL---A--NLKKLNQIDLSGNELTGEIPIS 444 (929)
Q Consensus 373 ~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~ 444 (929)
+.++++ |++|+|++|+++ .+|..+..++. |+.|+|++|++.+.+|... . .+++|+.|+|++|+++. +|..
T Consensus 614 l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~ 691 (876)
T 4ecn_A 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTE 691 (876)
T ss_dssp SCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHH
T ss_pred HhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHH
Confidence 999999 999999999999 78888887755 9999999999998776433 2 34589999999999994 5554
Q ss_pred -cccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchh--cCcCcceeecccccccccC
Q 002376 445 -FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLK--NCKSLEELLMAYNQFSGPI 521 (929)
Q Consensus 445 -~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~ 521 (929)
+..+++|+.|+|++|+|+ .+|...+...+....++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +
T Consensus 692 ~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-l 768 (876)
T 4ecn_A 692 LFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-F 768 (876)
T ss_dssp HHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-C
T ss_pred HHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-c
Confidence 558999999999999998 7777665544434556679999999999999 7888887 99999999999999998 7
Q ss_pred CccccCCCCCCEEECCC------CcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCC
Q 002376 522 PNIVAELKGLEVLDLSS------NKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQ 592 (929)
Q Consensus 522 p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~ 592 (929)
|..+..+++|+.|+|++ |++.+.+|..+.++++|+.|+|++|++ +.+|.. .+++++.+++++|+.....
T Consensus 769 p~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNISID 843 (876)
T ss_dssp CCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCEEE
T ss_pred chhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCccC
Confidence 88999999999999977 889999999999999999999999999 777776 4579999999999976543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=457.56 Aligned_cols=439 Identities=18% Similarity=0.215 Sum_probs=290.5
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57899999999999888889999999999999999999998999999999999999999999 57766 8999999999
Q ss_pred cccccCC-CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcc--cEEEeecccC--CCccCCccccCC-
Q 002376 151 MANKITG-RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL--KVLDLTINRL--AGTVPSTIYNMT- 224 (929)
Q Consensus 151 s~N~l~~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~- 224 (929)
++|++++ .+|.. |+++++|++|+|++|++.+ ..|..+++| +.|+|++|++ .+..|..|..+.
T Consensus 98 ~~N~l~~~~~p~~-~~~l~~L~~L~L~~n~l~~-----------~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~ 165 (520)
T 2z7x_B 98 SFNAFDALPICKE-FGNMSQLKFLGLSTTHLEK-----------SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165 (520)
T ss_dssp CSSCCSSCCCCGG-GGGCTTCCEEEEEESSCCG-----------GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCE
T ss_pred cCCccccccchhh-hccCCcceEEEecCcccch-----------hhccccccceeeEEEeeccccccccccccccccccc
Confidence 9999986 34454 9999999999999998854 235667777 9999999999 888999888876
Q ss_pred CCceEEeeecCCCCcCCcccccCCCCcceeeccCCc-------CCCCCCCcccccccccEEeccCccCcCCccCCCCCCC
Q 002376 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR-------FTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297 (929)
Q Consensus 225 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 297 (929)
+...+++++|++.+.++...+..+++|+.++++.|. +.+.+| .+..+++|+.|++++|.+++..+..+..
T Consensus 166 ~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~-- 242 (520)
T 2z7x_B 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQ-- 242 (520)
T ss_dssp EEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHH--
T ss_pred ceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHH--
Confidence 455678889998888877777777888888888776 666555 6677777777777777666432211100
Q ss_pred ccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchh-----hhccccccEEEecCCccccccC-C
Q 002376 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESI-----GNFSNELSKLYLGGNHIYGKIP-A 371 (929)
Q Consensus 298 ~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~~~~~L~~L~Ls~N~l~~~~p-~ 371 (929)
....++|++|++++|+++|.+|..+ ..+. .|+.+++++|.+ .+| .
T Consensus 243 --------------------------~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~ 293 (520)
T 2z7x_B 243 --------------------------LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQS 293 (520)
T ss_dssp --------------------------HHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCC-EEEEEEEEECCC--CSCTH
T ss_pred --------------------------HhhhCcccEEEeecccccCccccchhhcccccCc-eeEeccccccce--ecchh
Confidence 0012344455555555544444444 3333 455555555544 222 2
Q ss_pred CCCCC---CcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCccccc--ccCcccc
Q 002376 372 SIGRL---RSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG--EIPISFG 446 (929)
Q Consensus 372 ~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~ 446 (929)
.+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..+.++++|++|+|++|++++ .+|..|.
T Consensus 294 ~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~ 371 (520)
T 2z7x_B 294 YIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371 (520)
T ss_dssp HHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHT
T ss_pred hhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHh
Confidence 22222 34555555555544221 11345555555555555555555555555555555555555554 3344455
Q ss_pred cccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCcccc
Q 002376 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVA 526 (929)
Q Consensus 447 ~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 526 (929)
++++|++|++++|++++.+|.+ .+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 372 ~l~~L~~L~Ls~N~l~~~l~~~-------~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 372 QMKSLQQLDISQNSVSYDEKKG-------DCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp TCTTCCEEECCSSCCBCCGGGC-------SCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred hCCCCCEEECCCCcCCcccccc-------hhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 5555555555555555434221 133445556666666666555554443 56666666666666 4555555
Q ss_pred CCCCCCEEECCCCcCCCcCCc-ccccCCCCCeEeCCCCcCcccC
Q 002376 527 ELKGLEVLDLSSNKLSGSIPS-DLQNLQALRSLNLTFNNLEGVV 569 (929)
Q Consensus 527 ~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~ 569 (929)
.+++|++|+|++|++++ +|. .+..+++|++|++++|++++..
T Consensus 442 ~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 442 KLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp GCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccC
Confidence 66666666666666663 443 3666667777777777766543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=445.68 Aligned_cols=458 Identities=19% Similarity=0.223 Sum_probs=348.9
Q ss_pred EEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccccc
Q 002376 74 IGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMAN 153 (929)
Q Consensus 74 ~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 153 (929)
..+|++++++++ +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 678999999995 887775 89999999999999888889999999999999999999888999999999999999999
Q ss_pred ccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCC--ceEEe
Q 002376 154 KITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSL--VHLRL 231 (929)
Q Consensus 154 ~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L 231 (929)
+|+ .+|.. .+++|++|+|++|++++. | .|..|+++++|++|+|++|++++. .+..+++| ++|+|
T Consensus 111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l-~------~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L 176 (562)
T 3a79_B 111 RLQ-NISCC---PMASLRHLDLSFNDFDVL-P------VCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILL 176 (562)
T ss_dssp CCC-EECSC---CCTTCSEEECCSSCCSBC-C------CCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEE
T ss_pred cCC-ccCcc---ccccCCEEECCCCCcccc-C------chHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEe
Confidence 998 67765 799999999999988541 1 235677889999999999998863 45555555 99999
Q ss_pred eecCC--CCcCCcccccCCC-CcceeeccCCcCCCCCCC-cccccccccEEeccCccCcCCccCCCCCCCccceeccccc
Q 002376 232 ASNQL--GGEIPYDVRDTLP-NLLDFIYCFNRFTGKIPG-SLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFN 307 (929)
Q Consensus 232 s~N~l--~~~ip~~~~~~l~-~L~~l~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 307 (929)
++|++ ++..|..+.. +. ....++++.|.+.+.++. .+.++++|+.+++++|.....
T Consensus 177 ~~n~l~~~~~~~~~l~~-l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~------------------- 236 (562)
T 3a79_B 177 DLVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ------------------- 236 (562)
T ss_dssp EESSCCCCSSSCCEEEE-CCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-------------------
T ss_pred ecccccccccCcccccc-cCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-------------------
Confidence 99988 7666655443 22 122445556665554432 234555555555555531100
Q ss_pred cccCCCCCCCCccccccCCCCCCCEEEccCCcccccc----CchhhhccccccEEEecCCccccccCCCC-----CCCCc
Q 002376 308 KIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI----PESIGNFSNELSKLYLGGNHIYGKIPASI-----GRLRS 378 (929)
Q Consensus 308 ~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-----~~l~~ 378 (929)
.+. ..+..+..+++|+.|+|+++.+++.. +..+. .. +|++|++++|.++|.+|..+ .+++.
T Consensus 237 ~l~--------~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~-~~-~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~ 306 (562)
T 3a79_B 237 RLM--------TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW-PR-PVEYLNIYNLTITERIDREEFTYSETALKS 306 (562)
T ss_dssp HHH--------HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT-TS-SEEEEEEEEEEECSCCCCCCCCCCSCSCCE
T ss_pred hHH--------HHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh-cc-cccEEEEeccEeeccccchhhhcccccchh
Confidence 000 01123455666777777666665432 22221 22 79999999999998888887 88888
Q ss_pred ccEEEeeCCCCCcccC-ccccCC---CCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccccccee
Q 002376 379 LTLLDLSYNSISGEIP-IEIGQL---QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI 454 (929)
Q Consensus 379 L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 454 (929)
|+.++++.|.+ .+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|..|.++++|+.|
T Consensus 307 L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 382 (562)
T 3a79_B 307 LMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382 (562)
T ss_dssp EEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEE
T ss_pred eehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEE
Confidence 88888888887 345 333332 67999999999986432 12678899999999999998889999999999999
Q ss_pred cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCc-chhcCcCcceeecccccccccCCccccCCCCCCE
Q 002376 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPN-SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533 (929)
Q Consensus 455 ~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 533 (929)
+|++|++++. + .+|..+..+++|++|||++|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|++
T Consensus 383 ~L~~N~l~~~-~-----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~ 454 (562)
T 3a79_B 383 ILQRNGLKNF-F-----KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKV 454 (562)
T ss_dssp ECCSSCCCBT-T-----HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSE
T ss_pred ECCCCCcCCc-c-----cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCE
Confidence 9999999752 1 2256688899999999999999985554 588899999999999999988776654 78999
Q ss_pred EECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCC-CCCCCCCCcccccCCCCCcC
Q 002376 534 LDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPS-EGIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 534 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~l~~l~l~~N~~~c~ 591 (929)
|||++|+++ .+|..+..+++|++|+|++|++++.++. ...+++++.+++++||+.|.
T Consensus 455 L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp EECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred EECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 999999998 6777777999999999999999965544 35578889999999999883
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=461.87 Aligned_cols=514 Identities=22% Similarity=0.278 Sum_probs=416.3
Q ss_pred ChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCC----CCCCc-ceeeCCCC--CcEEEEEcCCCCCccccCCCCCCCCCCC
Q 002376 26 INTDKEALMSFKSQISQESPSSPLSYWNPSSS----PCTWP-GVICNNFG--NRVIGLNLSSFGLEGTISPHIGNLSFLR 98 (929)
Q Consensus 26 ~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~----~c~w~-gv~c~~~~--~~v~~l~l~~~~l~g~i~~~l~~L~~L~ 98 (929)
.+.+...-.++++-...- .-..|+...+ .|.|. +..|+.++ ..|++ + .. .+++
T Consensus 25 ~~~~~~d~~aL~~~~~~~----~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C-~--~~-------------~~V~ 84 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDAL----NGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL-N--SN-------------GRVT 84 (636)
T ss_dssp CCHHHHHHHHHHHHHHHT----TGGGCCCCC------CCCCCSSCGGGTTCCTTEEE-C--TT-------------CCEE
T ss_pred hhhHHHHHHHHHHHHHHc----CCCCcccCCcCCccCCCCCCCCCcccccCCCCeEE-c--CC-------------CCEE
Confidence 345556667777655432 1237985442 24896 44455441 13543 1 10 3578
Q ss_pred EEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCC------CC------CcccccccccccceecccccccCCCCChhhhcc
Q 002376 99 SIQLQNNKLSGNLPREIGNLFRLRVLNISFNNL------QG------ELPVNISKLTELKMLDLMANKITGRVTDDQLRN 166 (929)
Q Consensus 99 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~ 166 (929)
.|+|++|.++|.+|++|++|++|++|||++|.+ .| .+|... +..|+ +++++|.+.+.++...-..
T Consensus 85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHH
T ss_pred EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHH
Confidence 999999999999999999999999999999976 33 344433 56777 8888888887666552222
Q ss_pred CCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEe--ecccCCCccCCccccCCCCceEEeeecCCCCc-----
Q 002376 167 LRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL--TINRLAGTVPSTIYNMTSLVHLRLASNQLGGE----- 239 (929)
Q Consensus 167 l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~L--s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----- 239 (929)
+..+..+++....+.. .....++.+++ ..|++++ +|..|+++++|++|+|++|+++|.
T Consensus 162 ~~~l~~~~l~~~~~~~--------------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 226 (636)
T 4eco_A 162 IKDCINSDPQQKSIKK--------------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA 226 (636)
T ss_dssp HHHHHHHCTTSCCCCC--------------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSS
T ss_pred HHHHhhcCcccccccc--------------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccc
Confidence 3344444544433211 11112222223 3689998 899999999999999999999986
Q ss_pred ------------CCcccc-cCCCCcceeeccCCcCCCCCCCcccccccccEEeccCcc-CcC-CccCCCCCC------Cc
Q 002376 240 ------------IPYDVR-DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL-LEG-TLPPGLGNL------PF 298 (929)
Q Consensus 240 ------------ip~~~~-~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~ 298 (929)
+|..+. ..+++|++|++++|++.+.+|..+.++++|++|++++|+ ++| .+|..++++ ++
T Consensus 227 ~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~ 306 (636)
T 4eco_A 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306 (636)
T ss_dssp CSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGT
T ss_pred ccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCC
Confidence 998887 239999999999999999999999999999999999998 998 899888877 99
Q ss_pred cceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCc
Q 002376 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRS 378 (929)
Q Consensus 299 L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 378 (929)
|++|++++|++..++.. ..+.++++|++|+|++|+++|.+| .+..+. +|++|+|++|+++ .+|..+.++++
T Consensus 307 L~~L~L~~n~l~~ip~~------~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~ 377 (636)
T 4eco_A 307 IQIIYIGYNNLKTFPVE------TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTE 377 (636)
T ss_dssp CCEEECCSSCCSSCCCH------HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECT
T ss_pred CCEEECCCCcCCccCch------hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcc
Confidence 99999999999854310 168899999999999999999999 888877 8999999999999 88999999999
Q ss_pred -ccEEEeeCCCCCcccCccccCCC--CCCEEEecCCcCCCCCccccc-------CCCCCceecccCcccccccCcccccc
Q 002376 379 -LTLLDLSYNSISGEIPIEIGQLQ--GLQVLGLAGNEIPGGIPNSLA-------NLKKLNQIDLSGNELTGEIPISFGNF 448 (929)
Q Consensus 379 -L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l 448 (929)
|++|+|++|+++ .+|..+..+. +|++|++++|++++.+|..+. .+++|++|+|++|+++...+..+..+
T Consensus 378 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l 456 (636)
T 4eco_A 378 QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456 (636)
T ss_dssp TCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTT
T ss_pred cCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccC
Confidence 999999999999 7888887765 899999999999999999998 88899999999999995544556679
Q ss_pred cccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchh--cCcCcceeecccccccccCCcccc
Q 002376 449 QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLK--NCKSLEELLMAYNQFSGPIPNIVA 526 (929)
Q Consensus 449 ~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~ 526 (929)
++|+.|+|++|+++ .+|...+...+..+.++++|+.|||++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+.
T Consensus 457 ~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~ 533 (636)
T 4eco_A 457 SPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533 (636)
T ss_dssp CCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG
T ss_pred CCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhh
Confidence 99999999999998 7876665544434455669999999999999 7888887 99999999999999998 899999
Q ss_pred CCCCCCEEEC------CCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCC
Q 002376 527 ELKGLEVLDL------SSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQ 592 (929)
Q Consensus 527 ~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~ 592 (929)
.+++|++|+| ++|++.+.+|..+.++++|++|+|++|++ +.+|.. .+++++.+++++|+..|..
T Consensus 534 ~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp GCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred cCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence 9999999999 56889999999999999999999999999 667765 4489999999999998854
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=434.59 Aligned_cols=444 Identities=21% Similarity=0.211 Sum_probs=283.5
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|+|+ .+|.. .+++|++|||
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 47899999999999888889999999999999999999999999999999999999999999 67766 8999999999
Q ss_pred cccccCCCCC-hhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcc--cEEEeecccC--CCccCCccccCC-
Q 002376 151 MANKITGRVT-DDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL--KVLDLTINRL--AGTVPSTIYNMT- 224 (929)
Q Consensus 151 s~N~l~~~i~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~- 224 (929)
++|++++ ++ +..|+++++|++|+|++|++++. .|..+++| +.|+|++|++ ++..|..|.++.
T Consensus 129 s~N~l~~-l~~p~~~~~l~~L~~L~L~~n~l~~~-----------~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~ 196 (562)
T 3a79_B 129 SFNDFDV-LPVCKEFGNLTKLTFLGLSAAKFRQL-----------DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196 (562)
T ss_dssp CSSCCSB-CCCCGGGGGCTTCCEEEEECSBCCTT-----------TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCE
T ss_pred CCCCccc-cCchHhhcccCcccEEecCCCccccC-----------chhhhhhceeeEEEeecccccccccCcccccccCc
Confidence 9999984 44 35599999999999999998541 34445555 9999999999 889999998875
Q ss_pred CCceEEeeecCCCCcCCcccccCCCCcceeeccCCc-----CCCCCCCcccccccccEEeccCccCcCCc----cCCCCC
Q 002376 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR-----FTGKIPGSLHNLTNIQIIRMTHNLLEGTL----PPGLGN 295 (929)
Q Consensus 225 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~-----l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~ 295 (929)
+.-++++++|.+.+.++...+..+++|+.+++++|+ +.+. ...+..+++|+.|+++++.+++.. ++.+ .
T Consensus 197 ~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~ 274 (562)
T 3a79_B 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-W 274 (562)
T ss_dssp EEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-T
T ss_pred ceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhh-h
Confidence 233679999999998988888889999999999985 2222 234667788888888877765421 1111 1
Q ss_pred CCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccC-chhhhccccccEEEecCCccccccCCCCC
Q 002376 296 LPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP-ESIGNFSNELSKLYLGGNHIYGKIPASIG 374 (929)
Q Consensus 296 l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 374 (929)
.++|++|++++|.+....+...+. ....+++.|+.++++.|.+ .+| ..+..+.
T Consensus 275 ~~~L~~L~l~~n~l~~~ip~~~~~--~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~---------------------- 328 (562)
T 3a79_B 275 PRPVEYLNIYNLTITERIDREEFT--YSETALKSLMIEHVKNQVF--LFSKEALYSVF---------------------- 328 (562)
T ss_dssp TSSEEEEEEEEEEECSCCCCCCCC--CCSCSCCEEEEEEEEECCC--SSCHHHHHHHH----------------------
T ss_pred cccccEEEEeccEeeccccchhhh--cccccchheehhhccccee--ecChhhhhhhh----------------------
Confidence 224555555555544211110000 0013334444444444444 233 1221110
Q ss_pred CCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCccccc--ccCcccccccccc
Q 002376 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG--EIPISFGNFQSLL 452 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~ 452 (929)
...+|++|++++|.+.... ....+++|++|++++|++++.+|..+.++++|++|+|++|++++ .+|..|.++++|+
T Consensus 329 ~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~ 406 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406 (562)
T ss_dssp HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC
T ss_pred ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC
Confidence 0123445555555443211 01344555555555555555455555555555555555555554 2234455555555
Q ss_pred eecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCC
Q 002376 453 SIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLE 532 (929)
Q Consensus 453 ~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 532 (929)
.|++++|++++.+|.+ .+..+++|++|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+
T Consensus 407 ~L~l~~N~l~~~~~~~-------~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~ 476 (562)
T 3a79_B 407 TLDVSLNSLNSHAYDR-------TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQ 476 (562)
T ss_dssp EEECTTSCCBSCCSSC-------CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCS
T ss_pred EEECCCCcCCCccChh-------hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCC
Confidence 5555555555434322 123344555555555555554444332 45666666666666 3444444666666
Q ss_pred EEECCCCcCCCcCCcc-cccCCCCCeEeCCCCcCcccCC
Q 002376 533 VLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 533 ~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
+|+|++|+|++ +|.. +..+++|+.|++++|++++..|
T Consensus 477 ~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 477 ELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp EEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred EEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 66666666663 3433 6666666666666666665443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=411.31 Aligned_cols=410 Identities=23% Similarity=0.311 Sum_probs=207.2
Q ss_pred CCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccC
Q 002376 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167 (929)
Q Consensus 88 ~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l 167 (929)
.|.-...++|++|++++|++ |.+|++|++|++|++|++++|.++|.+|..++++++|+.++++.|..
T Consensus 4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------ 70 (454)
T 1jl5_A 4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------ 70 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------
T ss_pred cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------
Confidence 34444568889999999998 78898899999999999999999888898888888875555554432
Q ss_pred CCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccC
Q 002376 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDT 247 (929)
Q Consensus 168 ~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~ 247 (929)
.++++|++++|.+++ +|. -.++|++|++++|++++ +|.. +++|++|++++|++++ +|..
T Consensus 71 ~~l~~L~l~~~~l~~-lp~-----------~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---- 129 (454)
T 1jl5_A 71 RQAHELELNNLGLSS-LPE-----------LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---- 129 (454)
T ss_dssp HTCSEEECTTSCCSC-CCS-----------CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC----
T ss_pred cCCCEEEecCCcccc-CCC-----------CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC----
Confidence 345556666665543 111 01356666666666665 3432 2556666666666652 3221
Q ss_pred CCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCC
Q 002376 248 LPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS 327 (929)
Q Consensus 248 l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l 327 (929)
.++|++|++++|++++ +| .+.++++|++|++++|++++ +|..+ ++|++|++++|++..++ .+.++
T Consensus 130 ~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~---------~~~~l 194 (454)
T 1jl5_A 130 PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP---------ELQNL 194 (454)
T ss_dssp CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC---------CCTTC
T ss_pred CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc---------cccCC
Confidence 2456666666666665 44 36666666666666666664 44332 36666666666665431 34566
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 407 (929)
++|++|++++|++++ +|... .+|++|++++|+++ .+| .++.+++|++|++++|++++ +|.. +++|++|+
T Consensus 195 ~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ 263 (454)
T 1jl5_A 195 PFLTAIYADNNSLKK-LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALN 263 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEE
T ss_pred CCCCEEECCCCcCCc-CCCCc----CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEE
Confidence 666666666666664 44322 25667777777666 445 36667777777777777664 3332 35667777
Q ss_pred ecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEE
Q 002376 408 LAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487 (929)
Q Consensus 408 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~Ld 487 (929)
+++|++++ +|.. .++|++|++++|++++. |.. .++|+.|++++|++++ ++ .+| ++|+.|+
T Consensus 264 l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~-----~~~------~~L~~L~ 323 (454)
T 1jl5_A 264 VRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC-----DLP------PSLEELN 323 (454)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC-----CCC------TTCCEEE
T ss_pred CCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc-----CCc------CcCCEEE
Confidence 77777665 3432 25667777777777652 211 1466677777776653 21 111 3567777
Q ss_pred ecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCC--cCCcccccC-------------
Q 002376 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG--SIPSDLQNL------------- 552 (929)
Q Consensus 488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l------------- 552 (929)
+++|++++ +|.. +++|++|++++|++++ +|. .+++|++|++++|++++ .+|.++..+
T Consensus 324 Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~ 395 (454)
T 1jl5_A 324 VSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELP 395 (454)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------
T ss_pred CCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccccccccccc
Confidence 77777765 4443 4666777777777763 444 35667777777777776 566666655
Q ss_pred CCCCeEeCCCCcCcc--cCCCCCCCCCCCcccccCCCCCc
Q 002376 553 QALRSLNLTFNNLEG--VVPSEGIFRNMSNVHLKGNPKLC 590 (929)
Q Consensus 553 ~~L~~L~Ls~N~l~~--~~p~~~~~~~l~~l~l~~N~~~c 590 (929)
++|++|++++|++++ .+|. .++.+.+.+|...|
T Consensus 396 ~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~ 430 (454)
T 1jl5_A 396 QNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVD 430 (454)
T ss_dssp ----------------------------------------
T ss_pred CcCCEEECCCCcCCccccchh-----hHhheeCcCcccCC
Confidence 788999999999987 4553 35556666665444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=406.65 Aligned_cols=378 Identities=20% Similarity=0.239 Sum_probs=230.1
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCc-ccccccccccceecccccccCCCCChhhhccCCCCcEE
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL-PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVL 173 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L 173 (929)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++ +++..|+++++|++|
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVL 108 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCE-ECTTTTTTCTTCCEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCc-cChhhccCcccCCEE
Confidence 67888888888888777888888888888888888877555 4567777788888888877764 333347777777777
Q ss_pred EccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCc-cccCCCCceEEeeecCCCCcCCcccccCCCCcc
Q 002376 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPST-IYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLL 252 (929)
Q Consensus 174 ~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~ 252 (929)
+|++|++++.+|. +..|..+++|++|+|++|++++..|.. |.++++|++|+|++|++++
T Consensus 109 ~L~~n~l~~~~~~------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~-------------- 168 (455)
T 3v47_A 109 TLTQCNLDGAVLS------GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-------------- 168 (455)
T ss_dssp ECTTSCCBTHHHH------SSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC--------------
T ss_pred eCCCCCCCccccC------cccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc--------------
Confidence 7777766443221 122555666666666666666555554 5555666666665555553
Q ss_pred eeeccCCcCCCCCCCccccc--ccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCC
Q 002376 253 DFIYCFNRFTGKIPGSLHNL--TNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHL 330 (929)
Q Consensus 253 ~l~l~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L 330 (929)
..|..+..+ .+|+.|++++|.+.+..+..++. .....+..+++|
T Consensus 169 -----------~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~-----------------------~~~~~~~~~~~L 214 (455)
T 3v47_A 169 -----------ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW-----------------------EKCGNPFKNTSI 214 (455)
T ss_dssp -----------CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH-----------------------HHHCCTTTTCEE
T ss_pred -----------cChhhhhccccccccccccccCcccccchhhccc-----------------------ccccccccccee
Confidence 344444433 56777777777777544422210 001223455778
Q ss_pred CEEEccCCccccccCchhhhcc--ccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 331 NYLALDGNQFEGKIPESIGNFS--NELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
++|+|++|++++.+|..+.... .+|+.|++++|.+.+.. +..+.+.+..+..+..+
T Consensus 215 ~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-------- 272 (455)
T 3v47_A 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGL-------- 272 (455)
T ss_dssp EEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGG--------
T ss_pred eeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccc--------
Confidence 8888888888877777766541 25666666666554321 11122222222222221
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
..++|++|++++|++++..|..|.++++|+.|+|++|++++.. |..+..+++|++|+|
T Consensus 273 --------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~L 330 (455)
T 3v47_A 273 --------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID--------DNAFWGLTHLLKLNL 330 (455)
T ss_dssp --------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEEC--------TTTTTTCTTCCEEEC
T ss_pred --------------cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccC--------hhHhcCcccCCEEEC
Confidence 1134555555555555445555555555555555555554322 334445555566666
Q ss_pred cCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
++|++++..|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|++++..+..+..+++|++|++++|++++.
T Consensus 331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 66666555566667777777777777777777677777777777777777777766556667777777777777777777
Q ss_pred CCC
Q 002376 569 VPS 571 (929)
Q Consensus 569 ~p~ 571 (929)
+|.
T Consensus 411 ~~~ 413 (455)
T 3v47_A 411 CPR 413 (455)
T ss_dssp TTT
T ss_pred CCc
Confidence 664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=400.65 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=175.1
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|...++||+|+||+||+|++.+ ..++|.+|++++++++|||||+++|+|.+. .+|+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------NLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------eEEE
Confidence 4577788999999999999998752 246799999999999999999999998532 2699
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||||++|+|.++++... .++.|||.||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999996432 3467999999999998 9999999999999999999999999999876422
Q ss_pred cCCCCCccccceeccccccccccccCC---CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLG---ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. .......+||+.|||||++.+ ++|+.++||||+|+++||+.++..++...... +.+...+..... .+.
T Consensus 186 ~~----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~-~p~ 258 (307)
T 3omv_A 186 SG----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYA-SPD 258 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCC-CCC
T ss_pred Cc----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCC-CCC
Confidence 11 122345689999999999864 46899999999998888876665555433221 011111111000 000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
....+...++.+++++.+||+.||++||||+||++.|+.+...
T Consensus 259 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 259 -LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0011111222233488899999999999999999999887543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=403.58 Aligned_cols=235 Identities=22% Similarity=0.315 Sum_probs=171.8
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|...++||+|+||+||+|++. ...++|.+|+++|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 35667789999999999999642 12467999999999999999999999996543
Q ss_pred ceEEEEEEecCCCCccccccccc-----------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER-----------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
..|+|||||++|+|.++++..+ .++.|||+||+|||+. +||||||||+|||++
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 3899999999999999986421 3467999999999998 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~ 855 (929)
+++.+||+|||+|+.+.... ........+||+.|||||++.+..|+.++||||+|+++||+.+ ...++.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~----~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-- 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTD----YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-- 266 (329)
T ss_dssp TTTEEEECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--
T ss_pred CCCcEEEcccccceeccCCC----cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--
Confidence 99999999999999763221 1112234579999999999999999999999999988888654 3444332221
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.++++.-..+ . +.+.++..++-+.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 267 ~~~~~~i~~g-----~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 TEAIDCITQG-----R--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHHT-----C--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcC-----C--CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1222111111 0 0111111222233488899999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=402.35 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=177.8
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|...+.||+|+||+||+|++. ...++|.+|+++|++++|||||+++|+|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 46778899999999999999642 12467999999999999999999999996543
Q ss_pred ceEEEEEEecCCCCccccccccc---------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
..|+|||||++|+|.++++..+ .++.|||+||+|||+. +||||||||+|||++++
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 3899999999999999996421 3467999999999998 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
+.+||+|||+|+...... ........+||+.|||||++.++.|+.++||||+|+++||+.+ +..++..... .+
T Consensus 165 ~~~Ki~DFGla~~~~~~~----~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~ 238 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 238 (299)
T ss_dssp GCEEECCCSCHHHHTGGG----CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HH
T ss_pred CcEEECCcccceecCCCC----ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 999999999998763221 1112234579999999999999999999999999988888654 3444433221 12
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
++..-..+.. .+.++..++-+.+++.+||+.||++||||+||++.|+++.+..
T Consensus 239 ~~~~i~~~~~-------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 239 VIECITQGRV-------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCC-------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 2111111110 0111112222334888999999999999999999999987653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=419.80 Aligned_cols=466 Identities=21% Similarity=0.190 Sum_probs=377.4
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|||++|++++..+..|.+|++|++|+|++|+|++..+..|.+|++|++|+|++|+|++..+..|+++++|++|+|+
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 68899999999998777789999999999999999998888899999999999999999998888889999999999999
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCc----ccEEEeecccCCCccCCccccCCCCc
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLEN----LKVLDLTINRLAGTVPSTIYNMTSLV 227 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~----L~~L~Ls~N~l~~~~p~~~~~l~~L~ 227 (929)
+|++++...+..++++++|++|+|++|++++..|..+ ..+.+ +..++++.|.++.+.+..+.. ..++
T Consensus 157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l--------~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~ 227 (635)
T 4g8a_A 157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL--------RVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLH 227 (635)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG--------HHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEE
T ss_pred cCccccCCCchhhccchhhhhhcccCccccccccccc--------cchhhhhhhhhhhhcccCcccccCcccccc-hhhh
Confidence 9999854344558999999999999999876555443 33333 346788888888666555443 4567
Q ss_pred eEEeeecCCCCcCCcccccCCCCcceeecc------------------------------CCc---CCCCCCCccccccc
Q 002376 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYC------------------------------FNR---FTGKIPGSLHNLTN 274 (929)
Q Consensus 228 ~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~------------------------------~N~---l~~~~p~~~~~l~~ 274 (929)
.|++++|.....++...+..++.++...+. .+. ....++..+..+.+
T Consensus 228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~ 307 (635)
T 4g8a_A 228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN 307 (635)
T ss_dssp EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence 777877766544433333334444333221 111 11123345566778
Q ss_pred ccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcccc
Q 002376 275 IQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNE 354 (929)
Q Consensus 275 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 354 (929)
++.+++.+|.+.... .+.....|+.|++..|.+..... ..+..|+.++++.|.+....+ ...++ +
T Consensus 308 l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~----------~~l~~L~~l~l~~n~~~~~~~--~~~l~-~ 372 (635)
T 4g8a_A 308 VSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT----------LKLKSLKRLTFTSNKGGNAFS--EVDLP-S 372 (635)
T ss_dssp CSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC----------CBCTTCCEEEEESCCSCCBCC--CCBCT-T
T ss_pred ccccccccccccccc--ccccchhhhhhhcccccccCcCc----------ccchhhhhcccccccCCCCcc--ccccc-c
Confidence 999999999887543 35667789999999998876532 346789999999998874432 23455 7
Q ss_pred ccEEEecCCcccc--ccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCc-ccccCCCCCceec
Q 002376 355 LSKLYLGGNHIYG--KIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP-NSLANLKKLNQID 431 (929)
Q Consensus 355 L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 431 (929)
|+.|+++.|.+.. ..+..+..+.+|++|+++.|.+.. .+..+..+++|+.++++.|......+ ..|..+++++.++
T Consensus 373 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 373 LEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp CCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred cccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccc
Confidence 9999999999864 455667788999999999999874 56678899999999999988766554 5688999999999
Q ss_pred ccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceee
Q 002376 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELL 511 (929)
Q Consensus 432 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ 511 (929)
++.|.+++..|..+..+++|+.|+|++|++.+.++ |..+..+++|++|||++|++++.+|..|.++++|++|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~-------~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-------PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEE-------CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccC-------chhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 99999999999999999999999999998654332 56778889999999999999999999999999999999
Q ss_pred cccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccC-CCCCeEeCCCCcCcccC
Q 002376 512 MAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL-QALRSLNLTFNNLEGVV 569 (929)
Q Consensus 512 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~ 569 (929)
|++|+|++.+|..|..+++|++|||++|+|++..|..+..+ ++|++|+|++|+|++..
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999999999999999999999999999999999988 68999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=401.18 Aligned_cols=231 Identities=19% Similarity=0.248 Sum_probs=175.0
Q ss_pred CCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 662 NFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+++..+.||+|+||+||+|++. ...++|.+|+.++++++|||||+++|+|.+.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~---- 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ---- 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC----
Confidence 4556789999999999998752 12468999999999999999999999996543
Q ss_pred ceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL 775 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 775 (929)
..++|||||++|+|.++++... .++.|||+||+|||+. +||||||||+|||+
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 3799999999999999985321 2467999999999998 89999999999999
Q ss_pred cCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCch
Q 002376 776 DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPEN 854 (929)
Q Consensus 776 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~ 854 (929)
++++.+||+|||+|+.+..... .......+||++|||||++.++.|+.++||||||+++||+.+ ...++.....
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~- 253 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 253 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-
T ss_pred CCCCCEEECCcccceeccCCCc----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999997643211 112334579999999999999999999999999988888654 2333322221
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.+ +...+...... +...++...+. +++.+||+.||++||||+||+++|+.+
T Consensus 254 -~~-----~~~~i~~~~~~-~~p~~~~~~~~-~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 -QD-----VVEMIRNRQVL-PCPDDCPAWVY-ALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HH-----HHHHHHTTCCC-CCCTTCCHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HH-----HHHHHHcCCCC-CCcccchHHHH-HHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11111111100 01112223333 488899999999999999999999864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=386.64 Aligned_cols=293 Identities=29% Similarity=0.502 Sum_probs=229.1
Q ss_pred cCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCC--CcceeeCCCC--CcEEEEEcCCCCCcc--ccCCCCCCCCCC
Q 002376 24 VGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCT--WPGVICNNFG--NRVIGLNLSSFGLEG--TISPHIGNLSFL 97 (929)
Q Consensus 24 ~~~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~i~~~l~~L~~L 97 (929)
.|.++|++||++||+++.+ |. .+++|+.+.+||. |.||+|+..+ ++|+.|+|++++++| .+|+.|+++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~--~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGN--PT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTC--CG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCC--cc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 5889999999999999853 44 7899998889998 9999999765 799999999999999 999999999999
Q ss_pred CEEEeec-CCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEcc
Q 002376 98 RSIQLQN-NKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176 (929)
Q Consensus 98 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 176 (929)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|.. |.++++|++|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS-ISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG-GGGCTTCCEEECC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChH-HhcCCCCCeEECc
Confidence 9999995 9999999999999999999999999999999999999999999999999998777665 8888888888888
Q ss_pred ccccCCCCCccccccCCCccCCCC-cccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceee
Q 002376 177 KNLLWGSIPPSIANLIPSDLSRLE-NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255 (929)
Q Consensus 177 ~N~l~~~~p~~i~~l~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~ 255 (929)
+|++++.+|.. |..++ +|++|+|++|++++..|..|..++ |++|+|++|+++
T Consensus 158 ~N~l~~~~p~~--------l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~------------------ 210 (313)
T 1ogq_A 158 GNRISGAIPDS--------YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE------------------ 210 (313)
T ss_dssp SSCCEEECCGG--------GGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE------------------
T ss_pred CCcccCcCCHH--------HhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc------------------
Confidence 88876655543 34455 777777777777777777777665 777777666665
Q ss_pred ccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEc
Q 002376 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLAL 335 (929)
Q Consensus 256 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~L 335 (929)
+.+|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|
T Consensus 211 -------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------------------~~~l~~L~~L~L 251 (313)
T 1ogq_A 211 -------GDASVLFGSDKNTQKIHLAKNSLAFDLGK--------------------------------VGLSKNLNGLDL 251 (313)
T ss_dssp -------ECCGGGCCTTSCCSEEECCSSEECCBGGG--------------------------------CCCCTTCCEEEC
T ss_pred -------CcCCHHHhcCCCCCEEECCCCceeeecCc--------------------------------ccccCCCCEEEC
Confidence 34555566667777777777777655442 233455666666
Q ss_pred cCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCC
Q 002376 336 DGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388 (929)
Q Consensus 336 s~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 388 (929)
++|++++.+|..+..+. +|++|+|++|+++|.+|.. +.+++|+.|++++|.
T Consensus 252 s~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 252 RNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CSSCCEECCCGGGGGCT-TCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCCcccCcCChHHhcCc-CCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 66666666666666655 5666666666666666665 666666666676666
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=398.98 Aligned_cols=407 Identities=23% Similarity=0.263 Sum_probs=273.1
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCC-------------cEEeCCCCCCCCCccc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL-------------RVLNISFNNLQGELPV 137 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 137 (929)
.++..++++++++ |.+|+++++|++|++|+|++|.+.|.+|.+++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3788999999999 8999999999999999999999999999999999875 999999999996 444
Q ss_pred ccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccC
Q 002376 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVP 217 (929)
Q Consensus 138 ~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p 217 (929)
. .++|++|++++|++++ +|.. +++|++|++++|++++ +|. ..++|++|+|++|++++ +|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~-----------~~~~L~~L~L~~n~l~~-lp 147 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSD-----------LPPLLEYLGVSNNQLEK-LP 147 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCS-----------CCTTCCEEECCSSCCSS-CC
T ss_pred C---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccC-----------CCCCCCEEECcCCCCCC-Cc
Confidence 2 3789999999999996 7753 4899999999999864 221 01689999999999997 66
Q ss_pred CccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCC
Q 002376 218 STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297 (929)
Q Consensus 218 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 297 (929)
.|.++++|++|++++|++++ +|.. .++|++|++++|++++ +| .+.++++|+.|++++|.+++ +|... +
T Consensus 148 -~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~ 215 (454)
T 1jl5_A 148 -ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---L 215 (454)
T ss_dssp -CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---T
T ss_pred -ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---C
Confidence 59999999999999999984 6653 4589999999999998 56 68999999999999999996 45433 5
Q ss_pred ccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC
Q 002376 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377 (929)
Q Consensus 298 ~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 377 (929)
+|++|++++|.+..++ .+..+++|++|++++|++++ +|... .+|++|++++|++++ +|.. .+
T Consensus 216 ~L~~L~l~~n~l~~lp---------~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~N~l~~-l~~~---~~ 277 (454)
T 1jl5_A 216 SLESIVAGNNILEELP---------ELQNLPFLTTIYADNNLLKT-LPDLP----PSLEALNVRDNYLTD-LPEL---PQ 277 (454)
T ss_dssp TCCEEECCSSCCSSCC---------CCTTCTTCCEEECCSSCCSS-CCSCC----TTCCEEECCSSCCSC-CCCC---CT
T ss_pred cccEEECcCCcCCccc---------ccCCCCCCCEEECCCCcCCc-ccccc----cccCEEECCCCcccc-cCcc---cC
Confidence 8999999999987543 36788999999999999985 56532 479999999999986 5544 37
Q ss_pred cccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCC-CCCceecccCcccccccCcccccccccceecc
Q 002376 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANL-KKLNQIDLSGNELTGEIPISFGNFQSLLSIDL 456 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 456 (929)
+|++|++++|++++. |.. .++|++|++++|++++ ++ .+ ++|++|++++|++++ +|.. +++|++|++
T Consensus 278 ~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L 344 (454)
T 1jl5_A 278 SLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIA 344 (454)
T ss_dssp TCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred cCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEEC
Confidence 899999999999862 321 2689999999999985 22 23 589999999999986 5654 578999999
Q ss_pred cCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCC--CCCcchhcCcCcceeecccccccccCCccccCCCCCCEE
Q 002376 457 SNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG--NLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534 (929)
Q Consensus 457 s~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (929)
++|+++ .+ |. .+++|++|||++|++++ .+|.++++ |+.|.+.|.+|.. +++|++|
T Consensus 345 ~~N~l~-~l--------p~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L 401 (454)
T 1jl5_A 345 SFNHLA-EV--------PE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQL 401 (454)
T ss_dssp CSSCCS-CC--------CC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC------------------
T ss_pred CCCccc-cc--------cc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEE
Confidence 999987 34 33 35789999999999998 67776654 3457777788764 5789999
Q ss_pred ECCCCcCCC--cCCcccccCCCCCeEeCCCCcCcccCCCC
Q 002376 535 DLSSNKLSG--SIPSDLQNLQALRSLNLTFNNLEGVVPSE 572 (929)
Q Consensus 535 ~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (929)
|+++|++++ .+|.+ ++.|.+.+|.+.+.+|..
T Consensus 402 ~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 402 HVETNPLREFPDIPES------VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp ----------------------------------------
T ss_pred ECCCCcCCccccchhh------HhheeCcCcccCCccccC
Confidence 999999997 66644 566778999998877644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=395.31 Aligned_cols=364 Identities=21% Similarity=0.252 Sum_probs=273.3
Q ss_pred CcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEe
Q 002376 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIR 279 (929)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~ 279 (929)
++|++|+|++|++++..|..|.++++|++|+|++|.+.+.++...+..+++|++|++++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 35555556666665555556666666666666666665555555444566666666666666666677777777777777
Q ss_pred ccCccCcCCccCC--CCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcc-cccc
Q 002376 280 MTHNLLEGTLPPG--LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFS-NELS 356 (929)
Q Consensus 280 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-~~L~ 356 (929)
|++|.+++..|.. |..+++|++|++++|++...... ..+.++++|++|+|++|++++..|..+..+. .+|+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~ 183 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA------SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC------GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEE
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcc------cccCCCCcccEEeCCCCcccccChhhhhcccccccc
Confidence 7777777644433 77777777777777776654321 1256777888888888888877777766552 2688
Q ss_pred EEEecCCccccccCCCC--------CCCCcccEEEeeCCCCCcccCccccCC---CCCCEEEecCCcCCCCCcccccCCC
Q 002376 357 KLYLGGNHIYGKIPASI--------GRLRSLTLLDLSYNSISGEIPIEIGQL---QGLQVLGLAGNEIPGGIPNSLANLK 425 (929)
Q Consensus 357 ~L~Ls~N~l~~~~p~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~ 425 (929)
.|++++|.+.+..+..+ ..+++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+..
T Consensus 184 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------- 255 (455)
T 3v47_A 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------- 255 (455)
T ss_dssp EEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------
T ss_pred ccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------
Confidence 88888888876655443 356788888888888888777776554 77888888888765421
Q ss_pred CCceecccCcccccccCccccc--ccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhc
Q 002376 426 KLNQIDLSGNELTGEIPISFGN--FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN 503 (929)
Q Consensus 426 ~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~ 503 (929)
+..+.+.+..+..|.. .++|+.|++++|++++.+ |..+..+++|++|+|++|++++..|..|.+
T Consensus 256 ------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~--------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 321 (455)
T 3v47_A 256 ------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL--------KSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321 (455)
T ss_dssp ------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC--------TTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ------cchhhhccCcccccccccccCceEEEecCccccccc--------hhhcccCCCCCEEECCCCcccccChhHhcC
Confidence 1222333333334443 368999999999998654 677888999999999999999999999999
Q ss_pred CcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC-CCCCCCCccc
Q 002376 504 CKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE-GIFRNMSNVH 582 (929)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~l~~l~ 582 (929)
+++|++|+|++|++++..|..|+.+++|++|||++|++++..|..|.++++|++|+|++|++++.++.. ..+++++.++
T Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 401 (455)
T 3v47_A 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401 (455)
T ss_dssp CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEE
Confidence 999999999999999999999999999999999999999999999999999999999999999876654 5678999999
Q ss_pred ccCCCCCcC
Q 002376 583 LKGNPKLCL 591 (929)
Q Consensus 583 l~~N~~~c~ 591 (929)
+++|++.|.
T Consensus 402 l~~N~l~~~ 410 (455)
T 3v47_A 402 LHTNPWDCS 410 (455)
T ss_dssp CCSSCBCCC
T ss_pred ccCCCcccC
Confidence 999999885
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=400.80 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=185.5
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCC-ccccce
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRH-RNLVKL 707 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~H-pniv~l 707 (929)
++.++++...++|+..+.||+|+||+||+|++. ...++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 344566667789999999999999999998643 124579999999999965 999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCE
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPV 763 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~i 763 (929)
+|+|.+.+ ..+++|||||++|+|.++++..+ .++.|||+||+|||+. +|
T Consensus 134 ~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~i 206 (353)
T 4ase_A 134 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 206 (353)
T ss_dssp EEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ce
Confidence 99996533 23799999999999999996422 2356999999999998 99
Q ss_pred EecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch
Q 002376 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 764 iHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
|||||||+|||+++++.+||+|||+|+.+... .........+||+.|||||++.++.|+.++||||+||++||+.+
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~----~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTC----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccC----CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 99999999999999999999999999976322 11122345689999999999999999999999999988888653
Q ss_pred -hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhH-HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 844 -VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHD-CLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 844 -~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
+..++.... ..+.+...+.. .. +...++ +..++. +++.+||+.||++||||+||++.|+++.+..
T Consensus 283 ~G~~Pf~~~~--~~~~~~~~i~~----g~--~~~~p~~~~~~~~-~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 283 LGASPYPGVK--IDEEFCRRLKE----GT--RMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TSCCSSTTCC--CSHHHHHHHHH----TC--CCCCCTTCCHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCC--HHHHHHHHHHc----CC--CCCCCccCCHHHH-HHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 333332221 11111111211 11 111111 222333 3888999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=393.27 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=175.2
Q ss_pred CCCCceeecccCceeEEeccccC-----------cHHHHH--HHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------SWKSFI--AECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~--~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
+|...++||+|+||+||+|++.+ ..+.+. +|+..+.+++|||||+++|+|.+.+. ....+|+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEEecC
Confidence 56778999999999999998763 233444 45556678899999999999976442 23458999999
Q ss_pred cCCCCccccccccc-------cccccHHHHHHHhhhC-----CCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 729 LSNGSLGDWIHGER-------KNELDITSALDYLHND-----CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
|++|+|.++++... .++.|+|+||+|||++ +.++||||||||+|||+|+++.+||+|||+|+......
T Consensus 83 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 99999999997432 4478999999999986 25689999999999999999999999999998764321
Q ss_pred CCCCCccccceeccccccccccccCCC------CCCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhcc--C---hH
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGE------RPSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVL--D---PE 862 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~--~---~~ 862 (929)
.. ........+||++|||||++.+. .++.++||||+|+++||+.+...++....+ ...... + ..
T Consensus 163 ~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 163 DT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TE--ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred Cc--eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 11 11122346899999999999765 367899999999998887654333222111 111110 0 11
Q ss_pred HHHhhccc-----chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 863 LRQLMTSN-----ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 863 l~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
+....... .+......++...+.+ ++.+||+.||++||||+||+++|+++.++
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~-li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHH-HHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHH-HHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111100 0111111123333444 89999999999999999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=392.08 Aligned_cols=244 Identities=18% Similarity=0.175 Sum_probs=179.1
Q ss_pred hhCCCCCceeecccCceeEEeccccCc-----------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGS-----------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
..+.|+..++||+|+||+||+|++... ...+.+|+.++++++|||||++++++.+ ...+|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEe
Confidence 345678888999999999999987622 1223589999999999999999999854 345899999
Q ss_pred ecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEeccccccccccccCC
Q 002376 728 FLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~~~ 798 (929)
||++|+|.+++++.. .++.||+.||+|||++ +||||||||+|||++.+| .+||+|||+|+.+......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999997433 3467999999999998 999999999999999988 6999999999976432111
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLH 878 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 878 (929)
........++||+.|||||++.+..|+.++||||+||++|++..+..++..... .+++ ..+.. ... .....+
T Consensus 208 -~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~-~~i~~---~~~-~~~~~~ 279 (336)
T 4g3f_A 208 -KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--GPLC-LKIAS---EPP-PIREIP 279 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--SCCH-HHHHH---SCC-GGGGSC
T ss_pred -cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHH-HHHHc---CCC-CchhcC
Confidence 111122346899999999999999999999999999888777655544432211 1111 11111 111 001111
Q ss_pred HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 879 DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 879 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
..++..+++++.+||+.||++|||++|+++.|..+.+...
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 2233344457779999999999999999999988877654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.77 Aligned_cols=227 Identities=24% Similarity=0.357 Sum_probs=167.4
Q ss_pred CCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 664 SHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
+..++||+|+||+||+|.+.. ..+.|.+|++++++++|||||+++++|.+.. .....+|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 566789999999999997651 2457999999999999999999999985432 234568999
Q ss_pred EEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~ 796 (929)
||||++|+|.+++++.. .++.||+.||+|||++ .++||||||||+|||++ +++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 99999999999997432 3467999999999997 22499999999999998 479999999999985421
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
......+||+.|||||++.+ +|+.++||||+||++|++.++..++..... ..+ +......... ...
T Consensus 185 ------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~-----~~~~i~~~~~-~~~ 250 (290)
T 3fpq_A 185 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQ-----IYRRVTSGVK-PAS 250 (290)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHH-----HHHHHTTTCC-CGG
T ss_pred ------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHH-----HHHHHHcCCC-CCC
Confidence 12345689999999999865 699999999999888887666555533221 011 1111111100 001
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+.....-+++++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111122334777999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=389.38 Aligned_cols=227 Identities=22% Similarity=0.249 Sum_probs=175.1
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|+..+.||+|+||+||+|++. ...+.+.+|+++|++++|||||++++++.+. ..+|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 46888999999999999999875 2345688999999999999999999999653 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||||++|+|.++++..+ .++.||+.||+|||+. +||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 999999999999986432 3467999999999998 9999999999999999999999999999876322
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......+||+.|||||++.+..|+.++||||+||++|++..+..++..... .+.+. .+...... ....
T Consensus 224 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~-~i~~~~~~----~~~~ 292 (346)
T 4fih_A 224 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK-MIRDNLPP----RLKN 292 (346)
T ss_dssp ----SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH-HHHHSSCC----CCSC
T ss_pred ----CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH-HHHcCCCC----CCCc
Confidence 1223456899999999999999999999999999888887665555433221 11111 11111111 1111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..++..+++++.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1222333444777999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=391.31 Aligned_cols=227 Identities=22% Similarity=0.250 Sum_probs=175.2
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|+..+.||+|+||+||+|++. ...+.+.+|+.+|++++|||||+++++|.+. ..+|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 56899999999999999999865 2345688999999999999999999999653 35899
Q ss_pred EEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||||++|+|.++++..+ .++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 999999999999986432 3467999999999998 9999999999999999999999999999876322
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......+||+.|||||++.+..|+.++||||+||++|++..+..++..... .+.+. .+....... ...
T Consensus 301 ----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~-~i~~~~~~~----~~~ 369 (423)
T 4fie_A 301 ----VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK-MIRDNLPPR----LKN 369 (423)
T ss_dssp ----CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH-HHHHSCCCC----CSC
T ss_pred ----CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH-HHHcCCCCC----Ccc
Confidence 1223456899999999999999999999999999888877665555433221 11111 111111111 111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..++..+++++.+||+.||++|||++|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112233344777999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=380.36 Aligned_cols=225 Identities=23% Similarity=0.295 Sum_probs=174.1
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|++. ...+.+.+|++++++++|||||++++++.+ ...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 57999999999999999999765 124568899999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+|||||++|+|.+++++.. .++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.+.
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 899999999999999987432 3467999999999998 99999999999999999999999999999764
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ........++||+.|||||++.+..|+.++||||+||++|++..+..++.... ..+++...... ...
T Consensus 184 ~~----~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~----~~~- 252 (311)
T 4aw0_A 184 PE----SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKL----EYD- 252 (311)
T ss_dssp TT----TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT----CCC-
T ss_pred CC----CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC----CCC-
Confidence 22 11122345689999999999999999999999999988777665554443221 11222111111 111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
.++.++.-+++++.+|++.||++|||++|+.
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112223344577799999999999999874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=380.20 Aligned_cols=364 Identities=20% Similarity=0.217 Sum_probs=258.0
Q ss_pred CccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChh
Q 002376 83 LEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDD 162 (929)
Q Consensus 83 l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~ 162 (929)
..+..+.+++++++|++|+|++|.+++. | .|+.+++|++|+|++|+|++. | ++.+++|++|+|++|+|++ ++
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--
Confidence 3445556788888999999999988864 5 688888999999999998864 4 8888888888888888885 43
Q ss_pred hhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCc
Q 002376 163 QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPY 242 (929)
Q Consensus 163 ~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~ 242 (929)
++++++|++|++++|++++ + | ++.+++|++|++++|++++. .+.++++|++|++++|+..+.++
T Consensus 102 -~~~l~~L~~L~L~~N~l~~-l--------~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~- 165 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTK-L--------D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD- 165 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSC-C--------C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC-
T ss_pred -cCCCCcCCEEECCCCcCCe-e--------c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc-
Confidence 7788888888888887754 1 1 56777888888888888764 26677777777777775443332
Q ss_pred ccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCcccc
Q 002376 243 DVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFIT 322 (929)
Q Consensus 243 ~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~ 322 (929)
+..+++|+.|++++|++++ +| ++.+++|+.|++++|++...
T Consensus 166 --------------------------~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---------- 206 (457)
T 3bz5_A 166 --------------------------VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---------- 206 (457)
T ss_dssp --------------------------CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC----------
T ss_pred --------------------------cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee----------
Confidence 3344555555555555554 23 55555555555555555432
Q ss_pred ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCC
Q 002376 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402 (929)
Q Consensus 323 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 402 (929)
.+..+++|++|+|++|++++ +| +..++ +|+.|++++|++++.. ++.+++|+.|++++|+
T Consensus 207 ~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~-~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~-------------- 265 (457)
T 3bz5_A 207 DLNQNIQLTFLDCSSNKLTE-ID--VTPLT-QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD-------------- 265 (457)
T ss_dssp CCTTCTTCSEEECCSSCCSC-CC--CTTCT-TCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------
T ss_pred ccccCCCCCEEECcCCcccc-cC--ccccC-CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------
Confidence 24455667777777777765 45 45554 5777777777776643 3455667777766653
Q ss_pred CCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccC
Q 002376 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482 (929)
Q Consensus 403 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~ 482 (929)
|+.|++++|.+.+.+| +..+++|+.|++++|.+.+.+|. ...+|+.|++++| ++
T Consensus 266 L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~---------------------~~ 319 (457)
T 3bz5_A 266 LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN---------------------PK 319 (457)
T ss_dssp CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC---------------------TT
T ss_pred CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc---------------------cc
Confidence 4456677777666665 45677777888888777766664 3355666666555 36
Q ss_pred ccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCC
Q 002376 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTF 562 (929)
Q Consensus 483 L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (929)
|++|+|++|++++. + ++++++|+.|++++|+|++ ++.|..|++++|+++|. ..+..|..+++++
T Consensus 320 L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~ 383 (457)
T 3bz5_A 320 LVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTN 383 (457)
T ss_dssp CCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBT
T ss_pred CCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCcccccc
Confidence 88999999999984 3 8889999999999999986 35677788999999876 3556788899999
Q ss_pred CcCcccCCCC
Q 002376 563 NNLEGVVPSE 572 (929)
Q Consensus 563 N~l~~~~p~~ 572 (929)
|+++|.+|..
T Consensus 384 N~l~g~ip~~ 393 (457)
T 3bz5_A 384 NSLTIAVSPD 393 (457)
T ss_dssp TBEEEECCTT
T ss_pred CcEEEEcChh
Confidence 9999999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.35 Aligned_cols=225 Identities=21% Similarity=0.293 Sum_probs=167.9
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+ ...+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence 689999999999999999997651 24578999999999999999999999854 3458
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|+|||||++|+|.++++..+ .++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+.+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999986322 2367999999999998 9999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......+||+.|||||++.+..|+.++||||+||++|++..+..++.... ..+++........+ .
T Consensus 176 ~~~------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~---~ 244 (350)
T 4b9d_A 176 NST------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISGSFP---P 244 (350)
T ss_dssp CHH------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCC---C
T ss_pred cCC------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCC---C
Confidence 321 112345689999999999999999999999999988877665554443221 12222221221111 1
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... ++.-+++++.+||+.||++|||++|+++
T Consensus 245 ~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 2223344777999999999999999975
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=379.12 Aligned_cols=352 Identities=18% Similarity=0.211 Sum_probs=243.8
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|+++++.+++. | .++.+++|++|+|++|++++. | ++.+++|++|+|++|+|++. | ++++++|++|+|+
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECC
Confidence 688999999999974 4 799999999999999999975 4 99999999999999999975 4 8999999999999
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEe
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRL 231 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 231 (929)
+|++++ ++ ++++++|++|++++|++++. .++.+++|++|++++|+..+.+ .+..+++|++|++
T Consensus 115 ~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-----------~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 115 TNKLTK-LD---VSQNPLLTYLNCARNTLTEI-----------DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp SSCCSC-CC---CTTCTTCCEEECTTSCCSCC-----------CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred CCcCCe-ec---CCCCCcCCEEECCCCcccee-----------ccccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 999995 54 89999999999999998662 2678899999999999765555 5889999999999
Q ss_pred eecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccC
Q 002376 232 ASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311 (929)
Q Consensus 232 s~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 311 (929)
++|++++ +| ...+++|+.|++++|++++. .+..+++|+.|++++|++++ +| ++.+++|+.|++++|++..
T Consensus 178 s~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 178 SFNKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CSSCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 9999985 55 33477788888888887765 36777778888888887776 44 6666666666666666654
Q ss_pred CCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCc
Q 002376 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISG 391 (929)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 391 (929)
.+ +..+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|+|++|.+.+
T Consensus 248 ~~----------~~~l~~L~~L~l~~n---------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 248 LD----------VSTLSKLTTLHCIQT---------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CC----------CTTCTTCCEEECTTC---------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred cC----------HHHCCCCCEEeccCC---------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence 32 223445555555443 23444555555544444 3444555555555555444
Q ss_pred ccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCccc
Q 002376 392 EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILR 471 (929)
Q Consensus 392 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~ 471 (929)
.+|. ...+|+.|++++| ++|+.|++++|+|++ +
T Consensus 301 ~l~~---------------------------~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l------ 333 (457)
T 3bz5_A 301 LLDC---------------------------QAAGITELDLSQN-------------PKLVYLYLNNTELTE-L------ 333 (457)
T ss_dssp EEEC---------------------------TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-C------
T ss_pred eecc---------------------------CCCcceEechhhc-------------ccCCEEECCCCcccc-c------
Confidence 4432 2233444444433 345555555555553 1
Q ss_pred CCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCccc
Q 002376 472 PLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL 549 (929)
Q Consensus 472 ~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 549 (929)
+ ++.+++|+.||+++|++++ ++.|+.|++++|.++|. ..+..|+.+++++|+++|.+|..+
T Consensus 334 --~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 334 --D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp --C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred --c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 1 3445556666666665554 23455566666666654 233455666666666666666543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=365.58 Aligned_cols=223 Identities=26% Similarity=0.329 Sum_probs=158.6
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+ ..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence 3689999999999999999997651 23578999999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.+|+||||| +|+|.+++.+.. .+..||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 589999999 689999886433 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... ......+||+.|||||++.+..+ +.++||||+||++|++..+..++.... ..+++.. +.. ...
T Consensus 163 ~~~-------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~-i~~---~~~ 229 (275)
T 3hyh_A 163 TDG-------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKN-ISN---GVY 229 (275)
T ss_dssp -------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH-HHH---TCC
T ss_pred CCC-------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHH-HHc---CCC
Confidence 321 12334689999999999998886 579999999988777665554443211 1111111 111 111
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .++.++.-+++++.+|++.||++|||++|+++
T Consensus 230 ~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 11122233344777999999999999999976
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=369.85 Aligned_cols=234 Identities=20% Similarity=0.291 Sum_probs=161.3
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCC-------
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS------- 716 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~------- 716 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468889999999999999997651 23578899999999999999999999875432
Q ss_pred CCcceEEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEec
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
....++|+|||||++|+|.++++... .++.||+.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 12345799999999999999986432 2457999999999998 999999999999999999999999
Q ss_pred cccccccccccCCCC------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc
Q 002376 786 FGLARFLLERVDNQS------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL 859 (929)
Q Consensus 786 fGla~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~ 859 (929)
||+|+.+........ .....+..+||+.|||||++.+..|+.++||||+||++|++.. ++ ...... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf---~~~~~~-~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF---STQMER-V 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC---SSHHHH-H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC---CCccHH-H
Confidence 999997754322111 1112244689999999999999999999999999998888642 11 111100 0
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+....... .+....+..+.. .+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~~~~~~~--~p~~~~~~~~~~-~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 -RTLTDVRNLK--FPPLFTQKYPCE-YVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHTTC--CCHHHHHHCHHH-HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHhcCC--CCCCCcccCHHH-HHHHHHHcCCChhHCcCHHHHhc
Confidence 0011110000 011111111222 33778999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=368.12 Aligned_cols=119 Identities=26% Similarity=0.340 Sum_probs=52.1
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEE
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLN 174 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 174 (929)
++|+.|++++|.+. .+| .+..+++|++|+|++|.+++..| +.++++|++|+|++|++++ +++ +.++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc-Chh--hcCCCCCCEEE
Confidence 34444444444443 222 24444444444444444443322 4444444444444444442 221 44444444444
Q ss_pred ccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEee
Q 002376 175 FGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLA 232 (929)
Q Consensus 175 Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 232 (929)
|++|.+++. + .+..+++|++|+|++|++++. + .+.++++|++|+++
T Consensus 119 L~~n~l~~~---------~-~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~ 164 (466)
T 1o6v_A 119 LFNNQITDI---------D-PLKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG 164 (466)
T ss_dssp CCSSCCCCC---------G-GGTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE
T ss_pred CCCCCCCCC---------h-HHcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC
Confidence 444443221 0 134444555555555544432 1 24445555555553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=366.56 Aligned_cols=345 Identities=30% Similarity=0.414 Sum_probs=185.2
Q ss_pred CCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCcc
Q 002376 117 NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDL 196 (929)
Q Consensus 117 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~ 196 (929)
.+++|+.|++++|.++. +|. +..+++|++|||++|.+++ +++ +.++++|++|++++|.+.+.. + +
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~--------~--~ 108 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIADIT--------P--L 108 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCCG--------G--G
T ss_pred HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCC-chh--hhccccCCEEECCCCccccCh--------h--h
Confidence 45678888888888874 553 7788888888888888874 443 788888888888888775421 1 6
Q ss_pred CCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCccccccccc
Q 002376 197 SRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQ 276 (929)
Q Consensus 197 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~ 276 (929)
+.+++|++|+|++|++++..+ +.++++|++|+|++|.+++ ++ .+..+++|+
T Consensus 109 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~--------------------------~~~~l~~L~ 159 (466)
T 1o6v_A 109 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS--------------------------ALSGLTSLQ 159 (466)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG--------------------------GGTTCTTCS
T ss_pred cCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch--------------------------hhccCCccc
Confidence 677888888888888876544 7778888888888887763 22 133344444
Q ss_pred EEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcccccc
Q 002376 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS 356 (929)
Q Consensus 277 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~ 356 (929)
.|+++ |.+.+..+ +.++++|+.|++++|.+... ..+..+++|++|++++|++++..| ++.+. +|+
T Consensus 160 ~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~---------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~ 224 (466)
T 1o6v_A 160 QLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI---------SVLAKLTNLESLIATNNQISDITP--LGILT-NLD 224 (466)
T ss_dssp EEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC---------GGGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCC
T ss_pred EeecC-CcccCchh--hccCCCCCEEECcCCcCCCC---------hhhccCCCCCEEEecCCccccccc--ccccC-CCC
Confidence 44443 23332211 44444444444444443321 123445555555555555554333 33333 455
Q ss_pred EEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcc
Q 002376 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNE 436 (929)
Q Consensus 357 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 436 (929)
.|++++|++++. ..+..+++|++|++++|.+++..| +..+++|++|++++|++++..+ +..+++|+.|++++|+
T Consensus 225 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~ 298 (466)
T 1o6v_A 225 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred EEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCc
Confidence 555555555432 234445555555555555554332 4445555555555555544322 4444555555555555
Q ss_pred cccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccc
Q 002376 437 LTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQ 516 (929)
Q Consensus 437 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (929)
+++..+ +..+++|+.|++++|++++.. | +..+++|+.|++++|++++. ..+.++++|+.|++++|+
T Consensus 299 l~~~~~--~~~l~~L~~L~L~~n~l~~~~--------~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 299 LEDISP--ISNLKNLTYLTLYFNNISDIS--------P--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp CSCCGG--GGGCTTCSEEECCSSCCSCCG--------G--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred ccCchh--hcCCCCCCEEECcCCcCCCch--------h--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence 543322 344444444444444444321 1 33344444444444444432 234444444444444444
Q ss_pred ccccCCccccCCCCCCEEECCCCcCC
Q 002376 517 FSGPIPNIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 517 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (929)
+++.+| +..+++|+.|++++|+++
T Consensus 365 l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 365 ISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred cCccch--hhcCCCCCEEeccCCccc
Confidence 444333 344444444444444444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.45 Aligned_cols=219 Identities=25% Similarity=0.286 Sum_probs=161.3
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||+||+|+.. .....+.+|++++++++|||||++++++.+ .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 47999999999999999988642 113468899999999999999999999854 3
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..+|+|||||++|+|.+++++.. .++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 45899999999999999987433 3467999999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... .......+||+.|||||++.+..|+.++||||+||++|++.++..++.... ..+++...... ..
T Consensus 176 ~~~~------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~----~~ 243 (304)
T 3ubd_A 176 SIDH------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILKA----KL 243 (304)
T ss_dssp -----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----CC
T ss_pred ccCC------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHcC----CC
Confidence 5321 112334689999999999999999999999999988877766555443222 11111111111 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
. .++.++.-+++++.+||+.||++|||+
T Consensus 244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 G----MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 111222334447779999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=368.21 Aligned_cols=346 Identities=18% Similarity=0.183 Sum_probs=285.2
Q ss_pred eEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccc
Q 002376 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFN 307 (929)
Q Consensus 228 ~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 307 (929)
.++.++++++ .+|..+. ++++.|++++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4444555554 4444332 34556666666666666677777777888888888877777777888888888888888
Q ss_pred cccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCC
Q 002376 308 KIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYN 387 (929)
Q Consensus 308 ~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 387 (929)
++..++. ..|.++++|++|+|++|++++..|..+..+. +|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 91 ~l~~~~~-------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 162 (477)
T 2id5_A 91 RLKLIPL-------GVFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162 (477)
T ss_dssp CCCSCCT-------TSSTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred cCCccCc-------ccccCCCCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCC
Confidence 7776543 3567788999999999999888888888877 7999999999999999999999999999999999
Q ss_pred CCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCC
Q 002376 388 SISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPK 467 (929)
Q Consensus 388 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~ 467 (929)
++++..+..+..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|..+....+|+.|+|++|++++ +|
T Consensus 163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~- 240 (477)
T 2id5_A 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VP- 240 (477)
T ss_dssp CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCS-CC-
T ss_pred cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccc-cC-
Confidence 9998777789999999999999999998888899999999999999999888888777777799999999999974 32
Q ss_pred CcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCc
Q 002376 468 GILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547 (929)
Q Consensus 468 ~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 547 (929)
+..+..+++|+.|||++|.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus 241 ------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 314 (477)
T 2id5_A 241 ------YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314 (477)
T ss_dssp ------HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGG
T ss_pred ------HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHh
Confidence 35788899999999999999988888999999999999999999999999999999999999999999988778
Q ss_pred ccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCCC
Q 002376 548 DLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 548 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
.|..+++|+.|+|++|++++..+....+.....+.+.++...|..|
T Consensus 315 ~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 315 VFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp GBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred HcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 8899999999999999998765433333444456677777777544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=357.89 Aligned_cols=315 Identities=19% Similarity=0.201 Sum_probs=256.7
Q ss_pred CCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCC
Q 002376 81 FGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVT 160 (929)
Q Consensus 81 ~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~ 160 (929)
++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .++
T Consensus 21 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~ 96 (477)
T 2id5_A 21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIP 96 (477)
T ss_dssp CCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCC
T ss_pred CCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccC
Confidence 3444 5676654 68999999999999988999999999999999999999988999999999999999999998 688
Q ss_pred hhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcC
Q 002376 161 DDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240 (929)
Q Consensus 161 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i 240 (929)
...|.++++|++|+|++|++.+ +.|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+++ .+
T Consensus 97 ~~~~~~l~~L~~L~Ls~n~i~~--------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~ 167 (477)
T 2id5_A 97 LGVFTGLSNLTKLDISENKIVI--------LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SI 167 (477)
T ss_dssp TTSSTTCTTCCEEECTTSCCCE--------ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS-SC
T ss_pred cccccCCCCCCEEECCCCcccc--------CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc-cc
Confidence 8779999999999999998754 34566788999999999999999999999999999999999999998 45
Q ss_pred CcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCcc
Q 002376 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSF 320 (929)
Q Consensus 241 p~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~ 320 (929)
|...+..+++|+.|++++|++++..+..|..+++|+.|++++|.+.+.+|..+.
T Consensus 168 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~-------------------------- 221 (477)
T 2id5_A 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL-------------------------- 221 (477)
T ss_dssp CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT--------------------------
T ss_pred ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc--------------------------
Confidence 655555577777777777777776666777777777777777666555553322
Q ss_pred ccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCC
Q 002376 321 ITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQL 400 (929)
Q Consensus 321 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 400 (929)
...+|++|+|++|++++..+..+..+. +|+.|+|++|.|++..+..|.++++|++|+|++|++++..|..|..+
T Consensus 222 -----~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 295 (477)
T 2id5_A 222 -----YGLNLTSLSITHCNLTAVPYLAVRHLV-YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295 (477)
T ss_dssp -----TTCCCSEEEEESSCCCSCCHHHHTTCT-TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC
T ss_pred -----cCccccEEECcCCcccccCHHHhcCcc-ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc
Confidence 234677777777777733224555555 78888888888888878888888888888888888888888888888
Q ss_pred CCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccc
Q 002376 401 QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440 (929)
Q Consensus 401 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 440 (929)
++|++|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 296 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp TTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred ccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 8888888888888887777888888888899988888753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.43 Aligned_cols=349 Identities=17% Similarity=0.178 Sum_probs=232.9
Q ss_pred CCCCCCCCCCCC-CcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCC
Q 002376 49 LSYWNPSSSPCT-WPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNIS 127 (929)
Q Consensus 49 l~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 127 (929)
+++|.++.+||. |.+..|.....++ ............-..++++++|++++|.++...+..|..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 578988777774 4444443222122 2222222223334457899999999999986555567899999999999
Q ss_pred CCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEe
Q 002376 128 FNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDL 207 (929)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~L 207 (929)
+|.+++..|..|..+++|++|+|++|+++ .+++..|+++++|++|+|++|++.. +.+..|..+++|++|+|
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~--------l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS--------LPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCC--------CCTTTTTTCTTCCEEEC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEEECCCCccCc--------CCHHHhcCCCCCcEEEC
Confidence 99999888889999999999999999998 4666669999999999999998752 23344688999999999
Q ss_pred ecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcC
Q 002376 208 TINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG 287 (929)
Q Consensus 208 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 287 (929)
++|++++..|..|.++++|++|+|++|++++ ++ ...+++|+.+++++|.+++. ....+|+.|++++|.++.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~---~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINV 219 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CC---GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCE
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCc-cc---cccccccceeeccccccccc-----CCCCcceEEECCCCeeee
Confidence 9999999889999999999999999999984 33 22366777777777766542 233456666666666653
Q ss_pred CccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCcccc
Q 002376 288 TLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYG 367 (929)
Q Consensus 288 ~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~ 367 (929)
. |.. ..++|++|+|++|++++. ..+..++ +|++|+|++|.+++
T Consensus 220 ~-~~~---------------------------------~~~~L~~L~l~~n~l~~~--~~l~~l~-~L~~L~Ls~n~l~~ 262 (390)
T 3o6n_A 220 V-RGP---------------------------------VNVELTILKLQHNNLTDT--AWLLNYP-GLVEVDLSYNELEK 262 (390)
T ss_dssp E-ECC---------------------------------CCSSCCEEECCSSCCCCC--GGGGGCT-TCSEEECCSSCCCE
T ss_pred c-ccc---------------------------------ccccccEEECCCCCCccc--HHHcCCC-CccEEECCCCcCCC
Confidence 3 211 124555555555555532 3444444 56666666666666
Q ss_pred ccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccc
Q 002376 368 KIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGN 447 (929)
Q Consensus 368 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 447 (929)
..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++.. | +..
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~ 337 (390)
T 3o6n_A 263 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LST 337 (390)
T ss_dssp EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chh
Confidence 666666666666666666666653 3445556666666666666665 3455556666666666666666543 2 455
Q ss_pred ccccceecccCCcCC
Q 002376 448 FQSLLSIDLSNNRIN 462 (929)
Q Consensus 448 l~~L~~L~Ls~N~l~ 462 (929)
+++|+.|++++|+++
T Consensus 338 ~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 338 HHTLKNLTLSHNDWD 352 (390)
T ss_dssp TCCCSEEECCSSCEE
T ss_pred hccCCEEEcCCCCcc
Confidence 666666666666665
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=359.84 Aligned_cols=350 Identities=17% Similarity=0.198 Sum_probs=259.8
Q ss_pred CCCCCCCCCCCCCCC----CcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCC
Q 002376 46 SSPLSYWNPSSSPCT----WPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL 121 (929)
Q Consensus 46 ~~~l~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 121 (929)
...+++|.++.+||. |.++.|+. ++ +...... ..+..-..+++++.|++++|.+....+..|.++++|
T Consensus 6 ~~~l~~~~~~~~C~~~~~~~~c~~~~~---~i---~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L 77 (597)
T 3oja_B 6 RYNVKPRQPEYKCIDSNLQYDCVFYDV---HI---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77 (597)
T ss_dssp -----CCCSEECCCCC--CCSEEECSC---EE---CSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred cccccCCCCCCcCcccCcCceeEecCc---ee---ccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence 456789998888774 66666542 11 1111111 122223357899999999999987666678899999
Q ss_pred cEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCc
Q 002376 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLEN 201 (929)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~ 201 (929)
++|+|++|.|++..|..|+.+++|++|+|++|.|++ +++..|+++++|++|+|++|.+++ +.+..|+.+++
T Consensus 78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~--------l~~~~~~~l~~ 148 (597)
T 3oja_B 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSS--------LPRGIFHNTPK 148 (597)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCC--------CCTTTTTTCTT
T ss_pred cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEEeeCCCCCC--------CCHHHhccCCC
Confidence 999999999998888899999999999999999985 666668999999999999998753 23345688999
Q ss_pred ccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEecc
Q 002376 202 LKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMT 281 (929)
Q Consensus 202 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls 281 (929)
|++|+|++|++++..|..|.++++|++|+|++|.+++ ++ ...+++|+.+++++|.+++. ....+|+.|+++
T Consensus 149 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls 219 (597)
T 3oja_B 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDAS 219 (597)
T ss_dssp CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECC
T ss_pred CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cC---hhhhhhhhhhhcccCccccc-----cCCchhheeecc
Confidence 9999999999999999999999999999999999884 33 22256666666666665532 233455556666
Q ss_pred CccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEec
Q 002376 282 HNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLG 361 (929)
Q Consensus 282 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls 361 (929)
+|.++...+. ..++|+.|+|++|.+++ +..+..++ +|+.|+|+
T Consensus 220 ~n~l~~~~~~----------------------------------~~~~L~~L~L~~n~l~~--~~~l~~l~-~L~~L~Ls 262 (597)
T 3oja_B 220 HNSINVVRGP----------------------------------VNVELTILKLQHNNLTD--TAWLLNYP-GLVEVDLS 262 (597)
T ss_dssp SSCCCEEECS----------------------------------CCSCCCEEECCSSCCCC--CGGGGGCT-TCSEEECC
T ss_pred CCcccccccc----------------------------------cCCCCCEEECCCCCCCC--ChhhccCC-CCCEEECC
Confidence 6555432211 12467777777777775 35666666 68888888
Q ss_pred CCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCccccccc
Q 002376 362 GNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEI 441 (929)
Q Consensus 362 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 441 (929)
+|.+++.+|..|+.+++|++|+|++|.+++ +|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|.+++.
T Consensus 263 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~- 339 (597)
T 3oja_B 263 YNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 339 (597)
T ss_dssp SSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-
T ss_pred CCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-
Confidence 888888888888888888888888888875 5666777888888888888887 5677778888888888888888754
Q ss_pred CcccccccccceecccCCcCCC
Q 002376 442 PISFGNFQSLLSIDLSNNRING 463 (929)
Q Consensus 442 p~~~~~l~~L~~L~Ls~N~l~g 463 (929)
| +..+++|+.|++++|.+++
T Consensus 340 ~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 340 K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp C--CCTTCCCSEEECCSSCEEH
T ss_pred C--hhhcCCCCEEEeeCCCCCC
Confidence 2 5667888888888888875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.12 Aligned_cols=182 Identities=24% Similarity=0.353 Sum_probs=146.3
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~ 721 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|+++|++++|||||++++++..... .....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999997651 23568899999999999999999999865432 23356
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+|||||+ |+|.+++...+ .++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 78999887443 3467999999999998 99999999999999999999999999998764
Q ss_pred cccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.... .........+||+.|||||++.+. .++.++||||+||++|++.++..++
T Consensus 210 ~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 210 TSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp --------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred cCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 2211 111223456899999999998876 4699999999999888876665444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.54 Aligned_cols=183 Identities=22% Similarity=0.240 Sum_probs=145.7
Q ss_pred HhhCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCc
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~ 719 (929)
+..+.|+..+.||+|+||+||+|+.+ ....++.+|+++++.+ +|||||++++++.+ .
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-----~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-----N 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----T
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----C
Confidence 44678999999999999999998642 2345788999999998 69999999999854 3
Q ss_pred ceEEEEEEecCCCCccccccc-----cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEeccccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLL 793 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~-----~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfGla~~~~ 793 (929)
.++|+|||||++|+|.++++. .+.+..|++.||+|||+. +||||||||+|||++.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 458999999999999998863 345578999999999998 99999999999999876 799999999998653
Q ss_pred cccCCC----------------------CCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQ----------------------SSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~----------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
...... .........+||++|||||++.+.. |+.++||||+||++|++.++..++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 211100 0001123457999999999998764 899999999999888876665544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.85 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=242.6
Q ss_pred CCCCEEEccCCcccc--ccCchhhhccccccEEEecC-CccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCC
Q 002376 328 THLNYLALDGNQFEG--KIPESIGNFSNELSKLYLGG-NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 404 (929)
.+++.|+|++|++++ .+|..+..+. +|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 578999999999999 8999999987 899999995 999999999999999999999999999999999999999999
Q ss_pred EEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccc-ccceecccCCcCCCCCCCCcccCCchhhhcccCc
Q 002376 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQ-SLLSIDLSNNRINGNIPKGILRPLPEEISRLENV 483 (929)
Q Consensus 405 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L 483 (929)
+|+|++|++++.+|..+..+++|++|+|++|++++.+|..|..++ +|+.|++++|++++.+ |..+..++ |
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~--------~~~~~~l~-L 199 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI--------PPTFANLN-L 199 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC--------CGGGGGCC-C
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccC--------ChHHhCCc-c
Confidence 999999999999999999999999999999999999999999998 9999999999998766 67778887 9
Q ss_pred cEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCC
Q 002376 484 VTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 484 ~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (929)
+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus 200 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred cEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 9999999999999999999999999999999999988776 889999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCCCcccccCCCCCcCCC
Q 002376 564 NLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 564 ~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
+++|.+|....+++++.+++.+||++|+.|
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cccccCCCCccccccChHHhcCCCCccCCC
Confidence 999999999889999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=363.72 Aligned_cols=224 Identities=22% Similarity=0.263 Sum_probs=166.5
Q ss_pred CCCCCceeecccCceeEEeccccCc-------------------HHHHHHH---HHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAE---CETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E---~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..++||+|+||+||+|+...+ ...+.+| +.+++.++|||||++++++.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----- 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-----
Confidence 5799999999999999999986521 1223334 566777899999999999954
Q ss_pred cceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...+|+|||||+||+|.+++... +.++.||+.||+|||+. +||||||||+|||++.+|.+||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 34599999999999999998743 24478999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
.+... .....+||+.|||||++.+ ..|+.++||||+||++|++..+..++..... ...++. .....
T Consensus 341 ~~~~~--------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~ 408 (689)
T 3v5w_A 341 DFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT 408 (689)
T ss_dssp ECSSC--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHH
T ss_pred ecCCC--------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcC
Confidence 76321 1234689999999999975 5799999999999888877665555532211 111111 11111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.... .++.++.-+++++.+|++.||++|++ ++||.+
T Consensus 409 ~~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111 11223333445777999999999998 677753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=328.19 Aligned_cols=275 Identities=20% Similarity=0.230 Sum_probs=213.7
Q ss_pred CCcCChhhHHHHHHHHhhcCCCCCCCCCCCC----CCCCCCCCCcceeeCC--------CCCcEEEEEcCCCCCccccCC
Q 002376 22 ASVGINTDKEALMSFKSQISQESPSSPLSYW----NPSSSPCTWPGVICNN--------FGNRVIGLNLSSFGLEGTISP 89 (929)
Q Consensus 22 ~~~~~~~~~~aLl~~k~~~~~~~~~~~l~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~i~~ 89 (929)
.+.+..+|++||++||+++..+ +.+.+++| +...++|.|.|+.|+. ...+|+.|+|++++++ .+|+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~-~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNAD-RNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHC-CTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccccCchHHHHHHHHHHhccCC-chhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 3556689999999999998655 66778899 4567899999999953 2347888888888887 7888
Q ss_pred CCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhh------
Q 002376 90 HIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQ------ 163 (929)
Q Consensus 90 ~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~------ 163 (929)
.++++++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..|+++++|++|+|++|++.+.+|...
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 8888888888888888888 88888888888888888888888 778888888888888888888777777652
Q ss_pred --hccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCC
Q 002376 164 --LRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIP 241 (929)
Q Consensus 164 --~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 241 (929)
|.++++|++|+|++|+++ .+ |..|+.+++|++|+|++|++++ +|..|.++++|++|+|++|++.+.+|
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~-~l--------p~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p 246 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR-SL--------PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYP 246 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC-CC--------CGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCC
T ss_pred hhhccCCCCCEEECcCCCcC-cc--------hHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhH
Confidence 234788888888888774 33 3445667788888888888875 45567788888888888888777777
Q ss_pred cccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccC
Q 002376 242 YDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311 (929)
Q Consensus 242 ~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 311 (929)
..+.. +++|+.|++++|++.+.+|..+.++++|+.|+|++|++.+.+|..++++++|+.+++..|.+..
T Consensus 247 ~~~~~-l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 247 PIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CCTTC-CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred HHhcC-CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 66554 7788888888888888888778888888888888888877888777777777777777665543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=330.43 Aligned_cols=335 Identities=19% Similarity=0.207 Sum_probs=176.7
Q ss_pred CCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEE
Q 002376 199 LENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQII 278 (929)
Q Consensus 199 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L 278 (929)
+.++++|++++|.++...+..|.++++|++|+|++|+++ .++...+..+++|++|++++|++++..|..|.++++|++|
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 566777777777776555555666777777777777766 3333333345666666666666665555556666666666
Q ss_pred eccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEE
Q 002376 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358 (929)
Q Consensus 279 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L 358 (929)
+|++|.++...+..|.++++|++|++++|++..... ..+.++++|++|++++|++++. + +..++ +|+.|
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-------~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~-~L~~L 191 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED-------DTFQATTSLQNLQLSSNRLTHV-D--LSLIP-SLFHA 191 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT-------TTTSSCTTCCEEECCSSCCSBC-C--GGGCT-TCSEE
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh-------hhccCCCCCCEEECCCCcCCcc-c--ccccc-cccee
Confidence 666666654433344555555555555555544322 2344455555555555555432 1 22222 44555
Q ss_pred EecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc
Q 002376 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438 (929)
Q Consensus 359 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 438 (929)
++++|.+++. ...++|++|++++|.++.. |.. ..+ +|+.|++++|+++
T Consensus 192 ~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~------------------------~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 192 NVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNV------------------------ELTILKLQHNNLT 239 (390)
T ss_dssp ECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCS------------------------SCCEEECCSSCCC
T ss_pred eccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccc------------------------cccEEECCCCCCc
Confidence 5555544432 1122444444444444422 211 123 4444444444444
Q ss_pred cccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccccc
Q 002376 439 GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFS 518 (929)
Q Consensus 439 ~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (929)
+. ..+.++++|+.|+|++|++++.. |..+..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++
T Consensus 240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~ 308 (390)
T 3o6n_A 240 DT--AWLLNYPGLVEVDLSYNELEKIM--------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308 (390)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCEEE--------SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred cc--HHHcCCCCccEEECCCCcCCCcC--------hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce
Confidence 32 23444444444455444444322 3344444455555555555543 3344455566666666666665
Q ss_pred ccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCCC
Q 002376 519 GPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 519 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
.+|..+..+++|++|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|..+
T Consensus 309 -~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 309 -HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred -ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 3444555666666677777666643 2 55566777777777777664211 234555556667777777543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=362.93 Aligned_cols=228 Identities=21% Similarity=0.260 Sum_probs=172.2
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||+||+|++.. ..+.+.+|+++|+.++|||||++++++.+ ...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 3689999999999999999987651 24568899999999999999999999954 34589
Q ss_pred EEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC--CceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE--MTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~ki~DfGla~~~ 792 (929)
+|||||++|+|.+++... +.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999999988533 23467999999999998 99999999999999854 89999999999976
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ......+||+.|||||++.+..|+.++||||+||++|++..+..++..... .+.+ .........
T Consensus 308 ~~~-------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~----~~i~~~~~~ 374 (573)
T 3uto_A 308 DPK-------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETL----RNVKSCDWN 374 (573)
T ss_dssp CTT-------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH----HHHHTTCCC
T ss_pred cCC-------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH----HHHHhCCCC
Confidence 321 223456899999999999999999999999999887776554444322211 1111 111111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+..+++-+++++.+||+.||++|||++|+++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111122333344777999999999999999976
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=349.78 Aligned_cols=335 Identities=19% Similarity=0.216 Sum_probs=189.8
Q ss_pred CCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEE
Q 002376 199 LENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQII 278 (929)
Q Consensus 199 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L 278 (929)
+.+++.|++++|.+..+.+..|.++++|++|+|++|.|++ ++...+..+++|+.|++++|.+++..|..|.++++|++|
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 5677777777777776666666777777777777777763 332223335666666666666666555555666666666
Q ss_pred eccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEE
Q 002376 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358 (929)
Q Consensus 279 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L 358 (929)
+|++|.|++..+..|+++++|++|++++|.+ ++..|..+..+. +|++|
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l-------------------------------~~~~~~~~~~l~-~L~~L 176 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-------------------------------ERIEDDTFQATT-SLQNL 176 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-------------------------------CBCCTTTTTTCT-TCCEE
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcC-------------------------------CCCChhhhhcCC-cCcEE
Confidence 6666666544444445555555555555554 444444444433 34444
Q ss_pred EecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc
Q 002376 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438 (929)
Q Consensus 359 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 438 (929)
+|++|.+++.. ++.+++|+.|++++|.+++ +...++|+.|++++|.++...+. + .++|+.|+|++|.++
T Consensus 177 ~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~ 245 (597)
T 3oja_B 177 QLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLT 245 (597)
T ss_dssp ECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCC
T ss_pred ECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCC
Confidence 44444444321 2334444455555554442 12233455555555554422111 1 134555555555555
Q ss_pred cccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccccc
Q 002376 439 GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFS 518 (929)
Q Consensus 439 ~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (929)
+ +..+..+++|+.|+|++|.+++.+ |..++.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++
T Consensus 246 ~--~~~l~~l~~L~~L~Ls~N~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 246 D--TAWLLNYPGLVEVDLSYNELEKIM--------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCCEEE--------SGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred C--ChhhccCCCCCEEECCCCccCCCC--------HHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC
Confidence 3 234555555555555555555433 4445555555666666665554 3445555667777777777776
Q ss_pred ccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcCCC
Q 002376 519 GPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 519 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
.+|..+..+++|++|+|++|++++. | +..+++|+.|++++|++++..+. ..+..+....+.+++..|+.+
T Consensus 315 -~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 315 -HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred -ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 4555666777777777777777654 2 55667788888888888765322 235556666677888888754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.28 Aligned_cols=307 Identities=25% Similarity=0.373 Sum_probs=203.9
Q ss_pred cCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccc
Q 002376 196 LSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNI 275 (929)
Q Consensus 196 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L 275 (929)
+..+++|+.|++++|.+... + .+..+++|++|+|++|++++ +|. +..+++|++|++++|+++.. ..+.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 34567777777777777643 3 36677777777777777762 332 23345555555555554432 134444444
Q ss_pred cEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccc
Q 002376 276 QIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNEL 355 (929)
Q Consensus 276 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L 355 (929)
++|++++|.+++.. .+..+++|++|++++|.....++ .+..+. +|
T Consensus 113 ~~L~l~~n~i~~~~---------------------------------~~~~l~~L~~L~l~~n~~~~~~~-~~~~l~-~L 157 (347)
T 4fmz_A 113 RELYLNEDNISDIS---------------------------------PLANLTKMYSLNLGANHNLSDLS-PLSNMT-GL 157 (347)
T ss_dssp SEEECTTSCCCCCG---------------------------------GGTTCTTCCEEECTTCTTCCCCG-GGTTCT-TC
T ss_pred CEEECcCCcccCch---------------------------------hhccCCceeEEECCCCCCccccc-chhhCC-CC
Confidence 44444444444321 24455556666666664443332 244444 56
Q ss_pred cEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCc
Q 002376 356 SKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435 (929)
Q Consensus 356 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 435 (929)
++|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|
T Consensus 158 ~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231 (347)
T ss_dssp CEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred cEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence 666666666664433 6667777777777777765433 6677777777777777775544 677777888888888
Q ss_pred ccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccc
Q 002376 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYN 515 (929)
Q Consensus 436 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (929)
++++..+ +..+++|+.|++++|++++ + +.+..+++|++|++++|++++. ..+..+++|++|++++|
T Consensus 232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~-~---------~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n 297 (347)
T 4fmz_A 232 KITDLSP--LANLSQLTWLEIGTNQISD-I---------NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNN 297 (347)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCC-C---------GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred ccCCCcc--hhcCCCCCEEECCCCccCC-C---------hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCC
Confidence 7775443 7777888888888887764 1 3466777888888888888764 45788888888888888
Q ss_pred cccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCc
Q 002376 516 QFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
++++..|..++.+++|++|+|++|++++..| +..+++|++|++++|.++
T Consensus 298 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8888888888888889999999998887665 788888899999888875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=327.98 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=185.2
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCccccceeeecccC
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHRNLVKLITSCSSL 714 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 714 (929)
++++.++..++++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++||||+++++++...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4555667778999999999999999999998754 2346789999999999999999999998543
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 108 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 108 -----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp -----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEE
T ss_pred -----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEE
Confidence 34799999999999999986432 2367899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccCh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDP 861 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~ 861 (929)
|+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++.....++..... ........
T Consensus 180 l~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 180 ITDFGISKKGTELD----QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp ECCCTTCEECSSSS----CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred Eeeccccccccccc----ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999998643211 11122345699999999999989999999999999888776555444322111 10000000
Q ss_pred HHHHh----hcc--cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 862 ELRQL----MTS--NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 862 ~l~~~----~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
..... ... ...............+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 00000 000 0000001111222333348889999999999999999999998865
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.04 Aligned_cols=319 Identities=23% Similarity=0.331 Sum_probs=221.1
Q ss_pred cccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCce
Q 002376 149 DLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVH 228 (929)
Q Consensus 149 ~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 228 (929)
.+..+.+++. ..+..+++|+.|++++|.+.. ++ .+..+++|++|+|++|++++..+ |.++++|++
T Consensus 28 ~~~~~~~~~~---~~~~~l~~L~~L~l~~~~i~~---------~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~ 92 (347)
T 4fmz_A 28 VLQKASVTDV---VTQEELESITKLVVAGEKVAS---------IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92 (347)
T ss_dssp HHTCSCTTSE---ECHHHHTTCSEEECCSSCCCC---------CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hccccccCCc---ccchhcccccEEEEeCCcccc---------ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCE
Confidence 3444555422 236788999999999998743 12 36789999999999999997655 999999999
Q ss_pred EEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecccccc
Q 002376 229 LRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNK 308 (929)
Q Consensus 229 L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 308 (929)
|+|++|.+++ +| .+..+++|++|++++|++++..+ +..+++|+.|++++|.....++. +..+++|++|++++|.
T Consensus 93 L~L~~n~i~~-~~--~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~ 166 (347)
T 4fmz_A 93 LYIGTNKITD-IS--ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK 166 (347)
T ss_dssp EECCSSCCCC-CG--GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSC
T ss_pred EEccCCcccC-ch--HHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCC
Confidence 9999999984 54 35569999999999999987654 88999999999999966544442 5555555555555555
Q ss_pred ccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCC
Q 002376 309 IVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388 (929)
Q Consensus 309 i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 388 (929)
+.... .+..+++ |++|++++|.+.+..+ +..+++|++|++++|.
T Consensus 167 ~~~~~---------~~~~l~~-------------------------L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 167 VKDVT---------PIANLTD-------------------------LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp CCCCG---------GGGGCTT-------------------------CSEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred cCCch---------hhccCCC-------------------------CCEEEccCCccccccc--ccCCCccceeecccCC
Confidence 43321 1333444 5555555555543322 5556666666666666
Q ss_pred CCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCC
Q 002376 389 ISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKG 468 (929)
Q Consensus 389 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~ 468 (929)
+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 211 l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~---- 280 (347)
T 4fmz_A 211 ITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI---- 280 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC----
T ss_pred CCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC----
Confidence 664433 5666666666666666665433 66667777777777776643 3466677777777777776531
Q ss_pred cccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCC
Q 002376 469 ILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 469 ~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 542 (929)
..+..+++|+.|++++|.+++..|..++.+++|++|++++|++++..| +..+++|+.||+++|.|+
T Consensus 281 ------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 281 ------SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ------GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ------hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 235667777777787777777777777888888888888888877666 777888888888888775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.34 Aligned_cols=245 Identities=20% Similarity=0.316 Sum_probs=178.2
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|...+.||+|+||.||+|++.. ..+.|.+|++++++++||||+++++++.+. ...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 3578889999999999999987641 246788999999999999999999999643 3489
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999999999987422 2367999999999998 999999999999999999999999999987643
Q ss_pred ccCCCC--------CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 795 RVDNQS--------SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 795 ~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
...... ........+||+.|+|||++.+..++.++||||+|++++++.....++......... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~ 239 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-FGLNVRGF 239 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-SSBCHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-Hhhhhhcc
Confidence 211110 001112457999999999999999999999999998777754433322221111000 01111111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
..... ....++.+. +++.+||+.||++|||++|+++.|+++++....
T Consensus 240 ~~~~~--~~~~~~~l~----~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 240 LDRYC--PPNCPPSFF----PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHTC--CTTCCTTHH----HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ccccC--CCCCCHHHH----HHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11000 111112222 377799999999999999999999999887653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.77 Aligned_cols=251 Identities=20% Similarity=0.229 Sum_probs=179.3
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|+..++||+|+||.||+|++.+ ....+.+|+.++++++|||||++++++..... .....++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEEEE
Confidence 4688899999999999999997652 13356678889999999999999999876432 234579999
Q ss_pred EecCCCCccccccccc-------cccccHHHHHHHhhhC-------CCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 727 EFLSNGSLGDWIHGER-------KNELDITSALDYLHND-------CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~-------~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
||+++|+|.++++... .++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|||+|+..
T Consensus 102 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 102 AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred ecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 9999999999987432 3467999999999985 1348999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCC-----CCCCCCCCCCCcCCCCCcchhHHhhhcCCc----hhh----hcc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGE-----RPSTAGDVPTSESFAGEFNIVKWVESNLPE----NVL----QVL 859 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~----~~~----~~~ 859 (929)
..... ........||+.|+|||++.+. .++.++||||+|++++++.....++....+ ... ...
T Consensus 182 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 182 EAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 43211 1122335799999999999873 466788999999888887665444432111 000 000
Q ss_pred Ch-HHHHhhccc-c----hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 860 DP-ELRQLMTSN-E----SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 860 ~~-~l~~~~~~~-~----~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.. .+....... . ........+..++. +++.+||+.||++|||++||+++|+++.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC-ETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHH-HHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 111100000 0 00001112222333 488899999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=321.56 Aligned_cols=228 Identities=23% Similarity=0.248 Sum_probs=172.4
Q ss_pred hCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+|.+. ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 458999999999999999999653 2356788999999999999999999998653 3489
Q ss_pred EEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
+||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999999998643 23467899999999998 99999999999999999999999999998653221
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.......||+.|+|||++.+..++.++||||+|++++++.....++..... .+........ ......
T Consensus 171 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~-----~~~~~~ 237 (297)
T 3fxz_A 171 ------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATN-----GTPELQ 237 (297)
T ss_dssp ------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHH-----CSCCCS
T ss_pred ------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC-----CCCCCC
Confidence 122345799999999999999999999999999877776554444322211 0000000000 000111
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.++.+...+++++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11222333444777999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.58 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=173.4
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHHc--cCCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRN--VRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|+..+.||+|+||.||+|++.+ ..+.+.+|.+++.. ++||||+++++++.... ......++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEEeh
Confidence 4678999999999999999997652 34567778777776 79999999999976533 2345689999
Q ss_pred EecCCCCccccccccc-------cccccHHHHHHHhh--------hCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 727 EFLSNGSLGDWIHGER-------KNELDITSALDYLH--------NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
||+++|+|.++++... .++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 9999999999986432 34679999999999 65 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCC------CCCCCCCCCCCcCCCCCcchhHHhhh-----cCCch--hh-h
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGE------RPSTAGDVPTSESFAGEFNIVKWVES-----NLPEN--VL-Q 857 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~s~g~~~~~~~~~~~~~~-----~~~~~--~~-~ 857 (929)
....... .........||+.|+|||++.+. .++.++||||+|++++++.....+.+ ..|.. .. +
T Consensus 163 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 163 HSQSTNQ--LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EETTTTE--EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccccc--ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 5432111 01112334799999999999877 45579999999988777654411111 11110 00 0
Q ss_pred ccChHHHHhhcccc---h-hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 858 VLDPELRQLMTSNE---S-QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 858 ~~~~~l~~~~~~~~---~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.............. . ......+.....+.+++.+||+.||++||||+||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 00011111110000 0 00001112233344488899999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.02 Aligned_cols=245 Identities=31% Similarity=0.470 Sum_probs=187.7
Q ss_pred CCCCChHHHHHhhCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeec
Q 002376 648 HPKISYDELRRATGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSC 711 (929)
Q Consensus 648 ~~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~ 711 (929)
...++++++..++++|+..+.||+|+||.||+|+... ....|.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3468899999999999999999999999999987641 123689999999999999999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM 779 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 779 (929)
...+ ..++||||+++|+|.++++... .++.|++.||+|||+.+.++|+||||||+||++++++
T Consensus 97 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 97 MTPT-----ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCSS-----CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred ecCC-----ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 6543 3699999999999999987432 2367899999999998777899999999999999999
Q ss_pred ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcC--------
Q 002376 780 TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNL-------- 851 (929)
Q Consensus 780 ~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~-------- 851 (929)
.+||+|||+++..... .........||+.|+|||++.+..++.++||||+|++++++.....++...
T Consensus 172 ~~kl~Dfg~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYK-----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp CEEECCCSSCEECCSS-----SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred CEEeccCccccccCcc-----cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 9999999999865321 112233456999999999998889999999999998777755443332100
Q ss_pred ----------Cc-hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 852 ----------PE-NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 852 ----------~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
.. ......+..... ....+....+.+ ++.+||+.||++|||++||++.|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~-li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQG---------NYKDEEVEQLIQ-VALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTT---------SCCHHHHHHHHH-HHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hHHHHHHHHhhchhhhhhcChhhcc---------ccCHHHHHHHHH-HHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 001111111100 001122334444 8889999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.81 Aligned_cols=244 Identities=26% Similarity=0.369 Sum_probs=170.8
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
+++....++|+..+.||+|+||.||+|+..+ ..++|.+|++++++++||||+++++++...+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-- 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 3334445688999999999999999987552 2357889999999999999999999995433
Q ss_pred CcceEEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCC--EEecCCCCCCeeecCCCceEEe
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVP--VVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~ki~ 784 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. + |+||||||+||+++.++.+||+
T Consensus 108 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 108 ---NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ---CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ---ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 3799999999999999987432 2367899999999998 7 9999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|||+++..... ........||+.|+|||++.+..++.++||||+|++++++.....++..... .+... .+.
T Consensus 182 Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~-~~~ 252 (309)
T 3p86_A 182 DFGLSRLKAST------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVA-AVG 252 (309)
T ss_dssp CCC-----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHH-HHH
T ss_pred CCCCCcccccc------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH-HHH
Confidence 99999854321 1122345799999999999999999999999999877776555444433221 11000 000
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
. ........ ..+...+.+++.+||+.||++|||++|+++.|+++.+...+
T Consensus 253 ~-~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 253 F-KCKRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp H-SCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred h-cCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 0 00000111 11122233477799999999999999999999998766443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=319.13 Aligned_cols=250 Identities=28% Similarity=0.367 Sum_probs=185.4
Q ss_pred CCCCChHHHHHhhCCCCCc------eeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCcc
Q 002376 648 HPKISYDELRRATGNFSHE------NLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRN 703 (929)
Q Consensus 648 ~~~~~~~~l~~~~~~~~~~------~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpn 703 (929)
...|+++++.+++++|+.. +.||+|+||.||+|+..+ ..+.|.+|++++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999988 899999999999987541 2467899999999999999
Q ss_pred ccceeeecccCCCCCcceEEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCC
Q 002376 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGN 772 (929)
Q Consensus 704 iv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~N 772 (929)
|+++++++...+ ..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|
T Consensus 92 i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 92 LVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp BCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred eEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 999999986533 3799999999999999886321 2367899999999998 99999999999
Q ss_pred eeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCC
Q 002376 773 ILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLP 852 (929)
Q Consensus 773 ILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~ 852 (929)
|++++++.+||+|||+++...... .........||+.|+|||++.+ .++.++||||+|++++++.....++....
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFA----QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCS----SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EEEcCCCcEEEeeccccccccccc----ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999999998653211 1112234579999999998865 58999999999987777655443332221
Q ss_pred chhhhccCh----------HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 853 ENVLQVLDP----------ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 853 ~~~~~~~~~----------~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
. .+.... .+........ . .......+.+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 239 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKM--N-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp S--SSBTTHHHHHHHTTSCCHHHHSCSSC--S-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred c--hHHHHHHHHHhhhhhhhhhhhccccc--c-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 011111 0111111000 0 0011122333348889999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=323.04 Aligned_cols=238 Identities=19% Similarity=0.302 Sum_probs=176.9
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|+..+.||+|+||.||+|++. ...+++.+|+++++++ +|||||+++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999988631 1235788999999999 899999999999653
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+ ..|+||||+++|+|.++++..+ .++.||+.||+|||+. +|+||||||
T Consensus 160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 3 3799999999999999987432 1356899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+|||++.++.+||+|||+++....... ........||+.|||||++.+..++.++||||+|+++|++.+ ...++.
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hhEEECCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999986532211 111233467889999999999999999999999988777544 333332
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
..+. .++.. .+..... ....... ...+ .+++.+||+.||++||+++|+++.|+++.....
T Consensus 308 ~~~~--~~~~~-~~~~~~~--~~~~~~~---~~~l-~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 308 GIPV--EELFK-LLKEGHR--MDKPANC---TNEL-YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp TCCG--GGHHH-HHHTTCC--CCCCTTS---CHHH-HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCH--HHHHH-HHhcCCC--CCCCCCC---CHHH-HHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 2221 11110 1111000 0011111 1223 337779999999999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=320.36 Aligned_cols=240 Identities=22% Similarity=0.229 Sum_probs=178.5
Q ss_pred CCCCChHHHHHhhCC----------CCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCC
Q 002376 648 HPKISYDELRRATGN----------FSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRH 701 (929)
Q Consensus 648 ~~~~~~~~l~~~~~~----------~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~H 701 (929)
.+.+++++++.+++. |+..+.||+|+||.||+|+.. ...+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356889999988865 677789999999999998754 234678899999999999
Q ss_pred ccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCee
Q 002376 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNIL 774 (929)
Q Consensus 702 pniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 774 (929)
|||+++++++... ...++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999998653 34899999999999999886432 3467899999999998 9999999999999
Q ss_pred ecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch
Q 002376 775 LDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN 854 (929)
Q Consensus 775 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~ 854 (929)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+|++++++.....++.....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~- 246 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP- 246 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred ECCCCcEEEeeeeeeeecccCc------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 9999999999999998653221 112345799999999999999999999999999877776544433322111
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+.. ..+........ .....+...+++++.+||+.||++|||++|+++
T Consensus 247 -~~~~-~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 -VQAM-KRLRDSPPPKL----KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHH-HHHHHSSCCCC----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHH-HHHhcCCCCCc----CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 01111110000 011112223334777999999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.14 Aligned_cols=288 Identities=18% Similarity=0.257 Sum_probs=184.6
Q ss_pred CCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecc
Q 002376 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI 304 (929)
Q Consensus 225 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 304 (929)
+++.+++++|.++ .+|..+. ++++.|++++|++++..|..|.++++|++|++++|.+++..|..|+++++|++|++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 4555556555554 4554432 34555555555555555566666777777777777777665655555555555555
Q ss_pred ccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEe
Q 002376 305 GFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDL 384 (929)
Q Consensus 305 ~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 384 (929)
++|++. .+|..++ .+|++|++++|++++..+..|.++++|++|++
T Consensus 110 ~~n~l~--------------------------------~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 154 (332)
T 2ft3_A 110 SKNHLV--------------------------------EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154 (332)
T ss_dssp CSSCCC--------------------------------SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEEC
T ss_pred CCCcCC--------------------------------ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEEC
Confidence 444443 3333332 24666666666666555555666666666666
Q ss_pred eCCCCC--cccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCC
Q 002376 385 SYNSIS--GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 385 s~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 462 (929)
++|.++ +..|..+..+ +|++|++++|++++ +|..+. ++|++|++++|++++..+..|.++++|+.|+|++|+++
T Consensus 155 ~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 155 GGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp CSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred CCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 666664 2455556666 66777777777664 344333 56777777777777766677777777777777777776
Q ss_pred CCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCC------CCCCEEEC
Q 002376 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAEL------KGLEVLDL 536 (929)
Q Consensus 463 g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L 536 (929)
+.. |..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..|... ..|+.|++
T Consensus 231 ~~~--------~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l 301 (332)
T 2ft3_A 231 MIE--------NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301 (332)
T ss_dssp CCC--------TTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEEC
T ss_pred cCC--------hhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEe
Confidence 532 445667777777777777777 667777778888888888888877766666543 56888888
Q ss_pred CCCcCC--CcCCcccccCCCCCeEeCCCCc
Q 002376 537 SSNKLS--GSIPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 537 s~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 564 (929)
++|.+. +..|..|..+++|+.+++++|+
T Consensus 302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecCcccccccCcccccccchhhhhhccccc
Confidence 888877 5667778888888888888774
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.53 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=173.0
Q ss_pred hCCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||.||+|++. ...+.|.+|++++++++||||+++++++...+ .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 357888999999999999998731 12357889999999999999999999986422 2
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 34799999999999999986433 2367899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc---------Ch
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL---------DP 861 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 861 (929)
....... .........||..|+|||++.+..++.++||||+|++++++.....++...+....+.. ..
T Consensus 163 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 163 VLPQDKE---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccCCcc---eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 7643211 11112234578889999999999999999999999887776553322221111110000 00
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
.+........ +...+...+.-+.+++.+||+.||++|||++|++++|+++++.+
T Consensus 240 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 240 HLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111111000 00001111222333777999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.70 Aligned_cols=249 Identities=18% Similarity=0.260 Sum_probs=183.0
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccc
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVK 706 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~ 706 (929)
.+...++....++|+..+.||+|+||.||+|++. ...+.+.+|+++++++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556677777889999999999999999999621 1235689999999999 7999999
Q ss_pred eeeecccCCCCCcceEEEEEEecCCCCcccccccccc-------------------------------------------
Q 002376 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK------------------------------------------- 743 (929)
Q Consensus 707 l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------- 743 (929)
++++|.+.+ ...++||||+++|+|.++++..+.
T Consensus 91 ~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 91 LLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp EEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999986533 237999999999999999864321
Q ss_pred -------------------------------ccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 744 -------------------------------NELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 744 -------------------------------~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 246899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... ..........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+.+...+..... .
T Consensus 244 ~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~--~ 315 (359)
T 3vhe_A 244 YKD----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGTR--M 315 (359)
T ss_dssp TSC----TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--SHHHHHHHHHTCC--C
T ss_pred ccc----ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--hHHHHHHHHcCCC--C
Confidence 321 11122334578999999999999999999999999987777543 3333222111 1111111111100 0
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
....... .++. +++.+||+.||++||||+|+++.|+++.+..
T Consensus 316 ~~~~~~~---~~l~-~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 RAPDYTT---PEMY-QTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCTTCC---HHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCC---HHHH-HHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0001111 2233 3777999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=327.04 Aligned_cols=238 Identities=22% Similarity=0.300 Sum_probs=165.4
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|+.. ...++|.+|++++++++||||+++++++...+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK----- 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----
Confidence 47889999999999999998753 12357899999999999999999999996533
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.++++... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 3799999999999999987432 2367899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
...... .........+|+.|+|||++.+..++.++||||+|++++++.. ...++..... .++. ..+.....
T Consensus 197 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~-~~i~~~~~-- 268 (373)
T 2qol_A 197 LEDDPE---AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVI-KAVDEGYR-- 268 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHH-HHHHTTEE--
T ss_pred cccCCc---cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHH-HHHHcCCC--
Confidence 643211 1111222346789999999999999999999999987777543 3333322211 1111 01111000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
..... .+...+. +++.+||+.||++||+|+||+++|+++.+...
T Consensus 269 ~~~~~---~~~~~l~-~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 269 LPPPM---DCPAALY-QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp CCCCT---TCBHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCCCc---cccHHHH-HHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 00011 1112233 37779999999999999999999999987643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-32 Score=298.51 Aligned_cols=289 Identities=19% Similarity=0.242 Sum_probs=157.1
Q ss_pred CCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecc
Q 002376 225 SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNI 304 (929)
Q Consensus 225 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 304 (929)
+++.++++++.++ .+|..+. ++++.|++++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 4555666655555 4554332 35556666666666666666777777777777777777766766766666666666
Q ss_pred ccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCcccc--ccCCCCCCCCcccEE
Q 002376 305 GFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYG--KIPASIGRLRSLTLL 382 (929)
Q Consensus 305 ~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L 382 (929)
++|++..++.. + .++|++|++++|++++..+..+..+. +|+.|++++|.+.. ..+..|.++++|++|
T Consensus 108 s~n~l~~l~~~--------~--~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 176 (330)
T 1xku_A 108 SKNQLKELPEK--------M--PKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176 (330)
T ss_dssp CSSCCSBCCSS--------C--CTTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CCCcCCccChh--------h--cccccEEECCCCcccccCHhHhcCCc-cccEEECCCCcCCccCcChhhccCCCCcCEE
Confidence 66666543321 1 14556666666666544444444444 45555555555532 444455555555555
Q ss_pred EeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCC
Q 002376 383 DLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 383 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 462 (929)
++++|.++. +|..+. ++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+
T Consensus 177 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-------------- 239 (330)
T 1xku_A 177 RIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT-------------- 239 (330)
T ss_dssp ECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS--------------
T ss_pred ECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC--------------
Confidence 555555542 333222 444555555555444444444444444555554444444444444444
Q ss_pred CCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccC------CCCCCEEEC
Q 002376 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAE------LKGLEVLDL 536 (929)
Q Consensus 463 g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L 536 (929)
++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|.. ...|+.|++
T Consensus 240 ------------------~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l 300 (330)
T 1xku_A 240 ------------------PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300 (330)
T ss_dssp ------------------TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred ------------------CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEe
Confidence 44555555555554 44445555555555555555555544444432 256667777
Q ss_pred CCCcCCC--cCCcccccCCCCCeEeCCCCc
Q 002376 537 SSNKLSG--SIPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 537 s~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 564 (929)
++|.+.. ..|..|..+..++.++|++|+
T Consensus 301 ~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ecCcccccccCccccccccceeEEEecccC
Confidence 7776653 445666777777777777764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-32 Score=300.87 Aligned_cols=252 Identities=25% Similarity=0.281 Sum_probs=142.9
Q ss_pred CccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccc
Q 002376 194 SDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLT 273 (929)
Q Consensus 194 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~ 273 (929)
..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..++ ++|++|++++|++++..+..|.+++
T Consensus 72 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~ 147 (332)
T 2ft3_A 72 DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLR 147 (332)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCS
T ss_pred hHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCc
Confidence 34455555666666666666555666666666666666666665 4554433 4555555555555555455566666
Q ss_pred cccEEeccCccCc--CCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhc
Q 002376 274 NIQIIRMTHNLLE--GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF 351 (929)
Q Consensus 274 ~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 351 (929)
+|+.|++++|.++ +..|..|..+ +|+.|++++|++.. +|..+.
T Consensus 148 ~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~--------------------------------l~~~~~-- 192 (332)
T 2ft3_A 148 NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG--------------------------------IPKDLP-- 192 (332)
T ss_dssp SCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS--------------------------------CCSSSC--
T ss_pred cCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc--------------------------------cCcccc--
Confidence 6667777666664 2444444444 44444444444433 333322
Q ss_pred cccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceec
Q 002376 352 SNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431 (929)
Q Consensus 352 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 431 (929)
.+|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+
T Consensus 193 -~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 270 (332)
T 2ft3_A 193 -ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270 (332)
T ss_dssp -SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred -CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence 24566666666666555566666666666666666666555556666666666666666665 4555566666666666
Q ss_pred ccCcccccccCccccc------ccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCC
Q 002376 432 LSGNELTGEIPISFGN------FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492 (929)
Q Consensus 432 Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~ 492 (929)
+++|++++..+..|.. ..+|+.|++++|.+... ...|..+..+++|+.++|++|+
T Consensus 271 l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~------~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW------EVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG------GSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCCCccChhHccccccccccccccceEeecCccccc------ccCcccccccchhhhhhccccc
Confidence 6666666555555543 24566677777766410 1124556666777777777664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.95 Aligned_cols=238 Identities=25% Similarity=0.328 Sum_probs=171.9
Q ss_pred CCCCCceeecccCceeEEecccc------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
++|+..+.||+|+||.||++++. ...+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEEEEc
Confidence 46788899999999999998765 235679999999999999999999999852 15999999
Q ss_pred cCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc-eEEecccccccccccc
Q 002376 729 LSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-AKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~ki~DfGla~~~~~~~ 796 (929)
+++|+|.++++... .++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999987432 22468999999999943348999999999999998886 799999999754211
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.....||+.|+|||++.+..++.++||||+|++++++.....++........++.. .... .......
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~-- 226 (307)
T 2eva_A 160 --------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-AVHN--GTRPPLI-- 226 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH-HHHT--TCCCCCB--
T ss_pred --------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH-HHhc--CCCCCcc--
Confidence 12346899999999999999999999999998877765554443322211100000 0000 0000001
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
..++..+++++.+||+.||++|||++|+++.|+++.+.++...
T Consensus 227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 1112223347779999999999999999999999987765433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.83 Aligned_cols=256 Identities=15% Similarity=0.136 Sum_probs=177.1
Q ss_pred hhCCCCCceeecccCceeEEeccccC-----------------cHHH---------------HHHHHHHHHccCCccccc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKS---------------FIAECETLRNVRHRNLVK 706 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~---------------~~~E~~~l~~l~Hpniv~ 706 (929)
..++|+..+.||+|+||.||+|.+.. .... +..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999996531 1112 334555666778999999
Q ss_pred eeeecccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-
Q 002376 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD- 776 (929)
Q Consensus 707 l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~- 776 (929)
+++++.... .+..+.++||||+ +|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 999987643 2345689999999 999999986431 3467999999999998 999999999999999
Q ss_pred -CCCceEEeccccccccccccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-
Q 002376 777 -EEMTAKVGDFGLARFLLERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE- 853 (929)
Q Consensus 777 -~~~~~ki~DfGla~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~- 853 (929)
.++.+||+|||+|+.+........ ........+||+.|||||++.+..++.++||||+|++++++.....++.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987653322111 11122345699999999999999999999999999887776655555442111
Q ss_pred -hhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 854 -NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 854 -~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
.......................... .+.-+.+++.+||+.||++||+++++++.|+++.+.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAAN-APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTC-CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhccccc-CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11000000000000000000000000 1122333777999999999999999999999998875433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=314.38 Aligned_cols=236 Identities=22% Similarity=0.265 Sum_probs=172.4
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|++. ...+.|.+|++++++++||||+++++++... .
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----R 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----G
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 46778899999999999998763 1245789999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 4799999999999999986332 2367899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
...... .........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .++. ..+.... .
T Consensus 201 ~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~-~~~~~~~--~ 272 (325)
T 3kul_A 201 LEDDPD---AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVI-SSVEEGY--R 272 (325)
T ss_dssp CC-------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHH-HHHHTTC--C
T ss_pred cccCcc---ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHH-HHHHcCC--C
Confidence 643211 1112233456889999999998899999999999987776543 3333222211 1111 0111100 0
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
...... ....+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 273 ~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 LPAPMG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 001111 122233377799999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.47 Aligned_cols=234 Identities=21% Similarity=0.234 Sum_probs=171.8
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|+.++++++||||++++++|..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------ 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence 478889999999999999987531 12456789999999999999999999842
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 23799999999999999986432 2357899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.+..... ........||++|+|||++.+..++.++||||+|++++++.+ ...++..... ..+......
T Consensus 164 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~ 232 (325)
T 3kex_A 164 LLPPDDK----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-------AEVPDLLEK 232 (325)
T ss_dssp GSCCCTT----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-------THHHHHHHT
T ss_pred ccCcccc----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-------HHHHHHHHc
Confidence 7643211 112234568889999999999999999999999987777544 3333322211 111111110
Q ss_pred cc--hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 870 NE--SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 870 ~~--~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.. ......+. .+. +++.+||+.||++||+++|+++.|+++.+...
T Consensus 233 ~~~~~~~~~~~~---~~~-~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 233 GERLAQPQICTI---DVY-MVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp TCBCCCCTTBCT---TTT-HHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred CCCCCCCCcCcH---HHH-HHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 00 00001111 122 27779999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=318.46 Aligned_cols=228 Identities=21% Similarity=0.238 Sum_probs=170.7
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.+.|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 4578999999999999999987541 24678999999999999999999999854
Q ss_pred CcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEec
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGD 785 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~D 785 (929)
....++||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+||++++++ .+||+|
T Consensus 87 -~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 -RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 345899999999999999986433 3367899999999998 999999999999998877 799999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
||+++..... ......+||+.|+|||++.+..++.++||||+|+++|++..+..++..... .+.+. .+.
T Consensus 163 FG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~-~i~- 231 (361)
T 2yab_A 163 FGLAHEIEDG-------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA-NIT- 231 (361)
T ss_dssp CSSCEECCTT-------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH-HHH-
T ss_pred cCCceEcCCC-------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH-HHH-
Confidence 9999875321 112345799999999999999999999999999877765544433322111 11111 111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..........+..++..+++++.+|++.||++|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 --AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111111222333445777999999999999999984
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-31 Score=296.38 Aligned_cols=291 Identities=24% Similarity=0.334 Sum_probs=148.7
Q ss_pred CCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCC
Q 002376 120 RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRL 199 (929)
Q Consensus 120 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l 199 (929)
+|+.++++++.++ .+|..+. ++|++|+|++|+|+ .+++..|.++++|++|+|++|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~-------------------- 87 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK-------------------- 87 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSC--------------------
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCc--------------------
Confidence 5666666666666 4454443 45666666666665 3444335555555555555554
Q ss_pred CcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEe
Q 002376 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIR 279 (929)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~ 279 (929)
+++..|..|.++++|++|+|++|+++ .+|..++ ++|++|++++|++++..+..|.++++|+.|+
T Consensus 88 ------------l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (330)
T 1xku_A 88 ------------ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVE 151 (330)
T ss_dssp ------------CCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEE
T ss_pred ------------CCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEE
Confidence 44444444445555555555555544 3343332 3444444444444444444555556666666
Q ss_pred ccCccCcC--CccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccE
Q 002376 280 MTHNLLEG--TLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSK 357 (929)
Q Consensus 280 Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~ 357 (929)
+++|.++. ..+..|.++++ |++|++++|+++ .+|..+. .+|++
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~-------------------------------L~~L~l~~n~l~-~l~~~~~---~~L~~ 196 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKK-------------------------------LSYIRIADTNIT-TIPQGLP---PSLTE 196 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTT-------------------------------CCEEECCSSCCC-SCCSSCC---TTCSE
T ss_pred CCCCcCCccCcChhhccCCCC-------------------------------cCEEECCCCccc-cCCcccc---ccCCE
Confidence 66665542 33333434444 444444444443 2333222 24555
Q ss_pred EEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCccc
Q 002376 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNEL 437 (929)
Q Consensus 358 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 437 (929)
|++++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++
T Consensus 197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 555555555555555555555555555555555554555555555555555555555 4455555555666666666666
Q ss_pred ccccCccccc------ccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCC
Q 002376 438 TGEIPISFGN------FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNS 492 (929)
Q Consensus 438 ~~~~p~~~~~------l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~ 492 (929)
++..+..|.. ..+|+.|++++|.+... ...|..+..+.+++.+||++|+
T Consensus 276 ~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~------~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW------EIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG------GSCGGGGTTCCCGGGEEC----
T ss_pred CccChhhcCCcccccccccccceEeecCccccc------ccCccccccccceeEEEecccC
Confidence 5544444432 24566666666665421 1124556666667777777664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-34 Score=316.23 Aligned_cols=225 Identities=23% Similarity=0.299 Sum_probs=169.2
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
..++|+..+.||+|+||.||+|++.. ..+.+.+|+++++.++||||+++++++.. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 35689999999999999999987631 23568899999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 5899999999999999886432 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCC-CCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPS-TAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... ......+||+.|+|||++.+..++ .++||||+|++++++..+..++.... ..+........ ..
T Consensus 165 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~----~~ 231 (328)
T 3fe3_A 165 TVG-------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRG----KY 231 (328)
T ss_dssp SSS-------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----CC
T ss_pred CCC-------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC----CC
Confidence 321 123345799999999999988875 79999999987776654443332211 11111111111 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ++.-+.+++.+|++.||++|||++|+++
T Consensus 232 ~~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 RIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 1222334777999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-34 Score=320.81 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=177.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHH--ccCCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLR--NVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~--~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|+..+.||+|+||.||+|+..+ ..+.+..|.++.. .++||||+++++++......+....++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 4688999999999999999997652 2445666665544 58999999999866543334455689999
Q ss_pred EecCCCCccccccccc-------cccccHHHHHHHhhhCC------CCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 727 EFLSNGSLGDWIHGER-------KNELDITSALDYLHNDC------EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
||+++|+|.++++... .++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171 (336)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence 9999999999986433 34679999999999863 2389999999999999999999999999998764
Q ss_pred cccCCC--CCccccceeccccccccccccCC-------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhcc---
Q 002376 794 ERVDNQ--SSISSTHVFMGSIGYVPPEYGLG-------ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVL--- 859 (929)
Q Consensus 794 ~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~--- 859 (929)
...... .........+||+.|+|||++.+ ..++.++||||+|++++++.+...++..... .....+
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp SSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred cccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 321111 11112234579999999999987 4567899999999888886554333211111 000000
Q ss_pred ---Ch---HHHHhhcccchhhhhhh------HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 860 ---DP---ELRQLMTSNESQTIQLH------DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 860 ---~~---~l~~~~~~~~~~~~~~~------~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
.+ ....... ....+...+ ......+.+++.+||+.||++|||++|++++|+++...+.+..
T Consensus 252 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 252 VGNHPTFEDMQVLVS-REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HCSSCCHHHHHHHHT-TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cCCCchHHHHHhhhc-ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 00 0000000 000000000 1122233348889999999999999999999999998877554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-34 Score=308.72 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=171.5
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||++++.. ..+.|.+|+.++++++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence 3578999999999999999986541 13578899999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 5899999999999999986432 3367899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .........||+.|+|||++.+..++.++||||+|+++|++.....++..... .+. ...........
T Consensus 162 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~---~~~~~~~~~~~ 231 (294)
T 4eqm_A 162 SET-----SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--VSI---AIKHIQDSVPN 231 (294)
T ss_dssp ------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--HHH---HHHHHSSCCCC
T ss_pred ccc-----cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHH---HHHHhhccCCC
Confidence 322 11122345799999999999999999999999999877776554444322211 000 00000000000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHhhHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRI-GIREALRRLKSSQEI 916 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~ 916 (929)
........++..+.+++.+|++.||++|| +++++.+.|+++...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00001111222333477799999999999 899999999887544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-33 Score=312.58 Aligned_cols=234 Identities=20% Similarity=0.269 Sum_probs=174.6
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||.||+|++. ...++|.+|+.++++++||||++++++|....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----
Confidence 47888999999999999998753 12457899999999999999999999996422
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
.++|+||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp --EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred --eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 689999999999999987432 2467899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
...... .........||+.|+|||++.+..++.++||||+|++++++.+ ...++...+. ...+ .+....
T Consensus 166 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~- 236 (327)
T 3poz_A 166 LLGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE- 236 (327)
T ss_dssp HHTTTC----C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC-
T ss_pred EccCCc----ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH----HHHcCC-
Confidence 764321 1112233467889999999999999999999999988777554 4444332222 1111 111100
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
...... .+...+.+ ++.+||+.||++||+|+|+++.|+++.+..
T Consensus 237 -~~~~~~---~~~~~~~~-li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 237 -RLPQPP---ICTIDVYM-IMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -CCCCCT---TBCHHHHH-HHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -CCCCCc---cCCHHHHH-HHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 000111 11222333 777999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-34 Score=313.53 Aligned_cols=228 Identities=21% Similarity=0.223 Sum_probs=171.1
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEE
Confidence 4689999999999999999987641 245688999999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC--CCceEEeccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE--EMTAKVGDFGLARFLL 793 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~ki~DfGla~~~~ 793 (929)
||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999999986432 2367899999999998 9999999999999987 7899999999998753
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......||+.|+|||++.+..++.++||||+|+++|++.....++..... .+.+....... ...
T Consensus 156 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~----~~~ 222 (321)
T 1tki_A 156 PG-------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAE----YTF 222 (321)
T ss_dssp TT-------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTC----CCC
T ss_pred CC-------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHcCC----CCC
Confidence 21 123446799999999999998899999999999877776554443322211 11111111111 111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......++..+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111112223334777999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=312.44 Aligned_cols=225 Identities=24% Similarity=0.285 Sum_probs=169.1
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||+||+++... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence 3578899999999999999987641 234678999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 5899999999999998886432 3467999999999998 9999999999999999999999999999853
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......+||+.|||||++.+..++.++||||+|+++|++..+..++.... ..+....... ....
T Consensus 156 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~----~~~~ 223 (337)
T 1o6l_A 156 ISD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILM----EEIR 223 (337)
T ss_dssp CCT------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----CCCC
T ss_pred ccC------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHc----CCCC
Confidence 211 112344689999999999999999999999999987777655443332211 1111111111 1111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
.. ..+...+++++.+|++.||++|| +++|+++
T Consensus 224 ~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 11222233477799999999999 8888875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=312.57 Aligned_cols=234 Identities=20% Similarity=0.316 Sum_probs=167.8
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCC------
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDS------ 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~------ 716 (929)
.++|+..+.||+|+||.||+|++. ...+.+.+|++++++++|||||+++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999998764 134678999999999999999999999865432
Q ss_pred ----------------------------------------------CCcceEEEEEEecCCCCccccccccc--------
Q 002376 717 ----------------------------------------------KNMEFLALVYEFLSNGSLGDWIHGER-------- 742 (929)
Q Consensus 717 ----------------------------------------------~~~~~~~lV~e~~~~gsL~~~l~~~~-------- 742 (929)
....+.++||||+++|+|.++++...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234799999999999999987422
Q ss_pred ---cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC------ccccceeccccc
Q 002376 743 ---KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS------ISSTHVFMGSIG 813 (929)
Q Consensus 743 ---~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~------~~~~~~~~gt~~ 813 (929)
.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........... .......+||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 3467999999999998 9999999999999999999999999999876432211100 112234579999
Q ss_pred cccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch-hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccc
Q 002376 814 YVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN-VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSC 892 (929)
Q Consensus 814 y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 892 (929)
|+|||++.+..++.++||||+|++++++.. +..+.. ..+.. ...... . ...........+ .+++.+|
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~-----~~~~~~~~~~~~-~~~~~~---~--~~~~~~~~~~~~-~~li~~~ 309 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY-----SFSTQMERVRII-TDVRNL---K--FPLLFTQKYPQE-HMMVQDM 309 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-----CCCCHHHHHHHH-HHHHTT---C--CCHHHHHHCHHH-HHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHH-----cCCChhHHHHHH-HHhhcc---C--CCcccccCChhH-HHHHHHH
Confidence 999999999999999999999987766532 322221 11100 001110 0 000111111223 3477899
Q ss_pred cCCCCCCCCCHHHHHH
Q 002376 893 TTESPGGRIGIREALR 908 (929)
Q Consensus 893 l~~dP~~RPs~~ev~~ 908 (929)
|+.||++|||++|+++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-33 Score=311.55 Aligned_cols=239 Identities=18% Similarity=0.214 Sum_probs=177.2
Q ss_pred CCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...++||+|+||.||+|++. ...+.+.+|++++++++||||+++++++...+ ....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence 46888999999999999998765 12467889999999999999999999986533 23579
Q ss_pred EEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee----cCCCceEEecccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDFGL 788 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DfGl 788 (929)
+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999987432 2367899999999998 99999999999999 7888999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccC--------CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL--------GERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV 858 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~ 858 (929)
++..... .......||+.|+|||++. +..++.++||||+|++++++.....++..... ...++
T Consensus 163 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 163 ARELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CEECCTT-------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred ceecCCC-------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 9876322 1123357999999999986 57799999999999888776665554432221 11111
Q ss_pred cChHHHHhhcc-----------------cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 002376 859 LDPELRQLMTS-----------------NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912 (929)
Q Consensus 859 ~~~~l~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 912 (929)
+...+.+.... .........+.+...+.+++.+|++.||++|||++|+++...+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 11111110000 0000112223455566668889999999999999999988765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=312.97 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=178.0
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHHcc--CCccccceeeecccCCCCCcceEE
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRNV--RHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
....++|+..+.||+|+||.||+|++.+ ....+.+|.+++... +||||+++++++..... .....+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~ 111 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLY 111 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceE
Confidence 3445689999999999999999998762 234566677776665 89999999999876432 224689
Q ss_pred EEEEecCCCCccccccccc-------cccccHHHHHHHhhhCC-----CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDC-----EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+||||+++|+|.++++... .++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 9999999999999986432 34678999999999752 34899999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCC------CCCCCCcCCCCCcchhHHhhh-----cCCchhhhccC
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTA------GDVPTSESFAGEFNIVKWVES-----NLPENVLQVLD 860 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DV~s~g~~~~~~~~~~~~~~-----~~~~~~~~~~~ 860 (929)
+...... .........||+.|+|||++.+..++.+ +||||+|+++|++.....++. ..|.......+
T Consensus 192 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 192 FISDTNE--VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp CC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ecccccc--ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 5432111 1111224579999999999988877666 999999988887655522221 11110000000
Q ss_pred ---hHHHHhhc-----ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 861 ---PELRQLMT-----SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 861 ---~~l~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
........ ..........++..++. +++.+||+.||++|||++|+++.|+++.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHH-HHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CchhhhHHHHhhhccCccccccchhhHHHHHHH-HHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 01111110 00011111112333344 4888999999999999999999999987754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-34 Score=321.24 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=174.2
Q ss_pred hhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
..++|...+.||+|+||.||+|++.. ..++|.+|++++++++|||||+++++|...+ .
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----P 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----S
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----C
Confidence 34678889999999999999987641 1246889999999999999999999996533 3
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 799999999999999986432 2367899999999998 9999999999999999999999999999864
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
..... ........+++.|+|||++.++.++.++||||+|++++++.. ...++..... ...........
T Consensus 264 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~ 332 (377)
T 3cbl_A 264 ADGVY----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGG 332 (377)
T ss_dssp TTSEE----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTC
T ss_pred CCCce----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC
Confidence 32110 011112246788999999998899999999999987776543 2222222111 11111111110
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. ...++..+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 333 ~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 R--LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 001111122233377799999999999999999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=312.06 Aligned_cols=227 Identities=20% Similarity=0.235 Sum_probs=169.1
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
+.|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 468889999999999999987541 24679999999999999999999999854
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~Df 786 (929)
....++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 334899999999999999986433 3367899999999998 999999999999999887 8999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
|+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.+. .+...
T Consensus 163 g~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~-~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA-NVSAV 232 (326)
T ss_dssp TTCEECCTT-------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH-HHHHT
T ss_pred CCCeECCCC-------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHH-HHHhc
Confidence 999875321 112335799999999999999999999999999877765544333321111 11110 11110
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............+..+++++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000011111112223344777999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-34 Score=330.25 Aligned_cols=237 Identities=20% Similarity=0.197 Sum_probs=175.4
Q ss_pred ChHHHHHhhCCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccceeeecc
Q 002376 652 SYDELRRATGNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKLITSCS 712 (929)
Q Consensus 652 ~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~ 712 (929)
.+++++..+++|+..++||+|+||+||+|+.... .+.+.+|+.++..++|||||+++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4566677788999999999999999999986521 123789999999999999999999995
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
+ ....|+|||||++|+|.++++... .++.|++.||+|||+. +||||||||+|||++.++.+||
T Consensus 145 ~-----~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 145 D-----DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp C-----SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred e-----CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEE
Confidence 4 345899999999999999987521 2467899999999998 9999999999999999999999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhh
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVL 856 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~ 856 (929)
+|||+|+..... ........+||+.|||||++. ...++.++||||+|+++|++..+..++..... ...
T Consensus 217 ~DFGla~~~~~~-----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 217 ADFGSCLKLMED-----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp CCCTTCEECCTT-----SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cchhhhhhcccC-----CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 999999865321 111223458999999999987 56799999999999887776655544432221 111
Q ss_pred hccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCC--CCCHHHHHH
Q 002376 857 QVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGG--RIGIREALR 908 (929)
Q Consensus 857 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~ 908 (929)
.++........+. .... ++..+++++.+|+..+|++ ||+++|+++
T Consensus 292 ~i~~~~~~~~~p~---~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKERFQFPT---QVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHHHCCCCS---SCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccccccCCc---cccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1211111100110 0001 1222334777999888888 999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=301.05 Aligned_cols=234 Identities=27% Similarity=0.344 Sum_probs=174.6
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||+|++. ...+++.+|++++++++||||+++++++.+.. ..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceEEEE
Confidence 57888899999999999998764 23568999999999999999999999986533 389999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.++++..+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999999986432 2357899999999998 999999999999999999999999999986532211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.......||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+.. ..+...... .....
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~-~~~~~~~~~--~~~~~ 231 (269)
T 4hcu_A 162 -----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV-EDISTGFRL--YKPRL 231 (269)
T ss_dssp -----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH-HHHHTTCCC--CCCTT
T ss_pred -----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHH-HHHhcCccC--CCCCc
Confidence 11223457888999999998999999999999977666543 3333222111 1111 111110000 00011
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
....+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 232 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 232 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112233377799999999999999999999998763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-36 Score=345.94 Aligned_cols=369 Identities=18% Similarity=0.170 Sum_probs=179.3
Q ss_pred cccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccc-
Q 002376 143 TELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY- 221 (929)
Q Consensus 143 ~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~- 221 (929)
++|++|||++|+++.......+..+++|++|+|++|.+++... ..++..+..+++|++|+|++|+++...+..+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~----~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 78 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC----KDISSALRVNPALAELNLRSNELGDVGVHCVLQ 78 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHH----HHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHH----HHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHH
Confidence 5677788888877632222235666777777777776532110 01233445556666666666666543333222
Q ss_pred cCC----CCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCC-----
Q 002376 222 NMT----SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG----- 292 (929)
Q Consensus 222 ~l~----~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----- 292 (929)
.+. +|++|+|++|+++..-- +.++..+..+++|+.|++++|.+++..+..
T Consensus 79 ~l~~~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 137 (461)
T 1z7x_W 79 GLQTPSCKIQKLSLQNCCLTGAGC---------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 137 (461)
T ss_dssp TTCSTTCCCCEEECTTSCCBGGGH---------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred HHhhCCCceeEEEccCCCCCHHHH---------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHH
Confidence 222 45555555555541000 123444555555666666665554322211
Q ss_pred CCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhc----cccccEEEecCCccccc
Q 002376 293 LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNF----SNELSKLYLGGNHIYGK 368 (929)
Q Consensus 293 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~Ls~N~l~~~ 368 (929)
+...++|++|++++|++..... ..+...+..+++|++|+|++|.+++..+..+... ..+|++|+|++|.+++.
T Consensus 138 ~~~~~~L~~L~L~~n~l~~~~~---~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 214 (461)
T 1z7x_W 138 LDPQCRLEKLQLEYCSLSAASC---EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD 214 (461)
T ss_dssp TSTTCCCCEEECTTSCCBGGGH---HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT
T ss_pred hcCCCcceEEECCCCCCCHHHH---HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHH
Confidence 1123344445554444432110 0011233445566666666666654433333221 11466666666665542
Q ss_pred ----cCCCCCCCCcccEEEeeCCCCCccc-----CccccCCCCCCEEEecCCcCCCC----CcccccCCCCCceecccCc
Q 002376 369 ----IPASIGRLRSLTLLDLSYNSISGEI-----PIEIGQLQGLQVLGLAGNEIPGG----IPNSLANLKKLNQIDLSGN 435 (929)
Q Consensus 369 ----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N 435 (929)
++..+..+++|++|+|++|.+++.. +..+..+++|++|++++|++++. ++..+..+++|++|+|++|
T Consensus 215 ~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 294 (461)
T 1z7x_W 215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294 (461)
T ss_dssp HHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred HHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence 3444555566666666666555322 11222355566666666655542 3444555556666666666
Q ss_pred ccccccCccccc-----ccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhc-----Cc
Q 002376 436 ELTGEIPISFGN-----FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN-----CK 505 (929)
Q Consensus 436 ~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~-----l~ 505 (929)
.+++..+..+.. .++|+.|++++|.+++.. ...++..+..+++|++|||++|.+++..+..+.. .+
T Consensus 295 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~----~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC----CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG----HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCchHHHHHHHHHhccCCccceeeEcCCCCCchHH----HHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 655433332222 145556666666554321 0112344445555555555555555433333332 34
Q ss_pred Ccceeecccccccc----cCCccccCCCCCCEEECCCCcCCC
Q 002376 506 SLEELLMAYNQFSG----PIPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 506 ~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
+|++|+|++|++++ .+|..+..+++|++|||++|++++
T Consensus 371 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 55555555555553 445555555555555555555543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-33 Score=317.05 Aligned_cols=237 Identities=20% Similarity=0.227 Sum_probs=173.9
Q ss_pred CCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||+||+|++. ....++.+|+.++++++|||||++++++....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 147 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--- 147 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence 57888999999999999998832 12346889999999999999999999986533
Q ss_pred cceEEEEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC---c
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM---T 780 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~ 780 (929)
..++||||+++|+|.++++..+ .++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 148 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 148 --PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp --SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 3699999999999999987432 2367899999999998 999999999999999554 5
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhcc
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVL 859 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 859 (929)
+||+|||+|+.+...... .......||+.|+|||++.+..++.++||||+|++++++.. ...++..... .
T Consensus 223 ~kL~DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~--- 293 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--Q--- 293 (367)
T ss_dssp EEECCCHHHHHHHHHSSC----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H---
T ss_pred EEECCCcccccccccccc----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--H---
Confidence 999999999865332111 11233468999999999999999999999999987776543 2222221111 1
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.+.......... .........+.+++.+||+.||++||+++||++.|+.+.+...
T Consensus 294 --~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 294 --EVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp --HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --HHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111111110000 0001111222337779999999999999999999999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-34 Score=325.59 Aligned_cols=235 Identities=19% Similarity=0.244 Sum_probs=174.9
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccceeeeccc
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
..+++...++|+..++||+|+||+||+|+.... .+.+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 355666778999999999999999999876521 2247799999999999999999999954
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
....|+||||+++|+|.++++..+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 -----~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 -----DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp -----SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred -----CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 345899999999999999886432 3467999999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC----CCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER----PSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD 860 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~ 860 (929)
|+|+.+... ........+||+.|||||++.+.. ++.++||||+|+++|++..+..++..... ....+..
T Consensus 213 G~a~~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 213 GTCMKMNKE-----GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp TTCEECCTT-----SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ceeEeeccC-----CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 999865321 111223468999999999998765 88999999999887776655544432221 1111111
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCC--CCCHHHHHH
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGG--RIGIREALR 908 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~ 908 (929)
....... ..... ++..+++++.+|++.+|++ ||+++||++
T Consensus 288 ~~~~~~~----p~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNSLTF----PDDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHCCC----CTTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccccccC----CCccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1110000 00011 2223334777999999998 999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-33 Score=316.46 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=177.7
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|...+.||+|+||.||+|++. ...+++.+|+++++++ +|||||+++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999998641 1235688999999999 999999999999653
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+ ..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||
T Consensus 148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 148 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred C-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 3 3799999999999999986432 2357899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+|||+++++.+||+|||+|+....... ........||+.|+|||++.+..++.++||||+|++++++.. ...++.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999986532211 112233467899999999999999999999999987766543 322222
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
... ..++. ..+..... ........+ ++. +++.+||+.||++|||++|+++.|+++......+.
T Consensus 296 ~~~--~~~~~-~~~~~~~~--~~~~~~~~~---~l~-~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 296 GVP--VEELF-KLLKEGHR--MDKPSNCTN---ELY-MMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp TCC--HHHHH-HHHHTTCC--CCCCSSCCH---HHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred CCC--HHHHH-HHHHcCCC--CCCCccCCH---HHH-HHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111 11111 11111000 000111112 233 37779999999999999999999999987755443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-33 Score=312.84 Aligned_cols=245 Identities=15% Similarity=0.131 Sum_probs=179.2
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|+++++++ +||||+++++++.. ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence 357899999999999999999753 1234688999999999 99999999999854 335899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc-----eEEecccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-----AKVGDFGLAR 790 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~ki~DfGla~ 790 (929)
||||+ +|+|.+++... ..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+|+
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999 99999998742 13467999999999998 9999999999999998887 9999999998
Q ss_pred ccccccCCC-CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQ-SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
.+....... ..........||+.|+|||++.+..++.++||||+|++++++.....++..... ...+.+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 764322111 111122456899999999999999999999999999887776655555443322 111111111110000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
. . .....+..+++.+ ++.+||+.||++||+++++.+.|+++.+..
T Consensus 239 ~-~--~~~~~~~~p~~~~-li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 T-P--IEVLCENFPEMAT-YLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp S-C--HHHHTTTCHHHHH-HHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C-C--HHHHhccChHHHH-HHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 0 0000011223333 778999999999999999999999988765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=308.75 Aligned_cols=238 Identities=19% Similarity=0.237 Sum_probs=172.1
Q ss_pred hCCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
.++|+..+.||+|+||.||+|++. ...+.+.+|+.++++++||||++++++|....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---
Confidence 357899999999999999998753 13567999999999999999999999986422
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++|+||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 ---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 689999999999999986432 3367899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCc-hhhhccChHHHHhh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPE-NVLQVLDPELRQLM 867 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~-~~~~~~~~~l~~~~ 867 (929)
+....... ........||+.|+|||++.+..++.++||||+|++++++.. ...++...+. ...+ .+....
T Consensus 165 ~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~~~~ 236 (327)
T 3lzb_A 165 KLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE 236 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC
T ss_pred eEccCccc----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCC
Confidence 87642211 112233457889999999999999999999999987777544 3333332222 1111 111100
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
........+. .+. +++.+||+.||++||+++|+++.|+++.+.....
T Consensus 237 --~~~~~~~~~~---~l~-~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 283 (327)
T 3lzb_A 237 --RLPQPPICTI---DVY-MIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp --CCCCCTTBCH---HHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred --CCCCCccCCH---HHH-HHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence 0001111112 223 3777999999999999999999999998665433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-33 Score=301.03 Aligned_cols=235 Identities=24% Similarity=0.308 Sum_probs=174.0
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..+.||+|+||.||+|+... ..+++.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceEEE
Confidence 4578889999999999999987652 356799999999999999999999998543 348999
Q ss_pred EEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
|||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 99999999999986432 2367899999999998 9999999999999999999999999999865321
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
.........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+.. ..+.... ......
T Consensus 158 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~-~~~~~~~--~~~~~~ 228 (268)
T 3sxs_A 158 ----QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVV-LKVSQGH--RLYRPH 228 (268)
T ss_dssp ----CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHH-HHHHTTC--CCCCCT
T ss_pred ----hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHH-HHHHcCC--CCCCCC
Confidence 1111223456788999999998899999999999977666543 3333322211 0000 0011100 000001
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..++ .+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 229 ~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 229 LASD----TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TSCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cChH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1112 233377799999999999999999999988654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-35 Score=344.20 Aligned_cols=311 Identities=20% Similarity=0.185 Sum_probs=186.6
Q ss_pred cccEEEeecccCCC----ccCCccccCCCCceEEeeecCCCCcCCcccc----cCCCCcceeeccCCcCCCC----CCCc
Q 002376 201 NLKVLDLTINRLAG----TVPSTIYNMTSLVHLRLASNQLGGEIPYDVR----DTLPNLLDFIYCFNRFTGK----IPGS 268 (929)
Q Consensus 201 ~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~----~~l~~L~~l~l~~N~l~~~----~p~~ 268 (929)
+|++|+|++|+++. .++..|.++++|++|+|++|.+++..+..+. ...++|++|++++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 45555555555542 3345555555555555555555432222111 1123344444444444432 2344
Q ss_pred ccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCcccccc-CCCCCCCEEEccCCccccc----
Q 002376 269 LHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSL-TNSTHLNYLALDGNQFEGK---- 343 (929)
Q Consensus 269 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~---- 343 (929)
+..+++|+.|++++|.+++..+..+. ..+ ...++|++|+|++|++++.
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~---------------------------~~l~~~~~~L~~L~L~~n~l~~~~~~~ 218 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLC---------------------------QGLKDSPCQLEALKLESCGVTSDNCRD 218 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHH---------------------------HHHHHSCCCCCEEECTTSCCBTTHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHH---------------------------HHHhcCCCCceEEEccCCCCcHHHHHH
Confidence 45556666666666666533221111 001 1234666666666666643
Q ss_pred cCchhhhccccccEEEecCCcccccc-----CCCCCCCCcccEEEeeCCCCCcc----cCccccCCCCCCEEEecCCcCC
Q 002376 344 IPESIGNFSNELSKLYLGGNHIYGKI-----PASIGRLRSLTLLDLSYNSISGE----IPIEIGQLQGLQVLGLAGNEIP 414 (929)
Q Consensus 344 ~p~~~~~~~~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 414 (929)
++..+..+. +|++|+|++|.+++.. +..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.++
T Consensus 219 l~~~l~~~~-~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 219 LCGIVASKA-SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHhCC-CccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 355555554 6777777777766432 23344577888888888888754 5666777888888888888876
Q ss_pred CCCcccccC-----CCCCceecccCcccccc----cCcccccccccceecccCCcCCCCCCCCcccCCchhhhc-----c
Q 002376 415 GGIPNSLAN-----LKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR-----L 480 (929)
Q Consensus 415 ~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~-----l 480 (929)
+..+..+.. .++|++|+|++|.+++. ++..+..+++|+.|+|++|++++.. +..+.. .
T Consensus 298 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~--------~~~l~~~l~~~~ 369 (461)
T 1z7x_W 298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG--------VRELCQGLGQPG 369 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH--------HHHHHHHHTSTT
T ss_pred hHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc--------HHHHHHHHcCCC
Confidence 544443332 26888888888888765 4556667788888888888876432 222322 5
Q ss_pred cCccEEEecCCCCCC----CCCcchhcCcCcceeecccccccccCCcccc-----CCCCCCEEECCCCcCCCcCCc
Q 002376 481 ENVVTIDLSDNSLSG----NLPNSLKNCKSLEELLMAYNQFSGPIPNIVA-----ELKGLEVLDLSSNKLSGSIPS 547 (929)
Q Consensus 481 ~~L~~LdLs~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~ 547 (929)
++|++|+|++|++++ .+|..+..+++|++|+|++|++++.....+. ....|+.|++.++.+....++
T Consensus 370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~ 445 (461)
T 1z7x_W 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 445 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred CceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHH
Confidence 688899999998886 6788888889999999999988754222211 234677777777776644433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=315.11 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=165.8
Q ss_pred CCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.|+..+.||+|+||.||+|+.. ...++|.+|+.++++++|||||+++++|...+ ..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CC
Confidence 3566789999999999988642 12467899999999999999999999986433 24
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+++|+|.++++... .++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 799999999999999986432 2357899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh--HHHHhhccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP--ELRQLMTSN 870 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~ 870 (929)
..... ..........||+.|+|||++.+..++.++||||+|+++|++.+. +..|.......+. .+.... .
T Consensus 243 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~----~~~p~~~~~~~~~~~~~~~~~--~ 314 (373)
T 3c1x_A 243 YDKEF--DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR----GAPPYPDVNTFDITVYLLQGR--R 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT----SCCSCTTSCSSCHHHHHHTTC--C
T ss_pred ccccc--ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhC----cCCCCCCCCHHHHHHHHHcCC--C
Confidence 32211 111122334678899999999999999999999999877765431 1112111111111 111100 0
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
...... .+..+.+++.+||+.||++||+++|+++.|+++...+...
T Consensus 315 ~~~p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 000111 1122333777999999999999999999999998876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-34 Score=313.78 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=177.6
Q ss_pred CCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 663 FSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
|+..+.||+|+||.||++.+. ...+.+.+|++++++++||||+++++++...+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence 488899999999999765421 12456889999999999999999999986532 345
Q ss_pred EEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 899999999999999987533 3467899999999998 999999999999999999999999999987642
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh---ccCh-----HHHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ---VLDP-----ELRQL 866 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~l~~~ 866 (929)
.. ..........||..|+|||++.+..++.++||||+|++++++.+...++...+....+ .... .+...
T Consensus 187 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 187 GH---EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TC---SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cc---cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 21 1111123346888999999999989999999999998877766554443322111100 0000 11111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
..... ........+..+.+++.+||+.||++|||++|+++.|+++.+.+..
T Consensus 264 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 264 LERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred Hhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 10000 0000111112233377799999999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-34 Score=318.89 Aligned_cols=226 Identities=24% Similarity=0.261 Sum_probs=165.8
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..++||+|+||+||+++... ..+.+.+|..++.++ +|||||++++++.+ .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 4578999999999999999987652 123577899999887 89999999999854 3
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...|+||||+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 45899999999999999886432 3467999999999998 999999999999999999999999999985
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccC-hHHHHh-hc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLD-PELRQL-MT 868 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~-~~l~~~-~~ 868 (929)
... ........+||+.|||||++.+..++.++||||+|+++|++..+..++..... ....... ..+... ..
T Consensus 203 ~~~------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 203 GLR------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp CCC------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ccc------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 321 11223456899999999999999999999999999888776665554432211 0000000 111111 11
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
.... .+..+...+++++.+||+.||++||++
T Consensus 277 ~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQIR----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cccC----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 111122233447779999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-34 Score=316.04 Aligned_cols=241 Identities=19% Similarity=0.274 Sum_probs=176.0
Q ss_pred HhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
...++|+..+.||+|+||.||+|++. ...+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578899999999999999998751 1235788999999999 899999999998653
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc-------------------------------cccccHHHHHHHhhhCCCCCE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER-------------------------------KNELDITSALDYLHNDCEVPV 763 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------~~~~~ia~aL~yLH~~~~~~i 763 (929)
+ ..++||||+++|+|.+++...+ .++.|++.||+|||+. +|
T Consensus 122 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 122 G-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred C-----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 3 3799999999999999986432 1356899999999998 99
Q ss_pred EecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch
Q 002376 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 764 iHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
+||||||+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCc----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 999999999999999999999999998664221 1112234568899999999999999999999999987776543
Q ss_pred -hHHhhhcCCchhhhccChHHHHhhccc--chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 844 -VKWVESNLPENVLQVLDPELRQLMTSN--ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 844 -~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
...++...+. +.......... .......++ -+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 270 ~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 270 LGVNPYPGIPV------DANFYKLIQNGFKMDQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp TSCCSSTTCCC------SHHHHHHHHTTCCCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred CCCCCcccCCc------HHHHHHHHhcCCCCCCCCCCCH----HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 3333322211 11111111111 000111112 2233777999999999999999999999987765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-33 Score=313.48 Aligned_cols=237 Identities=20% Similarity=0.238 Sum_probs=168.7
Q ss_pred HHHhhCCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccC
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSL 714 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 714 (929)
+....++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++|||||++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 4455678999999999999999998654 123578899999999999999999999954
Q ss_pred CCCCcceEEEEEEecCCCCccccccc------------------------------------------------cccccc
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHG------------------------------------------------ERKNEL 746 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~------------------------------------------------~~~~~~ 746 (929)
....++||||+++|+|.+++.. ...++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 3358999999999999998841 012467
Q ss_pred cHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC--ceEEeccccccccccccCCCCCccccceeccccccccccccCC--
Q 002376 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEM--TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-- 822 (929)
Q Consensus 747 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 822 (929)
|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.+...... .........||+.|+|||++.+
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--EYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc--ccccccccCCCccccCchhhccCC
Confidence 899999999998 999999999999998776 8999999999866432111 1112334579999999999875
Q ss_pred CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC
Q 002376 823 ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG 902 (929)
Q Consensus 823 ~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs 902 (929)
..++.++||||+|++++++.....++..... .+........ ...........+...+.+++.+|++.||++||+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND--ADTISQVLNK----KLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC----CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhc----ccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 6789999999999877765554443322221 1111111111 100000111112223334777999999999999
Q ss_pred HHHHHH
Q 002376 903 IREALR 908 (929)
Q Consensus 903 ~~ev~~ 908 (929)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-34 Score=316.85 Aligned_cols=228 Identities=23% Similarity=0.292 Sum_probs=167.9
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++|||||++++++.+. ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 4578999999999999999987641 235688999999999999999999998543 35
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DfGla~ 790 (929)
.|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 899999999999998886433 3367899999999998 99999999999999865 459999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... ......+||+.|+|||++.+..++.++||||+|+++|++.....++..... .+.... +... .
T Consensus 180 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~-i~~~---~ 246 (362)
T 2bdw_A 180 EVNDS-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQ-IKAG---A 246 (362)
T ss_dssp CCTTC-------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-HHHT---C
T ss_pred EecCC-------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHhC---C
Confidence 65321 112345799999999999999999999999999877766544333322111 111111 1110 0
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......+..+...+++++.+||+.||++||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011111112223334777999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-34 Score=307.97 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=165.9
Q ss_pred hhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
..++|+..+.||+|+||.||+|+..+ ..+.|.+|++++++++||||+++++++.. ...+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQLA 95 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------CccE
Confidence 35689999999999999999987652 24678999999999999999999997632 2369
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999885322 3467899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.. .........||+.|+|||++. +..++.++||||+|++++++.....++...... ..+.............
T Consensus 173 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 173 WS----GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSCCCCT
T ss_pred cc----ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhcccccCcch
Confidence 11 111223457999999999987 667899999999998777765544444332220 0000000010000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
. ......++.+.+++.+||+.||++|||++|++++|+++.+
T Consensus 248 --~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 --S-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --T-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --h-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 0000111223337779999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-33 Score=319.45 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=174.1
Q ss_pred hCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.++|+..+.||+|+||.||+|++.+ ..+.|.+|++++++++|||||++++++...+ ...++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEEEEE
Confidence 4578888999999999999987652 3568999999999999999999999986533 24899999
Q ss_pred ecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 728 FLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||++|+|.++++... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999987432 2367899999999998 9999999999999999999999999999854211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.....+++.|+|||++.+..++.++||||+|++++++.. ...++...+. .++. ..+..... ..
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~-~~i~~~~~------~~ 406 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVV-PRVEKGYK------MD 406 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHH-HHHHTTCC------CC
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH-HHHHcCCC------CC
Confidence 112357889999999999999999999999987777543 3333222211 1111 11111100 00
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.+...+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111122233377799999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=303.27 Aligned_cols=240 Identities=23% Similarity=0.316 Sum_probs=173.1
Q ss_pred CCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
..|+..+.||+|+||.||+|+.. ...+.+.+|+.++++++||||++++++|...+ .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----C
Confidence 46778899999999999998743 12357889999999999999999999976433 3
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 4799999999999999986422 2356899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc-
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN- 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~- 870 (929)
....... .........||+.|+|||.+.+..++.++||||+|++++++... +..+.......+.. .......
T Consensus 178 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~----~~~~~~~~~~~~~~-~~~~~~~~ 250 (298)
T 3f66_A 178 MYDKEYY--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR----GAPPYPDVNTFDIT-VYLLQGRR 250 (298)
T ss_dssp CSCGGGC--BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT----SCCSSTTSCTTTHH-HHHHTTCC
T ss_pred ccccchh--ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhC----CCCCCccCCHHHHH-HHHhcCCC
Confidence 6432111 11223345688999999999999999999999999776664331 11111111111110 0000000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.......++ .+.+++.+||+.||++|||++|++++|+++...+.
T Consensus 251 ~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 LLQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCCCccCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000111112 23337779999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-33 Score=305.54 Aligned_cols=249 Identities=16% Similarity=0.128 Sum_probs=181.0
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|+.+++++ +|+|++++++++.. ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----CceeEE
Confidence 357899999999999999999853 1235688999999999 79999999999843 335899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc-----eEEecccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-----AKVGDFGLAR 790 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~ki~DfGla~ 790 (929)
||||+ +|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999 999999987432 2367899999999998 9999999999999987776 9999999998
Q ss_pred ccccccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
.......... .........||+.|+|||++.+..++.++||||+|++++++.....++..... ...+.+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7643221111 11123456799999999999999999999999999888776665555443322 111111110000000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
. . .......+++.+.+++.+||+.||++||+++++++.|+++.+.....
T Consensus 240 ~-~--~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 240 T-P--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp S-C--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred c-c--HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 0 0 00000111223334777999999999999999999999998875533
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-34 Score=315.45 Aligned_cols=246 Identities=17% Similarity=0.238 Sum_probs=179.8
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHcc-CCccccceeeec
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNV-RHRNLVKLITSC 711 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~ 711 (929)
+++...++|+..+.||+|+||.||+|.... ..+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556789999999999999999987431 235688999999999 899999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc----------------------cccccHHHHHHHhhhCCCCCEEecCCC
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER----------------------KNELDITSALDYLHNDCEVPVVHSDLK 769 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk 769 (929)
...+ ..++||||+++|+|.+++.... .++.|++.||+|||+. +|+|||||
T Consensus 120 ~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 191 (333)
T 2i1m_A 120 THGG-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191 (333)
T ss_dssp CSSS-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred ecCC-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence 6533 3799999999999999986321 2356899999999998 99999999
Q ss_pred CCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhh
Q 002376 770 PGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVE 848 (929)
Q Consensus 770 ~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~ 848 (929)
|+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++.. ...++
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDS----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCT----TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cceEEECCCCeEEECcccccccccccc----ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999998653321 1111233467889999999999999999999999987776543 22222
Q ss_pred hcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 849 SNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 849 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
..... .+.+........... .....++ .+.+++.+||+.||++|||+.|+++.|+++.+.....
T Consensus 268 ~~~~~--~~~~~~~~~~~~~~~--~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 268 PGILV--NSKFYKLVKDGYQMA--QPAFAPK----NIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp TTCCS--SHHHHHHHHHTCCCC--CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred cccch--hHHHHHHHhcCCCCC--CCCCCCH----HHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 11111 000001111111000 0111112 2233777999999999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=306.26 Aligned_cols=229 Identities=20% Similarity=0.270 Sum_probs=164.0
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------------------------------cHHHHHHHHHHHH
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------------------------------SWKSFIAECETLR 697 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------------------------------~~~~~~~E~~~l~ 697 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999986531 0246889999999
Q ss_pred ccCCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 698 ~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+++||||+++++++.+. .....++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 99999999999998652 2346899999999999998765322 3467899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCC---CCCCCCCCCCcCCCCCcchhHHh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER---PSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
+||+++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++||||+|++++++.....+
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEECCCCCEEEecCCCccccccc------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999865321 11123457999999999998765 37889999999877665444333
Q ss_pred hhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 848 ESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 848 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.... ..... ..+...... .......++ .+++++.+||+.||++|||++|+++
T Consensus 240 f~~~~--~~~~~-~~~~~~~~~-~~~~~~~~~----~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDER--IMCLH-SKIKSQALE-FPDQPDIAE----DLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSS--HHHHH-HHHHHCCCC-CCSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc--HHHHH-HHHhcccCC-CCCccccCH----HHHHHHHHHhhcChhhCCCHHHHhc
Confidence 22111 11110 111110000 000111112 2333777999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=317.41 Aligned_cols=230 Identities=22% Similarity=0.198 Sum_probs=167.4
Q ss_pred hhCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
..++|+..+.||+|+||.||+|... ...+.+.+|++++++++|||||++++++.+ ..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CC
Confidence 3467899999999999999998654 123568899999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec---CCCceEEeccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLA 789 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DfGla 789 (929)
..|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+|
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 5899999999999998886433 3467899999999998 999999999999998 5678999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+..... .......+||++|||||++.+..++.++||||+|+++|++..+..++.... ..+.......+...
T Consensus 161 ~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~- 231 (444)
T 3soa_A 161 IEVEGE------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYD- 231 (444)
T ss_dssp BCCCTT------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCC-
T ss_pred EEecCC------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCC-
Confidence 865321 112234579999999999999999999999999987776544433322111 11111111111110
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+..++..+++++.+|++.||++|||+.|+++
T Consensus 232 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 ---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 001111112223334777999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-33 Score=314.20 Aligned_cols=249 Identities=16% Similarity=0.121 Sum_probs=170.9
Q ss_pred CCCCCceeecccCceeEEeccccC------------------------------cHHHHHHHHHHHHccCCccccceeee
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------------------SWKSFIAECETLRNVRHRNLVKLITS 710 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------------------~~~~~~~E~~~l~~l~Hpniv~l~~~ 710 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 578899999999999999997642 01235678888899999999999999
Q ss_pred cccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC--c
Q 002376 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM--T 780 (929)
Q Consensus 711 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~--~ 780 (929)
+.... .+....|+||||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 117 ~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEES-SSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred ccccc-CCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 86632 2345689999999 999999987543 3367899999999998 999999999999999887 9
Q ss_pred eEEeccccccccccccCCC-CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhh
Q 002376 781 AKVGDFGLARFLLERVDNQ-SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQ 857 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~ 857 (929)
+||+|||+|+.+....... ..........||+.|+|||++.+..++.++||||+|++++++.....++..... ....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764332211 111222455799999999999999999999999999888776665554432111 0000
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
..........+........ ...++.-+.+++.+||+.||++||+++++++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAP-SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSC-TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcccccHHHHhhcc-ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0001111100000000000 00111223337779999999999999999999998644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-33 Score=314.89 Aligned_cols=226 Identities=25% Similarity=0.265 Sum_probs=164.5
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|+..++||+|+||+||+|+... ..+.+.+|..+++.+ +|||||++++++.+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----- 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----- 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----
Confidence 35689999999999999999987651 234577899999988 79999999999854
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
....|+||||+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 335899999999999999886432 3467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.... ........+||+.|||||++.+..++.++||||+|+++|++.....++.... ..++...... ..
T Consensus 173 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~----~~ 240 (353)
T 3txo_A 173 EGIC------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILN----DE 240 (353)
T ss_dssp CSCC---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----CC
T ss_pred eccc------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHHHc----CC
Confidence 5321 1122345689999999999998899999999999987777655444332221 1111111111 11
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCH------HHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI------REALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~------~ev~~ 908 (929)
...... +...+.+++.+|++.||++||++ +|+++
T Consensus 241 ~~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111111 22223347779999999999998 66664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-33 Score=301.79 Aligned_cols=236 Identities=21% Similarity=0.246 Sum_probs=164.6
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||.||+|.+.. ..+.|.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence 4578889999999999999987531 13568899999999999999999999843
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 12699999999999999986432 2357899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
...... ........+|+.|+|||++.+..++.++||||+|++++++.+ ...++..... .+.. ..+....
T Consensus 165 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~-~~i~~~~-- 234 (281)
T 1mp8_A 165 YMEDST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVI-GRIENGE-- 234 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHH-HHHHTTC--
T ss_pred ccCccc-----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHH-HHHHcCC--
Confidence 763221 111223457889999999998899999999999987766543 2222222111 0100 0111100
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
....... .+..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 235 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 235 RLPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0001111 12223337779999999999999999999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-34 Score=314.51 Aligned_cols=247 Identities=22% Similarity=0.230 Sum_probs=174.7
Q ss_pred CCCCCceeecccCceeEEeccc----c----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNER----T----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~----~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||++++ . ...+.+.+|++++++++||||+++++++... ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence 5788899999999999999873 1 1235689999999999999999999998642 334
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 5899999999999999986422 2357899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc-----C---hHH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL-----D---PEL 863 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~l 863 (929)
...... .........||+.|+|||++.+..++.++||||+|++++++.....++........... . ..+
T Consensus 177 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 177 LPLDKD---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CCTTCS---EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred cccCCc---cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 642211 11112334688999999999998999999999999887776554333221111100000 0 011
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
........ ...........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 254 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11110000 000011112223337779999999999999999999999877644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-34 Score=313.84 Aligned_cols=223 Identities=25% Similarity=0.309 Sum_probs=166.6
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...+.||+|+||+||+|++.. ..+.+.+|+++++.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 4689999999999999999998641 124688999999999999999999998653 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 489999999 789988875332 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... ......+||+.|+|||++.+..+ +.++||||+|++++++..+..++.... ..+........ ..
T Consensus 159 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~----~~ 225 (336)
T 3h4j_B 159 TDG-------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF--IPNLFKKVNSC----VY 225 (336)
T ss_dssp TTS-------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS--STTCBCCCCSS----CC
T ss_pred cCC-------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHcC----CC
Confidence 321 11234579999999999988876 789999999987776655444332211 11111110000 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .++.++..+++++.+|++.||++|||++|+++
T Consensus 226 ~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 V----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp C----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 00111222334777999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=305.48 Aligned_cols=222 Identities=19% Similarity=0.244 Sum_probs=168.1
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||+||+++.. ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 357889999999999999998764 123567789999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.++++... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence 5899999999999999986432 3467899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. .....+||+.|+|||++.+..++.++||||+|+++|++.....++..... .+....... ....
T Consensus 157 ~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~----~~~~ 221 (318)
T 1fot_A 157 PD---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILN----AELR 221 (318)
T ss_dssp SS---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHH----CCCC
T ss_pred CC---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHh----CCCC
Confidence 31 12345799999999999999999999999999877776554433322111 111111111 1111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
.... +..-+++++.+|++.||++|| +++|+++
T Consensus 222 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 122233477799999999999 8888873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-33 Score=316.52 Aligned_cols=228 Identities=21% Similarity=0.231 Sum_probs=168.9
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+|.... ....+.+|++++++++|||||++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence 4679999999999999999987641 23468899999999999999999999854 34589
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC--CCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE--EMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~ki~DfGla~~~ 792 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999999886432 2367899999999998 9999999999999974 578999999999875
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.+.. +.. ....
T Consensus 202 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~-i~~---~~~~ 268 (387)
T 1kob_A 202 NPD-------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQN-VKR---CDWE 268 (387)
T ss_dssp CTT-------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH-HHH---CCCC
T ss_pred CCC-------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHH-HHh---CCCC
Confidence 321 122345799999999999999999999999999877776554433322111 111111 111 0000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........+...+++++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000111112222334777999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-33 Score=306.17 Aligned_cols=226 Identities=22% Similarity=0.282 Sum_probs=169.0
Q ss_pred CCCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
++|...+.||+|+||.||+|+.. ...+.|.+|++++++++||||+++++++...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-- 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT--
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC--
Confidence 57888999999999999998543 12467899999999999999999999996533
Q ss_pred CcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc--------
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT-------- 780 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------- 780 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ---ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ---CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred ---CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 3699999999999999987433 2367899999999998 9999999999999998887
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHH-hhhcCCchhhhc
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKW-VESNLPENVLQV 858 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~-~~~~~~~~~~~~ 858 (929)
+||+|||+++.... .....||+.|+|||++.+ ..++.++||||+|++++++..... ++.....
T Consensus 160 ~kl~Dfg~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----- 224 (289)
T 4fvq_A 160 IKLSDPGISITVLP----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----- 224 (289)
T ss_dssp EEECCCCSCTTTSC----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred eeeccCcccccccC----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----
Confidence 99999999875421 123468999999999988 679999999999987776544211 1111110
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
.................++.+. +++.+||+.||++|||++|+++.|+++..
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~l~----~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 225 --QRKLQFYEDRHQLPAPKAAELA----NLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --HHHHHHHHTTCCCCCCSSCTTH----HHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --HHHHHHhhccCCCCCCCCHHHH----HHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111111111111112222 36679999999999999999999999765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-33 Score=308.39 Aligned_cols=227 Identities=22% Similarity=0.221 Sum_probs=166.9
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.|+..+.||+|+||.||+|.... ..+.+.+|+.+++.++|||||++++++.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD----- 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 468889999999999999986541 246789999999999999999999998543
Q ss_pred ceEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc---eEEe
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT---AKVG 784 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~ 784 (929)
...|+||||+++|+|.+++... ..++.||+.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEe
Confidence 3589999999999998877532 12357999999999998 9999999999999986654 9999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|||+++..... .......+||+.|+|||++.+..++.++||||+|+++|++.....++....+ +.......
T Consensus 176 Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i~~ 246 (351)
T 3c0i_A 176 GFGVAIQLGES------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGIIK 246 (351)
T ss_dssp CCTTCEECCTT------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHHHH
T ss_pred cCcceeEecCC------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHHHc
Confidence 99999876321 1112345799999999999999999999999999877765544333322111 11111111
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ........+..++..+++++.+||+.||++|||+.|+++
T Consensus 247 ~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 G----KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp T----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C----CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 111111111112233344777999999999999999974
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.77 Aligned_cols=294 Identities=18% Similarity=0.243 Sum_probs=198.9
Q ss_pred CCCCCCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCC
Q 002376 51 YWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNN 130 (929)
Q Consensus 51 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 130 (929)
.|.+...+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 46566778999987 64 3455666 6777665 589999999999998777799999999999999999
Q ss_pred CCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecc
Q 002376 131 LQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210 (929)
Q Consensus 131 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N 210 (929)
+++..|..|.++++|++|+|++|+++ .++...|.++++|++|+|++|++++ +|. ...|..+++|++|++++|
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-l~~------~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT-LGE------TSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSS-SCS------SCSCTTCTTCCEEEEEES
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcc-cCc------hhhhccCCCCcEEECCCC
Confidence 99888889999999999999999998 6888879999999999999998853 221 135788999999999999
Q ss_pred -cCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCc
Q 002376 211 -RLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTL 289 (929)
Q Consensus 211 -~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 289 (929)
.+....+..|.++++|++|++++|++++..|..+.. +++|++|++++|+++...+..+..+++|+.|++++|.+++..
T Consensus 160 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 238 (353)
T 2z80_A 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS-IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238 (353)
T ss_dssp SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT-CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred ccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhc-cccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence 577777888999999999999999888544544433 556666666666654333333334555666666666555433
Q ss_pred cCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCcccccc
Q 002376 290 PPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI 369 (929)
Q Consensus 290 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~ 369 (929)
+..+. .......++.++|++|.+++. .+. .+
T Consensus 239 ~~~l~----------------------------~~~~~~~l~~l~L~~~~l~~~--------------------~l~-~l 269 (353)
T 2z80_A 239 FSELS----------------------------TGETNSLIKKFTFRNVKITDE--------------------SLF-QV 269 (353)
T ss_dssp CC----------------------------------CCCCCCEEEEESCBCCHH--------------------HHH-HH
T ss_pred ccccc----------------------------cccccchhhccccccccccCc--------------------chh-hh
Confidence 21111 112233455555555554431 111 23
Q ss_pred CCCCCCCCcccEEEeeCCCCCcccCcc-ccCCCCCCEEEecCCcCCCCC
Q 002376 370 PASIGRLRSLTLLDLSYNSISGEIPIE-IGQLQGLQVLGLAGNEIPGGI 417 (929)
Q Consensus 370 p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~ 417 (929)
|..+..+++|++|+|++|+++. +|.. |..+++|++|+|++|.+.+..
T Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 270 MKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 4445555666666666666653 3333 456666666666666665443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=298.60 Aligned_cols=236 Identities=22% Similarity=0.336 Sum_probs=173.1
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||.||++++.. ..+++.+|++++++++||||+++++++... ...++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCeEE
Confidence 34578889999999999999987652 357899999999999999999999998543 34899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999986522 2367899999999998 9999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
.. .......||+.|+|||++.+..++.++||||+|++++++.. ...++...... +. ...+....... ..
T Consensus 174 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~-~~~~~~~~~~~--~~ 243 (283)
T 3gen_A 174 EY-----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ET-AEHIAQGLRLY--RP 243 (283)
T ss_dssp HH-----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH-HHHHHTTCCCC--CC
T ss_pred cc-----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HH-HHHHhcccCCC--CC
Confidence 11 11223357888999999998999999999999987776543 33333322210 00 01111110000 00
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
...++ .+.+++.+||+.||++|||++|+++.|+++...
T Consensus 244 ~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 HLASE----KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11112 233377799999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-33 Score=304.00 Aligned_cols=236 Identities=22% Similarity=0.278 Sum_probs=174.2
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++|...+.||+|+||.||+|+.. ...+.+.+|++++++++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-- 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence 467888999999999999998641 12357889999999999999999999986533
Q ss_pred CcceEEEEEEecCCCCccccccccc--------------------------------cccccHHHHHHHhhhCCCCCEEe
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------------------------------KNELDITSALDYLHNDCEVPVVH 765 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------~~~~~ia~aL~yLH~~~~~~iiH 765 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+|
T Consensus 100 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 100 ---PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ---ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 3799999999999999986432 2356899999999998 9999
Q ss_pred cCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-h
Q 002376 766 SDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-V 844 (929)
Q Consensus 766 rDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~ 844 (929)
|||||+||++++++.+||+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++.. .
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTS----CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccchheEEEcCCCCEEEccccccccccccc----cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999998653221 1111233467889999999999889999999999987776543 3
Q ss_pred HHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 845 KWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..++..... .+.. ..+..... ...... +...+.+++.+||+.||++||+++|+++.|+++...
T Consensus 250 ~~p~~~~~~--~~~~-~~~~~~~~--~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPP--ERLF-NLLKTGHR--MERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCG--GGHH-HHHHTTCC--CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCH--HHHH-HHhhcCCc--CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 222221111 1110 11111000 001111 122233377799999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-33 Score=311.87 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=178.0
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC-----------cHHHHHHHHHHHHc--cCCccccceeeecccCCCCCcceEE
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRN--VRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
....++|+..+.||+|+||.||+|++.+ ..+.+.+|++++.. ++||||+++++++..... .....+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~ 116 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLW 116 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeE
Confidence 3445689999999999999999987652 34678889999887 789999999999866442 223589
Q ss_pred EEEEecCCCCccccccccc-------cccccHHHHHHHhh--------hCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-------KNELDITSALDYLH--------NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
+||||+++|+|.++++... .++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999986432 34679999999999 55 899999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCC------CCCCCCCCCCcCCCCCcchh----------HHhhhcCC
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER------PSTAGDVPTSESFAGEFNIV----------KWVESNLP 852 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~s~g~~~~~~~~~----------~~~~~~~~ 852 (929)
++........ .........||+.|+|||++.+.. ++.++||||+|++++++... ..++....
T Consensus 194 ~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 194 AVRHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp CEEEETTTTE--EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ceeccccccc--cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9876432110 000123457999999999988763 34789999999888776544 22221111
Q ss_pred chhhhccChHHHHhhcc-----cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 853 ENVLQVLDPELRQLMTS-----NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 853 ~~~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. .+.....+...... .........++ ...+.+++.+||+.||++|||++||++.|+++.++
T Consensus 272 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 272 P--SDPSVEEMRKVVCEQKLRPNIPNRWQSCEA-LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp C--SSCCHHHHHHHHTTSCCCCCCCGGGGTSHH-HHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c--CcccHHHHHHHHHHHHhCCCCcccccchhH-HHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 0 00000111111100 00000011122 23334488899999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=311.14 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=176.2
Q ss_pred HHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeeccc
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSS 713 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~ 713 (929)
+....++|+..+.||+|+||.||+|++.+ ..+.|.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 33456789999999999999999987631 13578899999999999999999999965
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc--------------------------------cccccHHHHHHHhhhCCCC
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER--------------------------------KNELDITSALDYLHNDCEV 761 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------~~~~~ia~aL~yLH~~~~~ 761 (929)
.+ ..++||||+++|+|.++++... .++.||+.||+|||+.
T Consensus 122 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--- 193 (343)
T 1luf_A 122 GK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 193 (343)
T ss_dssp SS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred CC-----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 33 3799999999999999986421 1367899999999998
Q ss_pred CEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCc
Q 002376 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEF 841 (929)
Q Consensus 762 ~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~ 841 (929)
+|+||||||+||++++++.+||+|||+++....... ........||+.|+|||++.+..++.++||||+|++++++
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 999999999999999999999999999987632211 1112334689999999999999999999999999877765
Q ss_pred ch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 842 NI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 842 ~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.. ...++..... . .+......... ...++..+..+.+++.+||+.||++||++.|+++.|+++.+.+.
T Consensus 270 ~t~g~~p~~~~~~--~-----~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 270 FSYGLQPYYGMAH--E-----EVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HTTTCCTTTTSCH--H-----HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HhcCCCcCCCCCh--H-----HHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 43 3222222111 1 11111100000 00001111223337779999999999999999999999876654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-33 Score=307.16 Aligned_cols=245 Identities=19% Similarity=0.243 Sum_probs=167.5
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
....++|+..+.||+|+||.||+|++.. ..+.|.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999987541 2356889999999999999999999987643
Q ss_pred CCC-cceEEEEEEecCCCCccccccccc--------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc
Q 002376 716 SKN-MEFLALVYEFLSNGSLGDWIHGER--------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT 780 (929)
Q Consensus 716 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 780 (929)
..+ ....++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 211 123489999999999999885321 2367899999999998 9999999999999999999
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhcc
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVL 859 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~ 859 (929)
+||+|||+++....... ........+|+.|+|||++.+..++.++||||+|++++++.. ...++..... .+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~ 249 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIY 249 (323)
T ss_dssp EEECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHH
T ss_pred EEEeecccccccccccc----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHH
Confidence 99999999986532211 111223457889999999999999999999999987777544 3333322221 1111
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
.. +.... ........++ .+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 250 ~~-~~~~~--~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 NY-LIGGN--RLKQPPECME----EVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HH-HHTTC--CCCCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HH-HhcCC--CCCCCCccCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00 11000 0011111112 2233777999999999999999999999987753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=323.54 Aligned_cols=238 Identities=21% Similarity=0.304 Sum_probs=176.9
Q ss_pred HHhhCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+...++|+..+.||+|+||.||+|.+. ...++|.+|++++++++|||||++++++.. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Ccc
Confidence 344567888999999999999999764 235789999999999999999999999852 237
Q ss_pred EEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
++|||||++|+|.++++... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999987431 2367999999999998 9999999999999999999999999999875
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... ........+|+.|+|||++.+..++.++||||+|++++++.. ...++..... .++.. .+.......
T Consensus 335 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~-~i~~~~~~~- 405 (454)
T 1qcf_A 335 EDNE-----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIR-ALERGYRMP- 405 (454)
T ss_dssp CCHH-----HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH-HHHHTCCCC-
T ss_pred CCCc-----eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHH-HHHcCCCCC-
Confidence 3211 011122356889999999998999999999999987776544 3333222111 11111 111111000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
... .+...+ .+++.+||+.||++||||++|+++|+++....
T Consensus 406 -~~~---~~~~~l-~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 -RPE---NCPEEL-YNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCT---TSCHHH-HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCC---CCCHHH-HHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 001 111223 33778999999999999999999999976543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=303.39 Aligned_cols=230 Identities=20% Similarity=0.221 Sum_probs=168.3
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||+||+|+... ..+.+.+|+.+++.++|||||++++++.+. ...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence 3689999999999999999986541 135688999999999999999999998543 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999999987442 3467999999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ........+||+.|+|||++.+..+ +.++||||+|++++++.....++...... .............
T Consensus 158 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~- 227 (323)
T 3tki_A 158 NN----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEKKTY- 227 (323)
T ss_dssp TT----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-----SHHHHHHHTTCTT-
T ss_pred CC----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhccccc-
Confidence 21 1111234579999999999988775 78999999998777665544443222111 1111111111000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......+...+.+++.+|++.||++|||++|+++
T Consensus 228 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001111222233777999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-33 Score=320.99 Aligned_cols=178 Identities=24% Similarity=0.282 Sum_probs=139.8
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||+||+|.+.. ..+++.+|+.+++.++|||||++++++..... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 5689999999999999999986541 24568899999999999999999999865432 2235
Q ss_pred eEEEEEEecCCCCccccccc------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHG------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
..|+||||+++ ++.+.+.. .+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 68999999975 46555542 224578999999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. ......+||++|+|||++.+..++.++||||+|++++++..+..++
T Consensus 217 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 217 S-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp C-------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred C-------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence 1 1234468999999999999999999999999998888766554443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-33 Score=305.79 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=170.5
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecc
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCS 712 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~ 712 (929)
+++....++|...+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344456688889999999999999875431 1356889999999999999999999997
Q ss_pred cCCCCCcceEEEEEEecCCCCcccccccc--------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGE--------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
..+.......++||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 65543344579999999999999988321 12367899999999998 99999999999999999
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~ 857 (929)
+.+||+|||+++....... ........|++.|+|||++.+..++.++||||+|++++++.. ...++..... .+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~ 257 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HE 257 (313)
T ss_dssp SCEEECSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GG
T ss_pred CcEEEeecCcceecccccc----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HH
Confidence 9999999999986532211 111233467889999999999999999999999987766544 2222221111 11
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
..+ .+.... ........++ .+ .+++.+||+.||++|||++|+++.|+++.+..+
T Consensus 258 ~~~-~~~~~~--~~~~~~~~~~---~l-~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYD-YLLHGH--RLKQPEDCLD---EL-YEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHH-HHHTTC--CCCCBTTCCH---HH-HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHH-HHHcCC--CCCCCccccH---HH-HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 111100 0001111112 22 337779999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=303.95 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=141.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|++.. ..+.+.+|++++++++||||+++++++.+. ...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 94 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RCL 94 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SCE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CEE
Confidence 4689999999999999999987641 135688999999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99999997 57877765432 2367899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.. ........||+.|+|||++.+ ..++.++||||+|++++++.....++
T Consensus 171 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (311)
T 3niz_A 171 IP------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220 (311)
T ss_dssp SC------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CC------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence 21 112233578999999999876 46899999999998877765554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-33 Score=311.99 Aligned_cols=227 Identities=24% Similarity=0.311 Sum_probs=168.1
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
....++|...+.||+|+||+||+|+... ..+.+.+|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--- 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--- 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe---
Confidence 4456789999999999999999997652 234577899999887 99999999999854
Q ss_pred CCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
....|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 90 --~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 90 --KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 335899999999999999986422 3467999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
|+..... .......+||+.|+|||++.+..++.++||||+|+++|++..+..++.... ..++.. .+..
T Consensus 165 a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~-~i~~--- 232 (345)
T 1xjd_A 165 CKENMLG------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFH-SIRM--- 232 (345)
T ss_dssp CBCCCCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHH-HHHH---
T ss_pred hhhcccC------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHH-HHHh---
Confidence 9854211 112345689999999999999999999999999987777655443332211 111111 1111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHH-HHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIR-EAL 907 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~ 907 (929)
...... ..+...+++++.+|++.||++||++. |+.
T Consensus 233 ~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 DNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 11222333477799999999999997 654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=314.32 Aligned_cols=230 Identities=23% Similarity=0.218 Sum_probs=163.4
Q ss_pred CceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 665 HENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 665 ~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
..+.||+|+||.||+|+.. ...+.|.+|++++++++|||||++++++... ...++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeC
Confidence 3578999999999998754 1346789999999999999999999999543 348999999
Q ss_pred cCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee--cCCCceEEeccccccccccccC
Q 002376 729 LSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL--DEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 729 ~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~ki~DfGla~~~~~~~~ 797 (929)
+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-- 242 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence 99999998875322 2357999999999998 99999999999999 67789999999999876322
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
......+||+.|+|||++.+..++.++||||+|++++++.....++..... .+.+...... ........
T Consensus 243 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~----~~~~~~~~ 311 (373)
T 2x4f_A 243 -----EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILAC----RWDLEDEE 311 (373)
T ss_dssp -----CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT----CCCSCSGG
T ss_pred -----cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc----cCCCChhh
Confidence 112234799999999999999999999999999877776554443322221 1111111111 00000001
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQE 915 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 915 (929)
...+...+.+++.+|++.||++|||++|+++ .+++...
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 1112223334777999999999999999986 5666543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=309.23 Aligned_cols=226 Identities=25% Similarity=0.278 Sum_probs=165.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||+||+++... ..+.+.+|+.+++++ +|||||++++++.+ ..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----CC
Confidence 578889999999999999987641 134577899999988 89999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 5899999999999999886432 3467899999999998 9999999999999999999999999999853
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCch--hhhccChHHHHhhccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPEN--VLQVLDPELRQLMTSN 870 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~ 870 (929)
... .......+||+.|+|||++.+..++.++||||+|+++|++.....++...... ........+.......
T Consensus 161 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 161 LRP------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp CCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred cCC------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 211 11234468999999999999999999999999998888776655444321110 0000001111111000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
. ...+..+...+++++.+||+.||++||++
T Consensus 235 ~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 Q---IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C---CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C---CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0 01111122233347779999999999996
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=309.10 Aligned_cols=239 Identities=18% Similarity=0.258 Sum_probs=175.9
Q ss_pred hhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLD 715 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 715 (929)
..++|+..+.||+|+||.||+|++. ...+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 3467889999999999999998631 1246788999999999 9999999999996543
Q ss_pred CCCcceEEEEEEecCCCCccccccccc--------------------------cccccHHHHHHHhhhCCCCCEEecCCC
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER--------------------------KNELDITSALDYLHNDCEVPVVHSDLK 769 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk 769 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+|||||
T Consensus 101 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 101 -----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp -----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred -----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 3799999999999999986432 1256899999999998 99999999
Q ss_pred CCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhh
Q 002376 770 PGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVE 848 (929)
Q Consensus 770 ~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~ 848 (929)
|+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++.. ...++
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT----TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cceEEEcCCCCEEEccccccccccccc----cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998664321 1111233467889999999999999999999999987776543 33222
Q ss_pred hcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 849 SNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 849 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
...+. +............. ......+..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 249 ~~~~~------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 249 PGMPV------DSKFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TTCCS------SHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred Ccccc------hhHHHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 22111 11111111100000 000111122333777999999999999999999999987754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-33 Score=308.34 Aligned_cols=230 Identities=23% Similarity=0.257 Sum_probs=156.4
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS-----SEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEEE
Confidence 35679999999999999999988752 245688999999999999999999999543 34899
Q ss_pred EEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEeccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLL 793 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~ 793 (929)
||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999886433 3367899999999998 9999999999999975 8899999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......||+.|+|||++.+..++.++||||+|++++++.....++...... +. ............
T Consensus 203 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~---~~~~i~~~~~~~ 270 (349)
T 2w4o_A 203 HQ-------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QF---MFRRILNCEYYF 270 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HH---HHHHHHTTCCCC
T ss_pred cc-------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HH---HHHHHHhCCCcc
Confidence 21 1123457999999999999999999999999998777765544333221110 00 011111111000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......+...+++++.+|++.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011112222334777999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-33 Score=320.21 Aligned_cols=180 Identities=24% Similarity=0.330 Sum_probs=135.2
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||+||+|++.. ..+++.+|++++++++|||||++++++...+......
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999986541 2457889999999999999999999997655444566
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+ +|+|.++++... .++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 578988876432 3467999999999998 99999999999999999999999999998764
Q ss_pred cccCCCCC---------------------ccccceecccccccccccc-CCCCCCCCCCCCCCcCCCCCcch
Q 002376 794 ERVDNQSS---------------------ISSTHVFMGSIGYVPPEYG-LGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 794 ~~~~~~~~---------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
........ .......+||++|||||++ .+..++.++||||+||+++++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 22111000 0123456899999999976 45679999999999998888654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-33 Score=310.23 Aligned_cols=242 Identities=20% Similarity=0.304 Sum_probs=165.1
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||++++.. ..+.|.+|++++++++||||+++++++..... ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence 4689999999999999999987531 12468899999999999999999999865432 223
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 4699999999999999986432 3467899999999998 9999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
..... .........||+.|+|||++.+..++.++||||+|+++|++.....++..... .+........ ...
T Consensus 167 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~----~~~ 237 (311)
T 3ork_A 167 ADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVRE----DPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHC----CCC
T ss_pred ccccc---ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcC----CCC
Confidence 43211 11222345799999999999999999999999999877776554433322211 1111111111 111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH-HHHHhhH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL-RRLKSSQ 914 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~-~~L~~~~ 914 (929)
........++.-+.+++.+||+.||++||++.+++ ..+.++.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 10000111222233477799999999999766554 4555543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-33 Score=322.82 Aligned_cols=233 Identities=20% Similarity=0.300 Sum_probs=173.8
Q ss_pred hCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||.||+|++. ...++|.+|++++++++|||||+++++|...+ ..++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEEE
Confidence 456888899999999999998765 23578999999999999999999999996543 3799
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|||||++|+|.++++... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999986422 2357999999999998 999999999999999999999999999987532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. .........+++.|+|||++.+..++.++||||+|++++++.. ...++.... ..+ +...+....
T Consensus 371 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~-----~~~~~~~~~-- 436 (495)
T 1opk_A 371 D-----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ-----VYELLEKDY-- 436 (495)
T ss_dssp C-----CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGG-----HHHHHHTTC--
T ss_pred C-----ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHH-----HHHHHHcCC--
Confidence 1 1111223356789999999998899999999999987777543 222222111 111 111111110
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
+...+...+..+.+++.+||+.||++||||+|++++|+++.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00011111222333778999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-33 Score=320.40 Aligned_cols=237 Identities=21% Similarity=0.191 Sum_probs=173.3
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeec
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSC 711 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~ 711 (929)
+.+++++...++|+..+.||+|+||+||+++... ..+.+.+|+.++..++|||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3456666778899999999999999999988651 123477899999999999999999998
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
.+ ....|+||||+++|+|.++++... .++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 131 ~~-----~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QD-----ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EC-----SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred ee-----CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEE
Confidence 54 345899999999999999986422 2367899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccC-------CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-------GERPSTAGDVPTSESFAGEFNIVKWVESNLPE-N 854 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~ 854 (929)
|+|||+|+..... ........+||+.|||||++. +..++.++||||+|+++|++..+..++..... .
T Consensus 203 L~DFGla~~~~~~-----~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 277 (412)
T 2vd5_A 203 LADFGSCLKLRAD-----GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277 (412)
T ss_dssp ECCCTTCEECCTT-----SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EeechhheeccCC-----CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence 9999999865321 111123458999999999987 45789999999999888776655544432221 1
Q ss_pred -hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCC---CCHHHHHH
Q 002376 855 -VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGR---IGIREALR 908 (929)
Q Consensus 855 -~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~ev~~ 908 (929)
..+++........ +. ....++.-+++++.+|+. +|++| |+++|+.+
T Consensus 278 ~~~~i~~~~~~~~~---p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEHLSL---PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHHCCC---C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccCcCC---Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111100000 00 001122233447779999 99998 58888864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=308.47 Aligned_cols=222 Identities=21% Similarity=0.219 Sum_probs=168.1
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+++.. ...+.+.+|++++++++||||+++++++.+ ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 357889999999999999998764 123567889999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence 5899999999999999987432 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. .....+||+.|+|||++.+..++.++||||+|+++|++.....++.... ..++....... ...
T Consensus 192 ~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~----~~~ 256 (350)
T 1rdq_E 192 KG---------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSG----KVR 256 (350)
T ss_dssp SS---------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----CCC
T ss_pred cC---------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--HHHHHHHHHcC----CCC
Confidence 32 1234579999999999999999999999999987777655433332111 11111111111 111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.... +..-+++++.+|++.||++||+ ++|+.+
T Consensus 257 ~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111 1222334777999999999998 777764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=296.68 Aligned_cols=233 Identities=24% Similarity=0.316 Sum_probs=165.0
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|++.+ ..+.+.+|+++++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----PN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 3578889999999999999987541 135788999999999999999999999643 34
Q ss_pred EEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC--------CCceEEecc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE--------EMTAKVGDF 786 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~ki~Df 786 (929)
.++||||+++|+|.++++..+ .++.|++.||+|||+....+|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 799999999999999886432 33678999999999982223999999999999986 678999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
|+++..... ......||+.|+|||++.+..++.++||||+|++++++.....++...... +.. ......
T Consensus 161 g~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~-~~~~~~ 229 (271)
T 3dtc_A 161 GLAREWHRT--------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVA-YGVAMN 229 (271)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--HHH-HHHHTS
T ss_pred Ccccccccc--------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HhhhcC
Confidence 999865321 112347899999999999999999999999998777665544443322210 000 000000
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
......... .++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 230 -~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -KLALPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000111 112233377799999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=297.39 Aligned_cols=240 Identities=24% Similarity=0.313 Sum_probs=174.5
Q ss_pred CCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 662 NFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.|+..++||+|+||.||+|++. ...+.|.+|+.++++++||||+++++++.+.+. .
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG----L 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----C
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC----C
Confidence 4555689999999999998642 123678899999999999999999999865332 3
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+.+|+|.++++... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 589999999999999987422 2356899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc--
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN-- 870 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-- 870 (929)
...... .........||+.|+|||.+.+..++.++||||+|++++++.....+ +..... ...+.......
T Consensus 175 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~----~~~~~~--~~~~~~~~~~~~~ 246 (298)
T 3pls_A 175 LDREYY--SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP----PYRHID--PFDLTHFLAQGRR 246 (298)
T ss_dssp TTGGGG--CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCC----TTTTSC--GGGHHHHHHTTCC
T ss_pred cCCccc--ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCC----CCccCC--HHHHHHHhhcCCC
Confidence 332111 11122344689999999999999999999999999776665432211 111000 00111111100
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
.......++ .+.+++.+||+.||++|||++|++++|+++.+.+...
T Consensus 247 ~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 LPQPEYCPD----SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCCccchH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 001111112 2333777999999999999999999999998886544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-33 Score=316.31 Aligned_cols=182 Identities=17% Similarity=0.144 Sum_probs=146.8
Q ss_pred hCCCCCceeeccc--CceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSG--SFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G--~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+| +||.||+|+... ..+.+.+|+.++++++|||||++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD----- 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-----
Confidence 4679999999999 999999988651 135677899999999999999999999643
Q ss_pred ceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
...++|||||++|+|.+++... ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 3489999999999999998643 13367899999999998 9999999999999999999999999998
Q ss_pred cccccccCC-CCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcchhHHhhh
Q 002376 790 RFLLERVDN-QSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFNIVKWVES 849 (929)
Q Consensus 790 ~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~~~~~~~~ 849 (929)
......... ..........+||+.|+|||++.+ ..++.++||||+|++++++.....++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 755322111 111112233479999999999988 579999999999988888766555543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-33 Score=308.52 Aligned_cols=243 Identities=21% Similarity=0.271 Sum_probs=172.8
Q ss_pred CCCCCceeecccCceeEEeccc----c-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNER----T-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~----~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.|+..+.||+|+||.||+|++ . ...+.+.+|++++++++||||+++++++...+ .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence 3578889999999999999872 1 12367899999999999999999999987532 2
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 34799999999999999985322 3367899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc--------cChH
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV--------LDPE 862 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 862 (929)
....... .........||..|+|||++.+..++.++||||+|++++++..+..++.......... ....
T Consensus 175 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 175 AIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp ECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccCCCc---ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 7642211 1112233468889999999999999999999999988777654332211000000000 0001
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
+........ ....+..++..+.+++.+||+.||++|||++|++++|+++.
T Consensus 252 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111110000 00000111222334777999999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-33 Score=309.06 Aligned_cols=228 Identities=20% Similarity=0.167 Sum_probs=147.1
Q ss_pred ceeecccCceeEEeccccC-------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEEEecCC
Q 002376 666 ENLIGSGSFGSVLHNERTG-------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSN 731 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~~-------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~ 731 (929)
.+.||+|+||.||+|.+.. ....+.+|+.+++.+. ||||+++++++.+ ....|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEEEEEEccCC
Confidence 4789999999999987652 2467889999999997 9999999999854 3458999999999
Q ss_pred CCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC---ceEEeccccccccccccCCCC
Q 002376 732 GSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM---TAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 732 gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki~DfGla~~~~~~~~~~~ 800 (929)
|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----- 162 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----- 162 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-----
Confidence 99999987433 3467899999999998 999999999999997665 8999999999865321
Q ss_pred CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH-hhcccchhhhhhhH
Q 002376 801 SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ-LMTSNESQTIQLHD 879 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~~ 879 (929)
.......+||+.|+|||++.+..++.++||||+|++++++.....++..............+.. ............+.
T Consensus 163 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 163 -NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred -CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence 1122345789999999999999999999999999877776554444432211000000011111 11111111111111
Q ss_pred HHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 880 CLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 880 ~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
.++..+++++.+|++.||++|||++|++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 1223334477799999999999999886
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-33 Score=318.18 Aligned_cols=243 Identities=18% Similarity=0.203 Sum_probs=179.1
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...++||+|+||.||+|++.. ..+.+.+|++++++++||||+++++++...+ ....+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence 468889999999999999987651 2467889999999999999999999986533 23579
Q ss_pred EEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee----cCCCceEEecccc
Q 002376 724 LVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVGDFGL 788 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DfGl 788 (929)
+||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999987432 2357899999999998 99999999999999 7788899999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCC--------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG--------ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV 858 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~ 858 (929)
++..... .......||+.|+|||++.+ ..++.++||||+|+++|++.....++..... ...++
T Consensus 163 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 163 ARELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp CEECCCG-------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred ceEccCC-------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 9876322 11233579999999999865 5678899999999888776665554432221 11111
Q ss_pred cChHHHHhhcc-----------------cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 859 LDPELRQLMTS-----------------NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 859 ~~~~l~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
+...+.+.... .........+.+...+.+++.+||+.||++||+++|+++.++++...
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111110000 00001112234555666688899999999999999999999887653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=302.21 Aligned_cols=232 Identities=18% Similarity=0.245 Sum_probs=171.3
Q ss_pred CCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
++|+..+.||+|+||.||+|++.+ ..+.|.+|+.++++++||||+++++++.+.+ ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCCeEe
Confidence 578889999999999999997652 2357899999999999999999999986532 234799
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||+++|+|.++++... .++.|++.||+|||+. .++|+||||||+||++++++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999997543 2357899999999997 1229999999999999999999999999876421
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCC---CCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPST---AGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.....||+.|+|||++.+..++. ++||||+|++++++.....++..... .+.......... ..
T Consensus 165 ----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--~~ 230 (271)
T 3kmu_A 165 ----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALEGL--RP 230 (271)
T ss_dssp ----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--HHHHHHHHHSCC--CC
T ss_pred ----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--HHHHHHHHhcCC--CC
Confidence 12246899999999998776554 79999999877776554444332221 111001111100 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
... ..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 231 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 TIP----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011 1112223347779999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-33 Score=307.16 Aligned_cols=226 Identities=22% Similarity=0.266 Sum_probs=167.9
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|+..+.||+|+||+||+|+... ..+.+.+|..++..+ +||+|+++++++.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence 35689999999999999999987652 234577899999988 89999999999854
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
....|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 345899999999999999987432 3467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... .......+||+.|||||++.+..++.++||||+|+++|++..+..++.... ..++...... ..
T Consensus 170 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~----~~ 237 (353)
T 2i0e_A 170 ENIWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIME----HN 237 (353)
T ss_dssp CCCCT------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----CC
T ss_pred ccccC------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHHHHHHHh----CC
Confidence 53211 112345689999999999999999999999999987777655443332211 1111111111 11
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.... ..+...+++++.+|++.||++||+ ++|+.+
T Consensus 238 ~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 112223334777999999999996 456553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=305.58 Aligned_cols=225 Identities=23% Similarity=0.270 Sum_probs=166.9
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+++... ..+.+.+|+++++.++|||||++++++.+. ..
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----ED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CE
Confidence 578899999999999999987642 235688999999999999999999998543 34
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 899999999999999987532 3467999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCC---CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcc
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG---ERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTS 869 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~ 869 (929)
.. ......+||+.|||||++.+ ..++.++||||+|+++|++..+..++..... ...+.+ ......
T Consensus 167 ~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~ 235 (384)
T 4fr4_A 167 RE-------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETT 235 (384)
T ss_dssp TT-------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHC
T ss_pred CC-------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhc
Confidence 21 12344689999999999874 4589999999999877776554444322111 111111 111001
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-HHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-IREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~ev~~ 908 (929)
....... +...+.+++.+||+.||++||+ ++++.+
T Consensus 236 ~~~~p~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 VVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCTT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccCCCCc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111111 1222333777999999999998 666653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-33 Score=320.85 Aligned_cols=240 Identities=24% Similarity=0.320 Sum_probs=172.9
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||.||+|.+.. ..++|.+|++++++++||||+++++++.. ...++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence 34578888999999999999987652 34689999999999999999999999854 23699
Q ss_pred EEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999987321 2367899999999998 999999999999999999999999999987532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ........+|+.|+|||++.+..++.++||||+|++++++.. ...++..... .+ +........
T Consensus 333 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~-----~~~~i~~~~-- 398 (452)
T 1fmk_A 333 NE-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE-----VLDQVERGY-- 398 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH-----HHHHHHTTC--
T ss_pred Cc-----eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HH-----HHHHHHcCC--
Confidence 11 111223457889999999999999999999999987776544 2322221111 11 111111100
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
+...+...++.+.+++.+||+.||++|||++++++.|+++.....++.
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 000011112223347779999999999999999999999865544333
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-33 Score=300.47 Aligned_cols=241 Identities=20% Similarity=0.260 Sum_probs=178.5
Q ss_pred HHHhhCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 656 LRRATGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 656 l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++...++|+..+.||+|+||.||+|.+. ...+.+.+|++++++++||||+++++++... .
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 82 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----P 82 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 3345678899999999999999998765 2346799999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..++||||+++|+|.++++... .++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 3899999999999999986422 2356899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
..... .........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+. ...+......
T Consensus 160 ~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~-~~~~~~~~~~ 231 (288)
T 3kfa_A 160 LMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV-YELLEKDYRM 231 (288)
T ss_dssp TSCSS-----SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGH-HHHHHTTCCC
T ss_pred eccCC-----ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHH-HHHHhccCCC
Confidence 65321 1122233467889999999999999999999999977666543 2222211111 110 0111111000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
. .... .+..+.+++.+|++.||++|||++|++++|+++.+...
T Consensus 232 ~--~~~~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 232 E--RPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp C--CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C--CCCC----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 0111 11223337779999999999999999999999887644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-33 Score=300.98 Aligned_cols=249 Identities=18% Similarity=0.189 Sum_probs=177.6
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||.||+|++.. ..+++.+|+++++.++|++++..++++... ....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEE
Confidence 45789999999999999999998541 234688999999999999988888877542 345799
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEecccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFL 792 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla~~~ 792 (929)
||||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999 999999986321 3367899999999998 99999999999999 78899999999999876
Q ss_pred ccccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhccc
Q 002376 793 LERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSN 870 (929)
Q Consensus 793 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~ 870 (929)
........ .........||+.|+|||++.+..++.++||||+|++++++.....++..... ...+.+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 43221110 11122346799999999999999999999999999887776665555543322 11111111111100000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
. . .....++.-+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 239 ~--~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 I--E-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H--H-HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h--h-hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0 0000111223337779999999999999999999999988765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=306.59 Aligned_cols=174 Identities=24% Similarity=0.399 Sum_probs=128.3
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++|||||++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 4578899999999999999986641 23578899999999999999999999854 3358
Q ss_pred EEEEEecCCCCccccccccc--------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 69988875321 2246899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
++..... ........||+.|+|||++.+. .++.++||||+|++++++.....++
T Consensus 155 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 155 ARAFGIP------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CEETTSC------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceecCCC------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9865321 1112334789999999999764 6899999999998877765554433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=300.81 Aligned_cols=169 Identities=25% Similarity=0.411 Sum_probs=137.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 578899999999999999987641 236788999999999999999999998543 358
Q ss_pred EEEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++||||+++ ++.+++.. .+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999999975 55554432 123467999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~ 844 (929)
.. ........||+.|+|||++.+.. ++.++||||+|++++++...
T Consensus 153 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~ 198 (292)
T 3o0g_A 153 IP------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp SC------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred Cc------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence 21 11223457899999999998776 89999999999877765433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=302.82 Aligned_cols=237 Identities=21% Similarity=0.277 Sum_probs=168.7
Q ss_pred CCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..+.||+|+||.||+|+... ..+.|.+|++++++++||||+++++++...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----- 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-----
Confidence 456678999999999999986431 234688999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 34899999999999999986432 2367899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
....... .........+|+.|+|||++.+..++.++||||+|++++++.. ...++..... ..+......
T Consensus 196 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~ 265 (333)
T 1mqb_A 196 VLEDDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAIND 265 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHT
T ss_pred hhccccc---cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHC
Confidence 7643211 1111223356889999999999999999999999987776543 3322222111 111111111
Q ss_pred c--chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 870 N--ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 870 ~--~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
. .......++ .+.+++.+||+.||++||+++|+++.|+++.+....
T Consensus 266 ~~~~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 266 GFRLPTPMDCPS----AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp TCCCCCCTTCBH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCcCCCcccCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 0 001111112 223377799999999999999999999998876553
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=296.10 Aligned_cols=237 Identities=24% Similarity=0.268 Sum_probs=172.6
Q ss_pred hhCCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|...+.||+|+||.||+|++. ...+.|.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 3467889999999999999998632 1246788999999999999999999997532
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 2589999999999999986432 2357899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+...... ........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+.. ..+....
T Consensus 161 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~-~~~~~~~- 231 (281)
T 3cc6_A 161 RYIEDED-----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVI-GVLEKGD- 231 (281)
T ss_dssp GCC--------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHH-HHHHHTC-
T ss_pred ccccccc-----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHH-HHHhcCC-
Confidence 8653221 111233467889999999998899999999999987776543 3333221111 1110 0111100
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
....... ....+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 232 -~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 232 -RLPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 0000111 12223347779999999999999999999999877543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-33 Score=305.70 Aligned_cols=217 Identities=27% Similarity=0.257 Sum_probs=156.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..++||+|+||+||+|++.. ....+.+|+..+.++ +|||||+++++|.+ ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 578999999999999999987651 123455666666555 89999999999954 345
Q ss_pred EEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 89999999 679988876322 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhccChHHHHhhcc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVLDPELRQLMTS 869 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~ 869 (929)
... .......||++|+|||++.+ .++.++||||+|++++++.... ..+. ...++.....
T Consensus 208 ~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~----~~~~~~~~~~~~~~~~~------ 269 (311)
T 3p1a_A 208 GTA-------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM----ELPHGGEGWQQLRQGYL------ 269 (311)
T ss_dssp C-------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC----CCCSSHHHHHHHTTTCC------
T ss_pred ccC-------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC----CCCCCccHHHHHhccCC------
Confidence 321 11233469999999999876 7999999999997766643321 1121 1111111000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......+...+.+++.+|++.||++|||++|+++
T Consensus 270 ----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 ----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00011112222334777999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=302.86 Aligned_cols=228 Identities=22% Similarity=0.242 Sum_probs=169.5
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--- 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC---
Confidence 3568899999999999999987541 246799999999999999999999998543
Q ss_pred CcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEec
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGD 785 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~D 785 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++ .+||+|
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp --SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 34899999999999999986433 3367899999999998 999999999999999888 799999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
||+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.+. .+..
T Consensus 163 fg~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~-~i~~ 232 (321)
T 2a2a_A 163 FGLAHEIEDG-------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA-NITS 232 (321)
T ss_dssp CTTCEECCTT-------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH-HHHT
T ss_pred CccceecCcc-------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHH-HHHh
Confidence 9999865321 112335799999999999999999999999999877665544333322111 11100 0110
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.............+..+.+++.+|++.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 ---VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ---TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ---cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000011111112223344777999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=302.73 Aligned_cols=249 Identities=19% Similarity=0.292 Sum_probs=181.5
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccce
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKL 707 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l 707 (929)
+...++....++|+..+.||+|+||.||+|++. ...+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445555666789999999999999999998631 1235688999999999 79999999
Q ss_pred eeecccCCCCCcceEEEEEEecCCCCcccccccccc------------------------ccccHHHHHHHhhhCCCCCE
Q 002376 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERK------------------------NELDITSALDYLHNDCEVPV 763 (929)
Q Consensus 708 ~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------~~~~ia~aL~yLH~~~~~~i 763 (929)
++++...+ ...++||||+++|+|.+++..... ++.|++.||+|||+. +|
T Consensus 97 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i 169 (316)
T 2xir_A 97 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169 (316)
T ss_dssp EEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 99986432 247999999999999999864321 246899999999998 99
Q ss_pred EecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch
Q 002376 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 764 iHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
+||||||+||+++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++||||+|++++++..
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTC----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccC----ccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999865321 11112234568999999999999999999999999987766543
Q ss_pred -hHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 844 -VKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 844 -~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
...++.... .+..+.......... ..+.....-+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 246 ~g~~p~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 246 LGASPYPGVK------IDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TSCCSSTTCC------CSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCcccc------hhHHHHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 322222111 111111111110000 0000111122337779999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=295.90 Aligned_cols=229 Identities=22% Similarity=0.279 Sum_probs=168.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------------cHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||.||+|++.. ..+.+.+|++++++++||||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 4678899999999999999987641 016789999999999999999999998432
Q ss_pred CCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCC--EEecCCCCCCeeecCCCc-----
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVP--VVHSDLKPGNILLDEEMT----- 780 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~--iiHrDlk~~NILl~~~~~----- 780 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred -----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence 279999999999988875332 2467899999999998 7 999999999999988776
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccC--CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL--GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV 858 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~ 858 (929)
+||+|||+++.... ......||+.|+|||++. ...++.++||||+|++++++.....++..........
T Consensus 168 ~kl~Dfg~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 168 AKVADFGLSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp EEECCCTTCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred EEeCCCCccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence 99999999974321 123457999999999984 4557899999999987777655544443322210000
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
......... .. ..++..+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 239 ~~~~~~~~~--~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 INMIREEGL--RP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHSCC--CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHhccCC--CC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000000000 00 01111122233477799999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=296.68 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=175.7
Q ss_pred HhhCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
...++|+..+.||+|+||.||+|+.. ...+.|.+|++++++++||||+++++++... ..+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcE
Confidence 34567889999999999999998754 1356899999999999999999999998532 269
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999987432 2367899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ........|++.|+|||++.+..++.++||||+|++++++.. ...++..... ..+.........
T Consensus 161 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~ 228 (279)
T 1qpc_A 161 DNE-----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR 228 (279)
T ss_dssp SSC-----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC
T ss_pred Ccc-----cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhcccC
Confidence 211 111223457889999999988889999999999977666543 2222221111 111111100000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
..........+.+++.+|++.||++|||++++++.|+++......+.
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 00001111223337779999999999999999999999987755443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=297.98 Aligned_cols=227 Identities=24% Similarity=0.346 Sum_probs=165.9
Q ss_pred CCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.|+..+.||+|+||.||+|.+.. ..+.+.+|+.++++++||||+++++++.... ......+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 46777899999999999987641 2356889999999999999999999886533 2345689
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCC--EEecCCCCCCeeec-CCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVP--VVHSDLKPGNILLD-EEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~--iiHrDlk~~NILl~-~~~~~ki~DfGla~~~ 792 (929)
+||||+++|+|.+++.... .++.+++.||+|||+. + |+||||||+||+++ +++.+||+|||+++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999986422 3367899999999998 6 99999999999997 7899999999999754
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. .......||+.|+|||++.+ .++.++||||+|++++++.....++...... .+ ..........
T Consensus 183 ~~--------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~-----~~~~~~~~~~ 247 (290)
T 1t4h_A 183 RA--------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ-----IYRRVTSGVK 247 (290)
T ss_dssp CT--------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH-----HHHHHTTTCC
T ss_pred cc--------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HH-----HHHHHhccCC
Confidence 21 12234579999999998864 5999999999998777765544444322210 00 1110000000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...........+.+++.+||+.||++|||++|+++
T Consensus 248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00011111112333777999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=296.76 Aligned_cols=225 Identities=21% Similarity=0.279 Sum_probs=166.4
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence 35688999999999999999997652 134688999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccccc
Confidence 34899999999999999886432 3467899999999998 999999999999999999999999999865
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... ......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.. ..+... ..
T Consensus 159 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~-~~~~~~---~~ 224 (279)
T 3fdn_A 159 APSS--------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETY-KRISRV---EF 224 (279)
T ss_dssp C----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH-HHHHHT---CC
T ss_pred CCcc--------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--HHHH-HHHHhC---CC
Confidence 4211 12345789999999999999999999999999777665444333322111 1111 111110 01
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
... +.....+++++.+||+.||++|||++|+++.
T Consensus 225 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 1112223347779999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=299.35 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=176.9
Q ss_pred hhCCCCCce-eecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 659 ATGNFSHEN-LIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 659 ~~~~~~~~~-~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
..++|...+ .||+|+||.||+|.+. ...+++.+|++++++++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 345677777 9999999999998431 014678899999999999999999999832
Q ss_pred CcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
...++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 23799999999999999987433 3367899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+....... .........||+.|+|||++.+..++.++||||+|++++++.. ...++..... ..+.....
T Consensus 165 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~ 234 (291)
T 1xbb_A 165 KALRADEN---YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLE 234 (291)
T ss_dssp EECCTTCS---EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHH
T ss_pred eeeccCCC---cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHH
Confidence 86632211 1111223356789999999998889999999999977766543 3333222111 11111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhccCCCC
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQVPNG 925 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~p~~ 925 (929)
.... ...+...+..+.+++.+||+.||++||++.|++++|+++.........|++
T Consensus 235 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 289 (291)
T 1xbb_A 235 KGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289 (291)
T ss_dssp TTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC--
T ss_pred cCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcccccc
Confidence 1100 000011122233377799999999999999999999999888776655543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-33 Score=329.74 Aligned_cols=235 Identities=20% Similarity=0.275 Sum_probs=170.0
Q ss_pred CCCce-eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 663 FSHEN-LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 663 ~~~~~-~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+...+ .||+|+||.||+|.+. ...++|.+|++++++++|||||+++++|.. +..
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence 33344 7999999999988542 235789999999999999999999999853 127
Q ss_pred EEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
++|||||++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999999986432 2367899999999998 99999999999999999999999999998764
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.... .........+|+.|||||++.+..++.++||||+|++++++.. ...++..... ..+...+....
T Consensus 488 ~~~~---~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~- 556 (613)
T 2ozo_A 488 ADDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGK- 556 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-------HHHHHHHHTTC-
T ss_pred CCCc---eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCC-
Confidence 2211 1111222356789999999999999999999999987777543 3333322211 11221111111
Q ss_pred hhhhhh-HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 873 QTIQLH-DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 873 ~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
+...+ .+...+.+ ++.+||+.||++||++++++++|+++......
T Consensus 557 -~~~~p~~~~~~l~~-li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 -RMECPPECPPELYA-LMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -CCCCCTTCCHHHHH-HHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -CCCCCCcCCHHHHH-HHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 00111 11223333 77899999999999999999999998877653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=302.25 Aligned_cols=240 Identities=19% Similarity=0.319 Sum_probs=175.9
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|+..+.||+|+||.||+|++. ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468889999999999999998642 1235688999999999 899999999999653
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+ ..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||
T Consensus 114 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 114 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp S-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred C-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 3 4799999999999999986432 1256899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+||+++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||||+|++++++.+ ...++.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTS----SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEEcCCCCEEEccccccccccccc----cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999998653211 1111233467889999999988889999999999987766543 222222
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
..+ ..++.. .+..... .......+ ..+. +++.+||+.||++|||++|+++.|+++.......
T Consensus 262 ~~~--~~~~~~-~~~~~~~--~~~~~~~~---~~l~-~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 262 GIP--VEELFK-LLKEGHR--MDKPANCT---NELY-MMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp TCC--HHHHHH-HHHHTCC--CCCCTTCC---HHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cCC--HHHHHH-HHhcCCC--CCCCccCC---HHHH-HHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 111 111111 1111000 00111111 2233 3777999999999999999999999998876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-33 Score=312.68 Aligned_cols=227 Identities=26% Similarity=0.309 Sum_probs=161.2
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHH-HHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECET-LRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||+||+++... ..+.+.+|..+ ++.++|||||++++++.+ .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence 3578899999999999999987652 12345567666 567899999999999854 3
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...|+||||+++|+|.+++...+ .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 35899999999999999886432 3467999999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... .......+||+.|||||++.+..++.++||||+|+++|++..+..++.... ..+..+..+.. ..
T Consensus 189 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~----~~ 256 (373)
T 2r5t_A 189 NIEH------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNK----PL 256 (373)
T ss_dssp GBCC------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHHHHS----CC
T ss_pred cccC------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhc----cc
Confidence 4211 112344689999999999999999999999999988777655444432211 11111111111 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
..... +...+++++.+|++.||++||++.+.++.+
T Consensus 257 ~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11111 222233477799999999999986544443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-34 Score=313.06 Aligned_cols=259 Identities=22% Similarity=0.266 Sum_probs=171.7
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++.....++|+..+.||+|+||.||+|+..+ ..+.|.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-- 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--
Confidence 34444556789999999999999999987542 2346778999999999999999999996533
Q ss_pred CcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+
T Consensus 103 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 ---HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp ---CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ---ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 4899999999999999987533 2367899999999998 999999999999998 67999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCC---------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG---------ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL 859 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~ 859 (929)
++........ ..........||+.|+|||++.+ ..++.++||||+|++++++.....++..... .+..
T Consensus 176 ~~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAII 252 (319)
T ss_dssp CC-----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--HHHH
T ss_pred cccccccccc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 8765321111 11112233469999999999875 4579999999999877776554444332221 1110
Q ss_pred ChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhccCCCCCCCC
Q 002376 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQVPNGKTKS 929 (929)
Q Consensus 860 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~p~~~~~s 929 (929)
..+........ .....++.+. +++.+||+.||++|||++|++++|+++.+.......|...++|
T Consensus 253 -~~~~~~~~~~~-~~~~~~~~l~----~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 253 -WQMGTGMKPNL-SQIGMGKEIS----DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp -HHHHTTCCCCC-CCSSCCTTHH----HHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred -HHhccCCCCCC-CcCCCCHHHH----HHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 01111000000 0001112222 3777999999999999999999999999988777777766553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-33 Score=304.27 Aligned_cols=242 Identities=20% Similarity=0.265 Sum_probs=178.8
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCcccccee
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLI 708 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~ 708 (929)
+..++++...++|+..+.||+|+||.||+|++. .....|.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556667789999999999999999997643 1234688999999999999999999
Q ss_pred eecccCCCCCcceEEEEEEecCCCCccccccccc------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+++...+ ..++||||+++|+|.++++..+ .++.|++.||+|||+. +|+||||||
T Consensus 95 ~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp 166 (322)
T 1p4o_A 95 GVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166 (322)
T ss_dssp EEECSSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred EEEccCC-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence 9985533 3799999999999999986421 2356899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||+|++++++.. ...++.
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred ceEEEcCCCeEEECcCccccccccccc----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 999999999999999999986532211 111223467899999999999999999999999987776544 222222
Q ss_pred cCCchhhhccChHHHHhhccc--chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 850 NLPENVLQVLDPELRQLMTSN--ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
.... . ......... ...... ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 243 ~~~~--~-----~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 243 GLSN--E-----QVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TSCH--H-----HHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCH--H-----HHHHHHHcCCcCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2111 1 111111000 000111 11223337779999999999999999999998744
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=301.04 Aligned_cols=237 Identities=24% Similarity=0.291 Sum_probs=168.3
Q ss_pred hhCCCCCceeecccCceeEEeccccC---------------------cHHHHHHHHHHHHccC---CccccceeeecccC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG---------------------SWKSFIAECETLRNVR---HRNLVKLITSCSSL 714 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~ 714 (929)
..++|+..+.||+|+||.||+|++.. ....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35789999999999999999998541 1246778888887775 99999999999765
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
........++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5444456899999996 69999886432 2367899999999998 89999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|||+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.......
T Consensus 163 Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQ-------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFD 233 (308)
T ss_dssp SCSCTTTSTTC-------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--HHHHHHHHH
T ss_pred eCccccccCCC-------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 99999865321 122345799999999999999999999999999887776554433322211 000000000
Q ss_pred Hh------------------hcccc-hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QL------------------MTSNE-SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~------------------~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. +.... .........+.+.+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 00000 0000000011222334777999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=298.19 Aligned_cols=249 Identities=18% Similarity=0.181 Sum_probs=179.8
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..+.||+|+||.||+|++. ...+++.+|+.+++.++|+++++.++++... ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEE
Confidence 568999999999999999999853 1235789999999999999988888777542 3357999
Q ss_pred EEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEeccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla~~~~ 793 (929)
|||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 899999986221 3367899999999998 99999999999999 588899999999998764
Q ss_pred cccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 794 ERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 794 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
....... .........||+.|+|||++.+..++.++||||+|++++++.....++..... ...+.+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence 3321110 11122445799999999999999999999999999888776665555443221 11111111011100000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
.......+++-+.+++.+||+.||++|||++|+++.|+++......
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 --IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp --HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000011112233377799999999999999999999998877553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=293.81 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=179.6
Q ss_pred CCCCCce-eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHEN-LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~-~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|...+ .||+|+||.||+|.+. ...+.+.+|++++++++||||+++++++.. +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~----- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C-----
Confidence 3555555 8999999999998642 124578899999999999999999999832 1
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 2799999999999999985322 2367899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
...... .........||+.|+|||++.+..++.++||||+|++++++.. ...++..... ..+.......
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~i~~~ 229 (287)
T 1u59_A 160 LGADDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQG 229 (287)
T ss_dssp CTTCSC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTT
T ss_pred eccCcc---eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHhcC
Confidence 642211 1111223357899999999988889999999999987776543 3333322211 1111111111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhccCCCCCC
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQVPNGKT 927 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~p~~~~ 927 (929)
.. ...+...+..+.+++.+||+.||++||++.|+++.|+++......+..++++.
T Consensus 230 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 284 (287)
T 1u59_A 230 KR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 284 (287)
T ss_dssp CC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCCT
T ss_pred Cc--CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCccc
Confidence 00 00001112223337779999999999999999999999999988776665543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=313.33 Aligned_cols=180 Identities=23% Similarity=0.320 Sum_probs=142.1
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|...+.||+|+||.||+|++.. ..+.+.+|++++++++|||||++++++...+......
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999997541 2357889999999999999999999997654333356
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||||++ |+|.++++... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999996 69999887433 3467999999999998 99999999999999999999999999998764
Q ss_pred cccCCCC----------------Cccccceecccccccccccc-CCCCCCCCCCCCCCcCCCCCcch
Q 002376 794 ERVDNQS----------------SISSTHVFMGSIGYVPPEYG-LGERPSTAGDVPTSESFAGEFNI 843 (929)
Q Consensus 794 ~~~~~~~----------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~s~g~~~~~~~~ 843 (929)
....... ........+||+.|+|||++ .+..++.++||||+||+++++..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 3211100 00123456899999999986 55669999999999998888654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=299.12 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=165.4
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|... ...+.+.+|+.++++++||||+++++++... .
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence 357889999999999999998753 1235688999999999999999999998653 3
Q ss_pred eEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..++||||+++|+|.+++... ..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 489999999999999988631 13367899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
++...... .......||+.|+|||++.+..++.++||||+|++++++.....++........ .+.....
T Consensus 183 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~ 251 (310)
T 2wqm_A 183 GRFFSSKT------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIE 251 (310)
T ss_dssp ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-----HHHHHHH
T ss_pred eeeecCCC------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-----HHHHHhh
Confidence 98653211 112335789999999999999999999999999877765544333221111110 1111110
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
....... ........+.+++.+||+.||++|||++|+++.|+++++....+.
T Consensus 252 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 252 QCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp TTCSCCC-CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred cccCCCC-cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000000 001112223337779999999999999999999999988866443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-33 Score=309.45 Aligned_cols=228 Identities=21% Similarity=0.248 Sum_probs=159.2
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||.||+++... ..+.+.+|+.++++++|||||++++++.+. ...++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEEE
Confidence 4689999999999999999987651 236788999999999999999999999643 34899
Q ss_pred EEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc--eEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT--AKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~ki~DfGla~~~~~ 794 (929)
||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+|+....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999886322 3467999999999998 9999999999999987765 99999999974321
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCC-CCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc--
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTA-GDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE-- 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-- 871 (929)
. ......+||+.|+|||++.+..++.+ +||||+|+++|++..+..++..... .+.....+........
T Consensus 171 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~ 241 (361)
T 3uc3_A 171 H-------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--PRDYRKTIQRILSVKYSI 241 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC------CCCHHHHHHHHHTTCCCC
T ss_pred c-------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhcCCCCC
Confidence 1 11234579999999999988887666 8999999877765554443322211 0000111111111110
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......++ .+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~s~----~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDIRISP----ECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTSCCCH----HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcCCCCH----HHHHHHHHHccCChhHCcCHHHHHh
Confidence 00001112 2233777999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-33 Score=324.48 Aligned_cols=228 Identities=23% Similarity=0.293 Sum_probs=169.6
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..++||+|+||+||+|+... ..+.+.+|++++++++|||||++++++.+ ..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence 4578889999999999999987641 23457899999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccce
Confidence 5899999999999999886432 2357899999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.+... ......+||+.|||||++.+..++.++||||+|+++|++..+..++...... .....+.......
T Consensus 335 ~~~~~-------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~---~~~~~i~~~i~~~ 404 (576)
T 2acx_A 335 HVPEG-------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEVERLVKEV 404 (576)
T ss_dssp ECCTT-------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC---CCHHHHHHHHHHC
T ss_pred ecccC-------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc---hhHHHHHHHhhcc
Confidence 65321 1123458999999999999999999999999998877765544443322110 0001111111100
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
. ...+..++.-+++++.+|++.||++|| +++||++
T Consensus 405 ~---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 P---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 001111222334477799999999999 7788864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=303.72 Aligned_cols=225 Identities=24% Similarity=0.260 Sum_probs=159.0
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||.||+++.. .....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 457899999999999999987652 0123577899999999999999999998543
Q ss_pred CCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
...|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 ---GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp ---SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred ---CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 34899999999999999886432 2367899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
++..... .......+||+.|+|||++.+..++.++||||+|+++|++.....++.... ..+.++.....
T Consensus 168 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~--- 236 (327)
T 3a62_A 168 CKESIHD------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKC--- 236 (327)
T ss_dssp C----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT---
T ss_pred ccccccC------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhC---
Confidence 9854221 111234579999999999999999999999999987776554433332211 11111111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
....... +...+++++.+||+.||++|| +++|+++
T Consensus 237 -~~~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -KLNLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCCCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111111 222233477799999999999 6677764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=307.20 Aligned_cols=236 Identities=13% Similarity=0.060 Sum_probs=175.5
Q ss_pred HHhhCCCCCceeecccCceeEEeccc-----c-------------CcHHHHHHHHHHHHccC---CccccceeeecccCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNER-----T-------------GSWKSFIAECETLRNVR---HRNLVKLITSCSSLD 715 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-----~-------------~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~ 715 (929)
....++|...+.||+|+||.||+|.+ . ....++.+|++++++++ |+||+++++++...+
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34567899999999999999999942 1 23567889999999987 999999999986543
Q ss_pred CCCcceEEEEEEecCCCCcccccccc-------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-----
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGE-------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE----- 777 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----- 777 (929)
..++|||||++|+|.++++.. ..++.|++.||+|||+. +||||||||+|||++.
T Consensus 141 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 141 -----GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp -----CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred -----CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 379999999999999998631 13467999999999998 9999999999999998
Q ss_pred ------CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcC
Q 002376 778 ------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNL 851 (929)
Q Consensus 778 ------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~ 851 (929)
++.+||+|||+|+.+... .........+||++|||||++.+..++.++||||+|+++|++.++..++...
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLF----PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGS----CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccccCCEEEeeCchhhhhhcc----CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 899999999999865321 1112234467999999999999999999999999997776655544333211
Q ss_pred CchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCC-CCHHHHHHHHHhhHHHHh
Q 002376 852 PENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGR-IGIREALRRLKSSQEILL 918 (929)
Q Consensus 852 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~~~~~~~ 918 (929)
... .......... ....+... +++..|++.+|.+| |+++++.+.|+++.+...
T Consensus 289 ~~~-~~~~~~~~~~---------~~~~~~~~----~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 289 EGG-ECKPEGLFRR---------LPHLDMWN----EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ETT-EEEECSCCTT---------CSSHHHHH----HHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCC-ceeechhccc---------cCcHHHHH----HHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 110 0001111110 01112223 36669999999998 688899999998877643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-33 Score=306.42 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=176.5
Q ss_pred CCCCCceeecccCceeEEeccc----c----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNER----T----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~----~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||++++ . ...+.|.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---CC
Confidence 4688889999999999999873 1 12457899999999999999999999986532 23
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4799999999999999987432 2367899999999998 999999999999999999999999999987
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhcc---------ChH
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVL---------DPE 862 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 862 (929)
...... .........|+..|+|||++.+..++.++||||+|++++++.....++...+....+.. ...
T Consensus 195 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 195 LPQDKE---YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CCSSCS---EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccc---ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 642211 00111234578889999999988899999999999888776554333221111111100 001
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
+......... ...+...+..+.+++.+||+.||++|||++|++++|+++++.+.
T Consensus 272 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 272 LIELLKNNGR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111111000 00011112223337779999999999999999999999988753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=310.11 Aligned_cols=251 Identities=12% Similarity=0.078 Sum_probs=177.8
Q ss_pred CCCCCceeecccCceeEEeccccCc-------------------HHHHHHHHHHHHccCCccccce--------------
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAECETLRNVRHRNLVKL-------------- 707 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E~~~l~~l~Hpniv~l-------------- 707 (929)
++|+..+.||+|+||.||+|+...+ .+.+.+|++++++++|||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 6899999999999999999976531 2358899999999999999984
Q ss_pred -eeecccCCCCCcceEEEEEEecCCCCcccccccc--c--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 708 -ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE--R--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 708 -~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
++++.. .....++||||+ +|+|.+++... . .++.|++.||+|||+. +|+||||||+||+++
T Consensus 122 ~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 122 CMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp CCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred hhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 444432 234689999999 99999998753 1 2367899999999998 999999999999999
Q ss_pred CCC--ceEEeccccccccccccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc
Q 002376 777 EEM--TAKVGDFGLARFLLERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE 853 (929)
Q Consensus 777 ~~~--~~ki~DfGla~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~ 853 (929)
.++ .+||+|||+++.+........ .........||+.|+|||++.+..++.++||||+|++++++.....++.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 999999999987653322111 11112334799999999999999999999999999887776554444433221
Q ss_pred hhhhccChHHHHhhcccchhh--hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 854 NVLQVLDPELRQLMTSNESQT--IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 854 ~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
....+. .............. ......+...+.+++.+||+.||++||+++|++++|+++.+.....
T Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 274 NTEDIM-KQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp CHHHHH-HHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CHHHHH-HHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 111110 00110000000000 0000001122333777999999999999999999999998886544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=311.56 Aligned_cols=231 Identities=23% Similarity=0.231 Sum_probs=167.2
Q ss_pred hCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|+..+.||+|+||+||+|+... ....+.+|++++.++ +||||+++++++.+ ....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD-----GKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEEEEEE
Confidence 4578999999999999999987652 123456899999888 79999999999854 34589999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC----CceEEecccccccccc
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE----MTAKVGDFGLARFLLE 794 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ki~DfGla~~~~~ 794 (929)
||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999886443 3467899999999998 99999999999998433 3599999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ......+||+.|+|||++.+..++.++||||+|+++|++.....++...+. ...+++........ ..
T Consensus 173 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~----~~ 242 (342)
T 2qr7_A 173 EN------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF----SL 242 (342)
T ss_dssp TT------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC----CC
T ss_pred CC------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc----cc
Confidence 21 112345789999999999888899999999999887776655444432221 11111111111111 00
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....+..++..+++++.+|++.||++||+++|+++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111112233344777999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-33 Score=320.11 Aligned_cols=225 Identities=26% Similarity=0.286 Sum_probs=161.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|+++++.++||||++++++|... .
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 4679999999999999999887541 124567899999999999999999999543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhh-CCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHN-DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+.
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 4899999999999999886432 346799999999998 6 899999999999999999999999999985
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... .......+||++|||||++.+..++.++||||+|++++++.....++..... .+........ ..
T Consensus 299 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~----~~ 366 (446)
T 4ejn_A 299 GIKD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME----EI 366 (446)
T ss_dssp TCC-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC----CC
T ss_pred ccCC------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhC----CC
Confidence 4211 1123346899999999999999999999999999877776554444322211 1111111111 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
..... +...+.+++.+||+.||++|| +++|+++
T Consensus 367 ~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111 122233477799999999999 9999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-33 Score=313.83 Aligned_cols=183 Identities=23% Similarity=0.338 Sum_probs=136.0
Q ss_pred hhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccC-CccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~ 719 (929)
..++|+..+.||+|+||.||+|.+.. ..+.+.+|+.+++++. |||||++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence 45789999999999999999986541 2356779999999997 999999999986532 2
Q ss_pred ceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
...|+|||||+ |+|.++++.. +.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 35899999997 6898887642 23467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCC---------------CCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 793 LERVDNQ---------------SSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 793 ~~~~~~~---------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
....... .........+||+.|+|||++.+ ..++.++||||+|++++++..+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 3211100 01112344689999999999987 57899999999998888766554433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=313.89 Aligned_cols=224 Identities=25% Similarity=0.299 Sum_probs=168.1
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...+.||+|+||+||+|++.. ..+.+.+|+++++.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 3578899999999999999987641 134688999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 4899999999999999986432 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... ......+||+.|+|||++.+..+ +.++||||+|++++++..+..++.... ..+... .+.. ...
T Consensus 167 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~-~i~~---~~~ 233 (476)
T 2y94_A 167 SDG-------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFK-KICD---GIF 233 (476)
T ss_dssp CTT-------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHH-HHHT---TCC
T ss_pred ccc-------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHH-HHhc---CCc
Confidence 321 11234579999999999998875 789999999987777654433332111 111110 1111 000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... +..-+.+++.+||+.||++|||++|+++
T Consensus 234 ~~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00111 1122233777999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=308.38 Aligned_cols=229 Identities=22% Similarity=0.237 Sum_probs=159.8
Q ss_pred hhCCCCCceeecccCceeEEeccccCc------------------------HHHHHHHHHHHHccCCccccceeeecccC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTGS------------------------WKSFIAECETLRNVRHRNLVKLITSCSSL 714 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~------------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~ 714 (929)
..++|...+.||+|+||.||+|..... ...+.+|++++++++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999865411 1247899999999999999999999732
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEE
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKV 783 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki 783 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 212 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 23699999999999999886433 2367999999999998 99999999999999654 45999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCC---CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccC
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG---ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLD 860 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (929)
+|||+|+..... ......+||+.|+|||++.+ ..++.++||||+|++++++.....++...... ..+.
T Consensus 284 ~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~ 354 (419)
T 3i6u_A 284 TDFGHSKILGET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLK 354 (419)
T ss_dssp CCSSTTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHH
T ss_pred eecccceecCCC-------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHH
Confidence 999999875321 12234679999999999864 56889999999998777765544443322110 0000
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+.. .........+..+...+.+++.+|++.||++|||++|+++
T Consensus 355 ~~i~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 DQITS---GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHT---TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhc---CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111 0000011111112223334777999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=290.98 Aligned_cols=233 Identities=27% Similarity=0.341 Sum_probs=173.5
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||++.+. ...+++.+|++++++++||||+++++++...+ ..++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeEEEE
Confidence 57888899999999999998764 13468999999999999999999999986533 379999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|+|.++++..+ .++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 9999999999986432 2357899999999998 99999999999999999999999999998653211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .+.. ..+...... .....
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~-~~i~~~~~~--~~~~~ 229 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV-EDISTGFRL--YKPRL 229 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH-HHHHTTCCC--CCCTT
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHH-HHHhcCCcC--CCCcc
Confidence 111123457889999999998899999999999977666543 2322221111 1111 111110000 00011
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
....+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11223337779999999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=307.06 Aligned_cols=235 Identities=19% Similarity=0.152 Sum_probs=161.2
Q ss_pred CCCCCc-eeecccCceeEEeccccC-----------cHHHHHHHHHHHHc-cCCccccceeeecccCCCCCcceEEEEEE
Q 002376 661 GNFSHE-NLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRN-VRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 661 ~~~~~~-~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
++|... ++||+|+||+||++.+.. ....+.+|+.++.+ .+||||+++++++.... .+....|+|||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E 139 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVME 139 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEEEE
Confidence 456665 689999999999997652 23567889998754 58999999999885321 12456899999
Q ss_pred ecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEecccccccccc
Q 002376 728 FLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLLE 794 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 794 (929)
||++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999987432 2367899999999998 9999999999999997 78999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
. ......+||+.|||||++.+..++.++||||+|+++|++..+..++..... ...................
T Consensus 217 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 217 H-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp -----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT--CSSCCSHHHHHHHTCCCCC
T ss_pred C-------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc--ccccHHHHHHHHcCcccCC
Confidence 1 122345799999999999999999999999999877776554443322111 0100001111000000000
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...+..+...+.+++.+||+.||++|||++|+++
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000112222334777999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=293.29 Aligned_cols=232 Identities=25% Similarity=0.319 Sum_probs=167.5
Q ss_pred hCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYE 727 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e 727 (929)
.++|+..+.||+|+||.||+++..+ ..+.|.+|++++++++||||+++++++...+ ...++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceEEEEe
Confidence 4578899999999999999987652 3567999999999999999999999975432 24799999
Q ss_pred ecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 728 FLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 728 ~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999986432 3367899999999998 9999999999999999999999999999854211
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
.....+++.|+|||++.+..++.++||||+|++++++.. ...++...+. .+.. ..+..... ......
T Consensus 171 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~-~~~~~~~~--~~~~~~ 238 (278)
T 1byg_A 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVV-PRVEKGYK--MDAPDG 238 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHH-HHHTTTCC--CCCCTT
T ss_pred -------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHH-HHHhcCCC--CCCccc
Confidence 122357889999999999999999999999987766543 3322222211 1110 11110000 000111
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. +..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 239 ~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 239 C----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1 12223377799999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-33 Score=299.28 Aligned_cols=172 Identities=27% Similarity=0.386 Sum_probs=137.5
Q ss_pred CCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence 57888999999999999998754 1135788999999999999999999998643 3489
Q ss_pred EEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++ +|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 99999975 888877532 13467999999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
. ........||+.|+|||++.+. .++.++||||+|++++++.....+
T Consensus 153 ~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 153 P------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred c------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 1 1112334789999999998764 589999999999887776554433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=295.53 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=173.3
Q ss_pred hCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCC-----------
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS----------- 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~----------- 716 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 3578889999999999999997651 23578899999999999999999998753110
Q ss_pred CCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
......++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence 12345799999999999999986431 2357899999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQ 865 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 865 (929)
|+++...... ......||+.|+|||++.+..++.++||||+|++++++.. +..+. ...+.. ..+..
T Consensus 167 g~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-----~~~~~~~~~~~~-~~~~~ 233 (284)
T 2a19_B 167 GLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-----VCDTAFETSKFF-TDLRD 233 (284)
T ss_dssp TTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-----CCSSHHHHHHHH-HHHHT
T ss_pred hhheeccccc-------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-----cCCcchhHHHHH-HHhhc
Confidence 9998663221 1223468999999999999999999999999977666432 22222 111100 01111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
.. .... +...+++++.+||+.||++|||+.|+++.|+.+.......+
T Consensus 234 ----~~-~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 234 ----GI-ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp ----TC-CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred ----cc-cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 00 0011 11222347779999999999999999999999876655443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=293.32 Aligned_cols=234 Identities=21% Similarity=0.265 Sum_probs=169.7
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK---- 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence 468889999999999999986541 256799999999999999999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~Df 786 (929)
...++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||++++++ .+||+||
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 81 -TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred -CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 34899999999999999986432 3467899999999998 999999999999998877 8999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
|+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+. ....
T Consensus 157 g~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~ 223 (283)
T 3bhy_A 157 GIAHKIEAG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--QET----LTNI 223 (283)
T ss_dssp TTCEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH----HHHH
T ss_pred ccceeccCC-------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HHH----HHHh
Confidence 999865321 112334689999999999999999999999999877765544433322211 000 0000
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQE 915 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 915 (929)
..................+.+++.+||+.||++||+++|+++ .++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000000001111111223334777999999999999999986 4555543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=292.58 Aligned_cols=225 Identities=21% Similarity=0.291 Sum_probs=147.4
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 4578899999999999999997531 13568899999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 5899999999999999886432 2367899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+. +........
T Consensus 162 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~ 229 (278)
T 3cok_A 162 LKMPH------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--KNT----LNKVVLADY 229 (278)
T ss_dssp CC----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC--C---------CCSSCC
T ss_pred ccCCC------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH--HHH----HHHHhhccc
Confidence 53211 112235789999999999999999999999999877765544333322111 111 111000010
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... +...+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00111 1122233777999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=294.59 Aligned_cols=223 Identities=20% Similarity=0.274 Sum_probs=167.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.+. .
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence 3578899999999999999987641 135688999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 5899999999999999886432 3467899999999998 9999999999999999999999999998754
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ......||+.|+|||++.+..++.++||||+|++++++.....++..... .+. ..........
T Consensus 165 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~----~~~~~~~~~~ 230 (284)
T 2vgo_A 165 PSL--------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TET----HRRIVNVDLK 230 (284)
T ss_dssp SSS--------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHH----HHHHHTTCCC
T ss_pred ccc--------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--hHH----HHHHhccccC
Confidence 211 12335789999999999999999999999999877765544333322111 000 0111111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... +...+++++.+|++.||++||+++|+++
T Consensus 231 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 1222334777999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=307.44 Aligned_cols=182 Identities=26% Similarity=0.330 Sum_probs=149.8
Q ss_pred CCCChHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccC-----Ccccccee
Q 002376 649 PKISYDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVR-----HRNLVKLI 708 (929)
Q Consensus 649 ~~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~-----Hpniv~l~ 708 (929)
..+++++.....++|+..++||+|+||.||+|++.. ..+.+..|+.++++++ |||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345666666677899999999999999999988741 1356778999999996 99999999
Q ss_pred eecccCCCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-
Q 002376 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE- 777 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~- 777 (929)
+++... ...++||||+ +|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+++
T Consensus 103 ~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 103 GKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEET-----TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred ceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 998653 3489999999 899999886432 2367899999999998 9999999999999975
Q ss_pred ------------------------CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCC
Q 002376 778 ------------------------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT 833 (929)
Q Consensus 778 ------------------------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s 833 (929)
++.+||+|||+|+.... ......||+.|+|||++.+..++.++||||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---------YHGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC---------CCcCccCcccccCcHHHcCCCCCCccchHH
Confidence 78999999999986421 112357899999999999999999999999
Q ss_pred CcCCCCCcchhHHhh
Q 002376 834 SESFAGEFNIVKWVE 848 (929)
Q Consensus 834 ~g~~~~~~~~~~~~~ 848 (929)
+|++++++.....++
T Consensus 245 lG~il~ell~g~~pf 259 (360)
T 3llt_A 245 FGCVLAELYTGSLLF 259 (360)
T ss_dssp HHHHHHHHHHSSCSC
T ss_pred HHHHHHHHHHCCCCC
Confidence 998877765554443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=335.87 Aligned_cols=455 Identities=14% Similarity=0.081 Sum_probs=280.1
Q ss_pred CCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCC---CCCCCcCCC------------CCCCC
Q 002376 57 SPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKL---SGNLPREIG------------NLFRL 121 (929)
Q Consensus 57 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l---~~~~p~~~~------------~l~~L 121 (929)
-|++|.++.+... + .+.+.+ .....++..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 3558999865321 2 222322 23333444566788999999998643 245666555 78999
Q ss_pred cEEeCCCCCCCCCcccccccc--cccceecccccc-cCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCC
Q 002376 122 RVLNISFNNLQGELPVNISKL--TELKMLDLMANK-ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSR 198 (929)
Q Consensus 122 ~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~ 198 (929)
++|+|++|.+++..+..+... .+|++|+|++|. ++..-......++++|++|+|++|.+++.-+.++ +..+..
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l----~~~~~~ 190 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWL----HELAQH 190 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHH----HHHHHH
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHH----HHHHhc
Confidence 999999999988777777764 459999999987 2210011223478999999999998865432222 223456
Q ss_pred CCcccEEEeecccCCC----ccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCC---CCCCCcccc
Q 002376 199 LENLKVLDLTINRLAG----TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFT---GKIPGSLHN 271 (929)
Q Consensus 199 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~---~~~p~~~~~ 271 (929)
+++|+.|+|++|.+++ .++..+.++++|++|+|++|.+.+ +|..+ ..+++|++|.++..... +..+..+..
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~-~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFF-KAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHH-HHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHH-hhhhHHHhhcccccccccchHHHHHHhhc
Confidence 7899999999999973 345556788999999999998874 66444 44888888888753322 344566777
Q ss_pred cccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccc-cCchhhh
Q 002376 272 LTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGK-IPESIGN 350 (929)
Q Consensus 272 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~ 350 (929)
+++|+.|+++++.. +.+|..+..+++|++|++++|.+.... ....+..+++|++|+++ |.+... ++.....
T Consensus 269 ~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~------~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~ 340 (592)
T 3ogk_B 269 PRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETED------HCTLIQKCPNLEVLETR-NVIGDRGLEVLAQY 340 (592)
T ss_dssp CTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHH------HHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHH
T ss_pred cccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHH------HHHHHHhCcCCCEEecc-CccCHHHHHHHHHh
Confidence 88888888887533 356777777888888888877753211 11224667778888877 444332 2222233
Q ss_pred ccccccEEEec-----------CCcccccc-CCCCCCCCcccEEEeeCCCCCcccCccccC-CCCCCEEEec----CCcC
Q 002376 351 FSNELSKLYLG-----------GNHIYGKI-PASIGRLRSLTLLDLSYNSISGEIPIEIGQ-LQGLQVLGLA----GNEI 413 (929)
Q Consensus 351 ~~~~L~~L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l 413 (929)
++ +|++|+|+ .|.+++.. +..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+
T Consensus 341 ~~-~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l 419 (592)
T 3ogk_B 341 CK-QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI 419 (592)
T ss_dssp CT-TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred CC-CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence 43 67777777 35555331 222334677777777777777666555554 6777777775 5666
Q ss_pred CCC-----CcccccCCCCCceecccCc--ccccccCccccc-ccccceecccCCcCCCCCCCCcccCCchhhhcccCccE
Q 002376 414 PGG-----IPNSLANLKKLNQIDLSGN--ELTGEIPISFGN-FQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485 (929)
Q Consensus 414 ~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~ 485 (929)
++. ++..+.++++|++|+|++| .+++..+..+.. +++|+.|++++|++++.. ++..+..+++|+.
T Consensus 420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-------~~~~~~~~~~L~~ 492 (592)
T 3ogk_B 420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-------LMEFSRGCPNLQK 492 (592)
T ss_dssp SSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHH-------HHHHHTCCTTCCE
T ss_pred cCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHH-------HHHHHhcCcccCe
Confidence 653 3334555667777777533 244443333332 566666666666665311 1333455566666
Q ss_pred EEecCCCCCCC-CCcchhcCcCcceeecccccccccCCccc-cCCCCCCEEECCC
Q 002376 486 IDLSDNSLSGN-LPNSLKNCKSLEELLMAYNQFSGPIPNIV-AELKGLEVLDLSS 538 (929)
Q Consensus 486 LdLs~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~ 538 (929)
|+|++|.+++. ++..+..+++|++|+|++|+++..--..+ ..++.+....+..
T Consensus 493 L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp EEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred eeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 66666665433 23333456666666666666654322222 2345554444443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-33 Score=301.30 Aligned_cols=238 Identities=22% Similarity=0.246 Sum_probs=165.7
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||.||+|++. ...+.+.+|++++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 357888999999999999998642 01356889999999999999999999986432
Q ss_pred CcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 ----MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp ----CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ----ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccc
Confidence 689999999999999886432 2367899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
++....... .........||+.|+|||++.+..++.++||||+|++++++.. ...++..... . ......
T Consensus 168 ~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~-----~~~~~~ 237 (291)
T 1u46_A 168 MRALPQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--S-----QILHKI 237 (291)
T ss_dssp CEECCC-CC---EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H-----HHHHHH
T ss_pred ccccccccc---chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--H-----HHHHHH
Confidence 987642211 1111233467889999999998889999999999977766544 3333222211 1 111111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
...... .......+..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 238 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 238 DKEGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HTSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HccCCC-CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 000000 0000111222333777999999999999999999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=321.85 Aligned_cols=230 Identities=20% Similarity=0.228 Sum_probs=165.9
Q ss_pred eeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
+.||+|+||+||+|.+. ...++|.+|++++++++|||||+++++|... ..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence 47999999999998432 1246899999999999999999999998431 278999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
|||++|+|.++++..+ .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~- 524 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 524 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-
Confidence 9999999999987433 3467999999999998 999999999999999999999999999987643211
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.........||+.|+|||++.+..++.++||||+|++++++.. ...++..... . .+......... ...
T Consensus 525 --~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~-----~~~~~i~~~~~--~~~ 593 (635)
T 4fl3_A 525 --YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--S-----EVTAMLEKGER--MGC 593 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H-----HHHHHHHTTCC--CCC
T ss_pred --ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--H-----HHHHHHHcCCC--CCC
Confidence 1112233457889999999999999999999999987776543 3333322221 1 11111111100 000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
+...+.-+.+++.+||+.||++||++++|+++|+++....
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0111122233777999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=304.17 Aligned_cols=219 Identities=21% Similarity=0.283 Sum_probs=165.9
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------------cHHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
.++|+..+.||+|+||.||+|++.. ..+.+.+|+.++++++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4578999999999999999996541 12356789999999999999999999854
Q ss_pred CCCcceEEEEEEecCCC-Cccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 716 SKNMEFLALVYEFLSNG-SLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~g-sL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
....++||||+.+| +|.+++.... .++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 34589999999777 9998886443 3467999999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
|+++..... ......+||+.|+|||++.+..+ +.++||||+|++++++.....++.. ..+.......
T Consensus 175 g~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~----~~~~~~~~~~- 242 (335)
T 3dls_A 175 GSAAYLERG-------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----LEETVEAAIH- 242 (335)
T ss_dssp TTCEECCTT-------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS----GGGGTTTCCC-
T ss_pred ccceECCCC-------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh----HHHHHhhccC-
Confidence 999865321 12234579999999999988886 8899999999776665443333221 1111111110
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~ 909 (929)
.....++. +.+++.+||+.||++|||++|+++.
T Consensus 243 -------~~~~~~~~----l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 -------PPYLVSKE----LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------CSSCCCHH----HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------CCcccCHH----HHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011122 2337779999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-33 Score=306.96 Aligned_cols=221 Identities=27% Similarity=0.317 Sum_probs=162.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+.|+..+.||+|+||.||+|+... ..+++.+|++++++++|||||++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 357888999999999999987531 125688999999999999999999998643 34
Q ss_pred EEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||++ |++.+++... ..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 899999997 6887777422 13467899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.. .....||+.|+|||++. ++.++.++||||+|++++++.....++..... .+.+. .+......
T Consensus 205 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~-~~~~~~~~ 271 (348)
T 1u5q_A 205 AP----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALY-HIAQNESP 271 (348)
T ss_dssp SS----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH-HHHHSCCC
T ss_pred CC----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHH-HHHhcCCC
Confidence 21 12357999999999984 56789999999999877776554433322211 01000 01110000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...... ....+++++.+||+.||++|||++|+++
T Consensus 272 -~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 272 -ALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCC----CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 000011 1222334777999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=298.81 Aligned_cols=231 Identities=24% Similarity=0.322 Sum_probs=171.2
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||.||+|+.. ...+.+.+|+++++++ +||||+++++++... .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence 57888999999999999998653 1235688999999999 899999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 721 FLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 5899999999999999986432 2357899999999998 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~ 855 (929)
.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||+|++++++.. ...++.....
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-- 247 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 247 (327)
T ss_dssp GGGCEEECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCeEEEcccCcCcccccc-------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--
Confidence 9999999999999743211 11223357889999999988889999999999987776543 3333322211
Q ss_pred hhccChHHHHhhccc--chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 856 LQVLDPELRQLMTSN--ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
. .+....... .......++ .+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 248 ~-----~~~~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 248 A-----ELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp H-----HHHHHGGGTCCCCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H-----HHHHHhhcCCCCCCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 111111110 001111112 2233777999999999999999999999987754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.76 Aligned_cols=227 Identities=25% Similarity=0.248 Sum_probs=166.6
Q ss_pred hCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+|... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEE
Confidence 357888999999999999998764 2356899999999999999999999998543 3489
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla~~~ 792 (929)
+||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999998876432 3467899999999998 99999999999999 78899999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......||+.|+|||++.+. ++.++||||+|++++++.....++..... .+... .+.. ....
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~-~~~~---~~~~ 225 (277)
T 3f3z_A 160 KPG-------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVML-KIRE---GTFT 225 (277)
T ss_dssp CTT-------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH-HHHH---CCCC
T ss_pred cCc-------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHH-HHHh---CCCC
Confidence 321 112334799999999998654 99999999999777665544333322211 11111 1111 0000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........+...+.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000011222334777999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=296.76 Aligned_cols=237 Identities=25% Similarity=0.352 Sum_probs=163.2
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCC--------
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-------- 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-------- 716 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4578899999999999999997541 24578899999999999999999998865321
Q ss_pred CCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
......++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 22456899999999999999986322 2367899999999998 99999999999999999999999999
Q ss_pred cccccccccCCC--------CCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhh
Q 002376 788 LARFLLERVDNQ--------SSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQ 857 (929)
Q Consensus 788 la~~~~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~ 857 (929)
+++......... ..........||+.|+|||++.+. .++.++||||+|++++++.. +..+. ...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-----p~~~~~~~~~ 236 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGMERVN 236 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-----CCSSHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-----ccCCchhHHH
Confidence 998653211000 001122345799999999999865 68999999999987777543 11111 0000
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. ..+... ...............+++++.+||+.||++|||++|+++
T Consensus 237 ~~-~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 IL-KKLRSV---SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH-HHHHST---TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH-Hhcccc---ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 011110 000001111111222334777999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=294.03 Aligned_cols=240 Identities=18% Similarity=0.170 Sum_probs=164.5
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
..++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----- 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID----- 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence 35789999999999999999987541 125688999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++||||+++++|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 35899999999999999986432 3467899999999998 999999999999999999999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
..... ........||+.|+|||++.+..++.++||||+|++++++.....++.... ...+...+........
T Consensus 184 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~ 255 (309)
T 2h34_A 184 TTDEK-----LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRPS 255 (309)
T ss_dssp ------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCGG
T ss_pred ccccc-----cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCcc
Confidence 53221 111234578999999999999999999999999977666544333322111 1111111111110000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHhhHHHHh
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRI-GIREALRRLKSSQEILL 918 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~~ 918 (929)
......++ .+.+++.+||+.||++|| +++++++.|++..+...
T Consensus 256 ~~~~~~~~----~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 TVRPGIPV----AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GTSTTCCT----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ccCCCCCH----HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11111122 233377799999999999 99999999998765543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=314.80 Aligned_cols=243 Identities=21% Similarity=0.221 Sum_probs=169.5
Q ss_pred CCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEE
Q 002376 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406 (929)
Q Consensus 327 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 406 (929)
+++|++|+|++|.+++..|..+..++ +|++|+|++|.+++..| |+.+++|++|+|++|.|++..+ .++|++|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34777888888888776666777766 68888888888877665 7778888888888887774332 3778888
Q ss_pred EecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhh-cccCccE
Q 002376 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEIS-RLENVVT 485 (929)
Q Consensus 407 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~-~l~~L~~ 485 (929)
++++|.|++..+. .+++|+.|+|++|.+++..|..|+++++|+.|+|++|.|++.+ |..+. .+++|+.
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~l~~~l~~L~~ 173 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN--------FAELAASSDTLEH 173 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE--------GGGGGGGTTTCCE
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC--------hHHHhhhCCcccE
Confidence 8888888765554 3467788888888888777777777888888888888877654 44444 5677888
Q ss_pred EEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcC
Q 002376 486 IDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNL 565 (929)
Q Consensus 486 LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 565 (929)
|+|++|.+++..+ +..+++|+.|+|++|+|++.+|. +..+++|+.|||++|+|++ +|..+..+++|+.|++++|++
T Consensus 174 L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 174 LNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp EECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred EecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 8888888776522 33577788888888888765544 7777888888888888875 666777777888888888887
Q ss_pred c-ccCCCC-CCCCCCCccccc-------CCCCCcCC
Q 002376 566 E-GVVPSE-GIFRNMSNVHLK-------GNPKLCLQ 592 (929)
Q Consensus 566 ~-~~~p~~-~~~~~l~~l~l~-------~N~~~c~~ 592 (929)
. +.+|.. ..++.+..+.+. +|+..|..
T Consensus 250 ~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~ 285 (487)
T 3oja_A 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285 (487)
T ss_dssp CHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSS
T ss_pred cCcchHHHHHhCCCCcEEeccccccccCCCcccccC
Confidence 7 333321 223334444443 56666643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=288.50 Aligned_cols=228 Identities=23% Similarity=0.295 Sum_probs=166.5
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 4689999999999999999986541 23568899999999999999999999854 334
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc---eEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT---AKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DfGla~ 790 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 799999999999988775432 3467899999999998 9999999999999986654 9999999997
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+... .+....
T Consensus 157 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~-~~~~~~--- 223 (284)
T 3kk8_A 157 EVNDS-------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA-QIKAGA--- 223 (284)
T ss_dssp ECCSS-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH-HHHHTC---
T ss_pred EcccC-------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHH-HHHhcc---
Confidence 65321 112335799999999999999999999999999776665444333322111 11111 111100
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..........+...+.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000111222334777999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=301.74 Aligned_cols=239 Identities=19% Similarity=0.204 Sum_probs=170.4
Q ss_pred CCCChHHHHHhhCCCCCc-eeecccCceeEEeccccC------------------cHHHHHHHHHHHHccC-Ccccccee
Q 002376 649 PKISYDELRRATGNFSHE-NLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVR-HRNLVKLI 708 (929)
Q Consensus 649 ~~~~~~~l~~~~~~~~~~-~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~-Hpniv~l~ 708 (929)
+.+.++..+...+.|... +.||+|+||.||+|+... ..+.+.+|+.++++++ ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344455555566677776 889999999999986541 2467899999999995 69999999
Q ss_pred eecccCCCCCcceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-
Q 002376 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE- 777 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~- 777 (929)
+++.. ....++||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 96 ~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 96 EVYEN-----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI 167 (327)
T ss_dssp EEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred EEEEe-----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence 99854 34489999999999999998532 13367899999999998 9999999999999987
Q ss_pred --CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchh
Q 002376 778 --EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENV 855 (929)
Q Consensus 778 --~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~ 855 (929)
++.+||+|||+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++.....
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-- 238 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHA-------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-- 238 (327)
T ss_dssp TTBCCEEECCGGGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred CCCCcEEEeeCccccccCCc-------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--
Confidence 789999999999875321 112335799999999999999999999999999777665544333322111
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+... .+... ...........+...+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~-~i~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 239 QETYL-NISQV---NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHH-HHHHT---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHHHH-HHHhc---ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 11000 01110 000011111112223334777999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=315.63 Aligned_cols=223 Identities=24% Similarity=0.318 Sum_probs=166.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...++||+|+||+||+|+... ..+.+.+|++++++++|||||++++++.+ ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 3578888999999999999987641 23567899999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecce
Confidence 5899999999999998886422 2357899999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH-hh
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ-LM 867 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~ 867 (929)
++.+... .......+||+.|||||++.+..++.++||||+|+++|++..+..++...... .....+.. ..
T Consensus 336 a~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~---~~~~~~~~~i~ 406 (543)
T 3c4z_A 336 AVELKAG------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVL 406 (543)
T ss_dssp CEECCTT------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC---CCHHHHHHHHH
T ss_pred eeeccCC------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc---hhHHHHHHHHh
Confidence 9875321 11123458999999999999999999999999998877766554444322110 00011111 11
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
....... ..++..+++++.+|++.||++||++
T Consensus 407 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 EQAVTYP----DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred hcccCCC----cccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111111 1122333447779999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=294.83 Aligned_cols=225 Identities=21% Similarity=0.258 Sum_probs=168.8
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...+.||+|+||.||+++... ..+.+.+|+.++++++||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence 3578889999999999999987641 23568899999999999999999999854 33
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 5899999999999999876322 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ........||+.|+|||++.+..++.++||||+|++++++.....++..... .+. ..........
T Consensus 166 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~----~~~~~~~~~~ 233 (294)
T 2rku_A 166 EYD------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KET----YLRIKKNEYS 233 (294)
T ss_dssp CST------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH----HHHHHTTCCC
T ss_pred ccC------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH----HHHHhhccCC
Confidence 321 1112335799999999999999999999999999877765544433322211 110 1111111111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... .+...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 IPK----HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred Ccc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111 11222334777999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=298.69 Aligned_cols=173 Identities=25% Similarity=0.330 Sum_probs=137.4
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++... ...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence 578899999999999999987641 135678999999999999999999998543 348
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||+++++|.++++..+ .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999999988876332 3467899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
.. .......||+.|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 155 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 155 PS------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cc------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 11 11234478999999999876 5689999999999877776554433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=321.38 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=176.2
Q ss_pred HhhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
...++|+..+.||+|+||.||+|++.. ..++|.+|+++|++++|||||++++++.. ...+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 345678888999999999999987652 34689999999999999999999999854 2379
Q ss_pred EEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|||||++|+|.++++... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999997421 2367899999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ........++..|||||++.+..++.++||||+|++++++.. ...++..... .+ +...+....
T Consensus 415 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~-----~~~~i~~~~- 481 (535)
T 2h8h_A 415 DNE-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE-----VLDQVERGY- 481 (535)
T ss_dssp CHH-----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HH-----HHHHHHTTC-
T ss_pred CCc-----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH-----HHHHHHcCC-
Confidence 211 011122357889999999999999999999999987777554 3322221111 11 111111100
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
+..........+.+++.+||+.||++|||++++++.|+++.....
T Consensus 482 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 000001112223337779999999999999999999998765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-33 Score=312.72 Aligned_cols=248 Identities=19% Similarity=0.279 Sum_probs=168.2
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCC--------
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-------- 716 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-------- 716 (929)
....++|+..+.||+|+||.||+|++.. +.+...+|+++++.++|||||++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4456789999999999999999997642 22345589999999999999999999865432
Q ss_pred -------------------------CCcceEEEEEEecCCCCccccccc------------cccccccHHHHHHHhhhCC
Q 002376 717 -------------------------KNMEFLALVYEFLSNGSLGDWIHG------------ERKNELDITSALDYLHNDC 759 (929)
Q Consensus 717 -------------------------~~~~~~~lV~e~~~~gsL~~~l~~------------~~~~~~~ia~aL~yLH~~~ 759 (929)
....+.++||||++ |+|.+.++. .+.++.|+++||+|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 23345899999998 587776652 123467999999999998
Q ss_pred CCCEEecCCCCCCeeec-CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCC
Q 002376 760 EVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESF 837 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~ 837 (929)
+|+||||||+||+++ .++.+||+|||+|+.+... .......||+.|+|||++.+.. ++.++||||+|++
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999998 6889999999999865322 1123347899999999988755 8999999999988
Q ss_pred CCCcchhHHhhhcCCc--hhhhccC----h---HHHHhhc--------c--cchhhhhhhHHHHHHHHHHhccccCCCCC
Q 002376 838 AGEFNIVKWVESNLPE--NVLQVLD----P---ELRQLMT--------S--NESQTIQLHDCLITIIGSVGLSCTTESPG 898 (929)
Q Consensus 838 ~~~~~~~~~~~~~~~~--~~~~~~~----~---~l~~~~~--------~--~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~ 898 (929)
++++.....++..... ...+++. + .+...-. . ........++..+..+.+++.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 8776655444332211 1111100 0 0000000 0 00000000111122233488899999999
Q ss_pred CCCCHHHHHH--HHHhhHH
Q 002376 899 GRIGIREALR--RLKSSQE 915 (929)
Q Consensus 899 ~RPs~~ev~~--~L~~~~~ 915 (929)
+|||+.|+++ .+++++.
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999984 4555544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=302.19 Aligned_cols=178 Identities=24% Similarity=0.276 Sum_probs=136.0
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|+.+++.++||||+++++++...+. ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999986541 13568899999999999999999999865432 1234
Q ss_pred eEEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
..|+||||++ |+|.+++... ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 6899999997 5787776522 23467999999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. ......+||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 180 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 226 (371)
T 2xrw_A 180 S-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred c-------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 1 1123457999999999999999999999999998887766554433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=304.45 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=162.7
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||.||+|.+.. ..+++.+|++++++++||||+++++++...+. ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678999999999999999987541 13567899999999999999999999875432 1123
Q ss_pred eEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
..|+||||+ +++|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 789998886422 3467999999999998 99999999999999999999999999998642
Q ss_pred cccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc------------
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV------------ 858 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~------------ 858 (929)
. .....+||+.|+|||++.+ ..++.++||||+|++++++..+..++..... .+..+
T Consensus 180 ~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 180 S---------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp S---------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred c---------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1 1233578999999999887 6799999999999887776555443322111 01000
Q ss_pred ---cChHHHHhhc---ccchhh-hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 859 ---LDPELRQLMT---SNESQT-IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 859 ---~~~~l~~~~~---~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......... ...... ..........+.+++.+|++.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000110000 000000 0000011222334778999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=307.22 Aligned_cols=173 Identities=23% Similarity=0.359 Sum_probs=143.6
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..+.||+|+||.||++++.. ..+.+.+|++++++++||||+++++++... ...+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 107 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS 107 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEEE
Confidence 578889999999999999987651 135788999999999999999999998643 3489
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+++|+|.++++... .++.+++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999987432 34678999999999832 7999999999999999999999999999765321
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
......||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 186 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 186 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp --------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred --------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 123357999999999999999999999999998887766555444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=300.59 Aligned_cols=225 Identities=21% Similarity=0.264 Sum_probs=169.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...+.||+|+||.||++++.. ..+.+.+|+.++++++||||+++++++.+. .
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----C
Confidence 4578889999999999999987541 235688999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 5899999999999999876422 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ........||+.|+|||++.+..++.++||||+|++++++.....++..... .+... .+.. ....
T Consensus 192 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~-~~~~---~~~~ 259 (335)
T 2owb_A 192 EYD------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYL-RIKK---NEYS 259 (335)
T ss_dssp CST------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH-HHHH---TCCC
T ss_pred ccC------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHHH-HHhc---CCCC
Confidence 321 1112345799999999999999999999999999877776544433322111 11110 1111 0111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. ..+...+.+++.+||+.||++||+++|+++
T Consensus 260 ~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 IP----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 111222334777999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=323.49 Aligned_cols=221 Identities=23% Similarity=0.285 Sum_probs=166.7
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|+..++||+|+||+||+|+... ..+.+.+|..++..+ +||+|+++++++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----- 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence 35689999999999999999987652 234577899999988 79999999999854
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...+|+||||+++|+|.++++... .++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 345899999999999999987432 3467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... .......+||+.|||||++.+..++.++||||+|+++|++.....++..... .+++ .......
T Consensus 491 ~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~----~~i~~~~ 558 (674)
T 3pfq_A 491 ENIWD------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELF----QSIMEHN 558 (674)
T ss_dssp ECCCT------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHSSC
T ss_pred ccccC------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHH----HHHHhCC
Confidence 53211 1223456899999999999999999999999999887776555444432211 1111 1111111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGI 903 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~ 903 (929)
.... ..+...+.+++.+|++.||++||++
T Consensus 559 ~~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 VAYP----KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCC----ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1111 1122233347779999999999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=303.74 Aligned_cols=228 Identities=23% Similarity=0.319 Sum_probs=159.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCC--ccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRH--RNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~~~ 720 (929)
.+.|+..+.||+|+||.||++.... ..+.+.+|++++++++| |||+++++++... .
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----C
Confidence 4568899999999999999986541 13578899999999986 9999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++|||| .+|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++..
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 58999995 5789999987433 3467899999999998 999999999999997 578999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCC-----------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLG-----------ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
.... ........+||+.|+|||++.+ ..++.++||||+|++++++.....++........
T Consensus 158 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----- 228 (343)
T 3dbq_A 158 QPDT----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 228 (343)
T ss_dssp ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred Cccc----ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----
Confidence 4221 1112234579999999999864 6789999999999887776555444432222110
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+........ ....+......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 KLHAIIDPNH--EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHCTTS--CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCc--ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 0111110000 00000111112233777999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=303.80 Aligned_cols=182 Identities=22% Similarity=0.298 Sum_probs=146.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4689999999999999999986541 13578899999999999999999999976554444568
Q ss_pred EEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||++ |+|.++++... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999997 58988876432 3467999999999998 9999999999999999999999999999876432
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
... .......+||+.|+|||++.+. .++.++||||+|++++++.....++
T Consensus 182 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 182 HDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp GCB---CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCc---cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 111 1112345899999999987654 4899999999998877765544333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=296.58 Aligned_cols=244 Identities=20% Similarity=0.160 Sum_probs=170.7
Q ss_pred hCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+++.. ...+.+.+|++++++++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 457889999999999999998753 12457889999999999999999999986432 2344689
Q ss_pred EEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988641 12367899999999998 999999999999999999999999999876
Q ss_pred cccccCCCC---CccccceeccccccccccccCCCC---CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 792 LLERVDNQS---SISSTHVFMGSIGYVPPEYGLGER---PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 792 ~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
......... .........||+.|+|||++.+.. ++.++||||+|++++++.....++...... .+.+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~ 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSVALAVQN 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCHHHHHHC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchhhHHhhc
Confidence 532111000 000112346799999999987664 689999999998777655443332211000 0000000111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
.. ........++ .+.+++.+||+.||++|||++|+++.|+++.
T Consensus 263 ~~--~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 QL--SIPQSPRHSS----ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp C----CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred cC--CCCccccCCH----HHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0000111112 2333777999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-33 Score=312.83 Aligned_cols=230 Identities=13% Similarity=0.058 Sum_probs=162.8
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHH---HHHHccCCccccceeeecc-----
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAEC---ETLRNVRHRNLVKLITSCS----- 712 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~---~~l~~l~Hpniv~l~~~~~----- 712 (929)
.++|+..+.||+|+||.||+|++. ...+.|.+|+ +.+++++|||||++++.+.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999998864 1246788999 5556668999999984433
Q ss_pred --cCCC---------CCc---ceEEEEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCE
Q 002376 713 --SLDS---------KNM---EFLALVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPV 763 (929)
Q Consensus 713 --~~~~---------~~~---~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~i 763 (929)
..+. .+. ...|+||||+ +|+|.+++.... .++.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 2210 000 1268999999 689999986311 2467999999999998 99
Q ss_pred EecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCC-----------CCCCCCCCC
Q 002376 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-----------RPSTAGDVP 832 (929)
Q Consensus 764 iHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~ 832 (929)
+||||||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+. .++.++|||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999999999999985321 2234567 999999999887 899999999
Q ss_pred CCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HH
Q 002376 833 TSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RL 910 (929)
Q Consensus 833 s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L 910 (929)
|+|++++++.....++..... .+.... +.. .. ...++ -+.+++.+||+.||++|||+.|+++ .+
T Consensus 298 SlG~il~elltg~~Pf~~~~~--~~~~~~-~~~----~~---~~~~~----~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAA--LGGSEW-IFR----SC---KNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHHHHHHHHSSCCC--------CCSGG-GGS----SC---CCCCH----HHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHHHHHHHHCCCCCccccc--ccchhh-hhh----hc---cCCCH----HHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999877766544333321111 011100 000 00 01112 2233777999999999999999985 56
Q ss_pred HhhHHHH
Q 002376 911 KSSQEIL 917 (929)
Q Consensus 911 ~~~~~~~ 917 (929)
+++.+..
T Consensus 364 ~~~~~~~ 370 (377)
T 3byv_A 364 EQLRTEL 370 (377)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6665543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=296.54 Aligned_cols=175 Identities=23% Similarity=0.280 Sum_probs=144.2
Q ss_pred CCCCCceeecccCceeEEecccc-------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++ ||||+++++++.... ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceEEEE
Confidence 57889999999999999999653 24678999999999997 999999999986522 34579999
Q ss_pred EecCCCCccccccc-----cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEeccccccccccccCCCC
Q 002376 727 EFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 727 e~~~~gsL~~~l~~-----~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~~~~~ 800 (929)
||+++++|.++++. ...++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----- 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG----- 184 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-----
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-----
Confidence 99999999998763 224578999999999998 999999999999999776 8999999999865322
Q ss_pred CccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 801 SISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.......||..|+|||++.+ ..++.++||||+|++++++.....++
T Consensus 185 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 185 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred --CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 11233478999999999887 66899999999998877765554443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=307.88 Aligned_cols=244 Identities=9% Similarity=-0.020 Sum_probs=155.0
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc--CCccccceee-------ec
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV--RHRNLVKLIT-------SC 711 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l--~Hpniv~l~~-------~~ 711 (929)
...|+..+.||+|+||.||+|++.. ..+.+.+|+.+++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458889999999999999997541 134566775444444 6999888553 32
Q ss_pred ccCCCC------------CcceEEEEEEecCCCCcccccccc--------c-------cccccHHHHHHHhhhCCCCCEE
Q 002376 712 SSLDSK------------NMEFLALVYEFLSNGSLGDWIHGE--------R-------KNELDITSALDYLHNDCEVPVV 764 (929)
Q Consensus 712 ~~~~~~------------~~~~~~lV~e~~~~gsL~~~l~~~--------~-------~~~~~ia~aL~yLH~~~~~~ii 764 (929)
...... .....|+|||||+ |+|.++++.. + .++.||+.||+|||+. +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 221110 0144799999998 8999998732 1 2347999999999998 999
Q ss_pred ecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCC--CCCCCCCCCCCCcCCCCCcc
Q 002376 765 HSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTSESFAGEFN 842 (929)
Q Consensus 765 HrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~g~~~~~~~ 842 (929)
||||||+|||++.++.+||+|||+|+..... .....||+.|+|||++.+ ..++.++||||+|++++++.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE---------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC---------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999865211 113467799999999987 67999999999998877766
Q ss_pred hhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHHHH
Q 002376 843 IVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQEIL 917 (929)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~ 917 (929)
....++........+........... ...........++..+.+++.+||+.||++|||+.|+++ .++++....
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPG-TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCC-CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred hCCCCCCCcCcccccchhhhhhhhcc-ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 55544433311111111100000000 000000000011222334777999999999999999974 455554443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.40 Aligned_cols=225 Identities=22% Similarity=0.256 Sum_probs=160.3
Q ss_pred CCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...+.||+|+||.||+++.. ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeEE
Confidence 46888999999999999988754 134678999999999999999999999854 33489
Q ss_pred EEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEecccc
Q 002376 724 LVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGL 788 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGl 788 (929)
+||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 999999999999887522 13467899999999998 99999999999999 4567899999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
++..... .......||+.|+|||++. +.++.++||||+|++++++.....++..... .+.... ...
T Consensus 174 a~~~~~~-------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~~~-~~~--- 239 (285)
T 3is5_A 174 AELFKSD-------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQK-ATY--- 239 (285)
T ss_dssp CCC-----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-HHH---
T ss_pred ceecCCc-------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHHhh-hcc---
Confidence 9865321 1123457999999999985 5689999999999877765554433322211 111100 000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...............+. +++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 240 KEPNYAVECRPLTPQAV-DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCCCC--CCCCHHHH-HHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCcccccccCcCCHHHH-HHHHHHccCChhhCcCHHHHhc
Confidence 00000000000011222 3777999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=296.26 Aligned_cols=229 Identities=23% Similarity=0.257 Sum_probs=164.3
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||.||+|.... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEE
Confidence 35679999999999999999987651 246789999999999999999999998643 34899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
||||+++|+|.+++... ..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999988621 13367899999999998 9999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......||+.|+|||++.+..++.++||||+|++++++.....++...... .. . ..... ......
T Consensus 179 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-~-~~~~~----~~~~~~ 245 (314)
T 3com_A 179 M------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-RA-I-FMIPT----NPPPTF 245 (314)
T ss_dssp B------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-HH-H-HHHHH----SCCCCC
T ss_pred c------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HH-H-HHHhc----CCCccc
Confidence 1 1123357899999999999999999999999998777655444333222110 00 0 00000 000000
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111222334777999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=301.07 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=168.3
Q ss_pred CCChHHHHHhhCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHcc-CCccccceeeeccc
Q 002376 650 KISYDELRRATGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNV-RHRNLVKLITSCSS 713 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~ 713 (929)
.+++.++....++|+..+.||+|+||.||+|++. ...+.+.+|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3455566677889999999999999999998764 2346789999999999 89999999999876
Q ss_pred CCCC-CcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceE
Q 002376 714 LDSK-NMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAK 782 (929)
Q Consensus 714 ~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 782 (929)
.... .....++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 4321 1346899999999999999986432 2357899999999998 999999999999999999999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
|+|||+++..... ........||+.|+|||++. +..++.++||||+|++++++.....++...... +
T Consensus 170 l~Dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~ 241 (326)
T 2x7f_A 170 LVDFGVSAQLDRT------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--R 241 (326)
T ss_dssp ECCCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--H
T ss_pred EeeCcCceecCcC------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--H
Confidence 9999999865321 11123357999999999987 567899999999998777765544333222110 0
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... .......... .......+.+++.+||+.||++||+++|+++
T Consensus 242 ----~~~~-~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ----ALFL-IPRNPAPRLK-SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HHHH-HHHSCCCCCS-CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHHH-hhcCccccCC-ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 0000000000 0011122333777999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=296.72 Aligned_cols=240 Identities=21% Similarity=0.167 Sum_probs=161.4
Q ss_pred CCCCC-ceeecccCceeEEecccc----------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceE
Q 002376 661 GNFSH-ENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~-~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+.|.. .+.||+|+||.||+|+.. ...+.+.+|++++.++ +||||+++++++.+. ...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEE
Confidence 46666 378999999999998754 1256789999999985 799999999998543 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc---eEEeccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT---AKVGDFGLARF 791 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DfGla~~ 791 (929)
++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999999986432 3467899999999998 9999999999999998775 99999999986
Q ss_pred cccccCCC-CCccccceeccccccccccccCC-----CCCCCCCCCCCCcCCCCCcchhHHhhhcCCch---hh-hccC-
Q 002376 792 LLERVDNQ-SSISSTHVFMGSIGYVPPEYGLG-----ERPSTAGDVPTSESFAGEFNIVKWVESNLPEN---VL-QVLD- 860 (929)
Q Consensus 792 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~---~~-~~~~- 860 (929)
........ .........+||+.|+|||++.+ ..++.++||||+|++++++.....++...... +. ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 53211100 01111233569999999999875 45899999999998877765544443222110 00 0000
Q ss_pred ---hHHHHhhc-ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 ---PELRQLMT-SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ---~~l~~~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+..... ............+...+++++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00111100 0000000000112223344778999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=296.11 Aligned_cols=238 Identities=20% Similarity=0.232 Sum_probs=170.0
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||.||+|++. ...+++.+|+.++++++||||+++++++...+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence 468899999999999999998732 12457889999999999999999999986533
Q ss_pred CcceEEEEEEecCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CC
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EM 779 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~ 779 (929)
..++||||+++|+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++. +.
T Consensus 107 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 107 ---PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred ---CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 3699999999999999987432 2356899999999998 9999999999999984 44
Q ss_pred ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhc
Q 002376 780 TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQV 858 (929)
Q Consensus 780 ~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~ 858 (929)
.+||+|||+++....... ........||+.|+|||++.+..++.++||||+|++++++.. ...++..... .
T Consensus 181 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~-- 252 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--Q-- 252 (327)
T ss_dssp CEEECCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H--
T ss_pred eEEECccccccccccccc----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--H--
Confidence 699999999986532211 111223468999999999999999999999999977666543 2222211111 1
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
.+.......... .........+.+++.+||+.||++||+++|+++.|+.+.....
T Consensus 253 ---~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 253 ---EVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---HHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 111111110000 0000111222337779999999999999999999999877543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=302.08 Aligned_cols=184 Identities=27% Similarity=0.342 Sum_probs=144.5
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccCc--------------------------HHHHHHHHHHHHccCCccccc
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTGS--------------------------WKSFIAECETLRNVRHRNLVK 706 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--------------------------~~~~~~E~~~l~~l~Hpniv~ 706 (929)
.+++....++|+..+.||+|+||.||+|..... .+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 567888899999999999999999999865410 267899999999999999999
Q ss_pred eeeecccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC
Q 002376 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE 777 (929)
Q Consensus 707 l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 777 (929)
+++++...+.......|+||||++ |+|.+++...+ .++.|++.||+|||+. +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 999987655445567899999997 68888776432 2367899999999998 9999999999999999
Q ss_pred CCceEEeccccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 778 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD-------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp TCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCEEEEecCcccccccc-------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 999999999999854221 11234578999999999887 6789999999999887776554433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=299.99 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=169.6
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC-------------c-----------HHHHHHHHHHHHcc-CCcccccee
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG-------------S-----------WKSFIAECETLRNV-RHRNLVKLI 708 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------~-----------~~~~~~E~~~l~~l-~Hpniv~l~ 708 (929)
+......++|+..+.||+|+||.||+|+... . .+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3344556789999999999999999987641 0 34678999999999 799999999
Q ss_pred eecccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc
Q 002376 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT 780 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 780 (929)
+++.. ....++||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+||++++++.
T Consensus 167 ~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 167 DSYES-----SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEB-----SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEee-----CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 99854 345899999999999999886432 3467899999999998 9999999999999999999
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCC------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCch
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG------ERPSTAGDVPTSESFAGEFNIVKWVESNLPEN 854 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~ 854 (929)
+||+|||+++.+... .......||+.|+|||++.+ ..++.++||||+|+++|++.....++.....
T Consensus 239 ikl~DfG~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~- 310 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPG-------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ- 310 (365)
T ss_dssp EEECCCTTCEECCTT-------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEEEecCcccccCCC-------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-
Confidence 999999999876422 11234579999999999863 3588999999999877766554433322111
Q ss_pred hhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 VLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+... .+.. .........+......+.+++.+|++.||++|||++|+++
T Consensus 311 -~~~~~-~i~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 -ILMLR-MIME---GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHH-HHHH---TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHH-HHHh---CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01000 0110 0000000011111222334777999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=305.28 Aligned_cols=229 Identities=20% Similarity=0.245 Sum_probs=166.9
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLD 715 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~ 715 (929)
.++|+..+.||+|+||.||+++.. ...+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 468999999999999999988652 1234577899999999 699999999998543
Q ss_pred CCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
...++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 132 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 ----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 34899999999999999986432 2356899999999998 99999999999999999999999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCC--CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccChHH
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE--RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLDPEL 863 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 863 (929)
+++...... .......+||+.|+|||++.+. .++.++||||+|++++++.....++..... ...++.
T Consensus 205 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---- 275 (355)
T 1vzo_A 205 LSKEFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---- 275 (355)
T ss_dssp EEEECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH----
T ss_pred CCeecccCC-----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH----
Confidence 998653221 1122345799999999999863 478999999999887776554444322111 111111
Q ss_pred HHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHHH
Q 002376 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALRR 909 (929)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~~ 909 (929)
........... ..+...+++++.+||+.||++|| +++|+++.
T Consensus 276 ~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 276 RRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11111111111 11223334477799999999999 89998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=300.46 Aligned_cols=244 Identities=17% Similarity=0.175 Sum_probs=159.3
Q ss_pred hhCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccC-CccccceeeecccCCC---CC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVR-HRNLVKLITSCSSLDS---KN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~---~~ 718 (929)
...+|+..+.||+|+||.||+|++.. ..+.+.+|+.+++++. ||||+++++++..... ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34578899999999999999998641 2457889999999996 9999999999853221 23
Q ss_pred cceEEEEEEecCCCCcccccccc-----------ccccccHHHHHHHhhhCCCCC--EEecCCCCCCeeecCCCceEEec
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE-----------RKNELDITSALDYLHNDCEVP--VVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~-----------~~~~~~ia~aL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~ki~D 785 (929)
....++||||++ |+|.+++... ..++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 456899999995 7998887531 13367899999999997 6 99999999999999999999999
Q ss_pred cccccccccccCCCC------Cccccceecccccccccccc---CCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhh
Q 002376 786 FGLARFLLERVDNQS------SISSTHVFMGSIGYVPPEYG---LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVL 856 (929)
Q Consensus 786 fGla~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~ 856 (929)
||+++.......... .........||+.|+|||++ .+..++.++||||+|++++++.....++.... ..
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~ 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--KL 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh--HH
Confidence 999987643211100 00111244699999999998 56678999999999977766544333322111 11
Q ss_pred hccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 857 QVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 857 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
++..... .... ....... +.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 260 ~~~~~~~----~~~~--~~~~~~~----~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 RIVNGKY----SIPP--HDTQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------C----CCCT--TCCSSGG----GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HhhcCcc----cCCc--ccccchH----HHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 1111100 0000 0011111 2236779999999999999999999999987644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-32 Score=300.74 Aligned_cols=172 Identities=26% Similarity=0.352 Sum_probs=134.5
Q ss_pred CCCCCceeecccCceeEEeccccCc-----------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-----------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|...+.||+|+||.||+|+.... ...+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence 5788999999999999999976511 11345799999999999999999998643 3489
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 9999997 68888876432 2367899999999998 999999999999999999999999999985432
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
. ........||+.|+|||++.+ ..++.++||||+|++++++.....+
T Consensus 153 ~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 153 P------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp ----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred C------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 1 112233478999999999877 5689999999999887776554433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-32 Score=305.98 Aligned_cols=227 Identities=23% Similarity=0.316 Sum_probs=160.1
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC--CccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR--HRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~~~~ 721 (929)
+.|+..+.||+|+||.||++.... ..+.+.+|++++++++ |||||++++++... ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CE
Confidence 358999999999999999986541 2357889999999996 59999999998643 34
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+||| +.+|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 899999 56889999986432 3367899999999998 999999999999996 5799999999998764
Q ss_pred cccCCCCCccccceeccccccccccccCC-----------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChH
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-----------ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPE 862 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (929)
.... .......+||+.|||||++.+ ..++.++||||+|+++|++.....++........ .
T Consensus 206 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~ 276 (390)
T 2zmd_A 206 PDTT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----K 276 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----H
T ss_pred CCCc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----H
Confidence 2211 111234579999999999875 4689999999999887776554444332221110 1
Q ss_pred HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 863 LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 863 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+......... ...+......+.+++.+||+.||++|||++|+++
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 LHAIIDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCcccc--CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111110000 0000011122333777999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-32 Score=293.30 Aligned_cols=227 Identities=21% Similarity=0.296 Sum_probs=162.9
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|....+||+|+||.||+|++. ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEE
Confidence 34555679999999999998754 1246788999999999999999999998543 35899
Q ss_pred EEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEecccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDFGLARFL 792 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DfGla~~~ 792 (929)
||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999886431 1356899999999998 9999999999999987 899999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
... ........||+.|+|||++.+.. ++.++||||+|++++++.....++................ ...
T Consensus 174 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~ 244 (295)
T 2clq_A 174 AGI------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF---KVH 244 (295)
T ss_dssp CC-----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH---CCC
T ss_pred CCC------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc---ccc
Confidence 321 11123357899999999987654 8999999999987777655444333222111000000000 000
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... ..+...+.+++.+||+.||++||+++|+++
T Consensus 245 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 111222333777999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=308.04 Aligned_cols=246 Identities=17% Similarity=0.171 Sum_probs=174.7
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..++||+|+||.||+|++. ...+++.+|+++++.++|++.+..+.++.. .....++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence 468999999999999999999754 123468899999999988665555544432 23357999
Q ss_pred EEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEeccccccccc
Q 002376 726 YEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla~~~~ 793 (929)
|||+ +|+|.+++... ..++.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++.+.
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 99999998632 23467999999999998 99999999999999 688999999999998764
Q ss_pred cccCCCC-CccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccc
Q 002376 794 ERVDNQS-SISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 794 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~ 871 (929)
....... .........||+.|+|||++.+..++.++||||+|+++|++.....++..... ...+.+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 3221110 11122356899999999999999999999999999888776665555543322 111111111111000000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
......+..-+.+++.+||+.||++||+++++++.|+++...
T Consensus 238 ---~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 ---EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp ---HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 000001112223377799999999999999999999998664
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-32 Score=298.85 Aligned_cols=175 Identities=26% Similarity=0.394 Sum_probs=133.7
Q ss_pred HhhCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
...++|+..+.||+|+||.||+|++.. ..+.+.+|++++++++||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----- 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----
Confidence 445689999999999999999986541 134577999999999999999999998543
Q ss_pred ceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee-----cCCCceEEecc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL-----DEEMTAKVGDF 786 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~ki~Df 786 (929)
...++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+|||+ ++++.+||+||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 35899999997 59998886432 3467999999999998 99999999999999 45556999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
|+++..... ........||+.|+|||++.+.. ++.++||||+|++++++.....+
T Consensus 182 g~a~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 237 (329)
T 3gbz_A 182 GLARAFGIP------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237 (329)
T ss_dssp THHHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCccccCCc------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999875321 11223457899999999998754 89999999999887776554433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-32 Score=296.67 Aligned_cols=228 Identities=20% Similarity=0.279 Sum_probs=164.2
Q ss_pred hCCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++||||+++++++... ...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence 467899999999999999998765 2346789999999999999999999998653 3489
Q ss_pred EEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
+||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999887532 13367899999999998 999999999999999999999999999864321
Q ss_pred ccCCCCCccccceecccccccccccc-----CCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYG-----LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.. .......||+.|+|||++ .+..++.++||||+|++++++.....++..... .+. .......
T Consensus 170 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~ 237 (302)
T 2j7t_A 170 TL------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRV----LLKIAKS 237 (302)
T ss_dssp HH------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH----HHHHHHS
T ss_pred cc------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HHH----HHHHhcc
Confidence 11 112234789999999998 467789999999999877765444333322211 010 0110000
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... .......+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 DPPT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCcc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 0001111222333777999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-31 Score=319.26 Aligned_cols=236 Identities=22% Similarity=0.270 Sum_probs=171.8
Q ss_pred hhCCCCCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
..++|+..+.||+|+||.||+|.+.. ..+.|.+|+.++++++|||||++++++.+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---- 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 34678889999999999999986531 136789999999999999999999998431
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
..++||||+++|+|.++++... .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 2699999999999999987432 2367899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+...... ........||+.|||||++.+..++.++||||+|++++++.+ ...++..... .+.+. .+..
T Consensus 539 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~-~i~~--- 607 (656)
T 2j0j_A 539 RYMEDST-----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIG-RIEN--- 607 (656)
T ss_dssp CSCCC---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH-HHHH---
T ss_pred eecCCCc-----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHH-HHHc---
Confidence 8753221 111223467889999999998999999999999987776543 2222221111 11110 1111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
.. +...+...+..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 608 -~~--~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 608 -GE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CC--CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 00 00001111222334777999999999999999999999987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-31 Score=307.86 Aligned_cols=235 Identities=22% Similarity=0.224 Sum_probs=167.1
Q ss_pred hCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.+.|+..+.||+|+||.||+|+.. ...+.+.+|+.+++.++|||||+++++|.. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 346888999999999999998764 124578899999999999999999999954 335
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~ 790 (929)
.|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 899999999999988875332 3467999999999998 9999999999999976 4569999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... ......+||+.|+|||++. +.++.++||||+|+++|++.....++..... .+++...........
T Consensus 188 ~~~~~-------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 188 VFENQ-------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEKGKYTFD 257 (494)
T ss_dssp ECBTT-------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCC
T ss_pred ECCCC-------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCC
Confidence 76321 1223457999999999986 5699999999999877765544433322211 111111111111101
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQEI 916 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~ 916 (929)
. ..+..++..+++++.+||+.||++|||+.|+++ .+++....
T Consensus 258 ~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 258 S----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301 (494)
T ss_dssp S----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH
T ss_pred c----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCccc
Confidence 1 111112223334777999999999999999984 35554433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=293.05 Aligned_cols=227 Identities=24% Similarity=0.268 Sum_probs=166.0
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|...+.||+|+||.||+++... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEE
Confidence 3578889999999999999987541 235688999999999999999999998543 3589
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla~~~ 792 (929)
+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999999886332 2367899999999998 99999999999999 78899999999998754
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
.. .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+... .+..... .
T Consensus 160 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~-~i~~~~~---~ 225 (304)
T 2jam_A 160 QN--------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFE-KIKEGYY---E 225 (304)
T ss_dssp CC--------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH-HHHHCCC---C
T ss_pred CC--------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH-HHHcCCC---C
Confidence 21 112334799999999999999999999999999877765544433322111 11111 1111000 0
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........++..+.+++.+|++.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000011112222334777999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-31 Score=282.05 Aligned_cols=230 Identities=20% Similarity=0.220 Sum_probs=168.1
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|... ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence 357888999999999999998654 1246788999999999999999999998543 347
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999999987432 3367899999999998 999999999999999999999999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... ........||+.|+|||++.+..+ +.++||||+|++++++.....++...... .............
T Consensus 158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~- 227 (276)
T 2yex_A 158 NNR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEKKTY- 227 (276)
T ss_dssp TTE----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-----SHHHHHHHTTCTT-
T ss_pred Ccc----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHhhhcccc-
Confidence 211 111234578999999999988775 78999999998777655444333222110 1111111110000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .....+...+.+++.+|++.||++|||++|+++
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L-NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 000111222334777999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-31 Score=306.59 Aligned_cols=227 Identities=23% Similarity=0.276 Sum_probs=166.4
Q ss_pred hCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++|||||++++++.. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence 357889999999999999998764 234578899999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec---CCCceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DfGla~ 790 (929)
.|+||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+|+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 899999999999998875332 3467899999999998 999999999999995 45689999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... ......+||+.|+|||++.+ .++.++||||+|+++|++.....++..... .+++.........
T Consensus 173 ~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~-- 240 (486)
T 3mwu_A 173 CFQQN-------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYA-- 240 (486)
T ss_dssp TBCCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC--
T ss_pred ECCCC-------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC--
Confidence 65321 11234579999999999876 599999999999877765554433322211 1111111111111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...+.+..++.-+++++.+||+.||++|||+.|+++
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111122223334777999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=297.91 Aligned_cols=173 Identities=24% Similarity=0.381 Sum_probs=136.3
Q ss_pred HHhhCCCCCceeecccCceeEEeccccCc---------------------HHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTGS---------------------WKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~---------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
....++|+..+.||+|+||.||+|++..+ .+.+.+|++++++++||||+++++++...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK- 84 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-
Confidence 34457899999999999999999876511 13678999999999999999999998543
Q ss_pred CCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
...++||||+++ +|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 85 ----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 85 ----SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp ----TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ----CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEec
Confidence 347999999975 8888776432 2367899999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~ 844 (929)
|+++..... ........||+.|+|||++.+. .++.++||||+|++++++...
T Consensus 157 g~a~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 209 (346)
T 1ua2_A 157 GLAKSFGSP------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209 (346)
T ss_dssp GGGSTTTSC------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccceeccCC------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999865321 1122345789999999998765 489999999999887776543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-32 Score=306.18 Aligned_cols=238 Identities=22% Similarity=0.261 Sum_probs=163.3
Q ss_pred CCCCCceeecccCceeEEeccccCc-----------HHHHHHHHHHHHccCCccccceeeecccCCC-CCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-----------WKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~~lV~e~ 728 (929)
.+|+..+.||+|+||+||+|+.... .+...+|+++++.++|||||++++++..... ....+.++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 4688899999999999999987521 2234479999999999999999999876543 334557899999
Q ss_pred cCCCCcccccc-----------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEecccccccccccc
Q 002376 729 LSNGSLGDWIH-----------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~-----------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~ 796 (929)
++++.+....+ ..+.++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+|+......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 98653332221 1123467999999999998 999999999999999 79999999999998753221
Q ss_pred CCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC------h-HHHHh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD------P-ELRQL 866 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~------~-~l~~~ 866 (929)
......||+.|+|||++.+. .++.++||||+|++++++..+..++..... ...+++. . .+...
T Consensus 197 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 197 -------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp -------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred -------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 12235789999999998775 489999999999888776655444332221 0111100 0 00000
Q ss_pred hc--------ccc--hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MT--------SNE--SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~--------~~~--~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. ... .............+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 000 0000000001122334778999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=298.84 Aligned_cols=181 Identities=24% Similarity=0.364 Sum_probs=141.4
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC---CC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS---KN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---~~ 718 (929)
.++|+..+.||+|+||.||+|+... ....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3578999999999999999987641 23478899999999999999999999876432 11
Q ss_pred cceEEEEEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
....++||||+++ ++.+.+... ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3458999999974 676665432 23467899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
+.+...... .........||+.|+|||++.+. .++.++||||+|++++++.....
T Consensus 172 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 172 RAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp EECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 876432111 11223345789999999998764 58999999999988777655433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-32 Score=300.38 Aligned_cols=240 Identities=25% Similarity=0.290 Sum_probs=154.6
Q ss_pred HhhCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
...++|+..+.||+|+||.||+|... ...+++.+|++++++++||||+++++++...+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----- 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----
Confidence 34578999999999999999998763 12356789999999999999999999986543
Q ss_pred eEEEEEEecCCCCcccccccc----------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 721 FLALVYEFLSNGSLGDWIHGE----------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~----------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
..++||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 389999999999999988621 12357899999999998 99999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPEL 863 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l 863 (929)
|||+++........ ..........||+.|+|||++.+ ..++.++||||+|++++++.....++...+.. +......
T Consensus 164 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 240 (303)
T 2vwi_A 164 DFGVSAFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLMLTL 240 (303)
T ss_dssp CCHHHHHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHH
T ss_pred eccchheeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHHHh
Confidence 99999865432111 11112234579999999999876 56899999999998877766555444333221 0000000
Q ss_pred HHhhcccch--hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 864 RQLMTSNES--QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 864 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......... ............+.+++.+||+.||++||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000 000000001122333777999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-31 Score=288.85 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=167.3
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+++... ..+.+.+|++++++++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 4578899999999999999987641 235688999999999999999999987542 2345
Q ss_pred EEEEEEecCCCCccccccccc------------cccccHHHHHHHhhhCCCCC-----EEecCCCCCCeeecCCCceEEe
Q 002376 722 LALVYEFLSNGSLGDWIHGER------------KNELDITSALDYLHNDCEVP-----VVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~------------~~~~~ia~aL~yLH~~~~~~-----iiHrDlk~~NILl~~~~~~ki~ 784 (929)
.++||||+++|+|.+++.... .++.|++.||+|||+. + |+||||||+||+++.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 899999999999999986321 2367899999999998 6 9999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
|||+++..... ........||+.|+|||++.+..++.++||||+|++++++.....++..... .++. ..+.
T Consensus 159 dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~-~~i~ 229 (279)
T 2w5a_A 159 DFGLARILNHD------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA-GKIR 229 (279)
T ss_dssp CCCHHHHC---------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH-HHHH
T ss_pred cCchheeeccc------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHH-HHHh
Confidence 99999865321 1112335789999999999999999999999999877766544333322211 1111 1111
Q ss_pred HhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 002376 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910 (929)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L 910 (929)
.... .......++ .+.+++.+||+.||++||+++|+++.+
T Consensus 230 ~~~~--~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 EGKF--RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HTCC--CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hccc--ccCCcccCH----HHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1000 000111112 233377799999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-31 Score=287.84 Aligned_cols=226 Identities=23% Similarity=0.272 Sum_probs=168.9
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.+.|+..+.||+|+||.||+|... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence 356888999999999999998653 1246789999999999999999999998643 348
Q ss_pred EEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999999999886432 3467899999999998 9999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.. ..+..... .....
T Consensus 173 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~-~~~~~~~~--~~~~~ 241 (303)
T 3a7i_A 173 Q------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVL-FLIPKNNP--PTLEG 241 (303)
T ss_dssp B------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH-HHHHHSCC--CCCCS
T ss_pred c------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHH-HHhhcCCC--CCCcc
Confidence 1 112345789999999999999999999999999877765544333322211 0000 00111000 00001
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 242 N----YSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp S----CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c----cCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 1122333777999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-32 Score=301.50 Aligned_cols=236 Identities=20% Similarity=0.271 Sum_probs=152.2
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||.||+|.... ..+.+.+|+++++.++||||+++++++..... ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999996531 23577899999999999999999999865321 1224
Q ss_pred eEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
..|+||||+ +++|.++++..+ .++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 479999999 789999886432 3467999999999998 99999999999999999999999999998643
Q ss_pred cccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhh-------------
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQ------------- 857 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~------------- 857 (929)
. .....+||+.|+|||++.+ ..++.++||||+|++++++..+..++..... .+..
T Consensus 184 ~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 184 D---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred c---------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1 1234579999999999887 6789999999999888776655444322211 0000
Q ss_pred --ccChHHHHhhcccch-hhhhhh---HHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 --VLDPELRQLMTSNES-QTIQLH---DCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 --~~~~~l~~~~~~~~~-~~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.............. ...... ......+.+++.+|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 001111110000000 000000 001122334888999999999999999985
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=278.60 Aligned_cols=255 Identities=24% Similarity=0.280 Sum_probs=181.6
Q ss_pred CCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCC-
Q 002376 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE- 134 (929)
Q Consensus 56 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~- 134 (929)
...|.|.+|.|+..+ ++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++..
T Consensus 4 ~C~C~~~~l~c~~~~------------l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 4 RCSCSGTEIRCNSKG------------LT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TCEEETTEEECCSSC------------CS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCeeCCCEEEcCCCC------------cc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 445899999887532 33 4555443 6899999999999855555689999999999999999843
Q ss_pred -cccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCC
Q 002376 135 -LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213 (929)
Q Consensus 135 -~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~ 213 (929)
.|..+..+++|++|+|++|.++ .++.. +..+++|++|++++|++.+..+ ...|..+++|++|+|++|++.
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~-------~~~~~~l~~L~~L~l~~n~l~ 139 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSE-------FSVFLSLRNLIYLDISHTHTR 139 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTT-------TTTTTTCTTCCEEECTTSCCE
T ss_pred CcccccccccccCEEECCCCccc-cChhh-cCCCCCCCEEECCCCccccccc-------chhhhhccCCCEEECCCCcCC
Confidence 3677778999999999999998 56665 8889999999999998754322 145778889999999999998
Q ss_pred CccCCccccCCCCceEEeeecCCCC-cCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCC
Q 002376 214 GTVPSTIYNMTSLVHLRLASNQLGG-EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG 292 (929)
Q Consensus 214 ~~~p~~~~~l~~L~~L~Ls~N~l~~-~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 292 (929)
+..+..|.++++|++|+|++|.+++ .+|..+. .+++|+.|++++|++++..|..+..+++|+.|+|++|.+++..+..
T Consensus 140 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 218 (306)
T 2z66_A 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218 (306)
T ss_dssp ECSTTTTTTCTTCCEEECTTCEEGGGEECSCCT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGG
T ss_pred ccchhhcccCcCCCEEECCCCccccccchhHHh-hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhh
Confidence 8888888889999999999888875 2443333 3666666666666666666666666666666666666666555545
Q ss_pred CCCCCccceeccccccccCCCCCCCCccccccCCC-CCCCEEEccCCcccc
Q 002376 293 LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS-THLNYLALDGNQFEG 342 (929)
Q Consensus 293 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~ 342 (929)
|..+++|+.|++++|++..... ..+..+ ++|++|+|++|.+++
T Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~-------~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 219 YKCLNSLQVLDYSLNHIMTSKK-------QELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp GTTCTTCCEEECTTSCCCBCSS-------SSCCCCCTTCCEEECTTCCEEC
T ss_pred ccCcccCCEeECCCCCCcccCH-------HHHHhhhccCCEEEccCCCeec
Confidence 5555555555555555544322 223333 255555555555553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-32 Score=306.01 Aligned_cols=176 Identities=26% Similarity=0.345 Sum_probs=128.0
Q ss_pred CCC-ceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 663 FSH-ENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 663 ~~~-~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
|.. .++||+|+||.||+|++. ...+.+.+|++++++++|||||++++++... .....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEEEE
Confidence 444 468999999999999843 1235788999999999999999999998642 23458999
Q ss_pred EEecCCCCccccccc-----------------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeee----cCCCceEEe
Q 002376 726 YEFLSNGSLGDWIHG-----------------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILL----DEEMTAKVG 784 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~-----------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~ 784 (929)
|||++ |+|.+++.. .+.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 588777642 123467999999999998 99999999999999 778899999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
|||+|+....... ........+||+.|+|||++.+. .++.++||||+|++++++.....++
T Consensus 175 Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 175 DMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp CTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 9999987642211 11123346899999999999875 4899999999998888876655444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-32 Score=308.94 Aligned_cols=237 Identities=21% Similarity=0.278 Sum_probs=162.8
Q ss_pred CCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcceEEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFLALVYE 727 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~~lV~e 727 (929)
.+|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||+++++|..... ....+.++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 468889999999999999998752 12334579999999999999999999865432 23345789999
Q ss_pred ecCCCCccccccc------------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-CceEEecccccccccc
Q 002376 728 FLSNGSLGDWIHG------------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLE 794 (929)
Q Consensus 728 ~~~~gsL~~~l~~------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DfGla~~~~~ 794 (929)
|+++ ++.+.+.. .+.++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 56555431 123467999999999998 99999999999999965 5789999999986532
Q ss_pred ccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC-------hHHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD-------PELR 864 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~l~ 864 (929)
. ......+||+.|+|||++.+. .++.++||||+|+++|++..+..++..... .+.+++. ..+.
T Consensus 210 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 210 G-------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp T-------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred C-------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1 112235789999999998775 699999999999888777655444332211 1111110 0000
Q ss_pred Hhhcccc----------hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNE----------SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~----------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....... .........+...+.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000000 0000000011122334788999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-31 Score=284.87 Aligned_cols=224 Identities=26% Similarity=0.322 Sum_probs=159.1
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|...+.||+|+||.||+|+... ..+.+.+|+++++.++||||+++++++... .
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 4678899999999999999987641 134688999999999999999999998543 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 4899999999999999986432 3467899999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
... .......||+.|+|||++.+..+ +.++||||+|++++++.....++.... ..+... .+... ..
T Consensus 162 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~-~~~~~---~~ 228 (276)
T 2h6d_A 162 SDG-------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFK-KIRGG---VF 228 (276)
T ss_dssp CC--------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHH-HHHHC---CC
T ss_pred CCC-------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHH-HhhcC---cc
Confidence 321 11223478999999999988775 689999999977666544333222111 111111 11110 00
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... +.+...+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 001 111122334777999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-31 Score=288.93 Aligned_cols=228 Identities=21% Similarity=0.222 Sum_probs=162.5
Q ss_pred hCCCCCceeecccCceeEEeccccCc------------------------HHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS------------------------WKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~------------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
.++|...+.||+|+||.||+|..... ...+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 35788999999999999999865411 12478999999999999999999998432
Q ss_pred CCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc---eEEe
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT---AKVG 784 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~ 784 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 2799999999999999886433 2367899999999998 9999999999999987654 9999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
|||+++..... .......||+.|+|||++. ...++.++||||+|++++++.....++...... ..+..
T Consensus 160 Dfg~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~ 230 (322)
T 2ycf_A 160 DFGHSKILGET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD 230 (322)
T ss_dssp CCTTCEECCCC-------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHH
T ss_pred cCccceecccc-------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHH
Confidence 99999865321 1123457999999999973 567899999999998777655443333221110 00001
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.+... ...........+...+.+++.+||+.||++||+++|+++
T Consensus 231 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSG---KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHT---CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhC---ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11110 000000111111222334777999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-31 Score=307.24 Aligned_cols=227 Identities=23% Similarity=0.305 Sum_probs=168.1
Q ss_pred hCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++|||||++++++.. ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 347888999999999999988754 235678999999999999999999999854 34
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee---cCCCceEEeccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL---DEEMTAKVGDFGLA 789 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DfGla 789 (929)
..++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+|
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 5899999999999998886433 3467899999999998 99999999999999 56789999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
+..... ......+||+.|+|||++.+ .++.++||||+|+++|++.....++..... .+++........
T Consensus 177 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~-- 244 (484)
T 3nyv_A 177 THFEAS-------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKY-- 244 (484)
T ss_dssp HHBCCC-------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC--
T ss_pred EEcccc-------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCC--
Confidence 865321 12234579999999999876 699999999999877765544433322211 111111111110
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....+.+..++..+++++.+|++.||++|||++|+++
T Consensus 245 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 --TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0111111122233344777999999999999999985
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=275.79 Aligned_cols=227 Identities=21% Similarity=0.291 Sum_probs=206.6
Q ss_pred CCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEE
Q 002376 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406 (929)
Q Consensus 327 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 406 (929)
.++++.|+|++|+++ .+|..++.+. +|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 468899999999998 7888888876 7999999999999 78889999999999999999998 778899999999999
Q ss_pred EecCCcCCCCCcccccC---------CCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhh
Q 002376 407 GLAGNEIPGGIPNSLAN---------LKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEI 477 (929)
Q Consensus 407 ~L~~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~ 477 (929)
+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..|.++++|++|+|++|++++ + |..+
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l--------~~~l 225 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-L--------GPAI 225 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-C--------CGGG
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-C--------chhh
Confidence 99999888888887664 999999999999998 788889999999999999999974 3 6678
Q ss_pred hcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCe
Q 002376 478 SRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRS 557 (929)
Q Consensus 478 ~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 557 (929)
..+++|++|+|++|++.+.+|..|+++++|++|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+.++++|+.
T Consensus 226 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~ 305 (328)
T 4fcg_A 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305 (328)
T ss_dssp GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCE
T ss_pred ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceE
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeCCCCcCcc
Q 002376 558 LNLTFNNLEG 567 (929)
Q Consensus 558 L~Ls~N~l~~ 567 (929)
+++..|.+..
T Consensus 306 l~l~~~~~~~ 315 (328)
T 4fcg_A 306 ILVPPHLQAQ 315 (328)
T ss_dssp EECCGGGSCC
T ss_pred EeCCHHHHHH
Confidence 9998777654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=299.94 Aligned_cols=294 Identities=25% Similarity=0.328 Sum_probs=161.7
Q ss_pred CCCCCCCCCCCCCCCCCcceeeC------CCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCC
Q 002376 45 PSSPLSYWNPSSSPCTWPGVICN------NFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNL 118 (929)
Q Consensus 45 ~~~~l~~w~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l 118 (929)
....+++|..+.+||.|+|..|. .....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|. .+
T Consensus 8 ~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 8 YDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp --CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 45566788878889999775321 11123667777777777 6666665 67777777777776 4554 45
Q ss_pred CCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCC
Q 002376 119 FRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSR 198 (929)
Q Consensus 119 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~ 198 (929)
++|++|+|++|+|++ +|. .+++|++|+|++|+|+ .+|. .+++|+.|++++|++++ +|. .
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~-----------~ 139 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPV-----------L 139 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCC-----------C
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCC-----------C
Confidence 677777777777763 443 5566677777777666 3443 34556666666665532 221 1
Q ss_pred CCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEE
Q 002376 199 LENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQII 278 (929)
Q Consensus 199 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L 278 (929)
+++|++|+|++|+++++ |. .+.+|+.|++++|+|+ + +| ..+++|+.|
T Consensus 140 l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~-------------------------~-l~---~~~~~L~~L 186 (622)
T 3g06_A 140 PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLT-------------------------S-LP---MLPSGLQEL 186 (622)
T ss_dssp CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-------------------------C-CC---CCCTTCCEE
T ss_pred CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCC-------------------------C-Cc---ccCCCCcEE
Confidence 24455555555554432 21 1233444444444443 2 12 123445555
Q ss_pred eccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEE
Q 002376 279 RMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358 (929)
Q Consensus 279 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L 358 (929)
++++|.|++ +|.. .++|+.|++++|.++ .+|..+ .+|+.|
T Consensus 187 ~Ls~N~l~~-l~~~----------------------------------~~~L~~L~L~~N~l~-~l~~~~----~~L~~L 226 (622)
T 3g06_A 187 SVSDNQLAS-LPTL----------------------------------PSELYKLWAYNNRLT-SLPALP----SGLKEL 226 (622)
T ss_dssp ECCSSCCSC-CCCC----------------------------------CTTCCEEECCSSCCS-SCCCCC----TTCCEE
T ss_pred ECCCCCCCC-CCCc----------------------------------cchhhEEECcCCccc-ccCCCC----CCCCEE
Confidence 555555543 2210 134555555555554 233211 246666
Q ss_pred EecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc
Q 002376 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438 (929)
Q Consensus 359 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 438 (929)
+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..+.++++|+.|+|++|.++
T Consensus 227 ~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 227 IVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp ECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred EccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 666666654 33 33456666666666666 3343 4556666666666666 45566666666666666666666
Q ss_pred cccCcccccc
Q 002376 439 GEIPISFGNF 448 (929)
Q Consensus 439 ~~~p~~~~~l 448 (929)
+..|..|..+
T Consensus 298 ~~~~~~l~~L 307 (622)
T 3g06_A 298 ERTLQALREI 307 (622)
T ss_dssp HHHHHHHHHH
T ss_pred CcCHHHHHhc
Confidence 6655554443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=283.24 Aligned_cols=273 Identities=20% Similarity=0.269 Sum_probs=170.3
Q ss_pred EEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcccccc
Q 002376 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS 356 (929)
Q Consensus 277 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~ 356 (929)
..++++|.++ .+|..+. ++|++|++++|++..++. ..+.++++|++|+|++|++++..|..+..+. +|+
T Consensus 35 ~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~-------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~ 103 (353)
T 2z80_A 35 ICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISN-------SDLQRCVNLQALVLTSNGINTIEEDSFSSLG-SLE 103 (353)
T ss_dssp EEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECT-------TTTTTCTTCCEEECTTSCCCEECTTTTTTCT-TCC
T ss_pred EeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCH-------HHhccCCCCCEEECCCCccCccCHhhcCCCC-CCC
Confidence 3455555554 2333322 245555555555544322 2345555666666666666655555555554 566
Q ss_pred EEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccC-ccccCCCCCCEEEecCC-cCCCCCcccccCCCCCceecccC
Q 002376 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIP-IEIGQLQGLQVLGLAGN-EIPGGIPNSLANLKKLNQIDLSG 434 (929)
Q Consensus 357 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~ 434 (929)
+|+|++|+|++..+..|+++++|++|+|++|++++..+ ..+..+++|++|++++| .+.+..+..|.++++|++|++++
T Consensus 104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 66666666665444446666666666666666664333 35666666666666666 35555556666777777777777
Q ss_pred cccccccCcccccccccceecccCCcCCCCCCCCcccCCch-hhhcccCccEEEecCCCCCCCCCcchh---cCcCccee
Q 002376 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPE-EISRLENVVTIDLSDNSLSGNLPNSLK---NCKSLEEL 510 (929)
Q Consensus 435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~-~~~~l~~L~~LdLs~N~l~~~~p~~~~---~l~~L~~L 510 (929)
|++++..|..|.++++|++|++++|+++. + |. .+..+++|+.|+|++|++++..+..+. ....++.+
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~--------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l 254 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQHIL-L--------LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSCSTT-H--------HHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEE
T ss_pred CCcCccCHHHHhccccCCeecCCCCcccc-c--------hhhhhhhcccccEEECCCCccccccccccccccccchhhcc
Confidence 77776667777777777777777777642 2 32 234466777777777777765544332 34566777
Q ss_pred ecccccccc----cCCccccCCCCCCEEECCCCcCCCcCCcc-cccCCCCCeEeCCCCcCcccCC
Q 002376 511 LMAYNQFSG----PIPNIVAELKGLEVLDLSSNKLSGSIPSD-LQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 511 ~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
+|++|.+++ .+|..+..+++|+.|||++|+++. +|.. |.++++|++|+|++|++++..|
T Consensus 255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 777777765 367778888888888888888884 5544 5888888888888888887655
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-32 Score=299.62 Aligned_cols=175 Identities=27% Similarity=0.390 Sum_probs=138.5
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|+... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence 3578889999999999999987651 13457899999999999999999999854 334
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+++++|.++..... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 899999999998888764322 3467999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
... .......||+.|+|||++.+. .++.++||||+|++++++.....++
T Consensus 176 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (331)
T 4aaa_A 176 APG------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCc------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC
Confidence 211 112334789999999999876 6899999999998877765554333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-31 Score=287.64 Aligned_cols=219 Identities=20% Similarity=0.230 Sum_probs=160.0
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||.||+|+... ...++.+|+..+.++ +||||+++++++.+. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----D 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----T
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----C
Confidence 4678899999999999999987641 245788999999999 999999999998543 3
Q ss_pred eEEEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-----------
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE----------- 777 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----------- 777 (929)
..++||||+++|+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccc
Confidence 589999999999999998642 12367999999999998 9999999999999984
Q ss_pred --------CCceEEeccccccccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 778 --------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 778 --------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
...+||+|||.++.... .....||+.|+|||++.+. .++.++||||+|++++++..
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~----- 226 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISS----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG----- 226 (289)
T ss_dssp --------CCCEEECCCTTCEETTC----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-----
T ss_pred ccccccCCceEEEEcccccccccCC----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-----
Confidence 44799999999986532 1123589999999999876 56789999999977665432
Q ss_pred hcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 849 SNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 849 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+..+....+.. ..+..... ...... +...+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~-~~~~~~~~--~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 227 AEPLPRNGDQW-HEIRQGRL--PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCCSSSHHH-HHHHTTCC--CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCcchhHH-HHHHcCCC--CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 22111000000 00111000 000111 1222333777999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=304.25 Aligned_cols=228 Identities=22% Similarity=0.255 Sum_probs=165.5
Q ss_pred hhCCCCCceeecccCceeEEeccccC-----------------------------cHHHHHHHHHHHHccCCccccceee
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-----------------------------SWKSFIAECETLRNVRHRNLVKLIT 709 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------------------~~~~~~~E~~~l~~l~Hpniv~l~~ 709 (929)
..++|...+.||+|+||.||+|+... ..+.+.+|+.++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35689999999999999999887541 1346889999999999999999999
Q ss_pred ecccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC--
Q 002376 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-- 779 (929)
Q Consensus 710 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-- 779 (929)
+|.+ ....|+|||||++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 9954 345899999999999998885332 3467999999999998 999999999999998776
Q ss_pred -ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc
Q 002376 780 -TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV 858 (929)
Q Consensus 780 -~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~ 858 (929)
.+||+|||+|+..... ......+||+.|+|||++. +.++.++||||+|+++|++..+..++..... .++
T Consensus 186 ~~~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~ 255 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD-------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDI 255 (504)
T ss_dssp SSEEECCCTTCEECCTT-------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH
T ss_pred ccEEEEECCCCEEcCCC-------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHH
Confidence 6999999999865321 1223457999999999986 4699999999999877765544333322211 111
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+...... ........+..++..+++++.+|++.||++|||++|+++
T Consensus 256 ~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKG----KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHC----CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcC----CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111 000011111112223344777999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-31 Score=295.73 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=168.7
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||.||+|++.. ....+.+|++++++++||||+++++++...........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999987651 13467899999999999999999999876443344568
Q ss_pred EEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++||||++ |+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99999997 6898887642 23467999999999998 9999999999999999999999999999876432
Q ss_pred cCCCCC----ccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCch----------------
Q 002376 796 VDNQSS----ISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPEN---------------- 854 (929)
Q Consensus 796 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~---------------- 854 (929)
...... .......+||+.|+|||++.+ ..++.++||||+|++++++.....++......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111110 011234578999999998764 67899999999998877765444333222110
Q ss_pred --hhhccChHHHHhhcccch---h-hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 855 --VLQVLDPELRQLMTSNES---Q-TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 855 --~~~~~~~~l~~~~~~~~~---~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.................. . .......+...+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000011111111100000 0 00000011222334777999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-31 Score=286.62 Aligned_cols=228 Identities=20% Similarity=0.307 Sum_probs=162.3
Q ss_pred hCCCCCceeecccCceeEEeccccC--------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG--------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||.||++.... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence 4689999999999999999987641 2356889999999999999999999985422 2
Q ss_pred ceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
...++||||+++| +.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 3589999999876 66665421 12367899999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhh
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
+...... .........||+.|+|||++.+.. ++.++||||+|++++++.....++.... ..+... .+..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~-~i~~-- 227 (305)
T 2wtk_C 157 EALHPFA----ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFE-NIGK-- 227 (305)
T ss_dssp EECCTTC----SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH-HHHH--
T ss_pred cccCccc----cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHH-HHhc--
Confidence 8653211 111223456999999999988654 3789999999977766554433322111 111111 1111
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.........++ .+.+++.+||+.||++|||++|+++
T Consensus 228 -~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 228 -GSYAIPGDCGP----PLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -CCCCCCSSSCH----HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCCCCCccCH----HHHHHHHHHccCChhhCCCHHHHhc
Confidence 00011111112 2233777999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-31 Score=304.64 Aligned_cols=169 Identities=26% Similarity=0.350 Sum_probs=139.2
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHcc------CCccccceeeecccCCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNV------RHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l------~Hpniv~l~~~~~~~~~~~ 718 (929)
..+|+..+.||+|+||.||+|.... ..+.+.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC----
Confidence 4578999999999999999996652 135677899888887 577999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc--eEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT--AKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~ki~Df 786 (929)
...++||||++ |+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 172 -~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 -NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp -TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred -CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 45899999996 68988876432 3467999999999998 9999999999999999887 999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
|+|+.... .....+||+.|||||++.+..++.++||||+|++++++.....
T Consensus 247 G~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 247 GSSCYEHQ---------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp TTCEETTC---------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccceecCC---------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 99975421 1223578999999999999999999999999988887665543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-31 Score=292.03 Aligned_cols=242 Identities=24% Similarity=0.292 Sum_probs=161.2
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCC-------
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS------- 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~------- 716 (929)
.++|+..+.||+|+||.||+|.... ..+++.+|++++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578899999999999999987652 24578899999999999999999998754321
Q ss_pred --CCcceEEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEecc
Q 002376 717 --KNMEFLALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDF 786 (929)
Q Consensus 717 --~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~Df 786 (929)
......++||||++ |+|.++++... .++.|++.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 12356899999997 69999886432 3467999999999998 999999999999997 5679999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhhcc----
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQVL---- 859 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~~~---- 859 (929)
|+++........ ........||..|+|||++.+ ..++.++||||+|++++++.....++..... . ...+.
T Consensus 166 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp TTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccccccCCCccc---ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999876322111 111233467999999998865 6789999999999887776554433322221 0 00000
Q ss_pred --ChH------------HHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 860 --DPE------------LRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 860 --~~~------------l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
... +.................+...+++++.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 0000000000000000112223344778999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-31 Score=287.32 Aligned_cols=229 Identities=22% Similarity=0.252 Sum_probs=167.0
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------------cHHHHHHHHHHHHccC-Cccccceeeecc
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------------SWKSFIAECETLRNVR-HRNLVKLITSCS 712 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~ 712 (929)
..++|+..+.||+|+||.||+|.... ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35689999999999999999987641 1246779999999996 999999999985
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEe
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVG 784 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 784 (929)
. ....++||||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 T-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp C-----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred c-----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 4 345899999999999999986432 3367899999999998 99999999999999999999999
Q ss_pred ccccccccccccCCCCCccccceeccccccccccccC------CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhc
Q 002376 785 DFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL------GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQV 858 (929)
Q Consensus 785 DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~ 858 (929)
|||+++..... .......||+.|+|||++. ...++.++||||+|++++++.....++..... .+.
T Consensus 167 dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~ 237 (298)
T 1phk_A 167 DFGFSCQLDPG-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLM 237 (298)
T ss_dssp CCTTCEECCTT-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH
T ss_pred cccchhhcCCC-------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHH
Confidence 99999865321 1123357899999999885 45689999999999777665544333322111 111
Q ss_pred cChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 859 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. .+.. .............+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~-~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LR-MIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HH-HHHH---TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-HHhc---CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 10 1111 0000000011112223334777999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-31 Score=297.57 Aligned_cols=236 Identities=23% Similarity=0.261 Sum_probs=164.1
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC-Ccc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK-NME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~-~~~ 720 (929)
.++|...+.||+|+||.||+|.+.. ..+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4688899999999999999996541 135788999999999999999999999764431 112
Q ss_pred eEEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
..++||||++ |+|.+++... ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 3499999997 6888776532 23467999999999998 999999999999999999999999999986432
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc-------------
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV------------- 858 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~------------- 858 (929)
. .....||+.|+|||++.+ ..++.++||||+|++++++.....++..... ....+
T Consensus 197 ~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 197 E---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred C---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 1 233578999999999887 6799999999999887776555444332211 00000
Q ss_pred -c-ChHHHHhh---cccchh-hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 859 -L-DPELRQLM---TSNESQ-TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 859 -~-~~~l~~~~---~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+ +....... ...... ...........+.+++.+|++.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 00000000 000000 00000011223334788999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-31 Score=300.76 Aligned_cols=176 Identities=25% Similarity=0.378 Sum_probs=140.5
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccC--------CccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVR--------HRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~--------Hpniv~l~~~~~~~~~ 716 (929)
.++|+..+.||+|+||+||+|+... ..+.+.+|++++++++ ||||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 3679999999999999999996541 2457889999999985 888999999986432
Q ss_pred CCcceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-------
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM------- 779 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~------- 779 (929)
......++||||+ +|++.+++... +.++.|++.||+|||+.+ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 1344689999999 56666655422 234679999999999853 799999999999999775
Q ss_pred ------------------------------------------ceEEeccccccccccccCCCCCccccceeccccccccc
Q 002376 780 ------------------------------------------TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817 (929)
Q Consensus 780 ------------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aP 817 (929)
.+||+|||+|+..... ....+||+.||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y~aP 262 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGGCCH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCCcccCC
Confidence 7999999999865321 2234789999999
Q ss_pred cccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 818 EYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 818 E~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
|++.+..++.++||||+|++++++.....++
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf 293 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLF 293 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCC
Confidence 9999999999999999998888766655444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-31 Score=296.25 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=134.0
Q ss_pred hHHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCC-
Q 002376 653 YDELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS- 716 (929)
Q Consensus 653 ~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~- 716 (929)
-.+.....++|+..+.||+|+||.||+|++.. ..+.+.+|++.++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 35667778999999999999999999987651 13467788888999999999999999876432
Q ss_pred -CCcceEEEEEEecCCCCcccccc----cc--------ccccccHHHHHHHhh--hCCCCCEEecCCCCCCeeecC-CCc
Q 002376 717 -KNMEFLALVYEFLSNGSLGDWIH----GE--------RKNELDITSALDYLH--NDCEVPVVHSDLKPGNILLDE-EMT 780 (929)
Q Consensus 717 -~~~~~~~lV~e~~~~gsL~~~l~----~~--------~~~~~~ia~aL~yLH--~~~~~~iiHrDlk~~NILl~~-~~~ 780 (929)
....+.++||||+++ ++.+.+. .. ..++.|++.|++||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 223457899999986 4443332 11 134678999999999 66 9999999999999996 899
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhh
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+||+|||+++..... .......||+.|+|||++.+.. ++.++||||+|++++++.....++
T Consensus 171 ~kl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS-------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp EEECCCTTCBCCCTT-------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEeeCCCceecCCC-------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 999999999865322 1122347899999999987655 899999999998877765554443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-31 Score=292.13 Aligned_cols=238 Identities=26% Similarity=0.341 Sum_probs=168.8
Q ss_pred HhhCCCCCceeecccCceeEEecccc-C------------------cHHHHHHHHHHHHcc---CCccccceeeecccCC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT-G------------------SWKSFIAECETLRNV---RHRNLVKLITSCSSLD 715 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~------------------~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~ 715 (929)
++.++|+..+.||+|+||.||+|++. . ....+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999762 0 123577888887776 8999999999986433
Q ss_pred CCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEec
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
.......++||||++ |+|.+++.... .++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 234456899999997 69999886432 2367899999999998 999999999999999999999999
Q ss_pred cccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 786 FGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 786 fGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
||+++..... .......||+.|+|||++.+..++.++||||+|++++++.....++..... .+.+...+..
T Consensus 164 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~ 234 (326)
T 1blx_A 164 FGLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDV 234 (326)
T ss_dssp CCSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHH
T ss_pred CcccccccCC-------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHH
Confidence 9999865321 122345789999999999999999999999999877776544433322211 0000000000
Q ss_pred h------------------hcc-cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 L------------------MTS-NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ~------------------~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. ... ...........+...+++++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000 000000000112223344777999999999999999984
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=274.66 Aligned_cols=210 Identities=19% Similarity=0.217 Sum_probs=104.8
Q ss_pred cCCCCCCCEEEccCCcccc--ccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccC-ccccCC
Q 002376 324 LTNSTHLNYLALDGNQFEG--KIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIP-IEIGQL 400 (929)
Q Consensus 324 ~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l 400 (929)
|.++++|++|+|++|+++. ..|..+..+. +|++|+|++|.+.. +|..+..+++|++|++++|++++..+ ..+..+
T Consensus 48 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~-~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 125 (306)
T 2z66_A 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125 (306)
T ss_dssp TTTCTTCSEEECCSSCCCEEEEEEHHHHSCS-CCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTC
T ss_pred hhccccCCEEECCCCccCcccCccccccccc-ccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhc
Confidence 3444555555555555441 1233333333 45555555555542 33334455555555555555543332 344555
Q ss_pred CCCCEEEecCCcCCCCCcccccCCCCCceecccCccccc-ccCcccccccccceecccCCcCCCCCCCCcccCCchhhhc
Q 002376 401 QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG-EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR 479 (929)
Q Consensus 401 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~ 479 (929)
++|++|++++|.+.+..+..+.++++|++|++++|.+++ ..|..|..+++|++|++++|++++.. |..+..
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~~~ 197 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS--------PTAFNS 197 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC--------TTTTTT
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcC--------HHHhcC
Confidence 555555555555555555555555555555555555544 34555555555555555555554322 333444
Q ss_pred ccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCC-CCCEEECCCCcCCC
Q 002376 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELK-GLEVLDLSSNKLSG 543 (929)
Q Consensus 480 l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 543 (929)
+++|+.|+|++|++++..+..+..+++|++|+|++|++++.+|..+..++ +|++|+|++|.+++
T Consensus 198 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 44555555555555544444455555555555555555555555555552 55555555555544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=282.94 Aligned_cols=250 Identities=24% Similarity=0.275 Sum_probs=221.6
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
....++.+++.++ .+|..+. .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 3567888888887 6787654 47999999999999998999999999999999999999888889999999999999
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
++|+|++..+..|..+++|++|+|++|+++...+..|.++++|+.|+|++|+..+.++ +..+..+++|++|+|
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~-------~~~~~~l~~L~~L~L 192 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS-------EGAFEGLSNLRYLNL 192 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-------TTTTTTCSSCCEEEC
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC-------cchhhcccccCeecC
Confidence 9999998888889999999999999999998888889999999999999966544554 345778889999999
Q ss_pred cCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
++|+++ .+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.
T Consensus 193 ~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 270 (440)
T 3zyj_A 193 AMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270 (440)
T ss_dssp TTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCC
T ss_pred CCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCcc
Confidence 999998 455 488999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CCCC-CCCCCCCcccccCCCCCcC
Q 002376 569 VPSE-GIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 569 ~p~~-~~~~~l~~l~l~~N~~~c~ 591 (929)
.+.. ..+++++.+++++||+.|.
T Consensus 271 ~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 271 PHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp CTTTTSSCTTCCEEECCSSCEECS
T ss_pred ChhHhccccCCCEEEcCCCCccCC
Confidence 7654 4578899999999999994
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=283.82 Aligned_cols=250 Identities=24% Similarity=0.260 Sum_probs=215.5
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
....++.+++.++ .+|..+. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 3457788888887 6776554 47999999999999988999999999999999999999888889999999999999
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
++|+|++..+..|.++++|++|+|++|+++...+..|.++++|+.|++++|+..+.++ +..+..+++|++|+|
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~-------~~~~~~l~~L~~L~L 203 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS-------EGAFEGLFNLKYLNL 203 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-------TTTTTTCTTCCEEEC
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccC-------hhhccCCCCCCEEEC
Confidence 9999998888889999999999999999998777789999999999999855444554 335677889999999
Q ss_pred cCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
++|++++. | .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.
T Consensus 204 ~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 281 (452)
T 3zyi_A 204 GMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281 (452)
T ss_dssp TTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCcc
Confidence 99999854 4 488899999999999999999999999999999999999999998899999999999999999999977
Q ss_pred CCCC-CCCCCCCcccccCCCCCcC
Q 002376 569 VPSE-GIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 569 ~p~~-~~~~~l~~l~l~~N~~~c~ 591 (929)
.+.. ..+++++.+++++||+.|.
T Consensus 282 ~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 282 PHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CTTSSTTCTTCCEEECCSSCEECS
T ss_pred ChHHhccccCCCEEEccCCCcCCC
Confidence 6654 4478889999999999884
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-31 Score=289.37 Aligned_cols=227 Identities=18% Similarity=0.227 Sum_probs=151.6
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|+... ..+.+.++...++.++||||+++++++...+ .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence 4678899999999999999988641 1123344555688889999999999996533 3
Q ss_pred EEEEEEecCCCCccccccc------------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 722 LALVYEFLSNGSLGDWIHG------------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.++||||++ |+|.++++. ...++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 899999997 588777642 1134679999999999842 7999999999999999999999999999
Q ss_pred cccccccCCCCCccccceecccccccccccc----CCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYG----LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
+..... .......||+.|+|||++ .+..++.++||||+|++++++.+...++......... +......
T Consensus 158 ~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~ 229 (290)
T 3fme_A 158 GYLVDD-------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEE 229 (290)
T ss_dssp -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHS
T ss_pred cccccc-------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhcc
Confidence 865322 112234699999999996 5667899999999998777765554444322211111 1111111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
...... ... .+..+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~--~~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLP--ADK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCC--TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcc--ccc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 001 1122233777999999999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-32 Score=323.83 Aligned_cols=419 Identities=15% Similarity=0.098 Sum_probs=216.3
Q ss_pred CCcCCCCCCCCcEEeCCCCCC---CCCcccccc------------cccccceecccccccCCCCChhhhcc-C-CCCcEE
Q 002376 111 LPREIGNLFRLRVLNISFNNL---QGELPVNIS------------KLTELKMLDLMANKITGRVTDDQLRN-L-RSLQVL 173 (929)
Q Consensus 111 ~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~~~------------~l~~L~~L~Ls~N~l~~~i~~~~~~~-l-~~L~~L 173 (929)
.+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+. .+.. + .+|++|
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~-~l~~~~~~~L~~L 143 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLD-RLAKARADDLETL 143 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH-HHHHHHGGGCCEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHH-HHHHhccccCcEE
Confidence 344456778899999877532 133443333 566677777777666532222 2333 2 236666
Q ss_pred EccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCc----cCCccccCCCCceEEeeecCCCCcCCcccccCCC
Q 002376 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT----VPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249 (929)
Q Consensus 174 ~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~ 249 (929)
+|++|.- ..+.. ++....++++|++|+|++|.+++. ++..+.++++|++|+|++|.+++.-+
T Consensus 144 ~L~~~~~--~~~~~----l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~-------- 209 (592)
T 3ogk_B 144 KLDKCSG--FTTDG----LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP-------- 209 (592)
T ss_dssp EEESCEE--EEHHH----HHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCH--------
T ss_pred ECcCCCC--cCHHH----HHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCH--------
Confidence 6666541 00000 111123456666666666665544 22233455666666666666542111
Q ss_pred CcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCC
Q 002376 250 NLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTH 329 (929)
Q Consensus 250 ~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~ 329 (929)
+.++..+.++++|+.|++++|.+.+ +|..+.++++|+.|+++.+...... ......+..+++
T Consensus 210 -------------~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~----~~~~~~l~~~~~ 271 (592)
T 3ogk_B 210 -------------KDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM----PEKYMNLVFPRK 271 (592)
T ss_dssp -------------HHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC----TTSSSCCCCCTT
T ss_pred -------------HHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch----HHHHHHhhcccc
Confidence 1122223344445555555544443 3344444455555554431111000 011133445566
Q ss_pred CCEEEccCCccccccCchhhhccccccEEEecCCccccccC-CCCCCCCcccEEEeeCCCCC-cccCccccCCCCCCEEE
Q 002376 330 LNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIP-ASIGRLRSLTLLDLSYNSIS-GEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 330 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 407 (929)
|+.|+++++.. +.+|..+..++ +|++|+|++|.+++... ..+..+++|++|+|+ |.+. +.++..+..+++|++|+
T Consensus 272 L~~L~l~~~~~-~~l~~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 272 LCRLGLSYMGP-NEMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp CCEEEETTCCT-TTGGGGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEE
T ss_pred ccccCccccch-hHHHHHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEE
Confidence 66666665432 24555554444 56666666666554332 234566667777776 3332 22333335566677777
Q ss_pred ec-----------CCcCCCC-CcccccCCCCCceecccCcccccccCccccc-ccccceeccc----CCcCCCCCCCCcc
Q 002376 408 LA-----------GNEIPGG-IPNSLANLKKLNQIDLSGNELTGEIPISFGN-FQSLLSIDLS----NNRINGNIPKGIL 470 (929)
Q Consensus 408 L~-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~g~i~~~~~ 470 (929)
++ .|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. |..
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~-p~~-- 425 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL-PLD-- 425 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC-CCH--
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc-hHH--
Confidence 76 2455432 2222344666777777666666655555544 6667777774 5555532 000
Q ss_pred cCCchhhhcccCccEEEecCC--CCCCCCCcchhc-CcCcceeecccccccc-cCCccccCCCCCCEEECCCCcCCCc-C
Q 002376 471 RPLPEEISRLENVVTIDLSDN--SLSGNLPNSLKN-CKSLEELLMAYNQFSG-PIPNIVAELKGLEVLDLSSNKLSGS-I 545 (929)
Q Consensus 471 ~~~p~~~~~l~~L~~LdLs~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 545 (929)
..++..+..+++|+.|+|+++ .+++..+..++. +++|++|+|++|++++ .++..+..+++|++|+|++|.+++. +
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 001333555667777777643 255444444433 6667777777777665 3444556667777777777776543 2
Q ss_pred CcccccCCCCCeEeCCCCcCccc
Q 002376 546 PSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 546 p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
+..+..+++|++|+|++|+++..
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHhcCccCeeECcCCcCCHH
Confidence 33345567777777777776543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=280.69 Aligned_cols=226 Identities=25% Similarity=0.299 Sum_probs=187.6
Q ss_pred CCEEEccCCcc-ccccCchhh-------hccccccEEEecCCccccccCCCC--CCCCcccEEEeeCCCCCcccCccccC
Q 002376 330 LNYLALDGNQF-EGKIPESIG-------NFSNELSKLYLGGNHIYGKIPASI--GRLRSLTLLDLSYNSISGEIPIEIGQ 399 (929)
Q Consensus 330 L~~L~Ls~N~l-~~~~p~~~~-------~~~~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~ 399 (929)
|+.|+|++|++ .+.+|..+. .+. +|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGIS-GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS-CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcC-CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 66666777776 345666554 455 79999999999998888876 8999999999999999987 888888
Q ss_pred C-----CCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccc--cCccc--ccccccceecccCCcCCCCCCCCcc
Q 002376 400 L-----QGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE--IPISF--GNFQSLLSIDLSNNRINGNIPKGIL 470 (929)
Q Consensus 400 l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~g~i~~~~~ 470 (929)
+ ++|++|+|++|++++..|..|.++++|++|+|++|++.+. .|..+ .++++|++|+|++|+|++. +
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~---- 217 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP-S---- 217 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCH-H----
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcch-H----
Confidence 7 8999999999999998889999999999999999998765 23333 8899999999999999731 0
Q ss_pred cCCc-hhhhcccCccEEEecCCCCCCCCC-cchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcc
Q 002376 471 RPLP-EEISRLENVVTIDLSDNSLSGNLP-NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD 548 (929)
Q Consensus 471 ~~~p-~~~~~l~~L~~LdLs~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 548 (929)
.++ ..+..+++|++|||++|++++.+| ..+..+++|++|+|++|+|+ .+|..+. ++|++|||++|+|++. |.
T Consensus 218 -~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~- 291 (312)
T 1wwl_A 218 -GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS- 291 (312)
T ss_dssp -HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-
T ss_pred -HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-
Confidence 112 234577899999999999998775 56677899999999999999 6777666 8999999999999976 66
Q ss_pred cccCCCCCeEeCCCCcCccc
Q 002376 549 LQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~ 568 (929)
+..+++|++|++++|++++.
T Consensus 292 ~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 292 PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp TTTSCEEEEEECTTCTTTCC
T ss_pred HhhCCCCCEEeccCCCCCCC
Confidence 89999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=286.30 Aligned_cols=227 Identities=17% Similarity=0.255 Sum_probs=166.6
Q ss_pred hCCCCCceeecccCceeEEeccccCc-------------------------------HHHHHHHHHHHHccCCcccccee
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTGS-------------------------------WKSFIAECETLRNVRHRNLVKLI 708 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------------------~~~~~~E~~~l~~l~Hpniv~l~ 708 (929)
.++|...+.||+|+||.||+|+..+. .+.|.+|++++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46899999999999999999876410 07899999999999999999999
Q ss_pred eecccCCCCCcceEEEEEEecCCCCcccc------cccc--c--------cccccHHHHHHHhhh-CCCCCEEecCCCCC
Q 002376 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDW------IHGE--R--------KNELDITSALDYLHN-DCEVPVVHSDLKPG 771 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~--~--------~~~~~ia~aL~yLH~-~~~~~iiHrDlk~~ 771 (929)
+++... ...++||||+++|+|.++ +... . .++.|++.||+|||+ . +|+||||||+
T Consensus 110 ~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 110 GIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp EEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred EEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 998653 358999999999999998 5431 1 236789999999998 7 9999999999
Q ss_pred CeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCC-CCCC-CCCCCCCcCCCCCcchhHHhhh
Q 002376 772 NILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPST-AGDVPTSESFAGEFNIVKWVES 849 (929)
Q Consensus 772 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~s~g~~~~~~~~~~~~~~ 849 (929)
||+++.++.+||+|||.++..... ......||+.|+|||++.+. .++. ++||||+|++++++.....++.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999865321 22345789999999999887 5666 9999999987777655443332
Q ss_pred cCCchhhhccChHHHHhhccc-chhh---------------hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 850 NLPENVLQVLDPELRQLMTSN-ESQT---------------IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~-~~~~---------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ..+....... .... ......+...+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 254 LKISL------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCS------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcH------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22110 1111100000 0000 0000111222334777999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=290.92 Aligned_cols=234 Identities=17% Similarity=0.152 Sum_probs=143.5
Q ss_pred hCCCCCc-eeecccCceeEEeccccCc-----------HHHHHHHH-HHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHE-NLIGSGSFGSVLHNERTGS-----------WKSFIAEC-ETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~-~~iG~G~~g~Vy~~~~~~~-----------~~~~~~E~-~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|... ++||+|+||.||+|++... .....+|+ ..++.++||||+++++++.... .+....++||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~ 105 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIM 105 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEE
Confidence 4678874 4699999999999976521 12333444 3466779999999999986532 2345589999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEeccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLL 793 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~ 793 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999986432 2367899999999998 9999999999999976 4569999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~ 872 (929)
.. ......||+.|+|||++.+..++.++||||+|++++++.....++..... .........+... ...
T Consensus 183 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~ 251 (336)
T 3fhr_A 183 QN--------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG---QYG 251 (336)
T ss_dssp -----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C
T ss_pred cc--------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc---ccc
Confidence 21 12335789999999999888899999999999877765544433322211 1100001111100 000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........+...+.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111222334777999999999999999986
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=269.69 Aligned_cols=251 Identities=22% Similarity=0.239 Sum_probs=178.5
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
..++.+++.++ .+|..+ +.+|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 46667777776 455543 23677777777777777667777777777788877777776677777777778888877
Q ss_pred Cc-CCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEec
Q 002376 411 NE-IPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489 (929)
Q Consensus 411 N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs 489 (929)
|. ++...|..|..+++|++|++++|++++..|..|.++++|++|++++|++++.. +..+..+++|++|+|+
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~~~~l~~L~~L~l~ 161 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP--------DDTFRDLGNLTHLFLH 161 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC--------TTTTTTCTTCCEEECC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC--------HhHhccCCCccEEECC
Confidence 76 66666777777777888888888777766777777777888888887776422 3346667778888888
Q ss_pred CCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccC
Q 002376 490 DNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVV 569 (929)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 569 (929)
+|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..
T Consensus 162 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence 88777666666777888888888888888777777888888888888888887766666777888888888888877654
Q ss_pred CCCCCCCCCCcccccCCCCCcCCC
Q 002376 570 PSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 570 p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
+.......++.+....|...|..|
T Consensus 242 ~~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 242 RARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp GGHHHHHHHHHCCSEECCCBEEES
T ss_pred CcHHHHHHHHhcccccCccccCCc
Confidence 432222233344445555555433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=293.89 Aligned_cols=231 Identities=21% Similarity=0.228 Sum_probs=154.7
Q ss_pred CCCCceeecccCceeEEec-ccc-----------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEEEe
Q 002376 662 NFSHENLIGSGSFGSVLHN-ERT-----------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~-~~~-----------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
.|...+.||+|+||+||.+ ... ...+.+.+|+++++++ +|||||++++++.+ ....|+||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEEEEec
Confidence 3445688999999999643 222 1245678999999986 89999999999853 3458999999
Q ss_pred cCCCCccccccccc---------------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC-------------Cc
Q 002376 729 LSNGSLGDWIHGER---------------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE-------------MT 780 (929)
Q Consensus 729 ~~~gsL~~~l~~~~---------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~ 780 (929)
|+ |+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 69999886321 2467999999999998 99999999999999754 48
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCC-------CCCCCCCCCCCCcCCCCCcch-hHHhhhcCC
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-------ERPSTAGDVPTSESFAGEFNI-VKWVESNLP 852 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~ 852 (929)
+||+|||+++.+...... ........+||++|||||++.+ ..++.++||||+|++++++.. ...++....
T Consensus 167 ~kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999876432111 0111234579999999999976 678999999999987777544 333322111
Q ss_pred chhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 853 ENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 853 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... ..+............. ...+...+.+++.+||+.||++|||+.||++
T Consensus 245 ~~~~----~i~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRES----NIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHH----HHHHTCCCCCCCTTCC-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHH----HHhcCCCCcccccccc-cccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1100 0011110000000000 1122333344888999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-31 Score=299.10 Aligned_cols=230 Identities=20% Similarity=0.255 Sum_probs=155.5
Q ss_pred hCCCCCceeecccCceeE-EeccccC-----------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHENLIGSGSFGSV-LHNERTG-----------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~V-y~~~~~~-----------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
..+|+..++||+|+||+| |++...+ ..+.+.+|+++++++ +|||||++++++.+ ....|+||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEEEEE
Confidence 346888899999999985 4443331 123467899999999 79999999999854 34589999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-----CCceEEecccccccc
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-----EMTAKVGDFGLARFL 792 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~ki~DfGla~~~ 792 (929)
|||+ |+|.+++.... .++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+|+..
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9996 69999886432 3467899999999998 9999999999999943 346889999999876
Q ss_pred ccccCCCCCccccceeccccccccccccC---CCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhc
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL---GERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
..... ........+||++|||||++. ...++.++||||+|++++++.. ...++..... ........
T Consensus 174 ~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~~ 243 (432)
T 3p23_A 174 AVGRH---SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILLG 243 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHTT
T ss_pred cCCCc---ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHhc
Confidence 43211 111234467999999999998 4567889999999987777544 3333321111 11111000
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
................+++++.+||+.||++|||++||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000000011112233444888999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=291.38 Aligned_cols=236 Identities=22% Similarity=0.247 Sum_probs=164.1
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCC-Ccc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSK-NME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~-~~~ 720 (929)
.++|...+.||+|+||.||+|.+.. ..+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3578889999999999999997541 135688999999999999999999998654321 112
Q ss_pred eEEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
..++||||++ |+|.+++... ..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 3599999997 6898887532 23467999999999998 999999999999999999999999999986421
Q ss_pred ccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhh--------------
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQ-------------- 857 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~-------------- 857 (929)
......||+.|+|||++.+ ..++.++||||+|++++++.....++..... ....
T Consensus 179 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 179 ---------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp --------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ---------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1233578999999999887 6789999999999887776554443322111 0000
Q ss_pred -ccChHHHHhhc---ccchhh-hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 -VLDPELRQLMT---SNESQT-IQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 -~~~~~l~~~~~---~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
+.+........ ...... ..........+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111110000 000000 0000111223334777999999999999999975
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-28 Score=280.71 Aligned_cols=231 Identities=23% Similarity=0.230 Sum_probs=203.2
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 407 (929)
+++++|+|++|++++..|..+..+. +|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 5678888888888877778888776 799999999999888888999999999999999999877777788899999999
Q ss_pred ecCCcCCCCCcccccCCCCCceecccC-cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEE
Q 002376 408 LAGNEIPGGIPNSLANLKKLNQIDLSG-NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486 (929)
Q Consensus 408 L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~L 486 (929)
|++|+|++..+..|.++++|++|+|++ |.+....+..|.++++|+.|+|++|++++ + | .+..+++|+.|
T Consensus 154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~--------~-~~~~l~~L~~L 223 (452)
T 3zyi_A 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M--------P-NLTPLVGLEEL 223 (452)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C--------C-CCTTCTTCCEE
T ss_pred CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c--------c-cccccccccEE
Confidence 999999877777899999999999998 55665555678999999999999999874 2 2 36678899999
Q ss_pred EecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCc
Q 002376 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 487 dLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
||++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..+..+++|+.|+|++|++.
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 99999999999999999999999999999999999999999999999999999999888888999999999999999998
Q ss_pred ccC
Q 002376 567 GVV 569 (929)
Q Consensus 567 ~~~ 569 (929)
+..
T Consensus 304 CdC 306 (452)
T 3zyi_A 304 CDC 306 (452)
T ss_dssp CST
T ss_pred CCC
Confidence 753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=288.56 Aligned_cols=170 Identities=25% Similarity=0.359 Sum_probs=138.9
Q ss_pred hCCCCCceeecccCceeEEecccc---C-------------cHHHHHHHHHHHHccCCcc------ccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT---G-------------SWKSFIAECETLRNVRHRN------LVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~---~-------------~~~~~~~E~~~l~~l~Hpn------iv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||.||+|.+. + ..+.+.+|+++++.++|++ ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~---- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH---- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc----
Confidence 358899999999999999998652 1 1356889999999987765 9999999854
Q ss_pred CcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC----------
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---------- 777 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---------- 777 (929)
....++||||+ +++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.
T Consensus 89 -~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 -HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred -CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 33589999999 889999886432 2367899999999998 9999999999999987
Q ss_pred ---------CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 778 ---------EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 778 ---------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+|++++++.....+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE---------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS---------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccCCCceEeeCcccccCcc---------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 67899999999986421 12234789999999999999999999999999887776554433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-31 Score=295.25 Aligned_cols=176 Identities=22% Similarity=0.318 Sum_probs=141.6
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccC-----------Cccccceeeeccc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVR-----------HRNLVKLITSCSS 713 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~~ 713 (929)
.++|...+.||+|+||.||+|++.. ..+.+.+|+.++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 3579999999999999999998541 2456889999999886 8999999999865
Q ss_pred CCCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec------C
Q 002376 714 LDSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD------E 777 (929)
Q Consensus 714 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~------~ 777 (929)
.+ ......++||||+ +++|.+++.... .++.||+.||+|||+.+ +|+||||||+|||++ .
T Consensus 98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KG-PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EE-TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cC-CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 43 2234689999999 899999886422 23678999999999853 799999999999994 4
Q ss_pred CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 778 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp EEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 458999999999865321 22347899999999999999999999999998887766554443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-31 Score=297.90 Aligned_cols=179 Identities=28% Similarity=0.309 Sum_probs=141.6
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccC-Cc-----cccceeeecc
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVR-HR-----NLVKLITSCS 712 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~-Hp-----niv~l~~~~~ 712 (929)
++-....++|+..+.||+|+||+||+|+... ..+++.+|+++++.++ |+ +|+++++++.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3344557899999999999999999997541 1356778888888885 44 4999999885
Q ss_pred cCCCCCcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec--CCCc
Q 002376 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD--EEMT 780 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~ 780 (929)
.. ...++||||++ |+|.+++.... .++.|++.||+|||++ ..+|+||||||+|||++ .++.
T Consensus 127 ~~-----~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 127 FR-----NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp ET-----TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred cC-----CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 43 35899999996 59999886432 3467899999999953 23899999999999994 5788
Q ss_pred eEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 781 AKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 781 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+||+|||+|+..... .....||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 200 ~kL~DFG~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 258 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258 (382)
T ss_dssp EEECCCTTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEEeccCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999865321 22357899999999999999999999999998888776655444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=277.80 Aligned_cols=230 Identities=24% Similarity=0.242 Sum_probs=190.6
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 407 (929)
+++++|+|++|++++..+..+..+. +|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCS-SCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCC-CCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 4566777777777766666666665 688888888888777777788888888888888888866666788888888888
Q ss_pred ecCCcCCCCCcccccCCCCCceecccC-cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEE
Q 002376 408 LAGNEIPGGIPNSLANLKKLNQIDLSG-NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486 (929)
Q Consensus 408 L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~L 486 (929)
|++|+|++..+..|.++++|++|+|++ |.++...+..|.++++|+.|+|++|+++ .+ | .+..+++|+.|
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~--------~-~~~~l~~L~~L 212 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI--------P-NLTPLIKLDEL 212 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC--------C-CCTTCSSCCEE
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc--------c-ccCCCcccCEE
Confidence 888888877777888888888888888 4455455557888889999999999887 33 3 36678899999
Q ss_pred EecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCc
Q 002376 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 487 dLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
||++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|||++|+|++..+..|..+++|+.|+|++|++.
T Consensus 213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 99999999888999999999999999999999999999999999999999999999888888899999999999999998
Q ss_pred cc
Q 002376 567 GV 568 (929)
Q Consensus 567 ~~ 568 (929)
+.
T Consensus 293 Cd 294 (440)
T 3zyj_A 293 CN 294 (440)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=274.75 Aligned_cols=227 Identities=23% Similarity=0.287 Sum_probs=164.1
Q ss_pred hCCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|+.. ...+.+.+|++++++++||||+++++++... ..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----Ce
Confidence 457899999999999999998754 1356789999999999999999999998543 34
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC---CceEEecccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE---MTAKVGDFGLAR 790 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DfGla~ 790 (929)
.++||||+++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 899999999999988875322 3467899999999998 99999999999999754 479999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
..... .......||+.|+|||++.+ .++.++||||+|++++++.....++..... .++.. .+.. ..
T Consensus 173 ~~~~~-------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~-~~~~---~~ 238 (287)
T 2wei_A 173 CFQQN-------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILK-RVET---GK 238 (287)
T ss_dssp TBCCC-------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH-HHHH---CC
T ss_pred eecCC-------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHH-HHHc---CC
Confidence 65321 11223468999999999876 489999999999776665443333221111 11111 1111 00
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..........++..+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000011111222333777999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-31 Score=287.60 Aligned_cols=237 Identities=22% Similarity=0.312 Sum_probs=162.5
Q ss_pred CChHHHHHhhCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccC--Cccccceeeec
Q 002376 651 ISYDELRRATGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVR--HRNLVKLITSC 711 (929)
Q Consensus 651 ~~~~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~--Hpniv~l~~~~ 711 (929)
+.++.+....++|+..+.||+|+||.||++.... ..+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444444556789999999999999999986541 2357889999999997 59999999998
Q ss_pred ccCCCCCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEE
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKV 783 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 783 (929)
... ...++||| +.+|+|.+++.... .++.|++.||+|||+. +|+||||||+||++++ +.+||
T Consensus 98 ~~~-----~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 98 ITD-----QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp ECS-----SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred ecC-----CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence 543 35899999 55889999986433 2367899999999998 9999999999999975 89999
Q ss_pred eccccccccccccCCCCCccccceeccccccccccccCC-----------CCCCCCCCCCCCcCCCCCcchhHHhhhcCC
Q 002376 784 GDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-----------ERPSTAGDVPTSESFAGEFNIVKWVESNLP 852 (929)
Q Consensus 784 ~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~ 852 (929)
+|||+++....... ........||+.|+|||++.+ ..++.++||||+|++++++.....++....
T Consensus 168 ~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 168 IDFGIANQMQPDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp CCCSSSCC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeccccccccCccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99999986632211 111234579999999999876 478999999999987777654444333221
Q ss_pred chhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 853 ENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 853 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.... .+......... ...+......+.+++.+||+.||++||+++|+++
T Consensus 244 ~~~~-----~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 244 NQIS-----KLHAIIDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SHHH-----HHHHHHCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH-----HHHHHHhcccc--cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1110 11111110000 0000011122233777999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-30 Score=301.38 Aligned_cols=238 Identities=21% Similarity=0.216 Sum_probs=163.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~ 721 (929)
.++|+..+.||+|+||.||+|.+.. ..+.+.+|++++++++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999987641 24568899999999999999999999755221 12345
Q ss_pred EEEEEEecCCCCccccccccc-----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCc---eEEeccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMT---AKVGDFG 787 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DfG 787 (929)
.++||||+++|+|.+++.... .++.+++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999986432 2367899999999998 9999999999999997664 9999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhc-------
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQV------- 858 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~------- 858 (929)
+++..... .......||+.|+|||++.+..++.++||||+|++++++..+..++..... .+...
T Consensus 170 ~a~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQG-------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSC-------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccc-------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 99865321 112345799999999999999999999999999887776555444322110 00000
Q ss_pred ---cChHHHHhh--cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 002376 859 ---LDPELRQLM--TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREAL 907 (929)
Q Consensus 859 ---~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~ 907 (929)
......+.. .............+...+.+++.+|++.||++|||++|++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000 0000000011122333444588899999999999998843
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-30 Score=286.53 Aligned_cols=171 Identities=22% Similarity=0.315 Sum_probs=137.2
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCcc------ccceeeecccCCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRN------LVKLITSCSSLDSK 717 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpn------iv~l~~~~~~~~~~ 717 (929)
.++|+..+.||+|+||+||+|.... ..+.+.+|+.++++++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~---- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----
Confidence 3689999999999999999986531 1356788999999998776 8888888744
Q ss_pred CcceEEEEEEecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeee------------
Q 002376 718 NMEFLALVYEFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILL------------ 775 (929)
Q Consensus 718 ~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl------------ 775 (929)
....++||||+ +|++.+++.... .++.|++.||+|||+. +|+||||||+|||+
T Consensus 94 -~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 -HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred -CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 33589999999 667777665322 3467999999999998 99999999999999
Q ss_pred -------cCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 776 -------DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 776 -------~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+|++++++.....++
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE---------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS---------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccCCCcEEEeecCccccccc---------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 5678999999999986421 122347999999999999999999999999998877765544333
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-30 Score=278.63 Aligned_cols=250 Identities=21% Similarity=0.247 Sum_probs=215.6
Q ss_pred cCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCcc-ccccCCCCC-------CCCcccEEEeeCCCCCcccCc
Q 002376 324 LTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHI-YGKIPASIG-------RLRSLTLLDLSYNSISGEIPI 395 (929)
Q Consensus 324 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~ 395 (929)
++..++|++|++++|.+ .+|..+.. .|+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 45567889999999999 78887765 389999999999 455666655 789999999999999999998
Q ss_pred cc--cCCCCCCEEEecCCcCCCCCcccccCC-----CCCceecccCcccccccCcccccccccceecccCCcCCCCCCCC
Q 002376 396 EI--GQLQGLQVLGLAGNEIPGGIPNSLANL-----KKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKG 468 (929)
Q Consensus 396 ~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~ 468 (929)
.+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.|.++
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-- 190 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-- 190 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH--
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH--
Confidence 87 8999999999999999987 8888877 999999999999999888999999999999999999876431
Q ss_pred cccCCchhh--hcccCccEEEecCCCCCCC--CC-cchhcCcCcceeecccccccccCC-ccccCCCCCCEEECCCCcCC
Q 002376 469 ILRPLPEEI--SRLENVVTIDLSDNSLSGN--LP-NSLKNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 469 ~~~~~p~~~--~~l~~L~~LdLs~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 542 (929)
+|..+ ..+++|++|+|++|++++. ++ ..+.++++|++|+|++|+|++.+| ..+..+++|++|+|++|+|+
T Consensus 191 ----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 191 ----LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp ----HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred ----HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 13444 7889999999999999842 22 345688999999999999999875 56777999999999999999
Q ss_pred CcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCC
Q 002376 543 GSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589 (929)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~ 589 (929)
.+|..+. ++|++|||++|++++. |....+++++.+++++|+..
T Consensus 267 -~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 267 -QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp -SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred -hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 7888776 8999999999999998 65667889999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-30 Score=309.27 Aligned_cols=227 Identities=22% Similarity=0.266 Sum_probs=164.4
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|++.. ..+.|.+|++++++++|||||++++++...+..+...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999986531 1346789999999999999999999997655433444
Q ss_pred EEEEEEecCCCCcccccccc------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGE------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
.|+||||+++++|.+++... ..++.||+.||+|||+. +||||||||+|||++++ .+||+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~- 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS- 233 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC-
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc-
Confidence 79999999999999987542 23467999999999998 99999999999999986 899999999986531
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
.....||++|||||++.++. +.++||||+|++++++.. +..+... ...+ .+ ... ....
T Consensus 234 ---------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~-----g~~~~~~-~~~~-~~----~~~-~~~~ 291 (681)
T 2pzi_A 234 ---------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL-----DLPTRNG-RYVD-GL----PED-DPVL 291 (681)
T ss_dssp ---------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHS-----CCCEETT-EECS-SC----CTT-CHHH
T ss_pred ---------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHh-----CCCCCcc-cccc-cc----ccc-cccc
Confidence 13357999999999987654 899999999987666432 2222110 0000 00 000 0000
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHhhHHHH
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRI-GIREALRRLKSSQEIL 917 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~ 917 (929)
. ....+.+++.+||+.||++|| +++++...+..+.+..
T Consensus 292 ~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 292 K----TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp H----HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred c----cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 112223377799999999999 5677777787776543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-30 Score=286.82 Aligned_cols=229 Identities=20% Similarity=0.226 Sum_probs=141.1
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHH-HHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECE-TLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|.... ..+++.+|+. +++.++||||+++++++... ..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence 4678889999999999999987651 1234556666 67778999999999998653 34
Q ss_pred EEEEEEecCCCCccccccc-------------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 722 LALVYEFLSNGSLGDWIHG-------------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~-------------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
.++||||+++ +|.+++.. ...++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 8999999974 77766641 113367899999999985 2799999999999999999999999999
Q ss_pred ccccccccCCCCCccccceecccccccccccc----CCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHH
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYG----LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 864 (929)
++..... .......||+.|+|||++ .+..++.++||||+|++++++.....++...... .+.+.....
T Consensus 173 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~ 244 (327)
T 3aln_A 173 SGQLVDS-------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQLTQVVK 244 (327)
T ss_dssp SCC-------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCC
T ss_pred ceecccc-------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-HHHHHHHhc
Confidence 9865321 112234799999999998 4667899999999998777765544433222110 011111000
Q ss_pred Hhhcccc-hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 865 QLMTSNE-SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 865 ~~~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
....... ......++ .+.+++.+||+.||++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSP----SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCH----HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000 00001112 2233777999999999999999964
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=261.53 Aligned_cols=235 Identities=21% Similarity=0.238 Sum_probs=191.6
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCC-CCcccCccccCCCCCCEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS-ISGEIPIEIGQLQGLQVL 406 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 406 (929)
++|++|+|++|++++..+..+..+. +|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|++|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCC-CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 5777888888888766666677766 78888888888888888888888888999998887 776668888888889999
Q ss_pred EecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEE
Q 002376 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486 (929)
Q Consensus 407 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~L 486 (929)
++++|++++..|..|.++++|++|++++|++++..+..|.++++|++|+|++|++++ ++ +..+..+++|+.|
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~-------~~~~~~l~~L~~L 182 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VP-------ERAFRGLHSLDRL 182 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-EC-------TTTTTTCTTCCEE
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cC-------HHHhcCccccCEE
Confidence 999998888888888888899999999999887777778888899999999998874 22 3356778889999
Q ss_pred EecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCc
Q 002376 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 487 dLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
+|++|++++..|..|.++++|+.|++++|++++.++..+..+++|+.|+|++|.+....+.. .-...++.+..+.|.+.
T Consensus 183 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~ 261 (285)
T 1ozn_A 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCB
T ss_pred ECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccc
Confidence 99999999888899999999999999999999887788999999999999999998654321 11233555667788888
Q ss_pred ccCCCC
Q 002376 567 GVVPSE 572 (929)
Q Consensus 567 ~~~p~~ 572 (929)
+..|..
T Consensus 262 c~~p~~ 267 (285)
T 1ozn_A 262 CSLPQR 267 (285)
T ss_dssp EEESGG
T ss_pred cCCchH
Confidence 888864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-30 Score=285.38 Aligned_cols=220 Identities=22% Similarity=0.240 Sum_probs=162.9
Q ss_pred HHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccC--Cccccceeeecc
Q 002376 657 RRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVR--HRNLVKLITSCS 712 (929)
Q Consensus 657 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~--Hpniv~l~~~~~ 712 (929)
....++|+..+.||+|+||.||+|+... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3445689999999999999999987541 1134668999999996 599999999995
Q ss_pred cCCCCCcceEEEEEEecCC-CCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceE
Q 002376 713 SLDSKNMEFLALVYEFLSN-GSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAK 782 (929)
Q Consensus 713 ~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 782 (929)
.. ...++||||+.+ ++|.+++.... .++.|++.||+|||+. +|+||||||+||+++ +++.+|
T Consensus 119 ~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 119 RP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp CS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred cC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 43 348999999976 89999886432 3467999999999998 999999999999999 789999
Q ss_pred EeccccccccccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccCh
Q 002376 783 VGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDP 861 (929)
Q Consensus 783 i~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (929)
|+|||+++..... ......||+.|+|||++.+..+ +.++||||+|++++++.. +..|..... .
T Consensus 191 L~Dfg~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-----g~~pf~~~~---~ 254 (320)
T 3a99_A 191 LIDFGSGALLKDT--------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDE---E 254 (320)
T ss_dssp ECCCTTCEECCSS--------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-----SSCSCCSHH---H
T ss_pred EeeCccccccccc--------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-----CCCCCCChh---h
Confidence 9999999865321 1223479999999999887765 788999999977666543 433331100 0
Q ss_pred HHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 862 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... .......++ .+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~----~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIRGQ----VFFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHCC----CCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccc----ccccccCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 01110 000111112 2233777999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-30 Score=281.38 Aligned_cols=222 Identities=23% Similarity=0.281 Sum_probs=157.6
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHcc----CCcccccee
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNV----RHRNLVKLI 708 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l----~Hpniv~l~ 708 (929)
+.....++|+..+.||+|+||.||+|+... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344456789999999999999999997641 112355799999998 899999999
Q ss_pred eecccCCCCCcceEEEEEEe-cCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CC
Q 002376 709 TSCSSLDSKNMEFLALVYEF-LSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EE 778 (929)
Q Consensus 709 ~~~~~~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~ 778 (929)
+++... ...++|||| +++++|.+++.... .++.|++.||+|||+. +|+||||||+||+++ ++
T Consensus 105 ~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred EEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 998543 347999999 78999999986432 3467899999999998 999999999999999 88
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhh
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQ 857 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~ 857 (929)
+.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||+|++++++.. +..+....+
T Consensus 177 ~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-----g~~pf~~~~ 243 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE--------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-----GDIPFERDQ 243 (312)
T ss_dssp TEEEECCCSSCEECCSS--------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-----SSCSCCSHH
T ss_pred CeEEEEEcchhhhcccC--------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-----CCCCCCChH
Confidence 99999999999865321 1233568999999999887766 458999999977666544 333331100
Q ss_pred ccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 858 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..... ........ ...+.+++.+||+.||++|||++|+++
T Consensus 244 ----~~~~~---~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 ----EILEA---ELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----HHHHT---CCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----HHhhh---ccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11110 00000111 122233777999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=276.25 Aligned_cols=228 Identities=20% Similarity=0.215 Sum_probs=142.7
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------c-HHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------S-WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||.||+|+... . .+.+..+..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 4578889999999999999987641 1 12334455578888999999999998643 34
Q ss_pred EEEEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.++||||+ ++.+..+... ...++.+++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 89999999 4444443321 1134678999999999831 8999999999999999999999999999765
Q ss_pred ccccCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 867 (929)
... .......||+.|+|||++. +..++.++||||+|++++++.....++...... .+.+.......
T Consensus 176 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~- 246 (318)
T 2dyl_A 176 VDD-------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLTKVLQEE- 246 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHHSC-
T ss_pred cCC-------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHHHHHHhccC-
Confidence 321 1123347899999999984 556899999999998777765544443322111 11111111110
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..........+.. +.+++.+||+.||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~----l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLLPGHMGFSGD----FQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCSSSCCCHH----HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCccCCCCHH----HHHHHHHHccCChhHCcCHHHHhh
Confidence 0000000011122 223777999999999999999975
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=272.13 Aligned_cols=270 Identities=18% Similarity=0.154 Sum_probs=208.6
Q ss_pred CcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecc
Q 002376 71 NRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150 (929)
Q Consensus 71 ~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 150 (929)
.+....+++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..| |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 356667788888776555566678899999999999998888899999999999999999997665 899999999999
Q ss_pred cccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEE
Q 002376 151 MANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLR 230 (929)
Q Consensus 151 s~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 230 (929)
++|++++ +...++|++|++++|++++..+ ..+++|+.|+|++|++++..+..|..+++|++|+
T Consensus 88 s~n~l~~------l~~~~~L~~L~l~~n~l~~~~~-----------~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 150 (317)
T 3o53_A 88 NNNYVQE------LLVGPSIETLHAANNNISRVSC-----------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (317)
T ss_dssp CSSEEEE------EEECTTCCEEECCSSCCSEEEE-----------CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred cCCcccc------ccCCCCcCEEECCCCccCCcCc-----------cccCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence 9999983 3455899999999998865322 2357899999999999998888999999999999
Q ss_pred eeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecccccccc
Q 002376 231 LASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIV 310 (929)
Q Consensus 231 Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 310 (929)
|++|++++..+..+...+++|++|++++|++++..+ ...+++|+.|+|++|+|++. |..|..+++|+.|++++|+|.
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc
Confidence 999999876666666568888888888888876622 23478888888888888854 444777777777777777776
Q ss_pred CCCCCCCCccccccCCCCCCCEEEccCCccc-cccCchhhhccccccEEEec-CCccccccCC
Q 002376 311 SSGDDEGLSFITSLTNSTHLNYLALDGNQFE-GKIPESIGNFSNELSKLYLG-GNHIYGKIPA 371 (929)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~~~~~L~~L~Ls-~N~l~~~~p~ 371 (929)
.++ ..+..+++|++|+|++|.+. +.+|..+..++ .|+.|+++ .+.++|..|.
T Consensus 228 ~l~--------~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~-~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 228 LIE--------KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ-RVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp EEC--------TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH-HHHHHHHHHHHHHHSSSSC
T ss_pred chh--------hHhhcCCCCCEEEccCCCccCcCHHHHHhccc-cceEEECCCchhccCCchh
Confidence 543 24556677777777777776 55666666655 57777776 3345554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-29 Score=273.59 Aligned_cols=246 Identities=22% Similarity=0.220 Sum_probs=129.8
Q ss_pred CCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCC
Q 002376 248 LPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNS 327 (929)
Q Consensus 248 l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l 327 (929)
+++|++|++++|++++..|..|.++++|+.|+|++|.+++..+ |..+++|++|++++|++..++ ..
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~------------~~ 98 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------VG 98 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE------------EC
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc------------CC
Confidence 3344444444444444444555555666666666666654433 444444555444444443211 12
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 407 (929)
++ |++|++++|++++..+.. +++|++|+|++|++++..+..+..+++|++|+
T Consensus 99 ~~-------------------------L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 150 (317)
T 3o53_A 99 PS-------------------------IETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (317)
T ss_dssp TT-------------------------CCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred CC-------------------------cCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence 34 444444444444433332 34455555555555554455555555555555
Q ss_pred ecCCcCCCCCccccc-CCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEE
Q 002376 408 LAGNEIPGGIPNSLA-NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486 (929)
Q Consensus 408 L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~L 486 (929)
|++|++++..+..+. .+++|++|+|++|++++..+ ...+++|++|+|++|+|++ + |..+..+++|+.|
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-l--------~~~~~~l~~L~~L 219 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-M--------GPEFQSAAGVTWI 219 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-E--------CGGGGGGTTCSEE
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCc-c--------hhhhcccCcccEE
Confidence 555555554444442 45555666666665554321 1235566666666666553 1 3345555666666
Q ss_pred EecCCCCCCCCCcchhcCcCcceeeccccccc-ccCCccccCCCCCCEEECCC-CcCCCcCCc
Q 002376 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFS-GPIPNIVAELKGLEVLDLSS-NKLSGSIPS 547 (929)
Q Consensus 487 dLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~ 547 (929)
||++|+++ .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++ +.++|..|.
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 66666666 34555666666666666666666 55666666666666666663 345554443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=276.45 Aligned_cols=161 Identities=19% Similarity=0.195 Sum_probs=126.5
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccC-----------------
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVR----------------- 700 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~----------------- 700 (929)
.++|+..+.||+|+||+||+|++.+ ..+.+.+|+++++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3568889999999999999987642 1277899999999886
Q ss_pred ---------CccccceeeecccCCC--------CCcceEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhh
Q 002376 701 ---------HRNLVKLITSCSSLDS--------KNMEFLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLH 756 (929)
Q Consensus 701 ---------Hpniv~l~~~~~~~~~--------~~~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH 756 (929)
|||||++++++.+... ......|+||||+++|++.+.+.+. +.++.||+.||+|||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Confidence 5555555555543100 0144689999999999777666432 234679999999999
Q ss_pred -hCCCCCEEecCCCCCCeeecCCC--------------------ceEEeccccccccccccCCCCCccccceeccccccc
Q 002376 757 -NDCEVPVVHSDLKPGNILLDEEM--------------------TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815 (929)
Q Consensus 757 -~~~~~~iiHrDlk~~NILl~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~ 815 (929)
+. +|+||||||+|||++.++ .+||+|||+|+.... ...+||+.||
T Consensus 179 ~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt~~y~ 244 (336)
T 2vuw_A 179 ASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFCDVSM 244 (336)
T ss_dssp HHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECCCCTT
T ss_pred HhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEeeccc
Confidence 77 999999999999999887 899999999986531 1347999999
Q ss_pred cccccCCCCCCCCCCCCCCc
Q 002376 816 PPEYGLGERPSTAGDVPTSE 835 (929)
Q Consensus 816 aPE~~~~~~~~~~~DV~s~g 835 (929)
|||++.+.. +.++||||++
T Consensus 245 aPE~~~g~~-~~~~Diwsl~ 263 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLM 263 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhh
Confidence 999998776 8999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=271.36 Aligned_cols=213 Identities=11% Similarity=0.089 Sum_probs=153.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||.||+|++.. ..+.|.+|+..+++++||||+++++++... ..
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----Cc
Confidence 579999999999999999987651 126789999999999999999999998543 34
Q ss_pred EEEEEEecCCCCccccccccc------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
.|+||||+++++|.++++... .++.|++.||+|||+. +|+||||||+|||+++++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 899999999999999986432 3467899999999998 99999999999999999999987443
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccchhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~ 874 (929)
|++| ++.++||||+|+++|++.....++..... .....................
T Consensus 175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229 (286)
T ss_dssp ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence 4443 68899999999887776665554432221 000000011111000000001
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhh
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLK 919 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 919 (929)
.. +...+++++.+||+.||++| |++|+++.|+++......
T Consensus 230 ~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 230 RD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp TT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred cC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 11 22223347779999999999 999999999998776543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=248.03 Aligned_cols=217 Identities=25% Similarity=0.314 Sum_probs=155.8
Q ss_pred CCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCc
Q 002376 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135 (929)
Q Consensus 56 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 135 (929)
.++|.|.|+.|.... .++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++...
T Consensus 2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 478999999986532 4567899999988 5777665 68899999999998777778899999999999999998766
Q ss_pred ccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCc
Q 002376 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT 215 (929)
Q Consensus 136 p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~ 215 (929)
+..|.++++|++|+|++|+++ .++...|.++++|++|+|++|++++. .+..|..+++|++|+|++|+|++.
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL--------PPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCCCC
T ss_pred hhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCee--------CHHHhCcCcCCCEEECCCCcCCcc
Confidence 667788889999999999887 56666678888888888888876442 334566777888888888888777
Q ss_pred cCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCc
Q 002376 216 VPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE 286 (929)
Q Consensus 216 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 286 (929)
.+..|..+++|++|+|++|+++ .+|...+..+++|+.|++++|++++..+..|..+++|+.|+|++|.+.
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CHhHccCCcccceeEecCCcCc-EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 6667777777777777777776 344333333455555555555554444444444444444444444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=272.00 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=133.0
Q ss_pred cccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEec
Q 002376 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRM 280 (929)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~L 280 (929)
+++.|++++|.|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|++++|++++ +|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 5778888888887 5565554 67888888888776 4554 24455555555555543 222 3344445555
Q ss_pred cCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEe
Q 002376 281 THNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360 (929)
Q Consensus 281 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L 360 (929)
++|.|++ +|. .+++|++|+|++|++++ +|..+ ++|++|+|
T Consensus 109 s~N~l~~-l~~----------------------------------~l~~L~~L~L~~N~l~~-lp~~l----~~L~~L~L 148 (622)
T 3g06_A 109 FSNPLTH-LPA----------------------------------LPSGLCKLWIFGNQLTS-LPVLP----PGLQELSV 148 (622)
T ss_dssp CSCCCCC-CCC----------------------------------CCTTCCEEECCSSCCSC-CCCCC----TTCCEEEC
T ss_pred cCCcCCC-CCC----------------------------------CCCCcCEEECCCCCCCc-CCCCC----CCCCEEEC
Confidence 5544443 121 22344555555555542 33321 24555555
Q ss_pred cCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccc
Q 002376 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE 440 (929)
Q Consensus 361 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 440 (929)
++|+|++. |. .+++|+.|++++|.|++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++.
T Consensus 149 s~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~- 215 (622)
T 3g06_A 149 SDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS- 215 (622)
T ss_dssp CSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-
T ss_pred cCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-
Confidence 55555432 22 12345555555555553 33 234455555555555543 2221 2445555555555542
Q ss_pred cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccccccccc
Q 002376 441 IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP 520 (929)
Q Consensus 441 ~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (929)
+|.. +++|+.|+|++|+|++ + | ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .
T Consensus 216 l~~~---~~~L~~L~Ls~N~L~~-l--------p---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~ 275 (622)
T 3g06_A 216 LPAL---PSGLKELIVSGNRLTS-L--------P---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-R 275 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCSC-C--------C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-S
T ss_pred cCCC---CCCCCEEEccCCccCc-C--------C---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-c
Confidence 2321 2445555555555543 2 1 122345555555555552 333 3445555555555555 3
Q ss_pred CCccccCCCCCCEEECCCCcCCCcCCcccccC
Q 002376 521 IPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL 552 (929)
Q Consensus 521 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 552 (929)
+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 276 lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 276 LPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp CCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 44455555555555555555555555444433
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=280.57 Aligned_cols=237 Identities=19% Similarity=0.171 Sum_probs=142.0
Q ss_pred ccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhh
Q 002376 271 NLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGN 350 (929)
Q Consensus 271 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 350 (929)
.+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+.... .+..+++|++|+|++|.|++..+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---------~l~~l~~L~~L~Ls~N~l~~l~~~---- 98 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL---------DLESLSTLRTLDLNNNYVQELLVG---- 98 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEE---------ECTTCTTCCEEECCSSEEEEEEEC----
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCc---------ccccCCCCCEEEecCCcCCCCCCC----
Confidence 3447788888888887766666666666666666666554321 244555666666666665532211
Q ss_pred ccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCcee
Q 002376 351 FSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQI 430 (929)
Q Consensus 351 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 430 (929)
++|++|++++|.|++..+.. +++|++|+|++|.+++..|..+.++++|++|
T Consensus 99 --~~L~~L~L~~N~l~~~~~~~---------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 149 (487)
T 3oja_A 99 --PSIETLHAANNNISRVSCSR---------------------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149 (487)
T ss_dssp --TTCCEEECCSSCCCCEEECC---------------------------CSSCEEEECCSSCCCSGGGBCGGGGSSEEEE
T ss_pred --CCcCEEECcCCcCCCCCccc---------------------------cCCCCEEECCCCCCCCCCchhhcCCCCCCEE
Confidence 14555555555544433322 3445555555555555445555555555555
Q ss_pred cccCcccccccCcccc-cccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcce
Q 002376 431 DLSGNELTGEIPISFG-NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509 (929)
Q Consensus 431 ~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 509 (929)
+|++|.+++..|..|. .+++|+.|+|++|.|++.. ....+++|+.|||++|++++.+| .+..+++|+.
T Consensus 150 ~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~----------~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 218 (487)
T 3oja_A 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK----------GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTW 218 (487)
T ss_dssp ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE----------CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSE
T ss_pred ECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc----------ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccE
Confidence 5555555555555543 4555666666666555321 11235566777777777765433 4777777788
Q ss_pred eecccccccccCCccccCCCCCCEEECCCCcCC-CcCCcccccCCCCCeEeCC
Q 002376 510 LLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS-GSIPSDLQNLQALRSLNLT 561 (929)
Q Consensus 510 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 561 (929)
|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 219 L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp EECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred EEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 8888888775 5666777888888888888887 5667777777777777775
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-29 Score=285.29 Aligned_cols=222 Identities=16% Similarity=0.064 Sum_probs=149.9
Q ss_pred hhCCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCC-ccccceeee--------
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRH-RNLVKLITS-------- 710 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~H-pniv~l~~~-------- 710 (929)
.+..|+..++||+|+||+||+|++. ...+.|.+|+.+++.++| +|......+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445778899999999999999854 124678899999999987 332221111
Q ss_pred -------------cccCCCCCcceEEEEEEecCCCCccccccc---------------cccccccHHHHHHHhhhCCCCC
Q 002376 711 -------------CSSLDSKNMEFLALVYEFLSNGSLGDWIHG---------------ERKNELDITSALDYLHNDCEVP 762 (929)
Q Consensus 711 -------------~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~---------------~~~~~~~ia~aL~yLH~~~~~~ 762 (929)
+...........+++|+++ +|+|.++++. ...++.|++.||+|||+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1100000012357777766 6899988841 112357999999999998 9
Q ss_pred EEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceecccccccccccc----------CCCCCCCCCCCC
Q 002376 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG----------LGERPSTAGDVP 832 (929)
Q Consensus 763 iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~ 832 (929)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|||||++ .+..++.++|||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999864321 233477 999999999 666689999999
Q ss_pred CCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 833 TSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 833 s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
|+|+++|++.....++.... ..+.....+. .. ...++. +++++.+||+.||++||++.|+++
T Consensus 302 SlGvil~elltg~~Pf~~~~--~~~~~~~~~~----~~----~~~~~~----~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDA--ALGGSEWIFR----SC----KNIPQP----VRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTG--GGSCSGGGGS----SC----CCCCHH----HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcc--hhhhHHHHHh----hc----ccCCHH----HHHHHHHHccCChhhCcCHHHHHh
Confidence 99987777654443332111 1111111111 00 011122 333777999999999999888853
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-30 Score=311.38 Aligned_cols=459 Identities=13% Similarity=0.083 Sum_probs=227.2
Q ss_pred CCCCCcceeeCCCCCcEEEEEcCCCCCccccC-CCCCCCCCCCEEEeecCCCC---CCCCcC------------CCCCCC
Q 002376 57 SPCTWPGVICNNFGNRVIGLNLSSFGLEGTIS-PHIGNLSFLRSIQLQNNKLS---GNLPRE------------IGNLFR 120 (929)
Q Consensus 57 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~-~~l~~L~~L~~L~Ls~N~l~---~~~p~~------------~~~l~~ 120 (929)
-|++|.++... ....+++++.. +..| ..+..+++|++|+|+++... +..|.. +..+++
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 106 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCC
Confidence 45579888321 22345555432 2222 23567789999999997632 122322 235678
Q ss_pred CcEEeCCCCCCCCCcccccc-cccccceeccccc-ccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCC
Q 002376 121 LRVLNISFNNLQGELPVNIS-KLTELKMLDLMAN-KITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSR 198 (929)
Q Consensus 121 L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~ 198 (929)
|++|+|++|.+++..+..+. .+++|++|+|++| .++.......+.++++|++|+|++|.+++..+..+.. ....
T Consensus 107 L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~----~~~~ 182 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH----FPDT 182 (594)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG----SCTT
T ss_pred CCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH----Hhhc
Confidence 88888888888877666665 6788888888888 4542212233457888888888888876654443332 2345
Q ss_pred CCcccEEEeeccc--CCCc-cCCccccCCCCceEEeeec-CCCCcCCcccccCCCCcceeeccCCcCCCCCCCccccccc
Q 002376 199 LENLKVLDLTINR--LAGT-VPSTIYNMTSLVHLRLASN-QLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274 (929)
Q Consensus 199 l~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~ 274 (929)
+++|+.|+|++|. ++.. ++..+.++++|++|+|++| .+. .+|..+. .+++|++|.++.+..
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~-~~~~L~~L~l~~~~~------------- 247 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQ-RAPQLEELGTGGYTA------------- 247 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHH-HCTTCSEEECSBCCC-------------
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHh-cCCcceEcccccccC-------------
Confidence 6778888888776 2211 1112234577777777776 222 2333222 255555555433211
Q ss_pred ccEEeccCccCcCCccCCCCCCCcccee-ccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCch-hhhcc
Q 002376 275 IQIIRMTHNLLEGTLPPGLGNLPFLRTY-NIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPES-IGNFS 352 (929)
Q Consensus 275 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~ 352 (929)
+++.|.+.+ ++..+.++++|+.+ .+....... +...+..+++|++|+|++|.+++..... +..++
T Consensus 248 ----~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~~--------l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~ 314 (594)
T 2p1m_B 248 ----EVRPDVYSG-LSVALSGCKELRCLSGFWDAVPAY--------LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP 314 (594)
T ss_dssp ----CCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGGG--------GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCT
T ss_pred ----ccchhhHHH-HHHHHhcCCCcccccCCcccchhh--------HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCC
Confidence 011222222 11233344444443 111111000 0011123445555555555544322222 12222
Q ss_pred ccccEEEecCCccccc-cCCCCCCCCcccEEEee---------CCCCCcccCcccc-CCCCCCEEEecCCcCCCCCcccc
Q 002376 353 NELSKLYLGGNHIYGK-IPASIGRLRSLTLLDLS---------YNSISGEIPIEIG-QLQGLQVLGLAGNEIPGGIPNSL 421 (929)
Q Consensus 353 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~ 421 (929)
+|++|++++| +... ++.....+++|++|+|+ .|.+++.....+. .+++|+.|+++.|.+++..+..+
T Consensus 315 -~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 315 -KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp -TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred -CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 4555555554 2211 11111234555555552 2334332222222 25556666555555554433333
Q ss_pred c-CCCCCceeccc--C----ccccc-----ccCcccccccccceecccCCcCCCCCCCCcccCCchhhhc-ccCccEEEe
Q 002376 422 A-NLKKLNQIDLS--G----NELTG-----EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISR-LENVVTIDL 488 (929)
Q Consensus 422 ~-~l~~L~~L~Ls--~----N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~-l~~L~~LdL 488 (929)
. .+++|+.|+|+ + |.+++ .++..+.++++|+.|+|++ .+++.. +..+.. +++|+.|+|
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~--------~~~l~~~~~~L~~L~L 463 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV--------FEYIGTYAKKMEMLSV 463 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH--------HHHHHHHCTTCCEEEE
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH--------HHHHHHhchhccEeec
Confidence 3 35556666665 2 33431 1112244555666666654 343211 223333 556666666
Q ss_pred cCCCCCCCCCcch-hcCcCcceeecccccccccCCc-cccCCCCCCEEECCCCcCCCcCCccc-ccCCCCCeEeCCCCc
Q 002376 489 SDNSLSGNLPNSL-KNCKSLEELLMAYNQFSGPIPN-IVAELKGLEVLDLSSNKLSGSIPSDL-QNLQALRSLNLTFNN 564 (929)
Q Consensus 489 s~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~ 564 (929)
++|.+++..+..+ ..+++|++|+|++|.+++.... .+..+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus 464 ~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 464 AFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp ESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred cCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 6666654433333 4566666666666666543332 33346666666666666643222222 344555544444443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=245.93 Aligned_cols=228 Identities=23% Similarity=0.243 Sum_probs=189.8
Q ss_pred EEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCC
Q 002376 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411 (929)
Q Consensus 332 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 411 (929)
..+.++..++ .+|..+. .+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 3455555565 5666543 37899999999998888888999999999999999998777778889999999999999
Q ss_pred cCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCC
Q 002376 412 EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491 (929)
Q Consensus 412 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N 491 (929)
++++..+..|.++++|++|++++|++++..+..|.++++|++|++++|++++. .+|..+..+++|++|+|++|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-------KLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-------CCCGGGGGCTTCCEEECCSS
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee-------cCchhhccCCCCCEEECCCC
Confidence 99888888899999999999999999887777888999999999999998742 13778888899999999999
Q ss_pred CCCCCCCcchhcCcCcc----eeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 492 SLSGNLPNSLKNCKSLE----ELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 492 ~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
++++..+..+..+.+|+ .|++++|++++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|++++|++++
T Consensus 160 ~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred CCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 99988888888888777 8899999999777666654 489999999999997777778889999999999999987
Q ss_pred cCCC
Q 002376 568 VVPS 571 (929)
Q Consensus 568 ~~p~ 571 (929)
..|.
T Consensus 239 ~c~~ 242 (276)
T 2z62_A 239 SCPR 242 (276)
T ss_dssp CTTT
T ss_pred cCCc
Confidence 6553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-28 Score=262.23 Aligned_cols=214 Identities=19% Similarity=0.196 Sum_probs=148.3
Q ss_pred hCCCCCc-eeecccCceeEEeccccC-----------cHHHHHHHHHHH-HccCCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHE-NLIGSGSFGSVLHNERTG-----------SWKSFIAECETL-RNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~-~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l-~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|... +.||+|+||.||++.... ....+.+|+.++ +..+||||+++++++.... ......++||
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~ 94 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM 94 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEE
Confidence 3466666 789999999999997642 245788999988 5669999999999985421 1245689999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEeccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLL 793 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~ 793 (929)
||+++|+|.+++.... .++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999986432 2367899999999998 9999999999999998 7899999999987431
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccch
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~ 872 (929)
+..++.++||||+|++++++.....++..... ............ ....
T Consensus 172 ----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~---~~~~ 220 (299)
T 3m2w_A 172 ----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYE 220 (299)
T ss_dssp ----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT---TCCS
T ss_pred ----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh---cccc
Confidence 23467789999999877776554443322111 000000000000 0000
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........+..-+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000111222334777999999999999999986
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-29 Score=296.25 Aligned_cols=422 Identities=16% Similarity=0.146 Sum_probs=257.6
Q ss_pred CEEEeecCCCCCCCC-cCCCCCCCCcEEeCCCCCCCC---Cccc------------ccccccccceecccccccCCCCCh
Q 002376 98 RSIQLQNNKLSGNLP-REIGNLFRLRVLNISFNNLQG---ELPV------------NISKLTELKMLDLMANKITGRVTD 161 (929)
Q Consensus 98 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~---~~p~------------~~~~l~~L~~L~Ls~N~l~~~i~~ 161 (929)
+.+++++... ..| ..+..+++|++|+|+++.... ..|. .+..+++|++|+|++|.+++..+.
T Consensus 46 ~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~ 123 (594)
T 2p1m_B 46 RKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLE 123 (594)
T ss_dssp CEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred eEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHH
Confidence 4566654332 222 235567788899988875321 1121 123566777777777776643333
Q ss_pred hhhc-cCCCCcEEEcccc-ccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccc----cCCCCceEEeeecC
Q 002376 162 DQLR-NLRSLQVLNFGKN-LLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIY----NMTSLVHLRLASNQ 235 (929)
Q Consensus 162 ~~~~-~l~~L~~L~Ls~N-~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls~N~ 235 (929)
. +. .+++|++|+|++| .++.. .++..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|.
T Consensus 124 ~-l~~~~~~L~~L~L~~~~~~~~~-------~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 124 L-IAKSFKNFKVLVLSSCEGFSTD-------GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA 195 (594)
T ss_dssp H-HHHHCTTCCEEEEESCEEEEHH-------HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred H-HHHhCCCCcEEeCCCcCCCCHH-------HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence 3 33 5677777777766 32110 0112233566777777777766654443333 44566666666664
Q ss_pred CCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCc-cCcCCccCCCCCCCccceeccccc-------
Q 002376 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHN-LLEGTLPPGLGNLPFLRTYNIGFN------- 307 (929)
Q Consensus 236 l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N------- 307 (929)
+.++... ++..+.++++|+.|++++| .+++ +|..+..+++|+.|+++.+
T Consensus 196 --~~~~~~~--------------------l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~ 252 (594)
T 2p1m_B 196 --SEVSFSA--------------------LERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPD 252 (594)
T ss_dssp --SCCCHHH--------------------HHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHH
T ss_pred --CcCCHHH--------------------HHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchh
Confidence 1121111 1111223455555555555 2332 4445555556666654333
Q ss_pred cccCCCCCCCCccccccCCCCCCCEE-EccCCccccccCchhhhccccccEEEecCCcccccc-CCCCCCCCcccEEEee
Q 002376 308 KIVSSGDDEGLSFITSLTNSTHLNYL-ALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI-PASIGRLRSLTLLDLS 385 (929)
Q Consensus 308 ~i~~~~~~~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls 385 (929)
.+... ...+.++++|+.| .+.+... +.+|..+..++ +|++|+|++|.+++.. +..+..+++|++|+++
T Consensus 253 ~~~~l--------~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~ 322 (594)
T 2p1m_B 253 VYSGL--------SVALSGCKELRCLSGFWDAVP-AYLPAVYSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322 (594)
T ss_dssp HHHHH--------HHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred hHHHH--------HHHHhcCCCcccccCCcccch-hhHHHHHHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCc
Confidence 22221 2356788899998 4554433 34555555555 7999999999977543 2335688999999999
Q ss_pred CCCCCcc-cCccccCCCCCCEEEecC---------CcCCCCCccccc-CCCCCceecccCcccccccCcccc-cccccce
Q 002376 386 YNSISGE-IPIEIGQLQGLQVLGLAG---------NEIPGGIPNSLA-NLKKLNQIDLSGNELTGEIPISFG-NFQSLLS 453 (929)
Q Consensus 386 ~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~ 453 (929)
+| +.+. ++.....+++|++|++++ |.+++.....+. ++++|+.|+++.|.+++..+..+. .+++|+.
T Consensus 323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~ 401 (594)
T 2p1m_B 323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR 401 (594)
T ss_dssp GG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE
T ss_pred Cc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce
Confidence 88 4432 233334589999999943 555543333333 478999999999999876665554 5889999
Q ss_pred eccc--C----CcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhc-CcCcceeecccccccccCCccc-
Q 002376 454 IDLS--N----NRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKN-CKSLEELLMAYNQFSGPIPNIV- 525 (929)
Q Consensus 454 L~Ls--~----N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~- 525 (929)
|+++ + |.+++. |.. ..++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+
T Consensus 402 L~L~~~~~~~~~~l~~~-~~~--~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~ 477 (594)
T 2p1m_B 402 FRLCIIEPKAPDYLTLE-PLD--IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVL 477 (594)
T ss_dssp EEEEESSTTCCCTTTCC-CTH--HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHH
T ss_pred eEeecccCCCcccccCC-chh--hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHH
Confidence 9998 4 555421 100 01133366788999999977 666655555655 8889999999999876655554
Q ss_pred cCCCCCCEEECCCCcCCCcCCc-ccccCCCCCeEeCCCCcCcc
Q 002376 526 AELKGLEVLDLSSNKLSGSIPS-DLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 526 ~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 567 (929)
..+++|++|+|++|.+++..+. ....+++|+.|++++|+++.
T Consensus 478 ~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 478 SGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred hcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 6688999999999998654433 44568899999999998743
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=230.98 Aligned_cols=202 Identities=23% Similarity=0.276 Sum_probs=105.9
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
..+.+++++|+++ .+|..+. .+++.|+|++|++++..+..|.++++|++|+|++|+++...+..|..+++|++|++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 3556666666666 3554332 24666666666666555555666666666666666655444444455555555555
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
++|++++..+..|.++++|++|+|++|++++..+..|.++++|++ |+|
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~--------------------------------L~L 140 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY--------------------------------LSL 140 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE--------------------------------EEC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE--------------------------------EEC
Confidence 555555444444455555555555555554444444444444444 444
Q ss_pred cCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCc
Q 002376 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 444444333344455555555555555555544445555555555555555555444444555555555555544443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=234.32 Aligned_cols=209 Identities=25% Similarity=0.248 Sum_probs=165.5
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 407 (929)
++|++|+|++|++++..+..+..+. +|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCT-TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhcccc-CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3577777777777765555666666 688888888888877777788888888888888888877777788888888888
Q ss_pred ecCCcCCCCCcccccCCCCCceecccCcccccc-cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCcc--
Q 002376 408 LAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE-IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV-- 484 (929)
Q Consensus 408 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~-- 484 (929)
+++|++++..+..+..+++|++|++++|++++. +|..|.++++|++|+|++|++++.. +..+..+.+|+
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~~~~l~~L~~l 178 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY--------CTDLRVLHQMPLL 178 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC--------GGGGHHHHTCTTC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC--------HHHhhhhhhcccc
Confidence 888888877776788888888888888888763 5778888888888888888887532 44555555665
Q ss_pred --EEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCC
Q 002376 485 --TIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIP 546 (929)
Q Consensus 485 --~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 546 (929)
.|++++|++++..+..+.. .+|++|+|++|++++.++..|..+++|+.|+|++|++++..|
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8999999998766655544 489999999999998888888999999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-26 Score=270.60 Aligned_cols=142 Identities=18% Similarity=0.084 Sum_probs=106.0
Q ss_pred HHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc-----cccccHHHHHHHhhhCC
Q 002376 686 WKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER-----KNELDITSALDYLHNDC 759 (929)
Q Consensus 686 ~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~~~~~ia~aL~yLH~~~ 759 (929)
.++|.+|+++|+++ +|+||+++++++.+ ....||||||++||+|.+++.... .+..||+.||+|+|++
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~- 358 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQSGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ- 358 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SSEEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CCEEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC-
Confidence 46799999999999 79999999999843 445899999999999999997433 3578999999999998
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCC
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAG 839 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~ 839 (929)
+||||||||+|||++++|.+||+|||+|+..... .......+||++|||||++.+ .+..++|+|+.|+..+
T Consensus 359 --GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~ 429 (569)
T 4azs_A 359 --GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPF 429 (569)
T ss_dssp --TCEESCCCGGGEEECTTSCEEECCCTTEESCC---------CCSHHHHHHHHHHHHHHC------------------C
T ss_pred --CceeccCchHhEEECCCCCEEEeecccCeeCCCC------CccccCceechhhccHHHhCC-CCCCcccccccccchh
Confidence 9999999999999999999999999999865321 122345689999999999875 5678899999998877
Q ss_pred Ccc
Q 002376 840 EFN 842 (929)
Q Consensus 840 ~~~ 842 (929)
++.
T Consensus 430 ~l~ 432 (569)
T 4azs_A 430 NLP 432 (569)
T ss_dssp CCC
T ss_pred hhc
Confidence 753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=233.68 Aligned_cols=205 Identities=24% Similarity=0.283 Sum_probs=141.2
Q ss_pred CCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccc
Q 002376 373 IGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLL 452 (929)
Q Consensus 373 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 452 (929)
++++++++++++++|.++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 344556666666666665 3444332 4566666666666666666666666677777777766654332 5667777
Q ss_pred eecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCC
Q 002376 453 SIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLE 532 (929)
Q Consensus 453 ~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 532 (929)
+|+|++|+|+ .+ |..+..+++|++|+|++|++++..|..|.++++|++|+|++|+|++.++..|..+++|+
T Consensus 81 ~L~Ls~N~l~-~l--------~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 151 (290)
T 1p9a_G 81 TLDLSHNQLQ-SL--------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151 (290)
T ss_dssp EEECCSSCCS-SC--------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCcCC-cC--------chhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCC
Confidence 7777777765 22 44556667777777777777776667777888888888888888877777777788888
Q ss_pred EEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcC
Q 002376 533 VLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 533 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~ 591 (929)
.|+|++|+|++..+..|..+++|+.|+|++|+++..++.......++.+++.+||+.|.
T Consensus 152 ~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred EEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 88888888886656667778888888888888875544444456677888888888883
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=236.75 Aligned_cols=186 Identities=23% Similarity=0.291 Sum_probs=87.1
Q ss_pred CCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCC
Q 002376 325 TNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404 (929)
Q Consensus 325 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 404 (929)
..+++|++|+|++|++++ + ..+..+. +|++|+|++|.+++..+..|+++++|++|+|++|++++..+..|..+++|+
T Consensus 60 ~~l~~L~~L~l~~n~l~~-~-~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 60 QYLPNVRYLALGGNKLHD-I-SALKELT-NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGCTTCCEEECTTSCCCC-C-GGGTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccCCCCcEEECCCCCCCC-c-hhhcCCC-CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 334444444555444442 1 2333333 344444444444444444444444444444444444444444444444444
Q ss_pred EEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCcc
Q 002376 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484 (929)
Q Consensus 405 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~ 484 (929)
+|++++|++++..+..|..+++|++|++++|++++..+..|.++ ++|+
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--------------------------------~~L~ 184 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKL--------------------------------TQLK 184 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC--------------------------------TTCC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCC--------------------------------ccCC
Confidence 44444444444444444444444444444444444333334444 4444
Q ss_pred EEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccC
Q 002376 485 TIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNL 552 (929)
Q Consensus 485 ~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 552 (929)
.|+|++|++++..|..+..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+|.+++.+
T Consensus 185 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 185 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred EEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 444444444444444445555555555555544432 2345555555555555555555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=237.44 Aligned_cols=200 Identities=21% Similarity=0.268 Sum_probs=167.9
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
+|+.|++++|.++.. ..+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++..+..|.++++|++|+|+
T Consensus 42 ~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 577777777776632 3467778888888888888753 367788888888888888888777778888888888888
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecc
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 513 (929)
+|++++..+..|.++++|++|++++|++++.. |..+..+++|+.|+|++|++++..|..|+.+++|+.|+|+
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 189 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP--------KGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLY 189 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC--------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCccC--------HHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECC
Confidence 88888777777888889999999999887432 3456778899999999999998888889999999999999
Q ss_pred cccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCC
Q 002376 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSE 572 (929)
Q Consensus 514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (929)
+|++++.+|..+..+++|+.|+|++|.+.+.. +.|+.++++.|.++|.+|..
T Consensus 190 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 190 QNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT-------TTTHHHHHHHHHTGGGBBCT
T ss_pred CCcCCccCHHHHhCCcCCCEEEccCCCccccC-------cHHHHHHHHHHhCCCcccCc
Confidence 99999999989999999999999999998654 46899999999999999975
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=234.36 Aligned_cols=228 Identities=24% Similarity=0.298 Sum_probs=186.2
Q ss_pred CCCCEEEccCCccccccCch---hhhccccccEEEecCCccccccCCCC--CCCCcccEEEeeCCCCCcccC----cccc
Q 002376 328 THLNYLALDGNQFEGKIPES---IGNFSNELSKLYLGGNHIYGKIPASI--GRLRSLTLLDLSYNSISGEIP----IEIG 398 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~---~~~~~~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~ 398 (929)
..++.|.+.++.++...-.. +.... +|++|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYS-RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHS-CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccC-ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 45778888888775321111 11233 69999999999999999998 999999999999999997655 4456
Q ss_pred CCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccc---c-CcccccccccceecccCCcCCCCCCCCcccCCc
Q 002376 399 QLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE---I-PISFGNFQSLLSIDLSNNRINGNIPKGILRPLP 474 (929)
Q Consensus 399 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~-p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p 474 (929)
.+++|++|+|++|++++..|..|..+++|++|||++|++.+. . +..+..+++|++|+|++|+++. ++ ..+
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~-----~~~ 216 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PT-----GVC 216 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HH-----HHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hH-----HHH
Confidence 799999999999999999999999999999999999998753 2 3345789999999999999963 21 012
Q ss_pred h-hhhcccCccEEEecCCCCCCCCCcchhcC---cCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccc
Q 002376 475 E-EISRLENVVTIDLSDNSLSGNLPNSLKNC---KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQ 550 (929)
Q Consensus 475 ~-~~~~l~~L~~LdLs~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 550 (929)
. .+..+++|++|||++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +.
T Consensus 217 ~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~ 291 (310)
T 4glp_A 217 AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PD 291 (310)
T ss_dssp HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TT
T ss_pred HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hh
Confidence 2 25788999999999999999888888877 69999999999999 5676664 7999999999999964 43 67
Q ss_pred cCCCCCeEeCCCCcCcc
Q 002376 551 NLQALRSLNLTFNNLEG 567 (929)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~ 567 (929)
.+++|+.|+|++|+++.
T Consensus 292 ~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 292 ELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCCCCSCEECSSTTTSC
T ss_pred hCCCccEEECcCCCCCC
Confidence 88999999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=224.65 Aligned_cols=186 Identities=15% Similarity=0.193 Sum_probs=153.1
Q ss_pred ccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCC-CCCCcccccccccccceecccc-cccCCCCChhh
Q 002376 86 TISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNN-LQGELPVNISKLTELKMLDLMA-NKITGRVTDDQ 163 (929)
Q Consensus 86 ~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~i~~~~ 163 (929)
.+|. +. ++|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |+++ .+++..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTS
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHH
Confidence 5666 43 389999999999998888899999999999999997 8877777899999999999999 9998 677777
Q ss_pred hccCCCCcEEEccccccCCCCCccccccCCCccCCCCccc---EEEeecc-cCCCccCCccccCCCCc-eEEeeecCCCC
Q 002376 164 LRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLK---VLDLTIN-RLAGTVPSTIYNMTSLV-HLRLASNQLGG 238 (929)
Q Consensus 164 ~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~ 238 (929)
|.++++|++|++++|++++ +| . |..+++|+ +|++++| +++++.+..|.++++|+ +|+|++|+++
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp--------~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~- 169 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FP--------D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CC--------C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-
T ss_pred hCCCCCCCEEeCCCCCCcc-cc--------c-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-
Confidence 9999999999999999865 33 2 55667777 9999999 99988888899999999 9999999998
Q ss_pred cCCcccccCCCCcceeeccCCc-CCCCCCCccccc-ccccEEeccCccCcC
Q 002376 239 EIPYDVRDTLPNLLDFIYCFNR-FTGKIPGSLHNL-TNIQIIRMTHNLLEG 287 (929)
Q Consensus 239 ~ip~~~~~~l~~L~~l~l~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~ 287 (929)
.+|...+.. ++|+.|++++|+ +++..+..|.++ ++|+.|++++|+|++
T Consensus 170 ~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 170 SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 777776664 667777777773 666556666666 667777777666664
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=227.73 Aligned_cols=205 Identities=22% Similarity=0.228 Sum_probs=128.7
Q ss_pred ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCC
Q 002376 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402 (929)
Q Consensus 323 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 402 (929)
.+.++++++++++++|.++ .+|..+. ..++.|+|++|+|++..+..|.++++|++|+|++|.|++..+. +.+++
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~ 78 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPV 78 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTT
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCc
Confidence 3566788888888888887 5666553 3688888888888877777888888888888888888754332 56777
Q ss_pred CCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccC
Q 002376 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482 (929)
Q Consensus 403 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~ 482 (929)
|++|+|++|+|+ .+|..+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|+
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-------------------- 137 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-------------------- 137 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC--------------------
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC--------------------
Confidence 777777777776 45566666666777777776666555556666666666666666655
Q ss_pred ccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCC
Q 002376 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTF 562 (929)
Q Consensus 483 L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (929)
+..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.++|++
T Consensus 138 ------------~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~ 204 (290)
T 1p9a_G 138 ------------TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (290)
T ss_dssp ------------CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred ------------ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCC
Confidence 333333444444444555555554444444444555555555555554 3444444445555555555
Q ss_pred CcCcc
Q 002376 563 NNLEG 567 (929)
Q Consensus 563 N~l~~ 567 (929)
|++.+
T Consensus 205 Np~~C 209 (290)
T 1p9a_G 205 NPWLC 209 (290)
T ss_dssp CCBCC
T ss_pred CCccC
Confidence 55543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-24 Score=223.24 Aligned_cols=191 Identities=27% Similarity=0.311 Sum_probs=150.3
Q ss_pred CCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcc
Q 002376 57 SPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELP 136 (929)
Q Consensus 57 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 136 (929)
+||.|.|.+|... ...+++++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 5889999999642 336889999988 6787776 689999999999998888899999999999999999999888
Q ss_pred cccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCcc
Q 002376 137 VNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV 216 (929)
Q Consensus 137 ~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~ 216 (929)
..|.++++|++|+|++|+|+ .+++..|.++++|++|+|++|++++ +.+..|..+++|++|+|++|+|+++.
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~--------~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS--------LPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCC--------CCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred hHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCC--------cChhHhccCCcccEEECcCCcCCccC
Confidence 88999999999999999998 5677778889999999999998753 23345677888888888888888777
Q ss_pred CCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCC
Q 002376 217 PSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTG 263 (929)
Q Consensus 217 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~ 263 (929)
+..|.++++|++|+|++|+|+ .+|...+..+++|+.+++++|.+++
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred HHHcCcCcCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeC
Confidence 778888888888888888877 3333333334444444444444443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=217.53 Aligned_cols=196 Identities=16% Similarity=0.227 Sum_probs=118.7
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCC-CCcccCccccCCCCCCEEEecC-CcCCCCCcccccCCCCCceec
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS-ISGEIPIEIGQLQGLQVLGLAG-NEIPGGIPNSLANLKKLNQID 431 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 431 (929)
+|++|++++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777777666677777777777777775 6655555677777777777776 777766666677777777777
Q ss_pred ccCcccccccCcccccccccc---eecccCC-cCCCCCCCCcccCCchhhhcccCcc-EEEecCCCCCCCCCcchhcCcC
Q 002376 432 LSGNELTGEIPISFGNFQSLL---SIDLSNN-RINGNIPKGILRPLPEEISRLENVV-TIDLSDNSLSGNLPNSLKNCKS 506 (929)
Q Consensus 432 Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~g~i~~~~~~~~p~~~~~l~~L~-~LdLs~N~l~~~~p~~~~~l~~ 506 (929)
+++|++++ +|. |..+++|+ +|++++| ++++ +| +..+..+++|+ .|++++|+++...+..|.. ++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~-i~-------~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~ 180 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS-IP-------VNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TK 180 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE-EC-------TTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CE
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhh-cC-------cccccchhcceeEEEcCCCCCcccCHhhcCC-CC
Confidence 77777765 444 55565555 6666666 5542 21 22344555555 6666666555222222333 55
Q ss_pred cceeeccccc-ccccCCccccCC-CCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCC
Q 002376 507 LEELLMAYNQ-FSGPIPNIVAEL-KGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 507 L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (929)
|+.|+|++|+ +++..+..|..+ ++|+.|||++|++++ +|.. .+++|+.|+++++
T Consensus 181 L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp EEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 6666666663 555555555555 566666666666653 2322 3445555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-25 Score=245.14 Aligned_cols=234 Identities=22% Similarity=0.292 Sum_probs=132.0
Q ss_pred EEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCC-CCCEEEccCCccccccCchhhhc----
Q 002376 277 IIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNST-HLNYLALDGNQFEGKIPESIGNF---- 351 (929)
Q Consensus 277 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~---- 351 (929)
.+++++|.+++.+|..+...++|++|++++|.+...+.. .....+..++ +|++|+|++|++++..+..+...
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~---~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTV---ELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHH---HHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHH---HHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 467888899988887777777788888888887654321 1113455666 77778888887776666666554
Q ss_pred cccccEEEecCCccccccCCCCC----CC-CcccEEEeeCCCCCcccCccccC-----CCCCCEEEecCCcCCCCCc---
Q 002376 352 SNELSKLYLGGNHIYGKIPASIG----RL-RSLTLLDLSYNSISGEIPIEIGQ-----LQGLQVLGLAGNEIPGGIP--- 418 (929)
Q Consensus 352 ~~~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p--- 418 (929)
..+|++|+|++|.+++..+..+. .+ ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 12577777777777655544332 22 66777777777766554433322 2466666666666664332
Q ss_pred -ccccCCC-CCceecccCcccccccCccccc----c-cccceecccCCcCCCCCCCCcccCCchhhhcc-cCccEEEecC
Q 002376 419 -NSLANLK-KLNQIDLSGNELTGEIPISFGN----F-QSLLSIDLSNNRINGNIPKGILRPLPEEISRL-ENVVTIDLSD 490 (929)
Q Consensus 419 -~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l-~~L~~LdLs~ 490 (929)
..+..++ +|++|+|++|++++..+..+.. + ++|+.|+|++|+|++.- ...++..+..+ ++|++|||++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~----~~~l~~~l~~~~~~L~~L~Ls~ 234 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKS----YAELAYIFSSIPNHVVSLNLCL 234 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC----HHHHHHHHHHSCTTCCEEECCS
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhH----HHHHHHHHhcCCCCceEEECcC
Confidence 2233343 6666666666665544433322 2 35666666666654311 01123334332 3555666666
Q ss_pred CCCCCCCCc----chhcCcCcceeecccccc
Q 002376 491 NSLSGNLPN----SLKNCKSLEELLMAYNQF 517 (929)
Q Consensus 491 N~l~~~~p~----~~~~l~~L~~L~Ls~N~l 517 (929)
|.+++..+. .+..+++|+.|+|++|.+
T Consensus 235 N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l 265 (362)
T 3goz_A 235 NCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265 (362)
T ss_dssp SCCCCCCHHHHHHTTTTTTTCSEEEEEHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCccEEEeccCCc
Confidence 655544332 223344555555555553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-25 Score=249.19 Aligned_cols=37 Identities=32% Similarity=0.489 Sum_probs=17.1
Q ss_pred cccEEEeecccCCCccC----CccccCC-CCceEEeeecCCC
Q 002376 201 NLKVLDLTINRLAGTVP----STIYNMT-SLVHLRLASNQLG 237 (929)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~ 237 (929)
+|++|||++|+|++..+ ..|.+++ +|++|+|++|+|+
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 64 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG 64 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC
Confidence 35555555555444433 3344444 4444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-25 Score=249.51 Aligned_cols=240 Identities=22% Similarity=0.275 Sum_probs=122.9
Q ss_pred cCCCCCCCEEEccCCccccccCch----hhhccccccEEEecCC---ccccccCCCC-------CCCCcccEEEeeCCCC
Q 002376 324 LTNSTHLNYLALDGNQFEGKIPES----IGNFSNELSKLYLGGN---HIYGKIPASI-------GRLRSLTLLDLSYNSI 389 (929)
Q Consensus 324 ~~~l~~L~~L~Ls~N~l~~~~p~~----~~~~~~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~N~l 389 (929)
+..+++|++|+|++|++++..+.. +..++ +|++|+|++| ++++.+|..+ ..+++|++|+|++|.+
T Consensus 28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 106 (386)
T 2ca6_A 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 106 (386)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCC-CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcC
Confidence 334445555555555554432222 22232 4555555443 2223333222 4556666666666666
Q ss_pred Cc----ccCccccCCCCCCEEEecCCcCCCCCccccc----CC---------CCCceecccCcccc-cccC---cccccc
Q 002376 390 SG----EIPIEIGQLQGLQVLGLAGNEIPGGIPNSLA----NL---------KKLNQIDLSGNELT-GEIP---ISFGNF 448 (929)
Q Consensus 390 ~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~~~~l 448 (929)
++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.+| ..|..+
T Consensus 107 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~ 186 (386)
T 2ca6_A 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 186 (386)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhC
Confidence 54 3455555566666666666665433222222 22 56666666666664 2233 244455
Q ss_pred cccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCC----CCCCcchhcCcCcceeeccccccccc----
Q 002376 449 QSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS----GNLPNSLKNCKSLEELLMAYNQFSGP---- 520 (929)
Q Consensus 449 ~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 520 (929)
++|++|+|++|+|+.. ++....|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|+|++.
T Consensus 187 ~~L~~L~L~~n~l~~~---g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPE---GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp TTCCEEECCSSCCCHH---HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred CCcCEEECcCCCCCHh---HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 5666666666655410 000001224455556666666666654 34555566666666666666666544
Q ss_pred CCcccc--CCCCCCEEECCCCcCCC----cCCccc-ccCCCCCeEeCCCCcCcc
Q 002376 521 IPNIVA--ELKGLEVLDLSSNKLSG----SIPSDL-QNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 521 ~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~ 567 (929)
+|..+. .+++|+.|+|++|++++ .+|..+ .++++|++|++++|++++
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 344442 26666666666666665 355555 445666666666666654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-22 Score=213.56 Aligned_cols=179 Identities=19% Similarity=0.249 Sum_probs=100.3
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
..++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4667777777776 3444443 466777777777776666666666666666666666666666666666666666666
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecc
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 513 (929)
+|++++..+..|..+++|++|+|++|+|++. | +..+..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 163 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSL-P-------SGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLS 163 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-C-------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCc-C-------hhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECC
Confidence 6666655555555566666666666655421 1 2223344445555555555444444444444444444444
Q ss_pred cccccccCCccccCCCCCCEEECCCCcCCC
Q 002376 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
+|+|++.++..|..+++|+.|+|++|++++
T Consensus 164 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 164 TNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 444444444444444444444444444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-25 Score=242.70 Aligned_cols=271 Identities=16% Similarity=0.199 Sum_probs=182.8
Q ss_pred CCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCC--CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCC
Q 002376 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNL--SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQG 133 (929)
Q Consensus 56 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 133 (929)
.-|.+|.++.|+.. .+..+|++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 45668999998743 4668899988776 3456666 8899999999999877665 5678999999999999886
Q ss_pred C-cccccccccccceecccccccCCCCChhhhccCCCCcEEEcccc-ccCCCCCccccccCCCccCCCCcccEEEeecc-
Q 002376 134 E-LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKN-LLWGSIPPSIANLIPSDLSRLENLKVLDLTIN- 210 (929)
Q Consensus 134 ~-~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N- 210 (929)
. +|..+..+++|++|+|++|++++..+. .+..+++|++|+|++| .+++. .++..+..+++|++|+|++|
T Consensus 108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~L~~~~~l~~~-------~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 108 STLHGILSQCSKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEF-------ALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp HHHHHHHTTBCCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHH-------HHHHHHHHCTTCCEEECCCCT
T ss_pred HHHHHHHhhCCCCCEEeCcCcccCHHHHH-HHhcCCCCCEEECCCCCCCCHH-------HHHHHHhcCCCCCEEcCCCCC
Confidence 6 788888899999999999988754444 4778888888888888 45331 12334556778888888888
Q ss_pred cCCCc-cCCccccCC-CCceEEeeec--CCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCcc-C
Q 002376 211 RLAGT-VPSTIYNMT-SLVHLRLASN--QLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNL-L 285 (929)
Q Consensus 211 ~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l 285 (929)
.+++. ++..+..++ +|++|+|++| .++. +.+|..+.++++|+.|++++|. +
T Consensus 180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~------------------------~~l~~~~~~~~~L~~L~l~~~~~l 235 (336)
T 2ast_B 180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQK------------------------SDLSTLVRRCPNLVHLDLSDSVML 235 (336)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCH------------------------HHHHHHHHHCTTCSEEECTTCTTC
T ss_pred CcChHHHHHHHHhcccCCCEEEeCCCcccCCH------------------------HHHHHHHhhCCCCCEEeCCCCCcC
Confidence 77754 466677777 7777777777 3431 1233344455556666666655 4
Q ss_pred cCCccCCCCCCCccceecccccc-ccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCc
Q 002376 286 EGTLPPGLGNLPFLRTYNIGFNK-IVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNH 364 (929)
Q Consensus 286 ~~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~ 364 (929)
++..+..+..+++|++|++++|. +.. . .+..+.++++|++|++++| ++ .+.+..+...+..|++++|+
T Consensus 236 ~~~~~~~l~~l~~L~~L~l~~~~~~~~----~---~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 236 KNDCFQEFFQLNYLQHLSLSRCYDIIP----E---TLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTCTTCCG----G---GGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCC
T ss_pred CHHHHHHHhCCCCCCEeeCCCCCCCCH----H---HHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEeccc
Confidence 44445555555555666555553 110 0 1124566778888888877 33 12344443357777778888
Q ss_pred cccccCCCCCC
Q 002376 365 IYGKIPASIGR 375 (929)
Q Consensus 365 l~~~~p~~~~~ 375 (929)
+++..|..++.
T Consensus 305 l~~~~~~~~~~ 315 (336)
T 2ast_B 305 FTTIARPTIGN 315 (336)
T ss_dssp SCCTTCSSCSS
T ss_pred CccccCCcccc
Confidence 87777776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=224.55 Aligned_cols=244 Identities=16% Similarity=0.120 Sum_probs=184.3
Q ss_pred CCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcc-
Q 002376 58 PCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELP- 136 (929)
Q Consensus 58 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p- 136 (929)
.|+|..|.|+. ++++ .||..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|
T Consensus 8 ~C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 8 HCSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp EEETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred EeeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 37777777754 3455 677766 3689999999999996666789999999999999999987666
Q ss_pred cccccccccce-ecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeec-ccCCC
Q 002376 137 VNISKLTELKM-LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTI-NRLAG 214 (929)
Q Consensus 137 ~~~~~l~~L~~-L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~-N~l~~ 214 (929)
..|.++++|++ ++++.|+|+ .++++.|.++++|++|++++|++.+. .+..+....++..|++.+ |++..
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~--------~~~~~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHL--------PDVHKIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSC--------CCCTTCCBSSCEEEEEESCTTCCE
T ss_pred hHhhcchhhhhhhcccCCccc-ccCchhhhhccccccccccccccccC--------Cchhhcccchhhhhhhcccccccc
Confidence 56889988765 677789998 67777799999999999999988543 233455667788899875 67887
Q ss_pred ccCCccccCC-CCceEEeeecCCCCcCCcccccCCCCcceeeccC-CcCCCCCCCcccccccccEEeccCccCcCCccCC
Q 002376 215 TVPSTIYNMT-SLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCF-NRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPG 292 (929)
Q Consensus 215 ~~p~~~~~l~-~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 292 (929)
+.+..|..+. .++.|+|++|+|+ .+|..++. ..+|+.+++.+ |.++...++.|.++++|++|||++|+|+...+..
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCC-EECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred ccccchhhcchhhhhhcccccccc-CCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 7777888775 6889999999998 78877776 56788888875 5555555567888899999999999998666666
Q ss_pred CCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCC
Q 002376 293 LGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGN 338 (929)
Q Consensus 293 ~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N 338 (929)
|.+|++|+.+++. .+..+ ..+.++++|+.++++++
T Consensus 222 ~~~L~~L~~l~~~--~l~~l---------P~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 222 LENLKKLRARSTY--NLKKL---------PTLEKLVALMEASLTYP 256 (350)
T ss_dssp CTTCCEEECTTCT--TCCCC---------CCTTTCCSCCEEECSCH
T ss_pred hccchHhhhccCC--CcCcC---------CCchhCcChhhCcCCCC
Confidence 7777777666552 23222 23556667777776544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.8e-25 Score=246.48 Aligned_cols=249 Identities=17% Similarity=0.226 Sum_probs=152.7
Q ss_pred CCCcccccccccEEeccCccCcCCcc----CCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCcc
Q 002376 265 IPGSLHNLTNIQIIRMTHNLLEGTLP----PGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQF 340 (929)
Q Consensus 265 ~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 340 (929)
++..+..+++|+.|+|++|.+++..+ ..|..+++|++|+|++|.+. ++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~----------------------------~l 75 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG----------------------------RV 75 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT----------------------------SC
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC----------------------------cc
Confidence 44555666777777777777765422 23444555555555444332 22
Q ss_pred ccccCchh-------hhccccccEEEecCCcccc----ccCCCCCCCCcccEEEeeCCCCCcccCcccc----CC-----
Q 002376 341 EGKIPESI-------GNFSNELSKLYLGGNHIYG----KIPASIGRLRSLTLLDLSYNSISGEIPIEIG----QL----- 400 (929)
Q Consensus 341 ~~~~p~~~-------~~~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l----- 400 (929)
++.+|..+ ..+. +|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+. .+
T Consensus 76 ~~~~~~~~~~l~~~l~~~~-~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~ 154 (386)
T 2ca6_A 76 KDEIPEALRLLLQALLKCP-KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154 (386)
T ss_dssp GGGSHHHHHHHHHHHTTCT-TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHHhhCC-cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhh
Confidence 23333332 2222 45555555555544 2444455555666666666665433332222 22
Q ss_pred ----CCCCEEEecCCcCC-CCCc---ccccCCCCCceecccCcccc--c---ccCcccccccccceecccCCcCCCCCCC
Q 002376 401 ----QGLQVLGLAGNEIP-GGIP---NSLANLKKLNQIDLSGNELT--G---EIPISFGNFQSLLSIDLSNNRINGNIPK 467 (929)
Q Consensus 401 ----~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~g~i~~ 467 (929)
++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++ | ..|..+..+++|+.|+|++|.++..-
T Consensus 155 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g-- 232 (386)
T 2ca6_A 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG-- 232 (386)
T ss_dssp HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--
T ss_pred cccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--
Confidence 66777777777765 3334 35566777777777777776 2 34446777777888888887774100
Q ss_pred CcccCCchhhhcccCccEEEecCCCCCCC----CCcchhc--CcCcceeecccccccc----cCCccc-cCCCCCCEEEC
Q 002376 468 GILRPLPEEISRLENVVTIDLSDNSLSGN----LPNSLKN--CKSLEELLMAYNQFSG----PIPNIV-AELKGLEVLDL 536 (929)
Q Consensus 468 ~~~~~~p~~~~~l~~L~~LdLs~N~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L 536 (929)
...+|..+..+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|.|++ .+|..+ .++++|++|+|
T Consensus 233 --~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l 310 (386)
T 2ca6_A 233 --SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310 (386)
T ss_dssp --HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred --HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEc
Confidence 011266677778888888888888765 4566633 8889999999999987 477776 66899999999
Q ss_pred CCCcCCCcCC
Q 002376 537 SSNKLSGSIP 546 (929)
Q Consensus 537 s~N~l~~~~p 546 (929)
++|++++..|
T Consensus 311 ~~N~l~~~~~ 320 (386)
T 2ca6_A 311 NGNRFSEEDD 320 (386)
T ss_dssp TTSBSCTTSH
T ss_pred cCCcCCcchh
Confidence 9999997664
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=206.55 Aligned_cols=188 Identities=23% Similarity=0.269 Sum_probs=150.4
Q ss_pred CCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCC
Q 002376 55 SSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134 (929)
Q Consensus 55 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 134 (929)
....|.|.+|.|+..+ ++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++.
T Consensus 3 ~~C~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp TTCEEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 3456899999997643 22 345444 45899999999999977777899999999999999999987
Q ss_pred cccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCC
Q 002376 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214 (929)
Q Consensus 135 ~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~ 214 (929)
.+..|.++++|++|+|++|+++ .+++..|.++++|++|+|++|++++ +.+..|..+++|++|+|++|++++
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~--------~~~~~~~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS--------LPDGVFDKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCC--------CCTTTTTTCTTCCEEECCSSCCSC
T ss_pred ChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcc--------cCHhHhccCCcCCEEECCCCccce
Confidence 7778899999999999999998 5777778999999999999998754 233457788999999999999998
Q ss_pred ccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCccccccc
Q 002376 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTN 274 (929)
Q Consensus 215 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~ 274 (929)
..+..|..+++|++|+|++|.+.+. +++|+.|++..|+++|.+|..++.+..
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~--------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCT--------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCC--------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred eCHHHhccCCCccEEEecCCCeecC--------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 8777888899999999999987643 456666677777777777766665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.5e-23 Score=225.34 Aligned_cols=225 Identities=20% Similarity=0.224 Sum_probs=186.5
Q ss_pred cccEEEecCCccccccCC---CCCCCCcccEEEeeCCCCCcccCccc--cCCCCCCEEEecCCcCCCCCc----ccccCC
Q 002376 354 ELSKLYLGGNHIYGKIPA---SIGRLRSLTLLDLSYNSISGEIPIEI--GQLQGLQVLGLAGNEIPGGIP----NSLANL 424 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 424 (929)
.++.+.+.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 478888888877532110 12234679999999999999999988 999999999999999998655 455689
Q ss_pred CCCceecccCcccccccCcccccccccceecccCCcCCCC--CCCCcccCCchhhhcccCccEEEecCCCCCCCCCc---
Q 002376 425 KKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN--IPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPN--- 499 (929)
Q Consensus 425 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~--- 499 (929)
++|++|+|++|++++..|..|.++++|++|+|++|++.+. ++. +..+..+++|++|+|++|+++. +|.
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 217 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMA------ALCPHKFPAIQNLALRNTGMET-PTGVCA 217 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHT------TSCTTSSCCCCSCBCCSSCCCC-HHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhH------HHhhhcCCCCCEEECCCCCCCc-hHHHHH
Confidence 9999999999999998889999999999999999998652 111 1224678899999999999973 333
Q ss_pred -chhcCcCcceeecccccccccCCccccCC---CCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCC
Q 002376 500 -SLKNCKSLEELLMAYNQFSGPIPNIVAEL---KGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIF 575 (929)
Q Consensus 500 -~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 575 (929)
.++++++|++|+|++|+|++.+|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |....+
T Consensus 218 ~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l 293 (310)
T 4glp_A 218 ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDEL 293 (310)
T ss_dssp HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSC
T ss_pred HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhC
Confidence 35788999999999999999888888777 69999999999999 6787775 8999999999999985 444567
Q ss_pred CCCCcccccCCCCC
Q 002376 576 RNMSNVHLKGNPKL 589 (929)
Q Consensus 576 ~~l~~l~l~~N~~~ 589 (929)
++++.+++++|+..
T Consensus 294 ~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 294 PEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCSCEECSSTTTS
T ss_pred CCccEEECcCCCCC
Confidence 89999999999864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-23 Score=243.34 Aligned_cols=207 Identities=25% Similarity=0.321 Sum_probs=168.7
Q ss_pred CCCCCCCCCCC-----CCcce-eeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCc
Q 002376 49 LSYWNPSSSPC-----TWPGV-ICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLR 122 (929)
Q Consensus 49 l~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 122 (929)
+.+|..+.++| .|.|+ .|.. .+++.|+|++|++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 45676666778 79999 6864 479999999999997 888774 89999999999999 777 5579999
Q ss_pred EEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcc
Q 002376 123 VLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL 202 (929)
Q Consensus 123 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L 202 (929)
+|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|++|+|++|++++ +|. .+++|
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~-----------~l~~L 162 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE-----------LPTSL 162 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-----------CCTTC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC-----------cCCCc
Confidence 99999999997 777 766 99999999999996 776 68999999999999865 442 36799
Q ss_pred cEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCc-------ceeeccCCcCCCCCCCcccccccc
Q 002376 203 KVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL-------LDFIYCFNRFTGKIPGSLHNLTNI 275 (929)
Q Consensus 203 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L-------~~l~l~~N~l~~~~p~~~~~l~~L 275 (929)
++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+|. +.. +| +.|++++|+++. +|..+..+++|
T Consensus 163 ~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~---~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L 232 (571)
T 3cvr_A 163 EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV---RNHHSEETEIFFRCRENRITH-IPENILSLDPT 232 (571)
T ss_dssp CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC-----------CCEEEECCSSCCCC-CCGGGGGSCTT
T ss_pred CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH---hhhcccccceEEecCCCccee-cCHHHhcCCCC
Confidence 999999999997 666 65 89999999999998 7777 433 55 888888888874 67777778888
Q ss_pred cEEeccCccCcCCccCCCCC
Q 002376 276 QIIRMTHNLLEGTLPPGLGN 295 (929)
Q Consensus 276 ~~L~Ls~N~l~~~~p~~~~~ 295 (929)
+.|+|++|.|++.+|..|..
T Consensus 233 ~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 233 CTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp EEEECCSSSCCHHHHHHHHH
T ss_pred CEEEeeCCcCCCcCHHHHHH
Confidence 88888888888777755443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-24 Score=251.32 Aligned_cols=161 Identities=19% Similarity=0.162 Sum_probs=119.9
Q ss_pred CCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 664 SHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
...++||+|+||+||+|...+ ..++|.+|++++++++||||+++..++...+ .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-----N 413 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-----T
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-----c
Confidence 446789999999999775431 1345889999999999999996655554322 2
Q ss_pred EEEEEEecCCCCccccccccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCC
Q 002376 722 LALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSS 801 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~ 801 (929)
.|+||||+++|+|.++++....++.|++.||+|||+. +|+||||||+|||+++ .+||+|||+|+...........
T Consensus 414 ~~lVmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp TEEEEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred cEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 5999999999999999988777789999999999998 9999999999999999 9999999999976432110000
Q ss_pred -ccccceeccccccccccccCC--CCCCCCCCCCCC
Q 002376 802 -ISSTHVFMGSIGYVPPEYGLG--ERPSTAGDVPTS 834 (929)
Q Consensus 802 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~s~ 834 (929)
.......+||+.|||||++.. ..|+..+|+|+.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~ 524 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEI 524 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHH
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHH
Confidence 001235689999999999876 557778888874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-24 Score=234.37 Aligned_cols=232 Identities=17% Similarity=0.210 Sum_probs=141.1
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccc-cCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK-IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 406 (929)
++++.|++++|.+.+..+. ++.+. +|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~-~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCB-CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh-hccCC-CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 4555555555555544433 33333 566666666666544 55556666666666666666666666666666667777
Q ss_pred EecCC-cCCC-CCcccccCCCCCceecccCc-ccccc-cCccccccc-ccceecccCC--cCCCCCCCCcccCCchhhhc
Q 002376 407 GLAGN-EIPG-GIPNSLANLKKLNQIDLSGN-ELTGE-IPISFGNFQ-SLLSIDLSNN--RINGNIPKGILRPLPEEISR 479 (929)
Q Consensus 407 ~L~~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~g~i~~~~~~~~p~~~~~ 479 (929)
++++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|++++| .++. ..+|..+..
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~-------~~l~~~~~~ 220 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK-------SDLSTLVRR 220 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCH-------HHHHHHHHH
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCH-------HHHHHHHhh
Confidence 77666 4554 24555666677777777777 66643 455566666 7777777777 3331 112555666
Q ss_pred ccCccEEEecCCC-CCCCCCcchhcCcCcceeeccccc-ccccCCccccCCCCCCEEECCCCcCCCcCCcccccCC-CCC
Q 002376 480 LENVVTIDLSDNS-LSGNLPNSLKNCKSLEELLMAYNQ-FSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ-ALR 556 (929)
Q Consensus 480 l~~L~~LdLs~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~ 556 (929)
+++|+.|+|++|. +++..+..+..+++|++|++++|. ++......++.+++|+.|++++| ++ ...+..+. .|+
T Consensus 221 ~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~ 296 (336)
T 2ast_B 221 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALP 296 (336)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHST
T ss_pred CCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCc
Confidence 7777777777777 665666677777777777777774 22221224666777777777777 32 22334442 366
Q ss_pred eEeCCCCcCcccCCCC
Q 002376 557 SLNLTFNNLEGVVPSE 572 (929)
Q Consensus 557 ~L~Ls~N~l~~~~p~~ 572 (929)
.|++++|++++..|..
T Consensus 297 ~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 297 HLQINCSHFTTIARPT 312 (336)
T ss_dssp TSEESCCCSCCTTCSS
T ss_pred ceEEecccCccccCCc
Confidence 6667777777776643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=219.74 Aligned_cols=189 Identities=25% Similarity=0.352 Sum_probs=88.4
Q ss_pred ccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccC
Q 002376 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 434 (929)
|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|++|+|++
T Consensus 43 L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCC
Confidence 4444444444432 12 23444444444444444443222 44444444444444444432 1 344444455555555
Q ss_pred cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccc
Q 002376 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY 514 (929)
Q Consensus 435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (929)
|++++. +. +..+++|+.|++++|++++. +. +..+++|+.|+|++|++++..+ +..+++|+.|++++
T Consensus 117 n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~---------~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~ 182 (308)
T 1h6u_A 117 TQITDV-TP-LAGLSNLQVLYLDLNQITNI---------SP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182 (308)
T ss_dssp SCCCCC-GG-GTTCTTCCEEECCSSCCCCC---------GG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCCCCc-hh-hcCCCCCCEEECCCCccCcC---------cc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCC
Confidence 544432 11 44445555555555554421 11 4444555555555555553222 55555555555555
Q ss_pred ccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 515 NQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++
T Consensus 183 n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp SCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 55554332 4555555555555555554332 4555555555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.2e-22 Score=215.37 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=171.6
Q ss_pred ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCC
Q 002376 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402 (929)
Q Consensus 323 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 402 (929)
.+..+++|++|++++|.++ .+| .+..+. +|++|+|++|++++..+ +..+++|++|+|++|++++. ..+..+++
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~-~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~ 108 (308)
T 1h6u_A 36 TQADLDGITTLSAFGTGVT-TIE-GVQYLN-NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQS 108 (308)
T ss_dssp CHHHHHTCCEEECTTSCCC-CCT-TGGGCT-TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTT
T ss_pred cHHHcCCcCEEEeeCCCcc-Cch-hhhccC-CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCC
Confidence 3456789999999999998 455 577776 79999999999997655 99999999999999999864 36899999
Q ss_pred CCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccC
Q 002376 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482 (929)
Q Consensus 403 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~ 482 (929)
|++|++++|++++. +. +..+++|++|++++|++++..+ +..+++|+.|++++|++++. +. +..+++
T Consensus 109 L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~---------~~-l~~l~~ 174 (308)
T 1h6u_A 109 IKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL---------TP-LANLSK 174 (308)
T ss_dssp CCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC---------GG-GTTCTT
T ss_pred CCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC---------hh-hcCCCC
Confidence 99999999999874 43 8999999999999999987554 88999999999999999752 33 788899
Q ss_pred ccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCc
Q 002376 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547 (929)
Q Consensus 483 L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 547 (929)
|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|+|++|++++ .|.
T Consensus 175 L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~-~~~ 234 (308)
T 1h6u_A 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN-QPV 234 (308)
T ss_dssp CCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC-CCE
T ss_pred CCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec-CCe
Confidence 9999999999996544 8899999999999999997664 8999999999999999985 443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=215.49 Aligned_cols=105 Identities=18% Similarity=0.146 Sum_probs=66.2
Q ss_pred CcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcce-eeccCCcCCCCCCCcccccccccEE
Q 002376 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD-FIYCFNRFTGKIPGSLHNLTNIQII 278 (929)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~-l~l~~N~l~~~~p~~~~~l~~L~~L 278 (929)
++++.|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|...+..++++.+ +.+..|++++..|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 356677777777776555667777777777777777766666666665666544 3444566666666667777777777
Q ss_pred eccCccCcCCccCCCCCCCccceecc
Q 002376 279 RMTHNLLEGTLPPGLGNLPFLRTYNI 304 (929)
Q Consensus 279 ~Ls~N~l~~~~p~~~~~l~~L~~L~L 304 (929)
++++|+|++..+..+.....+..+++
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l 135 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDI 135 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred cccccccccCCchhhcccchhhhhhh
Confidence 77777776555444444444444443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-21 Score=196.74 Aligned_cols=181 Identities=21% Similarity=0.217 Sum_probs=126.4
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
+.++.+++.++ .+|..+. .+|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 45666777766 4554432 3678888888888776666777888888888888888766666677778888888888
Q ss_pred CcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecC
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~ 490 (929)
|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++.. +..+..+++|+.|+|++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------~~~~~~l~~L~~L~l~~ 157 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVP--------DGVFDRLTSLQYIWLHD 157 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC--------TTTTTTCTTCCEEECCS
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeC--------HHHhccCCCccEEEecC
Confidence 8887766666777777888888888777666666777777777777777776422 23355666777777777
Q ss_pred CCCCCCCCcchhcCcCcceeecccccccccCCccccCCCC
Q 002376 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKG 530 (929)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (929)
|.+.+. +++|++|+++.|+++|.+|..++.++.
T Consensus 158 N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 158 NPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCeecC-------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 766543 345677777777777777766665543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=196.66 Aligned_cols=165 Identities=25% Similarity=0.294 Sum_probs=140.9
Q ss_pred CCCCCCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCC
Q 002376 51 YWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNN 130 (929)
Q Consensus 51 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 130 (929)
-|..+.+.|+|.+|.|+... + +.+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~~------------l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSKR------------H-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEEETTEEECTTSC------------C-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEEeCCEeEccCCC------------c-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence 35557788999999997532 2 25666554 899999999999999999999999999999999999
Q ss_pred CCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecc
Q 002376 131 LQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN 210 (929)
Q Consensus 131 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N 210 (929)
|++..+..|..+++|++|+|++|+|+ .+++..|..+++|++|+|++|+++ .+ |..+..+++|++|+|++|
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~l--------p~~~~~l~~L~~L~L~~N 145 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-EL--------PRGIERLTHLTHLALDQN 145 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SC--------CTTGGGCTTCSEEECCSS
T ss_pred CCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-cc--------CcccccCCCCCEEECCCC
Confidence 99777788899999999999999998 577777899999999999999885 33 445677899999999999
Q ss_pred cCCCccCCccccCCCCceEEeeecCCCCcC
Q 002376 211 RLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240 (929)
Q Consensus 211 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i 240 (929)
+|++..+..|..+++|++|+|++|.+.+..
T Consensus 146 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 146 QLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 999888888999999999999999887543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=221.14 Aligned_cols=188 Identities=24% Similarity=0.344 Sum_probs=135.5
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
+|+.|+|++|++++ +|..++ ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 78888888888885 776553 36888888888888 455 446788888888888886 666 554 7888888
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +| . +. ++|+.|||
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp--------~-l~--~~L~~L~L 187 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LP--------E-LP--ESLEALDV 187 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC--------C-CC--TTCCEEEC
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cc--------h-hh--CCCCEEEC
Confidence 8888876 554 56788888888888875 554 46778888888888775 43 2 22 67888888
Q ss_pred cCCCCCCCCCcchhcCcCc-------ceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCC
Q 002376 489 SDNSLSGNLPNSLKNCKSL-------EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQ 553 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (929)
++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus 188 s~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 188 STNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred cCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 888887 5555 543 56 77777777777 4566666677777777777777777777666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-21 Score=237.50 Aligned_cols=231 Identities=20% Similarity=0.203 Sum_probs=129.1
Q ss_pred CChhhHHHHHHHHhhcCCCCCCCCCCCCC-CCCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEee
Q 002376 25 GINTDKEALMSFKSQISQESPSSPLSYWN-PSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQ 103 (929)
Q Consensus 25 ~~~~~~~aLl~~k~~~~~~~~~~~l~~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls 103 (929)
..+.+++||+++..+.... ....-..|. .....+.|.++.++. .+++.++|.++++.+ ++..+ |+.++|+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls 199 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDS-KTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-----LQHKKLS 199 (727)
T ss_dssp ---CCCHHHHHHHHHHHHH-HTTC--------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccc-cCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhH-----hhcCccC
Confidence 3468899999999887443 223334564 334567899988875 579999999998886 34443 3444444
Q ss_pred cCCCCC---------CCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEE
Q 002376 104 NNKLSG---------NLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLN 174 (929)
Q Consensus 104 ~N~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 174 (929)
.|.|.+ ..|..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|.. |++|++|++|+
T Consensus 200 ~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~ 276 (727)
T 4b8c_D 200 QYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLD 276 (727)
T ss_dssp ----------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEE
T ss_pred cccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChh-hhCCCCCCEEe
Confidence 444433 45788999999999999999998 67777889999999999999998 78866 89999999999
Q ss_pred ccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCccee
Q 002376 175 FGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDF 254 (929)
Q Consensus 175 Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l 254 (929)
|++|+|+ .+ |..|+.|++|++|+|++|.|+ .+|..|.++++|++|+|++|.|++.+|..+......+..+
T Consensus 277 Ls~N~l~-~l--------p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l 346 (727)
T 4b8c_D 277 LSHNRLT-SL--------PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIF 346 (727)
T ss_dssp CTTSCCS-SC--------CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHH
T ss_pred CcCCcCC-cc--------ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHH
Confidence 9999885 33 455677899999999999997 6677899999999999999999988777665422223446
Q ss_pred eccCCcCCCCCCCcccccccccEEeccCc
Q 002376 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHN 283 (929)
Q Consensus 255 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 283 (929)
++.+|.+++.+|.. |+.|++++|
T Consensus 347 ~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 347 YLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp HHHHCCCCCCCCCC---------------
T ss_pred hhccCcccCcCccc------cceeEeecc
Confidence 77888888877754 445566665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.3e-20 Score=188.95 Aligned_cols=159 Identities=25% Similarity=0.323 Sum_probs=137.4
Q ss_pred CCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCC
Q 002376 55 SSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134 (929)
Q Consensus 55 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 134 (929)
....|.|..|.|.. ++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++.
T Consensus 7 ~~C~C~~~~v~c~~------------~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~ 71 (220)
T 2v9t_B 7 AACTCSNNIVDCRG------------KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL 71 (220)
T ss_dssp TTSEEETTEEECTT------------SCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE
T ss_pred CCCEECCCEEEcCC------------CCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc
Confidence 33446777666654 4454 5676665 7899999999999988888999999999999999999988
Q ss_pred cccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCC
Q 002376 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214 (929)
Q Consensus 135 ~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~ 214 (929)
.|..|.++++|++|+|++|+|+ .+|+..|.++++|++|+|++|++++. .|..|..+++|++|+|++|+|++
T Consensus 72 ~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~--------~~~~~~~l~~L~~L~L~~N~l~~ 142 (220)
T 2v9t_B 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCL--------RVDAFQDLHNLNLLSLYDNKLQT 142 (220)
T ss_dssp CTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCSC
T ss_pred CHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEe--------CHHHcCCCCCCCEEECCCCcCCE
Confidence 8999999999999999999998 68888899999999999999988553 45567889999999999999999
Q ss_pred ccCCccccCCCCceEEeeecCCC
Q 002376 215 TVPSTIYNMTSLVHLRLASNQLG 237 (929)
Q Consensus 215 ~~p~~~~~l~~L~~L~Ls~N~l~ 237 (929)
..+..|..+++|++|+|++|.+.
T Consensus 143 ~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 143 IAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECHHHHhCCCCCCEEEeCCCCcC
Confidence 88888999999999999999886
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.6e-20 Score=190.48 Aligned_cols=136 Identities=24% Similarity=0.277 Sum_probs=81.4
Q ss_pred CceecccCcccccccC-cccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCc
Q 002376 427 LNQIDLSGNELTGEIP-ISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCK 505 (929)
Q Consensus 427 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~ 505 (929)
+++|+|++|++++..| ..|.++++|+.|+|++|+|++.. +..|..+++|++|+|++|++++..|..|.+++
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 105 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE--------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE 105 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEEC--------TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCS
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEEC--------HHHhCCCCCCCEEECCCCccCccCHhHhcCCc
Confidence 3444555555544322 23445555555555555554321 23444555556666666666655556666666
Q ss_pred CcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 506 SLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 506 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
+|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+
T Consensus 106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 106 SLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 67777777777766666667777777777777777776666677777777777777777765443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.3e-20 Score=203.40 Aligned_cols=74 Identities=31% Similarity=0.351 Sum_probs=35.1
Q ss_pred ccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccc---cCCCCCCEEECCCCcCCCcCCcccccCC
Q 002376 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIV---AELKGLEVLDLSSNKLSGSIPSDLQNLQ 553 (929)
Q Consensus 480 l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 553 (929)
+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++..+..+..++
T Consensus 111 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~ 187 (361)
T 2xot_A 111 LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSC
T ss_pred CcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhcc
Confidence 3344444444444443444445555555555555555554333333 3455666666666666543334444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.9e-19 Score=192.97 Aligned_cols=168 Identities=26% Similarity=0.342 Sum_probs=86.9
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
+|+.|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|++|++++|++++ +| .+.
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~----------- 109 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLK----------- 109 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGT-----------
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhc-----------
Confidence 455555555555433 2 24555555555555555554332 4455555555555555543 11 244
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecc
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 513 (929)
.+++|+.|++++|++++ ...+..+++|+.|++++|++++. ..+..+++|+.|+|+
T Consensus 110 -------------~l~~L~~L~L~~n~i~~----------~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 110 -------------DLKKLKSLSLEHNGISD----------INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 164 (291)
T ss_dssp -------------TCTTCCEEECTTSCCCC----------CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred -------------cCCCCCEEECCCCcCCC----------ChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEcc
Confidence 44455555555554442 11344445555555555555543 345555566666666
Q ss_pred cccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
+|++++..| +..+++|+.|+|++|++++ +| .+..+++|+.|++++|+++.
T Consensus 165 ~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 165 DNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 666654443 5556666666666666654 23 25556666666666666554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=183.85 Aligned_cols=153 Identities=24% Similarity=0.336 Sum_probs=79.2
Q ss_pred cEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCC
Q 002376 380 TLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNN 459 (929)
Q Consensus 380 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 459 (929)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l----------- 79 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL----------- 79 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTC-----------
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCC-----------
Confidence 34555555555 3343332 344555555555444444444444444444444444444444444444
Q ss_pred cCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCC
Q 002376 460 RINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539 (929)
Q Consensus 460 ~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (929)
++|++|+|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 80 ---------------------~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 138 (220)
T 2v9t_B 80 ---------------------RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138 (220)
T ss_dssp ---------------------SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ---------------------cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC
Confidence 44444444444444443444555555555555555555555555666666666666666
Q ss_pred cCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 540 KLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 540 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
+|++..+..|..+++|+.|+|++|++.+
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 139 KLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 6665555555555566666655555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=193.64 Aligned_cols=145 Identities=21% Similarity=0.358 Sum_probs=111.0
Q ss_pred ccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC
Q 002376 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR 377 (929)
Q Consensus 298 ~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 377 (929)
.+..+.++.+.+... ..+..+++|++|++++|.++. +| .+..+. +|++|+|++|++++..+ +.+++
T Consensus 25 ~~~~~~l~~~~~~~~---------~~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~-~L~~L~L~~n~l~~~~~--l~~l~ 90 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDA---------VTQNELNSIDQIIANNSDIKS-VQ-GIQYLP-NVTKLFLNGNKLTDIKP--LANLK 90 (291)
T ss_dssp HHHHHHTTCSCTTSE---------ECHHHHHTCCEEECTTSCCCC-CT-TGGGCT-TCCEEECCSSCCCCCGG--GTTCT
T ss_pred HHHHHHhcCCCcccc---------cchhhcCcccEEEccCCCccc-Ch-hHhcCC-CCCEEEccCCccCCCcc--cccCC
Confidence 344556666655432 335567899999999999984 44 467766 89999999999998665 99999
Q ss_pred cccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceeccc
Q 002376 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLS 457 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 457 (929)
+|++|+|++|++++ +| .+..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|+++
T Consensus 91 ~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 91 NLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE 164 (291)
T ss_dssp TCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred CCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEcc
Confidence 99999999999986 33 489999999999999999864 4577778888888888877753 345566666666666
Q ss_pred CCcCC
Q 002376 458 NNRIN 462 (929)
Q Consensus 458 ~N~l~ 462 (929)
+|+++
T Consensus 165 ~N~l~ 169 (291)
T 1h6t_A 165 DNQIS 169 (291)
T ss_dssp SSCCC
T ss_pred CCccc
Confidence 66655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=183.96 Aligned_cols=155 Identities=24% Similarity=0.244 Sum_probs=105.4
Q ss_pred EEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCc-ccccCCCCCceecccCcccccccCcccccccccceecccCC
Q 002376 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP-NSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNN 459 (929)
Q Consensus 381 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 459 (929)
.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4444444444 2333321 234455555555554433 34566666666666666666666666777777777777777
Q ss_pred cCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCC
Q 002376 460 RINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539 (929)
Q Consensus 460 ~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (929)
+|++.. |..+..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 92 ~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 92 RLENVQ--------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp CCCCCC--------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred ccCccC--------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 776432 445666777778888888888777888888888888889888888888888888999999999999
Q ss_pred cCCCcCC
Q 002376 540 KLSGSIP 546 (929)
Q Consensus 540 ~l~~~~p 546 (929)
.+++..+
T Consensus 164 ~l~c~c~ 170 (220)
T 2v70_A 164 PFNCNCY 170 (220)
T ss_dssp CEECSGG
T ss_pred CCcCCCc
Confidence 8886544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=199.76 Aligned_cols=179 Identities=22% Similarity=0.242 Sum_probs=128.4
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCC-CCCcccEEEeeCCCCCcccCccccCCCCCCEEEec
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG-RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 409 (929)
+.+++++|+++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 57888888887 5776543 3688888888888888788787 88888888888888887777778888888888888
Q ss_pred CCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEec
Q 002376 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489 (929)
Q Consensus 410 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs 489 (929)
+|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++ +|...+. .+..+++|+.|||+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~----~~~~l~~L~~L~L~ 171 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIK----DGNKLPKLMLLDLS 171 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC--------CTTCCEEECC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhc----CcccCCcCCEEECC
Confidence 888887777778888888888888888887777788888888888888888763 3211110 01345666666666
Q ss_pred CCCCCCCCCcchhcCcCc--ceeeccccccc
Q 002376 490 DNSLSGNLPNSLKNCKSL--EELLMAYNQFS 518 (929)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l~ 518 (929)
+|+|++..+..|..++.+ +.|+|++|.+.
T Consensus 172 ~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp SSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 666665444555555542 45555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=213.40 Aligned_cols=190 Identities=23% Similarity=0.320 Sum_probs=109.3
Q ss_pred ccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcccc
Q 002376 275 IQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNE 354 (929)
Q Consensus 275 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 354 (929)
+..+++..+.+....+ +..|++|+.|++++|.|..+ ..+..+++|+.|+|++|++++..| +..+. +
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l---------~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~-~ 88 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV---------QGIQYLPNVTKLFLNGNKLTDIKP--LTNLK-N 88 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC---------TTGGGCTTCCEEECTTSCCCCCGG--GGGCT-T
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC---------hHHccCCCCCEEEeeCCCCCCChh--hccCC-C
Confidence 3444444444443322 34455555555555555433 234556666666666666664333 55554 5
Q ss_pred ccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccC
Q 002376 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 434 (929)
|+.|+|++|.|.+. ..+..+++|++|+|++|+|++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++
T Consensus 89 L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 162 (605)
T 1m9s_A 89 LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED 162 (605)
T ss_dssp CCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred CCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence 66666666666642 2566666777777777766642 3466666666666666666654 4566666666666666
Q ss_pred cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCC
Q 002376 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN 496 (929)
Q Consensus 435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~ 496 (929)
|+|++..| +..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|.+++.
T Consensus 163 N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l---------~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 163 NQISDIVP--LAGLTKLQNLYLSKNHISD-L---------RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCB-C---------GGGTTCTTCSEEECCSEEEECC
T ss_pred CcCCCchh--hccCCCCCEEECcCCCCCC-C---------hHHccCCCCCEEEccCCcCcCC
Confidence 66665544 5666666666666666653 1 1345555666666666665543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.7e-22 Score=232.17 Aligned_cols=206 Identities=20% Similarity=0.135 Sum_probs=139.1
Q ss_pred cCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCC
Q 002376 324 LTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403 (929)
Q Consensus 324 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 403 (929)
+...++|+.|+|++|+++ .+|+.++.+. +|+.|++++|......|. .+..+.+.+..|..++.+++|
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~-~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L 411 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCK-ELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTL 411 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHH-HHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHH-HHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhc
Confidence 355678888888888887 7888888887 688888877652111111 011223445666667777777
Q ss_pred CEEE-ecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccC
Q 002376 404 QVLG-LAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLEN 482 (929)
Q Consensus 404 ~~L~-L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~ 482 (929)
+.|+ ++.|.+ ..|+.+.+++|.++...+. .|+.|+|++|+|++ + |. ++.+++
T Consensus 412 ~~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-l--------p~-~~~l~~ 464 (567)
T 1dce_A 412 KAVDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-L--------CH-LEQLLL 464 (567)
T ss_dssp HHHCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-C--------CC-GGGGTT
T ss_pred ccCcchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-C--------cC-cccccc
Confidence 7776 555544 2455566666666643221 36777777777764 2 43 667777
Q ss_pred ccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcC-CcccccCCCCCeEeCC
Q 002376 483 VVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSI-PSDLQNLQALRSLNLT 561 (929)
Q Consensus 483 L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls 561 (929)
|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.+ |..+..+++|+.|+|+
T Consensus 465 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~ 541 (567)
T 1dce_A 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541 (567)
T ss_dssp CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECT
T ss_pred CcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEec
Confidence 777777777777 667777777777777777777775 45 6777777777777777777665 7777777777777777
Q ss_pred CCcCcccCCCC
Q 002376 562 FNNLEGVVPSE 572 (929)
Q Consensus 562 ~N~l~~~~p~~ 572 (929)
+|++++.+|..
T Consensus 542 ~N~l~~~~~~~ 552 (567)
T 1dce_A 542 GNSLCQEEGIQ 552 (567)
T ss_dssp TSGGGGSSSCT
T ss_pred CCcCCCCccHH
Confidence 77777776644
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=208.38 Aligned_cols=169 Identities=30% Similarity=0.385 Sum_probs=98.8
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
.|+.|++++|.|... | .+..+++|+.|+|++|+|++..| +..+++|+.|+|++|.|++ +| .+..+++|+.|+|+
T Consensus 44 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 44 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLE 117 (605)
T ss_dssp TCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECT
T ss_pred CCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEec
Confidence 466666666665532 2 35566666666666666665433 5566666666666666654 22 45666666666666
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecc
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 513 (929)
+|++++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|+
T Consensus 118 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l----------~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 183 (605)
T 1m9s_A 118 HNGISDI--NGLVHLPQLESLYLGNNKITDI----------TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 183 (605)
T ss_dssp TSCCCCC--GGGGGCTTCSEEECCSSCCCCC----------GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCCCC--ccccCCCccCEEECCCCccCCc----------hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECc
Confidence 6666542 2355566666666666666531 234555666666666666665444 5666666666666
Q ss_pred cccccccCCccccCCCCCCEEECCCCcCCCc
Q 002376 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSGS 544 (929)
Q Consensus 514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 544 (929)
+|+|++. | .+..+++|+.|+|++|++++.
T Consensus 184 ~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 184 KNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp SSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred CCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 6666643 2 456666666666666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.1e-20 Score=221.27 Aligned_cols=191 Identities=23% Similarity=0.234 Sum_probs=109.8
Q ss_pred EecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccc
Q 002376 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELT 438 (929)
Q Consensus 359 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 438 (929)
+++.|.+. ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|.++++|++|||++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 44445554 55777788888888888888887 56766778888888888888887 67777888888888888888888
Q ss_pred cccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcC-cceeecccccc
Q 002376 439 GEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS-LEELLMAYNQF 517 (929)
Q Consensus 439 ~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l 517 (929)
.+|..|+++++|++|+|++|.|+ .| |..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~l--------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l 353 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TL--------PWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRP 353 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CC--------CSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-cc--------ChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcc
Confidence 66888888888888888888875 33 556777888888888888888888877765532 23477888888
Q ss_pred cccCCccccCCCCCCEEECCCC--------cCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 518 SGPIPNIVAELKGLEVLDLSSN--------KLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 518 ~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
+|.+|. .|+.|++++| .|.+..+..+.++..+....+++|-+.+.
T Consensus 354 ~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 354 EIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp CCCCCC------C-----------------------------------------CCCGG
T ss_pred cCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccccc
Confidence 887775 3455667666 34444444555566666667777766544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-19 Score=194.21 Aligned_cols=136 Identities=18% Similarity=0.088 Sum_probs=108.3
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC---------------------------------cHHHHHHHHHHHHccC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG---------------------------------SWKSFIAECETLRNVR 700 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~---------------------------------~~~~~~~E~~~l~~l~ 700 (929)
..+......|+..+.||+|+||.||+|.+.. ....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3445555667778999999999999987530 1345889999999999
Q ss_pred CccccceeeecccCCCCCcceEEEEEEecCCCCcccccc--ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC
Q 002376 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIH--GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE 778 (929)
Q Consensus 701 Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 778 (929)
| +++.+++.. ...|+||||+++|+|.+ +. ....++.|++.||+|||+. +|+||||||+|||++ +
T Consensus 163 --~-~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 --G-LAVPKVYAW------EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp --T-SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred --C-CCcCeEEec------cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 4 666665522 23599999999999999 43 2234578999999999998 999999999999999 9
Q ss_pred CceEEeccccccccccccCCCCCccccceeccccccccccccCC
Q 002376 779 MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822 (929)
Q Consensus 779 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 822 (929)
+.+||+|||+|+. +..|+|||++.+
T Consensus 229 ~~vkl~DFG~a~~-------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE-------------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE-------------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE-------------------CCCCCHHHHHHH
Confidence 9999999999863 345889998743
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=177.85 Aligned_cols=153 Identities=22% Similarity=0.211 Sum_probs=70.3
Q ss_pred ccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccC
Q 002376 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 434 (929)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 445555555554 2333222 4455555555555544444444444444444444444433333444444444444444
Q ss_pred cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccc
Q 002376 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY 514 (929)
Q Consensus 435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (929)
|+|++..+..|..+++ |++|+|++|+++ .+|..+..+++|+.|+|++
T Consensus 98 N~l~~l~~~~~~~l~~--------------------------------L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 144 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVH--------------------------------LKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144 (229)
T ss_dssp SCCCCCCTTTTTTCTT--------------------------------CCEEECCSSCCC-SCCTTGGGCTTCSEEECCS
T ss_pred CcCCccChhHhCcchh--------------------------------hCeEeccCCccc-ccCcccccCCCCCEEECCC
Confidence 4444333333333333 333333333333 3344444444455555555
Q ss_pred ccccccCCccccCCCCCCEEECCCCcCCC
Q 002376 515 NQFSGPIPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
|+|++..+..|..+++|+.|+|++|.+.+
T Consensus 145 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 145 NQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 55544444445555555555555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-21 Score=224.76 Aligned_cols=170 Identities=19% Similarity=0.206 Sum_probs=100.4
Q ss_pred CCCcccccccccEEeccCcc-------------CcCCccCCCCCCCccceec-cccccccCCCCCCCCccccccCCCCCC
Q 002376 265 IPGSLHNLTNIQIIRMTHNL-------------LEGTLPPGLGNLPFLRTYN-IGFNKIVSSGDDEGLSFITSLTNSTHL 330 (929)
Q Consensus 265 ~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~i~~~~~~~~~~~~~~~~~l~~L 330 (929)
+|..++++++|+.|++++|. +.+..|..++++++|+.|+ ++.|.+. +|
T Consensus 364 Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~------------------~L 425 (567)
T 1dce_A 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD------------------DL 425 (567)
T ss_dssp HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH------------------HH
T ss_pred hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc------------------hh
Confidence 34444445555555554443 4445555666666666666 4555431 23
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecC
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG 410 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 410 (929)
..+.+++|.++.. |. ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..++.+++|++|+|++
T Consensus 426 ~~l~l~~n~i~~l-~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 495 (567)
T 1dce_A 426 RSKFLLENSVLKM-EY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495 (567)
T ss_dssp HHHHHHHHHHHHH-HH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred hhhhhhccccccc-Cc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCC
Confidence 3344555555421 11 136666666666665 344 666667777777777766 5566666667777777777
Q ss_pred CcCCCCCcccccCCCCCceecccCccccccc-CcccccccccceecccCCcCCCC
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEI-PISFGNFQSLLSIDLSNNRINGN 464 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~ 464 (929)
|+|++ +| .+.++++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++.
T Consensus 496 N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 496 NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 76665 45 5666666667777666666654 66666666666666666666643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.6e-19 Score=186.60 Aligned_cols=167 Identities=22% Similarity=0.273 Sum_probs=92.3
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
++..+++++|.+++.. .+..+++|++|++++|.++. +| .+..+++|++|+|++|+|++..+ +.++++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 4555666666665433 45566666666666666653 33 45666666666666666665433 6666666666666
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecc
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls 513 (929)
+|++++. |.. .. ++|+.|+|++|++++ + +.+..+++|+.|||++|++++. | .+..+++|+.|+|+
T Consensus 94 ~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~-~---------~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~ 158 (263)
T 1xeu_A 94 RNRLKNL-NGI-PS-ACLSRLFLDNNELRD-T---------DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLH 158 (263)
T ss_dssp SSCCSCC-TTC-CC-SSCCEEECCSSCCSB-S---------GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECT
T ss_pred CCccCCc-Ccc-cc-CcccEEEccCCccCC-C---------hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECC
Confidence 6666542 221 11 556666666666553 1 1344555555555555555543 2 45555555555555
Q ss_pred cccccccCCccccCCCCCCEEECCCCcCCC
Q 002376 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 514 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
+|+|++. ..+..+++|+.|++++|++++
T Consensus 159 ~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp TSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 5555544 345555555555555555553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=8e-18 Score=170.54 Aligned_cols=154 Identities=20% Similarity=0.312 Sum_probs=91.2
Q ss_pred CCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccce
Q 002376 374 GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLS 453 (929)
Q Consensus 374 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 453 (929)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..|..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44556666666666665 334 46666666666666665542 235666677777777777776666666666777777
Q ss_pred ecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCE
Q 002376 454 IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533 (929)
Q Consensus 454 L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 533 (929)
|++++|++++.. |..+..+++|++|+|++|++.+.+| .+..+++|+.|++++|++++. + .+..+++|+.
T Consensus 117 L~Ls~n~i~~~~--------~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~ 185 (197)
T 4ezg_A 117 LDISHSAHDDSI--------LTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQ 185 (197)
T ss_dssp EECCSSBCBGGG--------HHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCE
T ss_pred EEecCCccCcHh--------HHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCE
Confidence 777777665432 4556666666666666665222344 455666666666666666542 2 4555566666
Q ss_pred EECCCCcCC
Q 002376 534 LDLSSNKLS 542 (929)
Q Consensus 534 L~Ls~N~l~ 542 (929)
|++++|++.
T Consensus 186 L~l~~N~i~ 194 (197)
T 4ezg_A 186 LYAFSQTIG 194 (197)
T ss_dssp EEECBC---
T ss_pred EEeeCcccC
Confidence 666666554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=185.07 Aligned_cols=182 Identities=25% Similarity=0.430 Sum_probs=91.6
Q ss_pred CccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCC
Q 002376 185 PPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGK 264 (929)
Q Consensus 185 p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~ 264 (929)
|..|..+.|.. .+.++..+++++|.+++.. .+..+++|++|++++|+++ .+|
T Consensus 6 p~~i~~~~pd~--~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~----------------------- 57 (263)
T 1xeu_A 6 PTPINQVFPDP--GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA----------------------- 57 (263)
T ss_dssp CEEHHHHCCSH--HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-----------------------
T ss_pred CCCHHHhCCCH--HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-----------------------
Confidence 33444444443 4566666777777776543 4666777777777777665 233
Q ss_pred CCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCcccccc
Q 002376 265 IPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI 344 (929)
Q Consensus 265 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 344 (929)
.+..+++|+.|+|++|+|++..+ +..+++|+.|++++|++..++. +.. ++
T Consensus 58 ---~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~---------~~~-~~--------------- 107 (263)
T 1xeu_A 58 ---GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG---------IPS-AC--------------- 107 (263)
T ss_dssp ---TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT---------CCC-SS---------------
T ss_pred ---HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc---------ccc-Cc---------------
Confidence 23344455555555555553322 4444444444444444332211 111 33
Q ss_pred CchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCC
Q 002376 345 PESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANL 424 (929)
Q Consensus 345 p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 424 (929)
|+.|+|++|+|++. ..+..+++|++|+|++|++++. + .+..+++|++|+|++|++++. ..+..+
T Consensus 108 ----------L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l 171 (263)
T 1xeu_A 108 ----------LSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRL 171 (263)
T ss_dssp ----------CCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTC
T ss_pred ----------ccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccC
Confidence 44444444444332 1244455555555555555533 2 355555555555555555543 445555
Q ss_pred CCCceecccCcccccc
Q 002376 425 KKLNQIDLSGNELTGE 440 (929)
Q Consensus 425 ~~L~~L~Ls~N~l~~~ 440 (929)
++|+.|++++|.+++.
T Consensus 172 ~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 172 KKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCCCEEEEEEEEEECC
T ss_pred CCCCEEeCCCCcccCC
Confidence 5566666666655543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=168.93 Aligned_cols=155 Identities=21% Similarity=0.271 Sum_probs=87.5
Q ss_pred CCceecccCcccccccCc-ccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcC
Q 002376 426 KLNQIDLSGNELTGEIPI-SFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC 504 (929)
Q Consensus 426 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 504 (929)
+|++|+|++|++++..+. .|..+++|++|+|++|+|++.. |..+..+++|++|+|++|++++..|..|.++
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 101 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE--------PNAFEGASHIQELQLGENKIKEISNKMFLGL 101 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC--------TTTTTTCTTCCEEECCSCCCCEECSSSSTTC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcC--------HhHcCCcccCCEEECCCCcCCccCHHHhcCC
Confidence 455555555555544332 2555555555555555555432 3445555566666666666666666666777
Q ss_pred cCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCc-ccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccc
Q 002376 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS-DLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHL 583 (929)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l 583 (929)
++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+- ++. ..++...+..+...+..|.. ++.....++
T Consensus 102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~P~~--l~~~~l~~l 177 (192)
T 1w8a_A 102 HQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAPSK--VRDVQIKDL 177 (192)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCSSTT--TTTSBGGGS
T ss_pred CCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCCChH--HcCCChhhC
Confidence 7777777777777777777777777777777777777765442 111 11222234444444444432 344444556
Q ss_pred cCCCCCcCC
Q 002376 584 KGNPKLCLQ 592 (929)
Q Consensus 584 ~~N~~~c~~ 592 (929)
..+...|..
T Consensus 178 ~~~~~~C~~ 186 (192)
T 1w8a_A 178 PHSEFKCSS 186 (192)
T ss_dssp CTTTCCCCC
T ss_pred cHhhcCcCC
Confidence 666666643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=4e-18 Score=171.90 Aligned_cols=156 Identities=24% Similarity=0.351 Sum_probs=127.3
Q ss_pred ceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCc
Q 002376 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507 (929)
Q Consensus 428 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L 507 (929)
+.+++++|+++ .+|..+.. +|+.|+|++|+|++..+. ..+..+++|++|+|++|++++..|..|.++++|
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~-------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 80 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSD-------GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCS-------CSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCc-------cccccCCCCCEEECCCCCCCCcCHhHcCCcccC
Confidence 78899999996 56765543 899999999999854311 237888999999999999999999999999999
Q ss_pred ceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCC
Q 002376 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNP 587 (929)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~ 587 (929)
++|+|++|+|++..|..|..+++|++|+|++|+|++.+|..+..+++|++|+|++|++++..+.......+....+.++.
T Consensus 81 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~ 160 (192)
T 1w8a_A 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGA 160 (192)
T ss_dssp CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGG
T ss_pred CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999876532211112223344554
Q ss_pred CCcCCC
Q 002376 588 KLCLQL 593 (929)
Q Consensus 588 ~~c~~~ 593 (929)
..|..|
T Consensus 161 ~~C~~P 166 (192)
T 1w8a_A 161 ARCGAP 166 (192)
T ss_dssp CBBCSS
T ss_pred CCCCCC
Confidence 455443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=166.38 Aligned_cols=150 Identities=18% Similarity=0.281 Sum_probs=100.2
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
+|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 5666777776666 334 46666777777777775542 3356667777777777777776666667777777777777
Q ss_pred CcccccccCcccccccccceecccCCc-CCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeec
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNR-INGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLM 512 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~L 512 (929)
+|++++..|..|..+++|+.|++++|+ ++ .+ | .+..+++|+.|++++|++++ ++ .+..+++|+.|++
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~--------~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l 188 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DI--------M-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYA 188 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CC--------G-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEE
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-cc--------H-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEe
Confidence 777776666667777777777777776 43 22 3 46667777777777777775 33 6777788888888
Q ss_pred ccccccc
Q 002376 513 AYNQFSG 519 (929)
Q Consensus 513 s~N~l~~ 519 (929)
++|+|.+
T Consensus 189 ~~N~i~~ 195 (197)
T 4ezg_A 189 FSQTIGG 195 (197)
T ss_dssp CBC----
T ss_pred eCcccCC
Confidence 8887753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=183.01 Aligned_cols=125 Identities=15% Similarity=0.108 Sum_probs=86.1
Q ss_pred CCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCC-EE
Q 002376 328 THLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ-VL 406 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L 406 (929)
.+++.+.+.++-.. .....+.....+|+.++|++|+++...+.+|.++++|+.|+|++| ++...+..|.++++|+ .+
T Consensus 202 ~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 202 RDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 44555555554222 111222222236888888888887777777888888888888877 6666667778888887 88
Q ss_pred EecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceec
Q 002376 407 GLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSID 455 (929)
Q Consensus 407 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 455 (929)
++.+ .++...+.+|.++++|+.|++++|+++.+.+.+|.++++|+.|+
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 8877 66666667788888888888877887776677777777777765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.2e-18 Score=186.76 Aligned_cols=294 Identities=15% Similarity=0.122 Sum_probs=168.8
Q ss_pred cccCCCCCC--CCCCCEEEeecCCCCCCCCcCCCC-CCCCcEEeCCCCCCC--CCcccccccccccceecccccccCCCC
Q 002376 85 GTISPHIGN--LSFLRSIQLQNNKLSGNLPREIGN-LFRLRVLNISFNNLQ--GELPVNISKLTELKMLDLMANKITGRV 159 (929)
Q Consensus 85 g~i~~~l~~--L~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~i 159 (929)
|.++..+.. +.+++.|.++++ +.+..-..+.. +++|++|||++|+|. ...+. .++.++.+++..|. |
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~----I 84 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANF----V 84 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTE----E
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccc----c
Confidence 344444443 667777777754 11111112222 677788888888777 22222 22224555555553 4
Q ss_pred Chhhhcc--------CCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEe
Q 002376 160 TDDQLRN--------LRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRL 231 (929)
Q Consensus 160 ~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 231 (929)
|+.+|.+ +++|+.|+|.+ .+ ..+.+.+|.++++|+.|+|++|.+..+.+.+|.++.++..+.+
T Consensus 85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i--------~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~ 155 (329)
T 3sb4_A 85 PAYAFSNVVNGVTKGKQTLEKVILSE-KI--------KNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPL 155 (329)
T ss_dssp CTTTTEEEETTEEEECTTCCC-CBCT-TC--------CEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECT
T ss_pred CHHHhcccccccccccCCCcEEECCc-cc--------cchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecC
Confidence 5566777 77777777766 33 3344566777777777777777777777777777776666665
Q ss_pred eecCC---CCcCCcccccCCCCcc-eeeccCCcCCCCCCCcc----cccccccEEeccCccCcCCccCCCCCCCccceec
Q 002376 232 ASNQL---GGEIPYDVRDTLPNLL-DFIYCFNRFTGKIPGSL----HNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYN 303 (929)
Q Consensus 232 s~N~l---~~~ip~~~~~~l~~L~-~l~l~~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 303 (929)
..+.. ...+....+..+..|+ .+.+... +.++..+ ....+++.+.+.++-...........+++|+.++
T Consensus 156 ~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~---~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~ 232 (329)
T 3sb4_A 156 GSSDAYRFKNRWEHFAFIEGEPLETTIQVGAM---GKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLD 232 (329)
T ss_dssp TCTHHHHTSTTTTTSCEEESCCCEEEEEECTT---CCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEE
T ss_pred cchhhhhccccccccccccccccceeEEecCC---CcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEE
Confidence 55221 0112222233344444 2222211 1111111 1234455555544322111111111256666666
Q ss_pred cccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhcccccc-EEEecCCccccccCCCCCCCCcccEE
Q 002376 304 IGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS-KLYLGGNHIYGKIPASIGRLRSLTLL 382 (929)
Q Consensus 304 L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 382 (929)
+++|++..++. .+|.++++|+.|+|.+| ++..-+..|..+. +|+ .+++.+ .++...+.+|.++++|+.+
T Consensus 233 L~~n~i~~I~~-------~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~-~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 233 ISKTNATTIPD-------FTFAQKKYLLKIKLPHN-LKTIGQRVFSNCG-RLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTBCCCEECT-------TTTTTCTTCCEEECCTT-CCEECTTTTTTCT-TCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred CCCCCcceecH-------hhhhCCCCCCEEECCcc-cceehHHHhhCCh-hccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 66666666554 35677777777777776 6533334455554 688 888887 6776777888889999999
Q ss_pred EeeCCCCCcccCccccCCCCCCEEEe
Q 002376 383 DLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 383 ~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
+++.|+++...+..|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 99888888777778888888888763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=154.66 Aligned_cols=85 Identities=20% Similarity=0.185 Sum_probs=33.7
Q ss_pred CccEEEecCCCCCCCCCcchhcCcCcceeecccccccccC-CccccCCCCCCEEECCCCcCCCcCC---cccccCCCCCe
Q 002376 482 NVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPI-PNIVAELKGLEVLDLSSNKLSGSIP---SDLQNLQALRS 557 (929)
Q Consensus 482 ~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~ 557 (929)
+|++|+|++|++++.+|..+.++++|++|+|++|+|++.. +..+..+++|+.|++++|++++..+ ..+..+++|++
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 151 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence 3333333333333333333333444444444444443321 1334444444444444444443222 23444444444
Q ss_pred EeCCCCcCc
Q 002376 558 LNLTFNNLE 566 (929)
Q Consensus 558 L~Ls~N~l~ 566 (929)
|++++|.+.
T Consensus 152 L~l~~n~~~ 160 (168)
T 2ell_A 152 LDGYDREDQ 160 (168)
T ss_dssp ETTEETTSC
T ss_pred ecCCCCChh
Confidence 444444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-16 Score=151.86 Aligned_cols=132 Identities=26% Similarity=0.284 Sum_probs=80.5
Q ss_pred CCCCEEEccCCccc-cccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEE
Q 002376 328 THLNYLALDGNQFE-GKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVL 406 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~-~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 406 (929)
++|++|+|++|+++ +.+|..+..+. +|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFV-NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGG-GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCC-CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 56666666666665 55666555554 566666666666654 556666666666666666665556555556666666
Q ss_pred EecCCcCCCCCc-ccccCCCCCceecccCcccccccC---cccccccccceecccCCcCC
Q 002376 407 GLAGNEIPGGIP-NSLANLKKLNQIDLSGNELTGEIP---ISFGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 407 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 462 (929)
+|++|++++..+ ..+..+++|++|++++|.+++..+ ..|..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 666666664322 556666666666666666664333 24555666666666666553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-15 Score=152.07 Aligned_cols=109 Identities=28% Similarity=0.372 Sum_probs=74.8
Q ss_pred CCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCc
Q 002376 56 SSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135 (929)
Q Consensus 56 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 135 (929)
...|+|.++.|+.. +++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|+|++..
T Consensus 4 ~C~C~~~~l~~~~~------------~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 4 RCSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TCEEETTEEECCSS------------CCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCEeCCCEEEecCC------------CCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 34578888888653 233 3454433 67888888888888666667788888888888888888666
Q ss_pred ccccccccccceecccccccCCCCChhhhccCCCCcEEEcccccc
Q 002376 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180 (929)
Q Consensus 136 p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l 180 (929)
+..|..+++|++|+|++|+|+ .+++..|.++++|++|+|++|++
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l 112 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred hhHccCCCccCEEECCCCCcc-ccCHHHhhCCcccCEEECcCCcc
Confidence 666777777777777777777 35554456666666666666655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=154.14 Aligned_cols=128 Identities=27% Similarity=0.381 Sum_probs=79.9
Q ss_pred ceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCc
Q 002376 428 NQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSL 507 (929)
Q Consensus 428 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L 507 (929)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+ .+ |..+..+++|+.|||++|++++..|..|.++++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~i--------p~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L 80 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LV--------PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SC--------CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hh--------HHHhhcccCCCEEECCCCcCCEeCHhHccCCCCC
Confidence 45566666665 3444332 35666666666664 22 4455666666666666666666666666667777
Q ss_pred ceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcc
Q 002376 508 EELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (929)
++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus 81 ~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 777777777776666666677777777777777765555556666666666666666553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.3e-16 Score=149.99 Aligned_cols=81 Identities=23% Similarity=0.305 Sum_probs=37.3
Q ss_pred cCccEEEecCCCCCCCCCcchhcCcCcceeeccccccccc-CCccccCCCCCCEEECCCCcCCCcCC---cccccCCCCC
Q 002376 481 ENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP-IPNIVAELKGLEVLDLSSNKLSGSIP---SDLQNLQALR 556 (929)
Q Consensus 481 ~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~ 556 (929)
++|++|+|++|.+++.+|..+..+++|++|++++|++++. .+..++.+++|++|++++|++++..+ ..+..+++|+
T Consensus 64 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~ 143 (149)
T 2je0_A 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLT 143 (149)
T ss_dssp TTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCC
T ss_pred CCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcc
Confidence 3344444444444433444444444444444444444432 22444555555555555555554333 3445555555
Q ss_pred eEeCC
Q 002376 557 SLNLT 561 (929)
Q Consensus 557 ~L~Ls 561 (929)
.||++
T Consensus 144 ~L~l~ 148 (149)
T 2je0_A 144 YLDGY 148 (149)
T ss_dssp EETTB
T ss_pred cccCC
Confidence 55544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=149.72 Aligned_cols=130 Identities=19% Similarity=0.240 Sum_probs=113.8
Q ss_pred CCCCCCEEEecCCcCC-CCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhh
Q 002376 399 QLQGLQVLGLAGNEIP-GGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEI 477 (929)
Q Consensus 399 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~ 477 (929)
..++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..|.++++|++|++++|++++.+ |..+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~--------~~~~ 84 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL--------EVLA 84 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCT--------HHHH
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchH--------HHHh
Confidence 3478999999999998 78888889999999999999999876 77889999999999999998644 7778
Q ss_pred hcccCccEEEecCCCCCCC-CCcchhcCcCcceeecccccccccCC---ccccCCCCCCEEECCC
Q 002376 478 SRLENVVTIDLSDNSLSGN-LPNSLKNCKSLEELLMAYNQFSGPIP---NIVAELKGLEVLDLSS 538 (929)
Q Consensus 478 ~~l~~L~~LdLs~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 538 (929)
..+++|++|++++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 85 ~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp HHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred hhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8899999999999999874 34789999999999999999998776 6789999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2e-15 Score=152.00 Aligned_cols=125 Identities=22% Similarity=0.346 Sum_probs=67.0
Q ss_pred EEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccccccc
Q 002376 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKI 155 (929)
Q Consensus 76 l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 155 (929)
+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 344444444 4454432 35556666666555 4555555555555555555555555555555555555555555555
Q ss_pred CCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 156 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
+ .+++..| .++++|++|+|++|+|+...+..|..+++|++|+|++|.
T Consensus 91 ~-~i~~~~f--------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 137 (193)
T 2wfh_A 91 R-CIPPRTF--------------------------------DGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP 137 (193)
T ss_dssp C-BCCTTTT--------------------------------TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred C-EeCHHHh--------------------------------CCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence 4 2333334 445555555555555554444555566666666666665
Q ss_pred CC
Q 002376 236 LG 237 (929)
Q Consensus 236 l~ 237 (929)
+.
T Consensus 138 ~~ 139 (193)
T 2wfh_A 138 LY 139 (193)
T ss_dssp EE
T ss_pred ee
Confidence 54
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-14 Score=162.93 Aligned_cols=129 Identities=12% Similarity=0.123 Sum_probs=70.4
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCC-----cccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSIS-----GEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 428 (929)
+|+.+.+ .|.++...+.+|.++++|+.+++.+|.+. ...+..|.++++|+.+++. |.++.....+|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 4555555 33344444556666666666666665543 2344556666666666666 335545555666666666
Q ss_pred eecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCC
Q 002376 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493 (929)
Q Consensus 429 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l 493 (929)
.++|..| ++.+.+.+|.++ +|+.+++++|.+. .++.+.+..+| .+++.|++..|.+
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~-~l~~~~F~~~~------~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP-QVFEKVWYGFP------DDITVIRVPAESV 382 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC-BCCCSSCCCSC------TTCCEEEECGGGH
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc-ccccccccCCC------CCccEEEeCHHHH
Confidence 6666443 554555566666 6666666666554 23332222222 2455666655543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-14 Score=160.88 Aligned_cols=266 Identities=12% Similarity=0.120 Sum_probs=202.1
Q ss_pred CCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEE
Q 002376 94 LSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVL 173 (929)
Q Consensus 94 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L 173 (929)
...++.+.+.+ .++..-..+|.+. +|+.++|..| ++.+-...|.+. +|+.++|.. .++ .|+..+|.++++|+.+
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKA 185 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCee
Confidence 36677777754 4555566777775 7888888766 665666677774 688888875 665 6777788888888888
Q ss_pred EccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcce
Q 002376 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLD 253 (929)
Q Consensus 174 ~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 253 (929)
+|++|+++ .+....|. ..+|+.+.|.. .++.+...+|.++++|+.+++..| ++ .|+...|.. .+|+.
T Consensus 186 ~l~~n~l~--------~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 186 DLSKTKIT--------KLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGITT 252 (401)
T ss_dssp ECTTSCCS--------EECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCSE
T ss_pred ecCCCcce--------EechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCccE
Confidence 88888653 33344565 47888888874 477778888888888999988875 54 677777775 78888
Q ss_pred eeccCCcCCCCCCCcccccccccEEeccCccCc-----CCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCC
Q 002376 254 FIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE-----GTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNST 328 (929)
Q Consensus 254 l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~ 328 (929)
+.+ .|+++..-+..|.++++|+.+++.+|.+. .+.+.+|.++++|+.+++. +.+..++. .+|.+++
T Consensus 253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~-------~aF~~c~ 323 (401)
T 4fdw_A 253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQ-------GLLGGNR 323 (401)
T ss_dssp EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECT-------TTTTTCC
T ss_pred EEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhh-------hhhcCCC
Confidence 888 56677777788899999999999888775 4556789999999999998 45766655 4788899
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCC-cccEEEeeCCCCC
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLR-SLTLLDLSYNSIS 390 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 390 (929)
+|+.++|..| ++..-+..|..+ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 324 ~L~~l~lp~~-l~~I~~~aF~~~--~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 324 KVTQLTIPAN-VTQINFSAFNNT--GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SCCEEEECTT-CCEECTTSSSSS--CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CccEEEECcc-ccEEcHHhCCCC--CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 9999999655 663444455554 699999999999888888888884 7899999887754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.9e-15 Score=147.80 Aligned_cols=131 Identities=22% Similarity=0.233 Sum_probs=85.4
Q ss_pred CCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEec
Q 002376 330 LNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409 (929)
Q Consensus 330 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 409 (929)
.+.+++++|+++ .+|..+. .+|+.|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 356666777666 4554332 357777777777776666666777777777777777776555556667777777777
Q ss_pred CCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCC
Q 002376 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGN 464 (929)
Q Consensus 410 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 464 (929)
+|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 7777666666666666777777777776655555556666666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5e-17 Score=164.82 Aligned_cols=132 Identities=23% Similarity=0.308 Sum_probs=84.8
Q ss_pred cccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCc
Q 002376 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPN 499 (929)
Q Consensus 420 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~ 499 (929)
.+..+++|++|+|++|++++ +| .+.++++|+.|++++|+++ .+ |..+..+++|++|+|++|++++ +|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l--------~~~~~~~~~L~~L~L~~N~l~~-l~- 109 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KI--------ENLDAVADTLEELWISYNQIAS-LS- 109 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SC--------SSHHHHHHHCSEEEEEEEECCC-HH-
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cc--------cchhhcCCcCCEEECcCCcCCc-CC-
Confidence 56666666666666666664 44 5666666666666666665 22 4455555667777777777765 34
Q ss_pred chhcCcCcceeecccccccccCC-ccccCCCCCCEEECCCCcCCCcCCcc----------cccCCCCCeEeCCCCcCc
Q 002376 500 SLKNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLSGSIPSD----------LQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 500 ~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~ 566 (929)
.+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 110 ~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 56667777777777777765332 45677777777777777776655542 66777777776 45544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.1e-13 Score=153.76 Aligned_cols=311 Identities=13% Similarity=0.056 Sum_probs=159.3
Q ss_pred CCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCC
Q 002376 90 HIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRS 169 (929)
Q Consensus 90 ~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~ 169 (929)
+|.++++|+.+.|.. .++..-..+|.++++|+.++|..+ ++.+-...|.++++|+.+.+..+ ++ .+...+|.++..
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF~~~~~ 141 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAFKGCDF 141 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTTTCCC
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceeeecccc
Confidence 455666666666653 355444556666666666666543 44344455666666666665543 22 344455555543
Q ss_pred CcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCC
Q 002376 170 LQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLP 249 (929)
Q Consensus 170 L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~ 249 (929)
++...... +..+....|.++++|+.+.+..+ +..+....|.++++|+.+++..| ++ .++...+....
T Consensus 142 ~~~~~~~~----------~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~ 208 (394)
T 4fs7_A 142 KEITIPEG----------VTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECI 208 (394)
T ss_dssp SEEECCTT----------CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCT
T ss_pred cccccCcc----------ccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ce-EeCchhhcccc
Confidence 33322221 12223345666666666666543 33355556666666666666554 32 34444444444
Q ss_pred CcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCC
Q 002376 250 NLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTH 329 (929)
Q Consensus 250 ~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~ 329 (929)
.|+.+.+..+... +...+...++|+.+.+..+ ++..-.. .+.++..
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~-------------------------------~f~~~~~ 254 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKS-------------------------------VFYGCTD 254 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSS-------------------------------TTTTCSS
T ss_pred ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccc-------------------------------ccccccc
Confidence 5544444333211 1222222334444443322 1112222 3444555
Q ss_pred CCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEec
Q 002376 330 LNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409 (929)
Q Consensus 330 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 409 (929)
|+.+.+..+... .....+.... .++.+....+.+ ....|..+.+|+.+.+..+ ++..-..+|.++.+|+.+++.
T Consensus 255 l~~~~~~~~~~~-i~~~~F~~~~-~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 255 LESISIQNNKLR-IGGSLFYNCS-GLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp CCEEEECCTTCE-ECSCTTTTCT-TCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred ceeEEcCCCcce-eecccccccc-ccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 555555544332 2222333332 455555555432 2345666666666666544 444445566666667666665
Q ss_pred CCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCC
Q 002376 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNN 459 (929)
Q Consensus 410 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 459 (929)
.+ ++..-..+|.++++|+.+++..| ++.+-..+|.++.+|+.+++..+
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 43 54444566677777777777655 55455566777777777766544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=3.3e-15 Score=148.26 Aligned_cols=136 Identities=21% Similarity=0.254 Sum_probs=99.9
Q ss_pred CCCCCCCCCCEEEeecCCCCCCCCcCCCCCC-CCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccC
Q 002376 89 PHIGNLSFLRSIQLQNNKLSGNLPREIGNLF-RLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNL 167 (929)
Q Consensus 89 ~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l 167 (929)
+.+.++++|++|+|++|+++. +|. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|+ .+|+..|..+
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 87 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL 87 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHC
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcC
Confidence 345677788888888888874 454 44444 888888888888864 57888888888888888887 5666656888
Q ss_pred CCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCC----ccccCCCCceEEeeecCCC
Q 002376 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPS----TIYNMTSLVHLRLASNQLG 237 (929)
Q Consensus 168 ~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~ 237 (929)
++|++|+|++|++.. +|. ...+..+++|++|+|++|+++. .|. .+..+++|++||+++|.+.
T Consensus 88 ~~L~~L~L~~N~i~~-~~~------~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 88 PDLTELILTNNSLVE-LGD------LDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TTCCEEECCSCCCCC-GGG------GGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCEEECCCCcCCc-chh------hHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888887732 221 0246677888888888888874 454 3778888888888888764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=7.5e-17 Score=163.47 Aligned_cols=157 Identities=24% Similarity=0.304 Sum_probs=94.1
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
.++.++++.|.++|..|. ++ .+|..+..+++|++|++++|++++ +| .+.++++|++|+++
T Consensus 19 ~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~ 78 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLG 78 (198)
T ss_dssp CCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEE
T ss_pred cccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECC
Confidence 566666666666655554 00 112245555555555555555554 34 55555566666666
Q ss_pred CcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCC-cchhcCcCcceeec
Q 002376 434 GNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLP-NSLKNCKSLEELLM 512 (929)
Q Consensus 434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p-~~~~~l~~L~~L~L 512 (929)
+|+++ .+|..+..+++|+.|++++|++++ + | .+..+++|++|+|++|++++..+ ..+..+++|++|++
T Consensus 79 ~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l--------~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l 147 (198)
T 1ds9_A 79 RNLIK-KIENLDAVADTLEELWISYNQIAS-L--------S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLL 147 (198)
T ss_dssp EEEEC-SCSSHHHHHHHCSEEEEEEEECCC-H--------H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEE
T ss_pred CCCcc-cccchhhcCCcCCEEECcCCcCCc-C--------C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEe
Confidence 66665 345555555666666666666653 1 3 45666667777777777664322 35677777777777
Q ss_pred ccccccccCCc----------cccCCCCCCEEECCCCcCCC
Q 002376 513 AYNQFSGPIPN----------IVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 513 s~N~l~~~~p~----------~~~~l~~L~~L~Ls~N~l~~ 543 (929)
++|.+++.+|. .+..+++|+.|| +|.++.
T Consensus 148 ~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp CSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred cCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 77777766554 277788888886 666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.6e-15 Score=157.67 Aligned_cols=116 Identities=20% Similarity=0.169 Sum_probs=88.7
Q ss_pred CCCceeecccCceeEEeccc--cCcH----------------------------------------HHHHHHHHHHHccC
Q 002376 663 FSHENLIGSGSFGSVLHNER--TGSW----------------------------------------KSFIAECETLRNVR 700 (929)
Q Consensus 663 ~~~~~~iG~G~~g~Vy~~~~--~~~~----------------------------------------~~~~~E~~~l~~l~ 700 (929)
|+..+.||+|+||.||+|.. .+.. ..+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999876 1110 15778999999998
Q ss_pred Cccc--cceeeecccCCCCCcceEEEEEEecCC-C----Cccccccc-----cccccccHHHHHHHhh-hCCCCCEEecC
Q 002376 701 HRNL--VKLITSCSSLDSKNMEFLALVYEFLSN-G----SLGDWIHG-----ERKNELDITSALDYLH-NDCEVPVVHSD 767 (929)
Q Consensus 701 Hpni--v~l~~~~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~-----~~~~~~~ia~aL~yLH-~~~~~~iiHrD 767 (929)
|+++ ...+++. ..++||||+.+ | +|.++... ...++.|++.||+||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~~---------~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTYM---------KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEEE---------TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEcC---------CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8864 3333321 25899999942 4 55554432 2344679999999999 77 999999
Q ss_pred CCCCCeeecCCCceEEecccccccc
Q 002376 768 LKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 768 lk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|||+|||+++ .+||+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=143.22 Aligned_cols=134 Identities=21% Similarity=0.200 Sum_probs=105.1
Q ss_pred ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCC
Q 002376 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402 (929)
Q Consensus 323 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 402 (929)
.+.++.+|++|+|++|+++ .+|. +..+.++|+.|+|++|+|++. ..|..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4566788888999999888 4554 455544799999999999875 67888999999999999998665555688899
Q ss_pred CCEEEecCCcCCCCCcc--cccCCCCCceecccCcccccccCcc----cccccccceecccCCcCC
Q 002376 403 LQVLGLAGNEIPGGIPN--SLANLKKLNQIDLSGNELTGEIPIS----FGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 403 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 462 (929)
|++|+|++|+|+ .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.||+++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999999999986 4555 78888888888888888874 4553 777888888888888754
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-13 Score=151.90 Aligned_cols=315 Identities=9% Similarity=0.008 Sum_probs=163.4
Q ss_pred ccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcc
Q 002376 190 NLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSL 269 (929)
Q Consensus 190 ~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~ 269 (929)
.+-..+|.++++|+.+.|.. .++.+...+|.++++|+.++|.++ ++ .|+...+..+.+|+.+.+..+ +...-...|
T Consensus 61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF 136 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAF 136 (394)
T ss_dssp EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceee
Confidence 34556788888899888864 477777888888889998888755 44 566666666666666554432 333333444
Q ss_pred cccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhh
Q 002376 270 HNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIG 349 (929)
Q Consensus 270 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 349 (929)
.++..++....... ...-..+|.++++|+.+.+..+. ..++. ..|.++.+
T Consensus 137 ~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~-------~~F~~c~~-------------------- 186 (394)
T 4fs7_A 137 KGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHN-------GLFSGCGK-------------------- 186 (394)
T ss_dssp TTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECT-------TTTTTCTT--------------------
T ss_pred ecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceecc-------ccccCCCC--------------------
Confidence 44433322222211 11222344444444444443221 11111 23334444
Q ss_pred hccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCce
Q 002376 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429 (929)
Q Consensus 350 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 429 (929)
|+.+.+..| ++.....+|.++..|+.+.+..+... +...+....+|+.+.+..+ ++......|.++..|+.
T Consensus 187 -----L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~ 257 (394)
T 4fs7_A 187 -----LKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLES 257 (394)
T ss_dssp -----CCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCE
T ss_pred -----ceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceeccccccccccccee
Confidence 555555443 33333445555555555555444322 2222333345555555432 22223344555555666
Q ss_pred ecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcce
Q 002376 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509 (929)
Q Consensus 430 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~ 509 (929)
+.+..+... .....|.++..++.+....+.+. ...+....+|+.+.+.++ ++..-..+|.++.+|+.
T Consensus 258 ~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~-----------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~ 324 (394)
T 4fs7_A 258 ISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP-----------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVS 324 (394)
T ss_dssp EEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-----------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred EEcCCCcce-eeccccccccccceeccCceeec-----------cccccccccccccccccc-cceechhhhcCCCCCCE
Confidence 555555433 44445555555555555444321 123344555666665543 44334455666666666
Q ss_pred eecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCC
Q 002376 510 LLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTF 562 (929)
Q Consensus 510 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (929)
++|..+ ++.+-..+|.++.+|+.+++..| ++..-..+|.++.+|+.+++..
T Consensus 325 i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 325 IDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp ECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred EEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 666533 55455566666666666666655 5544455666666666666643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2e-13 Score=134.40 Aligned_cols=104 Identities=22% Similarity=0.229 Sum_probs=81.6
Q ss_pred EEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccc
Q 002376 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154 (929)
Q Consensus 75 ~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 154 (929)
.+++++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3555666666 4676664 788888888888888888888888888888888888887777778888888888888888
Q ss_pred cCCCCChhhhccCCCCcEEEccccccCC
Q 002376 155 ITGRVTDDQLRNLRSLQVLNFGKNLLWG 182 (929)
Q Consensus 155 l~~~i~~~~~~~l~~L~~L~Ls~N~l~~ 182 (929)
|+ .+++..|.++++|++|+|++|.+..
T Consensus 90 l~-~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LK-SIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CC-CCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cC-EeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 87 4666667788888888888887654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=135.74 Aligned_cols=109 Identities=21% Similarity=0.267 Sum_probs=78.5
Q ss_pred cceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCC
Q 002376 451 LLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKG 530 (929)
Q Consensus 451 L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (929)
.+.+++++|.++. +|. .+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++
T Consensus 11 ~~~l~~s~n~l~~-ip~--------~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~ 79 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPT--------GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 79 (170)
T ss_dssp TTEEECTTSCCSS-CCS--------CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEEEeCCCCcCc-cCc--------cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCC
Confidence 4566666666652 332 22 146777777777777777777778888888888888888777777778888
Q ss_pred CCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 531 LEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 531 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
|++|+|++|+|++..+..|..+++|++|+|++|++++..+
T Consensus 80 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 80 LTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 8888888888887666677778888888888887776543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=133.45 Aligned_cols=103 Identities=24% Similarity=0.269 Sum_probs=80.3
Q ss_pred EEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccc
Q 002376 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154 (929)
Q Consensus 75 ~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 154 (929)
.+++++++++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 5778888874 6777665 788888888888887778888888888888888888887666667788888888888888
Q ss_pred cCCCCChhhhccCCCCcEEEccccccC
Q 002376 155 ITGRVTDDQLRNLRSLQVLNFGKNLLW 181 (929)
Q Consensus 155 l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 181 (929)
|+ .+++..|..+++|++|+|++|.+.
T Consensus 93 l~-~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LK-SIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CC-CCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cc-eeCHHHhccccCCCEEEeCCCCcc
Confidence 87 466666777777777777777664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=134.05 Aligned_cols=106 Identities=21% Similarity=0.309 Sum_probs=74.6
Q ss_pred ceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCC
Q 002376 452 LSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGL 531 (929)
Q Consensus 452 ~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 531 (929)
+.+++++|+++ .+|. .+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++.++..|..+++|
T Consensus 15 ~~l~~~~n~l~-~iP~--------~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L 83 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA--------GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83 (174)
T ss_dssp SEEECCSSCCS-SCCS--------CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cEEEeCCCCCC-ccCC--------CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchh
Confidence 45666666664 3432 221 467777777777777777777777778888888887777666667777888
Q ss_pred CEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 532 EVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 532 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
++|||++|+|++..+..|..+++|++|+|++|++.+.
T Consensus 84 ~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 84 TQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred hEEECCCCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 8888888888765555677777777777777777654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-13 Score=151.75 Aligned_cols=134 Identities=13% Similarity=0.073 Sum_probs=90.4
Q ss_pred HHHHhhCCCCCceeecccCceeEEeccccCc-----------------------------HHHHHHHHHHHHccCCcccc
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERTGS-----------------------------WKSFIAECETLRNVRHRNLV 705 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------------------------~~~~~~E~~~l~~l~Hpniv 705 (929)
.+.+...-|+..+.||+|+||.||+|..... ......++++.+...|+|++
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3333333488899999999999999865410 11222333444444455655
Q ss_pred ceeeecccCCCC-CcceEEEEEEecCCCCcccccc--ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC---
Q 002376 706 KLITSCSSLDSK-NMEFLALVYEFLSNGSLGDWIH--GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM--- 779 (929)
Q Consensus 706 ~l~~~~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~--- 779 (929)
+++......... .....++||||++++.|.++.. ..+....|++.||.|||+. +||||||||.|||+++++
T Consensus 169 rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp HHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred HHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence 554332211000 0011379999999998887654 2334567999999999998 999999999999998776
Q ss_pred -------ceEEeccccccc
Q 002376 780 -------TAKVGDFGLARF 791 (929)
Q Consensus 780 -------~~ki~DfGla~~ 791 (929)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999998754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=143.40 Aligned_cols=109 Identities=23% Similarity=0.248 Sum_probs=91.3
Q ss_pred CCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeec-CCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcc
Q 002376 58 PCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQN-NKLSGNLPREIGNLFRLRVLNISFNNLQGELP 136 (929)
Q Consensus 58 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 136 (929)
.|.|.+|.|++. |+|+ .||. |..+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|
T Consensus 7 ~C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 388877777542 1566 4888 99999999999996 99998888899999999999999999999889
Q ss_pred cccccccccceecccccccCCCCChhhhccCCCCcEEEccccccC
Q 002376 137 VNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181 (929)
Q Consensus 137 ~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 181 (929)
..|.++++|++|||++|+|+ .+|+..|..++ |+.|+|++|.+.
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCS-CCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHhcCCcCCCEEeCCCCccc-eeCHHHcccCC-ceEEEeeCCCcc
Confidence 89999999999999999998 57777676666 888888888764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.3e-14 Score=159.53 Aligned_cols=13 Identities=31% Similarity=0.468 Sum_probs=6.8
Q ss_pred cccEEEecCCccc
Q 002376 354 ELSKLYLGGNHIY 366 (929)
Q Consensus 354 ~L~~L~Ls~N~l~ 366 (929)
.|+.|+|++|.|+
T Consensus 73 ~L~~L~Ls~n~l~ 85 (372)
T 3un9_A 73 SLRQLNLAGVRMT 85 (372)
T ss_dssp TCCEEECTTSCCC
T ss_pred hCCEEEecCCCCC
Confidence 4555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.5e-10 Score=127.29 Aligned_cols=329 Identities=12% Similarity=0.106 Sum_probs=167.2
Q ss_pred CCCCCC-CCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCC---CCCCcccccccccccceecccccccCCCCChhhhc
Q 002376 90 HIGNLS-FLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNN---LQGELPVNISKLTELKMLDLMANKITGRVTDDQLR 165 (929)
Q Consensus 90 ~l~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~ 165 (929)
.|.+.. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++.+-...|.++.+|+.+.+..+ ++ .++..+|.
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~aF~ 134 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEAFH 134 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhhhh
Confidence 455553 5788887643 665666778888888888887664 55444566777777877777654 43 56667777
Q ss_pred cCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccc
Q 002376 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVR 245 (929)
Q Consensus 166 ~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~ 245 (929)
++.+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. .+....+
T Consensus 135 ~c~~L~~i~lp~~---------~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~--~i~~~af 201 (394)
T 4gt6_A 135 HCEELDTVTIPEG---------VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT--RIGTNAF 201 (394)
T ss_dssp TCTTCCEEECCTT---------CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC--EECTTTT
T ss_pred hhcccccccccce---------eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc--ccccchh
Confidence 7777877777543 22334456677777777777544 55455555543 5677776654432 2333333
Q ss_pred cCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccC
Q 002376 246 DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLT 325 (929)
Q Consensus 246 ~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~ 325 (929)
....++.......+.........+.......... ..+.....+..+.+. +.+..++. .+|.
T Consensus 202 ~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip-~~v~~i~~-------~aF~ 262 (394)
T 4gt6_A 202 SECFALSTITSDSESYPAIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIP-NGVARIET-------HAFD 262 (394)
T ss_dssp TTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECC-TTEEEECT-------TTTT
T ss_pred hhccccceecccccccccccceeecccccccccc-----------cccccccccceEEcC-CcceEccc-------ceee
Confidence 3344444443333322211000000000000000 000011111111111 11111111 2455
Q ss_pred CCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCE
Q 002376 326 NSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405 (929)
Q Consensus 326 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 405 (929)
++..|+.+.+..+..+ .-...+.++. .|+.+.+. +.++.....+|.++.+|+.++|..+ ++..-..+|.++.+|+.
T Consensus 263 ~c~~L~~i~lp~~~~~-I~~~aF~~c~-~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~ 338 (394)
T 4gt6_A 263 SCAYLASVKMPDSVVS-IGTGAFMNCP-ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLER 338 (394)
T ss_dssp TCSSCCEEECCTTCCE-ECTTTTTTCT-TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred ecccccEEecccccce-ecCccccccc-ccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCE
Confidence 6666666666544332 2223333333 56666664 3445455566667777777777643 44444556666677777
Q ss_pred EEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcC
Q 002376 406 LGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRI 461 (929)
Q Consensus 406 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 461 (929)
+.+..+ ++..-..+|.++++|+.+++.+|.... ..|....+|+.+.+..|.+
T Consensus 339 i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 339 IAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp EEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred EEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 766543 554555666677777777766665432 2445555666666555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-10 Score=131.19 Aligned_cols=334 Identities=14% Similarity=0.115 Sum_probs=180.6
Q ss_pred CCCcCCCCCC-CCcEEeCCCCCCCCCcccccccccccceecccccc---cCCCCChhhhccCCCCcEEEccccccCCCCC
Q 002376 110 NLPREIGNLF-RLRVLNISFNNLQGELPVNISKLTELKMLDLMANK---ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIP 185 (929)
Q Consensus 110 ~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p 185 (929)
+-..+|.+++ .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++ .|...+|.++.+|+.+.+..+
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~------- 124 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS------- 124 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-------
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-------
Confidence 3455677764 5888888644 665566778888888888887764 44 566677777777776655433
Q ss_pred ccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCC
Q 002376 186 PSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKI 265 (929)
Q Consensus 186 ~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~ 265 (929)
+..+....|..+.+|+.+.+.. .+..+....|.++.+|+.+.+..+ +. .|....+. -.
T Consensus 125 --~~~I~~~aF~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~-~~---------------- 182 (394)
T 4gt6_A 125 --VTEIDSEAFHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFT-GT---------------- 182 (394)
T ss_dssp --CSEECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTT-TC----------------
T ss_pred --cceehhhhhhhhcccccccccc-eeeeecccceecccccccccccce-ee-Eecccccc-cc----------------
Confidence 3344455677777777777753 344456667777777777776544 22 33333333 12
Q ss_pred CCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccC
Q 002376 266 PGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP 345 (929)
Q Consensus 266 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 345 (929)
+|+.+.+..+... .-..+|.++..++......+........ .+........-... .|
T Consensus 183 --------~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~-------~~ 239 (394)
T 4gt6_A 183 --------ALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNV-------LYEKSANGDYALIR-------YP 239 (394)
T ss_dssp --------CCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSC-------EEEECTTSCEEEEE-------CC
T ss_pred --------ceeEEEECCcccc-cccchhhhccccceecccccccccccce-------eecccccccccccc-------cc
Confidence 3444444332211 2233444444444444333322211100 00000000000000 00
Q ss_pred chhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCC
Q 002376 346 ESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK 425 (929)
Q Consensus 346 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 425 (929)
.. ..+..+.+. +.++.....+|.++++|+.+.+..+..+ .....|.++++|+.+.+. +.++.....+|.++.
T Consensus 240 ----~~-~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~ 311 (394)
T 4gt6_A 240 ----SQ-REDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCI 311 (394)
T ss_dssp ----TT-CCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCT
T ss_pred ----cc-cccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCC
Confidence 00 022233322 2233344566777777777777655433 455667777777777775 445545556777788
Q ss_pred CCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCc
Q 002376 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCK 505 (929)
Q Consensus 426 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~ 505 (929)
+|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++ .|+ ...|.++++|+.+++.+|.... ..+..+.
T Consensus 312 ~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~-------~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~ 378 (394)
T 4gt6_A 312 SLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIP-------ESAFSNCTALNNIEYSGSRSQW---NAISTDS 378 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCC-------GGGGTTCTTCCEEEESSCHHHH---HTCBCCC
T ss_pred CcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEh-------HhHhhCCCCCCEEEECCceeeh---hhhhccC
Confidence 8888887654 55555667888888888877654 33 232 3456777788888888775431 4566777
Q ss_pred Ccceeeccccccc
Q 002376 506 SLEELLMAYNQFS 518 (929)
Q Consensus 506 ~L~~L~Ls~N~l~ 518 (929)
+|+.+.+..|.+.
T Consensus 379 ~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 379 GLQNLPVAPGSID 391 (394)
T ss_dssp CC-----------
T ss_pred CCCEEEeCCCCEE
Confidence 8888877766543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.6e-13 Score=151.01 Aligned_cols=87 Identities=21% Similarity=0.305 Sum_probs=50.5
Q ss_pred cCccEEEecCCCCCC----CCCcchhcCcCcceeeccccccccc----CCccccCCCCCCEEECCCCcCCCc----CCcc
Q 002376 481 ENVVTIDLSDNSLSG----NLPNSLKNCKSLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNKLSGS----IPSD 548 (929)
Q Consensus 481 ~~L~~LdLs~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 548 (929)
++|++|+|++|.++. .++..+..+++|++|+|++|.|+.. ++..+...++|+.|||++|.|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 445555555555542 1233345556666666666666532 244555666777777777777642 2334
Q ss_pred cccCCCCCeEeCCCCcCcc
Q 002376 549 LQNLQALRSLNLTFNNLEG 567 (929)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~ 567 (929)
+...+.|++|||++|.++.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHCSSCCEEECTTSSCCH
T ss_pred HHhCCCCCEEeccCCCCCH
Confidence 4455677777777777754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.4e-11 Score=134.44 Aligned_cols=106 Identities=19% Similarity=0.198 Sum_probs=84.4
Q ss_pred ceecccCC-cCCCCCCCCcccCCchhhhcccCccEEEecC-CCCCCCCCcchhcCcCcceeecccccccccCCccccCCC
Q 002376 452 LSIDLSNN-RINGNIPKGILRPLPEEISRLENVVTIDLSD-NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELK 529 (929)
Q Consensus 452 ~~L~Ls~N-~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (929)
..++++++ +|++ | |. +..+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++.+|..|..++
T Consensus 11 ~~v~~~~~n~l~~-i--------p~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 80 (347)
T 2ifg_A 11 SGLRCTRDGALDS-L--------HH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (347)
T ss_dssp SCEECCSSCCCTT-T--------TT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CEEEcCCCCCCCc-c--------CC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCc
Confidence 35677777 7763 3 55 77778888888885 888887778888888888888888888888888888888
Q ss_pred CCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCccc
Q 002376 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (929)
+|+.|||++|+|++..+..|..++ |+.|+|++|+|.+.
T Consensus 81 ~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 81 RLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp CCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 888888888888876666666665 88888888888764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.9e-08 Score=112.40 Aligned_cols=128 Identities=8% Similarity=0.109 Sum_probs=72.5
Q ss_pred CCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCC
Q 002376 91 IGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170 (929)
Q Consensus 91 l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 170 (929)
+..-.+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++ .|...+|.+. +|
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~-~L 115 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGT-DL 115 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTC-CC
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccC-Cc
Confidence 33445666666643 355444566777777777777643 554445566665 5666666543 43 4666666553 67
Q ss_pred cEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 171 ~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
+.+.+..+. ..+....|.+. +|+.+.+.. .++.+....|.++.+++...+..+.
T Consensus 116 ~~i~lp~~~---------~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~ 169 (379)
T 4h09_A 116 DDFEFPGAT---------TEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNN 169 (379)
T ss_dssp SEEECCTTC---------CEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTC
T ss_pred ccccCCCcc---------ccccccccccc-eeeeeeccc-eeeccccchhccccccccccccccc
Confidence 777765442 22223344443 455554433 3455566667777777777666544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.5e-08 Score=113.25 Aligned_cols=132 Identities=12% Similarity=0.196 Sum_probs=59.1
Q ss_pred ccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCc
Q 002376 395 IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLP 474 (929)
Q Consensus 395 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p 474 (929)
..+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+-..+|.++.+|+.+.+..+ ++ .++ .
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~-------~ 279 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVP-------Y 279 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EEC-------T
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-ecc-------c
Confidence 33444444555544433 22233344555555555555443 33334445555555555555332 21 111 1
Q ss_pred hhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCC
Q 002376 475 EEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSS 538 (929)
Q Consensus 475 ~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (929)
..|..+++|+.+++.++.++..-+.+|.+|.+|+.+.|..+ ++.+-..+|.++++|+.+.+..
T Consensus 280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp TTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 22334444444554444444333444555555555555432 4433344555555555555443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.4e-10 Score=125.96 Aligned_cols=161 Identities=16% Similarity=0.174 Sum_probs=94.2
Q ss_pred cEEEEEcCCCCCcc-c-------cCCCCCCCCCCCEEEeecCCCC---------CCCCcCCCCCCCCcEEeCCCCCCCCC
Q 002376 72 RVIGLNLSSFGLEG-T-------ISPHIGNLSFLRSIQLQNNKLS---------GNLPREIGNLFRLRVLNISFNNLQGE 134 (929)
Q Consensus 72 ~v~~l~l~~~~l~g-~-------i~~~l~~L~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~~ 134 (929)
+|+.|.+...+..| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .
T Consensus 108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~ 186 (362)
T 2ra8_A 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-S 186 (362)
T ss_dssp GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-B
T ss_pred hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-e
Confidence 67788877666553 2 2455677899999999776432 123344567788999999887311 2
Q ss_pred cccccccccccceecccccccCCCCChhhhc--cCCCCcEEEccc--cccCCCC-CccccccCCCccCCCCcccEEEeec
Q 002376 135 LPVNISKLTELKMLDLMANKITGRVTDDQLR--NLRSLQVLNFGK--NLLWGSI-PPSIANLIPSDLSRLENLKVLDLTI 209 (929)
Q Consensus 135 ~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~--~l~~L~~L~Ls~--N~l~~~~-p~~i~~l~p~~~~~l~~L~~L~Ls~ 209 (929)
++. + .+++|++|+|..|.++... ...+. .+++|+.|+|+. |...+.. ...+..++.. ..+++|++|+|++
T Consensus 187 l~~-~-~~~~L~~L~L~~~~l~~~~-l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~--~~~p~Lr~L~L~~ 261 (362)
T 2ra8_A 187 IGK-K-PRPNLKSLEIISGGLPDSV-VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK--DRFPNLKWLGIVD 261 (362)
T ss_dssp CCS-C-BCTTCSEEEEECSBCCHHH-HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT--TTCTTCCEEEEES
T ss_pred ecc-c-cCCCCcEEEEecCCCChHH-HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc--CCCCCcCEEeCCC
Confidence 333 3 3788899998888765211 11233 678888888863 2221110 0111111110 2467777777777
Q ss_pred ccCCCccCCccc---cCCCCceEEeeecCCCC
Q 002376 210 NRLAGTVPSTIY---NMTSLVHLRLASNQLGG 238 (929)
Q Consensus 210 N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~ 238 (929)
|.+....+..+. .+++|++|+|+.|.|++
T Consensus 262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred CCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 777643333332 35667777777776653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.9e-10 Score=123.47 Aligned_cols=64 Identities=16% Similarity=0.210 Sum_probs=32.8
Q ss_pred ccCccEEEecCCCCCCCCCcchh---cCcCcceeeccccccccc----CCccccCCCCCCEEECCCCcCCC
Q 002376 480 LENVVTIDLSDNSLSGNLPNSLK---NCKSLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 480 l~~L~~LdLs~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 543 (929)
+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.++.
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 44566666666655432222222 345566666666666542 22223345566666666665553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.4e-11 Score=125.86 Aligned_cols=162 Identities=18% Similarity=0.192 Sum_probs=91.7
Q ss_pred CCCCcceeeCCCCCcEEEEEcCC---CCCccccCC-CCCCCCCCCEEEeecCCCCCCCCc-CCCCCCCCcE--EeCCCCC
Q 002376 58 PCTWPGVICNNFGNRVIGLNLSS---FGLEGTISP-HIGNLSFLRSIQLQNNKLSGNLPR-EIGNLFRLRV--LNISFNN 130 (929)
Q Consensus 58 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~i~~-~l~~L~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~--L~Ls~N~ 130 (929)
.|.|.|++|+..+.+|+.+-..+ ..+.|.+++ .+..|+. .|...+|.-++.++- .|...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 58999999997666776655544 233444432 1222221 122222322222221 2444455555 6667664
Q ss_pred CC---CCcccccccccccceecccccccCC--CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEE
Q 002376 131 LQ---GELPVNISKLTELKMLDLMANKITG--RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205 (929)
Q Consensus 131 l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L 205 (929)
.. +.++....++++|++|+|++|+|++ .++. .+..+++|+.|+|++|++.+. ..+ ..+..+ +|+.|
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~-~~~~l~~L~~L~Ls~N~i~~~--~~l-----~~l~~l-~L~~L 225 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSS-IVQKAPNLKILNLSGNELKSE--REL-----DKIKGL-KLEEL 225 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTT-HHHHSTTCCEEECTTSCCCSG--GGG-----GGGTTS-CCSEE
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchh-HHhhCCCCCEEECCCCccCCc--hhh-----hhcccC-CcceE
Confidence 33 1122222456778888888888875 2222 366788888888888877542 111 122334 78888
Q ss_pred EeecccCCCccCC-------ccccCCCCceEE
Q 002376 206 DLTINRLAGTVPS-------TIYNMTSLVHLR 230 (929)
Q Consensus 206 ~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 230 (929)
+|++|.+.+..|. .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 8888888765552 366778888775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=4.7e-09 Score=110.86 Aligned_cols=132 Identities=14% Similarity=0.059 Sum_probs=99.0
Q ss_pred HHHHhhCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCc
Q 002376 655 ELRRATGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 655 ~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~ 719 (929)
.+....++|+.....|.|+.+.||+.... .....+.+|+++++.+. |..+.++++++.. .
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~ 82 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----D 82 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----T
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----C
Confidence 34555677888888888888999986532 12235889999999985 6677888888743 2
Q ss_pred ceEEEEEEecCCCCcccccc---ccccccccHHHHHHHhhhCC-------------------------------------
Q 002376 720 EFLALVYEFLSNGSLGDWIH---GERKNELDITSALDYLHNDC------------------------------------- 759 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~---~~~~~~~~ia~aL~yLH~~~------------------------------------- 759 (929)
+..|+||||++|.++.+... .......+++++++.||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred CceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 34799999999999887532 22234678889999999810
Q ss_pred -------------------CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 -------------------EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 -------------------~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+.++|+|++|.||+++++..+.|.||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998766677999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.61 E-value=2e-08 Score=105.77 Aligned_cols=127 Identities=14% Similarity=0.057 Sum_probs=86.2
Q ss_pred hhCCCCCceeecccCceeEEecccc------------CcHHHHHHHHHHHHccCCcc--ccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT------------GSWKSFIAECETLRNVRHRN--LVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~------------~~~~~~~~E~~~l~~l~Hpn--iv~l~~~~~~~~~~~~~~~~l 724 (929)
...+|......+.|..+.||+.... .....+.+|+++++.+.+.+ +.+++++.... +..++
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~ 92 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWL 92 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEE
Confidence 3444554333345556888876532 11245789999999996544 44577776432 33799
Q ss_pred EEEecCCCCccccccc-cccccccHHHHHHHhhhCC--------------------------------------------
Q 002376 725 VYEFLSNGSLGDWIHG-ERKNELDITSALDYLHNDC-------------------------------------------- 759 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~-~~~~~~~ia~aL~yLH~~~-------------------------------------------- 759 (929)
||||++|.++. +-.. ......+++++++.||+..
T Consensus 93 v~e~i~G~~l~-~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 93 LLGEVPGQDLL-SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EEECCSSEETT-TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEecCCcccC-cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 99999998885 2111 1234567788888888742
Q ss_pred -----------CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 -----------EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 -----------~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+.++|+|++|.||++++++.++|.|||.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876778999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.51 E-value=2.5e-08 Score=104.17 Aligned_cols=108 Identities=20% Similarity=0.282 Sum_probs=68.4
Q ss_pred cccccccce--ecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCC--CCCcchhcCcCcceeeccccccccc
Q 002376 445 FGNFQSLLS--IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG--NLPNSLKNCKSLEELLMAYNQFSGP 520 (929)
Q Consensus 445 ~~~l~~L~~--L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (929)
|...+.|.. ++++.|+.. .++ ..++....++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++.
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~----~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMA----ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHH----HHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred cCCCcchhhcCccccCCHHH-HHH----HHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 444455555 666766432 110 0001122456778888888888877 4456677788888888888888765
Q ss_pred CCccccCCC--CCCEEECCCCcCCCcCCc-------ccccCCCCCeEe
Q 002376 521 IPNIVAELK--GLEVLDLSSNKLSGSIPS-------DLQNLQALRSLN 559 (929)
Q Consensus 521 ~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 559 (929)
..+..++ +|+.|+|++|.+++.+|. .+..+++|+.||
T Consensus 212 --~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 --RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp --GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred --hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 2333344 788888888888876652 356677777776
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=3.6e-08 Score=97.92 Aligned_cols=42 Identities=19% Similarity=0.236 Sum_probs=19.2
Q ss_pred ccCCCCCCEEEC--CCCcCCCc----CCcccccCCCCCeEeCCCCcCc
Q 002376 525 VAELKGLEVLDL--SSNKLSGS----IPSDLQNLQALRSLNLTFNNLE 566 (929)
Q Consensus 525 ~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 566 (929)
+...+.|++|+| ++|.+... +...+...+.|++|+|++|.+.
T Consensus 117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 333444555555 44544432 1223333455555555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=5.2e-08 Score=96.75 Aligned_cols=122 Identities=16% Similarity=0.202 Sum_probs=89.8
Q ss_pred CcccccCCCCCceecccCc-ccccc----cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCC
Q 002376 417 IPNSLANLKKLNQIDLSGN-ELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491 (929)
Q Consensus 417 ~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N 491 (929)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|+|...- ...+...+...++|++|||++|
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g----~~~l~~~L~~n~~L~~L~L~~N 103 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPV----AFALAEMLKVNNTLKSLNVESN 103 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHH----HHHHHHHHHHCSSCCEEECCSS
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHH----HHHHHHHHHhCCCcCEEECcCC
Confidence 3445677889999999999 88643 3344566788999999999986311 1112344556688999999999
Q ss_pred CCCCC----CCcchhcCcCcceeec--cccccccc----CCccccCCCCCCEEECCCCcCC
Q 002376 492 SLSGN----LPNSLKNCKSLEELLM--AYNQFSGP----IPNIVAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 492 ~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 542 (929)
.++.. +...+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 104 ~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 104 FISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred cCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 98753 3556777788999999 88998754 3455666789999999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.23 E-value=9.7e-07 Score=97.66 Aligned_cols=124 Identities=15% Similarity=0.198 Sum_probs=87.2
Q ss_pred ceeecccCceeEEecccc---------C--------cHHHHHHHHHHHHccC--CccccceeeecccCCCCCcceEEEEE
Q 002376 666 ENLIGSGSFGSVLHNERT---------G--------SWKSFIAECETLRNVR--HRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~---------~--------~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.+.++.|.++.||+.... . ....+.+|+++++.+. +..+.++++++.+.+. .+..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEEEE
Confidence 467888888888875432 1 1246788999999997 4557888888754321 13468999
Q ss_pred EecCCCCcccc-ccc-----cccccccHHHHHHHhhhCC-----------------------------------------
Q 002376 727 EFLSNGSLGDW-IHG-----ERKNELDITSALDYLHNDC----------------------------------------- 759 (929)
Q Consensus 727 e~~~~gsL~~~-l~~-----~~~~~~~ia~aL~yLH~~~----------------------------------------- 759 (929)
||++|..+.+. +.. ......+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 99999888542 211 1233567888899999731
Q ss_pred --------------CCCEEecCCCCCCeeecCCCc--eEEeccccccc
Q 002376 760 --------------EVPVVHSDLKPGNILLDEEMT--AKVGDFGLARF 791 (929)
Q Consensus 760 --------------~~~iiHrDlk~~NILl~~~~~--~ki~DfGla~~ 791 (929)
.+.++|+|+++.||++++++. +.|.||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.79 E-value=2.4e-05 Score=84.09 Aligned_cols=124 Identities=15% Similarity=0.216 Sum_probs=81.4
Q ss_pred ceeecccCceeEEecccc---------CcHHHHHHHHHHHHccC-Ccc--ccceeeecccCCCCCcceEEEEEEecCCCC
Q 002376 666 ENLIGSGSFGSVLHNERT---------GSWKSFIAECETLRNVR-HRN--LVKLITSCSSLDSKNMEFLALVYEFLSNGS 733 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~---------~~~~~~~~E~~~l~~l~-Hpn--iv~l~~~~~~~~~~~~~~~~lV~e~~~~gs 733 (929)
.+.++.|....||+.... .....+.+|+++++.+. +.. +.+.+.+.... ......|+||||++|.+
T Consensus 25 i~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~~i~G~~ 102 (304)
T 3sg8_A 25 IEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFTKIKGVP 102 (304)
T ss_dssp CCEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEECCCCEE
T ss_pred eEecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEcccCCeE
Confidence 456899999999986532 12457889999999884 332 33444443221 11223589999999988
Q ss_pred ccccccc------cccccccHHHHHHHhhhC-------------------------------------------------
Q 002376 734 LGDWIHG------ERKNELDITSALDYLHND------------------------------------------------- 758 (929)
Q Consensus 734 L~~~l~~------~~~~~~~ia~aL~yLH~~------------------------------------------------- 758 (929)
+.+.... ....+.++++.++.||+.
T Consensus 103 l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 182 (304)
T 3sg8_A 103 LTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILE 182 (304)
T ss_dssp CCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHh
Confidence 8653211 122344556666666641
Q ss_pred ------CCCCEEecCCCCCCeeecC--CCceEEeccccccc
Q 002376 759 ------CEVPVVHSDLKPGNILLDE--EMTAKVGDFGLARF 791 (929)
Q Consensus 759 ------~~~~iiHrDlk~~NILl~~--~~~~ki~DfGla~~ 791 (929)
..+.++|+|++|.||++++ ...+.|.||+.+..
T Consensus 183 ~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 183 NEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp CGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred ccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 1246899999999999998 45688999998864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.42 E-value=5.9e-05 Score=72.89 Aligned_cols=34 Identities=15% Similarity=0.050 Sum_probs=17.5
Q ss_pred cccEEEeeCCCCCcccCccccCCCCCCEEEecCC
Q 002376 378 SLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411 (929)
Q Consensus 378 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 411 (929)
.|+.|||+++.|+..--..+.++++|+.|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555555443334445555555555555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.36 E-value=4.9e-05 Score=73.46 Aligned_cols=83 Identities=12% Similarity=0.079 Sum_probs=56.3
Q ss_pred cccEEEecCCccccccCCCCCCCCcccEEEeeCCC-CCcccCccccCC----CCCCEEEecCCc-CCCCCcccccCCCCC
Q 002376 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS-ISGEIPIEIGQL----QGLQVLGLAGNE-IPGGIPNSLANLKKL 427 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 427 (929)
.|+.||++++.|+..--..+.++++|++|+|++|. |++.--..+..+ ++|++|+|+++. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 58888888888776555667788999999999985 775544445553 357777777764 654333445566666
Q ss_pred ceecccCcc
Q 002376 428 NQIDLSGNE 436 (929)
Q Consensus 428 ~~L~Ls~N~ 436 (929)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00038 Score=74.72 Aligned_cols=122 Identities=16% Similarity=0.141 Sum_probs=75.7
Q ss_pred ceeecccCceeEEecccc---------CcHHHHHHHHHHHHccCCc---cccceeeecccCCCCCcceEEEEEEecCCCC
Q 002376 666 ENLIGSGSFGSVLHNERT---------GSWKSFIAECETLRNVRHR---NLVKLITSCSSLDSKNMEFLALVYEFLSNGS 733 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~---------~~~~~~~~E~~~l~~l~Hp---niv~l~~~~~~~~~~~~~~~~lV~e~~~~gs 733 (929)
.+.++.|....||+.... .....+.+|+++++.+.+. .+.+.+.++.. ..+..++||||++|..
T Consensus 24 v~~l~~G~~n~v~~vg~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEETTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEECCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEEeccCCeE
Confidence 356777877788765211 1245788999999999753 24455555431 1233689999999987
Q ss_pred cccccc------ccccccccHHHHHHHhhhC-------------------------------------------------
Q 002376 734 LGDWIH------GERKNELDITSALDYLHND------------------------------------------------- 758 (929)
Q Consensus 734 L~~~l~------~~~~~~~~ia~aL~yLH~~------------------------------------------------- 758 (929)
+.+..- .......++++.|+.||+.
T Consensus 100 l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~ 179 (306)
T 3tdw_A 100 LGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSY 179 (306)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHH
T ss_pred CchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHH
Confidence 765210 0011122222333333221
Q ss_pred --------CCCCEEecCCCCCCeeecC---CCc-eEEeccccccc
Q 002376 759 --------CEVPVVHSDLKPGNILLDE---EMT-AKVGDFGLARF 791 (929)
Q Consensus 759 --------~~~~iiHrDlk~~NILl~~---~~~-~ki~DfGla~~ 791 (929)
..+.++|+|+++.||++++ ++. +.|.||+.+..
T Consensus 180 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 180 MTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346899999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00086 Score=70.39 Aligned_cols=101 Identities=13% Similarity=0.061 Sum_probs=64.9
Q ss_pred HHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEEEecCCCCccccccc----cccccccHH-----------
Q 002376 686 WKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG----ERKNELDIT----------- 749 (929)
Q Consensus 686 ~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~ia----------- 749 (929)
...+.+|...|+.+. +--|-++++++.+. +..++|||++++.++.+.... ......+++
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCG
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCc
Confidence 456889999998885 22355677776443 347999999998766543210 001111222
Q ss_pred ----------------------------------------HHHHHhhhCC----CCCEEecCCCCCCeeecCCCceEEec
Q 002376 750 ----------------------------------------SALDYLHNDC----EVPVVHSDLKPGNILLDEEMTAKVGD 785 (929)
Q Consensus 750 ----------------------------------------~aL~yLH~~~----~~~iiHrDlk~~NILl~~~~~~ki~D 785 (929)
...+.+.... .+.++|+|+.+.||++++++.+-|.|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD 217 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID 217 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence 2233333221 23479999999999999887778999
Q ss_pred cccccc
Q 002376 786 FGLARF 791 (929)
Q Consensus 786 fGla~~ 791 (929)
|+.+..
T Consensus 218 we~a~~ 223 (272)
T 4gkh_A 218 VGRVGI 223 (272)
T ss_dssp CTTCEE
T ss_pred Cccccc
Confidence 998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00033 Score=68.98 Aligned_cols=62 Identities=11% Similarity=0.198 Sum_probs=29.7
Q ss_pred CcCcceeeccccccccc----CCccccCCCCCCEEECCCCc---CCC----cCCcccccCCCCCeEeCCCCcC
Q 002376 504 CKSLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNK---LSG----SIPSDLQNLQALRSLNLTFNNL 565 (929)
Q Consensus 504 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~---l~~----~~p~~~~~l~~L~~L~Ls~N~l 565 (929)
-+.|+.|+|++|+|+.. +-..+..-+.|+.|+|++|. +.. .+-..+..-+.|+.|+++.|..
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 34444444444444321 22334444556666666542 221 1223344456677777766553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00041 Score=68.30 Aligned_cols=16 Identities=38% Similarity=0.455 Sum_probs=8.0
Q ss_pred CCCCCCEEECCCCcCC
Q 002376 527 ELKGLEVLDLSSNKLS 542 (929)
Q Consensus 527 ~l~~L~~L~Ls~N~l~ 542 (929)
.-+.|+.|+|++|.|.
T Consensus 96 ~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 96 TSPSLRVLNVESNFLT 111 (197)
T ss_dssp HCSSCCEEECCSSBCC
T ss_pred cCCccCeEecCCCcCC
Confidence 3344555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0029 Score=58.12 Aligned_cols=34 Identities=29% Similarity=0.239 Sum_probs=13.1
Q ss_pred CcEEeCCCCCCCCCcccccccccccceecccccc
Q 002376 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154 (929)
Q Consensus 121 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 154 (929)
|++|+|++|+|+...+..|..+++|++|+|++|.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 3344444444433333333333333444443333
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.003 Score=58.00 Aligned_cols=35 Identities=34% Similarity=0.365 Sum_probs=19.1
Q ss_pred CCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCc
Q 002376 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 530 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (929)
+|+.|||++|+|+...+..|..+++|+.|+|++|.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 45666666666665444455555555555444333
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0026 Score=69.10 Aligned_cols=32 Identities=31% Similarity=0.383 Sum_probs=28.5
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+.++|+|+++.||+++.++.+.|.||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 45899999999999998888999999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.002 Score=70.64 Aligned_cols=32 Identities=22% Similarity=0.347 Sum_probs=27.1
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
.+.++|+|+.+.||+++++..+.|.||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34789999999999999654578999998874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0087 Score=63.97 Aligned_cols=64 Identities=17% Similarity=0.112 Sum_probs=45.6
Q ss_pred ceeecccCceeEEecccc-----------CcHHHHHHHHHHHHccC---CccccceeeecccCCCCCcceEEEEEEecCC
Q 002376 666 ENLIGSGSFGSVLHNERT-----------GSWKSFIAECETLRNVR---HRNLVKLITSCSSLDSKNMEFLALVYEFLSN 731 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~-----------~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~ 731 (929)
.+.|+.|....+|+.... .....|.+|.+.|+.+. ...+.++++++... +..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEEEeccC
Confidence 456788888888775432 23457889999998884 25577777776432 347999999998
Q ss_pred CCc
Q 002376 732 GSL 734 (929)
Q Consensus 732 gsL 734 (929)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0088 Score=66.55 Aligned_cols=31 Identities=32% Similarity=0.434 Sum_probs=26.4
Q ss_pred CCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
+.++|+|+.+.||+++++ .+++.||..+...
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 478999999999999876 4899999887743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.80 E-value=0.018 Score=61.92 Aligned_cols=141 Identities=20% Similarity=0.145 Sum_probs=78.0
Q ss_pred CCChHHHHHhhCCCCC-----ceeecccCceeEEecccc----------C--cHHHHHHHHHHHHccCCcc--ccceeee
Q 002376 650 KISYDELRRATGNFSH-----ENLIGSGSFGSVLHNERT----------G--SWKSFIAECETLRNVRHRN--LVKLITS 710 (929)
Q Consensus 650 ~~~~~~l~~~~~~~~~-----~~~iG~G~~g~Vy~~~~~----------~--~~~~~~~E~~~l~~l~Hpn--iv~l~~~ 710 (929)
.++.+++......|.. .+.|+.|....||+.... . ..+.+..|+.+++.+.... +.+++..
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 4566666666666654 234666777777765421 1 2346778888888774322 2333322
Q ss_pred cccCCC--CCcceEEEEEEecCCCCcccc--------------ccc-------cc----c-----------------cc-
Q 002376 711 CSSLDS--KNMEFLALVYEFLSNGSLGDW--------------IHG-------ER----K-----------------NE- 745 (929)
Q Consensus 711 ~~~~~~--~~~~~~~lV~e~~~~gsL~~~--------------l~~-------~~----~-----------------~~- 745 (929)
. +... ...+..++||||++|..+... +|. .. . ..
T Consensus 86 ~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 86 K-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp T-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred C-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 0000 011346899999998654321 110 00 0 00
Q ss_pred ---ccHHHHHHHhhhC----CCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 746 ---LDITSALDYLHND----CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 746 ---~~ia~aL~yLH~~----~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..+...+++++.. .+..++|+|+.+.||+++++..+.|.||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0133445555532 234789999999999999876668999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.17 E-value=0.032 Score=58.82 Aligned_cols=63 Identities=14% Similarity=0.004 Sum_probs=41.8
Q ss_pred CCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCc---cccceeeecccCCCCCcceEEEE
Q 002376 664 SHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHR---NLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hp---niv~l~~~~~~~~~~~~~~~~lV 725 (929)
...+.+|.|..+.||+.+.. .....|.+|++.|+.+.-. -+.+++++. + -++|
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~------~~lv 88 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D------RTLA 88 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T------TEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---C------ceEE
Confidence 34567899999999986543 1124688999999988532 244444442 1 2889
Q ss_pred EEecCCCCcc
Q 002376 726 YEFLSNGSLG 735 (929)
Q Consensus 726 ~e~~~~gsL~ 735 (929)
|||++++...
T Consensus 89 ~e~l~~~~~~ 98 (288)
T 3f7w_A 89 MEWVDERPPT 98 (288)
T ss_dssp EECCCCCCCC
T ss_pred EEeecccCCC
Confidence 9999876543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.034 Score=62.28 Aligned_cols=32 Identities=19% Similarity=0.412 Sum_probs=28.0
Q ss_pred CCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
.+.++|+|++|.||++++++ ++|.||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 34799999999999999876 999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.028 Score=59.79 Aligned_cols=118 Identities=13% Similarity=0.091 Sum_probs=68.3
Q ss_pred ceeecccCceeEEecccc-----C-cH---HHHHHHHHHHHccCCccc-cceeeecccCCCCCcceEEEEEEec-CCCCc
Q 002376 666 ENLIGSGSFGSVLHNERT-----G-SW---KSFIAECETLRNVRHRNL-VKLITSCSSLDSKNMEFLALVYEFL-SNGSL 734 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~-----~-~~---~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~~~~~~lV~e~~-~~gsL 734 (929)
.+.|+.|....+|+...- + .. ....+|+.+++.+....+ .++++++.+ . -++|+||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~-----~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRAGDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--T-----GVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEETTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--T-----CCEEEECCTTCEEC
T ss_pred eeEcCCccccccceeeeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--C-----CEEEEeecCCCccC
Confidence 567888888888876110 1 11 123568888877743333 355554321 1 27899999 65455
Q ss_pred cccc-cccccccccHHHHHHHhhhC--------------------------------------------------CCCCE
Q 002376 735 GDWI-HGERKNELDITSALDYLHND--------------------------------------------------CEVPV 763 (929)
Q Consensus 735 ~~~l-~~~~~~~~~ia~aL~yLH~~--------------------------------------------------~~~~i 763 (929)
...- ........++++.|+-+|+. .++.+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 3210 00011223333344444431 12348
Q ss_pred EecCCCCCCeeecCCCceEEeccccccc
Q 002376 764 VHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 764 iHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
+|+|+.+.||+ .+++.+.+.||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.96 E-value=0.11 Score=55.75 Aligned_cols=30 Identities=33% Similarity=0.366 Sum_probs=25.6
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
...++|+|+++.||+++ + .+.|.||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34689999999999999 4 899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=93.86 E-value=0.047 Score=61.25 Aligned_cols=39 Identities=23% Similarity=0.301 Sum_probs=26.4
Q ss_pred HHHHHHHHHHHccCCccc-cceeeecccCCCCCcceEEEEEEecCCCCc
Q 002376 687 KSFIAECETLRNVRHRNL-VKLITSCSSLDSKNMEFLALVYEFLSNGSL 734 (929)
Q Consensus 687 ~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~~~~~~lV~e~~~~gsL 734 (929)
..+.+|..+++.+...++ .++++++. . .+||||++|.++
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~----~-----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFS----G-----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEET----T-----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeC----C-----CEEEEEeCCccc
Confidence 567789999988853333 55666542 1 389999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.39 E-value=0.11 Score=56.97 Aligned_cols=31 Identities=35% Similarity=0.545 Sum_probs=27.3
Q ss_pred CCEEecCCCCCCeeecCC----CceEEeccccccc
Q 002376 761 VPVVHSDLKPGNILLDEE----MTAKVGDFGLARF 791 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~----~~~ki~DfGla~~ 791 (929)
..++|+|+.+.||+++++ +.+.+.||..|..
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 468999999999999876 7899999998874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.37 E-value=0.17 Score=54.47 Aligned_cols=32 Identities=31% Similarity=0.399 Sum_probs=27.7
Q ss_pred CCCEEecCCCCCCeeecCC----CceEEeccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEE----MTAKVGDFGLARF 791 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~----~~~ki~DfGla~~ 791 (929)
.+.++|||+.+.||+++++ +.+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6899999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.83 E-value=0.21 Score=56.28 Aligned_cols=36 Identities=17% Similarity=0.168 Sum_probs=24.8
Q ss_pred HHHHHHHHccCCccc-cceeeecccCCCCCcceEEEEEEecCCCCc
Q 002376 690 IAECETLRNVRHRNL-VKLITSCSSLDSKNMEFLALVYEFLSNGSL 734 (929)
Q Consensus 690 ~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~~~~~~lV~e~~~~gsL 734 (929)
.+|..+++.+...++ .++++++. . .+||||+++.++
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~----~-----G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT----N-----GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET----T-----EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC----C-----eEEEEeeCCccC
Confidence 589999999865444 45666651 1 359999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.49 E-value=0.13 Score=56.30 Aligned_cols=30 Identities=27% Similarity=0.490 Sum_probs=25.1
Q ss_pred CCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++|+|+++.|||++++. +.+.||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4689999999999998665 89999998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.17 E-value=0.52 Score=33.30 Aligned_cols=29 Identities=7% Similarity=0.044 Sum_probs=11.7
Q ss_pred ehhhHHHHHHHHHHHHhhhhhhhhccccc
Q 002376 608 LSIIVTIMAVIAGCFLIVWPIIVRKRKAK 636 (929)
Q Consensus 608 i~i~~~~~~~l~~~~~~~~~~~~rrr~~~ 636 (929)
++..+++..++++++...+++++|+|+.+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 33333333333333334444445554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.60 E-value=0.65 Score=51.55 Aligned_cols=30 Identities=20% Similarity=0.424 Sum_probs=26.6
Q ss_pred CCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++|+|+.+.||+ ++++.+.+.||..|..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 46899999999999 8888999999998874
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.71 E-value=1.2 Score=31.35 Aligned_cols=13 Identities=23% Similarity=0.644 Sum_probs=5.6
Q ss_pred hhhhhhhhccccc
Q 002376 624 IVWPIIVRKRKAK 636 (929)
Q Consensus 624 ~~~~~~~rrr~~~ 636 (929)
..+++++|+|+.+
T Consensus 28 ~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 28 LTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHTTCSS
T ss_pred HHHHHHhhhhhhh
Confidence 3444444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 929 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-34 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-29 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-29 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-27 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-05 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-21 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-20 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-14 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 4e-34
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 59/300 (19%)
Query: 652 SYDELRRATGNFSHE---------NLIGSGSFGSVL--HNERTG---------------- 684
++++ A F+ E +IG+G FG V H + G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 685 --SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
+ F++E + H N++ L + + ++ EF+ NGSL ++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 743 KNE---------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793
I + + YL + VH DL NIL++ + KV DFGL+RF L
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF-L 178
Query: 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV--ESNL 851
E + + +S I + PE + ++A DV + E
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 852 PENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911
++V+ ++ + R + + + L C + R + + L
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALH----------QLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 62/297 (20%), Positives = 96/297 (32%), Gaps = 80/297 (26%)
Query: 661 GNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLV 705
G + IGSGSFG+V + G ++F E LR RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITSALDYLH 756
+ ++ LA+V ++ SL +H +DYLH
Sbjct: 68 LFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
++H DLK NI L E++T K+GDFGLA S GSI ++
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK----SRWSGSHQFEQLSGSILWMA 174
Query: 817 PEYGLGERP---STAGDV---------------PTSESFAGEFNIVKWVESNLPENVLQV 858
PE + S DV P S + I L ++ +V
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 859 ---LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
+++LM C + R + L ++
Sbjct: 235 RSNCPKAMKRLM----------------------AECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-32
Identities = 55/295 (18%), Positives = 99/295 (33%), Gaps = 56/295 (18%)
Query: 666 ENLIGSGSFGSVLHNERTG-----------SWKSFIAECE--TLRNVRHRNLVKLITSCS 712
+ IG G FG V + G +S+ E E +RH N++ I + +
Sbjct: 8 QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLHNDC-----E 760
D+ L LV ++ +GSL D+++ L S L +LH + +
Sbjct: 68 K-DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
+ H DLK NIL+ + T + D GLA D + +G+ Y+ PE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH--RVGTKRYMAPEVL 184
Query: 821 LGERPSTAGDV-----------------------PTSESFAGEFNIVKWVESNLPENVLQ 857
+ E + + + + ++ E
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
V + +LR + N Q+ + + I+ C + R+ + L
Sbjct: 245 VCEQKLRPNI-PNRWQSCEALRVMAKIM----RECWYANGAARLTALRIKKTLSQ 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 49/202 (24%), Positives = 75/202 (37%), Gaps = 41/202 (20%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG----------------SWKSFIAECETLRNVRHRN 703
++ IG+GS+G + G + ++E LR ++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------LDITSA 751
+V+ + L +V E+ G L I K +T A
Sbjct: 65 IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 752 LDYLH--NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFM 809
L H +D V+H DLKP N+ LD + K+GDFGLAR L S F+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDTSFAKAFV 175
Query: 810 GSIGYVPPEYGLGERPSTAGDV 831
G+ Y+ PE + D+
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDI 197
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 57/286 (19%), Positives = 99/286 (34%), Gaps = 74/286 (25%)
Query: 662 NFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLIT 709
IG G FG V+ + G + ++F+AE + +RH NLV+L+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 710 SCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL----------DITSALDYLHNDC 759
+ L +V E+++ GSL D++ ++ L D+ A++YL +
Sbjct: 68 VIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
VH DL N+L+ E+ AKV DFGL + S+ + + PE
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTAPEA 171
Query: 820 GLGERPSTAGDV--------------PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865
++ ST DV ++V VE + P + +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911
+M +C R + +L+
Sbjct: 232 VM----------------------KNCWHLDAAMRPSFLQLREQLE 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 51/288 (17%), Positives = 93/288 (32%), Gaps = 74/288 (25%)
Query: 662 NFSHENLIGSGSFGSVLH--------------NERTGSWKSFIAECETLRNVRHRNLVKL 707
+G+G FG V + + S +F+AE ++ ++H+ LV+L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHN 757
+ E + ++ E++ NGSL D++ +L I + ++
Sbjct: 74 YAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
+H DL+ NIL+ + ++ K+ DFGLAR + + ++ I + P
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAP 179
Query: 818 EYGLGERPSTAGDV--------------PTSESFAGEFNIVKWVESNLPENVLQVLDPEL 863
E + DV +++ +E EL
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911
QLM C E P R L+
Sbjct: 240 YQLM----------------------RLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 38/195 (19%), Positives = 70/195 (35%), Gaps = 40/195 (20%)
Query: 662 NFSHENLIGSGSFGSVL-----------------HNERTGSWKSFIAECETLRNVRHRNL 704
+F + +G+G+ G V + I E + L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLH 756
V + S +++ E + GSL + + + + L YL
Sbjct: 67 VGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
++H D+KP NIL++ K+ DFG++ L++ S + F+G+ Y+
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------SMANSFVGTRSYMS 171
Query: 817 PEYGLGERPSTAGDV 831
PE G S D+
Sbjct: 172 PERLQGTHYSVQSDI 186
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 5e-31
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 75/285 (26%)
Query: 666 ENLIGSGSFGSV----------------LHNERT--GSWKSFIAECETLRNVRHRNLVKL 707
+ IG GSF +V L + + + F E E L+ ++H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDC 759
S S K + + LV E +++G+L ++ + ++ I L +LH
Sbjct: 74 YDSWES-TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 760 EVPVVHSDLKPGNILL-DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
P++H DLK NI + + K+GD GLA S +G+ ++ PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--------RASFAKAVIGTPEFMAPE 183
Query: 819 YGLGERPSTAGDV---------------PTSESFAGEFNIVKWVESNLPENVLQVLDPEL 863
E+ + DV P SE + P + +V PE+
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
++++ C ++ R I++ L
Sbjct: 243 KEII----------------------EGCIRQNKDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 9e-31
Identities = 62/302 (20%), Positives = 95/302 (31%), Gaps = 74/302 (24%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSVLH--------------NERTGSWKSFIAECE 694
++ D + E +G G FG V T S ++F+ E +
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ 64
Query: 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
++ +RH LV+L S E + +V E++S GSL D++ GE
Sbjct: 65 VMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 746 -LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
I S + Y+ VH DL+ NIL+ E + KV DFGLAR + + ++
Sbjct: 119 AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI-----EDNEYTA 170
Query: 805 THVFMGSIGYVPPEYGLGERPSTAGDV--------------PTSESFAGEFNIVKWVESN 850
I + PE L R + DV ++ VE
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230
Query: 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910
L LM C + P R L
Sbjct: 231 YRMPCPPECPESLHDLM----------------------CQCWRKEPEERPTFEYLQAFL 268
Query: 911 KS 912
+
Sbjct: 269 ED 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-30
Identities = 59/288 (20%), Positives = 91/288 (31%), Gaps = 66/288 (22%)
Query: 662 NFSHENLIGSGSFGSVLH--------------NERTGSWKSFIAECETLRNVRHRNLVKL 707
+ IGSG FG V E S + FI E E + + H LV+L
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD------ITSALDYLHNDCEV 761
C + LV+EF+ +G L D++ +R + + E
Sbjct: 66 YGVCL-----EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
V+H DL N L+ E KV DFG+ RF+ +S+ + + PE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-----LDDQYTSSTGTKFPVKWASPEVFS 175
Query: 822 GERPSTAGDV--------------PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867
R S+ DV +V+ + + ++ + Q+M
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235
Query: 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915
C E P R LR+L E
Sbjct: 236 ----------------------NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 9e-30
Identities = 54/309 (17%), Positives = 96/309 (31%), Gaps = 77/309 (24%)
Query: 655 ELRRATGNFSHENL-IGSGSFGSVL-------------------HNERTGSWKSFIAECE 694
+L N ++ +G G+FGSV + + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 695 TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------- 745
+ + + +V+LI C + L LV E G L ++ G+R+
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 746 LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISST 805
++ + YL VH DL N+LL AK+ DFGL++ L + S ++
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL---GADDSYYTAR 169
Query: 806 HVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEF--------------NIVKWVESNL 851
+ + PE + S+ DV + E ++ ++E
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229
Query: 852 PENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911
PEL LM C R +R++
Sbjct: 230 RMECPPECPPELYALM----------------------SDCWIYKWEDRPDFLTVEQRMR 267
Query: 912 SSQEILLKQ 920
+ L +
Sbjct: 268 ACYYSLASK 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 50/284 (17%), Positives = 93/284 (32%), Gaps = 66/284 (23%)
Query: 666 ENLIGSGSFGSV----LHNERTG----------------SWKSFIAECETLRNVRHRNLV 705
+ +GSG+FG+V ++ +AE ++ + + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYLHN 757
++I C E LV E G L ++ R + ++ + YL
Sbjct: 72 RMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 758 DCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPP 817
VH DL N+LL + AK+ DFGL++ L +++ + + + P
Sbjct: 126 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWPVKWYAP 179
Query: 818 EYGLGERPSTAGDVPTSESFAGEFNIVKW---------VESNLPENVLQVLDPELRQLMT 868
E + S+ DV F ++ W V +L+ R
Sbjct: 180 ECINYYKFSSKSDV-------WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232
Query: 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
+ + + + C T R G RL++
Sbjct: 233 AGCPREMY----------DLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 48/275 (17%)
Query: 662 NFSHENLIGSGSFGSVLH--------------NERTGSWKSFIAECETLRNVRHRNLVKL 707
+ + +G+G FG V + E + S FI E + + N+ H LV+L
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHND 758
C+ + ++ E+++NG L +++ R D+ A++YL +
Sbjct: 65 YGVCTK-----QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
+H DL N L++++ KV DFGL+R++ +S+ + + PPE
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-----LDDEYTSSVGSKFPVRWSPPE 171
Query: 819 YGLGERPSTAGDVPTSESFAGEFNIVKWV--ESNLPENVLQVLDPELRQLMTSNESQTIQ 876
+ + S+ D+ E + + E + + LR S+ +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231
Query: 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911
++ SC E R + L +
Sbjct: 232 ----------TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-28
Identities = 58/304 (19%), Positives = 95/304 (31%), Gaps = 76/304 (25%)
Query: 640 VSALFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVL--HNERTG------------- 684
V+ LF P+ + +LR IG GSFG+V + R
Sbjct: 4 VAELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 685 ----SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG 740
W+ I E L+ +RH N ++ LV E+ +
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVH 108
Query: 741 ERKNE--------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
++ + L YLH ++H D+K GNILL E K+GDFG A
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI- 164
Query: 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGD--------VPTSESFAGEFNIV 844
++ + F+G+ ++ PE L + E + +
Sbjct: 165 ---------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 845 KWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIR 904
+ ++ Q P L+ S + SC + P R
Sbjct: 216 NMNAMSALYHIAQNESPALQSGHWSEY---------FRNFV----DSCLQKIPQDRPTSE 262
Query: 905 EALR 908
L+
Sbjct: 263 VLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-28
Identities = 51/281 (18%), Positives = 94/281 (33%), Gaps = 49/281 (17%)
Query: 662 NFSHENLIGSGSFGSV--------------------LHNERT-GSWKSFIAECETLRNVR 700
+ + +IG+G FG V L T F+ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYL----- 755
H N+++L S + ++ E++ NG+L ++ E+ E + + L
Sbjct: 68 HHNIIRLEGVISKYKP-----MMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAA 121
Query: 756 --HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
+ VH DL NIL++ + KV DFGL+R L D+ + +T I
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE---DDPEATYTTSGGKIPIR 178
Query: 814 YVPPEYGLGERPSTAGDVPTSESFAGEFNIVK--WVESNLPENVLQVLDPELRQLMTSNE 871
+ PE + ++A DV + E V++ ++ R +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
I + + C + R + + L
Sbjct: 239 PSAIY----------QLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 54/290 (18%), Positives = 93/290 (32%), Gaps = 85/290 (29%)
Query: 662 NFSHENLIGSGSFGSVL-------------------HNERTGSWKSFIAECETLRNVRHR 702
+F +G G FG+V E+ G E E ++RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDY 754
N+++L + + L+ E+ G++ + K + ++ +AL Y
Sbjct: 67 NILRLYGYFH-----DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
H V+H D+KP N+LL K+ DFG + S G++ Y
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--------SRRTTLCGTLDY 170
Query: 815 VPPEYGLGERPSTAGDV---------------P-TSESFAGEFNIVKWVESNLPENVLQV 858
+PPE G D+ P + ++ + + VE P+ V
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV--- 227
Query: 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
R L++ +P R +RE L
Sbjct: 228 -TEGARDLIS----------------------RLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 8e-28
Identities = 47/267 (17%), Positives = 99/267 (37%), Gaps = 41/267 (15%)
Query: 667 NLIGSGSFGSV----------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITS 710
+G G+FG V + + + ++ E + L + H N+VKL+ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHNDCEV 761
++ L ++ EF + G++ + + AL+YLH +
Sbjct: 78 FYYENN-----LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DN 129
Query: 762 PVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
++H DLK GNIL + K+ DFG++ +I F+G+ ++ PE +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKN------TRTIQRRDSFIGTPYWMAPEVVM 183
Query: 822 GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCL 881
E ++ ++ +++ E P + L + + +E T+
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQPSRW 241
Query: 882 ITIIGSVGLSCTTESPGGRIGIREALR 908
+ C ++ R + L+
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 55/287 (19%), Positives = 89/287 (31%), Gaps = 56/287 (19%)
Query: 662 NFSHENLIGSGSFGSV---LHNERTG-------------------SWKSFIAECETLRNV 699
+ +G GSFG V + +G + FI E + ++
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN---------ELDITS 750
HRNL++L + + +V E GSL D + + + + +
Sbjct: 69 DHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 751 ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMG 810
+ YL + +H DL N+LL K+GDFGL R L N
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKV 176
Query: 811 SIGYVPPEYGLGERPSTAGDVPTSESFAGE---FNIVKWVESNLPENVLQVLDPELRQLM 867
+ PE S A D E + W+ N + + ++ R
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236
Query: 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914
+ Q I +V + C P R L +Q
Sbjct: 237 PEDCPQDIY----------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 56/289 (19%), Positives = 91/289 (31%), Gaps = 75/289 (25%)
Query: 661 GNFSHENLIGSGSFGSVL--HNERTG---------------SWKSFIAECETLRNVRHRN 703
++ +G G++G V N T ++ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDYL 755
+VK + L E+ S G L D I + + + + YL
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H + H D+KP N+LLDE K+ DFGLA R +N+ + + G++ YV
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNK--MCGTLPYV 172
Query: 816 PPEYGLGERPST----------------AGDVPTSESFAGEFNIVKWVESNLPENVLQVL 859
PE AG++P + W E N + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 860 DPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
D L+ E+P RI I + +
Sbjct: 233 DSAPLALLH----------------------KILVENPSARITIPDIKK 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (277), Expect = 2e-27
Identities = 50/291 (17%), Positives = 100/291 (34%), Gaps = 50/291 (17%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSVLH---------------NERTGSWKSFIAEC 693
+YD+ + + ++ +G G +G V E T + F+ E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64
Query: 694 ETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALD 753
++ ++H NLV+L+ C+ ++ EF++ G+L D++ + E+ L
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 754 YL-------HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
+ +H DL N L+ E KV DFGL+R + + ++
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHA 174
Query: 807 VFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEF-----NIVKWVESNLPENVLQVLDP 861
I + PE + S DV +F + V ++L+
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDV---WAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
+ R + + + +C +P R E + ++
Sbjct: 232 DYRMERPEGCPEKVY----------ELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 56/320 (17%), Positives = 101/320 (31%), Gaps = 75/320 (23%)
Query: 643 LFKVCHPKISYDELRRATGNFSHENLIGSGSFGSVLH--------------------NER 682
+ V H I L +F +IG G FG V H
Sbjct: 14 VQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 683 TGSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER 742
G F+ E +++ H N++ L+ C + + +V ++ +G L ++I E
Sbjct: 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNET 124
Query: 743 KNELDITSALDY-------LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
N + + + + VH DL N +LDE+ T KV DFGLAR + +
Sbjct: 125 HN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD- 182
Query: 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV--------------PTSESFAGEF 841
S+ + + ++ E ++ +T DV F
Sbjct: 183 -KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 842 NIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRI 901
+I ++ + L ++M L C R
Sbjct: 242 DITVYLLQGRRLLQPEYCPDPLYEVM----------------------LKCWHPKAEMRP 279
Query: 902 GIREALRRLKSSQEILLKQQ 921
E + R+ + + +
Sbjct: 280 SFSELVSRISAIFSTFIGEH 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-27
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 33/199 (16%)
Query: 657 RRATGNFSHENLIGSGSFGSVL-------------------HNERTGSWKSFIAECETLR 697
++ +F ++G GSF +V+ H + E + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 698 NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-----ERKNELDITSAL 752
+ H VKL + ++ E L + NG L +I E +
Sbjct: 64 RLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
L ++H DLKP NILL+E+M ++ DFG A+ + +S + + F+G+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV----LSPESKQARANSFVGTA 174
Query: 813 GYVPPEYGLGERPSTAGDV 831
YV PE + + D+
Sbjct: 175 QYVSPELLTEKSACKSSDL 193
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 8e-27
Identities = 41/195 (21%), Positives = 76/195 (38%), Gaps = 37/195 (18%)
Query: 660 TGNFSHENLIGSGSFGSV----------------LHNERTGSWKSFIAECETLRNVRHRN 703
++ IG G+ G+V ++ ++ + I E +R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLH 756
+V + S + L +V E+L+ GSL D + +E + AL++LH
Sbjct: 79 IVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
V+H D+K NILL + + K+ DFG + S +G+ ++
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMVGTPYWMA 184
Query: 817 PEYGLGERPSTAGDV 831
PE + D+
Sbjct: 185 PEVVTRKAYGPKVDI 199
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (269), Expect = 3e-26
Identities = 61/326 (18%), Positives = 105/326 (32%), Gaps = 86/326 (26%)
Query: 649 PKISYDELRRATGNFSHENLIGSGSFGSV-------LHNERTGS---------------W 686
PK+ E R N + IG G+FG V L +
Sbjct: 3 PKLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 687 KSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE- 745
F E + + N+VKL+ C + + L++E+++ G L +++ +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 746 -------------------------------LDITSALDYLHNDCEVPVVHSDLKPGNIL 774
+ + + YL E VH DL N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCL 172
Query: 775 LDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDV--- 831
+ E M K+ DFGL+R + + + I ++PPE R +T DV
Sbjct: 173 VGENMVVKIADFGLSRNI----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 832 --PTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVG 889
E F+ + E + V D + E+ ++L++ +
Sbjct: 229 GVVLWEIFSYGLQP--YYGMAHEEVIYYVRDGNILAC---PENCPLELYN--------LM 275
Query: 890 LSCTTESPGGRIGIREALRRLKSSQE 915
C ++ P R R L+ E
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 4e-26
Identities = 64/300 (21%), Positives = 108/300 (36%), Gaps = 51/300 (17%)
Query: 658 RATGNFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNV 699
+ IG G+FG V + NE+ G + + E + L+ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 700 RHRNLVKLITSCSSLDSKNMEF---LALVYEFLSNGSLGDWIHGERKNELD-----ITSA 751
+H N+V LI C + S + LV++F + G + K L +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L+ L+ ++H D+K N+L+ + K+ DFGLAR + S + + +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF--SLAKNSQPNRYTNRVVT 184
Query: 812 IGYVPPEYGLGERP-STAGDVPT-----SESFAGE------------FNIVKWVESNLPE 853
+ Y PPE LGER D+ +E + I + S PE
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 854 NVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGL-----SCTTESPGGRIGIREALR 908
V + EL + + + Q ++ D L + P RI +AL
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 107 bits (268), Expect = 1e-25
Identities = 54/313 (17%), Positives = 98/313 (31%), Gaps = 82/313 (26%)
Query: 662 NFSHENLIGSGSFGSV----------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
++ +G+G+FG V + ++ E +T+ +RH LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLH 756
L + ++ + ++YEF+S G L + + E + L ++H
Sbjct: 87 NLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 757 NDCEVPVVHSDLKPGNILL--DEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
+ VH DLKP NI+ K+ DFGL L S V G+ +
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------DPKQSVKVTTGTAEF 191
Query: 815 VPPEYGLGERPSTAGDVP----------------TSESFAGEFNIVKWVESNLPENVLQV 858
PE G+ D+ E+ VK + N+ ++
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 859 LDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSSQEI 916
+ + + + P R+ I +AL L
Sbjct: 252 ISEDGKDFIR----------------------KLLLADPNTRMTIHQALEHPWLTPGNAP 289
Query: 917 LLKQQVPNGKTKS 929
Q+P+ +
Sbjct: 290 GRDSQIPSSRYTK 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 57/323 (17%), Positives = 100/323 (30%), Gaps = 96/323 (29%)
Query: 648 HPKISYDELRRATGNFSHENLIGSGSFGSVL--HNERTG-----------------SWKS 688
+P + ++ + +++IG G+FG VL ++ G +
Sbjct: 4 YPVLDWN-------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 689 FIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD 747
F E E L + H N++ L+ +C ++ +L L E+ +G+L D++ R E D
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 748 ---------------------ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786
+ + +H DL NIL+ E AK+ DF
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 171
Query: 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPT------------S 834
GL+R Q + + ++ E +T DV +
Sbjct: 172 GLSRG-------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 835 ESFAGE--FNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSC 892
+ G + + + D E+ LM C
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM----------------------RQC 262
Query: 893 TTESPGGRIGIREALRRLKSSQE 915
E P R + L L E
Sbjct: 263 WREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 45/315 (14%), Positives = 93/315 (29%), Gaps = 93/315 (29%)
Query: 662 NFSHENLIGSGSFGSV----------------------LHNERTGSWKSFIAECETLRNV 699
N ++GSG+FG V + ++ ++E + + +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 700 -RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------- 745
H N+V L+ +C+ + L++E+ G L +++ +R+
Sbjct: 98 GSHENIVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 746 ------------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787
+ +++L VH DL N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847
LAR + + S+ + ++ PE + DV + I+ W
Sbjct: 210 LARDI----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV-------WSYGILLWE 258
Query: 848 ----------ESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESP 897
+ N +++ + ++ I + SC
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY----------IIMQSCWAFDS 308
Query: 898 GGRIGIREALRRLKS 912
R L
Sbjct: 309 RKRPSFPNLTSFLGC 323
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 45/289 (15%), Positives = 90/289 (31%), Gaps = 69/289 (23%)
Query: 663 FSHENLIGSGSFGSV---------------------LHNERTGSWKSFIAECETLRNVRH 701
F ++GSG+FG+V + K + E + +V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSAL 752
++ +L+ C + + L+ + + G L D++ + N + I +
Sbjct: 71 PHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
+YL + +VH DL N+L+ K+ DFGLA+ L + I
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPI 177
Query: 813 GYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV---------ESNLPENVLQVLDPEL 863
++ E L T +S + + W + + +L+
Sbjct: 178 KWMALESILHRI-------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230
Query: 864 RQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
R + + + + C R RE +
Sbjct: 231 RLPQPPICTIDVY----------MIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 56/297 (18%), Positives = 95/297 (31%), Gaps = 79/297 (26%)
Query: 666 ENLIGSGSFGSVL--------------------HNERTGSWKSFIAECETLRNVRHRNLV 705
IG G FG V + + F+ E T+R H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDY-------LHND 758
KLI + + ++ E + G L ++ RK LD+ S + Y L
Sbjct: 72 KLIGVITE------NPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL 124
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPE 818
VH D+ N+L+ K+GDFGL+R++ S+ I ++ PE
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPE 179
Query: 819 YGLGERPSTAGDVP--------------TSESFAGEFNIVKWVESNLPENVLQVLDPELR 864
R ++A DV +++ +E+ + P L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921
LM C P R E +L + +L+++
Sbjct: 240 SLM----------------------TKCWAYDPSRRPRFTELKAQLST----ILEEE 270
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (259), Expect = 2e-24
Identities = 82/388 (21%), Positives = 142/388 (36%), Gaps = 29/388 (7%)
Query: 73 VIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQ 132
+ L + T+S +L + ++Q + ++ + L L +N S N L
Sbjct: 24 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT 79
Query: 133 GELPV-NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANL 191
P+ N++KL ++ M + IT L L + L + L
Sbjct: 80 DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+ +S + L L G + + + +L L V L NL
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
I N+ + P LTN+ + + N L+ L +L L ++ N+I
Sbjct: 200 ESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI-- 253
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
S + L+ T L L L NQ P + + L N + +
Sbjct: 254 -------SNLAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDIS 301
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431
I L++LT L L +N+IS P+ L LQ L A N++ +SLANL +N +
Sbjct: 302 PISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNN 459
N+++ P N + + L++
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (258), Expect = 2e-24
Identities = 92/414 (22%), Positives = 150/414 (36%), Gaps = 63/414 (15%)
Query: 140 SKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRL 199
+ L E L +T V+ L + +LQ G I ++ + L
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLG-----------IKSI--DGVEYL 65
Query: 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFN 259
NL ++ + N+L P + N+T LV + + +NQ+ P L L F
Sbjct: 66 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 123
Query: 260 RFTGKIPGS--------------LHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305
+ + L+ + ++ + T L NL L +I
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183
Query: 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHI 365
NK+ L+ + SL + NQ P L +L L GN +
Sbjct: 184 SNKVSDISVLAKLTNLESLIAT---------NNQISDITPL---GILTNLDELSLNGNQL 231
Query: 366 YGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLK 425
++ L +LT LDL+ N IS P+ L L L L N+I P LA L
Sbjct: 232 KD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLT 285
Query: 426 KLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVT 485
L ++L+ N E N ++L + L N I+ P +S L +
Sbjct: 286 ALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP----------VSSLTKLQR 333
Query: 486 IDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
+ ++N +S +SL N ++ L +NQ S P +A L + L L+
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 7e-22
Identities = 79/421 (18%), Positives = 149/421 (35%), Gaps = 57/421 (13%)
Query: 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTS 225
L GK + ++ + DL ++ L+ L I + G + + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT-------DLDQVTTLQADRLGIKSIDG-----VEYLNN 67
Query: 226 LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLL 285
L + ++NQL P L L+D + N+ P + +
Sbjct: 68 LTQINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124
Query: 286 EGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIP 345
L + N ++++ + L+ L G
Sbjct: 125 IDPLKNLTNLNRLELSSN-------------------TISDISALSGLTSLQQLSFGNQV 165
Query: 346 ESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405
+ +N + L + + + +L +L L + N IS P+ I L
Sbjct: 166 TDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDE 223
Query: 406 LGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNI 465
L L GN++ +LA+L L +DL+ N+++ P L + L N+I+
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279
Query: 466 PKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIV 525
P ++ L + ++L++N L P N K+L L + +N S P V
Sbjct: 280 P----------LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--V 325
Query: 526 AELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKG 585
+ L L+ L ++NK+S S L NL + L+ N + + P ++ + L
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN-LTRITQLGLND 382
Query: 586 N 586
Sbjct: 383 Q 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 102 bits (254), Expect = 2e-24
Identities = 78/320 (24%), Positives = 123/320 (38%), Gaps = 29/320 (9%)
Query: 28 TDKEALMSFKSQISQESPSSPLSYWNPSSSPC--TWPGVICNNFGN--RVIGLNLSSFGL 83
DK+AL+ K + + LS W P++ C TW GV+C+ RV L+LS L
Sbjct: 6 QDKQALLQIKKDLG---NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 84 EG--TISPHIGNLSFLRSIQLQNN-KLSGNLPREIGNLFRLRVLNISFNNLQGELPVNIS 140
I + NL +L + + L G +P I L +L L I+ N+ G +P +S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 141 KLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLE 200
++ L LD N ++ + +L +L + F N + G+IP S + S
Sbjct: 123 QIKTLVTLDFSYNALS-GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 201 NLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNR 260
+ NRL G +P T N+ + G D +
Sbjct: 182 S-------RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 261 FTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSF 320
F N+ + + +N + GTLP GL L FL + N+ FN +
Sbjct: 235 FDLGKV---GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE-------- 283
Query: 321 ITSLTNSTHLNYLALDGNQF 340
I N + A N+
Sbjct: 284 IPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.8 bits (221), Expect = 4e-20
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 13/269 (4%)
Query: 325 TNSTHLNYLALDGNQFEGK--IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLL 382
T + +N L L G IP S+ N G N++ G IP +I +L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 383 DLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIP 442
+++ ++SG IP + Q++ L L + N + G +P S+++L L I GN ++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 443 ISFGNFQSLLS-IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSL 501
S+G+F L + + +S NR+ G IP + + ++ + L
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIP----------PTFANLNLAFVDLSRNMLEGDASVL 216
Query: 502 KNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561
+ + V K L LDL +N++ G++P L L+ L SLN++
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 562 FNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
FNNL G +P G + N LC
Sbjct: 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.2 bits (178), Expect = 2e-14
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 18/287 (6%)
Query: 159 VTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTIN-RLAGTVP 217
V D + L+ L P IPS L+ L L L + L G +P
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYP------IPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 218 STIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQI 277
I +T L +L + D + L+ + +N +G +P S+ +L N+
Sbjct: 95 PAIAKLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 278 IRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDG 337
I N + G +P G+ L T + +LN +D
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL---------TGKIPPTFANLNLAFVDL 204
Query: 338 NQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI 397
++ + S+ S++ ++ + +G ++L LDL N I G +P +
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 398 GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPIS 444
QL+ L L ++ N + G IP NL++ + + N+ P+
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 4e-14
Identities = 63/269 (23%), Positives = 101/269 (37%), Gaps = 12/269 (4%)
Query: 194 SDLSRLENLKVLDLTINRLAG--TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
++ + LDL+ L +PS++ N+ L L + L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
+G IP L + + + ++N L GTLPP + +LP L N+I
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ D SF T+ T N+ GKIP + N + ++ +
Sbjct: 164 AIPDSYGSFSKLFTSMTISR------NRLTGKIPPTFANLNL---AFVDLSRNMLEGDAS 214
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQID 431
+ T + ++G + L L L N I G +P L LK L+ ++
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNR 460
+S N L GEIP GN Q +NN+
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 56/288 (19%), Positives = 95/288 (32%), Gaps = 33/288 (11%)
Query: 257 CFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG--TLPPGLGNLPFLRTYNIGFNKIVSSGD 314
C + G + + + + ++ L +P L NLP+L IG +
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 315 DEGLSFITSLTNST------------------HLNYLALDGNQFEGKIPESIGNFSNELS 356
++ +T L L L N G +P SI + N +
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGG 416
GN I G IP S G L + I + G
Sbjct: 154 I-TFDGNRISGAIPDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 417 IPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEE 476
+ L K Q G ++L +DL NNRI G + P+
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL--------PQG 263
Query: 477 ISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQF--SGPIP 522
+++L+ + ++++S N+L G +P N + + A N+ P+P
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 36/148 (24%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 419 NSLANLKKLNQIDLSGNELTG--EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEE 476
++ ++N +DLSG L IP S N L + + ++ P+P
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN-------NLVGPIPPA 96
Query: 477 ISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDL 536
I++L + + ++ ++SG +P+ L K+L L +YN SG +P ++ L L +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 537 SSNKLSGSIPSDLQNLQALRSLNLTFNN 564
N++SG+IP + L + N
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 7e-24
Identities = 45/303 (14%), Positives = 96/303 (31%), Gaps = 74/303 (24%)
Query: 662 NFSHENLIGSGSFGSVL----------------------HNERTGSWKSFIAECETLRNV 699
S +G+G+FG V+ + ++ ++E + L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 700 -RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE------------- 745
H N+V L+ +C+ ++ E+ G L +++ +R +
Sbjct: 84 GNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 746 -------------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ + +L + +H DL NILL K+ DFGLAR +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGE---FNIVKWVES 849
N S+ + ++ PE + DV + F E +
Sbjct: 196 ----KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR 909
+ +++ R L + + + +C P R ++ ++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMY----------DIMKTCWDADPLKRPTFKQIVQL 301
Query: 910 LKS 912
++
Sbjct: 302 IEK 304
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 40/196 (20%), Positives = 76/196 (38%), Gaps = 28/196 (14%)
Query: 660 TGNFSHENLIGSGSFGSVL--HNERTG-----------------SWKSFIAECETLRNVR 700
+ + ++G G V + R + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-----ITSALDYL 755
H +V + + + ++ +V E++ +L D +H E I A L
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
+ + ++H D+KP NI++ KV DFG+AR + D+ +S++ T +G+ Y+
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYL 181
Query: 816 PPEYGLGERPSTAGDV 831
PE G+ DV
Sbjct: 182 SPEQARGDSVDARSDV 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 41/197 (20%), Positives = 73/197 (37%), Gaps = 32/197 (16%)
Query: 660 TGNFSHENLIGSGSFGSVL-----------------HNERTGSWKSFIAECETLRNVRHR 702
+++ + IG G++G V E + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYL 755
N++ + + + M+ + LV + L + + + I L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 756 HNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYV 815
H V+H DLKP N+LL+ K+ DFGLAR + ++ + Y
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA---DPDHDHTGFLTEYVATRWYR 179
Query: 816 PPEYGLGERPST-AGDV 831
PE L + T + D+
Sbjct: 180 APEIMLNSKGYTKSIDI 196
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.1 bits (241), Expect = 3e-22
Identities = 49/252 (19%), Positives = 81/252 (32%), Gaps = 62/252 (24%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG--------------------SWKSFIAECETLRNV 699
+FS +IG G FG V TG + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSA 751
+V + + + D L+ + + ++ G L + I
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 752 LDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
L+++HN VV+ DLKP NILLDE ++ D GLA S H +G+
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--------SKKKPHASVGT 168
Query: 812 IGYVPPEYGLGERPSTA----------------GDVPTSESFAGEFNIVKWVESNLPENV 855
GY+ PE + G P + + + + + + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228
Query: 856 LQVLDPELRQLM 867
PELR L+
Sbjct: 229 PDSFSPELRSLL 240
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 96.7 bits (240), Expect = 4e-22
Identities = 52/284 (18%), Positives = 88/284 (30%), Gaps = 80/284 (28%)
Query: 668 LIGSGSFGSV----------------LHNERTGSWKSFIAECETLRNVRHRNLVKLITSC 711
+GSG+FG V ++ + E + + H L+ L +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDYLHNDCEVP 762
++ + L+ EFLS G L D I E L ++H E
Sbjct: 96 -----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHS 147
Query: 763 VVHSDLKPGNILLD--EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
+VH D+KP NI+ + + + K+ DFGLA L + V + + PE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL-------NPDEIVKVTTATAEFAAPEIV 200
Query: 821 LGERPSTAGDVP----------------TSESFAGEFNIVKWVESNLPENVLQVLDPELR 864
E D+ E VK + E+ + PE +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
+ + + P R+ + +AL
Sbjct: 261 DFIK----------------------NLLQKEPRKRLTVHDALE 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.5 bits (237), Expect = 8e-22
Identities = 53/273 (19%), Positives = 95/273 (34%), Gaps = 48/273 (17%)
Query: 666 ENLIGSGSFGSVL--HNERTG---------SWKSFIAECETL-RNVRHRNLVKLITSCSS 713
++G G G VL N+RT E E R + ++V+++ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 714 LDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDCEVPV 763
L + + L +V E L G L I I A+ YLH + +
Sbjct: 77 LYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132
Query: 764 VHSDLKPGNILLDEEM---TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
H D+KP N+L + K+ DFG A+ +S +S + YV PE
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------TSHNSLTTPCYTPYYVAPEVL 185
Query: 821 LGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE-----SQTI 875
E+ + D+ S I+ N + P ++ + + +
Sbjct: 186 GPEKYDKSCDM---WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
++ + + +I + P R+ I E +
Sbjct: 243 EVSEEVKMLI----RNLLKTEPTQRMTITEFMN 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 46/299 (15%), Positives = 90/299 (30%), Gaps = 60/299 (20%)
Query: 662 NFSHENLIGSGSFGSVLHNERTGSWKS----------------------FIAECETLRNV 699
+ +G GSFG V G K F+ E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITS--------- 750
++V+L+ S + ++ E ++ G L ++ R +
Sbjct: 81 NCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 751 ------ALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISS 804
D + VH DL N ++ E+ T K+GDFG+ R +
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI----YETDYYRK 191
Query: 805 THVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVK---WVESNLPENVLQVLDP 861
+ + ++ PE +T DV + E + + + + + V++
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920
L + +L C +P R E + +K E ++
Sbjct: 252 GLLDKPDNCPDMLFEL-----------MRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.9 bits (233), Expect = 2e-21
Identities = 52/271 (19%), Positives = 90/271 (33%), Gaps = 49/271 (18%)
Query: 666 ENLIGSGSFGSVL--HNERTG---------------SWKSFIAECETLRNVRHRNLVKLI 708
+++G+G+F V+ ++RT S E L ++H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 709 TSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHNDCE 760
++ L L+ + +S G L D I + + A+ YLH+
Sbjct: 74 DIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
V LDE+ + DFGL++ S G+ GYV PE
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME-------DPGSVLSTACGTPGYVAPEVL 181
Query: 821 LGERPSTAGDVPTSESFAGEFNIVKWVESNLP---ENVLQVLDPELRQLMTSNESQTIQL 877
+ S A D ++ + P EN ++ + L+ + +
Sbjct: 182 AQKPYSKAVDC-----WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908
D I + P R +AL+
Sbjct: 237 SDSAKDFI----RHLMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (230), Expect = 4e-21
Identities = 35/190 (18%), Positives = 64/190 (33%), Gaps = 28/190 (14%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGSW-----------------KSFIAECETLRNVRHR 702
+F +G+GSFG V + G + + E L V H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVP 762
++++ + M + L + + L
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822
+++ DLKP NILLD+ K+ DFG A+++ + T+ G+ Y+ PE
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---------TYTLCGTPDYIAPEVVST 175
Query: 823 ERPSTAGDVP 832
+ + + D
Sbjct: 176 KPYNKSIDWW 185
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 1e-20
Identities = 47/302 (15%), Positives = 86/302 (28%), Gaps = 73/302 (24%)
Query: 662 NFSHENLIGSGSFGSV-------LHNERTG---------------SWKSFIAECETLRNV 699
+G G+FG V + T ++ ++E + L ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 700 RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------------- 745
H V + + L ++ EF G+L ++ +R
Sbjct: 74 GHHLNVVNLLGACTKPG---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 746 ----------LDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795
+ +++L +H DL NILL E+ K+ DFGLAR +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI--- 184
Query: 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGD-----VPTSESFAGEFNIVKWVESN 850
+ ++ PE + D V E F+ + +
Sbjct: 185 -YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVK 241
Query: 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910
+ E + L R + + L C P R E + L
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHL 291
Query: 911 KS 912
+
Sbjct: 292 GN 293
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 2e-20
Identities = 53/284 (18%), Positives = 89/284 (31%), Gaps = 81/284 (28%)
Query: 668 LIGSGSFGSVL--HNERTG-------------SWKSFIAECETLRNVRHRNLVKLITSCS 712
+G G FG V + E L RHRN++ L S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF- 70
Query: 713 SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD----------ITSALDYLHNDCEVP 762
++ME L +++EF+S + + I+ EL+ + AL +LH
Sbjct: 71 ----ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHN 122
Query: 763 VVHSDLKPGNILLD--EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
+ H D++P NI+ T K+ +FG AR L + + + Y PE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------KPGDNFRLLFTAPEYYAPEVH 175
Query: 821 LGERPSTAGDV----------------PTSESFAGEFNIVKWVESNLPENVLQVLDPELR 864
+ STA D+ +E+ + E E + + E
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 865 QLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
+ + R+ EAL+
Sbjct: 236 DFVD----------------------RLLVKERKSRMTASEALQ 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 3e-20
Identities = 60/310 (19%), Positives = 105/310 (33%), Gaps = 72/310 (23%)
Query: 663 FSHENL---------IGSGSFGSV----------------------LHNERTGSWKSFIA 691
F EN+ +GSG F V + R S +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 692 ECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD---- 747
E L+ ++H N++ L +N + L+ E ++ G L D++ + +
Sbjct: 63 EVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 748 -ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTA----KVGDFGLARFLLERVDNQSSI 802
+ L+ ++ + + H DLKP NI+L + K+ DFGLA +
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-------DFG 170
Query: 803 SSTHVFMGSIGYVPPEYGLGERPSTAGD-----VPTSESFAGEFNIVKWVESNLPENVLQ 857
+ G+ +V PE E D V T +G + + NV
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 858 VLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR----RLKSS 913
V + E SN S D + + P R+ I+++L+ + K +
Sbjct: 231 V-NYEFEDEYFSNTSA--LAKDFI--------RRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 914 QEILLKQQVP 923
Q+ L
Sbjct: 280 QQALSSAWSH 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 89.4 bits (221), Expect = 3e-20
Identities = 41/197 (20%), Positives = 71/197 (36%), Gaps = 49/197 (24%)
Query: 662 NFSHENLIGSGSFGSV-------------------------LHNERTGSWKSFIAECETL 696
N+ + ++G G V E ++ + E + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 697 RNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------- 747
R V H N+++L + + F LV++ + G L D++ +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 748 ITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHV 807
+ + LH ++ +VH DLKP NILLD++M K+ DFG + L
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------DPGEKLRE 168
Query: 808 FMGSIGYVPPEYGLGER 824
G+ Y+ PE
Sbjct: 169 VCGTPSYLAPEIIECSM 185
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 7e-20
Identities = 61/299 (20%), Positives = 95/299 (31%), Gaps = 58/299 (19%)
Query: 658 RATGNFSHENLIGSGSFGSV-------------------LHNERTGSWKSFIAECETLR- 697
RA + IG G++G V + G S I E LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 698 --NVRHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------L 746
H N+V+L C+ + L LV+E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTH 806
+ LD+LH+ VVH DLKP NIL+ K+ DFGLAR S +
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALT 173
Query: 807 VFMGSIGYVPPEYGLGERPSTAGDV-----------------PTSESFAGEFNIVKWVES 849
+ ++ Y PE L +T D+ S I+ +
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
E+ + + + + + + + + + L C T +P RI AL
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-19
Identities = 47/243 (19%), Positives = 79/243 (32%), Gaps = 45/243 (18%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG-----------------SWKSFIAECETLRNVRHR 702
+F + L+G G+FG V+ + TG + E L+N RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVP 762
L L + + D L + + E + + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 763 VVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG 822
VV+ D+K N++LD++ K+ DFGL + S ++ F G+ Y+ PE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEG------ISDGATMKTFCGTPEYLAPEVLED 179
Query: 823 ERPSTAGDVP----------------TSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866
A D ++ F ++ E P L PE + L
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSL 235
Query: 867 MTS 869
+
Sbjct: 236 LAG 238
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 1e-19
Identities = 46/198 (23%), Positives = 76/198 (38%), Gaps = 42/198 (21%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG-----------------SWKSFIAECETL-RNVRH 701
+F ++G GSFG V ++T + + E L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 702 RNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALD 753
L + + + E L V E+L+ G L I K +L I L
Sbjct: 63 PFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 754 YLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
+L +V+ DLK NILLD++ K+ DFG+ + + ++ F G+
Sbjct: 118 FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT------FCGTPD 168
Query: 814 YVPPEYGLGERPSTAGDV 831
Y+ PE LG++ + + D
Sbjct: 169 YIAPEILLGQKYNHSVDW 186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 51/301 (16%), Positives = 98/301 (32%), Gaps = 73/301 (24%)
Query: 662 NFSHENLIGSGSFGSV-----------------------LHNERT-GSWKSFIAECETLR 697
+G G+FG V L ++ T I+E E ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 698 NV-RHRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL---------- 746
+ +H+N++ L+ +C+ L ++ E+ S G+L +++ R L
Sbjct: 74 MIGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 747 --------------DITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+ ++YL +H DL N+L+ E+ K+ DFGLAR +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV--ESN 850
+ T + ++ PE + DV + E +
Sbjct: 186 ----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRL 910
E + ++L R SN + + + C P R ++ + L
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELY----------MMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 911 K 911
Sbjct: 292 D 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 2e-19
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 36/201 (17%)
Query: 657 RRATGNFSHENLIGSGSFGSVL--HNERTGSW----------KSFIAECETLRNVRHRNL 704
R +++ +IG+GSFG V +G + E + +R + H N+
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNI 75
Query: 705 VKLITSC-SSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-----------LDITSAL 752
V+L SS + K+ +L LV +++ H R + + +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGS 811
Y+H + H D+KP N+LLD + K+ DFG A+ L+ N S I S +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 187
Query: 812 IGYVPPEYGLGERP-STAGDV 831
Y PE G +++ DV
Sbjct: 188 --YRAPELIFGATDYTSSIDV 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 2e-19
Identities = 38/192 (19%), Positives = 69/192 (35%), Gaps = 38/192 (19%)
Query: 667 NLIGSGSFGSV---------------------LHNERTGSWKSFIAECETLRNVRHRNLV 705
+ +G G F +V + G ++ + E + L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 706 KLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-----ITSALDYLHNDCE 760
L+ + + ++LV++F+ + L L +
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYG 820
++H DLKP N+LLDE K+ DFGLA+ S + + + Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNRAYTHQVVTRWYRAPELL 172
Query: 821 LGERP-STAGDV 831
G R D+
Sbjct: 173 FGARMYGVGVDM 184
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 3e-19
Identities = 54/289 (18%), Positives = 95/289 (32%), Gaps = 45/289 (15%)
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSY 386
L L N+ N N L L L N I P + L L L LS
Sbjct: 30 PPDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88
Query: 387 NSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFG 446
N + LQ L+V ++ + N L + + + +G +F
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSGIENGAFQ 147
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKS 506
+ L I +++ I IP+G+ ++ + L N ++ SLK +
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGLPP----------SLTELHLDGNKITKVDAASLKGLNN 196
Query: 507 LEELLMAYNQFSGPI-----------------------PNIVAELKGLEVLDLSSNKLSG 543
L +L +++N S P +A+ K ++V+ L +N +S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 544 ------SIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFR---NMSNVHL 583
P + ++L N ++ FR + V L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 55/262 (20%), Positives = 95/262 (36%), Gaps = 12/262 (4%)
Query: 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409
+ + + L L N I L++L L L N IS P L L+ L L+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGI 469
N++ L++L NE+T F ++ ++L N +
Sbjct: 88 KNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLK------S 138
Query: 470 LRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELK 529
++ + I ++D +++ +P L SL EL + N+ + + L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 530 GLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589
L L LS N +S L N LR L+L N L V + + V+L N
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255
Query: 590 CLQLGCENPRSHGSRLIILSII 611
+ P + ++ S +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGV 277
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 5e-18
Identities = 60/297 (20%), Positives = 98/297 (32%), Gaps = 30/297 (10%)
Query: 168 RSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLV 227
+L+ N I + D L+NL L L N+++ P + L
Sbjct: 31 PDTALLDLQNN--------KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 228 HLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG 287
L L+ NQL E+P + TL L + + L+ + +++ G
Sbjct: 83 RLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-G 140
Query: 288 TLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPES 347
+ L I I + L L LDGN+ S
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQG----------LPPSLTELHLDGNKITKVDAAS 190
Query: 348 IGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLG 407
+ N L+KL L N I S+ L L L+ N + ++P + + +QV+
Sbjct: 191 LKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248
Query: 408 LAGNEIPG------GIPNSLANLKKLNQIDLSGNELT-GEI-PISFGNFQSLLSIDL 456
L N I P + + L N + EI P +F ++ L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 62/338 (18%), Positives = 113/338 (33%), Gaps = 44/338 (13%)
Query: 54 PSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPR 113
P C V C++ G + +L + LQNNK++
Sbjct: 5 PFRCQCHLRVVQCSDLGLEKVPKDLPPD---------------TALLDLQNNKITEIKDG 49
Query: 114 EIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVL 173
+ NL L L + N + P + L +L+ L L N++ + + + L+ L+V
Sbjct: 50 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVH 108
Query: 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLAS 233
+ S+ + + L + +G M L ++R+A
Sbjct: 109 ENEITKVRKSVF---------NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159
Query: 234 NQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL 293
+ IP + P+L + N+ T SL L N+ + ++ N + L
Sbjct: 160 TNI-TTIP---QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215
Query: 294 GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFS- 352
N P LR ++ NK+V L + ++ + L N
Sbjct: 216 ANTPHLRELHLNNNKLV--------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 353 ----NELSKLYLGGNHI-YGKIPASIGR-LRSLTLLDL 384
S + L N + Y +I S R + + L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 86.5 bits (213), Expect = 4e-19
Identities = 46/193 (23%), Positives = 73/193 (37%), Gaps = 34/193 (17%)
Query: 662 NFSHENLIGSGSFGSV-----------------LHNERTGSWKSFIAECETLRNVRHRNL 704
+ IG G++G V L E G + I E L+ ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 705 VKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-----ITSALDYLHNDC 759
VKL + L LV+E L E E + L+ +
Sbjct: 63 VKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEY 819
+ V+H DLKP N+L++ E K+ DFGLAR + + ++ Y P+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYRAPDV 171
Query: 820 GLGERP-STAGDV 831
+G + ST D+
Sbjct: 172 LMGSKKYSTTIDI 184
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 84.9 bits (209), Expect = 2e-18
Identities = 44/286 (15%), Positives = 82/286 (28%), Gaps = 45/286 (15%)
Query: 658 RATGNFSHENLIGSGSFGSVL--HNERTG------------SWKSFIAECETLRNVRHRN 703
R + IGSGSFG + + G E + + ++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL--------DITSALDYL 755
+ I C + ++ +V E L + RK L + S ++Y+
Sbjct: 64 GIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 756 HNDCEVPVVHSDLKPGNIL---LDEEMTAKVGDFGLARFLLERVDNQSSIS-STHVFMGS 811
H +H D+KP N L + + DFGLA+ + +Q G+
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 812 IGYVPPEYGLGERPSTAGD-----VPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866
Y LG S D G + + ++ + ++
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234
Query: 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKS 912
T E T + C + + + ++
Sbjct: 235 -TPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 82.9 bits (204), Expect = 8e-18
Identities = 36/199 (18%), Positives = 60/199 (30%), Gaps = 35/199 (17%)
Query: 661 GNFSHENLIGSGSFGSVL--HNERTG------------SWKSFIAECETLRNVRHRNLVK 706
++ IG GSFG + N E T + + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 707 LITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD--------ITSALDYLHND 758
+ N+ LV + L RK + + + + +H
Sbjct: 65 NVYYFGQEGLHNV----LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 118
Query: 759 CEVPVVHSDLKPGNILLDEEM-----TAKVGDFGLARFLLERVDNQSSIS-STHVFMGSI 812
E +V+ D+KP N L+ V DFG+ +F + V Q G+
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 813 GYVPPEYGLGERPSTAGDV 831
Y+ LG S D+
Sbjct: 178 RYMSINTHLGREQSRRDDL 196
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 5e-17
Identities = 51/195 (26%), Positives = 72/195 (36%), Gaps = 36/195 (18%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
NF IG G++G V L E G + I E L+ + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-------ITSALDYLH 756
+VKL+ L LV+EFL + L ++ + + L L
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
V+H DLKP N+L++ E K+ DFGLAR V TH + P
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-----THEVVTLWYRAP 171
Query: 817 PEYGLGERPSTAGDV 831
+ STA D+
Sbjct: 172 EILLGCKYYSTAVDI 186
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.1 bits (194), Expect = 2e-16
Identities = 40/201 (19%), Positives = 73/201 (36%), Gaps = 34/201 (16%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG-----------SWKSFIAECETLRNVR-HRNLVKL 707
++ +G G + V N K E + L N+R N++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 708 ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNEL-----DITSALDYLHNDCEVP 762
S+ ALV+E ++N ++ +I ALDY H+
Sbjct: 96 ADIVKDPVSRT---PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 763 VVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGL 821
++H D+KP N+++D E ++ D+GLA F +V + S + PE +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------HPGQEYNVRVASRYFKGPELLV 202
Query: 822 GERP-STAGDVPTSESFAGEF 841
+ + D+ +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASM 223
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (190), Expect = 3e-16
Identities = 50/289 (17%), Positives = 94/289 (32%), Gaps = 21/289 (7%)
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
C + +P + Q I + N + L + N +
Sbjct: 16 TSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI-- 71
Query: 315 DEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374
+ T L L L N + + + L L+L + P
Sbjct: 72 -----DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434
L +L L L N++ L L L L GN I + L L+++ L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
N + P +F + L+++ L N + E ++ L + + L+DN
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNL--------SALPTEALAPLRALQYLRLNDNPWV 238
Query: 495 GNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSG 543
+ + L++ + ++ +P L G ++ L++N L G
Sbjct: 239 CD-CRARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 5e-16
Identities = 63/334 (18%), Positives = 100/334 (29%), Gaps = 51/334 (15%)
Query: 58 PCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGN 117
PC PG C + + + GL+ + I + I L N++S
Sbjct: 1 PC--PGA-CVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRA 54
Query: 118 LFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGK 177
L +L + N L + L L+ LDL N V L L L+ +
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 178 NLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237
L L P L L+ L L N L T ++ +L HL L N++
Sbjct: 115 CGLQ--------ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLP 297
+P L +L + NR P + +L + + + N
Sbjct: 167 S-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN-------------- 211
Query: 298 FLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSK 357
+ +L L YL L+ N + L K
Sbjct: 212 -----------------NLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQK 252
Query: 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISG 391
+ + +P L L L+ N + G
Sbjct: 253 FRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 57/264 (21%), Positives = 100/264 (37%), Gaps = 17/264 (6%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
+P I +++L GN I AS R+LT+L L N ++ L L
Sbjct: 26 VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 404 QVLGLAGNEIPGGI-PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+ L L+ N + P + L +L+ + L L P F +L + L +N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
+ L N+ + L N +S + + SL+ LL+ N+ + P
Sbjct: 143 ALPD--------DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 523 NIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVH 582
+ +L L L L +N LS L L+AL+ L L N + ++ +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254
Query: 583 LKGNPKLCLQLGCENPRSHGSRLI 606
+ ++ C P+ R +
Sbjct: 255 GSSS-----EVPCSLPQRLAGRDL 273
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 48/237 (20%), Positives = 71/237 (29%), Gaps = 14/237 (5%)
Query: 51 YWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGN 110
W S+ + L L L ++ L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 111 LPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSL 170
P L L+ L + N LQ L L L L N+I+ V + R L SL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSL 179
Query: 171 QVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLR 230
L +N + + P L L L L N L+ + + +L +LR
Sbjct: 180 DRLLLHQNRVAH--------VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 231 LASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEG 287
L N + R L F + +P L + R+ N L+G
Sbjct: 232 LNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAGR---DLKRLAANDLQG 283
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 3e-16
Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 24/184 (13%)
Query: 662 NFSHENLIGSGSFGSV------------------LHNERTGSWKSFIAECETLRNVRHRN 703
+ IG G++G+V L ++ G S + E L+ ++H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELDITSALDYLHNDCEVPV 763
+V+L S + F + + + + L L V
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE 823
+H DLKP N+L++ K+ +FGLAR + + ++ Y PP+ G
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAF------GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 824 RPST 827
+ +
Sbjct: 177 KLYS 180
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.8 bits (188), Expect = 2e-15
Identities = 49/255 (19%), Positives = 92/255 (36%), Gaps = 60/255 (23%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTGS-----------------WKSFIAECETLRNVRHR 702
F +G+GSFG V+ ++ +G+ + + E L+ V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 703 NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE--------LDITSALDY 754
LVKL S K+ L +V E+++ G + + + I +Y
Sbjct: 102 FLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 755 LHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGY 814
LH + +++ DLKP N+L+D++ +V DFG A+ T G+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---------VKGRTWTLCGTPEA 204
Query: 815 VPPEYGLGERPSTAGDVP----------------TSESFAGEFNIVKWVESNLPENVLQV 858
+ PE L + + A D ++ + + + P +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 859 LDPELRQLMTSNESQ 873
L LR L+ + ++
Sbjct: 265 LKDLLRNLLQVDLTK 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (185), Expect = 3e-15
Identities = 42/229 (18%), Positives = 77/229 (33%), Gaps = 39/229 (17%)
Query: 668 LIGSGSFGSVL--HNERTG----------------SWKSFIAECETLRNVRHRNLVKLIT 709
IGSG+ G V ++ K E ++ V H+N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 710 SCSSLDS-KNMEFLALVYEFLSNGSLGDWIHGERKNEL-----DITSALDYLHNDCEVPV 763
+ + + + + LV E + + + + +LH+ +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 140
Query: 764 VHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE 823
+H DLKP NI++ + T K+ DFGLAR + ++ + Y PE LG
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 824 RPSTAGD-----VPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLM 867
D E + + V++ L + M
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 1e-14
Identities = 38/195 (19%), Positives = 71/195 (36%), Gaps = 36/195 (18%)
Query: 662 NFSHENLIGSGSFGSVL--HNERTG----------------SWKSFIAECETLRNVRHRN 703
+ + + +GSG++GSV + +TG K E L++++H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLH 756
++ L+ + S + L L + + ++ + I L Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
+ ++H DLKP N+ ++E+ K+ DFGLAR T P
Sbjct: 139 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT--------DDEMTGYVATRWYRAP 187
Query: 817 PEYGLGERPSTAGDV 831
+ D+
Sbjct: 188 EIMLNWMHYNQTVDI 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-14
Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 663 FSHENLIGSGSFGSVL--HNERTG----------------SWKSFIAECETLRNVRHRNL 704
+ +GSG++G+V + RTG K E L+++RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 705 VKLITSCSSLDSKNMEF-LALVYEFLSNGSLGDWIHGERKNE-------LDITSALDYLH 756
+ L+ + ++ + LV F+ G + E+ E + L Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 757 NDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVP 816
++H DLKPGN+ ++E+ K+ DFGLAR S ++ + Y
Sbjct: 139 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---------DSEMTGYVVTRWYRA 186
Query: 817 PEYGLGERPST 827
PE L T
Sbjct: 187 PEVILNWMRYT 197
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 2e-14
Identities = 51/287 (17%), Positives = 80/287 (27%), Gaps = 89/287 (31%)
Query: 668 LIGSGSFGSV----------------LHNERTGSW------KSFIAECETLRNVR--HRN 703
L+GSG FGSV + +R W E L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 704 LVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------LDITSALDY 754
+++L+ DS L+ E ER + A+ +
Sbjct: 71 VIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 755 LHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIG 813
V+H D+K NIL+D K+ DFG L + + F G+
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDFDGTRV 174
Query: 814 YVPPEYGLGER-PSTAGDVP----------TSES-FAGEFNIVKWVESNLPENVLQVLDP 861
Y PPE+ R + V + F + I++ + + V
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-QVFFRQRV----SS 229
Query: 862 ELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908
E + L+ C P R E
Sbjct: 230 ECQHLIR----------------------WCLALRPSDRPTFEEIQN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 9e-14
Identities = 37/192 (19%), Positives = 77/192 (40%), Gaps = 39/192 (20%)
Query: 662 NFSHENLIGSGSFGSV-----LHNERTG------------------SWKSFIAECETLRN 698
NF ++G+G++G V + TG + + E + L +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 699 VRHR-NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHG-----ERKNELDITSAL 752
+R LV L + + L L+ ++++ G L + E + ++ + +
Sbjct: 85 IRQSPFLVTLHYAF-----QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 753 DYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSI 812
L + ++ +++ D+K NILLD + DFGL++ + + + F G+I
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-----AYDFCGTI 194
Query: 813 GYVPPEYGLGER 824
Y+ P+ G
Sbjct: 195 EYMAPDIVRGGD 206
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.5 bits (153), Expect = 4e-11
Identities = 32/207 (15%), Positives = 62/207 (29%), Gaps = 41/207 (19%)
Query: 661 GNFSHENLIGSGSFGSVL--HNERTG-------------SWKSFIAECETLRNVRHRNLV 705
+ +G G F +V + ++ E + L+ V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 706 KLITSCS----------SLDSKNMEFLALVYEFLSNGSLGDWIHGERKNE---------L 746
K + + + N + +V+E L L E +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 747 DITSALDYLHNDCEVPVVHSDLKPGNILLDEE-MTAKVGDFGLARFLLERVDNQSSISST 805
+ LDY+H C ++H+D+KP N+L++ + +A
Sbjct: 133 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHY 186
Query: 806 HVFMGSIGYVPPEYGLGERPSTAGDVP 832
+ + Y PE LG D+
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIW 213
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 43/211 (20%), Positives = 73/211 (34%), Gaps = 22/211 (10%)
Query: 396 EIGQLQGLQVLGLAGN---EIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLL 452
E+ ++ + +P +P L LS N L + + L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTIL------HLSENLLYTFSLATLMPYTRLT 58
Query: 453 SIDLSNNRINGNIPKGILRPLPE-------------EISRLENVVTIDLSDNSLSGNLPN 499
++L + G L L L + +D+S N L+
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 500 SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLN 559
+L+ L+EL + N+ P ++ LE L L++N L+ L L+ L +L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 560 LTFNNLEGVVPSEGIFRNMSNVHLKGNPKLC 590
L N+L + + L GNP LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 39/197 (19%), Positives = 63/197 (31%), Gaps = 14/197 (7%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
+P + + T+L LS N + + L L L E+ + L L
Sbjct: 25 LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLG 80
Query: 429 QIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488
+DLS N+L + + + + L + + L
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPA---------LTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSD 548
N L P L LE+L +A N + ++ L+ L+ L L N L +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 549 LQNLQALRSLNLTFNNL 565
L L N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 41/218 (18%), Positives = 71/218 (32%), Gaps = 17/218 (7%)
Query: 90 HIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLD 149
+ ++ + L+ LP ++ +L++S N L + T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 150 LMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTI 209
L ++T D L L +L + + L A + +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV------------SF 109
Query: 210 NRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSL 269
NRL + + L L L N+ +P + P L N T G L
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168
Query: 270 HNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFN 307
+ L N+ + + N L T+P G L + N
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 42/227 (18%), Positives = 67/227 (29%), Gaps = 24/227 (10%)
Query: 114 EIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVL 173
E+ + +N NL LP ++ K + +L L N + + L L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYT-FSLATLMPYTRLTQL 60
Query: 174 NFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLAS 233
N + L L L LDL+ N+L V +
Sbjct: 61 NLDRAELTKLQVDG----------TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110
Query: 234 NQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL 293
+P L L + N PG L ++ + + +N L L
Sbjct: 111 RLTS--LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168
Query: 294 GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQF 340
L L T + N + + S L + L GN +
Sbjct: 169 NGLENLDTLLLQENSLYT--------IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 39/220 (17%), Positives = 60/220 (27%), Gaps = 39/220 (17%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
+P DL + + +L L+ N L +T+ T L L L + V TLP L
Sbjct: 25 LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE---LTKLQVDGTLPVL 79
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
N+ + + L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS------------------------- 114
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ +L L L L GN+ + P + N++
Sbjct: 115 -------LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL-ANNNLTELPAG 166
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGN 411
+ L +L L L NS+ IP L L GN
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 40/198 (20%), Positives = 70/198 (35%), Gaps = 15/198 (7%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
+P + + + L+L N +Y A++ LT L+L + G L L
Sbjct: 25 LPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
L L+ N++ L L +D+S N LT + L + L N
Sbjct: 80 GTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE--- 135
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPN 523
+ P ++ + + L++N+L+ L ++L+ LL+ N IP
Sbjct: 136 -----LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 524 IVAELKGLEVLDLSSNKL 541
L L N
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 45/258 (17%), Positives = 77/258 (29%), Gaps = 18/258 (6%)
Query: 255 IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGD 314
+ C R +P L + I+ ++ NLL L L N+ ++
Sbjct: 15 VNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV 72
Query: 315 DEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374
D L + +L S + Q + +F N + ++
Sbjct: 73 DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF-----------NRLTSLPLGALR 121
Query: 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434
L L L L N + P + L+ L LA N + L L+ L+ + L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLS 494
N L IP F L L N N + + V + +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE---ILYFRRWLQDNAENVYVWKQGVDVK 237
Query: 495 GNLPN-SLKNCKSLEELL 511
N + C + ++
Sbjct: 238 AMTSNVASVQCDNSDKFP 255
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 31/211 (14%), Positives = 52/211 (24%), Gaps = 41/211 (19%)
Query: 62 PGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRL 121
P + + + +N L + P + + L N L + RL
Sbjct: 2 PICEVSKVASHLE-VNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRL 57
Query: 122 RVLNISFNNLQGELPVNISKLTELKM---------------------------------- 147
LN+ L +
Sbjct: 58 TQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 148 --LDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVL 205
L + + ++L+ L + K ++ L L+ LENL L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 206 DLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
L N L T+P + L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.4 bits (147), Expect = 2e-10
Identities = 58/331 (17%), Positives = 108/331 (32%), Gaps = 21/331 (6%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLL 180
L ++ L LP L L N +T + +SL+ L N L
Sbjct: 40 AHELELNNLGLS-SLPELPPHLESL---VASCNSLT-----ELPELPQSLKSLLVDNNNL 90
Query: 181 WGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEI 240
++ L +S + K + + + N + L +
Sbjct: 91 K-ALSDLPPLLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 241 PYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLR 300
+ + LP L + + + + + + P L NLPFL
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 301 TYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYL 360
T N + + D ++ ++ + L + + E+I + +EL
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 361 GGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNS 420
N +I + SL L++S N + E+P + L+ L + N + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPEL 322
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSL 451
NLK+L + N L E P + + L
Sbjct: 323 PQNLKQL---HVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 1e-08
Identities = 50/342 (14%), Positives = 108/342 (31%), Gaps = 27/342 (7%)
Query: 66 CNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLN 125
C + L L++ GL ++ +L S+ N L+ LP +L + L
Sbjct: 35 CLDRQAHE--LELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSL---KSLL 84
Query: 126 ISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIP 185
+ NNL+ +S L L ++N ++ + Q + + ++ +P
Sbjct: 85 VDNNNLK-----ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 186 PSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVR 245
PS+ + + E ++ +L +++ + L + +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 246 DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305
L IY N +P +L + + L ++
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 306 FNKIV--SSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGN 363
+ + L L + N+ ++P L +L N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFN 314
Query: 364 HIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQV 405
H+ ++P L+ L + YN + E P ++ L++
Sbjct: 315 HL-AEVPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 9/77 (11%)
Query: 480 LENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539
++ +++S+N L LP LE L+ ++N + + + L+ L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA----EVPELPQNLKQLHVEYN 334
Query: 540 KLSGSIPSDLQNLQALR 556
L P ++++ LR
Sbjct: 335 PLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547
N+ S + + SLEEL ++ N+ + A LE L S N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHLA-EVPE 321
Query: 548 DLQNLQALRSLNLTFNNLEGV 568
QNL + L++ +N L
Sbjct: 322 LPQNL---KQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 25/102 (24%), Positives = 42/102 (41%), Gaps = 17/102 (16%)
Query: 432 LSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDN 491
N + EI SL +++SNN++ LP RLE + S N
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE---------LPALPPRLE---RLIASFN 314
Query: 492 SLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEV 533
L+ +P +N L++L + YN P+I ++ L +
Sbjct: 315 HLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 21/74 (28%), Positives = 37/74 (50%), Gaps = 7/74 (9%)
Query: 514 YNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEG 573
N S I ++ LE L++S+NKL +P+ L+ L +FN+L V
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEV---PE 321
Query: 574 IFRNMSNVHLKGNP 587
+ +N+ +H++ NP
Sbjct: 322 LPQNLKQLHVEYNP 335
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 25/154 (16%), Positives = 43/154 (27%), Gaps = 35/154 (22%)
Query: 667 NLIGSGSFGSV-------------------------LHNERTGSWKSFIAECETLRNVRH 701
L+G G +V + +R F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 702 RNLVKL--ITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKNELD-ITSALDYLHND 758
R L KL + + A++ E + L LD I + ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 759 CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792
+VH DL N+L+ E + DF + +
Sbjct: 123 G---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 40/258 (15%), Positives = 87/258 (33%), Gaps = 8/258 (3%)
Query: 333 LALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE 392
L L G + + S + + + + R + +DLS + I
Sbjct: 5 LDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 393 -IPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSL 451
+ + Q LQ L L G + I N+LA L +++LSG E +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 452 LSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELL 511
+L+ + K + + + + N +L ++ C +L L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 512 MAYN-QFSGPIPNIVAELKGLEVLDLSS-NKLSGSIPSDLQNLQALRSLNLTFNNLEGVV 569
++ + +L L+ L LS + +L + L++L + +G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 570 PSEGIFRNMSNVHLKGNP 587
+ + ++ + +
Sbjct: 242 QL--LKEALPHLQINCSH 257
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 40/295 (13%), Positives = 80/295 (27%), Gaps = 33/295 (11%)
Query: 180 LWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPS-TIYNMTSLVHLRLASNQLGG 238
LW ++ + NL P RL + V+ R P ++ + H+ L+++ +
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 239 EIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPF 298
+ + L + R + I +L +N+ + ++
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC--------------- 105
Query: 299 LRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358
+ LS + L + + +
Sbjct: 106 --------SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 157
Query: 359 YLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAG-NEIPGGI 417
Y + L + + E QL LQ L L+ +I
Sbjct: 158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 217
Query: 418 PNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRP 472
L + L + + G G + + L +IN + I RP
Sbjct: 218 LLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL--------QINCSHFTTIARP 264
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 21/114 (18%), Positives = 42/114 (36%), Gaps = 9/114 (7%)
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
Q L L G + + L + + + + + F F+ + +DLSN+ I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQF 517
+ L +S+ + + L LS + N+L +L L ++
Sbjct: 61 S-------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 6e-04
Identities = 29/233 (12%), Positives = 78/233 (33%), Gaps = 5/233 (2%)
Query: 321 ITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLT 380
+ + + ++ L + E I + ++L L L G + I ++ + +L
Sbjct: 39 LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 381 LLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTG- 439
L+LS S E ++ ++ L + + ++ L+G
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 440 EIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD-NSLSGNLP 498
+ + +L+ + ++ + + +E +L + + LS +
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 499 NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQN 551
L +L+ L + G + + + L L ++ + + + N
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIGN 268
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 378 SLTLLDLSYNSISGEIPIEI-GQLQGLQVLGLAGNEI----PGGIPNSLANLKKLNQIDL 432
+ LD+ +S E+ LQ QV+ L + I ++L L +++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 433 SGNELTGEIPISFG-----NFQSLLSIDLSNN 459
NEL + + L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 482 NVVTIDLSDNSLSGN-LPNSLKNCKSLEELLMAYNQFSG----PIPNIVAELKGLEVLDL 536
++ ++D+ LS L + + + + + I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 537 SSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567
SN+L + S + +L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 346 ESIGNFSNELSKLYLGGNHIYGK----IPASIGRLRSLTLLDLSYNSISGEIPIEIGQ-- 399
+ +G + L L+L + + A++ SL LDLS N + +++ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 400 ---LQGLQVLGLAGNEIPGGIPNSLANLKKLN 428
L+ L L + + L L+K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 11/96 (11%)
Query: 423 NLKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEIS 478
L + L+ +++ + + SL +DLSNN + ++ + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 479 RLENVVTIDLSDNSLSGNLPNSL----KNCKSLEEL 510
LE + L D S + + L K+ SL +
Sbjct: 427 LLE---QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 5/85 (5%)
Query: 403 LQVLGLAGNEI-PGGIPNSLANLKKLNQIDLSGNELTGE----IPISFGNFQSLLSIDLS 457
+Q L + E+ L L++ + L LT I + +L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 458 NNRINGNIPKGILRPLPEEISRLEN 482
+N + +L+ L +++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 9/78 (11%)
Query: 485 TIDLSDNSLSGN----LPNSLKNCKSLEELLMAYNQFSGPIPNIVAE-----LKGLEVLD 535
+ L+D +S + L +L SL EL ++ N + E LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 536 LSSNKLSGSIPSDLQNLQ 553
L S + LQ L+
Sbjct: 433 LYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 16/97 (16%), Positives = 32/97 (32%), Gaps = 9/97 (9%)
Query: 144 ELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLK 203
+++ LD+ +++ + L L+ QV+ + + I S L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC----GLTEARCKDISSALRVNPALA 58
Query: 204 VLDLTINRLAGTVPSTI-----YNMTSLVHLRLASNQ 235
L+L N L + + L L +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 9/76 (11%)
Query: 403 LQVLGLAGNEI----PGGIPNSLANLKKLNQIDLSGNELTGEIPISFG-----NFQSLLS 453
L+VL LA ++ + +L L ++DLS N L + L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 454 IDLSNNRINGNIPKGI 469
+ L + + + +
Sbjct: 431 LVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 10/101 (9%), Positives = 30/101 (29%), Gaps = 13/101 (12%)
Query: 423 NLKKLNQIDLSGNELTGE-IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLE 481
+++ L D+ EL+ Q + L + + + + +
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR----CKDISSALRVNP 55
Query: 482 NVVTIDLSDNSLSGNLPNSL-----KNCKSLEELLMAYNQF 517
+ ++L N L + + +++L +
Sbjct: 56 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 15/90 (16%), Positives = 36/90 (40%), Gaps = 9/90 (10%)
Query: 445 FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN----LPNS 500
L + L++ ++ + L + ++ +DLS+N L L S
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCS----SLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 501 LK-NCKSLEELLMAYNQFSGPIPNIVAELK 529
++ LE+L++ +S + + + L+
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 16/81 (19%), Positives = 23/81 (28%), Gaps = 9/81 (11%)
Query: 501 LKNCKSLEELLMAYNQFSG----PIPNIVAELKGLEVLDLSSNKLSGSIPSDL-----QN 551
+ L L +A S + + L LDLS+N L + L Q
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 552 LQALRSLNLTFNNLEGVVPSE 572
L L L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 12/161 (7%)
Query: 25 GINTDKEALMSFKSQISQESPSSPLSYWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLE 84
G E L+ Q+ S S + ++ L G+
Sbjct: 299 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358
Query: 85 GTISPHIGNLSFLRSIQLQNNKLSGN----LPREIGNLFRLRVLNISFNNLQGELPVNIS 140
S LR + L + +S + L + LR L++S N L + +
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 141 K-----LTELKMLDLMANKITGRVTD---DQLRNLRSLQVL 173
+ L+ L L + + D ++ SL+V+
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 9/78 (11%), Positives = 23/78 (29%), Gaps = 4/78 (5%)
Query: 327 STHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK----IPASIGRLRSLTLL 382
S + L + + + + + L + I +++ +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 383 DLSYNSISGEIPIEIGQL 400
+L N + + Q
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 14/88 (15%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 97 LRSIQLQNNKLSGN-LPREIGNLFRLRVLNISFNNLQGE----LPVNISKLTELKMLDLM 151
++S+ +Q +LS + L + +V+ + L + + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 152 ANKITGR----VTDDQLRNLRSLQVLNF 175
+N++ V +Q L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 12/99 (12%), Positives = 31/99 (31%), Gaps = 10/99 (10%)
Query: 266 PGSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFI 321
G + ++++ + + + L L LR ++ N + D G+ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL----GDAGILQL 417
Query: 322 TSL--TNSTHLNYLALDGNQFEGKIPESIGNFSNELSKL 358
L L L + ++ + + + L
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 14/86 (16%), Positives = 31/86 (36%), Gaps = 10/86 (11%)
Query: 76 LNLSSFGLEGTISPHI-GNLSFLRSIQLQNNKLSGNLPREIGNLFR----LRVLNISFNN 130
L++ L + L + ++L + L+ ++I + R L LN+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 131 LQGELPVNISKL-----TELKMLDLM 151
L + + +++ L L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 18/86 (20%), Positives = 30/86 (34%), Gaps = 11/86 (12%)
Query: 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRL----AGTVPSTIYNMT 224
+Q L+ L + + L L+ +V+ L L + S +
Sbjct: 3 DIQSLDIQCEELSDARWAEL-------LPLLQQCQVVRLDDCGLTEARCKDISSALRVNP 55
Query: 225 SLVHLRLASNQLGGEIPYDVRDTLPN 250
+L L L SN+LG + V L
Sbjct: 56 ALAELNLRSNELGDVGVHCVLQGLQT 81
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 12/79 (15%), Positives = 25/79 (31%), Gaps = 6/79 (7%)
Query: 145 LKMLDLMANKITGRVTD---DQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLEN 201
L++L L ++ L SL+ L+ N L + + +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC---L 427
Query: 202 LKVLDLTINRLAGTVPSTI 220
L+ L L + + +
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 6e-08
Identities = 32/205 (15%), Positives = 75/205 (36%), Gaps = 20/205 (9%)
Query: 369 IPASIGR------LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLA 422
+P I + +L S++ + +L + + ++I +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQ 65
Query: 423 NLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPE------- 475
L + ++ L+GN+LT P++ L +D + + ++
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 476 EISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLD 535
+I+ L ++ ++ + ++ + + + L + I + A L L+ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-AGLTKLQNLY 184
Query: 536 LSSNKLSGSIPSDLQNLQALRSLNL 560
LS N +S + + L L+ L L L
Sbjct: 185 LSKNHIS-DLRA-LAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 37/197 (18%), Positives = 63/197 (31%), Gaps = 16/197 (8%)
Query: 246 DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305
D + T + + + L +I I ++ ++ G+ LP + +
Sbjct: 21 DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPES--------IGNFSNELSK 357
NK+ L + L + + S I +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGI 417
L + + RL L L L N IS +P+ L LQ L L+ N I
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNHISD-- 192
Query: 418 PNSLANLKKLNQIDLSG 434
+LA LK L+ ++L
Sbjct: 193 LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 33/208 (15%), Positives = 59/208 (28%), Gaps = 19/208 (9%)
Query: 215 TVPSTI------YNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGS 268
TVP+ I + L + + ++ L ++ I +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG-- 63
Query: 269 LHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNST 328
+ L N+ + + N L P + K +SS D SL ++
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKI------PASIGRLRSLTLL 382
+ L + ++ L + L L L
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNL 183
Query: 383 DLSYNSISGEIPIEIGQLQGLQVLGLAG 410
LS N IS ++ + L+ L VL L
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDVLELFS 209
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 9e-08
Identities = 44/327 (13%), Positives = 93/327 (28%), Gaps = 25/327 (7%)
Query: 145 LKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKV 204
LK+ + L S++ + N +I A + +++ ++L++
Sbjct: 10 LKLDAITTEDEKSVF--AVLLEDDSVKEIVLSGN----TIGTEAARWLSENIASKKDLEI 63
Query: 205 LDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG--GEIPYDVRDTLPNLLDFIYCFNRFT 262
+ + + L+ L +L T L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 263 GKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFIT 322
+ + L ++ L E + N P LR+ G N++ + E
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNEL-----SKLYLGGNHIYGKIPASIGRLR 377
S + + + G + + + + ++
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 378 SLTLLDLSYNSISGEIPIEIGQ------LQGLQVLGLAGNEIPGGIPNSLA-----NLKK 426
+L L L+ +S + GLQ L L NEI +L +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 427 LNQIDLSGNELTGEIPISFGNFQSLLS 453
L ++L+GN E + + S
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 39/323 (12%), Positives = 83/323 (25%), Gaps = 21/323 (6%)
Query: 121 LRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTD---DQLRNLRSLQVLNFGK 177
L++ I+ + + + + + +K + L N I + + + + L++ F
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 178 NLLW--GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235
P L+ L + L + L+ N T + + S H L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS-KHTPLEHLY 127
Query: 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGN 295
L N+ P + +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 296 LPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNEL 355
L ++ G + L+ L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLL--EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 356 SKLYLGGNHIYGKIPASIGR------LRSLTLLDLSYNSISGEIPIEI-----GQLQGLQ 404
+L L + + A++ L L L YN I + + ++ L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 405 VLGLAGNEIPGGIPNSLANLKKL 427
L L GN + + ++++
Sbjct: 306 FLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 41/327 (12%), Positives = 97/327 (29%), Gaps = 24/327 (7%)
Query: 97 LRSIQLQNNKLSGN----LPREIGNLFRLRVLNISFNNLQGE----LPVNISKLTELKML 148
+ L+ + ++ + + ++ + +S N + E L NI+ +L++
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 149 DLMANKIT--GRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLD 206
+ + LR L + + + S + L L+
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 207 LTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIP 266
G P + + + + P N L+
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 267 GSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTN 326
L + + + +E L GL L+ ++ N G + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK---S 241
Query: 327 STHLNYLALDGNQFEGKIPESIGNF-----SNELSKLYLGGNHIYGKIPASI-----GRL 376
+L L L+ + ++ + + L L L N I ++ ++
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 377 RSLTLLDLSYNSISGEIPIEIGQLQGL 403
L L+L+ N S E + + +++ +
Sbjct: 302 PDLLFLELNGNRFSEEDDV-VDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 42/336 (12%), Positives = 93/336 (27%), Gaps = 35/336 (10%)
Query: 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL-----LDF 254
++LK+ +T +V + + S+ + L+ N +G E + + + + +F
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 255 IYCFNR--------FTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGF 306
F + +L + +R++ N T L + T
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 307 NKIVSSGDDEGLS----------FITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELS 356
+ + + N+ L + N+ E +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 357 KLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGG 416
L+ G P I L L + L +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL-----AIALKS 241
Query: 417 IPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEE 476
PN + G + S L ++ L N I + + + + E+
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVD-AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 477 ISRLENVVTIDLSDNSLS--GNLPNSLKNCKSLEEL 510
+ L ++L+ N S ++ + ++ S
Sbjct: 301 MPDLL---FLELNGNRFSEEDDVVDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 5/88 (5%)
Query: 425 KKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVV 484
K L ++ + + S+ I LS N I + L E I+ +++
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARW----LSENIASKKDLE 62
Query: 485 TIDLSDNSLSGNLPNSLKNCKSLEELLM 512
+ SD + + L + L+
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALL 90
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 487 DLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNKLS 542
++ ++ L S++E++++ N + +A K LE+ + S
Sbjct: 14 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG 72
Query: 543 GSIPSDLQNLQALRSLNLTFNNL 565
+ L+ L L L
Sbjct: 73 RVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 13/85 (15%)
Query: 488 LSDNSLSGNLPNSLKNC------KSLEELLMAYNQFSGPIPNIVAE-----LKGLEVLDL 536
L+D LS ++ + L+ L + YN+ + + L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 537 SSNKLS--GSIPSDLQNLQALRSLN 559
+ N+ S + +++ + + R
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 40/214 (18%), Positives = 70/214 (32%), Gaps = 14/214 (6%)
Query: 354 ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413
K+ G +++ + + L +T L ++ I + L L L L N+I
Sbjct: 20 NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLS--IDLSNNRINGNIPKGILR 471
P ++ + + I L+ + G +L
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 472 PLPEEISRLENVVTIDLSDNSLSGNLPNS----LKNCKSLEELLMAYNQFSGPIPNIVAE 527
+I+ + + + GN S L N L L N+ S P +A
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193
Query: 528 LKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561
L L + L +N++S P L N L + LT
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 35/219 (15%), Positives = 66/219 (30%), Gaps = 14/219 (6%)
Query: 246 DTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305
L N + + T + + +L I + + G+ L L +
Sbjct: 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 306 FNKIVSSGDDEGL-SFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGG-- 362
N+I + L + L ++ K + +++ L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 363 ---NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPN 419
+I L LS + + L L L N+I P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 420 SLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSN 458
LA+L L ++ L N+++ P N +L + L+N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 37/244 (15%), Positives = 75/244 (30%), Gaps = 36/244 (14%)
Query: 142 LTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLEN 201
L + + +T VT L + +L G + + + L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTG-----------VTTI--EGVQYLNN 64
Query: 202 LKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRF 261
L L+L N++ + + + +L + L ++ +
Sbjct: 65 LIGLELKDNQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQI 119
Query: 262 TGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFI 321
T + + L L + + N S + +S +
Sbjct: 120 T-------------DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL 166
Query: 322 TSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTL 381
T L N + L L D N+ P + + N L +++L N I P + +L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPN-LIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 382 LDLS 385
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 36/211 (17%), Positives = 65/211 (30%), Gaps = 16/211 (7%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
L + + ++++ + L G+ L G + I + L L ++L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDN 73
Query: 436 ELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD----- 490
++T P+ + L + + + I + S VT
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 491 -NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL 549
+ N ++ +A L L L NK+S P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 550 QNLQALRSLNLTFNNLEGVVPSEGIFRNMSN 580
+L L ++L N + V P N SN
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP----LANTSN 218
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 36/249 (14%), Positives = 69/249 (27%), Gaps = 47/249 (18%)
Query: 166 NLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTS 225
L + + GK+ + ++ + L+ + L + T + + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT----------QADLDGITTLSAFGTGV--TTIEGVQYLNN 64
Query: 226 LVHLRLASNQL------GGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIR 279
L+ L L NQ+ + N L + L + +
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 280 MTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQ 339
+ L L + + N S + +S +T L N + L L D N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 340 FEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQ 399
P + L +L + L N IS P +
Sbjct: 185 ISDISP---------------------------LASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 400 LQGLQVLGL 408
L ++ L
Sbjct: 216 TSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 30/220 (13%), Positives = 62/220 (28%), Gaps = 18/220 (8%)
Query: 117 NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176
L + +N+ + + L + L +T T + ++ L +L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71
Query: 177 KNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQL 236
N + P I LK + + + V + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 237 GGEIPYDVRDTLPNLLDF-----IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPP 291
+ T + L L NL+ + ++ N +
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--IS 189
Query: 292 GLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLN 331
L +LP L ++ N+I +S + + +N +
Sbjct: 190 PLASLPNLIEVHLKNNQI------SDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 16/100 (16%), Positives = 36/100 (36%), Gaps = 4/100 (4%)
Query: 51 YWNPSSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGN 110
+ LS + + + NLS L +++ +NK+S
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 111 LPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDL 150
P + +L L +++ N + P ++ + L ++ L
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 16/70 (22%), Positives = 32/70 (45%), Gaps = 12/70 (17%)
Query: 421 LANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRL 480
LANL KL + N+++ P + +L+ + L NN+I+ P ++
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP----------LANT 216
Query: 481 ENVVTIDLSD 490
N+ + L++
Sbjct: 217 SNLFIVTLTN 226
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 5e-07
Identities = 31/121 (25%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL 135
L+L+ L T+ H+ L + + L +N+L P + L L VL S N L+
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 136 PVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWG--SIPPSIANLIP 193
V + L L N++ L + L +LN N L I +A ++P
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 194 S 194
S
Sbjct: 118 S 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 33/133 (24%), Positives = 55/133 (41%), Gaps = 17/133 (12%)
Query: 122 RVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181
RVL+++ +L + ++ +L + LDL N++ L LR L+VL N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL--PPALAALRCLEVLQASDNALE 56
Query: 182 GSIPPSIANLIPSDLSRLENLKVLDLTINRLAGT-VPSTIYNMTSLVHLRLASNQLGGEI 240
++ L L+ L L NRL + + + LV L L N L E
Sbjct: 57 ----------NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106
Query: 241 PY--DVRDTLPNL 251
+ + LP++
Sbjct: 107 GIQERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 26/131 (19%), Positives = 51/131 (38%), Gaps = 14/131 (10%)
Query: 430 IDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLS 489
+ L+ +LT + + +DLS+NR+ P ++ L + + S
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP---------ALAALRCLEVLQAS 51
Query: 490 DNSLSGNLPNSLKNCKSLEELLMAYNQF-SGPIPNIVAELKGLEVLDLSSNKLSGSIPSD 548
DN+ + + N L+ELL+ N+ + L +L+L N L
Sbjct: 52 DNA--LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109
Query: 549 LQNLQALRSLN 559
+ + L S++
Sbjct: 110 ERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 14/116 (12%)
Query: 454 IDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMA 513
+ L++ + + +L V +DLS N L P +L + LE L +
Sbjct: 3 LHLAHKDLTV----------LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQAS 51
Query: 514 YNQFSGPIPNIVAELKGLEVLDLSSNKL-SGSIPSDLQNLQALRSLNLTFNNLEGV 568
N + L L +N+L + L + L LNL N+L
Sbjct: 52 DNALENVDGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 26/129 (20%), Positives = 46/129 (35%), Gaps = 15/129 (11%)
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
+VL LA ++ + L L + +DLS N L P + + L + S+N +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSDNSL-SGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
+ ++ L + + L +N L L +C L L + N
Sbjct: 58 ----------VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EE 106
Query: 523 NIVAELKGL 531
I L +
Sbjct: 107 GIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 8e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 26/106 (24%)
Query: 358 LYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL-------------- 403
L+L + + + +L +T LDLS+N + P + L+ L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 404 --------QVLGLAGNEIPGG-IPNSLANLKKLNQIDLSGNELTGE 440
Q L L N + L + +L ++L GN L E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 20/122 (16%), Positives = 42/122 (34%), Gaps = 14/122 (11%)
Query: 276 QIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLAL 335
+++ + H L T+ L L + ++ N++ + + ++ +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 336 DGNQFEGKIPESIGNFSNELSKLYLGGNHI-YGKIPASIGRLRSLTLLDLSYNSISGEIP 394
DG ++ E L L N + + L LL+L NS+ E
Sbjct: 59 DGVANLPRLQE-----------LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107
Query: 395 IE 396
I+
Sbjct: 108 IQ 109
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 5e-04
Identities = 23/130 (17%), Positives = 46/130 (35%), Gaps = 10/130 (7%)
Query: 203 KVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL--LDFIYCFNR 260
+VL L L TV + + + HL L+ N+L P L L L+ + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDN 53
Query: 261 FTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSF 320
+ G + +++ + L + L + P L N+ N + +
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERL 112
Query: 321 ITSLTNSTHL 330
L + + +
Sbjct: 113 AEMLPSVSSI 122
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 6e-06
Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 15/186 (8%)
Query: 203 KVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFT 262
+D T L +P I L L N+LG + LP+L+ N+ T
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 263 GKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFIT 322
G P + ++IQ +++ N ++ L L+T N+ N+I
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG------- 120
Query: 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLL 382
S + L L L N F + F+ L K L G P+ +R + +
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIK 175
Query: 383 DLSYNS 388
DL ++
Sbjct: 176 DLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 40/206 (19%), Positives = 74/206 (35%), Gaps = 40/206 (19%)
Query: 344 IPESIGNFSNELSKLYLGGNHIYGKIPASI-GRLRSLTLLDLSYNSISGEIPIEIGQLQG 402
IP I ++L L N + + GRL L L+L N ++G P
Sbjct: 23 IPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 403 LQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462
+Q L L N+I L +L ++L N+++ +P SF + SL S++L++N N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 463 GNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIP 522
N E + L+ + P
Sbjct: 140 CNCHLAWF---------AEWLRKKSLNGGAARCGAP------------------------ 166
Query: 523 NIVAELKGLEVLDLSSNKLSGSIPSD 548
++++ +++ DL ++ S +
Sbjct: 167 ---SKVRDVQIKDLPHSEFKCSSENS 189
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 44/191 (23%), Positives = 69/191 (36%), Gaps = 16/191 (8%)
Query: 376 LRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGN 435
L L +++ + L + L I + + L L QI+ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 436 ELTGEIPIS--------FGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTID 487
+LT P+ N + I N N + +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 488 LSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547
L +S + + ++L SL++L + NQ + P +A L LE LD+SSNK+S S
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 188
Query: 548 DLQNLQALRSL 558
L L L SL
Sbjct: 189 VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 31/202 (15%), Positives = 55/202 (27%), Gaps = 32/202 (15%)
Query: 142 LTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLEN 201
L E L +T V+ L + +LQ G + G + L N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-------------VEYLNN 63
Query: 202 LKVLDLTINRLAGTV-------------PSTIYNMTSLVHLRLASNQLGGEIPYDVRDTL 248
L ++ + N+L + + + L
Sbjct: 64 LTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 249 PNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNK 308
L + + I + ++ + + T L NL L +I NK
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNK 183
Query: 309 IVSSGDDEGLSFITSLTNSTHL 330
+ +S + LTN L
Sbjct: 184 V------SDISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 27/218 (12%), Positives = 58/218 (26%), Gaps = 24/218 (11%)
Query: 369 IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIP---------- 418
IP+ + R+ L + L+ + ++ N++ I
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 419 ----------NSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKG 468
N + + L I + +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 469 ILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAEL 528
+ V + L+ N + + + E L N ++
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 529 KGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLE 566
G +LD+S ++ L+NL+ LR+ + NL+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 38/241 (15%), Positives = 71/241 (29%), Gaps = 22/241 (9%)
Query: 192 IPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNL 251
IPSDL R N L + +L L + ++ N + I DV LP L
Sbjct: 23 IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 252 LDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVS 311
+ I + N + +++ +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISN------TGIKHLPDVHKIHSLQKVLLDI 134
Query: 312 SGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPA 371
+ + + + L N+ + + +L +L L N+ ++P
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 372 SI-GRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQI 430
+ +LD+S I + L+ L+ S NLKKL +
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR-------------STYNLKKLPTL 241
Query: 431 D 431
+
Sbjct: 242 E 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 6/49 (12%), Positives = 14/49 (28%), Gaps = 3/49 (6%)
Query: 499 NSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS 547
+ L ++ + + LK L + K +P+
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 21/138 (15%), Positives = 46/138 (33%), Gaps = 22/138 (15%)
Query: 88 SPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKM 147
+ N R + L+ K+ + L + ++ S N ++ +L L LK
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKT 67
Query: 148 LDLMANKITGRVTDDQ------------LRNLRSLQVLNFGKNL-------LWGSIPPSI 188
L + N+I +L L L+ +L + + +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 189 ANLIPSDLSRLENLKVLD 206
+ + ++ ++VLD
Sbjct: 128 KHYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 9e-05
Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 7/138 (5%)
Query: 400 LQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNN 459
+ L L G +IP I N A L + + ID S NE+ F + L ++ ++NN
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 460 RINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSG 519
RI L N ++L D +L + C
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL----RNPVTNKKH 129
Query: 520 PIPNIVAELKGLEVLDLS 537
++ ++ + VLD
Sbjct: 130 YRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 7/123 (5%)
Query: 106 KLSGNLPREIG---NLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDD 162
KL+ L + N R R L++ + + + L + +D N+I D
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLD 57
Query: 163 QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYN 222
LR L+ L N + L L N +++L ++ S Y
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 223 MTS 225
Sbjct: 118 CIL 120
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 27/147 (18%), Positives = 42/147 (28%), Gaps = 9/147 (6%)
Query: 346 ESIGNFSN--ELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGL 403
E ++N +L L G I I L +D S N I L+ L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRL 65
Query: 404 QVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463
+ L + N I L L ++ L+ N L + L+
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 464 NIPKGILRPLPEEISRLENVVTIDLSD 490
N I ++ V +D
Sbjct: 126 NKKHYR----LYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 6/100 (6%)
Query: 493 LSGNLPN---SLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDL 549
L+ L N EL + + I N+ A L + +D S N++
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 550 QNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKL 589
L+ L++L + N + + + N L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 31/141 (21%), Positives = 53/141 (37%), Gaps = 15/141 (10%)
Query: 314 DDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK--IPA 371
D +GL L L + + N L L L N +Y + +
Sbjct: 28 DLKGLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPE-LLSLNLSNNRLYRLDDMSS 85
Query: 372 SIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNS-------LANL 424
+ + +L +L+LS N + E ++ + L+ L L GN + +
Sbjct: 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
Query: 425 KKLNQIDLSGNELTGEIPISF 445
KL ++D G+EL PI+F
Sbjct: 146 PKLLRLD--GHELPP--PIAF 162
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 76 LNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSG--NLPREIGNLFRLRVLNISFNNLQG 133
LN S T+ N+ L S+ L NN+L ++ + L++LN+S N L+
Sbjct: 47 LNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 105
Query: 134 ELPVNISKLTELKMLDLMANKITGRVTDDQ------LRNLRSLQVLN 174
E ++ K +L+ L L N ++ D L L+
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 22/124 (17%), Positives = 48/124 (38%), Gaps = 2/124 (1%)
Query: 447 NFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG--NLPNSLKNC 504
+S + N + N + L + +++++LS+N L ++ + ++
Sbjct: 31 GLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKA 90
Query: 505 KSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564
+L+ L ++ N+ + LE L L N LS + + A+R
Sbjct: 91 PNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
Query: 565 LEGV 568
L+G
Sbjct: 151 LDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 15/129 (11%)
Query: 450 SLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEE 509
S ++DL R ++ V ++ + + L +N L
Sbjct: 23 SQQALDLKGLRS------------DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLS 69
Query: 510 LLMAYNQFSG--PIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEG 567
L ++ N+ + +IV + L++L+LS N+L D L L L N+L
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 568 VVPSEGIFR 576
+ +
Sbjct: 130 TFRDQSTYI 138
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 18/156 (11%), Positives = 41/156 (26%), Gaps = 8/156 (5%)
Query: 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFN 259
L T + + +L L + + Q + L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 260 RFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLS 319
P + H + + ++ N LE +L L+ + N + S
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA----- 120
Query: 320 FITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNEL 355
+ L + + + + + N
Sbjct: 121 -LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 31/177 (17%), Positives = 61/177 (34%), Gaps = 8/177 (4%)
Query: 163 QLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYN 222
+S+ K L G IPP I + + LS L+ K L L+ N + I +
Sbjct: 13 IFEERKSVVATEAEKVELHGMIPP-IEKM-DATLSTLKACKHLALSTNNI-----EKISS 65
Query: 223 MTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTH 282
++ + +LR+ S + D + + L+ ++ + G + + +
Sbjct: 66 LSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNN 125
Query: 283 NLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYL-ALDGN 338
+ L L L + N + + + + + L L LDG
Sbjct: 126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGM 182
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 929 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.62 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 80.36 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.9e-43 Score=382.97 Aligned_cols=293 Identities=29% Similarity=0.479 Sum_probs=207.9
Q ss_pred cCChhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCC--CCcceeeCCCCC--cEEEEEcCCCCCcc--ccCCCCCCCCCC
Q 002376 24 VGINTDKEALMSFKSQISQESPSSPLSYWNPSSSPC--TWPGVICNNFGN--RVIGLNLSSFGLEG--TISPHIGNLSFL 97 (929)
Q Consensus 24 ~~~~~~~~aLl~~k~~~~~~~~~~~l~~w~~~~~~c--~w~gv~c~~~~~--~v~~l~l~~~~l~g--~i~~~l~~L~~L 97 (929)
.|+++||+||++||+++.++ ..+++|..++||| .|+||+|++.++ ||+.|||++++++| .+|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~---~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP---TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC---GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCC---CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 58999999999999998753 4689999999999 599999997554 89999999999998 578899999999
Q ss_pred CEEEeec-CCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEcc
Q 002376 98 RSIQLQN-NKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFG 176 (929)
Q Consensus 98 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 176 (929)
++|+|++ |+++|.+|++|++|++|++|||++|+|.+..|..+..+.+|+++++++|++.+.+|.. +.++++|++++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~-l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS-ISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG-GGGCTTCCEEECC
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchh-hccCcccceeecc
Confidence 9999986 7888888888888888888888888888888888888888888888888887666655 7777777777777
Q ss_pred ccccCCCCCccccccCCCccCCCCcc-cEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceee
Q 002376 177 KNLLWGSIPPSIANLIPSDLSRLENL-KVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFI 255 (929)
Q Consensus 177 ~N~l~~~~p~~i~~l~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~ 255 (929)
+|.+.|.+|..+. .+.++ +.+++++|++++..|..+.++..+ .++
T Consensus 158 ~n~l~~~ip~~~~--------~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~------------------------- 203 (313)
T d1ogqa_ 158 GNRISGAIPDSYG--------SFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVD------------------------- 203 (313)
T ss_dssp SSCCEEECCGGGG--------CCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEE-------------------------
T ss_pred ccccccccccccc--------cccccccccccccccccccccccccccccc-ccc-------------------------
Confidence 7766555444332 23332 455555555555444444433222 233
Q ss_pred ccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEc
Q 002376 256 YCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLAL 335 (929)
Q Consensus 256 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~L 335 (929)
++.+.+.+.+|..+..+++++.+++++|.+++.+| .+..+++|++|+|
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~--------------------------------~~~~~~~L~~L~L 251 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--------------------------------KVGLSKNLNGLDL 251 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG--------------------------------GCCCCTTCCEEEC
T ss_pred ccccccccccccccccccccccccccccccccccc--------------------------------ccccccccccccC
Confidence 33333444445555555556666666665554433 3344566677777
Q ss_pred cCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCC
Q 002376 336 DGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNS 388 (929)
Q Consensus 336 s~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 388 (929)
++|+++|.+|+.++.++ +|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 252 s~N~l~g~iP~~l~~L~-~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 252 RNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CSSCCEECCCGGGGGCT-TCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ccCeecccCChHHhCCC-CCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 77777777777777665 577777777777776663 4666667777777665
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=384.68 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=176.7
Q ss_pred hCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||+||+|++. ...+.|.+|++++++++|||||+++|++.+. ..++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------EEEE
Confidence 468899999999999999999865 2356899999999999999999999997532 2699
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||||++|+|.++++... .++.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999986332 2367999999999998 9999999999999999999999999999876422
Q ss_pred cCCCCCccccceeccccccccccccCCC---CCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE---RPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
. .........||+.|||||++.+. .|+.++||||+|+++||+.++..++...... +.+...+...... +.
T Consensus 158 ~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~-p~ 230 (276)
T d1uwha_ 158 S----GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLS-PD 230 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCC-CC
T ss_pred C----CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCC-Cc
Confidence 1 11223456899999999998643 5899999999998888876655554433221 0111111111000 00
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
........++.+++++.+||+.||++||||+||++.|+.+.+..+
T Consensus 231 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 231 -LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 000111112223347779999999999999999999999887543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-44 Score=383.64 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=171.9
Q ss_pred CCChHHHHHhhC---------CCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccC
Q 002376 650 KISYDELRRATG---------NFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVR 700 (929)
Q Consensus 650 ~~~~~~l~~~~~---------~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~ 700 (929)
.++++|+.+++. +|+..++||+|+||+||+|++. ...++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 345556665554 4455689999999999998763 12457999999999999
Q ss_pred CccccceeeecccCCCCCcceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCC
Q 002376 701 HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPG 771 (929)
Q Consensus 701 Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~ 771 (929)
|||||+++|+|...+ ..++|||||++|+|.++++... .++.|||+||+|||+. +|+||||||+
T Consensus 86 HpnIv~l~g~~~~~~-----~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~ 157 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAAR 157 (299)
T ss_dssp CTTBCCEEEEECSSS-----SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred CCCCccEEEEEeeCC-----EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccc
Confidence 999999999996543 3799999999999999876432 2367999999999998 9999999999
Q ss_pred CeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhc
Q 002376 772 NILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESN 850 (929)
Q Consensus 772 NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~ 850 (929)
|||++.++.+||+|||+|+.+...... ..........||+.|||||++.++.++.++||||+|+++||+.+ ...++..
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GEEECTTCCEEECCC------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eEEECCCCcEEECCcccceEccCCCCc-ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 999999999999999999976432111 11112233468999999999999999999999999988887643 3333332
Q ss_pred CCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 851 LPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 851 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
... .+ +........ +.+.+...++.+.+++.+||+.||++||||+||++.|+++.+
T Consensus 237 ~~~--~~-----~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 237 MTN--QD-----VINAIEQDY--RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCH--HH-----HHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCH--HH-----HHHHHHcCC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 221 11 111111111 001111122233347889999999999999999999998865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=369.35 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=168.8
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.+ ..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEEE
Confidence 47888899999999999999764 23578999999999999999999999996543 379999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||++|+|.+++...+ .++.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+|+......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 9999999999886432 2468999999999998 99999999999999999999999999998764321
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
........||+.|||||++.+..++.++||||+|+++||+.....+..... ...+++. .+....... ...
T Consensus 156 ----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~-~i~~~~~~~--~p~-- 225 (263)
T d1sm2a_ 156 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVE-DISTGFRLY--KPR-- 225 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHH-HHHHTCCCC--CCT--
T ss_pred ----ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHH-HHHhcCCCC--Ccc--
Confidence 112234579999999999999999999999999988777644222111111 1111111 111110000 000
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.+..++. +++.+||+.||++||||+||++.|+++.+.
T Consensus 226 -~~~~~l~-~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 -LASTHVY-QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -TSCHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -ccCHHHH-HHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1112233 388899999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=378.32 Aligned_cols=241 Identities=20% Similarity=0.294 Sum_probs=179.7
Q ss_pred HHHHHhhCCCCCceeecccCceeEEecccc---------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERT---------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~---------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++++...++|+..+.||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.+
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 86 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--- 86 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC---
Confidence 334444568888999999999999999765 23578999999999999999999999996543
Q ss_pred cceEEEEEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
..++|||||++|+|.+++... ..++.|||.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 87 --~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 87 --PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp --SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred --eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 379999999999999988632 12367999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
|+..... .........||+.|||||++.++.|+.++||||+|+++|++.....++.... ...+ +.....
T Consensus 162 a~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~-----~~~~i~ 230 (287)
T d1opja_ 162 SRLMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQ-----VYELLE 230 (287)
T ss_dssp TTTCCSS-----SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHH-----HHHHHH
T ss_pred eeecCCC-----CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHH-----HHHHHh
Confidence 9876322 1122334568999999999999999999999999987777543222211110 1111 111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
... +.+.++..++-+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 231 ~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 KDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cCC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 110 111111122233348889999999999999999999988643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=368.41 Aligned_cols=240 Identities=20% Similarity=0.239 Sum_probs=178.3
Q ss_pred CCCCCce-eecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHEN-LIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~-~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|...+ +||+|+||+||+|.+. ...++|.+|+++|++++|||||+++|+|.+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence 4555666 4999999999998643 1246799999999999999999999998532
Q ss_pred eEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..|+|||||++|+|.+++...+ .++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 2799999999999999875432 3368999999999998 999999999999999999999999999997
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
+..... .........||+.|||||++.++.++.++||||+|+++||+.. +..++..... .++...+...
T Consensus 159 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~ 228 (285)
T d1u59a_ 159 LGADDS---YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQG 228 (285)
T ss_dssp CTTCSC---EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTT
T ss_pred cccccc---ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC
Confidence 643211 1112234578999999999999999999999999988877543 3333332221 1222211111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhcc
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQQ 921 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 921 (929)
. +.+.++.++.-+.+++.+||+.||++||||.+|++.|+.+........
T Consensus 229 ~--~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 229 K--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp C--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred C--CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 1 111111122223348889999999999999999999999877655443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=365.66 Aligned_cols=230 Identities=20% Similarity=0.221 Sum_probs=170.3
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+. ...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence 3579999999999999999997651 234688999999999999999999999653 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+|||||++|+|.++++... .+..|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999999997433 3467999999999998 999999999999999999999999999997643
Q ss_pred ccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... .......+||+.|||||++.+..+ +.++||||+|+++|++.++..++....+. +........... .
T Consensus 156 ~~~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~~~~~~~~-~ 225 (271)
T d1nvra_ 156 NNR----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEYSDWKEKKT-Y 225 (271)
T ss_dssp TTE----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-----SHHHHHHHTTCT-T
T ss_pred CCc----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcCCC-C
Confidence 211 112344689999999999988876 67899999998877766554444322211 111111111000 0
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......+++-+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112222334777999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=366.26 Aligned_cols=227 Identities=23% Similarity=0.243 Sum_probs=174.0
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
++|+..+.||+|+||+||+|++. ...+.+.+|++++++++|||||++++++.+. ...|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 47999999999999999999765 2346799999999999999999999999653 34899
Q ss_pred EEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 725 VYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
|||||++|+|.+++.+. +.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999999999987642 24467999999999998 9999999999999999999999999999876322
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
.......+||+.|||||++.+..++.++||||+|+++|++..+..++..... .+.+....... ......
T Consensus 170 ----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~-----~~~~~~ 238 (293)
T d1yhwa1 170 ----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNG-----TPELQN 238 (293)
T ss_dssp ----TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHC-----SCCCSS
T ss_pred ----cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCC-----CCCCCC
Confidence 1123345799999999999999999999999999887776655544432221 11111111110 011111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++.++..+++++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223333445777999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=360.66 Aligned_cols=222 Identities=22% Similarity=0.285 Sum_probs=171.8
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+. ..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence 478899999999999999997651 245688999999999999999999999643 35
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+|||||++|+|.+++.... .++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 899999999999999986432 3467999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. ......+||+.|||||++.+..++.++||||+|+++|++..+..++..... .+.. ..........
T Consensus 158 ~--------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~----~~i~~~~~~~ 223 (263)
T d2j4za1 158 S--------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETY----KRISRVEFTF 223 (263)
T ss_dssp C--------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH----HHHHTTCCCC
T ss_pred C--------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCCCC
Confidence 2 122345899999999999999999999999999888776665544432211 1111 1111111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
++.+++-+++++.+||+.||++|||++|+++
T Consensus 224 ----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112223334777999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=375.33 Aligned_cols=232 Identities=19% Similarity=0.283 Sum_probs=174.8
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..++||+|+||+||+|++. ...+.|.+|+.+++++ +|||||+++++|.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 357888999999999999998753 1234688999999998 8999999999996543
Q ss_pred CCcceEEEEEEecCCCCccccccccc-------------------------------cccccHHHHHHHhhhCCCCCEEe
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER-------------------------------KNELDITSALDYLHNDCEVPVVH 765 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------~~~~~ia~aL~yLH~~~~~~iiH 765 (929)
..|+|||||++|+|.++++..+ .++.||+.||+|||+. +|||
T Consensus 115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 115 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred ----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 3799999999999999986432 2357899999999998 9999
Q ss_pred cCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-h
Q 002376 766 SDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-V 844 (929)
Q Consensus 766 rDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~ 844 (929)
|||||+|||++.++.+||+|||+|+...... .........||+.|||||++.++.++.++||||+|+++||+.. +
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCC----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 9999999999999999999999998764321 1112234578999999999999999999999999988887653 3
Q ss_pred HHhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 002376 845 KWVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLK 911 (929)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~ 911 (929)
..++...+. +..+........ +.+.+...++.+++++.+||+.||++||||+||++.|.
T Consensus 264 ~~Pf~~~~~------~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPV------DANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCC------SHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH------HHHHHHHHhcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 444332221 111121111111 11111112223334778999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=367.61 Aligned_cols=237 Identities=20% Similarity=0.243 Sum_probs=168.7
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
+.|+..++||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence 46788899999999999998753 12347899999999999999999999996543
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
..++|||||.+|++.+++.... .++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred -ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 3899999999999988775322 3467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.+..... .........||+.|||||++.++.++.++||||+|+++||+.....+..... ...+ +.......
T Consensus 159 ~~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~-----~~~~i~~~ 229 (283)
T d1mqba_ 159 VLEDDPE---ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHE-----VMKAINDG 229 (283)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHH-----HHHHHHTT
T ss_pred cccCCCc---cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHH-----HHHHHhcc
Confidence 7643211 1112234578999999999999999999999999988877643221111111 1111 11111111
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. +.+.+...+..+.+++.+||+.||++||||+||+++|+++.+.
T Consensus 230 ~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 F--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C--CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 0011111112233488899999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=359.37 Aligned_cols=227 Identities=24% Similarity=0.355 Sum_probs=167.1
Q ss_pred CCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 664 SHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
+..++||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+.. .+...+|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence 556789999999999997651 2357889999999999999999999986533 234568999
Q ss_pred EEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec-CCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD-EEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~~ 796 (929)
||||++|+|.+++++.. .++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 99999999999986432 3467999999999997 12399999999999996 578999999999985421
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
......+||+.|||||++.+ .++.++||||+|+++|++.....++...... . .+......... ...
T Consensus 168 ------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~-----~~~~~i~~~~~-~~~ 233 (270)
T d1t4ha_ 168 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-A-----QIYRRVTSGVK-PAS 233 (270)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-H-----HHHHHHTTTCC-CGG
T ss_pred ------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-H-----HHHHHHHcCCC-Ccc
Confidence 12345689999999999865 6999999999998888876665554332210 0 11111110000 001
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......+-+++++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111122334777999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=365.03 Aligned_cols=229 Identities=21% Similarity=0.225 Sum_probs=169.4
Q ss_pred eeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 667 NLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 667 ~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++||+|+||+||+|.+. ...++|.+|++++++++|||||+++|+|... ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 57999999999998642 1135799999999999999999999998431 268999
Q ss_pred EecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 727 EFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
|||++|+|.++++..+ .++.|||.||+|||+. +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~-- 161 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-- 161 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC--
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccc--
Confidence 9999999999987543 3467999999999998 99999999999999999999999999998764221
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
..........||+.|||||++.+..++.++||||+|+++||+.. +..++..... . .+...+.... +.+.
T Consensus 162 -~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~-----~~~~~i~~~~--~~~~ 231 (277)
T d1xbba_ 162 -NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--S-----EVTAMLEKGE--RMGC 231 (277)
T ss_dssp -SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H-----HHHHHHHTTC--CCCC
T ss_pred -cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--H-----HHHHHHHcCC--CCCC
Confidence 11122334579999999999999999999999999988877543 3333332221 1 1111111111 1111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
+...++-+.+++.+||+.||++||||+||+++|++.-..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 111222333488899999999999999999999886543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=359.89 Aligned_cols=235 Identities=20% Similarity=0.260 Sum_probs=176.2
Q ss_pred hhCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
..++|+..+.||+|+||+||+|.+. ...++|.+|++++++++|||||+++|+|.+. ..++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeEE
Confidence 3467888999999999999999875 2356899999999999999999999988532 2699
Q ss_pred EEEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
||||+++|+|.+++... ..++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999999877532 23478999999999998 999999999999999999999999999997642
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQT 874 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 874 (929)
. .........||+.|||||++.++.++.++||||+|+++||+.+...+..... ...+++. .+.... +
T Consensus 162 ~-----~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~-~i~~~~------~ 228 (272)
T d1qpca_ 162 N-----EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQ-NLERGY------R 228 (272)
T ss_dssp S-----CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHH-HHHTTC------C
T ss_pred C-----ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHH-HHHhcC------C
Confidence 2 1112234578999999999999999999999999988777654322211111 1111111 111110 0
Q ss_pred hhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 875 IQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 875 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
...++.+++-+.+++.+||+.||++||||+||+++|+++-.
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 00111122223347789999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=357.50 Aligned_cols=231 Identities=22% Similarity=0.324 Sum_probs=177.6
Q ss_pred CCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||+||+|+++ ...++|.+|++++++++|||||+++|+|.+.+ ..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEEE
Confidence 58899999999999999999875 23578999999999999999999999996533 389999
Q ss_pred EecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccC
Q 002376 727 EFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVD 797 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 797 (929)
||+++|++.+++.... .++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+|+.+....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 9999999998865322 3467999999999998 99999999999999999999999999998764321
Q ss_pred CCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 798 NQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 798 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
........||+.|||||++.+..++.++||||+|+++||+.+ ...++..... .++. ..+..... ..
T Consensus 155 ----~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~-~~i~~~~~------~~ 221 (258)
T d1k2pa_ 155 ----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETA-EHIAQGLR------LY 221 (258)
T ss_dssp ----CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHH-HHHHTTCC------CC
T ss_pred ----ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHH-HHHHhCCC------CC
Confidence 112234578999999999999999999999999988887654 3444433322 1111 11111110 01
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.++..++.+++++.+||+.||++||||+|+++.|.++
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111222334488899999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=364.49 Aligned_cols=227 Identities=21% Similarity=0.294 Sum_probs=170.1
Q ss_pred CCCCCceeecccCceeEEecccc----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
+.|+..+.||+|+||+||+|++. ...+.|.+|++++++++|||||++++++.+. ...|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence 46888999999999999999865 2346789999999999999999999999643 34899
Q ss_pred EEEecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||||++|+|.+++.+. +.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999999987532 23467999999999998 9999999999999999999999999999865321
Q ss_pred cCCCCCccccceeccccccccccccC-----CCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhccc
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGL-----GERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSN 870 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 870 (929)
.......+||+.|||||++. +..|+.++||||+||++|++..+..++..... .+++...... .
T Consensus 164 ------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i~~~----~ 231 (288)
T d2jfla1 164 ------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKS----E 231 (288)
T ss_dssp ------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHHS----C
T ss_pred ------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC----C
Confidence 11223468999999999984 45689999999999888877665554433221 1111111111 1
Q ss_pred chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 871 ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 871 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .....+..++.-+++++.+||+.||++|||++|+++
T Consensus 232 ~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 P-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 011111112223334777999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=355.04 Aligned_cols=230 Identities=23% Similarity=0.287 Sum_probs=160.9
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+. ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 579999999999999999997651 235688999999999999999999998652 23347
Q ss_pred EEEEEecCCCCcccccccc------------ccccccHHHHHHHhhhCC--CCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE------------RKNELDITSALDYLHNDC--EVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~------------~~~~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
|+|||||++|+|.+++.+. ..++.|++.||+|||+.. ..+||||||||+|||+++++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999988531 234679999999999862 12499999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhc
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
|+.+... .......+||+.|||||++.+..|+.++||||+|+++|++.+...++..... .++...-......
T Consensus 161 a~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~ 232 (269)
T d2java1 161 ARILNHD------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFR 232 (269)
T ss_dssp HHHC-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC
T ss_pred eeecccC------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCC
Confidence 9976422 1123346899999999999999999999999999888877655544332221 1111111111110
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
......++ -+++++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---RIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCcccCH----HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111222 2334777999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=366.71 Aligned_cols=174 Identities=22% Similarity=0.361 Sum_probs=146.8
Q ss_pred hCCCCCceeecccCceeEEecccc-----------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT-----------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.++|+..+.||+|+||+||+|++. ...+++.+|+.++++++|||||+++++|.+. ..+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 568999999999999999999864 1245789999999999999999999999643 358
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+|||||++|+|.+++++.. .++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999986432 34679999999999732 799999999999999999999999999997642
Q ss_pred ccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
. .....+||+.|||||++.+..|+.++||||+||+++++.++..++
T Consensus 158 ~--------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf 203 (322)
T d1s9ja_ 158 S--------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203 (322)
T ss_dssp H--------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred C--------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 2 123468999999999999999999999999999888876655444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=357.00 Aligned_cols=226 Identities=23% Similarity=0.302 Sum_probs=169.4
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+ ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 579999999999999999997651 23568899999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+|||||++|+|.+++.... .++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+.
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecc
Confidence 899999999999999886432 3467999999999998 99999999999999999999999999998764
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
... ........+||+.|||||++.+..++.++||||+||++|++..+..++..... .++... + .......
T Consensus 160 ~~~----~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~-i---~~~~~~~ 229 (288)
T d1uu3a_ 160 PES----KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQK-I---IKLEYDF 229 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-H---HTTCCCC
T ss_pred cCC----cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHH-H---HcCCCCC
Confidence 221 11123345899999999999999999999999999887776655544432211 111111 1 1111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. +.+.+-+++++.+||+.||++|||++|+.+
T Consensus 230 p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 P----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 112223344777999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-41 Score=362.13 Aligned_cols=228 Identities=24% Similarity=0.271 Sum_probs=157.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.+.|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+ ....
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 4578999999999999999997651 23457789999999999999999999854 3458
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec---CCCceEEeccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLARF 791 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DfGla~~ 791 (929)
|+|||||++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||+. +++.+||+|||+|+.
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999999986433 3467999999999998 999999999999994 578999999999986
Q ss_pred cccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 792 LLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
.... ......+||+.|||||++.+..|+.++||||+|+++|++..+..++..... .+........ ..
T Consensus 160 ~~~~-------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~----~~ 226 (307)
T d1a06a_ 160 EDPG-------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQILKA----EY 226 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHTT----CC
T ss_pred ccCC-------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHhcc----CC
Confidence 5321 122345799999999999999999999999999877776555444322211 1111111111 11
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.........+++-+++++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111111112223344777999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=355.28 Aligned_cols=237 Identities=25% Similarity=0.304 Sum_probs=172.4
Q ss_pred hCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++|+..+.||+|+||+||+|++. ...+.|.+|+.++++++|||||+++|+|.+. ..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeEEE
Confidence 357889999999999999999875 2357899999999999999999999998532 26999
Q ss_pred EEecCCCCcccccccc----------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGE----------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~----------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
|||+++|+|.+++... ..++.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+|+.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 9999999999887632 23478999999999998 9999999999999999999999999999876422
Q ss_pred cCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTI 875 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 875 (929)
. ........||+.|||||++.++.++.++||||+|+++||+....-++.... ...++++. +.. .. +.
T Consensus 167 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~-i~~----~~--~~ 233 (285)
T d1fmka3 167 E-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQ-VER----GY--RM 233 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHH-HHT----TC--CC
T ss_pred C-----ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHH-HHh----cC--CC
Confidence 1 122334579999999999999999999999999987777544221111111 11111111 111 10 01
Q ss_pred hhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHh
Q 002376 876 QLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILL 918 (929)
Q Consensus 876 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 918 (929)
+.+..+++.+++++.+||+.||++||+|++|+++|++......
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 1111222333448889999999999999999999998665544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=358.19 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=176.9
Q ss_pred CCCCceeecccCceeEEeccccC-----------cHHHHHHHHH--HHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-----------SWKSFIAECE--TLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~--~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
+|...+.||+|+||.||+|++.+ ..+++.+|.+ .+.+++|||||+++|+|.+.+ .....+|+||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEEec
Confidence 56678899999999999998762 2344555555 455789999999999998654 233468999999
Q ss_pred cCCCCccccccccc-------cccccHHHHHHHhhhC-----CCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 729 LSNGSLGDWIHGER-------KNELDITSALDYLHND-----CEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
|++|+|.+++++.. .++.|+|.||+|+|+. ..++||||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 99999999997433 3478999999999974 13599999999999999999999999999999764321
Q ss_pred CCCCCccccceeccccccccccccCCCC------CCCCCCCCCCcCCCCCcchhHHhhhcCCc---hhhhcc--C---hH
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGER------PSTAGDVPTSESFAGEFNIVKWVESNLPE---NVLQVL--D---PE 862 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~s~g~~~~~~~~~~~~~~~~~~---~~~~~~--~---~~ 862 (929)
.. ........+||++|||||++.+.. ++.++||||+|+++||+.....++...+. ...+.. + ..
T Consensus 163 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 163 DT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred cc--eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 11 111233468999999999987653 67889999999988887654333322111 111110 0 11
Q ss_pred HHHhhccc-----chhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 863 LRQLMTSN-----ESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 863 l~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
+....... ........++...+.+ ++.+||+.||++||||.||+++|+++.++-
T Consensus 241 ~~~~~~~~~~~p~~~~~~~~~~~~~~l~~-li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGGCHHHHHHHH-HHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhccccCCCCCcccCChHHHHHHHH-HHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 11111110 0111112233334444 899999999999999999999999988653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=355.48 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=172.6
Q ss_pred HHHHHhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeee
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITS 710 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~ 710 (929)
++++...++|+..+.||+|+||+||+|++. ...+.+.+|...+.++ +|||||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444444568999999999999999998642 1235677888888877 68999999999
Q ss_pred cccCCCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEec
Q 002376 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHS 766 (929)
Q Consensus 711 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHr 766 (929)
+.+.+ ...++|||||++|+|.++++..+ .++.||++||+|||+. +||||
T Consensus 86 ~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 86 CTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp ECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 86533 24799999999999999986322 2356899999999998 99999
Q ss_pred CCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhH-
Q 002376 767 DLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVK- 845 (929)
Q Consensus 767 Dlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~- 845 (929)
||||+|||+++++.+||+|||+|+...... .........||+.|||||++.++.++.++||||+|+++||+....
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCT----TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCccceeECCCCcEEEccCcchhhccccc----cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 999999999999999999999998653221 112234467999999999999999999999999998887754321
Q ss_pred HhhhcCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 846 WVESNLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 846 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.++.... . +..+........ +...++..++-+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 235 ~p~~~~~--~----~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 235 SPYPGVK--I----DEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSSTTCC--C----SHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC--H----HHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1121111 1 111111111111 1111111222233488899999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=360.99 Aligned_cols=234 Identities=19% Similarity=0.260 Sum_probs=174.0
Q ss_pred CCCCCceeecccCceeEEecccc---------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT---------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~---------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
++|+..++||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 46899999999999999998653 23467999999999999999999999996532
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
.++||||+.+|+|.+++.... .++.|||.||+|||+. +||||||||+|||++.++.+||+|||+|+
T Consensus 85 --~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred --eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 689999999999988776322 3467999999999998 99999999999999999999999999999
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
...... .........||+.|||||++.++.++.++||||+|+++||+.+ ...++...+. .++. ..+..
T Consensus 160 ~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~-~~i~~---- 228 (317)
T d1xkka_ 160 LLGAEE----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEIS-SILEK---- 228 (317)
T ss_dssp HTTTTC----C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHH-HHHHH----
T ss_pred eccccc----ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHH-HHHHc----
Confidence 764321 1122234578999999999999999999999999988887644 3333332221 1111 11111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.. +...++..+.-+.+++.+||+.||++||||+|+++.|+.+...
T Consensus 229 ~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 GE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp TC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC--CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11 0111111122233478899999999999999999999988654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=357.49 Aligned_cols=239 Identities=22% Similarity=0.317 Sum_probs=178.6
Q ss_pred HHHHHhhCCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeec
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSC 711 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~ 711 (929)
.+++...++|+..+.||+|+||+||+|++.+ ..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3455567789999999999999999997531 245799999999999999999999999
Q ss_pred ccCCCCCcceEEEEEEecCCCCcccccccc--------------------------------ccccccHHHHHHHhhhCC
Q 002376 712 SSLDSKNMEFLALVYEFLSNGSLGDWIHGE--------------------------------RKNELDITSALDYLHNDC 759 (929)
Q Consensus 712 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------------------------------~~~~~~ia~aL~yLH~~~ 759 (929)
...+ ..++||||+++|+|.++++.. ..++.|+|.||+|||+.
T Consensus 86 ~~~~-----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 AVGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp CSSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ccCC-----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-
Confidence 6544 379999999999999988631 12367899999999998
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCC
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAG 839 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~ 839 (929)
+||||||||+|||+|.++.+||+|||+|+.+..... ........||+.|||||++.+..++.++||||+|+++|
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred --CeEeeEEcccceEECCCCcEEEccchhheeccCCcc----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence 999999999999999999999999999987643211 11223457899999999999999999999999998888
Q ss_pred CcchhHH-hhhcCCchhhhccChHHHHhhcccchhhhhhh-HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhH
Q 002376 840 EFNIVKW-VESNLPENVLQVLDPELRQLMTSNESQTIQLH-DCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQ 914 (929)
Q Consensus 840 ~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 914 (929)
|+..... ++.... ..++.. .+.. .. ....+ .+..++. +|+.+||+.||++||||.||+++|+++.
T Consensus 234 ell~~~~~p~~~~~--~~e~~~-~v~~----~~--~~~~p~~~~~~~~-~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 234 EIFSYGLQPYYGMA--HEEVIY-YVRD----GN--ILACPENCPLELY-NLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHTTTCCTTTTSC--HHHHHH-HHHT----TC--CCCCCTTCCHHHH-HHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHccCCCCCCCCC--HHHHHH-HHHc----CC--CCCCCccchHHHH-HHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7643321 111111 111111 1111 11 01111 1122333 3888999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=350.74 Aligned_cols=230 Identities=25% Similarity=0.325 Sum_probs=169.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEEEe
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVYEF 728 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~e~ 728 (929)
++|+..+.||+|+||.||+|++++ ..++|.+|++++++++|||||+++|+|.+.. ..+|+||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEEec
Confidence 467788999999999999998763 3578999999999999999999999986532 237999999
Q ss_pred cCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccccCC
Q 002376 729 LSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERVDN 798 (929)
Q Consensus 729 ~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 798 (929)
+++|+|.++++..+ .++.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999986432 3478999999999998 999999999999999999999999999986532
Q ss_pred CCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcccchhhhhh
Q 002376 799 QSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTSNESQTIQL 877 (929)
Q Consensus 799 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 877 (929)
......+|+.|||||++.++.++.++||||+|+++||+.. ...++...+. .++ ....... .+++.
T Consensus 156 -----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~-----~~~i~~~--~~~~~ 221 (262)
T d1byga_ 156 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV-----VPRVEKG--YKMDA 221 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGH-----HHHHTTT--CCCCC
T ss_pred -----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHH-----HHHHHcC--CCCCC
Confidence 1223468999999999999999999999999988877643 2333222221 111 1111110 01111
Q ss_pred hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 878 HDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 878 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
++....-+++++.+||+.||++||||+|++++|++++.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11122233347779999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.7e-40 Score=360.31 Aligned_cols=228 Identities=21% Similarity=0.241 Sum_probs=172.0
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+ ....|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 3589999999999999999997651 24578899999999999999999999854 34589
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec--CCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD--EEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~ki~DfGla~~~ 792 (929)
+|||||++|+|.+++.... .++.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.+
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999999885322 3467999999999998 999999999999995 4678999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......||+.|||||++.+..++.++||||+||++|++..+..++..... .+.+...... ...
T Consensus 177 ~~~-------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~----~~~ 243 (350)
T d1koaa2 177 DPK-------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSC----DWN 243 (350)
T ss_dssp CTT-------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT----CCC
T ss_pred ccc-------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CCC
Confidence 321 223456899999999999999999999999999887776655544432211 1111111111 111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........+++-+++++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111112223344777999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=349.87 Aligned_cols=227 Identities=20% Similarity=0.229 Sum_probs=171.5
Q ss_pred CCCCCceeecccCceeEEeccccC----------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG----------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~----------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 579999999999999999987641 24679999999999999999999999954
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC----ceEEecc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----TAKVGDF 786 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~Df 786 (929)
....|+|||||++|+|.+++.... .++.|++.||+|||+. +|+||||||+|||++.++ .+|++||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 345899999999999999986432 3467999999999998 999999999999998776 4999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHh
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQL 866 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 866 (929)
|+|+..... .......||+.|||||++.+..++.++||||+|+++|++.....++..... .+.+.. +..
T Consensus 162 G~a~~~~~~-------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~-i~~- 230 (293)
T d1jksa_ 162 GLAHKIDFG-------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLAN-VSA- 230 (293)
T ss_dssp TTCEECTTS-------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-HHT-
T ss_pred hhhhhcCCC-------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHHHH-HHh-
Confidence 999876321 122345799999999999999999999999999887776655544432221 111111 111
Q ss_pred hcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 867 MTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
............++..+++++.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 --VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111112223334777999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-40 Score=356.34 Aligned_cols=221 Identities=25% Similarity=0.278 Sum_probs=165.5
Q ss_pred CCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
.|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++.+. ...
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence 48889999999999999997641 134688999999999999999999998653 348
Q ss_pred EEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
|+|||||++|++..++... +.++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999999987665432 23478999999999998 999999999999999999999999999986421
Q ss_pred ccCCCCCccccceeccccccccccccCC---CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccc
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLG---ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNE 871 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 871 (929)
....+||+.|||||++.+ +.|+.++||||+|+++|++..+..++..... .+.+........+..
T Consensus 168 ----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~~~i~~~~~~~~- 234 (309)
T d1u5ra_ 168 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPAL- 234 (309)
T ss_dssp ----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCC-
T ss_pred ----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCCC-
Confidence 233579999999999864 4589999999999887776554444322211 111111111100000
Q ss_pred hhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 872 SQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 872 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.. ...++.+++++.+||+.||++|||++|+++
T Consensus 235 -~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -QS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -SC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CC----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 01 112223344777999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=351.79 Aligned_cols=233 Identities=23% Similarity=0.262 Sum_probs=167.4
Q ss_pred CCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..+.||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 46888999999999999998642 1135789999999999999999999999542
Q ss_pred cceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
..++||||+++|++.+++.... .++.|+|.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred --chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence 2689999999999998775322 3467999999999998 9999999999999999999999999999
Q ss_pred cccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhc
Q 002376 790 RFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMT 868 (929)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~ 868 (929)
+.+..... .........||+.|||||++.+..++.++||||+|+++||+.+ +..++..... .+++ .....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~----~~i~~ 229 (273)
T d1u46a_ 159 RALPQNDD---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQIL----HKIDK 229 (273)
T ss_dssp EECCC-CC---EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHT
T ss_pred hhcccCCC---cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHH----HHHHh
Confidence 97643211 1122334568899999999999999999999999988887654 3433322221 1111 11111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhh
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSS 913 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 913 (929)
.. .+.+.++.++..+++++.+||+.||++||||+||++.|++.
T Consensus 230 ~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 01111111222333477799999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=357.17 Aligned_cols=232 Identities=23% Similarity=0.294 Sum_probs=173.7
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..++||+|+||+||+|++. ...++|.+|+++++++ +|||||+++|+|.+. .
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence 56788899999999999998764 1245799999999998 799999999999653 3
Q ss_pred eEEEEEEecCCCCcccccccc------------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec
Q 002376 721 FLALVYEFLSNGSLGDWIHGE------------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD 776 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~------------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 776 (929)
..++||||+++|+|.++++.. ..++.|||.||+|+|+. +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 489999999999999998632 12367999999999998 999999999999999
Q ss_pred CCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHH-hhhcCCchh
Q 002376 777 EEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKW-VESNLPENV 855 (929)
Q Consensus 777 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~-~~~~~~~~~ 855 (929)
.++.+||+|||+|+..... .......||..|+|||.+.++.++.++||||+|+++|++..... ++.....
T Consensus 162 ~~~~~kl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-- 232 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 232 (309)
T ss_dssp GGGCEEECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCceEEcccccccccccc-------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999865322 11233468999999999999999999999999988877644322 1211111
Q ss_pred hhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 856 LQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 856 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
. .+...+.... +++.+..+++.+++++.+||+.||++||||+||++.|+++.+.
T Consensus 233 ~-----~~~~~i~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 233 A-----ELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp H-----HHHHHGGGTC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H-----HHHHHHHhcC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 1111111110 1111112223334477799999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=353.90 Aligned_cols=224 Identities=25% Similarity=0.305 Sum_probs=171.4
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|+.. ...+.+.+|+.+|++++|||||++++++.+ ...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence 57999999999999999999865 124568899999999999999999999954 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
+|+|||||++|+|.+++...+ .++.|++.||+|||+. +||||||||+|||++++|.+||+|||+|+...
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 899999999999999887433 3467999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. .......+||+.|||||++.+..|+.++||||+||++|++..+..++.... ..++....... ...
T Consensus 157 ~~------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~~----~~~- 223 (337)
T d1o6la_ 157 SD------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILME----EIR- 223 (337)
T ss_dssp CT------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----CCC-
T ss_pred cC------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhcC----CCC-
Confidence 21 122345689999999999999999999999999988777655543332211 11111111111 111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.+..++.-+++++.+|++.||++||+ +.|+++
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11122233345777999999999995 777765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-39 Score=357.66 Aligned_cols=228 Identities=21% Similarity=0.222 Sum_probs=171.9
Q ss_pred hCCCCCceeecccCceeEEeccccC----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
.++|+..+.||+|+||+||+|++.. ..+.+.+|++++++++|||||++++++.+ ...+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 3579999999999999999998651 24568899999999999999999999854 34589
Q ss_pred EEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeec--CCCceEEecccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLD--EEMTAKVGDFGLARFL 792 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~ki~DfGla~~~ 792 (929)
+|||||++|+|.+++.... .++.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.+
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999988765322 3467999999999998 999999999999998 6789999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... .......||+.|||||++.+..++.++||||+||++|++.++..++..... .+.+...... ...
T Consensus 180 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~----~~~ 246 (352)
T d1koba_ 180 NPD-------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRC----DWE 246 (352)
T ss_dssp CTT-------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHC----CCC
T ss_pred CCC-------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CCC
Confidence 321 223456899999999999999999999999999888776655444432221 1111111111 111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
........++.-+++++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111112223334777999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-39 Score=347.37 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=175.7
Q ss_pred ceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEE
Q 002376 666 ENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 666 ~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV 725 (929)
.++||+|+||+||+|++. ...++|.+|++++++++|||||+++|+|.+.+ ...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence 478999999999998753 12467999999999999999999999986533 348999
Q ss_pred EEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 726 YEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
||||++|+|.++++... .++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999886332 3467999999999998 99999999999999999999999999999764322
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchhhhh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQTIQ 876 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 876 (929)
... ........||+.|+|||++.++.++.++||||+|++++|+.....++..... ..++. ..+.. .. +..
T Consensus 185 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~-~~i~~----g~--~~~ 254 (311)
T d1r0pa_ 185 FDS--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDIT-VYLLQ----GR--RLL 254 (311)
T ss_dssp CCC--TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CH-HHHHT----TC--CCC
T ss_pred ccc--ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHH-HHHHc----CC--CCC
Confidence 111 1222345799999999999999999999999999877775443332211110 11111 11111 00 000
Q ss_pred hhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHHhhc
Q 002376 877 LHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEILLKQ 920 (929)
Q Consensus 877 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 920 (929)
.++...+-+.+++.+||+.||++||+|.||++.|+++.+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 11111122334888999999999999999999999998876544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=344.02 Aligned_cols=234 Identities=22% Similarity=0.284 Sum_probs=166.1
Q ss_pred hCCCCCceeecccCceeEEecccc--------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT--------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNM 719 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~--------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~ 719 (929)
.++|+..+.||+|+||+||+|++. ...+.|.+|++++++++|||||+++|+|.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 357888999999999999998753 123578999999999999999999999843
Q ss_pred ceEEEEEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 720 EFLALVYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 720 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...|+||||+++|++.+++.... .++.||++||+|||+. +|+||||||+||++++++.+||+|||+|+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 23799999999999998765322 3367999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhhcCCchhhhccChHHHHhhcc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVESNLPENVLQVLDPELRQLMTS 869 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~ 869 (929)
.+... .........||+.|||||++.+..++.++||||+|+++||+.+ ...++..... .++.. .+..
T Consensus 157 ~~~~~-----~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~-~i~~---- 224 (273)
T d1mp8a_ 157 YMEDS-----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIG-RIEN---- 224 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHH-HHHT----
T ss_pred eccCC-----cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHH-HHHc----
Confidence 76322 1112334578999999999999999999999999988877543 2322222221 11111 1111
Q ss_pred cchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 870 NESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.. +.+.+..++.-+++++.+||+.||++||||+||++.|+++.++
T Consensus 225 ~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 10 0011111222333477799999999999999999999998765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-39 Score=344.32 Aligned_cols=242 Identities=21% Similarity=0.299 Sum_probs=172.9
Q ss_pred hCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
.++|+..+.||+|+||+||+|++.. ..+.|.+|++++++++|||||++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4679999999999999999997641 1346889999999999999999999987644 2344
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+||||+++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.++..+++|||.++..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 5899999999999998886432 3467999999999998 9999999999999999999999999998765
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
..... ........+||+.|||||++.+..++.++||||+|+++|++.++..++..... .+.....+.. ...
T Consensus 162 ~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~~~~~----~~~ 232 (277)
T d1o6ya_ 162 ADSGN---SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVRE----DPI 232 (277)
T ss_dssp C-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHC----CCC
T ss_pred ccccc---cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--HHHHHHHHhc----CCC
Confidence 32211 11223456899999999999999999999999999887776655444332211 1111111111 111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCC-CHHHHHHHHHhhH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRI-GIREALRRLKSSQ 914 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~ 914 (929)
......+.+++-+++++.+|++.||++|| |++|+.+.|.+++
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111111222333477799999999999 8999999988775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-39 Score=347.00 Aligned_cols=221 Identities=19% Similarity=0.258 Sum_probs=170.4
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|++. ...+.+.+|+.++++++|||||++++++.+ ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 57889999999999999999865 124568899999999999999999999854 345
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.|+|||||++|++.+++.... .++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence 899999999999998876432 3467999999999998 99999999999999999999999999998753
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. .....+||+.|||||++.+..|+.++||||+|+++|++.++..++..... .++...... .....
T Consensus 156 ~---------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~----~~~~~ 220 (316)
T d1fota_ 156 D---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILN----AELRF 220 (316)
T ss_dssp S---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHH----CCCCC
T ss_pred c---------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--HHHHHHHHc----CCCCC
Confidence 2 12346899999999999999999999999999887776655554432221 111111111 11111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
....++. +++++.+|++.||++|| |++|+++
T Consensus 221 p~~~s~~----~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 PPFFNED----VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTSCHH----HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHH----HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112222 33467799999999996 8889875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=352.78 Aligned_cols=237 Identities=21% Similarity=0.261 Sum_probs=177.4
Q ss_pred HhhCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHccCCccccceeeecccCC
Q 002376 658 RATGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLD 715 (929)
Q Consensus 658 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~ 715 (929)
...++|...+.||+|+||+||+|.+. .....|.+|++++++++|||||+++|+|...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33467888899999999999998653 12346899999999999999999999996543
Q ss_pred CCCcceEEEEEEecCCCCcccccccc------------------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIHGE------------------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE 777 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~ 777 (929)
..++|||||++|+|.++++.. ..++.|+|+||.|||+. +|+||||||+|||+|+
T Consensus 97 -----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 97 -----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 168 (308)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred -----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence 379999999999999988622 13477999999999998 9999999999999999
Q ss_pred CCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhH-HhhhcCCchhh
Q 002376 778 EMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVK-WVESNLPENVL 856 (929)
Q Consensus 778 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~-~~~~~~~~~~~ 856 (929)
++.+||+|||+|+.+..... ........||+.|||||.+.++.++.++||||+|++++|+.+.. .++.... ..
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~ 242 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NE 242 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HH
T ss_pred CceEEEeecccceeccCCcc----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HH
Confidence 99999999999987643211 12233457899999999999999999999999998877765431 2222111 11
Q ss_pred hccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHH
Q 002376 857 QVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQE 915 (929)
Q Consensus 857 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 915 (929)
+++.. +.. .. ..+.++..+..+.+++.+||+.||++||||+||+++|++..+
T Consensus 243 ~~~~~-i~~----~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRF-VME----GG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHH-HHT----TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHH-HHh----CC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 111 00 111111122334448889999999999999999999988644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=344.49 Aligned_cols=237 Identities=18% Similarity=0.280 Sum_probs=177.0
Q ss_pred hCCCCCceeecccCceeEEecccc----------------------CcHHHHHHHHHHHHcc-CCccccceeeecccCCC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT----------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~----------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~ 716 (929)
.++|+..++||+|+||.||+|++. ...++|.+|+.+++++ +|||||+++|+|.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 468888999999999999998642 1245788999999999 6999999999996543
Q ss_pred CCcceEEEEEEecCCCCccccccccc--------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER--------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
..++|||||++|+|.++++..+ .++.||+.||+|||++ +||||||||
T Consensus 101 ----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 3799999999999999986322 2367999999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh-hh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV-ES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~-~~ 849 (929)
+||+++.++.+|++|||.++...... ........+||+.|||||++.++.++.++||||+|++++++.....+ +.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT----TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccCcccccccchheeccCCC----cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999998764221 11223446899999999999999999999999999877775432211 11
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..+ .+..+........ +...++..++.+.+++.+||+.||++||||+||+++|+++.++
T Consensus 250 ~~~------~~~~~~~~i~~~~--~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMP------VDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCC------SSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC------HHHHHHHHHhcCC--CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111 1111221111110 0111111222334478899999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=346.94 Aligned_cols=236 Identities=20% Similarity=0.315 Sum_probs=172.1
Q ss_pred hCCCCCceeecccCceeEEecccc------------------------CcHHHHHHHHHHHHcc-CCccccceeeecccC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERT------------------------GSWKSFIAECETLRNV-RHRNLVKLITSCSSL 714 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~------------------------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~ 714 (929)
.++|...+.||+|+||.||+|+.. ...+++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357888899999999999998642 1235788899999888 899999999999653
Q ss_pred CCCCcceEEEEEEecCCCCccccccccc------------------------cccccHHHHHHHhhhCCCCCEEecCCCC
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGER------------------------KNELDITSALDYLHNDCEVPVVHSDLKP 770 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------~~~~~ia~aL~yLH~~~~~~iiHrDlk~ 770 (929)
+ ..++|||||++|+|.++++..+ .++.|+|.||+|||+. +||||||||
T Consensus 92 ~-----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 92 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp S-----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred C-----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 3 4799999999999999986432 2357899999999998 999999999
Q ss_pred CCeeecCCCceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcch-hHHhhh
Q 002376 771 GNILLDEEMTAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNI-VKWVES 849 (929)
Q Consensus 771 ~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~-~~~~~~ 849 (929)
+|||++.++.+||+|||+++........ .......||+.|||||++.++.|+.++||||+|+++|++.. ...++.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceeecCCCCeEeccchhhccccccccc----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999976432211 12334578999999999999999999999999987777543 232222
Q ss_pred cCCchhhhccChHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 850 NLPENVLQVLDPELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 850 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
..+. .+ +........ ++..+..+++.+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 240 ~~~~--~~-----~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 240 GVPV--EE-----LFKLLKEGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TCCH--HH-----HHHHHHTTC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCH--HH-----HHHHHHcCC--CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2221 11 111111111 1111111222334488899999999999999999999998653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-38 Score=350.55 Aligned_cols=224 Identities=21% Similarity=0.246 Sum_probs=165.1
Q ss_pred CCCCCceeecccCceeEEeccccCc-------------------HHHHHHH---HHHHHccCCccccceeeecccCCCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS-------------------WKSFIAE---CETLRNVRHRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~-------------------~~~~~~E---~~~l~~l~Hpniv~l~~~~~~~~~~~ 718 (929)
++|+..++||+|+||+||+|++..+ ...+.+| +++++.++|||||++++++.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---- 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---- 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence 5799999999999999999987521 1233444 6677778899999999998543
Q ss_pred cceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
...|+|||||++|+|.+++.... .++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+
T Consensus 80 -~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 80 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred -CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 34899999999999999986432 3467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCC-CCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhc
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLG-ERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMT 868 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~ 868 (929)
.+... .....+||+.|||||++.+ ..|+.++||||+||++|++.++..++..... ...+ .......
T Consensus 156 ~~~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~ 223 (364)
T d1omwa3 156 DFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT 223 (364)
T ss_dssp ECSSS--------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSS
T ss_pred ecCCC--------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccc
Confidence 66321 1234579999999999875 5689999999999888877666555433221 1111 0111111
Q ss_pred ccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH
Q 002376 869 SNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR 908 (929)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~ 908 (929)
.... .++.+++-+++++.+||+.||++||| ++|+++
T Consensus 224 ~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCC----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111 11112223344777999999999999 577764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-38 Score=336.08 Aligned_cols=227 Identities=22% Similarity=0.268 Sum_probs=170.1
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------------cHHHHHHHHHHHHccC-CccccceeeecccC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------------SWKSFIAECETLRNVR-HRNLVKLITSCSSL 714 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~ 714 (929)
++|+..+.||+|+||+||+|+... ..+.+.+|+.++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 689999999999999999997641 1235889999999997 9999999999954
Q ss_pred CCCCcceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecc
Q 002376 715 DSKNMEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDF 786 (929)
Q Consensus 715 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~Df 786 (929)
....|+|||||++|+|.++++.. +.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 34589999999999999999643 24478999999999998 9999999999999999999999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCC------CCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccC
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLG------ERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLD 860 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (929)
|+|+.+... ......+||+.|+|||++.+ ..++.++||||+|++++++..+..++..... .+..
T Consensus 155 G~a~~~~~~-------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~- 224 (277)
T d1phka_ 155 GFSCQLDPG-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML- 224 (277)
T ss_dssp TTCEECCTT-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH-
T ss_pred hheeEccCC-------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHH-
Confidence 999876321 12234579999999998863 3478899999999888777666555543322 1111
Q ss_pred hHHHHhhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 PELRQLMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
..+.. ............+++-+++++.+||+.||++|||++||++
T Consensus 225 ~~i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 RMIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHH---TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHh---CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 1111111111112223334777999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-38 Score=344.05 Aligned_cols=221 Identities=21% Similarity=0.229 Sum_probs=169.4
Q ss_pred CCCCCceeecccCceeEEecccc-------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
++|+..+.||+|+||+||+|++. ...+.+.+|+++++.++|||||++++++.+. ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence 57999999999999999999765 1235688999999999999999999998543 34
Q ss_pred EEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.++||||+.+|+|.+++.... .++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 899999999999999886432 3478999999999998 99999999999999999999999999998763
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. .....+||+.|||||++.+..++.++||||+||++|++.++..++.... ..+.... +. ......
T Consensus 193 ~---------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~-i~---~~~~~~ 257 (350)
T d1rdqe_ 193 G---------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEK-IV---SGKVRF 257 (350)
T ss_dssp S---------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH-HH---HCCCCC
T ss_pred c---------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHH-Hh---cCCCCC
Confidence 2 1234589999999999999999999999999988777655544432211 1111111 11 111111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCC-----CHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRI-----GIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~ 908 (929)
....++ -+.+++.+|++.||++|+ |++|+++
T Consensus 258 p~~~s~----~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PSHFSS----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCH----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CccCCH----HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111222 233477799999999994 8899875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=340.13 Aligned_cols=228 Identities=22% Similarity=0.225 Sum_probs=171.3
Q ss_pred hCCCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLAL 724 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~l 724 (929)
.++|+..+.||+|+||+||+|.+.. ....+.+|+++|++++|||||++++++.+ ...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence 4689999999999999999998651 23468899999999999999999999854 345899
Q ss_pred EEEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCC--CceEEeccccccccc
Q 002376 725 VYEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEE--MTAKVGDFGLARFLL 793 (929)
Q Consensus 725 V~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~ki~DfGla~~~~ 793 (929)
|||||++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999999987433 2367999999999998 99999999999999854 589999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
. ........||+.|||||...+..++.++||||+|+++|++..+..++..... .+++..-... ....
T Consensus 156 ~-------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~~~~~i~~~----~~~~ 222 (321)
T d1tkia_ 156 P-------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNA----EYTF 222 (321)
T ss_dssp T-------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT----CCCC
T ss_pred c-------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC----CCCC
Confidence 2 1223445799999999999999999999999999888776655544432221 1111111111 1111
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......++.-+++++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111112222334777999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=338.57 Aligned_cols=236 Identities=19% Similarity=0.152 Sum_probs=168.8
Q ss_pred hCCCCCc-eeecccCceeEEeccccC-----------cHHHHHHHHHHHHcc-CCccccceeeecccCCCCCcceEEEEE
Q 002376 660 TGNFSHE-NLIGSGSFGSVLHNERTG-----------SWKSFIAECETLRNV-RHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 660 ~~~~~~~-~~iG~G~~g~Vy~~~~~~-----------~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
.++|... +.||+|+||+||+|++.. ..+.+.+|++++.++ +|||||++++++.+.. .....+|+||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivm 88 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVM 88 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEE
Confidence 3578776 469999999999998652 245788999987655 8999999999985422 2345689999
Q ss_pred EecCCCCccccccccc----------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC---CCceEEeccccccccc
Q 002376 727 EFLSNGSLGDWIHGER----------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE---EMTAKVGDFGLARFLL 793 (929)
Q Consensus 727 e~~~~gsL~~~l~~~~----------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DfGla~~~~ 793 (929)
|||++|+|.+++.... .++.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+|+...
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeecc
Confidence 9999999999986431 2367899999999998 9999999999999985 5679999999998753
Q ss_pred cccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccchh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNESQ 873 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 873 (929)
.. ......+||+.|||||++.+..|+.++||||+||++|++.++..++..... .+..+.............
T Consensus 166 ~~-------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~--~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 166 SH-------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CC-------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC--C--------CCCSCSSSC
T ss_pred CC-------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH--HHHHHHHHHHHhcCCCCC
Confidence 22 122345799999999999999999999999999888776665554432211 000010000000000000
Q ss_pred hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 874 TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 874 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.......+++.+++++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111122233344788999999999999999976
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-38 Score=339.57 Aligned_cols=224 Identities=25% Similarity=0.318 Sum_probs=168.9
Q ss_pred CCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHH-ccCCccccceeeecccCCCCCcc
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLR-NVRHRNLVKLITSCSSLDSKNME 720 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~-~l~Hpniv~l~~~~~~~~~~~~~ 720 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|..++. .++|||||++++++.+. .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 579999999999999999998752 2345677777765 68999999999999653 3
Q ss_pred eEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..|+|||||++|+|.++++... .++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+..
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhc
Confidence 4899999999999999987432 3467999999999998 9999999999999999999999999999865
Q ss_pred ccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHHhhcccch
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 872 (929)
... ........||+.|||||++.+..++.++||||+||++|++.++..++.... ..++... +.. ....
T Consensus 154 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~-i~~---~~~~ 221 (320)
T d1xjda_ 154 MLG------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHS-IRM---DNPF 221 (320)
T ss_dssp CCT------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH-HHH---CCCC
T ss_pred ccc------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHH-HHc---CCCC
Confidence 321 122334589999999999999999999999999988877766554443221 1111111 111 1111
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHH-HHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIR-EALR 908 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~~ 908 (929)
.+..+++.+++++.+||+.||++||++. |+++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111223344577799999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=333.79 Aligned_cols=167 Identities=23% Similarity=0.345 Sum_probs=136.6
Q ss_pred CceeecccCceeEEeccccCc---------------------HHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 665 HENLIGSGSFGSVLHNERTGS---------------------WKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 665 ~~~~iG~G~~g~Vy~~~~~~~---------------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
..++||+|+||+||+|++..+ .+.+.+|++++++++|||||++++++...+ ..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence 357899999999999987511 235889999999999999999999996543 489
Q ss_pred EEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||++++++..+.... +.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC
Confidence 999999988777665422 23467999999999998 9999999999999999999999999999865322
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhH
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~ 845 (929)
.......+||+.|||||++.+. .|+.++||||+||++|++.++.
T Consensus 154 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 198 (299)
T d1ua2a_ 154 ------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198 (299)
T ss_dssp ------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence 1122345799999999998755 5799999999999888876544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=335.37 Aligned_cols=240 Identities=26% Similarity=0.324 Sum_probs=169.3
Q ss_pred hhCCCCCceeecccCceeEEeccccC-------------------cHHHHHHHHHHHHcc---CCccccceeeecccCCC
Q 002376 659 ATGNFSHENLIGSGSFGSVLHNERTG-------------------SWKSFIAECETLRNV---RHRNLVKLITSCSSLDS 716 (929)
Q Consensus 659 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------------~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~ 716 (929)
..++|+..+.||+|+||+||+|++.. ....+.+|+.+++.+ +|||||+++++|.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 34689999999999999999997531 123566888887766 79999999999875544
Q ss_pred CCcceEEEEEEecCCCCccccccc---------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHG---------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~---------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
......++||||+++|.+...... .+.++.|++.||+|||+. +||||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 445678999999998776544321 224578999999999998 99999999999999999999999999
Q ss_pred cccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-h-hhhccC-----
Q 002376 788 LARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-N-VLQVLD----- 860 (929)
Q Consensus 788 la~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~-~~~~~~----- 860 (929)
+++..... ......+||+.|||||++.+..|+.++||||+||++|++..+..++..... . ...++.
T Consensus 162 ~~~~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 162 LARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp SCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhhhhccc-------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 99864321 223456899999999999999999999999999888887655444322211 0 000000
Q ss_pred ------h--HH-HHhh-cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 861 ------P--EL-RQLM-TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 861 ------~--~l-~~~~-~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
. .. .... .............+.+.+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00 0000 00000000011112233344777999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=328.48 Aligned_cols=173 Identities=29% Similarity=0.401 Sum_probs=139.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||+||+|++.. ..+++.+|++++++++|||||++++++.+. ...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 689999999999999999997651 245788999999999999999999999653 358
Q ss_pred EEEEEecCCCCccccccc----------cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHG----------ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~----------~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
|+||||+.++ +.+++.. .+.++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred eEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence 9999999754 4433321 123478999999999998 9999999999999999999999999999876
Q ss_pred ccccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHhh
Q 002376 793 LERVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 793 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
... ........||+.|+|||++.... ++.++||||+|+++|++..+..++
T Consensus 153 ~~~------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf 203 (298)
T d1gz8a_ 153 GVP------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203 (298)
T ss_dssp CCC------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCC------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC
Confidence 321 12233457999999999877766 589999999998877765554443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=319.84 Aligned_cols=216 Identities=23% Similarity=0.254 Sum_probs=160.7
Q ss_pred CCCCCceeecccCceeEEeccccCc----------------------HHHHHHHHHHHHccC--CccccceeeecccCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTGS----------------------WKSFIAECETLRNVR--HRNLVKLITSCSSLDS 716 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~~----------------------~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~ 716 (929)
++|+..+.||+|+||+||+|++..+ .+++.+|+.++++++ |||||++++++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-- 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-- 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence 5789999999999999999886521 123678999999997 89999999998543
Q ss_pred CCcceEEEEEEecCC-CCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-CCceEEecc
Q 002376 717 KNMEFLALVYEFLSN-GSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-EMTAKVGDF 786 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~-gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~Df 786 (929)
...++||||+.+ +++.+++... +.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 82 ---~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 ---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp ---SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred ---CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 348999999976 5777776532 23468999999999998 9999999999999985 579999999
Q ss_pred ccccccccccCCCCCccccceeccccccccccccCCCCC-CCCCCCCCCcCCCCCcchhHHhhhcCCchhhhccChHHHH
Q 002376 787 GLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERP-STAGDVPTSESFAGEFNIVKWVESNLPENVLQVLDPELRQ 865 (929)
Q Consensus 787 Gla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 865 (929)
|+|+.... ......+||+.|||||++.+..+ +.++||||+|+++|++..+ ..|....+ .+..
T Consensus 156 G~a~~~~~--------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g-----~~Pf~~~~----~i~~ 218 (273)
T d1xwsa_ 156 GSGALLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-----DIPFEHDE----EIIR 218 (273)
T ss_dssp TTCEECCS--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS-----SCSCCSHH----HHHH
T ss_pred ccceeccc--------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhC-----CCCCCCch----HHhh
Confidence 99986532 12234689999999999987765 6778999999877765544 44431110 1111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR 908 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~ 908 (929)
.....+...++ -+++++.+||+.||++|||++|+++
T Consensus 219 ---~~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 ---GQVFFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCCCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cccCCCCCCCH----HHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00111111222 2334777999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-35 Score=319.35 Aligned_cols=245 Identities=18% Similarity=0.197 Sum_probs=171.3
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..+.||+|+||+||+|++.. ..+++.+|+++++.++|+|+|..++.|... ....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence 569999999999999999997651 234688999999999988877776666432 33579999
Q ss_pred EecCCCCcccccccc---------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeec---CCCceEEecccccccccc
Q 002376 727 EFLSNGSLGDWIHGE---------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLD---EEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 727 e~~~~gsL~~~l~~~---------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DfGla~~~~~ 794 (929)
||+ +|++.+.+... ..++.|++.||+|||+. +||||||||+|||++ .+..+|++|||+|+.+..
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 45666554321 13467999999999998 999999999999875 456799999999998754
Q ss_pred ccCCC-CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhhcccch
Q 002376 795 RVDNQ-SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLMTSNES 872 (929)
Q Consensus 795 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~ 872 (929)
..... .........+||+.|||||++.+..++.++||||+|++++++.++..++..... .....+.......... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--P 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--C
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--C
Confidence 32211 111223456899999999999999999999999999888887666666544332 1111110000100000 0
Q ss_pred hhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHH
Q 002376 873 QTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEI 916 (929)
Q Consensus 873 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 916 (929)
.....+.+++-+.+++.+||+.+|++||+++++.+.|+++...
T Consensus 237 -~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 -IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000011112223377799999999999999999999987554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.6e-36 Score=319.26 Aligned_cols=173 Identities=26% Similarity=0.328 Sum_probs=138.9
Q ss_pred CCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFLA 723 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~~ 723 (929)
++|+..++||+|+||+||+|+++. ..+.|.+|+.++++++|||||++++++...+ ..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----cee
Confidence 578999999999999999997651 1457999999999999999999999996543 489
Q ss_pred EEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 724 LVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 724 lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
+||||+.++.+..+.+... .++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|......
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9999998877766655322 3478999999999998 9999999999999999999999999999875321
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
........|++.|+|||.+.+. .++.++||||+|++++++..+..+
T Consensus 154 ------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p 200 (286)
T d1ob3a_ 154 ------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence 1122344689999999998765 469999999999887776554443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-35 Score=318.27 Aligned_cols=184 Identities=24% Similarity=0.340 Sum_probs=142.2
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC---CC
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS---KN 718 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---~~ 718 (929)
.++|+..+.||+|+||+||+|++.. ..+++.+|+++|++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4689999999999999999998651 23568899999999999999999999865332 12
Q ss_pred cceEEEEEEecCCCCcccccccc--------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE--------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
....|+||||++++.+..+.... +.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 34589999999887766544322 23467999999999998 99999999999999999999999999998
Q ss_pred ccccccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhh
Q 002376 791 FLLERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVE 848 (929)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~ 848 (929)
......... .......+||+.|+|||++.+. .++.++||||+|++++++.++..++
T Consensus 166 ~~~~~~~~~--~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKNSQ--PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccccccc--cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 764322111 1122335799999999998766 5899999999998888766554443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-35 Score=312.78 Aligned_cols=243 Identities=16% Similarity=0.135 Sum_probs=176.2
Q ss_pred CCCCCceeecccCceeEEeccccC--------------cHHHHHHHHHHHHccCC-ccccceeeecccCCCCCcceEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG--------------SWKSFIAECETLRNVRH-RNLVKLITSCSSLDSKNMEFLALV 725 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~--------------~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~~~~~~lV 725 (929)
++|+..+.||+|+||+||+|++.. ..+.+.+|++.++.++| +|++.+++++.+ ....++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEEE
Confidence 579999999999999999997652 23457889999999976 899999988754 3347999
Q ss_pred EEecCCCCccccccccc---------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecC-----CCceEEeccccccc
Q 002376 726 YEFLSNGSLGDWIHGER---------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDE-----EMTAKVGDFGLARF 791 (929)
Q Consensus 726 ~e~~~~gsL~~~l~~~~---------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~ki~DfGla~~ 791 (929)
|||+ +|+|.++++... .++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 689988876322 3467899999999998 9999999999999974 56899999999997
Q ss_pred cccccCCC-CCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHHhh--
Q 002376 792 LLERVDNQ-SSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQLM-- 867 (929)
Q Consensus 792 ~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~-- 867 (929)
........ .........+||+.|||||++.+..++.++||||+|++++++.....++..... ...+.. ..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCC
Confidence 65332211 111223456899999999999999999999999999888887666665543322 111100 0111100
Q ss_pred cccchhhhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhhHHHH
Q 002376 868 TSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRRLKSSQEIL 917 (929)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 917 (929)
..........+ .++. +++..|++.+|++||+++.+.+.|+++.+..
T Consensus 235 ~~~~~l~~~~p---~~l~-~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 TPLRELCAGFP---EEFY-KYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCHHHHTTTSC---HHHH-HHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChHHhcCCCC---HHHH-HHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000001111 2233 3777999999999999999999999887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=321.85 Aligned_cols=181 Identities=23% Similarity=0.295 Sum_probs=140.6
Q ss_pred hCCCCCceeecccCceeEEeccccC-----------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG-----------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
+++|+..+.||+|+||+||+|++.. ..+++.+|+++|++++|||||++++++...........
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4578999999999999999997641 23578899999999999999999999976543333344
Q ss_pred EEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLER 795 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 795 (929)
++ +||+.+|+|.+++... +.++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 87 ~l-~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YL-VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EE-EEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EE-EEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 55 4566799999998633 23478999999999998 9999999999999999999999999999876433
Q ss_pred cCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHh
Q 002376 796 VDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 796 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
... .......+||+.|+|||++... .++.++||||+|++++++.++..+
T Consensus 163 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p 212 (345)
T d1pmea_ 163 HDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212 (345)
T ss_dssp GCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred Ccc---ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence 221 1123446799999999998554 578999999999888776655443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.7e-33 Score=304.52 Aligned_cols=257 Identities=34% Similarity=0.569 Sum_probs=238.0
Q ss_pred CCCCEEEccCCcccc--ccCchhhhccccccEEEecC-CccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCC
Q 002376 328 THLNYLALDGNQFEG--KIPESIGNFSNELSKLYLGG-NHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQ 404 (929)
Q Consensus 328 ~~L~~L~Ls~N~l~~--~~p~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 404 (929)
.+++.|+|++|+++| .+|..+++++ +|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 468899999999988 5899999998 799999997 899999999999999999999999999999999999999999
Q ss_pred EEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccccc-ceecccCCcCCCCCCCCcccCCchhhhcccCc
Q 002376 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSL-LSIDLSNNRINGNIPKGILRPLPEEISRLENV 483 (929)
Q Consensus 405 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L 483 (929)
++++++|.+.+.+|..+.+++.|+.+++++|++++.+|..+..+..+ +.+++++|+++|.. |..+..+..
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~--------~~~~~~l~~- 199 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI--------PPTFANLNL- 199 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC--------CGGGGGCCC-
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccc--------ccccccccc-
Confidence 99999999999999999999999999999999999999999888876 88999999999765 556666654
Q ss_pred cEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCC
Q 002376 484 VTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 484 ~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (929)
..+++++|.+.|.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|||++|+++|.+|..+.++++|++|||++|
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence 479999999999999999999999999999999998776 5889999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCCCcccccCCCCCcCCC--CC
Q 002376 564 NLEGVVPSEGIFRNMSNVHLKGNPKLCLQL--GC 595 (929)
Q Consensus 564 ~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~--~c 595 (929)
+|+|.+|+.+.+++++.+++.||+.+|+.| .|
T Consensus 279 ~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 999999998889999999999999999875 66
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=324.59 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=164.9
Q ss_pred CCCCceeecccCceeEEeccccCc------------HHHHHHHHHHHHccCCccccceeeecccCCC-CCcceEEEEEEe
Q 002376 662 NFSHENLIGSGSFGSVLHNERTGS------------WKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEFLALVYEF 728 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~~------------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~~~lV~e~ 728 (929)
+|+..++||+|+||+||+|++..+ .+.+.+|+++|++++|||||+++++|..... .+..++++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 578889999999999999987622 2345689999999999999999999865432 344568999999
Q ss_pred cCCCCcccccc-----------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEecccccccccccc
Q 002376 729 LSNGSLGDWIH-----------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERV 796 (929)
Q Consensus 729 ~~~gsL~~~l~-----------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~ 796 (929)
|++|.+....+ ..+.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~- 176 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG- 176 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC-
Confidence 98664333321 1224477999999999998 999999999999999775 8999999999876322
Q ss_pred CCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc--hhhhccC-------hHHHHh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE--NVLQVLD-------PELRQL 866 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~l~~~ 866 (929)
......+||+.|+|||.+.+. .++.++||||+||++|++..+..++..... ...+++. ......
T Consensus 177 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 177 ------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 112335799999999988754 689999999999888776655443322211 0111000 000000
Q ss_pred hcc--------cchh--hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHH--HHHhhH
Q 002376 867 MTS--------NESQ--TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALR--RLKSSQ 914 (929)
Q Consensus 867 ~~~--------~~~~--~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~ 914 (929)
... .... ...........+.+++.+|++.||++|||++|+++ .++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 0000 00000001122333777999999999999999985 355543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.8e-35 Score=318.62 Aligned_cols=172 Identities=23% Similarity=0.303 Sum_probs=141.6
Q ss_pred CCCCCceeecccCceeEEecccc-------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVY 726 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~ 726 (929)
++|+..++||+|+||+||+|++. ...+++.+|+++|++++ ||||+++++++... .....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence 57999999999999999999865 23578899999999995 99999999998642 234589999
Q ss_pred EecCCCCccccccc-----cccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-ceEEeccccccccccccCCCC
Q 002376 727 EFLSNGSLGDWIHG-----ERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM-TAKVGDFGLARFLLERVDNQS 800 (929)
Q Consensus 727 e~~~~gsL~~~l~~-----~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~~~~~ 800 (929)
|||++|+|.++.+. .+.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~----- 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG----- 183 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-----
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC-----
Confidence 99999999887642 235578999999999998 999999999999998655 6999999999876322
Q ss_pred CccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhH
Q 002376 801 SISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVK 845 (929)
Q Consensus 801 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~ 845 (929)
......+||+.|+|||.+.+.. ++.++||||+|++++++....
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~ 227 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCC
Confidence 1123457899999999987764 799999999998777654443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-35 Score=322.40 Aligned_cols=243 Identities=21% Similarity=0.271 Sum_probs=164.6
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcc
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNME 720 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~ 720 (929)
.++|+..+.||+|+||+||+|.+.. ..+.+.+|+++|++++|||||+++++|...+. ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999997651 13568899999999999999999999976542 1234
Q ss_pred eEEEEEEecCCCCcccccccc-------ccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccccccc
Q 002376 721 FLALVYEFLSNGSLGDWIHGE-------RKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLL 793 (929)
Q Consensus 721 ~~~lV~e~~~~gsL~~~l~~~-------~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~ 793 (929)
.+|+||||+ +++|..+.+.. +.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+|+...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 56777666432 24478999999999998 99999999999999999999999999998653
Q ss_pred cccCCCCCccccceeccccccccccccCCC-CCCCCCCCCCCcCCCCCcchhHHhhhcCCc----------------hhh
Q 002376 794 ERVDNQSSISSTHVFMGSIGYVPPEYGLGE-RPSTAGDVPTSESFAGEFNIVKWVESNLPE----------------NVL 856 (929)
Q Consensus 794 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~s~g~~~~~~~~~~~~~~~~~~----------------~~~ 856 (929)
. ..+..+||+.|||||++.+. .++.++||||+|++++++..+..++..... ...
T Consensus 173 ~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 173 S---------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp S---------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred C---------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 2 12345799999999998765 579999999999887776554433322111 000
Q ss_pred hccChHH----HHhhcccchh-hhhhhHHHHHHHHHHhccccCCCCCCCCCHHHHHHH--HHhhHH
Q 002376 857 QVLDPEL----RQLMTSNESQ-TIQLHDCLITIIGSVGLSCTTESPGGRIGIREALRR--LKSSQE 915 (929)
Q Consensus 857 ~~~~~~l----~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 915 (929)
+...... .......... .......+...+.+++.+|++.||++|||++|+++. ++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000 0000000000 000000112223347889999999999999999873 655543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5e-34 Score=315.23 Aligned_cols=177 Identities=23% Similarity=0.264 Sum_probs=134.5
Q ss_pred CCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCC-CCcce
Q 002376 661 GNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDS-KNMEF 721 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~~~~ 721 (929)
++|+..++||+|+||+||+|++.. ..+++.+|+.++++++|||||++++++...+. +....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999998652 13468899999999999999999999875432 23467
Q ss_pred EEEEEEecCCCCcccccc-----ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIH-----GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLERV 796 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~-----~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 796 (929)
.|+|||||.++.+..+.. ..+.++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc-
Confidence 899999997655544322 2234578999999999998 9999999999999999999999999998865321
Q ss_pred CCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchhHHh
Q 002376 797 DNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 797 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
......+||+.|+|||++.+..++.++||||+||+++++..+..+
T Consensus 173 ------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~p 217 (355)
T d2b1pa1 173 ------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCC
Confidence 223445799999999999999999999999999887776555443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-34 Score=313.91 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=168.6
Q ss_pred CCCCCceeecccCceeEEecccc-----------------------CcHHHHHHHHHHHHccCC-ccccceeeecccCCC
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT-----------------------GSWKSFIAECETLRNVRH-RNLVKLITSCSSLDS 716 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------------~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~ 716 (929)
++|+..+.||+|+||+||+|+.. ...+.+.+|++++++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 56999999999999999998642 123467799999999976 8999999998543
Q ss_pred CCcceEEEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccc
Q 002376 717 KNMEFLALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGL 788 (929)
Q Consensus 717 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGl 788 (929)
...++||||+.+|+|.+++...+ ..+.|++.|++|+|+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ---CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 35899999999999999986433 2367999999999998 999999999999999999999999999
Q ss_pred ccccccccCCCCCccccceeccccccccccccCCCC--CCCCCCCCCCcCCCCCcchhHHhhhcCCc-hhhhccChHHHH
Q 002376 789 ARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGER--PSTAGDVPTSESFAGEFNIVKWVESNLPE-NVLQVLDPELRQ 865 (929)
Q Consensus 789 a~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~s~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 865 (929)
|+.+.... ........|++.|+|||.+.+.. ++.++||||+||++|++.++..++..... .....+ ...
T Consensus 176 a~~~~~~~-----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~ 247 (322)
T d1vzoa_ 176 SKEFVADE-----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRR 247 (322)
T ss_dssp EEECCGGG-----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHH
T ss_pred hhhhcccc-----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHh
Confidence 98764221 11223457999999999997653 68899999999888777666555432221 111111 111
Q ss_pred hhcccchhhhhhhHHHHHHHHHHhccccCCCCCCCCC-----HHHHHH--HHHhh
Q 002376 866 LMTSNESQTIQLHDCLITIIGSVGLSCTTESPGGRIG-----IREALR--RLKSS 913 (929)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~--~L~~~ 913 (929)
............ +..+.+++.+||++||++||| ++|+++ .++++
T Consensus 248 ~~~~~~~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 248 ILKSEPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cccCCCCCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 111111111111 222233777999999999994 788875 34443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-34 Score=305.39 Aligned_cols=172 Identities=26% Similarity=0.371 Sum_probs=142.4
Q ss_pred CCCCCceeecccCceeEEecccc------------------CcHHHHHHHHHHHHccCCccccceeeecccCCCCCcceE
Q 002376 661 GNFSHENLIGSGSFGSVLHNERT------------------GSWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEFL 722 (929)
Q Consensus 661 ~~~~~~~~iG~G~~g~Vy~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~~ 722 (929)
++|+..+.||+|+||+||+|++. ...+++.+|+.++++++|||||+++++|.+.+ ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 57899999999999999999865 12467889999999999999999999996543 48
Q ss_pred EEEEEecCCCCccccccccc--------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 723 ALVYEFLSNGSLGDWIHGER--------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 723 ~lV~e~~~~gsL~~~l~~~~--------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
++|+||+.++++..+++..+ .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.|+....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999999998888765432 3467999999999998 999999999999999999999999999987642
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHH
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKW 846 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~ 846 (929)
.. .......+++.|+|||++.+.. ++.++||||+|++++++..+..
T Consensus 154 ~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~ 200 (292)
T d1unla_ 154 PV------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp CC------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred CC------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCC
Confidence 21 1222346788999999988765 6999999999988877655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-34 Score=314.07 Aligned_cols=176 Identities=23% Similarity=0.311 Sum_probs=139.7
Q ss_pred hCCCCCceeecccCceeEEeccccC------------------cHHHHHHHHHHHHccCCccccceeeecccCCCCCcce
Q 002376 660 TGNFSHENLIGSGSFGSVLHNERTG------------------SWKSFIAECETLRNVRHRNLVKLITSCSSLDSKNMEF 721 (929)
Q Consensus 660 ~~~~~~~~~iG~G~~g~Vy~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~~~~ 721 (929)
.++|+..+.||+|+||+||+|++.. ..+++.+|++++++++|||||++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999997651 2346889999999999999999999986544323334
Q ss_pred EEEEEEecCCCCccccccccc-------cccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEecccccccccc
Q 002376 722 LALVYEFLSNGSLGDWIHGER-------KNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLARFLLE 794 (929)
Q Consensus 722 ~~lV~e~~~~gsL~~~l~~~~-------~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 794 (929)
.++||||+.+|+|.++++..+ .++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence 567778888999999986432 3467999999999998 999999999999999999999999999975422
Q ss_pred ccCCCCCccccceeccccccccccccCCCC-CCCCCCCCCCcCCCCCcchhHHh
Q 002376 795 RVDNQSSISSTHVFMGSIGYVPPEYGLGER-PSTAGDVPTSESFAGEFNIVKWV 847 (929)
Q Consensus 795 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~s~g~~~~~~~~~~~~ 847 (929)
......||+.|+|||+..+.. ++.++||||+|+++|++..+..+
T Consensus 174 ---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 174 ---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp ---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ---------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence 123457999999999877664 68999999999888776555443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2e-29 Score=281.94 Aligned_cols=209 Identities=26% Similarity=0.397 Sum_probs=139.6
Q ss_pred CCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEe
Q 002376 329 HLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGL 408 (929)
Q Consensus 329 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 408 (929)
.........|... .+.....+. ++..+++++|.+++..| +...++|+.|++++|++++. ..+..+++|+.|++
T Consensus 176 ~~~~~~~~~~~~~--~~~~~~~l~-~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l 248 (384)
T d2omza2 176 TLERLDISSNKVS--DISVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDL 248 (384)
T ss_dssp TCCEEECCSSCCC--CCGGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred ccccccccccccc--ccccccccc-ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhcc
Confidence 3333444444432 223334444 56666666666665443 34456677777777777642 35666777777777
Q ss_pred cCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEe
Q 002376 409 AGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDL 488 (929)
Q Consensus 409 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdL 488 (929)
++|++++..+ +..+++|++|++++|++++..+ +.++..++.++++.|.+++ +..+..+++++.|++
T Consensus 249 ~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~----------~~~~~~~~~l~~L~l 314 (384)
T d2omza2 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED----------ISPISNLKNLTYLTL 314 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC----------CGGGGGCTTCSEEEC
T ss_pred ccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccccccccccc----------ccccchhcccCeEEC
Confidence 7777765433 6667777777777777765432 5667777777777777764 234566777888888
Q ss_pred cCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCc
Q 002376 489 SDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (929)
++|++++.. .+..+++|++|++++|+|++ ++ .++.+++|++|||++|++++..| +.++++|+.|+|++|.
T Consensus 315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 315 YFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp CSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred CCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 888887643 37778888888888888875 33 57788888888888888886554 7788888888888773
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=4.5e-29 Score=278.96 Aligned_cols=355 Identities=27% Similarity=0.345 Sum_probs=214.8
Q ss_pred cCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCC
Q 002376 78 LSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITG 157 (929)
Q Consensus 78 l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 157 (929)
++..++++.++ ...|.+|++|++++|.|+. + +.+..|++|++|||++|+|++..| |+++++|++|++++|+|++
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc
Confidence 33344444443 2456677888888887764 3 356777888888888888875433 7778888888888888763
Q ss_pred CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecCCC
Q 002376 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLG 237 (929)
Q Consensus 158 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 237 (929)
+++ +.++++|+.|++++|.+++..+ ......+..+....|.+....+..................+
T Consensus 103 -i~~--l~~l~~L~~L~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~- 168 (384)
T d2omza2 103 -ITP--LANLTNLTGLTLFNNQITDIDP----------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL- 168 (384)
T ss_dssp -CGG--GTTCTTCCEEECCSSCCCCCGG----------GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-
T ss_pred -ccc--cccccccccccccccccccccc----------ccccccccccccccccccccccccccccccccccccccchh-
Confidence 332 6777777777777776644211 22344556666666666544333322222222211111111
Q ss_pred CcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCC
Q 002376 238 GEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEG 317 (929)
Q Consensus 238 ~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~ 317 (929)
..+.............|.... .
T Consensus 169 -----------------------------~~~~~~~~~~~~~~~~~~~~~--~--------------------------- 190 (384)
T d2omza2 169 -----------------------------KPLANLTTLERLDISSNKVSD--I--------------------------- 190 (384)
T ss_dssp -----------------------------GGGTTCTTCCEEECCSSCCCC--C---------------------------
T ss_pred -----------------------------hhhcccccccccccccccccc--c---------------------------
Confidence 112222222333333332221 1
Q ss_pred CccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccc
Q 002376 318 LSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEI 397 (929)
Q Consensus 318 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 397 (929)
..+..+++++.+++++|++++..|. .... +|++|++++|+++.. +.+..+++|+.|++++|.+++..+ +
T Consensus 191 ----~~~~~l~~~~~l~l~~n~i~~~~~~--~~~~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 259 (384)
T d2omza2 191 ----SVLAKLTNLESLIATNNQISDITPL--GILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L 259 (384)
T ss_dssp ----GGGGGCTTCSEEECCSSCCCCCGGG--GGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred ----cccccccccceeeccCCccCCCCcc--cccC-CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--c
Confidence 1233344555555555555543331 2222 566666666666532 345666677777777777765432 6
Q ss_pred cCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhh
Q 002376 398 GQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEI 477 (929)
Q Consensus 398 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~ 477 (929)
..+++|++|++++|++++.. .+..++.++.+++++|.+++. ..+..+++++.|++++|++++. + .+
T Consensus 260 ~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l---------~-~l 325 (384)
T d2omza2 260 SGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI---------S-PV 325 (384)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC---------G-GG
T ss_pred cccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC---------c-cc
Confidence 66777777777777776543 266677777777777777652 3466777788888888887642 2 25
Q ss_pred hcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCC
Q 002376 478 SRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSN 539 (929)
Q Consensus 478 ~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 539 (929)
..+++|++|+|++|++++ +| .++++++|++|++++|+|++.+| +.++++|+.|+|++|
T Consensus 326 ~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 326 SSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 667788888888888874 34 58888888888888888887665 788888999988887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.5e-26 Score=248.11 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=139.0
Q ss_pred CCCCCCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCC
Q 002376 55 SSSPCTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGE 134 (929)
Q Consensus 55 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 134 (929)
..+-|.|.+|.|++. +++ ++|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+...
T Consensus 6 ~~c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp TTCEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCCEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc
Confidence 344578888888753 344 5666653 5677777777777755555677777777777777777766
Q ss_pred cccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCC
Q 002376 135 LPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAG 214 (929)
Q Consensus 135 ~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~ 214 (929)
.|..|.++++|++|++++|+|+ .+|... ...++.|++++|.+.+
T Consensus 71 ~~~~f~~l~~L~~L~l~~n~l~-~l~~~~-----------------------------------~~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 71 SPGAFAPLVKLERLYLSKNQLK-ELPEKM-----------------------------------PKTLQELRVHENEITK 114 (305)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-BCCSSC-----------------------------------CTTCCEEECCSSCCCB
T ss_pred chhhhhCCCccCEecccCCccC-cCccch-----------------------------------hhhhhhhhccccchhh
Confidence 6667777777777777777776 444321 1234445555555554
Q ss_pred ccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCC
Q 002376 215 TVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLG 294 (929)
Q Consensus 215 ~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 294 (929)
..+..+.....+..++...|... .....+..+..+++|+.+++++|.++. +|..
T Consensus 115 l~~~~~~~~~~~~~l~~~~n~~~-----------------------~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~-- 168 (305)
T d1xkua_ 115 VRKSVFNGLNQMIVVELGTNPLK-----------------------SSGIENGAFQGMKKLSYIRIADTNITT-IPQG-- 168 (305)
T ss_dssp BCHHHHTTCTTCCEEECCSSCCC-----------------------GGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS--
T ss_pred hhhhhhhcccccccccccccccc-----------------------ccCCCccccccccccCccccccCCccc-cCcc--
Confidence 44444444555555555544332 111223334445555555555555442 2210
Q ss_pred CCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCC
Q 002376 295 NLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIG 374 (929)
Q Consensus 295 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 374 (929)
..++|+.|++++|.+++..+..+..+. .+++|++++|++++..+.+|.
T Consensus 169 -------------------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~L~~s~n~l~~~~~~~~~ 216 (305)
T d1xkua_ 169 -------------------------------LPPSLTELHLDGNKITKVDAASLKGLN-NLAKLGLSFNSISAVDNGSLA 216 (305)
T ss_dssp -------------------------------CCTTCSEEECTTSCCCEECTGGGTTCT-TCCEEECCSSCCCEECTTTGG
T ss_pred -------------------------------cCCccCEEECCCCcCCCCChhHhhccc-ccccccccccccccccccccc
Confidence 123445555555555544444444443 455555555555555555555
Q ss_pred CCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCC
Q 002376 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPG 415 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 415 (929)
++++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+.
T Consensus 217 ~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 217 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 5555555555555555 334455555555555555555553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=2.4e-29 Score=279.08 Aligned_cols=169 Identities=21% Similarity=0.246 Sum_probs=129.0
Q ss_pred CCCCceeecccCceeEEeccccC---------------cHHHHHHHHHHHHccC-----------CccccceeeecccCC
Q 002376 662 NFSHENLIGSGSFGSVLHNERTG---------------SWKSFIAECETLRNVR-----------HRNLVKLITSCSSLD 715 (929)
Q Consensus 662 ~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~~~~ 715 (929)
+|+..++||+|+||+||+|+... ..+.+.+|++++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~- 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK- 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE-
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec-
Confidence 58999999999999999997652 1356788999988875 57899999887542
Q ss_pred CCCcceEEEEEEecCCCCcccccc-----------ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCC-----
Q 002376 716 SKNMEFLALVYEFLSNGSLGDWIH-----------GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEM----- 779 (929)
Q Consensus 716 ~~~~~~~~lV~e~~~~gsL~~~l~-----------~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----- 779 (929)
.....++||+++..+....... ..+.+..||+.||+|||+.. +|+||||||+|||++.++
T Consensus 93 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 --GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp --ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred --cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 2334677787776654332221 11234679999999999832 899999999999998655
Q ss_pred -ceEEeccccccccccccCCCCCccccceeccccccccccccCCCCCCCCCCCCCCcCCCCCcchh
Q 002376 780 -TAKVGDFGLARFLLERVDNQSSISSTHVFMGSIGYVPPEYGLGERPSTAGDVPTSESFAGEFNIV 844 (929)
Q Consensus 780 -~~ki~DfGla~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~s~g~~~~~~~~~ 844 (929)
.+|++|||.|+.... .....+||+.|+|||++.+..++.++||||+|++++++.++
T Consensus 169 ~~~kl~dfg~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g 225 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 225 (362)
T ss_dssp EEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ceeeEeeccccccccc---------ccccccccccccChhhccccCCCccccccchHHHHHHHHHC
Confidence 399999999975421 12335799999999999999999999999999877665443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3.7e-25 Score=238.77 Aligned_cols=288 Identities=20% Similarity=0.262 Sum_probs=157.5
Q ss_pred CceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccc
Q 002376 226 LVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305 (929)
Q Consensus 226 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 305 (929)
++++|-+++.++ .+|..+. +++++|++++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 344444444454 4444432 344555555555554444566667777777777777776666666666666666666
Q ss_pred cccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccc--cccCCCCCCCCcccEEE
Q 002376 306 FNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIY--GKIPASIGRLRSLTLLD 383 (929)
Q Consensus 306 ~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ 383 (929)
+|+|..++.. ....+..|++++|.+.+..+..+... ..+..++...|... ...+..|..+++|++++
T Consensus 88 ~n~l~~l~~~----------~~~~l~~L~~~~n~l~~l~~~~~~~~-~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~ 156 (305)
T d1xkua_ 88 KNQLKELPEK----------MPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156 (305)
T ss_dssp SSCCSBCCSS----------CCTTCCEEECCSSCCCBBCHHHHTTC-TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCccCcCccc----------hhhhhhhhhccccchhhhhhhhhhcc-ccccccccccccccccCCCccccccccccCccc
Confidence 6666554321 12456677777777764333333332 25666666666432 33344566666666666
Q ss_pred eeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCC
Q 002376 384 LSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463 (929)
Q Consensus 384 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 463 (929)
+++|.++. +|..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..|.++++|++|+|++|+|+
T Consensus 157 l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~- 232 (305)
T d1xkua_ 157 IADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232 (305)
T ss_dssp CCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred cccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-
Confidence 66666652 33322 455666666666666555666666666666666666666555555555555666666555554
Q ss_pred CCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCC-
Q 002376 464 NIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLS- 542 (929)
Q Consensus 464 ~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~- 542 (929)
.+ |.++..+++|++|+|++|+|+...+..|. .+..+..+.+|+.|+|++|.++
T Consensus 233 ~l--------p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~------------------~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 233 KV--------PGGLADHKYIQVVYLHNNNISAIGSNDFC------------------PPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SC--------CTTTTTCSSCCEEECCSSCCCCCCTTSSS------------------CSSCCTTSCCCSEEECCSSSSCG
T ss_pred cc--------ccccccccCCCEEECCCCccCccChhhcc------------------CcchhcccCCCCEEECCCCcCcc
Confidence 12 33444445555555555555432222221 1122334566777777777764
Q ss_pred -CcCCcccccCCCCCeE
Q 002376 543 -GSIPSDLQNLQALRSL 558 (929)
Q Consensus 543 -~~~p~~~~~l~~L~~L 558 (929)
...|..|..+.....+
T Consensus 287 ~~~~~~~f~~~~~~~~~ 303 (305)
T d1xkua_ 287 WEIQPSTFRCVYVRAAV 303 (305)
T ss_dssp GGSCGGGGTTCCCGGGE
T ss_pred CcCCHhHhcccccCccc
Confidence 2344555554444333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9.4e-26 Score=240.79 Aligned_cols=227 Identities=24% Similarity=0.278 Sum_probs=186.0
Q ss_pred EEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEec-C
Q 002376 332 YLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA-G 410 (929)
Q Consensus 332 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~ 410 (929)
.++.++++++ .+|..+. ..+++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..+..++.++.. .
T Consensus 15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4566777776 6676543 468888888888887777788888889999998888888888888888888887764 6
Q ss_pred CcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecC
Q 002376 411 NEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSD 490 (929)
Q Consensus 411 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~ 490 (929)
|.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|+|++ +| +..+..+++|+.|++++
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~-i~-------~~~f~~~~~L~~L~l~~ 162 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LP-------DDTFRDLGNLTHLFLHG 162 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CC-------TTTTTTCTTCCEEECCS
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc-cC-------hhHhccccchhhccccc
Confidence 67777778888888889999999988887777778888888889999888874 32 34566777888899999
Q ss_pred CCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCC
Q 002376 491 NSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVP 570 (929)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (929)
|++++..|..|.++++|+.+++++|++++..|..|..+++|++||+++|++++..|..|.++++|++|++++|++.+..+
T Consensus 163 N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 98888888888888999999999999988888888889999999999999988888888888889999999988887544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.9e-25 Score=237.01 Aligned_cols=218 Identities=22% Similarity=0.235 Sum_probs=159.9
Q ss_pred EcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc-cccc
Q 002376 77 NLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM-ANKI 155 (929)
Q Consensus 77 ~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l 155 (929)
+.++.+++ ++|..+. +.+++|+|++|+|+...+.+|.++++|++||+++|++.+..+..+.++..++.++.+ .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 44555666 6777664 678999999999997777789999999999999999998888888888899888765 4555
Q ss_pred CCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeecC
Q 002376 156 TGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQ 235 (929)
Q Consensus 156 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 235 (929)
+ .+++..|.++++|++|++++|.+.+ +.+..+....+|+.+++++|+|+++.+..|.++++|++|+|++|+
T Consensus 94 ~-~l~~~~~~~l~~L~~L~l~~n~~~~--------~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 94 R-SVDPATFHGLGRLHTLHLDRCGLQE--------LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp C-CCCTTTTTTCTTCCEEECTTSCCCC--------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred c-cccchhhcccccCCEEecCCccccc--------ccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 5 6777778999999999999887643 234456677888888888888888777888888888888888888
Q ss_pred CCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccccc
Q 002376 236 LGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFN 307 (929)
Q Consensus 236 l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 307 (929)
|+ .+|...+..+++|+.+++++|++++..|..|.++++|++|++++|.+.+..+..|+++++|++|++++|
T Consensus 165 l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N 235 (284)
T d1ozna_ 165 IS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (284)
T ss_dssp CC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred cc-ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCC
Confidence 87 455555555666666666666666666666666666666666666666555544444433333333333
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.1e-23 Score=219.89 Aligned_cols=199 Identities=23% Similarity=0.247 Sum_probs=108.5
Q ss_pred ccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccC
Q 002376 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSG 434 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 434 (929)
+.+++.+++.|+. +|..+. ++|++|||++|+|++..+..|.++++|++|+|++|+|+. +| .++.
T Consensus 12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~----------- 75 (266)
T d1p9ag_ 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGT----------- 75 (266)
T ss_dssp CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSC-----------
T ss_pred CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccc-----------
Confidence 4445555555553 343332 345555555555554444445555555555555555542 22 2334
Q ss_pred cccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeeccc
Q 002376 435 NELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAY 514 (929)
Q Consensus 435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (929)
+++|++|+|++|++++. +..+..+++|+.|++++|.+.+..+..+..+.++++|++++
T Consensus 76 -------------l~~L~~L~Ls~N~l~~~---------~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 76 -------------LPVLGTLDLSHNQLQSL---------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp -------------CTTCCEEECCSSCCSSC---------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred -------------ccccccccccccccccc---------ccccccccccccccccccccceeeccccccccccccccccc
Confidence 44555555555554321 22334445555555555555555555555666666666666
Q ss_pred ccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCCcCcccCCCCCCCCCCCcccccCCCCCcC
Q 002376 515 NQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFNNLEGVVPSEGIFRNMSNVHLKGNPKLCL 591 (929)
Q Consensus 515 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~N~~~c~ 591 (929)
|.+++..+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+...+.......++.+++.||||.|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence 66665555566666666666666666666555566666666666666666663322223355666777778888773
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=8.1e-23 Score=215.39 Aligned_cols=193 Identities=24% Similarity=0.253 Sum_probs=98.9
Q ss_pred EEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccc
Q 002376 75 GLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANK 154 (929)
Q Consensus 75 ~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 154 (929)
++|.++++|+ .||+.+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+
T Consensus 14 ~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSC
T ss_pred EEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccc
Confidence 3466666666 4565553 45666666666666554555666666666666666665 233 24455566666666666
Q ss_pred cCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEeeec
Q 002376 155 ITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASN 234 (929)
Q Consensus 155 l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 234 (929)
+++ ++. .+.++++|++|++++| ++....+..+..+.++++|++++|
T Consensus 89 l~~-~~~-~~~~l~~L~~L~l~~~--------------------------------~~~~~~~~~~~~l~~l~~L~l~~n 134 (266)
T d1p9ag_ 89 LQS-LPL-LGQTLPALTVLDVSFN--------------------------------RLTSLPLGALRGLGELQELYLKGN 134 (266)
T ss_dssp CSS-CCC-CTTTCTTCCEEECCSS--------------------------------CCCCCCSSTTTTCTTCCEEECTTS
T ss_pred ccc-ccc-cccccccccccccccc--------------------------------ccceeecccccccccccccccccc
Confidence 552 222 2444555555555544 444444444444444444444444
Q ss_pred CCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceecccccc
Q 002376 235 QLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNK 308 (929)
Q Consensus 235 ~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 308 (929)
.++ .+|...+..+++++.+++++|++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.
T Consensus 135 ~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 135 ELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred ccc-eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 444 333333333444444444444444444455555555666666666655 445444444444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=2.4e-19 Score=196.42 Aligned_cols=179 Identities=23% Similarity=0.295 Sum_probs=119.5
Q ss_pred cEEEEEcCCCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceeccc
Q 002376 72 RVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLM 151 (929)
Q Consensus 72 ~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 151 (929)
+++.|||++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|||+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 3568899999987 57754 468899999999998 778664 57888899999888 33321 1468999999
Q ss_pred ccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCCCCceEEe
Q 002376 152 ANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMTSLVHLRL 231 (929)
Q Consensus 152 ~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 231 (929)
+|.++ .+|. ++++++|+.|++++|.+.... .....+..+++.++... .+..+..++.++.|++
T Consensus 107 ~n~l~-~lp~--~~~l~~L~~L~l~~~~~~~~~------------~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 107 NNQLE-KLPE--LQNSSFLKIIDVDNNSLKKLP------------DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp SSCCS-SCCC--CTTCTTCCEEECCSSCCSCCC------------CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred ccccc-cccc--hhhhccceeeccccccccccc------------cccccccchhhcccccc--ccccccccccceeccc
Confidence 99997 5664 678899999999988764321 12345667777666554 3456777888888888
Q ss_pred eecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCc
Q 002376 232 ASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLE 286 (929)
Q Consensus 232 s~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 286 (929)
++|.+. .++.. ......+....+.+. .++ .+..++.|+.+++++|...
T Consensus 170 ~~n~~~-~~~~~----~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 170 DNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp CSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred cccccc-ccccc----ccccccccccccccc-ccc-ccccccccccccccccccc
Confidence 888876 22221 122233444433332 222 3455666666666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=3.2e-19 Score=195.38 Aligned_cols=96 Identities=32% Similarity=0.364 Sum_probs=62.0
Q ss_pred CCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEE
Q 002376 95 SFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLN 174 (929)
Q Consensus 95 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 174 (929)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .++|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~--l--p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD--L--PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS--C--CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh--h--cccccccc
Confidence 36788999999887 57754 467888888888888 667654 46778888888876 3432 1 13466666
Q ss_pred ccccccCCCCCccccccCCCccCCCCcccEEEeecccCC
Q 002376 175 FGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLA 213 (929)
Q Consensus 175 Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~ 213 (929)
+++|.+.. + | .++.+++|+.|++++|.+.
T Consensus 105 L~~n~l~~-l--------p-~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 105 VSNNQLEK-L--------P-ELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CCSSCCSS-C--------C-CCTTCTTCCEEECCSSCCS
T ss_pred cccccccc-c--------c-chhhhccceeecccccccc
Confidence 66665532 1 1 1344556666666665554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.1e-19 Score=183.21 Aligned_cols=213 Identities=15% Similarity=0.118 Sum_probs=166.6
Q ss_pred CCCCccccCCCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCc-ccccccccccceecccc-cccCC
Q 002376 80 SFGLEGTISPHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGEL-PVNISKLTELKMLDLMA-NKITG 157 (929)
Q Consensus 80 ~~~l~g~i~~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~ 157 (929)
+.+++ .+|+.+. +++++|||++|+|+...+.+|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+.
T Consensus 17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~- 92 (242)
T d1xwdc1 17 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL- 92 (242)
T ss_dssp SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC-
T ss_pred CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc-
Confidence 34555 6777664 58999999999999666678999999999999999998755 45788999999999865 6776
Q ss_pred CCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCccCCccccCC-CCceEEeeecCC
Q 002376 158 RVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTVPSTIYNMT-SLVHLRLASNQL 236 (929)
Q Consensus 158 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l 236 (929)
.+++..|.++++|++|++++|.+....+ ...+..+..+..+..+++++..+.+..|.+++ .++.|++++|++
T Consensus 93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~-------~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 93 YINPEAFQNLPNLQYLLISNTGIKHLPD-------VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp EECTTSEECCTTCCEEEEESCCCCSCCC-------CTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred ccccccccccccccccccchhhhccccc-------ccccccccccccccccccccccccccccccccccceeeecccccc
Confidence 5677779999999999999998753211 12345677888888888899888888888775 789999999999
Q ss_pred CCcCCcccccCCCCccee-eccCCcCCCCCCCcccccccccEEeccCccCcCCccCCCCCCCccceeccc
Q 002376 237 GGEIPYDVRDTLPNLLDF-IYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIG 305 (929)
Q Consensus 237 ~~~ip~~~~~~l~~L~~l-~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 305 (929)
+ .++..++. .+++.++ ++.+|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 166 ~-~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 166 Q-EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp C-EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred c-cccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 8 67777766 4555544 567777876666678888999999999999886656678888888777663
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=2.2e-18 Score=178.28 Aligned_cols=87 Identities=20% Similarity=0.252 Sum_probs=55.9
Q ss_pred CcccEEEeecccCCCccCCccccCCCCceEEeeecCCCCcCCcccccCCCCcceeecc-CCcCCCCCCCcccccccccEE
Q 002376 200 ENLKVLDLTINRLAGTVPSTIYNMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYC-FNRFTGKIPGSLHNLTNIQII 278 (929)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~-~N~l~~~~p~~~~~l~~L~~L 278 (929)
+++++|||++|+|+.+.+.+|.++++|++|+|++|.+...++...+..+++++++.+. .|++....+..|.++++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 3567777777777766666677777777777777777655665555556666665543 345555555556666666666
Q ss_pred eccCccCc
Q 002376 279 RMTHNLLE 286 (929)
Q Consensus 279 ~Ls~N~l~ 286 (929)
++++|.+.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred ccchhhhc
Confidence 66666655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.3e-19 Score=183.92 Aligned_cols=149 Identities=23% Similarity=0.345 Sum_probs=60.9
Q ss_pred cccccccEEeccCccCcCCccCCCCCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCccccccCchhh
Q 002376 270 HNLTNIQIIRMTHNLLEGTLPPGLGNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKIPESIG 349 (929)
Q Consensus 270 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 349 (929)
..+++|+.|++++|.+++..| +..+++|+++++++|.++.+ ..+.++++|++++++++...+..+ +.
T Consensus 60 ~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i---------~~l~~l~~L~~l~l~~~~~~~~~~--~~ 126 (227)
T d1h6ua2 60 QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV---------SAIAGLQSIKTLDLTSTQITDVTP--LA 126 (227)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC---------GGGTTCTTCCEEECTTSCCCCCGG--GT
T ss_pred hcCCCCcEeecCCceeecccc--cccccccccccccccccccc---------ccccccccccccccccccccccch--hc
Confidence 334444444444444443222 34444444444444443322 233445555555555555442211 11
Q ss_pred hccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCce
Q 002376 350 NFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQ 429 (929)
Q Consensus 350 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 429 (929)
... .+..+.++.+.+.... .+.++++|++|++++|.+++.. .++++++|++|+|++|++++. + .+.++++|++
T Consensus 127 ~~~-~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~ 199 (227)
T d1h6ua2 127 GLS-NLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIE 199 (227)
T ss_dssp TCT-TCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCE
T ss_pred ccc-chhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCE
Confidence 122 3444444444443221 2334444444444444443221 134444444444444444431 1 1344444444
Q ss_pred ecccCcccc
Q 002376 430 IDLSGNELT 438 (929)
Q Consensus 430 L~Ls~N~l~ 438 (929)
|+|++|+++
T Consensus 200 L~Ls~N~lt 208 (227)
T d1h6ua2 200 VHLKNNQIS 208 (227)
T ss_dssp EECTTSCCC
T ss_pred EECcCCcCC
Confidence 444444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.8e-18 Score=177.06 Aligned_cols=201 Identities=22% Similarity=0.312 Sum_probs=134.6
Q ss_pred EccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcC
Q 002376 334 ALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413 (929)
Q Consensus 334 ~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 413 (929)
+++.+++++.++ +..+. +|+.|++++|.|+.. ..+..+++|++|++++|++++..| +..+++|+++++++|.+
T Consensus 25 ~l~~~~~~d~~~--~~~l~-~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 25 AAGKSNVTDTVT--QADLD-GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HTTCSSTTSEEC--HHHHH-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HhCCCCcCCcCC--HHHcC-CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 444455554332 23343 577777777777643 346777777777777777765433 67777777777777777
Q ss_pred CCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCC
Q 002376 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493 (929)
Q Consensus 414 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l 493 (929)
+. ++ .+.++++|+.+++++|...+.. .+...+.++.+.++++.+.. ...+...++|+.|++++|.+
T Consensus 98 ~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~----------~~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 98 KN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITN----------ISPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp SC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCC----------CGGGGGCTTCCEEECCSSCC
T ss_pred cc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhch----------hhhhcccccccccccccccc
Confidence 63 32 4667777777777777766432 24556677777777777653 22355667788888888877
Q ss_pred CCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCC
Q 002376 494 SGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLT 561 (929)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 561 (929)
++.. .++++++|++|+|++|++++. + .++.+++|++|+|++|++++. | .+.++++|+.|+++
T Consensus 164 ~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 164 SDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred ccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 6432 377788888888888888753 3 377788888888888888754 3 37788888888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.4e-21 Score=220.63 Aligned_cols=109 Identities=23% Similarity=0.216 Sum_probs=48.5
Q ss_pred cccEEEecCCcccc-----ccCCCCCCCCcccEEEeeCCCCCccc----CccccCCCCCCEEEecCCcCCCCCcccc---
Q 002376 354 ELSKLYLGGNHIYG-----KIPASIGRLRSLTLLDLSYNSISGEI----PIEIGQLQGLQVLGLAGNEIPGGIPNSL--- 421 (929)
Q Consensus 354 ~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~--- 421 (929)
.++.+++++|++.. ..+..+.....++.+++++|.+.... ...+...+.++.+++++|.++......+
T Consensus 227 ~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~ 306 (460)
T d1z7xw1 227 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 306 (460)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred cccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcc
Confidence 45555555554421 12223334455666666666654321 1223345555666666665542111111
Q ss_pred --cCCCCCceecccCcccccccCcc----cccccccceecccCCcCC
Q 002376 422 --ANLKKLNQIDLSGNELTGEIPIS----FGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 422 --~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 462 (929)
.....|+.+++++|.++...... +...++|+.|+|++|+|+
T Consensus 307 l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~ 353 (460)
T d1z7xw1 307 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 353 (460)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred ccccccccccccccccchhhhhhhhcccccccccchhhhheeeeccc
Confidence 12234555555555554322111 222334555555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.3e-21 Score=220.71 Aligned_cols=394 Identities=18% Similarity=0.148 Sum_probs=217.4
Q ss_pred cccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCcc----CC
Q 002376 143 TELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV----PS 218 (929)
Q Consensus 143 ~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~----p~ 218 (929)
.+|++||+++|++++.--...+..+++|++|+|++|.++..- + ..++..+..+++|+.|||++|+|+... ..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~---~-~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~ 77 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR---C-KDISSALRVNPALAELNLRSNELGDVGVHCVLQ 77 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHH---H-HHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHH---H-HHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH
Confidence 468888888888874221334566777888888887654210 0 112334556677777777777765321 12
Q ss_pred ccc-cCCCCceEEeeecCCCCcCCcccccCCCCcceeeccCCcCCCCCCCcccccccccEEeccCccCcCCccCCC----
Q 002376 219 TIY-NMTSLVHLRLASNQLGGEIPYDVRDTLPNLLDFIYCFNRFTGKIPGSLHNLTNIQIIRMTHNLLEGTLPPGL---- 293 (929)
Q Consensus 219 ~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---- 293 (929)
.+. ...+|++|+|++|+++..--. .++..+..+++|++|++++|.++......+
T Consensus 78 ~l~~~~~~L~~L~L~~n~it~~~~~---------------------~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l 136 (460)
T d1z7xw1 78 GLQTPSCKIQKLSLQNCCLTGAGCG---------------------VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 136 (460)
T ss_dssp TTCSTTCCCCEEECTTSCCBGGGHH---------------------HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred HHhcCCCCCCEEECCCCCccccccc---------------------cccchhhccccccccccccccchhhhhhhhhhcc
Confidence 222 224566666666666521100 123344555666666666666653211110
Q ss_pred -CCCCccceeccccccccCCCCCCCCccccccCCCCCCCEEEccCCcccccc----CchhhhccccccEEEecCCccccc
Q 002376 294 -GNLPFLRTYNIGFNKIVSSGDDEGLSFITSLTNSTHLNYLALDGNQFEGKI----PESIGNFSNELSKLYLGGNHIYGK 368 (929)
Q Consensus 294 -~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~~~~~L~~L~Ls~N~l~~~ 368 (929)
...............+.... .......+.....++.++++++.+.... ...+.........+++..+.+...
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~ 213 (460)
T d1z7xw1 137 LDPQCRLEKLQLEYCSLSAAS---CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD 213 (460)
T ss_dssp TSTTCCCCEEECTTSCCBGGG---HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT
T ss_pred cccccccccccccccccchhh---hcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 00111111111111111000 0001122344567788888887765221 111222222456777777765421
Q ss_pred ----cCCCCCCCCcccEEEeeCCCCCcc-----cCccccCCCCCCEEEecCCcCCCC----CcccccCCCCCceecccCc
Q 002376 369 ----IPASIGRLRSLTLLDLSYNSISGE-----IPIEIGQLQGLQVLGLAGNEIPGG----IPNSLANLKKLNQIDLSGN 435 (929)
Q Consensus 369 ----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N 435 (929)
....+...+.++.+++++|.+... .+........++.+++++|.+... ....+...+.++.+++++|
T Consensus 214 ~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n 293 (460)
T d1z7xw1 214 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 293 (460)
T ss_dssp HHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred hhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccc
Confidence 112234567788899988876432 233344567788899998887643 2234556778888888888
Q ss_pred ccccccCccc-----ccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCC----CCcchh-cCc
Q 002376 436 ELTGEIPISF-----GNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN----LPNSLK-NCK 505 (929)
Q Consensus 436 ~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~----~p~~~~-~l~ 505 (929)
.++......+ .....|+.+++++|.++..- ...+...+....+|++|||++|++++. ++..+. ..+
T Consensus 294 ~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~----~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~ 369 (460)
T d1z7xw1 294 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC----CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 369 (460)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG----HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred cccccccchhhccccccccccccccccccchhhhh----hhhcccccccccchhhhheeeecccCcccchhhhhhhcccC
Confidence 8864322221 22356888888888876321 111122334556788888888887642 223332 356
Q ss_pred Ccceeeccccccccc----CCccccCCCCCCEEECCCCcCCCcCCccc----c-cCCCCCeEeCCCCcCccc
Q 002376 506 SLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNKLSGSIPSDL----Q-NLQALRSLNLTFNNLEGV 568 (929)
Q Consensus 506 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~ 568 (929)
.|++|+|++|+|+.. ++..+..+++|++|||++|+|+......+ . +...|+.|++.+|.+...
T Consensus 370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 688888888888642 44556667888888888888875322222 1 334688888888877643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=9.7e-19 Score=173.98 Aligned_cols=175 Identities=21% Similarity=0.266 Sum_probs=117.4
Q ss_pred EEEecCCcCCCCCcccccCCCCCceecccCcccccc-cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCc
Q 002376 405 VLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGE-IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENV 483 (929)
Q Consensus 405 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L 483 (929)
+++.++|+++ .+|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++++.. +..+..+++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~--------~~~~~~~~~L 80 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE--------PNAFEGASHI 80 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC--------TTTTTTCTTC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccc--------cccccccccc
Confidence 4444444444 2333222 3556666666666542 3445566666666666666665432 4455556677
Q ss_pred cEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCCCCeEeCCCC
Q 002376 484 VTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 484 ~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (929)
++|+|++|++++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+....+.. .-...++.+.+..|
T Consensus 81 ~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~ 159 (192)
T d1w8aa_ 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGG 159 (192)
T ss_dssp CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGG
T ss_pred ceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCC
Confidence 77777777777777778888888888888888888888888888899999999999887543221 11233566778888
Q ss_pred cCcccCCCCCCCCCCCcccccCCCCCcCCC
Q 002376 564 NLEGVVPSEGIFRNMSNVHLKGNPKLCLQL 593 (929)
Q Consensus 564 ~l~~~~p~~~~~~~l~~l~l~~N~~~c~~~ 593 (929)
.+++..|.. ++.++..+++.|...|..+
T Consensus 160 ~~~c~~p~~--l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 160 AARCGAPSK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp GCBBCSSTT--TTTSBGGGSCTTTCCCCCC
T ss_pred CeEeCCChh--hcCCEeeecCHhhCcCCCC
Confidence 888777743 6677778888888888554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.9e-18 Score=171.39 Aligned_cols=163 Identities=28% Similarity=0.358 Sum_probs=81.4
Q ss_pred CcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecc
Q 002376 377 RSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDL 456 (929)
Q Consensus 377 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 456 (929)
.+|++|++++|.++... .+..+++|++|++++|+|++.. .++++++|++|++++|++++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 33444444444443221 1344444444444444444322 13444455555555555543 22 2444555555555
Q ss_pred cCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEEC
Q 002376 457 SNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDL 536 (929)
Q Consensus 457 s~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 536 (929)
++|.+.. ...+..++.++.+++++|.+++ +..+..+++|+.+++++|++++..+ ++++++|+.|+|
T Consensus 120 ~~~~~~~----------~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~L 185 (210)
T d1h6ta2 120 EHNGISD----------INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (210)
T ss_dssp TTSCCCC----------CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccccc----------cccccccccccccccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEEC
Confidence 5554431 1234445555555555555543 2234555666666666666654322 556666666666
Q ss_pred CCCcCCCcCCcccccCCCCCeEeCC
Q 002376 537 SSNKLSGSIPSDLQNLQALRSLNLT 561 (929)
Q Consensus 537 s~N~l~~~~p~~~~~l~~L~~L~Ls 561 (929)
++|+++. +| .+.++++|++|+|+
T Consensus 186 s~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 186 SKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred CCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 6666653 33 46666666666664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.6e-18 Score=172.38 Aligned_cols=129 Identities=26% Similarity=0.366 Sum_probs=95.7
Q ss_pred CEEEccCCccccccCchhhhccccccEEEecCCccccc-cCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEec
Q 002376 331 NYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGK-IPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLA 409 (929)
Q Consensus 331 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 409 (929)
+.++.++|+++ .+|..+. .++++|+|++|+|++. .+..|.++++|++|+|++|++.+..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 46777777777 6676543 3677888888888653 35566777888888888888877777777777777778887
Q ss_pred CCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCC
Q 002376 410 GNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRING 463 (929)
Q Consensus 410 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 463 (929)
+|+|++..|.+|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 777777777777777777777777777777777777777777777777777653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=168.45 Aligned_cols=180 Identities=27% Similarity=0.374 Sum_probs=141.9
Q ss_pred EccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcC
Q 002376 334 ALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413 (929)
Q Consensus 334 ~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 413 (929)
.+..+.+++.++.. .+. +|+.|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|++++|+|
T Consensus 30 ~l~~~~~~~~~~~~--~L~-~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQN--ELN-SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECHH--HHH-TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCHH--Hhc-CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 45556666555532 333 6888888888887542 3778889999999999998643 367889999999999998
Q ss_pred CCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCC
Q 002376 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493 (929)
Q Consensus 414 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l 493 (929)
++ +| .+.++++|+.|++++|.+.. + ..+..+++++.+++++|.+++ +..+..+++|+.+++++|++
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~----------~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD----------ITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC----------CGGGGGCTTCSEEECCSSCC
T ss_pred cc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc----------cccccccccccccccccccc
Confidence 85 44 58888999999999998863 2 357888899999999999874 34567788999999999999
Q ss_pred CCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCC
Q 002376 494 SGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSS 538 (929)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 538 (929)
++. + .+.++++|+.|+|++|+|+. +| .+..+++|++|+|++
T Consensus 169 ~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 169 SDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 864 3 38899999999999999985 45 589999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.4e-17 Score=163.61 Aligned_cols=162 Identities=31% Similarity=0.416 Sum_probs=99.3
Q ss_pred CCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCccccccccccee
Q 002376 375 RLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSI 454 (929)
Q Consensus 375 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 454 (929)
.++++++|++++|.++.. ..+..+++|++|++++|++++..| ++++++|++|++++|.+... + .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence 345555555555555532 234556666666666666654332 56666666666666666532 2 25566666666
Q ss_pred cccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEE
Q 002376 455 DLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534 (929)
Q Consensus 455 ~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (929)
++++|.+.. ...+..+++|+.|++++|++.. +| .+..+++|++|++++|++++.. .++++++|++|
T Consensus 112 ~l~~~~~~~----------~~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L 177 (199)
T d2omxa2 112 TLFNNQITD----------IDPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERL 177 (199)
T ss_dssp ECCSSCCCC----------CGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred ccccccccc----------ccccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEE
Confidence 666666543 1234556667777777777653 22 4667777777777777777543 36777888888
Q ss_pred ECCCCcCCCcCCcccccCCCCCeE
Q 002376 535 DLSSNKLSGSIPSDLQNLQALRSL 558 (929)
Q Consensus 535 ~Ls~N~l~~~~p~~~~~l~~L~~L 558 (929)
++++|++++ ++ .+.++++|++|
T Consensus 178 ~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 178 DISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp ECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ECCCCCCCC-Cc-cccCCCCCCcC
Confidence 888888774 33 46777777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.3e-17 Score=162.22 Aligned_cols=176 Identities=25% Similarity=0.359 Sum_probs=127.0
Q ss_pred EccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcC
Q 002376 334 ALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEI 413 (929)
Q Consensus 334 ~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 413 (929)
.++.+.+++.++. ..+. ++++|++++|.|+.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.+
T Consensus 24 ~l~~~~~~~~~~~--~~l~-~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 24 VLGKTNVTDTVSQ--TDLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HTTCSSTTSEECH--HHHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCccCH--HHhc-CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 4555555544432 2333 677777777777643 346777888888888888876443 77888888888888887
Q ss_pred CCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCC
Q 002376 414 PGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSL 493 (929)
Q Consensus 414 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l 493 (929)
... + .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++.. .+.+..+++|+.|++++|++
T Consensus 97 ~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~----------~~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 97 ADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD----------ISALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC----------CGGGTTCTTCSEEECCSSCC
T ss_pred ccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc----------cccccccccccccccccccc
Confidence 643 3 377888888888888887643 346778888888888888753 23467778888888888888
Q ss_pred CCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEE
Q 002376 494 SGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVL 534 (929)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (929)
++. + .++++++|++|++++|++++ ++ .++.+++|+.|
T Consensus 163 ~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 163 TDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 864 2 47888899999999998885 33 47788888876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=1.2e-17 Score=165.86 Aligned_cols=116 Identities=19% Similarity=0.149 Sum_probs=91.7
Q ss_pred CCceeecccCceeEEeccccCc---------------------------------HHHHHHHHHHHHccCCccccceeee
Q 002376 664 SHENLIGSGSFGSVLHNERTGS---------------------------------WKSFIAECETLRNVRHRNLVKLITS 710 (929)
Q Consensus 664 ~~~~~iG~G~~g~Vy~~~~~~~---------------------------------~~~~~~E~~~l~~l~Hpniv~l~~~ 710 (929)
...++||+|+||+||+|+.... ...+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3568999999999999875410 1234468889999999999988876
Q ss_pred cccCCCCCcceEEEEEEecCCCCcccccc-ccccccccHHHHHHHhhhCCCCCEEecCCCCCCeeecCCCceEEeccccc
Q 002376 711 CSSLDSKNMEFLALVYEFLSNGSLGDWIH-GERKNELDITSALDYLHNDCEVPVVHSDLKPGNILLDEEMTAKVGDFGLA 789 (929)
Q Consensus 711 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~-~~~~~~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DfGla 789 (929)
.. .++||||++++.+.+.-. ....++.|++.|++|||+. +|+||||||+|||++++ .++++|||.|
T Consensus 83 ~~---------~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 83 EG---------NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp ET---------TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred cC---------CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCc
Confidence 41 379999998876655432 2234578999999999998 99999999999999976 4899999999
Q ss_pred ccc
Q 002376 790 RFL 792 (929)
Q Consensus 790 ~~~ 792 (929)
+..
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=1.8e-14 Score=131.04 Aligned_cols=101 Identities=30% Similarity=0.389 Sum_probs=49.8
Q ss_pred EEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCCCCcEEEccccccCCCCCccccccCCCccCCCCcc
Q 002376 123 VLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENL 202 (929)
Q Consensus 123 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L 202 (929)
+|||++|+|+ .++ .+.++++|++||+++|+|+ .+|+. |..+++|++|++++|++++ +| .+..+++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~---------l~-~~~~l~~L 67 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN---------VD-GVANLPRL 67 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC---------CG-GGTTCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc---------cC-cccccccc
Confidence 4445555554 222 2444555555555555554 34433 4445555555555554422 01 23445555
Q ss_pred cEEEeecccCCCcc-CCccccCCCCceEEeeecCCC
Q 002376 203 KVLDLTINRLAGTV-PSTIYNMTSLVHLRLASNQLG 237 (929)
Q Consensus 203 ~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 237 (929)
++|++++|+|+... ...+..+++|++|++++|.++
T Consensus 68 ~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55555555555432 234556666666666666664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=4.3e-15 Score=142.29 Aligned_cols=131 Identities=22% Similarity=0.257 Sum_probs=89.5
Q ss_pred CCCCCCCCCCEEEeecCCCCCCCCcCCCCCCCCcEEeCCCCCCCCCcccccccccccceecccccccCCCCChhhhccCC
Q 002376 89 PHIGNLSFLRSIQLQNNKLSGNLPREIGNLFRLRVLNISFNNLQGELPVNISKLTELKMLDLMANKITGRVTDDQLRNLR 168 (929)
Q Consensus 89 ~~l~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~ 168 (929)
+.+.+...|++|||++|+|+ .+|..+..+++|++||||+|+|+. ++ .|..+++|++|+|++|+|+ .+++..+..++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~ 87 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALP 87 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhccccccc-CCCcccccccc
Confidence 34567777888888888887 446666778888888888888873 43 4778888888888888887 56666567788
Q ss_pred CCcEEEccccccCCCCCccccccCCCccCCCCcccEEEeecccCCCcc---CCccccCCCCceEE
Q 002376 169 SLQVLNFGKNLLWGSIPPSIANLIPSDLSRLENLKVLDLTINRLAGTV---PSTIYNMTSLVHLR 230 (929)
Q Consensus 169 ~L~~L~Ls~N~l~~~~p~~i~~l~p~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 230 (929)
+|+.|++++|++.. +..+ ..+..+++|++|++++|.++... +..+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~-----~~~l--~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVE-----LGDL--DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCC-----GGGG--GGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccceeccccccc-----cccc--cccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 88888888887642 1111 23556677777777777765322 12355566666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=8.8e-16 Score=167.38 Aligned_cols=190 Identities=22% Similarity=0.220 Sum_probs=87.8
Q ss_pred CCCCcccEEEeeCCCCCcc----cCccccCCCCCCEEEecCCcCCCCCcc-------------cccCCCCCceecccCcc
Q 002376 374 GRLRSLTLLDLSYNSISGE----IPIEIGQLQGLQVLGLAGNEIPGGIPN-------------SLANLKKLNQIDLSGNE 436 (929)
Q Consensus 374 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~Ls~N~ 436 (929)
...++|+.|+|++|.+... +...+...++|+.|++++|.+...-.. .....+.|+.+++++|+
T Consensus 90 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~ 169 (344)
T d2ca6a1 90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 169 (344)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccc
Confidence 3345555555555555432 222233445555555555554311000 01233455555666555
Q ss_pred cccc----cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCC----CCcchhcCcCcc
Q 002376 437 LTGE----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN----LPNSLKNCKSLE 508 (929)
Q Consensus 437 l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~ 508 (929)
++.. +...+...+.|+.|+|++|.|+.. +....+...+...++|+.|||++|.++.. +...+..+++|+
T Consensus 170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~---g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~ 246 (344)
T d2ca6a1 170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246 (344)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred ccccccccccchhhhhhhhccccccccccccc---ccccchhhhhcchhhhcccccccccccccccccccccccccccch
Confidence 5421 122233445566666666655411 00000112233445566666666655321 223345556666
Q ss_pred eeecccccccccCC----ccccC--CCCCCEEECCCCcCCCc----CCcccc-cCCCCCeEeCCCCcCc
Q 002376 509 ELLMAYNQFSGPIP----NIVAE--LKGLEVLDLSSNKLSGS----IPSDLQ-NLQALRSLNLTFNNLE 566 (929)
Q Consensus 509 ~L~Ls~N~l~~~~p----~~~~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 566 (929)
+|+|++|.|++.-. ..+.. .+.|++||+++|+++.. +...+. +++.|+.|+|++|++.
T Consensus 247 ~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 66666666654311 12222 24566666666666532 122221 3556666666666664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.9e-14 Score=135.44 Aligned_cols=128 Identities=21% Similarity=0.139 Sum_probs=88.0
Q ss_pred ccCCCCCCCEEEccCCccccccCchhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCC
Q 002376 323 SLTNSTHLNYLALDGNQFEGKIPESIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQG 402 (929)
Q Consensus 323 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 402 (929)
.+.+..++++|+|++|+|+ .+|..+..+. +|+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~-~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLD-QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTT-CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccc-cCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccc
Confidence 3556677788888888887 4555444454 688888888888744 34777888888888888887655555667788
Q ss_pred CCEEEecCCcCCCCCc-ccccCCCCCceecccCcccccccCc----ccccccccceec
Q 002376 403 LQVLGLAGNEIPGGIP-NSLANLKKLNQIDLSGNELTGEIPI----SFGNFQSLLSID 455 (929)
Q Consensus 403 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 455 (929)
|+.|++++|+|+.... ..+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 8888888888764322 356677777777777777763 232 355566666666
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.2e-13 Score=125.55 Aligned_cols=18 Identities=28% Similarity=0.403 Sum_probs=7.8
Q ss_pred ccCCCCCCEEECCCCcCC
Q 002376 525 VAELKGLEVLDLSSNKLS 542 (929)
Q Consensus 525 ~~~l~~L~~L~Ls~N~l~ 542 (929)
++.+++|++|++++|+++
T Consensus 86 l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 86 LVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp GGGCTTCCEEECTTSGGG
T ss_pred hcCCCCCCEEECCCCcCC
Confidence 344444444444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.1e-14 Score=150.15 Aligned_cols=201 Identities=18% Similarity=0.196 Sum_probs=98.6
Q ss_pred ccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcc-cCccccCCCCCCEEEecCCcCCCCCcccccCCCCCceeccc
Q 002376 355 LSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGE-IPIEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLS 433 (929)
Q Consensus 355 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 433 (929)
+..+.++...+..... ......+|++|||+++.+++. ++..+..+++|++|+|+++.+++..+..++.+++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 3444444444332222 222334566666666655432 23334555666666666666655555555666666666666
Q ss_pred Cc-ccccc-cCcccccccccceecccCC-cCCCCCCCCcccCCchhhhc-ccCccEEEecCC--CCCCC-CCcchhcCcC
Q 002376 434 GN-ELTGE-IPISFGNFQSLLSIDLSNN-RINGNIPKGILRPLPEEISR-LENVVTIDLSDN--SLSGN-LPNSLKNCKS 506 (929)
Q Consensus 434 ~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~i~~~~~~~~p~~~~~-l~~L~~LdLs~N--~l~~~-~p~~~~~l~~ 506 (929)
++ .++.. +...+.++++|++|+++++ .++.. .++..+.. .++|+.|++++. .++.. +...+.++++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~-------~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~ 176 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred ccccccccccchhhHHHHhccccccccccccccc-------cchhhhcccccccchhhhccccccccccccccccccccc
Confidence 53 34321 1111234556666666653 23210 00111222 245666666543 22211 1222344566
Q ss_pred cceeecccc-cccccCCccccCCCCCCEEECCCC-cCCCcCCcccccCCCCCeEeCCCC
Q 002376 507 LEELLMAYN-QFSGPIPNIVAELKGLEVLDLSSN-KLSGSIPSDLQNLQALRSLNLTFN 563 (929)
Q Consensus 507 L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 563 (929)
|++|++++| .+++.....+..+++|++|+|+++ .+++.....+.++++|+.|+++++
T Consensus 177 L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 666666654 355555555566666666666663 455444445556666666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.5e-15 Score=157.61 Aligned_cols=61 Identities=28% Similarity=0.251 Sum_probs=30.1
Q ss_pred CCCcccEEEeeCC-CCCcccCccccCCCCCCEEEecC-CcCCCCCcccccCCCCCceecccCc
Q 002376 375 RLRSLTLLDLSYN-SISGEIPIEIGQLQGLQVLGLAG-NEIPGGIPNSLANLKKLNQIDLSGN 435 (929)
Q Consensus 375 ~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N 435 (929)
++++|++|+|++| .+++.....+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3445555555543 24444444455555555555555 2344433444455555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=6.4e-15 Score=160.45 Aligned_cols=261 Identities=18% Similarity=0.227 Sum_probs=124.2
Q ss_pred CcccccccccEEeccCccCcCC----ccCCCCCCCccceeccccccccCCCCCC---CCccccccCCCCCCCEEEccCCc
Q 002376 267 GSLHNLTNIQIIRMTHNLLEGT----LPPGLGNLPFLRTYNIGFNKIVSSGDDE---GLSFITSLTNSTHLNYLALDGNQ 339 (929)
Q Consensus 267 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~~~~~---~~~~~~~~~~l~~L~~L~Ls~N~ 339 (929)
..+.+..+|+.|+|++|.|... +...+...++|+.++++++.+....... ...+...+...++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3455566777777777776432 2334555566666666555432211100 00111234445566666666666
Q ss_pred cccccCc----hhhhccccccEEEecCCccccccCCCCCCCCcccEEEeeCCCCCcccCccccCCCCCCEEEecCCcCCC
Q 002376 340 FEGKIPE----SIGNFSNELSKLYLGGNHIYGKIPASIGRLRSLTLLDLSYNSISGEIPIEIGQLQGLQVLGLAGNEIPG 415 (929)
Q Consensus 340 l~~~~p~----~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 415 (929)
++..-.. .+...+ +|+.|++++|.+.......++. .|..+ .........+.|+.+++++|+++.
T Consensus 105 i~~~~~~~l~~~l~~~~-~L~~L~l~~n~l~~~~~~~l~~--~l~~~---------~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHT-PLEHLYLHNNGLGPQAGAKIAR--ALQEL---------AVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp CCTTTHHHHHHHHHHCT-TCCEEECCSSCCHHHHHHHHHH--HHHHH---------HHHHHHHTCCCCCEEECCSSCCTG
T ss_pred cccccccchhhhhcccc-cchheecccccccccccccccc--ccccc---------ccccccccCcccceeecccccccc
Confidence 5532111 111222 4555555555442110000000 00000 000001223445555555555432
Q ss_pred C----CcccccCCCCCceecccCcccccc-----cCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEE
Q 002376 416 G----IPNSLANLKKLNQIDLSGNELTGE-----IPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTI 486 (929)
Q Consensus 416 ~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~L 486 (929)
. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++..- ...+...+...++|++|
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g----~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG----SSALAIALKSWPNLREL 248 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH----HHHHHHHGGGCTTCCEE
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc----cccccccccccccchhh
Confidence 1 122234445566666666665421 2233455566666666666654210 01112344556667777
Q ss_pred EecCCCCCCCCCcc----hhc--CcCcceeeccccccccc----CCcccc-CCCCCCEEECCCCcCCC
Q 002376 487 DLSDNSLSGNLPNS----LKN--CKSLEELLMAYNQFSGP----IPNIVA-ELKGLEVLDLSSNKLSG 543 (929)
Q Consensus 487 dLs~N~l~~~~p~~----~~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~ 543 (929)
+|++|.+++.-... +.. ...|++|++++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 77777665432222 222 35688888888887642 233332 56789999999998864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.34 E-value=2.3e-14 Score=142.04 Aligned_cols=65 Identities=25% Similarity=0.294 Sum_probs=30.9
Q ss_pred ccccCCCCCCEEEecCCcCCCCCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCC
Q 002376 395 IEIGQLQGLQVLGLAGNEIPGGIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRIN 462 (929)
Q Consensus 395 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 462 (929)
..+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|+++ .+|..+..+++|+.|++++|+|+
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc
Confidence 344555555555555555543 22 2445555555555555554 23333333344555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=6.3e-13 Score=126.02 Aligned_cols=108 Identities=24% Similarity=0.230 Sum_probs=89.9
Q ss_pred CCCcceeeCCCCCcEEEEEcCCCCCccccCCCCCCCCCCCEEEeecC-CCCCCCCcCCCCCCCCcEEeCCCCCCCCCccc
Q 002376 59 CTWPGVICNNFGNRVIGLNLSSFGLEGTISPHIGNLSFLRSIQLQNN-KLSGNLPREIGNLFRLRVLNISFNNLQGELPV 137 (929)
Q Consensus 59 c~w~gv~c~~~~~~v~~l~l~~~~l~g~i~~~l~~L~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 137 (929)
+.+++++|... ++. .+|..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+.+.|.
T Consensus 8 ~~~~~l~c~~~------------~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 74 (156)
T d2ifga3 8 HGSSGLRCTRD------------GAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (156)
T ss_dssp SSSSCEECCSS------------CCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred CCCCeEEecCC------------CCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc
Confidence 34666777543 333 56778889999999999876 58877778899999999999999999988888
Q ss_pred ccccccccceecccccccCCCCChhhhccCCCCcEEEccccccC
Q 002376 138 NISKLTELKMLDLMANKITGRVTDDQLRNLRSLQVLNFGKNLLW 181 (929)
Q Consensus 138 ~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 181 (929)
.|..+++|++|||++|+|+ .+|.+.|..+ +|+.|+|++|.+.
T Consensus 75 ~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred cccccccccceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence 9999999999999999998 7888877665 6999999999773
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=6.2e-14 Score=138.95 Aligned_cols=131 Identities=24% Similarity=0.322 Sum_probs=104.3
Q ss_pred CCcccccCCCCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCC
Q 002376 416 GIPNSLANLKKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSG 495 (929)
Q Consensus 416 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~ 495 (929)
.++..+..+++|++|+|++|+|+. ++ .|.++++|+.|+|++|+|+ .+ |.....+++|+.|++++|+++.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i--------~~~~~~~~~L~~L~l~~N~i~~ 107 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KI--------ENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SC--------SSHHHHHHHCCEEECSEEECCC
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cc--------cccccccccccccccccccccc
Confidence 456788999999999999999984 44 5888999999999999986 33 4444556689999999999985
Q ss_pred CCCcchhcCcCcceeecccccccccCC-ccccCCCCCCEEECCCCcCCCcCCcc----------cccCCCCCeEe
Q 002376 496 NLPNSLKNCKSLEELLMAYNQFSGPIP-NIVAELKGLEVLDLSSNKLSGSIPSD----------LQNLQALRSLN 559 (929)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 559 (929)
+ +.+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 108 -l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 108 -L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp -H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred -c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 3 358889999999999999985432 56888999999999999887554432 56688888887
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=8e-12 Score=118.24 Aligned_cols=89 Identities=21% Similarity=0.191 Sum_probs=40.7
Q ss_pred hhhcccCccEEEecCC-CCCCCCCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCcccccCCC
Q 002376 476 EISRLENVVTIDLSDN-SLSGNLPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPSDLQNLQA 554 (929)
Q Consensus 476 ~~~~l~~L~~LdLs~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 554 (929)
.+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|||++|+|+...+..|.. ..
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~ 104 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LS 104 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-CC
T ss_pred cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-cc
Confidence 3344445555555433 244433444555555555555555555444445555555555555555554322222222 23
Q ss_pred CCeEeCCCCcC
Q 002376 555 LRSLNLTFNNL 565 (929)
Q Consensus 555 L~~L~Ls~N~l 565 (929)
|+.|+|++|+|
T Consensus 105 l~~L~L~~Np~ 115 (156)
T d2ifga3 105 LQELVLSGNPL 115 (156)
T ss_dssp CCEEECCSSCC
T ss_pred ccccccCCCcc
Confidence 44444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=1.6e-08 Score=95.70 Aligned_cols=82 Identities=20% Similarity=0.206 Sum_probs=46.7
Q ss_pred hcccCccEEEecCCCCCCC--CCcchhcCcCcceeecccccccccCCccccCCCCCCEEECCCCcCCCcCCc-------c
Q 002376 478 SRLENVVTIDLSDNSLSGN--LPNSLKNCKSLEELLMAYNQFSGPIPNIVAELKGLEVLDLSSNKLSGSIPS-------D 548 (929)
Q Consensus 478 ~~l~~L~~LdLs~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~ 548 (929)
..+++|++||||+|+++.. ++..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|.+++.... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 3455555555666555543 234455666677777777776654433333444667777777777654432 2
Q ss_pred cccCCCCCeEe
Q 002376 549 LQNLQALRSLN 559 (929)
Q Consensus 549 ~~~l~~L~~L~ 559 (929)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 44567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=1.2e-08 Score=96.56 Aligned_cols=104 Identities=24% Similarity=0.260 Sum_probs=62.9
Q ss_pred CCCceecccCcccccccCcccccccccceecccCCcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCCCCcchhcC
Q 002376 425 KKLNQIDLSGNELTGEIPISFGNFQSLLSIDLSNNRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGNLPNSLKNC 504 (929)
Q Consensus 425 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l 504 (929)
..+..++..+|... .++..+.++++|++|+|++|+|+. + ..++..+..+++|+.|||++|+++...+-.+...
T Consensus 42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~-l-----~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~ 114 (162)
T d1koha1 42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR-L-----DDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114 (162)
T ss_dssp TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC-C-----SGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTT
T ss_pred cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC-C-----chhHHHHhhCCcccccccccCccccchhhhhhhc
Confidence 33444444444333 334444556777777777777753 1 1124455667777777777777775433334444
Q ss_pred cCcceeecccccccccCC-------ccccCCCCCCEEE
Q 002376 505 KSLEELLMAYNQFSGPIP-------NIVAELKGLEVLD 535 (929)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~p-------~~~~~l~~L~~L~ 535 (929)
..|+.|++++|.++.... ..+..+++|+.||
T Consensus 115 ~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 567888888888876544 2366788888886
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=1.3e-05 Score=75.42 Aligned_cols=64 Identities=11% Similarity=0.148 Sum_probs=35.6
Q ss_pred hhcCcCcceeeccccccccc----CCccccCCCCCCEEECCCCcCCCc-------CCcccccCCCCCeEeCCCCc
Q 002376 501 LKNCKSLEELLMAYNQFSGP----IPNIVAELKGLEVLDLSSNKLSGS-------IPSDLQNLQALRSLNLTFNN 564 (929)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 564 (929)
+...+.|++|+|++|.|+.. +-..+...++|+.|+|++|++... +...+..-+.|+.|+++.+.
T Consensus 68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 34445566666666665432 223455566777777777765422 22334445667777776543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=1.5e-05 Score=75.02 Aligned_cols=16 Identities=25% Similarity=0.304 Sum_probs=7.8
Q ss_pred CCCCCceecccCcccc
Q 002376 423 NLKKLNQIDLSGNELT 438 (929)
Q Consensus 423 ~l~~L~~L~Ls~N~l~ 438 (929)
..+.|+.|+|++|.++
T Consensus 70 ~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLT 85 (167)
T ss_dssp HCSSCCEEECCSSBCC
T ss_pred hcccccceeeehhhcc
Confidence 3344555555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.18 E-value=0.00019 Score=72.51 Aligned_cols=133 Identities=14% Similarity=0.082 Sum_probs=77.4
Q ss_pred HHHHHhhCCCCCceeecccCceeEEecccc--------------CcHHHHHHHHHHHHccC-CccccceeeecccCCCCC
Q 002376 654 DELRRATGNFSHENLIGSGSFGSVLHNERT--------------GSWKSFIAECETLRNVR-HRNLVKLITSCSSLDSKN 718 (929)
Q Consensus 654 ~~l~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------------~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~ 718 (929)
.|+++..+.|+..+..+-++...||+.... .....+.+|...++.+. +--+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----
Confidence 355555566654444333334567764322 12235778998888774 3224556665532
Q ss_pred cceEEEEEEecCCCCcccccccc---ccccccHHHHHHHhh---------------------------------------
Q 002376 719 MEFLALVYEFLSNGSLGDWIHGE---RKNELDITSALDYLH--------------------------------------- 756 (929)
Q Consensus 719 ~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~ia~aL~yLH--------------------------------------- 756 (929)
.+..++|||++++..+.+..... .....++++.++.||
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred CCceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 23479999999987764432110 011122222333333
Q ss_pred --------------hCC---CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 757 --------------NDC---EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 757 --------------~~~---~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
... .+.++|+|+.|.||++++++.+-|.||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 211 12478999999999999877777999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.75 E-value=0.00065 Score=68.05 Aligned_cols=101 Identities=13% Similarity=0.063 Sum_probs=62.7
Q ss_pred cHHHHHHHHHHHHccCCc--cccceeeecccCCCCCcceEEEEEEecCCCCccccccccccc------------------
Q 002376 685 SWKSFIAECETLRNVRHR--NLVKLITSCSSLDSKNMEFLALVYEFLSNGSLGDWIHGERKN------------------ 744 (929)
Q Consensus 685 ~~~~~~~E~~~l~~l~Hp--niv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------ 744 (929)
....+.+|+..++.+... .+.++++++.+. +..++||||+++.++.+.-......
T Consensus 47 ~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~ 121 (255)
T d1nd4a_ 47 ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPAT 121 (255)
T ss_dssp TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGG
T ss_pred CHhHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhh
Confidence 344577888888877432 245566665432 2479999999886664421100000
Q ss_pred ---------------------------------cccHHHHHHHhhhCC----CCCEEecCCCCCCeeecCCCceEEeccc
Q 002376 745 ---------------------------------ELDITSALDYLHNDC----EVPVVHSDLKPGNILLDEEMTAKVGDFG 787 (929)
Q Consensus 745 ---------------------------------~~~ia~aL~yLH~~~----~~~iiHrDlk~~NILl~~~~~~ki~DfG 787 (929)
.......+..+.... .+.++|+|+.|.||+++++..+-|.||+
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~ 201 (255)
T d1nd4a_ 122 CPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCG 201 (255)
T ss_dssp CCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCT
T ss_pred CCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEch
Confidence 011233344444322 2347999999999999987777899999
Q ss_pred ccc
Q 002376 788 LAR 790 (929)
Q Consensus 788 la~ 790 (929)
.+.
T Consensus 202 ~~~ 204 (255)
T d1nd4a_ 202 RLG 204 (255)
T ss_dssp TCE
T ss_pred hcc
Confidence 875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.50 E-value=0.00021 Score=66.71 Aligned_cols=14 Identities=7% Similarity=0.048 Sum_probs=6.5
Q ss_pred ccccceecccCCcC
Q 002376 448 FQSLLSIDLSNNRI 461 (929)
Q Consensus 448 l~~L~~L~Ls~N~l 461 (929)
.++|+.|+|++|.+
T Consensus 45 n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 45 NTYVKKFSIVGTRS 58 (166)
T ss_dssp CCSCCEEECTTSCC
T ss_pred CCccCeeeccCCcc
Confidence 34444444444444
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.43 E-value=0.00021 Score=66.76 Aligned_cols=116 Identities=21% Similarity=0.231 Sum_probs=71.0
Q ss_pred ccccccceecccC-CcCCCCCCCCcccCCchhhhcccCccEEEecCCCCCCC----CCcchhcCcCcceeeccccccccc
Q 002376 446 GNFQSLLSIDLSN-NRINGNIPKGILRPLPEEISRLENVVTIDLSDNSLSGN----LPNSLKNCKSLEELLMAYNQFSGP 520 (929)
Q Consensus 446 ~~l~~L~~L~Ls~-N~l~g~i~~~~~~~~p~~~~~l~~L~~LdLs~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (929)
.+.++|+.|+|++ |.++. ..+..+-..+...+.|+.|+|++|.++.. +-..+...++++.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~----~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPV----PTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp TTCTTCCEEECTTCTTCCH----HHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred hcCCCCcEEEcCCCCCCCH----HHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 3456677777776 34531 11112233445667889999999987643 223455677888888888887533
Q ss_pred ----CCccccCCCCCCEEEC--CCCcCCC----cCCcccccCCCCCeEeCCCCcC
Q 002376 521 ----IPNIVAELKGLEVLDL--SSNKLSG----SIPSDLQNLQALRSLNLTFNNL 565 (929)
Q Consensus 521 ----~p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 565 (929)
+-..+...++|+.++| ++|.+.. .+...+...+.|+.|+++.|..
T Consensus 90 g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 90 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2345666778876555 4566643 2334455667788888766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.62 E-value=0.021 Score=60.55 Aligned_cols=31 Identities=32% Similarity=0.414 Sum_probs=26.6
Q ss_pred CCEEecCCCCCCeeecCCCceEEecccccccc
Q 002376 761 VPVVHSDLKPGNILLDEEMTAKVGDFGLARFL 792 (929)
Q Consensus 761 ~~iiHrDlk~~NILl~~~~~~ki~DfGla~~~ 792 (929)
..++|+|+.|.|||++++. ++|.||..|..-
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 3689999999999999764 899999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.31 E-value=0.14 Score=54.03 Aligned_cols=40 Identities=18% Similarity=0.172 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHccC-CccccceeeecccCCCCCcceEEEEEEecCCCCcc
Q 002376 687 KSFIAECETLRNVR-HRNLVKLITSCSSLDSKNMEFLALVYEFLSNGSLG 735 (929)
Q Consensus 687 ~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~~~~~~lV~e~~~~gsL~ 735 (929)
....+|..+++.+. +.-..++++++.. .+||||+++..+.
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~---------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG---------GRLEEYIPSRPLS 129 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT---------EEEECCCCEEECC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC---------ceEEEEeccccCC
Confidence 34567888888885 4334467777621 6899999875543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.54 E-value=0.33 Score=49.39 Aligned_cols=30 Identities=33% Similarity=0.369 Sum_probs=24.5
Q ss_pred CCCEEecCCCCCCeeecCCCceEEeccccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLARF 791 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~~ 791 (929)
..++||+|+.+.|||++++ ..+.||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45889998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=80.36 E-value=0.22 Score=50.50 Aligned_cols=31 Identities=26% Similarity=0.320 Sum_probs=27.9
Q ss_pred CCCEEecCCCCCCeeecCCCceEEecccccc
Q 002376 760 EVPVVHSDLKPGNILLDEEMTAKVGDFGLAR 790 (929)
Q Consensus 760 ~~~iiHrDlk~~NILl~~~~~~ki~DfGla~ 790 (929)
+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4589999999999999998877899999875
|